Citrus Sinensis ID: 002336
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 935 | 2.2.26 [Sep-21-2011] | |||||||
| C0LGI2 | 929 | Probable LRR receptor-lik | yes | no | 0.985 | 0.991 | 0.719 | 0.0 | |
| Q8LKZ1 | 924 | Nodulation receptor kinas | N/A | no | 0.913 | 0.924 | 0.360 | 1e-133 | |
| Q8L4H4 | 925 | Nodulation receptor kinas | N/A | no | 0.924 | 0.934 | 0.346 | 1e-128 | |
| C0LGG4 | 890 | Probable LRR receptor-lik | no | no | 0.893 | 0.938 | 0.333 | 1e-128 | |
| Q9ZQQ7 | 886 | Putative leucine-rich rep | no | no | 0.880 | 0.928 | 0.348 | 1e-128 | |
| Q9ZQR3 | 868 | Leucine-rich repeat recep | no | no | 0.867 | 0.934 | 0.344 | 1e-127 | |
| Q9FZB8 | 871 | Probable LRR receptor-lik | no | no | 0.863 | 0.926 | 0.333 | 1e-124 | |
| O65924 | 881 | Putative leucine-rich rep | no | no | 0.874 | 0.928 | 0.326 | 1e-123 | |
| C0LGD6 | 852 | Probable LRR receptor-lik | no | no | 0.863 | 0.947 | 0.345 | 1e-122 | |
| Q9FZB1 | 872 | Probable LRR receptor-lik | no | no | 0.869 | 0.932 | 0.331 | 1e-122 |
| >sp|C0LGI2|Y1677_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g67720 OS=Arabidopsis thaliana GN=At1g67720 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 1359 bits (3517), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 672/934 (71%), Positives = 777/934 (83%), Gaps = 13/934 (1%)
Query: 5 SHFLVIYLLFLSSVVSQVTEFISIDCGSTSNYTDPSTGLAWISDIGIMNNGKSVKVENPS 64
+ V L + V+SQVTEF+SIDCG +SNYTDP TGL W+SD I+ GK V + N +
Sbjct: 6 AQLAVTCLFLVPFVLSQVTEFVSIDCGCSSNYTDPRTGLGWVSDSEIIKQGKPVTLANTN 65
Query: 65 GNWMQYRTRRDLPIDNKKYCYNLITKERRRYLVRATFQYGSLGSEASYPKFQLYLDATLW 124
N MQYR RRD P DNKKYCY L TKERRRY+VR TF YG LGSE +YPKFQLYLDAT W
Sbjct: 66 WNSMQYRRRRDFPTDNKKYCYRLSTKERRRYIVRTTFLYGGLGSEEAYPKFQLYLDATKW 125
Query: 125 STVTVLDASRVYAKEMIIRAPSDSIDVCICCAVTGSPFISTLELRPLNLSMYATDFEDNF 184
+TVT+ + SRVY +E+I+RA S +DVC+CCA+TGSPF+STLELRPLNLSMYATD+EDNF
Sbjct: 126 ATVTIQEVSRVYVEELIVRATSSYVDVCVCCAITGSPFMSTLELRPLNLSMYATDYEDNF 185
Query: 185 FLKVAARVNFGALTKDALRYPDDPYDRIWDSDLDRRPNFVVGAASGTVRINTTKNIETRT 244
FLKVAARVNFGA DALRYPDDPYDRIW+SD+++RPN++VG A GT RINT+K I T T
Sbjct: 186 FLKVAARVNFGAPNMDALRYPDDPYDRIWESDINKRPNYLVGVAPGTTRINTSKTINTLT 245
Query: 245 REYPPVKVMQTAVVGTEGVLSYRLNLEDFPANARAFAYFAEIQDLGPSETRKFKLEQPYF 304
REYPP+KVMQTAVVGT+G++SYRLNLEDFPANARA+AYFAEI++LG +ETRKFKL QPYF
Sbjct: 246 REYPPMKVMQTAVVGTQGLISYRLNLEDFPANARAYAYFAEIEELGANETRKFKLVQPYF 305
Query: 305 ADYSNAVVNIAENANGSYTLYEPSYMNVTLNFVLSFSFVKTRDSTLGPLLNAIEISKYQK 364
DYSNAVVNIAENANGSYTLYEPSYMNVTL+FVL+FSF KT+DST GPLLNAIEISKY
Sbjct: 306 PDYSNAVVNIAENANGSYTLYEPSYMNVTLDFVLTFSFGKTKDSTQGPLLNAIEISKYLP 365
Query: 365 IAAKTEWQDVMVLEALRSISDESERTNDRGDPCVPVPWEWVTCSTTTPPRITKIALSGKN 424
I+ KT+ DV VL+A+RS+S +S+ ++ GDPC+PV W WV CS+T+PPR+TKIALS KN
Sbjct: 366 ISVKTDRSDVSVLDAIRSMSPDSDWASEGGDPCIPVLWSWVNCSSTSPPRVTKIALSRKN 425
Query: 425 LKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLP 484
L+GEIPP + MEALTELWLD N LTG LPDMS+L++L+I+HLENN+L+GSLP Y+ LP
Sbjct: 426 LRGEIPPGINYMEALTELWLDDNELTGTLPDMSKLVNLKIMHLENNQLSGSLPPYLAHLP 485
Query: 485 NLQELHIENNSFVGEIPPALLTGKVIFKYDNNPKLHKESRRRMRFKLILGTSIGVLAILL 544
NLQEL IENNSF G+IP ALL GKV+FKY+NNP+L E++R+ F ILG SI +AILL
Sbjct: 486 NLQELSIENNSFKGKIPSALLKGKVLFKYNNNPELQNEAQRK-HFWQILGISIAAVAILL 544
Query: 545 VLFLCSLIVLRKLRRKISNQKSYEKVCPLADSLRTSTKPSNTAYSIARGGHFMDEGVAYF 604
+L SL++L LR+ K DS T K AYS RGGH +DEGVAYF
Sbjct: 545 LLVGGSLVLLCALRKTKRADK--------GDSTETKKK-GLVAYSAVRGGHLLDEGVAYF 595
Query: 605 IPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLS 664
I LP LEEAT+NF KK+G+GSFGSVYYG+MKDGKEVAVKI AD SH +QFVTEVALLS
Sbjct: 596 ISLPVLEEATDNFSKKVGRGSFGSVYYGRMKDGKEVAVKITADPSSHLNRQFVTEVALLS 655
Query: 665 RIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKG 724
RIHHRNLVPLIGYCEE +RILVYEYMHNG+L D LHGS + KPLDWLTRLQIA DAAKG
Sbjct: 656 RIHHRNLVPLIGYCEEADRRILVYEYMHNGSLGDHLHGSSDYKPLDWLTRLQIAQDAAKG 715
Query: 725 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLD 784
LEYLHTGCNP IIHRDVKSSNILLDINMRAKVSDFGLSRQ EEDLTH+SSVA+GTVGYLD
Sbjct: 716 LEYLHTGCNPSIIHRDVKSSNILLDINMRAKVSDFGLSRQTEEDLTHVSSVAKGTVGYLD 775
Query: 785 PEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 844
PEYY +QQLTEKSDVYSFGVVL EL+SGKKPVS EDFG ELNIVHWARS+I+KGDV I+
Sbjct: 776 PEYYASQQLTEKSDVYSFGVVLFELLSGKKPVSAEDFGPELNIVHWARSLIRKGDVCGII 835
Query: 845 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKGGDQKF---SS 901
DP + NVKIES+WR+AEVA QCVEQRG +RP+MQE+++AIQD+I+IE+G + SS
Sbjct: 836 DPCIASNVKIESVWRVAEVANQCVEQRGHNRPRMQEVIVAIQDAIRIERGNENGLKSSSS 895
Query: 902 SSSKGQSSRKTLLTSFLEIESPDLSNECLAPAAR 935
SSSK QSSRKTLLTSFLE+ESPD+S LAPAAR
Sbjct: 896 SSSKAQSSRKTLLTSFLELESPDISRNSLAPAAR 929
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q8LKZ1|NORK_PEA Nodulation receptor kinase OS=Pisum sativum GN=NORK PE=1 SV=1 | Back alignment and function description |
|---|
Score = 475 bits (1223), Expect = e-133, Method: Compositional matrix adjust.
Identities = 333/923 (36%), Positives = 494/923 (53%), Gaps = 69/923 (7%)
Query: 13 LFLSSVVSQVTEFISIDCGSTSNYTDPSTGLAWISDIGIMNNGKSVKVENPSGNWMQYRT 72
+F+ S S F SI C + SNYTDP T L + +D ++ + + + P + +R+
Sbjct: 22 IFIRSASSATEGFESIACCADSNYTDPKTNLNYTTDYRWYSDKSNCR-QIPE-ILLSHRS 79
Query: 73 R---RDLPIDNKKYCYNLITKERRRYLVRATFQYGSLGSEASYPKFQLYLDATLWSTVTV 129
R ID K CYNL T + + YL+R TF + S+ + F + + AT VT
Sbjct: 80 NINFRLFDIDEGKRCYNLPTIKDQVYLIRGTFPFDSVNT-----SFYVSIGATELGEVT- 133
Query: 130 LDASRVYAKEM--IIRAPSDSIDVCICCAVTGSPFISTLELRPLNLSMYATDFEDNFFLK 187
+SR+ E+ + RAP D+ID C+ +PFIS LELRPL Y DF N LK
Sbjct: 134 --SSRLEDLEIEGVFRAPKDNIDFCLLKEDV-NPFISQLELRPLP-EEYLHDFSTNV-LK 188
Query: 188 VAARVNFGALTKDALRYPDDPYDRIWDSDLDRRPNFVVGAASGTVRINTTKNIETRTREY 247
+ +R N + +D +R+P D DRIW + P++ + + N + N+E +
Sbjct: 189 LISRNNLCGI-EDDIRFPVDQNDRIWKAT--STPSYAL-----PLSFNVS-NVELNGKVT 239
Query: 248 PPVKVMQTAVVGTEGVLSYRLNLEDFPANARAFAYFAEIQDLGPSETRKFKLEQPYFADY 307
PP++V+QTA+ E + + LE YF E+ D K Q F Y
Sbjct: 240 PPLQVLQTALTHPERLEFVHVGLETDDYEYSVLLYFLELND-------TLKAGQRVFDIY 292
Query: 308 SNAVV-----NIAENANG-SYTLYEPSYMNVTLNFVLSFSFVKTRDSTLGPLLNAIEISK 361
N+ + ++ E + SYT+ +N++ N L+ + VK S GPLLNA EI +
Sbjct: 293 LNSEIKKEGFDVLEGGSKYSYTV-----LNISANGSLNITLVKASGSKFGPLLNAYEILQ 347
Query: 362 YQKIAAKTEWQDVMVLEALRSISDESERTND-----RGDPCVPVPWEWVTCSTTTPPR-I 415
+ +T+ D+ V++ +R + N+ GDPC+ PW+ V C + I
Sbjct: 348 ARPWIDETDQTDLEVIQKMRKELLLQNQDNEALESWSGDPCMLFPWKGVACDGSNGSSVI 407
Query: 416 TKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGS 475
TK+ LS NLKG IP + M L L L N G +P L V L N+LTG
Sbjct: 408 TKLDLSSSNLKGTIPSSVTEMTKLQILNLSHNHFDGYIPSFPPSSLLISVDLSYNDLTGQ 467
Query: 476 LPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNNPKLHKESRRRMRF-KLILG 534
LP + SLP+L L+ N + + A L +I N + + ++ +F ++ +
Sbjct: 468 LPESIISLPHLNSLYFGCNQHMRDDDEAKLNSSLI-----NTDYGRCNAKKPKFGQVFMI 522
Query: 535 TSIGVLAILLVLFLCSLIVLRKLRRKISNQKSYEKVCPLADSLRTSTKPSNTAYSIARGG 594
+I +IL+ L + L R + I+ + K P+A +N +S+
Sbjct: 523 GAITSGSILITLAVVILFFCRYRHKSITLEGFGGKTYPMA---------TNIIFSLPSKD 573
Query: 595 HFMDEGVAYF-IPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRT 653
F + V+ L +E AT + IG+G FGSVY G + DG+EVAVK+ + + + T
Sbjct: 574 DFFIKSVSVKPFTLEYIELATEKYKTLIGEGGFGSVYRGTLDDGQEVAVKVRSATSTQGT 633
Query: 654 QQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGS-VNQKPLDWL 712
++F E+ LLS I H NLVPL+GYC E Q+ILVY +M NG+L DRL+G +K LDW
Sbjct: 634 REFDNELNLLSAIQHENLVPLLGYCNEYDQQILVYPFMSNGSLLDRLYGEPAKRKILDWP 693
Query: 713 TRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA-EEDLTH 771
TRL IA AA+GL YLHT +IHRDVKSSNILLD +M AKV+DFG S+ A +E ++
Sbjct: 694 TRLSIALGAARGLAYLHTFPGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSY 753
Query: 772 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWA 831
+S RGT GYLDPEYY QQL+EKSDV+SFGVVLLE++SG++P++++ E ++V WA
Sbjct: 754 VSLEVRGTAGYLDPEYYKTQQLSEKSDVFSFGVVLLEIVSGREPLNIKRPRVEWSLVEWA 813
Query: 832 RSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 891
+ I+ V IVDP + G E++WR+ EVA+QC+E RP M +IV ++D++ I
Sbjct: 814 KPYIRASKVDEIVDPGIKGGYHAEALWRVVEVALQCLEPYSTYRPCMVDIVRELEDALII 873
Query: 892 EKGGDQKFSSSSSKGQSSRKTLL 914
E + S S G S+R +++
Sbjct: 874 ENNASEYMKSIDSLGGSNRYSIV 896
|
Involved in the perception of symbiotic fungi and bacteria and required for the calcium spiking. Part of the perception/transduction system leading to nodulation or mycorrhizal infection. Pisum sativum (taxid: 3888) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8L4H4|NORK_MEDTR Nodulation receptor kinase OS=Medicago truncatula GN=NORK PE=1 SV=2 | Back alignment and function description |
|---|
Score = 461 bits (1185), Expect = e-128, Method: Compositional matrix adjust.
Identities = 321/926 (34%), Positives = 481/926 (51%), Gaps = 62/926 (6%)
Query: 7 FLVIYLLFLSSVVSQVTEFISIDCGSTSNYTDPSTGLAWISDIGIMNNGKSVK-VENPSG 65
F++ +F+ S S F SI C + SNYTDP T L + +D ++ +S + +
Sbjct: 16 FVLCLCIFIRSASSATKGFESIACCADSNYTDPKTTLTYTTDHIWFSDKRSCRQIPEILF 75
Query: 66 NWMQYRTRRDLPIDNKKYCYNLITKERRRYLVRATFQYGSLGSEASYPKFQLYLDATLWS 125
+ + R I K CYNL T + + YL+R F + SL S F + + T
Sbjct: 76 SHRSNKNVRKFEIYEGKRCYNLPTVKDQVYLIRGIFPFDSLNS-----SFYVSIGVT--- 127
Query: 126 TVTVLDASRVYAKEM--IIRAPSDSIDVCICCAVTGSPFISTLELRPLNLSMYATDFEDN 183
+ L +SR+ E+ + RA D ID C+ +PFIS +ELRPL Y F +
Sbjct: 128 ELGELRSSRLEDLEIEGVFRATKDYIDFCLLKEDV-NPFISQIELRPLP-EEYLHGFGTS 185
Query: 184 FFLKVAARVNFGALTKDALRYPDDPYDRIWDSDLDRRPNFVVGAASGTVRINTTKNIETR 243
LK+ +R N G T D +R+PDD DRIW +R ++ + N + N++ +
Sbjct: 186 V-LKLISRNNLGD-TNDDIRFPDDQNDRIW-----KRKETSTPTSALPLSFNVS-NVDLK 237
Query: 244 TREYPPVKVMQTAVVGTEGVLSYRLNLEDFPANARAFAYFAEIQDLGPSETRKFKLEQPY 303
PP++V+QTA+ E + LE F +F E+ + R F +
Sbjct: 238 DSVTPPLQVLQTALTHPERLEFVHDGLETDDYEYSVFLHFLELNGTVRAGQRVFDI---- 293
Query: 304 FADYSNAVVN------IAENANGSYTLYEPSYMNVTLNFVLSFSFVKTRDSTLGPLLNAI 357
Y N + +A + SYT +N++ N L+ + VK S GPLLNA
Sbjct: 294 ---YLNNEIKKEKFDVLAGGSKNSYTA-----LNISANGSLNITLVKASGSEFGPLLNAY 345
Query: 358 EISKYQKIAAKTEWQDVMVLEALRSISDESERTND-----RGDPCVPVPWEWVTCSTTTP 412
EI + + +T +D+ V++ +R + N+ GDPC+ PW+ +TC +T
Sbjct: 346 EILQARSWIEETNQKDLEVIQKMREELLLHNQENEALESWSGDPCMIFPWKGITCDDSTG 405
Query: 413 PRI-TKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNE 471
I TK+ LS NLKG IP + M L L L N P L + L N+
Sbjct: 406 SSIITKLDLSSNNLKGAIPSIVTKMTNLQILNLSHNQFDMLFPSFPPSSLLISLDLSYND 465
Query: 472 LTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNNPKLHKESRRRMRFKL 531
L+G LP + SLP+L+ L+ N + + L +I N + ++ +F
Sbjct: 466 LSGWLPESIISLPHLKSLYFGCNPSMSDEDTTKLNSSLI-----NTDYGRCKAKKPKFGQ 520
Query: 532 ILGTSIGVLAILLVLFLCSLIVLRKLRRKISNQKSYEKVCPLADSLRTSTKPSNTAYSIA 591
+ LL+ ++ + R K + + K P+A +N +S+
Sbjct: 521 VFVIGAITSGSLLITLAVGILFFCRYRHKSITLEGFGKTYPMA---------TNIIFSLP 571
Query: 592 RGGHFMDEGVAYF-IPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCS 650
F + V+ L +E+AT + IG+G FGSVY G + DG+EVAVK+ + + +
Sbjct: 572 SKDDFFIKSVSVKPFTLEYIEQATEQYKTLIGEGGFGSVYRGTLDDGQEVAVKVRSSTST 631
Query: 651 HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQ-KPL 709
T++F E+ LLS I H NLVPL+GYC E Q+ILVY +M NG+L DRL+G ++ K L
Sbjct: 632 QGTREFDNELNLLSAIQHENLVPLLGYCNEYDQQILVYPFMSNGSLLDRLYGEASKRKIL 691
Query: 710 DWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA-EED 768
DW TRL IA AA+GL YLHT +IHRDVKSSNILLD +M AKV+DFG S+ A +E
Sbjct: 692 DWPTRLSIALGAARGLAYLHTFPGRSVIHRDVKSSNILLDQSMCAKVADFGFSKYAPQEG 751
Query: 769 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIV 828
+++S RGT GYLDPEYY QQL+EKSDV+SFGVVLLE++SG++P++++ E ++V
Sbjct: 752 DSYVSLEVRGTAGYLDPEYYKTQQLSEKSDVFSFGVVLLEIVSGREPLNIKRPRIEWSLV 811
Query: 829 HWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 888
WA+ I+ V IVDP + G E++WR+ EVA+QC+E RP M +IV ++D+
Sbjct: 812 EWAKPYIRASKVDEIVDPGIKGGYHAEALWRVVEVALQCLEPYSTYRPCMVDIVRELEDA 871
Query: 889 IKIEKGGDQKFSSSSSKGQSSRKTLL 914
+ IE + S S G S+R +++
Sbjct: 872 LIIENNASEYMKSIDSLGGSNRYSIV 897
|
Involved in the perception of symbiotic fungi and bacteria. Part of the perception/transduction system leading to nodulation or mycorrhizal infection. Medicago truncatula (taxid: 3880) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGG4|Y1518_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g51860 OS=Arabidopsis thaliana GN=At1g51860 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 459 bits (1181), Expect = e-128, Method: Compositional matrix adjust.
Identities = 311/933 (33%), Positives = 494/933 (52%), Gaps = 98/933 (10%)
Query: 4 YSHFLVIYLLFLSSVVSQ-VTEFISIDCG---STSNYTDPSTGLAWISDIGIMNNGKSVK 59
+ H L+I L SV +Q FIS+DCG + YT+ ST + + SD+ +++G K
Sbjct: 7 FLHLLIIAFTVLRSVEAQNQAGFISLDCGLVPKETTYTEKSTNITYKSDVDYIDSGLVGK 66
Query: 60 VENPSGNWMQYRTR--RDLPIDNKKYCYNLITKERRRYLVRATFQYGSLGSEASYPKFQL 117
+ + Q + R P+ ++ CYN+ +YL+R TF YG+ +P F L
Sbjct: 67 INDAYKTQFQQQVWAVRSFPV-GQRNCYNVNLTANNKYLIRGTFVYGNYDGLNQFPSFDL 125
Query: 118 YLDATLWSTVTVLDASRVYAKEMIIRAPSDSIDVCICCAVTGSPFISTLELRPLNLSMYA 177
++ WS+V +L + E+I P DS++VC+ +PFIS+LE+RPLN Y
Sbjct: 126 HIGPNKWSSVKILGVTNTSMHEIIHVVPQDSLEVCLVKTGPTTPFISSLEVRPLNNESYL 185
Query: 178 TDFEDNFFLKVAARVNFGALTKDALRYPDDPYDRIWDSDLDRRPNFVVGAASGTVRINTT 237
T L + ARV F + + +RY +D +DR+W+S D TV I+T
Sbjct: 186 TQSGS---LMLFARVYFPSSSSSFIRYDEDIHDRVWNSFTDDE----------TVWISTD 232
Query: 238 KNIETRTREYPPVKVMQTAVVGTEGVLSYRL--NLEDFPANARAFAYFAEIQDLGPSETR 295
I+T P VM+TA V + L L++ A + + +FAE+Q+L +ETR
Sbjct: 233 LPIDTSNSYDMPQSVMKTAAVPKNASEPWLLWWTLDENTAQSYVYMHFAEVQNLTANETR 292
Query: 296 KFKLEQP----YFADYSNAVVNIAENANGSYTLYEPSYMNVTLNFVLSFSFVKTRDSTLG 351
+F + +F+ ++I+ T++ P ++ + N + +F+F T +STL
Sbjct: 293 EFNITYNGGLRWFSYLRPPNLSIS-------TIFNPRAVSSS-NGIFNFTFAMTGNSTLP 344
Query: 352 PLLNAIEISKYQKIAA-KTEWQDVMVLEALRSISDESERTNDRGDPCVP--VPWEWVTCS 408
PLLNA+EI I +T +V + ++ S++ + +GDPC P WE + CS
Sbjct: 345 PLLNALEIYTVVDILQLETNKDEVSAMMNIKETYGLSKKISWQGDPCAPQLYRWEGLNCS 404
Query: 409 --TTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVH 466
+ RI + L+G L G I D+S+L L ++
Sbjct: 405 YPDSEGSRIISLNLNGSELTGSI-----------------------TSDISKLTLLTVLD 441
Query: 467 LENNELTGSLPSYMGSLPNLQELHIENNSFVG--EIPPAL---LTGK--VIFKYDNNPKL 519
L NN+L+G +P++ + +L+ +++ N + IP +L + K + +N
Sbjct: 442 LSNNDLSGDIPTFFAEMKSLKLINLSGNPNLNLTAIPDSLQQRVNSKSLTLILGENLTLT 501
Query: 520 HKESRRRMRFKLILGTSIGVLAILLVLFLCSLIVLRKLRRKISNQKSYEKVCP----LAD 575
K+ +++ I + GV A+L++L + +I +RK N K+++ P
Sbjct: 502 PKKESKKVPMVAIAASVAGVFALLVILAIFFVI-----KRK--NVKAHKSPGPPPLVTPG 554
Query: 576 SLRTSTKPSNTAYSIARGGHFMDEGVAYFIPLPELEEATNNFCKKIGKGSFGSVYYGKMK 635
+++ T+ SN + I R + + Y PE+ + TNNF + +GKG FG+VY+G +
Sbjct: 555 IVKSETRSSNPSI-ITR-----ERKITY----PEVLKMTNNFERVLGKGGFGTVYHGNL- 603
Query: 636 DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGT 695
DG EVAVK+++ S + ++F EV LL R+HHR+LV L+GYC++ L+YEYM NG
Sbjct: 604 DGAEVAVKMLSHSSAQGYKEFKAEVELLLRVHHRHLVGLVGYCDDGDNLALIYEYMANGD 663
Query: 696 LRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAK 755
LR+ + G L W R+QIA +AA+GLEYLH GC P ++HRDVK++NILL+ AK
Sbjct: 664 LRENMSGKRGGNVLTWENRMQIAVEAAQGLEYLHNGCRPPMVHRDVKTTNILLNERCGAK 723
Query: 756 VSDFGLSRQAEED-LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKK 814
++DFGLSR D H+S+V GT GYLDPEYY L+EKSDVYSFGVVLLE+++ +
Sbjct: 724 LADFGLSRSFPIDGECHVSTVVAGTPGYLDPEYYRTNWLSEKSDVYSFGVVLLEIVT-NQ 782
Query: 815 PVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFS 874
PV ++ +I W M+ KGD+ SIVDP L+G+ W+I E+A+ CV
Sbjct: 783 PV-IDKTRERPHINDWVGFMLTKGDIKSIVDPKLMGDYDTNGAWKIVELALACVNPSSNR 841
Query: 875 RPKMQEIVLAIQDSIKIE----KGGDQKFSSSS 903
RP M +V+ + D + +E +G ++ +S S
Sbjct: 842 RPTMAHVVMELNDCVALENARRQGSEEMYSMGS 874
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZQQ7|Y2144_ARATH Putative leucine-rich repeat receptor-like serine/threonine-protein kinase At2g14440 OS=Arabidopsis thaliana GN=At2g14440 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 458 bits (1179), Expect = e-128, Method: Compositional matrix adjust.
Identities = 316/908 (34%), Positives = 480/908 (52%), Gaps = 85/908 (9%)
Query: 25 FISIDCGSTSN---YTDPSTGLAWISDIGIMNNGKSVKVENPSG---NWMQYRTRRDLPI 78
FIS+ CG SN Y +P T L +ISD+ + GK+ ++N S Y+ R P
Sbjct: 29 FISLYCGLPSNESPYIEPLTNLTYISDVNFVRGGKTGNIKNNSDIDFTSRPYKVLRYFP- 87
Query: 79 DNKKYCYNLITKERRRYLVRATFQYGSLGSEASYPKFQLYLDATLWSTVTV--LDASRVY 136
+ + CY+L K+ +YL+R F YG+ + P+F L+L +W++V V +D
Sbjct: 88 EGIRNCYSLSVKQGTKYLIRTLFFYGNYDGLNTSPRFDLFLGPNIWTSVDVQKVDGGDGV 147
Query: 137 AKEMIIRAPSDSIDVCICCAVTGSPFISTLELRPLNLSMYATDFEDNFFLKVAARVNFGA 196
+E+I + +D+C+ T +P IS +ELRPL Y LK F
Sbjct: 148 IEEIIHVTRCNILDICLVKTGTTTPMISAIELRPLRYDTYTARTGS---LKKILHFYFTN 204
Query: 197 LTKDALRYPDDPYDRIWDSDLDRRPNFVVGAASGTVRINTTKNIETRTREY-PPVKVMQT 255
K+ +RYP+D YDR+W + + +INTT+N+ + Y PP V++T
Sbjct: 205 SGKE-VRYPEDVYDRVW----------IPHSQPEWTQINTTRNVSGFSDGYNPPQDVIKT 253
Query: 256 AVVGTE--GVLSYRLNLEDFPANARAFAYFAEIQDLGPSETRKFKL--EQPYFADYSNAV 311
A + T L++ E A+ YFAEIQ L +ETR+FK+ Y+ DY
Sbjct: 254 ASIPTNVSEPLTFTWMSESSDDETYAYLYFAEIQQLKANETRQFKILVNGVYYIDY---- 309
Query: 312 VNIAENANGSYTLYEPSYMNVTLNFVLSFSFVKTRDSTLGPLLNAIEI-SKYQKIAAKTE 370
+ TL P+ + V KT STL P +NAIEI S Q + T
Sbjct: 310 ---IPRKFEAETLITPAALKCG-GGVCRVQLSKTPKSTLPPQMNAIEIFSVIQFPQSDTN 365
Query: 371 WQDVMVLEALRSISDESERTNDRGDPCVPVPWEW--VTCST---TTPPRITKIALSGKNL 425
+V+ ++ ++S S R + +GDPCVP+ + W V+C+ +TPPRI + LS L
Sbjct: 366 TDEVIAIKNIQSTYKVS-RISWQGDPCVPIQFSWMGVSCNVIDISTPPRIISLDLSSSGL 424
Query: 426 KGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPSYMGSLP 484
G I P ++N+ L EL L N LTG +P + L LR + L NN LTG +P ++ ++
Sbjct: 425 TGVITPSIQNLTMLRELDLSNNNLTGVIPPSLQNLTMLRELDLSNNNLTGEVPEFLATIK 484
Query: 485 NLQELHIENNSFVGEIPPALLTGKVIFKYDNNPKLHKESRRRMRFKLILGTSIGVLAILL 544
L +H+ N+ G +P AL + ++ KL + + + + + SI +A+ +
Sbjct: 485 PLLVIHLRGNNLRGSVPQALQDRE----NNDGLKLLRGKHQPKSWLVAIVASISCVAVTI 540
Query: 545 VLFLCSLIVLRKLRRKISNQKSYEKVCPLADSLRTSTKPSNTAYSIARGGHFMDEGVAYF 604
++ L + + R RRK S +K +R S + N + +
Sbjct: 541 IV-LVLIFIFR--RRKSSTRKV----------IRPSLEMKNRRFKYS------------- 574
Query: 605 IPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLS 664
E++E TNNF +GKG FG VY+G + + ++VAVK+++ S + ++F TEV LL
Sbjct: 575 ----EVKEMTNNFEVVLGKGGFGVVYHGFLNN-EQVAVKVLSQSSTQGYKEFKTEVELLL 629
Query: 665 RIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKG 724
R+HH NLV L+GYC++ + L+YE+M NG L++ L G L+W RL+IA ++A G
Sbjct: 630 RVHHVNLVSLVGYCDKGNDLALIYEFMENGNLKEHLSGKRGGPVLNWPGRLKIAIESALG 689
Query: 725 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ-AEEDLTHISSVARGTVGYL 783
+EYLH GC P ++HRDVKS+NILL + AK++DFGLSR TH+S+ GT+GYL
Sbjct: 690 IEYLHIGCKPPMVHRDVKSTNILLGLRFEAKLADFGLSRSFLVGSQTHVSTNVAGTLGYL 749
Query: 784 DPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISI 843
DPEYY LTEKSDVYSFG+VLLE+I+G +PV +E + IV WA+SM+ GD+ SI
Sbjct: 750 DPEYYQKNWLTEKSDVYSFGIVLLEIITG-QPV-IEQSRDKSYIVEWAKSMLANGDIESI 807
Query: 844 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI---EKGGDQKFS 900
+D L + S W+ E+A+ C+ RP M + + + ++I K Q +
Sbjct: 808 MDRNLHQDYDTSSSWKALELAMLCINPSSTLRPNMTRVAHELNECLEIYNLTKRRSQDQN 867
Query: 901 SSSSKGQS 908
SS S G +
Sbjct: 868 SSKSSGHT 875
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZQR3|Y2451_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase At2g14510 OS=Arabidopsis thaliana GN=At2g14510 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 457 bits (1176), Expect = e-127, Method: Compositional matrix adjust.
Identities = 319/925 (34%), Positives = 488/925 (52%), Gaps = 114/925 (12%)
Query: 15 LSSVVSQVTE-FISIDCG--STSNYTDPSTGLAWISDIGIMNNGKSVKVENPSGN---WM 68
+S V SQ + FIS+DCG S +Y +PS+ L +ISD+ + GK+ ++N S +
Sbjct: 18 MSLVKSQNQQGFISLDCGLPSKESYIEPSSNLTFISDVNFIRGGKTGNIQNNSRTNFIFK 77
Query: 69 QYRTRRDLPIDNKKYCYNLITKERRRYLVRATFQYGSLGSEASYPKFQLYLDATLWSTVT 128
++ R P D + CY+L K+ +YL+R F YG+ + P+F L+L +W++V
Sbjct: 78 PFKVLRYFP-DGIRNCYSLSVKQGTKYLIRTLFYYGNYDGLNTSPRFDLFLGPNIWTSVD 136
Query: 129 VL--DASRVYAKEMIIRAPSDSIDVCICCAVTGSPFISTLELRPLNLSMYATDFEDNFFL 186
VL D +E++ S+ +D+C+ T +P IS +ELRPL Y L
Sbjct: 137 VLIADVGDGVVEEIVHVTRSNILDICLVKTGTSTPMISAIELRPLRYDTYTARTGS---L 193
Query: 187 KVAARVNFGALTKDALRYPDDPYDRIWDSDLDRRPNFVVGAASGTVRINTTKNIETRTRE 246
K A F + +A+RYP+D YDR+W +P + +INTT+N+ +
Sbjct: 194 KSMAHFYFTN-SDEAIRYPEDVYDRVWMPY--SQPEWT--------QINTTRNVSGFSDG 242
Query: 247 Y-PPVKVMQTAVVGTEGV--LSYRLNLEDFPANARAFAYFAEIQDLGPSETRKFKLEQPY 303
Y PP V+QTA + T G L++ NLE A+ +FAEIQ L +ETR+FK+
Sbjct: 243 YNPPQGVIQTASIPTNGSEPLTFTWNLESSDDETYAYLFFAEIQQLKVNETREFKI---- 298
Query: 304 FADYSNAV--VNIAENANGSYTLYEPSYMNVTLNFVLSFSFVKTRDSTLGPLLNAIEI-S 360
+N V ++ + TL P+ + V KT STL PL+NAIEI S
Sbjct: 299 ---LANGVDYIDYTPWKFEARTLSNPAPLKCE-GGVCRVQLSKTPKSTLPPLMNAIEIFS 354
Query: 361 KYQKIAAKTEWQDVMVLEALRSISDESERTNDRGDPCVPVPWEW--VTCST---TTPPRI 415
Q + T +V+ ++ ++S S R + +GDPCVP + W V+C+ +TPPRI
Sbjct: 355 VIQFPQSDTNTDEVIAIKKIQSTYQLS-RISWQGDPCVPKQFSWMGVSCNVIDISTPPRI 413
Query: 416 TKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGS 475
+ LS L G I P ++N+ L EL L NN LTG
Sbjct: 414 ISLDLSLSGLTGVISPSIQNLTMLREL-----------------------DLSNNNLTGE 450
Query: 476 LPSYMGSLPNLQELHIENNSFVGEIPPALLT-----GKVIFKYDNNPKLHKESRRRMRFK 530
+P ++ ++ L +H+ N+ G +P AL G +F +P + + + + +
Sbjct: 451 VPEFLATIKPLLVIHLRGNNLRGSVPQALQDREKNDGLKLFV---DPNITRRGKHQPKSW 507
Query: 531 LI-LGTSIGVLAILLVLFLCSLIVLRKLRRKISNQKSYEKVCPLADSLRTSTKPSNTAYS 589
L+ + SI +A+ +++ L + + R RRK S +K +R S + N +
Sbjct: 508 LVAIVASISCVAVTIIV-LVLIFIFR--RRKSSTRKV----------IRPSLEMKNRRFK 554
Query: 590 IARGGHFMDEGVAYFIPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSC 649
+ E++E TNNF +GKG FG VY+G + + ++VAVK+++ S
Sbjct: 555 YS-----------------EVKEMTNNFEVVLGKGGFGVVYHGFLNN-EQVAVKVLSQSS 596
Query: 650 SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPL 709
+ ++F TEV LL R+HH NLV L+GYC+E L+YE+M NG L++ L G L
Sbjct: 597 TQGYKEFKTEVELLLRVHHVNLVSLVGYCDEGIDLALIYEFMENGNLKEHLSGKRGGSVL 656
Query: 710 DWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ-AEED 768
+W +RL+IA ++A G+EYLH GC P ++HRDVKS+NILL + AK++DFGLSR
Sbjct: 657 NWSSRLKIAIESALGIEYLHIGCQPPMVHRDVKSTNILLGLRFEAKLADFGLSRSFLVGS 716
Query: 769 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIV 828
H+S+ GT+GYLDPEYY LTEKSDVYSFG+VLLE I+G +PV +E + IV
Sbjct: 717 QAHVSTNVAGTLGYLDPEYYLKNWLTEKSDVYSFGIVLLESITG-QPV-IEQSRDKSYIV 774
Query: 829 HWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 888
WA+SM+ GD+ SI+DP L + S W+ E+A+ C+ RP M + + +
Sbjct: 775 EWAKSMLANGDIESIMDPNLHQDYDSSSSWKALELAMLCINPSSTQRPNMTRVAHELNEC 834
Query: 889 IKIEKGGDQKFSSSSSKGQSSRKTL 913
++I + S+ Q+S K+L
Sbjct: 835 LEI-----YNLTKIRSQDQNSSKSL 854
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FZB8|Y5181_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g51810 OS=Arabidopsis thaliana GN=At1g51810 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 445 bits (1145), Expect = e-124, Method: Compositional matrix adjust.
Identities = 309/926 (33%), Positives = 480/926 (51%), Gaps = 119/926 (12%)
Query: 7 FLVIYLLFLSSVVSQ-VTEFISIDCGST---SNYTDPSTGLAWISDIGIMNNGKSVKV-- 60
F VI+ L L V +Q FI++DCG + S Y + STGL + SD G + +GK K+
Sbjct: 7 FFVIFSLILHLVQAQDPIGFINLDCGLSIQGSPYKESSTGLTYTSDDGFVQSGKIGKITK 66
Query: 61 ENPSGNWMQYRTRRDLPIDNKKYCYNLITKERRRYLVRATFQYGSLGSEASYPKFQLYLD 120
E S RT R P D + C++L +YL++ TF YG+ P F LY+
Sbjct: 67 ELESLYKKPERTLRYFP-DGVRNCFSLNVTRGTKYLIKPTFLYGNYDGRNVIPDFDLYIG 125
Query: 121 ATLWSTVTVLDASRVYAKEMIIRAPSDSIDVCICCAVTGSPFISTLELRPLNLSMYATDF 180
+W TV + KE++ + S+++ VC+ T P+I+TLELRPL +Y +
Sbjct: 126 PNMWITVNTDNT----IKEILHVSKSNTLQVCLVKTGTSIPYINTLELRPLADDIYTNES 181
Query: 181 EDNFFLKVAARVNFGALTKDALRYPDDPYDRIWDSDLDRRPNFVVGAASGTVRINTTKNI 240
L RV + L K + YPDD +DRIW L + ++ + ++IN + +
Sbjct: 182 GS---LNYLFRVYYSNL-KGYIEYPDDVHDRIWKQILPYQDWQIL---TTNLQINVSNDY 234
Query: 241 ETRTREYPPVKVMQTAVV---GTEGVLSYRLNLEDFPANARAFAYFAEIQDLGPSETRKF 297
+ P +VM+TAV + + + NLE + F +FAE+Q L +ETR+F
Sbjct: 235 DL------PQRVMKTAVTPIKASTTTMEFPWNLEPPTSQFYLFLHFAELQSLQANETREF 288
Query: 298 KLEQPYFADYSNAVVNIAENANGSYTLYEPSYMNVTLNFVLS----------FSFVKTRD 347
N+ N N ++ Y P ++ + + + VKT
Sbjct: 289 ---------------NVVLNGNVTFKSYSPKFLEMQTVYSTAPKQCDGGKCLLQLVKTSR 333
Query: 348 STLGPLLNAIE---ISKYQKIAAKTEWQDVMVLEALRSISDESERTNDRGDPCVPVP--W 402
STL PL+NA+E + + +I +T +V+ ++ ++S S +T +GDPCVP W
Sbjct: 334 STLPPLINAMEAYTVLDFPQI--ETNVDEVIAIKNIQSTYGLS-KTTWQGDPCVPKKFLW 390
Query: 403 EWVTCSTT---TPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRL 459
+ + C+ + TPP IT + LS L G I ++N+ L EL
Sbjct: 391 DGLNCNNSDDSTPPIITSLNLSSSGLTGIIVLTIQNLANLQEL----------------- 433
Query: 460 IDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVI-FKYDNNPK 518
L NN L+G +P ++ + +L +++ N+ G +P L+ K++ + NPK
Sbjct: 434 ------DLSNNNLSGGVPEFLADMKSLLVINLSGNNLSGVVPQKLIEKKMLKLNIEGNPK 487
Query: 519 LH----------KESRRRMRFKLI-LGTSIGVLAILLVLFLCSLIVLRKLRRKISNQKSY 567
L+ +E R+++ I + SIG + V F +L++ +R+ +
Sbjct: 488 LNCTVESCVNKDEEGGRQIKSMTIPIVASIGSV----VAFTVALMIFCVVRKNNPSNDEA 543
Query: 568 EKVCPLADSLRTSTKPSNTAYSIARGGHFMDEGVAYFIPLPELEEATNNFCKKIGKGSFG 627
C L R+S +P+ + + F E+ TNNF K +GKG FG
Sbjct: 544 PTSCMLPADSRSS-EPT----IVTKNKKFT---------YAEVLTMTNNFQKILGKGGFG 589
Query: 628 SVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILV 687
VYYG + ++VAVK+++ S + +QF EV LL R+HH+NLV L+GYCEE + L+
Sbjct: 590 IVYYGSVNGTEQVAVKMLSHSSAQGYKQFKAEVELLLRVHHKNLVGLVGYCEEGDKLALI 649
Query: 688 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNIL 747
YEYM NG L + + G L+W TRL+IA +AA+GLEYLH GC P ++HRDVK++NIL
Sbjct: 650 YEYMANGDLDEHMSGKRGGSILNWGTRLKIALEAAQGLEYLHNGCKPLMVHRDVKTTNIL 709
Query: 748 LDINMRAKVSDFGLSRQAE-EDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVL 806
L+ + K++DFGLSR E TH+S+V GT+GYLDPEYY LTEKSDVYSFGVVL
Sbjct: 710 LNEHFDTKLADFGLSRSFPIEGETHVSTVVAGTIGYLDPEYYRTNWLTEKSDVYSFGVVL 769
Query: 807 LELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQ 866
L +I+ +PV ++ + +I W M+ KGD+ SI DP L+G+ S+W+ E+A+
Sbjct: 770 LVMIT-NQPV-IDQNREKRHIAEWVGGMLTKGDIKSITDPNLLGDYNSGSVWKAVELAMS 827
Query: 867 CVEQRGFSRPKMQEIVLAIQDSIKIE 892
C+ +RP M ++V +++ + E
Sbjct: 828 CMNPSSMTRPTMSQVVFELKECLASE 853
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O65924|Y2921_ARATH Putative leucine-rich repeat receptor-like protein kinase At2g19210 OS=Arabidopsis thaliana GN=At2g19210 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 443 bits (1139), Expect = e-123, Method: Compositional matrix adjust.
Identities = 307/939 (32%), Positives = 474/939 (50%), Gaps = 121/939 (12%)
Query: 1 MVLYSHFLVIYLLFLSSVVSQVTEFISIDCG--STSNYTDPSTGLAWISDIGIMNNGKSV 58
+++++ F +++L + + + F+SIDCG S+Y D +T + ++SD + +G
Sbjct: 9 LIIFACFFAVFVLLVRA--QDQSGFVSIDCGIPEDSSYNDETTDIKYVSDAAFVESGTIH 66
Query: 59 KVE---NPSGNWMQYRTRRDLPIDNKKYCYNLITKERR--RYLVRATFQYGSLGSEASYP 113
++ S Q++ R P N+ CY++ + + +YL+R F YG+ + P
Sbjct: 67 SIDPEFQTSSLEKQFQNVRSFPEGNRN-CYDVKPPQGKGFKYLIRTRFMYGNYDNLGKAP 125
Query: 114 KFQLYLDATLWSTVTVLDASRVYAKEMIIRAPSDSIDVCICCAVTGSPFISTLELRPLNL 173
F LYL +W +VT+ +A+ + KE+I SD + VC+ G+PF+S LE+R L
Sbjct: 126 DFDLYLGFNIWDSVTIDNATTIVTKEIIHTLRSDHVHVCLVDKNRGTPFLSALEIRLLKS 185
Query: 174 SMYATDFEDNFFLKVAARVNFGALTKDALRYPDDPYDRIWDSDLDRRPNFVVGAASGTVR 233
+ Y T ++ K R + G L +RY DD +DRIW R P + + AS T+
Sbjct: 186 NTYETPYDSLILFK---RWDLGGLGALPVRYKDDVFDRIWIPL--RFPKYTIFNASLTID 240
Query: 234 INTTKNIETRTREYPPVKVMQTAVVGTEGVLSYRLNLEDFPANARAFAY--FAEIQDLGP 291
N + + P VM TA + + E + F Y FAE+ +L
Sbjct: 241 SNNNEGFQ------PARFVMNTATSPEDLSQDIIFSWEPKDPTWKYFVYMHFAEVVELPS 294
Query: 292 SETRKFKLEQPYFADYSNAVVNIAENANGSYTLYEPSYMNVTLNFV--------LSFSFV 343
+ETR+FK+ ++N E S++ P Y+ FV L F
Sbjct: 295 NETREFKV-----------LLNEKEINMSSFS---PRYLYTDTLFVQNPVSGPKLEFRLQ 340
Query: 344 KTRDSTLGPLLNAIEISKYQK-IAAKTEWQDVMVLEALRSISDESERTNDRGDPCVPV-- 400
+T STL P++NAIE + + + + T+ QDV + +R S + + GDPC PV
Sbjct: 341 QTPRSTLPPIINAIETYRVNEFLQSPTDQQDVDAI--MRIKSKYGVKKSWLGDPCAPVKY 398
Query: 401 PWEWVTCS--TTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSR 458
PW+ + CS PRI + LS L GEI D F S
Sbjct: 399 PWKDINCSYVDNESPRIISVNLSSSGLTGEI---------------DAAF--------SN 435
Query: 459 LIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGK----VIFKYD 514
L L I+ L NN LTG +P ++G+L NL EL++E N G IP LL ++ + D
Sbjct: 436 LTLLHILDLSNNSLTGKIPDFLGNLHNLTELNLEGNKLSGAIPVKLLERSNKKLILLRID 495
Query: 515 NNPKL---------HKESRRRMRFKLILGTSIGVLAILLVLFLCSLIVLRKLRRKISNQK 565
NP L +++++ + ++ + +GVL ++L + +L +L K R +
Sbjct: 496 GNPDLCVSASCQISDEKTKKNVYIIPLVASVVGVLGLVLAI---ALFLLYKKRHRRGGSG 552
Query: 566 SYEKVCPLADSLRTSTKPSNTAYSIARGGHFMDEGVAYFIPLPELEEATNNFCKKIGKGS 625
+ PL + R + E+ + TNNF + +G+G
Sbjct: 553 GV-RAGPLDTTKR-------------------------YYKYSEVVKVTNNFERVLGQGG 586
Query: 626 FGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRI 685
FG VY+G + D +VAVKI+++S + ++F EV LL R+HH+NL LIGYC E +
Sbjct: 587 FGKVYHGVLND-DQVAVKILSESSAQGYKEFRAEVELLLRVHHKNLTALIGYCHEGKKMA 645
Query: 686 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSN 745
L+YE+M NGTL D L G L W RLQI+ DAA+GLEYLH GC P I+ RDVK +N
Sbjct: 646 LIYEFMANGTLGDYLSGE-KSYVLSWEERLQISLDAAQGLEYLHNGCKPPIVQRDVKPAN 704
Query: 746 ILLDINMRAKVSDFGLSRQAEEDLTHISSVA-RGTVGYLDPEYYGNQQLTEKSDVYSFGV 804
IL++ ++AK++DFGLSR D + + A GT+GYLDPEY+ Q+L+EKSD+YSFGV
Sbjct: 705 ILINEKLQAKIADFGLSRSVALDGNNQDTTAVAGTIGYLDPEYHLTQKLSEKSDIYSFGV 764
Query: 805 VLLELISGKKPVSVEDFGAE-LNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEV 863
VLLE++SG+ ++ AE ++I M+ GD+ IVDP L S W+I EV
Sbjct: 765 VLLEVVSGQPVIARSRTTAENIHITDRVDLMLSTGDIRGIVDPKLGERFDAGSAWKITEV 824
Query: 864 AIQCVEQRGFSRPKMQEIVLAIQDSIKIEKGGDQKFSSS 902
A+ C +RP M +V +++S+ + G +SS
Sbjct: 825 AMACASSSSKNRPTMSHVVAELKESVSRARAGGGSGASS 863
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGD6|Y1570_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g05700 OS=Arabidopsis thaliana GN=At1g05700 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 440 bits (1131), Expect = e-122, Method: Compositional matrix adjust.
Identities = 312/903 (34%), Positives = 462/903 (51%), Gaps = 96/903 (10%)
Query: 13 LFLSSVVSQVTEFISIDCG--STSNYTDPSTGLAWISDIGIMNNGKSVKVENPSGNWMQY 70
L +S + + FISIDCG S S+Y D +TG+ ++SD + G S + P Q
Sbjct: 19 LVVSVLAQDQSGFISIDCGIPSGSSYKDDTTGINYVSDSSFVETGVSKSI--PFTAQRQL 76
Query: 71 RTRRDLPIDNKKYCYNLI--TKERRRYLVRATFQYGSLGSEASYPKFQLYLDATLWSTVT 128
+ R P + + CY LI + ++YL+RA+F YG+ E P+F L+L +W TV
Sbjct: 77 QNLRSFP-EGSRNCYTLIPIQGKGKKYLIRASFMYGNYDGENGSPEFDLFLGGNIWDTVL 135
Query: 129 VLDASRVYAKEMIIRAPSDSIDVCICCAVTGSPFISTLELRPLNLSMYATDFEDNFFLKV 188
+ + S + +KE++ + S++I VC+ G+PFISTLELR L D N L
Sbjct: 136 LSNGSSIVSKEVVYLSQSENIFVCLGNKGKGTPFISTLELRFLGNDNTTYD-SPNGALFF 194
Query: 189 AARVNFGALTKDALRYPDDPYDRIWDSDLDRRPNFVVGAASGTVR-INTTKNIETRTREY 247
+ R + +L +RY DD YDRIW + R NF G R INT+ + + Y
Sbjct: 195 SRRWDLRSLMGSPVRYDDDVYDRIW---IPR--NF------GYCREINTSLPVTSDNNSY 243
Query: 248 PPVK-VMQTAVVGTEGVLSYRLNLEDFPANARAFAY--FAEIQDLG--PSETRKFKLEQP 302
VM TA+ + LE+ N R F Y FAE++DL P++TR+F
Sbjct: 244 SLSSLVMSTAMTPINTTRPITMTLENSDPNVRYFVYMHFAEVEDLSLKPNQTREF----- 298
Query: 303 YFADYSNAVVNIAENANGSYTLYEPSYMNVTLNFVLSFSFVKTRDSTLGPLLNAIEISKY 362
D S V +A + Y ++N ++FS V+T STL P++NA+EI
Sbjct: 299 ---DISINGVTVAAGFSPKYLQTNTFFLNPESQSKIAFSLVRTPKSTLPPIVNALEIYVA 355
Query: 363 QKIAAK-TEWQDVMVLEALRSISDESERTNDRGDPCVP--VPWEWVTCS--TTTPPRITK 417
+ T +D + +L++ + N GDPC+P WE + CS + TPPRIT
Sbjct: 356 NSFSQSLTNQEDGDAVTSLKT--SYKVKKNWHGDPCLPNDYIWEGLNCSYDSLTPPRITS 413
Query: 418 IALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLP 477
+ LS L G I N+ + EL L NN LTG +P
Sbjct: 414 LNLSSSGLTGHISSSFSNLTMIQEL-----------------------DLSNNGLTGDIP 450
Query: 478 SYMGSLPNLQELHIENNSFVGEIPPALL----TGKVIFKYDNNPKLHKE-SRRRMRFKLI 532
++ L L+ L++ENN+ G +P LL TG + NP L E S R+ K +
Sbjct: 451 EFLSKLKFLRVLNLENNTLTGSVPSELLERSNTGSFSLRLGENPGLCTEISCRKSNSKKL 510
Query: 533 LGTSIGVLAILLVLFLCSLIVLRKLRRKISNQKSYEKVCPLADSLRTSTKPSNTAYSIAR 592
+ + A L +L L S + R R+ + S + P+A S
Sbjct: 511 VIPLVASFAALFILLLLSGVFWRIRNRRNKSVNSAPQTSPMAKS---------------- 554
Query: 593 GGHFMDEGVAYFIPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHR 652
E F ++ + TNNF + +GKG FG+VY+G D +VAVK+++++ +
Sbjct: 555 ------ENKLLFT-FADVIKMTNNFGQVLGKGGFGTVYHG-FYDNLQVAVKLLSETSAQG 606
Query: 653 TQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWL 712
++F +EV +L R+HH NL LIGY E Q L+YE+M NG + D L G Q L W
Sbjct: 607 FKEFRSEVEVLVRVHHVNLTALIGYFHEGDQMGLIYEFMANGNMADHLAGKY-QHTLSWR 665
Query: 713 TRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE-EDLTH 771
RLQIA DAA+GLEYLH GC P I+HRDVK+SNILL+ RAK++DFGLSR E +H
Sbjct: 666 QRLQIALDAAQGLEYLHCGCKPPIVHRDVKTSNILLNEKNRAKLADFGLSRSFHTESRSH 725
Query: 772 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWA 831
+S++ GT GYLDP + L EKSD+YSFGVVLLE+I+GK + E +++ W
Sbjct: 726 VSTLVAGTPGYLDPLCFETNGLNEKSDIYSFGVVLLEMITGKTVIK-ESQTKRVHVSDWV 784
Query: 832 RSMIKK-GDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 890
S+++ DV +++D + + + S+W++ E+A+ V Q RP M IV + + ++
Sbjct: 785 ISILRSTNDVNNVIDSKMAKDFDVNSVWKVVELALSSVSQNVSDRPNMPHIVRGLNECLQ 844
Query: 891 IEK 893
E+
Sbjct: 845 REE 847
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FZB1|Y5188_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g51880 OS=Arabidopsis thaliana GN=At1g51880 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 438 bits (1127), Expect = e-122, Method: Compositional matrix adjust.
Identities = 303/915 (33%), Positives = 471/915 (51%), Gaps = 102/915 (11%)
Query: 7 FLVIYLLFLSSVVSQ-VTEFISIDCG---STSNYTDPSTGLAWISDIGIMNNG--KSVKV 60
FL+ + L SV +Q FIS+DCG + YT+ +T + + SD +++G +
Sbjct: 10 FLITAYVILESVQAQDQLGFISLDCGLVPKNATYTEKTTNITYKSDANYIDSGLVGRISA 69
Query: 61 ENPSGNWMQYRTRRDLPIDNKKYCYNLITKERRRYLVRATFQYGSLGSEASYPKFQLYLD 120
E + Q T R P + ++ CYN + RYL+RATF YG+ PKF +++
Sbjct: 70 EYKAQLQQQTWTVRSFP-EGERNCYNFNLTAKSRYLIRATFTYGNYDGLRQVPKFDIHIG 128
Query: 121 ATLWSTVTVLDASRVYAKEMIIRAPSDSIDVCICCAVTGSPFISTLELRPLNLSMYATDF 180
+ W++V + EMI D + +C+ G PFIS+LELRPLN + Y T
Sbjct: 129 PSKWTSVKLDGVGNGAVLEMIHVLTQDRLQICLVKTGKGIPFISSLELRPLNNNTYLTQS 188
Query: 181 EDNFFLKVAARVNFGALTKDALRYPDDPYDRIWDSDLDRRPNFVVGAASGTVRINTTKNI 240
L ARV F A T +RY +D +DR+W V +G I+T +
Sbjct: 189 GS---LIGFARVFFSA-TPTFIRYDEDIHDRVW----------VRQFGNGLKSISTDLLV 234
Query: 241 ETRTREYPPVKVMQTAVVGTEGV--LSYRLNLEDFPANARAFAYFAEIQDLGPSETRKFK 298
+T P V +TA V + L + L++ + + + +FAEIQ L ++ R+F
Sbjct: 235 DTSNPYDVPQAVAKTACVPSNASQPLIFDWTLDNITSQSYVYMHFAEIQTLKDNDIREF- 293
Query: 299 LEQPYFADYSNAVVNIAENANGSYTLYEPSYMNVTLNF----------VLSFSFVKTRDS 348
N N +N Y+ P ++ F S SF KT +S
Sbjct: 294 ----------NITYNGGQNV---YSYLRPEKFEISTLFDSKPLSSPDGSFSLSFTKTGNS 340
Query: 349 TLGPLLNAIEISK-YQKIAAKTEWQDVMVLEALRSISDESERTNDRGDPCVPVPWEW--V 405
TL PL+N +EI K + +T+ +V + +++ D S++ + +GDPC P ++W +
Sbjct: 341 TLPPLINGLEIYKVLDLLELETDQDEVSAMINIKATYDLSKKVSWQGDPCAPKSYQWEGL 400
Query: 406 TCS--TTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLR 463
CS + PRI + L+ L G I PE+ + L EL L N L+G +P+ D++
Sbjct: 401 NCSYPNSDQPRIISLNLAENKLTGTITPEISKLTQLIELDLSKNDLSGEIPEF--FADMK 458
Query: 464 IVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNNPKLHKES 523
++ L N L+G+L ++P+ + +++ S + L+ K + K K
Sbjct: 459 LLKLIN--LSGNL-GLNSTIPDSIQQRLDSKSLI------LILSKTVTK----TVTLKGK 505
Query: 524 RRRMRFKLILGTSIGVLAILLVLFLCSLIVLRKLRRKISNQKSYEKVCPLADSLRTSTKP 583
+++ I+ + GV A+L++L + ++ RRK N +S + P TK
Sbjct: 506 SKKVPMIPIVASVAGVFALLVILAIFFVV-----RRK--NGESNKGTNP-----SIITKE 553
Query: 584 SNTAYSIARGGHFMDEGVAYFIPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVK 643
Y PE+ + TNNF + +GKG FG+VY+G ++D +VAVK
Sbjct: 554 RRITY-------------------PEVLKMTNNFERVLGKGGFGTVYHGNLED-TQVAVK 593
Query: 644 IMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGS 703
+++ S + ++F EV LL R+HHRNLV L+GYC++ L+YEYM NG L++ + G
Sbjct: 594 MLSHSSAQGYKEFKAEVELLLRVHHRNLVGLVGYCDDGDNLALIYEYMANGDLKENMSGK 653
Query: 704 VNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 763
L W R+QIA +AA+GLEYLH GC P ++HRDVK++NILL+ AK++DFGLSR
Sbjct: 654 RGGNVLTWENRMQIAVEAAQGLEYLHNGCTPPMVHRDVKTTNILLNERYGAKLADFGLSR 713
Query: 764 QAEED-LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFG 822
D +H+S+V GT GYLDPEYY L+EKSDVYSFGVVLLE+++ +PV+ +
Sbjct: 714 SFPVDGESHVSTVVAGTPGYLDPEYYRTNWLSEKSDVYSFGVVLLEIVT-NQPVT-DKTR 771
Query: 823 AELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIV 882
+I W SM+ KGD+ SI+DP L+G+ W+I E+A+ CV RP M +V
Sbjct: 772 ERTHINEWVGSMLTKGDIKSILDPKLMGDYDTNGAWKIVELALACVNPSSNRRPTMAHVV 831
Query: 883 LAIQDSIKIEKGGDQ 897
+ + + +E Q
Sbjct: 832 TELNECVALENARRQ 846
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 935 | ||||||
| 224107699 | 934 | predicted protein [Populus trichocarpa] | 0.993 | 0.994 | 0.790 | 0.0 | |
| 224100089 | 932 | predicted protein [Populus trichocarpa] | 0.993 | 0.996 | 0.792 | 0.0 | |
| 255547926 | 911 | protein with unknown function [Ricinus c | 0.970 | 0.995 | 0.775 | 0.0 | |
| 225425928 | 930 | PREDICTED: probable LRR receptor-like se | 0.992 | 0.997 | 0.758 | 0.0 | |
| 297738322 | 926 | unnamed protein product [Vitis vinifera] | 0.988 | 0.997 | 0.756 | 0.0 | |
| 356567402 | 929 | PREDICTED: probable LRR receptor-like se | 0.974 | 0.980 | 0.747 | 0.0 | |
| 449512995 | 956 | PREDICTED: probable LRR receptor-like se | 0.979 | 0.958 | 0.754 | 0.0 | |
| 449435025 | 923 | PREDICTED: LOW QUALITY PROTEIN: probable | 0.975 | 0.988 | 0.756 | 0.0 | |
| 356538111 | 930 | PREDICTED: probable LRR receptor-like se | 0.972 | 0.977 | 0.742 | 0.0 | |
| 357463139 | 930 | Leucine-rich repeat family protein / pro | 0.975 | 0.980 | 0.730 | 0.0 |
| >gi|224107699|ref|XP_002314568.1| predicted protein [Populus trichocarpa] gi|222863608|gb|EEF00739.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1542 bits (3992), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 743/940 (79%), Positives = 829/940 (88%), Gaps = 11/940 (1%)
Query: 1 MVLYSHFLVIYLLFLSSVVSQVTEFISIDCGSTSNYTDPSTGLAWISDIG-IMNNGKSVK 59
M YSHFL++YL +SSV+ QVTEFISIDCG TSNYTDP TGLAW+SD G IMN GKS +
Sbjct: 1 MASYSHFLLLYLFLMSSVICQVTEFISIDCGGTSNYTDPITGLAWVSDNGAIMNYGKSAE 60
Query: 60 VENPSGNWMQYRTRRDLPIDNKKYCYNLITKERRRYLVRATFQYGSLGSEASYPKFQLYL 119
VE P+GN MQYR RRD PID+KKYCY L TKERRRYLVRATFQYG LG+ +YPKF LYL
Sbjct: 61 VEIPNGN-MQYRRRRDFPIDSKKYCYTLGTKERRRYLVRATFQYGILGNGDAYPKFDLYL 119
Query: 120 DATLWSTVTVLDASRVYAKEMIIRAPSDSIDVCICCAVTGSPFISTLELRPLNLSMYATD 179
DAT WSTV VLDASRVY KEMIIRAPS SIDVCICCA TGSPFISTLELRPLNLSMYATD
Sbjct: 120 DATKWSTVVVLDASRVYVKEMIIRAPSSSIDVCICCASTGSPFISTLELRPLNLSMYATD 179
Query: 180 FEDNFFLKVAARVNFGALTKDALRYPDDPYDRIWDSDLDRRPNFVVGAASGTVRINTTKN 239
FEDNFFL+VAARVNFGAL+KD +RYPDDPYDRIWDSDL++R N++VG A GTVRINT+K
Sbjct: 180 FEDNFFLEVAARVNFGALSKDVIRYPDDPYDRIWDSDLEKRQNYLVGVAPGTVRINTSKY 239
Query: 240 IETRTREYPPVKVMQTAVVGTEGVLSYRLNLEDFPANARAFAYFAEIQDLGPSETRKFKL 299
I+TRTREYPPVKVMQTAVVGT+G+LSYRLNL+DFPANARA+AYFAEI+DLG +ETRKFKL
Sbjct: 240 IDTRTREYPPVKVMQTAVVGTQGILSYRLNLDDFPANARAYAYFAEIEDLGANETRKFKL 299
Query: 300 EQPYFADYSNAVVNIAENANGSYTLYEPSYMNVTLNFVLSFSFVKTRDSTLGPLLNAIEI 359
+QPYF DYSNAVVNIAENANGS+TLYEPSYMNVTL+FVLSFSFVKTRDST GPLLNAIEI
Sbjct: 300 QQPYFPDYSNAVVNIAENANGSHTLYEPSYMNVTLDFVLSFSFVKTRDSTQGPLLNAIEI 359
Query: 360 SKYQKIAAKTEWQDVMVLEALRSISDESERTNDRGDPCVPVPWEWVTCSTTTPPRITKIA 419
SKY KI +T+ QDV VL ALRS+S ES TN++GDPCVP W+WV C++TTPPRITKIA
Sbjct: 360 SKYLKIEPRTDSQDVTVLNALRSLSAESAWTNEQGDPCVPAHWDWVNCTSTTPPRITKIA 419
Query: 420 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSY 479
LSGKNLKGEIPPE+ NME LTELWLDGNFLTGP+P +S L++L+IVHLENN+L+G LP Y
Sbjct: 420 LSGKNLKGEIPPEINNMETLTELWLDGNFLTGPIPSISNLVNLKIVHLENNKLSGQLPKY 479
Query: 480 MGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNNPKLHKESRRRMRFKLILGTSIGV 539
+GSLP+LQEL+I+NN F GEIP LLTGKVI Y++NP LHKE+ ++ KLILG SIG+
Sbjct: 480 LGSLPDLQELYIQNNYFSGEIPSGLLTGKVIINYEHNPGLHKEAGKKKHSKLILGVSIGI 539
Query: 540 LAILLVLFLCSLIVLRKLRRKISNQKSYEKVCPLADSLRTSTKPSNTAYSIARGGHFMDE 599
LA LLV+ + SL+ LR L+RK S+QK+ + SLR S KPS TAYS++RG H MDE
Sbjct: 540 LAALLVVLIGSLLFLRNLQRKTSHQKTAVQ----GSSLRVSAKPS-TAYSVSRGWHMMDE 594
Query: 600 GVAYFIPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTE 659
GV+Y+IPL E+EEAT NF KKIG+GSFG+VYYG+MK+GKEVAVKIM DS +H TQQFVTE
Sbjct: 595 GVSYYIPLSEIEEATKNFSKKIGRGSFGTVYYGQMKEGKEVAVKIMGDSTTHMTQQFVTE 654
Query: 660 VALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAH 719
VALLSRIHHRNLVPLIGYCEEE+QRILVYEYMHNGTLRD +HGSVNQK LDWL RLQIA
Sbjct: 655 VALLSRIHHRNLVPLIGYCEEENQRILVYEYMHNGTLRDHIHGSVNQKRLDWLARLQIAE 714
Query: 720 DAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGT 779
D+AKGLEYLHTGCNP IIHRDVK+SNILLDINMRAKVSDFGLSRQAEEDLTH+SSVARGT
Sbjct: 715 DSAKGLEYLHTGCNPSIIHRDVKTSNILLDINMRAKVSDFGLSRQAEEDLTHVSSVARGT 774
Query: 780 VGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD 839
VGYLDPEYY NQQLTEKSDVYSFGVVLLEL+SGKKPVS EDFGAE+NIVHWAR++I+KGD
Sbjct: 775 VGYLDPEYYANQQLTEKSDVYSFGVVLLELLSGKKPVSTEDFGAEMNIVHWARALIRKGD 834
Query: 840 VISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKG--GDQ 897
+SIVDPVLIGNVKIESIWRIAEVAIQCVEQR SRP+MQEI+LAIQ++ KIEKG G Q
Sbjct: 835 AMSIVDPVLIGNVKIESIWRIAEVAIQCVEQRAVSRPRMQEIILAIQEANKIEKGTYGSQ 894
Query: 898 KFSSSSSKGQSSRKTLLTSFLEIE--SPDLSNECLAPAAR 935
K S SSK QSSRKTLLTSFLEIE SPDLSN CL PAAR
Sbjct: 895 KLPSGSSKAQSSRKTLLTSFLEIESQSPDLSNGCLVPAAR 934
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224100089|ref|XP_002311739.1| predicted protein [Populus trichocarpa] gi|222851559|gb|EEE89106.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1523 bits (3944), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 743/938 (79%), Positives = 826/938 (88%), Gaps = 9/938 (0%)
Query: 1 MVLYSHFLVIYLLFLSSVVSQVTEFISIDCGSTSNYTDPSTGLAWISDIG-IMNNGKSVK 59
M LYSHFLV+YL F+SSV+ QVTEFISIDCG TSNYTDP TGLAW+SD G IM GKS +
Sbjct: 1 MALYSHFLVLYLFFVSSVICQVTEFISIDCGGTSNYTDPRTGLAWVSDNGTIMKYGKSSE 60
Query: 60 VENPSGNWMQYRTRRDLPIDNKKYCYNLITKERRRYLVRATFQYGSLGSEASYPKFQLYL 119
+ +GN QY+ RRD PID+ KYCY L TKERRRYLVRATFQYGS +E +YPKF LYL
Sbjct: 61 AQVSNGN-TQYQRRRDFPIDSNKYCYTLGTKERRRYLVRATFQYGSSENEDAYPKFDLYL 119
Query: 120 DATLWSTVTVLDASRVYAKEMIIRAPSDSIDVCICCAVTGSPFISTLELRPLNLSMYATD 179
D T WST+ VLDASRVY KEMIIRAPS SIDVCICCA TGSPFISTLELRPLNLSMYATD
Sbjct: 120 DTTKWSTMVVLDASRVYVKEMIIRAPSSSIDVCICCATTGSPFISTLELRPLNLSMYATD 179
Query: 180 FEDNFFLKVAARVNFGALTKDALRYPDDPYDRIWDSDLDRRPNFVVGAASGTVRINTTKN 239
FEDNFFL+VAARVNFGAL+KDA+RYPDDPYDRIW SDL++R N++VG A GTVRINT+K
Sbjct: 180 FEDNFFLEVAARVNFGALSKDAIRYPDDPYDRIWGSDLEKRQNYLVGVAPGTVRINTSKY 239
Query: 240 IETRTREYPPVKVMQTAVVGTEGVLSYRLNLEDFPANARAFAYFAEIQDLGPSETRKFKL 299
++TRTREYPPVKVMQTAVVGTEG+LSYRLNLEDFPANARA+AYFAEI+DLG +ETRKFKL
Sbjct: 240 VDTRTREYPPVKVMQTAVVGTEGILSYRLNLEDFPANARAYAYFAEIEDLGANETRKFKL 299
Query: 300 EQPYFADYSNAVVNIAENANGSYTLYEPSYMNVTLNFVLSFSFVKTRDSTLGPLLNAIEI 359
+QP+ +DYSNAVVNIAENANGSYTLYEPSYMNV+L+FVLSFSF KTRDSTLGPLLNAIEI
Sbjct: 300 QQPFLSDYSNAVVNIAENANGSYTLYEPSYMNVSLDFVLSFSFAKTRDSTLGPLLNAIEI 359
Query: 360 SKYQKIAAKTEWQDVMVLEALRSISDESERTNDRGDPCVPVPWEWVTCSTTTPPRITKIA 419
SKY KI KT+ +DV VL ALR +S ES N++GDPCVP WEWV CS+TTPPRITKIA
Sbjct: 360 SKYLKIEPKTDSKDVTVLNALRFLSAESAWANEQGDPCVPAHWEWVNCSSTTPPRITKIA 419
Query: 420 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSY 479
LSGKNLKGEIPPE+ NME LTELWLDGNFLTGP+P +S L++L+IVHLENN+L G LP Y
Sbjct: 420 LSGKNLKGEIPPEINNMEQLTELWLDGNFLTGPIPGISNLVNLKIVHLENNKLNGPLPKY 479
Query: 480 MGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNNPKLHKESRRRMRFKLILGTSIGV 539
+GSLP LQ L+I+NNSF GEIP LTGKVIF Y++NP LHKE+R++M KLI+G SIG+
Sbjct: 480 LGSLPKLQALYIQNNSFSGEIPSEFLTGKVIFNYEHNPGLHKEARKKMHLKLIVGISIGI 539
Query: 540 LAILLVLFLCSLIVLRKLRRKISNQKSYEKVCPLADSLRTSTKPSNTAYSIARGGHFMDE 599
LA LLV+ + SL+ LR L+RK S++KS + +SLR STKPS TAYS+ARG H MDE
Sbjct: 540 LAGLLVVVIGSLLFLRNLQRKTSHKKSEVQ----GNSLRASTKPS-TAYSVARGWHMMDE 594
Query: 600 GVAYFIPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTE 659
GV+Y+IPLPELEEAT NF KKIG+GSFG+VYYG+MKDGKEVAVKIMADS +H T QFVTE
Sbjct: 595 GVSYYIPLPELEEATKNFSKKIGRGSFGTVYYGQMKDGKEVAVKIMADSSTHLTLQFVTE 654
Query: 660 VALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAH 719
VALLSRIHHRNLVPL+GYCEEEHQRILVYEYMHNGTLRD +HG VNQK LDWL RLQIA
Sbjct: 655 VALLSRIHHRNLVPLLGYCEEEHQRILVYEYMHNGTLRDHIHGPVNQKRLDWLARLQIAE 714
Query: 720 DAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGT 779
DAAKGLEYLHTGCNP IIHRDVK+SNILLDINMRAKVSDFGLSRQAEEDLTH+SSVARGT
Sbjct: 715 DAAKGLEYLHTGCNPSIIHRDVKTSNILLDINMRAKVSDFGLSRQAEEDLTHVSSVARGT 774
Query: 780 VGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD 839
VGYLDPEYY NQQLTEKSDVYSFGVVLLEL+SGKKPVS EDFG+ELNIVHWARS+I+KGD
Sbjct: 775 VGYLDPEYYANQQLTEKSDVYSFGVVLLELVSGKKPVSTEDFGSELNIVHWARSLIRKGD 834
Query: 840 VISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKG--GDQ 897
V+SIVDPVLIGN KIESIWRIAEVAIQCVEQR FSRP+M EI+LAIQ++ KIEKG G Q
Sbjct: 835 VMSIVDPVLIGNAKIESIWRIAEVAIQCVEQRAFSRPRMHEIILAIQEANKIEKGTDGSQ 894
Query: 898 KFSSSSSKGQSSRKTLLTSFLEIESPDLSNECLAPAAR 935
K S+SSK QSSRKTLLTSFLEIESPDLSN CL PAAR
Sbjct: 895 KQQSASSKAQSSRKTLLTSFLEIESPDLSNGCLVPAAR 932
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255547926|ref|XP_002515020.1| protein with unknown function [Ricinus communis] gi|223546071|gb|EEF47574.1| protein with unknown function [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1462 bits (3785), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 728/939 (77%), Positives = 807/939 (85%), Gaps = 32/939 (3%)
Query: 1 MVLYSH-FLVIYLLFLSSVVSQVTEFISIDCGSTSNYTDPSTGLAWISDIGIMNNGKSVK 59
M LYSH +LV+Y+ +SS+V QVTEFISIDCGSTSNYTD TGL WISD GIMN+GKSV+
Sbjct: 1 MALYSHIYLVLYISLVSSIVCQVTEFISIDCGSTSNYTDKRTGLEWISDNGIMNHGKSVE 60
Query: 60 VENPSGNWMQYRTRRDLPIDNKKYCYNLITKERRRYLVRATFQYGSLGSEASYPKFQLYL 119
V+NP G W QY RRD PID+KKYCYNL TKERRRYLVRATFQYGSL +E SYPKF LYL
Sbjct: 61 VKNPDGYWAQYGKRRDFPIDSKKYCYNLGTKERRRYLVRATFQYGSLENEDSYPKFDLYL 120
Query: 120 DATLWSTVTVLDASRVYAKEMIIRAPSDSIDVCICCAVTGSPFISTLELRPLNLSMYATD 179
DAT WSTVTVL+ASR+Y KEMIIRAPS SIDVCICCA TGSPFISTLELRPLNLSMYATD
Sbjct: 121 DATKWSTVTVLEASRIYVKEMIIRAPSSSIDVCICCATTGSPFISTLELRPLNLSMYATD 180
Query: 180 FEDNFFLKVAARVNFGALTKDALRYPDDPYDRIWDSDLDRRPNFVVGAASGTVRINTTKN 239
+ED FFLK+AARVNFGA + ALRYPDDPYDRIWDSDL +R NF+VG A GTVRINT+KN
Sbjct: 181 YEDRFFLKLAARVNFGAPDEFALRYPDDPYDRIWDSDLAKRQNFLVGVAPGTVRINTSKN 240
Query: 240 IETRTREYPPVKVMQTAVVGTEGVLSYRLNLEDFPANARAFAYFAEIQDLGPSETRKFKL 299
I+ +TREYPPVKVMQTAVVGTEG+LSYRLNLEDFPANARA+AYF+EI+DLG +ETRKFKL
Sbjct: 241 IDIQTREYPPVKVMQTAVVGTEGLLSYRLNLEDFPANARAYAYFSEIEDLGSNETRKFKL 300
Query: 300 EQPYFADYSNAVVNIAENANGSYTLYEPSYMNVTLNFVLSFSFVKTRDSTLGPLLNAIEI 359
+PY +DYSNAVVNIAENANGSY LYEPSYMNVTL+FVLSFSFVKTRDST GPL+NAIEI
Sbjct: 301 MKPYISDYSNAVVNIAENANGSYRLYEPSYMNVTLDFVLSFSFVKTRDSTQGPLINAIEI 360
Query: 360 SKYQKIAAKTEWQDVMVLEALRSISDESERTNDRGDPCVPVPWEWVTCSTTTPPRITKIA 419
SKY KI +KT+ QD VL A RSIS S T + GDPCVP WEWV CS+T+PPRITKIA
Sbjct: 361 SKYLKIESKTDIQDANVLNAFRSISAGSYWTTEGGDPCVPAQWEWVNCSSTSPPRITKIA 420
Query: 420 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSY 479
LSGKNLKGE+PPE+ NM L+EL HLENN+L+GSLP Y
Sbjct: 421 LSGKNLKGEVPPEINNMVELSEL-----------------------HLENNKLSGSLPKY 457
Query: 480 MGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNNPKLHKESRRRMRFKLILGTSIGV 539
+GSLPNL+EL+I+NNSFVG++P ALLTGKV Y++NP LHKE ++M FKL LG SIGV
Sbjct: 458 LGSLPNLRELYIQNNSFVGKVPAALLTGKVNLNYEDNPGLHKEVAKKMHFKLTLGISIGV 517
Query: 540 LAILLVLFLCSLIVLRKLRRKISNQKSYEKVCPLADSLRTSTKPSNTAYSIARGGHFMDE 599
LAILLVL L +LI LR+L+RK S+QK+ +S+R STKPS TAYSI RG H MDE
Sbjct: 518 LAILLVLLLGTLIYLRRLQRKTSHQKTDNP----GNSMRASTKPS-TAYSITRGWHLMDE 572
Query: 600 GVAYFIPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTE 659
G +Y+I ELEEAT NF KKIGKGSFGSVYYG+MKDGKEVAVKIMADSCSH TQQFVTE
Sbjct: 573 GGSYYISFAELEEATKNFFKKIGKGSFGSVYYGQMKDGKEVAVKIMADSCSHLTQQFVTE 632
Query: 660 VALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAH 719
VALLSRIHHRNLVPLIG+CEEEHQRILVYEYMHNGTLRD +HG N+K LDWLTRLQIA
Sbjct: 633 VALLSRIHHRNLVPLIGFCEEEHQRILVYEYMHNGTLRDHIHGIDNRKSLDWLTRLQIAE 692
Query: 720 DAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGT 779
DAAKGLEYLHTGC+P IIHRDVK+SNILLDINMRAKVSDFGLSRQAE+DLTHISSVARGT
Sbjct: 693 DAAKGLEYLHTGCSPSIIHRDVKTSNILLDINMRAKVSDFGLSRQAEDDLTHISSVARGT 752
Query: 780 VGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD 839
VGYLDPEYY NQQLTEKSDVYSFGVVLLELISGKKPVS EDFGAE+NIVHWAR++I+KGD
Sbjct: 753 VGYLDPEYYANQQLTEKSDVYSFGVVLLELISGKKPVSTEDFGAEMNIVHWARALIRKGD 812
Query: 840 VISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKG--GDQ 897
V+SIVDPVLIGNVKIESIWR+AEVAIQCV+QR SRP+MQE++L+IQ++IKIEKG G Q
Sbjct: 813 VVSIVDPVLIGNVKIESIWRVAEVAIQCVQQRAVSRPRMQEVILSIQEAIKIEKGTDGSQ 872
Query: 898 KFSSS-SSKGQSSRKTLLTSFLEIESPDLSNECLAPAAR 935
K S+S SSK QSSRKTLLTSFLEIESPDLSN CL PAAR
Sbjct: 873 KLSNSGSSKAQSSRKTLLTSFLEIESPDLSNGCLVPAAR 911
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225425928|ref|XP_002267668.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g67720-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1450 bits (3754), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 711/937 (75%), Positives = 803/937 (85%), Gaps = 9/937 (0%)
Query: 1 MVLYSHFLVIYLLFLSSVVSQVTEFISIDCGSTSNYTDPSTGLAWISDIGIMNNGKSVKV 60
M L+SHFLV +L +++ + QVTEFISIDCG TSNYTD TGL WISD G ++ GKSV+V
Sbjct: 1 MGLFSHFLVSFLCLITTTLCQVTEFISIDCGGTSNYTDSRTGLQWISDTGAISYGKSVQV 60
Query: 61 ENPSGNWMQYRTRRDLPIDNKKYCYNLITKERRRYLVRATFQYGSLGSEASYPKFQLYLD 120
ENP G W+QY+ RRD P ++K YCY L T+ERRRYLVRATFQYGSL SE +YPKFQLYLD
Sbjct: 61 ENPYGGWLQYQQRRDFPTESK-YCYTLKTEERRRYLVRATFQYGSLESEGTYPKFQLYLD 119
Query: 121 ATLWSTVTVLDASRVYAKEMIIRAPSDSIDVCICCAVTGSPFISTLELRPLNLSMYATDF 180
AT W+TVTVL+++RVY KEMIIRAPS SIDVC+CCA TGSPFISTLELRPLNLSMYATDF
Sbjct: 120 ATKWATVTVLESARVYVKEMIIRAPSSSIDVCLCCATTGSPFISTLELRPLNLSMYATDF 179
Query: 181 EDNFFLKVAARVNFGALTKDALRYPDDPYDRIWDSDLDRRPNFVVGAASGTVRINTTKNI 240
ED FFLKV+ARVNFGA ++D +RYPDDPYDRIW+SDL +R N++VG A GT R+NT+K I
Sbjct: 180 EDGFFLKVSARVNFGAPSEDPIRYPDDPYDRIWESDLVKRQNYLVGVAPGTERVNTSKQI 239
Query: 241 ETRTREYPPVKVMQTAVVGTEGVLSYRLNLEDFPANARAFAYFAEIQDLGPSETRKFKLE 300
+ RTREYPPVKVMQTAVVGT G LSYRLNLEDFPANARA+A+FAEI++LG +ETRKF++E
Sbjct: 240 DVRTREYPPVKVMQTAVVGTRGRLSYRLNLEDFPANARAYAFFAEIEELGVNETRKFRME 299
Query: 301 QPYFADYSNAVVNIAENANGSYTLYEPSYMNVTLNFVLSFSFVKTRDSTLGPLLNAIEIS 360
+PY DYSNAVVNIAENANGSY+LYEPSYMNVT++FVLSFSFVKTRDST GPLL+AIEIS
Sbjct: 300 RPYLPDYSNAVVNIAENANGSYSLYEPSYMNVTMDFVLSFSFVKTRDSTRGPLLSAIEIS 359
Query: 361 KYQKIAAKTEWQDVMVLEALRSISDESERTNDRGDPCVPVPWEWVTCSTTTPPRITKIAL 420
KY +IA KT+ DV VL AL ++S ES +N+ DPCVP W WV CS TT PRITKI L
Sbjct: 360 KYVQIAPKTDKGDVTVLNALCAMSTESAWSNEGRDPCVPAHWSWVACSPTTTPRITKITL 419
Query: 421 SGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYM 480
SGKNL G IP ELKNME LTELWLDGN+LTGP+PDMS LI L+IVHLENN LTG LPSY+
Sbjct: 420 SGKNLNGVIPSELKNMEGLTELWLDGNYLTGPIPDMSNLISLKIVHLENNRLTGPLPSYL 479
Query: 481 GSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNNPKLHKESRRRMRFKLILGTSIGVL 540
GSLP+LQELH++NN GEIPPALLTGKVIF Y+ N KLHKE+ + FKLILG S+G+L
Sbjct: 480 GSLPSLQELHVQNNLLSGEIPPALLTGKVIFNYEGNSKLHKEA-HKTHFKLILGASVGLL 538
Query: 541 AILLVLFLCSLIVLRKLRRKISNQKSYEKVCPLADSLRTSTKPSNTAYSIARGGHFMDEG 600
A+LLVL + SL +L RRK S KS +K SLRTSTK S T+YSIARGG+ MDEG
Sbjct: 539 ALLLVLCIGSLFLLCNTRRKESQSKSNDK----GSSLRTSTKAS-TSYSIARGGNLMDEG 593
Query: 601 VAYFIPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEV 660
VA +I L +LEEAT NF K+IG+GSFG VYYGKM DGKE+AVKIMADS SH TQQFVTEV
Sbjct: 594 VACYISLSDLEEATKNFAKQIGRGSFGPVYYGKMPDGKEIAVKIMADSSSHGTQQFVTEV 653
Query: 661 ALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHD 720
ALLSRIHHRNLVPLIGYCE+EHQ +LVYEYMHNGTLR+ +H S NQK LDWL RL +A D
Sbjct: 654 ALLSRIHHRNLVPLIGYCEDEHQHLLVYEYMHNGTLRNHIHDSTNQKCLDWLGRLYVAED 713
Query: 721 AAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTV 780
AAKGLEYLHTGCNP IIHRDVK+SNILLDINMRAKVSDFGLSRQAEEDLTH+SSVARGTV
Sbjct: 714 AAKGLEYLHTGCNPSIIHRDVKTSNILLDINMRAKVSDFGLSRQAEEDLTHVSSVARGTV 773
Query: 781 GYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV 840
GYLDPEYY NQQLTEKSDVYSFG+VLLELISG+KPVS ED+GAE NIVHWARS+I GDV
Sbjct: 774 GYLDPEYYANQQLTEKSDVYSFGIVLLELISGRKPVSPEDYGAEWNIVHWARSLICNGDV 833
Query: 841 ISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKG--GDQK 898
ISIVDP L+GNVKIESIWRIAE+AI CVEQ G SRPKMQEI+LAIQD+IKIE+G GD K
Sbjct: 834 ISIVDPFLLGNVKIESIWRIAEIAILCVEQHGTSRPKMQEIILAIQDAIKIERGNEGDHK 893
Query: 899 FSSSSSKGQSSRKTLLTSFLEIESPDLSNECLAPAAR 935
S SSKGQSSRKTLLT+FL+IESPDLSN+CL P+AR
Sbjct: 894 ACSGSSKGQSSRKTLLTNFLDIESPDLSNDCLVPSAR 930
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297738322|emb|CBI27523.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1444 bits (3739), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 709/937 (75%), Positives = 800/937 (85%), Gaps = 13/937 (1%)
Query: 1 MVLYSHFLVIYLLFLSSVVSQVTEFISIDCGSTSNYTDPSTGLAWISDIGIMNNGKSVKV 60
M L+SHFLV +L +++ + QVTEFISIDCG TSNYTD TGL WISD G ++ GKSV+V
Sbjct: 1 MGLFSHFLVSFLCLITTTLCQVTEFISIDCGGTSNYTDSRTGLQWISDTGAISYGKSVQV 60
Query: 61 ENPSGNWMQYRTRRDLPIDNKKYCYNLITKERRRYLVRATFQYGSLGSEASYPKFQLYLD 120
ENP G W+QY+ RRD P ++K YCY L T+ERRRYLVRATFQYGSL SE +YPKFQLYLD
Sbjct: 61 ENPYGGWLQYQQRRDFPTESK-YCYTLKTEERRRYLVRATFQYGSLESEGTYPKFQLYLD 119
Query: 121 ATLWSTVTVLDASRVYAKEMIIRAPSDSIDVCICCAVTGSPFISTLELRPLNLSMYATDF 180
AT W+TVTVL+++RVY KEMIIRAPS SIDVC+CCA TGSPFISTLELRPLNLSMYATDF
Sbjct: 120 ATKWATVTVLESARVYVKEMIIRAPSSSIDVCLCCATTGSPFISTLELRPLNLSMYATDF 179
Query: 181 EDNFFLKVAARVNFGALTKDALRYPDDPYDRIWDSDLDRRPNFVVGAASGTVRINTTKNI 240
ED FFLKV+ARVNFGA ++D +RYPDDPYDRIW+SDL +R N++VG A GT R+NT+K I
Sbjct: 180 EDGFFLKVSARVNFGAPSEDPIRYPDDPYDRIWESDLVKRQNYLVGVAPGTERVNTSKQI 239
Query: 241 ETRTREYPPVKVMQTAVVGTEGVLSYRLNLEDFPANARAFAYFAEIQDLGPSETRKFKLE 300
+ RTREYPPVKVMQTAVVGT G LSYRLNLEDFPANARA+A+FAEI++LG +ETRKF++E
Sbjct: 240 DVRTREYPPVKVMQTAVVGTRGRLSYRLNLEDFPANARAYAFFAEIEELGVNETRKFRME 299
Query: 301 QPYFADYSNAVVNIAENANGSYTLYEPSYMNVTLNFVLSFSFVKTRDSTLGPLLNAIEIS 360
+PY DYSNAVVNIAENANGSY+LYEPSYMNVT++FVLSFSFVKTRDST GPLL+AIEIS
Sbjct: 300 RPYLPDYSNAVVNIAENANGSYSLYEPSYMNVTMDFVLSFSFVKTRDSTRGPLLSAIEIS 359
Query: 361 KYQKIAAKTEWQDVMVLEALRSISDESERTNDRGDPCVPVPWEWVTCSTTTPPRITKIAL 420
KY +IA KT+ DV VL AL ++S ES +N+ DPCVP W WV CS TT PRITKI L
Sbjct: 360 KYVQIAPKTDKGDVTVLNALCAMSTESAWSNEGRDPCVPAHWSWVACSPTTTPRITKITL 419
Query: 421 SGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYM 480
SGKNL G IP ELKNME LTELWLDGN+LTGP+PDMS LI L+IVHLENN LTG LPSY+
Sbjct: 420 SGKNLNGVIPSELKNMEGLTELWLDGNYLTGPIPDMSNLISLKIVHLENNRLTGPLPSYL 479
Query: 481 GSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNNPKLHKESRRRMRFKLILGTSIGVL 540
GSLP+LQELH++NN GEIPPALLTGKVIF Y+ N KLHKE+ + FKLILG S+G+L
Sbjct: 480 GSLPSLQELHVQNNLLSGEIPPALLTGKVIFNYEGNSKLHKEA-HKTHFKLILGASVGLL 538
Query: 541 AILLVLFLCSLIVLRKLRRKISNQKSYEKVCPLADSLRTSTKPSNTAYSIARGGHFMDEG 600
A+LLVL + SL +L RRK S K SLRTSTK S T+YSIARGG+ MDEG
Sbjct: 539 ALLLVLCIGSLFLLCNTRRKESQSKR--------SSLRTSTKAS-TSYSIARGGNLMDEG 589
Query: 601 VAYFIPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEV 660
VA +I L +LEEAT NF K+IG+GSFG VYYGKM DGKE+AVKIMADS SH TQQFVTEV
Sbjct: 590 VACYISLSDLEEATKNFAKQIGRGSFGPVYYGKMPDGKEIAVKIMADSSSHGTQQFVTEV 649
Query: 661 ALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHD 720
ALLSRIHHRNLVPLIGYCE+EHQ +LVYEYMHNGTLR+ +H S NQK LDWL RL +A D
Sbjct: 650 ALLSRIHHRNLVPLIGYCEDEHQHLLVYEYMHNGTLRNHIHDSTNQKCLDWLGRLYVAED 709
Query: 721 AAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTV 780
AAKGLEYLHTGCNP IIHRDVK+SNILLDINMRAKVSDFGLSRQAEEDLTH+SSVARGTV
Sbjct: 710 AAKGLEYLHTGCNPSIIHRDVKTSNILLDINMRAKVSDFGLSRQAEEDLTHVSSVARGTV 769
Query: 781 GYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV 840
GYLDPEYY NQQLTEKSDVYSFG+VLLELISG+KPVS ED+GAE NIVHWARS+I GDV
Sbjct: 770 GYLDPEYYANQQLTEKSDVYSFGIVLLELISGRKPVSPEDYGAEWNIVHWARSLICNGDV 829
Query: 841 ISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKG--GDQK 898
ISIVDP L+GNVKIESIWRIAE+AI CVEQ G SRPKMQEI+LAIQD+IKIE+G GD K
Sbjct: 830 ISIVDPFLLGNVKIESIWRIAEIAILCVEQHGTSRPKMQEIILAIQDAIKIERGNEGDHK 889
Query: 899 FSSSSSKGQSSRKTLLTSFLEIESPDLSNECLAPAAR 935
S SSKGQSSRKTLLT+FL+IESPDLSN+CL P+AR
Sbjct: 890 ACSGSSKGQSSRKTLLTNFLDIESPDLSNDCLVPSAR 926
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356567402|ref|XP_003551909.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g67720-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1397 bits (3617), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 690/923 (74%), Positives = 781/923 (84%), Gaps = 12/923 (1%)
Query: 16 SSVVSQVTEFISIDCGSTSNYTDPSTGLAWISDIGIMNNGKSVKVENPSGNWMQYRTRRD 75
S V Q+ EFISIDCG T+NYTD STGLAWISD GIM +GK V+V+NPSGN +QY+ RR+
Sbjct: 16 SYAVCQLEEFISIDCGGTNNYTDKSTGLAWISDYGIMKHGKPVEVQNPSGNKVQYQRRRE 75
Query: 76 LPIDNKKYCYNLITKERRRYLVRATFQYGSLGSEASYPKFQLYLDATLWSTVTVLDASRV 135
PID++KYCY L T+ERRR+LVRATFQYGSL +YP+FQLYLDAT W+TV++ DASR+
Sbjct: 76 FPIDSRKYCYTLGTEERRRHLVRATFQYGSLDDGDTYPQFQLYLDATKWATVSIYDASRI 135
Query: 136 YAKEMIIRAPSDSIDVCICCAVTGSPFISTLELRPLNLSMYATDFEDNFFLKVAARVNFG 195
Y KEMI RAPS+SIDVC+CCA TGSPFISTLELRPLNLSMYATDFE +FFLKVAAR+NFG
Sbjct: 136 YVKEMIFRAPSNSIDVCMCCATTGSPFISTLELRPLNLSMYATDFEGSFFLKVAARINFG 195
Query: 196 ALTKDALRYPDDPYDRIWDSDLDRRPNFVVGAASGTVRINTTKNIETRTREYPPVKVMQT 255
A ++D +RYPDDPYDRIW+SDL +R N++VG A GT RINTTK IE TREYPPVKVMQT
Sbjct: 196 APSEDVVRYPDDPYDRIWESDLIKRQNYLVGVAPGTERINTTKKIEIETREYPPVKVMQT 255
Query: 256 AVVGTEGVLSYRLNLEDFPANARAFAYFAEIQDLGPSETRKFKLEQPYFADYSNAVVNIA 315
AVVGT+G+LSYRLNLEDFP NARA+AYFAEI+DL +ETRKFKLEQPY ADYSNAVVNIA
Sbjct: 256 AVVGTKGILSYRLNLEDFPGNARAYAYFAEIEDLPKNETRKFKLEQPYIADYSNAVVNIA 315
Query: 316 ENANGSYTLYEPSYMNVTLNFVLSFSFVKTRDSTLGPLLNAIEISKYQKIAAKTEWQDVM 375
ENANGSYTLYEPSYMNV+L FVLSFSFVKTRDST GPLLNA+EISKY IA+KT+ QD
Sbjct: 316 ENANGSYTLYEPSYMNVSLEFVLSFSFVKTRDSTQGPLLNAMEISKYVSIASKTDRQDSN 375
Query: 376 VLEALRSISDESERTNDRGDPCVPVPWEWVTCSTTTPPRITKIALSGKNLKGEIPPELKN 435
+ A R +S ES N+ GDPCVP PWEWV CSTTTPPRITKI LS +N+KGEIP EL N
Sbjct: 376 FVNAFRFLSAESVLKNE-GDPCVPTPWEWVNCSTTTPPRITKINLSRRNMKGEIPRELNN 434
Query: 436 MEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNS 495
MEALTELWLDGN LTG LPDM LI+L+IVHLENN+L+G LPSY+GSLP+LQ L I+NNS
Sbjct: 435 MEALTELWLDGNMLTGQLPDMRNLINLKIVHLENNKLSGPLPSYLGSLPSLQALFIQNNS 494
Query: 496 FVGEIPPALLTGKVIFKYDNNPKLHKESRRRMRFKLILGTSIGVLAILLVLFLCSLIVLR 555
F G IP LL+GK+IF +D+NP+LHK +++ F+L+LG SIGVLAILL+LFL SL++L
Sbjct: 495 FSGVIPSGLLSGKIIFNFDDNPELHKGNKK--HFQLMLGISIGVLAILLILFLTSLVLLL 552
Query: 556 KLRRKISNQKSYEKVCPLADSLRTSTKPSNTAYSIARGGHFMDEGVAYFIPLPELEEATN 615
LRRK S QK EK S R+STKP T YS R G+ MDEG AY+I L EL+EATN
Sbjct: 553 NLRRKTSRQKCDEK----GISGRSSTKPL-TGYSFGRNGNIMDEGTAYYITLSELKEATN 607
Query: 616 NFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLI 675
NF K IGKGSFGSVYYGKMKDGKEVAVK M D S+ QQFV EVALLSRIHHRNLVPLI
Sbjct: 608 NFSKNIGKGSFGSVYYGKMKDGKEVAVKTMTDPSSYGNQQFVNEVALLSRIHHRNLVPLI 667
Query: 676 GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 735
GYCEEE+Q ILVYEYMHNGTLR+ +H +QK LDWL RL+IA DA+KGLEYLHTGCNP
Sbjct: 668 GYCEEEYQHILVYEYMHNGTLREYIHECSSQKQLDWLARLRIAEDASKGLEYLHTGCNPS 727
Query: 736 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTE 795
IIHRDVK+SNILLDINMRAKVSDFGLSR AEEDLTHISSVARGTVGYLDPEYY NQQLTE
Sbjct: 728 IIHRDVKTSNILLDINMRAKVSDFGLSRLAEEDLTHISSVARGTVGYLDPEYYANQQLTE 787
Query: 796 KSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIE 855
KSDVYSFGVVLLELISGKKPVS ED+G E+NIVHWARS+I+KGDVISI+DP L+GNVK E
Sbjct: 788 KSDVYSFGVVLLELISGKKPVSSEDYGPEMNIVHWARSLIRKGDVISIMDPSLVGNVKTE 847
Query: 856 SIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKGGDQKF---SSSSSKGQSSRKT 912
S+WR+AE+AIQCVEQ G RP+MQE++LAIQD+ IEKG + + SS SK QSSRKT
Sbjct: 848 SVWRVAEIAIQCVEQHGACRPRMQEVILAIQDASNIEKGSEIQLKLSSSGGSKPQSSRKT 907
Query: 913 LLTSFLEIESPDLSNECLAPAAR 935
LL SFLEIESPDLSN CL P+AR
Sbjct: 908 LLASFLEIESPDLSNSCL-PSAR 929
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449512995|ref|XP_004164199.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g67720-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1392 bits (3604), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 704/933 (75%), Positives = 787/933 (84%), Gaps = 17/933 (1%)
Query: 5 SHFLVIYLLFLSSVVSQVTEFISIDCGSTSNYTDPSTGLAWISDIGIMNNGKSVKVENPS 64
S + +I LL +SSV QV EFISIDCG T NYTDP TGLAWISD GIMN G S VENP+
Sbjct: 39 SFWGLILLLVVSSVHCQVKEFISIDCGGTKNYTDPVTGLAWISDAGIMNAGGSSPVENPN 98
Query: 65 GNWMQYRTRRDLPIDNKKYCYNLITKERRRYLVRATFQYGSLGSEASYPKFQLYLDATLW 124
GN MQY+TRRD PID+KKYCY L T+ERRRYLVRATFQYGSL E +YPKFQLYLDAT W
Sbjct: 99 GNLMQYQTRRDFPIDDKKYCYTLKTEERRRYLVRATFQYGSLKDEETYPKFQLYLDATKW 158
Query: 125 STVTVLDASRVYAKEMIIRAPSDSIDVCICCAVTGSPFISTLELRPLNLSMYATDFEDNF 184
STVT+ DASRVY KEMIIRAPS+S DVCICCA TGSPFISTLELRP NLSMYATDFEDNF
Sbjct: 159 STVTIFDASRVYVKEMIIRAPSNSFDVCICCATTGSPFISTLELRPFNLSMYATDFEDNF 218
Query: 185 FLKVAARVNFGALTKDALRYPDDPYDRIWDSDLDRRPNFVVGAASGTVRINTTKNIETRT 244
FL+VAARVNFGALTKDA+RYPDDPYDRIWDSDL++R N++VG A GT RI+T NI T
Sbjct: 219 FLEVAARVNFGALTKDAIRYPDDPYDRIWDSDLEKRQNYLVGVAPGTERISTLNNINVMT 278
Query: 245 REYPPVKVMQTAVVGTEGVLSYRLNLEDFPANARAFAYFAEIQDLGPSETRKFKLEQPYF 304
REYPPVKVMQTAV+GT+GVLSYRLNL+DFPANARA+AYFAEI+DLG +ETRKFKLE+P
Sbjct: 279 REYPPVKVMQTAVLGTKGVLSYRLNLDDFPANARAYAYFAEIEDLGWNETRKFKLEEPNI 338
Query: 305 ADYSNAVVNIAENANGSYTLYEPSYMNVTLNFVLSFSFVKTRDSTLGPLLNAIEISKYQK 364
D SNAVVNIAENANG+YTLYEPSYMNVTL+FVLSFSFVKTRDST GPLLNA+EIS+Y +
Sbjct: 339 PDSSNAVVNIAENANGTYTLYEPSYMNVTLSFVLSFSFVKTRDSTRGPLLNALEISRYVE 398
Query: 365 IAAKTEWQDVMVLEALRSISDESERTNDRGDPCVPVPWEWVTCSTTTPPRITKIALSGKN 424
IA KT+ +D V R++S E+ +N GDPCVP WEWVTCS T PPRITKI LS KN
Sbjct: 399 IAPKTDGRDEAVANIFRNVSAENVWSN-IGDPCVPTSWEWVTCSATQPPRITKIELSRKN 457
Query: 425 LKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLP 484
LKGEIPPE+ M+ L ELWLDGN L GPLPDMS LI+L+I+HLENN+LTG+LPSY+ SLP
Sbjct: 458 LKGEIPPEINTMDGLVELWLDGNSLAGPLPDMSNLINLKILHLENNKLTGTLPSYLCSLP 517
Query: 485 NLQELHIENNSFVGEIPPALLTGKVIFKYDNNPKLHKESRRRMRFKLILGTSIGVLAILL 544
NLQEL+I+NN+F GEIP LL K+IFKYD N LHK R ++ KLILG S+GVL +L+
Sbjct: 518 NLQELYIQNNTFSGEIPSELLAKKLIFKYDGNVGLHKTERYKVHSKLILGVSLGVLVLLV 577
Query: 545 VLFLCSLIVLRKLRRKISNQKSYEKVCPLADSLRTSTKPSNTAYSIARGGHFMDEGVAYF 604
+L L SL++LRKLRRK + Y+K SL STK S +AYSI +G DEG+AY+
Sbjct: 578 ILLLGSLLLLRKLRRKTA---PYQKK---GGSLNISTKRS-SAYSIGKG----DEGMAYY 626
Query: 605 IPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLS 664
+ L ELEEATNNF KKIGKGSFGSV+YGKM DGKEVAVKIMA+S +H QQF+TEVALLS
Sbjct: 627 LSLSELEEATNNFSKKIGKGSFGSVFYGKMIDGKEVAVKIMAESSTHGNQQFMTEVALLS 686
Query: 665 RIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKG 724
RIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRD L+GS QK LDWL RL IA DAAKG
Sbjct: 687 RIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDHLYGSTTQKHLDWLARLHIAEDAAKG 746
Query: 725 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLD 784
LEYLHTGC+P IIHRDVK+SNILLDINMRAKVSDFGLSRQAEEDLTH+SSVARGTVGYLD
Sbjct: 747 LEYLHTGCSPSIIHRDVKTSNILLDINMRAKVSDFGLSRQAEEDLTHVSSVARGTVGYLD 806
Query: 785 PEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 844
PEYY QQLTEKSDVYSFGVVLLELISGKKPVS ED+G ELNIVHWARS++ KGDV SIV
Sbjct: 807 PEYYACQQLTEKSDVYSFGVVLLELISGKKPVSPEDYGNELNIVHWARSLVHKGDVTSIV 866
Query: 845 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKG--GDQKFSSS 902
DP L G VKIES+WRIAEVAIQCV+Q G SRP+MQE++LAIQD+IKIE G G+QK SS
Sbjct: 867 DPFLEGKVKIESVWRIAEVAIQCVQQHGVSRPRMQEVILAIQDAIKIEHGTEGNQKLSSE 926
Query: 903 SSKGQSSRKTLLTSFLEIESPDLSNECLAPAAR 935
+ K QSSRKTLLT+FLEIESPD S L P+AR
Sbjct: 927 NLKAQSSRKTLLTTFLEIESPDGS---LLPSAR 956
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449435025|ref|XP_004135296.1| PREDICTED: LOW QUALITY PROTEIN: probable LRR receptor-like serine/threonine-protein kinase At1g67720-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1387 bits (3591), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 704/930 (75%), Positives = 785/930 (84%), Gaps = 18/930 (1%)
Query: 9 VIYLLFLSSVVSQVTEFISIDCGSTSNYTDPSTGLAWISDIGIMNNGKSVKVENPSGNWM 68
+I LL +SSV QV EFISIDCG T NYTDP TGLAWISD GIMN G S VENP+GN M
Sbjct: 9 LILLLVVSSVHCQVKEFISIDCGGTKNYTDPVTGLAWISDAGIMNAGGSSPVENPNGNLM 68
Query: 69 QYRTRRDLPIDNKKYCYNLITKERRRYLVRATFQYGSLGSEASYPKFQLYLDATLWSTVT 128
QY+TRRD PID+KKYCY L T+ERRRYLVRATFQYGSL E +YPKFQLYLDAT WSTVT
Sbjct: 69 QYQTRRDFPIDDKKYCYTLKTEERRRYLVRATFQYGSLKDEETYPKFQLYLDATKWSTVT 128
Query: 129 VLDASRVYAKEMIIRAPSDSIDVCICCAVTGSPFISTLELRPLNLSMYATDFEDNFFLKV 188
+ DASRVY KEMIIRAPS+S DVCICCA TGSPFISTLELRP NLSMYATDFEDNFFL+V
Sbjct: 129 IFDASRVYVKEMIIRAPSNSFDVCICCATTGSPFISTLELRPFNLSMYATDFEDNFFLEV 188
Query: 189 AARVNFGALTKDALRYPDDPYDRIWDSDLDRRPNFVVGAASGTVRINTTKNIETRTREYP 248
AARVNFGALTKDA+RYPDDPYDRIWDSDL++R N++VG A GT RI+T NI TREYP
Sbjct: 189 AARVNFGALTKDAIRYPDDPYDRIWDSDLEKRQNYLVGVAPGTERISTLNNINVMTREYP 248
Query: 249 PVKVMQTAVVGTEGVLSYRLNLEDFPANARAFAYFAEIQDLGPSETRKFKLEQPYFADYS 308
PVKVMQTAV+GT+GVLSYRLNL+DFPANARA+AYFAEI+DLG +ETRKFKLE+P D S
Sbjct: 249 PVKVMQTAVLGTKGVLSYRLNLDDFPANARAYAYFAEIEDLGWNETRKFKLEEPNIPDSS 308
Query: 309 NAVVNIAENANGSYTLYEPSYMNVTLNFVLSFSFVKTRDSTLGPLLNAIEISKYQKIAAK 368
NAVVNIAENANG+YTLYEPSYMNVTL+FVLSFSFVKTRDST GPLLNA+EIS+Y +IA K
Sbjct: 309 NAVVNIAENANGTYTLYEPSYMNVTLSFVLSFSFVKTRDSTRGPLLNALEISRYVEIAPK 368
Query: 369 TEWQDVMVLEALRSISDESERTNDRGDPCVPVPWEWVTCSTTTPPRITKIALSGKNLKGE 428
T+ +D V R++S E+ TN GDPCVP WEWVTCS T PPRITKI LS KNLKGE
Sbjct: 369 TDGRDEAVANIFRNVSAENVWTN-IGDPCVPTSWEWVTCSATQPPRITKIELSRKNLKGE 427
Query: 429 IPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQE 488
IPPE+ M+ L ELWLDGN L GPLPDMS LI+L+I+HLENN+LTG+LPSY+ SLPNLQE
Sbjct: 428 IPPEINTMDGLVELWLDGNSLAGPLPDMSNLINLKILHLENNKLTGTLPSYLCSLPNLQE 487
Query: 489 LHIENNSFVGEIPPALLTGKVIFKYDNNPKLHKESRRRMRFKLILGTSIGVLAILLVLFL 548
L+I+NN+F GEIP LL K+IFKYD N LHK R ++ KLILG S+GVL +L++L L
Sbjct: 488 LYIQNNTFSGEIPSELLAKKLIFKYDGNVGLHKTERYKVHSKLILGVSLGVLVLLVILLL 547
Query: 549 CSLIVLRKLRRKISNQKSYEKVCPLADSLRTSTKPSNTAYSIARGGHFMDEGVAYFIPLP 608
SL++LRKLRRK + Y+K SL STK S +AYSI +G DEG+AY++ L
Sbjct: 548 GSLLLLRKLRRKTA---PYQKK---GGSLNISTKRS-SAYSIGKG----DEGMAYYLSLS 596
Query: 609 ELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHH 668
ELEEATNNF KKIGKGSFGSV+YGKM DGKEVAVKIMA+S +H QQF+TEVALLSRIHH
Sbjct: 597 ELEEATNNFSKKIGKGSFGSVFYGKMIDGKEVAVKIMAESSTHGNQQFMTEVALLSRIHH 656
Query: 669 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYL 728
RNLVPLIGYCEEEHQRILVYEYMHNGTLRD L+GS QK LDWL RL IA DAAKGLEYL
Sbjct: 657 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDHLYGSTTQKHLDWLARLHIAEDAAKGLEYL 716
Query: 729 HTGCNPG-IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 787
HTGC+P IIHRDVK+SNILLDINMRAKVSDFGLSRQAEEDLTH+SSVARGTVGYLDPEY
Sbjct: 717 HTGCSPSIIIHRDVKTSNILLDINMRAKVSDFGLSRQAEEDLTHVSSVARGTVGYLDPEY 776
Query: 788 YGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 847
Y QQLTEKSDVYSFGVVLLELISGKKPVS ED+G ELNIVHWARS++ KGDV SIVDP
Sbjct: 777 YACQQLTEKSDVYSFGVVLLELISGKKPVSPEDYGNELNIVHWARSLVHKGDVTSIVDPF 836
Query: 848 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKG--GDQKFSSSSSK 905
L G VKIES+WRIAEVAIQCV+Q G SRP+MQE++LAIQD+IKIE G G+QK SS + K
Sbjct: 837 LEGKVKIESVWRIAEVAIQCVQQHGVSRPRMQEVILAIQDAIKIEHGTEGNQKLSSENLK 896
Query: 906 GQSSRKTLLTSFLEIESPDLSNECLAPAAR 935
QSSRKTLLT+FLEIESPD S L P+AR
Sbjct: 897 AQSSRKTLLTTFLEIESPDGS---LLPSAR 923
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356538111|ref|XP_003537548.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g67720-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1379 bits (3569), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 685/922 (74%), Positives = 779/922 (84%), Gaps = 13/922 (1%)
Query: 18 VVSQVTEFISIDCGSTSNYTDPSTGLAWISDIGIMNNGKSVKVENPSGNWMQYRTRRDLP 77
V Q+ EFISIDCG TSNYTD STGLAWISD GIM +GK V+V+NPSGN QY+ RR+ P
Sbjct: 18 AVCQLEEFISIDCGGTSNYTDKSTGLAWISDSGIMKHGKPVEVQNPSGNKFQYQRRREFP 77
Query: 78 IDNKKYCYNLITKERRRYLVRATFQYGSLGSEASYPKFQLYLDATLWSTVTVLDASRVYA 137
ID++KYCY L+T+ERRRYLVRATF+YG+L +YP+FQLYLDAT W+TV++ DASR+YA
Sbjct: 78 IDSRKYCYTLVTEERRRYLVRATFKYGNLDDGDTYPQFQLYLDATKWATVSIYDASRIYA 137
Query: 138 KEMIIRAPSDSIDVCICCAVTGSPFISTLELRPLNLSMYATDFEDNFFLKVAARVNFGAL 197
KEMI RAPS+SIDVC+CCA TGSPFISTLELRPLNLSMYATDFE +FFLKVAAR+NFGA
Sbjct: 138 KEMIFRAPSNSIDVCMCCATTGSPFISTLELRPLNLSMYATDFEGSFFLKVAARINFGAP 197
Query: 198 TKDALRYPDDPYDRIWDSDLDRRPNFVVGAASGTVRINTTKNIETRTREYPPVKVMQTAV 257
++D +RYPDDPYDRIW+SDL +R N++VG A GT RINTTK IE TRE PPVKVMQTAV
Sbjct: 198 SEDVVRYPDDPYDRIWESDLIKRQNYLVGVAPGTERINTTKKIEIETRENPPVKVMQTAV 257
Query: 258 VGTEGVLSYRLNLEDFPANARAFAYFAEIQDLGPSETRKFKLEQPYFADYSNAVVNIAEN 317
VGT+G+LSYRLNLEDFP NARA+AYFAEI+DL +ETRKFKLEQPY ADYSNAVVNIAEN
Sbjct: 258 VGTKGILSYRLNLEDFPGNARAYAYFAEIEDLPKNETRKFKLEQPYIADYSNAVVNIAEN 317
Query: 318 ANGSYTLYEPSYMNVTLNFVLSFSFVKTRDSTLGPLLNAIEISKYQKIAAKTEWQDVMVL 377
ANGSYTLYEPSYMNV+L FVLSFSFVKTRDST GPLLNA+EISKY IA+KT+ QD +
Sbjct: 318 ANGSYTLYEPSYMNVSLEFVLSFSFVKTRDSTQGPLLNAMEISKYMPIASKTDRQDSNFV 377
Query: 378 EALRSISDESERTNDRGDPCVPVPWEWVTCSTTTPPRITKIALSGKNLKGEIPPELKNME 437
A R +S ES N+ GDPCVP PWEWV CSTTTPPRITKI LS +NLKGEIP +L NME
Sbjct: 378 NAFRFLSAESVLKNE-GDPCVPTPWEWVNCSTTTPPRITKINLSRRNLKGEIPGKLNNME 436
Query: 438 ALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFV 497
ALTELWLDGN LTG LPDMS LI+++I+HLENN+LTG LPSY+GSLP+LQ L I+NNSF
Sbjct: 437 ALTELWLDGNMLTGQLPDMSNLINVKIMHLENNKLTGPLPSYLGSLPSLQALFIQNNSFS 496
Query: 498 GEIPPALLTGKVIFKYDNNPKLHKESRRRMRFKLILGTSIGVLAILLVLFLCSLIVLRKL 557
G IP LL+GK+IF +D+NP+LHK +++ F+L+LG SIGVL ILL+LFL SL++L L
Sbjct: 497 GVIPSGLLSGKIIFNFDDNPELHKGNKK--HFQLMLGISIGVLVILLILFLTSLVLLLIL 554
Query: 558 RRKISNQKSYEKVCPLADSLRTSTKPSNTAYSIARGGHFMDEGVAYFIPLPELEEATNNF 617
RRK S QK EK S R+STKP T YS R G+ MDEG AY+I L EL+EATNNF
Sbjct: 555 RRKTSQQKRDEK----GVSGRSSTKPL-TGYSFGRDGNIMDEGTAYYITLSELKEATNNF 609
Query: 618 CKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 677
K IGKGSFGSVYYGKMKDGKEVAVK M D S+ QQFV EVALLSRIHHRNLVPLIGY
Sbjct: 610 SKNIGKGSFGSVYYGKMKDGKEVAVKTMTDPSSYGNQQFVNEVALLSRIHHRNLVPLIGY 669
Query: 678 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGII 737
CEEE+Q ILVYEYMHNGTLR+ +H +QK LDWL RL+IA DAAKGLEYLHTGCNP II
Sbjct: 670 CEEEYQHILVYEYMHNGTLREYIHECSSQKQLDWLARLRIAEDAAKGLEYLHTGCNPSII 729
Query: 738 HRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKS 797
HRDVK+SNILLDINMRAKVSDFGLSR AEEDLTHISSVARGTVGYLDPEYY NQQLTEKS
Sbjct: 730 HRDVKTSNILLDINMRAKVSDFGLSRLAEEDLTHISSVARGTVGYLDPEYYANQQLTEKS 789
Query: 798 DVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESI 857
DVYSFGVVLLEL+SGKK VS ED+G E+NIVHWARS+I+KGDVISI+DP L+GN+K ES+
Sbjct: 790 DVYSFGVVLLELLSGKKAVSSEDYGPEMNIVHWARSLIRKGDVISIMDPSLVGNLKTESV 849
Query: 858 WRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKGGDQKFSSSSSKG----QSSRKTL 913
WR+AE+A+QCVEQ G RP+MQE++LAIQD+ IEKG + + SSS G QSSRKTL
Sbjct: 850 WRVAEIAMQCVEQHGACRPRMQEVILAIQDASNIEKGTESQLKLSSSGGNSKPQSSRKTL 909
Query: 914 LTSFLEIESPDLSNECLAPAAR 935
L SFLEIESPDLSN CL P+AR
Sbjct: 910 LASFLEIESPDLSNSCL-PSAR 930
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357463139|ref|XP_003601851.1| Leucine-rich repeat family protein / protein kinase family protein [Medicago truncatula] gi|355490899|gb|AES72102.1| Leucine-rich repeat family protein / protein kinase family protein [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 1373 bits (3555), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 676/925 (73%), Positives = 775/925 (83%), Gaps = 13/925 (1%)
Query: 15 LSSVVSQVTEFISIDCGST-SNYTDPSTGLAWISDIGIMNNGKSVKVENPSGNWMQYRTR 73
+S Q+ EFISIDCG T SNYTD +TGL WISD IM +G++V+V+NP+GN +QY+ R
Sbjct: 15 ISCASCQLQEFISIDCGGTRSNYTDTTTGLTWISDSEIMKHGETVEVKNPNGNKVQYQKR 74
Query: 74 RDLPIDNKKYCYNLITKERRRYLVRATFQYGSLGSEASYPKFQLYLDATLWSTVTVLDAS 133
RD P D++KYCY L +ERRRYLVRATFQYGSL + +YP+FQLYLDAT W+TV++ D S
Sbjct: 75 RDFPTDSRKYCYTLEAEERRRYLVRATFQYGSLQNGDTYPQFQLYLDATKWATVSIYDES 134
Query: 134 RVYAKEMIIRAPSDSIDVCICCAVTGSPFISTLELRPLNLSMYATDFEDNFFLKVAARVN 193
R+Y KEMI RAPS+S+DVCICCA TGSPFIST+ELRPLNLSMYATDFED+FFLKVAAR+N
Sbjct: 135 RIYVKEMIFRAPSNSVDVCICCATTGSPFISTIELRPLNLSMYATDFEDDFFLKVAARIN 194
Query: 194 FGALTKDALRYPDDPYDRIWDSDLDRRPNFVVGAASGTVRINTTKNIETRTREYPPVKVM 253
FGA T DA+RYP+DPYDRIW+SDL +R NF+VG A+GT RINTT+NI TREYPPVKVM
Sbjct: 195 FGAPTGDAVRYPEDPYDRIWESDLGKRQNFLVGVAAGTERINTTRNIAIETREYPPVKVM 254
Query: 254 QTAVVGTEGVLSYRLNLEDFPANARAFAYFAEIQDLGPSETRKFKLEQPYFADYSNAVVN 313
Q+AVVGT+G+LSYRLNLEDFP NARA+AY AEI+DL +ETRKFKLEQP+ ADYSNAVVN
Sbjct: 255 QSAVVGTKGLLSYRLNLEDFPGNARAYAYLAEIEDLSQNETRKFKLEQPFIADYSNAVVN 314
Query: 314 IAENANGSYTLYEPSYMNVTLNFVLSFSFVKTRDSTLGPLLNAIEISKYQKIAAKTEWQD 373
IAENANGSYTLYEPSYMNV+L FVLSFSF +T DST GPLLNA+EISKYQ+IA+KT QD
Sbjct: 315 IAENANGSYTLYEPSYMNVSLEFVLSFSFKRTPDSTRGPLLNAMEISKYQEIASKTFKQD 374
Query: 374 VMVLEALRSISDESERTNDRGDPCVPVPWEWVTCSTTTPPRITKIALSGKNLKGEIPPEL 433
+ A S+SDE N+ GDPCVP PWEWV CST TP RIT I LSG+NL GEIP EL
Sbjct: 375 SNFVNAFSSLSDEIIPKNE-GDPCVPTPWEWVNCSTATPARITNINLSGRNLTGEIPREL 433
Query: 434 KNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIEN 493
NMEALTELWLD N LTG LPDMS LI+L+I+HLENN+LTG LP+Y+GSLP LQ L+I+N
Sbjct: 434 NNMEALTELWLDRNLLTGQLPDMSNLINLKIMHLENNKLTGPLPTYLGSLPGLQALYIQN 493
Query: 494 NSFVGEIPPALLTGKVIFKYDNNPKLHKESRRRMRFKLILGTSIGVLAILLVLFLCSLIV 553
NSF G+IP LL+ K+ F YD+NP LHK S++ F L++G SIGVL IL+V+FL SL++
Sbjct: 494 NSFTGDIPAGLLSTKITFIYDDNPGLHKRSKK--HFPLMIGISIGVLVILMVMFLASLVL 551
Query: 554 LRKLRRKISNQKSYEKVCPLADSLRTSTKPSNTAYSIARGGHFMDEGVAYFIPLPELEEA 613
LR LRRK S QKS E+ A S RT TK T YS R G+ MDEG AY+I L +L+ A
Sbjct: 552 LRYLRRKASQQKSDER----AISGRTGTK-HLTGYSFGRDGNLMDEGTAYYITLSDLKVA 606
Query: 614 TNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVP 673
TNNF KKIGKGSFGSVYYGKMKDGKE+AVK M D SH QFVTEVALLSRIHHRNLVP
Sbjct: 607 TNNFSKKIGKGSFGSVYYGKMKDGKEIAVKTMTDPSSHGNHQFVTEVALLSRIHHRNLVP 666
Query: 674 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 733
LIGYCEEE+Q ILVYEYMHNGTLRD +H ++K LDWLTRL+IA DAAKGLEYLHTGCN
Sbjct: 667 LIGYCEEEYQHILVYEYMHNGTLRDHIHECSSEKRLDWLTRLRIAEDAAKGLEYLHTGCN 726
Query: 734 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQL 793
P IIHRDVK+SNILLDINMRAKVSDFGLSR AEEDLTHISSVA+GTVGYLDPEYY NQQL
Sbjct: 727 PSIIHRDVKTSNILLDINMRAKVSDFGLSRLAEEDLTHISSVAKGTVGYLDPEYYANQQL 786
Query: 794 TEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVK 853
TEKSDVYSFGVVLLELI GKKPVS ED+G E+NIVHWARS+I+KGD+ISI+DP+LIGNVK
Sbjct: 787 TEKSDVYSFGVVLLELICGKKPVSPEDYGPEMNIVHWARSLIRKGDIISIMDPLLIGNVK 846
Query: 854 IESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKGGDQKFS---SSSSKGQSSR 910
ESIWR+AE+A+QCVE G SRP+MQE++LAIQD+ KIEKG + + SSSS QSSR
Sbjct: 847 TESIWRVAEIAMQCVEPHGASRPRMQEVILAIQDASKIEKGTESQLKVSSSSSSIPQSSR 906
Query: 911 KTLLTSFLEIESPDLSNECLAPAAR 935
KTLLTSFLEIESPDLSN CL P+AR
Sbjct: 907 KTLLTSFLEIESPDLSNGCL-PSAR 930
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 935 | ||||||
| TAIR|locus:2008565 | 929 | AT1G67720 [Arabidopsis thalian | 0.981 | 0.988 | 0.703 | 0.0 | |
| TAIR|locus:2057991 | 934 | AT2G37050 [Arabidopsis thalian | 0.927 | 0.928 | 0.481 | 1.7e-217 | |
| TAIR|locus:2126540 | 876 | AT4G29990 [Arabidopsis thalian | 0.447 | 0.477 | 0.394 | 1.9e-125 | |
| TAIR|locus:2055165 | 868 | AT2G14510 [Arabidopsis thalian | 0.299 | 0.322 | 0.464 | 3.1e-125 | |
| TAIR|locus:2055160 | 886 | AT2G14440 [Arabidopsis thalian | 0.299 | 0.316 | 0.461 | 1.3e-124 | |
| TAIR|locus:2028446 | 888 | AT1G49100 [Arabidopsis thalian | 0.301 | 0.317 | 0.491 | 6.5e-123 | |
| TAIR|locus:2195850 | 890 | AT1G51860 [Arabidopsis thalian | 0.304 | 0.320 | 0.477 | 1.2e-121 | |
| TAIR|locus:2824870 | 884 | AT1G51805 [Arabidopsis thalian | 0.296 | 0.313 | 0.482 | 1.5e-121 | |
| TAIR|locus:2078191 | 838 | AT3G46420 [Arabidopsis thalian | 0.298 | 0.332 | 0.471 | 1.1e-120 | |
| TAIR|locus:2066133 | 880 | AT2G28960 [Arabidopsis thalian | 0.460 | 0.489 | 0.352 | 2.8e-120 |
| TAIR|locus:2008565 AT1G67720 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 3409 (1205.1 bits), Expect = 0., P = 0.
Identities = 656/932 (70%), Positives = 755/932 (81%)
Query: 8 LVIYLLFLSS-VVSQVTEFISIDCGSTSNYTDPSTGLAWISDIGIMNNGKSVKVENPSGN 66
L + LFL V+SQVTEF+SIDCG +SNYTDP TGL W+SD I+ GK V + N + N
Sbjct: 8 LAVTCLFLVPFVLSQVTEFVSIDCGCSSNYTDPRTGLGWVSDSEIIKQGKPVTLANTNWN 67
Query: 67 WMQYRTRRDLPIDNKKYCYNLITKERRRYLVRATFQYGSLGSEASYPKFQLYLDATLWST 126
MQYR RRD P DNKKYCY L TKERRRY+VR TF YG LGSE +YPKFQLYLDAT W+T
Sbjct: 68 SMQYRRRRDFPTDNKKYCYRLSTKERRRYIVRTTFLYGGLGSEEAYPKFQLYLDATKWAT 127
Query: 127 VTVLDASRVYAKEMIIRAPSDSIDVCICCAVTGSPFISTLELRPLNLSMYATDFEDNFFL 186
VT+ + SRVY +E+I+RA S +DVC+CCA+TGSPF+STLELRPLNLSMYATD+EDNFFL
Sbjct: 128 VTIQEVSRVYVEELIVRATSSYVDVCVCCAITGSPFMSTLELRPLNLSMYATDYEDNFFL 187
Query: 187 KVAARVNFGALTKDALRYPDDPYDRIWDSDLDRRPNFVVGAASGTVRINTTKNIETRTRE 246
KVAARVNFGA DALRYPDDPYDRIW+SD+++RPN++VG A GT RINT+K I T TRE
Sbjct: 188 KVAARVNFGAPNMDALRYPDDPYDRIWESDINKRPNYLVGVAPGTTRINTSKTINTLTRE 247
Query: 247 YPPVKVMQTAVVGTEGVLSYRLNLEDFPANARAFAYFAEIQDLGPSETRKFKLEQPYFAD 306
YPP+KVMQTAVVGT+G++SYRLNLEDFPANARA+AYFAEI++LG +ETRKFKL QPYF D
Sbjct: 248 YPPMKVMQTAVVGTQGLISYRLNLEDFPANARAYAYFAEIEELGANETRKFKLVQPYFPD 307
Query: 307 YSNAVVNIAENANGSYTLYEPSYMNVTLNFVLSFSFVKTRDSTLGPLLNAIEISKYQKIA 366
YSNAVVNIAENANGSYTLYEPSYMNVTL+FVL+FSF KT+DST GPLLNAIEISKY I+
Sbjct: 308 YSNAVVNIAENANGSYTLYEPSYMNVTLDFVLTFSFGKTKDSTQGPLLNAIEISKYLPIS 367
Query: 367 AKTEWQDVMVLEALRSISDESERTNDRGDPCVPVPWEWVTCSTTTPPRITKIALSGKNLK 426
KT+ DV VL+A+RS+S +S+ ++ GDPC+PV W WV CS+T+PPR+TKIALS KNL+
Sbjct: 368 VKTDRSDVSVLDAIRSMSPDSDWASEGGDPCIPVLWSWVNCSSTSPPRVTKIALSRKNLR 427
Query: 427 GEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNL 486
GEIPP + MEALTELWLD N LTG LPDMS+L++L+I+HLENN+L+GSLP Y+ LPNL
Sbjct: 428 GEIPPGINYMEALTELWLDDNELTGTLPDMSKLVNLKIMHLENNQLSGSLPPYLAHLPNL 487
Query: 487 QELHIENNSFVGEIPPALLTGKVIFKYDNNPKLHKESRRRMRFKLILGTSXXXXXXXXXX 546
QEL IENNSF G+IP ALL GKV+FKY+NNP+L E++R+ F ILG S
Sbjct: 488 QELSIENNSFKGKIPSALLKGKVLFKYNNNPELQNEAQRK-HFWQILGISIAAVAILLLL 546
Query: 547 XXXXXXXXRKLRRKISNQKSYEKVCPLADSLRTSTKPSNTAYSIARGGHFMDEGVAYFIP 606
LR+ K +K DS T K AYS RGGH +DEGVAYFI
Sbjct: 547 VGGSLVLLCALRKT----KRADK----GDSTETKKK-GLVAYSAVRGGHLLDEGVAYFIS 597
Query: 607 LPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRI 666
LP LEEAT+NF KK+G+GSFGSVYYG+MKDGKEVAVKI AD SH +QFVTEVALLSRI
Sbjct: 598 LPVLEEATDNFSKKVGRGSFGSVYYGRMKDGKEVAVKITADPSSHLNRQFVTEVALLSRI 657
Query: 667 HHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLE 726
HHRNLVPLIGYCEE +RILVYEYMHNG+L D LHGS + KPLDWLTRLQIA DAAKGLE
Sbjct: 658 HHRNLVPLIGYCEEADRRILVYEYMHNGSLGDHLHGSSDYKPLDWLTRLQIAQDAAKGLE 717
Query: 727 YLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE 786
YLHTGCNP IIHRDVKSSNILLDINMRAKVSDFGLSRQ EEDLTH+SSVA+GTVGYLDPE
Sbjct: 718 YLHTGCNPSIIHRDVKSSNILLDINMRAKVSDFGLSRQTEEDLTHVSSVAKGTVGYLDPE 777
Query: 787 YYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP 846
YY +QQLTEKSDVYSFGVVL EL+SGKKPVS EDFG ELNIVHWARS+I+KGDV I+DP
Sbjct: 778 YYASQQLTEKSDVYSFGVVLFELLSGKKPVSAEDFGPELNIVHWARSLIRKGDVCGIIDP 837
Query: 847 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEXXXXX---XXXXXX 903
+ NVKIES+WR+AEVA QCVEQRG +RP+MQE+++AIQD+I+IE
Sbjct: 838 CIASNVKIESVWRVAEVANQCVEQRGHNRPRMQEVIVAIQDAIRIERGNENGLKSSSSSS 897
Query: 904 XXXXXXRKTLLTSFLEIESPDLSNECLAPAAR 935
RKTLLTSFLE+ESPD+S LAPAAR
Sbjct: 898 SKAQSSRKTLLTSFLELESPDISRNSLAPAAR 929
|
|
| TAIR|locus:2057991 AT2G37050 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2101 (744.6 bits), Expect = 1.7e-217, P = 1.7e-217
Identities = 429/891 (48%), Positives = 573/891 (64%)
Query: 8 LVIYLLFLSSVVSQVTEFISIDCGSTSNYTDPSTGLAWISDIGIMNNGKSVKVENPSGNW 67
LV LF SS +Q F+S+DCG +TD GL W D ++ G++ + + +
Sbjct: 12 LVSTCLFTSSS-AQAPGFVSLDCGGAEPFTD-ELGLKWSPDNHLIY-GETANISSVNETR 68
Query: 68 MQYRTRRDLPIDNKKYCYNLITKERRRYLVRATFQYGSL-GSEASYPKFQLYLDATLWST 126
QY T R P D++KYCY L R RYL+RATF YG+ S YPKF + L AT W+T
Sbjct: 69 TQYTTLRHFPADSRKYCYTLNVTSRNRYLIRATFLYGNFDNSNNVYPKFDISLGATHWAT 128
Query: 127 VTVLDASRVYAKEMIIRAPSDSIDVCICCAVTGSPFISTLELRPLNLSMYATDF-EDNFF 185
+ + + + E++ A S ++ VC+ A TG PFISTLELR L+ SMY + ED F+
Sbjct: 129 IVISETYIIETAELVFLASSPTVSVCLSNATTGQPFISTLELRQLSGSMYGSMLSEDRFY 188
Query: 186 LKVAARVNFGALTKDALRYPDDPYDRIWDSDLDRRPNFVVGAASGTVRINTTKNIETRTR 245
L VAAR+NFGA ++ ++RYPDDPYDRIW+SDL ++PN++V A+GTVR++TT IE+R
Sbjct: 189 LSVAARINFGAESEASVRYPDDPYDRIWESDLQKKPNYLVDVAAGTVRVSTTLPIESRVD 248
Query: 246 EYPPVKVMQTAVVGTEGVLSYRLNLEDFPANARAFAYFAEIQDLGPSETRKFKLEQPYFA 305
+ PP KVMQTAVVGT G L+YR+NL+ FP AF YFAEI+DL E+RKF+L P
Sbjct: 249 DRPPQKVMQTAVVGTNGSLTYRMNLDGFPGFGWAFTYFAEIEDLAEDESRKFRLVLPEQP 308
Query: 306 DYSNAVVNIAENANGSYTLYEPSYMNVTLNFVLSFSFVKTRDSTLGPLLNAIEISKYQKI 365
+YS +VVNI EN Y +Y P Y N+TL FVL+F F KT DS+ GP+LNA+EISKY +
Sbjct: 309 EYSKSVVNIKENTQRPYRVYAPGYPNITLPFVLNFRFAKTADSSRGPILNAMEISKYLR- 367
Query: 366 AAKTEWQ-DVMVLEALRSISDESERTNDRGDPCVPVPWEWVTCSTTTPPRITKIALSGKN 424
K++ D V+ + S+ +E + GDPC P PW WV C++ PR+ I LS N
Sbjct: 368 --KSDGSVDATVMANVASLYSSTEWAQEGGDPCSPSPWSWVQCNSDPQPRVVAIKLSSMN 425
Query: 425 LKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLP 484
L G IP +L + L ELWLDGN TGP+PD SR +L I+HLENN LTG +PS + LP
Sbjct: 426 LTGNIPSDLVKLTGLVELWLDGNSFTGPIPDFSRCPNLEIIHLENNRLTGKIPSSLTKLP 485
Query: 485 NLQELHIENNSFVGEIPPALLTGKVIFKYDNNPKLHKESRRRMRFKLILGTSXXXXXXXX 544
NL+EL+++NN G IP L VI + N L K + + +I+G S
Sbjct: 486 NLKELYLQNNVLTGTIPSDLAKD-VISNFSGNLNLEKSGDKGKKLGVIIGASVGAFVLLI 544
Query: 545 XXXXXXXXXXRKLRRKISNQKSYEKVCPLADSLRTSTKPSNTAYSIARGGHFMDEGVAYF 604
+ + N K + L + + S+T S A G A+
Sbjct: 545 ATIISCIVMCKSKK----NNKLGKTSAELTNRPLPIQRVSSTL-SEAHGD------AAHC 593
Query: 605 IPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLS 664
L E+EEAT F K+IG G FG VYYGK ++GKE+AVK++A++ ++F EV LLS
Sbjct: 594 FTLYEIEEATKKFEKRIGSGGFGIVYYGKTREGKEIAVKVLANNSYQGKREFANEVTLLS 653
Query: 665 RIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAK 723
RIHHRNLV +GYC+EE + +LVYE+MHNGTL++ L+G V + + W+ RL+IA DAA+
Sbjct: 654 RIHHRNLVQFLGYCQEEGKNMLVYEFMHNGTLKEHLYGVVPRDRRISWIKRLEIAEDAAR 713
Query: 724 GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYL 783
G+EYLHTGC P IIHRD+K+SNILLD +MRAKVSDFGLS+ A + +H+SS+ RGTVGYL
Sbjct: 714 GIEYLHTGCVPAIIHRDLKTSNILLDKHMRAKVSDFGLSKFAVDGTSHVSSIVRGTVGYL 773
Query: 784 DPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAEL-NIVHWARSMIKKGDVIS 842
DPEYY +QQLTEKSDVYSFGV+LLEL+SG++ +S E FG NIV WA+ I GD+
Sbjct: 774 DPEYYISQQLTEKSDVYSFGVILLELMSGQEAISNESFGVNCRNIVQWAKMHIDNGDIRG 833
Query: 843 IVDPVLI-GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 892
I+DP L + ++S+W+IAE A+ CV+ G RP M E+ IQD+I+IE
Sbjct: 834 IIDPALAEDDYSLQSMWKIAEKALLCVKPHGNMRPSMSEVQKDIQDAIRIE 884
|
|
| TAIR|locus:2126540 AT4G29990 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 762 (273.3 bits), Expect = 1.9e-125, Sum P(2) = 1.9e-125
Identities = 181/459 (39%), Positives = 259/459 (56%)
Query: 444 LDGNFLTGPL-PDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPP 502
L + LTG + P + L + + L NN LTG +P ++ SLPNL EL++E N G IP
Sbjct: 416 LSSSGLTGQIDPAFANLTSINKLDLSNNSLTGKVPDFLASLPNLTELNLEGNKLTGSIPA 475
Query: 503 ALLT----GKVIFKYDNNPKLHKE------SRRRMRFKLILGTSXXXXXXXXXXXXXXXX 552
LL G + ++ NP L + +++++ + + + S
Sbjct: 476 KLLEKSKDGSLSLRFGGNPDLCQSPSCQTTTKKKIGYIVPVVASLAGLLIVLTALALIWH 535
Query: 553 XXRKLRR-KISNQKSYEKVCPLADSLRTSTKPSNTAYSIARGGHFMDEGVAYFIPLPELE 611
++ RR ISN+ PL +T P +TA YFI E+
Sbjct: 536 FKKRSRRGTISNK-------PLG----VNTGPLDTAKR-------------YFI-YSEVV 570
Query: 612 EATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNL 671
TNNF + +GKG FG VY+G + +G +VAVKI+++ + ++F EV LL R+HH NL
Sbjct: 571 NITNNFERVLGKGGFGKVYHGFL-NGDQVAVKILSEESTQGYKEFRAEVELLMRVHHTNL 629
Query: 672 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 731
LIGYC E++ L+YEYM NG L D L G + L W RLQI+ DAA+GLEYLH G
Sbjct: 630 TSLIGYCNEDNHMALIYEYMANGNLGDYLSGK-SSLILSWEERLQISLDAAQGLEYLHYG 688
Query: 732 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE-EDLTHISSVARGTVGYLDPEYYGN 790
C P I+HRDVK +NILL+ N++AK++DFGLSR E + +S+V GT+GYLDPEYY
Sbjct: 689 CKPPIVHRDVKPANILLNENLQAKIADFGLSRSFPVEGSSQVSTVVAGTIGYLDPEYYAT 748
Query: 791 QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 850
+Q+ EKSDVYSFGVVLLE+I+GK P +++ SM+ GD+ IVD L
Sbjct: 749 RQMNEKSDVYSFGVVLLEVITGK-PAIWHSRTESVHLSDQVGSMLANGDIKGIVDQRLGD 807
Query: 851 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI 889
++ S W+I E+A+ C + RP M ++V+ ++ SI
Sbjct: 808 RFEVGSAWKITELALACASESSEQRPTMSQVVMELKQSI 846
|
|
| TAIR|locus:2055165 AT2G14510 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 658 (236.7 bits), Expect = 3.1e-125, Sum P(2) = 3.1e-125
Identities = 132/284 (46%), Positives = 187/284 (65%)
Query: 609 ELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHH 668
E++E TNNF +GKG FG VY+G + + ++VAVK+++ S + ++F TEV LL R+HH
Sbjct: 557 EVKEMTNNFEVVLGKGGFGVVYHGFLNN-EQVAVKVLSQSSTQGYKEFKTEVELLLRVHH 615
Query: 669 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYL 728
NLV L+GYC+E L+YE+M NG L++ L G L+W +RL+IA ++A G+EYL
Sbjct: 616 VNLVSLVGYCDEGIDLALIYEFMENGNLKEHLSGKRGGSVLNWSSRLKIAIESALGIEYL 675
Query: 729 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ-AEEDLTHISSVARGTVGYLDPEY 787
H GC P ++HRDVKS+NILL + AK++DFGLSR H+S+ GT+GYLDPEY
Sbjct: 676 HIGCQPPMVHRDVKSTNILLGLRFEAKLADFGLSRSFLVGSQAHVSTNVAGTLGYLDPEY 735
Query: 788 YGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 847
Y LTEKSDVYSFG+VLLE I+G+ PV +E + IV WA+SM+ GD+ SI+DP
Sbjct: 736 YLKNWLTEKSDVYSFGIVLLESITGQ-PV-IEQSRDKSYIVEWAKSMLANGDIESIMDPN 793
Query: 848 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 891
L + S W+ E+A+ C+ RP M + + + ++I
Sbjct: 794 LHQDYDSSSSWKALELAMLCINPSSTQRPNMTRVAHELNECLEI 837
|
|
| TAIR|locus:2055160 AT2G14440 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 654 (235.3 bits), Expect = 1.3e-124, Sum P(2) = 1.3e-124
Identities = 131/284 (46%), Positives = 188/284 (66%)
Query: 609 ELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHH 668
E++E TNNF +GKG FG VY+G + + ++VAVK+++ S + ++F TEV LL R+HH
Sbjct: 575 EVKEMTNNFEVVLGKGGFGVVYHGFLNN-EQVAVKVLSQSSTQGYKEFKTEVELLLRVHH 633
Query: 669 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYL 728
NLV L+GYC++ + L+YE+M NG L++ L G L+W RL+IA ++A G+EYL
Sbjct: 634 VNLVSLVGYCDKGNDLALIYEFMENGNLKEHLSGKRGGPVLNWPGRLKIAIESALGIEYL 693
Query: 729 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ-AEEDLTHISSVARGTVGYLDPEY 787
H GC P ++HRDVKS+NILL + AK++DFGLSR TH+S+ GT+GYLDPEY
Sbjct: 694 HIGCKPPMVHRDVKSTNILLGLRFEAKLADFGLSRSFLVGSQTHVSTNVAGTLGYLDPEY 753
Query: 788 YGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 847
Y LTEKSDVYSFG+VLLE+I+G+ PV +E + IV WA+SM+ GD+ SI+D
Sbjct: 754 YQKNWLTEKSDVYSFGIVLLEIITGQ-PV-IEQSRDKSYIVEWAKSMLANGDIESIMDRN 811
Query: 848 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 891
L + S W+ E+A+ C+ RP M + + + ++I
Sbjct: 812 LHQDYDTSSSWKALELAMLCINPSSTLRPNMTRVAHELNECLEI 855
|
|
| TAIR|locus:2028446 AT1G49100 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 720 (258.5 bits), Expect = 6.5e-123, Sum P(2) = 6.5e-123
Identities = 140/285 (49%), Positives = 192/285 (67%)
Query: 609 ELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHH 668
E+ E TNNF +GKG FG VY+G + ++VAVK+++ + H +QF EV LL R+HH
Sbjct: 575 EVTEMTNNFRSVLGKGGFGMVYHGYVNGREQVAVKVLSHASKHGHKQFKAEVELLLRVHH 634
Query: 669 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYL 728
+NLV L+GYCE+ + LVYEYM NG L++ G L W TRLQIA +AA+GLEYL
Sbjct: 635 KNLVSLVGYCEKGKELALVYEYMANGDLKEFFSGKRGDDVLRWETRLQIAVEAAQGLEYL 694
Query: 729 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ-AEEDLTHISSVARGTVGYLDPEY 787
H GC P I+HRDVK++NILLD + +AK++DFGLSR E +H+S+V GT+GYLDPEY
Sbjct: 695 HKGCRPPIVHRDVKTANILLDEHFQAKLADFGLSRSFLNEGESHVSTVVAGTIGYLDPEY 754
Query: 788 YGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 847
Y LTEKSDVYSFGVVLLE+I+ ++ + E + +I W MI KGD+ IVDP
Sbjct: 755 YRTNWLTEKSDVYSFGVVLLEIITNQRVI--ERTREKPHIAEWVNLMITKGDIRKIVDPN 812
Query: 848 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 892
L G+ +S+W+ E+A+ CV +RP M ++V + + + +E
Sbjct: 813 LKGDYHSDSVWKFVELAMTCVNDSSATRPTMTQVVTELTECVTLE 857
|
|
| TAIR|locus:2195850 AT1G51860 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 693 (249.0 bits), Expect = 1.2e-121, Sum P(2) = 1.2e-121
Identities = 138/289 (47%), Positives = 191/289 (66%)
Query: 605 IPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLS 664
I PE+ + TNNF + +GKG FG+VY+G + DG EVAVK+++ S + ++F EV LL
Sbjct: 574 ITYPEVLKMTNNFERVLGKGGFGTVYHGNL-DGAEVAVKMLSHSSAQGYKEFKAEVELLL 632
Query: 665 RIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKG 724
R+HHR+LV L+GYC++ L+YEYM NG LR+ + G L W R+QIA +AA+G
Sbjct: 633 RVHHRHLVGLVGYCDDGDNLALIYEYMANGDLRENMSGKRGGNVLTWENRMQIAVEAAQG 692
Query: 725 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED-LTHISSVARGTVGYL 783
LEYLH GC P ++HRDVK++NILL+ AK++DFGLSR D H+S+V GT GYL
Sbjct: 693 LEYLHNGCRPPMVHRDVKTTNILLNERCGAKLADFGLSRSFPIDGECHVSTVVAGTPGYL 752
Query: 784 DPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISI 843
DPEYY L+EKSDVYSFGVVLLE+++ + PV ++ +I W M+ KGD+ SI
Sbjct: 753 DPEYYRTNWLSEKSDVYSFGVVLLEIVTNQ-PV-IDKTRERPHINDWVGFMLTKGDIKSI 810
Query: 844 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 892
VDP L+G+ W+I E+A+ CV RP M +V+ + D + +E
Sbjct: 811 VDPKLMGDYDTNGAWKIVELALACVNPSSNRRPTMAHVVMELNDCVALE 859
|
|
| TAIR|locus:2824870 AT1G51805 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 691 (248.3 bits), Expect = 1.5e-121, Sum P(2) = 1.5e-121
Identities = 135/280 (48%), Positives = 192/280 (68%)
Query: 614 TNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVP 673
TNNF + +GKG FG VY+G + ++VAVKI++ S S +QF EV LL R+HH+NLV
Sbjct: 576 TNNFQRILGKGGFGIVYHGFVNGVEQVAVKILSHSSSQGYKQFKAEVELLLRVHHKNLVG 635
Query: 674 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 733
L+GYC+E L+YEYM NG L++ + G+ N+ L+W TRL+I D+A+GLEYLH GC
Sbjct: 636 LVGYCDEGENMALIYEYMANGDLKEHMSGTRNRFILNWETRLKIVIDSAQGLEYLHNGCK 695
Query: 734 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE-EDLTHISSVARGTVGYLDPEYYGNQQ 792
P ++HRDVK++NILL+ + AK++DFGLSR TH+S+V GT GYLDPEYY +
Sbjct: 696 PLMVHRDVKTTNILLNEHFEAKLADFGLSRSFPIGGETHVSTVVAGTPGYLDPEYYKTNR 755
Query: 793 LTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNV 852
LTEKSDVYSFG+VLLE+I+ + PV ++ + I W M+ KGD+ISI+DP L G+
Sbjct: 756 LTEKSDVYSFGIVLLEMITNR-PV-IDQSREKPYISEWVGIMLTKGDIISIMDPSLNGDY 813
Query: 853 KIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 892
S+W+ E+A+ C+ RP M ++++A+ + + E
Sbjct: 814 DSGSVWKAVELAMSCLNPSSTRRPTMSQVLIALNECLVSE 853
|
|
| TAIR|locus:2078191 AT3G46420 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 688 (247.2 bits), Expect = 1.1e-120, Sum P(2) = 1.1e-120
Identities = 133/282 (47%), Positives = 184/282 (65%)
Query: 612 EATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNL 671
+ TNNF + +G+G FG VY+G + ++VAVK+++ S ++F EV LL R+HH NL
Sbjct: 528 DMTNNFQRALGEGGFGVVYHGYLNGSEQVAVKLLSQSSVQGYKEFKAEVELLLRVHHINL 587
Query: 672 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 731
V L+GYC++ + LVYEYM NG L+ L G N L W TRLQIA DAA GLEYLH G
Sbjct: 588 VSLVGYCDDRNHLALVYEYMSNGDLKHHLSGRNNGFVLSWSTRLQIAVDAALGLEYLHIG 647
Query: 732 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE-EDLTHISSVARGTVGYLDPEYYGN 790
C P ++HRDVKS+NILL AK++DFGLSR + D HIS+V GT GYLDPEYY
Sbjct: 648 CRPSMVHRDVKSTNILLGEQFTAKMADFGLSRSFQIGDENHISTVVAGTPGYLDPEYYRT 707
Query: 791 QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 850
+L EKSD+YSFG+VLLE+I+ + +++ + +I W S+I +GD+ I+DP L G
Sbjct: 708 SRLAEKSDIYSFGIVLLEMITSQH--AIDRTRVKHHITDWVVSLISRGDITRIIDPNLQG 765
Query: 851 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 892
N S+WR E+A+ C RP M ++V+ +++ + E
Sbjct: 766 NYNSRSVWRALELAMSCANPTSEKRPNMSQVVIDLKECLATE 807
|
|
| TAIR|locus:2066133 AT2G28960 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 692 (248.7 bits), Expect = 2.8e-120, Sum P(2) = 2.8e-120
Identities = 163/463 (35%), Positives = 246/463 (53%)
Query: 439 LTELWLDGNFLTGPL-PDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFV 497
+ L L L G + P L +LR + L NN TG +P ++ S+ +L +++ N
Sbjct: 410 IISLDLSSRGLKGVIAPAFQNLTELRKLDLSNNSFTGGVPEFLASMKSLSIINLNWNDLT 469
Query: 498 GEIPPALLTGK---VIFKYDNNPKLHKES--RRRMRFKLILGTSXXXXXXXXXXXXXXXX 552
G +P LL + + NPKL ++ + I+
Sbjct: 470 GPLPKLLLDREKNGLKLTIQGNPKLCNDASCKNNNNQTYIVPVVASVASVLIIIAVLILI 529
Query: 553 XXRKLRR--KISNQKSYEKVCPLADSLRTSTKPSNTAYSIARGGHFMDEGVAYFIPLPEL 610
K RR ++ + + + P S+ T TK YS E+
Sbjct: 530 LVFKKRRPTQVDSLPTVQHGLPNRPSIFTQTK--RFTYS-------------------EV 568
Query: 611 EEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRN 670
E T+NF + +G+G FG VY+G + + +AVK+++ S ++F EV LL R+HH N
Sbjct: 569 EALTDNFERVLGEGGFGVVYHGILNGTQPIAVKLLSQSSVQGYKEFKAEVELLLRVHHVN 628
Query: 671 LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 730
LV L+GYC+EE L+YEY NG L+ L G PL W +RL+I + A+GLEYLHT
Sbjct: 629 LVSLVGYCDEESNLALLYEYAPNGDLKQHLSGERGGSPLKWSSRLKIVVETAQGLEYLHT 688
Query: 731 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED-LTHISSVARGTVGYLDPEYYG 789
GC P ++HRDVK++NILLD + +AK++DFGLSR TH+S+ GT GYLDPEYY
Sbjct: 689 GCKPPMVHRDVKTTNILLDEHFQAKLADFGLSRSFPVGGETHVSTAVAGTPGYLDPEYYR 748
Query: 790 NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 849
+L EKSDVYSFG+VLLE+I+ + PV ++ + +I W M+ KGD+ ++VDP L
Sbjct: 749 TNRLNEKSDVYSFGIVLLEIITSR-PV-IQQTREKPHIAAWVGYMLTKGDIENVVDPRLN 806
Query: 850 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 892
+ + S+W+ E+A+ CV RP M ++ ++ + +E
Sbjct: 807 RDYEPTSVWKALEIAMSCVNPSSEKRPTMSQVTNELKQCLTLE 849
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| C0LGI2 | Y1677_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7194 | 0.9850 | 0.9913 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | eugene3.00100504 | hypothetical protein (934 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 935 | |||
| pfam12819 | 335 | pfam12819, Malectin_like, Carbohydrate-binding pro | 3e-90 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 5e-53 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-52 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 4e-52 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 7e-52 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 6e-48 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 8e-48 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-43 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 5e-41 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-39 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 7e-34 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 7e-34 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 9e-34 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-33 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-32 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 3e-32 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 5e-32 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 9e-32 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 4e-31 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-29 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-29 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 3e-29 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 4e-29 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 4e-29 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 4e-29 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-28 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-28 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 3e-28 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 4e-28 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 7e-28 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-27 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-27 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 4e-27 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 7e-27 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-26 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-26 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-26 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 7e-26 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 7e-26 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-25 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-25 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-25 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 6e-25 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-24 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-24 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-24 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-24 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 4e-24 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 8e-24 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-23 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-23 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-23 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-23 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-23 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-23 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-23 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 3e-23 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 3e-23 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 3e-23 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 4e-23 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 6e-23 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 7e-23 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 7e-23 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-22 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-22 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-22 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-22 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 3e-22 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 4e-22 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 4e-22 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 6e-22 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 9e-22 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 9e-22 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-21 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-21 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-21 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-21 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 3e-21 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 3e-21 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 4e-21 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 4e-21 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 4e-21 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 5e-21 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 8e-21 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 8e-21 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-20 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-20 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-20 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-20 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-20 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-20 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-20 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-20 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 3e-20 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 4e-20 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 6e-20 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 8e-20 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 9e-20 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-19 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-19 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-19 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-19 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-19 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-19 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 3e-19 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 3e-19 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 4e-19 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 8e-19 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-18 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-18 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 1e-18 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-18 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-18 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-18 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-18 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-18 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-18 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 4e-18 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 7e-18 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 8e-18 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-17 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-17 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-17 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-17 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 3e-17 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 4e-17 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 4e-17 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 4e-17 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 4e-17 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 4e-17 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 4e-17 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 5e-17 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 5e-17 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 5e-17 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 5e-17 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 6e-17 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 7e-17 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 8e-17 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 9e-17 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 1e-16 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-16 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-16 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 3e-16 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 3e-16 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 4e-16 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 4e-16 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 5e-16 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 5e-16 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 9e-16 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 9e-16 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 1e-15 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-15 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-15 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-15 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-15 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-15 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-15 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 2e-15 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 3e-15 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 5e-15 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 5e-15 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 7e-15 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 7e-15 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 8e-15 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-14 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-14 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 1e-14 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-14 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-14 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-14 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-14 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-14 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-14 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 3e-14 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 4e-14 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 4e-14 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 4e-14 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 4e-14 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 5e-14 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 6e-14 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 6e-14 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 7e-14 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 7e-14 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 7e-14 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 7e-14 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-13 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-13 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-13 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-13 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-13 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-13 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-13 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-13 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-13 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-13 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-13 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 3e-13 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 3e-13 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 3e-13 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 4e-13 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 5e-13 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 5e-13 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 7e-13 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 7e-13 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 7e-13 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 7e-13 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 8e-13 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 9e-13 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-12 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-12 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-12 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-12 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-12 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-12 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-12 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-12 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-12 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-12 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-12 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 3e-12 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 3e-12 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 4e-12 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 4e-12 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 8e-12 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 9e-12 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-11 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-11 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-11 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-11 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-11 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 2e-11 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 2e-11 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-11 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-11 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-11 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-11 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-11 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-11 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-11 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 3e-11 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 3e-11 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-11 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 4e-11 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 4e-11 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 4e-11 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 4e-11 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 5e-11 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 5e-11 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 6e-11 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 8e-11 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-10 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-10 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-10 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-10 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-10 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-10 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-10 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-10 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-10 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 3e-10 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 4e-10 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 4e-10 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 4e-10 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 4e-10 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 5e-10 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 5e-10 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 5e-10 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 8e-10 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 9e-10 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 9e-10 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 9e-10 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-09 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 1e-09 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-09 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-09 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-09 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-09 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-09 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 3e-09 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 3e-09 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 3e-09 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-09 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 5e-09 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 5e-09 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-08 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-08 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-08 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-08 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-08 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 3e-08 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 3e-08 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 5e-08 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 6e-08 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 6e-08 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 7e-08 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 7e-08 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 8e-08 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 9e-08 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-07 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-07 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 2e-07 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-07 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 3e-07 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 3e-07 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-07 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 6e-07 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-06 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 1e-06 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 1e-06 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 1e-06 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 1e-06 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-06 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 2e-06 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 4e-06 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 6e-06 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-05 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 1e-04 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 2e-04 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 2e-04 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-04 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 4e-04 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 7e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 0.002 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.002 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 0.003 |
| >gnl|CDD|221790 pfam12819, Malectin_like, Carbohydrate-binding protein of the ER | Back alignment and domain information |
|---|
Score = 290 bits (743), Expect = 3e-90
Identities = 134/355 (37%), Positives = 185/355 (52%), Gaps = 40/355 (11%)
Query: 28 IDCGSTSN--YTDPSTGLAWISDIGIMNNGKSVKV-ENPSGNWM--QYRTRRDLPIDNKK 82
IDCG SN YTDPSTG+ W+SD G ++ GKS + + S +++ Y+T R P D K+
Sbjct: 1 IDCGLPSNESYTDPSTGITWVSDAGFIDTGKSGNISKENSSSFLSKPYKTLRSFP-DGKR 59
Query: 83 YCYNL--ITKERRRYLVRATFQYGS---LGSEASYPKFQLYLDATLWSTV-TVLDASRVY 136
CY L + +YL+RATF YG+ L S +S P F LYL LW+TV D+
Sbjct: 60 NCYTLPVTPGKGTKYLIRATFLYGNYDGLNSVSSPPSFDLYLGVNLWTTVNLSNDSGDSV 119
Query: 137 AKEMIIRAP-SDSIDVCICCAVTGSPFISTLELRPLNLSMYATDFEDNFFLKVAARVNFG 195
KE II SD++ VC+ TG+PFIS LELRPL S+Y + + LK+ AR+NFG
Sbjct: 120 VKEYIIHVTKSDTLSVCLVNTGTGTPFISALELRPLPDSLYPSSG-GSQALKLVARLNFG 178
Query: 196 ALTKDALRYPDDPYDRIWDSDLDRRPNFVVGAASGTVRINTTKNI---ETRTREYPPVKV 252
++ +RYPDD YDRIW+ + G +I+T+ ++ PP V
Sbjct: 179 G-SEGTIRYPDDVYDRIWEPFFS---------SPGWSQISTSLSVDISSNNAPYIPPSAV 228
Query: 253 MQTAVVGTEGVLSYRL--NLEDFPANARAFAYFAEIQDLGPSETRKFKL---EQPYFADY 307
+QTAV T +L D + +FAEIQ L ETR+F + + + D
Sbjct: 229 LQTAVTPTNASAPLNFTWDLVDPNFEYYVYLHFAEIQSL---ETREFDIYINGKTVYGDV 285
Query: 308 SNAVVNIAENANGSYTLYEPSYMNVTLNFVLSFSFVKTRDSTLGPLLNAIEISKY 362
S + LY +NV+ +L+ S V T STL PLLNA+EI K
Sbjct: 286 S-----PKYLGTDTGALYLDFPVNVSGGGLLNISLVPTSGSTLPPLLNALEIFKV 335
|
Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan. The domain is found on a number of plant receptor kinases. Length = 335 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 185 bits (472), Expect = 5e-53
Identities = 73/207 (35%), Positives = 115/207 (55%), Gaps = 13/207 (6%)
Query: 617 FCKKIGKGSFGSVYYGKMKDGKE-----VAVKIMADSCSHRTQQ-FVTEVALLSRIHHRN 670
KK+G+G+FG VY G +K E VAVK + + S ++ F+ E +++ ++ H N
Sbjct: 3 LGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPN 62
Query: 671 LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 730
+V L+G C + +V EYM G L D L + + L LQ+A AKG+EYL
Sbjct: 63 IVRLLGVCTQGEPLYIVTEYMPGGDLLDFLR--KHGEKLTLKDLLQMALQIAKGMEYLE- 119
Query: 731 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSV-ARGTVGYLDPEYYG 789
+ +HRD+ + N L+ N+ K+SDFGLSR ED + + + ++ PE
Sbjct: 120 --SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLK 177
Query: 790 NQQLTEKSDVYSFGVVLLELIS-GKKP 815
+ + T KSDV+SFGV+L E+ + G++P
Sbjct: 178 DGKFTSKSDVWSFGVLLWEIFTLGEQP 204
|
Length = 258 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 182 bits (463), Expect = 2e-52
Identities = 77/193 (39%), Positives = 113/193 (58%), Gaps = 10/193 (5%)
Query: 621 IGKGSFGSVYYGK-MKDGKEVAVKIM-ADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYC 678
+G+G FG+VY + K GK+VA+KI+ + S ++ + E+ +L +++H N+V L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 679 EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIH 738
E+E+ LV EY G+L+D L N+ L L+I +GLEYLH + GIIH
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLK--ENEGKLSEDEILRILLQILEGLEYLH---SNGIIH 115
Query: 739 RDVKSSNILLD-INMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY-GNQQLTEK 796
RD+K NILLD N + K++DFGLS+ D + GT Y+ PE G +EK
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSD-KSLLKTIVGTPAYMAPEVLLGKGYYSEK 174
Query: 797 SDVYSFGVVLLEL 809
SD++S GV+L EL
Sbjct: 175 SDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 183 bits (466), Expect = 4e-52
Identities = 74/206 (35%), Positives = 113/206 (54%), Gaps = 11/206 (5%)
Query: 617 FCKKIGKGSFGSVYYGKMKDGK-----EVAVKIMADSCSHRTQQ-FVTEVALLSRIHHRN 670
KK+G+G+FG VY G +K EVAVK + + S + + F+ E ++ ++ H N
Sbjct: 3 LGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPN 62
Query: 671 LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 730
+V L+G C EE ++V EYM G L D L + K L L A A+G+EYL +
Sbjct: 63 IVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRP-KELSLSDLLSFALQIARGMEYLES 121
Query: 731 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN 790
IHRD+ + N L+ N+ K+SDFGLSR +D + + + ++ PE
Sbjct: 122 K---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKE 178
Query: 791 QQLTEKSDVYSFGVVLLELIS-GKKP 815
+ T KSDV+SFGV+L E+ + G++P
Sbjct: 179 GKFTSKSDVWSFGVLLWEIFTLGEEP 204
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 181 bits (463), Expect = 7e-52
Identities = 74/206 (35%), Positives = 113/206 (54%), Gaps = 12/206 (5%)
Query: 617 FCKKIGKGSFGSVYYGKMKDGK-----EVAVKIMADSCS-HRTQQFVTEVALLSRIHHRN 670
KK+G+G+FG VY GK+K EVAVK + + S + ++F+ E ++ ++ H N
Sbjct: 3 LGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPN 62
Query: 671 LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 730
+V L+G C EE +V EYM G L L N+ L L A A+G+EYL +
Sbjct: 63 VVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRK--NRPKLSLSDLLSFALQIARGMEYLES 120
Query: 731 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN 790
IHRD+ + N L+ N+ K+SDFGLSR +D + + + ++ PE
Sbjct: 121 K---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKE 177
Query: 791 QQLTEKSDVYSFGVVLLELIS-GKKP 815
+ T KSDV+SFGV+L E+ + G++P
Sbjct: 178 GKFTSKSDVWSFGVLLWEIFTLGEQP 203
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 171 bits (435), Expect = 6e-48
Identities = 70/199 (35%), Positives = 105/199 (52%), Gaps = 10/199 (5%)
Query: 619 KKIGKGSFGSVYYGKMKD-GKEVAVKIM-ADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 676
+K+G+GSFG VY + K GK VA+K++ ++ + E+ +L ++ H N+V L
Sbjct: 5 EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64
Query: 677 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 736
E+E + LV EY G L D L + L LEYLH + GI
Sbjct: 65 VFEDEDKLYLVMEYCEGGDLFDLLK---KRGRLSEDEARFYLRQILSALEYLH---SKGI 118
Query: 737 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEK 796
+HRD+K NILLD + K++DFGL+RQ + + V GT Y+ PE + +
Sbjct: 119 VHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFV--GTPEYMAPEVLLGKGYGKA 176
Query: 797 SDVYSFGVVLLELISGKKP 815
D++S GV+L EL++GK P
Sbjct: 177 VDIWSLGVILYELLTGKPP 195
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 170 bits (434), Expect = 8e-48
Identities = 75/210 (35%), Positives = 109/210 (51%), Gaps = 16/210 (7%)
Query: 619 KKIGKGSFGSVYYGKMKDGK----EVAVKIMADSCSHRTQ-QFVTEVALLSRIHHRNLVP 673
KK+G+G+FG VY GK+K EVAVK + + S + F+ E ++ ++ H N+V
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 674 LIGYCEEEHQRILVYEYMHNGTLRDRL------HGSVNQKPLDWLTRLQIAHDAAKGLEY 727
L+G C EE LV EYM G L D L S + L L A AKG+EY
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 728 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGT-VGYLDPE 786
L + +HRD+ + N L+ ++ K+SDFGLSR +D + + ++ PE
Sbjct: 121 LA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPE 177
Query: 787 YYGNQQLTEKSDVYSFGVVLLELIS-GKKP 815
+ T KSDV+SFGV+L E+ + G P
Sbjct: 178 SLKDGIFTSKSDVWSFGVLLWEIFTLGATP 207
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 158 bits (401), Expect = 2e-43
Identities = 82/203 (40%), Positives = 112/203 (55%), Gaps = 15/203 (7%)
Query: 619 KKIGKGSFGSVYYGKMK-DGKEVAVKIM----ADSCSHRTQQFVTEVALLSRIHHRNLVP 673
+K+G GSFG+VY K K GK VAVKI+ S + Q E+ +L R+ H N+V
Sbjct: 5 RKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSK--KDQTARREIRILRRLSHPNIVR 62
Query: 674 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 733
LI E++ LV EY G L D L PL +IA +GLEYLH +
Sbjct: 63 LIDAFEDKDHLYLVMEYCEGGDLFDYL---SRGGPLSEDEAKKIALQILRGLEYLH---S 116
Query: 734 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE-YYGNQQ 792
GIIHRD+K NILLD N K++DFGL+++ + + +++ GT Y+ PE G
Sbjct: 117 NGIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFV-GTPWYMAPEVLLGGNG 175
Query: 793 LTEKSDVYSFGVVLLELISGKKP 815
K DV+S GV+L EL++GK P
Sbjct: 176 YGPKVDVWSLGVILYELLTGKPP 198
|
Length = 260 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 151 bits (383), Expect = 5e-41
Identities = 65/205 (31%), Positives = 110/205 (53%), Gaps = 16/205 (7%)
Query: 619 KKIGKGSFGSVYYGKMKD-GKEVAVK-IMADSCSHRT-QQFVTEVALLSRIHHRNLVPLI 675
+ +G+GSFGSVY KD G+ +AVK + S + E+ +LS + H N+V
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 676 G-YCEEEHQRILVY-EYMHNGTLRDRLH--GSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 731
G +EE + ++ EY+ G+L L G + + + TR QI GL YLH
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTR-QILE----GLAYLH-- 118
Query: 732 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ-AEEDLTHISSVARGTVGYLDPEYYGN 790
+ GI+HRD+K +NIL+D + K++DFG +++ + + + RGT ++ PE
Sbjct: 119 -SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRG 177
Query: 791 QQLTEKSDVYSFGVVLLELISGKKP 815
++ +D++S G ++E+ +GK P
Sbjct: 178 EEYGRAADIWSLGCTVIEMATGKPP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 147 bits (373), Expect = 1e-39
Identities = 74/201 (36%), Positives = 112/201 (55%), Gaps = 14/201 (6%)
Query: 619 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 677
+KIGKG FG VY + K GKEVA+K++ + ++ + E+ +L + H N+V G
Sbjct: 6 EKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGS 65
Query: 678 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA---HDAAKGLEYLHTGCNP 734
++ + +V E+ G+L+D L + NQ LT QIA + KGLEYLH +
Sbjct: 66 YLKKDELWIVMEFCSGGSLKDLLKST-NQT----LTESQIAYVCKELLKGLEYLH---SN 117
Query: 735 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLT 794
GIIHRD+K++NILL + K+ DFGLS Q + + V GT ++ PE +
Sbjct: 118 GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMV--GTPYWMAPEVINGKPYD 175
Query: 795 EKSDVYSFGVVLLELISGKKP 815
K+D++S G+ +EL GK P
Sbjct: 176 YKADIWSLGITAIELAEGKPP 196
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 130 bits (330), Expect = 7e-34
Identities = 75/216 (34%), Positives = 105/216 (48%), Gaps = 38/216 (17%)
Query: 619 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHR--TQQFVTEVALLSRIHHRNLVPLI 675
K+IGKGSFG VY + K DGK +K + S + + EV +L +++H N+ I
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNI---I 62
Query: 676 GYCE--EEHQRIL-VYEYMHNGTLRDRLHGSVNQKP----------LDWLTRLQIAHDAA 722
Y E EE ++ V EY G L ++ QK LDW Q+
Sbjct: 63 KYYESFEEKGKLCIVMEYADGGDLSQKIK---KQKKEGKPFPEEQILDWFV--QLC---- 113
Query: 723 KGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVG- 781
L+YLH+ I+HRD+K NI L N K+ DFG+S+ L+ +A+ VG
Sbjct: 114 LALKYLHS---RKILHRDIKPQNIFLTSNGLVKLGDFGISKV----LSSTVDLAKTVVGT 166
Query: 782 --YLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 815
YL PE N+ KSD++S G VL EL + K P
Sbjct: 167 PYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHP 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 140 bits (354), Expect = 7e-34
Identities = 126/491 (25%), Positives = 211/491 (42%), Gaps = 49/491 (9%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNE 471
+ ++ LS L GEIP EL + + L L L N L+G +P S + L + L N+
Sbjct: 499 SELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQ 558
Query: 472 LTGSLPSYMGSLPNLQELHIENNSFVGEIPP--ALL-------TGKVIFKYDNNPKLHKE 522
L+G +P +G++ +L +++I +N G +P A L G + +
Sbjct: 559 LSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPP 618
Query: 523 SRRRMRFKLILGTSIGVLAILLVLFLCSLIVLRKLRRKISNQKSYEKVCPLADSLRTSTK 582
+R + L LVL L + + R K E + +K
Sbjct: 619 CKRVRKTPSWWFYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFDSK 678
Query: 583 PSNTAYSIARGGHFMDEGVAYFIPLPELEEATNNFCKKIGKGSFGSVYYGK-MKDGKEVA 641
S + + L L+E N I +G G+ Y GK +K+G +
Sbjct: 679 VSKS---------ITINDI-----LSSLKE--ENV---ISRGKKGASYKGKSIKNGMQFV 719
Query: 642 VKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLH 701
VK + D S + +E+A + ++ H N+V LIG C E L++EY+ L + L
Sbjct: 720 VKEINDVNSIPS----SEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR 775
Query: 702 GSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGL 761
L W R +IA AK L +LH C+P ++ ++ I++D + L
Sbjct: 776 N------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSL 828
Query: 762 SRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDF 821
D S A Y+ PE + +TEKSD+Y FG++L+EL++GK P E F
Sbjct: 829 PGLLCTDTKCFISSA-----YVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAE-F 882
Query: 822 GAELNIVHWARSMIKKGDVISIVDPVLIGNVKIES--IWRIAEVAIQCVEQRGFSRPKMQ 879
G +IV WAR + +DP + G+V + I + +A+ C +RP
Sbjct: 883 GVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCAN 942
Query: 880 EIVLAIQDSIK 890
+++ ++ + +
Sbjct: 943 DVLKTLESASR 953
|
Length = 968 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 130 bits (328), Expect = 9e-34
Identities = 69/196 (35%), Positives = 110/196 (56%), Gaps = 11/196 (5%)
Query: 621 IGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEE 680
IGKG FG V G + G++VAVK + D S Q F+ E ++++ + H NLV L+G +
Sbjct: 14 IGKGEFGDVMLGDYR-GQKVAVKCLKDD-STAAQAFLAEASVMTTLRHPNLVQLLGVVLQ 71
Query: 681 EHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRD 740
+ +V EYM G+L D L S + + +L A D +G+EYL +HRD
Sbjct: 72 GNPLYIVTEYMAKGSLVDYLR-SRGRAVITLAQQLGFALDVCEGMEYLEE---KNFVHRD 127
Query: 741 VKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVY 800
+ + N+L+ ++ AKVSDFGL+++A + + V + PE ++ + KSDV+
Sbjct: 128 LAARNVLVSEDLVAKVSDFGLAKEASQGQD----SGKLPVKWTAPEALREKKFSTKSDVW 183
Query: 801 SFGVVLLELIS-GKKP 815
SFG++L E+ S G+ P
Sbjct: 184 SFGILLWEIYSFGRVP 199
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 136 bits (345), Expect = 2e-33
Identities = 148/605 (24%), Positives = 247/605 (40%), Gaps = 65/605 (10%)
Query: 14 FLSSVVSQVTEFISIDCGSTSNYTDPSTGLAWISDIGIMNNGKSVKVENPSGNWMQYRTR 73
L+S+ S + I CG+ N T W D G PS +T
Sbjct: 14 VLASLASPEPFTMRISCGARVNVRTAPTNTLWYKDFA-YTGGIPANATRPSFIAPPLKTL 72
Query: 74 RDLPI-DNKKYCYNLITKERRRYLVRATFQYGSLGSEASYPKFQLYLDATL-------WS 125
R P+ D + CYN+ + Y VR F + + S P F + ++ T WS
Sbjct: 73 RYFPLSDGPENCYNINRVPKGHYSVRVFFGLVAEPNFDSEPLFDVSVEGTQISSLKSGWS 132
Query: 126 TVTVLDASRVYAKEMIIRAPSDSIDVCICCAVTGSPFISTLELRPLNLSMY--ATDFEDN 183
+ +V+A E ++ S +C G P I ++E+ ++ Y +
Sbjct: 133 S----HDEQVFA-EALVFLTDGSASICFHSTGHGDPAILSIEILQVDDKAYNFGPSWGQG 187
Query: 184 FFLKVAARVNFGA-LTKDALRYPDDPY--DRIWDSDLDRRPNFVVGAASGTVRINTTKNI 240
L+ A R++ GA +K Y D + DR W+ F G+ N K
Sbjct: 188 VILRTAKRLSCGAGKSKFDEDYSGDHWGGDRFWNRM----QTFGSGSDQAISTENVIKKA 243
Query: 241 ETRTREYPPVKVMQTAVVGTEGV--LSYRLNLEDFP-ANARAFAYFAEI-QDLGPSETRK 296
YP + Q+A+V T+ LSY ++++ P N + +FAEI + R
Sbjct: 244 SNAPNFYPE-SLYQSALVSTDTQPDLSYTMDVD--PNRNYSVWLHFAEIDNSITAEGKRV 300
Query: 297 FKL---EQPYFADYSNAVVNIAENANGSYTLYEPSYMNVTLNF---VLSFSFVKTRDSTL 350
F + F D V+I + + YT +N T+ L+ + +
Sbjct: 301 FDVLINGDTAFKD-----VDIVKMSGERYTAL---VLNKTVAVSGRTLTIVLQPKKGTH- 351
Query: 351 GPLLNAIEISKYQKIAA--KTEWQDVMVLEALRSISDESERTNDRGDPCVPV--PWEWVT 406
++NAIE+ ++ I A KT ++V L+ L+S R GDPCVP PW
Sbjct: 352 -AIINAIEV--FEIITAESKTLLEEVSALQTLKSSLGLPLRFGWNGDPCVPQQHPWSGAD 408
Query: 407 C---STTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDL 462
C ST I + L + L+G IP ++ + L + L GN + G +P + + L
Sbjct: 409 CQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSL 468
Query: 463 RIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL---LTGKVIFKYDNNPKL 519
++ L N GS+P +G L +L+ L++ NS G +P AL L + F + +N L
Sbjct: 469 EVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGL 528
Query: 520 -----HKESRRRMRFKLILGTSIGVLAILLVLFLCSLIVLRKLRRKISNQKSYEKVCPLA 574
+ + +G + GV L L +C++ ++ + + Q+ + P A
Sbjct: 529 CGIPGLRACGPHLSVGAKIGIAFGVSVAFLFLVICAMCWWKRRQNILRAQRIAAREAPYA 588
Query: 575 DSLRT 579
+ RT
Sbjct: 589 KA-RT 592
|
Length = 623 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 2e-32
Identities = 72/208 (34%), Positives = 103/208 (49%), Gaps = 26/208 (12%)
Query: 619 KKIGKGSFGSVYYGKMK-DGKEVAVK-IMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 676
K +G+GS G VY + K GK A+K I D +Q + E+ L +V G
Sbjct: 7 KVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYG 66
Query: 677 -YCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 733
+ +E I V EYM G+L D L G + + L ++ R QI GL+YLHT +
Sbjct: 67 AFYKEGEISI-VLEYMDGGSLADLLKKVGKIPEPVLAYIAR-QILK----GLDYLHTKRH 120
Query: 734 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT-HISSVARGTVGY-----LDPEY 787
IIHRD+K SN+L++ K++DFG+S+ E L + V GTV Y + E
Sbjct: 121 --IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV--GTVTYMSPERIQGES 176
Query: 788 YGNQQLTEKSDVYSFGVVLLELISGKKP 815
Y +D++S G+ LLE GK P
Sbjct: 177 YSY-----AADIWSLGLTLLECALGKFP 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 3e-32
Identities = 71/201 (35%), Positives = 107/201 (53%), Gaps = 17/201 (8%)
Query: 619 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSC-----SHRTQQFVTEVALLSRIHHRNLVP 673
+KIGKG+FG VY G +K EVAVK +C ++F+ E +L + H N+V
Sbjct: 1 EKIGKGNFGDVYKGVLKGNTEVAVK----TCRSTLPPDLKRKFLQEAEILKQYDHPNIVK 56
Query: 674 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 733
LIG C ++ +V E + G+L L N+ + L LQ++ DAA G+EYL +
Sbjct: 57 LIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKL--LQMSLDAAAGMEYLESKN- 113
Query: 734 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGT--VGYLDPEYYGNQ 791
IHRD+ + N L+ N K+SDFG+SR+ EE + S + + PE
Sbjct: 114 --CIHRDLAARNCLVGENNVLKISDFGMSRE-EEGGIYTVSDGLKQIPIKWTAPEALNYG 170
Query: 792 QLTEKSDVYSFGVVLLELISG 812
+ T +SDV+S+G++L E S
Sbjct: 171 RYTSESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 128 bits (322), Expect = 5e-32
Identities = 75/218 (34%), Positives = 114/218 (52%), Gaps = 18/218 (8%)
Query: 616 NFCKKIGKGSFGSVYYGKMKDGKEVAVKIMA---DSCSHRTQQFVTEVALLSRI-HHRNL 671
+K+G+GSFG VY + D K VA+K++A +S S ++F+ E+ +L+ + H N+
Sbjct: 3 RILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNI 60
Query: 672 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 731
V L + ++E LV EY+ G+L D L + PL L I LEYLH+
Sbjct: 61 VKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK 120
Query: 732 CNPGIIHRDVKSSNILLDIN-MRAKVSDFGLSRQAEEDLTH-----ISSVARGTVGYLDP 785
GIIHRD+K NILLD + K+ DFGL++ + + + S + GT GY+ P
Sbjct: 121 ---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAP 177
Query: 786 EYYG---NQQLTEKSDVYSFGVVLLELISGKKPVSVED 820
E + SD++S G+ L EL++G P E
Sbjct: 178 EVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEK 215
|
Length = 384 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 9e-32
Identities = 67/206 (32%), Positives = 105/206 (50%), Gaps = 17/206 (8%)
Query: 617 FCKKIGKGSFGSVYYGKM-----KDGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHR 669
F K++G+G FG V + G++VAVK + S HR+ F E+ +L + H
Sbjct: 8 FIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSD-FEREIEILRTLDHE 66
Query: 670 NLVPLIGYCEEEHQRI--LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEY 727
N+V G CE+ R L+ EY+ +G+LRD L +Q ++ L + KG++Y
Sbjct: 67 NIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQ--INLKRLLLFSSQICKGMDY 124
Query: 728 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGT--VGYLDP 785
L + IHRD+ + NIL++ K+SDFGL++ ED + G + + P
Sbjct: 125 LG---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAP 181
Query: 786 EYYGNQQLTEKSDVYSFGVVLLELIS 811
E + + SDV+SFGV L EL +
Sbjct: 182 ECLRTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 4e-31
Identities = 61/202 (30%), Positives = 100/202 (49%), Gaps = 16/202 (7%)
Query: 620 KIGKGSFGSVYYG-KMKDGKEVAVK--IMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 676
IG+G+FG VY G ++ G VA+K + + + E+ LL + H N+V IG
Sbjct: 7 LIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIG 66
Query: 677 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA---HDAAKGLEYLHTGCN 733
E ++ EY NG+LR + K +A + +GL YLH
Sbjct: 67 SIETSDSLYIILEYAENGSLRQII------KKFGPFPESLVAVYVYQVLQGLAYLH---E 117
Query: 734 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQL 793
G+IHRD+K++NIL + K++DFG++ + + +SV GT ++ PE
Sbjct: 118 QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVV-GTPYWMAPEVIEMSGA 176
Query: 794 TEKSDVYSFGVVLLELISGKKP 815
+ SD++S G ++EL++G P
Sbjct: 177 STASDIWSLGCTVIELLTGNPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 1e-29
Identities = 64/205 (31%), Positives = 104/205 (50%), Gaps = 16/205 (7%)
Query: 616 NFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPL 674
+KIG+G+ G VY + GKEVA+K M + + E+ ++ H N+V
Sbjct: 22 KNLEKIGEGASGEVYKATDRATGKEVAIKKM-RLRKQNKELIINEILIMKDCKHPNIVDY 80
Query: 675 IG-YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA---HDAAKGLEYLHT 730
Y + +V EYM G+L D + Q + + QIA + +GLEYLH+
Sbjct: 81 YDSYLVGDEL-WVVMEYMDGGSLTD----IITQNFVR-MNEPQIAYVCREVLQGLEYLHS 134
Query: 731 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN 790
+IHRD+KS NILL + K++DFG + Q ++ + +SV GT ++ PE
Sbjct: 135 Q---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVV-GTPYWMAPEVIKR 190
Query: 791 QQLTEKSDVYSFGVVLLELISGKKP 815
+ K D++S G++ +E+ G+ P
Sbjct: 191 KDYGPKVDIWSLGIMCIEMAEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 1e-29
Identities = 68/200 (34%), Positives = 108/200 (54%), Gaps = 7/200 (3%)
Query: 617 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 676
F K++G G FG V+ GK + +VA+K++ + + F+ E ++ ++ H NLV L G
Sbjct: 8 FLKELGSGQFGVVHLGKWRGKIDVAIKMIREG-AMSEDDFIEEAKVMMKLSHPNLVQLYG 66
Query: 677 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 736
C ++ +V EYM NG L + L + +WL L + D + +EYL +
Sbjct: 67 VCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWL--LDMCSDVCEAMEYLESNG---F 121
Query: 737 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEK 796
IHRD+ + N L+ + KVSDFGL+R +D S + V + PE + + + K
Sbjct: 122 IHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSK 181
Query: 797 SDVYSFGVVLLELIS-GKKP 815
SDV+SFGV++ E+ S GK P
Sbjct: 182 SDVWSFGVLMWEVFSEGKMP 201
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 3e-29
Identities = 72/225 (32%), Positives = 110/225 (48%), Gaps = 34/225 (15%)
Query: 617 FCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVT-EVALLSRI-HHRNL 671
F K IG+GSF +V K K KE A+KI+ + ++V E +L+R+ H +
Sbjct: 5 FGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGI 64
Query: 672 VPLIGYCEEEHQRILVYEYMHNGTLRD--RLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 729
+ L ++E V EY NG L R +GS+++K TR A + LEYLH
Sbjct: 65 IKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEK----CTRF-YAAEILLALEYLH 119
Query: 730 TGCNPGIIHRDVKSSNILLDINMRAKVSDFG---------LSRQAEEDLTHISSVAR--- 777
+ GIIHRD+K NILLD +M K++DFG + D T+I S
Sbjct: 120 ---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNR 176
Query: 778 -------GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 815
GT Y+ PE + + SD+++ G ++ ++++GK P
Sbjct: 177 RRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 4e-29
Identities = 66/202 (32%), Positives = 103/202 (50%), Gaps = 6/202 (2%)
Query: 609 ELEEATNNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIH 667
E+E K+G G +G VY G K VAVK + + + ++F+ E A++ I
Sbjct: 2 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIK 60
Query: 668 HRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEY 727
H NLV L+G C E ++ E+M G L D L N++ ++ + L +A + +EY
Sbjct: 61 HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR-ECNRQEVNAVVLLYMATQISSAMEY 119
Query: 728 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 787
L IHRD+ + N L+ N KV+DFGLSR D + A+ + + PE
Sbjct: 120 LEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPES 176
Query: 788 YGNQQLTEKSDVYSFGVVLLEL 809
+ + KSDV++FGV+L E+
Sbjct: 177 LAYNKFSIKSDVWAFGVLLWEI 198
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 4e-29
Identities = 65/199 (32%), Positives = 106/199 (53%), Gaps = 6/199 (3%)
Query: 618 CKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 677
+K+G G FG V+ G K+ VA+KI+ + Q F EV L R+ H++L+ L
Sbjct: 11 ERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAV 70
Query: 678 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGII 737
C ++ E M G+L L S + L + + +A A+G+ YL I
Sbjct: 71 CSVGEPVYIITELMEKGSLLAFL-RSPEGQVLPVASLIDMACQVAEGMAYLE---EQNSI 126
Query: 738 HRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKS 797
HRD+ + NIL+ ++ KV+DFGL+R +ED+ ++SS + + PE + + KS
Sbjct: 127 HRDLAARNILVGEDLVCKVADFGLARLIKEDV-YLSSDKKIPYKWTAPEAASHGTFSTKS 185
Query: 798 DVYSFGVVLLELIS-GKKP 815
DV+SFG++L E+ + G+ P
Sbjct: 186 DVWSFGILLYEMFTYGQVP 204
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 4e-29
Identities = 71/201 (35%), Positives = 109/201 (54%), Gaps = 9/201 (4%)
Query: 617 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 676
F K++G G FG V YGK + +VA+K++ + S +F+ E ++ ++ H LV L G
Sbjct: 8 FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMKLSHEKLVQLYG 66
Query: 677 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 736
C ++ +V EYM NG L + L K L++ D +G+ YL +
Sbjct: 67 VCTKQRPIYIVTEYMSNGCLLNYLREH--GKRFQPSQLLEMCKDVCEGMAYLES---KQF 121
Query: 737 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSV-ARGTVGYLDPEYYGNQQLTE 795
IHRD+ + N L+D KVSDFGLSR +D + SSV ++ V + PE + +
Sbjct: 122 IHRDLAARNCLVDDQGCVKVSDFGLSRYVLDD-EYTSSVGSKFPVRWSPPEVLLYSKFSS 180
Query: 796 KSDVYSFGVVLLELIS-GKKP 815
KSDV++FGV++ E+ S GK P
Sbjct: 181 KSDVWAFGVLMWEVYSLGKMP 201
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 1e-28
Identities = 71/206 (34%), Positives = 107/206 (51%), Gaps = 15/206 (7%)
Query: 621 IGKGSFGSVYYGKMKD-GKEVAVKIM--ADSCSHRTQQFV-TEVALLSRIHHRNLVPLIG 676
+GKGSFG V + KD GK A+K++ + + TE +LSRI+H +V L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 677 YCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 734
+ E + LV EY G L L G +++ R A + LEYLH +
Sbjct: 61 AFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEE----RARFYAA-EIVLALEYLH---SL 112
Query: 735 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLT 794
GII+RD+K NILLD + K++DFGL+++ + + ++ GT YL PE +
Sbjct: 113 GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFC-GTPEYLAPEVLLGKGYG 171
Query: 795 EKSDVYSFGVVLLELISGKKPVSVED 820
+ D +S GV+L E+++GK P ED
Sbjct: 172 KAVDWWSLGVLLYEMLTGKPPFYAED 197
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 2e-28
Identities = 70/218 (32%), Positives = 102/218 (46%), Gaps = 35/218 (16%)
Query: 619 KKIGKGSFGSVYYGKMK-DGKEVAVK-----IMADSCSHRTQQFVTEVALLSRIHHRNLV 672
+ IGKGSFG+V + K DGK + K M QQ V+EV +L + H N+V
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMT---EKEKQQLVSEVNILRELKHPNIV 62
Query: 673 PLIGYCEEEH----QRI-LVYEYMHNGTLRDRL-HGSVNQKPLD----WLTRLQIAHDAA 722
Y + Q + +V EY G L + +K ++ W Q+
Sbjct: 63 ---RYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLL--- 116
Query: 723 KGLEYLHTGCNPG--IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTV 780
L H +PG ++HRD+K +NI LD N K+ DFGL++ L H SS A+ V
Sbjct: 117 -ALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAK----ILGHDSSFAKTYV 171
Query: 781 G---YLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 815
G Y+ PE + EKSD++S G ++ EL + P
Sbjct: 172 GTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPP 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 3e-28
Identities = 69/201 (34%), Positives = 107/201 (53%), Gaps = 12/201 (5%)
Query: 619 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYC 678
+K+G G FG V+ G +VAVK + + + F+ E ++ ++ H LV L C
Sbjct: 12 RKLGAGQFGEVWMGTWNGTTKVAVKTLKPG-TMSPEAFLQEAQIMKKLRHDKLVQLYAVC 70
Query: 679 EEEHQRILVYEYMHNGTLRDRLH-GSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGII 737
EE +V EYM G+L D L G + L L + +A A+G+ YL + I
Sbjct: 71 SEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQL--VDMAAQIAEGMAYLES---RNYI 125
Query: 738 HRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE--YYGNQQLTE 795
HRD+ + NIL+ N+ K++DFGL+R E+D A+ + + PE YG T
Sbjct: 126 HRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGR--FTI 183
Query: 796 KSDVYSFGVVLLELIS-GKKP 815
KSDV+SFG++L E+++ G+ P
Sbjct: 184 KSDVWSFGILLTEIVTYGRVP 204
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 4e-28
Identities = 64/204 (31%), Positives = 110/204 (53%), Gaps = 12/204 (5%)
Query: 619 KKIGKGSFGSVYYGKM----KDGKEVAVKIMADSCSHRTQ-QFVTEVALLSRIHHRNLVP 673
K IG G FG V G++ K +VA+K + S + + F+TE +++ + H N++
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIR 69
Query: 674 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 733
L G + +++ EYM NG+L L N + + A G++YL
Sbjct: 70 LEGVVTKSRPVMIITEYMENGSLDKFLR--ENDGKFTVGQLVGMLRGIASGMKYL---SE 124
Query: 734 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE-DLTHISSVARGTVGYLDPEYYGNQQ 792
+HRD+ + NIL++ N+ KVSDFGLSR+ E+ + T+ + + + + PE ++
Sbjct: 125 MNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRK 184
Query: 793 LTEKSDVYSFGVVLLELIS-GKKP 815
T SDV+SFG+V+ E++S G++P
Sbjct: 185 FTSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 7e-28
Identities = 70/219 (31%), Positives = 111/219 (50%), Gaps = 23/219 (10%)
Query: 617 FCKKIGKGSFGSVYYGKMKDGKE------VAVKIMADSCSHRTQQ-FVTEVALLSRIHHR 669
+++G+G+FG V+ G+ + VAVK + ++ S+ ++ F E LL+ H
Sbjct: 9 LKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHE 68
Query: 670 NLVPLIGYCEEEHQRILVYEYMHNGTLRD--RLHG------SVNQKPLDWLTR---LQIA 718
N+V G C E I+V+EYM +G L R HG P+ LT LQIA
Sbjct: 69 NIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIA 128
Query: 719 HDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA-EEDLTHISSVAR 777
A G+ YL + +HRD+ + N L+ ++ K+ DFG+SR D +
Sbjct: 129 VQIASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTM 185
Query: 778 GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 815
+ ++ PE ++ T +SDV+SFGVVL E+ + GK+P
Sbjct: 186 LPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 1e-27
Identities = 72/203 (35%), Positives = 115/203 (56%), Gaps = 23/203 (11%)
Query: 619 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYC 678
+ IG+G FG+V G+ G++VAVK + C Q F+ E A+++++HH+NLV L+G
Sbjct: 12 EIIGEGEFGAVLQGEYT-GQKVAVKNI--KCDVTAQAFLEETAVMTKLHHKNLVRLLGVI 68
Query: 679 EEEHQRI-LVYEYMHNGTL----RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 733
H + +V E M G L R R V+ L LQ + D A+G+EYL +
Sbjct: 69 L--HNGLYIVMELMSKGNLVNFLRTRGRALVSVIQL-----LQFSLDVAEGMEYLES--- 118
Query: 734 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQL 793
++HRD+ + NIL+ + AKVSDFGL+R + + ++ V + PE +++
Sbjct: 119 KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDN----SKLPVKWTAPEALKHKKF 174
Query: 794 TEKSDVYSFGVVLLELIS-GKKP 815
+ KSDV+S+GV+L E+ S G+ P
Sbjct: 175 SSKSDVWSYGVLLWEVFSYGRAP 197
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 2e-27
Identities = 67/203 (33%), Positives = 109/203 (53%), Gaps = 13/203 (6%)
Query: 617 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 676
++IG G FG V+ G + ++VA+K + + + + F+ E ++ ++ H LV L G
Sbjct: 8 LVQEIGSGQFGLVWLGYWLEKRKVAIKTIREG-AMSEEDFIEEAQVMMKLSHPKLVQLYG 66
Query: 677 YCEEEHQRILVYEYMHNGTLRDRLH---GSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 733
C E LV+E+M +G L D L G +Q+ L L + D +G+ YL +
Sbjct: 67 VCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETL-----LGMCLDVCEGMAYLESSN- 120
Query: 734 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQL 793
+IHRD+ + N L+ N KVSDFG++R +D S+ + V + PE + +
Sbjct: 121 --VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKY 178
Query: 794 TEKSDVYSFGVVLLELIS-GKKP 815
+ KSDV+SFGV++ E+ S GK P
Sbjct: 179 SSKSDVWSFGVLMWEVFSEGKTP 201
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 4e-27
Identities = 81/270 (30%), Positives = 131/270 (48%), Gaps = 23/270 (8%)
Query: 617 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 676
F K++G G FG V+ GK + +VA+K + + + + F+ E ++ ++ H LV L G
Sbjct: 8 FMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYG 66
Query: 677 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 736
C ++ +V E+M NG L + L + D L L + D +G+EYL
Sbjct: 67 VCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDML--LSMCQDVCEGMEYLERN---SF 121
Query: 737 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEK 796
IHRD+ + N L+ KVSDFG++R +D SS A+ V + PE + + + K
Sbjct: 122 IHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSK 181
Query: 797 SDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIE 855
SDV+SFGV++ E+ + GK P + + +V MI +G + P L
Sbjct: 182 SDVWSFGVLMWEVFTEGKMPFEKK---SNYEVV----EMISRGF--RLYRPKLASMT--- 229
Query: 856 SIWRIAEVAIQCVEQRGFSRPKMQEIVLAI 885
+ EV C ++ RP E++ AI
Sbjct: 230 ----VYEVMYSCWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 7e-27
Identities = 75/233 (32%), Positives = 117/233 (50%), Gaps = 30/233 (12%)
Query: 605 IPLPELEEATNNFCKKIGKGSFGSVYYGK------MKDGKEVAVKIMADSCSHRTQQ-FV 657
IPL + F +++G+G+FG VY G+ VA+K + ++ + QQ F
Sbjct: 2 IPLSAVR-----FLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFR 56
Query: 658 TEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRL-----HGSVN------- 705
E L+S + H N+V L+G C +E +++EY+ +G L + L H V
Sbjct: 57 QEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDET 116
Query: 706 -QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 764
+ LD L IA A G+EYL + +HRD+ + N L+ + K+SDFGLSR
Sbjct: 117 VKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVKISDFGLSRD 173
Query: 765 A-EEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 815
D + S + V ++ PE + T +SD++SFGVVL E+ S G +P
Sbjct: 174 IYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 68/197 (34%), Positives = 109/197 (55%), Gaps = 13/197 (6%)
Query: 621 IGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEE 680
IGKG FG V G + G +VAVK + + + Q F+ E ++++++ H NLV L+G E
Sbjct: 14 IGKGEFGDVMLGDYR-GNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 681 EHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHR 739
E + +V EYM G+L D L S + L L+ + D + +EYL +HR
Sbjct: 71 EKGGLYIVTEYMAKGSLVDYLR-SRGRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHR 126
Query: 740 DVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDV 799
D+ + N+L+ + AKVSDFGL+++A + + V + PE ++ + KSDV
Sbjct: 127 DLAARNVLVSEDNVAKVSDFGLTKEA----SSTQDTGKLPVKWTAPEALREKKFSTKSDV 182
Query: 800 YSFGVVLLELIS-GKKP 815
+SFG++L E+ S G+ P
Sbjct: 183 WSFGILLWEIYSFGRVP 199
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 63/207 (30%), Positives = 102/207 (49%), Gaps = 17/207 (8%)
Query: 619 KKIGKGSFGSVYYG-KMKDGKEVAVKIMA--DSCSHRTQQFVTEVALLSRIHHRNLVPLI 675
KIG G+FG VY + G+ +AVK + D+ ++ E+ +L + H NLV
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 676 GYCEEEHQRILVY-EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 734
G E +++ ++ EY GTL + L + LD +GL YLH+
Sbjct: 66 G-VEVHREKVYIFMEYCSGGTLEELLEHG---RILDEHVIRVYTLQLLEGLAYLHSH--- 118
Query: 735 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVG---YLDPEYYGNQ 791
GI+HRD+K +NI LD N K+ DFG + + + + T + + G Y+ PE
Sbjct: 119 GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGG 178
Query: 792 QLTEK---SDVYSFGVVLLELISGKKP 815
+ +D++S G V+LE+ +GK+P
Sbjct: 179 KGKGHGRAADIWSLGCVVLEMATGKRP 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 3e-26
Identities = 64/220 (29%), Positives = 119/220 (54%), Gaps = 25/220 (11%)
Query: 621 IGKGSFGSVYY------GKMKDGKEVAV-KIMADSCSHRTQQFV----TEVALLSRIHHR 669
IGKG++G VY G+M K+V + +A R + V +E+ L + H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 670 NLVPLIGYCEEEHQRILVYEYMHNGTLRD--RLHGSVNQKPLDWLTRLQIAHDAAKGLEY 727
N+V +G+ E + EY+ G++ R +G ++ + + T Q+ +GL Y
Sbjct: 69 NIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTE-QVL----EGLAY 123
Query: 728 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVA-RGTVGYLDPE 786
LH + GI+HRD+K+ N+L+D + K+SDFG+S+++++ + +++ +G+V ++ PE
Sbjct: 124 LH---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPE 180
Query: 787 YYGNQQ--LTEKSDVYSFGVVLLELISGKKPVS-VEDFGA 823
+ + K D++S G V+LE+ +G++P S E A
Sbjct: 181 VIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAA 220
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 7e-26
Identities = 75/218 (34%), Positives = 112/218 (51%), Gaps = 20/218 (9%)
Query: 621 IGKGSFGSVYYG-KMKDGKEVAVK-IMADSCSHRTQQFVT----EVALLSRIHHRNLVPL 674
+G GSFGSVY G + DG AVK + Q+ V E+ALLS++ H N+V
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 675 IGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 732
+G EE + E + G+L L +GS + + TR QI GLEYLH
Sbjct: 68 LGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTR-QIL----LGLEYLH--- 119
Query: 733 NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQ 792
+ +HRD+K +NIL+D N K++DFG+++Q E + S +G+ ++ PE Q
Sbjct: 120 DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVE-FSFAKSF-KGSPYWMAPEVIAQQG 177
Query: 793 L-TEKSDVYSFGVVLLELISGKKPVS-VEDFGAELNIV 828
+D++S G +LE+ +GK P S +E A I
Sbjct: 178 GYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIG 215
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 7e-26
Identities = 73/209 (34%), Positives = 109/209 (52%), Gaps = 23/209 (11%)
Query: 619 KKIGKGSFGSVYYG--KMKDGKE--VAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVP 673
K++G G+FGSV G MK GKE VAVK + ++F+ E ++++++ H +V
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60
Query: 674 LIGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 731
LIG C+ E +LV E G L L + L ++AH A G+ YL
Sbjct: 61 LIGVCKGE-PLMLVMELAPLGPLLKYLKKRREIPVSDL-----KELAHQVAMGMAYLE-S 113
Query: 732 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSR--QAEEDLTHISSVARGTVGYLDPE--Y 787
+ +HRD+ + N+LL +AK+SDFG+SR A D ++ R + + PE
Sbjct: 114 KH--FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECIN 171
Query: 788 YGNQQLTEKSDVYSFGVVLLELIS-GKKP 815
YG + + KSDV+S+GV L E S G KP
Sbjct: 172 YG--KFSSKSDVWSYGVTLWEAFSYGAKP 198
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 1e-25
Identities = 71/216 (32%), Positives = 113/216 (52%), Gaps = 24/216 (11%)
Query: 619 KKIGKGSFGSVYYGKMK--DGK--EVAVKIM-ADSCSHR-TQQFVTEVALLSRIHHRNLV 672
K +G+G FGSV G++ DG +VAVK M D ++ ++F++E A + H N++
Sbjct: 5 KILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVM 64
Query: 673 PLIGYC--EEEHQRI----LVYEYMHNGTLRD-----RLHGSVNQKPLDWLTRLQIAHDA 721
LIG C Q+I ++ +M +G L RL G + PL L + + D
Sbjct: 65 KLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMV--DI 122
Query: 722 AKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA-EEDLTHISSVARGTV 780
A G+EYL N IHRD+ + N +L +M V+DFGLS++ D +A+ V
Sbjct: 123 ALGMEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPV 179
Query: 781 GYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 815
++ E ++ T KSDV++FGV + E+ + G+ P
Sbjct: 180 KWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 65/213 (30%), Positives = 104/213 (48%), Gaps = 19/213 (8%)
Query: 619 KKIGKGSFGSVYYGKMK---DGKEVAVKIM-ADSCSHRTQQFVTEVALLSRIHHRNLVPL 674
++G G+ G V K+ GK +AVK + + +Q + E+ +L + + +V
Sbjct: 7 GELGAGNSGVVS--KVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGF 64
Query: 675 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 734
G + EYM G+L L + P L ++ +A KGL YLH
Sbjct: 65 YGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVA--VLKGLTYLHE--KH 120
Query: 735 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR---GTVGYLDPEYYGNQ 791
IIHRDVK SNIL++ + K+ DFG+S Q ++S+A+ GT Y+ PE
Sbjct: 121 KIIHRDVKPSNILVNSRGQIKLCDFGVSGQL------VNSLAKTFVGTSSYMAPERIQGN 174
Query: 792 QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAE 824
+ KSD++S G+ L+EL +G+ P E+ +
Sbjct: 175 DYSVKSDIWSLGLSLIELATGRFPYPPENDPPD 207
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 70/219 (31%), Positives = 108/219 (49%), Gaps = 18/219 (8%)
Query: 608 PELEEATNNFCKKIGKGSFGSVYYGKM--KDGK----EVAVKIMADSCSHRTQQ-FVTEV 660
PE+ + + +G G+FG VY G +DG +VAVK + +SCS + + F+ E
Sbjct: 1 PEVPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEA 60
Query: 661 ALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGS----VNQKPLDWLTRLQ 716
++S+ +H+N+V LIG E R ++ E M G L+ L + L L
Sbjct: 61 LIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLF 120
Query: 717 IAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI---NMRAKVSDFGLSRQA-EEDLTHI 772
A D AKG +YL IHRD+ + N LL AK++DFG++R
Sbjct: 121 CARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRK 177
Query: 773 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS 811
A + ++ PE + + T K+DV+SFGV+L E+ S
Sbjct: 178 GGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFS 216
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 6e-25
Identities = 71/210 (33%), Positives = 110/210 (52%), Gaps = 14/210 (6%)
Query: 611 EEATNNFCKKIGKGSFGSV---YYGKMKD--GKEVAVKIMADSCSHRTQQFVTEVALLSR 665
EE F +++GKG+FGSV Y ++D G+ VAVK + S + + F E+ +L
Sbjct: 2 EERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKS 61
Query: 666 IHHRNLVPLIGYCEEEHQR--ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK 723
+ H N+V G C +R LV EY+ G+LRD L +++ LD L A K
Sbjct: 62 LQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYL--QKHRERLDHRKLLLYASQICK 119
Query: 724 GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH--ISSVARGTVG 781
G+EYL + +HRD+ + NIL++ R K+ DFGL++ +D + + +
Sbjct: 120 GMEYLGS---KRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIF 176
Query: 782 YLDPEYYGNQQLTEKSDVYSFGVVLLELIS 811
+ PE + + SDV+SFGVVL EL +
Sbjct: 177 WYAPESLTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 1e-24
Identities = 62/208 (29%), Positives = 105/208 (50%), Gaps = 6/208 (2%)
Query: 609 ELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHH 668
E++ + +K+G G FG V+ G + VAVK + + + F+ E ++ ++ H
Sbjct: 2 EIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTL-KPGTMDPKDFLAEAQIMKKLRH 60
Query: 669 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYL 728
L+ L C E +V E M G+L + L G + L + +A A G+ YL
Sbjct: 61 PKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRA-LKLPQLIDMAAQVASGMAYL 119
Query: 729 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY 788
IHRD+ + N+L+ N KV+DFGL+R +ED+ A+ + + PE
Sbjct: 120 EA---QNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAA 176
Query: 789 GNQQLTEKSDVYSFGVVLLELIS-GKKP 815
+ + KSDV+SFG++L E+++ G+ P
Sbjct: 177 LYNRFSIKSDVWSFGILLTEIVTYGRMP 204
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 73/213 (34%), Positives = 113/213 (53%), Gaps = 27/213 (12%)
Query: 621 IGKGSFGSVYYG-KMKDGKEVAVK------IMADSCS-HRT--QQFVTEVALLSRIHHRN 670
IG GSFGSVY G G+ +AVK + A S R+ E+ALL + H N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 671 LVPLIG-YCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEY 727
+V +G + +H I + EY+ G++ L +G+ + + R QI KGL Y
Sbjct: 68 IVQYLGSSLDADHLNIFL-EYVPGGSVAALLNNYGAFEETLVRNFVR-QIL----KGLNY 121
Query: 728 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVA-----RGTVGY 782
LH N GIIHRD+K +NIL+D K+SDFG+S++ E + + +G+V +
Sbjct: 122 LH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFW 178
Query: 783 LDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 815
+ PE T K+D++S G +++E+++GK P
Sbjct: 179 MAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 2e-24
Identities = 70/209 (33%), Positives = 106/209 (50%), Gaps = 25/209 (11%)
Query: 619 KKIGKGSFGSVYYGKMKDG------KEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLV 672
KKIG+GSFG +Y K K KE+ + M +++ EV LL+++ H N+V
Sbjct: 6 KKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKK---EVILLAKMKHPNIV 62
Query: 673 PLIGYCEEEHQRILVYEYMHNGTLRDRL---HGSV--NQKPLDWLTRLQIAHDAAKGLEY 727
+E + +V EY G L R+ G + + L W ++ + GL++
Sbjct: 63 TFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISL------GLKH 116
Query: 728 LHTGCNPGIIHRDVKSSNILLDIN-MRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE 786
+H + I+HRD+KS NI L N M AK+ DFG++RQ D ++ GT YL PE
Sbjct: 117 IH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLN-DSMELAYTCVGTPYYLSPE 172
Query: 787 YYGNQQLTEKSDVYSFGVVLLELISGKKP 815
N+ K+D++S G VL EL + K P
Sbjct: 173 ICQNRPYNNKTDIWSLGCVLYELCTLKHP 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 78/272 (28%), Positives = 133/272 (48%), Gaps = 29/272 (10%)
Query: 619 KKIGKGSFGSVYYG--KMKDGKEVAVKIM---ADSCSHRTQQFVTEVALLSRIHHRNLVP 673
K IG G FG V+ G KM KEVAV I + Q F++E +++ + H N++
Sbjct: 11 KVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIR 70
Query: 674 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 733
L G + +++ EYM NG L L + + + A G++YL +
Sbjct: 71 LEGVVTKFKPAMIITEYMENGALDKYLRD--HDGEFSSYQLVGMLRGIAAGMKYL---SD 125
Query: 734 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED--LTHISSVARGTVGYLDPEYYGNQ 791
+HRD+ + NIL++ N+ KVSDFGLSR E+D T+ +S + + + PE +
Sbjct: 126 MNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYR 185
Query: 792 QLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 850
+ T SDV+SFG+V+ E++S G++P +W S +V+ ++
Sbjct: 186 KFTSASDVWSFGIVMWEVMSFGERP-------------YWDMS---NHEVMKAINDGFRL 229
Query: 851 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIV 882
++ + ++ +QC +Q RP+ +IV
Sbjct: 230 PAPMDCPSAVYQLMLQCWQQDRARRPRFVDIV 261
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 4e-24
Identities = 62/209 (29%), Positives = 96/209 (45%), Gaps = 11/209 (5%)
Query: 616 NFCKKIGKGSFGSVYYGKMKDGKE-VAVKIM-ADSCSHRTQQFVTEVALLSRIHHRNLVP 673
+ IG G+ VY E VA+K + + C + EV +S+ +H N+V
Sbjct: 4 ELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVK 63
Query: 674 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 733
+ LV Y+ G+L D + S + LD + + KGLEYLH+
Sbjct: 64 YYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN-- 121
Query: 734 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR----GTVGYLDPEYYG 789
G IHRD+K+ NILL + K++DFG+S + + R GT ++ PE
Sbjct: 122 -GQIHRDIKAGNILLGEDGSVKIADFGVSASLADG-GDRTRKVRKTFVGTPCWMAPEVME 179
Query: 790 NQQ-LTEKSDVYSFGVVLLELISGKKPVS 817
K+D++SFG+ +EL +G P S
Sbjct: 180 QVHGYDFKADIWSFGITAIELATGAAPYS 208
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 8e-24
Identities = 63/210 (30%), Positives = 100/210 (47%), Gaps = 29/210 (13%)
Query: 620 KIGKGSFGSVYYGKMKDGKEV-AVK-IMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 677
++G+G+ GSV ++K+ + A+K I D +Q + E+ + +V G
Sbjct: 8 RLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGA 67
Query: 678 CEEEHQRIL--VYEYMHNGTLRDRLHGSV-------NQKPLDWLTRLQIAHDAAKGLEYL 728
+E + EY G+L D ++ V +K L +IA KGL YL
Sbjct: 68 FLDESSSSIGIAMEYCEGGSL-DSIYKKVKKRGGRIGEKVL-----GKIAESVLKGLSYL 121
Query: 729 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR---GTVGYLDP 785
H+ IIHRD+K SNILL + K+ DFG+S + ++S+A GT Y+ P
Sbjct: 122 HS---RKIIHRDIKPSNILLTRKGQVKLCDFGVSGEL------VNSLAGTFTGTSFYMAP 172
Query: 786 EYYGNQQLTEKSDVYSFGVVLLELISGKKP 815
E + + SDV+S G+ LLE+ + P
Sbjct: 173 ERIQGKPYSITSDVWSLGLTLLEVAQNRFP 202
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 67/206 (32%), Positives = 99/206 (48%), Gaps = 15/206 (7%)
Query: 619 KKIGKGSFGSVYYGKMKD--GK--EVAVKIM-ADSCSHRTQQFVTEVALLSRIHHRNLVP 673
KK+G GSFG V G+ GK VAVK + +D S F+ E A++ + H NL+
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIR 60
Query: 674 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRL-QIAHDAAKGLEYLHTGC 732
L G H ++V E G+L DRL + ++ L A A G+ YL +
Sbjct: 61 LYGVVLT-HPLMMVTELAPLGSLLDRLRK--DALGHFLISTLCDYAVQIANGMRYLES-- 115
Query: 733 NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTV--GYLDPEYYGN 790
IHRD+ + NILL + + K+ DFGL R ++ H V + PE
Sbjct: 116 -KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRT 174
Query: 791 QQLTEKSDVYSFGVVLLELIS-GKKP 815
+ + SDV+ FGV L E+ + G++P
Sbjct: 175 RTFSHASDVWMFGVTLWEMFTYGEEP 200
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 64/198 (32%), Positives = 107/198 (54%), Gaps = 12/198 (6%)
Query: 619 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQ-QFVTEVALLSRIHHRNLVPLIG 676
++IG+G+FG V+ G+++ D VAVK ++ + +F+ E +L + H N+V LIG
Sbjct: 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 60
Query: 677 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKP-LDWLTRLQIAHDAAKGLEYLHTGCNPG 735
C ++ +V E + G L + P L +Q+ +AA G+EYL +
Sbjct: 61 VCTQKQPIYIVMELVQGGDFLTFLR---TEGPRLKVKELIQMVENAAAGMEYLESKH--- 114
Query: 736 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISS--VARGTVGYLDPEYYGNQQL 793
IHRD+ + N L+ K+SDFG+SR+ EED + S+ + + V + PE +
Sbjct: 115 CIHRDLAARNCLVTEKNVLKISDFGMSRE-EEDGVYASTGGMKQIPVKWTAPEALNYGRY 173
Query: 794 TEKSDVYSFGVVLLELIS 811
+ +SDV+SFG++L E S
Sbjct: 174 SSESDVWSFGILLWEAFS 191
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 62/203 (30%), Positives = 101/203 (49%), Gaps = 12/203 (5%)
Query: 619 KKIGKGSFGSVYYGKMKDGK----EVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVP 673
+ IG+G FG VY G + VAVK + S ++F+ E ++ + H ++V
Sbjct: 12 RCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVK 71
Query: 674 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 733
LIG E I V E G LR L VN+ LD + + ++ + L YL +
Sbjct: 72 LIGVITENPVWI-VMELAPLGELRSYL--QVNKYSLDLASLILYSYQLSTALAYLES--- 125
Query: 734 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQL 793
+HRD+ + N+L+ K+ DFGLSR E++ + +S + + ++ PE ++
Sbjct: 126 KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRF 185
Query: 794 TEKSDVYSFGVVLLELIS-GKKP 815
T SDV+ FGV + E++ G KP
Sbjct: 186 TSASDVWMFGVCMWEILMLGVKP 208
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 72/262 (27%), Positives = 128/262 (48%), Gaps = 21/262 (8%)
Query: 621 IGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQ-QFVTEVALLSRIHHRNLVPLIGYCE 679
+GKG+FG V+ G +KD VAVK + + +F++E +L + H N+V LIG C
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62
Query: 680 EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHR 739
+ +V E + G L ++ L + + DAA G+ YL + IHR
Sbjct: 63 QRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFAL--DAAAGMAYLES---KNCIHR 117
Query: 740 DVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDV 799
D+ + N L+ N K+SDFG+SRQ ++ + S + + + + PE + + +SDV
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESDV 177
Query: 800 YSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWR 859
+S+G++L E S + V + N AR ++KG +S + +++
Sbjct: 178 WSYGILLWETFS----LGVCPYPGMTN--QQAREQVEKGYRMSCPQKC------PDDVYK 225
Query: 860 IAEVAIQCVEQRGFSRPKMQEI 881
+ + +C + + +RPK E+
Sbjct: 226 VMQ---RCWDYKPENRPKFSEL 244
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 64/202 (31%), Positives = 107/202 (52%), Gaps = 15/202 (7%)
Query: 620 KIGKGSFGSVYYG-KMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYC 678
K+G+GS+GSVY + G+ VA+K++ Q+ + E+++L + +V G
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIKVV--PVEEDLQEIIKEISILKQCDSPYIVKYYGSY 67
Query: 679 EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA---HDAAKGLEYLHTGCNPG 735
+ +V EY G++ D + + K L T +IA + KGLEYLH +
Sbjct: 68 FKNTDLWIVMEYCGAGSVSDIM--KITNKTL---TEEEIAAILYQTLKGLEYLH---SNK 119
Query: 736 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTE 795
IHRD+K+ NILL+ +AK++DFG+S Q + + ++V GT ++ PE
Sbjct: 120 KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVI-GTPFWMAPEVIQEIGYNN 178
Query: 796 KSDVYSFGVVLLELISGKKPVS 817
K+D++S G+ +E+ GK P S
Sbjct: 179 KADIWSLGITAIEMAEGKPPYS 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 1e-23
Identities = 77/275 (28%), Positives = 135/275 (49%), Gaps = 35/275 (12%)
Query: 619 KKIGKGSFGSVYYGKMK--DGKEVAVKIMADSCSHRTQQ---FVTEVALLSRIHHRNLVP 673
K IG G FG V G++K +E+ V I + +Q F++E +++ + H N++
Sbjct: 10 KVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIH 69
Query: 674 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA---HDAAKGLEYLHT 730
L G + ++V EYM NG+L L Q T +Q+ A G++YL
Sbjct: 70 LEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQ-----FTVIQLVGMLRGIASGMKYL-- 122
Query: 731 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED--LTHISSVARGTVGYLDPEYY 788
+ G +HRD+ + NIL++ N+ KVSDFGLSR E+D + + + + + PE
Sbjct: 123 -SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAI 181
Query: 789 GNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 847
++ T SDV+S+G+V+ E++S G++P +W S DVI ++
Sbjct: 182 AYRKFTSASDVWSYGIVMWEVMSYGERP-------------YWEMS---NQDVIKAIEEG 225
Query: 848 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIV 882
++ + ++ + C ++ RPK ++IV
Sbjct: 226 YRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIV 260
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 66/214 (30%), Positives = 104/214 (48%), Gaps = 38/214 (17%)
Query: 619 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQF-VT---EVALLSRIHHRNLVP 673
+IG+G++G VY + K G+ VA+K + + + F +T E+ LL ++ H N+V
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVALKKI--RMENEKEGFPITAIREIKLLQKLRHPNIVR 62
Query: 674 LIGYCEEEHQR--ILVYEYM-HNGTLRDRLHGSVNQKPLDWLTRLQI---AHDAAKGLEY 727
L + + +V+EYM H+ T L S K T QI +GL+Y
Sbjct: 63 LKEIVTSKGKGSIYMVFEYMDHDLT---GLLDSPEVK----FTESQIKCYMKQLLEGLQY 115
Query: 728 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARG-------TV 780
LH + GI+HRD+K SNIL++ + K++DFGL+R + T+
Sbjct: 116 LH---SNGILHRDIKGSNILINNDGVLKLADFGLAR-------PYTKRNSADYTNRVITL 165
Query: 781 GYLDPE-YYGNQQLTEKSDVYSFGVVLLELISGK 813
Y PE G + + D++S G +L EL GK
Sbjct: 166 WYRPPELLLGATRYGPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 3e-23
Identities = 64/209 (30%), Positives = 107/209 (51%), Gaps = 22/209 (10%)
Query: 619 KKIGKGSFGSVYYGKMKD-GKEVAVKIM-----ADSCSHRTQQFVTEVALLSRIHHRNLV 672
K +G+G+FG VY D G+E+AVK + + E+ LL + H +V
Sbjct: 8 KLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIV 67
Query: 673 PLIGYCEEEHQRILVY-EYMHNGTLRD--RLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 729
G C + + + ++ EYM G+++D + +G++ + TR QI G+EYLH
Sbjct: 68 QYYG-CLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTR-QILE----GVEYLH 121
Query: 730 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE---DLTHISSVARGTVGYLDPE 786
+ I+HRD+K +NIL D K+ DFG S++ + T + SV GT ++ PE
Sbjct: 122 SN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVT-GTPYWMSPE 177
Query: 787 YYGNQQLTEKSDVYSFGVVLLELISGKKP 815
+ K+DV+S G ++E+++ K P
Sbjct: 178 VISGEGYGRKADVWSVGCTVVEMLTEKPP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 3e-23
Identities = 59/217 (27%), Positives = 107/217 (49%), Gaps = 14/217 (6%)
Query: 607 LPELEEATNNFCKKIGKGSFGSVYYGKMKDGKE-----VAVKIMADSCSHRTQQ-FVTEV 660
L L+E K +G G+FG+VY G E VA+K++ + S + + + E
Sbjct: 1 LRILKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEA 60
Query: 661 ALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHD 720
+++ + H ++V L+G C Q L+ + M G L D + ++ + L
Sbjct: 61 YVMASVDHPHVVRLLGICLSS-QVQLITQLMPLGCLLDYVRN--HKDNIGSQYLLNWCVQ 117
Query: 721 AAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH-ISSVARGT 779
AKG+ YL ++HRD+ + N+L+ K++DFGL++ + D + +
Sbjct: 118 IAKGMSYLE---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVP 174
Query: 780 VGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 815
+ ++ E ++ T KSDV+S+GV + EL++ G KP
Sbjct: 175 IKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKP 211
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 99.7 bits (249), Expect = 3e-23
Identities = 66/199 (33%), Positives = 98/199 (49%), Gaps = 12/199 (6%)
Query: 621 IGKGSFGSVYYGKMKDGKEV-AVKIMADS-C--SHRTQQFVTEVALLSRIHHRNLVPLIG 676
IGKG+FG V + +D K++ A+K M C + + E +L ++H LV L
Sbjct: 8 IGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWY 67
Query: 677 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 736
++E LV + + G LR H S K + + I + LEYLH + GI
Sbjct: 68 SFQDEENMYLVVDLLLGGDLR--YHLSQKVKFSEEQVKFWIC-EIVLALEYLH---SKGI 121
Query: 737 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEK 796
IHRD+K NILLD ++DF ++ + D T +S + GT GY+ PE Q +
Sbjct: 122 IHRDIKPDNILLDEQGHVHITDFNIATKVTPD-TLTTSTS-GTPGYMAPEVLCRQGYSVA 179
Query: 797 SDVYSFGVVLLELISGKKP 815
D +S GV E + GK+P
Sbjct: 180 VDWWSLGVTAYECLRGKRP 198
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 99.5 bits (248), Expect = 4e-23
Identities = 68/208 (32%), Positives = 105/208 (50%), Gaps = 10/208 (4%)
Query: 620 KIGKGSFGSVYYGKMKDGKEV-AVKIMADSCSHRTQQ--FVTEVALLSRIHHRNLVPLIG 676
KIGKGSFG V+ K K V A+K + S +R ++ + E +L+++ ++
Sbjct: 7 KIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYE 66
Query: 677 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQK-PLDWLTRLQIAHDAAKGLEYLHTGCNPG 735
++ + +V EY NG L L + P D + R I GL +LH+
Sbjct: 67 SFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFI--QILLGLAHLHSK---K 121
Query: 736 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTE 795
I+HRD+KS N+ LD K+ D G+++ D T+ ++ GT YL PE ++ E
Sbjct: 122 ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLS-DNTNFANTIVGTPYYLSPELCEDKPYNE 180
Query: 796 KSDVYSFGVVLLELISGKKPVSVEDFGA 823
KSDV++ GVVL E +GK P + GA
Sbjct: 181 KSDVWALGVVLYECCTGKHPFDANNQGA 208
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.9 bits (247), Expect = 6e-23
Identities = 64/211 (30%), Positives = 106/211 (50%), Gaps = 26/211 (12%)
Query: 619 KKIGKGSFGSVYYGKM-KDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 677
++IG G++G VY + G+ VA+K++ + E+++L H N+V G
Sbjct: 9 QRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGS 68
Query: 678 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAH---DAAKGLEYLHTGCNP 734
+ +V EY G+L+D V + PL + LQIA+ + KGL YLH
Sbjct: 69 YLRRDKLWIVMEYCGGGSLQDIYQ--VTRGPL---SELQIAYVCRETLKGLAYLH---ET 120
Query: 735 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR-----GTVGYLDPEYYG 789
G IHRD+K +NILL + K++DFG+S Q LT ++A+ GT ++ PE
Sbjct: 121 GKIHRDIKGANILLTEDGDVKLADFGVSAQ----LTA--TIAKRKSFIGTPYWMAPEVAA 174
Query: 790 NQQL---TEKSDVYSFGVVLLELISGKKPVS 817
++ K D+++ G+ +EL + P+
Sbjct: 175 VERKGGYDGKCDIWALGITAIELAELQPPMF 205
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 99.8 bits (248), Expect = 7e-23
Identities = 67/215 (31%), Positives = 107/215 (49%), Gaps = 21/215 (9%)
Query: 619 KKIGKGSFGSVYYGKM------KDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLV 672
+++G+G+FG V+ + +D VAVK + D+ + + F E LL+ + H ++V
Sbjct: 11 RELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIV 70
Query: 673 PLIGYCEEEHQRILVYEYMHNGTLRD--RLHGS-----VNQKPLDWLTR---LQIAHDAA 722
G C E I+V+EYM +G L R HG LT+ L IA A
Sbjct: 71 KFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIA 130
Query: 723 KGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA-EEDLTHISSVARGTVG 781
G+ YL + +HRD+ + N L+ N+ K+ DFG+SR D + +
Sbjct: 131 AGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIR 187
Query: 782 YLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 815
++ PE ++ T +SDV+S GVVL E+ + GK+P
Sbjct: 188 WMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 98.7 bits (246), Expect = 7e-23
Identities = 68/206 (33%), Positives = 105/206 (50%), Gaps = 18/206 (8%)
Query: 621 IGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRT-----QQFVTEVALLSRIHHRNLVPLI 675
IGKG FG VY+G + D + S + T +QF+ E ++ H N++ L+
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62
Query: 676 GYC-EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTR--LQIAHDAAKGLEYLHTGC 732
G C E ++V YM +G LR+ + + + L LQ+A KG+EYL
Sbjct: 63 GICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVA----KGMEYL---A 115
Query: 733 NPGIIHRDVKSSNILLDINMRAKVSDFGLSR---QAEEDLTHISSVARGTVGYLDPEYYG 789
+ +HRD+ + N +LD + KV+DFGL+R E H + A+ V ++ E
Sbjct: 116 SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQ 175
Query: 790 NQQLTEKSDVYSFGVVLLELISGKKP 815
Q+ T KSDV+SFGV+L EL++ P
Sbjct: 176 TQKFTTKSDVWSFGVLLWELMTRGAP 201
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 98.1 bits (245), Expect = 1e-22
Identities = 70/216 (32%), Positives = 102/216 (47%), Gaps = 24/216 (11%)
Query: 621 IGKGSFGSVYYGKMK-DGKEVAVKIM--AD-SCSHRTQQFVTEVALLSRIHHRNLVPLIG 676
I KG++G V+ K K G A+K++ AD ++ Q +TE +LS+ +V L
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 677 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 736
+ + LV EY+ G L L +V D R+ IA + LEYLH + GI
Sbjct: 61 SFQGKKNLYLVMEYLPGGDLASLLE-NVGSLDEDV-ARIYIA-EIVLALEYLH---SNGI 114
Query: 737 IHRDVKSSNILLDINMRAKVSDFGLSRQ--------AEEDLTHISSVARGTVGYLDPEYY 788
IHRD+K NIL+D N K++DFGLS+ +D + GT Y+ PE
Sbjct: 115 IHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIV-GTPDYIAPEVI 173
Query: 789 GNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAE 824
Q ++ D +S G +L E + G P F E
Sbjct: 174 LGQGHSKTVDWWSLGCILYEFLVGIPP-----FHGE 204
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 98.4 bits (245), Expect = 2e-22
Identities = 71/235 (30%), Positives = 107/235 (45%), Gaps = 47/235 (20%)
Query: 617 FCKKIGKGSFGSVYYGKM------KDGKEVAVKIMADSCSHRTQ-QFVTEVALLSRIHHR 669
+ + IG+G+FG V+ + + VAVK++ + S Q F E AL++ H
Sbjct: 9 YVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHP 68
Query: 670 NLVPLIGYCEEEHQRILVYEYMHNGTLRDRL------------HGSV-------NQKPLD 710
N+V L+G C L++EYM G L + L H + N PL
Sbjct: 69 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLS 128
Query: 711 WLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ------ 764
+L IA A G+ YL +HRD+ + N L+ NM K++DFGLSR
Sbjct: 129 CTEQLCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY 185
Query: 765 ---AEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 815
+E D I ++ PE + T +SDV+++GVVL E+ S G +P
Sbjct: 186 YKASENDAIPIR--------WMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQP 232
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 2e-22
Identities = 65/209 (31%), Positives = 107/209 (51%), Gaps = 8/209 (3%)
Query: 609 ELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHH 668
E+ + KK+G G FG V+ G + +VAVK + + Q F+ E L+ + H
Sbjct: 2 EIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPG-TMSVQAFLEEANLMKTLQH 60
Query: 669 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRL-QIAHDAAKGLEY 727
LV L +E ++ EYM G+L D L K L L +L + A+G+ Y
Sbjct: 61 DKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVL--LPKLIDFSAQIAEGMAY 118
Query: 728 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 787
+ IHRD++++N+L+ ++ K++DFGL+R E++ A+ + + PE
Sbjct: 119 IE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEA 175
Query: 788 YGNQQLTEKSDVYSFGVVLLELIS-GKKP 815
T KSDV+SFG++L E+++ GK P
Sbjct: 176 INFGSFTIKSDVWSFGILLYEIVTYGKIP 204
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 97.2 bits (242), Expect = 2e-22
Identities = 65/208 (31%), Positives = 106/208 (50%), Gaps = 7/208 (3%)
Query: 609 ELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHH 668
E+ T KK+G G FG V+ G +VA+K + S + F+ E L+ ++ H
Sbjct: 2 EVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQG-SMSPEAFLAEANLMKQLQH 60
Query: 669 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYL 728
LV L +E I + EYM NG+L D L K L + +A A+G+ ++
Sbjct: 61 PRLVRLYAVVTQEPIYI-ITEYMENGSLVDFLKTPEGIK-LTINKLIDMAAQIAEGMAFI 118
Query: 729 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY 788
IHRD++++NIL+ + K++DFGL+R E++ A+ + + PE
Sbjct: 119 ER---KNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAI 175
Query: 789 GNQQLTEKSDVYSFGVVLLELIS-GKKP 815
T KSDV+SFG++L E+++ G+ P
Sbjct: 176 NYGTFTIKSDVWSFGILLTEIVTYGRIP 203
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 97.5 bits (243), Expect = 3e-22
Identities = 57/209 (27%), Positives = 96/209 (45%), Gaps = 17/209 (8%)
Query: 621 IGKGSFGSVYYGKMK----DGKE--VAVKIMADSCSHRTQQ-FVTEVALLSRIHHRNLVP 673
+G+G FG V+ K K +G E V VK + + Q F E+ + ++ H+N+V
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVR 72
Query: 674 LIGYCEEEHQRILVYEYMHNGTLRDRLHGS------VNQKPLDWLTRLQIAHDAAKGLEY 727
L+G C E ++ EY G L+ L + + PL ++ + A G+++
Sbjct: 73 LLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDH 132
Query: 728 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 787
L +HRD+ + N L+ KVS LS+ + A + +L PE
Sbjct: 133 LSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEA 189
Query: 788 YGNQQLTEKSDVYSFGVVLLELIS-GKKP 815
+ KSDV+SFGV++ E+ + G+ P
Sbjct: 190 VQEDDFSTKSDVWSFGVLMWEVFTQGELP 218
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.0 bits (242), Expect = 4e-22
Identities = 65/218 (29%), Positives = 100/218 (45%), Gaps = 33/218 (15%)
Query: 621 IGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIG-- 676
IG+G++G VY + K G+ VA+KIM D ++ E +L + +H N+ G
Sbjct: 14 IGEGTYGKVYKARHKKTGQLVAIKIM-DIIEDEEEEIKEEYNILRKYSNHPNIATFYGAF 72
Query: 677 ----YCEEEHQRILVYEYMHNGTLRD---RLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 729
+ Q LV E G++ D L + +W+ I + +GL YLH
Sbjct: 73 IKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIA--YILRETLRGLAYLH 130
Query: 730 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR-----GTVGYLD 784
+IHRD+K NILL N K+ DFG+S Q + S++ R GT ++
Sbjct: 131 ---ENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLD------STLGRRNTFIGTPYWMA 181
Query: 785 PE-----YYGNQQLTEKSDVYSFGVVLLELISGKKPVS 817
PE + +SDV+S G+ +EL GK P+
Sbjct: 182 PEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLC 219
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 97.6 bits (243), Expect = 4e-22
Identities = 68/204 (33%), Positives = 100/204 (49%), Gaps = 18/204 (8%)
Query: 619 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRT---QQFVTEVALLSRIHHRNLVPL 674
++IG GSFG+VY+ + ++ + VA+K M+ S Q + EV L ++ H N +
Sbjct: 21 REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEY 80
Query: 675 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 734
G EH LV EY G+ D L V++KPL + I H A +GL YLH+
Sbjct: 81 KGCYLREHTAWLVMEYCL-GSASDIL--EVHKKPLQEVEIAAICHGALQGLAYLHSHER- 136
Query: 735 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY---YGNQ 791
IHRD+K+ NILL K++DFG + + + GT ++ PE
Sbjct: 137 --IHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV-----GTPYWMAPEVILAMDEG 189
Query: 792 QLTEKSDVYSFGVVLLELISGKKP 815
Q K DV+S G+ +EL K P
Sbjct: 190 QYDGKVDVWSLGITCIELAERKPP 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 6e-22
Identities = 68/218 (31%), Positives = 108/218 (49%), Gaps = 24/218 (11%)
Query: 619 KKIGKGSFGSVYYGK------MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLV 672
+++G+G+FG V+ + KD VAVK + D + F E LL+ + H ++V
Sbjct: 11 RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 70
Query: 673 PLIGYCEEEHQRILVYEYMHNGTLRD--RLHGS-----VNQKP------LDWLTRLQIAH 719
G C + I+V+EYM +G L R HG V+ +P L L IA
Sbjct: 71 KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 130
Query: 720 DAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA-EEDLTHISSVARG 778
A G+ YL + +HRD+ + N L+ N+ K+ DFG+SR D +
Sbjct: 131 QIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTML 187
Query: 779 TVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 815
+ ++ PE ++ T +SDV+SFGV+L E+ + GK+P
Sbjct: 188 PIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 225
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 96.2 bits (239), Expect = 9e-22
Identities = 65/216 (30%), Positives = 105/216 (48%), Gaps = 23/216 (10%)
Query: 620 KIGKGSFGSVYYGKM------KDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVP 673
++G+G+FG V+ + +D VAVK + ++ Q F E LL+ + H+++V
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71
Query: 674 LIGYCEEEHQRILVYEYMHNGTLRD--RLHG----------SVNQKPLDWLTRLQIAHDA 721
G C E ++V+EYM +G L R HG V L L IA
Sbjct: 72 FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131
Query: 722 AKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA-EEDLTHISSVARGTV 780
A G+ YL + +HRD+ + N L+ + K+ DFG+SR D + +
Sbjct: 132 ASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 188
Query: 781 GYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 815
++ PE ++ T +SD++SFGVVL E+ + GK+P
Sbjct: 189 RWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 9e-22
Identities = 63/205 (30%), Positives = 101/205 (49%), Gaps = 18/205 (8%)
Query: 616 NFCKKIGKGSFGSVYYG-KMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPL 674
NF KIG+GS G V G++VAVK M R + EV ++ H N+V +
Sbjct: 23 NF-VKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEM 81
Query: 675 IGYCEEEHQRILVYEYMHNGTLRDRL-HGSVNQKPLDWLTRLQIA---HDAAKGLEYLHT 730
+ +V E++ G L D + H +N++ QIA K L +LH
Sbjct: 82 YSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEE--------QIATVCLAVLKALSFLHA 133
Query: 731 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN 790
G+IHRD+KS +ILL + R K+SDFG Q +++ S+ GT ++ PE
Sbjct: 134 ---QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLV-GTPYWMAPEVISR 189
Query: 791 QQLTEKSDVYSFGVVLLELISGKKP 815
+ D++S G++++E++ G+ P
Sbjct: 190 LPYGTEVDIWSLGIMVIEMVDGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.4 bits (238), Expect = 1e-21
Identities = 64/205 (31%), Positives = 95/205 (46%), Gaps = 16/205 (7%)
Query: 618 CKKIGKGSFGSVYYGKMKD-GKEVAVKIM-ADSCSHRTQQFVTEVALLSRIHHRNLVPLI 675
+ IGKGSFG VY K + VA+K++ + + E+ LS+ +
Sbjct: 6 LECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYY 65
Query: 676 GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 735
G + + ++ EY G+ D L LD I + GLEYLH G
Sbjct: 66 GSFLKGSKLWIIMEYCGGGSCLDLLKPG----KLDETYIAFILREVLLGLEYLH---EEG 118
Query: 736 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVG---YLDPEYYGNQQ 792
IHRD+K++NILL K++DFG+S Q LT S VG ++ PE
Sbjct: 119 KIHRDIKAANILLSEEGDVKLADFGVSGQ----LTSTMSKRNTFVGTPFWMAPEVIKQSG 174
Query: 793 LTEKSDVYSFGVVLLELISGKKPVS 817
EK+D++S G+ +EL G+ P+S
Sbjct: 175 YDEKADIWSLGITAIELAKGEPPLS 199
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 1e-21
Identities = 67/229 (29%), Positives = 115/229 (50%), Gaps = 25/229 (10%)
Query: 609 ELEEATNNFCKKIGKGSFGSVYYGK-----MKDGKEVAVKIMAD-SCSHRTQQFVTEVAL 662
EL + F +++G+ +FG +Y G M + VA+K + D + + +F E +L
Sbjct: 1 ELPLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASL 60
Query: 663 LSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRL-----HGSVN---------QKP 708
++ +HH N+V L+G +E +++EY++ G L + L H V +
Sbjct: 61 MAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSS 120
Query: 709 LDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA-EE 767
LD L IA A G+EYL + +H+D+ + NIL+ + K+SD GLSR+
Sbjct: 121 LDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSA 177
Query: 768 DLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 815
D + + + ++ PE + + SD++SFGVVL E+ S G +P
Sbjct: 178 DYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 96.3 bits (239), Expect = 1e-21
Identities = 77/235 (32%), Positives = 115/235 (48%), Gaps = 19/235 (8%)
Query: 589 SIARGGHFMDEGVAYFIPLPELEEATNNFCKKIGKGSFGSVYYGK-MKDGKEVAVKIMAD 647
S +R G D +A + E+ + ++IG GSFG+VY+ + ++ + VA+K M+
Sbjct: 2 STSRAGSLKDPEIAELFFKEDPEKLFTDL-REIGHGSFGAVYFARDVRTNEVVAIKKMSY 60
Query: 648 SCSHRT---QQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSV 704
S Q + EV L RI H N + G EH LV EY G+ D L V
Sbjct: 61 SGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCL-GSASDLLE--V 117
Query: 705 NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 764
++KPL + I H A +GL YLH+ +IHRD+K+ NILL + K++DFG +
Sbjct: 118 HKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASI 174
Query: 765 AEEDLTHISSVARGTVGYLDPEY---YGNQQLTEKSDVYSFGVVLLELISGKKPV 816
A + + GT ++ PE Q K DV+S G+ +EL K P+
Sbjct: 175 ASPANSFV-----GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 224
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 2e-21
Identities = 65/205 (31%), Positives = 114/205 (55%), Gaps = 15/205 (7%)
Query: 621 IGKGSFGSVYYGKMK-DGKE---VAVKIMADSCSHRTQQ-FVTEVALLSRIHHRNLVPLI 675
IG G FG V G++K GK VA+K + + + ++ F++E +++ + H N++ L
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 676 GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 735
G + +++ E+M NG L L + Q + L + + A G++YL
Sbjct: 72 GVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQL--VGMLRGIAAGMKYL---SEMN 126
Query: 736 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEE---DLTHISSVA-RGTVGYLDPEYYGNQ 791
+HRD+ + NIL++ N+ KVSDFGLSR E+ D T+ SS+ + + + PE +
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYR 186
Query: 792 QLTEKSDVYSFGVVLLELIS-GKKP 815
+ T SDV+S+G+V+ E++S G++P
Sbjct: 187 KFTSASDVWSYGIVMWEVMSYGERP 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 3e-21
Identities = 66/223 (29%), Positives = 111/223 (49%), Gaps = 33/223 (14%)
Query: 619 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQ----FVTEVALLSRIHHRNLVP 673
KK+GKGS+GSVY K + D + A+K + +Q+ V E+ +L+ ++H N+
Sbjct: 6 KKLGKGSYGSVYKVKRLSDNQFYALKEV--DLGSMSQKEREDAVNEIRILASVNHPNI-- 61
Query: 674 LIGYCE---EEHQRILVYEYMHNGTLRDRLHGSVNQKPL-----DWLTRLQIAHDAAKGL 725
I Y E + ++ +V EY G L + ++ L W +Q+ +GL
Sbjct: 62 -ISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLL----RGL 116
Query: 726 EYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL--THISSVARGTVGYL 783
+ LH I+HRD+KS+NILL N K+ D G+S+ ++++ T I GT Y+
Sbjct: 117 QALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQI-----GTPHYM 168
Query: 784 DPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELN 826
PE + + + KSD++S G +L E+ + P +L
Sbjct: 169 APEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSM-QDLR 210
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 94.7 bits (236), Expect = 3e-21
Identities = 62/219 (28%), Positives = 103/219 (47%), Gaps = 22/219 (10%)
Query: 620 KIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQ-----QFVTEVALLSRIHHRNLVP 673
+IG+G+ G V+ K + G+ VA+K + R + Q + E+ L H +V
Sbjct: 7 RIGEGAHGIVFKAKDRETGETVALKKV---ALRRLEGGIPNQALREIKALQACQHPYVVK 63
Query: 674 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQI---AHDAAKGLEYLHT 730
L+ +LV EYM L + L ++PL Q+ KG+ Y+H
Sbjct: 64 LLDVFPHGSGFVLVMEYM-PSDLSEVLRDE--ERPL---PEAQVKSYMRMLLKGVAYMH- 116
Query: 731 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE-YYG 789
GI+HRD+K +N+L+ + K++DFGL+R E+ + S T Y PE YG
Sbjct: 117 --ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYG 174
Query: 790 NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIV 828
++ D+++ G + EL++G E+ +L IV
Sbjct: 175 ARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIV 213
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 4e-21
Identities = 65/198 (32%), Positives = 102/198 (51%), Gaps = 7/198 (3%)
Query: 619 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYC 678
KK+G G FG V+ G +VAVK + + + F+ E ++ ++ H LV L
Sbjct: 12 KKLGNGQFGEVWMGTWNGNTKVAVKTLKPG-TMSPESFLEEAQIMKKLRHDKLVQLYAVV 70
Query: 679 EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIH 738
EE I V EYM G+L D L + L + +A A G+ Y+ IH
Sbjct: 71 SEEPIYI-VTEYMSKGSLLDFLKDG-EGRALKLPNLVDMAAQVAAGMAYIE---RMNYIH 125
Query: 739 RDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSD 798
RD++S+NIL+ + K++DFGL+R E++ A+ + + PE + T KSD
Sbjct: 126 RDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 185
Query: 799 VYSFGVVLLELIS-GKKP 815
V+SFG++L EL++ G+ P
Sbjct: 186 VWSFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 4e-21
Identities = 55/199 (27%), Positives = 100/199 (50%), Gaps = 12/199 (6%)
Query: 621 IGKGSFGS-VYYGKMKDGKEVAVK-IMADSCSHRTQQFV-TEVALLSRIHHRNLVPLIGY 677
+GKG+FG Y + +D V K + S + ++ E+ +LS + H N++ +
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNH 67
Query: 678 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAH--DAAKGLEYLHTGCNPG 735
+++ ++ EY + GTL D++ V QK + + + + + Y+H G
Sbjct: 68 FMDDNTLLIEMEYANGGTLYDKI---VRQKGQLFEEEMVLWYLFQIVSAVSYIHKA---G 121
Query: 736 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTE 795
I+HRD+K+ NI L K+ DFG+S+ + + +V GT Y+ PE +
Sbjct: 122 ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVV-GTPYYMSPELCQGVKYNF 180
Query: 796 KSDVYSFGVVLLELISGKK 814
KSD+++ G VL EL++ K+
Sbjct: 181 KSDIWALGCVLYELLTLKR 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 93.6 bits (232), Expect = 4e-21
Identities = 64/197 (32%), Positives = 105/197 (53%), Gaps = 7/197 (3%)
Query: 620 KIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCE 679
K+G+G FG V+ G +VA+K + + + F+ E ++ ++ H LVPL
Sbjct: 13 KLGQGCFGEVWMGTWNGTTKVAIKTLKPG-TMMPEAFLQEAQIMKKLRHDKLVPLYAVVS 71
Query: 680 EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHR 739
EE I V E+M G+L D L + K L + +A A G+ Y+ IHR
Sbjct: 72 EEPIYI-VTEFMGKGSLLDFLKEG-DGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHR 126
Query: 740 DVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDV 799
D++++NIL+ N+ K++DFGL+R E++ A+ + + PE + T KSDV
Sbjct: 127 DLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 186
Query: 800 YSFGVVLLELIS-GKKP 815
+SFG++L EL++ G+ P
Sbjct: 187 WSFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 93.6 bits (232), Expect = 5e-21
Identities = 65/197 (32%), Positives = 103/197 (52%), Gaps = 7/197 (3%)
Query: 620 KIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCE 679
K+G+G FG V+ G VA+K + + + F+ E ++ ++ H LV L
Sbjct: 13 KLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 71
Query: 680 EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHR 739
EE I V EYM G+L D L G + K L + +A A G+ Y+ +HR
Sbjct: 72 EEPIYI-VTEYMSKGSLLDFLKGEMG-KYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 126
Query: 740 DVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDV 799
D++++NIL+ N+ KV+DFGL+R E++ A+ + + PE + T KSDV
Sbjct: 127 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 186
Query: 800 YSFGVVLLELIS-GKKP 815
+SFG++L EL + G+ P
Sbjct: 187 WSFGILLTELTTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 8e-21
Identities = 75/224 (33%), Positives = 111/224 (49%), Gaps = 27/224 (12%)
Query: 608 PELEEATNNFCKKIGKGSFGSVYYGKM-KDG--KEVAVKIMADSCS---HRTQQFVTEVA 661
P LE F IG+G+FG V ++ KDG + A+K M + S HR F E+
Sbjct: 2 PVLEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHR--DFAGELE 59
Query: 662 LLSRI-HHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGS----------VNQKPLD 710
+L ++ HH N++ L+G CE L EY +G L D L S +
Sbjct: 60 VLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAS 119
Query: 711 WLTRLQIAH---DAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 767
L+ Q+ H D A+G++YL IHRD+ + NIL+ N AK++DFGLSR E
Sbjct: 120 TLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEV 176
Query: 768 DLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS 811
+ ++ R V ++ E T SDV+S+GV+L E++S
Sbjct: 177 YVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 93.6 bits (233), Expect = 8e-21
Identities = 69/232 (29%), Positives = 113/232 (48%), Gaps = 33/232 (14%)
Query: 606 PLPELEEATNNFCKKIGKGSFGSVYYG------KMKDGKEVAVKIM-ADSCSHRTQQFVT 658
P EL K +G+G+FG V + VAVK++ D+ V+
Sbjct: 5 PEWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVS 64
Query: 659 EVALLSRI-HHRNLVPLIGYCEEEHQRILVYEYMHNGTLRD--RLHGSVNQK-------- 707
E+ ++ I H+N++ L+G C +E +V EY +G LRD R +
Sbjct: 65 EMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRP 124
Query: 708 PLDWLTR---LQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 764
P + LT+ + A+ A+G+E+L + IHRD+ + N+L+ + K++DFGL+R
Sbjct: 125 PEETLTQKDLVSFAYQVARGMEFLAS---KKCIHRDLAARNVLVTEDHVMKIADFGLAR- 180
Query: 765 AEEDLTHISSVARGTVGYLD-----PEYYGNQQLTEKSDVYSFGVVLLELIS 811
D+ HI + T G L PE ++ T +SDV+SFGV+L E+ +
Sbjct: 181 ---DIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 93.1 bits (231), Expect = 1e-20
Identities = 68/211 (32%), Positives = 109/211 (51%), Gaps = 27/211 (12%)
Query: 621 IGKGSFGSVYYGKMK-DGKEV--AVKIMADSCSHRTQQ-FVTEVALLSRI-HHRNLVPLI 675
IG+G+FG V +K DG ++ A+K++ + S + F E+ +L ++ HH N++ L+
Sbjct: 10 IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLL 69
Query: 676 GYCEEEHQRILVYEYMHNGTLRD---------------RLHGSVNQKPLDWLTRLQIAHD 720
G CE + EY G L D + HG+ + L LQ A D
Sbjct: 70 GACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTAST--LTSQQLLQFASD 127
Query: 721 AAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTV 780
A G++YL IHRD+ + N+L+ N+ +K++DFGLSR E++ ++ R V
Sbjct: 128 VATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSRG--EEVYVKKTMGRLPV 182
Query: 781 GYLDPEYYGNQQLTEKSDVYSFGVVLLELIS 811
++ E T KSDV+SFGV+L E++S
Sbjct: 183 RWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 92.3 bits (229), Expect = 2e-20
Identities = 60/213 (28%), Positives = 105/213 (49%), Gaps = 21/213 (9%)
Query: 621 IGKGSFGSVYYGKMKDGKEVAVKIMA------DSCSHRTQQFVTEVALLSRIHHRNLVPL 674
+GKG++G+VY G G+ +AVK + + ++ EV LL + H N+V
Sbjct: 8 LGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQY 67
Query: 675 IGYCEEEHQRILVYEYMHNGTLRDRLH--GSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 732
+G C +++ + E++ G++ L+ G + + T+ QI G+ YLH C
Sbjct: 68 LGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTK-QIL----DGVAYLHNNC 122
Query: 733 NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ---AEEDLTH--ISSVARGTVGYLDPEY 787
++HRD+K +N++L N K+ DFG +R+ TH + GT ++ PE
Sbjct: 123 ---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEV 179
Query: 788 YGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 820
KSD++S G + E+ +GK P++ D
Sbjct: 180 INESGYGRKSDIWSIGCTVFEMATGKPPLASMD 212
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 2e-20
Identities = 68/276 (24%), Positives = 126/276 (45%), Gaps = 31/276 (11%)
Query: 619 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQ------FVTEVALLSRIHHRNL 671
+++G G+F S Y + +K G +AVK + + ++Q E+ L++R++H ++
Sbjct: 6 QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65
Query: 672 VPLIG-YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 730
+ ++G CE+ H + V E+M G++ L + +GL YLH
Sbjct: 66 IRMLGATCEDSHFNLFV-EWMAGGSVSHLLS---KYGAFKEAVIINYTEQLLRGLSYLH- 120
Query: 731 GCNPGIIHRDVKSSNILLD-INMRAKVSDFGLSRQAEEDLT---HISSVARGTVGYLDPE 786
IIHRDVK +N+L+D R +++DFG + + T GT+ ++ PE
Sbjct: 121 --ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPE 178
Query: 787 YYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP 846
+Q DV+S G V++E+ + K P + E L ++ S + + P
Sbjct: 179 VLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSP 238
Query: 847 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIV 882
L +V ++C+E + RP +E++
Sbjct: 239 GL------------RDVTLRCLELQPEDRPPSRELL 262
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.1 bits (228), Expect = 2e-20
Identities = 66/211 (31%), Positives = 105/211 (49%), Gaps = 27/211 (12%)
Query: 621 IGKGSFGSVYYGKMK-DGKEV--AVKIMADSCSHRTQQ-FVTEVALLSRI-HHRNLVPLI 675
IG+G+FG V ++K DG + A+K M + S + F E+ +L ++ HH N++ L+
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 676 GYCEEEHQRILVYEYMHNGTLRD---------------RLHGSVNQKPLDWLTRLQIAHD 720
G CE L EY +G L D + + + L L A D
Sbjct: 63 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST--LSSQQLLHFAAD 120
Query: 721 AAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTV 780
A+G++YL IHRD+ + NIL+ N AK++DFGLSR +++ ++ R V
Sbjct: 121 VARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRG--QEVYVKKTMGRLPV 175
Query: 781 GYLDPEYYGNQQLTEKSDVYSFGVVLLELIS 811
++ E T SDV+S+GV+L E++S
Sbjct: 176 RWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 2e-20
Identities = 70/208 (33%), Positives = 105/208 (50%), Gaps = 24/208 (11%)
Query: 619 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADS---CSHRTQQFVTEVALLSRIHHRNLVPL 674
++IG GSFG+VY+ + +++ + VA+K M+ S + + Q + EV L ++ H N +
Sbjct: 21 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80
Query: 675 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 734
G EH LV EY G+ D L V++KPL + + H A +GL YLH +
Sbjct: 81 RGCYLREHTAWLVMEYCL-GSASDLLE--VHKKPLQEVEIAAVTHGALQGLAYLH---SH 134
Query: 735 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVG---YLDPEY---Y 788
+IHRDVK+ NILL K+ DFG + I + A VG ++ PE
Sbjct: 135 NMIHRDVKAGNILLSEPGLVKLGDFGSAS--------IMAPANXFVGTPYWMAPEVILAM 186
Query: 789 GNQQLTEKSDVYSFGVVLLELISGKKPV 816
Q K DV+S G+ +EL K P+
Sbjct: 187 DEGQYDGKVDVWSLGITCIELAERKPPL 214
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 2e-20
Identities = 64/213 (30%), Positives = 109/213 (51%), Gaps = 19/213 (8%)
Query: 619 KKIGKGSFGSVYYGKMKDGK---EVAVKIMADSCSHRTQ--QFVTEVALLSRIHHRNLVP 673
K +G+G FGSV G++ +VAVK M + R++ F++E + H N++
Sbjct: 5 KTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMR 64
Query: 674 LIGYCEEEHQR------ILVYEYMHNGTLRD-RLHGSVNQKPLDWLTRL--QIAHDAAKG 724
LIG C + + +++ +M +G L L+ + P T++ + D A G
Sbjct: 65 LIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASG 124
Query: 725 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE-DLTHISSVARGTVGYL 783
+EYL + IHRD+ + N +L+ NM V+DFGLS++ D +A+ V ++
Sbjct: 125 MEYLSS---KSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWI 181
Query: 784 DPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 815
E ++ T KSDV+SFGV + E+ + G+ P
Sbjct: 182 AIESLADRVYTTKSDVWSFGVTMWEIATRGQTP 214
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 2e-20
Identities = 60/197 (30%), Positives = 102/197 (51%), Gaps = 9/197 (4%)
Query: 620 KIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYC 678
KIG+GS G V + K G++VAVK+M R + EV ++ H+N+V +
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY 87
Query: 679 EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIH 738
+ ++ E++ G L D V+Q L+ + + L YLH+ G+IH
Sbjct: 88 LVGEELWVLMEFLQGGALTD----IVSQTRLNEEQIATVCESVLQALCYLHS---QGVIH 140
Query: 739 RDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSD 798
RD+KS +ILL ++ R K+SDFG Q +D+ S+ GT ++ PE + D
Sbjct: 141 RDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWMAPEVISRTPYGTEVD 199
Query: 799 VYSFGVVLLELISGKKP 815
++S G++++E++ G+ P
Sbjct: 200 IWSLGIMVIEMVDGEPP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 2e-20
Identities = 70/204 (34%), Positives = 104/204 (50%), Gaps = 18/204 (8%)
Query: 620 KIGKGSFGSVYYGKMKDGKE-VAVKIMADS---CSHRTQQFVTEVALLSRIHHRNLVPLI 675
+IG GSFG+VY+ E VAVK M+ S + + Q + EV L ++ H N +
Sbjct: 28 EIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYK 87
Query: 676 GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 735
G +EH LV EY G+ D L V++KPL + I H A +GL YLH+
Sbjct: 88 GCYLKEHTAWLVMEYCL-GSASDLLE--VHKKPLQEVEIAAITHGALQGLAYLHSHN--- 141
Query: 736 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY---YGNQQ 792
+IHRD+K+ NILL + K++DFG + ++ + + GT ++ PE Q
Sbjct: 142 MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV-----GTPYWMAPEVILAMDEGQ 196
Query: 793 LTEKSDVYSFGVVLLELISGKKPV 816
K DV+S G+ +EL K P+
Sbjct: 197 YDGKVDVWSLGITCIELAERKPPL 220
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 91.5 bits (227), Expect = 3e-20
Identities = 66/214 (30%), Positives = 110/214 (51%), Gaps = 20/214 (9%)
Query: 619 KKIGKGSFGSVYYGKMK----DGKEVAVKIM-AD-SCSHRTQQFVTEVALLSRIHHRNLV 672
+ +GKG FGSV ++K ++VAVK++ AD S ++F+ E A + H N++
Sbjct: 5 RMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVI 64
Query: 673 PLIGYC--EEEHQRI----LVYEYMHNGTLRDRLHGS-VNQKP--LDWLTRLQIAHDAAK 723
LIG R+ ++ +M +G L L S + ++P L T ++ D A
Sbjct: 65 KLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIAS 124
Query: 724 GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE-DLTHISSVARGTVGY 782
G+EYL + IHRD+ + N +L+ NM V+DFGLS++ D ++ V +
Sbjct: 125 GMEYLS---SKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKW 181
Query: 783 LDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 815
L E + T SDV++FGV + E+++ G+ P
Sbjct: 182 LALESLADNVYTTHSDVWAFGVTMWEIMTRGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 4e-20
Identities = 63/198 (31%), Positives = 101/198 (51%), Gaps = 11/198 (5%)
Query: 620 KIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYC 678
KIG+GS G V K GK+VAVK M R + EV ++ HH N+V +
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88
Query: 679 EEEHQRILVYEYMHNGTLRDRL-HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGII 737
+ +V E++ G L D + H +N++ + + + L YLH N G+I
Sbjct: 89 LVGDELWVVMEFLEGGALTDIVTHTRMNEEQI-----ATVCLSVLRALSYLH---NQGVI 140
Query: 738 HRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKS 797
HRD+KS +ILL + R K+SDFG Q +++ S+ GT ++ PE +
Sbjct: 141 HRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLV-GTPYWMAPEVISRLPYGTEV 199
Query: 798 DVYSFGVVLLELISGKKP 815
D++S G++++E+I G+ P
Sbjct: 200 DIWSLGIMVIEMIDGEPP 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 6e-20
Identities = 65/206 (31%), Positives = 105/206 (50%), Gaps = 17/206 (8%)
Query: 617 FCKKIGKGSFGSVY----YGKMKDGK--EVAVKIMADSCSHRT--QQFVTEVALLSRI-H 667
F K +G G+FG V YG K +VAVK M +H + + ++E+ ++S + +
Sbjct: 39 FGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVK-MLKPTAHSSEREALMSELKIMSHLGN 97
Query: 668 HRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEY 727
H N+V L+G C +++ EY G L + L + L L ++ AKG+ +
Sbjct: 98 HENIVNLLGACTIGGPILVITEYCCYGDLLNFLR-RKRESFLTLEDLLSFSYQVAKGMAF 156
Query: 728 LHT-GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS-SVARGTVGYLDP 785
L + C IHRD+ + N+LL K+ DFGL+R D ++ AR V ++ P
Sbjct: 157 LASKNC----IHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAP 212
Query: 786 EYYGNQQLTEKSDVYSFGVVLLELIS 811
E N T +SDV+S+G++L E+ S
Sbjct: 213 ESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 8e-20
Identities = 62/209 (29%), Positives = 108/209 (51%), Gaps = 9/209 (4%)
Query: 609 ELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHH 668
E+ + KK+G G FG V+ +VAVK M S + F+ E ++ + H
Sbjct: 2 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQH 60
Query: 669 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEY 727
LV L +E I+ E+M G+L D L +++PL L + + A+G+ +
Sbjct: 61 DKLVKLHAVVTKEPIYIIT-EFMAKGSLLDFLKSDEGSKQPLPKL--IDFSAQIAEGMAF 117
Query: 728 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 787
+ IHRD++++NIL+ ++ K++DFGL+R E++ A+ + + PE
Sbjct: 118 IE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEA 174
Query: 788 YGNQQLTEKSDVYSFGVVLLELIS-GKKP 815
T KSDV+SFG++L+E+++ G+ P
Sbjct: 175 INFGSFTIKSDVWSFGILLMEIVTYGRIP 203
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.1 bits (224), Expect = 9e-20
Identities = 60/208 (28%), Positives = 102/208 (49%), Gaps = 18/208 (8%)
Query: 619 KKIGKGSFGSVYYGKMKD------GKEVAVKIMADSCSHRTQ-QFVTEVALLSRIHHRNL 671
+++G+GSFG VY G K VA+K + ++ S R + +F+ E +++ + ++
Sbjct: 12 RELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHV 71
Query: 672 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHG----SVNQKPLDWLTR---LQIAHDAAKG 724
V L+G ++V E M G L+ L + N L T +Q+A + A G
Sbjct: 72 VRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADG 131
Query: 725 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA-EEDLTHISSVARGTVGYL 783
+ YL +HRD+ + N ++ ++ K+ DFG++R E D V ++
Sbjct: 132 MAYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 188
Query: 784 DPEYYGNQQLTEKSDVYSFGVVLLELIS 811
PE + T KSDV+SFGVVL E+ +
Sbjct: 189 APESLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.2 bits (225), Expect = 1e-19
Identities = 61/208 (29%), Positives = 101/208 (48%), Gaps = 27/208 (12%)
Query: 618 CKKIGKGSFGSVYYGK-MKDGKEVAVKIMA---------DSCSHRTQQFVTEVALLSRIH 667
+K+G+G++G VY + K G+ VA+K + + + E++LL +
Sbjct: 4 LEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTA-------LREISLLKELK 56
Query: 668 HRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEY 727
H N+V L+ E + LV+EY L+ L PL I + +GL Y
Sbjct: 57 HPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLD--KRPGPLSPNLIKSIMYQLLRGLAY 113
Query: 728 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL-THISSVARGTVGYLDPE 786
H+ I+HRD+K NIL++ + K++DFGL+R L T+ V T+ Y PE
Sbjct: 114 CHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV--TLWYRAPE 168
Query: 787 -YYGNQQLTEKSDVYSFGVVLLELISGK 813
G++ + D++S G + E+I+GK
Sbjct: 169 ILLGSKHYSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 90.0 bits (223), Expect = 1e-19
Identities = 67/209 (32%), Positives = 102/209 (48%), Gaps = 22/209 (10%)
Query: 617 FCKKI---GKGSFGSVY---YGKMKD--GKEVAVKIMADSCSHR-TQQFVTEVALLSRIH 667
+ KKI G+G FG V Y D G+ VAVK + C + T + E+ +L ++
Sbjct: 5 YLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLY 64
Query: 668 HRNLVPLIGYCEEEHQRI--LVYEYMHNGTLRDRL-HGSVNQKPLDWLTRLQIAHDAAKG 724
H N+V G C E+ + L+ EY+ G+LRD L +N L L A +G
Sbjct: 65 HENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQL-----LLFAQQICEG 119
Query: 725 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE--DLTHISSVARGTVGY 782
+ YLH+ IHRD+ + N+LLD + K+ DFGL++ E + + V +
Sbjct: 120 MAYLHS---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFW 176
Query: 783 LDPEYYGNQQLTEKSDVYSFGVVLLELIS 811
E + + SDV+SFGV L EL++
Sbjct: 177 YAVECLKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.3 bits (222), Expect = 2e-19
Identities = 55/204 (26%), Positives = 95/204 (46%), Gaps = 21/204 (10%)
Query: 619 KKIGKGSFGSVYYGKMKDGKE-VAVKIMADSCSHRTQQF----VTEVALLSRIHHRNLVP 673
KIG+G++G VY + K E VA+K + ++ + E+ LL ++H N++
Sbjct: 5 GKIGEGTYGVVYKARDKLTGEIVAIKKI--KLRFESEGIPKTALREIKLLKELNHPNIIK 62
Query: 674 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 733
L+ + LV+E+M L + Q+ L + +GL + H+
Sbjct: 63 LLDVFRHKGDLYLVFEFMDT-DLYKLIKD--RQRGLPESLIKSYLYQLLQGLAFCHSH-- 117
Query: 734 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED---LTHISSVARGTVGYLDPE-YYG 789
GI+HRD+K N+L++ K++DFGL+R TH T Y PE G
Sbjct: 118 -GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVV----TRWYRAPELLLG 172
Query: 790 NQQLTEKSDVYSFGVVLLELISGK 813
++ + D++S G + EL+S +
Sbjct: 173 DKGYSTPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 2e-19
Identities = 67/211 (31%), Positives = 92/211 (43%), Gaps = 26/211 (12%)
Query: 619 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHR-----NLV 672
K I KG+FGSVY K + G A+K++ S Q VT V I +
Sbjct: 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQ-VTNVKAERAIMMIQGESPYVA 60
Query: 673 PLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQK----PLDWLTRLQIAHDAAKGLEYL 728
L + + LV EY++ G S+ + P DW Q + G+E L
Sbjct: 61 KLYYSFQSKDYLYLVMEYLNGGDC-----ASLIKTLGGLPEDWAK--QYIAEVVLGVEDL 113
Query: 729 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY 788
H GIIHRD+K N+L+D K++DFGLSR E+ + GT YL PE
Sbjct: 114 H---QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKFV-----GTPDYLAPETI 165
Query: 789 GNQQLTEKSDVYSFGVVLLELISGKKPVSVE 819
+ SD +S G V+ E + G P E
Sbjct: 166 LGVGDDKMSDWWSLGCVIFEFLFGYPPFHAE 196
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 2e-19
Identities = 59/207 (28%), Positives = 104/207 (50%), Gaps = 18/207 (8%)
Query: 618 CKKIGKGSFGSVY----YGKMKDGKE--VAVKIMADSCSHRTQ-QFVTEVALLSRIHHRN 670
+++G+GSFG VY G +KD E VA+K + ++ S R + +F+ E +++ + +
Sbjct: 11 SRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 70
Query: 671 LVPLIGYCEEEHQRILVYEYMHNG-------TLRDRLHGSVNQKPLDWLTRLQIAHDAAK 723
+V L+G + +++ E M G +LR + + Q P +Q+A + A
Sbjct: 71 VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIAD 130
Query: 724 GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA-EEDLTHISSVARGTVGY 782
G+ YL+ +HRD+ + N ++ + K+ DFG++R E D V +
Sbjct: 131 GMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 187
Query: 783 LDPEYYGNQQLTEKSDVYSFGVVLLEL 809
+ PE + T SDV+SFGVVL E+
Sbjct: 188 MSPESLKDGVFTTYSDVWSFGVVLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 2e-19
Identities = 63/227 (27%), Positives = 112/227 (49%), Gaps = 33/227 (14%)
Query: 619 KKIGKGSFGSVYYGKMKDGK------EVAVKIMAD-SCSHRTQQFVTEVALLSRIHHRNL 671
K +G+G FG V K VAVK++ + + S + ++E LL +++H ++
Sbjct: 6 KTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHV 65
Query: 672 VPLIGYCEEEHQRILVYEYMHNGTLRDRLH-------------GSVN--------QKPLD 710
+ L G C ++ +L+ EY G+LR L G+ N ++ L
Sbjct: 66 IKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALT 125
Query: 711 WLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 770
+ A ++G++YL ++HRD+ + N+L+ + K+SDFGLSR E+ +
Sbjct: 126 MGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDS 182
Query: 771 HIS-SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 815
++ S R V ++ E + T +SDV+SFGV+L E+++ G P
Sbjct: 183 YVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 229
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 3e-19
Identities = 62/222 (27%), Positives = 109/222 (49%), Gaps = 28/222 (12%)
Query: 619 KKIGKGSFGSVYYG--------KMKDGKEVAVKIMADSCSHRT-QQFVTEVALLSRI-HH 668
K +G+G FG V K K+ VAVK++ D + + V+E+ ++ I H
Sbjct: 21 KPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 80
Query: 669 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGS-------------VNQKPLDWLTRL 715
+N++ L+G C ++ ++ EY G LR+ L V + + + +
Sbjct: 81 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLV 140
Query: 716 QIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE-DLTHISS 774
+ A+G+EYL + IHRD+ + N+L+ N K++DFGL+R D ++
Sbjct: 141 SCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTT 197
Query: 775 VARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 815
R V ++ PE ++ T +SDV+SFGV++ E+ + G P
Sbjct: 198 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 239
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 3e-19
Identities = 64/218 (29%), Positives = 113/218 (51%), Gaps = 29/218 (13%)
Query: 619 KKIGKGSFGSVY----YGKMKDGKE----VAVKIMADSCSHRT-QQFVTEVALLSRI-HH 668
K +G+G FG V YG K + VAVK++ D+ + + ++E+ L+ I H
Sbjct: 18 KPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKH 77
Query: 669 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHG-------------SVNQKPLDWLTRL 715
+N++ L+G C +E ++ EY G LR+ L V ++ L + +
Sbjct: 78 KNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLV 137
Query: 716 QIAHDAAKGLEYLHTG-CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE-DLTHIS 773
A+ A+G+EYL + C IHRD+ + N+L+ + K++DFGL+R + D +
Sbjct: 138 SCAYQVARGMEYLESRRC----IHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKT 193
Query: 774 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS 811
S R V ++ PE ++ T +SDV+SFG+++ E+ +
Sbjct: 194 SNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.7 bits (223), Expect = 4e-19
Identities = 66/254 (25%), Positives = 105/254 (41%), Gaps = 41/254 (16%)
Query: 615 NNFC--KKIGKGSFGSVYYGKMKDGKEV-AVKIMADSCSHRTQQ---FVTEVALLSRIHH 668
++F K IG+G+FG V+ + KD +V A+K++ S + Q E +L+
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60
Query: 669 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYL 728
+V L ++E LV EYM G L L + P + R IA + L+ +
Sbjct: 61 PWIVKLYYSFQDEEHLYLVMEYMPGGDLM-NLLIRKDVFPEET-ARFYIA-ELVLALDSV 117
Query: 729 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS-------------------------- 762
H G IHRD+K NIL+D + K++DFGL
Sbjct: 118 H---KLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVL 174
Query: 763 --RQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 820
R+ + ++ GT Y+ PE + D +S GV+L E++ G P +
Sbjct: 175 VRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT 234
Query: 821 -FGAELNIVHWARS 833
I++W S
Sbjct: 235 LQETYNKIINWKES 248
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 8e-19
Identities = 67/210 (31%), Positives = 110/210 (52%), Gaps = 22/210 (10%)
Query: 619 KKIGKGSFGSVYYGKMKD-GKEVAVK-IMADSCSHRTQQFVT----EVALLSRIHHRNLV 672
K +G+G+FG VY D G+E+AVK + D S T + V E+ LL + H +V
Sbjct: 8 KLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIV 67
Query: 673 PLIGYCEEEHQRIL--VYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYL 728
G + +R L E+M G+++D+L +G++ + TR QI +G+ YL
Sbjct: 68 QYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTR-QIL----EGVSYL 122
Query: 729 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE---DLTHISSVARGTVGYLDP 785
H+ I+HRD+K +NIL D K+ DFG S++ + T + SV GT ++ P
Sbjct: 123 HSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVT-GTPYWMSP 178
Query: 786 EYYGNQQLTEKSDVYSFGVVLLELISGKKP 815
E + K+D++S G ++E+++ K P
Sbjct: 179 EVISGEGYGRKADIWSVGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 1e-18
Identities = 64/207 (30%), Positives = 104/207 (50%), Gaps = 19/207 (9%)
Query: 619 KKIGKGSFGSV---YYGKMKDGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVP 673
++G G+FG+V Y K K VAVKI+ + + + + E ++ ++ + +V
Sbjct: 1 GELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVR 60
Query: 674 LIGYCEEEHQRILVYEYMHNGTLRDRLHGS--VNQKPLDWLTRLQIAHDAAKGLEYLHTG 731
+IG CE E +LV E G L L + V +K + ++ H + G++YL
Sbjct: 61 MIGICEAESW-MLVMELAELGPLNKFLQKNKHVTEKNI-----TELVHQVSMGMKYLE-- 112
Query: 732 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGT--VGYLDPEYYG 789
+HRD+ + N+LL AK+SDFGLS+ D + + G V + PE
Sbjct: 113 -ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMN 171
Query: 790 NQQLTEKSDVYSFGVVLLELIS-GKKP 815
+ + KSDV+SFGV++ E S G+KP
Sbjct: 172 YYKFSSKSDVWSFGVLMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 86.9 bits (215), Expect = 1e-18
Identities = 56/198 (28%), Positives = 103/198 (52%), Gaps = 9/198 (4%)
Query: 619 KKIGKGSFGSVYYG-KMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 677
+KIG+G+ G+VY + G+EVA+K M + + + E+ ++ H N+V +
Sbjct: 25 EKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDS 84
Query: 678 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGII 737
+ +V EY+ G+L D V + +D + + + LE+LH+ +I
Sbjct: 85 YLVGDELWVVMEYLAGGSLTD----VVTETCMDEGQIAAVCRECLQALEFLHSN---QVI 137
Query: 738 HRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKS 797
HRD+KS NILL ++ K++DFG Q + + S++ GT ++ PE + K
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKV 196
Query: 798 DVYSFGVVLLELISGKKP 815
D++S G++ +E++ G+ P
Sbjct: 197 DIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 1e-18
Identities = 66/208 (31%), Positives = 107/208 (51%), Gaps = 21/208 (10%)
Query: 624 GSFGSVYYGKMKDGK-----EVAVKIMADSCSH-RTQQFVTEVALLSRIHHRNLVPLIGY 677
G+FG ++YG + D K EV VK + D S + + E LL + H+N++P++
Sbjct: 17 GTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHV 76
Query: 678 CEEEHQRILV-YEYMHNGTLRDRL----HGSVNQKPLDWLTRLQIAHDA---AKGLEYLH 729
C E+ + V Y YM+ G L+ L G N L+ Q+ H A A G+ YLH
Sbjct: 77 CIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQA--LSTQQLVHMAIQIACGMSYLH 134
Query: 730 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH-ISSVARGTVGYLDPEYY 788
G+IH+D+ + N ++D ++ K++D LSR H + V ++ E
Sbjct: 135 ---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESL 191
Query: 789 GNQQLTEKSDVYSFGVVLLELIS-GKKP 815
N++ + SDV+SFGV+L EL++ G+ P
Sbjct: 192 VNKEYSSASDVWSFGVLLWELMTLGQTP 219
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 2e-18
Identities = 68/210 (32%), Positives = 109/210 (51%), Gaps = 22/210 (10%)
Query: 619 KKIGKGSFGSVYYGKMKD-GKEVAVK-IMADSCSHRTQQFVT----EVALLSRIHHRNLV 672
K +G+G+FG VY D G+E+AVK + D S T + V E+ LL + H +V
Sbjct: 8 KLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIV 67
Query: 673 PLIGYCEEEHQRIL--VYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYL 728
G + ++ L EYM G+++D+L +G++ + TR QI +G+ YL
Sbjct: 68 QYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTR-QIL----QGVSYL 122
Query: 729 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE---DLTHISSVARGTVGYLDP 785
H+ I+HRD+K +NIL D K+ DFG S++ + T I SV GT ++ P
Sbjct: 123 HSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVT-GTPYWMSP 178
Query: 786 EYYGNQQLTEKSDVYSFGVVLLELISGKKP 815
E + K+DV+S ++E+++ K P
Sbjct: 179 EVISGEGYGRKADVWSVACTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 86.6 bits (215), Expect = 2e-18
Identities = 68/223 (30%), Positives = 107/223 (47%), Gaps = 30/223 (13%)
Query: 616 NFCKKIGKGSFGSVYYGKM--------KDGKE---------VAVKIM-ADSCSHRTQQFV 657
NF +K+G+G FG V+ + K E VAVK++ D+ + + F+
Sbjct: 8 NFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFL 67
Query: 658 TEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSV--------NQKPL 709
EV +LSR+ N+ L+G C + ++ EYM NG L L V N K L
Sbjct: 68 KEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSL 127
Query: 710 DWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA-EED 768
+ T L +A A G+ YL + +HRD+ + N L+ N K++DFG+SR D
Sbjct: 128 SFSTLLYMATQIASGMRYLE---SLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSD 184
Query: 769 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS 811
+ A + ++ E + T KSDV++FGV L E+++
Sbjct: 185 YYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 2e-18
Identities = 60/198 (30%), Positives = 98/198 (49%), Gaps = 11/198 (5%)
Query: 620 KIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYC 678
KIG+GS G V +K GK VAVK M R + EV ++ H N+V +
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86
Query: 679 EEEHQRILVYEYMHNGTLRDRL-HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGII 737
+ +V E++ G L D + H +N++ + + K L LH G+I
Sbjct: 87 LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-----AVCLAVLKALSVLHA---QGVI 138
Query: 738 HRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKS 797
HRD+KS +ILL + R K+SDFG Q +++ S+ GT ++ PE +
Sbjct: 139 HRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLV-GTPYWMAPELISRLPYGPEV 197
Query: 798 DVYSFGVVLLELISGKKP 815
D++S G++++E++ G+ P
Sbjct: 198 DIWSLGIMVIEMVDGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 85.9 bits (212), Expect = 2e-18
Identities = 68/210 (32%), Positives = 110/210 (52%), Gaps = 22/210 (10%)
Query: 619 KKIGKGSFGSVYYGKMKD-GKEVAVK-IMADSCSHRTQQFVT----EVALLSRIHHRNLV 672
K +G+G+FG VY D G+E+A K + D S T + V+ E+ LL + H +V
Sbjct: 8 KLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIV 67
Query: 673 PLIGYCEEEHQRILV--YEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYL 728
G + ++ L EYM G+++D+L +G++ + TR QI +G+ YL
Sbjct: 68 QYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTR-QIL----EGMSYL 122
Query: 729 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE---DLTHISSVARGTVGYLDP 785
H+ I+HRD+K +NIL D K+ DFG S++ + T I SV GT ++ P
Sbjct: 123 HSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVT-GTPYWMSP 178
Query: 786 EYYGNQQLTEKSDVYSFGVVLLELISGKKP 815
E + K+DV+S G ++E+++ K P
Sbjct: 179 EVISGEGYGRKADVWSLGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 2e-18
Identities = 67/214 (31%), Positives = 105/214 (49%), Gaps = 22/214 (10%)
Query: 621 IGKGSFGSVYYGKMKD----GKE---VAVKIMADSCSHRTQ-QFVTEVALLSRIHHRNLV 672
+G G+FG VY G D G VAVK + + + + +F+ E L+S +H N+V
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 673 PLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQK---PLDWLTRL-QIAHDAAKGLEYL 728
L+G C + ++ E M G L L + ++ PL L L I D AKG YL
Sbjct: 63 KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122
Query: 729 HTGCNPGIIHRDVKSSNILL-----DINMRAKVSDFGLSRQA-EEDLTHISSVARGTVGY 782
IHRD+ + N L+ D + K+ DFGL+R + D V +
Sbjct: 123 E---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRW 179
Query: 783 LDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 815
+ PE + + T +SDV+SFGV++ E+++ G++P
Sbjct: 180 MAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQP 213
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 2e-18
Identities = 67/206 (32%), Positives = 102/206 (49%), Gaps = 24/206 (11%)
Query: 619 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLI 675
KKIG+GSFG K K DGK+ +K + S ++ EVA+LS + H N+V
Sbjct: 6 KKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQ 65
Query: 676 GYCEEEHQRILVYEYMHNGTLRDRLHGS-----VNQKPLDWLTRLQIAHDAAKGLEYLHT 730
EE +V +Y G L +++ + LDW ++ +A L+++H
Sbjct: 66 ESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLA------LKHVH- 118
Query: 731 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR---GTVGYLDPEY 787
+ I+HRD+KS NI L + K+ DFG++R L +AR GT YL PE
Sbjct: 119 --DRKILHRDIKSQNIFLTKDGTIKLGDFGIARV----LNSTVELARTCIGTPYYLSPEI 172
Query: 788 YGNQQLTEKSDVYSFGVVLLELISGK 813
N+ KSD+++ G VL E+ + K
Sbjct: 173 CENRPYNNKSDIWALGCVLYEMCTLK 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 4e-18
Identities = 59/204 (28%), Positives = 104/204 (50%), Gaps = 18/204 (8%)
Query: 621 IGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCE 679
+GKG++G VY + + +A+K + + S Q E+AL S + HRN+V +G
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75
Query: 680 EEHQRILVYEYMHNGTLRDRLHG-----SVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 734
E + E + G+L L N++ + + T+ QI +GL+YLH +
Sbjct: 76 ENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTK-QI----LEGLKYLH---DN 127
Query: 735 GIIHRDVKSSNILLDI-NMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY--YGNQ 791
I+HRD+K N+L++ + K+SDFG S++ + + GT+ Y+ PE G +
Sbjct: 128 QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL-AGINPCTETFTGTLQYMAPEVIDKGPR 186
Query: 792 QLTEKSDVYSFGVVLLELISGKKP 815
+D++S G ++E+ +GK P
Sbjct: 187 GYGAPADIWSLGCTIVEMATGKPP 210
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 7e-18
Identities = 64/217 (29%), Positives = 104/217 (47%), Gaps = 26/217 (11%)
Query: 619 KKIGKGSFGSVYYGKMK-DGKEVAVK-IMADSCSHRTQQFV-TEVALLSRIHHRNLVPLI 675
+ +G+G+FG V+ + K D K V +K I + + + E +L + H N+ I
Sbjct: 6 RVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNI---I 62
Query: 676 GYCE---EEHQRILVYEYMHNGTLRDRLHGSVN-----QKPLDWLTRLQIAHDAAKGLEY 727
Y E E+ ++V EY GTL + + N L + ++ +A L +
Sbjct: 63 EYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLA------LHH 116
Query: 728 LHTGCNPGIIHRDVKSSNILLDIN-MRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE 786
+HT I+HRD+K+ NILLD + M K+ DFG+S+ + V GT Y+ PE
Sbjct: 117 VHT---KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVV--GTPCYISPE 171
Query: 787 YYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGA 823
+ +KSD+++ G VL EL S K+ + A
Sbjct: 172 LCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPA 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 8e-18
Identities = 58/206 (28%), Positives = 103/206 (50%), Gaps = 14/206 (6%)
Query: 621 IGKGSFGSVYYGK-MKDGKEVAVKIM-ADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY- 677
IG+G++G+VY GK + G+ VA+KI+ D+ EVALLS++ + Y
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68
Query: 678 -CEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 735
+ R+ ++ EY G++R + P+ I + L+Y+H G
Sbjct: 69 GSYLKGPRLWIIMEYAEGGSVRTLMKAG----PIAEKYISVIIREVLVALKYIHKV---G 121
Query: 736 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY-GNQQLT 794
+IHRD+K++NIL+ K+ DFG++ ++ + S+ GT ++ PE +
Sbjct: 122 VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFV-GTPYWMAPEVITEGKYYD 180
Query: 795 EKSDVYSFGVVLLELISGKKPVSVED 820
K+D++S G+ + E+ +G P S D
Sbjct: 181 TKADIWSLGITIYEMATGNPPYSDVD 206
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 88.4 bits (219), Expect = 1e-17
Identities = 58/194 (29%), Positives = 92/194 (47%), Gaps = 21/194 (10%)
Query: 637 GKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRIL-VYEYMH 692
G EVA+K++ H+ +F E AL +R++H N+V L+ E + V+EY+
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62
Query: 693 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL---D 749
TLR+ L L ++ L H N GI+HRD+K NI++
Sbjct: 63 GRTLREVL---AADGALPAGETGRLMLQVLDALACAH---NQGIVHRDLKPQNIMVSQTG 116
Query: 750 INMRAKVSDFGLS-------RQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSF 802
+ AKV DFG+ LT + V GT Y PE + +T SD+Y++
Sbjct: 117 VRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVL-GTPTYCAPEQLRGEPVTPNSDLYAW 175
Query: 803 GVVLLELISGKKPV 816
G++ LE ++G++ V
Sbjct: 176 GLIFLECLTGQRVV 189
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 2e-17
Identities = 60/210 (28%), Positives = 95/210 (45%), Gaps = 23/210 (10%)
Query: 616 NFCKKIGKGSFGS--VYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVP 673
N + +G+GSFG + D K +I S + E LL+++ H N+V
Sbjct: 3 NVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVA 62
Query: 674 LIGYCEEEHQRILVYEYMHNGTLRDRL---HGSV--NQKPLDWLTRLQIAHDAAKGLEYL 728
E + +V EY G L ++ G + L W ++ + G++++
Sbjct: 63 FKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCL------GVQHI 116
Query: 729 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVG---YLDP 785
H ++HRD+KS NI L N + K+ DFG +R LT + A VG Y+ P
Sbjct: 117 H---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARL----LTSPGAYACTYVGTPYYVPP 169
Query: 786 EYYGNQQLTEKSDVYSFGVVLLELISGKKP 815
E + N KSD++S G +L EL + K P
Sbjct: 170 EIWENMPYNNKSDIWSLGCILYELCTLKHP 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 2e-17
Identities = 64/220 (29%), Positives = 114/220 (51%), Gaps = 13/220 (5%)
Query: 619 KKIGKGSFGSVYYGKMKDGKEV----AVKIMADSCSHRTQQFVT--EVALLSRIHHRNLV 672
K +G+GSFG V+ + G + A+K++ + + T E +L+ ++H +V
Sbjct: 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIV 61
Query: 673 PLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 732
L + E + L+ +++ G L RL V D + +A + A L++LH+
Sbjct: 62 KLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEED--VKFYLA-ELALALDHLHS-- 116
Query: 733 NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQ 792
GII+RD+K NILLD K++DFGLS+++ + S GTV Y+ PE +
Sbjct: 117 -LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC-GTVEYMAPEVVNRRG 174
Query: 793 LTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWAR 832
T+ +D +SFGV++ E+++G P +D + ++ A+
Sbjct: 175 HTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAK 214
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 2e-17
Identities = 69/235 (29%), Positives = 119/235 (50%), Gaps = 39/235 (16%)
Query: 619 KKIGKGSFGSVYYG------KMKDGK--EVAVKIM-ADSCSHRTQQFVTEVALLSRI-HH 668
K +G+G FG V K K + +VAVK++ +D+ ++E+ ++ I H
Sbjct: 24 KPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 83
Query: 669 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHG----------SVNQKPLDWLTR---L 715
+N++ L+G C ++ ++ EY G LR+ L + Q P + L+ +
Sbjct: 84 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLV 143
Query: 716 QIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSV 775
A+ A+G+EYL + IHRD+ + N+L+ + K++DFGL+R D+ HI
Sbjct: 144 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHIDYY 196
Query: 776 ARGTVG-----YLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP---VSVEDF 821
+ T G ++ PE ++ T +SDV+SFGV+L E+ + G P V VE+
Sbjct: 197 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 251
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 83.8 bits (208), Expect = 3e-17
Identities = 70/210 (33%), Positives = 112/210 (53%), Gaps = 27/210 (12%)
Query: 619 KKIGKGSFGSVYYGKMKDGKE-VAVKIMADSCSHRT--QQFVTEVALLSRI-HHRNLVPL 674
+K+GKG++G V+ + KE VA+K + D+ + T Q+ E+ L + H N+V L
Sbjct: 13 QKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKL 72
Query: 675 IGYCEEEHQR--ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 732
+ + E+ + LV+EYM D LH + L+ + + I + K L+Y+H+G
Sbjct: 73 LNVIKAENDKDIYLVFEYMET----D-LHAVIRANILEDVHKRYIMYQLLKALKYIHSG- 126
Query: 733 NPGIIHRDVKSSNILLDINMRAKVSDFGLSR--------QAEEDLTHISSVARGTVGYLD 784
+IHRD+K SNILL+ + R K++DFGL+R LT VA T Y
Sbjct: 127 --NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDY--VA--TRWYRA 180
Query: 785 PE-YYGNQQLTEKSDVYSFGVVLLELISGK 813
PE G+ + T+ D++S G +L E++ GK
Sbjct: 181 PEILLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 4e-17
Identities = 67/235 (28%), Positives = 114/235 (48%), Gaps = 28/235 (11%)
Query: 606 PLPELEEATNNFCKKIGKGSFGSVYYG------KMKDGK--EVAVKIMADSCSHRT-QQF 656
P EL K +G+G FG V K K K VAVK++ D + +
Sbjct: 5 PKWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDL 64
Query: 657 VTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHG------------- 702
V+E+ ++ I H+N++ L+G C ++ ++ EY G LR+ L
Sbjct: 65 VSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTC 124
Query: 703 SVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS 762
+ ++ L + + A+ A+G+EYL + IHRD+ + N+L+ + K++DFGL+
Sbjct: 125 KLPEEQLTFKDLVSCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLA 181
Query: 763 RQAEE-DLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 815
R D ++ R V ++ PE ++ T +SDV+SFGV+L E+ + G P
Sbjct: 182 RDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSP 236
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 83.0 bits (206), Expect = 4e-17
Identities = 60/218 (27%), Positives = 100/218 (45%), Gaps = 46/218 (21%)
Query: 619 KKIGKGSFGSVYYGKMK-DGKEVAVK-I------MADSCSHRTQQFVTEVALLSRIHHRN 670
KK+G+G++ VY + K G+ VA+K I A + T + E+ LL + H N
Sbjct: 6 KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTA--LREIKLLQELKHPN 63
Query: 671 LVPLIG-YCEEEHQRI-LVYEYMHN---GTLRDRLHGSVNQKPLDWLTRLQIAHDAA--- 722
++ L+ + + I LV+E+M ++D+ L A +
Sbjct: 64 IIGLLDVFGHK--SNINLVFEFMETDLEKVIKDKS------------IVLTPADIKSYML 109
Query: 723 ---KGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ---AEEDLTHISSVA 776
+GLEYLH + I+HRD+K +N+L+ + K++DFGL+R +TH V
Sbjct: 110 MTLRGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTH--QVV 164
Query: 777 RGTVGYLDPE-YYGNQQLTEKSDVYSFGVVLLELISGK 813
T Y PE +G + D++S G + EL+
Sbjct: 165 --TRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRV 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 4e-17
Identities = 63/204 (30%), Positives = 103/204 (50%), Gaps = 16/204 (7%)
Query: 619 KKIGKGSFGSVYYGK-MKDGKEVAVK-IMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 676
+G G+ GSV K + G +A K + + S +Q + E+ ++ +V G
Sbjct: 11 SDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYG 70
Query: 677 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 736
E+ + E+M G+L DR++ P++ L + IA +GL YL+ I
Sbjct: 71 AFLNENNICMCMEFMDCGSL-DRIYKKGGPIPVEILGK--IAVAVVEGLTYLYNVHR--I 125
Query: 737 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR---GTVGYLDPEYYGNQQL 793
+HRD+K SNIL++ + K+ DFG+S + I+S+A GT Y+ PE +
Sbjct: 126 MHRDIKPSNILVNSRGQIKLCDFGVSGEL------INSIADTFVGTSTYMSPERIQGGKY 179
Query: 794 TEKSDVYSFGVVLLELISGKKPVS 817
T KSDV+S G+ ++EL GK P +
Sbjct: 180 TVKSDVWSLGISIIELALGKFPFA 203
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 4e-17
Identities = 58/203 (28%), Positives = 105/203 (51%), Gaps = 13/203 (6%)
Query: 620 KIGKGSFGSVYYG--KMKDGK-EVAVKIMADSCSHR-TQQFVTEVALLSRIHHRNLVPLI 675
++G G+FG V G KM+ + +VA+K++ + + + E ++ ++ + +V +I
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61
Query: 676 GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 735
G CE E +LV E G L L G ++ + + L H + G++YL
Sbjct: 62 GVCEAE-ALMLVMEMASGGPLNKFLSGKKDEITVSNVVELM--HQVSMGMKYLE---GKN 115
Query: 736 IIHRDVKSSNILLDINMRAKVSDFGLSRQ--AEEDLTHISSVARGTVGYLDPEYYGNQQL 793
+HRD+ + N+LL AK+SDFGLS+ A++ S + + + PE ++
Sbjct: 116 FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKF 175
Query: 794 TEKSDVYSFGVVLLELIS-GKKP 815
+ +SDV+S+G+ + E S G+KP
Sbjct: 176 SSRSDVWSYGITMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 4e-17
Identities = 62/202 (30%), Positives = 102/202 (50%), Gaps = 12/202 (5%)
Query: 619 KKIGKGSFGSVYYG-KMKDGKEVAVKIM-ADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 676
+KIGKGSFG V+ G + K VA+KI+ + + E+ +LS+ + G
Sbjct: 10 EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 69
Query: 677 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 736
++ + ++ EY+ G+ D L PLD I + KGL+YLH+
Sbjct: 70 SYLKDTKLWIIMEYLGGGSALDLLEPG----PLDETQIATILREILKGLDYLHSEKK--- 122
Query: 737 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS-SVARGTVGYLDPEYYGNQQLTE 795
IHRD+K++N+LL + K++DFG++ Q + T I + GT ++ PE
Sbjct: 123 IHRDIKAANVLLSEHGEVKLADFGVAGQLTD--TQIKRNTFVGTPFWMAPEVIKQSAYDS 180
Query: 796 KSDVYSFGVVLLELISGKKPVS 817
K+D++S G+ +EL G+ P S
Sbjct: 181 KADIWSLGITAIELAKGEPPHS 202
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 4e-17
Identities = 60/230 (26%), Positives = 105/230 (45%), Gaps = 31/230 (13%)
Query: 617 FCKKIGKGSFGSVYYGKMKDGKE---------------VAVKIM-ADSCSHRTQQFVTEV 660
+K+G+G FG V+ + + E VAVK++ AD F+ E+
Sbjct: 9 LKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEI 68
Query: 661 ALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTL---------RDRLHGSVNQKPLDW 711
++SR+ + N++ L+G C + ++ EYM NG L + N +
Sbjct: 69 KIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSI 128
Query: 712 LTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA-EEDLT 770
L +A A G++YL + +HRD+ + N L+ + K++DFG+SR D
Sbjct: 129 ANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYY 185
Query: 771 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS--GKKPVSV 818
I A + ++ E + T SDV++FGV L E+ + ++P S+
Sbjct: 186 RIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSL 235
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 82.5 bits (203), Expect = 5e-17
Identities = 55/198 (27%), Positives = 103/198 (52%), Gaps = 9/198 (4%)
Query: 619 KKIGKGSFGSVYYG-KMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 677
+KIG+G+ G+VY + G+EVA++ M + + + E+ ++ + N+V +
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 678 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGII 737
+ +V EY+ G+L D V + +D + + + LE+LH+ +I
Sbjct: 86 YLVGDELWVVMEYLAGGSLTD----VVTETCMDEGQIAAVCRECLQALEFLHSN---QVI 138
Query: 738 HRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKS 797
HRD+KS NILL ++ K++DFG Q + + S++ GT ++ PE + K
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKV 197
Query: 798 DVYSFGVVLLELISGKKP 815
D++S G++ +E+I G+ P
Sbjct: 198 DIWSLGIMAIEMIEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 5e-17
Identities = 62/213 (29%), Positives = 95/213 (44%), Gaps = 19/213 (8%)
Query: 614 TNNFC--KKIGKGSFGSVYYGKMK-DGKEVA---VKIMADSCSHRTQQFVTEVALLSRIH 667
NF KKIGKG F VY DG+ VA V+I + Q + E+ LL ++
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 668 HRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPL-----DWLTRLQIAHDAA 722
H N++ + E ++ +V E G L + QK L W +Q+
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLC---- 116
Query: 723 KGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGY 782
LE++H+ I+HRD+K +N+ + K+ D GL R T S+ GT Y
Sbjct: 117 SALEHMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYY 172
Query: 783 LDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 815
+ PE KSD++S G +L E+ + + P
Sbjct: 173 MSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.4 bits (204), Expect = 5e-17
Identities = 61/203 (30%), Positives = 95/203 (46%), Gaps = 22/203 (10%)
Query: 620 KIGKGSFGSVYYGKMKD-GKEVAVKIMADSCS----HRTQQFVTEVALLSRIHHRNLVPL 674
+G+G++G V + K G+ VA+K +S +T + EV +L ++ H N+V L
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTA--LREVKVLRQLRHENIVNL 65
Query: 675 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 734
+ + LV+EY+ TL + L S P D R I + + Y H+
Sbjct: 66 KEAFRRKGRLYLVFEYVER-TLLELLEASPGGLPPD-AVRSYI-WQLLQAIAYCHSH--- 119
Query: 735 GIIHRDVKSSNILLDINMRAKVSDFGLSRQ----AEEDLTHISSVARGTVGYLDPEYY-G 789
IIHRD+K NIL+ + K+ DFG +R LT VA T Y PE G
Sbjct: 120 NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLT--DYVA--TRWYRAPELLVG 175
Query: 790 NQQLTEKSDVYSFGVVLLELISG 812
+ + DV++ G ++ EL+ G
Sbjct: 176 DTNYGKPVDVWAIGCIMAELLDG 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 5e-17
Identities = 54/199 (27%), Positives = 91/199 (45%), Gaps = 10/199 (5%)
Query: 621 IGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQF---VTEVALLSRIHHRNLVPLIG 676
+GKG FG V ++K GK A K + + + + E +L ++ R +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 677 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 736
E + LV M+ G L+ ++ +V + + A GLE+LH I
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIY-NVGEPGFPEARAIFYAAQIICGLEHLH---QRRI 116
Query: 737 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEK 796
++RD+K N+LLD + ++SD GL+ + + GT GY+ PE +
Sbjct: 117 VYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRA--GTPGYMAPEVLQGEVYDFS 174
Query: 797 SDVYSFGVVLLELISGKKP 815
D ++ G L E+I+G+ P
Sbjct: 175 VDWFALGCTLYEMIAGRSP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 82.1 bits (202), Expect = 6e-17
Identities = 54/198 (27%), Positives = 103/198 (52%), Gaps = 9/198 (4%)
Query: 619 KKIGKGSFGSVYYG-KMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 677
+KIG+G+ G+VY + G+EVA+K M + + + E+ ++ + N+V +
Sbjct: 25 EKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 84
Query: 678 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGII 737
+ +V EY+ G+L D V + +D + + + L++LH+ +I
Sbjct: 85 YLVGDELWVVMEYLAGGSLTD----VVTETCMDEGQIAAVCRECLQALDFLHSN---QVI 137
Query: 738 HRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKS 797
HRD+KS NILL ++ K++DFG Q + + S++ GT ++ PE + K
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKV 196
Query: 798 DVYSFGVVLLELISGKKP 815
D++S G++ +E++ G+ P
Sbjct: 197 DIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 82.1 bits (202), Expect = 7e-17
Identities = 52/198 (26%), Positives = 103/198 (52%), Gaps = 9/198 (4%)
Query: 619 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 677
+KIG+G+ G+V+ + G+EVA+K + + + + E+ ++ + + N+V +
Sbjct: 25 EKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDS 84
Query: 678 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGII 737
+ +V EY+ G+L D V + +D + + + LE+LH +I
Sbjct: 85 FLVGDELFVVMEYLAGGSLTD----VVTETCMDEAQIAAVCRECLQALEFLHAN---QVI 137
Query: 738 HRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKS 797
HRD+KS N+LL ++ K++DFG Q + + S++ GT ++ PE + K
Sbjct: 138 HRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKV 196
Query: 798 DVYSFGVVLLELISGKKP 815
D++S G++ +E++ G+ P
Sbjct: 197 DIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 8e-17
Identities = 59/215 (27%), Positives = 101/215 (46%), Gaps = 15/215 (6%)
Query: 609 ELEEATNNFCKKIGKGSFGSVYYGKMK-DGKE---VAVKIMADSCSHRTQQ-FVTEVALL 663
EL+ + + +G G FG + G +K K VA+ + CS + ++ F+ E L
Sbjct: 1 ELDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTL 60
Query: 664 SRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK 723
+ H N+V L G + ++V EYM NG L L Q L + + A
Sbjct: 61 GQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQ--LVAGQLMGMLPGLAS 118
Query: 724 GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARG--TVG 781
G++YL G +H+ + + +L++ ++ K+S F R E+ I + G V
Sbjct: 119 GMKYL---SEMGYVHKGLAAHKVLVNSDLVCKISGFR--RLQEDKSEAIYTTMSGKSPVL 173
Query: 782 YLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 815
+ PE + SDV+SFG+V+ E++S G++P
Sbjct: 174 WAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 82.2 bits (204), Expect = 9e-17
Identities = 60/213 (28%), Positives = 101/213 (47%), Gaps = 32/213 (15%)
Query: 619 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPLI 675
K IG G++G V K G++VA+K +++ ++ + E+ LL + H N++ L+
Sbjct: 6 KPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLL 65
Query: 676 -----GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAH---DAAKGLEY 727
E+ + +V E M D LH V + P LT I + +GL+Y
Sbjct: 66 DILRPPSPEDFNDVYIVTELMET----D-LH-KVIKSPQP-LTDDHIQYFLYQILRGLKY 118
Query: 728 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 787
LH+ +IHRD+K SNIL++ N K+ DFGL+R + D Y+ +
Sbjct: 119 LHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDE----KGFLTEYVVTRW 171
Query: 788 Y-------GNQQLTEKSDVYSFGVVLLELISGK 813
Y + + T+ D++S G + EL++ K
Sbjct: 172 YRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 1e-16
Identities = 62/230 (26%), Positives = 105/230 (45%), Gaps = 38/230 (16%)
Query: 617 FCKKIGKGSFGSVYYGKMKDGKE-----------------VAVKIM-ADSCSHRTQQFVT 658
F +K+G+G FG V+ ++ + ++ VAVKI+ D+ + F+
Sbjct: 9 FKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLK 68
Query: 659 EVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTL------RDRLHGSVNQKPLD-- 710
EV +LSR+ N++ L+G C +E ++ EYM NG L N
Sbjct: 69 EVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPP 128
Query: 711 --------WLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS 762
+ + L +A A G++YL + +HRD+ + N L+ N+ K++DFG+S
Sbjct: 129 AHCLPAISYSSLLHVALQIASGMKYLSS---LNFVHRDLATRNCLVGENLTIKIADFGMS 185
Query: 763 RQAEE-DLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS 811
R D I A + ++ E + T SDV++FGV L E++
Sbjct: 186 RNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM 235
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 2e-16
Identities = 61/211 (28%), Positives = 104/211 (49%), Gaps = 18/211 (8%)
Query: 616 NFCKKIGKGSFGSVYYGKMKD------GKEVAVKIMADSCSHRTQ-QFVTEVALLSRIHH 668
+++G+GSFG VY G +D VAVK + +S S R + +F+ E +++
Sbjct: 9 TLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTC 68
Query: 669 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHG----SVNQ--KPLDWLTRL-QIAHDA 721
++V L+G + ++V E M +G L+ L + N +P L + Q+A +
Sbjct: 69 HHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEI 128
Query: 722 AKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA-EEDLTHISSVARGTV 780
A G+ YL+ +HRD+ + N ++ + K+ DFG++R E D V
Sbjct: 129 ADGMAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 185
Query: 781 GYLDPEYYGNQQLTEKSDVYSFGVVLLELIS 811
++ PE + T SD++SFGVVL E+ S
Sbjct: 186 RWMAPESLKDGVFTTSSDMWSFGVVLWEITS 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 2e-16
Identities = 59/206 (28%), Positives = 91/206 (44%), Gaps = 19/206 (9%)
Query: 619 KKIGKGSFGSVYYGKMKDGKEVA---VKIMADSCSHRTQ-QFVTEVALLSRIHHRNLVPL 674
+IG G FG V G+ G A VK + S + Q F+ EV ++H N++
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60
Query: 675 IGYCEEEHQRILVYEYMHNGTLRDRL---HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 731
+G C E +LV E+ G L++ L G V Q ++A + A GL +LH
Sbjct: 61 LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMA-QKDVLQRMACEVASGLLWLHQA 119
Query: 732 CNPGIIHRDVKSSNILLDINMRAKVSDFGLS-RQAEEDLTHISSVARGTVGYLDPEYYGN 790
IH D+ N L ++ K+ D+GL+ Q ED + +L PE
Sbjct: 120 ---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEI 176
Query: 791 QQ-------LTEKSDVYSFGVVLLEL 809
+ T+KS+++S GV + EL
Sbjct: 177 RGQDLLPKDQTKKSNIWSLGVTMWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 3e-16
Identities = 62/208 (29%), Positives = 106/208 (50%), Gaps = 18/208 (8%)
Query: 617 FCKKI---GKGSFGSV---YYGKMKD--GKEVAVK-IMADSCSHRTQQFVTEVALLSRIH 667
F K+I G+G FG V Y D G++VAVK + +S + E+ +L ++
Sbjct: 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLY 64
Query: 668 HRNLVPLIGYCEEEHQR--ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGL 725
H N+V G C E+ L+ E++ +G+L++ L + N+ L +L+ A KG+
Sbjct: 65 HENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLK--QQLKYAVQICKGM 122
Query: 726 EYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH--ISSVARGTVGYL 783
+YL + +HRD+ + N+L++ + K+ DFGL++ E D + + V +
Sbjct: 123 DYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWY 179
Query: 784 DPEYYGNQQLTEKSDVYSFGVVLLELIS 811
PE + SDV+SFGV L EL++
Sbjct: 180 APECLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 79.4 bits (195), Expect = 3e-16
Identities = 59/210 (28%), Positives = 105/210 (50%), Gaps = 21/210 (10%)
Query: 621 IGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGYC 678
+G G++G VY G+ +K G+ A+K+M D ++ E+ +L + HHRN+ G
Sbjct: 14 VGNGTYGQVYKGRHVKTGQLAAIKVM-DVTGDEEEEIKQEINMLKKYSHHRNIATYYGAF 72
Query: 679 EEEH------QRILVYEYMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTG 731
+++ Q LV E+ G++ D + + N +W+ I + +GL +LH
Sbjct: 73 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIA--YICREILRGLSHLH-- 128
Query: 732 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ 791
+IHRD+K N+LL N K+ DFG+S Q + + ++ GT ++ PE
Sbjct: 129 -QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAPEVIACD 186
Query: 792 QLTE-----KSDVYSFGVVLLELISGKKPV 816
+ + KSD++S G+ +E+ G P+
Sbjct: 187 ENPDATYDFKSDLWSLGITAIEMAEGAPPL 216
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 4e-16
Identities = 60/201 (29%), Positives = 99/201 (49%), Gaps = 10/201 (4%)
Query: 619 KKIGKGSFGSVYYGKMKDGKEV-AVKIM-ADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 676
++IGKGSFG VY G KEV A+KI+ + + E+ +LS+ + G
Sbjct: 10 ERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYG 69
Query: 677 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 736
+ + ++ EY+ G+ D L PL+ I + KGL+YLH+
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALDLL----KPGPLEETYIATILREILKGLDYLHSERK--- 122
Query: 737 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEK 796
IHRD+K++N+LL K++DFG++ Q + ++ GT ++ PE K
Sbjct: 123 IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSAYDFK 181
Query: 797 SDVYSFGVVLLELISGKKPVS 817
+D++S G+ +EL G+ P S
Sbjct: 182 ADIWSLGITAIELAKGEPPNS 202
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 4e-16
Identities = 59/210 (28%), Positives = 103/210 (49%), Gaps = 21/210 (10%)
Query: 621 IGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGY- 677
+G G++G VY G+ +K G+ A+K+M D ++ E+ +L + HHRN+ G
Sbjct: 24 VGNGTYGQVYKGRHVKTGQLAAIKVM-DVTEDEEEEIKLEINMLKKYSHHRNIATYYGAF 82
Query: 678 -----CEEEHQRILVYEYMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTG 731
+ Q LV E+ G++ D + + N DW+ I + +GL +LH
Sbjct: 83 IKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIA--YICREILRGLAHLHAH 140
Query: 732 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ 791
+IHRD+K N+LL N K+ DFG+S Q + + ++ GT ++ PE
Sbjct: 141 ---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAPEVIACD 196
Query: 792 QLTE-----KSDVYSFGVVLLELISGKKPV 816
+ + +SD++S G+ +E+ G P+
Sbjct: 197 ENPDATYDYRSDIWSLGITAIEMAEGAPPL 226
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 5e-16
Identities = 63/228 (27%), Positives = 105/228 (46%), Gaps = 39/228 (17%)
Query: 606 PLPELEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIM----ADSCSHRTQQFVTEV 660
L ELE +IG G+ G+VY + G+ A+K++ D+ +Q E+
Sbjct: 72 SLSELERV-----NRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVR---RQICREI 123
Query: 661 ALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHD 720
+L ++H N+V + + ++ E+M G+L + + +A
Sbjct: 124 EILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGT---HIADEQ-------FLADV 173
Query: 721 AAK---GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI-SSVA 776
A + G+ YLH I+HRD+K SN+L++ K++DFG+SR + + SSV
Sbjct: 174 ARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV- 229
Query: 777 RGTVGYLDPEYYGNQQLTE------KSDVYSFGVVLLELISGKKPVSV 818
GT+ Y+ PE N L D++S GV +LE G+ P V
Sbjct: 230 -GTIAYMSPERI-NTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGV 275
|
Length = 353 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 5e-16
Identities = 60/206 (29%), Positives = 98/206 (47%), Gaps = 22/206 (10%)
Query: 621 IGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLI-GYC 678
+G G+FG VY + K+ G A KI+ + F+ E+ +LS H N+V L Y
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 679 EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA---HDAAKGLEYLHTGCNPG 735
E IL+ E+ G L S+ + LT QI + L +LH +
Sbjct: 73 YENKLWILI-EFCDGGAL-----DSIMLELERGLTEPQIRYVCRQMLEALNFLH---SHK 123
Query: 736 IIHRDVKSSNILLDINMRAKVSDFGLS-RQAEEDLTHISSVARGTVGYLDPEY-----YG 789
+IHRD+K+ NILL ++ K++DFG+S + + + GT ++ PE +
Sbjct: 124 VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI--GTPYWMAPEVVACETFK 181
Query: 790 NQQLTEKSDVYSFGVVLLELISGKKP 815
+ K+D++S G+ L+EL + P
Sbjct: 182 DNPYDYKADIWSLGITLIELAQMEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 9e-16
Identities = 60/200 (30%), Positives = 102/200 (51%), Gaps = 21/200 (10%)
Query: 621 IGKGSFGSVYYG-KMKDGKEVAVK-IMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYC 678
+G G+ G+VY + + +AVK I D +Q ++E+ +L + ++ G
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68
Query: 679 EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIH 738
E++ + E+M G+L ++ + P L R+ +A KGL YL + I+H
Sbjct: 69 FVENRISICTEFMDGGSLD--VYRKI---PEHVLGRIAVA--VVKGLTYLWS---LKILH 118
Query: 739 RDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR---GTVGYLDPEYYGNQQLTE 795
RDVK SN+L++ + K+ DFG+S Q ++S+A+ GT Y+ PE +Q
Sbjct: 119 RDVKPSNMLVNTRGQVKLCDFGVSTQL------VNSIAKTYVGTNAYMAPERISGEQYGI 172
Query: 796 KSDVYSFGVVLLELISGKKP 815
SDV+S G+ +EL G+ P
Sbjct: 173 HSDVWSLGISFMELALGRFP 192
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 79.0 bits (194), Expect = 9e-16
Identities = 64/218 (29%), Positives = 116/218 (53%), Gaps = 22/218 (10%)
Query: 610 LEEATNNFCKKIGKGSFGSVYYGK-MKDGKEV----AVKIMADSCSHRTQ-QFVTEVALL 663
L+E K +G G+FG+VY G + +G+ V A+KI+ ++ + +F+ E ++
Sbjct: 4 LKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIM 63
Query: 664 SRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVN----QKPLDWLTRLQIAH 719
+ + H +LV L+G C + LV + M +G L D +H + Q L+W ++
Sbjct: 64 ASMDHPHLVRLLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQI---- 118
Query: 720 DAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISS-VARG 778
AKG+ YL ++HRD+ + N+L+ K++DFGL+R E D ++ +
Sbjct: 119 --AKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKM 173
Query: 779 TVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 815
+ ++ E ++ T +SDV+S+GV + EL++ G KP
Sbjct: 174 PIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKP 211
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 1e-15
Identities = 74/228 (32%), Positives = 113/228 (49%), Gaps = 22/228 (9%)
Query: 605 IPLPELEEATNNF--CKKIGKGSFGSVY-YGKMKDGKEVAVKIMADSCSHRTQQFVTEVA 661
+ L L + T+ + + IGKG++G VY KDG AVKI+ D S ++ E
Sbjct: 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKIL-DPISDVDEEIEAEYN 70
Query: 662 LLSRI-HHRNLVPLIG-YCEEEH----QRILVYEYMHNGTLRDRLHGSVNQ-KPLDWLTR 714
+L + +H N+V G + + + Q LV E + G++ + + G + + LD
Sbjct: 71 ILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMI 130
Query: 715 LQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ-AEEDLTHIS 773
I + A GL++LH N IIHRDVK +NILL K+ DFG+S Q L +
Sbjct: 131 SYILYGALLGLQHLH---NNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNT 187
Query: 774 SVARGTVGYLDPEYYGNQQLTEKS-----DVYSFGVVLLELISGKKPV 816
SV GT ++ PE +Q + S DV+S G+ +EL G P+
Sbjct: 188 SV--GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPL 233
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 1e-15
Identities = 54/198 (27%), Positives = 104/198 (52%), Gaps = 8/198 (4%)
Query: 619 KKIGKGSFGSVYYGKMKDGKE-VAVK-IMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 676
+K+G+G++ +VY G+ + E VA+K I D+ + E++L+ + H N+V L
Sbjct: 6 EKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHD 65
Query: 677 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 736
E++ +LV+EYM + L+ + + LD T + KG+ + H +
Sbjct: 66 VIHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---RV 121
Query: 737 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE-YYGNQQLTE 795
+HRD+K N+L++ K++DFGL+R + S+ T+ Y P+ G++ +
Sbjct: 122 LHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV-TLWYRAPDVLLGSRTYST 180
Query: 796 KSDVYSFGVVLLELISGK 813
D++S G ++ E+I+G+
Sbjct: 181 SIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 1e-15
Identities = 58/198 (29%), Positives = 99/198 (50%), Gaps = 13/198 (6%)
Query: 620 KIGKGSFGSVYYGKMKD-GKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIG 676
+G+GS+G V K K+ G+ VA+K +S + + E+ +L ++ H NLV LI
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67
Query: 677 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 736
+ + LV+E++ + T+ D L N LD + +G+E+ H + I
Sbjct: 68 VFRRKKRLYLVFEFVDH-TVLDDLEKYPNG--LDESRVRKYLFQILRGIEFCH---SHNI 121
Query: 737 IHRDVKSSNILLDINMRAKVSDFGLSRQ-AEEDLTHISSVARGTVGYLDPEYY-GNQQLT 794
IHRD+K NIL+ + K+ DFG +R A + VA T Y PE G+ +
Sbjct: 122 IHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVA--TRWYRAPELLVGDTKYG 179
Query: 795 EKSDVYSFGVVLLELISG 812
D+++ G ++ E+++G
Sbjct: 180 RAVDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 2e-15
Identities = 58/216 (26%), Positives = 104/216 (48%), Gaps = 19/216 (8%)
Query: 617 FCKKIGKGSFGSVYYGKMK-DGKEVAVKIM--ADSCSHRTQQFVTEVALLSRIHHRNLVP 673
F + +GKGS+G V + + DGK+ +K + ++ + E LLS++ H N+V
Sbjct: 4 FVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVA 63
Query: 674 LIGYCE-EEHQRILVYEYMHNGTLRDRLHGSVNQ-----KPLDWLTRLQIAHDAAKGLEY 727
E E+ +V + G L +L + + ++W ++ +A L+Y
Sbjct: 64 YRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMA------LQY 117
Query: 728 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 787
LH I+HRD+K+ N+ L KV D G++R E+ ++S GT Y+ PE
Sbjct: 118 LH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIAR-VLENQCDMASTLIGTPYYMSPEL 173
Query: 788 YGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGA 823
+ N+ KSDV++ G + E+ + K + +D +
Sbjct: 174 FSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNS 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 2e-15
Identities = 56/201 (27%), Positives = 98/201 (48%), Gaps = 10/201 (4%)
Query: 619 KKIGKGSFGSVYYG-KMKDGKEVAVKIM-ADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 676
++IGKGSFG V+ G + + VA+KI+ + + E+ +LS+ + G
Sbjct: 10 ERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 69
Query: 677 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 736
+ + ++ EY+ G+ D L P D + + KGL+YLH+
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALDLLRAG----PFDEFQIATMLKEILKGLDYLHS---EKK 122
Query: 737 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEK 796
IHRD+K++N+LL K++DFG++ Q + ++ GT ++ PE K
Sbjct: 123 IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIQQSAYDSK 181
Query: 797 SDVYSFGVVLLELISGKKPVS 817
+D++S G+ +EL G+ P S
Sbjct: 182 ADIWSLGITAIELAKGEPPNS 202
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 2e-15
Identities = 63/208 (30%), Positives = 100/208 (48%), Gaps = 32/208 (15%)
Query: 621 IGKGSFGSVYYGKMKDGKE-VAVKIMA---DSCSH--RTQQFVTEVALLSRIHHRNLVPL 674
+G G++G V VA+K ++ S H RT + E+ LL + H N++ L
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYR---ELRLLKHMDHENVIGL 79
Query: 675 IG-YCEEEHQRIL--VYEYMHNGTLRDR-LHGSVNQKPL--DWLTRL--QIAHDAAKGLE 726
+ + VY H L L+ V + L D + L QI +GL+
Sbjct: 80 LDVFTPASSLEDFQDVYLVTH---LMGADLNNIVKCQKLSDDHIQFLVYQIL----RGLK 132
Query: 727 YLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE 786
Y+H+ GIIHRD+K SNI ++ + K+ DFGL+R ++++T VA T Y PE
Sbjct: 133 YIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMT--GYVA--TRWYRAPE 185
Query: 787 YYGN-QQLTEKSDVYSFGVVLLELISGK 813
N + D++S G ++ EL++GK
Sbjct: 186 IMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 2e-15
Identities = 49/144 (34%), Positives = 74/144 (51%), Gaps = 15/144 (10%)
Query: 689 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL 748
E+M G+L D++ + P + L ++ IA +GL YL I+HRDVK SNIL+
Sbjct: 79 EHMDGGSL-DQVLKKAGRIPENILGKISIA--VLRGLTYLRE--KHKIMHRDVKPSNILV 133
Query: 749 DINMRAKVSDFGLSRQAEEDLTHISSVAR---GTVGYLDPEYYGNQQLTEKSDVYSFGVV 805
+ K+ DFG+S Q I S+A GT Y+ PE T +SD++S G+
Sbjct: 134 NSRGEIKLCDFGVSGQL------IDSMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLS 187
Query: 806 LLELISGKKPVSVEDFGAELNIVH 829
L+E+ G+ P+ D EL +
Sbjct: 188 LVEMAIGRYPIPPPD-AKELEAMF 210
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 2e-15
Identities = 59/220 (26%), Positives = 105/220 (47%), Gaps = 32/220 (14%)
Query: 621 IGKGSFGSVYYGKMKDGK--------EVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLV 672
+G+G+F ++ G ++ EV +K++ S + ++ F +++S++ H++LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 673 PLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 732
G C + I+V EY+ G+L L + N + W +L++A A L +L
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISW--KLEVAKQLAWALHFLE--- 117
Query: 733 NPGIIHRDVKSSNILLDINMRA--------KVSDFGLS--RQAEEDLTHISSVARGTVGY 782
+ G+ H +V + N+LL K+SD G+S +E L + +
Sbjct: 118 DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLE-------RIPW 170
Query: 783 LDPEYYGN-QQLTEKSDVYSFGVVLLELISG-KKPVSVED 820
+ PE N Q L+ +D +SFG L E+ SG KP+S D
Sbjct: 171 VPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALD 210
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.8 bits (190), Expect = 3e-15
Identities = 59/220 (26%), Positives = 96/220 (43%), Gaps = 53/220 (24%)
Query: 619 KKIGKGSFGSVYYGKMKDGKE-VAVKIMADSCSHRTQQF--------VTEVALLSRI-HH 668
K++G G+FGSVY + K+ E VA+K M ++F + EV L ++ H
Sbjct: 5 KQLGDGTFGSVYLARNKETGELVAIKKM-------KKKFYSWEECMNLREVKSLRKLNEH 57
Query: 669 RNLVPLIGYCEEEHQRILVYEYMHN---GTLRDRLHGSVNQKPL------DWLTRLQIAH 719
N+V L E + V+EYM ++DR KP + QI
Sbjct: 58 PNIVKLKEVFRENDELYFVFEYMEGNLYQLMKDR-----KGKPFSESVIRSII--YQIL- 109
Query: 720 DAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGT 779
+GL ++H G HRD+K N+L+ K++DFGL+R+ + V T
Sbjct: 110 ---QGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYV--ST 161
Query: 780 VGYLDPE------YYGNQQLTEKSDVYSFGVVLLELISGK 813
Y PE Y + + D+++ G ++ EL + +
Sbjct: 162 RWYRAPEILLRSTSY-SSPV----DIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 5e-15
Identities = 55/214 (25%), Positives = 102/214 (47%), Gaps = 28/214 (13%)
Query: 621 IGKGSFGSVYYGKMKDG-------KEVAVKIMADSCSHRTQ-----QFVTEVALL-SRIH 667
+G G+FG VY + K+ KE+ V A R + V+EV ++ ++
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 668 HRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRL------HGSVNQKPLDWLTRLQIAHDA 721
H N+V E + +V + + L + ++ + W +Q+
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERI-WNIFVQMV--- 123
Query: 722 AKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVG 781
L YLH I+HRD+ +NI+L + + ++DFGL++Q + + + ++SV GT+
Sbjct: 124 -LALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPE-SKLTSVV-GTIL 178
Query: 782 YLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 815
Y PE N+ EK+DV++FG +L ++ + + P
Sbjct: 179 YSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPP 212
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 5e-15
Identities = 66/216 (30%), Positives = 103/216 (47%), Gaps = 40/216 (18%)
Query: 619 KKIGKGSFGSVYYGK-MKDGKEVAVKIMAD------SCSHRTQQFVTEVALLSRIHHRNL 671
+ IG G+FG V+ +DGK VA+K M + SC ++ E+ +L H N+
Sbjct: 6 RPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSC----KRVFRELKMLCFFKHDNV 61
Query: 672 V--------PLIGYCEEEHQRILVYEYMHNGTLRDRLHGS-VNQKPLD----WLTRLQIA 718
+ P I EE + +V E M + LH V+ +PL + QI
Sbjct: 62 LSALDILQPPHIDPFEEIY---VVTELMQSD-----LHKIIVSPQPLSSDHVKVFLYQIL 113
Query: 719 HDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARG 778
+GL+YLH+ GI+HRD+K N+L++ N K+ DFGL+R E D + +
Sbjct: 114 ----RGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVV 166
Query: 779 TVGYLDPE-YYGNQQLTEKSDVYSFGVVLLELISGK 813
T Y PE G++ T D++S G + EL+ +
Sbjct: 167 TQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 7e-15
Identities = 52/202 (25%), Positives = 96/202 (47%), Gaps = 11/202 (5%)
Query: 619 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 677
++IG G++G VY + + G+ A+K++ E+ ++ H N+V G
Sbjct: 15 QRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGS 74
Query: 678 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGII 737
+ + E+ G+L+D H + PL ++ + +GL YLH + G +
Sbjct: 75 YLRRDKLWICMEFCGGGSLQDIYHVT---GPLSESQIAYVSRETLQGLYYLH---SKGKM 128
Query: 738 HRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQ---LT 794
HRD+K +NILL N K++DFG+S Q + S GT ++ PE ++
Sbjct: 129 HRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFI-GTPYWMAPEVAAVERKGGYN 187
Query: 795 EKSDVYSFGVVLLELISGKKPV 816
+ D+++ G+ +EL + P+
Sbjct: 188 QLCDIWAVGITAIELAELQPPM 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 7e-15
Identities = 59/199 (29%), Positives = 98/199 (49%), Gaps = 10/199 (5%)
Query: 621 IGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQ---QFVTEVALLSRIHHRNLVPLIG 676
+GKG FG V +++ GK A K + + + + E +L +++ R +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAY 67
Query: 677 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 736
E + LV M+ G L+ ++ + + + + A + GLE LH I
Sbjct: 68 AYETKDALCLVLTLMNGGDLKFHIY-HMGEAGFEEGRAVFYAAEICCGLEDLH---QERI 123
Query: 737 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEK 796
++RD+K NILLD + ++SD GL+ E T V GTVGY+ PE N++ T
Sbjct: 124 VYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRV--GTVGYMAPEVVKNERYTFS 181
Query: 797 SDVYSFGVVLLELISGKKP 815
D ++ G +L E+I+G+ P
Sbjct: 182 PDWWALGCLLYEMIAGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 8e-15
Identities = 53/198 (26%), Positives = 89/198 (44%), Gaps = 21/198 (10%)
Query: 628 SVYYGKMKDGKEVAVKIMA---DSCSHRTQQFVTEVALLSRIHHRNLVPLIGY----CEE 680
S+Y G + KEV ++ E+ L RI N++ + G+ ++
Sbjct: 35 SIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDD 93
Query: 681 EHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN-PGIIHR 739
+ L+ EY G LR+ L +K L + T+L +A D KGL L+ N P ++
Sbjct: 94 LPRLSLILEYCTRGYLREVLD---KEKDLSFKTKLDMAIDCCKGLYNLYKYTNKP---YK 147
Query: 740 DVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN--QQLTEKS 797
++ S + L+ N + K+ GL E+ L+ + Y + + + T K
Sbjct: 148 NLTSVSFLVTENYKLKIICHGL----EKILSSPPFKNVNFMVYFSYKMLNDIFSEYTIKD 203
Query: 798 DVYSFGVVLLELISGKKP 815
D+YS GVVL E+ +GK P
Sbjct: 204 DIYSLGVVLWEIFTGKIP 221
|
Length = 283 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 1e-14
Identities = 55/200 (27%), Positives = 95/200 (47%), Gaps = 9/200 (4%)
Query: 621 IGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQF---VTEVALLSRIHHRNLVPLIG 676
+GKG FG V +M+ GK A K + + + + + E +L+++H R +V L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 677 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKP-LDWLTRLQIAHDAAKGLEYLHTGCNPG 735
+ + LV M+ G LR ++ + P GLE+LH
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH---QRR 117
Query: 736 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTE 795
II+RD+K N+LLD + ++SD GL+ + ++ + A GT G++ PE ++
Sbjct: 118 IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYA-GTPGFMAPELLQGEEYDF 176
Query: 796 KSDVYSFGVVLLELISGKKP 815
D ++ GV L E+I+ + P
Sbjct: 177 SVDYFALGVTLYEMIAARGP 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.8 bits (187), Expect = 1e-14
Identities = 63/217 (29%), Positives = 100/217 (46%), Gaps = 37/217 (17%)
Query: 620 KIGKGSFGSVYYGKMK---DGKEVAVKIMADSCSHRT---QQFVTEVALLSRIHHRNLVP 673
IG+G++G VY K K DGKE A+K T Q E+ALL + H N+V
Sbjct: 7 CIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVS 66
Query: 674 LIGYCEEEHQRI--LVYEY----------MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDA 721
L+ E + L+++Y H R + S+ K L W QI +
Sbjct: 67 LVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSM-VKSLLW----QILN-- 119
Query: 722 AKGLEYLHTGCNPGIIHRDVKSSNILL--DINMRA--KVSDFGLSRQAEEDLTHISSVAR 777
G+ YLH+ ++HRD+K +NIL+ + R K+ D GL+R L ++ +
Sbjct: 120 --GVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDP 174
Query: 778 G--TVGYLDPE-YYGNQQLTEKSDVYSFGVVLLELIS 811
T+ Y PE G + T+ D+++ G + EL++
Sbjct: 175 VVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 1e-14
Identities = 69/225 (30%), Positives = 107/225 (47%), Gaps = 26/225 (11%)
Query: 619 KKIGKGSFGSVYYGKMKDGKEV-AVKIMAD---SCSHRTQQFVTEVALLSRIHHRNLVPL 674
K IG+G+FG V K+K+ +V A+KI+ T F E +L ++ + L
Sbjct: 7 KVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTL 66
Query: 675 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLD----WLTRLQIAHDAAKGLEYLHT 730
++E+ LV +Y G L L ++ P D +L + IA D+ L Y
Sbjct: 67 HYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHY--- 123
Query: 731 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY-- 788
+HRD+K NIL+D+N +++DFG + ED T SSVA GT Y+ PE
Sbjct: 124 ------VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQA 177
Query: 789 ---GNQQLTEKSDVYSFGVVLLELISGKKPVS----VEDFGAELN 826
G + + D +S GV + E++ G+ P VE +G +N
Sbjct: 178 MEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN 222
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 74.6 bits (184), Expect = 1e-14
Identities = 61/211 (28%), Positives = 96/211 (45%), Gaps = 26/211 (12%)
Query: 621 IGKGSFGSVYYGKMK-DGKEVAVKIMA-DSCSHRTQQ--FVTEVALLSRIHHRNLVPLIG 676
+G G FG V K+K + A+K + QQ +E +L +H +V L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 677 YCEEEHQRILVYEYMHNGTLRDRLH--GSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 734
+++ ++ EY G L L G + ++ R IA EYLH N
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRDRGLFD----EYTARFYIAC-VVLAFEYLH---NR 112
Query: 735 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR-----GTVGYLDPEYYG 789
GII+RD+K N+LLD N K+ DFG +++ + S + GT Y+ PE
Sbjct: 113 GIIYRDLKPENLLLDSNGYVKLVDFGFAKK-------LKSGQKTWTFCGTPEYVAPEIIL 165
Query: 790 NQQLTEKSDVYSFGVVLLELISGKKPVSVED 820
N+ D +S G++L EL++G+ P +D
Sbjct: 166 NKGYDFSVDYWSLGILLYELLTGRPPFGEDD 196
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 2e-14
Identities = 63/209 (30%), Positives = 98/209 (46%), Gaps = 28/209 (13%)
Query: 620 KIGKGSFGSVYYGKMKDGKE-VAVKIMADSCSHR---TQQFVTEVALLSRIHHRNLVPLI 675
++G+G +G V+ K KD E VA+K M S + + +TE +L+ LV L+
Sbjct: 8 QVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLL 67
Query: 676 GYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLD------WLTRLQIAHDAAKGLEYL 728
Y ++ + + L EY+ G R L N L ++ + A DA L
Sbjct: 68 -YAFQDDEYLYLAMEYVPGGDFRTLL---NNLGVLSEDHARFYMAEMFEAVDA------L 117
Query: 729 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY 788
H G IHRD+K N L+D + K++DFGLS+ +T+ +SV G+ Y+ PE
Sbjct: 118 H---ELGYIHRDLKPENFLIDASGHIKLTDFGLSKGI---VTYANSVV-GSPDYMAPEVL 170
Query: 789 GNQQLTEKSDVYSFGVVLLELISGKKPVS 817
+ D +S G +L E + G P S
Sbjct: 171 RGKGYDFTVDYWSLGCMLYEFLCGFPPFS 199
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 2e-14
Identities = 58/229 (25%), Positives = 108/229 (47%), Gaps = 25/229 (10%)
Query: 609 ELEEATNNFCKKIGKGSFGSVYYGKM------KDGKEVAVKIMADSCS-HRTQQFVTEVA 661
E+ +T F +++G+ FG VY G + + + VA+K + D ++F E
Sbjct: 1 EINLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAM 60
Query: 662 LLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRL-----HGSVNQKPLDWLTR-- 714
+ SR+ H N+V L+G +E +++ Y + L + L H V D +
Sbjct: 61 MRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKST 120
Query: 715 ------LQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA-EE 767
+ I A G+E+L + ++H+D+ + N+L+ + K+SD GL R+
Sbjct: 121 LEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGLFREVYAA 177
Query: 768 DLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 815
D + + + ++ PE + + SD++S+GVVL E+ S G +P
Sbjct: 178 DYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 2e-14
Identities = 64/211 (30%), Positives = 98/211 (46%), Gaps = 20/211 (9%)
Query: 619 KKIGKGSFGSVYYGKMKDGKEV-AVK------IMADSCSHRTQQFVTEVALLSRIHHRNL 671
K +GKGSFG V ++K E A+K ++ D T V L H L
Sbjct: 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECT--MVERRVLALAWEHPFL 58
Query: 672 VPLIGYC--EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 729
L +C + + V EY++ G D + + D A + GL++LH
Sbjct: 59 THL--FCTFQTKEHLFFVMEYLNGG---DLMFHIQSSGRFDEARARFYAAEIICGLQFLH 113
Query: 730 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYG 789
GII+RD+K N+LLD + K++DFG+ ++ + +S GT Y+ PE
Sbjct: 114 KK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKE-NMNGEGKASTFCGTPDYIAPEILK 169
Query: 790 NQQLTEKSDVYSFGVVLLELISGKKPVSVED 820
Q+ E D +SFGV+L E++ G+ P ED
Sbjct: 170 GQKYNESVDWWSFGVLLYEMLIGQSPFHGED 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 2e-14
Identities = 66/212 (31%), Positives = 104/212 (49%), Gaps = 22/212 (10%)
Query: 621 IGKGSFGSVY-YGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIH-HRNLVPLIG-Y 677
IGKG++G V+ K+G + AVKI+ D ++ E +L + H N+V G Y
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKIL-DPIHDIDEEIEAEYNILKALSDHPNVVKFYGMY 84
Query: 678 CEEE----HQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA---HDAAKGLEYLHT 730
+++ Q LV E + G++ D + G + + + + IA H+A GL++LH
Sbjct: 85 YKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRG--ERMEEPIIAYILHEALMGLQHLH- 141
Query: 731 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYG- 789
IHRDVK +NILL K+ DFG+S Q + + GT ++ PE
Sbjct: 142 --VNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQL-TSTRLRRNTSVGTPFWMAPEVIAC 198
Query: 790 NQQL----TEKSDVYSFGVVLLELISGKKPVS 817
QQL + DV+S G+ +EL G P++
Sbjct: 199 EQQLDSTYDARCDVWSLGITAIELGDGDPPLA 230
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 2e-14
Identities = 74/261 (28%), Positives = 114/261 (43%), Gaps = 65/261 (24%)
Query: 619 KKIGKGSFGSVYYGKMKDGKEVA---VKIM-----ADSCSHRTQQFVTEVALLSRIHHRN 670
+++GKGSFG+VY +KD K VA +K++ + + T Q E LLS++ H
Sbjct: 6 QRLGKGSFGTVYL--VKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPA 63
Query: 671 LVP-------------LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQI 717
+V + YCE + E H G S NQ +W +L +
Sbjct: 64 IVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTL-----SENQV-CEWFIQLLL 117
Query: 718 AHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR--QAEEDLTHISSV 775
G+ Y+H I+HRD+K+ NI L N+ K+ DFG+SR DL ++
Sbjct: 118 ------GVHYMHQ---RRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDL---ATT 164
Query: 776 ARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLEL-------------------ISGKKPV 816
GT Y+ PE +Q KSD++S G +L E+ + G P
Sbjct: 165 FTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPS 224
Query: 817 SVEDFGAELNIVHWARSMIKK 837
E + +LN + +SM+ K
Sbjct: 225 LPETYSRQLNSI--MQSMLNK 243
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 3e-14
Identities = 62/228 (27%), Positives = 98/228 (42%), Gaps = 48/228 (21%)
Query: 616 NFCKKIGKGSFGSVYYGKMKDGKEV-AVKIMA--------DSCSHRTQQFVTEVALLSRI 666
NF +GKGSFG V + K E+ A+KI+ D ++ V +AL +
Sbjct: 3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRV--LALPGKP 60
Query: 667 HHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQI--------- 717
L L + + V EY++ G D + +Q
Sbjct: 61 PF--LTQLHSCFQTMDRLYFVMEYVNGG---------------DLMYHIQQVGKFKEPHA 103
Query: 718 ---AHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA--EEDLTHI 772
A + A GL +LH+ GII+RD+K N++LD K++DFG+ ++ T
Sbjct: 104 VFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRT 160
Query: 773 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 820
GT Y+ PE Q + D ++FGV+L E+++G+ P ED
Sbjct: 161 FC---GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED 205
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 4e-14
Identities = 58/205 (28%), Positives = 99/205 (48%), Gaps = 22/205 (10%)
Query: 619 KKIGKGSFGSVYYGKMKDGKE-VAVKIMA--DSCSHRTQQFV-TEVALLSRIHHRNLVPL 674
K +G G+FG V+ + + + A+K+MA + + +Q V E +L + H ++ L
Sbjct: 7 KTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRL 66
Query: 675 IGYCEEEHQRIL--VYEYMHNGTLRD--RLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 730
+ E QR L + EY+ G L R G + T L A + LEYLH+
Sbjct: 67 --FWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNS-----TGLFYASEIVCALEYLHS 119
Query: 731 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN 790
I++RD+K NILLD K++DFG +++ + + GT YL PE +
Sbjct: 120 ---KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWTLC----GTPEYLAPEVIQS 172
Query: 791 QQLTEKSDVYSFGVVLLELISGKKP 815
+ + D ++ G+++ E++ G P
Sbjct: 173 KGHNKAVDWWALGILIYEMLVGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 4e-14
Identities = 67/217 (30%), Positives = 111/217 (51%), Gaps = 35/217 (16%)
Query: 621 IGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQF----VTEVALLSRIHHRNLVPL- 674
IG+G++G VY + KD G+ VA+K + + + F + E+ +L +++HRN+V L
Sbjct: 15 IGEGTYGQVYKARDKDTGELVALKKV--RLDNEKEGFPITAIREIKILRQLNHRNIVNLK 72
Query: 675 ---------IGYCEEEHQRILVYEYM-HN--GTLRDRLHGSVNQKPLDWLTRLQIAHDAA 722
+ + +++ LV+EYM H+ G L L ++ +L
Sbjct: 73 EIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQL------L 126
Query: 723 KGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR--QAEEDLTHISSVARGTV 780
+GL Y H +HRD+K SNILL+ + K++DFGL+R +EE + + V T+
Sbjct: 127 EGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVI--TL 181
Query: 781 GYLDPE-YYGNQQLTEKSDVYSFGVVLLELISGKKPV 816
Y PE G ++ DV+S G +L EL + KKP+
Sbjct: 182 WYRPPELLLGEERYGPAIDVWSCGCILGELFT-KKPI 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 4e-14
Identities = 58/211 (27%), Positives = 109/211 (51%), Gaps = 22/211 (10%)
Query: 619 KKIGKGSFGSVYYGK-MKDGKE----VAVKIMADSCSHRTQQFVTEVAL-LSRIHHRNLV 672
K +G G FG+V+ G + +G VA+K + D +T Q +T+ L + + H +V
Sbjct: 13 KLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIV 72
Query: 673 PLIGYCEEEHQRILVYEYMHNGTLRDRLH---GSVN-QKPLDWLTRLQIAHDAAKGLEYL 728
L+G C + LV + G+L D + S++ Q+ L+W ++ AKG+ YL
Sbjct: 73 RLLGICPGASLQ-LVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQI------AKGMYYL 125
Query: 729 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA-EEDLTHISSVARGTVGYLDPEY 787
++HR++ + NILL + +++DFG++ +D + S + + ++ E
Sbjct: 126 EEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALES 182
Query: 788 YGNQQLTEKSDVYSFGVVLLELIS-GKKPVS 817
+ T +SDV+S+GV + E++S G +P +
Sbjct: 183 ILFGRYTHQSDVWSYGVTVWEMMSYGAEPYA 213
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 4e-14
Identities = 62/215 (28%), Positives = 102/215 (47%), Gaps = 31/215 (14%)
Query: 612 EATNNFC--KKIGKGSFGSVYYGK-MKDGKEVAVK-IMAD-SCSHRTQQFVTEVALLSRI 666
E TN + + +G G+FG V + G+ VA+K IM S ++ E+ LL +
Sbjct: 7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHL 66
Query: 667 HHRNLVPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGL 725
H N++ L + I V E + GT LH + +PL+ + +GL
Sbjct: 67 RHENIISLSDIFISPLEDIYFVTELL--GT---DLHRLLTSRPLEKQFIQYFLYQILRGL 121
Query: 726 EYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDP 785
+Y+H+ G++HRD+K SNIL++ N K+ DFGL+R + +T GY+
Sbjct: 122 KYVHSA---GVVHRDLKPSNILINENCDLKICDFGLARIQDPQMT----------GYVST 168
Query: 786 EYYGN-------QQLTEKSDVYSFGVVLLELISGK 813
YY Q+ + D++S G + E++ GK
Sbjct: 169 RYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 5e-14
Identities = 66/213 (30%), Positives = 106/213 (49%), Gaps = 25/213 (11%)
Query: 617 FCKKIGKGSFGSVYYGKMK-DGKEVAVK-IMADSCSHRTQQFVTEVALLSRIHHRNLVPL 674
++GKG++GSVY + G +A+K I + + Q + E+ +L + +V
Sbjct: 5 VLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDF 64
Query: 675 IGYCEEEHQRILVYEYMHNGTLRDRLHG---SVNQKPLDWLTRLQIAHDAAKGLEYLHTG 731
G E + EYM G+L D+L+ + P D L R I + KGL++L
Sbjct: 65 YGAFFIEGAVYMCMEYMDAGSL-DKLYAGGVATEGIPEDVLRR--ITYAVVKGLKFLKEE 121
Query: 732 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVG---YLDPEY- 787
N IIHRDVK +N+L++ N + K+ DFG+S +S+A+ +G Y+ PE
Sbjct: 122 HN--IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLV------ASLAKTNIGCQSYMAPERI 173
Query: 788 -----YGNQQLTEKSDVYSFGVVLLELISGKKP 815
N T +SDV+S G+ +LE+ G+ P
Sbjct: 174 KSGGPNQNPTYTVQSDVWSLGLSILEMALGRYP 206
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 6e-14
Identities = 58/222 (26%), Positives = 104/222 (46%), Gaps = 30/222 (13%)
Query: 617 FCKKIGKGSFGSVYYGK---MKDGKE--------------VAVKIM-ADSCSHRTQQFVT 658
F +K+G+G FG V+ + M+ + VAVK++ D+ + F+
Sbjct: 9 FKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLK 68
Query: 659 EVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTL-----RDRLHGSV---NQKPLD 710
E+ ++SR+ N++ L+ C ++ EYM NG L R + + +
Sbjct: 69 EIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTIS 128
Query: 711 WLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE-DL 769
+ T + +A A G++YL + +HRD+ + N L+ N K++DFG+SR D
Sbjct: 129 YSTLIFMATQIASGMKYLSS---LNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDY 185
Query: 770 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS 811
I A + ++ E + T SDV++FGV L E+++
Sbjct: 186 YRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 73.5 bits (181), Expect = 6e-14
Identities = 64/229 (27%), Positives = 104/229 (45%), Gaps = 46/229 (20%)
Query: 616 NFCKKIGKGSFGSVYYG-KMKDGKEVAVK--IMADSCSHRTQQF-VT---EVALLSRIHH 668
K+G+G+FG VY ++K G+ VA+K +M + F +T E+ +L ++ H
Sbjct: 11 EILGKLGEGTFGEVYKARQIKTGRVVALKKILM----HNEKDGFPITALREIKILKKLKH 66
Query: 669 RNLVPLIGYCEEEHQRI--------LVYEYM-H--NGTLRD-RLHGSVNQ-KPLDWLTRL 715
N+VPLI E + +V YM H +G L + + + +Q K L
Sbjct: 67 PNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIK----CYML 122
Query: 716 QIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED---LTHI 772
Q+ G+ YLH N I+HRD+K++NIL+D K++DFGL+R +
Sbjct: 123 QLLE----GINYLH--EN-HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGG 175
Query: 773 SSVARG-------TVGYLDPEY-YGNQQLTEKSDVYSFGVVLLELISGK 813
T Y PE G ++ T D++ G V E+ + +
Sbjct: 176 GGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 73.0 bits (180), Expect = 7e-14
Identities = 59/204 (28%), Positives = 99/204 (48%), Gaps = 14/204 (6%)
Query: 616 NFCKKIGKGSFGSVYYGKMKDGKEV-AVKIMADSCSHRTQQ---FVTEVALLSRIHHRNL 671
F K +G GSFG V + K + A+KI++ + + +Q + E +L I H L
Sbjct: 4 EFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFL 63
Query: 672 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 731
V L G +++ LV EY+ G L L + P R A LEYLH
Sbjct: 64 VNLYGSFQDDSNLYLVMEYVPGGELFSHLR-KSGRFPEPV-ARFYAA-QVVLALEYLH-- 118
Query: 732 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ 791
+ I++RD+K N+LLD + K++DFG +++ + + GT YL PE ++
Sbjct: 119 -SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYTLC----GTPEYLAPEIILSK 173
Query: 792 QLTEKSDVYSFGVVLLELISGKKP 815
+ D ++ G+++ E+++G P
Sbjct: 174 GYGKAVDWWALGILIYEMLAGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 7e-14
Identities = 61/201 (30%), Positives = 98/201 (48%), Gaps = 19/201 (9%)
Query: 620 KIGKGSFGSVYYGKMKD-GKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIG 676
KIG+GS+G V+ + ++ G+ VA+K +S + + E+ +L ++ H NLV LI
Sbjct: 8 KIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIE 67
Query: 677 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT-GCNPG 735
+ + LV+EY + T+ + L N + + +I + + + H C
Sbjct: 68 VFRRKRKLHLVFEYCDH-TVLNELEK--NPRGVPEHLIKKIIWQTLQAVNFCHKHNC--- 121
Query: 736 IIHRDVKSSNILLDINMRAKVSDFGLSR---QAEEDLTHISSVARGTVGYLDPEYY-GNQ 791
IHRDVK NIL+ + K+ DFG +R +D T VA T Y PE G+
Sbjct: 122 -IHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYT--DYVA--TRWYRAPELLVGDT 176
Query: 792 QLTEKSDVYSFGVVLLELISG 812
Q DV++ G V EL++G
Sbjct: 177 QYGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 7e-14
Identities = 67/208 (32%), Positives = 95/208 (45%), Gaps = 26/208 (12%)
Query: 621 IGKGSFGSVYYGKM---KDGKEVAVKIMADSCSHRTQQFV---TEVALLSRIHHR--NLV 672
IG G+ G VY KM K G +AVK M + + + + +V L S H +V
Sbjct: 23 IGSGTCGQVY--KMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKS---HDCPYIV 77
Query: 673 PLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQK-PLDWLTRLQIAHDAAKGLEYLHTG 731
GY + + E M T D+L + P D L ++ +A K L YL
Sbjct: 78 KCYGYFITDSDVFICMELM--STCLDKLLKRIQGPIPEDILGKMTVA--IVKALHYLKE- 132
Query: 732 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ 791
G+IHRDVK SNILLD + K+ DFG+S + + S G Y+ PE
Sbjct: 133 -KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSA--GCAAYMAPERIDPP 189
Query: 792 QLTEK----SDVYSFGVVLLELISGKKP 815
K +DV+S G+ L+EL +G+ P
Sbjct: 190 DPNPKYDIRADVWSLGISLVELATGQFP 217
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 73.6 bits (180), Expect = 7e-14
Identities = 61/206 (29%), Positives = 97/206 (47%), Gaps = 11/206 (5%)
Query: 619 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADS---CSHRTQQFVTEVALLSRIHHRNLVPL 674
K +GKG+FG V + K GK A+KI+ +TE +L H L L
Sbjct: 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60
Query: 675 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 734
+ + + V EY++ G L H S + + TR A + L+YLH+G
Sbjct: 61 KYSFQTKDRLCFVMEYVNGGELF--FHLSRERVFSEDRTRFYGA-EIVSALDYLHSG--- 114
Query: 735 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLT 794
I++RD+K N++LD + K++DFGL ++ D + + GT YL PE +
Sbjct: 115 KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFC-GTPEYLAPEVLEDNDYG 173
Query: 795 EKSDVYSFGVVLLELISGKKPVSVED 820
D + GVV+ E++ G+ P +D
Sbjct: 174 RAVDWWGLGVVMYEMMCGRLPFYNQD 199
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 1e-13
Identities = 40/102 (39%), Positives = 61/102 (59%), Gaps = 6/102 (5%)
Query: 402 WEWVTCSTTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD--MSRL 459
W+ +TC+ ++ R+ I LSGKN+ G+I + + + + L N L+GP+PD +
Sbjct: 60 WQGITCNNSS--RVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTS 117
Query: 460 IDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIP 501
LR ++L NN TGS+P GS+PNL+ L + NN GEIP
Sbjct: 118 SSLRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIP 157
|
Length = 968 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 1e-13
Identities = 61/201 (30%), Positives = 94/201 (46%), Gaps = 14/201 (6%)
Query: 621 IGKGSFGSV------YYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPL 674
+GKG FG V GKM K++ K + + E +L +++ R +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKR--KGEAMALNEKQILEKVNSRFVVSL 65
Query: 675 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 734
E + LV M+ G L+ ++ ++ D + A + GLE LH
Sbjct: 66 AYAYETKDALCLVLTLMNGGDLKFHIY-NMGNPGFDEERAVFYAAEITCGLEDLHR---E 121
Query: 735 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLT 794
I++RD+K NILLD ++SD GL+ + E T V GTVGY+ PE N++ T
Sbjct: 122 RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRV--GTVGYMAPEVVKNERYT 179
Query: 795 EKSDVYSFGVVLLELISGKKP 815
D + G ++ E+I GK P
Sbjct: 180 FSPDWWGLGCLIYEMIEGKSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 1e-13
Identities = 60/215 (27%), Positives = 99/215 (46%), Gaps = 16/215 (7%)
Query: 621 IGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIG 676
+GKGSFG V ++K G+ AVK++ + +TE +LS + + +
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62
Query: 677 YCEEEHQRIL-VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 735
C + R+ V E+++ G L + S + D A + L +LH + G
Sbjct: 63 CCFQTPDRLFFVMEFVNGGDLMFHIQKS---RRFDEARARFYAAEITSALMFLH---DKG 116
Query: 736 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTE 795
II+RD+K N+LLD K++DFG+ ++ + S+ GT Y+ PE
Sbjct: 117 IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFC-GTPDYIAPEILQEMLYGP 175
Query: 796 KSDVYSFGVVLLELISGKKPVSVED----FGAELN 826
D ++ GV+L E++ G P E+ F A LN
Sbjct: 176 SVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILN 210
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 1e-13
Identities = 63/213 (29%), Positives = 100/213 (46%), Gaps = 25/213 (11%)
Query: 619 KKIGKGSFGSVYYGKMK-DGKEVAVKIMA-------DSCSHRTQQFVTEVALLSRIHHRN 670
K +GKG+FG V + K GK A+KI+ D +H +TE +L H
Sbjct: 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHT----LTESRVLQNTRHPF 56
Query: 671 LVPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 729
L L Y + H R+ V EY + G L H S + + R A + L YLH
Sbjct: 57 LTAL-KYSFQTHDRLCFVMEYANGGELF--FHLSRERVFSEDRARFYGA-EIVSALGYLH 112
Query: 730 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR--GTVGYLDPEY 787
+ +++RD+K N++LD + K++DFGL + E ++ +++ GT YL PE
Sbjct: 113 SC---DVVYRDLKLENLMLDKDGHIKITDFGLCK---EGISDGATMKTFCGTPEYLAPEV 166
Query: 788 YGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 820
+ D + GVV+ E++ G+ P +D
Sbjct: 167 LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 199
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 1e-13
Identities = 57/205 (27%), Positives = 98/205 (47%), Gaps = 17/205 (8%)
Query: 619 KKIGKGSFGSVYYG-KMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 677
+++G G++G VY + G+ AVKI+ E+ ++ H N+V G
Sbjct: 15 QRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGS 74
Query: 678 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAH---DAAKGLEYLHTGCNP 734
+ + EY G+L+D H + PL + LQIA+ + +GL YLH+
Sbjct: 75 YLSREKLWICMEYCGGGSLQDIYHVT---GPL---SELQIAYVCRETLQGLAYLHS---K 125
Query: 735 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYG---NQ 791
G +HRD+K +NILL N K++DFG++ + + S GT ++ PE N
Sbjct: 126 GKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFI-GTPYWMAPEVAAVEKNG 184
Query: 792 QLTEKSDVYSFGVVLLELISGKKPV 816
+ D+++ G+ +EL + P+
Sbjct: 185 GYNQLCDIWAVGITAIELAELQPPM 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 1e-13
Identities = 64/220 (29%), Positives = 92/220 (41%), Gaps = 29/220 (13%)
Query: 617 FCKKIGKGSFG--SVYYGKMKD-GKEVAVKIMA-DSCSHRTQQFV-TEVALLSRIHHRNL 671
IGK V+ K K VAVK + DSCS + + E+ ++ H N+
Sbjct: 2 LLTLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNI 61
Query: 672 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAH---DAAKGLEYL 728
+P + + + +V M G+ D L + L L IA D L+Y+
Sbjct: 62 LPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFP----EGLPELAIAFILKDVLNALDYI 117
Query: 729 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS--------RQAEEDLTHISSVARGTV 780
H + G IHR VK+S+ILL + + +S S RQ SSV +
Sbjct: 118 H---SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVK--NL 172
Query: 781 GYLDPEYYGNQQL---TEKSDVYSFGVVLLELISGKKPVS 817
+L PE Q L EKSD+YS G+ EL +G P
Sbjct: 173 PWLSPEVL-QQNLQGYNEKSDIYSVGITACELANGHVPFK 211
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 1e-13
Identities = 62/213 (29%), Positives = 93/213 (43%), Gaps = 27/213 (12%)
Query: 618 CKKIGKGSFGSVYYGKM---KDGKEVAVK-IMADSCSHRTQQFVTEV-ALLSRIHHRNLV 672
+IG+G+FG+V KM G +AVK I + ++ + ++ ++ +V
Sbjct: 9 LGEIGRGAFGTVN--KMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIV 66
Query: 673 PLIGYCEEEHQRILVYEYMHNG--TLRDRLHGSVNQK-PLDWLTRLQIAHDAAKGLEYLH 729
G E + E M ++ + P + L + IA K L YL
Sbjct: 67 KFYGALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGK--IAVATVKALNYLK 124
Query: 730 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR----GTVGYLDP 785
IIHRDVK SNILLD N K+ DFG+S Q + S+A+ G Y+ P
Sbjct: 125 EELK--IIHRDVKPSNILLDRNGNIKLCDFGISGQLVD------SIAKTRDAGCRPYMAP 176
Query: 786 EY---YGNQQLTEKSDVYSFGVVLLELISGKKP 815
E +SDV+S G+ L E+ +GK P
Sbjct: 177 ERIDPSARDGYDVRSDVWSLGITLYEVATGKFP 209
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 2e-13
Identities = 67/217 (30%), Positives = 95/217 (43%), Gaps = 13/217 (5%)
Query: 619 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQ----FVTEVALLSRIHHRNLVP 673
K IGKGSFG V K K DG AVK++ + ++ LL + H LV
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60
Query: 674 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 733
L + + V +Y++ G L H + L+ R A + A + YLH+
Sbjct: 61 LHYSFQTAEKLYFVLDYVNGGELF--FHLQRERCFLEPRARFYAA-EVASAIGYLHS--- 114
Query: 734 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQL 793
II+RD+K NILLD ++DFGL ++ E S+ GT YL PE +
Sbjct: 115 LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFC-GTPEYLAPEVLRKEPY 173
Query: 794 TEKSDVYSFGVVLLELISGKKPVSVEDFGAEL-NIVH 829
D + G VL E++ G P D NI+H
Sbjct: 174 DRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILH 210
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 2e-13
Identities = 59/219 (26%), Positives = 95/219 (43%), Gaps = 51/219 (23%)
Query: 620 KIGKGSFGSVYYGKMKDGKE-VAVKIMADSCSHRTQQ--------FVTEVALLSRIHHRN 670
+IG+G++G VY + E VA+K + R + E+ LL + H N
Sbjct: 14 RIGEGTYGIVYRARDTTSGEIVALKKV------RMDNERDGIPISSLREITLLLNLRHPN 67
Query: 671 LVPL---------------IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRL 715
+V L + YCE++ +L D + ++ + L L
Sbjct: 68 IVELKEVVVGKHLDSIFLVMEYCEQDLASLL-----------DNMPTPFSESQVKCLM-L 115
Query: 716 QIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSV 775
Q+ +GL+YLH IIHRD+K SN+LL K++DFGL+R ++
Sbjct: 116 QLL----RGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPK 168
Query: 776 ARGTVGYLDPE-YYGNQQLTEKSDVYSFGVVLLELISGK 813
T+ Y PE G T D+++ G +L EL++ K
Sbjct: 169 VV-TLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.5 bits (176), Expect = 2e-13
Identities = 56/203 (27%), Positives = 98/203 (48%), Gaps = 24/203 (11%)
Query: 621 IGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHR--TQQFVTEVALLSRI---HHRNLVPL 674
IG+G++G+VY + + G+ VA+K + S + E+ALL ++ H N+V L
Sbjct: 7 IGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRL 66
Query: 675 IGYC-----EEEHQRILVYEYMHNGTLRDRLHG---SVNQKPLDWLTRLQIAHDAAKGLE 726
+ C + E + LV+E++ +D L + L T + +G++
Sbjct: 67 LDVCHGPRTDRELKLTLVFEHVD----QD-LATYLSKCPKPGLPPETIKDLMRQLLRGVD 121
Query: 727 YLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE 786
+LH+ I+HRD+K NIL+ + + K++DFGL+R ++ S V T+ Y PE
Sbjct: 122 FLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVV--TLWYRAPE 176
Query: 787 YYGNQQLTEKSDVYSFGVVLLEL 809
D++S G + EL
Sbjct: 177 VLLQSSYATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-13
Identities = 60/199 (30%), Positives = 104/199 (52%), Gaps = 14/199 (7%)
Query: 619 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQ-QFVTEVALLSRIHHRNLVPLIG 676
+K+G+GS+ +VY GK K +GK VA+K++ T + E +LL + H N+V L
Sbjct: 11 EKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHD 70
Query: 677 YCEEEHQRILVYEYMHNGTLR--DRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 734
+ LV+EY+H + D+ G ++ + + L Q+ +GL Y+H
Sbjct: 71 IIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVK-LFLFQLL----RGLSYIH---QR 122
Query: 735 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE-YYGNQQL 793
I+HRD+K N+L+ K++DFGL+R A+ +H S T+ Y P+ G+ +
Sbjct: 123 YILHRDLKPQNLLISDTGELKLADFGLAR-AKSVPSHTYSNEVVTLWYRPPDVLLGSTEY 181
Query: 794 TEKSDVYSFGVVLLELISG 812
+ D++ G + +E+I G
Sbjct: 182 STCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 3e-13
Identities = 61/257 (23%), Positives = 98/257 (38%), Gaps = 68/257 (26%)
Query: 597 MDEGVAYFIPLPELEEATNNFCKKIGKGSFGSVY-YGKMKDGKEVAVKIM------ADSC 649
+I +G+G++G V GK VA+K + D
Sbjct: 3 SFSISERYIQKG----------AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVT 52
Query: 650 SHRTQ------QFVT--EVALLSRIHHRNLVPLIG-YCEEEHQRILVYEYMHNGTLRDRL 700
R F T E+ +++ I H N++ L+ Y E + LV + M L+
Sbjct: 53 KDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGDFIN-LVMDIMA-SDLK--- 107
Query: 701 HGSVNQKPLDWLTRLQIAH------DAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRA 754
K +D RL + GL LH +HRD+ +NI ++
Sbjct: 108 ------KVVDRKIRLTESQVKCILLQILNGLNVLH---KWYFMHRDLSPANIFINSKGIC 158
Query: 755 KVSDFGLSR-----------------QAEEDLTHISSVARGTVGYLDPE-YYGNQQLTEK 796
K++DFGL+R Q E++T S V T+ Y PE G ++
Sbjct: 159 KIADFGLARRYGYPPYSDTLSKDETMQRREEMT--SKVV--TLWYRAPELLMGAEKYHFA 214
Query: 797 SDVYSFGVVLLELISGK 813
D++S G + EL++GK
Sbjct: 215 VDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 3e-13
Identities = 63/212 (29%), Positives = 101/212 (47%), Gaps = 18/212 (8%)
Query: 619 KKIGKGSFGSVYYGKMKDG---KEVAVKIMADSCSHRTQ-QFVTEVALLSRIHHRNLVPL 674
K+IG G FG V G++ G +V VK + S S + Q +F+ E + H NL+
Sbjct: 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQC 60
Query: 675 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPL--DWLTRLQIAHDAAKGLEYLHTGC 732
+G C E +LV E+ G L+ L + + D T ++A + A GL +LH
Sbjct: 61 LGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN- 119
Query: 733 NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISS-----VARGTVGYLDPEY 787
IH D+ N LL ++ K+ D+GLS ++ +++ R L E
Sbjct: 120 --NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEV 177
Query: 788 YGNQQL---TEKSDVYSFGVVLLELIS-GKKP 815
+GN + T++S+V+S GV + EL G +P
Sbjct: 178 HGNLLVVDQTKESNVWSLGVTIWELFELGSQP 209
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 3e-13
Identities = 64/233 (27%), Positives = 109/233 (46%), Gaps = 42/233 (18%)
Query: 619 KKIGKGSFGSVYYGKMKDGKEV-AVKIM--------ADSCSHRTQQFVT---EVALLSRI 666
K IG+G+FG V KMK + + A+KI+ A++ R ++ V + ++ +
Sbjct: 7 KVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTL 66
Query: 667 HHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLD----WLTRLQIAHDAA 722
H+ ++E+ LV +Y G L L ++ P D ++ + +A +
Sbjct: 67 HYA--------FQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSI 118
Query: 723 KGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGY 782
L Y +HRD+K N+LLD+N +++DFG + +D T SSVA GT Y
Sbjct: 119 HQLHY---------VHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDY 169
Query: 783 LDPEYY-----GNQQLTEKSDVYSFGVVLLELISGKKPVS----VEDFGAELN 826
+ PE G + + D +S GV + E++ G+ P VE +G +N
Sbjct: 170 ISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN 222
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 4e-13
Identities = 68/231 (29%), Positives = 105/231 (45%), Gaps = 38/231 (16%)
Query: 619 KKIGKGSFGSVYYGKMKDGKEV-AVKIM---------ADSCSHRTQQFVTEVALLSRIHH 668
K IG+G+FG V KMK+ +V A+KI+ +C F E +L
Sbjct: 7 KVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETAC------FREERDVLVNGDR 60
Query: 669 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLD----WLTRLQIAHDAAKG 724
R + L ++E+ LV +Y G L L ++ P D +L + +A D+
Sbjct: 61 RWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQ 120
Query: 725 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLD 784
L Y +HRD+K N+LLD N +++DFG + D T S+VA GT Y+
Sbjct: 121 LGY---------VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYIS 171
Query: 785 PEYY-----GNQQLTEKSDVYSFGVVLLELISGKKPV----SVEDFGAELN 826
PE G + + D +S GV + E++ G+ P VE +G +N
Sbjct: 172 PEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN 222
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 5e-13
Identities = 66/212 (31%), Positives = 106/212 (50%), Gaps = 31/212 (14%)
Query: 621 IGKGSFGSVYYGKMK---DGKEVAVKIMADSCSHRTQ-QFVTEVALLSR-IHHRNLVPLI 675
+G+G++G V KM+ G +AVK + + + + Q + + ++ + R + V
Sbjct: 9 LGRGAYGVVD--KMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFY 66
Query: 676 GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPL----DWLTRLQIAHDAAKGLEYLHTG 731
G E + E M T D+ + V K L D L + IA K LEYLH+
Sbjct: 67 GALFREGDVWICMEVMD--TSLDKFYKKVYDKGLTIPEDILGK--IAVSIVKALEYLHSK 122
Query: 732 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR----GTVGYLDPEY 787
+ +IHRDVK SN+L++ N + K+ DFG+S + SVA+ G Y+ PE
Sbjct: 123 LS--VIHRDVKPSNVLINRNGQVKLCDFGISGYL------VDSVAKTIDAGCKPYMAPER 174
Query: 788 Y---GNQQLTE-KSDVYSFGVVLLELISGKKP 815
NQ+ + KSDV+S G+ ++EL +G+ P
Sbjct: 175 INPELNQKGYDVKSDVWSLGITMIELATGRFP 206
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 5e-13
Identities = 58/199 (29%), Positives = 94/199 (47%), Gaps = 10/199 (5%)
Query: 621 IGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQ---QFVTEVALLSRIHHRNLVPLIG 676
+GKG FG V +++ GK A K + + + + E +L +++ + +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAY 67
Query: 677 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 736
E + LV M+ G L+ ++ N + L A + GLE LH
Sbjct: 68 AYETKDALCLVLTIMNGGDLKFHIYNMGNPG-FEEERALFYAAEILCGLEDLH---RENT 123
Query: 737 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEK 796
++RD+K NILLD ++SD GL+ + E + V GTVGY+ PE NQ+ T
Sbjct: 124 VYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRV--GTVGYMAPEVLNNQRYTLS 181
Query: 797 SDVYSFGVVLLELISGKKP 815
D + G ++ E+I G+ P
Sbjct: 182 PDYWGLGCLIYEMIEGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 7e-13
Identities = 60/207 (28%), Positives = 95/207 (45%), Gaps = 12/207 (5%)
Query: 619 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRI-HHRNLVP 673
K +GKGSFG V+ ++K + A+K + + + E +LS H L
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60
Query: 674 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 733
L + + V EY++ G L H K D A + GL++LH+
Sbjct: 61 LYCTFQTKENLFFVMEYLNGGDLM--FHIQSCHK-FDLPRATFYAAEIICGLQFLHS--- 114
Query: 734 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQL 793
GI++RD+K NILLD + K++DFG+ ++ + GT Y+ PE Q+
Sbjct: 115 KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFC-GTPDYIAPEILLGQKY 173
Query: 794 TEKSDVYSFGVVLLELISGKKPVSVED 820
D +SFGV+L E++ G+ P D
Sbjct: 174 NTSVDWWSFGVLLYEMLIGQSPFHGHD 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 7e-13
Identities = 59/218 (27%), Positives = 92/218 (42%), Gaps = 27/218 (12%)
Query: 616 NFCKKIGKGSFGSVYYGKMKDGKEV-AVKIMA--------DSCSHRTQQFVTEVALLSRI 666
+G+G FG V + K E+ A+K + + S ++ + E A +
Sbjct: 2 RCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETA--NSE 59
Query: 667 HHRNLVPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQI-AHDAAKG 724
H LV L C + + V EY G L +H V +P R A G
Sbjct: 60 RHPFLVNLFA-CFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEP-----RAVFYAACVVLG 113
Query: 725 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR--GTVGY 782
L+YLH I++RD+K N+LLD K++DFGL + E + + GT +
Sbjct: 114 LQYLH---ENKIVYRDLKLDNLLLDTEGFVKIADFGLCK---EGMGFGDRTSTFCGTPEF 167
Query: 783 LDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 820
L PE T D + GV++ E++ G+ P +D
Sbjct: 168 LAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDD 205
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 7e-13
Identities = 63/231 (27%), Positives = 112/231 (48%), Gaps = 21/231 (9%)
Query: 619 KKIGKGSFGSVYYGKM----KDGKEVAVKIMADSC----SHRTQQFVTEVALLSRIHHRN 670
K +G G++G V+ + GK A+K++ + + T+ TE +L I
Sbjct: 6 KVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 65
Query: 671 LVPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQI-AHDAAKGLEYL 728
+ + Y + ++ L+ +Y++ G L L K +QI + + LE+L
Sbjct: 66 FLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKE----QEVQIYSGEIVLALEHL 121
Query: 729 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY 788
H GII+RD+K NILLD N ++DFGLS++ ED + GT+ Y+ P+
Sbjct: 122 H---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIV 178
Query: 789 --GNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKK 837
G+ + D +S GV++ EL++G P +V+ G + + +R ++K
Sbjct: 179 RGGDGGHDKAVDWWSMGVLMYELLTGASPFTVD--GEKNSQAEISRRILKS 227
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 7e-13
Identities = 60/208 (28%), Positives = 98/208 (47%), Gaps = 15/208 (7%)
Query: 616 NFCKKIGKGSFGSVYYGKMKDGKEV-AVKIMA-DSCSHRTQQ--FVTEVALLSRIHHRNL 671
+ K IG+G+FG V + K K+V A+K+++ R+ F E +++ + +
Sbjct: 46 DVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWI 105
Query: 672 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 731
V L +++ +V EYM G L + + S P W R A + L+ +H
Sbjct: 106 VQLHYAFQDDKYLYMVMEYMPGGDLVNLM--SNYDIPEKW-ARFYTA-EVVLALDAIH-- 159
Query: 732 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ 791
+ G IHRDVK N+LLD + K++DFG + + + A GT Y+ PE +Q
Sbjct: 160 -SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQ 218
Query: 792 ----QLTEKSDVYSFGVVLLELISGKKP 815
+ D +S GV L E++ G P
Sbjct: 219 GGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 8e-13
Identities = 62/225 (27%), Positives = 102/225 (45%), Gaps = 42/225 (18%)
Query: 616 NFCKKIGKGSFGSVYYGKMKDGKEV-AVKIMAD---------SCS---HRTQQFVTEVAL 662
NF +GKGSFG V + K E+ A+KI+ C+ R +
Sbjct: 3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPF 62
Query: 663 LSRIHHRNLVPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAH-- 719
L+++H C + R+ V EY++ G L ++ + R + H
Sbjct: 63 LTQLHS---------CFQTMDRLYFVMEYVNGGDLMYQIQQ---------VGRFKEPHAV 104
Query: 720 ----DAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSV 775
+ A GL +LH+ GII+RD+K N++LD K++DFG+ ++ D +
Sbjct: 105 FYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTF 161
Query: 776 ARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 820
GT Y+ PE Q + D ++FGV+L E+++G+ P ED
Sbjct: 162 C-GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED 205
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 9e-13
Identities = 58/210 (27%), Positives = 112/210 (53%), Gaps = 24/210 (11%)
Query: 619 KKIGKGSFGSVYYGK-MKDGKE----VAVKIMADSCSHRT-QQFVTEVALLSRIHHRNLV 672
K +G G+FG+VY G + +G++ VA+K + ++ S + ++ + E +++ + + ++
Sbjct: 13 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 72
Query: 673 PLIGYCEEEHQRILVYEYMHNGTLRD--RLHGS--VNQKPLDWLTRLQIAHDAAKGLEYL 728
L+G C + L+ + M G L D R H +Q L+W ++ AKG+ YL
Sbjct: 73 RLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNYL 125
Query: 729 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR--QAEEDLTHISSVARGTVGYLDPE 786
++HRD+ + N+L+ K++DFGL++ A+E H + + ++ E
Sbjct: 126 E---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEG-GKVPIKWMALE 181
Query: 787 YYGNQQLTEKSDVYSFGVVLLELIS-GKKP 815
++ T +SDV+S+GV + EL++ G KP
Sbjct: 182 SILHRIYTHQSDVWSYGVTVWELMTFGSKP 211
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 1e-12
Identities = 59/208 (28%), Positives = 106/208 (50%), Gaps = 20/208 (9%)
Query: 616 NFCK--KIGKGSFGSVYYGKMKD-GKEVAVK-IMADSCSHRT-QQFVTEVALLSRIHHRN 670
NF K KIG+G++G VY + K G+ VA+K I D+ + + E++LL ++H N
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60
Query: 671 LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA---HDAAKGLEY 727
+V L+ E++ LV+E++H L ++ PL + I +GL +
Sbjct: 61 IVKLLDVIHTENKLYLVFEFLHQD-----LKKFMDASPLSGIPLPLIKSYLFQLLQGLAF 115
Query: 728 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL-THISSVARGTVGYLDPE 786
H+ ++HRD+K N+L++ K++DFGL+R + T+ V T+ Y PE
Sbjct: 116 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPE 170
Query: 787 -YYGNQQLTEKSDVYSFGVVLLELISGK 813
G + + D++S G + E+++ +
Sbjct: 171 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 1e-12
Identities = 71/225 (31%), Positives = 99/225 (44%), Gaps = 29/225 (12%)
Query: 619 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVA----LLSRIHHRNLVP 673
K IGKGSFG V K K DGK AVK++ + ++ +A LL + H LV
Sbjct: 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 674 LIGYCEEEHQRILVYEYMHNGTL-----RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYL 728
L + + V +Y++ G L R+R + A + A L YL
Sbjct: 61 LHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRAR--------FYAAEIASALGYL 112
Query: 729 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ--AEEDLTHISSVARGTVGYLDPE 786
H+ II+RD+K NILLD ++DFGL ++ T S GT YL PE
Sbjct: 113 HS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTT---STFCGTPEYLAPE 166
Query: 787 YYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAEL--NIVH 829
Q D + G VL E++ G P D AE+ NI++
Sbjct: 167 VLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT-AEMYDNILN 210
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 1e-12
Identities = 71/220 (32%), Positives = 102/220 (46%), Gaps = 19/220 (8%)
Query: 619 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVT--EVALLSRIHHRNLVP 673
K IGKGSFG V K K DGK AVK++ + + Q+ + LL + H LV
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 674 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 733
L + + V ++++ G L H + + R A + A L YLH+
Sbjct: 61 LHYSFQTTEKLYFVLDFVNGGELF--FHLQRERSFPEPRARFYAA-EIASALGYLHS--- 114
Query: 734 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQ--AEEDLTHISSVARGTVGYLDPEYYGNQ 791
I++RD+K NILLD ++DFGL ++ A+ D T + GT YL PE Q
Sbjct: 115 INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTT---TTFCGTPEYLAPEVIRKQ 171
Query: 792 QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAEL--NIVH 829
D + G VL E++ G P D AE+ NI+H
Sbjct: 172 PYDNTVDWWCLGAVLYEMLYGLPPFYCRDV-AEMYDNILH 210
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 1e-12
Identities = 61/220 (27%), Positives = 103/220 (46%), Gaps = 25/220 (11%)
Query: 619 KKIGKGSFGSVYYGK-MKDGKEVAVKI-----MADSCSHRTQQFVTEVALLSRIHHRNLV 672
KKIG+G F VY + D K VA+K M D+ + Q V E+ LL +++H N++
Sbjct: 8 KKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKAR--QDCVKEIDLLKQLNHPNVI 65
Query: 673 PLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLD-----WLTRLQIAHDAAKGLEY 727
+ E+++ +V E G L + QK L W +Q+ +E+
Sbjct: 66 KYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLC----SAVEH 121
Query: 728 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 787
+H+ ++HRD+K +N+ + K+ D GL R T S+ GT Y+ PE
Sbjct: 122 MHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPER 177
Query: 788 YGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNI 827
KSD++S G +L E+ + + P +G ++N+
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEMAALQSPF----YGDKMNL 213
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 1e-12
Identities = 56/211 (26%), Positives = 105/211 (49%), Gaps = 19/211 (9%)
Query: 620 KIGKGSFGSVYYGKMKDGKE-VAVK-IMADSCSHRTQQF-VTEVALLSRIHHRNLVPLIG 676
KIG+G++G+V+ K ++ E VA+K + D + E+ LL + H+N+V L
Sbjct: 7 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYD 66
Query: 677 YCEEEHQRILVYEYMHNGTLR--DRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 734
+ + LV+EY + D +G ++ + + Q+ KGL + H+
Sbjct: 67 VLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFM-FQLL----KGLAFCHS---H 118
Query: 735 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE-YYGNQQL 793
++HRD+K N+L++ N K++DFGL+R + S+ T+ Y P+ +G +
Sbjct: 119 NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV-TLWYRPPDVLFGAKLY 177
Query: 794 TEKSDVYSFGVVLLELISGKKPV----SVED 820
+ D++S G + EL + +P+ V+D
Sbjct: 178 STSIDMWSAGCIFAELANAGRPLFPGNDVDD 208
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 1e-12
Identities = 54/202 (26%), Positives = 103/202 (50%), Gaps = 12/202 (5%)
Query: 620 KIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYC 678
++G G+FG VY K K+ G A K++ + ++ E+ +L+ +H +V L+G
Sbjct: 19 ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78
Query: 679 EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIH 738
+ + ++ E+ G + D + +++ LT QI + LE L + IIH
Sbjct: 79 YWDGKLWIMIEFCPGGAV-DAIMLELDRG----LTEPQIQVICRQMLEALQYLHSMKIIH 133
Query: 739 RDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTE--- 795
RD+K+ N+LL ++ K++DFG+S + + L S GT ++ PE + + +
Sbjct: 134 RDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI-GTPYWMAPEVVMCETMKDTPY 192
Query: 796 --KSDVYSFGVVLLELISGKKP 815
K+D++S G+ L+E+ + P
Sbjct: 193 DYKADIWSLGITLIEMAQIEPP 214
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 59/218 (27%), Positives = 99/218 (45%), Gaps = 21/218 (9%)
Query: 619 KKIGKGSFGSVYYGK-MKDGKEVAVK---IMADSCSHRTQQFVTEVALLSRIHHRNLVPL 674
KKIG+G F VY + DG VA+K I + + E+ LL +++H N++
Sbjct: 8 KKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKY 67
Query: 675 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLD-----WLTRLQIAHDAAKGLEYLH 729
E+++ +V E G L + QK L W +Q+ LE++H
Sbjct: 68 YASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLC----SALEHMH 123
Query: 730 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYG 789
+ ++HRD+K +N+ + K+ D GL R T S+ GT Y+ PE
Sbjct: 124 S---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERIH 179
Query: 790 NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNI 827
KSD++S G +L E+ + + P +G ++N+
Sbjct: 180 ENGYNFKSDIWSLGCLLYEMAALQSPF----YGDKMNL 213
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 2e-12
Identities = 62/216 (28%), Positives = 100/216 (46%), Gaps = 30/216 (13%)
Query: 619 KKIGKGSFGSVYYGKMK-DGKEVAVKIMA-------DSCSHRTQQFVTEVALLSRIHHRN 670
K +GKG+FG V K K G+ A+KI+ D +H +TE +L H
Sbjct: 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHT----LTENRVLQNSRHPF 56
Query: 671 LVPLIGYCEEEHQRI-LVYEYMHNGTL-----RDRLHGSVNQKPLDWLTRLQIAHDAAKG 724
L L Y + H R+ V EY + G L R+R+ + +
Sbjct: 57 LTAL-KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRAR--------FYGAEIVSA 107
Query: 725 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLD 784
L+YLH+ N +++RD+K N++LD + K++DFGL ++ +D + + GT YL
Sbjct: 108 LDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFC-GTPEYLA 164
Query: 785 PEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 820
PE + D + GVV+ E++ G+ P +D
Sbjct: 165 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 200
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 2e-12
Identities = 60/199 (30%), Positives = 94/199 (47%), Gaps = 10/199 (5%)
Query: 621 IGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQ---QFVTEVALLSRIHHRNLVPLIG 676
+GKG FG V +++ GK A K + + + + E +L +++ R +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAY 67
Query: 677 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 736
E + LV M+ G L+ ++ N D + A + GLE L I
Sbjct: 68 AYETKDALCLVLTIMNGGDLKFHIYNMGNPG-FDEQRAIFYAAELCCGLEDLQ---RERI 123
Query: 737 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEK 796
++RD+K NILLD ++SD GL+ Q E T V GTVGY+ PE N++ T
Sbjct: 124 VYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRV--GTVGYMAPEVINNEKYTFS 181
Query: 797 SDVYSFGVVLLELISGKKP 815
D + G ++ E+I G+ P
Sbjct: 182 PDWWGLGCLIYEMIQGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 2e-12
Identities = 64/211 (30%), Positives = 99/211 (46%), Gaps = 21/211 (9%)
Query: 619 KKIGKGSFGSVYYGKMK-DGKEVAVKIM-------ADSCSHRTQQFVTEVALLSRIHHRN 670
K +GKG+FG V + K G+ A+KI+ D +H VTE +L H
Sbjct: 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHT----VTESRVLQNTRHPF 56
Query: 671 LVPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 729
L L Y + H R+ V EY + G L H S + + R A + LEYLH
Sbjct: 57 LTAL-KYAFQTHDRLCFVMEYANGGELF--FHLSRERVFTEERARFYGA-EIVSALEYLH 112
Query: 730 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYG 789
+ +++RD+K N++LD + K++DFGL ++ D + + GT YL PE
Sbjct: 113 S---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPEYLAPEVLE 168
Query: 790 NQQLTEKSDVYSFGVVLLELISGKKPVSVED 820
+ D + GVV+ E++ G+ P +D
Sbjct: 169 DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 199
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 68.5 bits (168), Expect = 2e-12
Identities = 58/213 (27%), Positives = 92/213 (43%), Gaps = 45/213 (21%)
Query: 620 KIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVT---EVALLSRI-HHRNLVPL 674
KIG+G+F V + K GK A+K M Q V E+ L R+ H N++ L
Sbjct: 6 KIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQ--VNNLREIQALRRLSPHPNILRL 63
Query: 675 IGYC-EEEHQRI-LV--------YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKG 724
I + + R+ LV YE + + R ++ ++ +L K
Sbjct: 64 IEVLFDRKTGRLALVFELMDMNLYELI-----KGRKRPLPEKRVKSYMYQL------LKS 112
Query: 725 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLD 784
L+++H GI HRD+K NIL+ + K++DFG R + ++ T Y
Sbjct: 113 LDHMHRN---GIFHRDIKPENILIKDD-ILKLADFGSCRGIYSKPPYTEYIS--TRWYRA 166
Query: 785 PE------YYGNQQLTEKSDVYSFGVVLLELIS 811
PE YYG K D+++ G V E++S
Sbjct: 167 PECLLTDGYYG-----PKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 3e-12
Identities = 81/324 (25%), Positives = 145/324 (44%), Gaps = 48/324 (14%)
Query: 619 KKIGKGSFGSVYYGKMK-DGKEVAVK-------IMAD--SCS---HRTQQFVTEVALLSR 665
K +GKGSFG V ++K G+ AVK ++ D C+ R E L+
Sbjct: 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60
Query: 666 IHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGL 725
++ + +EH V E+++ G L + ++ D A + GL
Sbjct: 61 LY-------CTFQTKEHL-FFVMEFLNGGDLMFHIQ---DKGRFDLYRATFYAAEIVCGL 109
Query: 726 EYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDP 785
++LH+ GII+RD+K N++LD + K++DFG+ ++ S+ GT Y+ P
Sbjct: 110 QFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFC-GTPDYIAP 165
Query: 786 EYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED----FGA-ELNIVHWARSMIKKG-D 839
E + T D +SFGV+L E++ G+ P +D F + ++ H+ R + K+ D
Sbjct: 166 EILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKD 225
Query: 840 VISIV---DPV----LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 892
++ + DP ++GN++ ++ +E+R P + V + D
Sbjct: 226 ILEKLFERDPTRRLGVVGNIRGHPFFKTINWTA--LEKRELD-PPFKPKVKSPSDYSNF- 281
Query: 893 KGGDQKFSSSSSKGQSSRKTLLTS 916
D++F S + S K L+ S
Sbjct: 282 ---DREFLSEKPRLSYSDKNLIDS 302
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 3e-12
Identities = 63/221 (28%), Positives = 116/221 (52%), Gaps = 28/221 (12%)
Query: 610 LEEATNNFCKKIGKGSFGSVYYGK-MKDGKE----VAVKIMADSCSHRT-QQFVTEVALL 663
L+E K +G G+FG+VY G + DG+ VA+K++ ++ S + ++ + E ++
Sbjct: 4 LKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVM 63
Query: 664 SRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTL-------RDRLHGSVNQKPLDWLTRLQ 716
+ + + L+G C + LV + M G L +DR+ GS Q L+W ++
Sbjct: 64 AGVGSPYVCRLLGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRI-GS--QDLLNWCVQI- 118
Query: 717 IAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI-SSV 775
AKG+ YL ++HRD+ + N+L+ K++DFGL+R + D T +
Sbjct: 119 -----AKGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADG 170
Query: 776 ARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 815
+ + ++ E +++ T +SDV+S+GV + EL++ G KP
Sbjct: 171 GKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKP 211
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 4e-12
Identities = 65/217 (29%), Positives = 101/217 (46%), Gaps = 28/217 (12%)
Query: 619 KKIGKGSFGSVYYGKMKDGKE--VAVKIMADSCSHRTQ--QFVTEVALLSRIHHRNLVPL 674
K I G++G+VY + K+ ++ KI + R Q Q E +L+ + +V +
Sbjct: 7 KLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSM 66
Query: 675 IGYCEEEHQRIL--VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 732
+C E +R L V EY+ G L ++ P+D + R+ A + LEYLH
Sbjct: 67 --FCSFETKRHLCMVMEYVEGGDCATLLK-NIGALPVD-MARMYFA-ETVLALEYLH--- 118
Query: 733 NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT------HISSVAR--------G 778
N GI+HRD+K N+L+ K++DFGLS+ LT HI R G
Sbjct: 119 NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCG 178
Query: 779 TVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 815
T Y+ PE Q + D ++ G++L E + G P
Sbjct: 179 TPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVP 215
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.3 bits (165), Expect = 4e-12
Identities = 61/212 (28%), Positives = 107/212 (50%), Gaps = 35/212 (16%)
Query: 620 KIGKGSFGSVYYGKMK-DGKEVAVK-IMAD-------SCSHRTQQFVTEVALLSRIHHRN 670
KIG+G++G VY + K G+ VA+K I + S + R E++LL ++H N
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIR------EISLLKELNHPN 59
Query: 671 LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA---HDAAKGLEY 727
+V L+ E++ LV+E++ L ++ PL L I + +G+ Y
Sbjct: 60 IVRLLDVVHSENKLYLVFEFLDLD-----LKKYMDSSPLTGLDPPLIKSYLYQLLQGIAY 114
Query: 728 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL---THISSVARGTVGYLD 784
H+ ++HRD+K N+L+D K++DFGL+R + TH V T+ Y
Sbjct: 115 CHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTH--EVV--TLWYRA 167
Query: 785 PE-YYGNQQLTEKSDVYSFGVVLLELISGKKP 815
PE G++Q + D++S G + E+++ ++P
Sbjct: 168 PEILLGSRQYSTPVDIWSIGCIFAEMVN-RRP 198
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 8e-12
Identities = 52/169 (30%), Positives = 84/169 (49%), Gaps = 14/169 (8%)
Query: 655 QFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTR 714
Q + E+ +L + +V G + + + E+M G+L D++ + P + L +
Sbjct: 49 QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKEAKRIPEEILGK 107
Query: 715 LQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISS 774
+ IA +GL YL I+HRDVK SNIL++ K+ DFG+S Q I S
Sbjct: 108 VSIA--VLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQL------IDS 157
Query: 775 VAR---GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 820
+A GT Y+ PE + +SD++S G+ L+EL G+ P+ D
Sbjct: 158 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPD 206
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 9e-12
Identities = 57/207 (27%), Positives = 95/207 (45%), Gaps = 30/207 (14%)
Query: 621 IGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQ---FVTEVALLSRIHHRNLVPLIG 676
+G GSFG V K K G+ A+K + + +Q E ++L + H +V ++
Sbjct: 26 LGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMC 85
Query: 677 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK--------GLEYL 728
++E++ + E++ G L L + P +D AK EYL
Sbjct: 86 SFQDENRVYFLLEFVVGGELFTHLR-KAGRFP----------NDVAKFYHAELVLAFEYL 134
Query: 729 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY 788
H + II+RD+K N+LLD KV+DFG +++ + + GT YL PE
Sbjct: 135 H---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFTLC----GTPEYLAPEVI 187
Query: 789 GNQQLTEKSDVYSFGVVLLELISGKKP 815
++ + D ++ GV+L E I+G P
Sbjct: 188 QSKGHGKAVDWWTMGVLLYEFIAGYPP 214
|
Length = 329 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 1e-11
Identities = 58/214 (27%), Positives = 99/214 (46%), Gaps = 16/214 (7%)
Query: 614 TNNFCKKIGKGSFGSVYYGKMKDGKEV-AVKIMADSC---SHRTQQFVTEVALLSRIHHR 669
NF +GKGSFG V + K E+ A+KI+ + + E +L+
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60
Query: 670 NLVPLIGYCEEEHQRI-LVYEYMHNGTLRDRLH--GSVNQKPLDWLTRLQIAHDAAKGLE 726
+ + C + R+ V EY++ G L + G + + A + + GL
Sbjct: 61 PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEP-----QAVFYAAEISVGLF 115
Query: 727 YLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE 786
+LH GII+RD+K N++LD K++DFG+ ++ D + GT Y+ PE
Sbjct: 116 FLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFC-GTPDYIAPE 171
Query: 787 YYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 820
Q + D +++GV+L E+++G+ P ED
Sbjct: 172 IIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGED 205
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-11
Identities = 53/202 (26%), Positives = 99/202 (49%), Gaps = 12/202 (5%)
Query: 620 KIGKGSFGSVYYGKMKDGKEVAVKIMADSCSH-RTQQFVTEVALLSRIHHRNLVPLIGYC 678
++G G+FG VY + K+ +A + D+ S + ++ E+ +L+ H N+V L+
Sbjct: 12 ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71
Query: 679 EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIH 738
E+ ++ E+ G + D + + ++PL + + L YLH IIH
Sbjct: 72 YYENNLWILIEFCAGGAV-DAVMLEL-ERPLTEPQIRVVCKQTLEALNYLH---ENKIIH 126
Query: 739 RDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY-----GNQQL 793
RD+K+ NIL ++ K++DFG+S + + S GT ++ PE ++
Sbjct: 127 RDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-GTPYWMAPEVVMCETSKDRPY 185
Query: 794 TEKSDVYSFGVVLLELISGKKP 815
K+DV+S G+ L+E+ + P
Sbjct: 186 DYKADVWSLGITLIEMAQIEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 1e-11
Identities = 67/233 (28%), Positives = 104/233 (44%), Gaps = 25/233 (10%)
Query: 619 KKIGKGSFGSVYYGKMKDGKEV-AVK------IMADSCSHRTQQFVTEVALLSRIHHRNL 671
K +GKGSFG V ++K E+ AVK I+ D T +AL + H L
Sbjct: 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGK--HPFL 58
Query: 672 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 731
L + + + V EY++ G L + D A + GL++LH
Sbjct: 59 TQLHSCFQTKDRLFFVMEYVNGGDLMFHIQ---RSGRFDEPRARFYAAEIVLGLQFLH-- 113
Query: 732 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA--EEDLTHISSVARGTVGYLDPEYYG 789
GII+RD+K N+LLD K++DFG+ ++ T S GT Y+ PE
Sbjct: 114 -ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTT---STFCGTPDYIAPEILS 169
Query: 790 NQQLTEKSDVYSFGVVLLELISGKKPVSVED----FGAELNI-VHWARSMIKK 837
Q D ++ GV+L E+++G+ P +D F + L V + R + K+
Sbjct: 170 YQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLSKE 222
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 1e-11
Identities = 65/214 (30%), Positives = 99/214 (46%), Gaps = 31/214 (14%)
Query: 620 KIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQ--------QFVTEVALLSRIH--- 667
+IG G++G+VY + G VA+K S R Q V EVALL R+
Sbjct: 7 EIGVGAYGTVYKARDPHSGHFVALK------SVRVQTNEDGLPLSTVREVALLKRLEAFD 60
Query: 668 HRNLVPLIGYC-----EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAA 722
H N+V L+ C + E + LV+E++ + LR L V L T +
Sbjct: 61 HPNIVRLMDVCATSRTDRETKVTLVFEHV-DQDLRTYLD-KVPPPGLPAETIKDLMRQFL 118
Query: 723 KGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGY 782
+GL++LH C I+HRD+K NIL+ + K++DFGL+R + V T+ Y
Sbjct: 119 RGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVV--TLWY 173
Query: 783 LDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPV 816
PE D++S G + E+ +KP+
Sbjct: 174 RAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPL 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 1e-11
Identities = 58/205 (28%), Positives = 104/205 (50%), Gaps = 16/205 (7%)
Query: 619 KKIGKGSFGSVYYGKMKD-GKEVAVK-IMADSCSHRT-QQFVTEVALLSRIHHRNLVPLI 675
+KIG+G++G VY G+ K G+ VA+K I +S + E++LL + H N+V L
Sbjct: 6 EKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQ 65
Query: 676 GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 735
+E + L++E++ + L+ L + +D + +G+ + H+
Sbjct: 66 DVLMQESRLYLIFEFL-SMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHS---RR 121
Query: 736 IIHRDVKSSNILLDINMRAKVSDFGLSRQ---AEEDLTHISSVARGTVGYLDPE-YYGNQ 791
++HRD+K N+L+D K++DFGL+R TH V T+ Y PE G+
Sbjct: 122 VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTH--EVV--TLWYRAPEVLLGSP 177
Query: 792 QLTEKSDVYSFGVVLLELISGKKPV 816
+ + D++S G + E+ + KKP+
Sbjct: 178 RYSTPVDIWSIGTIFAEMAT-KKPL 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 2e-11
Identities = 68/237 (28%), Positives = 107/237 (45%), Gaps = 53/237 (22%)
Query: 619 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHR------TQQFVTEVALLSRIHHRNLV 672
KKIG G FG V+ K K +E + S+R Q V EV ++ + H+N+V
Sbjct: 19 KKIGNGRFGEVFLVKHKRTQEF---FCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIV 75
Query: 673 PLIG-YCEEEHQRI-LVYEYMHNGTLRD------RLHGSVNQKPLDWLTRLQIAHDAAKG 724
I + + +Q++ ++ E+ G L ++ G + + + +TR Q+ H
Sbjct: 76 RYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITR-QLLH----A 130
Query: 725 LEYLHT---GCN-PGIIHRDVKSSNILLDINMR-----------------AKVSDFGLSR 763
L Y H G N ++HRD+K NI L +R AK+ DFGLS+
Sbjct: 131 LAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSK 190
Query: 764 QAEEDLTHISSVARGTVG---YLDPEY--YGNQQLTEKSDVYSFGVVLLELISGKKP 815
I S+A VG Y PE + + +KSD+++ G ++ EL SGK P
Sbjct: 191 N-----IGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTP 242
|
Length = 1021 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 2e-11
Identities = 67/218 (30%), Positives = 108/218 (49%), Gaps = 33/218 (15%)
Query: 621 IGKGSFGSVYYGKMKD---------GKEVAVKI-MADSCSHRTQQFVTEVALLSRIHHRN 670
+G+G+F ++Y G ++ G+EV+V + + S + F +L+S++ H++
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 671 LVPLIGYC-EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 729
LV L G C +E+ I+V EY+ G L LH N L W L +A A L YL
Sbjct: 63 LVKLYGVCVRDEN--IMVEEYVKFGPLDVFLHREKNNVSLHWK--LDVAKQLASALHYLE 118
Query: 730 TGCNPGIIHRDVKSSNILL---DINMR----AKVSDFGLSRQAEEDLTHISSVARGTVGY 782
+ ++H +V NIL+ +N K+SD G+ L+ V R + +
Sbjct: 119 ---DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITV---LSREERVER--IPW 170
Query: 783 LDPEYYGNQQ--LTEKSDVYSFGVVLLELIS-GKKPVS 817
+ PE N Q LT +D +SFG LLE+ S G++P+S
Sbjct: 171 IAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLS 208
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 2e-11
Identities = 64/208 (30%), Positives = 100/208 (48%), Gaps = 27/208 (12%)
Query: 621 IGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLV-----PL 674
IG+G FG VY + D GK A+K + D + +Q T +AL RI +LV P
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCL-DKKRIKMKQGET-LALNERIM-LSLVSTGDCPF 58
Query: 675 I---GYCEEEHQRI-LVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYL 728
I Y ++ + + M+ G L L HG ++ + + A + GLE++
Sbjct: 59 IVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFY-----AAEIILGLEHM 113
Query: 729 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY 788
H N +++RD+K +NILLD + ++SD GL+ + H S GT GY+ PE
Sbjct: 114 H---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVL 167
Query: 789 GNQQLTEKS-DVYSFGVVLLELISGKKP 815
+ S D +S G +L +L+ G P
Sbjct: 168 QKGVAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 2e-11
Identities = 65/216 (30%), Positives = 106/216 (49%), Gaps = 36/216 (16%)
Query: 619 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVT--EVALLSRIHHRNLVPLI 675
K IG+G++G V K + ++VA+K +A++ +R T E+ LL + H N++ +
Sbjct: 11 KPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIK 70
Query: 676 GYCEEEHQRI-----LVYEYMHNGTLRDRLHGSV--NQKPLD-----WLTRLQIAHDAAK 723
H+ +VYE M LH + +Q D +L +L +
Sbjct: 71 DIMPPPHREAFNDVYIVYELMDTD-----LHQIIRSSQTLSDDHCQYFLYQL------LR 119
Query: 724 GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISS--VARGTVG 781
GL+Y+H+ ++HRD+K SN+LL+ N K+ DFGL+R E ++ V R
Sbjct: 120 GLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTR---W 173
Query: 782 YLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPV 816
Y PE N + T DV+S G + EL+ G+KP+
Sbjct: 174 YRAPELLLNCSEYTTAIDVWSVGCIFAELL-GRKPL 208
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 52/201 (25%), Positives = 98/201 (48%), Gaps = 14/201 (6%)
Query: 621 IGKGSFGSV------YYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPL 674
+GKG FG V GKM K++ K + + + E +L +++ +V L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMA--LLEKEILEKVNSPFIVNL 58
Query: 675 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 734
E + LV M+ G L+ ++ +V ++ L+ + + G+ +LH+
Sbjct: 59 AYAFESKTHLCLVMSLMNGGDLKYHIY-NVGERGLEMERVIHYSAQITCGILHLHS---M 114
Query: 735 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLT 794
I++RD+K N+LLD ++SD GL+ + ++ T I+ A GT GY+ PE + +
Sbjct: 115 DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT-ITQRA-GTNGYMAPEILKEEPYS 172
Query: 795 EKSDVYSFGVVLLELISGKKP 815
D ++ G + E+++G+ P
Sbjct: 173 YPVDWFAMGCSIYEMVAGRTP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-11
Identities = 52/169 (30%), Positives = 83/169 (49%), Gaps = 14/169 (8%)
Query: 655 QFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTR 714
Q + E+ +L + +V G + + + E+M G+L D++ + P L +
Sbjct: 49 QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGK 107
Query: 715 LQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISS 774
+ IA KGL YL I+HRDVK SNIL++ K+ DFG+S Q I S
Sbjct: 108 VSIA--VIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL------IDS 157
Query: 775 VAR---GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 820
+A GT Y+ PE + +SD++S G+ L+E+ G+ P+ D
Sbjct: 158 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPD 206
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 2e-11
Identities = 60/216 (27%), Positives = 105/216 (48%), Gaps = 23/216 (10%)
Query: 619 KKIGKGSFGSVYY----GKMKDGKEVAVKIMADSC---SHRTQQFV-TEVALLSRIHHRN 670
+ +G G++G V+ G GK A+K++ + +T + TE +L +
Sbjct: 6 RVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCP 65
Query: 671 -LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 729
LV L + + + L+ +Y++ G L L+ + + R+ IA + L++LH
Sbjct: 66 FLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESE--VRVYIA-EIVLALDHLH 122
Query: 730 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ---AEEDLTHISSVARGTVGYLDPE 786
GII+RD+K NILLD ++DFGLS++ EE+ + GT+ Y+ PE
Sbjct: 123 ---QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFC---GTIEYMAPE 176
Query: 787 YY--GNQQLTEKSDVYSFGVVLLELISGKKPVSVED 820
G+ + D +S GV+ EL++G P +V+
Sbjct: 177 VIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDG 212
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 2e-11
Identities = 65/244 (26%), Positives = 112/244 (45%), Gaps = 37/244 (15%)
Query: 619 KKIGKGSFGSVYYGKMKDGKE----VAVKIMADSCSHRTQQFVT----EVALLSRIHHRN 670
K +GKG +G V+ + G + A+K++ + R Q+ E +L + H
Sbjct: 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPF 61
Query: 671 LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGS---VNQKPLDWLTRLQIAHDAAKGLEY 727
+V LI + + L+ EY+ G L L + +L+ + +A LE+
Sbjct: 62 IVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLA------LEH 115
Query: 728 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA--EEDLTHISSVARGTVGYLDP 785
LH GII+RD+K NILLD K++DFGL +++ E +TH GT+ Y+ P
Sbjct: 116 LHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFC---GTIEYMAP 169
Query: 786 EYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED--------FGAELNI----VHWARS 833
E + D +S G ++ ++++G P + E+ +LN+ AR
Sbjct: 170 EILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEARD 229
Query: 834 MIKK 837
++KK
Sbjct: 230 LLKK 233
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.8 bits (161), Expect = 2e-11
Identities = 64/213 (30%), Positives = 105/213 (49%), Gaps = 36/213 (16%)
Query: 620 KIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPLI- 675
IG+G++G V K G +VA+K ++ H+T Q+ + E+ +L R H N++ ++
Sbjct: 12 YIGEGAYGMVCSATHKPTGVKVAIKKIS-PFEHQTFCQRTLREIKILRRFKHENIIGILD 70
Query: 676 ----GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPL--DWLTRL--QIAHDAAKGLEY 727
E + +V E M L+ + + L D + QI +GL+Y
Sbjct: 71 IIRPPSFESFNDVYIVQELMETD-----LYKLIKTQHLSNDHIQYFLYQIL----RGLKY 121
Query: 728 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISS------VARGTVG 781
+H N ++HRD+K SN+LL+ N K+ DFGL+R A D H + VA T
Sbjct: 122 IH-SAN--VLHRDLKPSNLLLNTNCDLKICDFGLARIA--DPEHDHTGFLTEYVA--TRW 174
Query: 782 YLDPEYYGNQQLTEKS-DVYSFGVVLLELISGK 813
Y PE N + K+ D++S G +L E++S +
Sbjct: 175 YRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 3e-11
Identities = 58/210 (27%), Positives = 104/210 (49%), Gaps = 32/210 (15%)
Query: 619 KKIGKGSFGSVYYG-KMKDGKEVAVK-----IMADSCSHRTQQFVTEVALLSRIHHRNLV 672
K++G G++G+V + G +VA+K ++ + R + E+ LL + H N++
Sbjct: 21 KQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYR---ELRLLKHMKHENVI 77
Query: 673 PLIGY------CEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKG 724
L+ + H LV +M GT +L H +++ + +L + KG
Sbjct: 78 GLLDVFTPDLSLDRFHDFYLVMPFM--GTDLGKLMKHEKLSEDRIQFLV-----YQMLKG 130
Query: 725 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLD 784
L+Y+H GIIHRD+K N+ ++ + K+ DFGL+RQ + ++T T Y
Sbjct: 131 LKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVV----TRWYRA 183
Query: 785 PEYYGN-QQLTEKSDVYSFGVVLLELISGK 813
PE N T+ D++S G ++ E+++GK
Sbjct: 184 PEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 3e-11
Identities = 41/111 (36%), Positives = 63/111 (56%), Gaps = 7/111 (6%)
Query: 708 PLDWLTRLQIAHDAAKGLEYLHT-GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 766
PLD L+ + A+G+++L + C IHRDV + N+LL AK+ DFGL+R
Sbjct: 208 PLDLDDLLRFSSQVAQGMDFLASKNC----IHRDVAARNVLLTDGRVAKICDFGLARDIM 263
Query: 767 EDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 815
D + + AR V ++ PE + T +SDV+S+G++L E+ S GK P
Sbjct: 264 NDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSP 314
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 4e-11
Identities = 34/81 (41%), Positives = 50/81 (61%), Gaps = 1/81 (1%)
Query: 425 LKGEIPPELKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNELTGSLPSYMGSL 483
L G IPP + +++ L L L N L+G +P++ +L +L I+HL +N TG +P + SL
Sbjct: 272 LSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSL 331
Query: 484 PNLQELHIENNSFVGEIPPAL 504
P LQ L + +N F GEIP L
Sbjct: 332 PRLQVLQLWSNKFSGEIPKNL 352
|
Length = 968 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 4e-11
Identities = 59/233 (25%), Positives = 99/233 (42%), Gaps = 34/233 (14%)
Query: 619 KKIGKGSFGSVYYG-KMKDGKEVAVKIMADSCSHRT---QQFVTEVALLSRIHHRNLVPL 674
+ IGKG G VY + VA+K + + S ++F+ E + + + H +VP+
Sbjct: 8 RLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPV 67
Query: 675 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQ-----KPLDWLTR----LQIAHDAAKGL 725
C + Y+ TL+ L SV Q K L T L I H +
Sbjct: 68 YSICSDGDPVYYTMPYIEGYTLKSLLK-SVWQKESLSKELAEKTSVGAFLSIFHKICATI 126
Query: 726 EYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFG--LSRQAEEDLTHISSVAR------ 777
EY+H+ G++HRD+K NILL + + D+G + ++ EE+ V
Sbjct: 127 EYVHS---KGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYS 183
Query: 778 ---------GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDF 821
GT Y+ PE +E +D+Y+ GV+L ++++ P +
Sbjct: 184 SMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKG 236
|
Length = 932 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 4e-11
Identities = 56/209 (26%), Positives = 97/209 (46%), Gaps = 16/209 (7%)
Query: 619 KKIGKGSFGSVYYGKMKDGKEV-AVKIMADSCSHRTQQF---VTEVALLS-RIHHRNLVP 673
K +GKGSFG V ++K EV A+K++ + +TE +L+ H L
Sbjct: 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60
Query: 674 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 733
L + + + V EY++ G L ++ S + D A + L +LH
Sbjct: 61 LHCCFQTKDRLFFVMEYVNGGDLMFQIQRS---RKFDEPRSRFYAAEVTLALMFLHRH-- 115
Query: 734 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQ--AEEDLTHISSVARGTVGYLDPEYYGNQ 791
G+I+RD+K NILLD K++DFG+ ++ T + GT Y+ PE
Sbjct: 116 -GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTT---TTFCGTPDYIAPEILQEL 171
Query: 792 QLTEKSDVYSFGVVLLELISGKKPVSVED 820
+ D ++ GV++ E+++G+ P ++
Sbjct: 172 EYGPSVDWWALGVLMYEMMAGQPPFEADN 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.0 bits (159), Expect = 4e-11
Identities = 58/232 (25%), Positives = 96/232 (41%), Gaps = 42/232 (18%)
Query: 619 KKIGKGSFGSVYYGKMKDGKEV-AVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPL 674
K +GKG G V+ ++K ++ A+K++ ++ ++ +TE +L+ + H L L
Sbjct: 7 KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTL 66
Query: 675 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK---GLEYLHTG 731
+ E LV +Y G L + ++P L+ AA+ LEYLH
Sbjct: 67 YASFQTETYLCLVMDYCPGG----ELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLH-- 120
Query: 732 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA----------------------EEDL 769
GI++RD+K NILL + +SDF LS+Q+
Sbjct: 121 -LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSE 179
Query: 770 THI-SSVAR-----GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 815
T R GT Y+ PE D ++ G++L E++ G P
Sbjct: 180 TFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTP 231
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 64.6 bits (158), Expect = 4e-11
Identities = 56/207 (27%), Positives = 105/207 (50%), Gaps = 22/207 (10%)
Query: 620 KIGKGSFGSVYYGK-MKDGKEVAVK-IMADSCSHRTQQFVT---EVALLSRIHHRNLVPL 674
+I +G++G VY + K G+ VA+K + + + +T E+ +L ++ H N+V +
Sbjct: 12 RIEEGTYGVVYRARDKKTGEIVALKKLKMEK--EKEGFPITSLREINILLKLQHPNIVTV 69
Query: 675 --IGYCEEEHQRILVYEYMHNG--TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 730
+ + +V EY+ + +L + + Q + L LQ+ G+ +LH
Sbjct: 70 KEVVVGSNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLM-LQLL----SGVAHLHD 124
Query: 731 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE-YYG 789
I+HRD+K+SN+LL+ K+ DFGL+R+ L + + T+ Y PE G
Sbjct: 125 NW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVV-TLWYRAPELLLG 180
Query: 790 NQQLTEKSDVYSFGVVLLELISGKKPV 816
++ + D++S G + EL++ KKP+
Sbjct: 181 AKEYSTAIDMWSVGCIFAELLT-KKPL 206
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 5e-11
Identities = 69/268 (25%), Positives = 112/268 (41%), Gaps = 75/268 (27%)
Query: 619 KKIGKGSFGSVY------YGKMKDGKEVAVKIMADSCSHRTQQ-FVTEVALLSRI-HHRN 670
K +G G+FG V K VAVK++ + + + ++E+ +L I +H N
Sbjct: 13 KVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLN 72
Query: 671 LVPLIGYCEEEHQRILV-YEYMHNGTL---------------------RDRLHGSVNQKP 708
+V L+G C + + ++V E+ G L R R V Q
Sbjct: 73 VVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSR 132
Query: 709 LD--------------------------------WLTRLQI------AHDAAKGLEYLHT 730
+D W + L + + A+G+E+L +
Sbjct: 133 VDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLAS 192
Query: 731 -GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI-SSVARGTVGYLDPEYY 788
C IHRD+ + NILL N K+ DFGL+R +D ++ AR + ++ PE
Sbjct: 193 RKC----IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESI 248
Query: 789 GNQQLTEKSDVYSFGVVLLELIS-GKKP 815
++ T +SDV+SFGV+L E+ S G P
Sbjct: 249 FDKVYTTQSDVWSFGVLLWEIFSLGASP 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 5e-11
Identities = 63/211 (29%), Positives = 100/211 (47%), Gaps = 33/211 (15%)
Query: 621 IGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLI--GY 677
IG+G FG VY + D GK A+K + D + +Q T +AL RI ++ L+ G
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCL-DKKRIKMKQGET-LALNERI----MLSLVSTGD 55
Query: 678 C----------EEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGL 725
C + + + M+ G L L HG ++K + + A + GL
Sbjct: 56 CPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFY-----ATEIILGL 110
Query: 726 EYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDP 785
E++H N +++RD+K +NILLD + ++SD GL+ + H S GT GY+ P
Sbjct: 111 EHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAP 164
Query: 786 EYYGNQQLTEKS-DVYSFGVVLLELISGKKP 815
E + S D +S G +L +L+ G P
Sbjct: 165 EVLQKGTAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 6e-11
Identities = 59/203 (29%), Positives = 97/203 (47%), Gaps = 20/203 (9%)
Query: 619 KKIGKGSFGSVYYG-KMKDGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPLI 675
K IG G+ G V G VAVK ++ ++T ++ E+ LL ++H+N++ L+
Sbjct: 27 KPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLL 86
Query: 676 GY------CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 729
EE LV E M + L +H ++ + + +L + G+++LH
Sbjct: 87 NVFTPQKSLEEFQDVYLVMELM-DANLCQVIHMELDHERMSYLLYQMLC-----GIKHLH 140
Query: 730 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYG 789
+ GIIHRD+K SNI++ + K+ DFGL+R A + V T Y PE
Sbjct: 141 SA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVV--TRYYRAPEVIL 195
Query: 790 NQQLTEKSDVYSFGVVLLELISG 812
E D++S G ++ EL+ G
Sbjct: 196 GMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 8e-11
Identities = 63/207 (30%), Positives = 107/207 (51%), Gaps = 30/207 (14%)
Query: 621 IGKGSFGSV---YYGKMKDGKEVAVKIMA---DSCSHRTQQFVTEVALLSRIHHRNLVPL 674
+G G++GSV Y +++ ++VAVK ++ S H + + E+ LL + H N++ L
Sbjct: 23 VGSGAYGSVCSAYDTRLR--QKVAVKKLSRPFQSLIHARRTY-RELRLLKHMKHENVIGL 79
Query: 675 IGY------CEEEHQRILVYEYMHNGTLRDRLHGSVN-QKPLDWLTRLQIAHDAAKGLEY 727
+ E ++ LV M L+ V QK D + I + +GL+Y
Sbjct: 80 LDVFTPATSIENFNEVYLVTNLMGAD-----LNNIVKCQKLSDEHVQFLI-YQLLRGLKY 133
Query: 728 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 787
+H+ GIIHRD+K SN+ ++ + ++ DFGL+RQA++++T VA T Y PE
Sbjct: 134 IHSA---GIIHRDLKPSNVAVNEDCELRILDFGLARQADDEMT--GYVA--TRWYRAPEI 186
Query: 788 YGN-QQLTEKSDVYSFGVVLLELISGK 813
N + D++S G ++ EL+ GK
Sbjct: 187 MLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 1e-10
Identities = 65/223 (29%), Positives = 103/223 (46%), Gaps = 36/223 (16%)
Query: 621 IGKGSFGSVYYGK-MKDGKEVAVKI-----MADSCSHRTQQFVTEVALLSRIH------- 667
+G G+ G+V K + DG+ AVK+ M+++ +R Q EV L
Sbjct: 40 LGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQ---AEVCCLLNCDFFSIVKC 96
Query: 668 HRNLVPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLE 726
H + E I LV +Y + G LR + R H+A GL
Sbjct: 97 HEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKT------NRTFREHEA--GLL 148
Query: 727 YL------HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR--- 777
++ H + +IHRD+KS+NILL N K+ DFG S+ ++ V R
Sbjct: 149 FIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVS--DDVGRTFC 206
Query: 778 GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 820
GT Y+ PE + + ++K+D++S GV+L EL++ K+P E+
Sbjct: 207 GTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN 249
|
Length = 496 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 1e-10
Identities = 63/202 (31%), Positives = 91/202 (45%), Gaps = 12/202 (5%)
Query: 619 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEV-ALLSRIHHRNLVP 673
K IGKGSFG V + K + K AVK++ + ++E LL + H LV
Sbjct: 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60
Query: 674 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 733
L + + V +Y++ G L H + L+ R A + A L YLH+
Sbjct: 61 LHFSFQTADKLYFVLDYINGGELF--YHLQRERCFLEPRARFYAA-EIASALGYLHS--- 114
Query: 734 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQL 793
I++RD+K NILLD ++DFGL ++ E S+ GT YL PE Q
Sbjct: 115 LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFC-GTPEYLAPEVLHKQPY 173
Query: 794 TEKSDVYSFGVVLLELISGKKP 815
D + G VL E++ G P
Sbjct: 174 DRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 2e-10
Identities = 56/207 (27%), Positives = 102/207 (49%), Gaps = 27/207 (13%)
Query: 619 KKIGKGSFGSVYYG-KMKDGKEVAVKIMADSCSHRTQQFVT----EVALLSRIHHRNLVP 673
K++G G++GSV + G++VA+K + S +++ F E+ LL + H N++
Sbjct: 21 KQVGSGAYGSVCSAIDKRTGEKVAIKKL--SRPFQSEIFAKRAYRELTLLKHMQHENVIG 78
Query: 674 LIGY------CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEY 727
L+ +E LV YM + H +++ + +L + GL+Y
Sbjct: 79 LLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGH-PLSEDKVQYLV-----YQMLCGLKY 132
Query: 728 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 787
+H+ GIIHRD+K N+ ++ + K+ DFGL+R A+ ++T T Y PE
Sbjct: 133 IHSA---GIIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVV----TRWYRAPEV 185
Query: 788 YGN-QQLTEKSDVYSFGVVLLELISGK 813
N + D++S G ++ E+++GK
Sbjct: 186 ILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 2e-10
Identities = 58/203 (28%), Positives = 101/203 (49%), Gaps = 22/203 (10%)
Query: 621 IGKGSFGSVYYG-KMKDGKEVAVKIMA---DSCSHRTQQFVTEVALLSRIHHRNLVPLI- 675
+G G++GSV K G VAVK ++ S H + + E+ LL + H N++ L+
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 83
Query: 676 ----GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 731
EE + + ++ L + + QK D + I + +GL+Y+H+
Sbjct: 84 VFTPARSLEEFNDVYLVTHLMGADLNNIVKC---QKLTDDHVQFLI-YQILRGLKYIHSA 139
Query: 732 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN- 790
IIHRD+K SN+ ++ + K+ DFGL+R ++++T VA T Y PE N
Sbjct: 140 ---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--GYVA--TRWYRAPEIMLNW 192
Query: 791 QQLTEKSDVYSFGVVLLELISGK 813
+ D++S G ++ EL++G+
Sbjct: 193 MHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 58/205 (28%), Positives = 100/205 (48%), Gaps = 24/205 (11%)
Query: 619 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVT-----EVALLSRIHHRNLV 672
+K+G+GS+ +VY G + +G+ VA+K++ S +T++ V E +LL + H N+V
Sbjct: 11 EKLGEGSYATVYKGISRINGQLVALKVI----SMKTEEGVPFTAIREASLLKGLKHANIV 66
Query: 673 PLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKP--LDWLTRLQIAHDAAKGLEYLHT 730
L + V+EYMH L + Q P L +GL Y+H
Sbjct: 67 LLHDIIHTKETLTFVFEYMHTD-----LAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIH- 120
Query: 731 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR-QAEEDLTHISSVARGTVGYLDPE-YY 788
I+HRD+K N+L+ K++DFGL+R ++ T+ S V T+ Y P+
Sbjct: 121 --GQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV--TLWYRPPDVLL 176
Query: 789 GNQQLTEKSDVYSFGVVLLELISGK 813
G + D++ G + +E++ G+
Sbjct: 177 GATDYSSALDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 2e-10
Identities = 61/210 (29%), Positives = 99/210 (47%), Gaps = 25/210 (11%)
Query: 619 KKIGKGSFGSVYYGKMKDGKEV-AVKIMAD-SCSHRTQQ--FVTEVALLSRIHHRNLVPL 674
K IG+G+FG V + K ++V A+K+++ R+ F E +++ + +V L
Sbjct: 49 KVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL 108
Query: 675 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 734
+++ +V EYM G L + + S P W + A + L+ +H+
Sbjct: 109 FCAFQDDKYLYMVMEYMPGGDLVNLM--SNYDVPEKW-AKFYTA-EVVLALDAIHS---M 161
Query: 735 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE-------- 786
G+IHRDVK N+LLD + K++DFG + +E A GT Y+ PE
Sbjct: 162 GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGD 221
Query: 787 -YYGNQQLTEKSDVYSFGVVLLELISGKKP 815
YYG + D +S GV L E++ G P
Sbjct: 222 GYYGRE-----CDWWSVGVFLFEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 54/207 (26%), Positives = 98/207 (47%), Gaps = 20/207 (9%)
Query: 621 IGKGSFGSVYYGKMKDGKEV-AVKIMADSCSH--------RTQQFVTEVALLSRIHHRNL 671
IG+GS+ V ++K ++ A+K++ H +T++ V E A + L
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPF----L 58
Query: 672 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 731
V L + + LV EY++ G L H +K + R A + L +LH
Sbjct: 59 VGLHSCFQTTSRLFLVIEYVNGGDLM--FHMQRQRKLPEEHARFYAA-EICIALNFLH-- 113
Query: 732 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ 791
GII+RD+K N+LLD + K++D+G+ ++ S+ GT Y+ PE +
Sbjct: 114 -ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFC-GTPNYIAPEILRGE 171
Query: 792 QLTEKSDVYSFGVVLLELISGKKPVSV 818
+ D ++ GV++ E+++G+ P +
Sbjct: 172 EYGFSVDWWALGVLMFEMMAGRSPFDI 198
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 2e-10
Identities = 62/212 (29%), Positives = 98/212 (46%), Gaps = 23/212 (10%)
Query: 621 IGKGSFGSVYYGKMKDGKEV-AVKIMADSCSHRTQQF---VTEVALLSRIHHRN---LVP 673
IGKG+FG VY + KD + + A+K+++ ++ + E +L R +V
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 674 LIGYCEEEHQRILVYEYMHNGTLRDRLH--GSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 731
L + + LV +YM G L L G ++ + IA + LE+LH
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDR----AKFYIA-ELVLALEHLHKY 115
Query: 732 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ--AEEDLTHISSVARGTVGYLDPEYYG 789
I++RD+K NILLD + DFGLS+ + T+ GT YL PE
Sbjct: 116 ---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFC---GTTEYLAPEVLL 169
Query: 790 NQQ-LTEKSDVYSFGVVLLELISGKKPVSVED 820
+++ T+ D +S GV++ E+ G P ED
Sbjct: 170 DEKGYTKHVDFWSLGVLVFEMCCGWSPFYAED 201
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 3e-10
Identities = 36/100 (36%), Positives = 55/100 (55%), Gaps = 7/100 (7%)
Query: 412 PPRITKIA------LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRI 464
P +T + L+ L G+IP EL M++L ++L N L+G +P ++ L L
Sbjct: 181 PNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNH 240
Query: 465 VHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 504
+ L N LTG +PS +G+L NLQ L + N G IPP++
Sbjct: 241 LDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSI 280
|
Length = 968 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 3e-10
Identities = 68/272 (25%), Positives = 108/272 (39%), Gaps = 64/272 (23%)
Query: 619 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFV---TEVALLSRIHHRNLVPL 674
K IG+G+FG V + KD G A+K + S +Q E +L+ + +V L
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKL 66
Query: 675 IGYC--EEEHQRILVYEYMHNG---TL---RDRLHGSVNQKPLDWLTRLQIAHDAAKGLE 726
Y ++E+ L+ EY+ G TL +D TR IA + ++
Sbjct: 67 --YYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEE--------TRFYIA-ETILAID 115
Query: 727 YLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGL--------SRQAEEDLTHISS---- 774
+H G IHRD+K N+LLD K+SDFGL + L+H
Sbjct: 116 SIHK---LGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFL 172
Query: 775 ----------------------VARGTVG---YLDPEYYGNQQLTEKSDVYSFGVVLLEL 809
+A TVG Y+ PE + ++ D +S GV++ E+
Sbjct: 173 DFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEM 232
Query: 810 ISGKKP-VSVEDFGAELNIVHWARSMIKKGDV 840
+ G P S I++W ++ +V
Sbjct: 233 LVGYPPFCSDNPQETYRKIINWKETLQFPDEV 264
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 4e-10
Identities = 59/232 (25%), Positives = 99/232 (42%), Gaps = 30/232 (12%)
Query: 621 IGKGSFGSVYYGKMKDGKEV-AVKIMADS---CSHRTQQFVTEVALLSRIHHRNLVPLIG 676
+G+G FG V + K ++ A+K+M S F E +LS + + L
Sbjct: 9 VGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQY 68
Query: 677 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLD------WLTRLQIAHDAAKGLEYLHT 730
+++ LV EY G L L + + D +L L +A +H+
Sbjct: 69 AFQDKDNLYLVMEYQPGGDLLSLL--NRYEDQFDEDMAQFYLAELVLA---------IHS 117
Query: 731 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY--- 787
G +HRD+K N+L+D K++DFG + + + S + GT Y+ PE
Sbjct: 118 VHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTT 177
Query: 788 ---YGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAEL--NIVHWARSM 834
G + D +S GV+ E+I G+ P E A+ NI+++ R +
Sbjct: 178 MNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFH-EGTSAKTYNNIMNFQRFL 228
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 4e-10
Identities = 58/208 (27%), Positives = 95/208 (45%), Gaps = 19/208 (9%)
Query: 621 IGKGSFGSVYYGKMKDGKEV-AVKIMADS---CSHRTQQFVTEVALLSRIHHRNLVPLIG 676
IGKGSFG V + +D + + A+K + + + E +L++++ +VPL
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 677 YCEEEHQRILVYEYMHNGTLRDRLH--GSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 734
+ + LV +++ G L L G + R A + LE LH
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQREGRFDL----SRARFYTA-ELLCALENLHKF--- 112
Query: 735 GIIHRDVKSSNILLDINMRAKVSDFGLSR--QAEEDLTHISSVARGTVGYLDPEYYGNQQ 792
+I+RD+K NILLD + DFGL + ++D T+ GT YL PE
Sbjct: 113 NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFC---GTPEYLAPELLLGHG 169
Query: 793 LTEKSDVYSFGVVLLELISGKKPVSVED 820
T+ D ++ GV+L E+++G P E+
Sbjct: 170 YTKAVDWWTLGVLLYEMLTGLPPFYDEN 197
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 4e-10
Identities = 38/97 (39%), Positives = 58/97 (59%), Gaps = 7/97 (7%)
Query: 722 AKGLEYLHT-GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI-SSVARGT 779
A+G+E+L + C IHRD+ + NILL N K+ DFGL+R +D ++ AR
Sbjct: 183 ARGMEFLASRKC----IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 238
Query: 780 VGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 815
+ ++ PE ++ T +SDV+SFGV+L E+ S G P
Sbjct: 239 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASP 275
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 4e-10
Identities = 56/204 (27%), Positives = 96/204 (47%), Gaps = 24/204 (11%)
Query: 620 KIGKGSFGSVYYGKMK-DGKEVAVK-IMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 677
K+G+G++ +V+ G+ K VA+K I + + EV+LL + H N+V L
Sbjct: 12 KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDI 71
Query: 678 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAA-------KGLEYLHT 730
E LV+EY+ + ++ LD L H+ +GL Y H
Sbjct: 72 IHTERCLTLVFEYLDSDL----------KQYLDNCGNLMSMHNVKIFMFQLLRGLSYCH- 120
Query: 731 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE-YYG 789
I+HRD+K N+L++ K++DFGL+R A+ T S T+ Y P+ G
Sbjct: 121 --KRKILHRDLKPQNLLINEKGELKLADFGLAR-AKSVPTKTYSNEVVTLWYRPPDVLLG 177
Query: 790 NQQLTEKSDVYSFGVVLLELISGK 813
+ + + D++ G +L E+ +G+
Sbjct: 178 STEYSTPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 5e-10
Identities = 49/162 (30%), Positives = 77/162 (47%), Gaps = 16/162 (9%)
Query: 608 PELEEATNNFCKKIGKGSFGSVYYG-KMKDGKEVAVKIMADS---CSHRTQQFVTEVALL 663
P +EE K I +G+FG VY G K + K AVK++ + + Q E L
Sbjct: 1 PSIEEFV--IVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDAL 58
Query: 664 SRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLH--GSVNQKPLDWLTRLQIAHDA 721
+ +V L + + LV EY+ G ++ LH G +++ ++ +
Sbjct: 59 ALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEE-----MAVKYISEV 113
Query: 722 AKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 763
A L+YLH GIIHRD+K N+L+ K++DFGLS+
Sbjct: 114 ALALDYLH---RHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 5e-10
Identities = 42/160 (26%), Positives = 83/160 (51%), Gaps = 5/160 (3%)
Query: 658 TEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQK-PLDWLTRLQ 716
+E+ L+ H +V + + + +L+ EY G L ++ + + P
Sbjct: 114 SELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGL 173
Query: 717 IAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT-HISSV 775
+ + L+ +H+ ++HRD+KS+NI L K+ DFG S+Q + ++ ++S
Sbjct: 174 LFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASS 230
Query: 776 ARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 815
GT YL PE + ++ ++K+D++S GV+L EL++ +P
Sbjct: 231 FCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRP 270
|
Length = 478 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 5e-10
Identities = 65/212 (30%), Positives = 96/212 (45%), Gaps = 36/212 (16%)
Query: 619 KKIGKGSFGSV---YYGKMKDGKEVAVKIMADSCSHRTQQFVT-------EVALLSRIHH 668
K IG G+ G V Y G+ VA+K ++ R Q VT E+ L+ ++H
Sbjct: 22 KPIGSGAQGIVCAAYD--TVTGQNVAIKKLS-----RPFQNVTHAKRAYRELVLMKLVNH 74
Query: 669 RNLVPLIGYCE-----EEHQRI-LVYEYM-HNGTLRDRLHGSVNQKPLDWLTRLQIAHDA 721
+N++ L+ EE Q + LV E M N L V Q LD + +
Sbjct: 75 KNIIGLLNVFTPQKSLEEFQDVYLVMELMDAN------LC-QVIQMDLDHERMSYLLYQM 127
Query: 722 AKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVG 781
G+++LH + GIIHRD+K SNI++ + K+ DFGL+R A V T
Sbjct: 128 LCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV--TRY 182
Query: 782 YLDPEYYGNQQLTEKSDVYSFGVVLLELISGK 813
Y PE E D++S G ++ E+I G
Sbjct: 183 YRAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 8e-10
Identities = 58/236 (24%), Positives = 103/236 (43%), Gaps = 45/236 (19%)
Query: 617 FCKKIGKGSFG---SVYYGKMKDGKEVAVKIMADSCSHR--TQQFVTEVALLSRIH-HRN 670
K++G+G++G S + + + VA+K + + S + ++ + E+ LL H+N
Sbjct: 4 LIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKN 63
Query: 671 LVPLI--------GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAH--- 719
+ L + E + +YE + L + L AH
Sbjct: 64 ITCLYDMDIVFPGNFNE-----LYLYEELMEADLHQIIRSGQ---------PLTDAHFQS 109
Query: 720 ---DAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR----QAEEDLTHI 772
GL+Y+H+ ++HRD+K N+L++ + K+ DFGL+R E+ +
Sbjct: 110 FIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFM 166
Query: 773 SS-VARGTVGYLDPE-YYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELN 826
+ VA T Y PE Q T+ DV+S G +L EL+ K +D+ +LN
Sbjct: 167 TEYVA--TRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLN 220
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 9e-10
Identities = 61/210 (29%), Positives = 98/210 (46%), Gaps = 25/210 (11%)
Query: 619 KKIGKGSFGSVYYGKMKDGKEV-AVKIMAD-SCSHRTQQ--FVTEVALLSRIHHRNLVPL 674
K IG+G+FG V + K ++V A+K+++ R+ F E +++ + +V L
Sbjct: 49 KVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL 108
Query: 675 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 734
+++ +V EYM G L + + S P W R A + L+ +H+
Sbjct: 109 FYAFQDDRYLYMVMEYMPGGDLVNLM--SNYDVPEKW-ARFYTA-EVVLALDAIHS---M 161
Query: 735 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE-------- 786
G IHRDVK N+LLD + K++DFG + ++ A GT Y+ PE
Sbjct: 162 GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGD 221
Query: 787 -YYGNQQLTEKSDVYSFGVVLLELISGKKP 815
YYG + D +S GV L E++ G P
Sbjct: 222 GYYGRE-----CDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 9e-10
Identities = 39/109 (35%), Positives = 58/109 (53%), Gaps = 5/109 (4%)
Query: 709 LDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 768
LD L ++ AKG+ +L + IHRD+ + NILL K+ DFGL+R D
Sbjct: 211 LDTEDLLSFSYQVAKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRND 267
Query: 769 LTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 815
+ + AR V ++ PE N T +SDV+S+G++L E+ S G P
Sbjct: 268 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSP 316
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 9e-10
Identities = 55/207 (26%), Positives = 98/207 (47%), Gaps = 20/207 (9%)
Query: 621 IGKGSFGSVYYGKMKDGKEV-AVKIMADSCSH--------RTQQFVTEVALLSRIHHRNL 671
IG+GS+ V ++K + + A+K++ + +T++ V E A +H L
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQA----SNHPFL 58
Query: 672 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 731
V L + E + V EY++ G L H +K + R A + + L YLH
Sbjct: 59 VGLHSCFQTESRLFFVIEYVNGGDLM--FHMQRQRKLPEEHARFYSA-EISLALNYLH-- 113
Query: 732 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ 791
GII+RD+K N+LLD K++D+G+ ++ +S GT Y+ PE +
Sbjct: 114 -ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP-GDTTSTFCGTPNYIAPEILRGE 171
Query: 792 QLTEKSDVYSFGVVLLELISGKKPVSV 818
D ++ GV++ E+++G+ P +
Sbjct: 172 DYGFSVDWWALGVLMFEMMAGRSPFDI 198
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 1e-09
Identities = 64/210 (30%), Positives = 102/210 (48%), Gaps = 29/210 (13%)
Query: 621 IGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQ--QFVTEVALLSRIHHRNLVP---- 673
IGKGS+G V G++VA+K + D H + + + E+ LL + H ++V
Sbjct: 8 IGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHI 67
Query: 674 LIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQ---IAHDAAKGLEYLH 729
++ E + I +V+E M + LH + K D LT + + L+Y+H
Sbjct: 68 MLPPSRREFKDIYVVFELMESD-----LHQVI--KANDDLTPEHHQFFLYQLLRALKYIH 120
Query: 730 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL-THI---SSVARGTVGYLDP 785
T + HRD+K NIL + + + K+ DFGL+R A D T I VA T Y P
Sbjct: 121 TA---NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVA--TRWYRAP 175
Query: 786 EYYGN--QQLTEKSDVYSFGVVLLELISGK 813
E G+ + T D++S G + E+++GK
Sbjct: 176 ELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 1e-09
Identities = 39/97 (40%), Positives = 58/97 (59%), Gaps = 7/97 (7%)
Query: 722 AKGLEYLHT-GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI-SSVARGT 779
AKG+E+L + C IHRD+ + NILL N K+ DFGL+R +D ++ AR
Sbjct: 189 AKGMEFLASRKC----IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 244
Query: 780 VGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 815
+ ++ PE ++ T +SDV+SFGV+L E+ S G P
Sbjct: 245 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 281
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 60.5 bits (146), Expect = 1e-09
Identities = 53/211 (25%), Positives = 100/211 (47%), Gaps = 22/211 (10%)
Query: 620 KIGKGSFGSVYYGKMKDG---KEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPL-- 674
K+G+G++G VY K KDG KE A+K + + + E+ALL + H N++ L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI--SMSACREIALLRELKHPNVIALQK 65
Query: 675 IGYCEEEHQRILVYEYMHNG---TLRDRLHGSVNQKPLDWLTRL--QIAHDAAKGLEYLH 729
+ + + L+++Y + ++ N+KP+ + + + G+ YLH
Sbjct: 66 VFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH 125
Query: 730 TGCNPGIIHRDVKSSNILL----DINMRAKVSDFGLSRQAEEDLTHISSV--ARGTVGYL 783
++HRD+K +NIL+ R K++D G +R L ++ + T Y
Sbjct: 126 ANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYR 182
Query: 784 DPE-YYGNQQLTEKSDVYSFGVVLLELISGK 813
PE G + T+ D+++ G + EL++ +
Sbjct: 183 APELLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 2e-09
Identities = 60/241 (24%), Positives = 111/241 (46%), Gaps = 53/241 (21%)
Query: 620 KIGKGSFGSVYYGKMKDGKE-VAVK-IMADSCSHRTQQF----VTEVALLSRIHHRNLVP 673
KIG+G+FG V+ + K K+ VA+K ++ + + + F + E+ +L + H N+V
Sbjct: 19 KIGQGTFGEVFKARHKKTKQIVALKKVLME---NEKEGFPITALREIKILQLLKHENVVN 75
Query: 674 LIGYCEEEHQR--------ILVYEYM-HNGTLRDRLHGSVNQKPLDW-LTRLQ-IAHDAA 722
LI C + LV+E+ H+ L G ++ K + + L+ ++ +
Sbjct: 76 LIEICRTKATPYNRYKGSFYLVFEFCEHD------LAGLLSNKNVKFTLSEIKKVMKMLL 129
Query: 723 KGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR---QAEEDLTHISSVARGT 779
GL Y+H I+HRD+K++NIL+ + K++DFGL+R ++ + + T
Sbjct: 130 NGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVT 186
Query: 780 VGYLDPE-YYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG 838
+ Y PE G + D++ G ++ E+ W RS I +G
Sbjct: 187 LWYRPPELLLGERDYGPPIDMWGAGCIMAEM--------------------WTRSPIMQG 226
Query: 839 D 839
+
Sbjct: 227 N 227
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 2e-09
Identities = 53/204 (25%), Positives = 98/204 (48%), Gaps = 20/204 (9%)
Query: 619 KKIGKGSFGSV--YYGKMKDGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPL 674
K IG G+ G V Y + D + VA+K ++ ++T ++ E+ L+ ++H+N++ L
Sbjct: 23 KPIGSGAQGIVCAAYDAVLD-RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISL 81
Query: 675 IGYCE-----EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 729
+ EE Q + + + + L + ++ + + +L + G+++LH
Sbjct: 82 LNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLC-----GIKHLH 136
Query: 730 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYG 789
+ GIIHRD+K SNI++ + K+ DFGL+R A V T Y PE
Sbjct: 137 SA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV--TRYYRAPEVIL 191
Query: 790 NQQLTEKSDVYSFGVVLLELISGK 813
E D++S G ++ E++ K
Sbjct: 192 GMGYKENVDIWSVGCIMGEMVRHK 215
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 2e-09
Identities = 53/204 (25%), Positives = 98/204 (48%), Gaps = 20/204 (9%)
Query: 619 KKIGKGSFGSV--YYGKMKDGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPL 674
K IG G+ G V Y + + + VA+K ++ ++T ++ E+ L+ ++H+N++ L
Sbjct: 30 KPIGSGAQGIVCAAYDAILE-RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGL 88
Query: 675 IGYCE-----EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 729
+ EE Q + + + + L + ++ + + +L + G+++LH
Sbjct: 89 LNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLC-----GIKHLH 143
Query: 730 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYG 789
+ GIIHRD+K SNI++ + K+ DFGL+R A V T Y PE
Sbjct: 144 SA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV--TRYYRAPEVIL 198
Query: 790 NQQLTEKSDVYSFGVVLLELISGK 813
E D++S G ++ E+I G
Sbjct: 199 GMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 2e-09
Identities = 53/219 (24%), Positives = 99/219 (45%), Gaps = 32/219 (14%)
Query: 619 KKIGKGSFGSVYY----GKMKDGKEVAVKIMADSC---SHRTQQFV-TEVALLSRIHHRN 670
K +G G++G V+ GK A+K++ + +T + TE +L +
Sbjct: 6 KVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSP 65
Query: 671 LVPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK------ 723
+ + Y + ++ L+ +Y+ G + L+ R + D +
Sbjct: 66 FLVTLHYAFQTEAKLHLILDYVSGGEMFTHLY-----------QRDNFSEDEVRFYSGEI 114
Query: 724 --GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVG 781
LE+LH GI++RD+K NILLD ++DFGLS++ + + GT+
Sbjct: 115 ILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIE 171
Query: 782 YLDPEYYGNQQLTEKS-DVYSFGVVLLELISGKKPVSVE 819
Y+ PE + K+ D +S G+++ EL++G P ++E
Sbjct: 172 YMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLE 210
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 3e-09
Identities = 54/219 (24%), Positives = 96/219 (43%), Gaps = 37/219 (16%)
Query: 619 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLI-- 675
+ +G GS G V+ D K VAVK + + + + E+ ++ R+ H N+V +
Sbjct: 11 RPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEV 70
Query: 676 ----GYCEEEHQRIL--------VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK 723
G E L V EYM L + Q PL + +
Sbjct: 71 LGPSGSDLTEDVGSLTELNSVYIVQEYMETD-----LANVLEQGPLSEEHARLFMYQLLR 125
Query: 724 GLEYLHTGCNPGIIHRDVKSSNILLDI-NMRAKVSDFGLSRQAEEDLTHISSVARGTVG- 781
GL+Y+H+ ++HRD+K +N+ ++ ++ K+ DFGL+R + +H ++ G V
Sbjct: 126 GLKYIHSA---NVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTK 182
Query: 782 -------YLDPEYYGNQQLTEKSDVYSFGVVLLELISGK 813
L P Y T+ D+++ G + E+++GK
Sbjct: 183 WYRSPRLLLSPNNY-----TKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 3e-09
Identities = 58/213 (27%), Positives = 102/213 (47%), Gaps = 37/213 (17%)
Query: 619 KKIGKGSFGSVYYGKMKDGKE-VAVKIMADSCSHRTQQ--------FVTEVALLSRIHHR 669
+KIG+G++G VY + + E +A+K + R +Q + E++LL + H
Sbjct: 8 EKIGEGTYGVVYKARDRVTNETIALKKI------RLEQEDEGVPSTAIREISLLKEMQHG 61
Query: 670 NLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA----HDAAKGL 725
N+V L E + LV+EY L L ++ P D+ ++ + +G+
Sbjct: 62 NIVRLQDVVHSEKRLYLVFEY-----LDLDLKKHMDSSP-DFAKNPRLIKTYLYQILRGI 115
Query: 726 EYLHTGCNPGIIHRDVKSSNILLDINMRA-KVSDFGLSRQ---AEEDLTHISSVARGTVG 781
Y H+ ++HRD+K N+L+D A K++DFGL+R TH V T+
Sbjct: 116 AYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTH--EVV--TLW 168
Query: 782 YLDPE-YYGNQQLTEKSDVYSFGVVLLELISGK 813
Y PE G++ + D++S G + E+++ K
Sbjct: 169 YRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 3e-09
Identities = 53/212 (25%), Positives = 101/212 (47%), Gaps = 24/212 (11%)
Query: 620 KIGKGSFGSVYYGKMKDG---KEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPL-- 674
K+G+G++G VY K KDG ++ A+K + + + E+ALL + H N++ L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQK 65
Query: 675 IGYCEEEHQRILVYEYMHNG---TLRDRLHGSVNQKPLDWLTRLQIA---HDAAKGLEYL 728
+ + + L+++Y + ++ N+KP+ L R + + G+ YL
Sbjct: 66 VFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQ-LPRGMVKSLLYQILDGIHYL 124
Query: 729 HTGCNPGIIHRDVKSSNILL----DINMRAKVSDFGLSRQAEEDLTHISSV--ARGTVGY 782
H ++HRD+K +NIL+ R K++D G +R L ++ + T Y
Sbjct: 125 HANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWY 181
Query: 783 LDPE-YYGNQQLTEKSDVYSFGVVLLELISGK 813
PE G + T+ D+++ G + EL++ +
Sbjct: 182 RAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 4e-09
Identities = 35/85 (41%), Positives = 49/85 (57%), Gaps = 1/85 (1%)
Query: 418 IALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSL 476
I L NL GEIP E+ + +L L L N LTGP+P + L +L+ + L N+L+G +
Sbjct: 217 IYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPI 276
Query: 477 PSYMGSLPNLQELHIENNSFVGEIP 501
P + SL L L + +NS GEIP
Sbjct: 277 PPSIFSLQKLISLDLSDNSLSGEIP 301
|
Length = 968 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 5e-09
Identities = 56/199 (28%), Positives = 96/199 (48%), Gaps = 14/199 (7%)
Query: 620 KIGKGSFGSVYYGKMKDGKE-VAVK-IMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 677
K+G+G++ +VY G+ K VA+K I + + EV+LL + H N+V L
Sbjct: 13 KLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 678 CEEEHQRILVYEYMHNGTLR--DRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 735
E LV+EY+ + D S+N + L Q+ +GL Y H
Sbjct: 73 IHTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVK-LFLFQLL----RGLNYCH---RRK 124
Query: 736 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE-YYGNQQLT 794
++HRD+K N+L++ K++DFGL+R A+ T S T+ Y P+ G+ +
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLAR-AKSIPTKTYSNEVVTLWYRPPDILLGSTDYS 183
Query: 795 EKSDVYSFGVVLLELISGK 813
+ D++ G + E+ +G+
Sbjct: 184 TQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 5e-09
Identities = 53/209 (25%), Positives = 94/209 (44%), Gaps = 36/209 (17%)
Query: 620 KIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQ-------FVTEVALLSRIHHRNL 671
K+G+GS+ +VY G+ K G+ VA+K + R + + E +LL + H N+
Sbjct: 12 KLGEGSYATVYKGRSKLTGQLVALKEI------RLEHEEGAPFTAIREASLLKDLKHANI 65
Query: 672 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAA-------KG 724
V L + LV+EY+ D ++ +D H+ +G
Sbjct: 66 VTLHDIIHTKKTLTLVFEYLD----TDL------KQYMDDCGGGLSMHNVRLFLFQLLRG 115
Query: 725 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLD 784
L Y H ++HRD+K N+L+ K++DFGL+R A+ + S T+ Y
Sbjct: 116 LAYCH---QRRVLHRDLKPQNLLISERGELKLADFGLAR-AKSVPSKTYSNEVVTLWYRP 171
Query: 785 PE-YYGNQQLTEKSDVYSFGVVLLELISG 812
P+ G+ + + D++ G + E+ +G
Sbjct: 172 PDVLLGSTEYSTSLDMWGVGCIFYEMATG 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 55/201 (27%), Positives = 92/201 (45%), Gaps = 19/201 (9%)
Query: 621 IGKGSFGSVYYGKMKDGKE-VAVKIMADSCSHRTQQFVT--EVALLSRIHHRNLVPLIGY 677
+G+G++G V + K+ KE VA+K DS + + T E+ +L + N+V L
Sbjct: 9 VGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEA 68
Query: 678 CEEEHQRILVYEYMHNGTLR---DRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 734
+ LV+EY+ L + +G +K ++ +L K + + H
Sbjct: 69 FRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQL------IKAIHWCHKN--- 119
Query: 735 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE--DLTHISSVARGTVGYLDPEYYGNQQ 792
I+HRD+K N+L+ N K+ DFG +R E + + VA T Y PE
Sbjct: 120 DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVA--TRWYRSPELLLGAP 177
Query: 793 LTEKSDVYSFGVVLLELISGK 813
+ D++S G +L EL G+
Sbjct: 178 YGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 1e-08
Identities = 55/206 (26%), Positives = 97/206 (47%), Gaps = 24/206 (11%)
Query: 621 IGKGSFGSVYYGKMKDGKEV-AVKIMADSCSH--------RTQQFVTEVALLSRIHHRNL 671
IG+GS+ V ++K + + A+K++ + +T++ V E A +H L
Sbjct: 3 IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETA----SNHPFL 58
Query: 672 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 731
V L + E + V E++ G L H +K + R A + + L +LH
Sbjct: 59 VGLHSCFQTESRLFFVIEFVSGGDLM--FHMQRQRKLPEEHARFYSA-EISLALNFLHER 115
Query: 732 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA--EEDLTHISSVARGTVGYLDPEYYG 789
GII+RD+K N+LLD K++D+G+ ++ D T S GT Y+ PE
Sbjct: 116 ---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTT---STFCGTPNYIAPEILR 169
Query: 790 NQQLTEKSDVYSFGVVLLELISGKKP 815
+ D ++ GV++ E+++G+ P
Sbjct: 170 GEDYGFSVDWWALGVLMFEMMAGRSP 195
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 1e-08
Identities = 54/200 (27%), Positives = 100/200 (50%), Gaps = 14/200 (7%)
Query: 619 KKIGKGSFGSVYYGKMKDGKE-VAVK-IMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 676
+K+G+G++ +V+ G+ K + VA+K I + + EV+LL + H N+V L
Sbjct: 12 EKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71
Query: 677 YCEEEHQRILVYEYMHNGTLRDRLH--GSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 734
+ LV+EY+ + L+ + G++ + QI +GL Y H
Sbjct: 72 IVHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSMHNVKIFLYQIL----RGLAYCH---RR 123
Query: 735 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE-YYGNQQL 793
++HRD+K N+L++ K++DFGL+R A+ T S T+ Y P+ G+ +
Sbjct: 124 KVLHRDLKPQNLLINERGELKLADFGLAR-AKSVPTKTYSNEVVTLWYRPPDVLLGSSEY 182
Query: 794 TEKSDVYSFGVVLLELISGK 813
+ + D++ G + E+ SG+
Sbjct: 183 STQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 2e-08
Identities = 56/205 (27%), Positives = 93/205 (45%), Gaps = 15/205 (7%)
Query: 616 NFCKKIGKGSFGSVYYGKMKDGK--EVAVKIMADSCSHRTQQ---FVTEVALLSRIHHRN 670
NF + +G GSFG V K+ VA+K S + +Q +E +L+ I+H
Sbjct: 33 NFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPF 92
Query: 671 LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 730
V L G ++E LV E++ G L + + P D A EYL +
Sbjct: 93 CVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRN-KRFPND--VGCFYAAQIVLIFEYLQS 149
Query: 731 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN 790
I++RD+K N+LLD + K++DFG ++ + + GT Y+ PE N
Sbjct: 150 ---LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTYTLC----GTPEYIAPEILLN 202
Query: 791 QQLTEKSDVYSFGVVLLELISGKKP 815
+ +D ++ G+ + E++ G P
Sbjct: 203 VGHGKAADWWTLGIFIYEILVGCPP 227
|
Length = 340 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 2e-08
Identities = 53/216 (24%), Positives = 100/216 (46%), Gaps = 35/216 (16%)
Query: 620 KIGKGSFGSVYYG-KMKDGKEVAVKIMADS-----CSHRTQQFVTEVALLSRIHHRNLVP 673
IG G++G V + GK+VA+K + + + RT + E+ +L H N++
Sbjct: 12 NIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRT---LRELKILRHFKHDNIIA 68
Query: 674 L--IGYCEEEHQR--ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRL---QIAHDAAKGLE 726
+ I + +V + M + L +H +Q + R Q+ +GL+
Sbjct: 69 IRDILRPPGADFKDVYVVMDLMES-DLHHIIHS--DQPLTEEHIRYFLYQLL----RGLK 121
Query: 727 YLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA----EEDLTHISS-VARGTVG 781
Y+H+ +IHRD+K SN+L++ + ++ DFG++R E ++ VA T
Sbjct: 122 YIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVA--TRW 176
Query: 782 YLDPE-YYGNQQLTEKSDVYSFGVVLLELISGKKPV 816
Y PE + T D++S G + E++ G++ +
Sbjct: 177 YRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRRQL 211
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 3e-08
Identities = 50/194 (25%), Positives = 85/194 (43%), Gaps = 24/194 (12%)
Query: 628 SVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLV--------PLIGYCE 679
S GK K + +A ++ A S Q E+ L R++H N++ Y
Sbjct: 184 STNQGKPKCERLIAKRVKAGS--RAAIQLENEILALGRLNHENILKIEEILRSEANTYMI 241
Query: 680 EEHQRILVYEYMHNGTL--RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGII 737
+ +Y +M++ +DR PL TR I +EY+H + +I
Sbjct: 242 TQKYDFDLYSFMYDEAFDWKDR--------PLLKQTR-AIMKQLLCAVEYIH---DKKLI 289
Query: 738 HRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKS 797
HRD+K NI L+ + + + DFG + E++ GTV PE E +
Sbjct: 290 HRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEIT 349
Query: 798 DVYSFGVVLLELIS 811
D++S G++LL+++S
Sbjct: 350 DIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 3e-08
Identities = 56/213 (26%), Positives = 95/213 (44%), Gaps = 17/213 (7%)
Query: 619 KKIGKGSFGSVYYGKMKDGKEVA---VKIMADSCSHRTQ-QFVTEVALLSRIHHRNLVPL 674
++IG G FG V ++ VA VK + + S + Q +F+ + + H N++
Sbjct: 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQC 60
Query: 675 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQ-IAHDAAKGLEYLHTGCN 733
+G C E +LV+EY G L+ L + L LQ +A + A G+ ++H
Sbjct: 61 LGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH---K 117
Query: 734 PGIIHRDVKSSNILLDINMRAKVSDFGLS-RQAEEDLTHISSVARGTVGYLDPEYYGNQQ 792
+H D+ N L ++ KV D+G+ + +ED + +L PE G
Sbjct: 118 HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFH 177
Query: 793 -------LTEKSDVYSFGVVLLELI-SGKKPVS 817
T+ S+V++ GV L EL + +P S
Sbjct: 178 GGLITAEQTKPSNVWALGVTLWELFENAAQPYS 210
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 54.9 bits (133), Expect = 5e-08
Identities = 41/145 (28%), Positives = 63/145 (43%), Gaps = 15/145 (10%)
Query: 685 ILVYEYMHNGTLRDRLHGSVNQKPLDW-LTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKS 743
+L+ +Y+ +G L D L + L + I + L LH IIH D+K
Sbjct: 85 VLIMDYIKDGDLFDLLK---KEGKLSEAEVKK-IIRQLVEALNDLH---KHNIIHNDIKL 137
Query: 744 SNILLDINM-RAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSF 802
N+L D R + D+GL + + S GT+ Y PE D ++
Sbjct: 138 ENVLYDRAKDRIYLCDYGLCK-----IIGTPSCYDGTLDYFSPEKIKGHNYDVSFDWWAV 192
Query: 803 GVVLLELISGKKPVSVEDFGAELNI 827
GV+ EL++GK P ED EL++
Sbjct: 193 GVLTYELLTGKHPF-KEDEDEELDL 216
|
Length = 267 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 6e-08
Identities = 32/94 (34%), Positives = 51/94 (54%), Gaps = 1/94 (1%)
Query: 420 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPS 478
LS +L GEIP + ++ L L L N TG +P ++ L L+++ L +N+ +G +P
Sbjct: 291 LSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPK 350
Query: 479 YMGSLPNLQELHIENNSFVGEIPPALLTGKVIFK 512
+G NL L + N+ GEIP L + +FK
Sbjct: 351 NLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFK 384
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 6e-08
Identities = 30/90 (33%), Positives = 51/90 (56%), Gaps = 1/90 (1%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNE 471
P + + LS L GEIP ++ + +L L L GN L G +P ++ L L + L +N+
Sbjct: 140 PNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQ 199
Query: 472 LTGSLPSYMGSLPNLQELHIENNSFVGEIP 501
L G +P +G + +L+ +++ N+ GEIP
Sbjct: 200 LVGQIPRELGQMKSLKWIYLGYNNLSGEIP 229
|
Length = 968 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 7e-08
Identities = 54/200 (27%), Positives = 94/200 (47%), Gaps = 30/200 (15%)
Query: 694 GTLRDRLHGSVNQKP-LDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM 752
T RD L +N+ P L ++ + ++ A G+E+L + +HRD+ + N+L+
Sbjct: 223 RTRRDTL---INESPALSYMDLVGFSYQVANGMEFL---ASKNCVHRDLAARNVLICEGK 276
Query: 753 RAKVSDFGLSRQAEEDLTHISSVARGT----VGYLDPEYYGNQQLTEKSDVYSFGVVLLE 808
K+ DFGL+R D +IS +G+ + ++ PE N T SDV+SFG++L E
Sbjct: 277 LVKICDFGLARDIMRDSNYIS---KGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWE 333
Query: 809 LIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQC 867
+ + G P EL + + IK+G + P + I E+ +C
Sbjct: 334 IFTLGGTPYP------ELPMNEQFYNAIKRG--YRMAKPAHASD-------EIYEIMQKC 378
Query: 868 VEQRGFSRPKMQEIVLAIQD 887
E++ RP ++V + D
Sbjct: 379 WEEKFEIRPDFSQLVHLVGD 398
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 7e-08
Identities = 59/212 (27%), Positives = 102/212 (48%), Gaps = 28/212 (13%)
Query: 619 KKIGKGSFGSVYYGKMKD-GKEVAVKI----MADSCSHRTQQFVTEVALLSRIHHRN-LV 672
+KIG+G++G VY + K+ GK VA+K M + T + E++LL + +V
Sbjct: 7 EKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTA--LREISLLQMLSESIYIV 64
Query: 673 PLIG--YCEEEHQRI---LVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGL 725
L+ + EE++ + LV+EY+ + L+ + +G +PL T + KG+
Sbjct: 65 RLLDVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGV 123
Query: 726 EYLHTGCNPGIIHRDVKSSNILLD-INMRAKVSDFGLSRQAEEDL---THISSVARGTVG 781
+ H G++HRD+K N+L+D K++D GL R + TH V T+
Sbjct: 124 AHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTH-EIV---TLW 176
Query: 782 YLDPE-YYGNQQLTEKSDVYSFGVVLLELISG 812
Y PE G+ + D++S G + E+
Sbjct: 177 YRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 8e-08
Identities = 36/108 (33%), Positives = 60/108 (55%), Gaps = 12/108 (11%)
Query: 709 LDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 768
L L L + A+G+E+L + +HRD+ + N+LL K+ DFGL+R D
Sbjct: 234 LTTLDLLSFTYQVARGMEFL---ASKNCVHRDLAARNVLLAQGKIVKICDFGLAR----D 286
Query: 769 LTHISS-VARGT----VGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS 811
+ H S+ V++G+ V ++ PE + T SDV+S+G++L E+ S
Sbjct: 287 IMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 9e-08
Identities = 55/208 (26%), Positives = 94/208 (45%), Gaps = 37/208 (17%)
Query: 636 DGKEVAVKIMADSCSHR--TQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 693
+G+E+ V + SHR F +L+S++ H +L + G C + I+V E++ +
Sbjct: 41 NGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEH 100
Query: 694 GTL-----RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL 748
G L +++ P+ W ++ +A A L YL + ++H +V + NILL
Sbjct: 101 GPLDVCLRKEKGR-----VPVAW--KITVAQQLASALSYLE---DKNLVHGNVCAKNILL 150
Query: 749 DINMRA-------KVSDFGLSRQAEEDLTHISSVARGTVGYLDPE-YYGNQQLTEKSDVY 800
A K+SD G+S A L+ V R + ++ PE G L+ +D +
Sbjct: 151 ARLGLAEGTSPFIKLSDPGVSFTA---LSREERVER--IPWIAPECVPGGNSLSTAADKW 205
Query: 801 SFGVVLLEL-------ISGKKPVSVEDF 821
SFG LLE+ + + P E F
Sbjct: 206 SFGTTLLEICFDGEVPLKERTPSEKERF 233
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 1e-07
Identities = 56/206 (27%), Positives = 87/206 (42%), Gaps = 39/206 (18%)
Query: 619 KKIGKGSFGSVYYGKMKDGKE--VAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPL-- 674
K + GS G V+ K G+ V +KI + + E LL ++H +++ +
Sbjct: 72 KTLTPGSEGRVFVAT-KPGQPDPVVLKIGQKGTT------LIEAMLLQNVNHPSVIRMKD 124
Query: 675 ------IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYL 728
I H +Y Y+ T R R PL L I +GL YL
Sbjct: 125 TLVSGAITCMVLPHYSSDLYTYL---TKRSR--------PLPIDQALIIEKQILEGLRYL 173
Query: 729 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR---QAEEDLTHISSVARGTVGYLDP 785
H IIHRDVK+ NI ++ + + D G ++ A L +A GTV P
Sbjct: 174 HA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFL----GLA-GTVETNAP 225
Query: 786 EYYGNQQLTEKSDVYSFGVVLLELIS 811
E + K+D++S G+VL E+++
Sbjct: 226 EVLARDKYNSKADIWSAGIVLFEMLA 251
|
Length = 357 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 2e-07
Identities = 30/92 (32%), Positives = 49/92 (53%), Gaps = 1/92 (1%)
Query: 414 RITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNEL 472
R+ + LS G +P +L ++ L +L L N L+G +PD +S L + L +N+L
Sbjct: 476 RLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQL 535
Query: 473 TGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 504
+G +P+ +P L +L + N GEIP L
Sbjct: 536 SGQIPASFSEMPVLSQLDLSQNQLSGEIPKNL 567
|
Length = 968 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 2e-07
Identities = 63/275 (22%), Positives = 107/275 (38%), Gaps = 42/275 (15%)
Query: 619 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPL-IGY 677
K IG G FG VY + + + +A + + V E + + I+ + + L
Sbjct: 18 KLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNI 77
Query: 678 CEEEHQRILVY---------EYMHNGTLRDRLHGSVNQ---------KPLDWLTRLQIAH 719
+H I Y + L ++L + + K L I
Sbjct: 78 HNIDHLGIPKYYGCGSFKRCRMYYRFILLEKLVENTKEIFKRIKCKNKKL----IKNIMK 133
Query: 720 DAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS------ 773
D LEY+H GI H D+K NI++D N R + D+G++ HI
Sbjct: 134 DMLTTLEYIHEH---GISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQK 190
Query: 774 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARS 833
+ RGT+ Y + + +T + D+ S G +L+ + + FG N++H A
Sbjct: 191 DLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKW--AGIKLPWKGFGHNGNLIHAA-- 246
Query: 834 MIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCV 868
K D I + G +KI++ + I+CV
Sbjct: 247 ---KCDFIKRLHE---GKIKIKNANKFIYDFIECV 275
|
Length = 294 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 3e-07
Identities = 30/87 (34%), Positives = 47/87 (54%), Gaps = 5/87 (5%)
Query: 420 LSGKNLKGEIPP-ELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLP 477
LS N G IP + N+E L L N L+G +P D+ L+++ L N L G +P
Sbjct: 125 LSNNNFTGSIPRGSIPNLETLD---LSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIP 181
Query: 478 SYMGSLPNLQELHIENNSFVGEIPPAL 504
+ + +L +L+ L + +N VG+IP L
Sbjct: 182 NSLTNLTSLEFLTLASNQLVGQIPREL 208
|
Length = 968 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 3e-07
Identities = 57/215 (26%), Positives = 100/215 (46%), Gaps = 32/215 (14%)
Query: 620 KIGKGSFGSVYYGKMKD----GKEVAVKIMADSCSHRTQQFVT--EVALLSRIH---HRN 670
+IG+G++G V+ K +D G+ VA+K + T EVA+L + H N
Sbjct: 8 EIGEGAYGKVF--KARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPN 65
Query: 671 LVPLIGYC-----EEEHQRILVYEYMHNG--TLRDRLH--GSVNQKPLDWLTRLQIAHDA 721
+V L C + E + LV+E++ T D++ G + D + +L
Sbjct: 66 VVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQL------ 119
Query: 722 AKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVG 781
+GL++LH+ ++HRD+K NIL+ + + K++DFGL+R + T+
Sbjct: 120 LRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYS--FQMALTSVVVTLW 174
Query: 782 YLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPV 816
Y PE D++S G + E+ +KP+
Sbjct: 175 YRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPL 208
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 3e-07
Identities = 50/178 (28%), Positives = 78/178 (43%), Gaps = 22/178 (12%)
Query: 670 NLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 729
N+V L Y E LV ++ G L + P + + R A + L+ LH
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHI-SKFLNIPEECVKRW--AAEMVVALDALH 102
Query: 730 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE--DLTHISSVARGTVGYLDPEY 787
GI+ RD+ +NILLD +++ F + E+ D + ++ Y PE
Sbjct: 103 ---REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM------YCAPEV 153
Query: 788 YGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFG----AELNIVHW----ARSMIKK 837
G + TE D +S G +L EL++GK V G LNI W ARS++++
Sbjct: 154 GGISEETEACDWWSLGAILFELLTGKTLVECHPSGINTHTTLNIPEWVSEEARSLLQQ 211
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 4e-07
Identities = 34/105 (32%), Positives = 50/105 (47%)
Query: 410 TTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLEN 469
T P + + +S NL+G I +M +L L L N G LPD L + L
Sbjct: 425 TKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGSKRLENLDLSR 484
Query: 470 NELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYD 514
N+ +G++P +GSL L +L + N GEIP L + K + D
Sbjct: 485 NQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLD 529
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 6e-07
Identities = 34/87 (39%), Positives = 45/87 (51%), Gaps = 1/87 (1%)
Query: 415 ITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELT 473
+T + LS NL GEIP L + L +L L N L G +P + LR V L++N +
Sbjct: 358 LTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFS 417
Query: 474 GSLPSYMGSLPNLQELHIENNSFVGEI 500
G LPS LP + L I NN+ G I
Sbjct: 418 GELPSEFTKLPLVYFLDISNNNLQGRI 444
|
Length = 968 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 1e-06
Identities = 53/206 (25%), Positives = 91/206 (44%), Gaps = 26/206 (12%)
Query: 621 IGKGSFGSVYYGKMKDGKE-VAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCE 679
IG GSFG VY D E VA+K + ++ + E+ ++ ++H N++ L Y
Sbjct: 74 IGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNR----ELLIMKNLNHINIIFLKDYYY 129
Query: 680 EEHQRI--------LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 731
E + +V E++ + H + N L ++ + L Y+H+
Sbjct: 130 TECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK 189
Query: 732 CNPGIIHRDVKSSNILLDINMRA-KVSDFGLSRQ---AEEDLTHISSVARGTVGYLDPE- 786
I HRD+K N+L+D N K+ DFG ++ + +++I S Y PE
Sbjct: 190 F---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRF-----YRAPEL 241
Query: 787 YYGNQQLTEKSDVYSFGVVLLELISG 812
G T D++S G ++ E+I G
Sbjct: 242 MLGATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 1e-06
Identities = 56/223 (25%), Positives = 100/223 (44%), Gaps = 42/223 (18%)
Query: 621 IGKGSFGSVYYGKMKD-----------GKEVAVKIMADSCSHR--TQQFVTEVALLSRIH 667
+G+G+ +Y G + KE+ V + SHR + F +++ ++
Sbjct: 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62
Query: 668 HRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEY 727
H+++V L G C + + I+V E++ G L +H + W + ++A A L Y
Sbjct: 63 HKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPW--KFKVAKQLASALSY 120
Query: 728 LHTGCNPGIIHRDVKSSNILL-------DINMRAKVSDFG-----LSRQAEEDLTHISSV 775
L + ++H +V + NILL + K+SD G LSRQ E + I +
Sbjct: 121 LE---DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQ--ECVERIPWI 175
Query: 776 ARGTVGYLDPE-YYGNQQLTEKSDVYSFGVVLLEL-ISGKKPV 816
A PE ++ L+ +D +SFG L E+ +G+ P+
Sbjct: 176 A--------PECVEDSKNLSIAADKWSFGTTLWEICYNGEIPL 210
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 1e-06
Identities = 52/186 (27%), Positives = 81/186 (43%), Gaps = 23/186 (12%)
Query: 658 TEVALLSRIHHRNLVPLI-GYCEEEHQRILVYEYMHN-GTLRDRLHGSVNQKPLDWLTRL 715
E+ +L I HR ++ LI Y + +++ +Y + T DR PL +
Sbjct: 135 REIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKCDLFTYVDRS------GPLPLEQAI 188
Query: 716 QIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSV 775
I + L YLH GIIHRDVK+ NI LD A + DFG + + + H +
Sbjct: 189 TIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDA---HPDTP 242
Query: 776 A----RGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIV-HW 830
GT+ PE K+D++S G+VL E+ + FG ++
Sbjct: 243 QCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTL----FGKQVKSSSSQ 298
Query: 831 ARSMIK 836
RS+I+
Sbjct: 299 LRSIIR 304
|
Length = 392 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 1e-06
Identities = 61/245 (24%), Positives = 96/245 (39%), Gaps = 56/245 (22%)
Query: 619 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFV---TEVALLSRIHHRNLVPL 674
K IG+G+FG V + KD G A+KI+ + +Q E +L +V +
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKM 66
Query: 675 IGYCEEEHQRILVYEYMHNGTL------RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYL 728
+++ L+ E++ G + +D L Q ++ +A DA L
Sbjct: 67 FYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQF---YIAETVLAIDAIHQL--- 120
Query: 729 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGL--------------------------- 761
G IHRD+K N+LLD K+SDFGL
Sbjct: 121 ------GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQ 174
Query: 762 ----SRQAEEDLTHISSVARGTVG---YLDPEYYGNQQLTEKSDVYSFGVVLLELISGKK 814
R+AE + +A TVG Y+ PE + + D +S GV++ E++ G
Sbjct: 175 NMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234
Query: 815 PVSVE 819
P E
Sbjct: 235 PFCSE 239
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 1e-06
Identities = 42/166 (25%), Positives = 67/166 (40%), Gaps = 47/166 (28%)
Query: 712 LTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGL---------- 761
L R IA + +E +H G IHRD+K NIL+D + K++DFGL
Sbjct: 102 LARFYIA-ELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157
Query: 762 --------SRQ---------AEEDLTHISSVAR---------------GTVGYLDPEYYG 789
RQ +E D + + R GT Y+ PE
Sbjct: 158 KYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLL 217
Query: 790 NQQLTEKSDVYSFGVVLLELISGKKPVSVED-FGAELNIVHWARSM 834
T+ D +S GV+L E++ G+ P + +L +++W ++
Sbjct: 218 RTGYTQLCDWWSVGVILYEMLVGQPPFLADTPAETQLKVINWETTL 263
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 2e-06
Identities = 33/99 (33%), Positives = 51/99 (51%), Gaps = 13/99 (13%)
Query: 410 TTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-------MSRLIDL 462
T+ PR+ + L GEIP L LT L L N LTG +P+ + +LI
Sbjct: 329 TSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLI-- 386
Query: 463 RIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIP 501
L +N L G +P +G+ +L+ + +++NSF GE+P
Sbjct: 387 ----LFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELP 421
|
Length = 968 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 2e-06
Identities = 48/193 (24%), Positives = 91/193 (47%), Gaps = 22/193 (11%)
Query: 637 GKEVAVK-IMADSCSHRTQQFV-TEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNG 694
G+ V V+ I ++C++ F+ E+ + +H N+VP +++ +V +M G
Sbjct: 25 GEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYG 84
Query: 695 TLRDRLHGSVNQKPLDWLTRLQIAH---DAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN 751
+ +D + +D ++ L IA+ K L+Y+H + G +HR VK+S+IL+ ++
Sbjct: 85 SAKDLICTHF----MDGMSELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVD 137
Query: 752 ----MRAKVSDFGLSRQAEEDLTHISSVARGTVG---YLDPEYYGN--QQLTEKSDVYSF 802
+ S+ + + L + + +V +L PE Q KSD+YS
Sbjct: 138 GKVYLSGLRSNLSMINHGQR-LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSV 196
Query: 803 GVVLLELISGKKP 815
G+ EL +G P
Sbjct: 197 GITACELANGHVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 4e-06
Identities = 59/239 (24%), Positives = 95/239 (39%), Gaps = 44/239 (18%)
Query: 619 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQ---FVTEVALLSRIHHRNLVPL 674
K IG+G+FG V + KD G A+KI+ + +Q E +L +V +
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKM 66
Query: 675 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 734
+++ L+ E++ G + L D LT + A+ + + +
Sbjct: 67 FYSFQDKLNLYLIMEFLPGGDMMTLLMKK------DTLTEEETQFYIAETVLAIDSIHQL 120
Query: 735 GIIHRDVKSSNILLDINMRAKVSDFGL-------------------------------SR 763
G IHRD+K N+LLD K+SDFGL R
Sbjct: 121 GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKR 180
Query: 764 QAEEDLTHISSVARGTVG---YLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVE 819
+AE + +A TVG Y+ PE + + D +S GV++ E++ G P E
Sbjct: 181 KAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSE 239
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 6e-06
Identities = 63/258 (24%), Positives = 98/258 (37%), Gaps = 68/258 (26%)
Query: 619 KKIGKGSFGSV-YYGKMKDGKEVAVKIMADSCSHRTQQFV---TEVALLSRIHHRNLVPL 674
K IGKG+FG V K GK A+K + S + Q E +L+ +V L
Sbjct: 7 KVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSL 66
Query: 675 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDW------LTRLQIAHDAAKGLEYL 728
++ L+ E++ G L L + + +TR +A + +E +
Sbjct: 67 YYSFQDAQYLYLIMEFLPGGDLMTML--------IKYDTFSEDVTRFYMA-ECVLAIEAV 117
Query: 729 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS---------------RQAEEDLTHIS 773
H G IHRD+K NIL+D K+SDFGLS Q + + I
Sbjct: 118 H---KLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRID 174
Query: 774 S----------------------------VARGTVG---YLDPEYYGNQQLTEKSDVYSF 802
+ +A TVG Y+ PE + Q ++ D +S
Sbjct: 175 NRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL 234
Query: 803 GVVLLELISGKKPVSVED 820
G ++ E + G P E+
Sbjct: 235 GAIMFECLIGWPPFCSEN 252
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 1e-05
Identities = 30/86 (34%), Positives = 47/86 (54%), Gaps = 1/86 (1%)
Query: 420 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPS 478
L N G+IP L ++ L L L N +G +P ++ + +L ++ L N LTG +P
Sbjct: 315 LFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPE 374
Query: 479 YMGSLPNLQELHIENNSFVGEIPPAL 504
+ S NL +L + +NS GEIP +L
Sbjct: 375 GLCSSGNLFKLILFSNSLEGEIPKSL 400
|
Length = 968 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 1e-04
Identities = 36/150 (24%), Positives = 61/150 (40%), Gaps = 53/150 (35%)
Query: 735 GIIHRDVKSSNILLDINMRAKVSDFGL--------------------------------- 761
G IHRD+K NIL+D++ K++DFGL
Sbjct: 121 GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDV 180
Query: 762 ----------------SRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVV 805
++Q + L H S V GT Y+ PE + T+ D +S GV+
Sbjct: 181 SNCRCGDRLKTLEQRATKQHQRCLAH-SLV--GTPNYIAPEVLLRKGYTQLCDWWSVGVI 237
Query: 806 LLELISGKKP-VSVEDFGAELNIVHWARSM 834
L E++ G+ P ++ +L +++W ++
Sbjct: 238 LFEMLVGQPPFLAPTPTETQLKVINWENTL 267
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 2e-04
Identities = 57/212 (26%), Positives = 89/212 (41%), Gaps = 23/212 (10%)
Query: 620 KIGKG--SFGSVYYGK-MKDGKEVAVKIM-ADSCS-HRTQQFVTEVALLSRIHHRNLVPL 674
+IG+G + SVY + G V V+I ++C+ + EV L H N++
Sbjct: 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTS 64
Query: 675 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 734
++ +M G+ L + + L I A +GL YLH
Sbjct: 65 WTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIG-NILFGALRGLNYLHQN--- 120
Query: 735 GIIHRDVKSSNILLDINMRAKVSDFGLSR--------QAEEDLTHISSVARGTVGYLDPE 786
G IHR++K+S+IL I+ VS GLS Q + + + + +L PE
Sbjct: 121 GYIHRNIKASHIL--ISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPE 178
Query: 787 YYGNQQL---TEKSDVYSFGVVLLELISGKKP 815
Q L KSD+YS G+ EL +G+ P
Sbjct: 179 LL-RQDLYGYNVKSDIYSVGITACELATGRVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 2e-04
Identities = 36/147 (24%), Positives = 58/147 (39%), Gaps = 47/147 (31%)
Query: 735 GIIHRDVKSSNILLDINMRAKVSDFGLS------------------RQAEEDLT------ 770
G IHRD+K NIL+D + K++DFGL RQ D +
Sbjct: 121 GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDP 180
Query: 771 -------------------HISSVARGTVG---YLDPEYYGNQQLTEKSDVYSFGVVLLE 808
H +A VG Y+ PE T+ D +S GV+L E
Sbjct: 181 ANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 240
Query: 809 LISGKKP-VSVEDFGAELNIVHWARSM 834
++ G+ P ++ ++ +++W S+
Sbjct: 241 MLVGQPPFLAQTPLETQMKVINWQTSL 267
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 2e-04
Identities = 26/99 (26%), Positives = 43/99 (43%), Gaps = 3/99 (3%)
Query: 715 LQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISS 774
L I + ++YLH IIHRD+K+ NI ++ + DFG + + +
Sbjct: 185 LAIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYY 241
Query: 775 VARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGK 813
GT+ PE D++S G+VL E+ +
Sbjct: 242 GWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 4e-04
Identities = 32/149 (21%), Positives = 54/149 (36%), Gaps = 17/149 (11%)
Query: 618 CKKIGKGSFGSVYYGKMKDGKE-VAVKIMADSCSHRTQQFVTEVALLSRIHHRNL-VP-L 674
K + G VY + E +KI + EVA+L + + L VP +
Sbjct: 3 IKLLKGGLTNRVY--LLGTKDEDYVLKINPSR--EKGADREREVAILQLLARKGLPVPKV 58
Query: 675 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 734
+ E + L+ E++ TL + + IA A+ L LH
Sbjct: 59 LASGESDGWSYLLMEWIEGETL----------DEVSEEEKEDIAEQLAELLAKLHQLPLL 108
Query: 735 GIIHRDVKSSNILLDINMRAKVSDFGLSR 763
+ H D+ NIL+D + D+ +
Sbjct: 109 VLCHGDLHPGNILVDDGKILGIIDWEYAG 137
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 7e-04
Identities = 29/105 (27%), Positives = 48/105 (45%), Gaps = 8/105 (7%)
Query: 707 KPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 766
+PL +A ++Y+H GIIHRD+K+ N+L++ + DFG + A
Sbjct: 255 RPLGLAQVTAVARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAACFAR 311
Query: 767 EDLTHISSVARGTVGYLD---PEYYGNQQLTEKSDVYSFGVVLLE 808
+ + G G +D PE T D++S G+V+ E
Sbjct: 312 GSWS--TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.002
Identities = 28/89 (31%), Positives = 46/89 (51%), Gaps = 10/89 (11%)
Query: 617 FCKKIGKGSFGSVY------YGKMKDGKEVAVKIMADSCSHRTQQ--FVTEVALLSRI-H 667
F K +G G+FG V GK + VAVK M + +H ++ ++E+ +LS +
Sbjct: 42 FGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVK-MLKASAHTDEREALMSELKILSHLGQ 100
Query: 668 HRNLVPLIGYCEEEHQRILVYEYMHNGTL 696
H+N+V L+G C +++ EY G L
Sbjct: 101 HKNIVNLLGACTHGGPVLVITEYCCYGDL 129
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 37.1 bits (87), Expect = 0.002
Identities = 20/60 (33%), Positives = 30/60 (50%), Gaps = 3/60 (5%)
Query: 439 LTELWLDGNFLTGPLPDMS--RLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSF 496
L L L N LT +PD + L +L+++ L N LT P LP+L+ L + N+
Sbjct: 2 LKSLDLSNNRLTV-IPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 0.003
Identities = 30/83 (36%), Positives = 46/83 (55%), Gaps = 2/83 (2%)
Query: 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNE 471
+ + LSG N ++PPE++ + AL EL L N + L +S L +L + L NN+
Sbjct: 185 LSNLNNLDLSG-NKISDLPPEIELLSALEELDLSNNSIIELLSSLSNLKNLSGLELSNNK 243
Query: 472 LTGSLPSYMGSLPNLQELHIENN 494
L LP +G+L NL+ L + NN
Sbjct: 244 LE-DLPESIGNLSNLETLDLSNN 265
|
Length = 394 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 935 | |||
| PLN03150 | 623 | hypothetical protein; Provisional | 100.0 | |
| PF12819 | 347 | Malectin_like: Carbohydrate-binding protein of the | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.98 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.98 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.98 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 99.98 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.98 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 99.98 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.98 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.98 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.98 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.98 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.98 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.98 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.98 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.98 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.98 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.98 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.98 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.98 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.98 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.98 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.97 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.97 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.97 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.97 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.97 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.97 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.97 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.97 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.97 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.97 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.97 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.97 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.97 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.97 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.97 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.97 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.97 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.97 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.97 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.97 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.97 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.97 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.97 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.97 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.97 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.97 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.97 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.97 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.97 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.97 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.97 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.97 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.97 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.97 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.97 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.97 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.97 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.97 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.97 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.97 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.96 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.96 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.96 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.96 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.96 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.96 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.96 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.96 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.96 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.96 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.96 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.96 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.95 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.95 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.95 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.95 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.95 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.95 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.95 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.95 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.94 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.94 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.94 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.94 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.94 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.93 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.93 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.92 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.92 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.92 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.91 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.91 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.88 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.88 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.88 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.86 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.86 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.86 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.84 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.83 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.82 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.79 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.78 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.78 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.76 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.74 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.73 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.71 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.71 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.7 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.67 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.67 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.65 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.64 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.61 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.61 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.57 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.57 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.56 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.55 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.51 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.48 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.45 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.43 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.4 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.34 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.34 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.3 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.15 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.14 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.11 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.08 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.06 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.99 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 98.97 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 98.96 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.9 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 98.85 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.79 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.76 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.71 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.66 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.63 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.62 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 98.6 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.53 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 98.5 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 98.49 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.48 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.45 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.38 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.38 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 98.38 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 98.36 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.31 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.29 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.27 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 98.25 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.22 | |
| PF11721 | 174 | Malectin: Di-glucose binding within endoplasmic re | 98.18 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 98.1 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 98.09 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.09 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.08 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.08 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 98.06 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 98.06 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 98.02 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 97.99 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 97.96 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 97.95 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 97.94 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 97.92 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.89 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.85 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 97.83 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 97.78 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.78 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.77 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.74 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 97.73 | |
| PF12799 | 44 | LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_ | 97.72 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 97.7 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 97.68 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.63 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.61 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 97.61 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.58 |
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-83 Score=764.63 Aligned_cols=536 Identities=24% Similarity=0.396 Sum_probs=417.4
Q ss_pred HHHHHHHHHHhhhcccCCeEEEecCCCCCccCCCCCeEEecCCccccCCceeeecCCCCCcccccccccccC-CCCcceE
Q 002336 7 FLVIYLLFLSSVVSQVTEFISIDCGSTSNYTDPSTGLAWISDIGIMNNGKSVKVENPSGNWMQYRTRRDLPI-DNKKYCY 85 (935)
Q Consensus 7 ~~~~~~~~~~~~~~~~~~~~~idcg~~~~~~~~~~~~~~~~d~~~~~~g~~~~~~~~~~~~~~~~tlr~fp~-~~~~~cy 85 (935)
.+..+++++.+.+.++.++++||||++++++.+.+|++|++|..|+. |....+..+....+++.|+|+||. .|++|||
T Consensus 7 ~~~~~~~~~~~~~~~~~~~~~I~CGs~~~~~~d~~~~~w~~D~~~~~-~~~~~~~~~~~~~~~~~t~R~F~~~~g~~~cY 85 (623)
T PLN03150 7 AASALLAVLASLASPEPFTMRISCGARVNVRTAPTNTLWYKDFAYTG-GIPANATRPSFIAPPLKTLRYFPLSDGPENCY 85 (623)
T ss_pred HHHHHHHhhcccccCCCccEEEeCCCCCCcccCCCCCEEcCCccccc-CccccccCcccccchhhccccCCcccccccce
Confidence 33444566667777788999999999988843368999999999854 454444445556788999999996 5899999
Q ss_pred EeeecCCceeEEEEEeeecCCCCCCCCCeEEEEEcCceeEEEEec--CCccceEEEEEEecCCCCcccceeccCCCCcee
Q 002336 86 NLITKERRRYLVRATFQYGSLGSEASYPKFQLYLDATLWSTVTVL--DASRVYAKEMIIRAPSDSIDVCICCAVTGSPFI 163 (935)
Q Consensus 86 ~l~~~~~~~ylvr~~~~yg~yd~~~~~p~fd~~~~~~~w~~v~~~--~~~~~~~~e~~~~~~~~~~~vcl~~~~~~~pfi 163 (935)
+||+++++|||||++|+|||||+++++|.|||++|||+|.+|... ..+...++|+|+.+++++++|||+++++|+|||
T Consensus 86 ~~~~~~~g~ylVRl~F~~~~y~~~~~~~~Fdv~~~~~~~~tv~~~~~~~~~~v~~E~i~~~~~~~l~vcf~~~~~~~pFI 165 (623)
T PLN03150 86 NINRVPKGHYSVRVFFGLVAEPNFDSEPLFDVSVEGTQISSLKSGWSSHDEQVFAEALVFLTDGSASICFHSTGHGDPAI 165 (623)
T ss_pred EeeecCCCcEEEEEEeecCCcCCCCCCCceEEEECcEEEEEEecCcccCCCcEEEEEEEEecCCcEEEEEecCCCCCCce
Confidence 999999999999999999999999999999999999999999753 234456789999999999999999999999999
Q ss_pred eeeeeeecCCCCCcccc--cccceEEEEEeeecCCCC-CCCccCCCCCC--CCccccCCCCCCCceeccCCceeeecccc
Q 002336 164 STLELRPLNLSMYATDF--EDNFFLKVAARVNFGALT-KDALRYPDDPY--DRIWDSDLDRRPNFVVGAASGTVRINTTK 238 (935)
Q Consensus 164 s~le~~~l~~~~y~~~~--~~~~~l~l~~R~~~g~~~-~~~~~y~~d~~--~R~W~~~~~~~~~~~~~~~~~~~~i~~~~ 238 (935)
|+||||||++++|.... +.+.+|.++.|+|+|+.+ ...+|||+|+| ||+|.|+.+... +.+..+++..
T Consensus 166 s~iEv~~l~~~~y~~~~~~~~~~~L~~~~R~n~G~~~~~~~~d~~~D~~~~dR~W~~d~~~~~-------~~~~~~st~~ 238 (623)
T PLN03150 166 LSIEILQVDDKAYNFGPSWGQGVILRTAKRLSCGAGKSKFDEDYSGDHWGGDRFWNRMQTFGS-------GSDQAISTEN 238 (623)
T ss_pred eEEEEEEcCcccccccccccCceEEEEEEEEEecCcccccccCCCCCcccCccccCcCcccCC-------Cccccccccc
Confidence 99999999999995432 346679999999999864 24699999999 999998754211 1233455555
Q ss_pred cccC--CCCCCChHhHhhhceeccCc--eEEEeecCCCCccccceeeeeccccC-cCCCcceEEEeecCcccccccceee
Q 002336 239 NIET--RTREYPPVKVMQTAVVGTEG--VLSYRLNLEDFPANARAFAYFAEIQD-LGPSETRKFKLEQPYFADYSNAVVN 313 (935)
Q Consensus 239 ~i~~--~~~~~pP~~v~qtA~~~~~~--~~~~~~~~~~~~~~~~~~lyFae~~~-~~~~~~R~F~v~~~~~~~~~~~~~~ 313 (935)
.|+. ..++.+|+.|||||.+..++ .++|.|++ +....|+++|||||++. ....++|+|||.++..... ..++
T Consensus 239 ~I~~~~~~~~~~P~~VyqTA~~~~~~~~~lty~~~v-~~~~~Y~VrLhFaEi~~~~~~~~~R~F~V~ing~~~~--~~~d 315 (623)
T PLN03150 239 VIKKASNAPNFYPESLYQSALVSTDTQPDLSYTMDV-DPNRNYSVWLHFAEIDNSITAEGKRVFDVLINGDTAF--KDVD 315 (623)
T ss_pred ccccccCCCccChHHHhhhhccccCCCCceEEEeec-CCCCCEEEEEEEEeccCccCCCceEEEEEEECCEEee--cccC
Confidence 5542 35677899999999877553 46666664 23457888999999984 5677999999966653322 2234
Q ss_pred eeccCCCce-eeecccc-ceeeeeeEEEEEeeecCCCcchhhhhhhhhceeecccccCchhhHHHHHHHHhhcCCCCCCC
Q 002336 314 IAENANGSY-TLYEPSY-MNVTLNFVLSFSFVKTRDSTLGPLLNAIEISKYQKIAAKTEWQDVMVLEALRSISDESERTN 391 (935)
Q Consensus 314 ~~~~~~~~~-~~~~~~~-~~~~~~~~~~~~~~~~~~s~l~p~ina~e~~~~~~~~~~t~~~d~~~l~~l~~~~~~~~~~~ 391 (935)
+.....+.+ .++. .+ .+++ .+.+++++.|+.++ +|+|||+|+|++.+.+..|.+.|+.+|..+|+.+......+
T Consensus 316 i~~~~g~~~~~~~~-~~~v~~~-~g~l~isl~p~~~s--~pilNaiEI~~~~~~~~~t~~~~~~aL~~~k~~~~~~~~~~ 391 (623)
T PLN03150 316 IVKMSGERYTALVL-NKTVAVS-GRTLTIVLQPKKGT--HAIINAIEVFEIITAESKTLLEEVSALQTLKSSLGLPLRFG 391 (623)
T ss_pred hhhhcCCcccceEE-EeEEeec-CCeEEEEEeeCCCC--cceeeeeeeeeccccccccCchHHHHHHHHHHhcCCcccCC
Confidence 432222111 1111 11 1222 37788999998765 69999999999999988999999999999998886544458
Q ss_pred CCCCCCCCC--CCceEEEeCCC---CCcEEEEEccCCCCcccCCccccCcccccccccccccCCCCCC-Ccccccccccc
Q 002336 392 DRGDPCVPV--PWEWVTCSTTT---PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIV 465 (935)
Q Consensus 392 w~~dpC~~~--~w~~v~c~~~~---~~~l~~L~Ls~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p-~~~~l~~L~~L 465 (935)
|++|||+|. +|.|+.|.... ...|+.|+|++|+|+|.+|.+|++|++|+.|+|++|+|+|.+| .+++|++|+.|
T Consensus 392 W~g~~C~p~~~~w~Gv~C~~~~~~~~~~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~L 471 (623)
T PLN03150 392 WNGDPCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVL 471 (623)
T ss_pred CCCCCCCCcccccccceeeccCCCCceEEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEE
Confidence 999999875 79999996432 2369999999999999999999999999999999999999999 69999999999
Q ss_pred ccccccccCCCCCccCccccccccccccccCCCCCCccccC---CceeeeecCCCCCccc----ccc-cceeEEEeccch
Q 002336 466 HLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLT---GKVIFKYDNNPKLHKE----SRR-RMRFKLILGTSI 537 (935)
Q Consensus 466 ~L~~N~l~g~iP~~l~~l~~L~~L~l~~N~l~g~iP~~l~~---~~~~~~~~~n~~~~~~----~~~-~~~~~iiv~~~v 537 (935)
+|++|+|+|.+|+++++|++|+.|+|++|+|+|.+|..+.. ....+.+.+|+.+|+. .|. ......++++++
T Consensus 472 dLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p~l~~C~~~~~~~~~i~~~~ 551 (623)
T PLN03150 472 DLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPGLRACGPHLSVGAKIGIAF 551 (623)
T ss_pred ECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHHhhccccCceEEecCCccccCCCCCCCCcccCCCceEEEEEh
Confidence 99999999999999999999999999999999999998765 2346778999999963 242 223344555555
Q ss_pred hHHHHHHHHHhhhheeeeec
Q 002336 538 GVLAILLVLFLCSLIVLRKL 557 (935)
Q Consensus 538 ~~~~~lvll~~~~~~~~rr~ 557 (935)
++++++++++++.+++++++
T Consensus 552 ~~~~~~l~~~~~~~~~~~~r 571 (623)
T PLN03150 552 GVSVAFLFLVICAMCWWKRR 571 (623)
T ss_pred HHHHHHHHHHHHHhhheeeh
Confidence 55544444444444444443
|
|
| >PF12819 Malectin_like: Carbohydrate-binding protein of the ER; InterPro: IPR024788 Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan [] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-62 Score=543.83 Aligned_cols=322 Identities=36% Similarity=0.540 Sum_probs=255.4
Q ss_pred EecCCCCC---ccCCCCCeEEecCCccccCCceeeec-----CCCCCcccccccccccCCCCcceEEeeec--CCceeEE
Q 002336 28 IDCGSTSN---YTDPSTGLAWISDIGIMNNGKSVKVE-----NPSGNWMQYRTRRDLPIDNKKYCYNLITK--ERRRYLV 97 (935)
Q Consensus 28 idcg~~~~---~~~~~~~~~~~~d~~~~~~g~~~~~~-----~~~~~~~~~~tlr~fp~~~~~~cy~l~~~--~~~~ylv 97 (935)
||||++.+ |+|+.||++|++|.+|+++|++++|+ ......+++.|+|+|| +|.||||+||+. +|+||||
T Consensus 1 IdCG~~~~~s~y~D~~tg~~~~~D~~~~~~g~~~~i~~~~~~~~~~~~~~y~taR~F~-~g~r~cY~l~~~~~~~~~yli 79 (347)
T PF12819_consen 1 IDCGSSSNSSSYVDDSTGRTWVSDDDFIDTGKSGNISSQPDSSSSDSSPPYQTARIFP-EGSRNCYTLPVTPPGGGKYLI 79 (347)
T ss_pred CcCCCCCCCcccccCCCCcEEeCCCCcccCCCccccccccCCcCCccccccceEEEcC-CCCccEEEeeccCCCCceEEE
Confidence 89997644 88999999999999999999999883 1234568899999999 777899999998 6779999
Q ss_pred EEEeeecCCCCCC-----CCCeEEEEEcCceeEEEEecCCc-cceEEE-EEEecCCCCcccceeccCCCC-ceeeeeeee
Q 002336 98 RATFQYGSLGSEA-----SYPKFQLYLDATLWSTVTVLDAS-RVYAKE-MIIRAPSDSIDVCICCAVTGS-PFISTLELR 169 (935)
Q Consensus 98 r~~~~yg~yd~~~-----~~p~fd~~~~~~~w~~v~~~~~~-~~~~~e-~~~~~~~~~~~vcl~~~~~~~-pfis~le~~ 169 (935)
|+.|+|||||+++ +||.|||++|++.|++|+..+.. ..+.+| +|+++++++++|||+++++|+ ||||+||||
T Consensus 80 Rl~F~~gnyd~~~fs~~~~~~~FdL~~~~n~~~tV~~~~~~~~~~~~E~ii~v~~~~~l~vclv~~~~g~~pFIsaiEl~ 159 (347)
T PF12819_consen 80 RLHFYYGNYDGLNFSVSSSPPTFDLLLGFNFWSTVNLSNSPSSPVVKEFIINVTWSDTLSVCLVPTGSGTFPFISAIELR 159 (347)
T ss_pred EEEeccccccccccccccCCcceEEEECCceeEEEEecCCCcceEEEEEEEEEcCCCcEEEEEEeCCCCCCCceeEEEEE
Confidence 9999999999874 47899999999999999987621 347788 666666899999999999999 999999999
Q ss_pred ecCCCCCc-ccccccceEEEEEeeecCCCCCCCccCCCCCCCCccccCCCCCCCceeccCCceeeeccccccc---CCCC
Q 002336 170 PLNLSMYA-TDFEDNFFLKVAARVNFGALTKDALRYPDDPYDRIWDSDLDRRPNFVVGAASGTVRINTTKNIE---TRTR 245 (935)
Q Consensus 170 ~l~~~~y~-~~~~~~~~l~l~~R~~~g~~~~~~~~y~~d~~~R~W~~~~~~~~~~~~~~~~~~~~i~~~~~i~---~~~~ 245 (935)
||++++|+ .....+.+|.++.|.|+|+.. ..+|||+|+|||+|+|+.. .+.|..++++.+|+ ...+
T Consensus 160 ~lp~~ly~~~~~~~s~~L~~~~R~n~G~~~-~~iryp~D~~dR~W~~~~~---------~~~~~~ist~~~i~~~~~~~~ 229 (347)
T PF12819_consen 160 PLPDSLYPDTDANSSQALETVYRLNVGGSS-SFIRYPDDTYDRIWQPYSS---------SPGWSNISTTSNININSSNNP 229 (347)
T ss_pred ECCccceeccccCCCceeEEEEeecCCCcc-cccCCCCCcceeecccccc---------CccccccccceeeecccCCcc
Confidence 99999995 223557889999999999853 3599999999999998621 22455677766665 2468
Q ss_pred CCChHhHhhhceeccCce--EEEeecCCCCccccceeeeeccccCcC-CCcceEEEeecCcccccccceeeeeccCCCce
Q 002336 246 EYPPVKVMQTAVVGTEGV--LSYRLNLEDFPANARAFAYFAEIQDLG-PSETRKFKLEQPYFADYSNAVVNIAENANGSY 322 (935)
Q Consensus 246 ~~pP~~v~qtA~~~~~~~--~~~~~~~~~~~~~~~~~lyFae~~~~~-~~~~R~F~v~~~~~~~~~~~~~~~~~~~~~~~ 322 (935)
+.||.+|||||++..+.+ +.+.|...+...+||++|||||++.+. ..++|+|+|.++.-..++ .+.... ......
T Consensus 230 ~~~P~~V~~TA~~~~~~s~~~nltw~~~~~~~~y~v~lHFaEi~~~~~~~~~R~F~IyiN~~~~~~-~~~~~~-~~~~~~ 307 (347)
T PF12819_consen 230 YDAPSAVYQTARTPSNSSDPLNLTWSFVDPGFSYYVRLHFAEIQSLSPNNNQREFDIYINGQTAYS-DVSPPY-LGADTV 307 (347)
T ss_pred CcChHHHHHhhhcccccccceEEEeccCCCCccEEEEEEEeecccccCCCCeEEEEEEECCeEccC-ccCccc-ccCcce
Confidence 899999999999887665 888888855556889999999999975 444899999655444332 211111 111122
Q ss_pred eeeccccceeeeeeEEEEEeeecCCCcchhhhhhhhhcee
Q 002336 323 TLYEPSYMNVTLNFVLSFSFVKTRDSTLGPLLNAIEISKY 362 (935)
Q Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~~~s~l~p~ina~e~~~~ 362 (935)
.+|......+...+.+++++.++..|+|||+|||+|+|++
T Consensus 308 ~~~~d~~~~~~~~~~~~isL~~t~~S~lppiLNalEIy~v 347 (347)
T PF12819_consen 308 PYYSDYVVNVPDSGFLNISLGPTPDSTLPPILNALEIYKV 347 (347)
T ss_pred EeecceEEEecCCCEEEEEEEeCCCCCcCceeEeeeeEeC
Confidence 2344444555555678899999999999999999999975
|
This entry represents a malectin-like domain found in a number of plant receptor kinases. |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-51 Score=518.24 Aligned_cols=442 Identities=26% Similarity=0.485 Sum_probs=306.6
Q ss_pred CcEEEEEccCCCCcccCCccccCcccccccccccccCCCCCC-CccccccccccccccccccCCCCCccCcccccccccc
Q 002336 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 491 (935)
Q Consensus 413 ~~l~~L~Ls~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p-~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~l 491 (935)
+.++.|+|++|++.|.+|..+.+|++|+.|+|++|.++|.+| .+.+|++|+.|+|++|+++|.+|..+.++++|+.|++
T Consensus 499 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~l 578 (968)
T PLN00113 499 SELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNI 578 (968)
T ss_pred hccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEec
Confidence 356667777777777777777777777777777777777776 4677777777777777777777777777777777777
Q ss_pred ccccCCCCCCcccc-CCceeeeecCCCCCccc-------cccc----ceeEEEeccchhHHHHHHHHHhhhheeeeeccc
Q 002336 492 ENNSFVGEIPPALL-TGKVIFKYDNNPKLHKE-------SRRR----MRFKLILGTSIGVLAILLVLFLCSLIVLRKLRR 559 (935)
Q Consensus 492 ~~N~l~g~iP~~l~-~~~~~~~~~~n~~~~~~-------~~~~----~~~~iiv~~~v~~~~~lvll~~~~~~~~rr~r~ 559 (935)
++|+++|.+|..-. .......+.+|+.+|+. +|.. ....+++++++++++++++++ +.+++++++ +
T Consensus 579 s~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~-~ 656 (968)
T PLN00113 579 SHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRVRKTPSWWFYITCTLGAFLVLALVA-FGFVFIRGR-N 656 (968)
T ss_pred cCCcceeeCCCcchhcccChhhhcCCccccCCccccCCCCCccccccceeeeehhHHHHHHHHHHHHH-HHHHHHHhh-h
Confidence 77777777775322 12233456889988853 2321 112223333333222222222 222222222 1
Q ss_pred ccccccccccccCCcccccCCCCCCCCceeeccCCccccCcccccCChhhHHHHHHhhcccccccccEEEEEEEE-CCCc
Q 002336 560 KISNQKSYEKVCPLADSLRTSTKPSNTAYSIARGGHFMDEGVAYFIPLPELEEATNNFCKKIGKGSFGSVYYGKM-KDGK 638 (935)
Q Consensus 560 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~LG~G~fG~Vy~~~~-~~g~ 638 (935)
+.+.++. +. .+.. +.. .+........+...++... .+..+.||+|+||.||+|.+ .+++
T Consensus 657 ~~~~~~~-~~----~~~~----------~~~----~~~~~~~~~~~~~~~~~~~-~~~~~~ig~G~~g~Vy~~~~~~~~~ 716 (968)
T PLN00113 657 NLELKRV-EN----EDGT----------WEL----QFFDSKVSKSITINDILSS-LKEENVISRGKKGASYKGKSIKNGM 716 (968)
T ss_pred ccccccc-cc----cccc----------ccc----cccccccchhhhHHHHHhh-CCcccEEccCCCeeEEEEEECCCCc
Confidence 1111100 00 0000 000 0000011111223344332 33457899999999999987 4789
Q ss_pred EEEEEEccCcchhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHH
Q 002336 639 EVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA 718 (935)
Q Consensus 639 ~vAvK~~~~~~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~ 718 (935)
.||||++..... ...+|++.+++++|||||+++|+|.+++..++||||+++|+|.++++ .++|.++.+++
T Consensus 717 ~vavK~~~~~~~----~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~------~l~~~~~~~i~ 786 (968)
T PLN00113 717 QFVVKEINDVNS----IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR------NLSWERRRKIA 786 (968)
T ss_pred EEEEEEccCCcc----ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHh------cCCHHHHHHHH
Confidence 999999864322 22356889999999999999999999999999999999999999996 27899999999
Q ss_pred HHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccccceeecccCCccccCCCCCCCCCCCchhH
Q 002336 719 HDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSD 798 (935)
Q Consensus 719 ~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksD 798 (935)
.|+++||+|||+.+.++|+||||||+||+++.++..++. ||........ ....+++.|+|||++.+..++.++|
T Consensus 787 ~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~sD 860 (968)
T PLN00113 787 IGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD-----TKCFISSAYVAPETRETKDITEKSD 860 (968)
T ss_pred HHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC-----CCccccccccCcccccCCCCCcccc
Confidence 999999999997656899999999999999999888876 6654432211 1235789999999999999999999
Q ss_pred HHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccCC--CCHHHHHHHHHHHHHccccCCCCCC
Q 002336 799 VYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN--VKIESIWRIAEVAIQCVEQRGFSRP 876 (935)
Q Consensus 799 VwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~~--~~~~~~~~l~~li~~Cl~~dP~~RP 876 (935)
||||||++|||+||+.||+ .........++|++...........+|+.+... .+.++..++.+++.+||+.+|++||
T Consensus 861 v~S~Gvvl~el~tg~~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RP 939 (968)
T PLN00113 861 IYGFGLILIELLTGKSPAD-AEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARP 939 (968)
T ss_pred hhhHHHHHHHHHhCCCCCC-cccCCCCcHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCc
Confidence 9999999999999999996 334445568888887666655666677766443 3445667889999999999999999
Q ss_pred CHHHHHHHHhhhhhhcc
Q 002336 877 KMQEIVLAIQDSIKIEK 893 (935)
Q Consensus 877 s~~ev~~~L~~~~~~~~ 893 (935)
+|+||++.|+++.....
T Consensus 940 t~~evl~~L~~~~~~~~ 956 (968)
T PLN00113 940 CANDVLKTLESASRSSS 956 (968)
T ss_pred CHHHHHHHHHHhhcccc
Confidence 99999999998766433
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-50 Score=447.71 Aligned_cols=289 Identities=49% Similarity=0.835 Sum_probs=253.0
Q ss_pred cccCChhhHHHHHHhhc--ccccccccEEEEEEEECCCcEEEEEEccCcchhhhHHHHHHHHHHHhcCCCcccccceeee
Q 002336 602 AYFIPLPELEEATNNFC--KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCE 679 (935)
Q Consensus 602 ~~~~~~~~l~~~~~~~~--~~LG~G~fG~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~ 679 (935)
...+++.++.++|.+|. +.||+|+||.||+|.+.+|+.||||++........++|.+|++++.+++|||+|+++|||.
T Consensus 62 ~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~ 141 (361)
T KOG1187|consen 62 LRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCL 141 (361)
T ss_pred cceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEe
Confidence 34567999999999996 6999999999999999999999999887644321456999999999999999999999999
Q ss_pred ccc-eEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEee
Q 002336 680 EEH-QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSD 758 (935)
Q Consensus 680 ~~~-~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~D 758 (935)
+.+ +.+||||||++|+|.++|+..... +++|.+|++||.++|+||+|||+.|.+.|+|||||++|||+|+++++||+|
T Consensus 142 e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsD 220 (361)
T KOG1187|consen 142 EGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSD 220 (361)
T ss_pred cCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccC
Confidence 988 599999999999999999975433 899999999999999999999999888999999999999999999999999
Q ss_pred ccccccccccccceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcC
Q 002336 759 FGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG 838 (935)
Q Consensus 759 FGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~ 838 (935)
||+++.......+......||.+|+|||++..+..+.|+|||||||+|+||+||+.+.+.........+++|++..+.++
T Consensus 221 FGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~ 300 (361)
T KOG1187|consen 221 FGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEG 300 (361)
T ss_pred ccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCc
Confidence 99997654412221111169999999999999999999999999999999999999987444345556999999999999
Q ss_pred Ceeeccccccc-CCCCH-HHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhhhhh
Q 002336 839 DVISIVDPVLI-GNVKI-ESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 891 (935)
Q Consensus 839 ~~~~~~d~~l~-~~~~~-~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~~~~ 891 (935)
.+.+++|+.+. +.++. +++.++..++.+|++.+|++||+|.||+++|+.+...
T Consensus 301 ~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~ 355 (361)
T KOG1187|consen 301 KLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL 355 (361)
T ss_pred chhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence 99999999987 66664 6888999999999999999999999999999665544
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=385.34 Aligned_cols=261 Identities=36% Similarity=0.535 Sum_probs=213.1
Q ss_pred HHHhhcccccccccEEEEEEEECCCcEEEEEEccCcchhh--hHHHHHHHHHHHhcCCCcccccceeeeccc-eEEEEEE
Q 002336 613 ATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHR--TQQFVTEVALLSRIHHRNLVPLIGYCEEEH-QRILVYE 689 (935)
Q Consensus 613 ~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~~~~~~~~~--~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~-~~~lV~E 689 (935)
....+.+.||+|+||+||+|.++....||||++....... .+.|.+|+.+|.+++|||||+++|+|.+.. ..++|||
T Consensus 41 ~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtE 120 (362)
T KOG0192|consen 41 DELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTE 120 (362)
T ss_pred HHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEE
Confidence 3334456699999999999999944449999997654322 468999999999999999999999999887 7999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCc-eEecCCCCCCccccCCC-cEEEeeccccccccc
Q 002336 690 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG-IIHRDVKSSNILLDINM-RAKVSDFGLSRQAEE 767 (935)
Q Consensus 690 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~-ivH~DLkp~NILld~~~-~vkL~DFGla~~~~~ 767 (935)
||++|+|.++++.. ....+++..+++++.|||+||.|||+ .+ ||||||||+|||++.++ ++||+|||+++....
T Consensus 121 y~~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~---~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~ 196 (362)
T KOG0192|consen 121 YMPGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHS---EGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVI 196 (362)
T ss_pred eCCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhc---CCCeeecccChhhEEEcCCCCEEEECCCccceeecc
Confidence 99999999999864 46789999999999999999999998 66 99999999999999997 999999999987654
Q ss_pred cccceeecccCCccccCCCCCC--CCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeeccc
Q 002336 768 DLTHISSVARGTVGYLDPEYYG--NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 845 (935)
Q Consensus 768 ~~~~~~~~~~gt~~y~APE~l~--~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d 845 (935)
.. .......||..|||||++. ...++.|+||||||+++|||+||+.||..... .+-+......+....
T Consensus 197 ~~-~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~------~~~~~~v~~~~~Rp~--- 266 (362)
T KOG0192|consen 197 SK-TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP------VQVASAVVVGGLRPP--- 266 (362)
T ss_pred cc-ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH------HHHHHHHHhcCCCCC---
Confidence 32 1222356999999999999 66999999999999999999999999984332 122222222222222
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhhhhhcc
Q 002336 846 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 893 (935)
Q Consensus 846 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~~~~~~ 893 (935)
.+......+..++.+||..+|++||++.|++..|+.+...-.
T Consensus 267 ------~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~ 308 (362)
T KOG0192|consen 267 ------IPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHIS 308 (362)
T ss_pred ------CCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhc
Confidence 222244578899999999999999999999999998776444
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=366.24 Aligned_cols=250 Identities=27% Similarity=0.391 Sum_probs=207.3
Q ss_pred hcccccccccEEEEEEEEC-CCcEEEEEEccCc-chhhhHHHHHHHHHHHhcCCCcccccceeeeccc-eEEEEEEecCC
Q 002336 617 FCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS-CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH-QRILVYEYMHN 693 (935)
Q Consensus 617 ~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~-~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~-~~~lV~E~~~~ 693 (935)
..+.||+|..|+||++.|+ +++-+|+|++... .....+++.+|++++++.+|||||.++|.|.... ...++||||++
T Consensus 83 ~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMDg 162 (364)
T KOG0581|consen 83 RLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMDG 162 (364)
T ss_pred hhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcCC
Confidence 3568999999999999987 6888999999543 3455689999999999999999999999999888 59999999999
Q ss_pred CCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccccccccee
Q 002336 694 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 773 (935)
Q Consensus 694 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~~~ 773 (935)
|||++++.. .+.+++...-+++.+|++||.|||. .++|+||||||+|||++..|++||||||.+....+. ..
T Consensus 163 GSLd~~~k~---~g~i~E~~L~~ia~~VL~GL~YLh~--~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS---~a 234 (364)
T KOG0581|consen 163 GSLDDILKR---VGRIPEPVLGKIARAVLRGLSYLHE--ERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS---IA 234 (364)
T ss_pred CCHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhh--ccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh---hc
Confidence 999999984 4679999999999999999999996 389999999999999999999999999999887655 34
Q ss_pred ecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccCCCC
Q 002336 774 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVK 853 (935)
Q Consensus 774 ~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~~~~ 853 (935)
....||..|||||.+++..|+.++||||||++++|+.+|+.|+... ........+.+..... +.. |.+...
T Consensus 235 ~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~-~~~~~~~~~Ll~~Iv~-~pp-----P~lP~~-- 305 (364)
T KOG0581|consen 235 NTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPP-NPPYLDIFELLCAIVD-EPP-----PRLPEG-- 305 (364)
T ss_pred ccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCc-CCCCCCHHHHHHHHhc-CCC-----CCCCcc--
Confidence 5567999999999999999999999999999999999999999843 1112222222222222 111 222221
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002336 854 IESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 884 (935)
Q Consensus 854 ~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~ 884 (935)
....++.+++..||++||.+||+++|++++
T Consensus 306 -~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 306 -EFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred -cCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 133478899999999999999999999764
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=384.30 Aligned_cols=263 Identities=28% Similarity=0.462 Sum_probs=223.1
Q ss_pred hhHHHHHHhhcccccccccEEEEEEEECCCcEEEEEEccCcchhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEE
Q 002336 608 PELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILV 687 (935)
Q Consensus 608 ~~l~~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV 687 (935)
-++.+...++.+.||+|-||.||.|.++....||+|.++.. .....+|.+|+++|++|+|+|||+++|+|..++..+||
T Consensus 201 wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIV 279 (468)
T KOG0197|consen 201 WEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIV 279 (468)
T ss_pred eeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEE
Confidence 45667778889999999999999999997789999999764 23346899999999999999999999999998899999
Q ss_pred EEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccc
Q 002336 688 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 767 (935)
Q Consensus 688 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~ 767 (935)
||||+.|+|.++|+.. .+..+...+.+.++.|||+||+||++ +++|||||.++||||+++..+||+|||+|+...+
T Consensus 280 tE~m~~GsLl~yLr~~-~~~~l~~~~Ll~~a~qIaeGM~YLes---~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d 355 (468)
T KOG0197|consen 280 TEYMPKGSLLDYLRTR-EGGLLNLPQLLDFAAQIAEGMAYLES---KNYIHRDLAARNILVDEDLVVKISDFGLARLIGD 355 (468)
T ss_pred EEecccCcHHHHhhhc-CCCccchHHHHHHHHHHHHHHHHHHh---CCccchhhhhhheeeccCceEEEcccccccccCC
Confidence 9999999999999863 56778999999999999999999998 9999999999999999999999999999997666
Q ss_pred cccceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCcccchhHHHHHHHhhhcCCeeecccc
Q 002336 768 DLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP 846 (935)
Q Consensus 768 ~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~ 846 (935)
+....+....-+..|.|||.+....++.|||||||||+||||+| |+.|+...... + +-+.++.|-.
T Consensus 356 ~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~------e-v~~~le~GyR------ 422 (468)
T KOG0197|consen 356 DEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNE------E-VLELLERGYR------ 422 (468)
T ss_pred CceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHH------H-HHHHHhccCc------
Confidence 55555555556889999999999999999999999999999999 99998733221 1 2223333321
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhhhhh
Q 002336 847 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 891 (935)
Q Consensus 847 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~~~~ 891 (935)
=..|..++..+.+++..||..+|++|||++.+...|+++...
T Consensus 423 ---lp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~ 464 (468)
T KOG0197|consen 423 ---LPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS 464 (468)
T ss_pred ---CCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence 122344556788999999999999999999999988877653
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-41 Score=374.15 Aligned_cols=250 Identities=26% Similarity=0.442 Sum_probs=211.6
Q ss_pred HHHHHhhcccccccccEEEEEEEE-CCCcEEEEEEccCc---chhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEE
Q 002336 611 EEATNNFCKKIGKGSFGSVYYGKM-KDGKEVAVKIMADS---CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRIL 686 (935)
Q Consensus 611 ~~~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vAvK~~~~~---~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~l 686 (935)
...+|...+.||+|+|+.||.++. ..|+.||+|++.+. .....+.+.+|+++.+.|+|||||+++++|++.+..|+
T Consensus 16 ~~~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYi 95 (592)
T KOG0575|consen 16 RSKRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYI 95 (592)
T ss_pred CcceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEE
Confidence 335677789999999999999987 78999999999763 23455778999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccc
Q 002336 687 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 766 (935)
Q Consensus 687 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~ 766 (935)
|.|.|++++|..+++ .++++++.++..++.||+.||.|||+ ++|+|||||..|+|++++.++||+|||+|....
T Consensus 96 vLELC~~~sL~el~K---rrk~ltEpEary~l~QIv~GlkYLH~---~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le 169 (592)
T KOG0575|consen 96 VLELCHRGSLMELLK---RRKPLTEPEARYFLRQIVEGLKYLHS---LGIIHRDLKLGNLFLNENMNVKIGDFGLATQLE 169 (592)
T ss_pred EEEecCCccHHHHHH---hcCCCCcHHHHHHHHHHHHHHHHHHh---cCceecccchhheeecCcCcEEecccceeeeec
Confidence 999999999999998 47889999999999999999999998 999999999999999999999999999999876
Q ss_pred ccccceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccc
Q 002336 767 EDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP 846 (935)
Q Consensus 767 ~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~ 846 (935)
.+. ....+.+|||.|+|||++.....+..+||||+|||||-||.|++||+.....+. -..|+..+.
T Consensus 170 ~~~-Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vket-------y~~Ik~~~Y------ 235 (592)
T KOG0575|consen 170 YDG-ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKET-------YNKIKLNEY------ 235 (592)
T ss_pred Ccc-cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHH-------HHHHHhcCc------
Confidence 432 234567899999999999998899999999999999999999999984332221 122322221
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002336 847 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 884 (935)
Q Consensus 847 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~ 884 (935)
..|........+||.++|+.+|.+|||+++|+..
T Consensus 236 ----~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 236 ----SMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred ----ccccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 1122233366799999999999999999999753
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=362.18 Aligned_cols=256 Identities=29% Similarity=0.401 Sum_probs=205.6
Q ss_pred hhHHHHHHhhcccccccccEEEEEEEE-CCCcEEEEEEccCcchh-------hhHHHHHHHHHHHhcCCCcccccceeee
Q 002336 608 PELEEATNNFCKKIGKGSFGSVYYGKM-KDGKEVAVKIMADSCSH-------RTQQFVTEVALLSRIHHRNLVPLIGYCE 679 (935)
Q Consensus 608 ~~l~~~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vAvK~~~~~~~~-------~~~~~~~E~~iL~~L~HpnIv~l~g~~~ 679 (935)
++.....|-+.+.||+|+||.|-+|.. ++|+.||||+++..... ......+|+++|++|+|||||+++++++
T Consensus 167 pks~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~ 246 (475)
T KOG0615|consen 167 PKSFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFE 246 (475)
T ss_pred cchhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeee
Confidence 344556667789999999999999975 47999999999753221 2234679999999999999999999999
Q ss_pred ccceEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCC---CcEEE
Q 002336 680 EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN---MRAKV 756 (935)
Q Consensus 680 ~~~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~---~~vkL 756 (935)
..+..||||||++||.|.+++- ..+.+.+..-..++.|++.|+.|||+ .||+||||||+|||+..+ ..+||
T Consensus 247 ~~ds~YmVlE~v~GGeLfd~vv---~nk~l~ed~~K~~f~Qll~avkYLH~---~GI~HRDiKPeNILl~~~~e~~llKI 320 (475)
T KOG0615|consen 247 VPDSSYMVLEYVEGGELFDKVV---ANKYLREDLGKLLFKQLLTAVKYLHS---QGIIHRDIKPENILLSNDAEDCLLKI 320 (475)
T ss_pred cCCceEEEEEEecCccHHHHHH---hccccccchhHHHHHHHHHHHHHHHH---cCcccccCCcceEEeccCCcceEEEe
Confidence 9999999999999999999987 35667777888999999999999998 999999999999999765 77999
Q ss_pred eeccccccccccccceeecccCCccccCCCCCCCCCC---CchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHH
Q 002336 757 SDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQL---TEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARS 833 (935)
Q Consensus 757 ~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~---s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~ 833 (935)
+|||+|+..++. ......+||+.|.|||++.+... ..+.|+||+||+||-+++|.+||....... . +.+
T Consensus 321 tDFGlAK~~g~~--sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~--s----l~e 392 (475)
T KOG0615|consen 321 TDFGLAKVSGEG--SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP--S----LKE 392 (475)
T ss_pred cccchhhccccc--eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc--c----HHH
Confidence 999999987632 33456789999999999976533 358899999999999999999998433221 1 233
Q ss_pred hhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 834 MIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 834 ~i~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
++..|.+... | ..-....++..++|.+||..||++|||+.|+++
T Consensus 393 QI~~G~y~f~--p----~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 393 QILKGRYAFG--P----LQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred HHhcCccccc--C----hhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 4444443211 1 111234457889999999999999999999875
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=355.80 Aligned_cols=197 Identities=33% Similarity=0.559 Sum_probs=176.6
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCc--chhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEec
Q 002336 615 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 691 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~--~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~ 691 (935)
|.+.+.||+|.||+||+|+++ ++.+||||.+... .....+.+..|+.+|+.++|||||+++++++.++..+||||||
T Consensus 12 y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEyC 91 (429)
T KOG0595|consen 12 YELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEYC 91 (429)
T ss_pred ceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEeC
Confidence 344567999999999999987 5899999998765 4455677889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCC------CcEEEeeccccccc
Q 002336 692 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN------MRAKVSDFGLSRQA 765 (935)
Q Consensus 692 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~------~~vkL~DFGla~~~ 765 (935)
.||+|.++++. .+.+++.....++.|+|.||++||+ ++||||||||.||||+.. -.+||+|||+|+..
T Consensus 92 ~gGDLs~yi~~---~~~l~e~t~r~Fm~QLA~alq~L~~---~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L 165 (429)
T KOG0595|consen 92 NGGDLSDYIRR---RGRLPEATARHFMQQLASALQFLHE---NNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFL 165 (429)
T ss_pred CCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCcceEEeccCCCCCCCceEEecccchhhhC
Confidence 99999999984 5689999999999999999999998 999999999999999764 45899999999988
Q ss_pred cccccceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCcc
Q 002336 766 EEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVE 819 (935)
Q Consensus 766 ~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~ 819 (935)
.+.. .....+|++-|||||+++..+|+.|+|+||+|+++|||++|+.||+..
T Consensus 166 ~~~~--~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~ 217 (429)
T KOG0595|consen 166 QPGS--MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAE 217 (429)
T ss_pred Cchh--HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCcccc
Confidence 6443 234567999999999999999999999999999999999999999843
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=342.68 Aligned_cols=261 Identities=28% Similarity=0.371 Sum_probs=212.9
Q ss_pred HHHHHhhcccccccccEEEEEEEE-CCCcEEEEEEccCc--chhhhHHHHHHHHHHHhcCCCcccccce-eeeccce-EE
Q 002336 611 EEATNNFCKKIGKGSFGSVYYGKM-KDGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIG-YCEEEHQ-RI 685 (935)
Q Consensus 611 ~~~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vAvK~~~~~--~~~~~~~~~~E~~iL~~L~HpnIv~l~g-~~~~~~~-~~ 685 (935)
..+.+++.++||+|.||+||++.. .+|..||.|.++-. .....+....|+.+|++|+|||||++++ -+.++.. ++
T Consensus 17 ~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evln 96 (375)
T KOG0591|consen 17 TLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLN 96 (375)
T ss_pred cHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhH
Confidence 346678889999999999999964 58999999998633 2334567899999999999999999998 4444444 89
Q ss_pred EEEEecCCCCHHHHhccCC-CCCCCCHHHHHHHHHHHHHHhHHhhhcCC-CceEecCCCCCCccccCCCcEEEeeccccc
Q 002336 686 LVYEYMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCN-PGIIHRDVKSSNILLDINMRAKVSDFGLSR 763 (935)
Q Consensus 686 lV~E~~~~gsL~~~L~~~~-~~~~l~~~~~~~i~~qia~gL~yLHs~~~-~~ivH~DLkp~NILld~~~~vkL~DFGla~ 763 (935)
+|||+|..|+|..+++... .++.+++..+++++.|++.||.++|+... .-|+||||||.||+++.+|.+||+|||+++
T Consensus 97 ivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r 176 (375)
T KOG0591|consen 97 IVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGR 176 (375)
T ss_pred HHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHh
Confidence 9999999999999987544 45679999999999999999999997322 239999999999999999999999999999
Q ss_pred cccccccceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeec
Q 002336 764 QAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISI 843 (935)
Q Consensus 764 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~ 843 (935)
.+...... .....|||.||+||.+++..|+.|+||||+||++|||+.-+.||.+. ++.+ +.++|.+++...+
T Consensus 177 ~l~s~~tf-A~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~------n~~~-L~~KI~qgd~~~~ 248 (375)
T KOG0591|consen 177 FLSSKTTF-AHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD------NLLS-LCKKIEQGDYPPL 248 (375)
T ss_pred HhcchhHH-HHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc------cHHH-HHHHHHcCCCCCC
Confidence 88765443 34457999999999999999999999999999999999999999854 2322 3456666655443
Q ss_pred ccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhh
Q 002336 844 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 887 (935)
Q Consensus 844 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~ 887 (935)
.|. -...++.+|+..|+..||+.||+.-.+++.+..
T Consensus 249 p~~--------~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 249 PDE--------HYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred cHH--------HhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 332 223478899999999999999996555555444
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-40 Score=378.88 Aligned_cols=266 Identities=31% Similarity=0.493 Sum_probs=221.6
Q ss_pred hHHHHHHhhcccccccccEEEEEEEEC------CCcEEEEEEccCcchh-hhHHHHHHHHHHHhcCCCcccccceeeecc
Q 002336 609 ELEEATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSCSH-RTQQFVTEVALLSRIHHRNLVPLIGYCEEE 681 (935)
Q Consensus 609 ~l~~~~~~~~~~LG~G~fG~Vy~~~~~------~g~~vAvK~~~~~~~~-~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~ 681 (935)
++......+.+.||+|+||+||+|+.. +.+.||||.+++.... ..++|++|+++|..++|||||+++|.|.++
T Consensus 482 ~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~ 561 (774)
T KOG1026|consen 482 EIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREG 561 (774)
T ss_pred EechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccC
Confidence 455555667889999999999999754 3467999999987665 678999999999999999999999999999
Q ss_pred ceEEEEEEecCCCCHHHHhccCC-------C----CCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccC
Q 002336 682 HQRILVYEYMHNGTLRDRLHGSV-------N----QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI 750 (935)
Q Consensus 682 ~~~~lV~E~~~~gsL~~~L~~~~-------~----~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~ 750 (935)
+..+||+|||..|+|.++|.... . ..+++..+.+.||.|||.||.||-+ +.+|||||.++|+||++
T Consensus 562 ~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~---~~FVHRDLATRNCLVge 638 (774)
T KOG1026|consen 562 DPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSS---HHFVHRDLATRNCLVGE 638 (774)
T ss_pred CeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh---Ccccccchhhhhceecc
Confidence 99999999999999999997533 1 2238899999999999999999998 89999999999999999
Q ss_pred CCcEEEeecccccccccc-ccceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCcccchhHH
Q 002336 751 NMRAKVSDFGLSRQAEED-LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIV 828 (935)
Q Consensus 751 ~~~vkL~DFGla~~~~~~-~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~ 828 (935)
+..|||+|||+++..... ..+......-.++||+||.+..++++.++|||||||+|||+++ |+.||.+....
T Consensus 639 ~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~------ 712 (774)
T KOG1026|consen 639 NLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQ------ 712 (774)
T ss_pred ceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchH------
Confidence 999999999999875433 2222223345789999999999999999999999999999999 99998643322
Q ss_pred HHHHHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhhhhhcc
Q 002336 829 HWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 893 (935)
Q Consensus 829 ~~~~~~i~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~~~~~~ 893 (935)
-+.+.+++|.+.+ .+...+..+.+|+..||+.+|++||+++||...|+......+
T Consensus 713 -EVIe~i~~g~lL~---------~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s~ 767 (774)
T KOG1026|consen 713 -EVIECIRAGQLLS---------CPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQASP 767 (774)
T ss_pred -HHHHHHHcCCccc---------CCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcCc
Confidence 2344566665533 244455688999999999999999999999999988765443
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=323.83 Aligned_cols=261 Identities=23% Similarity=0.298 Sum_probs=203.1
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCcchh--hhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEec
Q 002336 615 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSH--RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 691 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~~--~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~ 691 (935)
|+..-++|+|+||.||+++++ +|+-||||++...... -.+-.++|+++|++++|+|+|.++++|......+||+|||
T Consensus 4 YE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~ 83 (396)
T KOG0593|consen 4 YEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYC 83 (396)
T ss_pred HhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeec
Confidence 344568999999999999987 5999999999765442 2355789999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccccc
Q 002336 692 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 771 (935)
Q Consensus 692 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~ 771 (935)
+..-|.++-+ ...+++...+.+++.|+++|+.|+|+ ++++||||||+||||+.++.+||||||+|+..... ..
T Consensus 84 dhTvL~eLe~---~p~G~~~~~vk~~l~Q~l~ai~~cHk---~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p-gd 156 (396)
T KOG0593|consen 84 DHTVLHELER---YPNGVPSELVKKYLYQLLKAIHFCHK---NNCIHRDIKPENILITQNGVVKLCDFGFARTLSAP-GD 156 (396)
T ss_pred chHHHHHHHh---ccCCCCHHHHHHHHHHHHHHhhhhhh---cCeecccCChhheEEecCCcEEeccchhhHhhcCC-cc
Confidence 8765555433 35568899999999999999999998 89999999999999999999999999999987642 22
Q ss_pred eeecccCCccccCCCCCCC-CCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHH-HH-------HhhhcCCeee
Q 002336 772 ISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHW-AR-------SMIKKGDVIS 842 (935)
Q Consensus 772 ~~~~~~gt~~y~APE~l~~-~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~-~~-------~~i~~~~~~~ 842 (935)
..+....|.+|+|||.+.+ .+|+...||||+||++.||++|.+-|.+...-+....+.- +. +......+..
T Consensus 157 ~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~ 236 (396)
T KOG0593|consen 157 NYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFH 236 (396)
T ss_pred hhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCcee
Confidence 2345668999999999876 7999999999999999999999999986655443322211 11 1111111111
Q ss_pred cc------cc-cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 843 IV------DP-VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 843 ~~------d~-~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
.+ ++ .+...+ +....-+++++++|++.||.+|++-++++.
T Consensus 237 Gv~lP~~~~~epLe~k~-p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 237 GVRLPEPEHPEPLERKY-PKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred eeecCCCCCccchhhhc-ccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 11 11 111112 223336889999999999999999999875
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=337.89 Aligned_cols=256 Identities=28% Similarity=0.409 Sum_probs=202.8
Q ss_pred HHhhcccccccccEEEEEEEECC-CcEEEEEEccCcchhhhHHHHHHHHHHHhcCCCcccccceeeeccc--eEEEEEEe
Q 002336 614 TNNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH--QRILVYEY 690 (935)
Q Consensus 614 ~~~~~~~LG~G~fG~Vy~~~~~~-g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~--~~~lV~E~ 690 (935)
.+...+.||+|.||.||++...+ |+..|||.+........+.+.+|+.+|.+++|||||+++|...... .++++|||
T Consensus 18 ~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy 97 (313)
T KOG0198|consen 18 NWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEY 97 (313)
T ss_pred hhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeec
Confidence 34557899999999999998764 8999999886543333677899999999999999999999854444 68999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccC-CCcEEEeeccccccccc--
Q 002336 691 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI-NMRAKVSDFGLSRQAEE-- 767 (935)
Q Consensus 691 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~-~~~vkL~DFGla~~~~~-- 767 (935)
+++|+|.+++.+.. + .+++..+..+..|+++||+|||+ ++|+||||||+|||++. ++.+||+|||+++....
T Consensus 98 ~~~GsL~~~~~~~g-~-~l~E~~v~~ytr~iL~GL~ylHs---~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~ 172 (313)
T KOG0198|consen 98 APGGSLSDLIKRYG-G-KLPEPLVRRYTRQILEGLAYLHS---KGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG 172 (313)
T ss_pred cCCCcHHHHHHHcC-C-CCCHHHHHHHHHHHHHHHHHHHh---CCEeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence 99999999998642 2 79999999999999999999998 99999999999999999 79999999999987653
Q ss_pred cccceeecccCCccccCCCCCCCC-CCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccc
Q 002336 768 DLTHISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP 846 (935)
Q Consensus 768 ~~~~~~~~~~gt~~y~APE~l~~~-~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~ 846 (935)
..........||+.|||||++..+ ....++||||+||++.||+||+.||... .....++-.....+.. |
T Consensus 173 ~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-----~~~~~~~~~ig~~~~~-----P 242 (313)
T KOG0198|consen 173 TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-----FEEAEALLLIGREDSL-----P 242 (313)
T ss_pred ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-----cchHHHHHHHhccCCC-----C
Confidence 222233456799999999999853 3445999999999999999999999732 1112222222222111 1
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhh
Q 002336 847 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 888 (935)
Q Consensus 847 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~ 888 (935)
..+........+++.+|++.+|++|||++++++..--.
T Consensus 243 ----~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~ 280 (313)
T KOG0198|consen 243 ----EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLK 280 (313)
T ss_pred ----CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhh
Confidence 22233344678999999999999999999998765433
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=332.93 Aligned_cols=247 Identities=29% Similarity=0.382 Sum_probs=202.4
Q ss_pred HHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc---hhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEE
Q 002336 613 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 688 (935)
Q Consensus 613 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~ 688 (935)
...++.++||+|+||+||.++.+ .++-+|+|++++.. ....+...+|..+|.+++||.||+++..|++.+.+|||+
T Consensus 25 ~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVl 104 (357)
T KOG0598|consen 25 DDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVL 104 (357)
T ss_pred hheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEE
Confidence 34456899999999999999765 58899999997642 234577889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccccc
Q 002336 689 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 768 (935)
Q Consensus 689 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~ 768 (935)
||+.||.|..+|+ .++.+++..+.-++.+|+.||.|||+ ++|+||||||+|||+|++|+++|+|||+++.....
T Consensus 105 d~~~GGeLf~hL~---~eg~F~E~~arfYlaEi~lAL~~LH~---~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~ 178 (357)
T KOG0598|consen 105 DYLNGGELFYHLQ---REGRFSEDRARFYLAEIVLALGYLHS---KGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKD 178 (357)
T ss_pred eccCCccHHHHHH---hcCCcchhHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHeeecCCCcEEEeccccchhcccC
Confidence 9999999999998 46789999999999999999999998 99999999999999999999999999999864333
Q ss_pred ccceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccccc
Q 002336 769 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 848 (935)
Q Consensus 769 ~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l 848 (935)
.. .....+||+.|||||++....++..+|-||+|+++|||++|.+||...+.. ++... +..++. .
T Consensus 179 ~~-~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~------~~~~~-I~~~k~------~- 243 (357)
T KOG0598|consen 179 GD-ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVK------KMYDK-ILKGKL------P- 243 (357)
T ss_pred CC-ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHH------HHHHH-HhcCcC------C-
Confidence 22 234468999999999999999999999999999999999999999854332 22222 222221 0
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCC----CHHHHH
Q 002336 849 IGNVKIESIWRIAEVAIQCVEQRGFSRP----KMQEIV 882 (935)
Q Consensus 849 ~~~~~~~~~~~l~~li~~Cl~~dP~~RP----s~~ev~ 882 (935)
..+.-......+++.+.+..+|++|- ++++|.
T Consensus 244 --~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik 279 (357)
T KOG0598|consen 244 --LPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIK 279 (357)
T ss_pred --CCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhh
Confidence 01111223567899999999999995 455543
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=345.38 Aligned_cols=251 Identities=30% Similarity=0.503 Sum_probs=209.7
Q ss_pred cccCChhhHHHHHHhhcccccccccEEEEEEEECCCcEEEEEEccCcchhhhHHHHHHHHHHHhcCCCcccccceeeecc
Q 002336 602 AYFIPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE 681 (935)
Q Consensus 602 ~~~~~~~~l~~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~ 681 (935)
.+.+++++|.+.. -||.|+.|.||+|+++ ++.||||+++.. -..+++-|++|+||||+.|.|+|...
T Consensus 118 ~WeiPFe~IsELe-----WlGSGaQGAVF~Grl~-netVAVKKV~el-------kETdIKHLRkLkH~NII~FkGVCtqs 184 (904)
T KOG4721|consen 118 LWEIPFEEISELE-----WLGSGAQGAVFLGRLH-NETVAVKKVREL-------KETDIKHLRKLKHPNIITFKGVCTQS 184 (904)
T ss_pred hccCCHHHhhhhh-----hhccCcccceeeeecc-CceehhHHHhhh-------hhhhHHHHHhccCcceeeEeeeecCC
Confidence 3456677766554 4999999999999998 899999987642 23478889999999999999999999
Q ss_pred ceEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccc
Q 002336 682 HQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGL 761 (935)
Q Consensus 682 ~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGl 761 (935)
..+|+|||||..|-|..+|+ .+.++.....+.|.++||.||.|||. ++|||||||.-||||..+..+||+|||-
T Consensus 185 PcyCIiMEfCa~GqL~~VLk---a~~~itp~llv~Wsk~IA~GM~YLH~---hKIIHRDLKSPNiLIs~~d~VKIsDFGT 258 (904)
T KOG4721|consen 185 PCYCIIMEFCAQGQLYEVLK---AGRPITPSLLVDWSKGIAGGMNYLHL---HKIIHRDLKSPNILISYDDVVKISDFGT 258 (904)
T ss_pred ceeEEeeeccccccHHHHHh---ccCccCHHHHHHHHHHhhhhhHHHHH---hhHhhhccCCCceEeeccceEEeccccc
Confidence 99999999999999999998 56778889999999999999999998 8999999999999999999999999999
Q ss_pred cccccccccceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCee
Q 002336 762 SRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVI 841 (935)
Q Consensus 762 a~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~ 841 (935)
++...+.... -...||..|||||++.+.+.++|.||||||||||||+||..||..-+..... |
T Consensus 259 S~e~~~~STk--MSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAII----w----------- 321 (904)
T KOG4721|consen 259 SKELSDKSTK--MSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAII----W----------- 321 (904)
T ss_pred hHhhhhhhhh--hhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeE----E-----------
Confidence 9877654332 2356999999999999999999999999999999999999999733321100 0
Q ss_pred ecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhh
Q 002336 842 SIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 888 (935)
Q Consensus 842 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~ 888 (935)
-+=...|.--.+...++.+.-|+++||+..|..||++.+++..|+-.
T Consensus 322 GVGsNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa 368 (904)
T KOG4721|consen 322 GVGSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIA 368 (904)
T ss_pred eccCCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhc
Confidence 00111222234556777899999999999999999999999998743
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=342.56 Aligned_cols=249 Identities=27% Similarity=0.391 Sum_probs=205.3
Q ss_pred HHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc---hhhhHHHHHHHHHHHhc-CCCcccccceeeeccceEEEE
Q 002336 613 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILV 687 (935)
Q Consensus 613 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~iL~~L-~HpnIv~l~g~~~~~~~~~lV 687 (935)
+.+.|++.||+|.|++|++|+.+ .++++|||++.+.. ....+.+..|-.+|.+| .||.|++++-.|.++..+|+|
T Consensus 73 ~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFv 152 (604)
T KOG0592|consen 73 NDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFV 152 (604)
T ss_pred hhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEE
Confidence 45678999999999999999765 68999999986532 12335677899999999 799999999999999999999
Q ss_pred EEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccc
Q 002336 688 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 767 (935)
Q Consensus 688 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~ 767 (935)
+||+++|+|.++|+. -+.+++.....++.||+.||+|||+ .|||||||||+|||+|.||++||+|||.|+.+..
T Consensus 153 Le~A~nGdll~~i~K---~Gsfde~caR~YAAeIldAleylH~---~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~ 226 (604)
T KOG0592|consen 153 LEYAPNGDLLDLIKK---YGSFDETCARFYAAEILDALEYLHS---NGIIHRDLKPENILLDKDGHIKITDFGSAKILSP 226 (604)
T ss_pred EEecCCCcHHHHHHH---hCcchHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeEcCCCcEEEeeccccccCCh
Confidence 999999999999984 4779999999999999999999998 9999999999999999999999999999988654
Q ss_pred cccc----------ee--ecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhh
Q 002336 768 DLTH----------IS--SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMI 835 (935)
Q Consensus 768 ~~~~----------~~--~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i 835 (935)
.... .+ ....||..|.+||++.....+..+|+|+||||||+|+.|++||..... ....+ +.+
T Consensus 227 ~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ne---yliFq---kI~ 300 (604)
T KOG0592|consen 227 SQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANE---YLIFQ---KIQ 300 (604)
T ss_pred hhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccH---HHHHH---HHH
Confidence 3221 11 335799999999999999999999999999999999999999973321 11111 111
Q ss_pred hcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002336 836 KKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 884 (935)
Q Consensus 836 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~ 884 (935)
. ++= .++...+..+.+|+.+.|..||.+|++.++|-++
T Consensus 301 ~-------l~y----~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 301 A-------LDY----EFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred H-------hcc----cCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence 1 111 1222233467899999999999999999998776
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=345.40 Aligned_cols=262 Identities=27% Similarity=0.449 Sum_probs=205.1
Q ss_pred HHHHHhhcccccccccEEEEEEEEC------CCcEEEEEEccCcc-hhhhHHHHHHHHHHHhc-CCCcccccceeeecc-
Q 002336 611 EEATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSC-SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEE- 681 (935)
Q Consensus 611 ~~~~~~~~~~LG~G~fG~Vy~~~~~------~g~~vAvK~~~~~~-~~~~~~~~~E~~iL~~L-~HpnIv~l~g~~~~~- 681 (935)
....+++.+.||+|+||.||+|.+. +++.||||++.... ....+.+.+|+.+++.+ +||||++++++|...
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN 84 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence 3456778899999999999999752 35689999987543 23446789999999999 899999999988764
Q ss_pred ceEEEEEEecCCCCHHHHhccCCC--------------------------------------------------------
Q 002336 682 HQRILVYEYMHNGTLRDRLHGSVN-------------------------------------------------------- 705 (935)
Q Consensus 682 ~~~~lV~E~~~~gsL~~~L~~~~~-------------------------------------------------------- 705 (935)
...++||||+++|+|.+++.....
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 457899999999999998864211
Q ss_pred ---CCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccccce-eecccCCcc
Q 002336 706 ---QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI-SSVARGTVG 781 (935)
Q Consensus 706 ---~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~~-~~~~~gt~~ 781 (935)
...+++..+..++.|+++||+|||+ ++|+||||||+|||++.++.+||+|||+++......... .....++..
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~ 241 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK 241 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence 2347888999999999999999998 899999999999999999999999999998653322211 222345678
Q ss_pred ccCCCCCCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccCCCCHHHHHHH
Q 002336 782 YLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRI 860 (935)
Q Consensus 782 y~APE~l~~~~~s~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~~~~~~~~~~l 860 (935)
|+|||++.+..++.++||||||+++|||++ |..||....... .. ...+..+.... . +......+
T Consensus 242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~--~~----~~~~~~~~~~~-----~----~~~~~~~l 306 (338)
T cd05102 242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE--EF----CQRLKDGTRMR-----A----PENATPEI 306 (338)
T ss_pred ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH--HH----HHHHhcCCCCC-----C----CCCCCHHH
Confidence 999999988899999999999999999997 999997433211 11 12222222111 1 11223468
Q ss_pred HHHHHHccccCCCCCCCHHHHHHHHhhhhh
Q 002336 861 AEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 890 (935)
Q Consensus 861 ~~li~~Cl~~dP~~RPs~~ev~~~L~~~~~ 890 (935)
.+++.+||+.+|++|||+.||++.|+++..
T Consensus 307 ~~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 307 YRIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 899999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=345.40 Aligned_cols=246 Identities=27% Similarity=0.420 Sum_probs=206.7
Q ss_pred hcccccccccEEEEEEEE-CCCcEEEEEEccCcchhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEecCCCC
Q 002336 617 FCKKIGKGSFGSVYYGKM-KDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGT 695 (935)
Q Consensus 617 ~~~~LG~G~fG~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~~~gs 695 (935)
-.++||+|+.|.||.|.. ..++.||||++.-......+-+.+|+.+|+..+|+|||++++.+...+++|+|||||+||+
T Consensus 277 ~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggs 356 (550)
T KOG0578|consen 277 DFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGS 356 (550)
T ss_pred chhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCCCc
Confidence 347899999999999964 5789999999976666666779999999999999999999999988899999999999999
Q ss_pred HHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccccceeec
Q 002336 696 LRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSV 775 (935)
Q Consensus 696 L~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~ 775 (935)
|.|.+.. ..+++.++..|+.++++||+|||. ++|+|||||.+|||++.+|.+||+|||++..+...... ...
T Consensus 357 LTDvVt~----~~~~E~qIA~Icre~l~aL~fLH~---~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~K-R~T 428 (550)
T KOG0578|consen 357 LTDVVTK----TRMTEGQIAAICREILQGLKFLHA---RGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSK-RST 428 (550)
T ss_pred hhhhhhc----ccccHHHHHHHHHHHHHHHHHHHh---cceeeeccccceeEeccCCcEEEeeeeeeeccccccCc-ccc
Confidence 9999973 459999999999999999999997 99999999999999999999999999999987766553 344
Q ss_pred ccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccCCCCHH
Q 002336 776 ARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIE 855 (935)
Q Consensus 776 ~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~~~~~~ 855 (935)
..||+.|||||++....|+.|.||||||++++||+-|.+||-.+... + +...+......++-. +..
T Consensus 429 mVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~Pl------r-AlyLIa~ng~P~lk~-------~~k 494 (550)
T KOG0578|consen 429 MVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPL------R-ALYLIATNGTPKLKN-------PEK 494 (550)
T ss_pred ccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChH------H-HHHHHhhcCCCCcCC-------ccc
Confidence 56999999999999999999999999999999999999999632221 1 111222222222222 222
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002336 856 SIWRIAEVAIQCVEQRGFSRPKMQEIVLA 884 (935)
Q Consensus 856 ~~~~l~~li~~Cl~~dP~~RPs~~ev~~~ 884 (935)
....+.+++.+||+.|+++||+++|+++.
T Consensus 495 lS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 495 LSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred cCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 33478899999999999999999999874
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=368.86 Aligned_cols=271 Identities=31% Similarity=0.474 Sum_probs=220.9
Q ss_pred hhhHHHHHHhhcccccccccEEEEEEEECC--Cc----EEEEEEccCcc-hhhhHHHHHHHHHHHhcCCCcccccceeee
Q 002336 607 LPELEEATNNFCKKIGKGSFGSVYYGKMKD--GK----EVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCE 679 (935)
Q Consensus 607 ~~~l~~~~~~~~~~LG~G~fG~Vy~~~~~~--g~----~vAvK~~~~~~-~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~ 679 (935)
++++......+.+.||+|.||.||.|...+ |. .||||.++... .+...+|.+|..+|++++|||||+++|+|-
T Consensus 686 lp~v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l 765 (1025)
T KOG1095|consen 686 LPEVPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCL 765 (1025)
T ss_pred cccCChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeec
Confidence 566777788889999999999999998653 43 48999987754 445678999999999999999999999999
Q ss_pred ccceEEEEEEecCCCCHHHHhccCC----CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEE
Q 002336 680 EEHQRILVYEYMHNGTLRDRLHGSV----NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAK 755 (935)
Q Consensus 680 ~~~~~~lV~E~~~~gsL~~~L~~~~----~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vk 755 (935)
+....++++|||++|+|..+|+..+ ....+...+.+.++.|||+|+.|||+ +++|||||.++|+|++....+|
T Consensus 766 ~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~---~~fvHRDLAaRNCLL~~~r~VK 842 (1025)
T KOG1095|consen 766 DSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLES---KHFVHRDLAARNCLLDERRVVK 842 (1025)
T ss_pred CCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHh---CCCcCcchhhhheeecccCcEE
Confidence 9999999999999999999998653 24568899999999999999999998 9999999999999999999999
Q ss_pred Eeeccccccccccccce-eecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCcccchhHHHHHHH
Q 002336 756 VSDFGLSRQAEEDLTHI-SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARS 833 (935)
Q Consensus 756 L~DFGla~~~~~~~~~~-~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~ 833 (935)
|+|||+|+...+..... .....-...|||||.+..+.++.|+|||||||++||++| |..||...+..+ + +..
T Consensus 843 IaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~---v---~~~ 916 (1025)
T KOG1095|consen 843 IADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFE---V---LLD 916 (1025)
T ss_pred EcccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHH---H---HHH
Confidence 99999999543332222 222234578999999999999999999999999999999 999997332211 1 111
Q ss_pred hhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhhhhhccCCC
Q 002336 834 MIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKGGD 896 (935)
Q Consensus 834 ~i~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~~~~~~~~~ 896 (935)
..+.|+ + ..|...+..+.+++..||+.+|++||++.+|++.+..+........
T Consensus 917 ~~~ggR----L------~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~~~ 969 (1025)
T KOG1095|consen 917 VLEGGR----L------DPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALGTI 969 (1025)
T ss_pred HHhCCc----c------CCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhccCc
Confidence 222331 1 2244556688899999999999999999999999888776655543
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=338.23 Aligned_cols=270 Identities=26% Similarity=0.438 Sum_probs=221.3
Q ss_pred ChhhHHHHHHhhcccccccccEEEEEEEECCCcEEEEEEccCcchh-hhHHHHHHHHHHHhcCCCcccccceeeeccceE
Q 002336 606 PLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSH-RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQR 684 (935)
Q Consensus 606 ~~~~l~~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~~~~~~~~-~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~ 684 (935)
.+.|+......|.++||+|-||.|.+++...+..||||+++..... ..++|.+|+++|.+++|||||+++|+|..++.+
T Consensus 531 al~EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePi 610 (807)
T KOG1094|consen 531 ALVEFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPL 610 (807)
T ss_pred chhhcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCch
Confidence 4567777788889999999999999999998899999999876544 458999999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccc
Q 002336 685 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 764 (935)
Q Consensus 685 ~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~ 764 (935)
++|+|||++|+|.+++..+.... +.....++|+.||+.||+||.+ .++|||||.++|+|+|.++++||+|||+++-
T Consensus 611 cmI~EYmEnGDLnqFl~aheapt-~~t~~~vsi~tqiasgmaYLes---~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~ 686 (807)
T KOG1094|consen 611 CMITEYMENGDLNQFLSAHELPT-AETAPGVSICTQIASGMAYLES---LNFVHRDLATRNCLVDGEFTIKIADFGMSRN 686 (807)
T ss_pred HHHHHHHhcCcHHHHHHhccCcc-cccchhHHHHHHHHHHHHHHHh---hchhhccccccceeecCcccEEecCcccccc
Confidence 99999999999999998764222 5666778899999999999998 8999999999999999999999999999985
Q ss_pred cccc-ccceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHh--CCCCCCccCcccchhHHHHHHHhhhcCCee
Q 002336 765 AEED-LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS--GKKPVSVEDFGAELNIVHWARSMIKKGDVI 841 (935)
Q Consensus 765 ~~~~-~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLlt--G~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~ 841 (935)
.... ..+......-+++|||+|.+..+.++.++|||+||+++||+++ ...||... .+.+.++........+...
T Consensus 687 lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~l---t~e~vven~~~~~~~~~~~ 763 (807)
T KOG1094|consen 687 LYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQL---TDEQVVENAGEFFRDQGRQ 763 (807)
T ss_pred cccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhh---hHHHHHHhhhhhcCCCCcc
Confidence 4333 3333334445789999999999999999999999999999866 77888622 2233444444444333222
Q ss_pred ecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhh
Q 002336 842 SIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 888 (935)
Q Consensus 842 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~ 888 (935)
..+ ..|...+.++.+++.+||..+.++||+++++...|++.
T Consensus 764 ~~l------~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 764 VVL------SRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred eec------cCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 221 12344556888999999999999999999999998764
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=337.84 Aligned_cols=263 Identities=22% Similarity=0.280 Sum_probs=207.7
Q ss_pred HHHHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcch-hhhHHHHHHHHHHHhcC-CCcccccceeeeccc-eEEE
Q 002336 611 EEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEH-QRIL 686 (935)
Q Consensus 611 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~-~~~~~~~~E~~iL~~L~-HpnIv~l~g~~~~~~-~~~l 686 (935)
....|...++||.|.||.||+|+-. .|+.||||+++..-. ...-.=++|++.|++|+ |||||++.+++.+.+ .+++
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f 87 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF 87 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence 3467888999999999999999754 789999999875422 22234568999999998 999999999998877 8999
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccc
Q 002336 687 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 766 (935)
Q Consensus 687 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~ 766 (935)
|||||+ .+|+++++.. ++.+++..+..|+.||++||+|+|+ +|+.|||+||+|||+.....+||+|||+|+...
T Consensus 88 VfE~Md-~NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk---~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~ 161 (538)
T KOG0661|consen 88 VFEFMD-CNLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHK---HGFFHRDLKPENILISGNDVIKIADFGLAREVR 161 (538)
T ss_pred eHHhhh-hhHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHh---cCcccccCChhheEecccceeEecccccccccc
Confidence 999995 5999999864 7889999999999999999999998 999999999999999989999999999999876
Q ss_pred ccccceeecccCCccccCCCCC-CCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCC---e--
Q 002336 767 EDLTHISSVARGTVGYLDPEYY-GNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD---V-- 840 (935)
Q Consensus 767 ~~~~~~~~~~~gt~~y~APE~l-~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~---~-- 840 (935)
.... .+....|.+|+|||++ +.+.|+.+.|+||+|||++|+.+-++-|.+.+.-++... +.+.+.... .
T Consensus 162 SkpP--YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~K---Ic~VLGtP~~~~~~e 236 (538)
T KOG0661|consen 162 SKPP--YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYK---ICEVLGTPDKDSWPE 236 (538)
T ss_pred cCCC--cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHH---HHHHhCCCccccchh
Confidence 5544 3446689999999975 678999999999999999999999999976554332221 112221111 1
Q ss_pred ----eecccccccC-------CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002336 841 ----ISIVDPVLIG-------NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 884 (935)
Q Consensus 841 ----~~~~d~~l~~-------~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~ 884 (935)
...+.-.+.. ..-+....+.++++.+|+.+||.+|||++|.+++
T Consensus 237 g~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 237 GYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 1111111110 1112244578999999999999999999999875
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=328.94 Aligned_cols=262 Identities=25% Similarity=0.338 Sum_probs=207.6
Q ss_pred HHHHhhcccccccccEEEEEEEEC-CCcEEEEEEccC-cchhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEE
Q 002336 612 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMAD-SCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 689 (935)
Q Consensus 612 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~-~~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E 689 (935)
...|++.+.||.|..++||+|... .++.||||++.- .+....+.+.+|+..|+.++||||++.+..|..+..+|+||.
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp 104 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP 104 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence 355778899999999999999754 689999999853 344556889999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccc
Q 002336 690 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 769 (935)
Q Consensus 690 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~ 769 (935)
||.+||+.+++.... ...+++..+..|++++++||.|||+ +|.||||||+.||||+++|.+||+|||.+..+.+..
T Consensus 105 fMa~GS~ldIik~~~-~~Gl~E~~Ia~iLre~LkaL~YLH~---~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G 180 (516)
T KOG0582|consen 105 FMAGGSLLDIIKTYY-PDGLEEASIATILREVLKALDYLHQ---NGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG 180 (516)
T ss_pred hhcCCcHHHHHHHHc-cccccHHHHHHHHHHHHHHHHHHHh---cCceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence 999999999998764 3459999999999999999999998 999999999999999999999999999876543322
Q ss_pred cc---eeecccCCccccCCCCCCC--CCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecc
Q 002336 770 TH---ISSVARGTVGYLDPEYYGN--QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 844 (935)
Q Consensus 770 ~~---~~~~~~gt~~y~APE~l~~--~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~ 844 (935)
.. ......||+.|||||+++. ..|+.|+||||||++..||.+|..||..... .+-+...+++ +.....
T Consensus 181 ~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pP------mkvLl~tLqn-~pp~~~ 253 (516)
T KOG0582|consen 181 DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPP------MKVLLLTLQN-DPPTLL 253 (516)
T ss_pred ceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCCh------HHHHHHHhcC-CCCCcc
Confidence 11 1144579999999999643 4789999999999999999999999972221 1111222322 222111
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002336 845 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 884 (935)
Q Consensus 845 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~ 884 (935)
-..+..+......+.+.+++..||+.||++|||++++++.
T Consensus 254 t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 254 TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 1111111122233478899999999999999999999864
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=335.77 Aligned_cols=266 Identities=24% Similarity=0.278 Sum_probs=204.8
Q ss_pred HHHHHhhcccccccccEEEEEEEE-CCCcEEEEEEccCcc--hhhhHHHHHHHHHHHhcCCCcccccceeeecc--ceEE
Q 002336 611 EEATNNFCKKIGKGSFGSVYYGKM-KDGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE--HQRI 685 (935)
Q Consensus 611 ~~~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vAvK~~~~~~--~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~--~~~~ 685 (935)
....++-.++||+|.||.||+|+. .+|+.||+|+++-.. .+...-..+|+.+|++|+||||+++.+...+. ...|
T Consensus 115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siY 194 (560)
T KOG0600|consen 115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIY 194 (560)
T ss_pred chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEE
Confidence 345566678999999999999975 579999999987543 22335567899999999999999999988765 6899
Q ss_pred EEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccc
Q 002336 686 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 765 (935)
Q Consensus 686 lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~ 765 (935)
||+|||++ +|.-++.. .+..+++.++..++.|+++||+|||+ ++|+|||||.+|||||.+|.+||+|||||+++
T Consensus 195 lVFeYMdh-DL~GLl~~--p~vkft~~qIKc~mkQLl~Gl~~cH~---~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y 268 (560)
T KOG0600|consen 195 LVFEYMDH-DLSGLLSS--PGVKFTEPQIKCYMKQLLEGLEYCHS---RGVLHRDIKGSNILIDNNGVLKIADFGLARFY 268 (560)
T ss_pred EEEecccc-hhhhhhcC--CCcccChHHHHHHHHHHHHHHHHHhh---cCeeeccccccceEEcCCCCEEeccccceeec
Confidence 99999976 77777763 35679999999999999999999998 99999999999999999999999999999988
Q ss_pred cccccceeecccCCccccCCCCCCC-CCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecc
Q 002336 766 EEDLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 844 (935)
Q Consensus 766 ~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~ 844 (935)
........+...-|.+|+|||++.+ ..|+.+.|+||.||||.||++|++.|.+...-++.+.+--+-....+... ...
T Consensus 269 ~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W-~~~ 347 (560)
T KOG0600|consen 269 TPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYW-PVS 347 (560)
T ss_pred cCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhcc-ccc
Confidence 7665554555668999999998766 58999999999999999999999999865443333222111111111111 100
Q ss_pred c-cc---cc--CCCCH-------HHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 845 D-PV---LI--GNVKI-------ESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 845 d-~~---l~--~~~~~-------~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
+ |. +. ..+.. ......++|+..+|..||.+|.|+.++++
T Consensus 348 kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 348 KLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred cCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 0 00 00 01110 11225678999999999999999999864
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=359.93 Aligned_cols=266 Identities=27% Similarity=0.467 Sum_probs=221.3
Q ss_pred hhhHHHHHHhhcccccccccEEEEEEEECC----CcEEEEEEccCcchh-hhHHHHHHHHHHHhcCCCcccccceeeecc
Q 002336 607 LPELEEATNNFCKKIGKGSFGSVYYGKMKD----GKEVAVKIMADSCSH-RTQQFVTEVALLSRIHHRNLVPLIGYCEEE 681 (935)
Q Consensus 607 ~~~l~~~~~~~~~~LG~G~fG~Vy~~~~~~----g~~vAvK~~~~~~~~-~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~ 681 (935)
-.||......+.++||.|.||.||+|+++- ...||||.++....+ +..+|+.|+.||.++.||||+++.|+....
T Consensus 623 akEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks 702 (996)
T KOG0196|consen 623 AKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKS 702 (996)
T ss_pred hhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecC
Confidence 446666666678899999999999999862 357999999876444 557899999999999999999999999999
Q ss_pred ceEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccc
Q 002336 682 HQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGL 761 (935)
Q Consensus 682 ~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGl 761 (935)
....+|.|||++|+|+.+|+.. .+.+.+.+...++++||.||+||-. .++|||||.++|||++.+..+|++|||+
T Consensus 703 ~PvMIiTEyMENGsLDsFLR~~--DGqftviQLVgMLrGIAsGMkYLsd---m~YVHRDLAARNILVNsnLvCKVsDFGL 777 (996)
T KOG0196|consen 703 KPVMIITEYMENGSLDSFLRQN--DGQFTVIQLVGMLRGIASGMKYLSD---MNYVHRDLAARNILVNSNLVCKVSDFGL 777 (996)
T ss_pred ceeEEEhhhhhCCcHHHHHhhc--CCceEeehHHHHHHHHHHHhHHHhh---cCchhhhhhhhheeeccceEEEeccccc
Confidence 9999999999999999999875 4569999999999999999999996 9999999999999999999999999999
Q ss_pred cccccccccceeecccC--CccccCCCCCCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCcccchhHHHHHHHhhhcC
Q 002336 762 SRQAEEDLTHISSVARG--TVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKG 838 (935)
Q Consensus 762 a~~~~~~~~~~~~~~~g--t~~y~APE~l~~~~~s~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~i~~~ 838 (935)
++...++.........| +.+|.|||.+..+.++.++|||||||+|||.++ |.+||....- + -+.+.+++|
T Consensus 778 SRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSN--Q-----dVIkaIe~g 850 (996)
T KOG0196|consen 778 SRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN--Q-----DVIKAIEQG 850 (996)
T ss_pred eeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccch--H-----HHHHHHHhc
Confidence 99886655333333222 578999999999999999999999999999888 9999862211 1 112222222
Q ss_pred CeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhhhhhcc
Q 002336 839 DVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 893 (935)
Q Consensus 839 ~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~~~~~~ 893 (935)
.+--.|++.+..|.+|++.||++|-.+||.+.+|+..|.+++....
T Consensus 851 ---------yRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~ 896 (996)
T KOG0196|consen 851 ---------YRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPN 896 (996)
T ss_pred ---------cCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCch
Confidence 2222356677789999999999999999999999999999886443
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=348.97 Aligned_cols=265 Identities=32% Similarity=0.481 Sum_probs=213.4
Q ss_pred hHHHHHHhhcccccccccEEEEEEEECC--C--cE-EEEEEccC---cchhhhHHHHHHHHHHHhcCCCcccccceeeec
Q 002336 609 ELEEATNNFCKKIGKGSFGSVYYGKMKD--G--KE-VAVKIMAD---SCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEE 680 (935)
Q Consensus 609 ~l~~~~~~~~~~LG~G~fG~Vy~~~~~~--g--~~-vAvK~~~~---~~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~ 680 (935)
++......+.++||+|+||.||+|+++. + .. ||||..+. ......++|++|+++|++++|||||+++|++..
T Consensus 153 el~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~ 232 (474)
T KOG0194|consen 153 ELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVL 232 (474)
T ss_pred EEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcC
Confidence 3444445566899999999999998763 2 23 89999885 235667899999999999999999999999999
Q ss_pred cceEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecc
Q 002336 681 EHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFG 760 (935)
Q Consensus 681 ~~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFG 760 (935)
+..+++|||+|.||+|.++|+.. ...++..++++++.+.|+||+|||+ ++++||||.++|+|++.++.+||+|||
T Consensus 233 ~~Pl~ivmEl~~gGsL~~~L~k~--~~~v~~~ek~~~~~~AA~Gl~YLh~---k~~IHRDIAARNcL~~~~~~vKISDFG 307 (474)
T KOG0194|consen 233 EEPLMLVMELCNGGSLDDYLKKN--KKSLPTLEKLRFCYDAARGLEYLHS---KNCIHRDIAARNCLYSKKGVVKISDFG 307 (474)
T ss_pred CCccEEEEEecCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHhHHHHHHH---CCCcchhHhHHHheecCCCeEEeCccc
Confidence 99999999999999999999854 3369999999999999999999998 999999999999999999999999999
Q ss_pred ccccccccccceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCcccchhHHHHHHHhh-hcC
Q 002336 761 LSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMI-KKG 838 (935)
Q Consensus 761 la~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~i-~~~ 838 (935)
+++.... .........-+..|+|||.+....++.++|||||||++||+++ |..||.+.... . ++..+ .++
T Consensus 308 Ls~~~~~-~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~---~----v~~kI~~~~ 379 (474)
T KOG0194|consen 308 LSRAGSQ-YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY---E----VKAKIVKNG 379 (474)
T ss_pred cccCCcc-eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH---H----HHHHHHhcC
Confidence 9876531 1111112235789999999999999999999999999999999 88898743321 1 22333 222
Q ss_pred CeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhhhhhccCC
Q 002336 839 DVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKGG 895 (935)
Q Consensus 839 ~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~~~~~~~~ 895 (935)
-.. ..+...+..+..++.+||..+|++||+|.++.+.|+.+.......
T Consensus 380 ~r~---------~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~~ 427 (474)
T KOG0194|consen 380 YRM---------PIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEAF 427 (474)
T ss_pred ccC---------CCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccccc
Confidence 111 112233446778888999999999999999999999888766643
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=308.66 Aligned_cols=263 Identities=22% Similarity=0.275 Sum_probs=205.0
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcchh--hhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEe
Q 002336 614 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSH--RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 690 (935)
Q Consensus 614 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~~--~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~ 690 (935)
+|...++||+|.||.||+|++. +|+.||||+++-.... -.....+|++.|+.++|+||+.+++.|...+...+|+||
T Consensus 3 rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEf 82 (318)
T KOG0659|consen 3 RYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEF 82 (318)
T ss_pred hhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEe
Confidence 4555789999999999999764 7999999999754322 235678999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccccccc
Q 002336 691 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 770 (935)
Q Consensus 691 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~ 770 (935)
|+ .+|+..++. ....+...++..++.++++||+|||+ +.|+||||||.|+||+++|.+||+|||+++.+.....
T Consensus 83 m~-tdLe~vIkd--~~i~l~pa~iK~y~~m~LkGl~y~H~---~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~ 156 (318)
T KOG0659|consen 83 MP-TDLEVVIKD--KNIILSPADIKSYMLMTLKGLAYCHS---KWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNR 156 (318)
T ss_pred cc-ccHHHHhcc--cccccCHHHHHHHHHHHHHHHHHHHh---hhhhcccCCccceEEcCCCcEEeecccchhccCCCCc
Confidence 96 589999985 46778999999999999999999998 9999999999999999999999999999999876543
Q ss_pred ceeecccCCccccCCCCCCC-CCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCC---eeeccc-
Q 002336 771 HISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD---VISIVD- 845 (935)
Q Consensus 771 ~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~---~~~~~d- 845 (935)
... ....|.+|+|||.+.+ ..|+...||||.|||+.||+-|.+-|.+..+-++...+--+-....... +.++.|
T Consensus 157 ~~~-~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY 235 (318)
T KOG0659|consen 157 IQT-HQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDY 235 (318)
T ss_pred ccc-cceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccH
Confidence 322 2257899999998765 6899999999999999999999888875554333222111111111111 111111
Q ss_pred --------ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002336 846 --------PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 884 (935)
Q Consensus 846 --------~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~ 884 (935)
+.+. ..-+.......+++.+|+..||.+|+++.|.+++
T Consensus 236 ~~~~~~P~~~~~-~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 236 VKIQQFPKPPLN-NLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred HHHhcCCCCccc-cccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 1111 1223334466999999999999999999998753
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=341.19 Aligned_cols=246 Identities=27% Similarity=0.414 Sum_probs=202.7
Q ss_pred HHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCc----ch-hhhHHHHHHHHHHHhcC-CCcccccceeeeccceEE
Q 002336 613 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS----CS-HRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQRI 685 (935)
Q Consensus 613 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~----~~-~~~~~~~~E~~iL~~L~-HpnIv~l~g~~~~~~~~~ 685 (935)
..|.+.+.||+|.||.|++|.+. +++.||+|++... .. ...+.+.+|+.++++++ ||||+++++++......+
T Consensus 17 g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~ 96 (370)
T KOG0583|consen 17 GKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKIY 96 (370)
T ss_pred CceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEE
Confidence 45667899999999999999765 6899999976553 11 23456778999999998 999999999999999999
Q ss_pred EEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCC-CcEEEeecccccc
Q 002336 686 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN-MRAKVSDFGLSRQ 764 (935)
Q Consensus 686 lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~-~~vkL~DFGla~~ 764 (935)
+||||+.+|+|.+.+.. .+++.+.++.+++.|++.|++|||+ ++|+||||||+|||++.+ +++||+|||++..
T Consensus 97 ivmEy~~gGdL~~~i~~---~g~l~E~~ar~~F~Qlisav~y~H~---~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~ 170 (370)
T KOG0583|consen 97 IVMEYCSGGDLFDYIVN---KGRLKEDEARKYFRQLISAVAYCHS---RGIVHRDLKPENILLDGNEGNLKLSDFGLSAI 170 (370)
T ss_pred EEEEecCCccHHHHHHH---cCCCChHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEecCCCCCEEEeccccccc
Confidence 99999999999999984 5778899999999999999999998 999999999999999999 9999999999987
Q ss_pred ccccccceeecccCCccccCCCCCCCCC-CC-chhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeee
Q 002336 765 AEEDLTHISSVARGTVGYLDPEYYGNQQ-LT-EKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVIS 842 (935)
Q Consensus 765 ~~~~~~~~~~~~~gt~~y~APE~l~~~~-~s-~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~ 842 (935)
.. .........+|++.|+|||++.+.. |+ .++||||+||+||.|++|+.||+.... .. +...+..+.+
T Consensus 171 ~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~---~~----l~~ki~~~~~-- 240 (370)
T KOG0583|consen 171 SP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNV---PN----LYRKIRKGEF-- 240 (370)
T ss_pred cC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccH---HH----HHHHHhcCCc--
Confidence 74 2223345678999999999998866 75 899999999999999999999984221 11 1122333322
Q ss_pred cccccccCCCCHHH-HHHHHHHHHHccccCCCCCCCHHHHH
Q 002336 843 IVDPVLIGNVKIES-IWRIAEVAIQCVEQRGFSRPKMQEIV 882 (935)
Q Consensus 843 ~~d~~l~~~~~~~~-~~~l~~li~~Cl~~dP~~RPs~~ev~ 882 (935)
.++... ..++..++.+|+..+|.+|+++.||.
T Consensus 241 --------~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 241 --------KIPSYLLSPEARSLIEKMLVPDPSTRITLLEIL 273 (370)
T ss_pred --------cCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 111111 34788999999999999999999998
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=342.88 Aligned_cols=245 Identities=27% Similarity=0.405 Sum_probs=206.7
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCcch---hhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEe
Q 002336 615 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 690 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~---~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~ 690 (935)
+++++.||.|..|.|-+|++. +|+.+|||++.+... .....+.+|+-+|+.+.|||++++++++++..++|+|.||
T Consensus 14 wkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEy 93 (786)
T KOG0588|consen 14 WKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEY 93 (786)
T ss_pred eeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEe
Confidence 456789999999999999875 799999999876522 2345789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccccccc
Q 002336 691 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 770 (935)
Q Consensus 691 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~ 770 (935)
+++|-|.+++- ..+++++.++.+++.||+.|+.|+|+ .+|+||||||+|+|+|..+++||+|||+|....++.
T Consensus 94 v~gGELFdylv---~kG~l~e~eaa~ff~QIi~gv~yCH~---~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gk- 166 (786)
T KOG0588|consen 94 VPGGELFDYLV---RKGPLPEREAAHFFRQILDGVSYCHA---FNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGK- 166 (786)
T ss_pred cCCchhHHHHH---hhCCCCCHHHHHHHHHHHHHHHHHhh---hcceeccCCchhhhhhcccCEeeeccceeecccCCc-
Confidence 99999999987 46789999999999999999999998 899999999999999999999999999998754332
Q ss_pred ceeecccCCccccCCCCCCCCCC-CchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeeccccccc
Q 002336 771 HISSVARGTVGYLDPEYYGNQQL-TEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 849 (935)
Q Consensus 771 ~~~~~~~gt~~y~APE~l~~~~~-s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~ 849 (935)
.-...+|.++|.|||++.+..| +.++||||+|||||.|+||+.||+++ ++.. +..+++.|.+
T Consensus 167 -lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDd------Nir~-LLlKV~~G~f--------- 229 (786)
T KOG0588|consen 167 -LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDD------NIRV-LLLKVQRGVF--------- 229 (786)
T ss_pred -cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCc------cHHH-HHHHHHcCcc---------
Confidence 2345679999999999999877 58999999999999999999999822 2222 2223444433
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002336 850 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 884 (935)
Q Consensus 850 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~ 884 (935)
+.|.....+..+|+.+|++.||++|.|++||.++
T Consensus 230 -~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 230 -EMPSNISSEAQDLLRRMLDVDPSTRITTEEILKH 263 (786)
T ss_pred -cCCCcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence 1223334467899999999999999999999876
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=326.68 Aligned_cols=258 Identities=22% Similarity=0.401 Sum_probs=205.5
Q ss_pred HHHHHHhhcccccccccEEEEEEEEC----CCcEEEEEEccCcch-hhhHHHHHHHHHHHhcCCCcccccceeeeccceE
Q 002336 610 LEEATNNFCKKIGKGSFGSVYYGKMK----DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQR 684 (935)
Q Consensus 610 l~~~~~~~~~~LG~G~fG~Vy~~~~~----~g~~vAvK~~~~~~~-~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~ 684 (935)
+....+++.+.||+|+||.||+|.++ .+..||+|+++.... .....+.+|+.++++++||||+++++++..++..
T Consensus 2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 81 (266)
T cd05064 2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTM 81 (266)
T ss_pred CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCc
Confidence 34566778899999999999999764 366899999876533 3346789999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccc
Q 002336 685 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 764 (935)
Q Consensus 685 ~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~ 764 (935)
++||||+++|+|.+++... ...+++..++.++.|++.||+|||+ ++++||||||+|||++.++.+|++|||.+..
T Consensus 82 ~lv~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~i~~al~~lH~---~~iiH~dikp~nili~~~~~~~l~dfg~~~~ 156 (266)
T cd05064 82 MIVTEYMSNGALDSFLRKH--EGQLVAGQLMGMLPGLASGMKYLSE---MGYVHKGLAAHKVLVNSDLVCKISGFRRLQE 156 (266)
T ss_pred EEEEEeCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHH---CCEeeccccHhhEEEcCCCcEEECCCccccc
Confidence 9999999999999998743 3468999999999999999999997 8999999999999999999999999998765
Q ss_pred ccccccceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCcccchhHHHHHHHhhhcCCeeec
Q 002336 765 AEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISI 843 (935)
Q Consensus 765 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~ 843 (935)
.............++..|+|||.+.+..++.++||||||+++|||++ |+.||...... ...+ .+..+...
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~---~~~~----~~~~~~~~-- 227 (266)
T cd05064 157 DKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ---DVIK----AVEDGFRL-- 227 (266)
T ss_pred ccccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH---HHHH----HHHCCCCC--
Confidence 43222111112234678999999988999999999999999999775 99999733221 1111 22222110
Q ss_pred ccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhh
Q 002336 844 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 888 (935)
Q Consensus 844 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~ 888 (935)
.. +...+..+.+++.+||+.+|++||++++|.+.|.+.
T Consensus 228 ---~~----~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 228 ---PA----PRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred ---CC----CCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 11 122334688999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=332.12 Aligned_cols=245 Identities=29% Similarity=0.400 Sum_probs=207.6
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCcch--hhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEec
Q 002336 615 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 691 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~--~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~ 691 (935)
|-+.+.||+|.||.||||+-+ +.+.||+|.+.+..+ ...+.+.+|+++++.++|||||.+++.|+...+.++|+||+
T Consensus 4 yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~a 83 (808)
T KOG0597|consen 4 YHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEYA 83 (808)
T ss_pred hhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehhh
Confidence 445678999999999999866 688999999865433 34567999999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccccc
Q 002336 692 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 771 (935)
Q Consensus 692 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~ 771 (935)
.| +|..+|. ..+.+++..+..++.++..||.|||+ .+|+|||+||+|||++..+.+|+||||+++-+..+ ..
T Consensus 84 ~g-~L~~il~---~d~~lpEe~v~~~a~~LVsaL~yLhs---~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~-t~ 155 (808)
T KOG0597|consen 84 VG-DLFTILE---QDGKLPEEQVRAIAYDLVSALYYLHS---NRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN-TS 155 (808)
T ss_pred hh-hHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHh---cCcccccCCcceeeecCCCceeechhhhhhhcccC-ce
Confidence 76 9999998 46789999999999999999999998 99999999999999999999999999999987653 34
Q ss_pred eeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccCC
Q 002336 772 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 851 (935)
Q Consensus 772 ~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~~ 851 (935)
......|||-|||||++.+..|+..+|+||+||++|||++|++||-.. .+.+.++ .|..++. .
T Consensus 156 vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~------si~~Lv~-~I~~d~v----------~ 218 (808)
T KOG0597|consen 156 VLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR------SITQLVK-SILKDPV----------K 218 (808)
T ss_pred eeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH------HHHHHHH-HHhcCCC----------C
Confidence 455667999999999999999999999999999999999999999622 1222222 2222211 1
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002336 852 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 884 (935)
Q Consensus 852 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~ 884 (935)
++......+.++++..+..||.+|.++.+++..
T Consensus 219 ~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 219 PPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred CcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 233445578999999999999999999999764
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=329.61 Aligned_cols=247 Identities=23% Similarity=0.334 Sum_probs=199.2
Q ss_pred ccccccccEEEEEEEECCCcEEEEEEccCcchhh---hHHHHHHHHHHHhcCCCcccccceeeec----cceEEEEEEec
Q 002336 619 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHR---TQQFVTEVALLSRIHHRNLVPLIGYCEE----EHQRILVYEYM 691 (935)
Q Consensus 619 ~~LG~G~fG~Vy~~~~~~g~~vAvK~~~~~~~~~---~~~~~~E~~iL~~L~HpnIv~l~g~~~~----~~~~~lV~E~~ 691 (935)
..||+|++|.||+|.+. |+.||||+++...... .+.+.+|+.+|++++||||++++|++.+ ....++||||+
T Consensus 26 ~~i~~g~~~~v~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIFN-NKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEEC-CEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 56999999999999985 8999999987543322 4678899999999999999999999866 34678999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccccc
Q 002336 692 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 771 (935)
Q Consensus 692 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~ 771 (935)
++|+|.+++.. ...+++...++++.|++.||.|||+ ..+++||||||+|||+++++.+||+|||+++......
T Consensus 105 ~~g~L~~~l~~---~~~~~~~~~~~i~~~i~~~l~~lH~--~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~-- 177 (283)
T PHA02988 105 TRGYLREVLDK---EKDLSFKTKLDMAIDCCKGLYNLYK--YTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP-- 177 (283)
T ss_pred CCCcHHHHHhh---CCCCChhHHHHHHHHHHHHHHHHHh--cCCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc--
Confidence 99999999974 4568899999999999999999997 2488899999999999999999999999987654322
Q ss_pred eeecccCCccccCCCCCCC--CCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeeccccccc
Q 002336 772 ISSVARGTVGYLDPEYYGN--QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 849 (935)
Q Consensus 772 ~~~~~~gt~~y~APE~l~~--~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~ 849 (935)
....|+..|+|||.+.+ ..++.++|||||||++|||++|+.||...... +........+.. +.
T Consensus 178 --~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~------~~~~~i~~~~~~-----~~-- 242 (283)
T PHA02988 178 --FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK------EIYDLIINKNNS-----LK-- 242 (283)
T ss_pred --ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHH------HHHHHHHhcCCC-----CC--
Confidence 12347889999999876 68899999999999999999999999743221 111111211111 11
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhhhh
Q 002336 850 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 890 (935)
Q Consensus 850 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~~~ 890 (935)
.+......+.+++.+||+.||++|||++|+++.|+....
T Consensus 243 --~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 243 --LPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred --CCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence 111233468899999999999999999999999987653
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=331.77 Aligned_cols=264 Identities=26% Similarity=0.403 Sum_probs=202.8
Q ss_pred HHHHhhcccccccccEEEEEEEECC-----------------CcEEEEEEccCcc-hhhhHHHHHHHHHHHhcCCCcccc
Q 002336 612 EATNNFCKKIGKGSFGSVYYGKMKD-----------------GKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVP 673 (935)
Q Consensus 612 ~~~~~~~~~LG~G~fG~Vy~~~~~~-----------------g~~vAvK~~~~~~-~~~~~~~~~E~~iL~~L~HpnIv~ 673 (935)
+..+.+.+.||+|+||.||++.+++ +..||+|.+.... ......+.+|++++.+++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 3456678899999999999997642 3469999987643 334567999999999999999999
Q ss_pred cceeeeccceEEEEEEecCCCCHHHHhccCC----------------CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceE
Q 002336 674 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSV----------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGII 737 (935)
Q Consensus 674 l~g~~~~~~~~~lV~E~~~~gsL~~~L~~~~----------------~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~iv 737 (935)
+++++.+.+..++||||+++|+|.+++.... ....+++..+++++.|++.||+|||+ .+|+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~iv 160 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS---LNFV 160 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH---CCcc
Confidence 9999999999999999999999999886421 11346788999999999999999998 8999
Q ss_pred ecCCCCCCccccCCCcEEEeecccccccccccc-ceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHh--CCC
Q 002336 738 HRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS--GKK 814 (935)
Q Consensus 738 H~DLkp~NILld~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLlt--G~~ 814 (935)
||||||+|||+++++.+||+|||+++....... .......++..|+|||.+....++.++||||||+++|||++ +..
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~ 240 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ 240 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence 999999999999999999999999976533221 11222345788999999988889999999999999999987 556
Q ss_pred CCCccCcccchhHHHHHHHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhh
Q 002336 815 PVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 887 (935)
Q Consensus 815 Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~ 887 (935)
||..... ......+............. ..+...+..+.+++.+||+.+|++|||++||.+.|++
T Consensus 241 p~~~~~~---~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 241 PYGELTD---EQVIENAGEFFRDQGRQVYL------FRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCCcCCH---HHHHHHHHHHhhhccccccc------cCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 7653221 22223333222211110000 0111223478899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=342.94 Aligned_cols=261 Identities=28% Similarity=0.441 Sum_probs=204.7
Q ss_pred HHHHHHhhcccccccccEEEEEEEE------CCCcEEEEEEccCcc-hhhhHHHHHHHHHHHhc-CCCcccccceeeecc
Q 002336 610 LEEATNNFCKKIGKGSFGSVYYGKM------KDGKEVAVKIMADSC-SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEE 681 (935)
Q Consensus 610 l~~~~~~~~~~LG~G~fG~Vy~~~~------~~g~~vAvK~~~~~~-~~~~~~~~~E~~iL~~L-~HpnIv~l~g~~~~~ 681 (935)
+....+++.+.||+|+||.||+|.+ ..+..||||+++... ....+.+.+|+++++.+ +||||++++++|.+.
T Consensus 32 ~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~ 111 (375)
T cd05104 32 FPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVG 111 (375)
T ss_pred cchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccC
Confidence 3445677889999999999999974 246689999987543 23446788999999999 899999999999999
Q ss_pred ceEEEEEEecCCCCHHHHhccCC---------------------------------------------------------
Q 002336 682 HQRILVYEYMHNGTLRDRLHGSV--------------------------------------------------------- 704 (935)
Q Consensus 682 ~~~~lV~E~~~~gsL~~~L~~~~--------------------------------------------------------- 704 (935)
...++||||+++|+|.+++....
T Consensus 112 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (375)
T cd05104 112 GPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRS 191 (375)
T ss_pred CcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccc
Confidence 99999999999999999886421
Q ss_pred ---------------CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccc
Q 002336 705 ---------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 769 (935)
Q Consensus 705 ---------------~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~ 769 (935)
....+++..+++++.|+++||+|||+ ++|+||||||+|||+++++.+||+|||+++......
T Consensus 192 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 268 (375)
T cd05104 192 GSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIRNDS 268 (375)
T ss_pred ceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCchhhEEEECCCcEEEecCccceeccCcc
Confidence 11257889999999999999999998 899999999999999999999999999998654332
Q ss_pred cc-eeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCcccchhHHHHHHHhhhcCCeeeccccc
Q 002336 770 TH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 847 (935)
Q Consensus 770 ~~-~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~ 847 (935)
.. ......++..|+|||.+.+..++.++||||||+++|||++ |..||..... .....++ +..+.... .
T Consensus 269 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~--~~~~~~~----~~~~~~~~--~-- 338 (375)
T cd05104 269 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPV--DSKFYKM----IKEGYRML--S-- 338 (375)
T ss_pred cccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCc--hHHHHHH----HHhCccCC--C--
Confidence 21 1112234667999999999999999999999999999998 8889863322 1122222 22221100 0
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhh
Q 002336 848 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 888 (935)
Q Consensus 848 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~ 888 (935)
+......+.+++.+||+.+|++||+++||++.|++.
T Consensus 339 -----~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 339 -----PECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred -----CCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 111123688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=322.70 Aligned_cols=258 Identities=26% Similarity=0.474 Sum_probs=207.6
Q ss_pred HHHHHHhhcccccccccEEEEEEEECCCcEEEEEEccCcchhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEE
Q 002336 610 LEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 689 (935)
Q Consensus 610 l~~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E 689 (935)
+....+++.+.||+|++|.||+|.+.+++.||+|.++... ...+.+.+|++++++++||||+++++++...+..++|||
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (261)
T cd05068 3 IDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTE 81 (261)
T ss_pred cchhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeee
Confidence 3455677889999999999999998888899999987543 235678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccc
Q 002336 690 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 769 (935)
Q Consensus 690 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~ 769 (935)
|+++++|.+++.... ...+++..+.+++.|++.||.|||+ ++++||||||+||++++++.+||+|||+++......
T Consensus 82 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05068 82 LMKYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEA---QNYIHRDLAARNVLVGENNICKVADFGLARVIKEDI 157 (261)
T ss_pred cccCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCcceEEEcCCCCEEECCcceEEEccCCc
Confidence 999999999987542 4568999999999999999999997 899999999999999999999999999998765332
Q ss_pred cceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCcccchhHHHHHHHhhhcCCeeecccccc
Q 002336 770 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 848 (935)
Q Consensus 770 ~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l 848 (935)
.........+..|+|||.+.+..++.++||||||++++||++ |+.||...... .... .+..+...
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~----~~~~~~~~------- 223 (261)
T cd05068 158 YEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA---EVLQ----QVDQGYRM------- 223 (261)
T ss_pred ccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH---HHHH----HHHcCCCC-------
Confidence 211111223457999999998899999999999999999999 99998633211 1111 11111100
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhh
Q 002336 849 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 888 (935)
Q Consensus 849 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~ 888 (935)
..+......+.+++.+|++.+|++||+++++++.|++.
T Consensus 224 --~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 224 --PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred --CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 01112234788999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=323.37 Aligned_cols=256 Identities=26% Similarity=0.463 Sum_probs=207.0
Q ss_pred HHHHHhhcccccccccEEEEEEEECCCcEEEEEEccCcchhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEe
Q 002336 611 EEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 690 (935)
Q Consensus 611 ~~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~ 690 (935)
....+++.++||+|++|.||+|...+++.||+|.+.... ...+.+.+|+.++++++|+||+++++.+...+..+++|||
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05072 4 PRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEY 82 (261)
T ss_pred chHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEec
Confidence 345567789999999999999998888999999886532 3456889999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccccccc
Q 002336 691 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 770 (935)
Q Consensus 691 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~ 770 (935)
+++++|.+++... ....+++.+++.++.|+++||+|||+ .+++||||||+||++++++.+||+|||++........
T Consensus 83 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05072 83 MAKGSLLDFLKSD-EGGKVLLPKLIDFSAQIAEGMAYIER---KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY 158 (261)
T ss_pred CCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEecCCCcEEECCCccceecCCCce
Confidence 9999999998753 34568889999999999999999998 8999999999999999999999999999987644322
Q ss_pred ceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCcccchhHHHHHHHhhhcCCeeeccccccc
Q 002336 771 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 849 (935)
Q Consensus 771 ~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~ 849 (935)
.......++..|+|||.+....++.++||||||+++|+|++ |+.||...... ....+ +..+... + ..
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~---~~~~~----~~~~~~~----~-~~ 226 (261)
T cd05072 159 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS---DVMSA----LQRGYRM----P-RM 226 (261)
T ss_pred eccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH---HHHHH----HHcCCCC----C-CC
Confidence 22222335678999999988889999999999999999998 99999632211 12221 1111110 1 01
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhh
Q 002336 850 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 887 (935)
Q Consensus 850 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~ 887 (935)
......+.+++.+|+..+|++||+++++.+.|++
T Consensus 227 ----~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 227 ----ENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred ----CCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 1123468899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=320.57 Aligned_cols=256 Identities=30% Similarity=0.466 Sum_probs=206.1
Q ss_pred HHHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcchhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEe
Q 002336 612 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 690 (935)
Q Consensus 612 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~ 690 (935)
...+.+.+.||+|++|.||+|.++ .++.||+|.+... ....+.+.+|++++++++|+||+++++++..+...+++|||
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (263)
T cd05052 5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 83 (263)
T ss_pred hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEe
Confidence 344567789999999999999876 5889999998654 33456789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccccccc
Q 002336 691 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 770 (935)
Q Consensus 691 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~ 770 (935)
+++++|.+++... ....+++..++.++.|+++||+|||+ ++++||||||+||++++++.+||+|||++........
T Consensus 84 ~~~~~L~~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~ 159 (263)
T cd05052 84 MTYGNLLDYLREC-NRQEVNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 159 (263)
T ss_pred CCCCcHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCcEEeCCCcccccccccee
Confidence 9999999998643 24568999999999999999999997 8999999999999999999999999999887644322
Q ss_pred ceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCcccchhHHHHHHHhhhcCCeeeccccccc
Q 002336 771 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 849 (935)
Q Consensus 771 ~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~ 849 (935)
.......++..|+|||.+.+..++.++||||||+++|||++ |..||...+.. ... ..+..+.. +
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~---~~~----~~~~~~~~-----~--- 224 (263)
T cd05052 160 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS---QVY----ELLEKGYR-----M--- 224 (263)
T ss_pred eccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---HHH----HHHHCCCC-----C---
Confidence 22222234668999999988899999999999999999998 99998743221 111 11211110 0
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhh
Q 002336 850 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 888 (935)
Q Consensus 850 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~ 888 (935)
..+......+.+++.+|++.+|++||++.++++.|+++
T Consensus 225 -~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 225 -ERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred -CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 11122234688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=330.75 Aligned_cols=262 Identities=23% Similarity=0.299 Sum_probs=202.3
Q ss_pred HHHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcch-hhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEE
Q 002336 612 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 689 (935)
Q Consensus 612 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~-~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E 689 (935)
...+++.+.||+|+||.||++.+. ++..+|+|.+..... ...+.+.+|++++++++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 345667789999999999999876 688899999875432 334679999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccc
Q 002336 690 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 769 (935)
Q Consensus 690 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~ 769 (935)
|+++++|.+++.. ...+++..+..++.|++.||.|||+ ..+|+||||||+|||++.++.+||+|||++.......
T Consensus 84 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~--~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 158 (331)
T cd06649 84 HMDGGSLDQVLKE---AKRIPEEILGKVSIAVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 158 (331)
T ss_pred cCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHhh--cCCEEcCCCChhhEEEcCCCcEEEccCcccccccccc
Confidence 9999999999873 4568899999999999999999997 2469999999999999999999999999987653322
Q ss_pred cceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCC---ee-----
Q 002336 770 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD---VI----- 841 (935)
Q Consensus 770 ~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~---~~----- 841 (935)
.....|+..|+|||++.+..++.++|||||||++|||++|+.||...+..+ +..........+. ..
T Consensus 159 ---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 232 (331)
T cd06649 159 ---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE---LEAIFGRPVVDGEEGEPHSISPR 232 (331)
T ss_pred ---cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHhcccccccccCCccccCcc
Confidence 223458999999999998899999999999999999999999997433211 1111110000000 00
Q ss_pred ----------------------eccc----ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002336 842 ----------------------SIVD----PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 884 (935)
Q Consensus 842 ----------------------~~~d----~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~ 884 (935)
...+ ..............+.+++.+||+.||++|||++|+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h 301 (331)
T cd06649 233 PRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH 301 (331)
T ss_pred cccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0000 000000001123468899999999999999999999875
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=340.94 Aligned_cols=262 Identities=29% Similarity=0.448 Sum_probs=205.0
Q ss_pred HHHHHHhhcccccccccEEEEEEEEC------CCcEEEEEEccCcc-hhhhHHHHHHHHHHHhc-CCCcccccceeeecc
Q 002336 610 LEEATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSC-SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEE 681 (935)
Q Consensus 610 l~~~~~~~~~~LG~G~fG~Vy~~~~~------~g~~vAvK~~~~~~-~~~~~~~~~E~~iL~~L-~HpnIv~l~g~~~~~ 681 (935)
+....+++.+.||+|+||.||+|.+. +++.||+|+++... ......+.+|+++++.+ +|+||++++++|...
T Consensus 35 ~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~ 114 (374)
T cd05106 35 FPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHG 114 (374)
T ss_pred ccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCC
Confidence 45567778899999999999998752 34579999997543 23346788999999999 899999999999999
Q ss_pred ceEEEEEEecCCCCHHHHhccCC---------------------------------------------------------
Q 002336 682 HQRILVYEYMHNGTLRDRLHGSV--------------------------------------------------------- 704 (935)
Q Consensus 682 ~~~~lV~E~~~~gsL~~~L~~~~--------------------------------------------------------- 704 (935)
...++||||+++|+|.+++....
T Consensus 115 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (374)
T cd05106 115 GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQS 194 (374)
T ss_pred CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccc
Confidence 99999999999999999875321
Q ss_pred ----------CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccccc-ee
Q 002336 705 ----------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH-IS 773 (935)
Q Consensus 705 ----------~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~-~~ 773 (935)
...++++.++++++.|+++||+|||+ ++|+||||||+|||+++++.+||+|||+++........ ..
T Consensus 195 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~---~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~ 271 (374)
T cd05106 195 SDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLAS---KNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVK 271 (374)
T ss_pred ccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeec
Confidence 11347888999999999999999998 89999999999999999999999999998765432211 11
Q ss_pred ecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccCCC
Q 002336 774 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNV 852 (935)
Q Consensus 774 ~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~~~ 852 (935)
....++..|+|||++.+..++.++||||||+++|||++ |+.||....... ... ..+..+. .+..
T Consensus 272 ~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~--~~~----~~~~~~~-----~~~~---- 336 (374)
T cd05106 272 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS--KFY----KMVKRGY-----QMSR---- 336 (374)
T ss_pred cCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH--HHH----HHHHccc-----CccC----
Confidence 12235668999999988899999999999999999997 999997332211 111 1111111 0000
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhhh
Q 002336 853 KIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI 889 (935)
Q Consensus 853 ~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~~ 889 (935)
+......+.+++.+||+.+|++||++.+|++.|+++.
T Consensus 337 ~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 337 PDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 1111246889999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=317.44 Aligned_cols=251 Identities=31% Similarity=0.515 Sum_probs=201.8
Q ss_pred HHHhhcccccccccEEEEEEEECCCcEEEEEEccCcchhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEecC
Q 002336 613 ATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 692 (935)
Q Consensus 613 ~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~~ 692 (935)
..+++.+.||+|+||.||++.++++..+|+|.+.... ...+.+.+|++++++++||||+++++++......++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 3456678999999999999999888899999876432 234678899999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccccce
Q 002336 693 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 772 (935)
Q Consensus 693 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~~ 772 (935)
+|+|.+++... ...+++..++.++.|++.||+|||+ ++++||||||+||++++++.+||+|||.++.........
T Consensus 83 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05114 83 NGCLLNYLRQR--QGKLSKDMLLSMCQDVCEGMEYLER---NSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS 157 (256)
T ss_pred CCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcceEEEcCCCeEEECCCCCccccCCCceec
Confidence 99999998743 2458899999999999999999998 899999999999999999999999999987654322222
Q ss_pred eecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccCC
Q 002336 773 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 851 (935)
Q Consensus 773 ~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~~ 851 (935)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.||..... ...... +..+.. ...+
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~---~~~~~~----i~~~~~--~~~~----- 223 (256)
T cd05114 158 SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN---YEVVEM----ISRGFR--LYRP----- 223 (256)
T ss_pred cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH---HHHHHH----HHCCCC--CCCC-----
Confidence 222235668999999988889999999999999999999 8999863321 122222 111111 1111
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 002336 852 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAI 885 (935)
Q Consensus 852 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L 885 (935)
......+.+++.+||+.+|++||+++|+++.|
T Consensus 224 --~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 224 --KLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred --CCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 11223688999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=320.34 Aligned_cols=255 Identities=27% Similarity=0.437 Sum_probs=209.9
Q ss_pred HHHHhhcccccccccEEEEEEEECCCcEEEEEEccCcchhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEec
Q 002336 612 EATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 691 (935)
Q Consensus 612 ~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~ 691 (935)
...|.+.+.||+|+||.||+|.+.+++.+++|.+..........+.+|+++++.++|+||+++++++......++||||+
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELM 84 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeec
Confidence 45677889999999999999999889999999998765555678999999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccccc
Q 002336 692 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 771 (935)
Q Consensus 692 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~ 771 (935)
++++|.+++... ....+++.++.+++.|++.||+|||+ ++++||||||+||++++++.+||+|||.+.........
T Consensus 85 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~ 160 (261)
T cd05148 85 EKGSLLAFLRSP-EGQVLPVASLIDMACQVAEGMAYLEE---QNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL 160 (261)
T ss_pred ccCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccCcceEEEcCCceEEEccccchhhcCCcccc
Confidence 999999999754 34568999999999999999999997 89999999999999999999999999998765433221
Q ss_pred eeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccC
Q 002336 772 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 850 (935)
Q Consensus 772 ~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~ 850 (935)
. ....++..|+|||.+.+..++.++||||||+++++|++ |+.||..... ....+... .+.. .
T Consensus 161 ~-~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~---~~~~~~~~----~~~~-----~---- 223 (261)
T cd05148 161 S-SDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNN---HEVYDQIT----AGYR-----M---- 223 (261)
T ss_pred c-cCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCH---HHHHHHHH----hCCc-----C----
Confidence 1 12335678999999988889999999999999999998 8999964321 11111111 1110 0
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhh
Q 002336 851 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 887 (935)
Q Consensus 851 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~ 887 (935)
..+......+.+++.+|++.+|++|||++++++.|+.
T Consensus 224 ~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 224 PCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 1112223468899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=324.95 Aligned_cols=250 Identities=24% Similarity=0.303 Sum_probs=198.6
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCcch---hhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEe
Q 002336 615 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 690 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~---~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~ 690 (935)
++..+.||+|+||.||++.+. +|+.||+|.+..... .....+.+|++++++++|+||+++++.+.+.+..++||||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 345688999999999999864 789999999864321 2234678899999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccccccc
Q 002336 691 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 770 (935)
Q Consensus 691 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~ 770 (935)
+++|+|.+.+... ....+++..+..++.|++.||+|||+ ++|+||||||+|||+++++.+||+|||++........
T Consensus 82 ~~~g~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 157 (285)
T cd05631 82 MNGGDLKFHIYNM-GNPGFDEQRAIFYAAELCCGLEDLQR---ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET 157 (285)
T ss_pred cCCCcHHHHHHhh-CCCCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCe
Confidence 9999999887643 23468999999999999999999998 8999999999999999999999999999876533221
Q ss_pred ceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccC
Q 002336 771 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 850 (935)
Q Consensus 771 ~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~ 850 (935)
.....|+..|+|||++.+..++.++|||||||++|||++|+.||......... +-+...+.... .
T Consensus 158 --~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~---~~~~~~~~~~~----------~ 222 (285)
T cd05631 158 --VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKR---EEVDRRVKEDQ----------E 222 (285)
T ss_pred --ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhH---HHHHHHhhccc----------c
Confidence 22345899999999999999999999999999999999999999743322111 11111111110 0
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 002336 851 NVKIESIWRIAEVAIQCVEQRGFSRPK-----MQEIVL 883 (935)
Q Consensus 851 ~~~~~~~~~l~~li~~Cl~~dP~~RPs-----~~ev~~ 883 (935)
.++......+.+++.+||+.+|++||+ ++|+++
T Consensus 223 ~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 223 EYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred cCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 111122346789999999999999997 777775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=332.92 Aligned_cols=242 Identities=24% Similarity=0.349 Sum_probs=196.3
Q ss_pred ccccccccEEEEEEEEC-CCcEEEEEEccCcc---hhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEecCCC
Q 002336 619 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNG 694 (935)
Q Consensus 619 ~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~~~g 694 (935)
+.||+|+||.||++..+ +|+.||+|+++... ......+.+|++++++++||||+++++.+...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999875 68999999987532 223456788999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccccceee
Q 002336 695 TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISS 774 (935)
Q Consensus 695 sL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~ 774 (935)
+|.+.+.. ...+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++....... ...
T Consensus 81 ~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~-~~~ 153 (323)
T cd05571 81 ELFFHLSR---ERVFSEDRARFYGAEIVSALGYLHS---CDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA-TMK 153 (323)
T ss_pred cHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCC-ccc
Confidence 99998873 4578999999999999999999998 8999999999999999999999999999875322211 122
Q ss_pred cccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccCCCCH
Q 002336 775 VARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKI 854 (935)
Q Consensus 775 ~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~~~~~ 854 (935)
...||+.|+|||++.+..++.++||||+||++|||++|+.||...+.. ... ..+..+.. .+ +.
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~---~~~----~~~~~~~~------~~----p~ 216 (323)
T cd05571 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---KLF----ELILMEEI------RF----PR 216 (323)
T ss_pred ceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHH---HHH----HHHHcCCC------CC----CC
Confidence 345899999999999999999999999999999999999999733221 111 11111111 11 11
Q ss_pred HHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 002336 855 ESIWRIAEVAIQCVEQRGFSRP-----KMQEIVLA 884 (935)
Q Consensus 855 ~~~~~l~~li~~Cl~~dP~~RP-----s~~ev~~~ 884 (935)
.....+.+++.+||+.||++|| +++++++.
T Consensus 217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 217 TLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred CCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 2234678999999999999999 79988753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=346.86 Aligned_cols=262 Identities=23% Similarity=0.281 Sum_probs=211.1
Q ss_pred HHHHhhcccccccccEEEEEEEECCC-cEEEEEEccCcchhhhHHHHHHHHHHHhcC-CCccccccee-eec------cc
Q 002336 612 EATNNFCKKIGKGSFGSVYYGKMKDG-KEVAVKIMADSCSHRTQQFVTEVALLSRIH-HRNLVPLIGY-CEE------EH 682 (935)
Q Consensus 612 ~~~~~~~~~LG~G~fG~Vy~~~~~~g-~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~-HpnIv~l~g~-~~~------~~ 682 (935)
....++.+.|.+|||+.||+|....+ .++|+|++-.......+.+.+|+++|++|+ |+|||.+++. ... .-
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~ 115 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW 115 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence 34456688999999999999988765 999999987777777889999999999997 9999999993 211 23
Q ss_pred eEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccc
Q 002336 683 QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS 762 (935)
Q Consensus 683 ~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla 762 (935)
+++|.||||+||.|-|++.... +..|++.++++|+.|+++|+++||. +..+|||||||.+||||+.+++.||||||.+
T Consensus 116 EvllLmEyC~gg~Lvd~mn~Rl-q~~lte~eVLkIf~dv~~AVa~mH~-~~pPiIHRDLKiENvLls~~g~~KLCDFGSa 193 (738)
T KOG1989|consen 116 EVLLLMEYCKGGSLVDFMNTRL-QTRLTEDEVLKIFYDVCEAVAAMHY-LKPPIIHRDLKIENVLLSADGNYKLCDFGSA 193 (738)
T ss_pred EEEeehhhccCCcHHHHHHHHH-hccCChHHHHHHHHHHHHHHHHHhc-CCCccchhhhhhhheEEcCCCCEEeCccccc
Confidence 6789999999999999998654 3449999999999999999999997 5778999999999999999999999999998
Q ss_pred ccccccccc--------eeecccCCccccCCCCC---CCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHH
Q 002336 763 RQAEEDLTH--------ISSVARGTVGYLDPEYY---GNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWA 831 (935)
Q Consensus 763 ~~~~~~~~~--------~~~~~~gt~~y~APE~l---~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~ 831 (935)
...-..... ..-....|+.|+|||.+ .+..+++|+|||+|||+||-|+....||+....
T Consensus 194 tt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~---------- 263 (738)
T KOG1989|consen 194 TTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK---------- 263 (738)
T ss_pred ccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc----------
Confidence 653222110 01123479999999975 677899999999999999999999999983211
Q ss_pred HHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhhhhhccC
Q 002336 832 RSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKG 894 (935)
Q Consensus 832 ~~~i~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~~~~~~~ 894 (935)
..|++-...--..+.....+.+||..||+.+|.+||++.+|+..+-++...+..
T Consensus 264 ---------laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~~ 317 (738)
T KOG1989|consen 264 ---------LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPCP 317 (738)
T ss_pred ---------eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCCC
Confidence 223332221111235667899999999999999999999999998877765544
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=323.04 Aligned_cols=263 Identities=19% Similarity=0.204 Sum_probs=199.7
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc--hhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEec
Q 002336 615 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 691 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~ 691 (935)
|++.+.||+|+||.||+++++ +++.+|+|++.... ....+.+.+|+++++.++||||+++++++...+..++||||+
T Consensus 3 y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 82 (287)
T cd07848 3 FEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYV 82 (287)
T ss_pred ceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEecC
Confidence 456789999999999999986 57899999986532 223467889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccccc
Q 002336 692 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 771 (935)
Q Consensus 692 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~ 771 (935)
+++.+..+.. ....+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||++.........
T Consensus 83 ~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 156 (287)
T cd07848 83 EKNMLELLEE---MPNGVPPEKVRSYIYQLIKAIHWCHK---NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNA 156 (287)
T ss_pred CCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccCcccccccccc
Confidence 9887765543 23568999999999999999999998 89999999999999999999999999999876433222
Q ss_pred eeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHH---------HHHhhhcCCeee
Q 002336 772 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHW---------ARSMIKKGDVIS 842 (935)
Q Consensus 772 ~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~---------~~~~i~~~~~~~ 842 (935)
......|++.|+|||++.+..++.++||||+||++|||++|+.||......+....... .+..........
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (287)
T cd07848 157 NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHG 236 (287)
T ss_pred cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcc
Confidence 22334589999999999888899999999999999999999999974432211111110 000001111111
Q ss_pred cccccccC------CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 843 IVDPVLIG------NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 843 ~~d~~l~~------~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
...+.... .........+.+++.+||+.+|++|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 237 LRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred cccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 10011000 001112346899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=327.32 Aligned_cols=202 Identities=26% Similarity=0.393 Sum_probs=175.2
Q ss_pred HHHHHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcch-hhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEE
Q 002336 610 LEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILV 687 (935)
Q Consensus 610 l~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~-~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV 687 (935)
+....|++.+.||+|+||.||++.+. +++.+|+|.+..... .....+.+|+++++.++||||+++++++.+.+..++|
T Consensus 2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 81 (333)
T cd06650 2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 81 (333)
T ss_pred cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEE
Confidence 34466788899999999999999886 688899998865432 3346789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccc
Q 002336 688 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 767 (935)
Q Consensus 688 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~ 767 (935)
|||+++++|.+++.. ...+++..+..++.|++.||.|||+ ..+++||||||+|||+++++.+||+|||++.....
T Consensus 82 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~l~~~l~~lH~--~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~ 156 (333)
T cd06650 82 MEHMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 156 (333)
T ss_pred EecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhh
Confidence 999999999999873 4568899999999999999999997 35799999999999999999999999999876533
Q ss_pred cccceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCcc
Q 002336 768 DLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVE 819 (935)
Q Consensus 768 ~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~ 819 (935)
.. .....|+..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 157 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~ 205 (333)
T cd06650 157 SM---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP 205 (333)
T ss_pred hc---cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 21 12345889999999999888999999999999999999999999743
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=312.92 Aligned_cols=249 Identities=23% Similarity=0.355 Sum_probs=212.2
Q ss_pred HHHHHhhcccccccccEEEEEEEE-CCCcEEEEEEccCcch---hhhHHHHHHHHHHHhcCCCcccccceeeeccceEEE
Q 002336 611 EEATNNFCKKIGKGSFGSVYYGKM-KDGKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRIL 686 (935)
Q Consensus 611 ~~~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vAvK~~~~~~~---~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~l 686 (935)
.+..|+|.+.||+|.||.|-+|.. ..|+.||||.++++.. ++.-.+.+|+++|..|+||||+.++.+|+..+...+
T Consensus 51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvi 130 (668)
T KOG0611|consen 51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVI 130 (668)
T ss_pred hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEE
Confidence 467888999999999999999964 6899999999976533 344568899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccc
Q 002336 687 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 766 (935)
Q Consensus 687 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~ 766 (935)
||||..+|.|+|++. ..+.+++.+...++.||..|+.|+|+ ++++|||||.+|||+|+++++||+|||++..+.
T Consensus 131 vMEYaS~GeLYDYiS---er~~LsErEaRhfFRQIvSAVhYCHk---nrVvHRDLKLENILLD~N~NiKIADFGLSNly~ 204 (668)
T KOG0611|consen 131 VMEYASGGELYDYIS---ERGSLSEREARHFFRQIVSAVHYCHK---NRVVHRDLKLENILLDQNNNIKIADFGLSNLYA 204 (668)
T ss_pred EEEecCCccHHHHHH---HhccccHHHHHHHHHHHHHHHHHHhh---ccceecccchhheeecCCCCeeeeccchhhhhc
Confidence 999999999999998 45789999999999999999999997 999999999999999999999999999998875
Q ss_pred ccccceeecccCCccccCCCCCCCCCC-CchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeeccc
Q 002336 767 EDLTHISSVARGTVGYLDPEYYGNQQL-TEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 845 (935)
Q Consensus 767 ~~~~~~~~~~~gt~~y~APE~l~~~~~-s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d 845 (935)
+.. ..+..+|++-|.+||++.+.+| ++..|-||+||+||-|+.|..||++.+.. .+-++|..|.+.+-
T Consensus 205 ~~k--fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk-------~lvrQIs~GaYrEP-- 273 (668)
T KOG0611|consen 205 DKK--FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHK-------RLVRQISRGAYREP-- 273 (668)
T ss_pred ccc--HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHH-------HHHHHhhcccccCC--
Confidence 542 2455789999999999999877 58999999999999999999999865542 12234444544221
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 002336 846 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAI 885 (935)
Q Consensus 846 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L 885 (935)
+.+....-+|++||..+|++|-|+++|....
T Consensus 274 ---------~~PSdA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 274 ---------ETPSDASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred ---------CCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 2222456789999999999999999998763
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=321.39 Aligned_cols=257 Identities=28% Similarity=0.478 Sum_probs=206.4
Q ss_pred HHHHhhcccccccccEEEEEEEECC------CcEEEEEEccCcchh-hhHHHHHHHHHHHhcCCCcccccceeeeccceE
Q 002336 612 EATNNFCKKIGKGSFGSVYYGKMKD------GKEVAVKIMADSCSH-RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQR 684 (935)
Q Consensus 612 ~~~~~~~~~LG~G~fG~Vy~~~~~~------g~~vAvK~~~~~~~~-~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~ 684 (935)
..++.+.+.||+|+||.||+|.+.+ ++.||+|.++..... ..+.+.+|++++++++|+||+++++++......
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 4567788999999999999998643 478999998765444 457899999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhccCC-----------CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCc
Q 002336 685 ILVYEYMHNGTLRDRLHGSV-----------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMR 753 (935)
Q Consensus 685 ~lV~E~~~~gsL~~~L~~~~-----------~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~ 753 (935)
++||||+++++|.+++.... ....+++.++..++.|++.||+|||+ ++++||||||+||+++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLAS---QHFVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeeccccccceEEEcCCCe
Confidence 99999999999999987432 23457899999999999999999997 89999999999999999999
Q ss_pred EEEeecccccccccccc-ceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCcccchhHHHHH
Q 002336 754 AKVSDFGLSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWA 831 (935)
Q Consensus 754 vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~ 831 (935)
+||+|||++........ .......+++.|+|||++.+..++.++||||||+++|||++ |+.||...... ...+.
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~---~~~~~- 236 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE---EVIEC- 236 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHH---HHHHH-
Confidence 99999999875432211 11223345788999999999999999999999999999998 99998633221 12222
Q ss_pred HHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhh
Q 002336 832 RSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 887 (935)
Q Consensus 832 ~~~i~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~ 887 (935)
+..+..... +......+.+++.+||+.+|++||+++||++.|++
T Consensus 237 ---~~~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 237 ---ITQGRLLQR---------PRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred ---HHcCCcCCC---------CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 222222111 11223468899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=330.72 Aligned_cols=261 Identities=30% Similarity=0.452 Sum_probs=218.7
Q ss_pred hhHHHHHHhhcccccccccEEEEEEEECC-CcEEEEEEccCcchhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEE
Q 002336 608 PELEEATNNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRIL 686 (935)
Q Consensus 608 ~~l~~~~~~~~~~LG~G~fG~Vy~~~~~~-g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~l 686 (935)
.|+++....+.++||-|-||.||.|.|+. .-.||||.++.+. ....+|++|+.+|+.++|||+|+++|+|..+...||
T Consensus 262 WEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt-MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYI 340 (1157)
T KOG4278|consen 262 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYI 340 (1157)
T ss_pred hhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc-hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEE
Confidence 35666666678899999999999999984 5679999998653 346889999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccc
Q 002336 687 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 766 (935)
Q Consensus 687 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~ 766 (935)
|+|||..|+|.++|+.. ++..++....+.++.||+.||.||.. +.+|||||.++|+|+.++..+|++|||+++++.
T Consensus 341 iTEfM~yGNLLdYLRec-nr~ev~avvLlyMAtQIsSaMeYLEk---knFIHRDLAARNCLVgEnhiVKvADFGLsRlMt 416 (1157)
T KOG4278|consen 341 ITEFMCYGNLLDYLREC-NRSEVPAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHIVKVADFGLSRLMT 416 (1157)
T ss_pred EEecccCccHHHHHHHh-chhhcchhHHHHHHHHHHHHHHHHHH---hhhhhhhhhhhhccccccceEEeeccchhhhhc
Confidence 99999999999999876 45567788889999999999999997 999999999999999999999999999999976
Q ss_pred ccccceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCcccchhHHHHHHHhhhcCCeeeccc
Q 002336 767 EDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 845 (935)
Q Consensus 767 ~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d 845 (935)
.+.........-.+.|.|||.+....++.|+|||+|||+|||+.| |..||.+.+... +-..+++|
T Consensus 417 gDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSq-------VY~LLEkg------- 482 (1157)
T KOG4278|consen 417 GDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-------VYGLLEKG------- 482 (1157)
T ss_pred CCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHH-------HHHHHhcc-------
Confidence 544333333345789999999999999999999999999999999 889987544321 22223322
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhhh
Q 002336 846 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI 889 (935)
Q Consensus 846 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~~ 889 (935)
.+-+.+..++.++.+|++.||+++|.+||++.|+.+.++.+.
T Consensus 483 --yRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf 524 (1157)
T KOG4278|consen 483 --YRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMF 524 (1157)
T ss_pred --ccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHh
Confidence 222334455668999999999999999999999999998655
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=331.74 Aligned_cols=265 Identities=28% Similarity=0.497 Sum_probs=208.4
Q ss_pred hhhHHHHHHhhcccccccccEEEEEEEECCCcEEEEEEccCc--chhhhHHHHHHHHHHHhcCCCcccccceeeeccceE
Q 002336 607 LPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQR 684 (935)
Q Consensus 607 ~~~l~~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~~~~~--~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~ 684 (935)
..|+......+.+.||+|.||+||+|.|. | .||||++... ..+..+.|++|+.++++-+|.||+-+.|+|.....
T Consensus 386 ~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh-G-dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~- 462 (678)
T KOG0193|consen 386 EWEIPPEEVLLGERIGSGSFGTVYRGRWH-G-DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL- 462 (678)
T ss_pred ccccCHHHhhccceeccccccceeecccc-c-ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-
Confidence 34455555567889999999999999998 3 4999998653 34467889999999999999999999999988876
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccc
Q 002336 685 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 764 (935)
Q Consensus 685 ~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~ 764 (935)
.+|+.+|+|-+|+.+|+-. +..++..+.+.|+.|+|+||.|||+ ++|||||||..||++.+++.|||+|||++..
T Consensus 463 AIiTqwCeGsSLY~hlHv~--etkfdm~~~idIAqQiaqGM~YLHA---K~IIHrDLKSnNIFl~~~~kVkIgDFGLatv 537 (678)
T KOG0193|consen 463 AIITQWCEGSSLYTHLHVQ--ETKFDMNTTIDIAQQIAQGMDYLHA---KNIIHRDLKSNNIFLHEDLKVKIGDFGLATV 537 (678)
T ss_pred eeeehhccCchhhhhccch--hhhhhHHHHHHHHHHHHHhhhhhhh---hhhhhhhccccceEEccCCcEEEecccceee
Confidence 9999999999999999854 4668899999999999999999998 9999999999999999999999999999865
Q ss_pred cccc-ccceeecccCCccccCCCCCCC---CCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCe
Q 002336 765 AEED-LTHISSVARGTVGYLDPEYYGN---QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV 840 (935)
Q Consensus 765 ~~~~-~~~~~~~~~gt~~y~APE~l~~---~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~ 840 (935)
-... ........-|...|||||+++. .+|+..+||||||+++|||++|..||.....+... | ++..|.
T Consensus 538 k~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIi----f---mVGrG~- 609 (678)
T KOG0193|consen 538 KTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQII----F---MVGRGY- 609 (678)
T ss_pred eeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheE----E---Eecccc-
Confidence 3221 1111112236778999999864 47899999999999999999999999722221100 0 111111
Q ss_pred eecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhhhhh
Q 002336 841 ISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 891 (935)
Q Consensus 841 ~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~~~~ 891 (935)
-..|... ......+.+.+|+..||..++++||.+.+|+..|++++..
T Consensus 610 -l~pd~s~---~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~ 656 (678)
T KOG0193|consen 610 -LMPDLSK---IRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS 656 (678)
T ss_pred -cCccchh---hhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence 1111111 1223455788999999999999999999999999888774
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=326.01 Aligned_cols=243 Identities=23% Similarity=0.308 Sum_probs=198.0
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc---hhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEe
Q 002336 615 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 690 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~ 690 (935)
|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++.+....++||||
T Consensus 3 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 82 (291)
T cd05612 3 LERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEY 82 (291)
T ss_pred ceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeC
Confidence 456789999999999999876 68999999986432 12345688999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccccccc
Q 002336 691 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 770 (935)
Q Consensus 691 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~ 770 (935)
+++|+|.+++.. ...+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 83 ~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~- 155 (291)
T cd05612 83 VPGGELFSYLRN---SGRFSNSTGLFYASEIVCALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT- 155 (291)
T ss_pred CCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEEecCcchhccCCc-
Confidence 999999999873 4568899999999999999999998 899999999999999999999999999987654321
Q ss_pred ceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccC
Q 002336 771 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 850 (935)
Q Consensus 771 ~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~ 850 (935)
....|++.|+|||.+.+..++.++|||||||++|+|++|+.||...... ... +.+..+.. .+
T Consensus 156 ---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~---~~~----~~i~~~~~------~~-- 217 (291)
T cd05612 156 ---WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPF---GIY----EKILAGKL------EF-- 217 (291)
T ss_pred ---ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHH----HHHHhCCc------CC--
Confidence 2245899999999999888999999999999999999999999743221 111 11111111 01
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 002336 851 NVKIESIWRIAEVAIQCVEQRGFSRPK-----MQEIVLA 884 (935)
Q Consensus 851 ~~~~~~~~~l~~li~~Cl~~dP~~RPs-----~~ev~~~ 884 (935)
+......+.+++.+||+.||++||+ ++|+++.
T Consensus 218 --~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 218 --PRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred --CccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 1111236789999999999999995 7777654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=333.19 Aligned_cols=251 Identities=22% Similarity=0.314 Sum_probs=201.1
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc---hhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEe
Q 002336 615 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 690 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~ 690 (935)
|++.+.||+|+||.||+|++. +++.||+|++.... ....+.+.+|++++..++||||+++++++...+..++||||
T Consensus 3 y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 82 (333)
T cd05600 3 FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEY 82 (333)
T ss_pred cEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeC
Confidence 456789999999999999886 58999999987532 22345788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccccccc
Q 002336 691 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 770 (935)
Q Consensus 691 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~ 770 (935)
+++|+|.+++.. ...+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++.....
T Consensus 83 ~~g~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~--- 153 (333)
T cd05600 83 VPGGDFRTLLNN---LGVLSEDHARFYMAEMFEAVDALHE---LGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT--- 153 (333)
T ss_pred CCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEEEeCcCCccccc---
Confidence 999999999973 4568899999999999999999998 8999999999999999999999999999976543
Q ss_pred ceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccC
Q 002336 771 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 850 (935)
Q Consensus 771 ~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~ 850 (935)
......|++.|+|||++.+..++.++|||||||++|||++|+.||......+.. ..+... . ..+......
T Consensus 154 -~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~---~~i~~~---~---~~~~~~~~~ 223 (333)
T cd05600 154 -YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETW---ENLKYW---K---ETLQRPVYD 223 (333)
T ss_pred -ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHH---HHHHhc---c---ccccCCCCC
Confidence 123345899999999999889999999999999999999999999744332111 111100 0 000000000
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002336 851 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 884 (935)
Q Consensus 851 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~ 884 (935)
.........+.+++.+|+..+|++||+++|+++.
T Consensus 224 ~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 224 DPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred ccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 0001223467899999999999999999999865
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=320.62 Aligned_cols=251 Identities=30% Similarity=0.418 Sum_probs=197.2
Q ss_pred HHHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcchh--------------hhHHHHHHHHHHHhcCCCcccccce
Q 002336 612 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSH--------------RTQQFVTEVALLSRIHHRNLVPLIG 676 (935)
Q Consensus 612 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~~--------------~~~~~~~E~~iL~~L~HpnIv~l~g 676 (935)
-..|.+.+.||+|.||.|-+|... +++.||||++.+.... ..+...+|+.+|++++|||||++++
T Consensus 96 lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiE 175 (576)
T KOG0585|consen 96 LNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIE 175 (576)
T ss_pred hhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEE
Confidence 356778899999999999999865 7899999998643211 1247889999999999999999999
Q ss_pred eeec--cceEEEEEEecCCCCHHHHhccCCCCCC-CCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCc
Q 002336 677 YCEE--EHQRILVYEYMHNGTLRDRLHGSVNQKP-LDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMR 753 (935)
Q Consensus 677 ~~~~--~~~~~lV~E~~~~gsL~~~L~~~~~~~~-l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~ 753 (935)
+..+ .+..|||+|||..|.+...- ..++ +.+.++++++.++..||+|||. ++|+||||||+|+||+++|+
T Consensus 176 vLDDP~s~~~YlVley~s~G~v~w~p----~d~~els~~~Ar~ylrDvv~GLEYLH~---QgiiHRDIKPsNLLl~~~g~ 248 (576)
T KOG0585|consen 176 VLDDPESDKLYLVLEYCSKGEVKWCP----PDKPELSEQQARKYLRDVVLGLEYLHY---QGIIHRDIKPSNLLLSSDGT 248 (576)
T ss_pred eecCcccCceEEEEEeccCCccccCC----CCcccccHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEEcCCCc
Confidence 9876 45789999999998876543 2344 8999999999999999999998 99999999999999999999
Q ss_pred EEEeecccccccccc-----ccceeecccCCccccCCCCCCCC----CCCchhHHHHHHHHHHHHHhCCCCCCccCcccc
Q 002336 754 AKVSDFGLSRQAEED-----LTHISSVARGTVGYLDPEYYGNQ----QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAE 824 (935)
Q Consensus 754 vkL~DFGla~~~~~~-----~~~~~~~~~gt~~y~APE~l~~~----~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~ 824 (935)
+||+|||.+..+... .... ....|||.|+|||.+.++ ..+.+.||||+||+||+|+.|+.||-.. . .
T Consensus 249 VKIsDFGVs~~~~~~~~~~~d~~L-~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~-~--~ 324 (576)
T KOG0585|consen 249 VKISDFGVSNEFPQGSDEGSDDQL-SRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDD-F--E 324 (576)
T ss_pred EEeeccceeeecccCCccccHHHH-hhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccc-h--H
Confidence 999999998866221 1222 235799999999988663 3457899999999999999999999722 1 1
Q ss_pred hhHHHHHHHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 002336 825 LNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAI 885 (935)
Q Consensus 825 ~~l~~~~~~~i~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L 885 (935)
.. ...+|.+ ..+.--..++....+.+||.++|++||++|.++.||..+.
T Consensus 325 ~~----l~~KIvn--------~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hp 373 (576)
T KOG0585|consen 325 LE----LFDKIVN--------DPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHP 373 (576)
T ss_pred HH----HHHHHhc--------CcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecc
Confidence 11 1222222 2222111224456789999999999999999999987654
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=325.41 Aligned_cols=249 Identities=40% Similarity=0.617 Sum_probs=193.8
Q ss_pred hcccccccccEEEEEEEEC-----CCcEEEEEEccCcch-hhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEe
Q 002336 617 FCKKIGKGSFGSVYYGKMK-----DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 690 (935)
Q Consensus 617 ~~~~LG~G~fG~Vy~~~~~-----~g~~vAvK~~~~~~~-~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~ 690 (935)
+.+.||+|.||.||+|.+. .+..|+||+++.... ...+.|.+|++.+++++||||++++|++...+..++|+||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 4578999999999999887 367899999966433 3468899999999999999999999999988889999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccc-
Q 002336 691 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL- 769 (935)
Q Consensus 691 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~- 769 (935)
+++|+|.++|... ....+++..+++|+.|+++||.|||+ ++++||||+++||++++++.+||+|||++.......
T Consensus 83 ~~~g~L~~~L~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~---~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~ 158 (259)
T PF07714_consen 83 CPGGSLDDYLKSK-NKEPLSEQQRLSIAIQIAEALSYLHS---NNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK 158 (259)
T ss_dssp -TTEBHHHHHHHT-CTTTSBHHHHHHHHHHHHHHHHHHHH---TTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred ccccccccccccc-cccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccc
Confidence 9999999999864 34678999999999999999999998 899999999999999999999999999998763221
Q ss_pred cceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCcccchhHHHHHHHhhhcCCeeecccccc
Q 002336 770 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 848 (935)
Q Consensus 770 ~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l 848 (935)
............|+|||.+....++.++||||||+++|||++ |+.||.... ...+ .. .+.++.....
T Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~---~~~~---~~-~~~~~~~~~~----- 226 (259)
T PF07714_consen 159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYD---NEEI---IE-KLKQGQRLPI----- 226 (259)
T ss_dssp EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSC---HHHH---HH-HHHTTEETTS-----
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccc---cccc---cc-ccccccccee-----
Confidence 122233446788999999988889999999999999999999 778886321 1111 21 2222222111
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 002336 849 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAI 885 (935)
Q Consensus 849 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L 885 (935)
+......+.+++.+||..+|++||+++++++.|
T Consensus 227 ----~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 227 ----PDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp ----BTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ----ccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 111233688999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=324.61 Aligned_cols=247 Identities=26% Similarity=0.376 Sum_probs=204.3
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc-hhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEecC
Q 002336 615 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 692 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~-~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~~ 692 (935)
++-.+.||+|.||.||+|... .++.||+|++.-.. .....++.+|+.+|..++++||.+.+|.+..+..++++||||.
T Consensus 15 ~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~ 94 (467)
T KOG0201|consen 15 YTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCG 94 (467)
T ss_pred cccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhc
Confidence 444578999999999999865 68899999986433 3345788999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccccce
Q 002336 693 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 772 (935)
Q Consensus 693 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~~ 772 (935)
||++.+.|+. +..+++..+.-++.+++.||.|||+ .+.+|||||+.|||+..+|.+||+|||.+-.........
T Consensus 95 gGsv~~lL~~---~~~~~E~~i~~ilre~l~~l~ylH~---~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr 168 (467)
T KOG0201|consen 95 GGSVLDLLKS---GNILDEFEIAVILREVLKGLDYLHS---EKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRR 168 (467)
T ss_pred Ccchhhhhcc---CCCCccceeeeehHHHHHHhhhhhh---cceecccccccceeEeccCcEEEEecceeeeeechhhcc
Confidence 9999999983 4555888889999999999999998 899999999999999999999999999998776554443
Q ss_pred eecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccCCC
Q 002336 773 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNV 852 (935)
Q Consensus 773 ~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~~~ 852 (935)
....||+.|||||+++...|+.|+||||||++.+||++|.+|+..... -++.-++-+......
T Consensus 169 -~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hP----------------mrvlflIpk~~PP~L 231 (467)
T KOG0201|consen 169 -KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHP----------------MRVLFLIPKSAPPRL 231 (467)
T ss_pred -ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCc----------------ceEEEeccCCCCCcc
Confidence 556799999999999988999999999999999999999999973222 111111221111112
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002336 853 KIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 884 (935)
Q Consensus 853 ~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~ 884 (935)
.......+.+++..||+.+|+.||+++++++.
T Consensus 232 ~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 232 DGDFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred ccccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 22333468899999999999999999999865
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=327.82 Aligned_cols=242 Identities=24% Similarity=0.359 Sum_probs=194.9
Q ss_pred ccccccccEEEEEEEEC-CCcEEEEEEccCcc---hhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEecCCC
Q 002336 619 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNG 694 (935)
Q Consensus 619 ~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~~~g 694 (935)
+.||+|+||.||++... +|+.||+|++.... ......+.+|+++++.++||||+++++.+...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46999999999999875 68999999987532 223456788999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccccceee
Q 002336 695 TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISS 774 (935)
Q Consensus 695 sL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~ 774 (935)
+|.+++.. ...+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++....... ...
T Consensus 81 ~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~~~ 153 (323)
T cd05595 81 ELFFHLSR---ERVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA-TMK 153 (323)
T ss_pred cHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCC-ccc
Confidence 99988863 4568999999999999999999998 8999999999999999999999999999875322211 122
Q ss_pred cccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccCCCCH
Q 002336 775 VARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKI 854 (935)
Q Consensus 775 ~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~~~~~ 854 (935)
...|++.|+|||++.+..++.++|||||||++|||++|+.||...+... .. . .+..+.. .+ +.
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~---~~---~-~~~~~~~------~~----p~ 216 (323)
T cd05595 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER---LF---E-LILMEEI------RF----PR 216 (323)
T ss_pred cccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHH---HH---H-HHhcCCC------CC----CC
Confidence 3458999999999998899999999999999999999999997332211 11 1 1111111 11 11
Q ss_pred HHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 002336 855 ESIWRIAEVAIQCVEQRGFSRP-----KMQEIVLA 884 (935)
Q Consensus 855 ~~~~~l~~li~~Cl~~dP~~RP-----s~~ev~~~ 884 (935)
.....+.+++.+||+.+|++|| ++.++++.
T Consensus 217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 217 TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred CCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 2233678999999999999998 88888653
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=315.75 Aligned_cols=266 Identities=26% Similarity=0.406 Sum_probs=203.1
Q ss_pred hhcccccccccEEEEEEEECCCcEEEEEEccCcchhhhHHHHHHHHHHHh--cCCCcccccceeeeccc----eEEEEEE
Q 002336 616 NFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSR--IHHRNLVPLIGYCEEEH----QRILVYE 689 (935)
Q Consensus 616 ~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~--L~HpnIv~l~g~~~~~~----~~~lV~E 689 (935)
++.+.||+|+||.||+|.+. ++.||||++.. +..+.|.+|-++.+. ++|+||++++++-+... +++||+|
T Consensus 213 ~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~ 288 (534)
T KOG3653|consen 213 QLLELIGRGRFGCVWKAQLD-NRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTE 288 (534)
T ss_pred hhHHHhhcCccceeehhhcc-CceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEee
Confidence 45688999999999999998 69999999863 456778888888776 48999999999876655 8899999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhc------CCCceEecCCCCCCccccCCCcEEEeeccccc
Q 002336 690 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG------CNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 763 (935)
Q Consensus 690 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~------~~~~ivH~DLkp~NILld~~~~vkL~DFGla~ 763 (935)
|.+.|+|.++|. ...++|....+++..+++||+|||+. .+++|+|||||.+||||..|+.+.|+|||+|.
T Consensus 289 fh~kGsL~dyL~----~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl 364 (534)
T KOG3653|consen 289 FHPKGSLCDYLK----ANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLAL 364 (534)
T ss_pred eccCCcHHHHHH----hccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeE
Confidence 999999999997 45799999999999999999999974 36789999999999999999999999999998
Q ss_pred cccccccc-eeecccCCccccCCCCCCCCC-C-----CchhHHHHHHHHHHHHHhCCCCCCccCccc-----------ch
Q 002336 764 QAEEDLTH-ISSVARGTVGYLDPEYYGNQQ-L-----TEKSDVYSFGVVLLELISGKKPVSVEDFGA-----------EL 825 (935)
Q Consensus 764 ~~~~~~~~-~~~~~~gt~~y~APE~l~~~~-~-----s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~-----------~~ 825 (935)
.+...... ......||.+|||||++.+.. + -.+.||||+|.|||||++...-+.....++ ..
T Consensus 365 ~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hP 444 (534)
T KOG3653|consen 365 RLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHP 444 (534)
T ss_pred EecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCC
Confidence 87543322 122367999999999986532 2 247899999999999999665442111110 01
Q ss_pred hHHHHHHH-hhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhhhhhccC
Q 002336 826 NIVHWARS-MIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKG 894 (935)
Q Consensus 826 ~l~~~~~~-~i~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~~~~~~~ 894 (935)
.+ +-++. .+++.....+.|.-. ....+..+.+.+..||++||+.|-|+.=+.+.+.++....+.
T Consensus 445 t~-e~mq~~VV~kK~RP~~p~~W~----~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~~ 509 (534)
T KOG3653|consen 445 TL-EEMQELVVRKKQRPKIPDAWR----KHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWED 509 (534)
T ss_pred CH-HHHHHHHHhhccCCCChhhhh----cCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCCc
Confidence 11 11111 111111112211111 113455788999999999999999999999999888877665
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=320.68 Aligned_cols=255 Identities=30% Similarity=0.526 Sum_probs=204.1
Q ss_pred HHhhcccccccccEEEEEEEECC------CcEEEEEEccCcch-hhhHHHHHHHHHHHhcCCCcccccceeeeccceEEE
Q 002336 614 TNNFCKKIGKGSFGSVYYGKMKD------GKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRIL 686 (935)
Q Consensus 614 ~~~~~~~LG~G~fG~Vy~~~~~~------g~~vAvK~~~~~~~-~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~l 686 (935)
.+++.+.||+|+||.||+|.+.. .+.||+|.+..... .....+.+|++++++++||||+++++++......++
T Consensus 6 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 85 (283)
T cd05048 6 AVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCM 85 (283)
T ss_pred HcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEE
Confidence 45678899999999999998653 25799999875433 334678999999999999999999999999889999
Q ss_pred EEEecCCCCHHHHhccCCC-------------CCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCc
Q 002336 687 VYEYMHNGTLRDRLHGSVN-------------QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMR 753 (935)
Q Consensus 687 V~E~~~~gsL~~~L~~~~~-------------~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~ 753 (935)
+|||+++++|.+++..... ...+++..++.++.|++.||+|||+ ++++||||||+||++++++.
T Consensus 86 ~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nil~~~~~~ 162 (283)
T cd05048 86 LFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSS---HHFVHRDLAARNCLVGEGLT 162 (283)
T ss_pred EEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccccceEEEcCCCc
Confidence 9999999999999864321 1468889999999999999999998 89999999999999999999
Q ss_pred EEEeecccccccccccc-ceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCcccchhHHHHH
Q 002336 754 AKVSDFGLSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWA 831 (935)
Q Consensus 754 vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~ 831 (935)
+||+|||+++....... .......+++.|+|||.+.+..++.++|||||||++|||++ |..||...... .+.+
T Consensus 163 ~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~---~~~~-- 237 (283)
T cd05048 163 VKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ---EVIE-- 237 (283)
T ss_pred EEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH---HHHH--
Confidence 99999999876433221 11223346788999999988889999999999999999998 99998743221 1222
Q ss_pred HHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhh
Q 002336 832 RSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 887 (935)
Q Consensus 832 ~~~i~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~ 887 (935)
.+..+.... .+...+..+.+++.+||+.+|++||+++||++.|+.
T Consensus 238 --~i~~~~~~~---------~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 238 --MIRSRQLLP---------CPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred --HHHcCCcCC---------CcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 222222211 122233578899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=317.49 Aligned_cols=252 Identities=30% Similarity=0.488 Sum_probs=202.0
Q ss_pred HHHhhcccccccccEEEEEEEECCCcEEEEEEccCcchhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEecC
Q 002336 613 ATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 692 (935)
Q Consensus 613 ~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~~ 692 (935)
..+.+.+.||+|+||.||+|.+.++..+|+|.+.... ...+.+.+|+.++++++||||+++++++......++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 3456788999999999999998877789999887543 234678999999999999999999999998888999999999
Q ss_pred CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccccce
Q 002336 693 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 772 (935)
Q Consensus 693 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~~ 772 (935)
+|+|.+++... ...+++..+++++.|++.||+|||+ ++++|+||||+||+++.++.+||+|||+++.........
T Consensus 83 ~~~l~~~i~~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05113 83 NGCLLNYLREH--GKRFQPSQLLEMCKDVCEGMAYLES---KQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTS 157 (256)
T ss_pred CCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCCEEECCCccceecCCCceee
Confidence 99999998743 3368999999999999999999997 899999999999999999999999999987654332221
Q ss_pred eecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccCC
Q 002336 773 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 851 (935)
Q Consensus 773 ~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~~ 851 (935)
.....++..|+|||.+.+..++.++||||||+++|+|++ |+.||...... .... .+..+....
T Consensus 158 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~---~~~~----~~~~~~~~~--------- 221 (256)
T cd05113 158 SVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS---ETVE----KVSQGLRLY--------- 221 (256)
T ss_pred cCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH---HHHH----HHhcCCCCC---------
Confidence 222235678999999988889999999999999999999 99998632211 1111 111111100
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 002336 852 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 886 (935)
Q Consensus 852 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~ 886 (935)
.+......+.+++.+||+.+|++||++.+|++.|+
T Consensus 222 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 222 RPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 01112347889999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=328.96 Aligned_cols=247 Identities=23% Similarity=0.391 Sum_probs=192.5
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcch-hhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEec
Q 002336 614 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 691 (935)
Q Consensus 614 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~-~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~ 691 (935)
.+++.+.||+|+||.||+|.+. +++.||||++..... .....+.+|+++++.++|+||+++++++...+..++||||+
T Consensus 75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 154 (353)
T PLN00034 75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFM 154 (353)
T ss_pred HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecC
Confidence 3456789999999999999876 689999999865432 33467899999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccccc
Q 002336 692 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 771 (935)
Q Consensus 692 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~ 771 (935)
++|+|.+.. ..++..+..++.||+.||+|||+ .+|+||||||+|||+++++.+||+|||+++........
T Consensus 155 ~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~ 224 (353)
T PLN00034 155 DGGSLEGTH-------IADEQFLADVARQILSGIAYLHR---RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDP 224 (353)
T ss_pred CCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEcccccceeccccccc
Confidence 999986532 34567888999999999999998 89999999999999999999999999999865432211
Q ss_pred eeecccCCccccCCCCCCC-----CCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccc
Q 002336 772 ISSVARGTVGYLDPEYYGN-----QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP 846 (935)
Q Consensus 772 ~~~~~~gt~~y~APE~l~~-----~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~ 846 (935)
.....|+..|+|||++.. ...+.++|||||||++|||++|+.||......+...... . +..... +
T Consensus 225 -~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~---~-~~~~~~-----~ 294 (353)
T PLN00034 225 -CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMC---A-ICMSQP-----P 294 (353)
T ss_pred -ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHH---H-HhccCC-----C
Confidence 223468999999998743 334568999999999999999999997332222111111 1 111100 0
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002336 847 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 884 (935)
Q Consensus 847 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~ 884 (935)
..+......+.+++.+||+.+|++||+++|+++.
T Consensus 295 ----~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 295 ----EAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred ----CCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1111223468899999999999999999999864
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=327.62 Aligned_cols=239 Identities=25% Similarity=0.335 Sum_probs=192.7
Q ss_pred ccccccEEEEEEEEC-CCcEEEEEEccCc---chhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEecCCCCH
Q 002336 621 IGKGSFGSVYYGKMK-DGKEVAVKIMADS---CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTL 696 (935)
Q Consensus 621 LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~---~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL 696 (935)
||+|+||.||+|... +++.||+|++... .......+.+|+.++++++||||+++++++...+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999876 5889999998643 223446788899999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccccceeecc
Q 002336 697 RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVA 776 (935)
Q Consensus 697 ~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~ 776 (935)
.+++.. ...+++..+..++.|+++||.|||+ ++|+||||||+|||++.++.+||+|||+++....... .....
T Consensus 81 ~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~-~~~~~ 153 (312)
T cd05585 81 FHHLQR---EGRFDLSRARFYTAELLCALENLHK---FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD-KTNTF 153 (312)
T ss_pred HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCC-ccccc
Confidence 999873 4568999999999999999999998 8999999999999999999999999999875432221 12334
Q ss_pred cCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccCCCCHHH
Q 002336 777 RGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIES 856 (935)
Q Consensus 777 ~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~~~~~~~ 856 (935)
.||+.|+|||.+.+..++.++||||+||++|||++|+.||..... .+..+.... +.. ..+...
T Consensus 154 ~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~------~~~~~~~~~-~~~----------~~~~~~ 216 (312)
T cd05585 154 CGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENV------NEMYRKILQ-EPL----------RFPDGF 216 (312)
T ss_pred cCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCH------HHHHHHHHc-CCC----------CCCCcC
Confidence 689999999999998999999999999999999999999973322 111222221 111 111122
Q ss_pred HHHHHHHHHHccccCCCCCCC---HHHHHH
Q 002336 857 IWRIAEVAIQCVEQRGFSRPK---MQEIVL 883 (935)
Q Consensus 857 ~~~l~~li~~Cl~~dP~~RPs---~~ev~~ 883 (935)
...+.+++.+||+.+|++||+ +.|++.
T Consensus 217 ~~~~~~li~~~L~~dp~~R~~~~~~~e~l~ 246 (312)
T cd05585 217 DRDAKDLLIGLLSRDPTRRLGYNGAQEIKN 246 (312)
T ss_pred CHHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence 346789999999999999986 455543
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=328.53 Aligned_cols=242 Identities=25% Similarity=0.355 Sum_probs=196.1
Q ss_pred ccccccccEEEEEEEEC-CCcEEEEEEccCcc---hhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEecCCC
Q 002336 619 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNG 694 (935)
Q Consensus 619 ~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~~~g 694 (935)
+.||+|+||.||++... +|+.||+|++.... ......+.+|+++++.++||||+++++.+...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999875 68999999987532 234467888999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccccceee
Q 002336 695 TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISS 774 (935)
Q Consensus 695 sL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~ 774 (935)
+|.+.+.. ...+++.++..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++....... ...
T Consensus 81 ~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~-~~~ 153 (328)
T cd05593 81 ELFFHLSR---ERVFSEDRTRFYGAEIVSALDYLHS---GKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA-TMK 153 (328)
T ss_pred CHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeEECCCCcEEEecCcCCccCCCccc-ccc
Confidence 99988863 4568999999999999999999998 8999999999999999999999999999875332211 122
Q ss_pred cccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccCCCCH
Q 002336 775 VARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKI 854 (935)
Q Consensus 775 ~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~~~~~ 854 (935)
...|++.|+|||.+.+..++.++|||||||++|||++|+.||...+.. +... .+..+.. .+ +.
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~------~~~~-~~~~~~~------~~----p~ 216 (328)
T cd05593 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------KLFE-LILMEDI------KF----PR 216 (328)
T ss_pred cccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH------HHHH-HhccCCc------cC----CC
Confidence 346899999999999889999999999999999999999999743221 1111 1111111 11 11
Q ss_pred HHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 002336 855 ESIWRIAEVAIQCVEQRGFSRP-----KMQEIVLA 884 (935)
Q Consensus 855 ~~~~~l~~li~~Cl~~dP~~RP-----s~~ev~~~ 884 (935)
.....+.+++.+||+.+|++|| +++|+++.
T Consensus 217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 217 TLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 2234678999999999999997 88988764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=320.55 Aligned_cols=266 Identities=25% Similarity=0.388 Sum_probs=201.2
Q ss_pred hhcccccccccEEEEEEEE-----CCCcEEEEEEccCcch-hhhHHHHHHHHHHHhcCCCcccccceeeecc--ceEEEE
Q 002336 616 NFCKKIGKGSFGSVYYGKM-----KDGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEE--HQRILV 687 (935)
Q Consensus 616 ~~~~~LG~G~fG~Vy~~~~-----~~g~~vAvK~~~~~~~-~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~--~~~~lV 687 (935)
.+.+.||+|+||+||++.. .+++.||+|.+..... .....+.+|++++++++||||+++++++... ...++|
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (283)
T cd05080 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI 86 (283)
T ss_pred eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence 6678999999999988653 3578899999875433 3456788999999999999999999987653 457899
Q ss_pred EEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccc
Q 002336 688 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 767 (935)
Q Consensus 688 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~ 767 (935)
|||+++++|.+++.. ..+++.++..++.|++.||.|||+ ++++||||||+||++++++.+||+|||+++....
T Consensus 87 ~e~~~~~~l~~~~~~----~~l~~~~~~~i~~~l~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 159 (283)
T cd05080 87 MEYVPLGSLRDYLPK----HKLNLAQLLLFAQQICEGMAYLHS---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 159 (283)
T ss_pred ecCCCCCCHHHHHHH----cCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccChheEEEcCCCcEEEeecccccccCC
Confidence 999999999999863 358999999999999999999998 8999999999999999999999999999886543
Q ss_pred cccc--eeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeeccc
Q 002336 768 DLTH--ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 845 (935)
Q Consensus 768 ~~~~--~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d 845 (935)
.... ......++..|+|||.+.+..++.++||||||++++||++|..|+...... ......+.............++
T Consensus 160 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 238 (283)
T cd05080 160 GHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKK-FEEMIGPKQGQMTVVRLIELLE 238 (283)
T ss_pred cchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcch-hhhhhcccccccchhhhhhhhh
Confidence 2211 111223566799999998888999999999999999999999998633211 0011110000000001111111
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhhh
Q 002336 846 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI 889 (935)
Q Consensus 846 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~~ 889 (935)
.......+...+..+.+++.+||+.+|++||++++|++.|+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 239 RGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred cCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 11111112233457899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=314.92 Aligned_cols=255 Identities=27% Similarity=0.464 Sum_probs=203.5
Q ss_pred HHHHHhhcccccccccEEEEEEEECCCcEEEEEEccCcchhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEe
Q 002336 611 EEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 690 (935)
Q Consensus 611 ~~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~ 690 (935)
....+++.+.||+|++|.||+|..+++..+|+|.+..... ..+.+.+|+.++++++|+|++++++++.. ...+++|||
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~ 81 (260)
T cd05070 4 PRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVTEY 81 (260)
T ss_pred chHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEEEEEe
Confidence 3456788899999999999999988888999999875432 34678999999999999999999998854 567899999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccccccc
Q 002336 691 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 770 (935)
Q Consensus 691 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~ 770 (935)
+++++|.+++... ....+++.++..++.|++.||+|||+ ++++||||||+||++++++.++|+|||++........
T Consensus 82 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05070 82 MSKGSLLDFLKDG-EGRALKLPNLVDMAAQVAAGMAYIER---MNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY 157 (260)
T ss_pred cCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEEeCCceEEeCCceeeeeccCccc
Confidence 9999999998753 23458999999999999999999998 8999999999999999999999999999976543322
Q ss_pred ceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCcccchhHHHHHHHhhhcCCeeeccccccc
Q 002336 771 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 849 (935)
Q Consensus 771 ~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~ 849 (935)
.......++..|+|||.+.+..++.++||||||+++|+|++ |+.||..... ....+. +..+..
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~---~~~~~~----~~~~~~--------- 221 (260)
T cd05070 158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN---REVLEQ----VERGYR--------- 221 (260)
T ss_pred ccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH---HHHHHH----HHcCCC---------
Confidence 22222235668999999988889999999999999999999 8999863221 111111 111110
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhh
Q 002336 850 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 887 (935)
Q Consensus 850 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~ 887 (935)
...+......+.+++.+|+..+|++|||+.++.+.|++
T Consensus 222 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 222 MPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 01112233468899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=320.80 Aligned_cols=262 Identities=27% Similarity=0.453 Sum_probs=209.1
Q ss_pred HHHHHhhcccccccccEEEEEEEEC------CCcEEEEEEccCcchhhhHHHHHHHHHHHhcCCCcccccceeeeccceE
Q 002336 611 EEATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQR 684 (935)
Q Consensus 611 ~~~~~~~~~~LG~G~fG~Vy~~~~~------~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~ 684 (935)
++..+.+.+.||+|+||.||++... ++..+|+|.+........+.+.+|++++++++||||+++++++......
T Consensus 3 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (288)
T cd05093 3 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL 82 (288)
T ss_pred chHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence 4456677889999999999999752 3456899998766555667899999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhccCC----------CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcE
Q 002336 685 ILVYEYMHNGTLRDRLHGSV----------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRA 754 (935)
Q Consensus 685 ~lV~E~~~~gsL~~~L~~~~----------~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~v 754 (935)
++||||+++++|.+++.... ....+++..++.++.|++.||+|||+ ++++||||||+||++++++.+
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~---~~i~H~dlkp~Nili~~~~~~ 159 (288)
T cd05093 83 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLV 159 (288)
T ss_pred EEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCCcE
Confidence 99999999999999986432 12358999999999999999999997 899999999999999999999
Q ss_pred EEeecccccccccccc-ceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCcccchhHHHHHH
Q 002336 755 KVSDFGLSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWAR 832 (935)
Q Consensus 755 kL~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~ 832 (935)
||+|||+++....... .......++..|+|||.+.+..++.++||||||+++++|++ |+.||....... . .
T Consensus 160 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~---~----~ 232 (288)
T cd05093 160 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE---V----I 232 (288)
T ss_pred EeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---H----H
Confidence 9999999876533221 11122335778999999998899999999999999999998 999986332211 1 1
Q ss_pred HhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhhhhh
Q 002336 833 SMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 891 (935)
Q Consensus 833 ~~i~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~~~~ 891 (935)
..+..+..... ... ....+.+++.+||+.+|.+||+++||.+.|+++...
T Consensus 233 ~~i~~~~~~~~-----~~~----~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 233 ECITQGRVLQR-----PRT----CPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred HHHHcCCcCCC-----CCC----CCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 22222222111 111 223689999999999999999999999999887753
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=315.80 Aligned_cols=251 Identities=29% Similarity=0.486 Sum_probs=200.9
Q ss_pred HHHhhcccccccccEEEEEEEECCCcEEEEEEccCcchhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEecC
Q 002336 613 ATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 692 (935)
Q Consensus 613 ~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~~ 692 (935)
..+++.+.||+|+||.||+|.++++..+|+|++..... ....+.+|++++++++||||+++++++......++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA 82 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence 34567889999999999999988788899999864322 33568889999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccccce
Q 002336 693 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 772 (935)
Q Consensus 693 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~~ 772 (935)
+++|.+++... ...+++..++.++.|+++||+|||+ .+++||||||+||++++++.+||+|||+++...+.....
T Consensus 83 ~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~ 157 (256)
T cd05059 83 NGCLLNYLRER--KGKLGTEWLLDMCSDVCEAMEYLES---NGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS 157 (256)
T ss_pred CCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHhhEEECCCCcEEECCcccceecccccccc
Confidence 99999998743 3468999999999999999999998 899999999999999999999999999987654322211
Q ss_pred eecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccCC
Q 002336 773 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 851 (935)
Q Consensus 773 ~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~~ 851 (935)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.||...... .... .+..+. .. .
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~~----~~~~~~-----~~----~ 221 (256)
T cd05059 158 SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS---EVVE----SVSAGY-----RL----Y 221 (256)
T ss_pred cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH---HHHH----HHHcCC-----cC----C
Confidence 111223457999999988889999999999999999999 89998633221 1111 111110 00 0
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 002336 852 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAI 885 (935)
Q Consensus 852 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L 885 (935)
.+......+.+++.+||..+|++||++.|+++.|
T Consensus 222 ~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 222 RPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 1112234788999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=324.92 Aligned_cols=261 Identities=24% Similarity=0.425 Sum_probs=204.8
Q ss_pred HHHHHHhhcccccccccEEEEEEEEC-CCc----EEEEEEccCcc-hhhhHHHHHHHHHHHhcCCCcccccceeeeccce
Q 002336 610 LEEATNNFCKKIGKGSFGSVYYGKMK-DGK----EVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQ 683 (935)
Q Consensus 610 l~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~----~vAvK~~~~~~-~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~ 683 (935)
+....++..+.||+|+||.||+|.+. +++ .||+|+++... ....+++.+|+.+++.++||||++++|+|... .
T Consensus 4 ~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~ 82 (316)
T cd05108 4 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-T 82 (316)
T ss_pred cchhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-C
Confidence 34556777899999999999999864 333 48999986543 34456789999999999999999999999765 5
Q ss_pred EEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccc
Q 002336 684 RILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 763 (935)
Q Consensus 684 ~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~ 763 (935)
.++++||+++|+|.+++... ...+++..+++++.|++.||+|||+ ++|+||||||+|||+++++.+||+|||+++
T Consensus 83 ~~~v~e~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH~---~~iiH~dlkp~Nill~~~~~~kl~DfG~a~ 157 (316)
T cd05108 83 VQLITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEE---RRLVHRDLAARNVLVKTPQHVKITDFGLAK 157 (316)
T ss_pred ceeeeecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEecCCCcEEEccccccc
Confidence 67999999999999998753 3458899999999999999999998 899999999999999999999999999998
Q ss_pred ccccccccee-ecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCcccchhHHHHHHHhhhcCCee
Q 002336 764 QAEEDLTHIS-SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVI 841 (935)
Q Consensus 764 ~~~~~~~~~~-~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~ 841 (935)
.......... ....++..|+|||.+.+..++.++||||||+++|||++ |+.||...... .+. ..+..+...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~---~~~----~~~~~~~~~ 230 (316)
T cd05108 158 LLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS---EIS----SILEKGERL 230 (316)
T ss_pred cccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH---HHH----HHHhCCCCC
Confidence 7643322211 11224678999999999899999999999999999998 99998743221 111 122221110
Q ss_pred ecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhhhhhc
Q 002336 842 SIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 892 (935)
Q Consensus 842 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~~~~~ 892 (935)
. . +......+.+++.+||..+|++||++.+++..|..+....
T Consensus 231 ~--~-------~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~ 272 (316)
T cd05108 231 P--Q-------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 272 (316)
T ss_pred C--C-------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence 0 0 1112236789999999999999999999999988776543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-35 Score=315.74 Aligned_cols=255 Identities=27% Similarity=0.484 Sum_probs=204.4
Q ss_pred HHHhhcccccccccEEEEEEEECC----CcEEEEEEccCcc-hhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEE
Q 002336 613 ATNNFCKKIGKGSFGSVYYGKMKD----GKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILV 687 (935)
Q Consensus 613 ~~~~~~~~LG~G~fG~Vy~~~~~~----g~~vAvK~~~~~~-~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV 687 (935)
..+++.+.||+|+||.||+|.++. ...||+|.++... ......|.+|+.++++++||||+++++++...+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 456678999999999999998752 4579999987543 33456789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccc
Q 002336 688 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 767 (935)
Q Consensus 688 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~ 767 (935)
|||+++++|.+++... ...+++..+++++.|++.||+|||+ ++|+||||||+||++++++.++|+|||+++....
T Consensus 84 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd05033 84 TEYMENGSLDKFLREN--DGKFTVGQLVGMLRGIASGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRRLED 158 (266)
T ss_pred EEcCCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCCEEECccchhhcccc
Confidence 9999999999998753 3468999999999999999999997 8999999999999999999999999999987642
Q ss_pred cccc-eeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCcccchhHHHHHHHhhhcCCeeeccc
Q 002336 768 DLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 845 (935)
Q Consensus 768 ~~~~-~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d 845 (935)
.... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||..... ....+ .+..+...
T Consensus 159 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~---~~~~~----~~~~~~~~---- 227 (266)
T cd05033 159 SEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN---QDVIK----AVEDGYRL---- 227 (266)
T ss_pred cccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCH---HHHHH----HHHcCCCC----
Confidence 2211 1112234678999999998889999999999999999998 9999863221 11222 12211110
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhh
Q 002336 846 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 888 (935)
Q Consensus 846 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~ 888 (935)
+ .+......+.+++.+|++.+|++||+++||++.|+++
T Consensus 228 ~-----~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 228 P-----PPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred C-----CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0 0112234688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=320.72 Aligned_cols=259 Identities=22% Similarity=0.290 Sum_probs=196.1
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCcch-hhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEecC
Q 002336 615 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 692 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~-~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~~ 692 (935)
|.+.+.||+|+||.||+|..+ +++.||+|+++.... .....+.+|++++++++||||+++++++..++..++||||++
T Consensus 7 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 86 (288)
T cd07871 7 YVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLD 86 (288)
T ss_pred ceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCCC
Confidence 566789999999999999876 688999999864322 233567899999999999999999999999999999999997
Q ss_pred CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccccce
Q 002336 693 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 772 (935)
Q Consensus 693 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~~ 772 (935)
+ +|.+.+... ...+++..+..++.|++.||+|||+ ++|+||||||+|||+++++.+||+|||+++........
T Consensus 87 ~-~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~- 159 (288)
T cd07871 87 S-DLKQYLDNC--GNLMSMHNVKIFMFQLLRGLSYCHK---RKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKT- 159 (288)
T ss_pred c-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCcc-
Confidence 5 898888642 3457889999999999999999998 89999999999999999999999999998764332211
Q ss_pred eecccCCccccCCCCCCC-CCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhc------------CC
Q 002336 773 SSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKK------------GD 839 (935)
Q Consensus 773 ~~~~~gt~~y~APE~l~~-~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~------------~~ 839 (935)
.....+++.|+|||.+.+ ..++.++||||+||++|||++|+.||......+.... +.+.+.. ..
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T cd07871 160 YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHL---IFRLLGTPTEETWPGITSNEE 236 (288)
T ss_pred ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHHhCCCChHHhhccccchh
Confidence 223457899999998765 5689999999999999999999999975433221111 1111100 00
Q ss_pred eeecccccccCCC----CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 840 VISIVDPVLIGNV----KIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 840 ~~~~~d~~l~~~~----~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
......+...... .........+++.+||+.||++|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 237 FRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred hhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 0111111100000 0011235789999999999999999999874
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=315.48 Aligned_cols=257 Identities=26% Similarity=0.444 Sum_probs=206.7
Q ss_pred hHHHHHHhhcccccccccEEEEEEEECCCcEEEEEEccCcchhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEE
Q 002336 609 ELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 688 (935)
Q Consensus 609 ~l~~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~ 688 (935)
++....+++.++||+|+||.||+|..++++.+|+|.+..... ...++.+|+.++++++|+||+++++++. .+..+++|
T Consensus 2 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~ 79 (260)
T cd05067 2 EVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIIT 79 (260)
T ss_pred ccchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEE
Confidence 345678888999999999999999998899999999875432 3467899999999999999999999874 45689999
Q ss_pred EecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccccc
Q 002336 689 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 768 (935)
Q Consensus 689 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~ 768 (935)
||+++++|.+++... .+..+++.++..++.|++.||+|||+ .+++||||||+||++++++.++|+|||++......
T Consensus 80 e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05067 80 EYMENGSLVDFLKTP-EGIKLTINKLIDMAAQIAEGMAFIER---KNYIHRDLRAANILVSETLCCKIADFGLARLIEDN 155 (260)
T ss_pred EcCCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHHhEEEcCCCCEEEccCcceeecCCC
Confidence 999999999998643 34568999999999999999999997 89999999999999999999999999998765532
Q ss_pred ccceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCcccchhHHHHHHHhhhcCCeeeccccc
Q 002336 769 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 847 (935)
Q Consensus 769 ~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~ 847 (935)
.........++..|+|||.+....++.++||||||++++||++ |+.||..... ....... ..+....
T Consensus 156 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---~~~~~~~----~~~~~~~----- 223 (260)
T cd05067 156 EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTN---PEVIQNL----ERGYRMP----- 223 (260)
T ss_pred CcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCCh---HHHHHHH----HcCCCCC-----
Confidence 2222222345678999999988889999999999999999999 9999973322 1122211 1111100
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhh
Q 002336 848 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 887 (935)
Q Consensus 848 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~ 887 (935)
. +......+.+++.+|+..+|++||+++++.+.|++
T Consensus 224 ~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 224 R----PDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred C----CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 1 11123468899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=330.27 Aligned_cols=245 Identities=23% Similarity=0.316 Sum_probs=199.7
Q ss_pred HHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc---hhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEE
Q 002336 613 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 688 (935)
Q Consensus 613 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~ 688 (935)
..+.+.+.||+|+||.||+|.++ +++.||+|++.... ....+.+.+|+.++++++||||+++++.+.+++..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 44677899999999999999886 68899999986532 123457889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccccc
Q 002336 689 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 768 (935)
Q Consensus 689 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~ 768 (935)
||+++|+|.+.+.. ...+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 98 e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 171 (329)
T PTZ00263 98 EFVVGGELFTHLRK---AGRFPNDVAKFYHAELVLAFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR 171 (329)
T ss_pred cCCCCChHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence 99999999999873 4568889999999999999999998 89999999999999999999999999999865432
Q ss_pred ccceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccccc
Q 002336 769 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 848 (935)
Q Consensus 769 ~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l 848 (935)
. ....|++.|+|||.+.+..++.++|||||||++|||++|+.||...... + ..+.+..+... +
T Consensus 172 ~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~------~-~~~~i~~~~~~------~ 234 (329)
T PTZ00263 172 T----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPF------R-IYEKILAGRLK------F 234 (329)
T ss_pred c----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHH------H-HHHHHhcCCcC------C
Confidence 2 1245899999999999988999999999999999999999999632211 1 11122222210 1
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 002336 849 IGNVKIESIWRIAEVAIQCVEQRGFSRPK-----MQEIVLA 884 (935)
Q Consensus 849 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs-----~~ev~~~ 884 (935)
+......+.+++.+||+.||++||+ ++|+++.
T Consensus 235 ----p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 235 ----PNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred ----CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 1111235789999999999999997 6777644
|
|
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=320.28 Aligned_cols=259 Identities=27% Similarity=0.457 Sum_probs=208.3
Q ss_pred HHHhhcccccccccEEEEEEEEC------CCcEEEEEEccCcchhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEE
Q 002336 613 ATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRIL 686 (935)
Q Consensus 613 ~~~~~~~~LG~G~fG~Vy~~~~~------~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~l 686 (935)
..+.+.+.||+|+||.||+|+.. ++..+++|.+........+.+.+|++++++++|+||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 34556789999999999999753 356799999877666666789999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhccCC-------------CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCc
Q 002336 687 VYEYMHNGTLRDRLHGSV-------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMR 753 (935)
Q Consensus 687 V~E~~~~gsL~~~L~~~~-------------~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~ 753 (935)
||||+++++|.+++.... ....+++..+++++.|++.||+|||+ ++++||||||+||+++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLAS---QHFVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCCc
Confidence 999999999999986432 12358899999999999999999997 89999999999999999999
Q ss_pred EEEeecccccccccccc-ceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCcccchhHHHHH
Q 002336 754 AKVSDFGLSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWA 831 (935)
Q Consensus 754 vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~ 831 (935)
++|+|||++........ .......++..|+|||.+.+..++.++||||||+++|||++ |+.||...... ...+
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~---~~~~-- 236 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT---EVIE-- 236 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---HHHH--
Confidence 99999999876543221 11223346788999999998899999999999999999999 99998633221 1111
Q ss_pred HHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhhhh
Q 002336 832 RSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 890 (935)
Q Consensus 832 ~~~i~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~~~ 890 (935)
.+..+..... +...+..+.+++.+||+.+|++||++++|+++|+++..
T Consensus 237 --~~~~~~~~~~---------~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 237 --CITQGRVLER---------PRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred --HHhCCCCCCC---------CccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence 1222222111 11123468899999999999999999999999998855
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=334.52 Aligned_cols=261 Identities=25% Similarity=0.399 Sum_probs=204.3
Q ss_pred HHHHhhcccccccccEEEEEEEEC------CCcEEEEEEccCcch-hhhHHHHHHHHHHHhcC-CCcccccceeeeccce
Q 002336 612 EATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQ 683 (935)
Q Consensus 612 ~~~~~~~~~LG~G~fG~Vy~~~~~------~g~~vAvK~~~~~~~-~~~~~~~~E~~iL~~L~-HpnIv~l~g~~~~~~~ 683 (935)
...+.+.+.||+|+||.||+|++. .+..||||++..... ...+.+.+|+++++++. ||||+++++++.+...
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~ 115 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP 115 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence 445667899999999999999863 234799999975433 33467999999999996 9999999999999999
Q ss_pred EEEEEEecCCCCHHHHhccCC-----------------------------------------------------------
Q 002336 684 RILVYEYMHNGTLRDRLHGSV----------------------------------------------------------- 704 (935)
Q Consensus 684 ~~lV~E~~~~gsL~~~L~~~~----------------------------------------------------------- 704 (935)
.++||||+++|+|.+++....
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (400)
T cd05105 116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK 195 (400)
T ss_pred eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence 999999999999998876421
Q ss_pred ----------------------------------CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccC
Q 002336 705 ----------------------------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI 750 (935)
Q Consensus 705 ----------------------------------~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~ 750 (935)
....+++..+++++.|+++||+|||+ .+|+||||||+|||++.
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dikp~Nill~~ 272 (400)
T cd05105 196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLAS---KNCVHRDLAARNVLLAQ 272 (400)
T ss_pred hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHhEEEeC
Confidence 01347888899999999999999998 89999999999999999
Q ss_pred CCcEEEeeccccccccccccc-eeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCcccchhHH
Q 002336 751 NMRAKVSDFGLSRQAEEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIV 828 (935)
Q Consensus 751 ~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~ 828 (935)
++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |..||...... ....
T Consensus 273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~--~~~~ 350 (400)
T cd05105 273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD--STFY 350 (400)
T ss_pred CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchh--HHHH
Confidence 999999999998765432221 1122346778999999988889999999999999999997 99998632211 1111
Q ss_pred HHHHHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhhhh
Q 002336 829 HWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 890 (935)
Q Consensus 829 ~~~~~~i~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~~~ 890 (935)
..+..+... ..+......+.+++.+||+.+|++||++.+|+++|+++..
T Consensus 351 ----~~~~~~~~~---------~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 351 ----NKIKSGYRM---------AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred ----HHHhcCCCC---------CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 112222110 0112233478899999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-35 Score=314.90 Aligned_cols=255 Identities=27% Similarity=0.427 Sum_probs=203.8
Q ss_pred HHHHhhcccccccccEEEEEEEECCCcEEEEEEccCcchhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEec
Q 002336 612 EATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 691 (935)
Q Consensus 612 ~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~ 691 (935)
...+++.++||+|+||.||+|.+.++..||+|++.... ...+.+.+|++++++++||||+++++.+.+ ...++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~ 82 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 82 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcC
Confidence 34578889999999999999998877789999987532 234578999999999999999999998754 5578999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccccc
Q 002336 692 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 771 (935)
Q Consensus 692 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~ 771 (935)
++|+|.+++... ....+++..+..++.|+++||+|||+ .+++||||||+||++++++.+||+|||.+.........
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~ 158 (262)
T cd05071 83 SKGSLLDFLKGE-MGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 158 (262)
T ss_pred CCCcHHHHHhhc-cccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcccEEEcCCCcEEeccCCceeeccccccc
Confidence 999999999743 23467899999999999999999998 89999999999999999999999999999765443322
Q ss_pred eeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccC
Q 002336 772 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 850 (935)
Q Consensus 772 ~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~ 850 (935)
......++..|+|||...+..++.++||||||+++|||++ |+.||...... . ....+..+.. .
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~---~----~~~~~~~~~~-----~---- 222 (262)
T cd05071 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR---E----VLDQVERGYR-----M---- 222 (262)
T ss_pred cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH---H----HHHHHhcCCC-----C----
Confidence 2223346678999999988889999999999999999999 88888633211 1 1111211110 0
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhh
Q 002336 851 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 888 (935)
Q Consensus 851 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~ 888 (935)
..+.+....+.+++.+|++.+|++||+++++++.|++.
T Consensus 223 ~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 223 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred CCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 01123345788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=311.52 Aligned_cols=247 Identities=28% Similarity=0.453 Sum_probs=196.5
Q ss_pred ccccccccEEEEEEEEC-CCcEEEEEEccCcc-hhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEecCCCCH
Q 002336 619 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTL 696 (935)
Q Consensus 619 ~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~-~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL 696 (935)
+.||+|+||.||+|.+. +++.+|+|.+.... ......+.+|++++++++||||+++++++......++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 47999999999999875 68999999876543 33456799999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccccce-eec
Q 002336 697 RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI-SSV 775 (935)
Q Consensus 697 ~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~~-~~~ 775 (935)
.+++... ...+++..++.++.|+++||.|||+ ++++||||||+||+++.++.+||+|||++....+..... ...
T Consensus 81 ~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 155 (252)
T cd05084 81 LTFLRTE--GPRLKVKELIQMVENAAAGMEYLES---KHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGM 155 (252)
T ss_pred HHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEEcCCCcEEECccccCcccccccccccCCC
Confidence 9998642 3468899999999999999999997 899999999999999999999999999987543321111 111
Q ss_pred ccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccCCCCH
Q 002336 776 ARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKI 854 (935)
Q Consensus 776 ~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~~~~~ 854 (935)
...+..|+|||.+.+..++.++||||||+++|||++ |..||...... . ....+..+.. ...+.
T Consensus 156 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~---~----~~~~~~~~~~---------~~~~~ 219 (252)
T cd05084 156 KQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ---Q----TREAIEQGVR---------LPCPE 219 (252)
T ss_pred CCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH---H----HHHHHHcCCC---------CCCcc
Confidence 123457999999998889999999999999999998 88888632211 1 1111111110 01111
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 002336 855 ESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 886 (935)
Q Consensus 855 ~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~ 886 (935)
.....+.+++.+|++.+|++||++.||.++|+
T Consensus 220 ~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 220 LCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 22347889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=307.84 Aligned_cols=247 Identities=29% Similarity=0.472 Sum_probs=199.3
Q ss_pred ccccccccEEEEEEEECCCcEEEEEEccCcch-hhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEecCCCCHH
Q 002336 619 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLR 697 (935)
Q Consensus 619 ~~LG~G~fG~Vy~~~~~~g~~vAvK~~~~~~~-~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL~ 697 (935)
+.||+|+||.||+|...+++.+|+|.+..... .....+.+|+++++.++||||+++++++......++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 46999999999999988899999999876543 23457889999999999999999999999999999999999999999
Q ss_pred HHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccccceeeccc
Q 002336 698 DRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR 777 (935)
Q Consensus 698 ~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~ 777 (935)
+++... ...+++..++.++.|++.+|.|||+ ++++||||||+||+++.++.+||+|||++...............
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (250)
T cd05085 81 SFLRKK--KDELKTKQLVKFALDAAAGMAYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQ 155 (250)
T ss_pred HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCC
Confidence 988643 3457899999999999999999997 89999999999999999999999999998754332222122223
Q ss_pred CCccccCCCCCCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccCCCCHHH
Q 002336 778 GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIES 856 (935)
Q Consensus 778 gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~~~~~~~ 856 (935)
++..|+|||++.+..++.++||||||+++|+|++ |..||...... .. ...+..+... ..+...
T Consensus 156 ~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~---~~----~~~~~~~~~~---------~~~~~~ 219 (250)
T cd05085 156 IPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ---QA----REQVEKGYRM---------SCPQKC 219 (250)
T ss_pred CcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH---HH----HHHHHcCCCC---------CCCCCC
Confidence 4677999999998889999999999999999998 99998633211 11 1122222111 111123
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 002336 857 IWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 886 (935)
Q Consensus 857 ~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~ 886 (935)
...+.+++.+|+..+|++||++.|+++.|.
T Consensus 220 ~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 220 PDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 347899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=311.82 Aligned_cols=258 Identities=23% Similarity=0.327 Sum_probs=205.4
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCc---chhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEe
Q 002336 615 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS---CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 690 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~---~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~ 690 (935)
+.+.+.||+|+||.||+|... +++.||+|.+... .......+.+|+++++.++||||+++++++...+..++|+||
T Consensus 4 ~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 83 (267)
T cd08228 4 FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLEL 83 (267)
T ss_pred eeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEEe
Confidence 456789999999999999875 7899999987542 223446788999999999999999999999998999999999
Q ss_pred cCCCCHHHHhccCC-CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccc
Q 002336 691 MHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 769 (935)
Q Consensus 691 ~~~gsL~~~L~~~~-~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~ 769 (935)
+++++|.+++.... ....+++..+..++.|+++||+|||+ ++++|+||||+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~ 160 (267)
T cd08228 84 ADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 160 (267)
T ss_pred cCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCCHHHEEEcCCCCEEECccccceeccchh
Confidence 99999998875432 23457889999999999999999997 899999999999999999999999999987754332
Q ss_pred cceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeeccccccc
Q 002336 770 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 849 (935)
Q Consensus 770 ~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~ 849 (935)
.. .....+++.|+|||.+.+..++.++|+||||+++|||++|+.||..... +...+.. .+....... .
T Consensus 161 ~~-~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~----~~~~~~~-~~~~~~~~~-----~- 228 (267)
T cd08228 161 TA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLFSLCQ-KIEQCDYPP-----L- 228 (267)
T ss_pred HH-HhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccc----cHHHHHH-HHhcCCCCC-----C-
Confidence 21 1223578899999999888889999999999999999999999863221 1112221 121111111 1
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhhh
Q 002336 850 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI 889 (935)
Q Consensus 850 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~~ 889 (935)
........+.+++.+||+.+|++||++.||++.|+++.
T Consensus 229 --~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 229 --PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred --ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 11123346889999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=294.57 Aligned_cols=263 Identities=21% Similarity=0.299 Sum_probs=207.1
Q ss_pred HHHHhhcccccccccEEEEEEE-ECCCcEEEEEEccCcchhhhHHHHHHHHHHHhcCCCcccccceeeec-----cceEE
Q 002336 612 EATNNFCKKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEE-----EHQRI 685 (935)
Q Consensus 612 ~~~~~~~~~LG~G~fG~Vy~~~-~~~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~-----~~~~~ 685 (935)
...|++.+.||+|||+-||+++ ..+++.+|+|++.-...++.+..++|++..++++|||++++++++.. ....|
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~y 99 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAY 99 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEE
Confidence 3567788999999999999997 45788999999987777788899999999999999999999998743 34589
Q ss_pred EEEEecCCCCHHHHhccCC-CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccc
Q 002336 686 LVYEYMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 764 (935)
Q Consensus 686 lV~E~~~~gsL~~~L~~~~-~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~ 764 (935)
++++|+..|+|.+.++... .+..+++.++++|+.++++||++||+. ..+++||||||.|||+++++.++|.|||.+..
T Consensus 100 ll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~ 178 (302)
T KOG2345|consen 100 LLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSATQ 178 (302)
T ss_pred EEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCccc
Confidence 9999999999999887655 445799999999999999999999982 23499999999999999999999999999876
Q ss_pred ccccccce--------eecccCCccccCCCCCC---CCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHH
Q 002336 765 AEEDLTHI--------SSVARGTVGYLDPEYYG---NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARS 833 (935)
Q Consensus 765 ~~~~~~~~--------~~~~~gt~~y~APE~l~---~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~ 833 (935)
..-..... ......|..|+|||.+. +...++++|||||||+||+|+.|..||+..-.
T Consensus 179 a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~------------ 246 (302)
T KOG2345|consen 179 APIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ------------ 246 (302)
T ss_pred cceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh------------
Confidence 43211110 11123688999999884 45778999999999999999999999972111
Q ss_pred hhhcCCeeec-ccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhhh
Q 002336 834 MIKKGDVISI-VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI 889 (935)
Q Consensus 834 ~i~~~~~~~~-~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~~ 889 (935)
+.|.+.-. ..+.+.---.....+.+.+++..|++.||.+||++.+++..+.++.
T Consensus 247 --~GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 247 --QGGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred --cCCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 11222111 1111110001114457899999999999999999999999887654
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=324.85 Aligned_cols=242 Identities=26% Similarity=0.363 Sum_probs=194.6
Q ss_pred ccccccccEEEEEEEE----CCCcEEEEEEccCcc----hhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEe
Q 002336 619 KKIGKGSFGSVYYGKM----KDGKEVAVKIMADSC----SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 690 (935)
Q Consensus 619 ~~LG~G~fG~Vy~~~~----~~g~~vAvK~~~~~~----~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~ 690 (935)
+.||+|+||.||+++. ..++.||+|+++... ......+.+|+++|+.++||||+++++.+..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 6799999999999975 357899999986532 12335678899999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccccccc
Q 002336 691 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 770 (935)
Q Consensus 691 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~ 770 (935)
+++++|.+.+.. .+.+.+..+..++.|+++||+|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (323)
T cd05584 82 LSGGELFMHLER---EGIFMEDTACFYLSEISLALEHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT 155 (323)
T ss_pred CCCchHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC
Confidence 999999999873 4567888899999999999999998 8999999999999999999999999999875432221
Q ss_pred ceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccC
Q 002336 771 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 850 (935)
Q Consensus 771 ~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~ 850 (935)
......|++.|+|||++.+..++.++||||||+++|||++|+.||...+.. ..... +..+.. .
T Consensus 156 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~------~~~~~-~~~~~~------~--- 218 (323)
T cd05584 156 -VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK------KTIDK-ILKGKL------N--- 218 (323)
T ss_pred -cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH------HHHHH-HHcCCC------C---
Confidence 122345899999999998888999999999999999999999999743221 11111 111111 0
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 002336 851 NVKIESIWRIAEVAIQCVEQRGFSRP-----KMQEIVLA 884 (935)
Q Consensus 851 ~~~~~~~~~l~~li~~Cl~~dP~~RP-----s~~ev~~~ 884 (935)
.+......+.+++.+||+.+|++|| +++++++.
T Consensus 219 -~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 219 -LPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred -CCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 1112233678999999999999999 78887663
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=325.38 Aligned_cols=248 Identities=22% Similarity=0.346 Sum_probs=198.0
Q ss_pred ccccccccEEEEEEEEC-CCcEEEEEEccCcc---hhhhHHHHHHHHHHHhc-CCCcccccceeeeccceEEEEEEecCC
Q 002336 619 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEYMHN 693 (935)
Q Consensus 619 ~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~iL~~L-~HpnIv~l~g~~~~~~~~~lV~E~~~~ 693 (935)
+.||+|+||.||++.+. +++.||+|+++... ....+.+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999876 68899999987532 22345688899999998 799999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccccccccee
Q 002336 694 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 773 (935)
Q Consensus 694 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~~~ 773 (935)
|+|.+++.. .+.+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++....... ..
T Consensus 81 g~L~~~~~~---~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~-~~ 153 (329)
T cd05588 81 GDLMFHMQR---QRKLPEEHARFYSAEISLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD-TT 153 (329)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEECcCccccccccCCC-cc
Confidence 999988863 4579999999999999999999998 8999999999999999999999999999874322111 12
Q ss_pred ecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCccc--chhHHHHHHHhhhcCCeeecccccccCC
Q 002336 774 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGA--ELNIVHWARSMIKKGDVISIVDPVLIGN 851 (935)
Q Consensus 774 ~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~--~~~l~~~~~~~i~~~~~~~~~d~~l~~~ 851 (935)
....||+.|+|||++.+..++.++|||||||++|||++|+.||+.....+ .....++..+.+..+... +
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~------~--- 224 (329)
T cd05588 154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIR------I--- 224 (329)
T ss_pred ccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCC------C---
Confidence 23468999999999999899999999999999999999999997433221 222333444444332211 1
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCC------HHHHHH
Q 002336 852 VKIESIWRIAEVAIQCVEQRGFSRPK------MQEIVL 883 (935)
Q Consensus 852 ~~~~~~~~l~~li~~Cl~~dP~~RPs------~~ev~~ 883 (935)
+......+.+++.+||+.+|++||+ ++++++
T Consensus 225 -p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 225 -PRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred -CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 1122336789999999999999997 667754
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-35 Score=318.40 Aligned_cols=261 Identities=29% Similarity=0.443 Sum_probs=201.2
Q ss_pred HHhhcccccccccEEEEEEEEC-----CCcEEEEEEccCcchhhhHHHHHHHHHHHhcCCCcccccceeeec--cceEEE
Q 002336 614 TNNFCKKIGKGSFGSVYYGKMK-----DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEE--EHQRIL 686 (935)
Q Consensus 614 ~~~~~~~LG~G~fG~Vy~~~~~-----~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~--~~~~~l 686 (935)
.+++.+.||+|+||.||++..+ +++.||+|.+........+.+.+|++++++++||||+++++++.. ....++
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 84 (284)
T cd05081 5 HLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRL 84 (284)
T ss_pred cceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEE
Confidence 4567789999999999999753 578999999887666666789999999999999999999998743 346789
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccc
Q 002336 687 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 766 (935)
Q Consensus 687 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~ 766 (935)
||||+++++|.+++... ...+++..+..++.|++.||+|||+ ++++||||||+||++++++.+||+|||++....
T Consensus 85 v~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~aL~~LH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~ 159 (284)
T cd05081 85 VMEYLPYGSLRDYLQKH--RERLDHRKLLLYASQICKGMEYLGS---KRYVHRDLATRNILVESENRVKIGDFGLTKVLP 159 (284)
T ss_pred EEEecCCCCHHHHHHhc--CcCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHhhEEECCCCeEEECCCccccccc
Confidence 99999999999998643 3468999999999999999999998 899999999999999999999999999998754
Q ss_pred ccccce--eecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCccc------c---hhHHHHHHHhh
Q 002336 767 EDLTHI--SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGA------E---LNIVHWARSMI 835 (935)
Q Consensus 767 ~~~~~~--~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~------~---~~l~~~~~~~i 835 (935)
...... .....++..|+|||.+.+..++.++||||||++++||++|..|+....... . ........+.+
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd05081 160 QDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELL 239 (284)
T ss_pred CCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHH
Confidence 332211 111223456999999988889999999999999999999887764222110 0 00011111111
Q ss_pred hcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhh
Q 002336 836 KKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 888 (935)
Q Consensus 836 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~ 888 (935)
..+.. ...+......+.+++.+||+.+|++|||++||++.|+.+
T Consensus 240 ~~~~~---------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 240 KNNGR---------LPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred hcCCc---------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 11100 001112234688999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=341.80 Aligned_cols=250 Identities=20% Similarity=0.311 Sum_probs=201.8
Q ss_pred HhhcccccccccEEEEEEEEC-C-CcEEEEEEccCcchhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEecC
Q 002336 615 NNFCKKIGKGSFGSVYYGKMK-D-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 692 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~-~-g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~~ 692 (935)
|.+.+.||+|++|.||+|... + ++.||+|.+..........+.+|+++++.++|||||++++++...+..++||||++
T Consensus 69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~ 148 (478)
T PTZ00267 69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGS 148 (478)
T ss_pred EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCC
Confidence 667889999999999999765 3 67889998755544555678889999999999999999999999999999999999
Q ss_pred CCCHHHHhccCC-CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccccccc-
Q 002336 693 NGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT- 770 (935)
Q Consensus 693 ~gsL~~~L~~~~-~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~- 770 (935)
+|+|.+.+.... ...++++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 149 gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~ 225 (478)
T PTZ00267 149 GGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHS---RKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSL 225 (478)
T ss_pred CCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCcCHHhEEECCCCcEEEEeCcCceecCCcccc
Confidence 999998876432 34568899999999999999999998 8999999999999999999999999999987644322
Q ss_pred ceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccC
Q 002336 771 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 850 (935)
Q Consensus 771 ~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~ 850 (935)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||...... +.... +..+.... .
T Consensus 226 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~------~~~~~-~~~~~~~~-----~-- 291 (478)
T PTZ00267 226 DVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQR------EIMQQ-VLYGKYDP-----F-- 291 (478)
T ss_pred ccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHH-HHhCCCCC-----C--
Confidence 1223446899999999999999999999999999999999999999743221 11111 11121110 1
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 851 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 851 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
+......+.+++.+||+.+|++||++++++.
T Consensus 292 --~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 292 --PCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred --CccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 1112236889999999999999999999864
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=297.97 Aligned_cols=234 Identities=26% Similarity=0.357 Sum_probs=196.3
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCcchh---hhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEe
Q 002336 615 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSH---RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 690 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~~---~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~ 690 (935)
+++.+.||.|+||.|.+++.+ +|..+|+|++.....- +.+...+|..+|+.+.||.++++.+.+.+.+.++|||||
T Consensus 46 fe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvmey 125 (355)
T KOG0616|consen 46 FERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVMEY 125 (355)
T ss_pred hhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEec
Confidence 456789999999999999877 5788999999765332 345678899999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccccccc
Q 002336 691 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 770 (935)
Q Consensus 691 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~ 770 (935)
.+||.|.++|++ .+.+++..+.-++.||+.||+|||+ .+|++|||||+|||+|.+|.+||+|||+|+.....
T Consensus 126 v~GGElFS~Lrk---~~rF~e~~arFYAAeivlAleylH~---~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r-- 197 (355)
T KOG0616|consen 126 VPGGELFSYLRK---SGRFSEPHARFYAAEIVLALEYLHS---LDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR-- 197 (355)
T ss_pred cCCccHHHHHHh---cCCCCchhHHHHHHHHHHHHHHHHh---cCeeeccCChHHeeeccCCcEEEEeccceEEecCc--
Confidence 999999999984 5679999999999999999999998 99999999999999999999999999999987554
Q ss_pred ceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccC
Q 002336 771 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 850 (935)
Q Consensus 771 ~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~ 850 (935)
.-..+|||.|+|||+++...+..++|-|||||++|||+.|..||-.... .. +-++|-++++
T Consensus 198 --T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~---~~----iY~KI~~~~v---------- 258 (355)
T KOG0616|consen 198 --TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP---IQ----IYEKILEGKV---------- 258 (355)
T ss_pred --EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh---HH----HHHHHHhCcc----------
Confidence 3456799999999999999999999999999999999999999973322 11 1122323322
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCC
Q 002336 851 NVKIESIWRIAEVAIQCVEQRGFSR 875 (935)
Q Consensus 851 ~~~~~~~~~l~~li~~Cl~~dP~~R 875 (935)
.+|......+.+|+.+.++.|-.+|
T Consensus 259 ~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 259 KFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred cCCcccCHHHHHHHHHHHhhhhHhh
Confidence 1222222367788889999998888
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=321.08 Aligned_cols=242 Identities=24% Similarity=0.359 Sum_probs=198.3
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCcch---hhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEe
Q 002336 615 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 690 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~---~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~ 690 (935)
+++.+.||+|+||.||+++-+ +|+.+|+|++++..- .+.+.+..|-.+|....+|+||+++..|.+.+.+||||||
T Consensus 143 Fe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEy 222 (550)
T KOG0605|consen 143 FELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEY 222 (550)
T ss_pred chhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEe
Confidence 445789999999999999765 699999999987543 3456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccc---
Q 002336 691 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE--- 767 (935)
Q Consensus 691 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~--- 767 (935)
++||++..+|. ....|++..+..++.+++.|+.-||+ .|+|||||||+|+|||..|++||+||||+.....
T Consensus 223 lPGGD~mTLL~---~~~~L~e~~arfYiaE~vlAI~~iH~---~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~ 296 (550)
T KOG0605|consen 223 LPGGDMMTLLM---RKDTLTEDWARFYIAETVLAIESIHQ---LGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHR 296 (550)
T ss_pred cCCccHHHHHH---hcCcCchHHHHHHHHHHHHHHHHHHH---cCcccccCChhheeecCCCCEeeccccccchhhhhhh
Confidence 99999999998 46789999999999999999999998 9999999999999999999999999999853211
Q ss_pred ------------c--------ccc----e-------------------eecccCCccccCCCCCCCCCCCchhHHHHHHH
Q 002336 768 ------------D--------LTH----I-------------------SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGV 804 (935)
Q Consensus 768 ------------~--------~~~----~-------------------~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gv 804 (935)
. ... . .....|||.|||||++.+..|+..+|.||+||
T Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~ 376 (550)
T KOG0605|consen 297 IESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGC 376 (550)
T ss_pred hhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHH
Confidence 0 000 0 01134999999999999999999999999999
Q ss_pred HHHHHHhCCCCCCccCccc-chhHHHHHHHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCC
Q 002336 805 VLLELISGKKPVSVEDFGA-ELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPK 877 (935)
Q Consensus 805 il~eLltG~~Pf~~~~~~~-~~~l~~~~~~~i~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs 877 (935)
|+||||.|.+||..+...+ ...++.|-........ .....+..++|.+|+. ||++|--
T Consensus 377 ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~--------------~~~s~eA~DLI~rll~-d~~~RLG 435 (550)
T KOG0605|consen 377 IMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEE--------------VDLSDEAKDLITRLLC-DPENRLG 435 (550)
T ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCc--------------CcccHHHHHHHHHHhc-CHHHhcC
Confidence 9999999999998665543 3345555433222110 0111467799999999 9999985
|
|
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=317.62 Aligned_cols=256 Identities=27% Similarity=0.470 Sum_probs=202.1
Q ss_pred HHHhhcccccccccEEEEEEEE-----CCCcEEEEEEccCcc-hhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEE
Q 002336 613 ATNNFCKKIGKGSFGSVYYGKM-----KDGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRIL 686 (935)
Q Consensus 613 ~~~~~~~~LG~G~fG~Vy~~~~-----~~g~~vAvK~~~~~~-~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~l 686 (935)
..+++.+.||+|+||.||+|.+ ..++.+++|.+.... ....+.+.+|++++++++||||+++++++..+...++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 4566788999999999999975 246789999987533 3344678999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhccCC--------------CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCC
Q 002336 687 VYEYMHNGTLRDRLHGSV--------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM 752 (935)
Q Consensus 687 V~E~~~~gsL~~~L~~~~--------------~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~ 752 (935)
||||+++++|.+++.... ....+++.+++.++.|++.||+|||+ ++++||||||+|||+++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSS---HFFVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---cCeehhccccceEEEcCCC
Confidence 999999999999885321 12357889999999999999999998 8999999999999999999
Q ss_pred cEEEeeccccccccccc-cceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCcccchhHHHH
Q 002336 753 RAKVSDFGLSRQAEEDL-THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHW 830 (935)
Q Consensus 753 ~vkL~DFGla~~~~~~~-~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~ 830 (935)
.+||+|||+++...... ........++..|+|||.+.+..++.++||||||+++|||++ |..||..... ...
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~---~~~--- 235 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN---QEV--- 235 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH---HHH---
Confidence 99999999997653322 111222335678999999988889999999999999999998 9999863221 111
Q ss_pred HHHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhh
Q 002336 831 ARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 887 (935)
Q Consensus 831 ~~~~i~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~ 887 (935)
.+.+..+.... . +......+.+++.+|++.+|++||++.+|.+.|+.
T Consensus 236 -~~~~~~~~~~~-----~----~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 236 -IEMVRKRQLLP-----C----SEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred -HHHHHcCCcCC-----C----CCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 12222222111 1 11123468899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=316.39 Aligned_cols=258 Identities=24% Similarity=0.430 Sum_probs=202.0
Q ss_pred HHHHHhhcccccccccEEEEEEEEC------CCcEEEEEEccCcc-hhhhHHHHHHHHHHHhcCCCcccccceeeeccce
Q 002336 611 EEATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQ 683 (935)
Q Consensus 611 ~~~~~~~~~~LG~G~fG~Vy~~~~~------~g~~vAvK~~~~~~-~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~ 683 (935)
....+++.+.||+|+||.||+|.+. .++.||+|++.... .....++.+|+.+++.++||||+++++++.....
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 3455777899999999999999764 25679999986432 2344678899999999999999999999999999
Q ss_pred EEEEEEecCCCCHHHHhccCCC-------CCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEE
Q 002336 684 RILVYEYMHNGTLRDRLHGSVN-------QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKV 756 (935)
Q Consensus 684 ~~lV~E~~~~gsL~~~L~~~~~-------~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL 756 (935)
.++||||+++++|.+++..... ...+++..++.++.|+++||+|||+ .+++||||||+||++++++.++|
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCcchheEEEcCCCCEEE
Confidence 9999999999999999864321 2346788999999999999999998 89999999999999999999999
Q ss_pred eeccccccccccccce-eecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCcccchhHHHHHHHh
Q 002336 757 SDFGLSRQAEEDLTHI-SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSM 834 (935)
Q Consensus 757 ~DFGla~~~~~~~~~~-~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~ 834 (935)
+|||+++......... .....++..|+|||++.+..++.++||||||+++|||++ |..||...... ...+ .
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~---~~~~----~ 233 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE---QVLR----F 233 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHH----H
Confidence 9999987543322211 112235778999999988889999999999999999999 78888633211 1111 1
Q ss_pred hhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhh
Q 002336 835 IKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 887 (935)
Q Consensus 835 i~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~ 887 (935)
+..+.... .+......+.+++.+|++.+|++||++.|+++.|++
T Consensus 234 ~~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 234 VMEGGLLD---------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred HHcCCcCC---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 11221111 111223468899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=326.12 Aligned_cols=261 Identities=28% Similarity=0.470 Sum_probs=204.3
Q ss_pred HHHHhhcccccccccEEEEEEEEC------CCcEEEEEEccCcc-hhhhHHHHHHHHHHHhc-CCCcccccceeeec-cc
Q 002336 612 EATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSC-SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEE-EH 682 (935)
Q Consensus 612 ~~~~~~~~~LG~G~fG~Vy~~~~~------~g~~vAvK~~~~~~-~~~~~~~~~E~~iL~~L-~HpnIv~l~g~~~~-~~ 682 (935)
...+++.+.||+|+||.||+|.+. .++.||+|+++... ....+.+.+|++++.++ +|+||++++++|.. +.
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 456788999999999999999643 35789999987543 23346788899999999 79999999998864 45
Q ss_pred eEEEEEEecCCCCHHHHhccCCC---------------------------------------------------------
Q 002336 683 QRILVYEYMHNGTLRDRLHGSVN--------------------------------------------------------- 705 (935)
Q Consensus 683 ~~~lV~E~~~~gsL~~~L~~~~~--------------------------------------------------------- 705 (935)
..+++|||+++++|.+.+.....
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 67899999999999998853211
Q ss_pred -CCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccccce-eecccCCcccc
Q 002336 706 -QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI-SSVARGTVGYL 783 (935)
Q Consensus 706 -~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~~-~~~~~gt~~y~ 783 (935)
...+++..+.+++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++......... .....++..|+
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~---~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 242 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 242 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence 1368899999999999999999998 899999999999999999999999999998754322211 12234567899
Q ss_pred CCCCCCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccCCCCHHHHHHHHH
Q 002336 784 DPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAE 862 (935)
Q Consensus 784 APE~l~~~~~s~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~~~~~~~~~~l~~ 862 (935)
|||++.+..++.++|||||||+++||++ |..||......+ . ....+..+.... .+......+.+
T Consensus 243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~--~----~~~~~~~~~~~~---------~~~~~~~~~~~ 307 (337)
T cd05054 243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE--E----FCRRLKEGTRMR---------APEYATPEIYS 307 (337)
T ss_pred CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH--H----HHHHHhccCCCC---------CCccCCHHHHH
Confidence 9999999999999999999999999998 999997432211 1 112222221111 01122346889
Q ss_pred HHHHccccCCCCCCCHHHHHHHHhhhhh
Q 002336 863 VAIQCVEQRGFSRPKMQEIVLAIQDSIK 890 (935)
Q Consensus 863 li~~Cl~~dP~~RPs~~ev~~~L~~~~~ 890 (935)
++.+||+.+|++||++.||+++|++++.
T Consensus 308 l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 308 IMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 9999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=328.73 Aligned_cols=247 Identities=23% Similarity=0.279 Sum_probs=200.3
Q ss_pred HHHHHhhcccccccccEEEEEEEECC--CcEEEEEEccCcc---hhhhHHHHHHHHHHHhcCCCcccccceeeeccceEE
Q 002336 611 EEATNNFCKKIGKGSFGSVYYGKMKD--GKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRI 685 (935)
Q Consensus 611 ~~~~~~~~~~LG~G~fG~Vy~~~~~~--g~~vAvK~~~~~~---~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~ 685 (935)
....+++.+.||+|+||.||+|.++. +..||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus 28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~ 107 (340)
T PTZ00426 28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLY 107 (340)
T ss_pred ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEE
Confidence 34557788999999999999998653 3689999986432 223456889999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccc
Q 002336 686 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 765 (935)
Q Consensus 686 lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~ 765 (935)
+||||+++|+|.+++.. ...+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++..
T Consensus 108 lv~Ey~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~ 181 (340)
T PTZ00426 108 LVLEFVIGGEFFTFLRR---NKRFPNDVGCFYAAQIVLIFEYLQS---LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVV 181 (340)
T ss_pred EEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEecCCCCeec
Confidence 99999999999999973 4568999999999999999999998 89999999999999999999999999999765
Q ss_pred cccccceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeeccc
Q 002336 766 EEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 845 (935)
Q Consensus 766 ~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d 845 (935)
.... ....||+.|+|||++.+..++.++|||||||++|||++|+.||...+.. . ..+.+..+..
T Consensus 182 ~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~---~----~~~~i~~~~~----- 245 (340)
T PTZ00426 182 DTRT----YTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL---L----IYQKILEGII----- 245 (340)
T ss_pred CCCc----ceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH---H----HHHHHhcCCC-----
Confidence 4321 2345899999999998888999999999999999999999999743221 1 1111222211
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 002336 846 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRP-----KMQEIVLA 884 (935)
Q Consensus 846 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----s~~ev~~~ 884 (935)
..+......+.+++.+|++.+|++|+ +++|+.+.
T Consensus 246 -----~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 246 -----YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred -----CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 01111223578999999999999995 89888765
|
|
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=310.33 Aligned_cols=247 Identities=28% Similarity=0.452 Sum_probs=196.4
Q ss_pred ccccccccEEEEEEEEC---CCcEEEEEEccCcch--hhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEecCC
Q 002336 619 KKIGKGSFGSVYYGKMK---DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 693 (935)
Q Consensus 619 ~~LG~G~fG~Vy~~~~~---~g~~vAvK~~~~~~~--~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~~~ 693 (935)
+.||+|+||.||+|.++ +++.+|+|+++.... ...+.+.+|+.+++.++||||+++++++.. +..++||||+++
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~ 79 (257)
T cd05116 1 GELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAEL 79 (257)
T ss_pred CcCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCC
Confidence 36899999999999753 578899999864432 345678999999999999999999998864 467899999999
Q ss_pred CCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccccce-
Q 002336 694 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI- 772 (935)
Q Consensus 694 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~~- 772 (935)
++|.+++.. ...+++..+.+++.|++.||+|||+ ++++||||||+||+++.++.+||+|||++..........
T Consensus 80 ~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 153 (257)
T cd05116 80 GPLNKFLQK---NKHVTEKNITELVHQVSMGMKYLEE---TNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK 153 (257)
T ss_pred CcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeee
Confidence 999999863 3568999999999999999999997 899999999999999999999999999998654432211
Q ss_pred -eecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccC
Q 002336 773 -SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 850 (935)
Q Consensus 773 -~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~ 850 (935)
.....++..|+|||.+....++.++||||||+++|||++ |+.||...... ... ..+.++....
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~----~~i~~~~~~~-------- 218 (257)
T cd05116 154 AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN---EVT----QMIESGERME-------- 218 (257)
T ss_pred ecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH---HHH----HHHHCCCCCC--------
Confidence 112234578999999988889999999999999999998 99999732221 111 2223222111
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhh
Q 002336 851 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 888 (935)
Q Consensus 851 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~ 888 (935)
.+......+.+++.+||+.+|++||++.+|++.|++.
T Consensus 219 -~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 219 -CPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred -CCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 1112234678999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-35 Score=326.92 Aligned_cols=260 Identities=22% Similarity=0.309 Sum_probs=193.8
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc--hhhhHHHHHHHHHHHhcCCCcccccceeeecc-----ceEEE
Q 002336 615 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE-----HQRIL 686 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~-----~~~~l 686 (935)
|++.+.||+|+||.||+|... +|+.||||++.... ......+.+|++++++++||||+++++++... ...++
T Consensus 2 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~l 81 (338)
T cd07859 2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYV 81 (338)
T ss_pred eEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEE
Confidence 456789999999999999875 68999999986432 23345788999999999999999999987532 34799
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccc
Q 002336 687 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 766 (935)
Q Consensus 687 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~ 766 (935)
||||+. ++|.+.+.. ...+++..+..++.|+++||+|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 82 v~e~~~-~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~ 154 (338)
T cd07859 82 VFELME-SDLHQVIKA---NDDLTPEHHQFFLYQLLRALKYIHT---ANVFHRDLKPKNILANADCKLKICDFGLARVAF 154 (338)
T ss_pred EEecCC-CCHHHHHHh---cccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEccCccccccc
Confidence 999995 689888863 4568999999999999999999998 899999999999999999999999999997643
Q ss_pred cccc--ceeecccCCccccCCCCCCC--CCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHh--------
Q 002336 767 EDLT--HISSVARGTVGYLDPEYYGN--QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSM-------- 834 (935)
Q Consensus 767 ~~~~--~~~~~~~gt~~y~APE~l~~--~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~-------- 834 (935)
.... .......|++.|+|||++.+ ..++.++|||||||++|||++|+.||...+..... ..+...
T Consensus 155 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~---~~~~~~~~~~~~~~ 231 (338)
T cd07859 155 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQL---DLITDLLGTPSPET 231 (338)
T ss_pred cccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHH---HHHHHHhCCCCHHH
Confidence 2211 11233468999999998865 67899999999999999999999999744321111 111000
Q ss_pred ---hhcCCeeeccc---ccccC---CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002336 835 ---IKKGDVISIVD---PVLIG---NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 884 (935)
Q Consensus 835 ---i~~~~~~~~~d---~~l~~---~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~ 884 (935)
+........++ +.... ...+.....+.+++.+||+.+|++||+++|+++.
T Consensus 232 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 232 ISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred HHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 00000000000 00000 0000112357899999999999999999999864
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=309.08 Aligned_cols=259 Identities=22% Similarity=0.326 Sum_probs=206.4
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCc---chhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEE
Q 002336 614 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS---CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 689 (935)
Q Consensus 614 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~---~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E 689 (935)
.+++.+.||+|++|.||++... +++.+|||.+... .....+++.+|+.+++.++||||+++++++.+.+..+++||
T Consensus 3 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 82 (267)
T cd08229 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLE 82 (267)
T ss_pred hhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEE
Confidence 4567789999999999999864 7899999987642 22334678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCC-CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccccc
Q 002336 690 YMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 768 (935)
Q Consensus 690 ~~~~gsL~~~L~~~~-~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~ 768 (935)
|+++++|.+++.... ....+++..++.++.|+++||+|||+ .+++|+||||+||+++.++.++|+|||++......
T Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd08229 83 LADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred ecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEECcchhhhccccC
Confidence 999999999886422 34568999999999999999999997 89999999999999999999999999998765433
Q ss_pred ccceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccccc
Q 002336 769 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 848 (935)
Q Consensus 769 ~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l 848 (935)
... .....++..|+|||.+.+..++.++||||||+++|+|++|..||...... .....+. +.... .+..
T Consensus 160 ~~~-~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~~~~-~~~~~-----~~~~ 228 (267)
T cd08229 160 TTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSLCKK-IEQCD-----YPPL 228 (267)
T ss_pred Ccc-cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch----HHHHhhh-hhcCC-----CCCC
Confidence 221 12335788999999998888999999999999999999999999633221 1111111 11111 1111
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhhh
Q 002336 849 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI 889 (935)
Q Consensus 849 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~~ 889 (935)
. .......+.+++.+||+.+|++||||.+|++.++++-
T Consensus 229 ~---~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 229 P---SDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred C---cccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 1 1123347889999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=323.54 Aligned_cols=249 Identities=23% Similarity=0.352 Sum_probs=196.5
Q ss_pred ccccccccEEEEEEEEC-CCcEEEEEEccCcc---hhhhHHHHHHHHHHHhc-CCCcccccceeeeccceEEEEEEecCC
Q 002336 619 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEYMHN 693 (935)
Q Consensus 619 ~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~iL~~L-~HpnIv~l~g~~~~~~~~~lV~E~~~~ 693 (935)
+.||+|+||.||+|... +++.+|+|+++... ....+.+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999876 57899999987532 23345678899988877 799999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccccccccee
Q 002336 694 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 773 (935)
Q Consensus 694 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~~~ 773 (935)
|+|.+++.. ...+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++....... ..
T Consensus 81 ~~L~~~~~~---~~~l~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~-~~ 153 (329)
T cd05618 81 GDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD-TT 153 (329)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC-cc
Confidence 999988863 4568999999999999999999998 8999999999999999999999999999875322211 12
Q ss_pred ecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcc--cchhHHHHHHHhhhcCCeeecccccccCC
Q 002336 774 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFG--AELNIVHWARSMIKKGDVISIVDPVLIGN 851 (935)
Q Consensus 774 ~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~--~~~~l~~~~~~~i~~~~~~~~~d~~l~~~ 851 (935)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .......++.+.+..+.. .
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~----------~ 223 (329)
T cd05618 154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI----------R 223 (329)
T ss_pred ccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC----------C
Confidence 2346899999999999989999999999999999999999999632221 112223333333332221 1
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCC------HHHHHHH
Q 002336 852 VKIESIWRIAEVAIQCVEQRGFSRPK------MQEIVLA 884 (935)
Q Consensus 852 ~~~~~~~~l~~li~~Cl~~dP~~RPs------~~ev~~~ 884 (935)
.+......+.+++.+||+.+|++||+ ++++++.
T Consensus 224 ~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 224 IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred CCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 11222346789999999999999998 4666543
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=328.30 Aligned_cols=259 Identities=18% Similarity=0.188 Sum_probs=195.4
Q ss_pred HHHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcchhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEe
Q 002336 612 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 690 (935)
Q Consensus 612 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~ 690 (935)
...|.+.+.||+|+||.||++... .++.||+|... .+.+.+|++++++++||||+++++++......++|+|+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 345777899999999999999875 68899999643 24577899999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccccccc
Q 002336 691 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 770 (935)
Q Consensus 691 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~ 770 (935)
+. ++|.+++.. ...+++..++.++.|+++||+|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 165 ~~-~~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~ylH~---~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~ 237 (391)
T PHA03212 165 YK-TDLYCYLAA---KRNIAICDILAIERSVLRAIQYLHE---NRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA 237 (391)
T ss_pred CC-CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHhEEEcCCCCEEEEeCCcccccccccc
Confidence 95 688888763 4568899999999999999999998 8999999999999999999999999999975433222
Q ss_pred ceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCccc-c---hhHHHHHHHhhhcCC-------
Q 002336 771 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGA-E---LNIVHWARSMIKKGD------- 839 (935)
Q Consensus 771 ~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~-~---~~l~~~~~~~i~~~~------- 839 (935)
.......||+.|+|||++.+..++.++|||||||++|||++|+.|+-...... . ......+........
T Consensus 238 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~ 317 (391)
T PHA03212 238 NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDA 317 (391)
T ss_pred cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcch
Confidence 22234568999999999998899999999999999999999998864322110 0 000110100000000
Q ss_pred ---eeecc---------cccccCCC--CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 840 ---VISIV---------DPVLIGNV--KIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 840 ---~~~~~---------d~~l~~~~--~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
..... .+...... .......+.+++.+||+.||++|||++|+++
T Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 318 QANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred hHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 00000 00000000 0123447889999999999999999999975
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=324.89 Aligned_cols=251 Identities=24% Similarity=0.305 Sum_probs=197.1
Q ss_pred HhhcccccccccEEEEEEEEC----CCcEEEEEEccCcc----hhhhHHHHHHHHHHHhc-CCCcccccceeeeccceEE
Q 002336 615 NNFCKKIGKGSFGSVYYGKMK----DGKEVAVKIMADSC----SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRI 685 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~----~g~~vAvK~~~~~~----~~~~~~~~~E~~iL~~L-~HpnIv~l~g~~~~~~~~~ 685 (935)
|++.+.||+|+||.||+++.. +++.||+|++.... ....+.+..|+++++.+ +|+||+++++++...+..+
T Consensus 2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (332)
T cd05614 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLH 81 (332)
T ss_pred ceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEE
Confidence 456789999999999999753 58899999986432 12345678899999999 5999999999999999999
Q ss_pred EEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccc
Q 002336 686 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 765 (935)
Q Consensus 686 lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~ 765 (935)
+||||+++|+|.+++.. ...+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++..
T Consensus 82 lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~ 155 (332)
T cd05614 82 LILDYVSGGEMFTHLYQ---RDNFSEDEVRFYSGEIILALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (332)
T ss_pred EEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHeEECCCCCEEEeeCcCCccc
Confidence 99999999999999873 4568999999999999999999998 89999999999999999999999999999865
Q ss_pred cccccceeecccCCccccCCCCCCCC-CCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecc
Q 002336 766 EEDLTHISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 844 (935)
Q Consensus 766 ~~~~~~~~~~~~gt~~y~APE~l~~~-~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~ 844 (935)
............||+.|+|||.+.+. .++.++|||||||++|||++|+.||......... ..+...+...
T Consensus 156 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~---~~~~~~~~~~------ 226 (332)
T cd05614 156 LSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQ---SEVSRRILKC------ 226 (332)
T ss_pred cccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCH---HHHHHHHhcC------
Confidence 43333223345689999999998764 4788999999999999999999999743222111 1111111111
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 002336 845 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRP-----KMQEIVLA 884 (935)
Q Consensus 845 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----s~~ev~~~ 884 (935)
++.+. ......+.+++.+||+.||++|| +++++++.
T Consensus 227 ~~~~~----~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 227 DPPFP----SFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred CCCCC----CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 11111 12233678999999999999999 67777653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=321.57 Aligned_cols=240 Identities=27% Similarity=0.390 Sum_probs=190.1
Q ss_pred ccccccccEEEEEEEEC-CCcEEEEEEccCcc---hhhhHHHHHHHHHHHhc-CCCcccccceeeeccceEEEEEEecCC
Q 002336 619 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEYMHN 693 (935)
Q Consensus 619 ~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~iL~~L-~HpnIv~l~g~~~~~~~~~lV~E~~~~ 693 (935)
+.||+|+||.||+|.+. +++.||+|+++... ....+.+..|..++..+ +||||+++++++......++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999876 57899999987532 22334566677777654 899999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccccccccee
Q 002336 694 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 773 (935)
Q Consensus 694 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~~~ 773 (935)
|+|.+++.. ...+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 g~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~~ 153 (316)
T cd05592 81 GDLMFHIQS---SGRFDEARARFYAAEIICGLQFLHK---KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GKA 153 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Ccc
Confidence 999998873 4568999999999999999999998 899999999999999999999999999987643222 122
Q ss_pred ecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccCCCC
Q 002336 774 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVK 853 (935)
Q Consensus 774 ~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~~~~ 853 (935)
....||+.|+|||.+.+..++.++|||||||++|||++|+.||...+.. ... . .+.... +. .+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~---~~~---~-~i~~~~------~~----~~ 216 (316)
T cd05592 154 STFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDED---ELF---D-SILNDR------PH----FP 216 (316)
T ss_pred ccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHH---HHH---H-HHHcCC------CC----CC
Confidence 3346899999999999888999999999999999999999999743321 111 1 111110 11 11
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHH-HHH
Q 002336 854 IESIWRIAEVAIQCVEQRGFSRPKMQ-EIV 882 (935)
Q Consensus 854 ~~~~~~l~~li~~Cl~~dP~~RPs~~-ev~ 882 (935)
......+.+++.+||+.+|++||++. ++.
T Consensus 217 ~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05592 217 RWISKEAKDCLSKLFERDPTKRLGVDGDIR 246 (316)
T ss_pred CCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 11233678999999999999999875 443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=317.87 Aligned_cols=259 Identities=21% Similarity=0.277 Sum_probs=192.1
Q ss_pred HhhcccccccccEEEEEEEEC--CCcEEEEEEccCcch--hhhHHHHHHHHHHHhc---CCCcccccceeee-----ccc
Q 002336 615 NNFCKKIGKGSFGSVYYGKMK--DGKEVAVKIMADSCS--HRTQQFVTEVALLSRI---HHRNLVPLIGYCE-----EEH 682 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~--~g~~vAvK~~~~~~~--~~~~~~~~E~~iL~~L---~HpnIv~l~g~~~-----~~~ 682 (935)
|++.+.||+|+||.||+|+.. +++.||+|.++.... .....+.+|+.+++.+ +||||+++++++. ...
T Consensus 3 Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~ 82 (290)
T cd07862 3 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRET 82 (290)
T ss_pred cceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCC
Confidence 566789999999999999863 468899998864322 2234566777777766 6999999999885 345
Q ss_pred eEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccc
Q 002336 683 QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS 762 (935)
Q Consensus 683 ~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla 762 (935)
..++||||+. ++|.+++... ....+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||++
T Consensus 83 ~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~---~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~ 157 (290)
T cd07862 83 KLTLVFEHVD-QDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLA 157 (290)
T ss_pred cEEEEEccCC-CCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEcCCCCEEEccccce
Confidence 6899999996 6899888643 24458999999999999999999998 89999999999999999999999999999
Q ss_pred ccccccccceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhc---CC
Q 002336 763 RQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKK---GD 839 (935)
Q Consensus 763 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~---~~ 839 (935)
+..... .......|++.|+|||.+.+..++.++|||||||++|||++|+.||......+ ....+...... .+
T Consensus 158 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~---~~~~i~~~~~~~~~~~ 232 (290)
T cd07862 158 RIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD---QLGKILDVIGLPGEED 232 (290)
T ss_pred EeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHH---HHHHHHHHhCCCChhh
Confidence 765433 12233458999999999988889999999999999999999999997443221 11111111100 00
Q ss_pred eee---cccccccC-------CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 840 VIS---IVDPVLIG-------NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 840 ~~~---~~d~~l~~-------~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
... .....+.. ...+.....+.+++.+||+.+|++|||+.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 233 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred chhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 000 00000000 000112246789999999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=320.92 Aligned_cols=264 Identities=29% Similarity=0.449 Sum_probs=218.2
Q ss_pred hHHHHHHhhcccccccccEEEEEEEEC---CC--cEEEEEEccCcc-hhhhHHHHHHHHHHHhcCCCcccccceeeeccc
Q 002336 609 ELEEATNNFCKKIGKGSFGSVYYGKMK---DG--KEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH 682 (935)
Q Consensus 609 ~l~~~~~~~~~~LG~G~fG~Vy~~~~~---~g--~~vAvK~~~~~~-~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~ 682 (935)
+|.++...+.+.||+|-||.||+|... .| -.||||..+..+ ....+.|+.|..+|++++|||||+++|+|.+.
T Consensus 385 el~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~- 463 (974)
T KOG4257|consen 385 ELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ- 463 (974)
T ss_pred eeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-
Confidence 566666677889999999999999754 23 358999988754 34567899999999999999999999999765
Q ss_pred eEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccc
Q 002336 683 QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS 762 (935)
Q Consensus 683 ~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla 762 (935)
..|+|||.++-|.|.++|+. +...++......++.||+.||+|||+ +++|||||.++|||+...--+||+|||++
T Consensus 464 P~WivmEL~~~GELr~yLq~--nk~sL~l~tL~ly~~Qi~talaYLeS---krfVHRDIAaRNiLVsSp~CVKLaDFGLS 538 (974)
T KOG4257|consen 464 PMWIVMELAPLGELREYLQQ--NKDSLPLRTLTLYCYQICTALAYLES---KRFVHRDIAARNILVSSPQCVKLADFGLS 538 (974)
T ss_pred ceeEEEecccchhHHHHHHh--ccccchHHHHHHHHHHHHHHHHHHHh---hchhhhhhhhhheeecCcceeeecccchh
Confidence 57999999999999999985 35678889999999999999999998 99999999999999999999999999999
Q ss_pred ccccccccceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCcccchhHHHHHHHhhhcCCee
Q 002336 763 RQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVI 841 (935)
Q Consensus 763 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~ 841 (935)
+...+......+...-++.|||||.+.-.+++.++|||.|||.+||++. |..||.+-.-.+- ...+++|+.
T Consensus 539 R~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDV-------I~~iEnGeR- 610 (974)
T KOG4257|consen 539 RYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDV-------IGHIENGER- 610 (974)
T ss_pred hhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccce-------EEEecCCCC-
Confidence 9987766555555556789999999999999999999999999999887 9999984332211 111222222
Q ss_pred ecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhhhhhccC
Q 002336 842 SIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKG 894 (935)
Q Consensus 842 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~~~~~~~ 894 (935)
--.|+.++..+..++.+||..+|.+||.+.|+...|.++...+..
T Consensus 611 --------lP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qeek~ 655 (974)
T KOG4257|consen 611 --------LPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQEEKI 655 (974)
T ss_pred --------CCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHHhhh
Confidence 122344455788999999999999999999999999888775544
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=326.29 Aligned_cols=243 Identities=24% Similarity=0.355 Sum_probs=195.1
Q ss_pred ccccccccEEEEEEEEC-CCcEEEEEEccCcc---hhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEecCCC
Q 002336 619 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNG 694 (935)
Q Consensus 619 ~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~~~g 694 (935)
+.||+|+||.||++... +|+.||+|++.... ......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999865 68999999987532 223456788999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccccceee
Q 002336 695 TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISS 774 (935)
Q Consensus 695 sL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~ 774 (935)
+|.+++.. ...+++..+..++.|++.||+|||+ .++|+||||||+|||++.++.+||+|||+++........ ..
T Consensus 81 ~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~--~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~-~~ 154 (325)
T cd05594 81 ELFFHLSR---ERVFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT-MK 154 (325)
T ss_pred cHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcc-cc
Confidence 99998863 4568999999999999999999996 369999999999999999999999999998753322111 22
Q ss_pred cccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccCCCCH
Q 002336 775 VARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKI 854 (935)
Q Consensus 775 ~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~~~~~ 854 (935)
...|++.|+|||++.+..++.++|||||||++|||++|+.||....... ..+ .+..+.. .+ +.
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~---~~~----~i~~~~~------~~----p~ 217 (325)
T cd05594 155 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK---LFE----LILMEEI------RF----PR 217 (325)
T ss_pred cccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHH---HHH----HHhcCCC------CC----CC
Confidence 3458999999999988899999999999999999999999997433211 111 1111111 11 11
Q ss_pred HHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 002336 855 ESIWRIAEVAIQCVEQRGFSRP-----KMQEIVLA 884 (935)
Q Consensus 855 ~~~~~l~~li~~Cl~~dP~~RP-----s~~ev~~~ 884 (935)
.....+.+++.+||+.||++|+ +++++++.
T Consensus 218 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 218 TLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred CCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 1233678999999999999996 89998754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=308.33 Aligned_cols=253 Identities=27% Similarity=0.442 Sum_probs=201.4
Q ss_pred HHHhhcccccccccEEEEEEEECCCcEEEEEEccCcchhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEecC
Q 002336 613 ATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 692 (935)
Q Consensus 613 ~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~~ 692 (935)
..+++.+.||+|++|.||+|.++.+..+|+|.+.... ...+.+.+|++++++++|+|++++++++.. +..+++|||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~ 83 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTEFMG 83 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEEEcCC
Confidence 4467788999999999999998877789999876532 234678899999999999999999998754 56789999999
Q ss_pred CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccccce
Q 002336 693 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 772 (935)
Q Consensus 693 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~~ 772 (935)
+++|.+++... ....+++..+..++.|++.||+|||+ .+++|+||||+||++++++.++|+|||++..........
T Consensus 84 ~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~ 159 (260)
T cd05069 84 KGSLLDFLKEG-DGKYLKLPQLVDMAAQIADGMAYIER---MNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTA 159 (260)
T ss_pred CCCHHHHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCeEEECCCccceEccCCcccc
Confidence 99999999753 23458899999999999999999997 899999999999999999999999999997654322211
Q ss_pred eecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccCC
Q 002336 773 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 851 (935)
Q Consensus 773 ~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~~ 851 (935)
.....++..|+|||...+..++.++||||||+++|||++ |+.||...... ...++ +..+... .
T Consensus 160 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~~----~~~~~~~---------~ 223 (260)
T cd05069 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR---EVLEQ----VERGYRM---------P 223 (260)
T ss_pred cCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHH----HHcCCCC---------C
Confidence 122235678999999988889999999999999999999 89998732211 11121 1111100 0
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhh
Q 002336 852 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 887 (935)
Q Consensus 852 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~ 887 (935)
.+......+.+++.+||..+|++||++++|++.|++
T Consensus 224 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 224 CPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 112234578899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=309.44 Aligned_cols=257 Identities=28% Similarity=0.479 Sum_probs=206.4
Q ss_pred HHHHHHhhcccccccccEEEEEEEECCCcEEEEEEccCcchhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEE
Q 002336 610 LEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 689 (935)
Q Consensus 610 l~~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E 689 (935)
+....+.+.+.||+|++|.||+|..++++.+|+|.+.... ...+++.+|+.++++++|+||+++++++......++|||
T Consensus 3 ~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 81 (261)
T cd05034 3 IPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTE 81 (261)
T ss_pred cchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEe
Confidence 3445667789999999999999998888999999987543 234678999999999999999999999998889999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccc
Q 002336 690 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 769 (935)
Q Consensus 690 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~ 769 (935)
|+++++|.+++... ....+++..+..++.|++.||+|||+ .+++|+||||+||++++++.+||+|||++.......
T Consensus 82 ~~~~~~L~~~i~~~-~~~~~~~~~~~~~~~~i~~al~~lh~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~ 157 (261)
T cd05034 82 YMSKGSLLDFLKSG-EGKKLRLPQLVDMAAQIAEGMAYLES---RNYIHRDLAARNILVGENLVCKIADFGLARLIEDDE 157 (261)
T ss_pred ccCCCCHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcchheEEEcCCCCEEECccccceeccchh
Confidence 99999999999753 23568999999999999999999997 899999999999999999999999999987664322
Q ss_pred cceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCcccchhHHHHHHHhhhcCCeeecccccc
Q 002336 770 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 848 (935)
Q Consensus 770 ~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l 848 (935)
........++..|+|||.+.+..++.++||||+|+++++|++ |+.||...... ...+. +..+.. .
T Consensus 158 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~---~~~~~----~~~~~~-----~-- 223 (261)
T cd05034 158 YTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR---EVLEQ----VERGYR-----M-- 223 (261)
T ss_pred hhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHH----HHcCCC-----C--
Confidence 211122234568999999988889999999999999999998 99999633211 11111 111100 0
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhh
Q 002336 849 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 887 (935)
Q Consensus 849 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~ 887 (935)
..+......+.+++.+|++.+|++||+++++.+.|++
T Consensus 224 --~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 224 --PRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred --CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 0111123468899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=316.32 Aligned_cols=261 Identities=22% Similarity=0.275 Sum_probs=195.0
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcch-hhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEec
Q 002336 614 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 691 (935)
Q Consensus 614 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~-~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~ 691 (935)
.|++.+.||+|+||.||+|... +++.||+|++..... .....+.+|+.+++.++||||+++++++.++...++||||+
T Consensus 6 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 85 (303)
T cd07869 6 SYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYV 85 (303)
T ss_pred cceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEECC
Confidence 4667889999999999999876 689999999865432 22346788999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccccc
Q 002336 692 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 771 (935)
Q Consensus 692 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~ 771 (935)
. ++|.+.+... ...+++..+..++.|++.||+|||+ ++|+||||||+|||+++++.+||+|||++........
T Consensus 86 ~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~- 158 (303)
T cd07869 86 H-TDLCQYMDKH--PGGLHPENVKLFLFQLLRGLSYIHQ---RYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSH- 158 (303)
T ss_pred C-cCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCc-
Confidence 5 6787777642 4568889999999999999999998 8999999999999999999999999999875432211
Q ss_pred eeecccCCccccCCCCCCC-CCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCC---eee-----
Q 002336 772 ISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD---VIS----- 842 (935)
Q Consensus 772 ~~~~~~gt~~y~APE~l~~-~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~---~~~----- 842 (935)
......+++.|+|||++.+ ..++.++||||+||++|||++|+.||...... ....+.+........ ...
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (303)
T cd07869 159 TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDI--QDQLERIFLVLGTPNEDTWPGVHSLP 236 (303)
T ss_pred cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccH--HHHHHHHHHHhCCCChhhccchhhcc
Confidence 1223457899999998765 56889999999999999999999999743221 111111111110000 000
Q ss_pred cccc-cccCCCCH---------HHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 843 IVDP-VLIGNVKI---------ESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 843 ~~d~-~l~~~~~~---------~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
..++ ......+. .....+.+++.+||+.||++|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 237 HFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred ccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 0000 00000000 01135779999999999999999999975
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=309.02 Aligned_cols=249 Identities=30% Similarity=0.513 Sum_probs=204.4
Q ss_pred HHHhhcccccccccEEEEEEEECCCcEEEEEEccCcchhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEecC
Q 002336 613 ATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 692 (935)
Q Consensus 613 ~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~~ 692 (935)
..+++.+.||+|++|.||+|... |+.||+|.+..... ..+++.+|+.+++.++|+||+++++++......++||||++
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 83 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMA 83 (256)
T ss_pred hhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecC
Confidence 45667889999999999999886 89999999976544 56789999999999999999999999998899999999999
Q ss_pred CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccccce
Q 002336 693 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 772 (935)
Q Consensus 693 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~~ 772 (935)
+++|.+++... ....+++..+..++.|++.||.|||+ .+++||||||+||++++++.+||+|||.++.......
T Consensus 84 ~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~-- 157 (256)
T cd05039 84 KGSLVDYLRSR-GRAVITLAQQLGFALDVCEGMEYLEE---KNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD-- 157 (256)
T ss_pred CCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHh---CCccchhcccceEEEeCCCCEEEcccccccccccccc--
Confidence 99999998743 23468999999999999999999998 9999999999999999999999999999987633222
Q ss_pred eecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccCC
Q 002336 773 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 851 (935)
Q Consensus 773 ~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~~ 851 (935)
....+..|+|||.+....++.++||||||++++||++ |..||...... .+ ...+..+....
T Consensus 158 --~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~----~~~~~~~~~~~--------- 219 (256)
T cd05039 158 --SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DV----VPHVEKGYRME--------- 219 (256)
T ss_pred --cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH---HH----HHHHhcCCCCC---------
Confidence 2234668999999988889999999999999999997 99998633221 11 11222211111
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhh
Q 002336 852 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 887 (935)
Q Consensus 852 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~ 887 (935)
.+...+..+.+++.+||..+|++||+++|++++|++
T Consensus 220 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 220 APEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred CccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 111223478899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=322.40 Aligned_cols=243 Identities=24% Similarity=0.332 Sum_probs=192.1
Q ss_pred hhcccccccccEEEEEEEEC-CCcEEEEEEccCcc---hhhhHHHHHHHHHH---HhcCCCcccccceeeeccceEEEEE
Q 002336 616 NFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALL---SRIHHRNLVPLIGYCEEEHQRILVY 688 (935)
Q Consensus 616 ~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~iL---~~L~HpnIv~l~g~~~~~~~~~lV~ 688 (935)
++.+.||+|+||.||+|.+. +++.||||+++... ....+.+.+|.+++ +.++||||+++++++...+..++||
T Consensus 2 ~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~ 81 (324)
T cd05589 2 RCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVM 81 (324)
T ss_pred eEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEE
Confidence 45789999999999999876 68999999987532 22335566676665 4567999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccccc
Q 002336 689 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 768 (935)
Q Consensus 689 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~ 768 (935)
||+++++|...+. ...+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++.....
T Consensus 82 E~~~~~~L~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05589 82 EYAAGGDLMMHIH----TDVFSEPRAVFYAACVVLGLQYLHE---NKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF 154 (324)
T ss_pred cCCCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCcEEeCcccCCccCCCC
Confidence 9999999998886 3468999999999999999999998 89999999999999999999999999998753222
Q ss_pred ccceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccccc
Q 002336 769 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 848 (935)
Q Consensus 769 ~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l 848 (935)
.. ......|++.|+|||.+.+..++.++|||||||++|||++|+.||...+.. +.... +..+.. .
T Consensus 155 ~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~------~~~~~-i~~~~~------~- 219 (324)
T cd05589 155 GD-RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE------EVFDS-IVNDEV------R- 219 (324)
T ss_pred CC-cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHH------HHHHH-HHhCCC------C-
Confidence 11 123346899999999999989999999999999999999999999743221 11111 111111 1
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 002336 849 IGNVKIESIWRIAEVAIQCVEQRGFSRP-----KMQEIVL 883 (935)
Q Consensus 849 ~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----s~~ev~~ 883 (935)
.+......+.+++.+||+.+|++|| +++++++
T Consensus 220 ---~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 220 ---YPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred ---CCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 1112234678999999999999999 5666655
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=313.16 Aligned_cols=256 Identities=24% Similarity=0.410 Sum_probs=202.3
Q ss_pred HHHhhcccccccccEEEEEEEEC------CCcEEEEEEccCcchh-hhHHHHHHHHHHHhcCCCcccccceeeeccceEE
Q 002336 613 ATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSCSH-RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRI 685 (935)
Q Consensus 613 ~~~~~~~~LG~G~fG~Vy~~~~~------~g~~vAvK~~~~~~~~-~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~ 685 (935)
..+++.+.||+|+||.||+|.+. .++.||+|++...... ....+.+|+.++..++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 45677899999999999999864 2578999998755433 3466889999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhccCC-------------CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCC
Q 002336 686 LVYEYMHNGTLRDRLHGSV-------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM 752 (935)
Q Consensus 686 lV~E~~~~gsL~~~L~~~~-------------~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~ 752 (935)
+++||+.+++|.+++.... ....+++..+.+++.|++.||+|||+ ++|+||||||+||++++++
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~---~gi~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSS---HHVVHKDLATRNVLVFDKL 161 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---cCccccccchhheEecCCC
Confidence 9999999999999885321 12357888999999999999999998 8999999999999999999
Q ss_pred cEEEeecccccccccccc-ceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCcccchhHHHH
Q 002336 753 RAKVSDFGLSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHW 830 (935)
Q Consensus 753 ~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~ 830 (935)
.+||+|||+++....... .......+++.|+|||.+.+..++.++||||||+++|||++ |..||..... .++
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~------~~~ 235 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN------QDV 235 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH------HHH
Confidence 999999999876533221 11222345778999999988889999999999999999998 8888863221 111
Q ss_pred HHHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhh
Q 002336 831 ARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 887 (935)
Q Consensus 831 ~~~~i~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~ 887 (935)
. ..+..+.... .+......+.+++.+|++.+|++||++++|++.|+.
T Consensus 236 ~-~~i~~~~~~~---------~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 236 I-EMIRNRQVLP---------CPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred H-HHHHcCCcCC---------CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 1 2222222111 112233468899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=316.94 Aligned_cols=267 Identities=24% Similarity=0.442 Sum_probs=210.3
Q ss_pred hHHHHHHhhcccccccccEEEEEEEEC--------CCcEEEEEEccCcc-hhhhHHHHHHHHHHHhc-CCCcccccceee
Q 002336 609 ELEEATNNFCKKIGKGSFGSVYYGKMK--------DGKEVAVKIMADSC-SHRTQQFVTEVALLSRI-HHRNLVPLIGYC 678 (935)
Q Consensus 609 ~l~~~~~~~~~~LG~G~fG~Vy~~~~~--------~g~~vAvK~~~~~~-~~~~~~~~~E~~iL~~L-~HpnIv~l~g~~ 678 (935)
++....+.+.+.||+|+||.||+|.+. ++..||+|.+.... ....+.+.+|+.+++.+ +||||+++++++
T Consensus 11 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 90 (304)
T cd05101 11 EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 90 (304)
T ss_pred cccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEE
Confidence 345566778899999999999999742 24579999987542 34457799999999999 899999999999
Q ss_pred eccceEEEEEEecCCCCHHHHhccCC-------------CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCC
Q 002336 679 EEEHQRILVYEYMHNGTLRDRLHGSV-------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSN 745 (935)
Q Consensus 679 ~~~~~~~lV~E~~~~gsL~~~L~~~~-------------~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~N 745 (935)
......++||||+++|+|.+++.... ....+++..++.++.|+++||.|||+ ++++||||||+|
T Consensus 91 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~N 167 (304)
T cd05101 91 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLAS---QKCIHRDLAARN 167 (304)
T ss_pred ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHH---CCeeecccccce
Confidence 99999999999999999999987532 12457888999999999999999998 899999999999
Q ss_pred ccccCCCcEEEeeccccccccccccce-eecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCccc
Q 002336 746 ILLDINMRAKVSDFGLSRQAEEDLTHI-SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGA 823 (935)
Q Consensus 746 ILld~~~~vkL~DFGla~~~~~~~~~~-~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~ 823 (935)
|++++++.+||+|||+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |..||.....
T Consensus 168 ili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-- 245 (304)
T cd05101 168 VLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV-- 245 (304)
T ss_pred EEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH--
Confidence 999999999999999998664322211 122335678999999988889999999999999999998 7888863321
Q ss_pred chhHHHHHHHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhhhhhccC
Q 002336 824 ELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKG 894 (935)
Q Consensus 824 ~~~l~~~~~~~i~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~~~~~~~ 894 (935)
.++ ...+..+.... .+......+.+++.+||+.+|++||++.|+++.|+++......
T Consensus 246 ----~~~-~~~~~~~~~~~---------~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~~~ 302 (304)
T cd05101 246 ----EEL-FKLLKEGHRMD---------KPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLTTN 302 (304)
T ss_pred ----HHH-HHHHHcCCcCC---------CCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhhhc
Confidence 111 11222221110 1112234688999999999999999999999999998876543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=307.05 Aligned_cols=253 Identities=26% Similarity=0.442 Sum_probs=197.6
Q ss_pred hcccccccccEEEEEEEECCC-c--EEEEEEccCc--chhhhHHHHHHHHHHHhcCCCcccccceeeecc------ceEE
Q 002336 617 FCKKIGKGSFGSVYYGKMKDG-K--EVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE------HQRI 685 (935)
Q Consensus 617 ~~~~LG~G~fG~Vy~~~~~~g-~--~vAvK~~~~~--~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~------~~~~ 685 (935)
+.+.||+|+||.||+|.+.+. + .+|+|.++.. .....+.+.+|+++++.++|+||+++++++... ...+
T Consensus 3 i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 82 (272)
T cd05075 3 LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPV 82 (272)
T ss_pred cccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcE
Confidence 568899999999999987643 2 6899988653 234457789999999999999999999987432 2468
Q ss_pred EEEEecCCCCHHHHhccCC---CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccc
Q 002336 686 LVYEYMHNGTLRDRLHGSV---NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS 762 (935)
Q Consensus 686 lV~E~~~~gsL~~~L~~~~---~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla 762 (935)
++|||+++|+|.+++.... ....+++..+..++.|++.||+|||+ ++|+||||||+|||+++++.+||+|||++
T Consensus 83 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 159 (272)
T cd05075 83 VILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSS---KSFIHRDLAARNCMLNENMNVCVADFGLS 159 (272)
T ss_pred EEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhheEEcCCCCEEECCCCcc
Confidence 9999999999998874221 23458899999999999999999998 89999999999999999999999999999
Q ss_pred ccccccccce-eecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCcccchhHHHHHHHhhhcCCe
Q 002336 763 RQAEEDLTHI-SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDV 840 (935)
Q Consensus 763 ~~~~~~~~~~-~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~i~~~~~ 840 (935)
+......... .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||..... ..+ ...+..+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~~~----~~~~~~~~~ 232 (272)
T cd05075 160 KKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN---SEI----YDYLRQGNR 232 (272)
T ss_pred cccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH---HHH----HHHHHcCCC
Confidence 8754332111 122345678999999999899999999999999999999 8899863221 111 122222222
Q ss_pred eecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhh
Q 002336 841 ISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 888 (935)
Q Consensus 841 ~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~ 888 (935)
.. .+......+.+++.+||+.+|++|||+.||++.|+++
T Consensus 233 ~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 233 LK---------QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CC---------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 11 0112234688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=317.74 Aligned_cols=261 Identities=26% Similarity=0.454 Sum_probs=206.2
Q ss_pred HHHHHHhhcccccccccEEEEEEEEC------CCcEEEEEEccCcc-hhhhHHHHHHHHHHHhc-CCCcccccceeeecc
Q 002336 610 LEEATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSC-SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEE 681 (935)
Q Consensus 610 l~~~~~~~~~~LG~G~fG~Vy~~~~~------~g~~vAvK~~~~~~-~~~~~~~~~E~~iL~~L-~HpnIv~l~g~~~~~ 681 (935)
+....+++.+.||+|+||.||++.+. ....+|+|.+.... ......+.+|+++++++ +|+||+++++++..+
T Consensus 9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 88 (293)
T cd05053 9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE 88 (293)
T ss_pred cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence 34455667889999999999999864 23679999987532 33446788999999999 799999999999999
Q ss_pred ceEEEEEEecCCCCHHHHhccC-------------CCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccc
Q 002336 682 HQRILVYEYMHNGTLRDRLHGS-------------VNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL 748 (935)
Q Consensus 682 ~~~~lV~E~~~~gsL~~~L~~~-------------~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILl 748 (935)
...+++|||+++|+|.++++.. .....+++..+++++.|++.||+|||+ ++|+||||||+||++
T Consensus 89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~Nil~ 165 (293)
T cd05053 89 GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLAS---KKCIHRDLAARNVLV 165 (293)
T ss_pred CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCccccccceeeEEE
Confidence 9999999999999999998642 134568999999999999999999997 899999999999999
Q ss_pred cCCCcEEEeeccccccccccccce-eecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCcccchh
Q 002336 749 DINMRAKVSDFGLSRQAEEDLTHI-SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELN 826 (935)
Q Consensus 749 d~~~~vkL~DFGla~~~~~~~~~~-~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~ 826 (935)
++++.+||+|||+++......... .....++..|+|||.+.+..++.++|||||||++|||++ |..||.......
T Consensus 166 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--- 242 (293)
T cd05053 166 TEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE--- 242 (293)
T ss_pred cCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH---
Confidence 999999999999998654332111 112234678999999988889999999999999999998 999986332211
Q ss_pred HHHHHHHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhhh
Q 002336 827 IVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI 889 (935)
Q Consensus 827 l~~~~~~~i~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~~ 889 (935)
.. +.+..+... ..+......+.+++.+|++.+|++|||++|+++.|++++
T Consensus 243 ~~----~~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 243 LF----KLLKEGYRM---------EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred HH----HHHHcCCcC---------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 11 112111110 111222347889999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=329.23 Aligned_cols=263 Identities=26% Similarity=0.428 Sum_probs=205.9
Q ss_pred hHHHHHHhhcccccccccEEEEEEEEC------CCcEEEEEEccCcch-hhhHHHHHHHHHHHhcC-CCcccccceeeec
Q 002336 609 ELEEATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIH-HRNLVPLIGYCEE 680 (935)
Q Consensus 609 ~l~~~~~~~~~~LG~G~fG~Vy~~~~~------~g~~vAvK~~~~~~~-~~~~~~~~E~~iL~~L~-HpnIv~l~g~~~~ 680 (935)
++....+.+.+.||+|+||.||+|++. .++.||+|+++.... ...+.+.+|+++|.++. ||||+++++++..
T Consensus 33 ~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~ 112 (401)
T cd05107 33 EMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTK 112 (401)
T ss_pred eecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEcc
Confidence 445556667899999999999999864 346899999975433 23457889999999997 9999999999999
Q ss_pred cceEEEEEEecCCCCHHHHhccCC--------------------------------------------------------
Q 002336 681 EHQRILVYEYMHNGTLRDRLHGSV-------------------------------------------------------- 704 (935)
Q Consensus 681 ~~~~~lV~E~~~~gsL~~~L~~~~-------------------------------------------------------- 704 (935)
....++||||+++|+|.++++...
T Consensus 113 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (401)
T cd05107 113 GGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPM 192 (401)
T ss_pred CCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccch
Confidence 999999999999999999986431
Q ss_pred ---------------------------------------CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCC
Q 002336 705 ---------------------------------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSN 745 (935)
Q Consensus 705 ---------------------------------------~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~N 745 (935)
....+++..+++++.|++.||+|||+ ++++||||||+|
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrdlkp~N 269 (401)
T cd05107 193 QDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLAS---KNCVHRDLAARN 269 (401)
T ss_pred hcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhc---CCcCcccCCcce
Confidence 11246778889999999999999997 899999999999
Q ss_pred ccccCCCcEEEeeccccccccccccc-eeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCccc
Q 002336 746 ILLDINMRAKVSDFGLSRQAEEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGA 823 (935)
Q Consensus 746 ILld~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~ 823 (935)
||+++++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |..||......+
T Consensus 270 iLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~ 349 (401)
T cd05107 270 VLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE 349 (401)
T ss_pred EEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchH
Confidence 99999999999999999764332211 1122346788999999988889999999999999999998 889986332211
Q ss_pred chhHHHHHHHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhhh
Q 002336 824 ELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI 889 (935)
Q Consensus 824 ~~~l~~~~~~~i~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~~ 889 (935)
.....+..+... ..+......+.+++.+||..+|++||+++||++.|++++
T Consensus 350 ------~~~~~~~~~~~~---------~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 350 ------QFYNAIKRGYRM---------AKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred ------HHHHHHHcCCCC---------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 111122222110 011122347889999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=321.66 Aligned_cols=236 Identities=25% Similarity=0.379 Sum_probs=190.3
Q ss_pred ccccccccEEEEEEEEC-CCcEEEEEEccCcc---hhhhHHHHHHHHHHHhc-CCCcccccceeeeccceEEEEEEecCC
Q 002336 619 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEYMHN 693 (935)
Q Consensus 619 ~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~iL~~L-~HpnIv~l~g~~~~~~~~~lV~E~~~~ 693 (935)
+.||+|+||.||+|+.+ +++.||+|++.... ....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999876 58899999986532 22345677888888877 699999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccccccccee
Q 002336 694 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 773 (935)
Q Consensus 694 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~~~ 773 (935)
|+|.+.+.. ...+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++....... ..
T Consensus 81 g~L~~~i~~---~~~l~~~~~~~~~~ql~~~L~~lH~---~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~-~~ 153 (320)
T cd05590 81 GDLMFHIQK---SRRFDEARARFYAAEITSALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK-TT 153 (320)
T ss_pred chHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC-cc
Confidence 999998873 4568999999999999999999998 9999999999999999999999999999875322211 12
Q ss_pred ecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccCCCC
Q 002336 774 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVK 853 (935)
Q Consensus 774 ~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~~~~ 853 (935)
....|++.|+|||++.+..++.++|||||||++|||++|+.||...... .. . +.+..+.. . .+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~---~~---~-~~i~~~~~------~----~~ 216 (320)
T cd05590 154 STFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED---DL---F-EAILNDEV------V----YP 216 (320)
T ss_pred cccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH---HH---H-HHHhcCCC------C----CC
Confidence 2345899999999999889999999999999999999999999743221 11 1 11222111 0 11
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCH
Q 002336 854 IESIWRIAEVAIQCVEQRGFSRPKM 878 (935)
Q Consensus 854 ~~~~~~l~~li~~Cl~~dP~~RPs~ 878 (935)
......+.+++.+||+.||++||++
T Consensus 217 ~~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 217 TWLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred CCCCHHHHHHHHHHcccCHHHCCCC
Confidence 1123367899999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=311.91 Aligned_cols=246 Identities=23% Similarity=0.298 Sum_probs=194.1
Q ss_pred ccccccEEEEEEEEC-CCcEEEEEEccCcch---hhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEecCCCCH
Q 002336 621 IGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTL 696 (935)
Q Consensus 621 LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~---~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL 696 (935)
||+|+||+||++.+. +++.+|+|++..... ...+.+..|+++++.++|+||+++.+++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 799999999999875 688999999864322 2235678899999999999999999999999999999999999999
Q ss_pred HHHhccCC-CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccccceeec
Q 002336 697 RDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSV 775 (935)
Q Consensus 697 ~~~L~~~~-~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~ 775 (935)
.+.+.... ....+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||++......... ...
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~-~~~ 156 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ---RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK-TKG 156 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc-ccc
Confidence 98775322 34568999999999999999999998 89999999999999999999999999998765433221 223
Q ss_pred ccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccCCCCHH
Q 002336 776 ARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIE 855 (935)
Q Consensus 776 ~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~~~~~~ 855 (935)
..|++.|+|||.+.+..++.++||||||+++|||++|+.||....... .... ....+..+.. ..+..
T Consensus 157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~--~~~~-~~~~~~~~~~----------~~~~~ 223 (280)
T cd05608 157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV--ENKE-LKQRILNDSV----------TYPDK 223 (280)
T ss_pred cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcch--hHHH-HHHhhcccCC----------CCccc
Confidence 458999999999999999999999999999999999999997432211 1111 1111111100 11122
Q ss_pred HHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 002336 856 SIWRIAEVAIQCVEQRGFSRP-----KMQEIVL 883 (935)
Q Consensus 856 ~~~~l~~li~~Cl~~dP~~RP-----s~~ev~~ 883 (935)
....+.+++.+||+.+|++|| +++++++
T Consensus 224 ~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 224 FSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred CCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 334688999999999999999 6666664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=321.59 Aligned_cols=242 Identities=24% Similarity=0.368 Sum_probs=193.7
Q ss_pred ccccccccEEEEEEEEC-CCcEEEEEEccCcc---hhhhHHHHHHHHHHHhc-CCCcccccceeeeccceEEEEEEecCC
Q 002336 619 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEYMHN 693 (935)
Q Consensus 619 ~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~iL~~L-~HpnIv~l~g~~~~~~~~~lV~E~~~~ 693 (935)
+.||+|+||.||+|+.+ +++.||+|++.... ....+.+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999876 57899999987532 23345677899998876 799999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccccccccee
Q 002336 694 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 773 (935)
Q Consensus 694 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~~~ 773 (935)
|+|.+.+.. ...+++..+..++.|+++||.|||+ ++|+||||||+|||++.++.+||+|||++........ ..
T Consensus 81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~-~~ 153 (321)
T cd05591 81 GDLMFQIQR---SRKFDEPRSRFYAAEVTLALMFLHR---HGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV-TT 153 (321)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeecccceecccCCc-cc
Confidence 999998873 4568899999999999999999998 8999999999999999999999999999875432221 12
Q ss_pred ecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccCCCC
Q 002336 774 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVK 853 (935)
Q Consensus 774 ~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~~~~ 853 (935)
....|++.|+|||++.+..++.++|||||||++|||++|+.||...... ...+ .+..+.. . .+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~---~~~~----~i~~~~~------~----~p 216 (321)
T cd05591 154 TTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNED---DLFE----SILHDDV------L----YP 216 (321)
T ss_pred cccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHH---HHHH----HHHcCCC------C----CC
Confidence 2345899999999999889999999999999999999999999743221 1111 1111111 0 11
Q ss_pred HHHHHHHHHHHHHccccCCCCCC-------CHHHHHHH
Q 002336 854 IESIWRIAEVAIQCVEQRGFSRP-------KMQEIVLA 884 (935)
Q Consensus 854 ~~~~~~l~~li~~Cl~~dP~~RP-------s~~ev~~~ 884 (935)
......+.+++.+||+.+|++|| +++++++.
T Consensus 217 ~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 217 VWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred CCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 11223678999999999999999 77877654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=310.27 Aligned_cols=256 Identities=29% Similarity=0.493 Sum_probs=202.5
Q ss_pred HHHhhcccccccccEEEEEEEEC-CC---cEEEEEEccCcc-hhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEE
Q 002336 613 ATNNFCKKIGKGSFGSVYYGKMK-DG---KEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILV 687 (935)
Q Consensus 613 ~~~~~~~~LG~G~fG~Vy~~~~~-~g---~~vAvK~~~~~~-~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV 687 (935)
..++..+.||+|+||.||+|.+. ++ ..+|+|.+.... ....+.+..|++++++++|||++++++++...+..++|
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII 84 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence 34556789999999999999875 23 379999986543 33456789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccc
Q 002336 688 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 767 (935)
Q Consensus 688 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~ 767 (935)
|||+++++|.+++... ...+++.++..++.|++.||+|||+ .+++||||||+||++++++.+||+|||++.....
T Consensus 85 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 159 (268)
T cd05063 85 TEYMENGALDKYLRDH--DGEFSSYQLVGMLRGIAAGMKYLSD---MNYVHRDLAARNILVNSNLECKVSDFGLSRVLED 159 (268)
T ss_pred EEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEEcCCCcEEECCCccceeccc
Confidence 9999999999998642 3568999999999999999999998 8999999999999999999999999999876543
Q ss_pred cccceee--cccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCcccchhHHHHHHHhhhcCCeeecc
Q 002336 768 DLTHISS--VARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 844 (935)
Q Consensus 768 ~~~~~~~--~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~ 844 (935)
....... ....+..|+|||++....++.++||||||+++|||++ |+.||..... . +..+ .+..+...
T Consensus 160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~---~---~~~~-~i~~~~~~--- 229 (268)
T cd05063 160 DPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN---H---EVMK-AINDGFRL--- 229 (268)
T ss_pred ccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH---H---HHHH-HHhcCCCC---
Confidence 3221111 1123457999999988889999999999999999998 9999963321 1 1111 12211100
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhhh
Q 002336 845 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI 889 (935)
Q Consensus 845 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~~ 889 (935)
+ ........+.+++.+|++.+|++||++.+|++.|++++
T Consensus 230 -~-----~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~~ 268 (268)
T cd05063 230 -P-----APMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKLL 268 (268)
T ss_pred -C-----CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence 0 01122346889999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-34 Score=310.02 Aligned_cols=248 Identities=21% Similarity=0.300 Sum_probs=194.6
Q ss_pred ccccccEEEEEEEEC-CCcEEEEEEccCcch---hhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEecCCCCH
Q 002336 621 IGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTL 696 (935)
Q Consensus 621 LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~---~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL 696 (935)
||+|+||.||++..+ +|+.+|+|.+..... ...+.+..|++++++++||||+++++.+..+...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 799999999999875 689999999864221 2234566799999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccccceeecc
Q 002336 697 RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVA 776 (935)
Q Consensus 697 ~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~ 776 (935)
.+++... ....+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.++|+|||++........ ....
T Consensus 81 ~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~--~~~~ 154 (277)
T cd05607 81 KYHIYNV-GERGLEMERVIHYSAQITCGILHLHS---MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT--ITQR 154 (277)
T ss_pred HHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHH---CCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCce--eecc
Confidence 9887643 34468899999999999999999998 9999999999999999999999999999876543322 2234
Q ss_pred cCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccCCCCHHH
Q 002336 777 RGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIES 856 (935)
Q Consensus 777 ~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~~~~~~~ 856 (935)
.|+..|+|||++.+..++.++||||+||++|||++|+.||...... ....+..+.... ..... ... ..
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~--~~~~~~~~~~~~-~~~~~-----~~~----~~ 222 (277)
T cd05607 155 AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEK--VAKEELKRRTLE-DEVKF-----EHQ----NF 222 (277)
T ss_pred CCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcch--hhHHHHHHHhhc-ccccc-----ccc----cC
Confidence 5899999999998888999999999999999999999999632211 111111111111 11100 001 12
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 002336 857 IWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 886 (935)
Q Consensus 857 ~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~ 886 (935)
...+.+++.+||+.+|++||+++|+++.+.
T Consensus 223 ~~~~~~li~~~L~~~P~~R~~~~~~~~~~~ 252 (277)
T cd05607 223 TEESKDICRLFLAKKPEDRLGSREKNDDPR 252 (277)
T ss_pred CHHHHHHHHHHhccCHhhCCCCccchhhhh
Confidence 236789999999999999999987765443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=308.13 Aligned_cols=247 Identities=25% Similarity=0.457 Sum_probs=195.2
Q ss_pred cccccccEEEEEEEEC---CCcEEEEEEccCcch-hhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEecCCCC
Q 002336 620 KIGKGSFGSVYYGKMK---DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGT 695 (935)
Q Consensus 620 ~LG~G~fG~Vy~~~~~---~g~~vAvK~~~~~~~-~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~~~gs 695 (935)
.||+|+||.||+|.+. .+..||+|++..... ...+.+.+|+.++++++||||+++++++.. ...++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCC
Confidence 4899999999999764 355799999876533 234678999999999999999999998864 56899999999999
Q ss_pred HHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccccccccee--
Q 002336 696 LRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS-- 773 (935)
Q Consensus 696 L~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~~~-- 773 (935)
|.+++... ...+++..+++++.|++.||+|||+ ++++||||||+||+++.++.+||+|||++...........
T Consensus 81 L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05115 81 LNKFLSGK--KDEITVSNVVELMHQVSMGMKYLEG---KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR 155 (257)
T ss_pred HHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHh---cCeeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence 99998742 4568999999999999999999997 8999999999999999999999999999876543322111
Q ss_pred ecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccCCC
Q 002336 774 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNV 852 (935)
Q Consensus 774 ~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~~~ 852 (935)
....++..|+|||.+....++.++||||||+++|||++ |+.||...... ... ..+..+... ..
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~----~~~~~~~~~---------~~ 219 (257)
T cd05115 156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP---EVM----SFIEQGKRL---------DC 219 (257)
T ss_pred CCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH---HHH----HHHHCCCCC---------CC
Confidence 11223578999999988889999999999999999996 99999733211 111 122222110 11
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhh
Q 002336 853 KIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 888 (935)
Q Consensus 853 ~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~ 888 (935)
+......+.+++.+||..+|++||++.+|.+.|+..
T Consensus 220 ~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 220 PAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 122334788999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=314.15 Aligned_cols=256 Identities=27% Similarity=0.443 Sum_probs=202.5
Q ss_pred hhcccccccccEEEEEEEEC------CCcEEEEEEccCcch-hhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEE
Q 002336 616 NFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 688 (935)
Q Consensus 616 ~~~~~LG~G~fG~Vy~~~~~------~g~~vAvK~~~~~~~-~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~ 688 (935)
++.+.||+|+||.||+|... ....+++|.+..... ...+++.+|+.+++.++||||+++++.+..++..++++
T Consensus 3 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (290)
T cd05045 3 VLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIV 82 (290)
T ss_pred cccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEEE
Confidence 45688999999999999763 235789998875433 34567899999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCC---------------------CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCcc
Q 002336 689 EYMHNGTLRDRLHGSV---------------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNIL 747 (935)
Q Consensus 689 E~~~~gsL~~~L~~~~---------------------~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NIL 747 (935)
||+.+++|.+++.... ....+++..++.++.|++.||+|||+ ++++||||||+|||
T Consensus 83 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~ivH~dikp~nil 159 (290)
T cd05045 83 EYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAE---MKLVHRDLAARNVL 159 (290)
T ss_pred EecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHH---CCeehhhhhhheEE
Confidence 9999999999876421 12357899999999999999999997 89999999999999
Q ss_pred ccCCCcEEEeeccccccccccccce-eecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCcccch
Q 002336 748 LDINMRAKVSDFGLSRQAEEDLTHI-SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAEL 825 (935)
Q Consensus 748 ld~~~~vkL~DFGla~~~~~~~~~~-~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~ 825 (935)
+++++.+||+|||+++......... .....++..|+|||.+.+..++.++||||||++++||++ |..||..... .
T Consensus 160 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~ 236 (290)
T cd05045 160 VAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP---E 236 (290)
T ss_pred EcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCH---H
Confidence 9999999999999987653322211 122335678999999988889999999999999999998 9999863321 1
Q ss_pred hHHHHHHHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhhhh
Q 002336 826 NIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 890 (935)
Q Consensus 826 ~l~~~~~~~i~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~~~ 890 (935)
.+.++ +..+.. . ..+......+.+++.+|++.+|++||+++|+++.|+++..
T Consensus 237 ~~~~~----~~~~~~-----~----~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 237 RLFNL----LKTGYR-----M----ERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred HHHHH----HhCCCC-----C----CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 12222 111110 0 1111223468899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=312.69 Aligned_cols=261 Identities=26% Similarity=0.439 Sum_probs=207.2
Q ss_pred HHHHHhhcccccccccEEEEEEEECC-----CcEEEEEEccCcc-hhhhHHHHHHHHHHHhcCCCcccccceeeec-cce
Q 002336 611 EEATNNFCKKIGKGSFGSVYYGKMKD-----GKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEE-EHQ 683 (935)
Q Consensus 611 ~~~~~~~~~~LG~G~fG~Vy~~~~~~-----g~~vAvK~~~~~~-~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~-~~~ 683 (935)
....+.+.+.||+|+||.||+|.+.+ ++.|++|++.... ....+.+.+|+.++++++|+||+++++++.. ...
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 44566778999999999999999875 7889999887543 3345678899999999999999999998765 567
Q ss_pred EEEEEEecCCCCHHHHhccCCCC-----CCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEee
Q 002336 684 RILVYEYMHNGTLRDRLHGSVNQ-----KPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSD 758 (935)
Q Consensus 684 ~~lV~E~~~~gsL~~~L~~~~~~-----~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~D 758 (935)
.++++||+++++|.+++...... ..+++.+++.++.|++.||+|||+ .+++||||||+||++++++.+||+|
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK---RGVIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCHhhEEEcCCCcEEECC
Confidence 89999999999999998654322 568999999999999999999997 8999999999999999999999999
Q ss_pred ccccccccccccc-eeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCcccchhHHHHHHHhhh
Q 002336 759 FGLSRQAEEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIK 836 (935)
Q Consensus 759 FGla~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~i~ 836 (935)
||+++.+...... ......++..|+|||.+.+..++.++||||||+++||+++ |+.||..... ..+..++.
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---~~~~~~~~---- 233 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP---FEMAAYLK---- 233 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH---HHHHHHHH----
Confidence 9999865432221 1222345678999999988889999999999999999999 9999963221 12222222
Q ss_pred cCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhhhh
Q 002336 837 KGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 890 (935)
Q Consensus 837 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~~~ 890 (935)
.+... .. +......+.+++.+||..+|++||++.|+++.|+++..
T Consensus 234 ~~~~~-----~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 234 DGYRL-----AQ----PINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred cCCCC-----CC----CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 11110 00 11123468899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=309.60 Aligned_cols=256 Identities=25% Similarity=0.442 Sum_probs=205.1
Q ss_pred HHHHHHhhcccccccccEEEEEEEECCCcEEEEEEccCcchhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEE
Q 002336 610 LEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 689 (935)
Q Consensus 610 l~~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E 689 (935)
+....+++.+.||+|+||.||++.+.++..+|+|.+... ....+.+.+|++++++++|+||+++++.+.. ...+++||
T Consensus 3 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e 80 (260)
T cd05073 3 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITE 80 (260)
T ss_pred ccccceeEEeEecCccceEEEEEEecCCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEE
Confidence 344567788999999999999999888888999988754 2345678999999999999999999999877 67899999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccc
Q 002336 690 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 769 (935)
Q Consensus 690 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~ 769 (935)
|+++++|.+++... ....+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||.+.......
T Consensus 81 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 156 (260)
T cd05073 81 FMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE 156 (260)
T ss_pred eCCCCcHHHHHHhC-CccccCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCCcceeeccCCC
Confidence 99999999998754 34567889999999999999999997 899999999999999999999999999987654322
Q ss_pred cceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCcccchhHHHHHHHhhhcCCeeecccccc
Q 002336 770 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 848 (935)
Q Consensus 770 ~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l 848 (935)
........++..|+|||++....++.++|+||||+++++|++ |+.||...+. .....+ +..+....
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~---~~~~~~----~~~~~~~~------ 223 (260)
T cd05073 157 YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN---PEVIRA----LERGYRMP------ 223 (260)
T ss_pred cccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCH---HHHHHH----HhCCCCCC------
Confidence 222222335677999999988889999999999999999999 9999873322 112222 22221111
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhh
Q 002336 849 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 887 (935)
Q Consensus 849 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~ 887 (935)
........+.+++.+|++.+|++||++.++.+.|++
T Consensus 224 ---~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 224 ---RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred ---CcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 011223468899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=323.27 Aligned_cols=251 Identities=21% Similarity=0.266 Sum_probs=199.5
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCcch---hhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEe
Q 002336 615 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 690 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~---~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~ 690 (935)
|++.+.||+|+||.||++... +|+.||+|+++.... ...+.+.+|+.+++.++|+||+++++++.+.+..++||||
T Consensus 3 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~ 82 (330)
T cd05601 3 FDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEY 82 (330)
T ss_pred ceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECC
Confidence 456789999999999999875 689999999875322 2345688899999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccccccc
Q 002336 691 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 770 (935)
Q Consensus 691 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~ 770 (935)
+++|+|.+++... ...+++..+..++.|+++||.|||+ ++|+||||||+|||++.++.+||+|||++........
T Consensus 83 ~~~~~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~lH~---~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~ 157 (330)
T cd05601 83 QPGGDLLSLLNRY--EDQFDEDMAQFYLAELVLAIHSVHQ---MGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM 157 (330)
T ss_pred CCCCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEcccCchHheEECCCCCEEeccCCCCeECCCCCc
Confidence 9999999998743 3568999999999999999999998 8999999999999999999999999999987654433
Q ss_pred ceeecccCCccccCCCCCC------CCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecc
Q 002336 771 HISSVARGTVGYLDPEYYG------NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 844 (935)
Q Consensus 771 ~~~~~~~gt~~y~APE~l~------~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~ 844 (935)
.......||+.|+|||++. ...++.++|||||||++|||++|+.||...... ................
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~------~~~~~i~~~~~~~~~~ 231 (330)
T cd05601 158 VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA------KTYNNIMNFQRFLKFP 231 (330)
T ss_pred eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHH------HHHHHHHcCCCccCCC
Confidence 3333446899999999886 456789999999999999999999999733221 1112222111111100
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002336 845 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 884 (935)
Q Consensus 845 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~ 884 (935)
+ .......+.+++.+|++ +|++||+++++++.
T Consensus 232 ~-------~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 232 E-------DPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred C-------CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 0 01123467889999998 99999999998753
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=318.68 Aligned_cols=241 Identities=26% Similarity=0.395 Sum_probs=191.4
Q ss_pred ccccccccEEEEEEEEC-CCcEEEEEEccCcc---hhhhHHHHHHHHHHHhc-CCCcccccceeeeccceEEEEEEecCC
Q 002336 619 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEYMHN 693 (935)
Q Consensus 619 ~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~iL~~L-~HpnIv~l~g~~~~~~~~~lV~E~~~~ 693 (935)
+.||+|+||.||+|.+. +++.||+|+++... ......+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999876 57899999987542 22335566788888764 899999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccccccccee
Q 002336 694 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 773 (935)
Q Consensus 694 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~~~ 773 (935)
|+|.+++.. ...+++.++..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++....... ..
T Consensus 81 g~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~ 153 (316)
T cd05619 81 GDLMFHIQS---CHKFDLPRATFYAAEIICGLQFLHS---KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA-KT 153 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC-ce
Confidence 999999873 3568899999999999999999998 8999999999999999999999999999875322111 12
Q ss_pred ecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccCCCC
Q 002336 774 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVK 853 (935)
Q Consensus 774 ~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~~~~ 853 (935)
....||+.|+|||++.+..++.++||||+||++|||++|+.||...+.. ...+. +..+. +.. +
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~---~~~~~----i~~~~------~~~----~ 216 (316)
T cd05619 154 CTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE---ELFQS----IRMDN------PCY----P 216 (316)
T ss_pred eeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH---HHHHH----HHhCC------CCC----C
Confidence 2345899999999999888999999999999999999999999743321 11111 11111 111 1
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHH-HHHH
Q 002336 854 IESIWRIAEVAIQCVEQRGFSRPKMQ-EIVL 883 (935)
Q Consensus 854 ~~~~~~l~~li~~Cl~~dP~~RPs~~-ev~~ 883 (935)
......+.+++.+||+.+|++||++. ++.+
T Consensus 217 ~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 217 RWLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred ccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 11223678999999999999999997 5543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=312.55 Aligned_cols=257 Identities=29% Similarity=0.463 Sum_probs=200.4
Q ss_pred HHHHhhcccccccccEEEEEEEECC------CcEEEEEEccCcch-hhhHHHHHHHHHHHhcCCCcccccceeeeccceE
Q 002336 612 EATNNFCKKIGKGSFGSVYYGKMKD------GKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQR 684 (935)
Q Consensus 612 ~~~~~~~~~LG~G~fG~Vy~~~~~~------g~~vAvK~~~~~~~-~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~ 684 (935)
...+.+.+.||+|++|.||+|.+.+ +..||+|.+..... .....+.+|+.++++++|+||+++++++.+.+..
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR 84 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence 3456667899999999999998753 56789998865433 3345789999999999999999999999988899
Q ss_pred EEEEEecCCCCHHHHhccCCC----CCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCC---cEEEe
Q 002336 685 ILVYEYMHNGTLRDRLHGSVN----QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM---RAKVS 757 (935)
Q Consensus 685 ~lV~E~~~~gsL~~~L~~~~~----~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~---~vkL~ 757 (935)
++||||+++++|.+++..... ...+++..+++++.||+.||+|||+ ++++||||||+||+++.++ .+||+
T Consensus 85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEE---NHFIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchheEEEeccCCCcceEec
Confidence 999999999999999875421 2358999999999999999999998 8999999999999998654 59999
Q ss_pred eccccccccccccce-eecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCcccchhHHHHHHHhh
Q 002336 758 DFGLSRQAEEDLTHI-SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMI 835 (935)
Q Consensus 758 DFGla~~~~~~~~~~-~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~i 835 (935)
|||+++......... ......+..|+|||++.+..++.++|||||||++|||++ |+.||....... +.+ .+
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~---~~~----~~ 234 (277)
T cd05036 162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE---VME----FV 234 (277)
T ss_pred cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHH----HH
Confidence 999998653221111 111223568999999988889999999999999999997 999997433221 111 11
Q ss_pred hcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhh
Q 002336 836 KKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 887 (935)
Q Consensus 836 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~ 887 (935)
..+... ..+......+.+++.+|++.+|++||++.+|++.|++
T Consensus 235 ~~~~~~---------~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~~ 277 (277)
T cd05036 235 TGGGRL---------DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQY 277 (277)
T ss_pred HcCCcC---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhhC
Confidence 111110 1112223478899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=320.08 Aligned_cols=243 Identities=22% Similarity=0.337 Sum_probs=194.1
Q ss_pred ccccccccEEEEEEEEC-CCcEEEEEEccCcc---hhhhHHHHHHHHHHHhc-CCCcccccceeeeccceEEEEEEecCC
Q 002336 619 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEYMHN 693 (935)
Q Consensus 619 ~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~iL~~L-~HpnIv~l~g~~~~~~~~~lV~E~~~~ 693 (935)
+.||+|+||.||++... +++.+|+|+++... ....+.+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999875 57899999987532 22345688899999888 699999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccccccccee
Q 002336 694 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 773 (935)
Q Consensus 694 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~~~ 773 (935)
|+|.+.+.. ...+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++....... ..
T Consensus 81 ~~L~~~~~~---~~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~-~~ 153 (327)
T cd05617 81 GDLMFHMQR---QRKLPEEHARFYAAEICIALNFLHE---RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD-TT 153 (327)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCC-ce
Confidence 999988863 4569999999999999999999998 8999999999999999999999999999875322111 12
Q ss_pred ecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccCCCC
Q 002336 774 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVK 853 (935)
Q Consensus 774 ~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~~~~ 853 (935)
....||+.|+|||++.+..++.++|||||||++|||++|+.||............++..+.+...... .+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~----------~p 223 (327)
T cd05617 154 STFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIR----------IP 223 (327)
T ss_pred ecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCC----------CC
Confidence 23468999999999999999999999999999999999999997433322223333333333322110 11
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCH
Q 002336 854 IESIWRIAEVAIQCVEQRGFSRPKM 878 (935)
Q Consensus 854 ~~~~~~l~~li~~Cl~~dP~~RPs~ 878 (935)
......+.+++.+||+.||++|+++
T Consensus 224 ~~~~~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 224 RFLSVKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred CCCCHHHHHHHHHHhccCHHHcCCC
Confidence 1122367899999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=314.45 Aligned_cols=258 Identities=30% Similarity=0.496 Sum_probs=201.4
Q ss_pred HhhcccccccccEEEEEEEECC-Cc--EEEEEEccCc-chhhhHHHHHHHHHHHhc-CCCcccccceeeeccceEEEEEE
Q 002336 615 NNFCKKIGKGSFGSVYYGKMKD-GK--EVAVKIMADS-CSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYE 689 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~~-g~--~vAvK~~~~~-~~~~~~~~~~E~~iL~~L-~HpnIv~l~g~~~~~~~~~lV~E 689 (935)
+++.+.||+|+||.||+|..++ +. .+++|.++.. .....+.+.+|++++.++ +||||+++++++......++++|
T Consensus 4 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e 83 (297)
T cd05089 4 IKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIE 83 (297)
T ss_pred ceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEE
Confidence 5667899999999999998753 33 4788888743 233456789999999999 79999999999999899999999
Q ss_pred ecCCCCHHHHhccCC-------------CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEE
Q 002336 690 YMHNGTLRDRLHGSV-------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKV 756 (935)
Q Consensus 690 ~~~~gsL~~~L~~~~-------------~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL 756 (935)
|+++++|.+++.... ....+++..+.+++.|++.||+|||+ ++++||||||+|||+++++.+||
T Consensus 84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kl 160 (297)
T cd05089 84 YAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSE---KQFIHRDLAARNVLVGENLASKI 160 (297)
T ss_pred ecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCcCCcceEEECCCCeEEE
Confidence 999999999986432 12358899999999999999999997 89999999999999999999999
Q ss_pred eeccccccccccccceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCcccchhHHHHHHHhh
Q 002336 757 SDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMI 835 (935)
Q Consensus 757 ~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~i 835 (935)
+|||++........ ......+..|+|||.+.+..++.++|||||||++|||++ |..||...... .. ... +
T Consensus 161 ~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~---~~---~~~-~ 231 (297)
T cd05089 161 ADFGLSRGEEVYVK--KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCA---EL---YEK-L 231 (297)
T ss_pred CCcCCCccccceec--cCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH---HH---HHH-H
Confidence 99999864322111 111123557999999988889999999999999999997 99999633221 11 111 1
Q ss_pred hcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhhhhhcc
Q 002336 836 KKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 893 (935)
Q Consensus 836 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~~~~~~ 893 (935)
..+. .. ..+......+.+++.+|++.+|.+||+++++++.|+++....+
T Consensus 232 ~~~~-----~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~ 280 (297)
T cd05089 232 PQGY-----RM----EKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARK 280 (297)
T ss_pred hcCC-----CC----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence 1110 00 0111223468899999999999999999999999998876553
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=304.73 Aligned_cols=258 Identities=24% Similarity=0.344 Sum_probs=207.0
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCc---chhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEe
Q 002336 615 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS---CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 690 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~---~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~ 690 (935)
|.+.+.||+|++|.||+|... +|+.||+|.++.. .....+.+.+|++++++++|+|++++++.+...+..++||||
T Consensus 4 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 83 (267)
T cd08224 4 FKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLEL 83 (267)
T ss_pred eeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEec
Confidence 566789999999999999887 7999999988642 223356789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCC-CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccc
Q 002336 691 MHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 769 (935)
Q Consensus 691 ~~~gsL~~~L~~~~-~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~ 769 (935)
+++++|.+++.... ....+++.+++.++.|+++||+|||+ .+++||||||+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~ 160 (267)
T cd08224 84 ADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 160 (267)
T ss_pred CCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecCCcChhhEEECCCCcEEEeccceeeeccCCC
Confidence 99999999886432 34568999999999999999999998 899999999999999999999999999987654332
Q ss_pred cceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeeccccccc
Q 002336 770 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 849 (935)
Q Consensus 770 ~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~ 849 (935)
.. .....++..|+|||.+.+..++.++||||||+++|+|++|+.||..... +..+... .+..+......
T Consensus 161 ~~-~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~~-~~~~~~~~~~~----- 229 (267)
T cd08224 161 TA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLYSLCK-KIEKCDYPPLP----- 229 (267)
T ss_pred cc-cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc----cHHHHHh-hhhcCCCCCCC-----
Confidence 21 1223578899999999888899999999999999999999999863321 1222111 11111111110
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhhh
Q 002336 850 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI 889 (935)
Q Consensus 850 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~~ 889 (935)
.......+.+++.+||..+|++||++.+|+++|+++.
T Consensus 230 ---~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 230 ---ADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred ---hhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 1123347889999999999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=307.48 Aligned_cols=260 Identities=25% Similarity=0.420 Sum_probs=205.4
Q ss_pred HHHHHhhcccccccccEEEEEEEECC----CcEEEEEEccCcc-hhhhHHHHHHHHHHHhcCCCcccccceeeeccceEE
Q 002336 611 EEATNNFCKKIGKGSFGSVYYGKMKD----GKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRI 685 (935)
Q Consensus 611 ~~~~~~~~~~LG~G~fG~Vy~~~~~~----g~~vAvK~~~~~~-~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~ 685 (935)
....+.+.+.||+|+||.||+|.+.+ ...|++|...... ....+.+.+|+.++++++||||+++++++.+ ...+
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~ 82 (270)
T cd05056 4 QREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVW 82 (270)
T ss_pred chhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcE
Confidence 34556778899999999999998653 2468999887654 3455689999999999999999999999876 4578
Q ss_pred EEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccc
Q 002336 686 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 765 (935)
Q Consensus 686 lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~ 765 (935)
+||||+++++|.+++... ...+++..++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||+++..
T Consensus 83 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~l~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~ 157 (270)
T cd05056 83 IVMELAPLGELRSYLQVN--KYSLDLASLILYSYQLSTALAYLES---KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYL 157 (270)
T ss_pred EEEEcCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccChheEEEecCCCeEEccCceeeec
Confidence 999999999999999743 3458999999999999999999997 89999999999999999999999999998765
Q ss_pred cccccceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCcccchhHHHHHHHhhhcCCeeecc
Q 002336 766 EEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 844 (935)
Q Consensus 766 ~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~ 844 (935)
............++..|+|||.+....++.++||||||++++||++ |+.||...... ....+ +..+....
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~---~~~~~----~~~~~~~~-- 228 (270)
T cd05056 158 EDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN---DVIGR----IENGERLP-- 228 (270)
T ss_pred ccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH---HHHHH----HHcCCcCC--
Confidence 4432222222334568999999988889999999999999999986 99999733221 11111 11221111
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhhhhhc
Q 002336 845 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 892 (935)
Q Consensus 845 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~~~~~ 892 (935)
. +......+.+++.+|+..+|++||++.++++.|+++...+
T Consensus 229 ---~----~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~~ 269 (270)
T cd05056 229 ---M----PPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQEE 269 (270)
T ss_pred ---C----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 1 1122346889999999999999999999999999877643
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=325.06 Aligned_cols=238 Identities=26% Similarity=0.355 Sum_probs=192.1
Q ss_pred ccccccccEEEEEEEE----CCCcEEEEEEccCcch--hhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEecC
Q 002336 619 KKIGKGSFGSVYYGKM----KDGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 692 (935)
Q Consensus 619 ~~LG~G~fG~Vy~~~~----~~g~~vAvK~~~~~~~--~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~~ 692 (935)
+.||+|+||.||++.. .+|+.+|+|++..... .....+..|++++++++||||+++++++...+..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999875 3588999999875322 233567789999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccccce
Q 002336 693 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 772 (935)
Q Consensus 693 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~~ 772 (935)
+|+|.+.+.. ...+++..+..++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||+++........
T Consensus 82 ~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~- 154 (318)
T cd05582 82 GGDLFTRLSK---EVMFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK- 154 (318)
T ss_pred CCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCc-
Confidence 9999999863 4568999999999999999999998 89999999999999999999999999998765433221
Q ss_pred eecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccCCC
Q 002336 773 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNV 852 (935)
Q Consensus 773 ~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~~~ 852 (935)
.....|++.|+|||.+.+..++.++||||||+++|||++|+.||...+.. .. ... +..... ..
T Consensus 155 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~---~~---~~~-i~~~~~----------~~ 217 (318)
T cd05582 155 AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRK---ET---MTM-ILKAKL----------GM 217 (318)
T ss_pred eecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHH---HH---HHH-HHcCCC----------CC
Confidence 22346899999999998888899999999999999999999999743221 11 111 111111 01
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHH
Q 002336 853 KIESIWRIAEVAIQCVEQRGFSRPKMQE 880 (935)
Q Consensus 853 ~~~~~~~l~~li~~Cl~~dP~~RPs~~e 880 (935)
+......+.+++.+||+.+|++||++.+
T Consensus 218 p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 218 PQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 1122336789999999999999999555
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=313.33 Aligned_cols=255 Identities=26% Similarity=0.421 Sum_probs=202.0
Q ss_pred HHHhhcccccccccEEEEEEEEC------CCcEEEEEEccCcchhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEE
Q 002336 613 ATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRIL 686 (935)
Q Consensus 613 ~~~~~~~~LG~G~fG~Vy~~~~~------~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~l 686 (935)
..+.+.++||+|+||.||++... ++..+|+|.+........+.+.+|+++++.++|+||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 34556789999999999999642 356899999877666666789999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhccCCC------------CCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcE
Q 002336 687 VYEYMHNGTLRDRLHGSVN------------QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRA 754 (935)
Q Consensus 687 V~E~~~~gsL~~~L~~~~~------------~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~v 754 (935)
+|||+++++|.+++..... ...+++..++.++.|++.||+|||+ .+++||||||+|||+++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLAS---LHFVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHH---CCeecccccHhhEEEcCCCCE
Confidence 9999999999999874321 1358899999999999999999997 899999999999999999999
Q ss_pred EEeeccccccccccccc-eeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCcccchhHHHHHH
Q 002336 755 KVSDFGLSRQAEEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWAR 832 (935)
Q Consensus 755 kL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~ 832 (935)
||+|||++......... ......+++.|+|||.+.+..++.++|||||||++|||++ |+.||...... ...+
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~~~--- 235 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNT---EAIE--- 235 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHH---HHHH---
Confidence 99999998754332211 1122235678999999988889999999999999999998 89998632221 1111
Q ss_pred HhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 002336 833 SMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 886 (935)
Q Consensus 833 ~~i~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~ 886 (935)
.+..+.... .+......+.+++.+||+.+|++||+++||++.|+
T Consensus 236 -~~~~~~~~~---------~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 236 -CITQGRELE---------RPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred -HHHcCccCC---------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 111111111 01112236789999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=302.76 Aligned_cols=248 Identities=27% Similarity=0.397 Sum_probs=201.8
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCc--chhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEec
Q 002336 615 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 691 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~--~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~ 691 (935)
+.+.+.||+|++|.||+|..+ +++.|++|.+... .....+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd08529 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYA 81 (256)
T ss_pred ceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeC
Confidence 345688999999999999876 6899999987642 2345577899999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccccc
Q 002336 692 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 771 (935)
Q Consensus 692 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~ 771 (935)
++++|.+++... ....+++..+++++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||+++........
T Consensus 82 ~~~~L~~~l~~~-~~~~~~~~~~~~i~~~l~~al~~lH~---~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~ 157 (256)
T cd08529 82 ENGDLHKLLKMQ-RGRPLPEDQVWRFFIQILLGLAHLHS---KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF 157 (256)
T ss_pred CCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEeCCCCEEEcccccceeccCccch
Confidence 999999998754 24578999999999999999999997 89999999999999999999999999998865443222
Q ss_pred eeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccCC
Q 002336 772 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 851 (935)
Q Consensus 772 ~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~~ 851 (935)
.....|++.|+|||++.+..++.++|+||||+++++|++|+.||..... .... ..+..+.... .
T Consensus 158 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~----~~~~~~~~~~-----~--- 221 (256)
T cd08529 158 -ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ---GALI----LKIIRGVFPP-----V--- 221 (256)
T ss_pred -hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH---HHHH----HHHHcCCCCC-----C---
Confidence 1233578899999999988899999999999999999999999974331 1111 1122221111 1
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 852 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 852 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
+......+.+++.+|++.+|++||++.++++
T Consensus 222 -~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 252 (256)
T cd08529 222 -SQMYSQQLAQLIDQCLTKDYRQRPDTFQLLR 252 (256)
T ss_pred -ccccCHHHHHHHHHHccCCcccCcCHHHHhh
Confidence 1122346889999999999999999999976
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=312.23 Aligned_cols=265 Identities=23% Similarity=0.374 Sum_probs=201.0
Q ss_pred HHHHHhhcccccccccEEEEEEEECC---------------CcEEEEEEccCcch-hhhHHHHHHHHHHHhcCCCccccc
Q 002336 611 EEATNNFCKKIGKGSFGSVYYGKMKD---------------GKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPL 674 (935)
Q Consensus 611 ~~~~~~~~~~LG~G~fG~Vy~~~~~~---------------g~~vAvK~~~~~~~-~~~~~~~~E~~iL~~L~HpnIv~l 674 (935)
.+..+++.+.||+|+||.||++...+ ...||+|.++.... .....+.+|++++++++|+|++++
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~ 82 (295)
T cd05097 3 PRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRL 82 (295)
T ss_pred chHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeE
Confidence 44567788999999999999987642 23589999876432 344679999999999999999999
Q ss_pred ceeeeccceEEEEEEecCCCCHHHHhccCC---------CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCC
Q 002336 675 IGYCEEEHQRILVYEYMHNGTLRDRLHGSV---------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSN 745 (935)
Q Consensus 675 ~g~~~~~~~~~lV~E~~~~gsL~~~L~~~~---------~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~N 745 (935)
++++......++||||+++++|.+++.... ....+++..+++++.|++.||+|||+ .+++||||||+|
T Consensus 83 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~N 159 (295)
T cd05097 83 LGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLAS---LNFVHRDLATRN 159 (295)
T ss_pred EEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHh---cCeeccccChhh
Confidence 999999999999999999999999886421 11246889999999999999999997 899999999999
Q ss_pred ccccCCCcEEEeecccccccccccc-ceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHh--CCCCCCccCcc
Q 002336 746 ILLDINMRAKVSDFGLSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS--GKKPVSVEDFG 822 (935)
Q Consensus 746 ILld~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLlt--G~~Pf~~~~~~ 822 (935)
|++++++.+||+|||++........ .......++..|+|||.+.+..++.++||||||+++++|++ +..||......
T Consensus 160 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~ 239 (295)
T cd05097 160 CLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDE 239 (295)
T ss_pred EEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChH
Confidence 9999999999999999876433221 11122235678999999988889999999999999999998 56677532221
Q ss_pred cchhHHHHHHHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhh
Q 002336 823 AELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 887 (935)
Q Consensus 823 ~~~~l~~~~~~~i~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~ 887 (935)
.......+........... ..+......+.+++.+|++.+|++||++.+|++.|++
T Consensus 240 ---~~~~~~~~~~~~~~~~~~~------~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 240 ---QVIENTGEFFRNQGRQIYL------SQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred ---HHHHHHHHhhhhccccccC------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 1111111111111000000 0111123478999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=318.04 Aligned_cols=264 Identities=30% Similarity=0.506 Sum_probs=205.0
Q ss_pred hHHHHHHhhcccccccccEEEEEEEEC-CCc--EEEEEEccCcc-hhhhHHHHHHHHHHHhc-CCCcccccceeeeccce
Q 002336 609 ELEEATNNFCKKIGKGSFGSVYYGKMK-DGK--EVAVKIMADSC-SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQ 683 (935)
Q Consensus 609 ~l~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~--~vAvK~~~~~~-~~~~~~~~~E~~iL~~L-~HpnIv~l~g~~~~~~~ 683 (935)
.++...+++.+.||+|+||.||+|.++ ++. .+++|.++... ....+.+.+|++++.++ +||||+++++++..++.
T Consensus 3 ~~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~ 82 (303)
T cd05088 3 VLEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY 82 (303)
T ss_pred ccchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCC
Confidence 345566778899999999999999875 454 46777766432 33456788999999999 89999999999999999
Q ss_pred EEEEEEecCCCCHHHHhccCC-------------CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccC
Q 002336 684 RILVYEYMHNGTLRDRLHGSV-------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI 750 (935)
Q Consensus 684 ~~lV~E~~~~gsL~~~L~~~~-------------~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~ 750 (935)
.++||||+++++|.+++.... ....+++.+++.++.|+++||+|||+ ++++||||||+|||+++
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dlkp~Nili~~ 159 (303)
T cd05088 83 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGE 159 (303)
T ss_pred ceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEecC
Confidence 999999999999999986432 12358899999999999999999997 89999999999999999
Q ss_pred CCcEEEeeccccccccccccceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCcccchhHHH
Q 002336 751 NMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVH 829 (935)
Q Consensus 751 ~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~ 829 (935)
++.+||+|||++........ .....++..|+|||.+.+..++.++||||||++++||+| |..||...... ...+
T Consensus 160 ~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~~~~ 234 (303)
T cd05088 160 NYVAKIADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA---ELYE 234 (303)
T ss_pred CCcEEeCccccCcccchhhh--cccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH---HHHH
Confidence 99999999999864321111 111224567999999988889999999999999999998 99998633221 1111
Q ss_pred HHHHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhhhhhcc
Q 002336 830 WARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 893 (935)
Q Consensus 830 ~~~~~i~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~~~~~~ 893 (935)
.+..+... ..+......+.+++.+|++.+|++||+++++++.|+++...+.
T Consensus 235 ----~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~ 285 (303)
T cd05088 235 ----KLPQGYRL---------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 285 (303)
T ss_pred ----HHhcCCcC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhh
Confidence 11111000 0111123367899999999999999999999999988766554
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=320.02 Aligned_cols=240 Identities=25% Similarity=0.349 Sum_probs=191.3
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc---hhhhHHHHHHHHHHHhcCC-CcccccceeeeccceEEEEEE
Q 002336 615 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHH-RNLVPLIGYCEEEHQRILVYE 689 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~iL~~L~H-pnIv~l~g~~~~~~~~~lV~E 689 (935)
|++.+.||+|+||.||+|..+ +++.||+|++.... ....+.+..|.+++..++| ++|+++++++...+..++|||
T Consensus 2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (324)
T cd05587 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVME 81 (324)
T ss_pred ceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEc
Confidence 456789999999999999876 57899999987532 2344668889999999976 568889999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccc
Q 002336 690 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 769 (935)
Q Consensus 690 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~ 769 (935)
|+++|+|.+.+.. ...+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||++.......
T Consensus 82 ~~~~g~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~ 155 (324)
T cd05587 82 YVNGGDLMYHIQQ---VGKFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG 155 (324)
T ss_pred CCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC
Confidence 9999999998873 4568899999999999999999998 899999999999999999999999999987532211
Q ss_pred cceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeeccccccc
Q 002336 770 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 849 (935)
Q Consensus 770 ~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~ 849 (935)
. ......|++.|+|||++.+..++.++||||+||++|||++|+.||...+.. .... .+.....
T Consensus 156 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~---~~~~----~i~~~~~--------- 218 (324)
T cd05587 156 K-TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED---ELFQ----SIMEHNV--------- 218 (324)
T ss_pred C-ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH---HHHH----HHHcCCC---------
Confidence 1 122345899999999999989999999999999999999999999743321 1111 1111110
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCH
Q 002336 850 GNVKIESIWRIAEVAIQCVEQRGFSRPKM 878 (935)
Q Consensus 850 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~ 878 (935)
..+......+.+++.+||..+|++|++.
T Consensus 219 -~~~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 219 -SYPKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred -CCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 1111223367899999999999999976
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=309.63 Aligned_cols=254 Identities=27% Similarity=0.445 Sum_probs=199.4
Q ss_pred hhcccccccccEEEEEEEECC----CcEEEEEEccCcc--hhhhHHHHHHHHHHHhcCCCcccccceeeeccce------
Q 002336 616 NFCKKIGKGSFGSVYYGKMKD----GKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQ------ 683 (935)
Q Consensus 616 ~~~~~LG~G~fG~Vy~~~~~~----g~~vAvK~~~~~~--~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~------ 683 (935)
.+.+.||+|+||.||+|.+.. +..||+|+++... ......+.+|++.++.++||||+++++++.....
T Consensus 2 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 81 (273)
T cd05035 2 KLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPK 81 (273)
T ss_pred ccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcc
Confidence 456889999999999998752 3679999987532 2344678999999999999999999998865444
Q ss_pred EEEEEEecCCCCHHHHhccCC---CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecc
Q 002336 684 RILVYEYMHNGTLRDRLHGSV---NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFG 760 (935)
Q Consensus 684 ~~lV~E~~~~gsL~~~L~~~~---~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFG 760 (935)
.++++||+++|+|.+++.... ....+++..+..++.|++.||+|||+ .+++||||||+||++++++.+||+|||
T Consensus 82 ~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~dfg 158 (273)
T cd05035 82 PMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSN---RNFIHRDLAARNCMLREDMTVCVADFG 158 (273)
T ss_pred cEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchheEEECCCCeEEECCcc
Confidence 789999999999999885432 23468999999999999999999998 899999999999999999999999999
Q ss_pred ccccccccccce-eecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCcccchhHHHHHHHhhhcC
Q 002336 761 LSRQAEEDLTHI-SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKG 838 (935)
Q Consensus 761 la~~~~~~~~~~-~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~i~~~ 838 (935)
+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |..||..... ....++ +..+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~---~~~~~~----~~~~ 231 (273)
T cd05035 159 LSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN---HEIYDY----LRHG 231 (273)
T ss_pred ceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH---HHHHHH----HHcC
Confidence 988654332211 112234678999999988889999999999999999999 8898863221 112222 1122
Q ss_pred CeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhh
Q 002336 839 DVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 888 (935)
Q Consensus 839 ~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~ 888 (935)
.... .+......+.+++.+||+.+|++||++.||++.|+++
T Consensus 232 ~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 232 NRLK---------QPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred CCCC---------CCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 1111 1122334789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=319.26 Aligned_cols=242 Identities=26% Similarity=0.361 Sum_probs=194.2
Q ss_pred ccccccccEEEEEEEEC-CCcEEEEEEccCcc---hhhhHHHHHHHHHHHhc-CCCcccccceeeeccceEEEEEEecCC
Q 002336 619 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEYMHN 693 (935)
Q Consensus 619 ~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~iL~~L-~HpnIv~l~g~~~~~~~~~lV~E~~~~ 693 (935)
+.||+|+||.||+|.+. +++.||+|+++... ......+..|.++++.+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999876 57899999987532 22345677899999888 699999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccccccccee
Q 002336 694 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 773 (935)
Q Consensus 694 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~~~ 773 (935)
|+|.+.+.. ...+++..+..++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++....... ..
T Consensus 81 ~~L~~~~~~---~~~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~ 153 (318)
T cd05570 81 GDLMFHIQR---SGRFDEPRARFYAAEIVLGLQFLHE---RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV-TT 153 (318)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC-cc
Confidence 999998873 4568999999999999999999998 8999999999999999999999999999865322111 12
Q ss_pred ecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccCCCC
Q 002336 774 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVK 853 (935)
Q Consensus 774 ~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~~~~ 853 (935)
....|++.|+|||++.+..++.++|||||||++|+|++|+.||...+.. ... ..+..+.. . .+
T Consensus 154 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~---~~~----~~i~~~~~------~----~~ 216 (318)
T cd05570 154 STFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDED---ELF----QSILEDEV------R----YP 216 (318)
T ss_pred cceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHH---HHH----HHHHcCCC------C----CC
Confidence 2345899999999999999999999999999999999999999743321 111 11111111 0 11
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCH-----HHHHHH
Q 002336 854 IESIWRIAEVAIQCVEQRGFSRPKM-----QEIVLA 884 (935)
Q Consensus 854 ~~~~~~l~~li~~Cl~~dP~~RPs~-----~ev~~~ 884 (935)
......+.+++.+||+.||++||++ .++++.
T Consensus 217 ~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 217 RWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred CcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 1223467899999999999999999 777653
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=312.71 Aligned_cols=251 Identities=25% Similarity=0.304 Sum_probs=199.7
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCcch---hhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEe
Q 002336 615 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 690 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~---~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~ 690 (935)
|+..+.||+|+||.||++... +++.||+|++..... .....+.+|+.++++++||||+++++.+..++..++||||
T Consensus 2 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05605 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEec
Confidence 456788999999999999875 689999999865322 2234578899999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccccccc
Q 002336 691 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 770 (935)
Q Consensus 691 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~ 770 (935)
+++|+|.+++... ....+++..+..++.|++.||.|||+ .+++||||||+||++++++.++|+|||++........
T Consensus 82 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05605 82 MNGGDLKFHIYNM-GNPGFDEERAVFYAAEITCGLEDLHR---ERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET 157 (285)
T ss_pred cCCCcHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc
Confidence 9999999888643 23568999999999999999999998 8999999999999999999999999999876543222
Q ss_pred ceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccC
Q 002336 771 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 850 (935)
Q Consensus 771 ~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~ 850 (935)
.....|+..|+|||++.+..++.++||||+|+++|||++|+.||....... ..+.+...+..+. .
T Consensus 158 --~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~---~~~~~~~~~~~~~----------~ 222 (285)
T cd05605 158 --IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKV---KREEVERRVKEDQ----------E 222 (285)
T ss_pred --cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhh---HHHHHHHHhhhcc----------c
Confidence 122358899999999988889999999999999999999999997433211 1111112222111 1
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 002336 851 NVKIESIWRIAEVAIQCVEQRGFSRP-----KMQEIVLA 884 (935)
Q Consensus 851 ~~~~~~~~~l~~li~~Cl~~dP~~RP-----s~~ev~~~ 884 (935)
.++......+.+++.+|++.||++|| +++++++.
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 223 EYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred ccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 11222334678999999999999999 78888653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=320.99 Aligned_cols=250 Identities=24% Similarity=0.371 Sum_probs=209.8
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCc--chhhhHHHHHHHHHHHhcCCCcccccceeeeccce-EEEEEE
Q 002336 614 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQ-RILVYE 689 (935)
Q Consensus 614 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~--~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~-~~lV~E 689 (935)
.|...+.+|+|+||.+++.+++ +++.+++|.+.-. .....+...+|+.++++++|||||.+.+.+.+++. .++||+
T Consensus 5 ~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~ 84 (426)
T KOG0589|consen 5 NYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVME 84 (426)
T ss_pred hhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEe
Confidence 4667789999999999999876 6788999988543 22234578899999999999999999999998888 899999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccc
Q 002336 690 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 769 (935)
Q Consensus 690 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~ 769 (935)
|++||++.+.+.... +..++++++.+|+.|++.|+.|||+ ++|+|||||+.||+++.++.+||.|||+|+......
T Consensus 85 Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~---~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~ 160 (426)
T KOG0589|consen 85 YCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHE---NRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED 160 (426)
T ss_pred ecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHh---hhhhcccchhhhhhccccCceeecchhhhhhcCCch
Confidence 999999999998653 6779999999999999999999997 999999999999999999999999999999987665
Q ss_pred cceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeeccccccc
Q 002336 770 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 849 (935)
Q Consensus 770 ~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~ 849 (935)
.. .....||+.|+.||++.+.+|..|+||||+||++|||++-+++|...+... ++. .+..+. .+|
T Consensus 161 ~~-a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~---Li~----ki~~~~----~~P--- 225 (426)
T KOG0589|consen 161 SL-ASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSE---LIL----KINRGL----YSP--- 225 (426)
T ss_pred hh-hheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHH---HHH----HHhhcc----CCC---
Confidence 33 345679999999999999999999999999999999999999998554432 111 111111 111
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002336 850 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 884 (935)
Q Consensus 850 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~ 884 (935)
.+......+..++..|++.+|+.||++.+++..
T Consensus 226 --lp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 226 --LPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred --CCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 223344578899999999999999999999876
|
|
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=315.92 Aligned_cols=265 Identities=25% Similarity=0.434 Sum_probs=207.7
Q ss_pred hHHHHHHhhcccccccccEEEEEEEEC--------CCcEEEEEEccCcc-hhhhHHHHHHHHHHHhc-CCCcccccceee
Q 002336 609 ELEEATNNFCKKIGKGSFGSVYYGKMK--------DGKEVAVKIMADSC-SHRTQQFVTEVALLSRI-HHRNLVPLIGYC 678 (935)
Q Consensus 609 ~l~~~~~~~~~~LG~G~fG~Vy~~~~~--------~g~~vAvK~~~~~~-~~~~~~~~~E~~iL~~L-~HpnIv~l~g~~ 678 (935)
++....+.+.+.||+|+||.||++.+. .+..+|+|.+.... ......+.+|+++++++ +||||+++++++
T Consensus 14 ~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (307)
T cd05098 14 EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC 93 (307)
T ss_pred eeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence 344566778899999999999999753 23579999987542 33456788999999999 799999999999
Q ss_pred eccceEEEEEEecCCCCHHHHhccCC-------------CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCC
Q 002336 679 EEEHQRILVYEYMHNGTLRDRLHGSV-------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSN 745 (935)
Q Consensus 679 ~~~~~~~lV~E~~~~gsL~~~L~~~~-------------~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~N 745 (935)
......++||||+++|+|.+++.... ....+++.++++++.|++.||+|||+ .+++||||||+|
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~N 170 (307)
T cd05098 94 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLAS---KKCIHRDLAARN 170 (307)
T ss_pred ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHHh
Confidence 99999999999999999999997532 12358899999999999999999997 899999999999
Q ss_pred ccccCCCcEEEeeccccccccccccce-eecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCccc
Q 002336 746 ILLDINMRAKVSDFGLSRQAEEDLTHI-SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGA 823 (935)
Q Consensus 746 ILld~~~~vkL~DFGla~~~~~~~~~~-~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~ 823 (935)
|+++.++.+||+|||+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |+.||......
T Consensus 171 ill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~- 249 (307)
T cd05098 171 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE- 249 (307)
T ss_pred eEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHH-
Confidence 999999999999999987654321111 111224568999999988889999999999999999998 88888632211
Q ss_pred chhHHHHHHHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhhhhhc
Q 002336 824 ELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 892 (935)
Q Consensus 824 ~~~l~~~~~~~i~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~~~~~ 892 (935)
. +...+..+... ..+......+.+++.+|+..+|++||++.||++.|+++....
T Consensus 250 --~----~~~~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~ 303 (307)
T cd05098 250 --E----LFKLLKEGHRM---------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALT 303 (307)
T ss_pred --H----HHHHHHcCCCC---------CCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHh
Confidence 1 11122222111 111222347889999999999999999999999999887653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-34 Score=307.96 Aligned_cols=256 Identities=23% Similarity=0.379 Sum_probs=201.1
Q ss_pred HHHHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcchhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEE
Q 002336 611 EEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 689 (935)
Q Consensus 611 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E 689 (935)
....|++.+.||+|+||.||+|+.. +++.||+|++..........+.+|+.++++++||||+++++.+..++..++|||
T Consensus 7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e 86 (267)
T cd06646 7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICME 86 (267)
T ss_pred chhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEe
Confidence 3456778899999999999999874 688999999876544555678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccc
Q 002336 690 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 769 (935)
Q Consensus 690 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~ 769 (935)
|+++++|.++++. ...+++..+..++.|+++||.|||+ .+|+||||||+||+++.++.+||+|||++.......
T Consensus 87 ~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06646 87 YCGGGSLQDIYHV---TGPLSELQIAYVCRETLQGLAYLHS---KGKMHRDIKGANILLTDNGDVKLADFGVAAKITATI 160 (267)
T ss_pred CCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEECcCccceeecccc
Confidence 9999999998863 4568999999999999999999997 899999999999999999999999999988654322
Q ss_pred cceeecccCCccccCCCCCC---CCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccc
Q 002336 770 THISSVARGTVGYLDPEYYG---NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP 846 (935)
Q Consensus 770 ~~~~~~~~gt~~y~APE~l~---~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~ 846 (935)
.. .....++..|+|||.+. ...++.++||||||+++|||++|+.||........ .. .+.... ...+
T Consensus 161 ~~-~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~--~~-----~~~~~~---~~~~ 229 (267)
T cd06646 161 AK-RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA--LF-----LMSKSN---FQPP 229 (267)
T ss_pred cc-cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhh--he-----eeecCC---CCCC
Confidence 11 12235788999999874 44578899999999999999999999852221110 00 000000 0001
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 002336 847 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAI 885 (935)
Q Consensus 847 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L 885 (935)
.... .......+.+++.+||+.+|++||+++++++.|
T Consensus 230 ~~~~--~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 230 KLKD--KTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred CCcc--ccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 1110 112234788999999999999999999998643
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=315.23 Aligned_cols=260 Identities=28% Similarity=0.440 Sum_probs=205.2
Q ss_pred HHHHHHhhcccccccccEEEEEEEEC------CCcEEEEEEccCcc-hhhhHHHHHHHHHHHhc-CCCcccccceeeecc
Q 002336 610 LEEATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSC-SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEE 681 (935)
Q Consensus 610 l~~~~~~~~~~LG~G~fG~Vy~~~~~------~g~~vAvK~~~~~~-~~~~~~~~~E~~iL~~L-~HpnIv~l~g~~~~~ 681 (935)
+....+.+.+.||+|+||.||++... .+..||+|+++... ....+.+.+|+++++++ +||||+++++++...
T Consensus 32 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 111 (302)
T cd05055 32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIG 111 (302)
T ss_pred ccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecC
Confidence 44456777899999999999999752 35579999987543 33446789999999999 799999999999999
Q ss_pred ceEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccc
Q 002336 682 HQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGL 761 (935)
Q Consensus 682 ~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGl 761 (935)
+..++||||+.+|+|.++++... ...+++.++..++.|++.||+|||+ ++++|+||||+|||++.++.++|+|||+
T Consensus 112 ~~~~lv~e~~~~~~L~~~i~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~dfg~ 187 (302)
T cd05055 112 GPILVITEYCCYGDLLNFLRRKR-ESFLTLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNVLLTHGKIVKICDFGL 187 (302)
T ss_pred CceEEEEEcCCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHH---CCeehhhhccceEEEcCCCeEEECCCcc
Confidence 99999999999999999987432 3348999999999999999999998 8999999999999999999999999999
Q ss_pred cccccccccc-eeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCcccchhHHHHHHHhhhcCC
Q 002336 762 SRQAEEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGD 839 (935)
Q Consensus 762 a~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~i~~~~ 839 (935)
++........ ......++..|+|||.+.+..++.++||||+|+++|||++ |+.||....... .... .+..+.
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~--~~~~----~~~~~~ 261 (302)
T cd05055 188 ARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS--KFYK----LIKEGY 261 (302)
T ss_pred cccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH--HHHH----HHHcCC
Confidence 8765433221 1112235678999999988889999999999999999998 999986332211 1111 121111
Q ss_pred eeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhh
Q 002336 840 VISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 888 (935)
Q Consensus 840 ~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~ 888 (935)
.. . .+......+.+++.+|+..+|++||++.|+++.|++.
T Consensus 262 ~~-----~----~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 262 RM-----A----QPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred cC-----C----CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 10 0 0111234688999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=325.74 Aligned_cols=250 Identities=24% Similarity=0.330 Sum_probs=200.5
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc---hhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEe
Q 002336 615 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 690 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~ 690 (935)
|.+.+.||+|+||.||+|... +|+.||+|++.... ......+.+|++++..++||||+++++++.+++..++||||
T Consensus 3 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 82 (350)
T cd05573 3 FEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEY 82 (350)
T ss_pred ceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEcC
Confidence 456789999999999999876 68999999986532 13346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccc-
Q 002336 691 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL- 769 (935)
Q Consensus 691 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~- 769 (935)
+++++|.+++.. ...+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||++.......
T Consensus 83 ~~~~~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~---~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~ 156 (350)
T cd05573 83 MPGGDLMNLLIR---KDVFPEETARFYIAELVLALDSVHK---LGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKD 156 (350)
T ss_pred CCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCc
Confidence 999999999874 3678999999999999999999998 999999999999999999999999999997654432
Q ss_pred ---------------------------cceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcc
Q 002336 770 ---------------------------THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFG 822 (935)
Q Consensus 770 ---------------------------~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~ 822 (935)
........||+.|+|||.+.+..++.++|||||||++|||++|+.||......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~ 236 (350)
T cd05573 157 REYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQ 236 (350)
T ss_pred ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHH
Confidence 11122345899999999999999999999999999999999999999743321
Q ss_pred cchhHHHHHHHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCC-HHHHHHH
Q 002336 823 AELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPK-MQEIVLA 884 (935)
Q Consensus 823 ~~~~l~~~~~~~i~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs-~~ev~~~ 884 (935)
. ............. -+. .......+.+++.+|+. +|++||+ ++|+++.
T Consensus 237 ~------~~~~i~~~~~~~~--~p~-----~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 237 E------TYNKIINWKESLR--FPP-----DPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred H------HHHHHhccCCccc--CCC-----CCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 1 1111111000000 000 00123467899999997 9999999 9999874
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=311.89 Aligned_cols=264 Identities=28% Similarity=0.443 Sum_probs=204.2
Q ss_pred HHHHhhcccccccccEEEEEEEECC-----------------CcEEEEEEccCcc-hhhhHHHHHHHHHHHhcCCCcccc
Q 002336 612 EATNNFCKKIGKGSFGSVYYGKMKD-----------------GKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVP 673 (935)
Q Consensus 612 ~~~~~~~~~LG~G~fG~Vy~~~~~~-----------------g~~vAvK~~~~~~-~~~~~~~~~E~~iL~~L~HpnIv~ 673 (935)
...+++.+.||+|+||.||+|.+.+ +..||+|++.... ....+.+.+|++++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 3456778999999999999987652 2468999987543 334567899999999999999999
Q ss_pred cceeeeccceEEEEEEecCCCCHHHHhccCC--------CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCC
Q 002336 674 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSV--------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSN 745 (935)
Q Consensus 674 l~g~~~~~~~~~lV~E~~~~gsL~~~L~~~~--------~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~N 745 (935)
+++++..+...+++||++++++|.+++.... ....+++..++.++.|++.||+|||+ .+++||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~---~~i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES---LNFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHH---cCccccccchhc
Confidence 9999999899999999999999999987532 12368999999999999999999998 899999999999
Q ss_pred ccccCCCcEEEeecccccccccccc-ceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHh--CCCCCCccCcc
Q 002336 746 ILLDINMRAKVSDFGLSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS--GKKPVSVEDFG 822 (935)
Q Consensus 746 ILld~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLlt--G~~Pf~~~~~~ 822 (935)
|+++.++.++|+|||+++....... .......++..|+|||.+.+..++.++||||||+++|||++ +..||.....
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~- 239 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD- 239 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh-
Confidence 9999999999999999876433221 11223346778999999988889999999999999999998 6777753221
Q ss_pred cchhHHHHHHHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhh
Q 002336 823 AELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 887 (935)
Q Consensus 823 ~~~~l~~~~~~~i~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~ 887 (935)
......+....+......... .+......+.+++.+|++.+|++||++.||++.|++
T Consensus 240 --~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 240 --QQVIENAGHFFRDDGRQIYLP------RPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred --HHHHHHHHhccccccccccCC------CccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 122222222211111111111 111223478999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=308.75 Aligned_cols=256 Identities=24% Similarity=0.383 Sum_probs=199.6
Q ss_pred HHHhhcccccccccEEEEEEEEC-CCc----EEEEEEccCcch-hhhHHHHHHHHHHHhcCCCcccccceeeeccceEEE
Q 002336 613 ATNNFCKKIGKGSFGSVYYGKMK-DGK----EVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRIL 686 (935)
Q Consensus 613 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~----~vAvK~~~~~~~-~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~l 686 (935)
..+++.+.||+|+||.||+|.+. +++ .+++|.+..... ....++..|+..+++++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence 34556789999999999999874 344 478888754322 234678888999999999999999998864 45788
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccc
Q 002336 687 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 766 (935)
Q Consensus 687 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~ 766 (935)
++||+++|+|.+++... ...+++..+..++.|++.||+|||+ ++++||||||+|||+++++.+||+|||+++...
T Consensus 86 i~e~~~~gsL~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~ 160 (279)
T cd05111 86 VTQLSPLGSLLDHVRQH--RDSLDPQRLLNWCVQIAKGMYYLEE---HRMVHRNLAARNILLKSDSIVQIADFGVADLLY 160 (279)
T ss_pred EEEeCCCCcHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEEcCCccceecc
Confidence 99999999999999742 4568999999999999999999998 899999999999999999999999999998654
Q ss_pred cccc-ceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCcccchhHHHHHHHhhhcCCeeecc
Q 002336 767 EDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 844 (935)
Q Consensus 767 ~~~~-~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~ 844 (935)
.... .......++..|+|||.+.+..++.++||||||+++|||++ |+.||...... .. .+.+..+....
T Consensus 161 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~---~~----~~~~~~~~~~~-- 231 (279)
T cd05111 161 PDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH---EV----PDLLEKGERLA-- 231 (279)
T ss_pred CCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH---HH----HHHHHCCCcCC--
Confidence 3221 11223446778999999988889999999999999999998 99999733221 11 12222222111
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhhhh
Q 002336 845 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 890 (935)
Q Consensus 845 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~~~ 890 (935)
.+. . ....+.+++.+|+..+|++||++.|+++.|..+..
T Consensus 232 ~~~---~----~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 232 QPQ---I----CTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred CCC---C----CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 111 1 12356789999999999999999999999887664
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-35 Score=308.45 Aligned_cols=259 Identities=23% Similarity=0.342 Sum_probs=199.6
Q ss_pred cccccccccEEEEEEEEC-CCcEEEEEEccCc--chhhhHHHHHHHHHHHhcCCCcccccceeeec-----cceEEEEEE
Q 002336 618 CKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEE-----EHQRILVYE 689 (935)
Q Consensus 618 ~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~--~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~-----~~~~~lV~E 689 (935)
.+.||+|+||.|+.+..+ +|+.||||++... .....++..+|+++|+.++|+||+.+.+.+.. -+..|+|+|
T Consensus 27 ~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~e 106 (359)
T KOG0660|consen 27 IEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFE 106 (359)
T ss_pred cccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehh
Confidence 578999999999999876 7899999998743 33456788999999999999999999998754 456899999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccccc-
Q 002336 690 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED- 768 (935)
Q Consensus 690 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~- 768 (935)
+| +.+|...++ .+..++......++.|+++||+|+|+ .+|+||||||+|+|++.+..+||+|||+|+.....
T Consensus 107 lM-etDL~~iik---~~~~L~d~H~q~f~YQiLrgLKyiHS---AnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~ 179 (359)
T KOG0660|consen 107 LM-ETDLHQIIK---SQQDLTDDHAQYFLYQILRGLKYIHS---ANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFF 179 (359)
T ss_pred HH-hhHHHHHHH---cCccccHHHHHHHHHHHHHhcchhhc---ccccccccchhheeeccCCCEEeccccceeeccccC
Confidence 99 568999998 45569999999999999999999998 89999999999999999999999999999987542
Q ss_pred ccceeecccCCccccCCCCCC-CCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHH--------HhhhcCC
Q 002336 769 LTHISSVARGTVGYLDPEYYG-NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWAR--------SMIKKGD 839 (935)
Q Consensus 769 ~~~~~~~~~gt~~y~APE~l~-~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~--------~~i~~~~ 839 (935)
.....+....|.+|+|||++. ...|+...||||.|||+.||++|+.-|.+.+.-++..++..+. ..+.+..
T Consensus 180 ~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ 259 (359)
T KOG0660|consen 180 EDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEK 259 (359)
T ss_pred cccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHH
Confidence 111224456899999999864 5689999999999999999999999998766543332222111 1111100
Q ss_pred eeeccc-------ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002336 840 VISIVD-------PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 884 (935)
Q Consensus 840 ~~~~~d-------~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~ 884 (935)
....+. ..+...++ ......++++.+||..||.+|+|++|.++.
T Consensus 260 ar~yi~slp~~p~~~f~~~fp-~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 260 ARPYIKSLPQIPKQPFSSIFP-NANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred HHHHHHhCCCCCCCCHHHHcC-CCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 000000 00000011 112256899999999999999999998764
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=318.16 Aligned_cols=240 Identities=26% Similarity=0.378 Sum_probs=191.1
Q ss_pred ccccccccEEEEEEEEC-CCcEEEEEEccCcc---hhhhHHHHHHHHHHHhc-CCCcccccceeeeccceEEEEEEecCC
Q 002336 619 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEYMHN 693 (935)
Q Consensus 619 ~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~iL~~L-~HpnIv~l~g~~~~~~~~~lV~E~~~~ 693 (935)
+.||+|+||.||+|+++ +|+.||+|+++... ......+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 47999999999999876 68899999987532 22345567788888765 899999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccccccccee
Q 002336 694 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 773 (935)
Q Consensus 694 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~~~ 773 (935)
|+|.+++.. ...+++..+..++.|+++||+|||+ ++|+||||||+|||++.++.+||+|||+++....... ..
T Consensus 81 g~L~~~i~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~ 153 (316)
T cd05620 81 GDLMFHIQD---KGRFDLYRATFYAAEIVCGLQFLHS---KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN-RA 153 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCC-ce
Confidence 999998873 4568899999999999999999998 8999999999999999999999999999875322111 12
Q ss_pred ecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccCCCC
Q 002336 774 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVK 853 (935)
Q Consensus 774 ~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~~~~ 853 (935)
....|++.|+|||++.+..++.++||||+||++|||++|+.||...+.. .+.+ .+..+. +.+.
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~---~~~~----~~~~~~------~~~~---- 216 (316)
T cd05620 154 STFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED---ELFE----SIRVDT------PHYP---- 216 (316)
T ss_pred eccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH---HHHH----HHHhCC------CCCC----
Confidence 3356899999999999989999999999999999999999999743221 1111 111111 1111
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHH-HHH
Q 002336 854 IESIWRIAEVAIQCVEQRGFSRPKMQ-EIV 882 (935)
Q Consensus 854 ~~~~~~l~~li~~Cl~~dP~~RPs~~-ev~ 882 (935)
......+.+++.+||+.||++||++. ++.
T Consensus 217 ~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 217 RWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred CCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 11223678999999999999999985 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=305.60 Aligned_cols=240 Identities=23% Similarity=0.405 Sum_probs=190.0
Q ss_pred ccccccccEEEEEEEECC-------------CcEEEEEEccCcchhhhHHHHHHHHHHHhcCCCcccccceeeeccceEE
Q 002336 619 KKIGKGSFGSVYYGKMKD-------------GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRI 685 (935)
Q Consensus 619 ~~LG~G~fG~Vy~~~~~~-------------g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~ 685 (935)
+.||+|+||.||+|.+.. ...|++|.+..........+.+|+.+++.++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 468999999999998542 2358999887655555567899999999999999999999999988999
Q ss_pred EEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCc-------EEEee
Q 002336 686 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMR-------AKVSD 758 (935)
Q Consensus 686 lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~-------vkL~D 758 (935)
+||||+++++|..++... ...+++..+++++.|+++||+|||+ ++|+||||||+|||++.++. ++++|
T Consensus 81 lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d 155 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRK--SDVLTTPWKFKVAKQLASALSYLED---KDLVHGNVCTKNILLAREGIDGECGPFIKLSD 155 (262)
T ss_pred EEEecccCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHhhh---CCeECCCCCcccEEEecCCccCCCCceeEeCC
Confidence 999999999999888642 3468999999999999999999998 89999999999999987664 89999
Q ss_pred ccccccccccccceeecccCCccccCCCCCC-CCCCCchhHHHHHHHHHHHHH-hCCCCCCccCcccchhHHHHHHHhhh
Q 002336 759 FGLSRQAEEDLTHISSVARGTVGYLDPEYYG-NQQLTEKSDVYSFGVVLLELI-SGKKPVSVEDFGAELNIVHWARSMIK 836 (935)
Q Consensus 759 FGla~~~~~~~~~~~~~~~gt~~y~APE~l~-~~~~s~ksDVwS~Gvil~eLl-tG~~Pf~~~~~~~~~~l~~~~~~~i~ 836 (935)
||++...... ....++..|+|||.+. +..++.++||||||+++|||+ +|..|+......+. . . ..
T Consensus 156 ~g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~----~---~-~~ 222 (262)
T cd05077 156 PGIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK----E---R-FY 222 (262)
T ss_pred CCCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH----H---H-HH
Confidence 9998654322 1234788899999886 567899999999999999998 58888763322111 0 0 11
Q ss_pred cCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 002336 837 KGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 886 (935)
Q Consensus 837 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~ 886 (935)
.+.. .. .......+.+++.+||+.+|++||++++|++.++
T Consensus 223 ~~~~-~~---------~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 223 EGQC-ML---------VTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred hcCc-cC---------CCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 1110 00 0112346889999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-34 Score=308.43 Aligned_cols=255 Identities=27% Similarity=0.491 Sum_probs=202.9
Q ss_pred HHHhhcccccccccEEEEEEEEC----CCcEEEEEEccCcc-hhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEE
Q 002336 613 ATNNFCKKIGKGSFGSVYYGKMK----DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILV 687 (935)
Q Consensus 613 ~~~~~~~~LG~G~fG~Vy~~~~~----~g~~vAvK~~~~~~-~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV 687 (935)
..+++.+.||+|+||.||+|.+. .+..+|+|.++... ....+.+.+|+.++++++||||+++++++..++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 45567889999999999999864 23479999986543 33456889999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccc
Q 002336 688 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 767 (935)
Q Consensus 688 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~ 767 (935)
|||+++++|.+++... ...+++.+++.++.|++.||+|||+ ++++||||||+|||++.++.++|+|||++.....
T Consensus 84 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd05066 84 TEYMENGSLDAFLRKH--DGQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 158 (267)
T ss_pred EEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCEeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence 9999999999998743 3468999999999999999999998 8999999999999999999999999999987654
Q ss_pred cccceeec--ccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCcccchhHHHHHHHhhhcCCeeecc
Q 002336 768 DLTHISSV--ARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 844 (935)
Q Consensus 768 ~~~~~~~~--~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~ 844 (935)
........ ..++..|+|||.+.+..++.++||||||+++||+++ |+.||...... ..... +.++..
T Consensus 159 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~---~~~~~----~~~~~~---- 227 (267)
T cd05066 159 DPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ---DVIKA----IEEGYR---- 227 (267)
T ss_pred ccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH---HHHHH----HhCCCc----
Confidence 33222111 123567999999998889999999999999999887 99998633221 12221 111110
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhh
Q 002336 845 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 888 (935)
Q Consensus 845 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~ 888 (935)
... +...+..+.+++.+|++.+|++||++.++++.|+++
T Consensus 228 -~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 228 -LPA----PMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred -CCC----CCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 000 112234678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=288.92 Aligned_cols=246 Identities=26% Similarity=0.383 Sum_probs=204.3
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCcch---hhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEe
Q 002336 615 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 690 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~---~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~ 690 (935)
.++++.||+|-||.||.|+.+ ++--||+|++.+..- +-..++.+|+++-..|+||||++++++|.+....||++||
T Consensus 24 feigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLilEy 103 (281)
T KOG0580|consen 24 FEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLILEY 103 (281)
T ss_pred ccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEEEe
Confidence 456899999999999999876 567899999865432 2236789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccccccc
Q 002336 691 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 770 (935)
Q Consensus 691 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~ 770 (935)
..+|.|...|... ..+.+++.....++.|+|.||.|+|. ++|+||||||+|+|++..+.+||+|||-+.... .
T Consensus 104 a~~gel~k~L~~~-~~~~f~e~~~a~Yi~q~A~Al~y~h~---k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p---~ 176 (281)
T KOG0580|consen 104 APRGELYKDLQEG-RMKRFDEQRAATYIKQLANALLYCHL---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP---S 176 (281)
T ss_pred cCCchHHHHHHhc-ccccccccchhHHHHHHHHHHHHhcc---CCcccCCCCHHHhccCCCCCeeccCCCceeecC---C
Confidence 9999999999854 35668889999999999999999997 999999999999999999999999999886543 2
Q ss_pred ceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccC
Q 002336 771 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 850 (935)
Q Consensus 771 ~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~ 850 (935)
......+||..|.+||...+...+.+.|+|++|++.||++.|.+||.....+ ..+.+ +.+- ++.+
T Consensus 177 ~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~--etYkr-----I~k~---~~~~----- 241 (281)
T KOG0580|consen 177 NKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHS--ETYKR-----IRKV---DLKF----- 241 (281)
T ss_pred CCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhH--HHHHH-----HHHc---cccC-----
Confidence 2345567999999999999999999999999999999999999999844321 11111 1111 1111
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002336 851 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 884 (935)
Q Consensus 851 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~ 884 (935)
+........++|.+|+..+|.+|.+..|+++.
T Consensus 242 --p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 242 --PSTISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred --CcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 22334478899999999999999999998764
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=326.28 Aligned_cols=251 Identities=21% Similarity=0.309 Sum_probs=193.4
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc---hhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEe
Q 002336 615 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 690 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~ 690 (935)
+.+.+.||+|+||.||+|... +++.||+|++.... ......+.+|++++++++||||+++++++.+.+..++||||
T Consensus 3 f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~ 82 (381)
T cd05626 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDY 82 (381)
T ss_pred ceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEec
Confidence 345788999999999999875 68899999986532 23346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccccccc
Q 002336 691 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 770 (935)
Q Consensus 691 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~ 770 (935)
+++|+|.+++.. ...+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 83 ~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~aL~~LH~---~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~ 156 (381)
T cd05626 83 IPGGDMMSLLIR---MEVFPEVLARFYIAELTLAIESVHK---MGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHN 156 (381)
T ss_pred CCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccc
Confidence 999999999873 4568899999999999999999998 8999999999999999999999999999754311000
Q ss_pred ----------------------------------------------ceeecccCCccccCCCCCCCCCCCchhHHHHHHH
Q 002336 771 ----------------------------------------------HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGV 804 (935)
Q Consensus 771 ----------------------------------------------~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gv 804 (935)
.......||+.|+|||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~ 236 (381)
T cd05626 157 SKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGV 236 (381)
T ss_pred cccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhh
Confidence 0011245899999999998888999999999999
Q ss_pred HHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccCCCCHHHHHHHHHHHHH--ccccCCCCCCCHHHHH
Q 002336 805 VLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQ--CVEQRGFSRPKMQEIV 882 (935)
Q Consensus 805 il~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~--Cl~~dP~~RPs~~ev~ 882 (935)
++|||++|+.||........ ....+........ .+ .... ...+.+++.+ |+..++..||+++|++
T Consensus 237 il~elltG~~Pf~~~~~~~~------~~~i~~~~~~~~~-~~--~~~~----s~~~~dli~~ll~~~~~~~~R~~~~~~l 303 (381)
T cd05626 237 ILFEMLVGQPPFLAPTPTET------QLKVINWENTLHI-PP--QVKL----SPEAVDLITKLCCSAEERLGRNGADDIK 303 (381)
T ss_pred HHHHHHhCCCCCcCCCHHHH------HHHHHccccccCC-CC--CCCC----CHHHHHHHHHHccCcccccCCCCHHHHh
Confidence 99999999999974332111 1111111000000 00 0011 2256677777 5566777799999998
Q ss_pred HH
Q 002336 883 LA 884 (935)
Q Consensus 883 ~~ 884 (935)
+.
T Consensus 304 ~h 305 (381)
T cd05626 304 AH 305 (381)
T ss_pred cC
Confidence 74
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-34 Score=305.57 Aligned_cols=247 Identities=29% Similarity=0.458 Sum_probs=196.8
Q ss_pred ccccccccEEEEEEEECC----CcEEEEEEccCcch-hhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEecCC
Q 002336 619 KKIGKGSFGSVYYGKMKD----GKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 693 (935)
Q Consensus 619 ~~LG~G~fG~Vy~~~~~~----g~~vAvK~~~~~~~-~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~~~ 693 (935)
++||+|+||.||+|.+.. +..+|+|.+..... ...+++.+|+++++.+.||||+++++++.. +..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKG-EPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcC-CceEEEEEeCCC
Confidence 479999999999997642 26899999876543 345679999999999999999999998764 467999999999
Q ss_pred CCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccccccccee
Q 002336 694 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 773 (935)
Q Consensus 694 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~~~ 773 (935)
++|.+++.. ...+++..++.++.|++.||+|||. .+++||||||+|||++.++.+||+|||+++..........
T Consensus 80 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~ 153 (257)
T cd05060 80 GPLLKYLKK---RREIPVSDLKELAHQVAMGMAYLES---KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR 153 (257)
T ss_pred CcHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHhh---cCeeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence 999999974 3468999999999999999999997 8999999999999999999999999999886543332211
Q ss_pred e--cccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccC
Q 002336 774 S--VARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 850 (935)
Q Consensus 774 ~--~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~ 850 (935)
. ...++..|+|||.+.+..++.++||||||+++|+|++ |+.||...+. .....++ ..+....
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~---~~~~~~~----~~~~~~~-------- 218 (257)
T cd05060 154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG---AEVIAML----ESGERLP-------- 218 (257)
T ss_pred cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH---HHHHHHH----HcCCcCC--------
Confidence 1 1123467999999988899999999999999999998 9999973321 1222222 2221111
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhh
Q 002336 851 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 888 (935)
Q Consensus 851 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~ 888 (935)
.+......+.+++.+||..+|++||++.+|++.|++.
T Consensus 219 -~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 219 -RPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred -CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 1112234688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=320.40 Aligned_cols=237 Identities=29% Similarity=0.392 Sum_probs=188.1
Q ss_pred ccccccccEEEEEEEEC-CCcEEEEEEccCcc---hhhhHHHHHHHH-HHHhcCCCcccccceeeeccceEEEEEEecCC
Q 002336 619 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVA-LLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 693 (935)
Q Consensus 619 ~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~-iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~~~ 693 (935)
+.||+|+||.||+|... +|+.||+|++.... ....+.+..|.. +++.++||||+++++.+...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999876 68999999986432 122344555555 56788999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccccccccee
Q 002336 694 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 773 (935)
Q Consensus 694 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~~~ 773 (935)
|+|.+++.. ...+++..+..++.||++||.|||+ ++|+||||||+|||++.++.+||+|||+++....... ..
T Consensus 81 g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~-~~ 153 (323)
T cd05575 81 GELFFHLQR---ERSFPEPRARFYAAEIASALGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK-TT 153 (323)
T ss_pred CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCC-cc
Confidence 999998873 4578899999999999999999998 8999999999999999999999999999875322211 12
Q ss_pred ecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccCCCC
Q 002336 774 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVK 853 (935)
Q Consensus 774 ~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~~~~ 853 (935)
....|++.|+|||++.+..++.++|||||||++|||++|+.||...+.. +...... .+.. .+ +
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~------~~~~~i~-~~~~------~~----~ 216 (323)
T cd05575 154 STFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTA------EMYDNIL-NKPL------RL----K 216 (323)
T ss_pred ccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHH------HHHHHHH-cCCC------CC----C
Confidence 2345899999999999989999999999999999999999999743221 1111111 1111 11 1
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHH
Q 002336 854 IESIWRIAEVAIQCVEQRGFSRPKMQ 879 (935)
Q Consensus 854 ~~~~~~l~~li~~Cl~~dP~~RPs~~ 879 (935)
......+.+++.+|++.+|++||+++
T Consensus 217 ~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 217 PNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred CCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 11234678999999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=312.53 Aligned_cols=262 Identities=23% Similarity=0.407 Sum_probs=203.2
Q ss_pred HHHHhhcccccccccEEEEEEEE-----CCCcEEEEEEccCcc-hhhhHHHHHHHHHHHhcCCCcccccceeeecc--ce
Q 002336 612 EATNNFCKKIGKGSFGSVYYGKM-----KDGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE--HQ 683 (935)
Q Consensus 612 ~~~~~~~~~LG~G~fG~Vy~~~~-----~~g~~vAvK~~~~~~-~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~--~~ 683 (935)
...+.+.+.||+|+||.||++.+ .+++.||+|.++... ......+.+|+++++.++||||+++++++... ..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (284)
T cd05079 3 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 82 (284)
T ss_pred hhhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCc
Confidence 45667788999999999999974 257889999987543 33446799999999999999999999998765 56
Q ss_pred EEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccc
Q 002336 684 RILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 763 (935)
Q Consensus 684 ~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~ 763 (935)
.++||||+++++|.+++... ...+++..+..++.|++.||+|||+ ++++||||||+||+++.++.+||+|||+++
T Consensus 83 ~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~i~~~i~~aL~~lH~---~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05079 83 IKLIMEFLPSGSLKEYLPRN--KNKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTK 157 (284)
T ss_pred eEEEEEccCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccchheEEEcCCCCEEECCCcccc
Confidence 88999999999999998643 3458999999999999999999998 999999999999999999999999999988
Q ss_pred cccccccc--eeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcc---------cchhHHHHHH
Q 002336 764 QAEEDLTH--ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFG---------AELNIVHWAR 832 (935)
Q Consensus 764 ~~~~~~~~--~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~---------~~~~l~~~~~ 832 (935)
........ ......++..|+|||.+.+..++.++||||||+++|||++++.|....... .......+ .
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 236 (284)
T cd05079 158 AIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRL-V 236 (284)
T ss_pred ccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHH-H
Confidence 65433221 112234677899999998888999999999999999999987765321100 01111111 1
Q ss_pred HhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhh
Q 002336 833 SMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 888 (935)
Q Consensus 833 ~~i~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~ 888 (935)
..+..+.... .+......+.+++.+|++.+|++||+++++++.|+++
T Consensus 237 ~~~~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 237 RVLEEGKRLP---------RPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHHHcCccCC---------CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 1222221111 1112234789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-34 Score=323.97 Aligned_cols=254 Identities=23% Similarity=0.341 Sum_probs=199.5
Q ss_pred HHHHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc---hhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEE
Q 002336 611 EEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRIL 686 (935)
Q Consensus 611 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~l 686 (935)
....+++.+.||+|+||.||+++.. +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.++...++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 3456777899999999999999876 68899999986421 2233457889999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccc
Q 002336 687 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 766 (935)
Q Consensus 687 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~ 766 (935)
||||+++|+|.+++.. ..+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||++....
T Consensus 121 v~Ey~~gg~L~~~l~~----~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~ 193 (370)
T cd05596 121 VMEYMPGGDLVNLMSN----YDIPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMD 193 (370)
T ss_pred EEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence 9999999999999863 357888899999999999999998 899999999999999999999999999987654
Q ss_pred ccccceeecccCCccccCCCCCCCC----CCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeee
Q 002336 767 EDLTHISSVARGTVGYLDPEYYGNQ----QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVIS 842 (935)
Q Consensus 767 ~~~~~~~~~~~gt~~y~APE~l~~~----~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~ 842 (935)
...........||+.|+|||.+.+. .++.++|||||||++|||++|+.||....... . ............
T Consensus 194 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~---~---~~~i~~~~~~~~ 267 (370)
T cd05596 194 ANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG---T---YSKIMDHKNSLT 267 (370)
T ss_pred CCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHH---H---HHHHHcCCCcCC
Confidence 3322222345689999999988643 47899999999999999999999997433211 1 111111110000
Q ss_pred cccccccCCCCHHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 002336 843 IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFS--RPKMQEIVLA 884 (935)
Q Consensus 843 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~--RPs~~ev~~~ 884 (935)
..+ .......+.+++.+|++.+|++ ||+++|+++.
T Consensus 268 ~~~-------~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 268 FPD-------DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred CCC-------cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 000 0112346789999999999988 9999999764
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-34 Score=323.19 Aligned_cols=261 Identities=25% Similarity=0.350 Sum_probs=195.5
Q ss_pred hhcccccccccEEEEEEEEC-CCcEEEEEEccCcc--hhhhHHHHHHHHHHHhcCCCcccccceeeeccc-----eEEEE
Q 002336 616 NFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH-----QRILV 687 (935)
Q Consensus 616 ~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~-----~~~lV 687 (935)
++.+.||+|+||.||++... +|+.||+|++.... ....+.+.+|+++++.++||||+++++++...+ ..++|
T Consensus 3 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 82 (372)
T cd07853 3 EPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVV 82 (372)
T ss_pred cccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEE
Confidence 45688999999999999874 78999999986532 234467889999999999999999999998766 78999
Q ss_pred EEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccc
Q 002336 688 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 767 (935)
Q Consensus 688 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~ 767 (935)
|||+. ++|.+.+. ....+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 83 ~e~~~-~~l~~~~~---~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~ 155 (372)
T cd07853 83 TELMQ-SDLHKIIV---SPQPLSSDHVKVFLYQILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEP 155 (372)
T ss_pred eeccc-cCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHHEEECCCCCEEeccccceeeccc
Confidence 99996 57877775 34578999999999999999999998 8999999999999999999999999999976543
Q ss_pred cccceeecccCCccccCCCCCCC-CCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHH----------------H
Q 002336 768 DLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVH----------------W 830 (935)
Q Consensus 768 ~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~----------------~ 830 (935)
..........+++.|+|||.+.+ ..++.++||||+||++|||++|+.||...+......... .
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 235 (372)
T cd07853 156 DESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEG 235 (372)
T ss_pred CccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHH
Confidence 32222233457889999998876 457899999999999999999999997543321111100 0
Q ss_pred HHHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002336 831 ARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 884 (935)
Q Consensus 831 ~~~~i~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~ 884 (935)
.+..+.......-..+.+. .........+.+++.+||+.||++|||++|+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 236 ARAHILRGPHKPPSLPVLY-TLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHHHHHhCCCCCCchHHhc-ccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 0111100000000000000 0011123467899999999999999999999764
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=309.37 Aligned_cols=255 Identities=26% Similarity=0.460 Sum_probs=202.0
Q ss_pred HHHhhcccccccccEEEEEEEECC-C---cEEEEEEccCc-chhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEE
Q 002336 613 ATNNFCKKIGKGSFGSVYYGKMKD-G---KEVAVKIMADS-CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILV 687 (935)
Q Consensus 613 ~~~~~~~~LG~G~fG~Vy~~~~~~-g---~~vAvK~~~~~-~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV 687 (935)
..+++.+.||+|+||.||+|.+.. + ..||+|++... .....++|..|+.+++.++||||+++++++.++...++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 346678999999999999998753 3 36999998754 233457899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccc
Q 002336 688 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 767 (935)
Q Consensus 688 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~ 767 (935)
|||+++++|.+++... ...+++.+++.++.|++.||+|||+ ++++||||||+||+++.++.+||+|||++.....
T Consensus 84 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~~l~~al~~lH~---~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 158 (269)
T cd05065 84 TEFMENGALDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 158 (269)
T ss_pred EecCCCCcHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccChheEEEcCCCcEEECCCcccccccc
Confidence 9999999999998743 3568999999999999999999998 8999999999999999999999999999876543
Q ss_pred cccce--eeccc--CCccccCCCCCCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCcccchhHHHHHHHhhhcCCeee
Q 002336 768 DLTHI--SSVAR--GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVIS 842 (935)
Q Consensus 768 ~~~~~--~~~~~--gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~ 842 (935)
..... ..... .+..|+|||.+....++.++||||||+++|||++ |..||..... ....+++. ....
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~---~~~~~~i~----~~~~-- 229 (269)
T cd05065 159 DTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN---QDVINAIE----QDYR-- 229 (269)
T ss_pred CccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCH---HHHHHHHH----cCCc--
Confidence 22111 11111 2357999999998899999999999999999887 9999863221 12222221 1100
Q ss_pred cccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhh
Q 002336 843 IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 888 (935)
Q Consensus 843 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~ 888 (935)
.. .+.+.+..+.+++.+||+.+|++||++++|++.|+++
T Consensus 230 ---~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 230 ---LP----PPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred ---CC----CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 00 0112234678999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=325.55 Aligned_cols=250 Identities=23% Similarity=0.332 Sum_probs=196.0
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc---hhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEe
Q 002336 615 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 690 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~ 690 (935)
|++.+.||+|+||.||+|+.. +|+.||||++.... ......+.+|+++++.++||||+++++.+.+.+..++||||
T Consensus 3 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~ 82 (364)
T cd05599 3 FESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEY 82 (364)
T ss_pred ceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECC
Confidence 456789999999999999876 68999999986432 23345688899999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccccccc
Q 002336 691 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 770 (935)
Q Consensus 691 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~ 770 (935)
+++|+|.+++.. ...+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||++........
T Consensus 83 ~~~g~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 156 (364)
T cd05599 83 LPGGDMMTLLMK---KDTFTEEETRFYIAETILAIDSIHK---LGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHR 156 (364)
T ss_pred CCCcHHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEeecccceecccccc
Confidence 999999999873 4568999999999999999999998 8999999999999999999999999999875422110
Q ss_pred c-------------------------------------eeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCC
Q 002336 771 H-------------------------------------ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGK 813 (935)
Q Consensus 771 ~-------------------------------------~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~ 813 (935)
. ......||+.|+|||++....++.++|||||||++|||++|.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~ 236 (364)
T cd05599 157 TEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGY 236 (364)
T ss_pred ccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCC
Confidence 0 001235899999999998889999999999999999999999
Q ss_pred CCCCccCcccchhHHHHHHHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCC---HHHHHHH
Q 002336 814 KPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPK---MQEIVLA 884 (935)
Q Consensus 814 ~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs---~~ev~~~ 884 (935)
.||...... +.............. + .. ......+.+++.+|+. +|.+|++ ++|+++.
T Consensus 237 ~Pf~~~~~~------~~~~~i~~~~~~~~~--~---~~--~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 237 PPFCSDNPQ------ETYRKIINWKETLQF--P---DE--VPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred CCCCCCCHH------HHHHHHHcCCCccCC--C---CC--CCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 999743321 111111111100000 0 00 0112357788999996 9999998 8888763
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=303.20 Aligned_cols=249 Identities=24% Similarity=0.362 Sum_probs=198.4
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc-----hhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEE
Q 002336 615 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-----SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 688 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~-----~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~ 688 (935)
+...+.||+|++|.||++... +++.+|+|.+.... ....+.+.+|++++++++||||+++++++.+++..++|+
T Consensus 4 ~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 83 (263)
T cd06625 4 WRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFM 83 (263)
T ss_pred ccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEE
Confidence 455789999999999999865 68999999876432 123357889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccccc
Q 002336 689 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 768 (935)
Q Consensus 689 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~ 768 (935)
||+++++|.+.+.. ...+++..+.+++.|++.||.|||+ .+++||||+|+||++++++.++|+|||+++.....
T Consensus 84 e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~ 157 (263)
T cd06625 84 EYMPGGSVKDQLKA---YGALTETVTRKYTRQILEGVEYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTI 157 (263)
T ss_pred EECCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccceecccc
Confidence 99999999998873 3568889999999999999999997 89999999999999999999999999998765332
Q ss_pred cccee--ecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccc
Q 002336 769 LTHIS--SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP 846 (935)
Q Consensus 769 ~~~~~--~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~ 846 (935)
..... ....++..|+|||.+.+..++.++||||+|+++|||++|+.||...... ... .........
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~---~~~---~~~~~~~~~------ 225 (263)
T cd06625 158 CSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAM---AAI---FKIATQPTN------ 225 (263)
T ss_pred ccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchH---HHH---HHHhccCCC------
Confidence 21111 2345778999999999888999999999999999999999998632211 111 111111110
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002336 847 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 884 (935)
Q Consensus 847 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~ 884 (935)
...+......+.+++.+||..+|++||++.|+++.
T Consensus 226 ---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 226 ---PQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred ---CCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 11122233468899999999999999999999763
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=306.16 Aligned_cols=248 Identities=26% Similarity=0.365 Sum_probs=195.4
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc-hhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEecC
Q 002336 615 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 692 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~-~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~~ 692 (935)
+++.+.||+|+||.||+|.+. +++.||+|++.... ....+.+.+|++++++++||||+++++++...+..++||||++
T Consensus 3 ~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 82 (279)
T cd06619 3 IQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMD 82 (279)
T ss_pred chheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCC
Confidence 356789999999999999864 68899999986542 3345678999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccccce
Q 002336 693 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 772 (935)
Q Consensus 693 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~~ 772 (935)
+++|.... .+++..+..++.|++.||.|||+ .+|+|+||||+||+++.++.++|+|||++.......
T Consensus 83 ~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~--- 149 (279)
T cd06619 83 GGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWS---LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI--- 149 (279)
T ss_pred CCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc---
Confidence 99996542 36788899999999999999998 999999999999999999999999999987654322
Q ss_pred eecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccc-hhHHHHHHHhhhcCCeeecccccccCC
Q 002336 773 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAE-LNIVHWARSMIKKGDVISIVDPVLIGN 851 (935)
Q Consensus 773 ~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~-~~l~~~~~~~i~~~~~~~~~d~~l~~~ 851 (935)
.....++..|+|||.+.+..++.++||||||+++|+|++|+.||........ .....+... +..... +.+.
T Consensus 150 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~-----~~~~-- 221 (279)
T cd06619 150 AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQC-IVDEDP-----PVLP-- 221 (279)
T ss_pred ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHH-HhccCC-----CCCC--
Confidence 2234588999999999988899999999999999999999999964322111 111111111 111110 1110
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002336 852 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 884 (935)
Q Consensus 852 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~ 884 (935)
.......+.+++.+|++.+|++||+++|+++.
T Consensus 222 -~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 222 -VGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred -CCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 11122367899999999999999999998763
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-34 Score=311.80 Aligned_cols=260 Identities=25% Similarity=0.434 Sum_probs=202.4
Q ss_pred HHHHHhhcccccccccEEEEEEEEC------CCcEEEEEEccCcch-hhhHHHHHHHHHHHhcCCCcccccceeeeccce
Q 002336 611 EEATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQ 683 (935)
Q Consensus 611 ~~~~~~~~~~LG~G~fG~Vy~~~~~------~g~~vAvK~~~~~~~-~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~ 683 (935)
....+++.+.||+|+||.||+|..+ .+..||+|.+..... .....+.+|+.+++.++||||+++++++.+...
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 3456777899999999999999754 245899998865432 234568899999999999999999999999899
Q ss_pred EEEEEEecCCCCHHHHhccCC-------CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEE
Q 002336 684 RILVYEYMHNGTLRDRLHGSV-------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKV 756 (935)
Q Consensus 684 ~~lV~E~~~~gsL~~~L~~~~-------~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL 756 (935)
.++||||+++|+|.+++.... ....+.+..+.+++.|++.||+|||+ ++|+||||||+||++++++.+||
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA---KKFVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCCChheEEEcCCCcEEE
Confidence 999999999999999996432 12345677889999999999999998 89999999999999999999999
Q ss_pred eeccccccccccccc-eeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCcccchhHHHHHHHh
Q 002336 757 SDFGLSRQAEEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSM 834 (935)
Q Consensus 757 ~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~ 834 (935)
+|||+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |..||...... +... .
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~------~~~~-~ 233 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE------QVLK-F 233 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH------HHHH-H
Confidence 999998754332211 1112234678999999988889999999999999999998 78888632221 1111 1
Q ss_pred hhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhhh
Q 002336 835 IKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI 889 (935)
Q Consensus 835 i~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~~ 889 (935)
+..+.... .+......+.+++.+|++.+|++||++.++++.|++..
T Consensus 234 ~~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 234 VMDGGYLD---------QPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred HHcCCCCC---------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 11111111 01112347899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-34 Score=308.79 Aligned_cols=259 Identities=25% Similarity=0.440 Sum_probs=205.0
Q ss_pred HHHHHHhhcccccccccEEEEEEEECC------CcEEEEEEccCcc-hhhhHHHHHHHHHHHhcCCCcccccceeeeccc
Q 002336 610 LEEATNNFCKKIGKGSFGSVYYGKMKD------GKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH 682 (935)
Q Consensus 610 l~~~~~~~~~~LG~G~fG~Vy~~~~~~------g~~vAvK~~~~~~-~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~ 682 (935)
+....+.+.+.||+|+||.||+|..+. ++.||+|.+.... ......+.+|+.+++.++||||+++++++....
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~ 82 (277)
T cd05032 3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQ 82 (277)
T ss_pred cchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCC
Confidence 344566778899999999999998652 4689999986543 234567889999999999999999999999999
Q ss_pred eEEEEEEecCCCCHHHHhccCC-------CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEE
Q 002336 683 QRILVYEYMHNGTLRDRLHGSV-------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAK 755 (935)
Q Consensus 683 ~~~lV~E~~~~gsL~~~L~~~~-------~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vk 755 (935)
..++||||+++|+|.+++.... ....+++..++.++.|++.||.|||+ .+++||||||+||+++.++.+|
T Consensus 83 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~di~p~nill~~~~~~k 159 (277)
T cd05032 83 PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAA---KKFVHRDLAARNCMVAEDLTVK 159 (277)
T ss_pred CcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccChheEEEcCCCCEE
Confidence 9999999999999999986432 12347889999999999999999997 8999999999999999999999
Q ss_pred Eeecccccccccccc-ceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCcccchhHHHHHHH
Q 002336 756 VSDFGLSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARS 833 (935)
Q Consensus 756 L~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~ 833 (935)
|+|||+++....... .......++..|+|||.+.+..++.++||||||+++|||++ |+.||...+. ....++.
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~---~~~~~~~-- 234 (277)
T cd05032 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN---EEVLKFV-- 234 (277)
T ss_pred ECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCH---HHHHHHH--
Confidence 999999876543221 11223346788999999988889999999999999999998 9999863222 1222221
Q ss_pred hhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhh
Q 002336 834 MIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 887 (935)
Q Consensus 834 ~i~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~ 887 (935)
..+..... +......+.+++.+||+.+|++|||+.++++.|++
T Consensus 235 --~~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 235 --IDGGHLDL---------PENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred --hcCCCCCC---------CCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 12211111 11123478899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-34 Score=306.05 Aligned_cols=249 Identities=30% Similarity=0.504 Sum_probs=199.4
Q ss_pred HHHhhcccccccccEEEEEEEECCCcEEEEEEccCcchhhhHHHHHHHHHHHhcCCCcccccceee-eccceEEEEEEec
Q 002336 613 ATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYC-EEEHQRILVYEYM 691 (935)
Q Consensus 613 ~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~-~~~~~~~lV~E~~ 691 (935)
..+.+.+.||+|+||.||++... |+.+|+|.++... ..+.+.+|+.++++++|+|++++++++ ......+++|||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 45667889999999999999876 8889999986432 346789999999999999999999975 4556789999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccccc
Q 002336 692 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 771 (935)
Q Consensus 692 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~ 771 (935)
++++|.+++... ....+++..+++++.|++.||+|||+ ++++||||||+||++++++.+||+|||+++......
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-- 156 (256)
T cd05082 83 AKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEA---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 156 (256)
T ss_pred CCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeccccchheEEEcCCCcEEecCCccceeccccC--
Confidence 999999998753 23458899999999999999999997 899999999999999999999999999987543322
Q ss_pred eeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccC
Q 002336 772 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 850 (935)
Q Consensus 772 ~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~ 850 (935)
....++..|+|||++.+..++.++||||||+++|||++ |+.||..... .....+ +..+....
T Consensus 157 --~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~---~~~~~~----~~~~~~~~-------- 219 (256)
T cd05082 157 --DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---KDVVPR----VEKGYKMD-------- 219 (256)
T ss_pred --CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH---HHHHHH----HhcCCCCC--------
Confidence 12234678999999988889999999999999999998 9999863322 111111 22221111
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhh
Q 002336 851 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 888 (935)
Q Consensus 851 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~ 888 (935)
.+......+.+++.+|++.+|++||++.++++.|+++
T Consensus 220 -~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 220 -APDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred -CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 1112234688999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=301.80 Aligned_cols=249 Identities=33% Similarity=0.541 Sum_probs=202.6
Q ss_pred ccccccccEEEEEEEECC----CcEEEEEEccCcchhh-hHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEecCC
Q 002336 619 KKIGKGSFGSVYYGKMKD----GKEVAVKIMADSCSHR-TQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 693 (935)
Q Consensus 619 ~~LG~G~fG~Vy~~~~~~----g~~vAvK~~~~~~~~~-~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~~~ 693 (935)
+.||+|+||.||+|.... +..+++|.+....... .+.+.+|++.++.++|+||+++++++......++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 479999999999998764 7889999987654433 67899999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCC------CCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccc
Q 002336 694 GTLRDRLHGSVN------QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 767 (935)
Q Consensus 694 gsL~~~L~~~~~------~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~ 767 (935)
++|.+++..... ...+++..+.+++.|+++||+|||+ ++++||||||+||++++++.+||+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHc---CCcccCccCcceEEECCCCcEEEccccccccccc
Confidence 999999985421 3679999999999999999999997 9999999999999999999999999999987654
Q ss_pred ccc-ceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCcccchhHHHHHHHhhhcCCeeeccc
Q 002336 768 DLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 845 (935)
Q Consensus 768 ~~~-~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d 845 (935)
... .......++..|+|||.+....++.++||||+|++++||++ |..||..... ..+.+ .+..+...
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~~----~~~~~~~~---- 226 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN---EEVLE----YLRKGYRL---- 226 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH---HHHHH----HHHcCCCC----
Confidence 321 11223447889999999988889999999999999999999 6999974321 11222 12211111
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 002336 846 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 886 (935)
Q Consensus 846 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~ 886 (935)
..+......+.+++.+|++.+|++||+++|+++.|+
T Consensus 227 -----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 227 -----PKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred -----CCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 111122347889999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=300.90 Aligned_cols=248 Identities=29% Similarity=0.437 Sum_probs=199.0
Q ss_pred ccccccccEEEEEEEECC--C--cEEEEEEccCcch-hhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEecCC
Q 002336 619 KKIGKGSFGSVYYGKMKD--G--KEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 693 (935)
Q Consensus 619 ~~LG~G~fG~Vy~~~~~~--g--~~vAvK~~~~~~~-~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~~~ 693 (935)
+.||+|++|.||+|.+.+ + ..||+|.+..... ...+.+.+|++++++++||||+++++++.. ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 478999999999998753 3 3699999987655 556789999999999999999999999888 889999999999
Q ss_pred CCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccccc--
Q 002336 694 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH-- 771 (935)
Q Consensus 694 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~-- 771 (935)
++|.+.+..... ..+++..++.++.|+++||+|||+ ++++|+||||+||+++.++.+||+|||+++........
T Consensus 80 ~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 155 (257)
T cd05040 80 GSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLES---KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV 155 (257)
T ss_pred CcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHh---CCccccccCcccEEEecCCEEEecccccccccccccccee
Confidence 999999875422 568999999999999999999997 89999999999999999999999999999876442221
Q ss_pred eeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccC
Q 002336 772 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 850 (935)
Q Consensus 772 ~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~ 850 (935)
......++..|+|||.+.+..++.++||||||++++||++ |+.||...... ...+. ....+....
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~~---~~~~~~~~~-------- 221 (257)
T cd05040 156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS---QILKK---IDKEGERLE-------- 221 (257)
T ss_pred cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHH---HHHHH---HHhcCCcCC--------
Confidence 1112346788999999998899999999999999999999 99998632211 11111 111111100
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 002336 851 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 886 (935)
Q Consensus 851 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~ 886 (935)
.+...+..+.+++.+|++.+|++||++.||++.|.
T Consensus 222 -~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 222 -RPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred -CCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 11122346889999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=311.24 Aligned_cols=248 Identities=24% Similarity=0.380 Sum_probs=200.5
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcchhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEecC
Q 002336 614 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 692 (935)
Q Consensus 614 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~~ 692 (935)
.|++.+.||+|++|.||+|... +++.+++|.+........+.+.+|+.+++.++|+||+++++.+..+...++||||++
T Consensus 21 ~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~ 100 (296)
T cd06654 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLA 100 (296)
T ss_pred ceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccC
Confidence 4566788999999999999864 689999999876555556778999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccccce
Q 002336 693 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 772 (935)
Q Consensus 693 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~~ 772 (935)
+++|.+++.. ..+++.++..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++.........
T Consensus 101 ~~~L~~~~~~----~~~~~~~~~~i~~ql~~aL~~LH~---~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~- 172 (296)
T cd06654 101 GGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK- 172 (296)
T ss_pred CCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCEEECccccchhccccccc-
Confidence 9999999863 357899999999999999999998 89999999999999999999999999998764332211
Q ss_pred eecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccCCC
Q 002336 773 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNV 852 (935)
Q Consensus 773 ~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~~~ 852 (935)
.....+++.|+|||.+.+..++.++|||||||++|+|++|+.||....... .+.. ....+. .. + ..
T Consensus 173 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~--~~~~----~~~~~~-~~-----~--~~ 238 (296)
T cd06654 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR--ALYL----IATNGT-PE-----L--QN 238 (296)
T ss_pred cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH--hHHH----HhcCCC-CC-----C--CC
Confidence 122357889999999988888999999999999999999999997332211 1111 111110 00 0 01
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 853 KIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 853 ~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
+......+.+++.+||..+|++||+++|+++
T Consensus 239 ~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 239 PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred ccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 1223346889999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=322.74 Aligned_cols=241 Identities=24% Similarity=0.361 Sum_probs=199.7
Q ss_pred HHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc---hhhhHHHHHHHHHHHhc-CCCcccccceeeeccceEEEE
Q 002336 613 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILV 687 (935)
Q Consensus 613 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~iL~~L-~HpnIv~l~g~~~~~~~~~lV 687 (935)
...+|.++||+|.||+|+++..+ +++.+|||++++.. ..+.+..+.|.+++... +||.+++++..|...+++++|
T Consensus 368 ~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fv 447 (694)
T KOG0694|consen 368 DDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFV 447 (694)
T ss_pred cceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEE
Confidence 33467899999999999999987 57889999998753 34456788899998887 599999999999999999999
Q ss_pred EEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccc
Q 002336 688 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 767 (935)
Q Consensus 688 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~ 767 (935)
|||+.||++..+.+ ...+++.++.-++..|+.||.|||+ ++|||||||.+|||+|.+|++||+|||+++..-.
T Consensus 448 mey~~Ggdm~~~~~----~~~F~e~rarfyaAev~l~L~fLH~---~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~ 520 (694)
T KOG0694|consen 448 MEYVAGGDLMHHIH----TDVFSEPRARFYAAEVVLGLQFLHE---NGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMG 520 (694)
T ss_pred EEecCCCcEEEEEe----cccccHHHHHHHHHHHHHHHHHHHh---cCceeeecchhheEEcccCcEEecccccccccCC
Confidence 99999999554443 4679999999999999999999998 9999999999999999999999999999986432
Q ss_pred cccceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeeccccc
Q 002336 768 DLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 847 (935)
Q Consensus 768 ~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~ 847 (935)
.. ....+.+||+.|||||++.+..|+.+.|-|||||+|||||.|..||.+++-++.. + .|... |+
T Consensus 521 ~g-~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~F---d----sI~~d------~~- 585 (694)
T KOG0694|consen 521 QG-DRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVF---D----SIVND------EV- 585 (694)
T ss_pred CC-CccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHH---H----HHhcC------CC-
Confidence 22 2345678999999999999999999999999999999999999999855433211 1 11111 11
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCCCH
Q 002336 848 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKM 878 (935)
Q Consensus 848 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~ 878 (935)
.+|.-...+.++|+++++..+|++|--+
T Consensus 586 ---~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 586 ---RYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred ---CCCCcccHHHHHHHHHHhccCcccccCC
Confidence 2344455678899999999999999976
|
|
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-34 Score=305.33 Aligned_cols=250 Identities=30% Similarity=0.528 Sum_probs=200.5
Q ss_pred HHhhcccccccccEEEEEEEECCCcEEEEEEccCcchhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEecCC
Q 002336 614 TNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 693 (935)
Q Consensus 614 ~~~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~~~ 693 (935)
.+++.+.||+|+||.||++.+.+++.+|+|.+..... ....+.+|++++++++|||++++++++......++||||+++
T Consensus 5 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 83 (256)
T cd05112 5 ELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEH 83 (256)
T ss_pred HeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCC
Confidence 4566789999999999999988788999998865322 345788999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccccccccee
Q 002336 694 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 773 (935)
Q Consensus 694 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~~~ 773 (935)
++|.+++... ...+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++....+......
T Consensus 84 ~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~ 158 (256)
T cd05112 84 GCLSDYLRAQ--RGKFSQETLLGMCLDVCEGMAYLES---SNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSS 158 (256)
T ss_pred CcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccccceEEEcCCCeEEECCCcceeecccCccccc
Confidence 9999998742 3457899999999999999999997 8999999999999999999999999999876543322112
Q ss_pred ecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccCCC
Q 002336 774 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNV 852 (935)
Q Consensus 774 ~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~~~ 852 (935)
....++.+|+|||.+.+..++.++||||||+++|||++ |+.||...... ...+ .+..+. ....+..
T Consensus 159 ~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~---~~~~----~~~~~~--~~~~~~~---- 225 (256)
T cd05112 159 TGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS---EVVE----TINAGF--RLYKPRL---- 225 (256)
T ss_pred CCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH---HHHH----HHhCCC--CCCCCCC----
Confidence 22234678999999988889999999999999999998 99998632211 1111 111110 1111111
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 002336 853 KIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAI 885 (935)
Q Consensus 853 ~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L 885 (935)
....+.+++.+||+.+|++||+++|+++.|
T Consensus 226 ---~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 226 ---ASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred ---CCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 124688999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=315.81 Aligned_cols=263 Identities=27% Similarity=0.450 Sum_probs=203.1
Q ss_pred HHHHHHhhcccccccccEEEEEEEE------CCCcEEEEEEccCcc-hhhhHHHHHHHHHHHhc-CCCcccccceeeecc
Q 002336 610 LEEATNNFCKKIGKGSFGSVYYGKM------KDGKEVAVKIMADSC-SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEE 681 (935)
Q Consensus 610 l~~~~~~~~~~LG~G~fG~Vy~~~~------~~g~~vAvK~~~~~~-~~~~~~~~~E~~iL~~L-~HpnIv~l~g~~~~~ 681 (935)
+....+++.+.||+|+||.||+|.+ .+++.||||+++... ....+.+.+|+.++.++ +||||+++++++...
T Consensus 4 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (343)
T cd05103 4 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 83 (343)
T ss_pred cchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecC
Confidence 3456688899999999999999974 357889999987543 23446788999999999 689999999988654
Q ss_pred -ceEEEEEEecCCCCHHHHhccCCC-------------------------------------------------------
Q 002336 682 -HQRILVYEYMHNGTLRDRLHGSVN------------------------------------------------------- 705 (935)
Q Consensus 682 -~~~~lV~E~~~~gsL~~~L~~~~~------------------------------------------------------- 705 (935)
...++||||+++|+|.+++.....
T Consensus 84 ~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (343)
T cd05103 84 GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEE 163 (343)
T ss_pred CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchh
Confidence 467899999999999998864210
Q ss_pred ---------CCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccccc-eeec
Q 002336 706 ---------QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH-ISSV 775 (935)
Q Consensus 706 ---------~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~-~~~~ 775 (935)
...+++.++.+++.|+++||+|||+ ++|+||||||+|||+++++.+||+|||++......... ....
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 240 (343)
T cd05103 164 EEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGD 240 (343)
T ss_pred hhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCC
Confidence 1246788899999999999999998 89999999999999999999999999998765332211 1112
Q ss_pred ccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccCCCCH
Q 002336 776 ARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKI 854 (935)
Q Consensus 776 ~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~~~~~ 854 (935)
..++..|+|||.+.+..++.++||||||+++|||++ |..||....... . ....+.++..... + ..
T Consensus 241 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~----~~~~~~~~~~~~~--~---~~--- 306 (343)
T cd05103 241 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--E----FCRRLKEGTRMRA--P---DY--- 306 (343)
T ss_pred CCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH--H----HHHHHhccCCCCC--C---CC---
Confidence 335678999999988889999999999999999997 999986432211 1 1112222221111 0 01
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhhhh
Q 002336 855 ESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 890 (935)
Q Consensus 855 ~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~~~ 890 (935)
....+.+++.+||+.+|++||++.||++.|+.+..
T Consensus 307 -~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 307 -TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred -CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 12357899999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-33 Score=303.60 Aligned_cols=251 Identities=22% Similarity=0.356 Sum_probs=199.2
Q ss_pred HHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcchhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEec
Q 002336 613 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 691 (935)
Q Consensus 613 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~ 691 (935)
.-+++.+.||+|+||.||+|... ++..+++|.+........+.+.+|+++++.++||||+++++++..+...++||||+
T Consensus 5 ~~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~ 84 (282)
T cd06643 5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 84 (282)
T ss_pred HHHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEec
Confidence 34667789999999999999876 47788999987655556678899999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccccc
Q 002336 692 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 771 (935)
Q Consensus 692 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~ 771 (935)
++++|.+++.. ...++++..+..++.|+++||.|||+ .+++||||||+||+++.++.+||+|||++........
T Consensus 85 ~~~~l~~~~~~--~~~~l~~~~~~~~~~qi~~~L~~LH~---~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~- 158 (282)
T cd06643 85 AGGAVDAVMLE--LERPLTEPQIRVVCKQTLEALNYLHE---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ- 158 (282)
T ss_pred CCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEccCCCEEEcccccccccccccc-
Confidence 99999988764 24568999999999999999999998 8999999999999999999999999999876533221
Q ss_pred eeecccCCccccCCCCCC-----CCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccc
Q 002336 772 ISSVARGTVGYLDPEYYG-----NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP 846 (935)
Q Consensus 772 ~~~~~~gt~~y~APE~l~-----~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~ 846 (935)
......++..|+|||++. ...++.++|||||||++|||++|+.||..... .... ..... +.......
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~--~~~~----~~~~~-~~~~~~~~- 230 (282)
T cd06643 159 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNP--MRVL----LKIAK-SEPPTLAQ- 230 (282)
T ss_pred ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCH--HHHH----HHHhh-cCCCCCCC-
Confidence 122345889999999874 34577899999999999999999999863221 1111 11111 11111111
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 847 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 847 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
+......+.+++.+||+.+|++||+++++++
T Consensus 231 ------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 261 (282)
T cd06643 231 ------PSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ 261 (282)
T ss_pred ------ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1112346889999999999999999999875
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-34 Score=322.67 Aligned_cols=199 Identities=25% Similarity=0.396 Sum_probs=171.7
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc---hhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEe
Q 002336 615 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 690 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~ 690 (935)
+++.+.||+|+||.||++... +++.||+|++.... ......+.+|+.++.+++|+||+++++.+.+....++||||
T Consensus 3 y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~ 82 (363)
T cd05628 3 FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEF 82 (363)
T ss_pred ceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcC
Confidence 456789999999999999876 58899999986532 22345688899999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccccccc
Q 002336 691 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 770 (935)
Q Consensus 691 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~ 770 (935)
+++|+|.+++.. ...+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 83 ~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~---~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~ 156 (363)
T cd05628 83 LPGGDMMTLLMK---KDTLTEEETQFYIAETVLAIDSIHQ---LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHR 156 (363)
T ss_pred CCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCCEEEeeccCccccccccc
Confidence 999999999873 4678999999999999999999998 8999999999999999999999999999875432110
Q ss_pred ----------------------------------ceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCC
Q 002336 771 ----------------------------------HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPV 816 (935)
Q Consensus 771 ----------------------------------~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf 816 (935)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf 236 (363)
T cd05628 157 TEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236 (363)
T ss_pred ccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCC
Confidence 0012346899999999999889999999999999999999999999
Q ss_pred Ccc
Q 002336 817 SVE 819 (935)
Q Consensus 817 ~~~ 819 (935)
...
T Consensus 237 ~~~ 239 (363)
T cd05628 237 CSE 239 (363)
T ss_pred CCC
Confidence 743
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=308.83 Aligned_cols=258 Identities=25% Similarity=0.416 Sum_probs=202.0
Q ss_pred HHHHhhcccccccccEEEEEEEEC-CCc----EEEEEEccCcc-hhhhHHHHHHHHHHHhcCCCcccccceeeeccceEE
Q 002336 612 EATNNFCKKIGKGSFGSVYYGKMK-DGK----EVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRI 685 (935)
Q Consensus 612 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~----~vAvK~~~~~~-~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~ 685 (935)
...+++.+.||+|+||.||+|.+. +|+ .||+|+++... ....+.+.+|+.+++.++||||+++++++... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcE
Confidence 345566789999999999999864 444 48999986543 33456788999999999999999999998754 468
Q ss_pred EEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccc
Q 002336 686 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 765 (935)
Q Consensus 686 lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~ 765 (935)
+++||+++|+|.+.+... ...+++..++.++.|++.||+|||+ ++++||||||+|||+++++.+||+|||+++..
T Consensus 85 l~~~~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~lH~---~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~ 159 (279)
T cd05109 85 LVTQLMPYGCLLDYVREN--KDRIGSQDLLNWCVQIAKGMSYLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (279)
T ss_pred EEEEcCCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccceEEEcCCCcEEECCCCceeec
Confidence 999999999999998742 3468999999999999999999998 89999999999999999999999999999876
Q ss_pred cccccce-eecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCcccchhHHHHHHHhhhcCCeeec
Q 002336 766 EEDLTHI-SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISI 843 (935)
Q Consensus 766 ~~~~~~~-~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~ 843 (935)
....... .....++..|+|||...+..++.++||||||+++|||++ |..||..... ..+..+ +..+.....
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~~~~~----~~~~~~~~~ 232 (279)
T cd05109 160 DIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA---REIPDL----LEKGERLPQ 232 (279)
T ss_pred ccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHH----HHCCCcCCC
Confidence 4322211 111234678999999988889999999999999999998 8999863322 112222 222211110
Q ss_pred ccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhhhhh
Q 002336 844 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 891 (935)
Q Consensus 844 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~~~~ 891 (935)
+......+.+++.+||..+|++||++.|+++.|+++...
T Consensus 233 ---------~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05109 233 ---------PPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARD 271 (279)
T ss_pred ---------CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcC
Confidence 112234688999999999999999999999998876543
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-34 Score=317.56 Aligned_cols=240 Identities=25% Similarity=0.351 Sum_probs=191.6
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc---hhhhHHHHHHHHHHHhc-CCCcccccceeeeccceEEEEEE
Q 002336 615 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYE 689 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~iL~~L-~HpnIv~l~g~~~~~~~~~lV~E 689 (935)
+++.+.||+|+||.||+|... +++.||+|++.... ....+.+..|..++..+ +|++|+++++++...+..++|||
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (323)
T cd05616 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVME 81 (323)
T ss_pred ceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEc
Confidence 356789999999999999876 57899999987532 22334567788888877 58999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccc
Q 002336 690 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 769 (935)
Q Consensus 690 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~ 769 (935)
|+++|+|.+.+.. ...+++..+..++.|++.||+|||+ ++|+||||||+|||+++++.+||+|||+++......
T Consensus 82 ~~~~g~L~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~ 155 (323)
T cd05616 82 YVNGGDLMYQIQQ---VGRFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG 155 (323)
T ss_pred CCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCEEecCCCHHHeEECCCCcEEEccCCCceecCCCC
Confidence 9999999998863 4568899999999999999999998 899999999999999999999999999987543221
Q ss_pred cceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeeccccccc
Q 002336 770 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 849 (935)
Q Consensus 770 ~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~ 849 (935)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+.. .+.+ .+.....
T Consensus 156 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~---~~~~----~i~~~~~--------- 218 (323)
T cd05616 156 V-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED---ELFQ----SIMEHNV--------- 218 (323)
T ss_pred C-ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH---HHHH----HHHhCCC---------
Confidence 1 122346899999999999999999999999999999999999999743221 1111 1111111
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCH
Q 002336 850 GNVKIESIWRIAEVAIQCVEQRGFSRPKM 878 (935)
Q Consensus 850 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~ 878 (935)
..+......+.+++.+|++.+|++|++.
T Consensus 219 -~~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 219 -AYPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred -CCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 1112223467899999999999999984
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=333.07 Aligned_cols=253 Identities=23% Similarity=0.330 Sum_probs=200.6
Q ss_pred HHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCc--chhhhHHHHHHHHHHHhcCCCcccccceeeeccc-------
Q 002336 613 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH------- 682 (935)
Q Consensus 613 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~--~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~------- 682 (935)
..|.+.+.||+|+||.||+|+.. +|+.||||++... .......+.+|+..+..++|+||+++++.+....
T Consensus 32 ~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~ 111 (496)
T PTZ00283 32 KKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENV 111 (496)
T ss_pred CCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccc
Confidence 35667889999999999999864 7899999998643 2334567889999999999999999987764322
Q ss_pred -eEEEEEEecCCCCHHHHhccCC-CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecc
Q 002336 683 -QRILVYEYMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFG 760 (935)
Q Consensus 683 -~~~lV~E~~~~gsL~~~L~~~~-~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFG 760 (935)
..++||||+++|+|.+++.... ....+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||
T Consensus 112 ~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~---~~IiHrDLKP~NILl~~~~~vkL~DFG 188 (496)
T PTZ00283 112 LMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHS---KHMIHRDIKSANILLCSNGLVKLGDFG 188 (496)
T ss_pred eEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEeCCCCEEEEecc
Confidence 3679999999999999886432 34578999999999999999999998 899999999999999999999999999
Q ss_pred cccccccccc-ceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCC
Q 002336 761 LSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD 839 (935)
Q Consensus 761 la~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~ 839 (935)
+++....... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+.....+ .+.
T Consensus 189 ls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~------~~~~~~~~-~~~ 261 (496)
T PTZ00283 189 FSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENM------EEVMHKTL-AGR 261 (496)
T ss_pred cCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH------HHHHHHHh-cCC
Confidence 9987543221 122345689999999999999999999999999999999999999974322 12222211 121
Q ss_pred eeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002336 840 VISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 884 (935)
Q Consensus 840 ~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~ 884 (935)
... .+......+.+++.+||+.+|++||++.++++.
T Consensus 262 ~~~---------~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 262 YDP---------LPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred CCC---------CCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 111 112223468899999999999999999998763
|
|
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=320.50 Aligned_cols=241 Identities=28% Similarity=0.398 Sum_probs=189.7
Q ss_pred ccccccccEEEEEEEEC-CCcEEEEEEccCcc---hhhhHHHHHHHH-HHHhcCCCcccccceeeeccceEEEEEEecCC
Q 002336 619 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVA-LLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 693 (935)
Q Consensus 619 ~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~-iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~~~ 693 (935)
+.||+|+||.||+|... +|+.+|+|++.... ......+..|.. +++.++||||+++++.+...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999875 68999999986532 123345555655 46778999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccccccccee
Q 002336 694 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 773 (935)
Q Consensus 694 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~~~ 773 (935)
|+|.+.+. ....+++..+..++.||+.||+|||+ ++|+||||||+|||+++++.+||+|||+++....... ..
T Consensus 81 ~~L~~~l~---~~~~~~~~~~~~~~~qi~~al~~lH~---~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~-~~ 153 (325)
T cd05604 81 GELFFHLQ---RERSFPEPRARFYAAEIASALGYLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD-TT 153 (325)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC-Cc
Confidence 99998886 34578999999999999999999998 8999999999999999999999999999875322211 12
Q ss_pred ecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccCCCC
Q 002336 774 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVK 853 (935)
Q Consensus 774 ~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~~~~ 853 (935)
....|++.|+|||.+.+..++.++|||||||++|||++|+.||...+.. +...... .+.. .+ +
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~------~~~~~~~-~~~~------~~----~ 216 (325)
T cd05604 154 TTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA------EMYDNIL-HKPL------VL----R 216 (325)
T ss_pred ccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHH------HHHHHHH-cCCc------cC----C
Confidence 3345899999999999989999999999999999999999999743221 1111111 1111 01 1
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 854 IESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 854 ~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
+.....+.+++.+|++.+|++||++++.++
T Consensus 217 ~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~ 246 (325)
T cd05604 217 PGASLTAWSILEELLEKDRQRRLGAKEDFL 246 (325)
T ss_pred CCCCHHHHHHHHHHhccCHHhcCCCCCCHH
Confidence 112336779999999999999998864433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=305.95 Aligned_cols=250 Identities=30% Similarity=0.521 Sum_probs=195.7
Q ss_pred ccccccccEEEEEEEECC-Cc--EEEEEEccCcc-hhhhHHHHHHHHHHHhc-CCCcccccceeeeccceEEEEEEecCC
Q 002336 619 KKIGKGSFGSVYYGKMKD-GK--EVAVKIMADSC-SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEYMHN 693 (935)
Q Consensus 619 ~~LG~G~fG~Vy~~~~~~-g~--~vAvK~~~~~~-~~~~~~~~~E~~iL~~L-~HpnIv~l~g~~~~~~~~~lV~E~~~~ 693 (935)
+.||+|+||.||+|.+++ +. .+++|.++... ....+.+.+|+++++++ +||||+++++++......++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 469999999999998763 43 57888887532 34456788999999999 799999999999999999999999999
Q ss_pred CCHHHHhccCC-------------CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecc
Q 002336 694 GTLRDRLHGSV-------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFG 760 (935)
Q Consensus 694 gsL~~~L~~~~-------------~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFG 760 (935)
|+|.+++.... ....+++..+..++.|++.||+|||+ ++++||||||+||++++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccccceEEEcCCCeEEECCCC
Confidence 99999986432 12357899999999999999999998 899999999999999999999999999
Q ss_pred ccccccccccceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCcccchhHHHHHHHhhhcCC
Q 002336 761 LSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGD 839 (935)
Q Consensus 761 la~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~i~~~~ 839 (935)
++........ ......+..|+|||++....++.++||||||++++||++ |..||...+.. ... . .+..+.
T Consensus 158 l~~~~~~~~~--~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~---~~~---~-~~~~~~ 228 (270)
T cd05047 158 LSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA---ELY---E-KLPQGY 228 (270)
T ss_pred Cccccchhhh--ccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHH---HHH---H-HHhCCC
Confidence 9863221111 111223567999999988889999999999999999997 99999633221 111 1 111111
Q ss_pred eeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhhh
Q 002336 840 VISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI 889 (935)
Q Consensus 840 ~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~~ 889 (935)
.. ..+......+.+++.+|+..+|.+||++.|+++.|+++.
T Consensus 229 ~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 229 RL---------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred CC---------CCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 00 011112336789999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=306.35 Aligned_cols=252 Identities=33% Similarity=0.545 Sum_probs=199.2
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCcchhhh--HHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEec
Q 002336 615 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 691 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~~~~--~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~ 691 (935)
|++.+.||+|+||+||++... +++.+|+|++........ ....+|+.++++++||||+++++++......++|||++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 356789999999999999887 466899999987644433 23456999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccccc
Q 002336 692 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 771 (935)
Q Consensus 692 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~ 771 (935)
++++|.+++. ....+++..+..++.|+++||++||+ .+++|+||||+||+++.++.++|+|||.+...... ..
T Consensus 81 ~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~Lh~---~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~-~~ 153 (260)
T PF00069_consen 81 PGGSLQDYLQ---KNKPLSEEEILKIAYQILEALAYLHS---KGIVHRDIKPENILLDENGEVKLIDFGSSVKLSEN-NE 153 (260)
T ss_dssp TTEBHHHHHH---HHSSBBHHHHHHHHHHHHHHHHHHHH---TTEEESSBSGGGEEESTTSEEEESSGTTTEESTST-TS
T ss_pred cccccccccc---cccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc-cc
Confidence 9999999997 35678999999999999999999998 89999999999999999999999999998754221 22
Q ss_pred eeecccCCccccCCCCCC-CCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccC
Q 002336 772 ISSVARGTVGYLDPEYYG-NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 850 (935)
Q Consensus 772 ~~~~~~gt~~y~APE~l~-~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~ 850 (935)
......++..|+|||.+. +...+.++||||+|+++++|++|..||............. +.... .. ....
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~---~~~~~-~~----~~~~-- 223 (260)
T PF00069_consen 154 NFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIE---KILKR-PL----PSSS-- 223 (260)
T ss_dssp EBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHH---HHHHT-HH----HHHT--
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhh---hcccc-cc----cccc--
Confidence 233456899999999998 8899999999999999999999999998441111111111 11100 00 0000
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 851 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 851 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
.........+.+++.+||+.+|++||++.++++
T Consensus 224 ~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 224 QQSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred cccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000011257899999999999999999999875
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=309.34 Aligned_cols=264 Identities=24% Similarity=0.393 Sum_probs=201.0
Q ss_pred HHHHhhcccccccccEEEEEEEEC-----------------CCcEEEEEEccCcc-hhhhHHHHHHHHHHHhcCCCcccc
Q 002336 612 EATNNFCKKIGKGSFGSVYYGKMK-----------------DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVP 673 (935)
Q Consensus 612 ~~~~~~~~~LG~G~fG~Vy~~~~~-----------------~g~~vAvK~~~~~~-~~~~~~~~~E~~iL~~L~HpnIv~ 673 (935)
...+++.+.||+|+||.||++.+. ++..+|+|++.... ....+.+.+|+++++.++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 345677899999999999998643 23468999987543 334568999999999999999999
Q ss_pred cceeeeccceEEEEEEecCCCCHHHHhccCC--------CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCC
Q 002336 674 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSV--------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSN 745 (935)
Q Consensus 674 l~g~~~~~~~~~lV~E~~~~gsL~~~L~~~~--------~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~N 745 (935)
+++++...+..++||||+++++|.+++.... ....+++..+..++.|++.||+|||+ .+++||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dlkp~N 160 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS---LNFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCeecccCChhe
Confidence 9999999999999999999999999887532 12347788999999999999999998 899999999999
Q ss_pred ccccCCCcEEEeeccccccccccccc-eeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHh--CCCCCCccCcc
Q 002336 746 ILLDINMRAKVSDFGLSRQAEEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS--GKKPVSVEDFG 822 (935)
Q Consensus 746 ILld~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLlt--G~~Pf~~~~~~ 822 (935)
||++.++.++|+|||+++........ ......++..|++||......++.++||||||+++|||++ |..||......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE 240 (296)
T ss_pred EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence 99999999999999998765332211 1112234678999998888889999999999999999998 77887633221
Q ss_pred cchhHHHHHHHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhh
Q 002336 823 AELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 887 (935)
Q Consensus 823 ~~~~l~~~~~~~i~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~ 887 (935)
. ................ ..+ .+......+.+++.+||+.+|++||++.||++.|++
T Consensus 241 ~---~~~~~~~~~~~~~~~~-~~~-----~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 241 Q---VIENTGEFFRDQGRQV-YLP-----KPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred H---HHHHHHHHHhhccccc-cCC-----CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 1 1111111111111000 001 011123478899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-35 Score=308.72 Aligned_cols=255 Identities=25% Similarity=0.319 Sum_probs=193.1
Q ss_pred cccccccccEEEEEEEEC-CCcEEEEEEccCcchhhhHHHHHHHHHHHhcCCCcccccceeeeccc-----eEEEEEEec
Q 002336 618 CKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH-----QRILVYEYM 691 (935)
Q Consensus 618 ~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~-----~~~lV~E~~ 691 (935)
.+++|.|.||.||+|... +++.||||+..+... --.+|+++|+++.|||||+++-+|.... ...+|||||
T Consensus 29 ~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleym 104 (364)
T KOG0658|consen 29 VRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYM 104 (364)
T ss_pred eEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhc
Confidence 478999999999999876 468999999865432 2246999999999999999998875432 234899999
Q ss_pred CCCCHHHHhccCC-CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCC-CcEEEeeccccccccccc
Q 002336 692 HNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN-MRAKVSDFGLSRQAEEDL 769 (935)
Q Consensus 692 ~~gsL~~~L~~~~-~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~-~~vkL~DFGla~~~~~~~ 769 (935)
+. +|.+.++... .+..++...+.-+..||++||+|||+ .+|+||||||.|+|+|.+ |.+||||||.|+......
T Consensus 105 P~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~---~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~e 180 (364)
T KOG0658|consen 105 PE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHS---HGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGE 180 (364)
T ss_pred hH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHh---cCcccCCCChheEEEcCCCCeEEeccCCcceeeccCC
Confidence 65 8888887432 35667888888999999999999998 999999999999999976 899999999999876655
Q ss_pred cceeecccCCccccCCCCCCC-CCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHH-------HhhhcCCe-
Q 002336 770 THISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWAR-------SMIKKGDV- 840 (935)
Q Consensus 770 ~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~-------~~i~~~~~- 840 (935)
...+ ...+..|+|||.+.+ ..|+.+.||||.||++.||+-|++-|.+++..+. ++..++ +.+.....
T Consensus 181 pniS--YicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQ--L~eIik~lG~Pt~e~I~~mn~~ 256 (364)
T KOG0658|consen 181 PNIS--YICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQ--LVEIIKVLGTPTREDIKSMNPN 256 (364)
T ss_pred Ccee--EEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHH--HHHHHHHhCCCCHHHHhhcCcc
Confidence 5433 446889999998765 6899999999999999999999999986554332 222221 11111111
Q ss_pred -eecccccccCC-----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002336 841 -ISIVDPVLIGN-----VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 884 (935)
Q Consensus 841 -~~~~d~~l~~~-----~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~ 884 (935)
.+...|.+... .......+..+++.++++.+|.+|.++.|++..
T Consensus 257 y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 257 YTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred cccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 11111211111 122334478899999999999999999998754
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-34 Score=295.87 Aligned_cols=258 Identities=21% Similarity=0.245 Sum_probs=198.2
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCcchh-h-hHHHHHHHHHHHhcCCCcccccceeeec--cceEEEEEE
Q 002336 615 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSH-R-TQQFVTEVALLSRIHHRNLVPLIGYCEE--EHQRILVYE 689 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~~-~-~~~~~~E~~iL~~L~HpnIv~l~g~~~~--~~~~~lV~E 689 (935)
++..++|++|.||.||+|+.+ +++.||+|+++..... + --.-.+|+.+|.+.+|||||.+-.+... -+..|+|||
T Consensus 78 fe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe 157 (419)
T KOG0663|consen 78 FEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVME 157 (419)
T ss_pred HHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHH
Confidence 445678999999999999876 6889999999754322 1 1346789999999999999999887643 456899999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccc
Q 002336 690 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 769 (935)
Q Consensus 690 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~ 769 (935)
||+. +|.+.++.. ..++...++.-+..|+++|++|||. ..|+|||||++|+|+++.|.+||+|||+|+.+++..
T Consensus 158 ~~Eh-DLksl~d~m--~q~F~~~evK~L~~QlL~glk~lH~---~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~ 231 (419)
T KOG0663|consen 158 YVEH-DLKSLMETM--KQPFLPGEVKTLMLQLLRGLKHLHD---NWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPL 231 (419)
T ss_pred HHHh-hHHHHHHhc--cCCCchHHHHHHHHHHHHHHHHHhh---ceeEecccchhheeeccCCcEEecccchhhhhcCCc
Confidence 9976 888888753 4678899999999999999999997 899999999999999999999999999999988764
Q ss_pred cceeecccCCccccCCCCCCC-CCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeeccccc-
Q 002336 770 THISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV- 847 (935)
Q Consensus 770 ~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~- 847 (935)
.. .+...-|.+|+|||++.+ ..|+...|+||+|||+.||+++++-|.+....++.+.+ -+.+ |...+.+.|.
T Consensus 232 k~-~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~I---f~ll--GtPte~iwpg~ 305 (419)
T KOG0663|consen 232 KP-YTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKI---FKLL--GTPSEAIWPGY 305 (419)
T ss_pred cc-CcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHH---HHHh--CCCccccCCCc
Confidence 43 233457999999998765 58999999999999999999999999755433322211 1111 1111111111
Q ss_pred ------------------ccCCCCHH-HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002336 848 ------------------LIGNVKIE-SIWRIAEVAIQCVEQRGFSRPKMQEIVLA 884 (935)
Q Consensus 848 ------------------l~~~~~~~-~~~~l~~li~~Cl~~dP~~RPs~~ev~~~ 884 (935)
+...+... ..+.-.+++...+..||.+|.|++|.++.
T Consensus 306 ~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 306 SELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred cccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 11111111 12355789999999999999999998753
|
|
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=306.10 Aligned_cols=248 Identities=27% Similarity=0.402 Sum_probs=200.4
Q ss_pred HHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc-hhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEe
Q 002336 613 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 690 (935)
Q Consensus 613 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~-~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~ 690 (935)
+.|...+.||+|+||.||+|.+. +++.||+|.+.... ....+.+.+|++++++++||||+++++.+......++||||
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence 45666788999999999999865 57889999886432 33456789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccccccc
Q 002336 691 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 770 (935)
Q Consensus 691 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~ 770 (935)
+++++|.+++.. ..+++..+..++.|+++||.|||+ ++++|+||+|+||++++++.++|+|||++........
T Consensus 84 ~~~~~L~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~---~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06642 84 LGGGSALDLLKP----GPLEETYIATILREILKGLDYLHS---ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred cCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhc---CCeeccCCChheEEEeCCCCEEEccccccccccCcch
Confidence 999999998863 468899999999999999999997 8999999999999999999999999999876543221
Q ss_pred ceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccC
Q 002336 771 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 850 (935)
Q Consensus 771 ~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~ 850 (935)
. .....++..|+|||++.+..++.++||||||++++||++|+.|+...... .... .+..+. .+.+
T Consensus 157 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~---~~~~----~~~~~~-----~~~~-- 221 (277)
T cd06642 157 K-RNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPM---RVLF----LIPKNS-----PPTL-- 221 (277)
T ss_pred h-hhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchh---hHHh----hhhcCC-----CCCC--
Confidence 1 12234788999999999888999999999999999999999998622111 1111 111111 1111
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002336 851 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 884 (935)
Q Consensus 851 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~ 884 (935)
.......+.+++.+|++.+|++||++.|+++.
T Consensus 222 --~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 222 --EGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred --CcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 12233468899999999999999999999874
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=301.51 Aligned_cols=247 Identities=32% Similarity=0.487 Sum_probs=198.5
Q ss_pred ccccccccEEEEEEEECCCcEEEEEEccCcchh-hhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEecCCCCHH
Q 002336 619 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSH-RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLR 697 (935)
Q Consensus 619 ~~LG~G~fG~Vy~~~~~~g~~vAvK~~~~~~~~-~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL~ 697 (935)
++||+|++|.||++.+.+++.|++|.+...... ....+.+|++++++++|+||+++++++......++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 479999999999999877999999998765433 4568999999999999999999999999999999999999999999
Q ss_pred HHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccccccccee-ecc
Q 002336 698 DRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS-SVA 776 (935)
Q Consensus 698 ~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~~~-~~~ 776 (935)
+++... ...+++..++.++.++++||+|||+ ++++||||||+||+++.++.+||+|||++........... ...
T Consensus 81 ~~l~~~--~~~~~~~~~~~~~~~~~~~l~~lH~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (251)
T cd05041 81 TFLRKK--KNRLTVKKLLQMSLDAAAGMEYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK 155 (251)
T ss_pred HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHh---CCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence 998643 3467899999999999999999997 8999999999999999999999999999876542211111 112
Q ss_pred cCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccCCCCHH
Q 002336 777 RGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIE 855 (935)
Q Consensus 777 ~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~~~~~~ 855 (935)
..+..|+|||.+.+..++.++|+||||++++||++ |..||...... ...+ .+..+.. . ..+..
T Consensus 156 ~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~---~~~~----~~~~~~~--~-------~~~~~ 219 (251)
T cd05041 156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ---QTRE----RIESGYR--M-------PAPQL 219 (251)
T ss_pred cceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHH---HHHH----HHhcCCC--C-------CCCcc
Confidence 23567999999988889999999999999999999 88888633221 1111 1111110 0 01112
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 002336 856 SIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 886 (935)
Q Consensus 856 ~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~ 886 (935)
....+.+++.+|+..+|++||++.||++.|+
T Consensus 220 ~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 220 CPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred CCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 2347889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-33 Score=301.53 Aligned_cols=253 Identities=27% Similarity=0.398 Sum_probs=191.9
Q ss_pred ccccccccEEEEEEEECC---CcEEEEEEccCcch-hhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEecCCC
Q 002336 619 KKIGKGSFGSVYYGKMKD---GKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNG 694 (935)
Q Consensus 619 ~~LG~G~fG~Vy~~~~~~---g~~vAvK~~~~~~~-~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~~~g 694 (935)
+.||+|+||.||+|.+.+ +..+|+|.++.... .....+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 469999999999998653 45799998875432 33457889999999999999999999999988999999999999
Q ss_pred CHHHHhccCC--CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccccce
Q 002336 695 TLRDRLHGSV--NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 772 (935)
Q Consensus 695 sL~~~L~~~~--~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~~ 772 (935)
+|.+++.... .....++..+..++.|++.||+|||+ .+++|+||||+||+++.++.+||+|||+++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK---NNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 9999987532 22356778888999999999999998 899999999999999999999999999987543322111
Q ss_pred -eecccCCccccCCCCCCCC-------CCCchhHHHHHHHHHHHHHh-CCCCCCccCcccchhHHHHHHHhhhcCCeeec
Q 002336 773 -SSVARGTVGYLDPEYYGNQ-------QLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISI 843 (935)
Q Consensus 773 -~~~~~gt~~y~APE~l~~~-------~~s~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~ 843 (935)
.....++..|+|||++... .++.++||||||+++|||++ |+.||......+ .... .+. +.....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~---~~~~---~~~-~~~~~~ 230 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQ---VLTY---TVR-EQQLKL 230 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHH---HHHH---Hhh-cccCCC
Confidence 1223467889999987542 35789999999999999996 999996332211 1111 111 111122
Q ss_pred ccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 002336 844 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 886 (935)
Q Consensus 844 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~ 886 (935)
.++.+.. .....+.+++.+|+ .+|++|||++||++.|.
T Consensus 231 ~~~~~~~----~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 231 PKPRLKL----PLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCccCC----CCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 2222221 12235778999998 58999999999998875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=306.22 Aligned_cols=239 Identities=24% Similarity=0.379 Sum_probs=187.8
Q ss_pred cccccccEEEEEEEECC-------------------------CcEEEEEEccCcchhhhHHHHHHHHHHHhcCCCccccc
Q 002336 620 KIGKGSFGSVYYGKMKD-------------------------GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPL 674 (935)
Q Consensus 620 ~LG~G~fG~Vy~~~~~~-------------------------g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~HpnIv~l 674 (935)
.||+|+||.||+|.+.. ...|++|++..........+.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 69999999999997521 13589998876544455678899999999999999999
Q ss_pred ceeeeccceEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCC--
Q 002336 675 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM-- 752 (935)
Q Consensus 675 ~g~~~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~-- 752 (935)
++++.+....++||||+++|+|..++.. ....+++..+++++.|+++||+|||+ ++|+||||||+|||++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~Nill~~~~~~ 156 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRK--EKGRVPVAWKITVAQQLASALSYLED---KNLVHGNVCAKNILLARLGLA 156 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHc---CCccCCCCCcccEEEeccCcc
Confidence 9999999999999999999999999864 24568899999999999999999997 8999999999999997643
Q ss_pred -----cEEEeeccccccccccccceeecccCCccccCCCCCCC-CCCCchhHHHHHHHHHHHHH-hCCCCCCccCcccch
Q 002336 753 -----RAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELI-SGKKPVSVEDFGAEL 825 (935)
Q Consensus 753 -----~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwS~Gvil~eLl-tG~~Pf~~~~~~~~~ 825 (935)
.+|++|||++...... ....++..|+|||.+.+ ..++.++||||||+++|||+ +|+.||.......
T Consensus 157 ~~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~-- 229 (274)
T cd05076 157 EGTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE-- 229 (274)
T ss_pred cCccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH--
Confidence 3899999987643222 12346788999998865 56899999999999999985 6999986432211
Q ss_pred hHHHHHHHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 002336 826 NIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 886 (935)
Q Consensus 826 ~l~~~~~~~i~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~ 886 (935)
...+.. ... .+. ......+.+++.+||+.+|++||++++|++.|.
T Consensus 230 -~~~~~~----~~~-------~~~----~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 230 -KERFYE----KKH-------RLP----EPSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred -HHHHHH----hcc-------CCC----CCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 111111 000 000 111236889999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=326.27 Aligned_cols=253 Identities=23% Similarity=0.333 Sum_probs=196.5
Q ss_pred HHHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc---hhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEE
Q 002336 612 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILV 687 (935)
Q Consensus 612 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV 687 (935)
...|++.+.||+|+||.||++++. +++.+|+|++.... ....+.+.+|+.+++.++||||+++++.+.++...++|
T Consensus 42 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv 121 (370)
T cd05621 42 AEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMV 121 (370)
T ss_pred HHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEE
Confidence 345667889999999999999886 57899999986421 22345688899999999999999999999999999999
Q ss_pred EEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccc
Q 002336 688 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 767 (935)
Q Consensus 688 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~ 767 (935)
|||+++|+|.+++.. ..+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||++.....
T Consensus 122 ~Ey~~gg~L~~~l~~----~~~~~~~~~~~~~qil~aL~~LH~---~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~ 194 (370)
T cd05621 122 MEYMPGGDLVNLMSN----YDVPEKWAKFYTAEVVLALDAIHS---MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDE 194 (370)
T ss_pred EcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEEecccceeccc
Confidence 999999999999863 357889999999999999999998 8999999999999999999999999999987643
Q ss_pred cccceeecccCCccccCCCCCCCC----CCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeec
Q 002336 768 DLTHISSVARGTVGYLDPEYYGNQ----QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISI 843 (935)
Q Consensus 768 ~~~~~~~~~~gt~~y~APE~l~~~----~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~ 843 (935)
..........||+.|+|||++... .++.++||||+||++|||++|+.||...... ...............
T Consensus 195 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~------~~~~~i~~~~~~~~~ 268 (370)
T cd05621 195 TGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLV------GTYSKIMDHKNSLNF 268 (370)
T ss_pred CCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHH------HHHHHHHhCCcccCC
Confidence 332223345699999999988653 3788999999999999999999999743321 111111111110000
Q ss_pred ccccccCCCCHHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 002336 844 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFS--RPKMQEIVLA 884 (935)
Q Consensus 844 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~--RPs~~ev~~~ 884 (935)
.. .......+.+++.+|++.++.+ ||+++|+++.
T Consensus 269 -----p~--~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 269 -----PE--DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred -----CC--cccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 00 0112335778888999865544 8899998775
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=318.90 Aligned_cols=243 Identities=26% Similarity=0.367 Sum_probs=189.4
Q ss_pred ccccccccEEEEEEEEC-CCcEEEEEEccCcch---hhhHHHHHHHH-HHHhcCCCcccccceeeeccceEEEEEEecCC
Q 002336 619 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVA-LLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 693 (935)
Q Consensus 619 ~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~---~~~~~~~~E~~-iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~~~ 693 (935)
+.||+|+||.||+|++. +++.+|+|++..... .....+..|.. +++.++||||+++++.+...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999876 578899999864321 22234444444 56778999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccccccccee
Q 002336 694 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 773 (935)
Q Consensus 694 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~~~ 773 (935)
|+|.+.+.. ...+.+..+..++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||+++....... ..
T Consensus 81 ~~L~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~---~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~-~~ 153 (325)
T cd05602 81 GELFYHLQR---ERCFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG-TT 153 (325)
T ss_pred CcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC-Cc
Confidence 999999873 4567888889999999999999998 8999999999999999999999999999875422211 12
Q ss_pred ecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccCCCC
Q 002336 774 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVK 853 (935)
Q Consensus 774 ~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~~~~ 853 (935)
....|++.|+|||++.+..++.++||||+||++|||++|+.||...... ...+ .... ... ..+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~~~---~i~~-~~~----------~~~ 216 (325)
T cd05602 154 STFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA---EMYD---NILN-KPL----------QLK 216 (325)
T ss_pred ccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHH---HHHH---HHHh-CCc----------CCC
Confidence 3346899999999999989999999999999999999999999733221 1111 1111 111 011
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 002336 854 IESIWRIAEVAIQCVEQRGFSRPKMQEIVLAI 885 (935)
Q Consensus 854 ~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L 885 (935)
......+.+++.+|++.+|.+||++.+.+..+
T Consensus 217 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i 248 (325)
T cd05602 217 PNITNSARHLLEGLLQKDRTKRLGAKDDFMEI 248 (325)
T ss_pred CCCCHHHHHHHHHHcccCHHHCCCCCCCHHHH
Confidence 12233678999999999999999987544433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=313.89 Aligned_cols=265 Identities=25% Similarity=0.447 Sum_probs=206.8
Q ss_pred HHHHHHhhcccccccccEEEEEEEEC--------CCcEEEEEEccCcc-hhhhHHHHHHHHHHHhc-CCCcccccceeee
Q 002336 610 LEEATNNFCKKIGKGSFGSVYYGKMK--------DGKEVAVKIMADSC-SHRTQQFVTEVALLSRI-HHRNLVPLIGYCE 679 (935)
Q Consensus 610 l~~~~~~~~~~LG~G~fG~Vy~~~~~--------~g~~vAvK~~~~~~-~~~~~~~~~E~~iL~~L-~HpnIv~l~g~~~ 679 (935)
+....+.+.+.||+|+||.||++... ....+|+|+++... ......+.+|+++++++ +||||+++++++.
T Consensus 9 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 88 (314)
T cd05099 9 FPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCT 88 (314)
T ss_pred ccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEc
Confidence 34456677899999999999999752 24579999987542 33456788999999999 6999999999999
Q ss_pred ccceEEEEEEecCCCCHHHHhccCC-------------CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCc
Q 002336 680 EEHQRILVYEYMHNGTLRDRLHGSV-------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNI 746 (935)
Q Consensus 680 ~~~~~~lV~E~~~~gsL~~~L~~~~-------------~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NI 746 (935)
.....+++|||+++|+|.+++.... ....+++.++.+++.|++.||.|||+ ++++||||||+||
T Consensus 89 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~Ni 165 (314)
T cd05099 89 QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES---RRCIHRDLAARNV 165 (314)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHH---CCeeeccccceeE
Confidence 9889999999999999999986432 12458899999999999999999998 8999999999999
Q ss_pred cccCCCcEEEeeccccccccccccce-eecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCcccc
Q 002336 747 LLDINMRAKVSDFGLSRQAEEDLTHI-SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAE 824 (935)
Q Consensus 747 Lld~~~~vkL~DFGla~~~~~~~~~~-~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~ 824 (935)
|+++++.+||+|||+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |..||......
T Consensus 166 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~-- 243 (314)
T cd05099 166 LVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVE-- 243 (314)
T ss_pred EEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHH--
Confidence 99999999999999998654322111 111224467999999988889999999999999999999 88888633221
Q ss_pred hhHHHHHHHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhhhhhcc
Q 002336 825 LNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 893 (935)
Q Consensus 825 ~~l~~~~~~~i~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~~~~~~ 893 (935)
... ..+..+.... .+......+.+++.+|+..+|++||++.|+++.|+++.....
T Consensus 244 -~~~----~~~~~~~~~~---------~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~~ 298 (314)
T cd05099 244 -ELF----KLLREGHRMD---------KPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAVS 298 (314)
T ss_pred -HHH----HHHHcCCCCC---------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHhc
Confidence 111 1222221111 111223467899999999999999999999999998876443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=313.79 Aligned_cols=263 Identities=20% Similarity=0.279 Sum_probs=195.7
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcch-hhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEec
Q 002336 614 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 691 (935)
Q Consensus 614 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~-~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~ 691 (935)
.|.+.+.||+|+||.||+|..+ +++.||+|.++.... .....+.+|++++++++||||+++++++..++..++||||+
T Consensus 7 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 86 (309)
T cd07872 7 TYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYL 86 (309)
T ss_pred ceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCC
Confidence 3566789999999999999876 678899999864322 23346788999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccccc
Q 002336 692 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 771 (935)
Q Consensus 692 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~ 771 (935)
++ +|.+.+... +..+++..+..++.|+++||+|||+ ++|+||||||+||+++.++.+||+|||++.........
T Consensus 87 ~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 160 (309)
T cd07872 87 DK-DLKQYMDDC--GNIMSMHNVKIFLYQILRGLAYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKT 160 (309)
T ss_pred CC-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECccccceecCCCccc
Confidence 75 788877642 3457889999999999999999998 89999999999999999999999999998764332211
Q ss_pred eeecccCCccccCCCCCCC-CCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCee------ecc
Q 002336 772 ISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVI------SIV 844 (935)
Q Consensus 772 ~~~~~~gt~~y~APE~l~~-~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~------~~~ 844 (935)
.....+++.|+|||.+.+ ..++.++||||+|+++|||++|+.||...+..+.................. ...
T Consensus 161 -~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (309)
T cd07872 161 -YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFK 239 (309)
T ss_pred -cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhh
Confidence 122357889999998754 568899999999999999999999997544332221111100000000000 000
Q ss_pred cccccCC-------CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 845 DPVLIGN-------VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 845 d~~l~~~-------~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
+...... ........+.+++.+|++.||++|||++|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 240 NYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 0000000 00112235789999999999999999999976
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=313.16 Aligned_cols=266 Identities=26% Similarity=0.456 Sum_probs=208.4
Q ss_pred hHHHHHHhhcccccccccEEEEEEEEC--------CCcEEEEEEccCcc-hhhhHHHHHHHHHHHhc-CCCcccccceee
Q 002336 609 ELEEATNNFCKKIGKGSFGSVYYGKMK--------DGKEVAVKIMADSC-SHRTQQFVTEVALLSRI-HHRNLVPLIGYC 678 (935)
Q Consensus 609 ~l~~~~~~~~~~LG~G~fG~Vy~~~~~--------~g~~vAvK~~~~~~-~~~~~~~~~E~~iL~~L-~HpnIv~l~g~~ 678 (935)
++....+++.+.||+|+||.||++... .+..||+|.+.... ....+.+.+|+++++++ +||||+++++++
T Consensus 8 ~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 87 (334)
T cd05100 8 ELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGAC 87 (334)
T ss_pred ccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEE
Confidence 455567888999999999999999753 12368999887543 33457899999999999 799999999999
Q ss_pred eccceEEEEEEecCCCCHHHHhccCC-------------CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCC
Q 002336 679 EEEHQRILVYEYMHNGTLRDRLHGSV-------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSN 745 (935)
Q Consensus 679 ~~~~~~~lV~E~~~~gsL~~~L~~~~-------------~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~N 745 (935)
......+++|||+++|+|.+++.... ....+++.++++++.|+++||+|||+ ++++||||||+|
T Consensus 88 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~N 164 (334)
T cd05100 88 TQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLAS---QKCIHRDLAARN 164 (334)
T ss_pred ccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccce
Confidence 99999999999999999999986431 23457889999999999999999998 899999999999
Q ss_pred ccccCCCcEEEeeccccccccccccce-eecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCccc
Q 002336 746 ILLDINMRAKVSDFGLSRQAEEDLTHI-SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGA 823 (935)
Q Consensus 746 ILld~~~~vkL~DFGla~~~~~~~~~~-~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~ 823 (935)
||++.++.+||+|||+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |..||.....
T Consensus 165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-- 242 (334)
T cd05100 165 VLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV-- 242 (334)
T ss_pred EEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH--
Confidence 999999999999999987654322111 111224567999999999899999999999999999998 8888863322
Q ss_pred chhHHHHHHHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhhhhhcc
Q 002336 824 ELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 893 (935)
Q Consensus 824 ~~~l~~~~~~~i~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~~~~~~ 893 (935)
.++.. .+..+.... .+......+.+++.+|++.+|++||++.|+++.|+++.....
T Consensus 243 ----~~~~~-~~~~~~~~~---------~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~~ 298 (334)
T cd05100 243 ----EELFK-LLKEGHRMD---------KPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTS 298 (334)
T ss_pred ----HHHHH-HHHcCCCCC---------CCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhcC
Confidence 11111 122211111 111223468899999999999999999999999998885443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=306.03 Aligned_cols=259 Identities=25% Similarity=0.367 Sum_probs=206.6
Q ss_pred HHHHHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc-hhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEE
Q 002336 610 LEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILV 687 (935)
Q Consensus 610 l~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~-~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV 687 (935)
+....+++.+.||+|+||+||++... +|+.+|+|++.... ....+.+.+|+++++.++||||+++++++......++|
T Consensus 2 l~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (284)
T cd06620 2 LRNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMC 81 (284)
T ss_pred ccHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEE
Confidence 34566788899999999999999875 68899999876432 33456889999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccc
Q 002336 688 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 767 (935)
Q Consensus 688 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~ 767 (935)
|||+++++|.+++.. .+.+++..+..++.|++.||.|||+ ..+++||||||+||++++++.++|+|||++.....
T Consensus 82 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~ 156 (284)
T cd06620 82 MEFMDCGSLDRIYKK---GGPIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELIN 156 (284)
T ss_pred EecCCCCCHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHH--hcCeeccCCCHHHEEECCCCcEEEccCCcccchhh
Confidence 999999999998873 3568999999999999999999996 36899999999999999999999999999865432
Q ss_pred cccceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcc-----cchhHHHHHHHhhhcCCeee
Q 002336 768 DLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFG-----AELNIVHWARSMIKKGDVIS 842 (935)
Q Consensus 768 ~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~-----~~~~l~~~~~~~i~~~~~~~ 842 (935)
.. .....|+..|+|||++.+..++.++|||||||++|+|++|+.||...... ......++....+....
T Consensus 157 ~~---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 230 (284)
T cd06620 157 SI---ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPP--- 230 (284)
T ss_pred hc---cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccC---
Confidence 21 12345889999999998888999999999999999999999999743321 11122333333332110
Q ss_pred cccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 002336 843 IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAI 885 (935)
Q Consensus 843 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L 885 (935)
+.+. .......+.+++.+|++.+|++||+++|++++.
T Consensus 231 ---~~~~---~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 231 ---PRLP---SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred ---CCCC---chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 1111 111334688999999999999999999998753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=315.69 Aligned_cols=237 Identities=27% Similarity=0.375 Sum_probs=187.5
Q ss_pred ccccccccEEEEEEEEC-CCcEEEEEEccCcch---hhhHHHHHHHH-HHHhcCCCcccccceeeeccceEEEEEEecCC
Q 002336 619 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVA-LLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 693 (935)
Q Consensus 619 ~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~---~~~~~~~~E~~-iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~~~ 693 (935)
+.||+|+||.||+|+.. +++.||+|++..... .....+.+|.. +++.++||||+++++.+.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999876 688999999864321 22344555554 57889999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccccccccee
Q 002336 694 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 773 (935)
Q Consensus 694 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~~~ 773 (935)
++|.+.+.. ...+++..+..++.||++||+|||+ .+|+||||||+||+++.++.+||+|||+++....... ..
T Consensus 81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~-~~ 153 (321)
T cd05603 81 GELFFHLQR---ERCFLEPRARFYAAEVASAIGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE-TT 153 (321)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCC-cc
Confidence 999988863 4568888999999999999999998 8999999999999999999999999999875322211 12
Q ss_pred ecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccCCCC
Q 002336 774 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVK 853 (935)
Q Consensus 774 ~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~~~~ 853 (935)
....|++.|+|||.+.+..++.++|||||||++|||++|+.||...+.. .. ... +..+.. ..+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~---~~~-i~~~~~----------~~~ 216 (321)
T cd05603 154 STFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVS---QM---YDN-ILHKPL----------QLP 216 (321)
T ss_pred ccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHH---HH---HHH-HhcCCC----------CCC
Confidence 3346899999999999888999999999999999999999999743221 11 111 111111 111
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHH
Q 002336 854 IESIWRIAEVAIQCVEQRGFSRPKMQ 879 (935)
Q Consensus 854 ~~~~~~l~~li~~Cl~~dP~~RPs~~ 879 (935)
......+.+++.+|++.+|++||+..
T Consensus 217 ~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 217 GGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 22234688999999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=321.11 Aligned_cols=252 Identities=25% Similarity=0.378 Sum_probs=205.6
Q ss_pred HHHhhcccccccccEEEEEEEEC--CCc--EEEEEEccCcchh-hhHHHHHHHHHHHhcCCCcccccceeeeccceEEEE
Q 002336 613 ATNNFCKKIGKGSFGSVYYGKMK--DGK--EVAVKIMADSCSH-RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILV 687 (935)
Q Consensus 613 ~~~~~~~~LG~G~fG~Vy~~~~~--~g~--~vAvK~~~~~~~~-~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV 687 (935)
....+.|+||+|.||.|++|.|+ +|+ .||||+++..... ...+|.+|+.+|.+|+|||++++||+.-+ ....||
T Consensus 110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV 188 (1039)
T KOG0199|consen 110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMV 188 (1039)
T ss_pred HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHH
Confidence 34456789999999999999987 344 6899999876544 56889999999999999999999999987 667899
Q ss_pred EEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccc
Q 002336 688 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 767 (935)
Q Consensus 688 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~ 767 (935)
+|.++.|+|.+.|++ ..+..+.....-.++.|||.||.||.+ +++|||||.++|+|+-....+||+|||+.+-.+.
T Consensus 189 ~ELaplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLes---krlvHRDLAARNlllasprtVKI~DFGLmRaLg~ 264 (1039)
T KOG0199|consen 189 FELAPLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLES---KRLVHRDLAARNLLLASPRTVKICDFGLMRALGE 264 (1039)
T ss_pred hhhcccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhhhheecccceeeeecccceeccCC
Confidence 999999999999997 356678888889999999999999998 9999999999999999999999999999988765
Q ss_pred cccce--eecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCcccchhHHHHHHHhhhcCCeeecc
Q 002336 768 DLTHI--SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 844 (935)
Q Consensus 768 ~~~~~--~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~ 844 (935)
..... .....-...|+|||.+....++.++|||+|||++|||+| |..||.+-.-. .+. +. +
T Consensus 265 ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~---qIL----~~---------i 328 (1039)
T KOG0199|consen 265 NEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGI---QIL----KN---------I 328 (1039)
T ss_pred CCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHH---HHH----Hh---------c
Confidence 43322 222334678999999999999999999999999999999 88888743221 111 11 2
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 002336 845 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAI 885 (935)
Q Consensus 845 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L 885 (935)
|..-.-.-+..+.+.+.++++.||.++|++||++..|.+.+
T Consensus 329 D~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 329 DAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred cccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 21111122455677899999999999999999999997443
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=300.72 Aligned_cols=238 Identities=26% Similarity=0.435 Sum_probs=189.5
Q ss_pred ccccccccEEEEEEEECCCc-----------EEEEEEccCcchhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEE
Q 002336 619 KKIGKGSFGSVYYGKMKDGK-----------EVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILV 687 (935)
Q Consensus 619 ~~LG~G~fG~Vy~~~~~~g~-----------~vAvK~~~~~~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV 687 (935)
+.||+|+||.||+|.+.+.. .+++|.+...... ...+.+|+.+++.++||||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 47999999999999886433 5788877654333 6789999999999999999999999987 778999
Q ss_pred EEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCC-------cEEEeecc
Q 002336 688 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM-------RAKVSDFG 760 (935)
Q Consensus 688 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~-------~vkL~DFG 760 (935)
|||+++|+|.+++... ...+++..++.++.|++.||+|||+ ++|+||||||+||+++.++ .+||+|||
T Consensus 79 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg 153 (259)
T cd05037 79 EEYVKFGPLDVFLHRE--KNNVSLHWKLDVAKQLASALHYLED---KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPG 153 (259)
T ss_pred EEcCCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHhh---CCeecccCccceEEEecCccccCCceeEEeCCCC
Confidence 9999999999998753 2268999999999999999999997 8999999999999999887 79999999
Q ss_pred ccccccccccceeecccCCccccCCCCCCCC--CCCchhHHHHHHHHHHHHHh-CCCCCCccCcccchhHHHHHHHhhhc
Q 002336 761 LSRQAEEDLTHISSVARGTVGYLDPEYYGNQ--QLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKK 837 (935)
Q Consensus 761 la~~~~~~~~~~~~~~~gt~~y~APE~l~~~--~~s~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~i~~ 837 (935)
++..... .....++..|+|||++... .++.++||||||+++|||++ |..|+...... ....+.. .
T Consensus 154 ~a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~---~~~~~~~----~ 221 (259)
T cd05037 154 IPITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSS---EKERFYQ----D 221 (259)
T ss_pred ccccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCch---hHHHHHh----c
Confidence 9876543 1223467789999998776 78999999999999999999 57777633211 1111111 0
Q ss_pred CCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 002336 838 GDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 886 (935)
Q Consensus 838 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~ 886 (935)
... .+......+.+++.+||..+|++||++.||++.|+
T Consensus 222 ~~~-----------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 222 QHR-----------LPMPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred CCC-----------CCCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 000 00111147889999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=302.06 Aligned_cols=248 Identities=25% Similarity=0.378 Sum_probs=194.6
Q ss_pred cccccccccEEEEEEEEC-CCcEEEEEEccCcchhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEecCCCCH
Q 002336 618 CKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTL 696 (935)
Q Consensus 618 ~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL 696 (935)
...||+|+||.||+|.+. +++.|++|.+........+.+.+|++++++++|+||+++++++..++..++|+||+++++|
T Consensus 13 ~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 92 (268)
T cd06624 13 RVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSL 92 (268)
T ss_pred eEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCH
Confidence 457999999999999865 5788999998776666677899999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccC-CCcEEEeeccccccccccccceeec
Q 002336 697 RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI-NMRAKVSDFGLSRQAEEDLTHISSV 775 (935)
Q Consensus 697 ~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~-~~~vkL~DFGla~~~~~~~~~~~~~ 775 (935)
.+++.........++..+..++.|++.||+|||+ ++|+||||||+||+++. ++.++|+|||++......... ...
T Consensus 93 ~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~-~~~ 168 (268)
T cd06624 93 SALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHD---NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPC-TET 168 (268)
T ss_pred HHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCCc-ccc
Confidence 9998743211122788889999999999999998 89999999999999976 678999999998765332221 222
Q ss_pred ccCCccccCCCCCCCC--CCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccCCCC
Q 002336 776 ARGTVGYLDPEYYGNQ--QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVK 853 (935)
Q Consensus 776 ~~gt~~y~APE~l~~~--~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~~~~ 853 (935)
..++..|+|||++... .++.++||||||+++|+|++|+.||...... ....+...... ..+ ..+
T Consensus 169 ~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~---~~~~~~~~~~~-------~~~----~~~ 234 (268)
T cd06624 169 FTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEP---QAAMFKVGMFK-------IHP----EIP 234 (268)
T ss_pred CCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccCh---hhhHhhhhhhc-------cCC----CCC
Confidence 3478999999998654 3789999999999999999999998632211 11111110000 001 112
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 854 IESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 854 ~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
......+.+++.+||+.+|++||+++|+++
T Consensus 235 ~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 235 ESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred cccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 223346889999999999999999999875
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=302.95 Aligned_cols=251 Identities=22% Similarity=0.355 Sum_probs=200.0
Q ss_pred HHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcchhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEec
Q 002336 613 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 691 (935)
Q Consensus 613 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~ 691 (935)
..|++.+.||+|+||.||+|... +++.+++|++........+.+.+|+.+++.++||||+++++.+..+...++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 45778899999999999999876 58999999987766666778999999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccccc
Q 002336 692 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 771 (935)
Q Consensus 692 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~ 771 (935)
++++|..++... ...+++..+..++.|++++|.|||+ .+++||||||+||+++.++.+||+|||++.........
T Consensus 92 ~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~ 166 (292)
T cd06644 92 PGGAVDAIMLEL--DRGLTEPQIQVICRQMLEALQYLHS---MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQR 166 (292)
T ss_pred CCCcHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhc---CCeeecCCCcceEEEcCCCCEEEccCccceeccccccc
Confidence 999998887542 3568999999999999999999997 89999999999999999999999999988754332111
Q ss_pred eeecccCCccccCCCCCC-----CCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccc
Q 002336 772 ISSVARGTVGYLDPEYYG-----NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP 846 (935)
Q Consensus 772 ~~~~~~gt~~y~APE~l~-----~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~ 846 (935)
.....++..|+|||++. ...++.++||||||+++|||++|+.||..... ........ ........
T Consensus 167 -~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~------~~~~~~~~-~~~~~~~~-- 236 (292)
T cd06644 167 -RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP------MRVLLKIA-KSEPPTLS-- 236 (292)
T ss_pred -cceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH------HHHHHHHh-cCCCccCC--
Confidence 12334788999999874 34568899999999999999999999863221 11111111 11111110
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 847 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 847 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
.+......+.+++.+||+.+|++||+++|+++
T Consensus 237 -----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 237 -----QPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred -----CCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 11122346889999999999999999999975
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=292.26 Aligned_cols=250 Identities=24% Similarity=0.336 Sum_probs=199.6
Q ss_pred HHHhhcccccccccEEEEEEEEC-CCcEEEEEEccC--cchhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEE
Q 002336 613 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMAD--SCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 689 (935)
Q Consensus 613 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~--~~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E 689 (935)
..|++.+.||+|.|+.||+..+. +|+.+|+|++.- -...+.+++.+|+++.+.|+|||||++.+.+.+....++|+|
T Consensus 11 d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe 90 (355)
T KOG0033|consen 11 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD 90 (355)
T ss_pred hhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEe
Confidence 45677889999999999998765 789999998743 223466789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCcccc---CCCcEEEeecccccccc
Q 002336 690 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD---INMRAKVSDFGLSRQAE 766 (935)
Q Consensus 690 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld---~~~~vkL~DFGla~~~~ 766 (935)
+|.|++|..-+-. +.-.++..+-..+.||+++|.|+|. ++|||||+||+|+|+- ..--+||+|||++....
T Consensus 91 ~m~G~dl~~eIV~---R~~ySEa~aSH~~rQiLeal~yCH~---n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~ 164 (355)
T KOG0033|consen 91 LVTGGELFEDIVA---REFYSEADASHCIQQILEALAYCHS---NGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN 164 (355)
T ss_pred cccchHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeeeeccCCCceeecccceEEEeC
Confidence 9999998654431 2446778888999999999999998 9999999999999994 34458999999999876
Q ss_pred ccccceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccc
Q 002336 767 EDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP 846 (935)
Q Consensus 767 ~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~ 846 (935)
+ ........|||+|||||++...+++..+|||+.||+||-|+.|.+||.+++.. . +-+.|..|... +++
T Consensus 165 ~--g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~---r----lye~I~~g~yd--~~~ 233 (355)
T KOG0033|consen 165 D--GEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH---R----LYEQIKAGAYD--YPS 233 (355)
T ss_pred C--ccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHH---H----HHHHHhccccC--CCC
Confidence 3 22334567999999999999999999999999999999999999999854332 1 22234334321 122
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 847 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 847 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
..... ......+++.+||..||.+|.|+.|.++
T Consensus 234 ~~w~~----is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 234 PEWDT----VTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred cccCc----CCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 11111 1235679999999999999999998764
|
|
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-33 Score=303.22 Aligned_cols=252 Identities=26% Similarity=0.393 Sum_probs=200.0
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCc-chhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEec
Q 002336 614 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS-CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 691 (935)
Q Consensus 614 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~-~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~ 691 (935)
.+++.+.||+|+||.||++.+. +++.+|+|.+... .....+.+.+|++++++++|+||+++++.+...+..++||||+
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM 81 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence 3567889999999999999886 7899999988653 2334567899999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccccc
Q 002336 692 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 771 (935)
Q Consensus 692 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~ 771 (935)
++++|.+++........+++..+..++.|+++||.|||+ ..+++||||||+||+++.++.+||+|||++........
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~- 158 (286)
T cd06622 82 DAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLA- 158 (286)
T ss_pred CCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh--cCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCcc-
Confidence 999999988754334578999999999999999999996 35999999999999999999999999999876533221
Q ss_pred eeecccCCccccCCCCCCCC------CCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeeccc
Q 002336 772 ISSVARGTVGYLDPEYYGNQ------QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 845 (935)
Q Consensus 772 ~~~~~~gt~~y~APE~l~~~------~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d 845 (935)
....++..|+|||.+.+. .++.++|+|||||++|+|++|+.||....... ...... .+..+...
T Consensus 159 --~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~~~-~~~~~~~~---- 228 (286)
T cd06622 159 --KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN---IFAQLS-AIVDGDPP---- 228 (286)
T ss_pred --ccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh---HHHHHH-HHhhcCCC----
Confidence 223478899999988543 35889999999999999999999996332211 111111 11111111
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 846 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 846 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
..+......+.+++.+|++.+|++||++++++.
T Consensus 229 -----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 229 -----TLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred -----CCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 112223446889999999999999999999876
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=308.94 Aligned_cols=257 Identities=29% Similarity=0.461 Sum_probs=202.1
Q ss_pred HHHHhhcccccccccEEEEEEEEC------CCcEEEEEEccCcch-hhhHHHHHHHHHHHhcCCCcccccceeeeccceE
Q 002336 612 EATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQR 684 (935)
Q Consensus 612 ~~~~~~~~~LG~G~fG~Vy~~~~~------~g~~vAvK~~~~~~~-~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~ 684 (935)
...+++.+.||+|+||.||+|.+. +++.+|+|++..... ...+.+.+|+.++++++||||+++++++.++...
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 344566789999999999999864 467899999875432 3446799999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhccCC-------------------CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCC
Q 002336 685 ILVYEYMHNGTLRDRLHGSV-------------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSN 745 (935)
Q Consensus 685 ~lV~E~~~~gsL~~~L~~~~-------------------~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~N 745 (935)
++||||+++|+|.+++.... ....+++..++.++.|++.||+|||+ ++++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~---~~i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSE---RKFVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCeecccccHhh
Confidence 99999999999999986321 12357888999999999999999997 899999999999
Q ss_pred ccccCCCcEEEeecccccccccccc-ceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCccc
Q 002336 746 ILLDINMRAKVSDFGLSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGA 823 (935)
Q Consensus 746 ILld~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~ 823 (935)
|++++++.++|+|||++........ ........+..|+|||.+.+..++.++|||||||++|||++ |..||......
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~- 239 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE- 239 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-
Confidence 9999999999999999875432211 11112234667999999988889999999999999999998 88888532211
Q ss_pred chhHHHHHHHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhh
Q 002336 824 ELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 887 (935)
Q Consensus 824 ~~~l~~~~~~~i~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~ 887 (935)
+... .+..+..... +......+.+++.+|++.+|++||++.|+++.|++
T Consensus 240 -----~~~~-~~~~~~~~~~---------~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 240 -----EVIY-YVRDGNVLSC---------PDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred -----HHHH-HHhcCCCCCC---------CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 1111 2222322111 11223468899999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=317.61 Aligned_cols=254 Identities=23% Similarity=0.320 Sum_probs=197.3
Q ss_pred HHHHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc---hhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEE
Q 002336 611 EEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRIL 686 (935)
Q Consensus 611 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~l 686 (935)
....+++.+.||+|+||.||++.++ +++.+|+|++.... ....+.+.+|+.+++.++||||+++++.+.++...++
T Consensus 41 ~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l 120 (371)
T cd05622 41 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYM 120 (371)
T ss_pred chhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEE
Confidence 3466777899999999999999886 68899999986421 2234567889999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccc
Q 002336 687 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 766 (935)
Q Consensus 687 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~ 766 (935)
||||+++|+|.+++.. ..+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 121 v~Ey~~gg~L~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~ 193 (371)
T cd05622 121 VMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMN 193 (371)
T ss_pred EEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHEEECCCCCEEEEeCCceeEcC
Confidence 9999999999999863 357888899999999999999998 999999999999999999999999999998764
Q ss_pred ccccceeecccCCccccCCCCCCCC----CCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeee
Q 002336 767 EDLTHISSVARGTVGYLDPEYYGNQ----QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVIS 842 (935)
Q Consensus 767 ~~~~~~~~~~~gt~~y~APE~l~~~----~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~ 842 (935)
...........||+.|+|||++... .++.++|||||||++|||++|+.||...+.. ..............
T Consensus 194 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~------~~~~~i~~~~~~~~ 267 (371)
T cd05622 194 KEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV------GTYSKIMNHKNSLT 267 (371)
T ss_pred cCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHH------HHHHHHHcCCCccc
Confidence 4332223345699999999998643 3789999999999999999999999743321 11111111111111
Q ss_pred cccccccCCCCHHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 002336 843 IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFS--RPKMQEIVLA 884 (935)
Q Consensus 843 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~--RPs~~ev~~~ 884 (935)
..+ .......+.+++.+|+...+.+ ||+++|+.+.
T Consensus 268 ~~~-------~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h 304 (371)
T cd05622 268 FPD-------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 304 (371)
T ss_pred CCC-------cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence 111 0112336778999999844433 7789888775
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=325.13 Aligned_cols=250 Identities=22% Similarity=0.276 Sum_probs=193.4
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc---hhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEe
Q 002336 615 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 690 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~ 690 (935)
|++.+.||+|+||.||+++.. +++.||+|++.... ......+.+|+++|++++||||+++++.+.+++..++||||
T Consensus 3 y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~ 82 (376)
T cd05598 3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDY 82 (376)
T ss_pred ceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeC
Confidence 456789999999999999875 68999999986432 12345688999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccc-
Q 002336 691 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL- 769 (935)
Q Consensus 691 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~- 769 (935)
+++|+|.+++.. ...+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||++..+....
T Consensus 83 ~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~ 156 (376)
T cd05598 83 IPGGDMMSLLIR---LGIFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 156 (376)
T ss_pred CCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccc
Confidence 999999999874 4568888999999999999999998 899999999999999999999999999975321000
Q ss_pred -----------------------------------------cceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHH
Q 002336 770 -----------------------------------------THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLE 808 (935)
Q Consensus 770 -----------------------------------------~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~e 808 (935)
........||+.|+|||++.+..++.++|||||||++||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilye 236 (376)
T cd05598 157 SKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 236 (376)
T ss_pred ccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeee
Confidence 000112358999999999998899999999999999999
Q ss_pred HHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCC---CHHHHHHH
Q 002336 809 LISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRP---KMQEIVLA 884 (935)
Q Consensus 809 LltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP---s~~ev~~~ 884 (935)
|++|+.||......+ .............. +. ... ....+.+++.+|+ .+|++|+ ++.|+++.
T Consensus 237 ll~G~~Pf~~~~~~~------~~~~i~~~~~~~~~--~~-~~~----~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 237 MLVGQPPFLADTPAE------TQLKVINWETTLHI--PS-QAK----LSREASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred hhhCCCCCCCCCHHH------HHHHHhccCccccC--CC-CCC----CCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 999999997443211 11111110000000 00 011 1234667777766 5999999 88888765
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=307.87 Aligned_cols=262 Identities=27% Similarity=0.462 Sum_probs=204.6
Q ss_pred HHHhhcccccccccEEEEEEEEC-----CCcEEEEEEccCcchh-hhHHHHHHHHHHHhcCCCcccccceeeec--cceE
Q 002336 613 ATNNFCKKIGKGSFGSVYYGKMK-----DGKEVAVKIMADSCSH-RTQQFVTEVALLSRIHHRNLVPLIGYCEE--EHQR 684 (935)
Q Consensus 613 ~~~~~~~~LG~G~fG~Vy~~~~~-----~g~~vAvK~~~~~~~~-~~~~~~~E~~iL~~L~HpnIv~l~g~~~~--~~~~ 684 (935)
..+++.+.||+|+||.||+|.+. .++.+|+|++...... ..+.+.+|+++++.++||||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 44566789999999999999864 3688999998765443 46789999999999999999999999877 5578
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccc
Q 002336 685 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 764 (935)
Q Consensus 685 ~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~ 764 (935)
+++|||+++++|.+++... ...+++..+..++.|++.||+|||+ .+++|+||||+||+++.++.++|+|||++..
T Consensus 84 ~lv~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRH--RDQINLKRLLLFSSQICKGMDYLGS---QRYIHRDLAARNILVESEDLVKISDFGLAKV 158 (284)
T ss_pred EEEEecCCCCCHHHHHHhC--ccccCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEcccccccc
Confidence 9999999999999999743 3358999999999999999999998 8999999999999999999999999999987
Q ss_pred ccccccc--eeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccch--------hHHHHHHHh
Q 002336 765 AEEDLTH--ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAEL--------NIVHWARSM 834 (935)
Q Consensus 765 ~~~~~~~--~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~--------~l~~~~~~~ 834 (935)
....... ......++..|++||.+.+..++.++||||||++++||++|+.|+......... .........
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05038 159 LPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLEL 238 (284)
T ss_pred cccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHH
Confidence 6532221 111223456799999998888999999999999999999999998633221100 011111112
Q ss_pred hhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhh
Q 002336 835 IKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 888 (935)
Q Consensus 835 i~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~ 888 (935)
+..+... ..+......+.+++.+|++.+|++||++.||+++|+.+
T Consensus 239 ~~~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 239 LKEGERL---------PRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHcCCcC---------CCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 2211110 01112234688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-34 Score=324.54 Aligned_cols=250 Identities=25% Similarity=0.335 Sum_probs=193.6
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc---hhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEe
Q 002336 615 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 690 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~ 690 (935)
|.+.+.||+|+||.||++... +++.||||++.... ....+.+.+|++++++++||||+++++++.+....++||||
T Consensus 3 y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~ 82 (377)
T cd05629 3 FHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEF 82 (377)
T ss_pred ceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeC
Confidence 456789999999999999865 68999999986432 22345788899999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccccccc
Q 002336 691 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 770 (935)
Q Consensus 691 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~ 770 (935)
+++|+|.+++.. ...+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.+.....
T Consensus 83 ~~gg~L~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH~---~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 156 (377)
T cd05629 83 LPGGDLMTMLIK---YDTFSEDVTRFYMAECVLAIEAVHK---LGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHD 156 (377)
T ss_pred CCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEEeecccccccccccc
Confidence 999999999873 4568899999999999999999998 8999999999999999999999999999864321000
Q ss_pred c----------------------------------------------eeecccCCccccCCCCCCCCCCCchhHHHHHHH
Q 002336 771 H----------------------------------------------ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGV 804 (935)
Q Consensus 771 ~----------------------------------------------~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gv 804 (935)
. ......||+.|+|||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv 236 (377)
T cd05629 157 SAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGA 236 (377)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecch
Confidence 0 001235899999999998889999999999999
Q ss_pred HHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCC---CCHHHH
Q 002336 805 VLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSR---PKMQEI 881 (935)
Q Consensus 805 il~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~R---Ps~~ev 881 (935)
++|||++|+.||......+ . ............. + .. ......+.+++.+|+. +|.+| +++.|+
T Consensus 237 il~elltG~~Pf~~~~~~~---~---~~~i~~~~~~~~~--p---~~--~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~ 302 (377)
T cd05629 237 IMFECLIGWPPFCSENSHE---T---YRKIINWRETLYF--P---DD--IHLSVEAEDLIRRLIT-NAENRLGRGGAHEI 302 (377)
T ss_pred hhhhhhcCCCCCCCCCHHH---H---HHHHHccCCccCC--C---CC--CCCCHHHHHHHHHHhc-CHhhcCCCCCHHHH
Confidence 9999999999997433211 1 1111110000000 0 00 0112367899999997 66665 599998
Q ss_pred HHH
Q 002336 882 VLA 884 (935)
Q Consensus 882 ~~~ 884 (935)
++.
T Consensus 303 l~h 305 (377)
T cd05629 303 KSH 305 (377)
T ss_pred hcC
Confidence 765
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-33 Score=301.38 Aligned_cols=253 Identities=23% Similarity=0.366 Sum_probs=199.6
Q ss_pred HHHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcchhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEe
Q 002336 612 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 690 (935)
Q Consensus 612 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~ 690 (935)
...+.+.+.||+|+||.||+|... +++.||+|.++.........+.+|+.+++.++||||+++++.+...+..++||||
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~ 87 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF 87 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence 346777899999999999999865 6889999998765545556788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccccccc
Q 002336 691 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 770 (935)
Q Consensus 691 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~ 770 (935)
+++++|.+++.. .+.+++.++..++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||++........
T Consensus 88 ~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd06645 88 CGGGSLQDIYHV---TGPLSESQIAYVSRETLQGLYYLHS---KGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIA 161 (267)
T ss_pred cCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECcceeeeEccCccc
Confidence 999999999863 4568999999999999999999998 8999999999999999999999999999876543221
Q ss_pred ceeecccCCccccCCCCCC---CCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeeccccc
Q 002336 771 HISSVARGTVGYLDPEYYG---NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 847 (935)
Q Consensus 771 ~~~~~~~gt~~y~APE~l~---~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~ 847 (935)
......|+..|+|||.+. ...++.++||||+||++|+|++|+.||....... .... ... ... ..+.
T Consensus 162 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~--~~~~----~~~-~~~---~~~~ 230 (267)
T cd06645 162 -KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR--ALFL----MTK-SNF---QPPK 230 (267)
T ss_pred -ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchh--hHHh----hhc-cCC---CCCc
Confidence 122345889999999874 4568899999999999999999999985222111 1100 011 110 0011
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 848 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 848 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
... .......+.+++.+|++.+|++||++++|++
T Consensus 231 ~~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 231 LKD--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred ccc--cCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 110 0012235789999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=300.40 Aligned_cols=248 Identities=25% Similarity=0.367 Sum_probs=200.0
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCc-chhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEecC
Q 002336 615 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS-CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 692 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~-~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~~ 692 (935)
+++.+.||+|+||.||++... +++.+|+|.++.. .....+.+.+|+.+++.++|+||+++++.+..++..+++|||++
T Consensus 2 y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 81 (255)
T cd08219 2 YNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCD 81 (255)
T ss_pred ceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCC
Confidence 356789999999999999876 6889999988543 23345678899999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccccce
Q 002336 693 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 772 (935)
Q Consensus 693 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~~ 772 (935)
+++|.+.+... ....+++..++.++.|++.||.|||+ ++++|+||||+||++++++.++|+|||++.........
T Consensus 82 ~~~l~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~- 156 (255)
T cd08219 82 GGDLMQKIKLQ-RGKLFPEDTILQWFVQMCLGVQHIHE---KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAY- 156 (255)
T ss_pred CCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEECCCCcEEEcccCcceeecccccc-
Confidence 99999988643 34557899999999999999999997 89999999999999999999999999998765432221
Q ss_pred eecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccCCC
Q 002336 773 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNV 852 (935)
Q Consensus 773 ~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~~~ 852 (935)
.....++..|+|||.+.+..++.++|+||||+++|+|++|+.||...+.. .... .+..+.....
T Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~------~~~~-~~~~~~~~~~--------- 220 (255)
T cd08219 157 ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWK------NLIL-KVCQGSYKPL--------- 220 (255)
T ss_pred cccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHH------HHHH-HHhcCCCCCC---------
Confidence 22345888999999998888999999999999999999999999733221 1111 1222221111
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 853 KIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 853 ~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
+......+.+++.+||+.+|++||++.|++.
T Consensus 221 ~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 251 (255)
T cd08219 221 PSHYSYELRSLIKQMFKRNPRSRPSATTILS 251 (255)
T ss_pred CcccCHHHHHHHHHHHhCCcccCCCHHHHhh
Confidence 1112236789999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=303.03 Aligned_cols=256 Identities=25% Similarity=0.408 Sum_probs=201.3
Q ss_pred HHHhhcccccccccEEEEEEEEC------CCcEEEEEEccCcchh-hhHHHHHHHHHHHhcCCCcccccceeeeccceEE
Q 002336 613 ATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSCSH-RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRI 685 (935)
Q Consensus 613 ~~~~~~~~LG~G~fG~Vy~~~~~------~g~~vAvK~~~~~~~~-~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~ 685 (935)
..+...+.||+|+||.||+|+.+ +.+.+++|.+...... ..+.+.+|++++++++|+||+++++++.+....+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 34556788999999999999864 3467999988654333 4578999999999999999999999999989999
Q ss_pred EEEEecCCCCHHHHhccCCCCC------CCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeec
Q 002336 686 LVYEYMHNGTLRDRLHGSVNQK------PLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDF 759 (935)
Q Consensus 686 lV~E~~~~gsL~~~L~~~~~~~------~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DF 759 (935)
+||||+++|+|.+++....... .+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.++|+||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSN---ARFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhh---cCcccCcCccceEEEeCCCcEEEccc
Confidence 9999999999999987543222 68999999999999999999997 89999999999999999999999999
Q ss_pred cccccccccccceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCcccchhHHHHHHHhhhcC
Q 002336 760 GLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKG 838 (935)
Q Consensus 760 Gla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~i~~~ 838 (935)
|++...............++..|+|||.+.+...+.++||||||+++++|++ |..||..... ...... +..+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~---~~~~~~----~~~~ 234 (275)
T cd05046 162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD---EEVLNR----LQAG 234 (275)
T ss_pred ccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch---HHHHHH----HHcC
Confidence 9986543222212222345778999999988888999999999999999999 7888853221 112221 1111
Q ss_pred CeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 002336 839 DVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 886 (935)
Q Consensus 839 ~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~ 886 (935)
..... .+......+.+++.+||+.+|++||++.|+++.|.
T Consensus 235 ~~~~~--------~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 235 KLELP--------VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred CcCCC--------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 11110 11122347889999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-33 Score=308.02 Aligned_cols=259 Identities=22% Similarity=0.319 Sum_probs=198.7
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCcch-hhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEecC
Q 002336 615 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 692 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~-~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~~ 692 (935)
+++.+.||+|+||.||++.+. +++.+|+|.+..... ....++.+|++++++++||||+++++.+..++..++||||++
T Consensus 3 ~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~ 82 (308)
T cd06615 3 FEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMD 82 (308)
T ss_pred ceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccC
Confidence 456788999999999999876 578899998865432 334568899999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccccce
Q 002336 693 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 772 (935)
Q Consensus 693 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~~ 772 (935)
+++|.++++. ...+++..+..++.|+++||.|||+ ..+++||||||+|||++.++.+||+|||++.......
T Consensus 83 ~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~--- 154 (308)
T cd06615 83 GGSLDQVLKK---AGRIPENILGKISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--- 154 (308)
T ss_pred CCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh--hCCEEECCCChHHEEEecCCcEEEccCCCcccccccc---
Confidence 9999999974 3568899999999999999999996 3589999999999999999999999999987543321
Q ss_pred eecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCee-----------
Q 002336 773 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVI----------- 841 (935)
Q Consensus 773 ~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~----------- 841 (935)
.....++..|+|||.+.+..++.++||||||+++++|++|+.||...+.. ....+...........
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (308)
T cd06615 155 ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAK---ELEAMFGRPVSEGEAKESHRPVSGHPP 231 (308)
T ss_pred cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchh---hHHHhhcCccccccccCCcccccCCCC
Confidence 22345789999999998888999999999999999999999998643321 1111111100000000
Q ss_pred ---------eccccccc---CCCC-HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002336 842 ---------SIVDPVLI---GNVK-IESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 884 (935)
Q Consensus 842 ---------~~~d~~l~---~~~~-~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~ 884 (935)
+..+.... ...+ ......+.+++.+||..+|++||+++||++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 232 DSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred CccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000000 0000 0122358899999999999999999999765
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=301.26 Aligned_cols=251 Identities=29% Similarity=0.469 Sum_probs=193.0
Q ss_pred ccccccccEEEEEEEEC----CCcEEEEEEccCc-chhhhHHHHHHHHHHHhcCCCcccccceeee-ccceEEEEEEecC
Q 002336 619 KKIGKGSFGSVYYGKMK----DGKEVAVKIMADS-CSHRTQQFVTEVALLSRIHHRNLVPLIGYCE-EEHQRILVYEYMH 692 (935)
Q Consensus 619 ~~LG~G~fG~Vy~~~~~----~g~~vAvK~~~~~-~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~-~~~~~~lV~E~~~ 692 (935)
+.||+|+||.||+|.+. ++..+|+|.+... .....+.+.+|+.+++.++||||+++++++. .+...+++|||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46899999999999864 2457999988543 2344568889999999999999999999775 4556789999999
Q ss_pred CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccccc-
Q 002336 693 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH- 771 (935)
Q Consensus 693 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~- 771 (935)
+++|.+++... ...+++..+..++.|+++||+|||+ .+++||||||+|||+++++.+||+|||+++........
T Consensus 81 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~ 155 (262)
T cd05058 81 HGDLRNFIRSE--THNPTVKDLIGFGLQVAKGMEYLAS---KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS 155 (262)
T ss_pred CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence 99999998743 3346778889999999999999997 89999999999999999999999999998754332111
Q ss_pred --eeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhC-CCCCCccCcccchhHHHHHHHhhhcCCeeecccccc
Q 002336 772 --ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISG-KKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 848 (935)
Q Consensus 772 --~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG-~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l 848 (935)
......++..|+|||.+.+..++.++||||||+++|||++| ..||.... ...+... +..+... ..
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~---~~~~~~~----~~~~~~~-----~~ 223 (262)
T cd05058 156 VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVD---SFDITVY----LLQGRRL-----LQ 223 (262)
T ss_pred ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCC---HHHHHHH----HhcCCCC-----CC
Confidence 11122356789999999888899999999999999999995 55564221 1122221 1111110 00
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhhhh
Q 002336 849 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 890 (935)
Q Consensus 849 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~~~ 890 (935)
+...+..+.+++.+||+.+|++||++.||++.|+++..
T Consensus 224 ----~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 224 ----PEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred ----CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 11112368899999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=307.08 Aligned_cols=250 Identities=24% Similarity=0.308 Sum_probs=197.1
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc---hhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEe
Q 002336 615 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 690 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~ 690 (935)
++..+.||+|+||.||++.+. +++.+|+|.+.... ....+.+.+|+.++++++|+|++++++.+.+.+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 345678999999999999876 68899999886432 12235677899999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccccccc
Q 002336 691 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 770 (935)
Q Consensus 691 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~ 770 (935)
+++++|.+++... ....+++..+..++.|++.||.|||+ .+|+||||||+||++++++.++|+|||++........
T Consensus 82 ~~g~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05630 82 MNGGDLKFHIYHM-GEAGFEEGRAVFYAAEICCGLEDLHQ---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT 157 (285)
T ss_pred cCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc
Confidence 9999999988643 23468999999999999999999998 9999999999999999999999999999876533222
Q ss_pred ceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccC
Q 002336 771 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 850 (935)
Q Consensus 771 ~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~ 850 (935)
.....|+..|+|||.+.+..++.++||||+|+++|+|++|+.||........... ......... ...
T Consensus 158 --~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~---~~~~~~~~~------~~~-- 224 (285)
T cd05630 158 --IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREE---VERLVKEVQ------EEY-- 224 (285)
T ss_pred --ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHH---HHhhhhhhh------hhc--
Confidence 1223589999999999988999999999999999999999999974322111111 111111000 011
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 002336 851 NVKIESIWRIAEVAIQCVEQRGFSRPK-----MQEIVL 883 (935)
Q Consensus 851 ~~~~~~~~~l~~li~~Cl~~dP~~RPs-----~~ev~~ 883 (935)
+......+.+++.+||+.+|++||+ ++|+++
T Consensus 225 --~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 225 --SEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred --CccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 1112235789999999999999999 888876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=307.18 Aligned_cols=247 Identities=23% Similarity=0.376 Sum_probs=199.9
Q ss_pred HhhcccccccccEEEEEEEE-CCCcEEEEEEccCcchhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEecCC
Q 002336 615 NNFCKKIGKGSFGSVYYGKM-KDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 693 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~~~ 693 (935)
|++.+.||.|++|.||+|.. .+++.|++|.+........+.+.+|+.+++.++||||+++++++...+..++|+||+++
T Consensus 21 y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 100 (296)
T cd06655 21 YTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAG 100 (296)
T ss_pred EEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecCC
Confidence 55678899999999999986 47899999998765445567789999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccccccccee
Q 002336 694 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 773 (935)
Q Consensus 694 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~~~ 773 (935)
++|.+++.. ..+++.++..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++......... .
T Consensus 101 ~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~---~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~-~ 172 (296)
T cd06655 101 GSLTDVVTE----TCMDEAQIAAVCRECLQALEFLHA---NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK-R 172 (296)
T ss_pred CcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccchhccccccc-C
Confidence 999998863 458999999999999999999998 89999999999999999999999999998765433221 2
Q ss_pred ecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccCCCC
Q 002336 774 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVK 853 (935)
Q Consensus 774 ~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~~~~ 853 (935)
....++..|+|||.+.+..++.++|||||||++|+|++|+.||...+.... ... +........ ..+
T Consensus 173 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~------~~~-~~~~~~~~~-------~~~ 238 (296)
T cd06655 173 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA------LYL-IATNGTPEL-------QNP 238 (296)
T ss_pred CCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------HHH-HHhcCCccc-------CCc
Confidence 234578899999999988899999999999999999999999974332111 111 111111000 011
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 854 IESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 854 ~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
......+.+++.+||..+|++||++.++++
T Consensus 239 ~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 239 EKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred ccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 122236789999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=299.09 Aligned_cols=249 Identities=28% Similarity=0.422 Sum_probs=201.4
Q ss_pred HHHhhcccccccccEEEEEEEECC-CcEEEEEEccCcchhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEec
Q 002336 613 ATNNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 691 (935)
Q Consensus 613 ~~~~~~~~LG~G~fG~Vy~~~~~~-g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~ 691 (935)
..+++.+.||+|++|.||+|.+.+ ++.+++|.+..... .+.+.+|++++++++||||+++++.+......++++||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 346677899999999999999874 78999999865422 678999999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccccc
Q 002336 692 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 771 (935)
Q Consensus 692 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~ 771 (935)
++++|.+++... ...+++..+..++.|+++||.|||+ .+++||||+|+||+++.++.+||+|||++........
T Consensus 81 ~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~- 154 (256)
T cd06612 81 GAGSVSDIMKIT--NKTLTEEEIAAILYQTLKGLEYLHS---NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA- 154 (256)
T ss_pred CCCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEECCCCcEEEcccccchhcccCcc-
Confidence 999999998642 4578999999999999999999997 8999999999999999999999999999887644321
Q ss_pred eeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccCC
Q 002336 772 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 851 (935)
Q Consensus 772 ~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~~ 851 (935)
......++..|+|||++.+..++.++||||||+++|+|++|+.||........ . . .+.... .+.+ .
T Consensus 155 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~--~-~----~~~~~~-----~~~~--~ 220 (256)
T cd06612 155 KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRA--I-F----MIPNKP-----PPTL--S 220 (256)
T ss_pred ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhh--h-h----hhccCC-----CCCC--C
Confidence 12233478899999999888899999999999999999999999973322110 0 0 000000 0001 0
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 852 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 852 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
.+......+.+++.+|++.+|++||+++|+++
T Consensus 221 ~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 221 DPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred chhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 11122346889999999999999999999975
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=324.02 Aligned_cols=249 Identities=22% Similarity=0.267 Sum_probs=190.9
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc---hhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEe
Q 002336 615 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 690 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~ 690 (935)
+.+.+.||+|+||.||+|+.. +++.+|+|++.... ......+.+|++++++++||||+++++.+.+.+..++||||
T Consensus 3 f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~ 82 (382)
T cd05625 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDY 82 (382)
T ss_pred cEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeC
Confidence 345789999999999999875 68899999986532 23345788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccc-
Q 002336 691 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL- 769 (935)
Q Consensus 691 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~- 769 (935)
+++|+|.+.+.. ...+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++.......
T Consensus 83 ~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~al~~lH~---~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~ 156 (382)
T cd05625 83 IPGGDMMSLLIR---MGIFPEDLARFYIAELTCAVESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 156 (382)
T ss_pred CCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEEeECCCCcccccccc
Confidence 999999999873 3568889999999999999999998 899999999999999999999999999975321000
Q ss_pred ---------------------------------------------cceeecccCCccccCCCCCCCCCCCchhHHHHHHH
Q 002336 770 ---------------------------------------------THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGV 804 (935)
Q Consensus 770 ---------------------------------------------~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gv 804 (935)
........||+.|+|||++.+..++.++||||+||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGv 236 (382)
T cd05625 157 SKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV 236 (382)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechH
Confidence 00011235899999999999889999999999999
Q ss_pred HHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCC---HHHH
Q 002336 805 VLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPK---MQEI 881 (935)
Q Consensus 805 il~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs---~~ev 881 (935)
++|||++|+.||...+... .....+........ +. .... .....+++.+|+ .+|++|++ ++|+
T Consensus 237 il~elltG~~Pf~~~~~~~------~~~~i~~~~~~~~~--p~-~~~~----s~~~~~li~~l~-~~p~~R~~~~~~~ei 302 (382)
T cd05625 237 ILYEMLVGQPPFLAQTPLE------TQMKVINWQTSLHI--PP-QAKL----SPEASDLIIKLC-RGPEDRLGKNGADEI 302 (382)
T ss_pred HHHHHHhCCCCCCCCCHHH------HHHHHHccCCCcCC--CC-cccC----CHHHHHHHHHHc-cCHhHcCCCCCHHHH
Confidence 9999999999997432211 11111111000000 00 0011 224567777765 49999997 7777
Q ss_pred HH
Q 002336 882 VL 883 (935)
Q Consensus 882 ~~ 883 (935)
++
T Consensus 303 ~~ 304 (382)
T cd05625 303 KA 304 (382)
T ss_pred hc
Confidence 65
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=301.06 Aligned_cols=248 Identities=26% Similarity=0.390 Sum_probs=202.0
Q ss_pred HHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc-hhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEe
Q 002336 613 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 690 (935)
Q Consensus 613 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~-~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~ 690 (935)
..++..+.||+|+||.||+|.+. .++.||+|.+.... ....+.+.+|+.++++++||||+++++++.+....++||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 44566788999999999999876 58899999886432 34457789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccccccc
Q 002336 691 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 770 (935)
Q Consensus 691 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~ 770 (935)
+++++|.+++.. ..+++.++..++.|++.||+|||+ .+++|+||+|+||+++.++.++|+|||++........
T Consensus 84 ~~~~~L~~~i~~----~~l~~~~~~~~~~~l~~~l~~lh~---~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06640 84 LGGGSALDLLRA----GPFDEFQIATMLKEILKGLDYLHS---EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHh---CCccCcCCChhhEEEcCCCCEEEcccccceeccCCcc
Confidence 999999998863 458889999999999999999998 8999999999999999999999999999876543322
Q ss_pred ceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccC
Q 002336 771 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 850 (935)
Q Consensus 771 ~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~ 850 (935)
. .....++..|+|||.+.+..++.++|+||||+++|||++|+.||....... .. ..+..+. ..
T Consensus 157 ~-~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~---~~----~~~~~~~---------~~ 219 (277)
T cd06640 157 K-RNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMR---VL----FLIPKNN---------PP 219 (277)
T ss_pred c-cccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHh---Hh----hhhhcCC---------CC
Confidence 1 222357889999999988889999999999999999999999987332111 00 0111111 11
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002336 851 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 884 (935)
Q Consensus 851 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~ 884 (935)
.........+.+++.+||+.+|++||+++|+++.
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 220 TLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred CCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 2233455678999999999999999999999765
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=305.23 Aligned_cols=262 Identities=21% Similarity=0.261 Sum_probs=195.5
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCcch--hhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEec
Q 002336 615 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 691 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~--~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~ 691 (935)
|++.+.||+|++|.||+|... +++.||+|.++.... ...+.+.+|+.+++.++||||+++++++.++...++||||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (285)
T cd07861 2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFL 81 (285)
T ss_pred ceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecC
Confidence 345688999999999999876 689999999864322 23357889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccccc
Q 002336 692 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 771 (935)
Q Consensus 692 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~ 771 (935)
+ ++|.+++.....+..+++..+..++.|+++||+|||+ ++++||||||+||+++.++.+||+|||++........
T Consensus 82 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~- 156 (285)
T cd07861 82 S-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHS---RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR- 156 (285)
T ss_pred C-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEEcCCCcEEECcccceeecCCCcc-
Confidence 7 6888888654445678999999999999999999998 8999999999999999999999999999875433211
Q ss_pred eeecccCCccccCCCCCCC-CCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhh--cC---------C
Q 002336 772 ISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIK--KG---------D 839 (935)
Q Consensus 772 ~~~~~~gt~~y~APE~l~~-~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~--~~---------~ 839 (935)
......+++.|+|||.+.+ ..++.++||||||+++++|++|+.||....... ........... +. +
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (285)
T cd07861 157 VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEID--QLFRIFRILGTPTEDVWPGVTSLPD 234 (285)
T ss_pred cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHHHHhCCCChhhhhcchhhHH
Confidence 1122346889999998765 457899999999999999999999997432211 11110000000 00 0
Q ss_pred eeecccccccC---CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 840 VISIVDPVLIG---NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 840 ~~~~~d~~l~~---~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
.....+..... ........++.+++.+||+.||++|||+.+|++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 235 YKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred HHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 00000000000 000112236779999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=303.49 Aligned_cols=240 Identities=25% Similarity=0.437 Sum_probs=189.6
Q ss_pred ccccccccEEEEEEEECC--------CcEEEEEEccCcchhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEe
Q 002336 619 KKIGKGSFGSVYYGKMKD--------GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 690 (935)
Q Consensus 619 ~~LG~G~fG~Vy~~~~~~--------g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~ 690 (935)
+.||+|+||.||+|..+. ...+++|.+........+.+.+|+.+++.++||||+++++++..+...++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 479999999999997642 335888887655555567889999999999999999999999998899999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCc--------EEEeecccc
Q 002336 691 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMR--------AKVSDFGLS 762 (935)
Q Consensus 691 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~--------vkL~DFGla 762 (935)
+++|+|.++++.. +..+++..+++++.|++.||+|||+ ++|+||||||+||+++.++. ++++|||++
T Consensus 81 ~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~ 155 (258)
T cd05078 81 VKFGSLDTYLKKN--KNLINISWKLEVAKQLAWALHFLED---KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155 (258)
T ss_pred CCCCcHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccceEEEecccccccCCCceEEecccccc
Confidence 9999999999743 3468899999999999999999998 99999999999999987765 699999988
Q ss_pred ccccccccceeecccCCccccCCCCCCC-CCCCchhHHHHHHHHHHHHHhCC-CCCCccCcccchhHHHHHHHhhhcCCe
Q 002336 763 RQAEEDLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGK-KPVSVEDFGAELNIVHWARSMIKKGDV 840 (935)
Q Consensus 763 ~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwS~Gvil~eLltG~-~Pf~~~~~~~~~~l~~~~~~~i~~~~~ 840 (935)
...... ....++..|+|||.+.+ ..++.++||||||+++|||++|. .|+...+... ... .... .
T Consensus 156 ~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~---~~~----~~~~-~- 221 (258)
T cd05078 156 ITVLPK-----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK---KLQ----FYED-R- 221 (258)
T ss_pred cccCCc-----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHH---HHH----HHHc-c-
Confidence 654322 12347889999999876 45789999999999999999985 5554221111 111 0110 0
Q ss_pred eecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 002336 841 ISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 886 (935)
Q Consensus 841 ~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~ 886 (935)
. ..+......+.+++.+||+.+|++|||++++++.|+
T Consensus 222 ~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 222 H---------QLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred c---------cCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0 111122246889999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=314.31 Aligned_cols=240 Identities=25% Similarity=0.350 Sum_probs=191.2
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc---hhhhHHHHHHHHHHHhcC-CCcccccceeeeccceEEEEEE
Q 002336 615 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQRILVYE 689 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~iL~~L~-HpnIv~l~g~~~~~~~~~lV~E 689 (935)
+++.+.||+|+||.||+|... +|+.||+|++.... ....+.+..|..+++.+. |++|+++++++...+..++|||
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (323)
T cd05615 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVME 81 (323)
T ss_pred ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEc
Confidence 356789999999999999875 68899999987532 223456778999998885 5778889999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccc
Q 002336 690 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 769 (935)
Q Consensus 690 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~ 769 (935)
|+++|+|.+++.. ...+++.++..++.|++.||+|||+ ++|+||||||+|||+++++.+||+|||+++......
T Consensus 82 y~~~g~L~~~i~~---~~~l~~~~~~~i~~qi~~al~~lH~---~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~ 155 (323)
T cd05615 82 YVNGGDLMYHIQQ---VGKFKEPQAVFYAAEISVGLFFLHR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG 155 (323)
T ss_pred CCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeccccccccCCCC
Confidence 9999999998873 4568999999999999999999998 899999999999999999999999999987543221
Q ss_pred cceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeeccccccc
Q 002336 770 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 849 (935)
Q Consensus 770 ~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~ 849 (935)
. ......|++.|+|||++.+..++.++||||+||++|||++|+.||..... ....+ . +..+..
T Consensus 156 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~---~~~~~---~-i~~~~~--------- 218 (323)
T cd05615 156 V-TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE---DELFQ---S-IMEHNV--------- 218 (323)
T ss_pred c-cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH---HHHHH---H-HHhCCC---------
Confidence 1 12234589999999999888899999999999999999999999974322 11111 1 111111
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCH
Q 002336 850 GNVKIESIWRIAEVAIQCVEQRGFSRPKM 878 (935)
Q Consensus 850 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~ 878 (935)
..+......+.+++.+||+.+|++|++.
T Consensus 219 -~~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 219 -SYPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred -CCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 1111223467899999999999999984
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-33 Score=306.67 Aligned_cols=249 Identities=25% Similarity=0.386 Sum_probs=201.4
Q ss_pred HHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcchhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEec
Q 002336 613 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 691 (935)
Q Consensus 613 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~ 691 (935)
..|.+.+.||+|++|.||+|... +++.||+|.+........+.+.+|+.+++.++|+||+++++++..++..++||||+
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 98 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 98 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence 55667889999999999999864 79999999987655555577889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccccc
Q 002336 692 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 771 (935)
Q Consensus 692 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~ 771 (935)
++++|.+++.. ..+++.++..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++.........
T Consensus 99 ~~~~L~~~~~~----~~~~~~~~~~~~~~l~~~L~~LH~---~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~ 171 (297)
T cd06656 99 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALDFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 171 (297)
T ss_pred CCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEECcCccceEccCCccC
Confidence 99999999863 457889999999999999999998 89999999999999999999999999998765433221
Q ss_pred eeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccCC
Q 002336 772 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 851 (935)
Q Consensus 772 ~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~~ 851 (935)
.....+++.|+|||.+.+..++.++||||||+++|+|++|+.||...+...... .....+ . +.+ .
T Consensus 172 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~------~~~~~~-~-----~~~--~ 236 (297)
T cd06656 172 -RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY------LIATNG-T-----PEL--Q 236 (297)
T ss_pred -cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhee------eeccCC-C-----CCC--C
Confidence 123357889999999988889999999999999999999999997433211100 000000 0 000 0
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 852 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 852 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
.+......+.+++.+||+.+|++||+++++++
T Consensus 237 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 237 NPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11222345789999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=296.24 Aligned_cols=264 Identities=21% Similarity=0.282 Sum_probs=199.0
Q ss_pred HHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcchh--hhHHHHHHHHHHHhcCCCc-ccccceeeeccc------
Q 002336 613 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSH--RTQQFVTEVALLSRIHHRN-LVPLIGYCEEEH------ 682 (935)
Q Consensus 613 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~~--~~~~~~~E~~iL~~L~Hpn-Iv~l~g~~~~~~------ 682 (935)
..+...++||+|.||+||+|+.+ +|+.||+|+++-...+ ......+|+-+|++++|+| ||++++++...+
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 34555678999999999999865 7899999998755332 2345789999999999999 999999998877
Q ss_pred eEEEEEEecCCCCHHHHhccCCCC-CCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccc
Q 002336 683 QRILVYEYMHNGTLRDRLHGSVNQ-KPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGL 761 (935)
Q Consensus 683 ~~~lV~E~~~~gsL~~~L~~~~~~-~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGl 761 (935)
..++|+||++ -+|..++...... ..++...+..++.||++||+|||+ ++|+||||||.||||+++|.+||+|||+
T Consensus 91 ~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~---~~IlHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 91 KLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHS---HGILHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred eEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCcceEEECCCCcEeeeccch
Confidence 7889999995 5898888754321 467778899999999999999998 9999999999999999999999999999
Q ss_pred cccccccccceeecccCCccccCCCCCCCC-CCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhc---
Q 002336 762 SRQAEEDLTHISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKK--- 837 (935)
Q Consensus 762 a~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~--- 837 (935)
|+...-.... .....+|..|+|||++.+. .|+...||||+|||+.||++++.-|.+....+ ++. .+-+.+..
T Consensus 167 Ara~~ip~~~-yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~--ql~-~If~~lGtP~e 242 (323)
T KOG0594|consen 167 ARAFSIPMRT-YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEID--QLF-RIFRLLGTPNE 242 (323)
T ss_pred HHHhcCCccc-ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHH--HHH-HHHHHcCCCCc
Confidence 9866533222 2334589999999998765 89999999999999999999999887544311 111 11111111
Q ss_pred CCeee---ccc--ccccCCC-C----HHHH---HHHHHHHHHccccCCCCCCCHHHHHHH
Q 002336 838 GDVIS---IVD--PVLIGNV-K----IESI---WRIAEVAIQCVEQRGFSRPKMQEIVLA 884 (935)
Q Consensus 838 ~~~~~---~~d--~~l~~~~-~----~~~~---~~l~~li~~Cl~~dP~~RPs~~ev~~~ 884 (935)
..... ..+ ....... + .... ....+++.+|++.+|.+|.|++..+++
T Consensus 243 ~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 243 KDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred cCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 11000 001 0000000 0 1111 267899999999999999999998864
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=305.46 Aligned_cols=249 Identities=23% Similarity=0.290 Sum_probs=196.4
Q ss_pred hhcccccccccEEEEEEEEC-CCcEEEEEEccCcch---hhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEec
Q 002336 616 NFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 691 (935)
Q Consensus 616 ~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~---~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~ 691 (935)
+..+.||+|+||+||+|.+. +++.+|+|.+..... .....+.+|+++++.++|+||+++.+.+..++..++||||+
T Consensus 3 ~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 82 (285)
T cd05632 3 RQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIM 82 (285)
T ss_pred eEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEec
Confidence 34578999999999999875 688999999865322 22345788999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccccc
Q 002336 692 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 771 (935)
Q Consensus 692 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~ 771 (935)
++++|.+++... ....+++..+..++.|++.||.|||+ ++|+||||||+||++++++.+||+|||++........
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~ql~~~l~~lH~---~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~- 157 (285)
T cd05632 83 NGGDLKFHIYNM-GNPGFEEERALFYAAEILCGLEDLHR---ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES- 157 (285)
T ss_pred cCccHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCc-
Confidence 999999888643 23469999999999999999999997 8999999999999999999999999999876433221
Q ss_pred eeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccCC
Q 002336 772 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 851 (935)
Q Consensus 772 ~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~~ 851 (935)
.....|+..|+|||.+.+..++.++|+||||+++|||++|+.||........ . +-+...+..+.. .
T Consensus 158 -~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~--~-~~~~~~~~~~~~----------~ 223 (285)
T cd05632 158 -IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK--R-EEVDRRVLETEE----------V 223 (285)
T ss_pred -ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH--H-HHHHHhhhcccc----------c
Confidence 1234589999999999888899999999999999999999999974322111 1 111111221110 0
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 002336 852 VKIESIWRIAEVAIQCVEQRGFSRPK-----MQEIVL 883 (935)
Q Consensus 852 ~~~~~~~~l~~li~~Cl~~dP~~RPs-----~~ev~~ 883 (935)
++......+.+++.+|++.+|++||+ +.++++
T Consensus 224 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 224 YSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred cCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 11122235789999999999999999 666655
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-33 Score=312.52 Aligned_cols=251 Identities=27% Similarity=0.386 Sum_probs=208.5
Q ss_pred HHHHhhcccccccccEEEEEEEECC-CcEEEEEEccCcchh---hhHHHHHHHHHHHhcC-CCcccccceeeeccceEEE
Q 002336 612 EATNNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSH---RTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQRIL 686 (935)
Q Consensus 612 ~~~~~~~~~LG~G~fG~Vy~~~~~~-g~~vAvK~~~~~~~~---~~~~~~~E~~iL~~L~-HpnIv~l~g~~~~~~~~~l 686 (935)
...|.+.+.||+|.||.||+++.+. |+.+|+|.+.+.... ....+.+|+.+|+++. |||||.+.+.+++....++
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 4556778999999999999998875 999999999764332 3358899999999998 9999999999999999999
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCC----CcEEEeecccc
Q 002336 687 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN----MRAKVSDFGLS 762 (935)
Q Consensus 687 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~----~~vkL~DFGla 762 (935)
|||++.||.|.+.+... .+++..+..++.|++.+++|||+ .+|+||||||+|+|+... +.+|++|||++
T Consensus 114 vmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~---~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla 186 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHS---LGVVHRDLKPENLLLASKDEGSGRIKLIDFGLA 186 (382)
T ss_pred EEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHh---CCceeccCCHHHeeeccccCCCCcEEEeeCCCc
Confidence 99999999999998754 39999999999999999999998 999999999999999633 47999999999
Q ss_pred ccccccccceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeee
Q 002336 763 RQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVIS 842 (935)
Q Consensus 763 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~ 842 (935)
..... .......+||+.|+|||++....++..+||||+|+++|.|++|..||.......... .+..++.
T Consensus 187 ~~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~-------~i~~~~~-- 255 (382)
T KOG0032|consen 187 KFIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL-------AILRGDF-- 255 (382)
T ss_pred eEccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH-------HHHcCCC--
Confidence 98766 334456779999999999999999999999999999999999999998544322111 2333333
Q ss_pred cccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002336 843 IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 884 (935)
Q Consensus 843 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~ 884 (935)
.+....-+.....+.+++.+|+..||.+|++++++++.
T Consensus 256 ----~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 256 ----DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred ----CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 11111222334578899999999999999999999874
|
|
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=301.12 Aligned_cols=252 Identities=24% Similarity=0.356 Sum_probs=201.5
Q ss_pred HHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcchhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEec
Q 002336 613 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 691 (935)
Q Consensus 613 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~ 691 (935)
..|++.+.||+|++|.||++.+. +++.+|+|.+........+.+.+|++++++++||||+++++.+..+...++||||+
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFC 84 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeecc
Confidence 45778899999999999999875 68999999987665566678999999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccccc
Q 002336 692 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 771 (935)
Q Consensus 692 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~ 771 (935)
++++|.+++... +..+++..+..++.|++.||.|||+ .+|+|+||||+||+++.++.++|+|||++.........
T Consensus 85 ~~~~L~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~ 159 (280)
T cd06611 85 DGGALDSIMLEL--ERGLTEPQIRYVCRQMLEALNFLHS---HKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQK 159 (280)
T ss_pred CCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEECCCCCEEEccCccchhhcccccc
Confidence 999999998742 3568999999999999999999998 89999999999999999999999999988654332221
Q ss_pred eeecccCCccccCCCCCC-----CCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccc
Q 002336 772 ISSVARGTVGYLDPEYYG-----NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP 846 (935)
Q Consensus 772 ~~~~~~gt~~y~APE~l~-----~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~ 846 (935)
.....+++.|+|||.+. ...++.++||||||+++|||++|+.||...+.. +.... +..+......
T Consensus 160 -~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~------~~~~~-~~~~~~~~~~-- 229 (280)
T cd06611 160 -RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM------RVLLK-ILKSEPPTLD-- 229 (280)
T ss_pred -cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH------HHHHH-HhcCCCCCcC--
Confidence 22235788999999874 345678999999999999999999999733211 11111 1111111110
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002336 847 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 884 (935)
Q Consensus 847 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~ 884 (935)
.+......+.+++.+||+.+|++||+++++++.
T Consensus 230 -----~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 230 -----QPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred -----CcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 011123367899999999999999999999763
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=298.32 Aligned_cols=253 Identities=24% Similarity=0.368 Sum_probs=189.9
Q ss_pred ccccccccEEEEEEEECCC---cEEEEEEccCcc-hhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEecCCC
Q 002336 619 KKIGKGSFGSVYYGKMKDG---KEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNG 694 (935)
Q Consensus 619 ~~LG~G~fG~Vy~~~~~~g---~~vAvK~~~~~~-~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~~~g 694 (935)
+.||+|+||.||+|...++ ..+++|.+.... ....+.+.+|+.+++.++||||+++++.+......++||||+++|
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 3699999999999976543 346677665433 234568999999999999999999999999999999999999999
Q ss_pred CHHHHhccCC-CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccccc-ccce
Q 002336 695 TLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED-LTHI 772 (935)
Q Consensus 695 sL~~~L~~~~-~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~-~~~~ 772 (935)
+|.++++... .....++..+..++.|+++||+|||+ .+++||||||+|||++.++.+||+|||++...... ....
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHK---HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH---CCeeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence 9999987532 22346677888999999999999998 89999999999999999999999999987642211 1111
Q ss_pred eecccCCccccCCCCCCC-------CCCCchhHHHHHHHHHHHHHh-CCCCCCccCcccchhHHHHHHHhhhcCCeeecc
Q 002336 773 SSVARGTVGYLDPEYYGN-------QQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 844 (935)
Q Consensus 773 ~~~~~gt~~y~APE~l~~-------~~~s~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~ 844 (935)
.....++..|+|||++.. ..++.++||||||+++|||++ |..||..... .+.....+.. ......
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~------~~~~~~~~~~-~~~~~~ 230 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD------REVLNHVIKD-QQVKLF 230 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH------HHHHHHHHhh-cccccC
Confidence 223457889999998743 245789999999999999997 5677752211 1122222222 222333
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 002336 845 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 886 (935)
Q Consensus 845 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~ 886 (935)
++.+...+ ...+.+++..|| .+|++||+++||++.|.
T Consensus 231 ~~~~~~~~----~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 231 KPQLELPY----SERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CCccCCCC----cHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 44333222 236778999999 67999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=307.07 Aligned_cols=196 Identities=24% Similarity=0.383 Sum_probs=160.1
Q ss_pred cccccccccEEEEEEEEC---CCcEEEEEEccCcchhhhHHHHHHHHHHHhcCCCcccccceeeec--cceEEEEEEecC
Q 002336 618 CKKIGKGSFGSVYYGKMK---DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEE--EHQRILVYEYMH 692 (935)
Q Consensus 618 ~~~LG~G~fG~Vy~~~~~---~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~--~~~~~lV~E~~~ 692 (935)
.++||+|+||.||+|... +++.+|+|.+.... ....+.+|++++++++||||+++++++.. +...+++|||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 468999999999999865 46789999986532 23457889999999999999999998843 456789999985
Q ss_pred CCCHHHHhccCC------CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccc----cCCCcEEEeecccc
Q 002336 693 NGTLRDRLHGSV------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL----DINMRAKVSDFGLS 762 (935)
Q Consensus 693 ~gsL~~~L~~~~------~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILl----d~~~~vkL~DFGla 762 (935)
++|.+++.... ....+++..+..++.|++.||+|||+ .+|+||||||+|||+ +.++.+||+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 58877765321 12358899999999999999999998 899999999999999 45678999999999
Q ss_pred ccccccccc--eeecccCCccccCCCCCCC-CCCCchhHHHHHHHHHHHHHhCCCCCCcc
Q 002336 763 RQAEEDLTH--ISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVE 819 (935)
Q Consensus 763 ~~~~~~~~~--~~~~~~gt~~y~APE~l~~-~~~s~ksDVwS~Gvil~eLltG~~Pf~~~ 819 (935)
+........ ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 876443221 1223468999999998876 46899999999999999999999999743
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=297.71 Aligned_cols=253 Identities=25% Similarity=0.372 Sum_probs=189.5
Q ss_pred ccccccccEEEEEEEECC---CcEEEEEEccCcch-hhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEecCCC
Q 002336 619 KKIGKGSFGSVYYGKMKD---GKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNG 694 (935)
Q Consensus 619 ~~LG~G~fG~Vy~~~~~~---g~~vAvK~~~~~~~-~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~~~g 694 (935)
+.||+|+||.||+|.... ...+++|.+..... .....+.+|+++++.++|+||+++++.+......++||||+++|
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 369999999999997643 35688887764432 33467889999999999999999999999999999999999999
Q ss_pred CHHHHhccCCC--CCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccccc-
Q 002336 695 TLRDRLHGSVN--QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH- 771 (935)
Q Consensus 695 sL~~~L~~~~~--~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~- 771 (935)
+|.+++..... ....++.....++.|++.||+|||+ ++|+||||||+|||+++++.+||+|||++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ---ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHh---cCEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 99999875432 2335678889999999999999998 89999999999999999999999999998654322111
Q ss_pred eeecccCCccccCCCCCC-------CCCCCchhHHHHHHHHHHHHHh-CCCCCCccCcccchhHHHHHHHhhhcCCeeec
Q 002336 772 ISSVARGTVGYLDPEYYG-------NQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISI 843 (935)
Q Consensus 772 ~~~~~~gt~~y~APE~l~-------~~~~s~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~ 843 (935)
......++..|+|||++. ...++.++||||||+++|||++ |..||...... . -....+..+. ...
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~---~---~~~~~~~~~~-~~~ 230 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDE---Q---VLKQVVREQD-IKL 230 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHH---H---HHHHHhhccC-ccC
Confidence 112233567899999863 3456889999999999999999 78888632211 1 1112222221 122
Q ss_pred ccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 002336 844 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 886 (935)
Q Consensus 844 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~ 886 (935)
.++.+.. .....+.+++..|+ .+|++||+++||++.|.
T Consensus 231 ~~~~~~~----~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 231 PKPQLDL----KYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CCCcccc----cCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 2222221 22235677888898 59999999999998763
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=326.41 Aligned_cols=258 Identities=22% Similarity=0.256 Sum_probs=189.5
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcchhhhHHHHHHHHHHHhcCCCcccccceeeecc--------ceE
Q 002336 614 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE--------HQR 684 (935)
Q Consensus 614 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~--------~~~ 684 (935)
.|.+.+.||+|+||.||+|... +++.||||++.... ....+|+.+|+.++||||+++++++... ...
T Consensus 67 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l 142 (440)
T PTZ00036 67 SYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFL 142 (440)
T ss_pred eEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEE
Confidence 4667889999999999999875 68899999885432 2345799999999999999998876321 246
Q ss_pred EEEEEecCCCCHHHHhccC-CCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCC-cEEEeecccc
Q 002336 685 ILVYEYMHNGTLRDRLHGS-VNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM-RAKVSDFGLS 762 (935)
Q Consensus 685 ~lV~E~~~~gsL~~~L~~~-~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~-~vkL~DFGla 762 (935)
++||||+++ +|.+.+... .....+++..+..++.|++.||+|||+ ++|+||||||+|||++.++ .+||+|||++
T Consensus 143 ~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~---~~IiHrDLKp~NILl~~~~~~vkL~DFGla 218 (440)
T PTZ00036 143 NVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHS---KFICHRDLKPQNLLIDPNTHTLKLCDFGSA 218 (440)
T ss_pred EEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCcCHHHEEEcCCCCceeeeccccc
Confidence 799999975 676665432 245678999999999999999999998 8999999999999999665 6999999999
Q ss_pred ccccccccceeecccCCccccCCCCCCC-CCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhc----
Q 002336 763 RQAEEDLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKK---- 837 (935)
Q Consensus 763 ~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~---- 837 (935)
+....... .....|++.|+|||++.+ ..++.++|||||||++|||++|+.||.+....+ .+...+ +.+..
T Consensus 219 ~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~--~~~~i~-~~~~~p~~~ 293 (440)
T PTZ00036 219 KNLLAGQR--SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVD--QLVRII-QVLGTPTED 293 (440)
T ss_pred hhccCCCC--cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHH-HHhCCCCHH
Confidence 86543322 123457999999998765 478999999999999999999999997443221 111111 11100
Q ss_pred ------CCeeec-----ccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002336 838 ------GDVISI-----VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 884 (935)
Q Consensus 838 ------~~~~~~-----~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~ 884 (935)
.....+ ....+....+......+.+++.+||+.+|++|||+.|+++.
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 294 QLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred HHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 000000 00011111122223468899999999999999999999754
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=312.29 Aligned_cols=253 Identities=25% Similarity=0.316 Sum_probs=193.9
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc---hhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEe
Q 002336 615 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 690 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~ 690 (935)
|++.+.||+|+||.||++... +++.||+|++.... ....+.+.+|..++..++|+||+++++++.+++..++||||
T Consensus 3 y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 82 (331)
T cd05597 3 FEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDY 82 (331)
T ss_pred ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEec
Confidence 456789999999999999876 58999999986421 22345688999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccccccc
Q 002336 691 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 770 (935)
Q Consensus 691 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~ 770 (935)
+++|+|.+++... ...+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||++........
T Consensus 83 ~~g~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 157 (331)
T cd05597 83 YVGGDLLTLLSKF--EDRLPEDMARFYLAEMVLAIDSVHQ---LGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT 157 (331)
T ss_pred CCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCC
Confidence 9999999998642 4568899999999999999999998 9999999999999999999999999999876544333
Q ss_pred ceeecccCCccccCCCCCCC-----CCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeeccc
Q 002336 771 HISSVARGTVGYLDPEYYGN-----QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 845 (935)
Q Consensus 771 ~~~~~~~gt~~y~APE~l~~-----~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d 845 (935)
.......||+.|+|||++.. ..++.++||||+||++|||++|+.||...... +.............+ .
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~------~~~~~i~~~~~~~~~-~ 230 (331)
T cd05597 158 VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV------ETYGKIMNHKEHFQF-P 230 (331)
T ss_pred ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHH------HHHHHHHcCCCcccC-C
Confidence 22333458999999998863 45788999999999999999999999743221 111112211111111 0
Q ss_pred ccccCCCCHHHHHHHHHHHHHcccc--CCCCCCCHHHHHHH
Q 002336 846 PVLIGNVKIESIWRIAEVAIQCVEQ--RGFSRPKMQEIVLA 884 (935)
Q Consensus 846 ~~l~~~~~~~~~~~l~~li~~Cl~~--dP~~RPs~~ev~~~ 884 (935)
+. .......+.+++.+|+.. ++..||+++++++.
T Consensus 231 ~~-----~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 231 PD-----VTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred Cc-----cCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 00 011223567788787654 33447899998776
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=336.63 Aligned_cols=260 Identities=23% Similarity=0.372 Sum_probs=201.6
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCcch---hhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEe
Q 002336 615 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 690 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~---~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~ 690 (935)
|++.++||+|+||.||+|... .|+.||+|++..... ...+++.+|++++++++||||+++++++.+.+..++||||
T Consensus 4 YeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVMEY 83 (932)
T PRK13184 4 YDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPY 83 (932)
T ss_pred eEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEEc
Confidence 456789999999999999876 589999999875322 2346799999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCC--------CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccc
Q 002336 691 MHNGTLRDRLHGSV--------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS 762 (935)
Q Consensus 691 ~~~gsL~~~L~~~~--------~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla 762 (935)
+++|+|.+++.... .....++..+++++.|+++||+|||+ ++|+||||||+|||++.++.+||+|||++
T Consensus 84 ~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs---~GIIHRDLKPeNILLd~dg~vKLiDFGLA 160 (932)
T PRK13184 84 IEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHS---KGVLHRDLKPDNILLGLFGEVVILDWGAA 160 (932)
T ss_pred CCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHH---CCccccCCchheEEEcCCCCEEEEecCcc
Confidence 99999999886421 12345677889999999999999998 89999999999999999999999999999
Q ss_pred cccccccc-----------------ceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccch
Q 002336 763 RQAEEDLT-----------------HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAEL 825 (935)
Q Consensus 763 ~~~~~~~~-----------------~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~ 825 (935)
+....... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...+...
T Consensus 161 k~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k-- 238 (932)
T PRK13184 161 IFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK-- 238 (932)
T ss_pred eecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh--
Confidence 76521110 00112358999999999999999999999999999999999999997422111
Q ss_pred hHHHHHHHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHHhhhhhh
Q 002336 826 NIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRP-KMQEIVLAIQDSIKI 891 (935)
Q Consensus 826 ~l~~~~~~~i~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-s~~ev~~~L~~~~~~ 891 (935)
.. + ...+ .++.-.. .....+..+.+++.+|++.+|++|| +++++.+.|+..+..
T Consensus 239 -i~-~-~~~i--------~~P~~~~-p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~ 293 (932)
T PRK13184 239 -IS-Y-RDVI--------LSPIEVA-PYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQG 293 (932)
T ss_pred -hh-h-hhhc--------cChhhcc-ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 00 0 0000 0000000 0012234678999999999999996 677788888776654
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=303.12 Aligned_cols=250 Identities=28% Similarity=0.456 Sum_probs=196.7
Q ss_pred ccccccccEEEEEEEECC-------CcEEEEEEccCcc-hhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEe
Q 002336 619 KKIGKGSFGSVYYGKMKD-------GKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 690 (935)
Q Consensus 619 ~~LG~G~fG~Vy~~~~~~-------g~~vAvK~~~~~~-~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~ 690 (935)
+.||+|+||.||+|++.+ ++.+|+|.+.... ......+.+|+++++.++||||+++++++......++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 469999999999998653 2579999876543 23456789999999999999999999999998999999999
Q ss_pred cCCCCHHHHhccCC----CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCC-----cEEEeeccc
Q 002336 691 MHNGTLRDRLHGSV----NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM-----RAKVSDFGL 761 (935)
Q Consensus 691 ~~~gsL~~~L~~~~----~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~-----~vkL~DFGl 761 (935)
+++++|.+++.... ....+++.+++.++.|++.||+|||+ .+++|+||||+||+++.++ .++|+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHh---CCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 99999999986432 22447889999999999999999997 8999999999999999877 899999999
Q ss_pred ccccccccc-ceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCcccchhHHHHHHHhhhcCC
Q 002336 762 SRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGD 839 (935)
Q Consensus 762 a~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~i~~~~ 839 (935)
++....... .......++..|+|||.+.+..++.++||||||+++|||++ |+.||..... .+.... +..+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~---~~~~~~----~~~~~ 230 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN---QEVLQH----VTAGG 230 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH---HHHHHH----HhcCC
Confidence 876433211 11122235678999999998899999999999999999998 9999863221 112111 11111
Q ss_pred eeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhh
Q 002336 840 VISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 887 (935)
Q Consensus 840 ~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~ 887 (935)
.. ..+......+.+++.+||+.+|++||++++|.+.|++
T Consensus 231 ~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 231 RL---------QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred cc---------CCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 10 1112234578899999999999999999999998864
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-33 Score=299.05 Aligned_cols=265 Identities=25% Similarity=0.394 Sum_probs=200.7
Q ss_pred HhhcccccccccEEEEEEEECCCcEEEEEEccCcchhhhHHHHHHHHHHHhc--CCCcccccceeeecc----ceEEEEE
Q 002336 615 NNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRI--HHRNLVPLIGYCEEE----HQRILVY 688 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L--~HpnIv~l~g~~~~~----~~~~lV~ 688 (935)
..+.+.||+|.||.||+|.|+ |+.||||++... +.+.+.+|.++.+.+ +|+||+.+++.-..+ ..++||+
T Consensus 213 I~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~sr---dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvT 288 (513)
T KOG2052|consen 213 IVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSR---DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVT 288 (513)
T ss_pred eEEEEEecCccccceeecccc-CCceEEEEeccc---chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEee
Confidence 345789999999999999999 999999999743 345678888888764 999999999875333 2579999
Q ss_pred EecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhc-----CCCceEecCCCCCCccccCCCcEEEeeccccc
Q 002336 689 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG-----CNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 763 (935)
Q Consensus 689 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~-----~~~~ivH~DLkp~NILld~~~~vkL~DFGla~ 763 (935)
+|.+.|||+|+|. ..+++....++++..+|.||+|||.+ .++.|.|||||.+||||..++.+.|+|+|+|.
T Consensus 289 dYHe~GSL~DyL~----r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv 364 (513)
T KOG2052|consen 289 DYHEHGSLYDYLN----RNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 364 (513)
T ss_pred ecccCCcHHHHHh----hccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeE
Confidence 9999999999997 46799999999999999999999952 36789999999999999999999999999998
Q ss_pred cccccc---cceeecccCCccccCCCCCCCCC----C--CchhHHHHHHHHHHHHHhC----------CCCCCccCcccc
Q 002336 764 QAEEDL---THISSVARGTVGYLDPEYYGNQQ----L--TEKSDVYSFGVVLLELISG----------KKPVSVEDFGAE 824 (935)
Q Consensus 764 ~~~~~~---~~~~~~~~gt~~y~APE~l~~~~----~--s~ksDVwS~Gvil~eLltG----------~~Pf~~~~~~~~ 824 (935)
...... .-......||.+|||||++.+.- + -..+||||||+++||+... +.||-..- +.+
T Consensus 365 ~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~V-p~D 443 (513)
T KOG2052|consen 365 RHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVV-PSD 443 (513)
T ss_pred EecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCC-CCC
Confidence 765432 22345567999999999986532 1 2478999999999998763 24543111 111
Q ss_pred hhHHHHHHHhhhcCCeeecccccccCC-CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhhhhhcc
Q 002336 825 LNIVHWARSMIKKGDVISIVDPVLIGN-VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 893 (935)
Q Consensus 825 ~~l~~~~~~~i~~~~~~~~~d~~l~~~-~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~~~~~~ 893 (935)
... +-+++.+=.. .+.|.+... ...+.+..+.++++.||..+|..|-|+-.+-+.|.++...++
T Consensus 444 Ps~-eeMrkVVCv~----~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~~~e 508 (513)
T KOG2052|consen 444 PSF-EEMRKVVCVQ----KLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSNSDE 508 (513)
T ss_pred CCH-HHHhcceeec----ccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhcChh
Confidence 111 1111111111 111222222 235677889999999999999999999999998888775444
|
|
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=297.33 Aligned_cols=252 Identities=26% Similarity=0.405 Sum_probs=201.9
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcchhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEecC
Q 002336 614 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 692 (935)
Q Consensus 614 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~~ 692 (935)
.+++.+.||+|++|.||+|... +++.+++|.+........+.+.+|++++++++||||+++++++......+++|||++
T Consensus 4 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~ 83 (262)
T cd06613 4 DYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCG 83 (262)
T ss_pred ceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCC
Confidence 4566789999999999999875 578899999876555566789999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccccce
Q 002336 693 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 772 (935)
Q Consensus 693 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~~ 772 (935)
+++|.+++... ...+++..+..++.|++.||+|||+ .+++||||||+||++++++.+||+|||++........ .
T Consensus 84 ~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-~ 157 (262)
T cd06613 84 GGSLQDIYQVT--RGPLSELQIAYVCRETLKGLAYLHE---TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA-K 157 (262)
T ss_pred CCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHh---CCceecCCChhhEEECCCCCEEECccccchhhhhhhh-c
Confidence 99999988742 3568999999999999999999997 8999999999999999999999999999876543221 1
Q ss_pred eecccCCccccCCCCCCCC---CCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeeccccccc
Q 002336 773 SSVARGTVGYLDPEYYGNQ---QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 849 (935)
Q Consensus 773 ~~~~~gt~~y~APE~l~~~---~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~ 849 (935)
.....++..|+|||.+... .++.++||||||+++|||++|+.||....... .... +..... ..+.+
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~--~~~~-----~~~~~~---~~~~~- 226 (262)
T cd06613 158 RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMR--ALFL-----ISKSNF---PPPKL- 226 (262)
T ss_pred cccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHH--HHHH-----HHhccC---CCccc-
Confidence 2234578899999998766 88899999999999999999999997332111 1111 111100 00111
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 850 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 850 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
.........+.+++.+||..+|++||++++|+.
T Consensus 227 -~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 227 -KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred -cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 112233457889999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=298.63 Aligned_cols=246 Identities=29% Similarity=0.403 Sum_probs=200.2
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc-hhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEecC
Q 002336 615 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 692 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~-~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~~ 692 (935)
|++.+.||.|++|.||+|.+. +++.+|+|.+.... ......+.+|+++++.++|+||+++++++.++...++|+||++
T Consensus 3 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 82 (274)
T cd06609 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCG 82 (274)
T ss_pred hhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEeeC
Confidence 566789999999999999876 68899999986543 3345678899999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccccce
Q 002336 693 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 772 (935)
Q Consensus 693 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~~ 772 (935)
+++|.+++.. ..+++..+..++.|++.||.|||+ ++++||||+|+||++++++.++|+|||+++........
T Consensus 83 ~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~- 154 (274)
T cd06609 83 GGSCLDLLKP----GKLDETYIAFILREVLLGLEYLHE---EGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSK- 154 (274)
T ss_pred CCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEcccccceeecccccc-
Confidence 9999999873 278999999999999999999997 89999999999999999999999999999876543221
Q ss_pred eecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccCCC
Q 002336 773 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNV 852 (935)
Q Consensus 773 ~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~~~ 852 (935)
.....+++.|+|||.+.+..++.++||||||+++|+|++|+.||...+.. ... ..+..+.... +...
T Consensus 155 ~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~------~~~-~~~~~~~~~~-----~~~~- 221 (274)
T cd06609 155 RNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPM------RVL-FLIPKNNPPS-----LEGN- 221 (274)
T ss_pred cccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchH------HHH-HHhhhcCCCC-----Cccc-
Confidence 22235788999999998888999999999999999999999999743211 111 1111111111 1111
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 853 KIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 853 ~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
.....+.+++.+||..+|++||+++++++
T Consensus 222 --~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 222 --KFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred --ccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 02336889999999999999999999976
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=305.43 Aligned_cols=259 Identities=25% Similarity=0.310 Sum_probs=191.2
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCcchh--hhHHHHHHHHHHHhc---CCCcccccceeeec-----cce
Q 002336 615 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSH--RTQQFVTEVALLSRI---HHRNLVPLIGYCEE-----EHQ 683 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~~--~~~~~~~E~~iL~~L---~HpnIv~l~g~~~~-----~~~ 683 (935)
|++.+.||+|+||.||+|... +++.||+|.++..... ....+.+|+++++.+ +||||+++++++.. ...
T Consensus 2 y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~ 81 (288)
T cd07863 2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETK 81 (288)
T ss_pred ceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCce
Confidence 456788999999999999876 6889999988653221 223566777777665 69999999998754 345
Q ss_pred EEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccc
Q 002336 684 RILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 763 (935)
Q Consensus 684 ~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~ 763 (935)
.++||||+. ++|.+++... ....+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++
T Consensus 82 ~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~kl~dfg~~~ 156 (288)
T cd07863 82 VTLVFEHVD-QDLRTYLDKV-PPPGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGQVKLADFGLAR 156 (288)
T ss_pred EEEEEcccc-cCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccCccc
Confidence 789999997 4888888643 23458999999999999999999998 899999999999999999999999999997
Q ss_pred cccccccceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhc---CCe
Q 002336 764 QAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKK---GDV 840 (935)
Q Consensus 764 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~---~~~ 840 (935)
....... .....++..|+|||.+.+..++.++||||+||++|||++|+.||......+. +.+ +...... ...
T Consensus 157 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~--~~~-~~~~~~~~~~~~~ 231 (288)
T cd07863 157 IYSCQMA--LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQ--LGK-IFDLIGLPPEDDW 231 (288)
T ss_pred cccCccc--CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHH--HHH-HHHHhCCCChhhC
Confidence 6543221 1234578999999999888899999999999999999999999974332111 111 1111000 000
Q ss_pred ee-------ccccccc---CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 841 IS-------IVDPVLI---GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 841 ~~-------~~d~~l~---~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
.. ...+... ....+.....+.+++.+||+.||++|||++|++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 232 PRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred cccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 00 0000000 0011122346789999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=297.51 Aligned_cols=254 Identities=23% Similarity=0.375 Sum_probs=199.8
Q ss_pred HhhcccccccccEEEEEEEECC--CcEEEEEEccCcc----------hhhhHHHHHHHHHHHh-cCCCcccccceeeecc
Q 002336 615 NNFCKKIGKGSFGSVYYGKMKD--GKEVAVKIMADSC----------SHRTQQFVTEVALLSR-IHHRNLVPLIGYCEEE 681 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~~--g~~vAvK~~~~~~----------~~~~~~~~~E~~iL~~-L~HpnIv~l~g~~~~~ 681 (935)
|.+.+.||+|+||.||+|.++. ++.+|+|.+.... .....++..|+.++.+ ++||||+++++++.+.
T Consensus 2 y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 81 (269)
T cd08528 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLEN 81 (269)
T ss_pred chhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccC
Confidence 4567889999999999999865 6889999875321 1233557788888875 6999999999999999
Q ss_pred ceEEEEEEecCCCCHHHHhccCC-CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecc
Q 002336 682 HQRILVYEYMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFG 760 (935)
Q Consensus 682 ~~~~lV~E~~~~gsL~~~L~~~~-~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFG 760 (935)
+..+++|||+++++|.+.+.... ....+++..+++++.|++.||.|||+ ..+++|+||+|+||+++.++.+||+|||
T Consensus 82 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~--~~~i~H~dl~~~nil~~~~~~~~l~dfg 159 (269)
T cd08528 82 DRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFG 159 (269)
T ss_pred CeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhcc--CCceeecCCCHHHEEECCCCcEEEeccc
Confidence 99999999999999998875321 34568999999999999999999995 3689999999999999999999999999
Q ss_pred ccccccccccceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCe
Q 002336 761 LSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV 840 (935)
Q Consensus 761 la~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~ 840 (935)
++....... ......++..|+|||.+.+..++.++||||||+++|+|++|+.||...... .... .+..+..
T Consensus 160 ~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~------~~~~-~~~~~~~ 230 (269)
T cd08528 160 LAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNML------SLAT-KIVEAVY 230 (269)
T ss_pred ceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHH------HHHH-HHhhccC
Confidence 998754432 223345888999999999888999999999999999999999998632211 1111 1111111
Q ss_pred eecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhh
Q 002336 841 ISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 887 (935)
Q Consensus 841 ~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~ 887 (935)
... ... .....+.+++.+||+.+|++||++.|+..++++
T Consensus 231 ~~~----~~~----~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~ 269 (269)
T cd08528 231 EPL----PEG----MYSEDVTDVITSCLTPDAEARPDIIQVSAMISD 269 (269)
T ss_pred CcC----Ccc----cCCHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence 111 001 122468899999999999999999999998863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-33 Score=307.41 Aligned_cols=260 Identities=22% Similarity=0.327 Sum_probs=195.6
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc-hhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEec
Q 002336 614 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 691 (935)
Q Consensus 614 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~-~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~ 691 (935)
.|.+.+.||+|+||.||+|..+ +++.||+|.+.... ......+.+|+.+++.++||||+++++++...+..++||||+
T Consensus 7 ~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~ 86 (301)
T cd07873 7 TYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYL 86 (301)
T ss_pred ceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEecc
Confidence 3566789999999999999876 68899999986432 223356788999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccccc
Q 002336 692 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 771 (935)
Q Consensus 692 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~ 771 (935)
+ ++|.+.+... ...+++..+..++.|+++||+|||+ .+|+||||||+||++++++.+||+|||++.........
T Consensus 87 ~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 160 (301)
T cd07873 87 D-KDLKQYLDDC--GNSINMHNVKLFLFQLLRGLNYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT 160 (301)
T ss_pred c-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCc
Confidence 7 5898887643 3468899999999999999999998 89999999999999999999999999998764322211
Q ss_pred eeecccCCccccCCCCCCC-CCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhc---CCeeeccc--
Q 002336 772 ISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKK---GDVISIVD-- 845 (935)
Q Consensus 772 ~~~~~~gt~~y~APE~l~~-~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~---~~~~~~~d-- 845 (935)
.....+++.|+|||.+.+ ..++.++||||||+++|||++|+.||...+..+. ...+...... .....+++
T Consensus 161 -~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 236 (301)
T cd07873 161 -YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQ---LHFIFRILGTPTEETWPGILSNE 236 (301)
T ss_pred -ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHcCCCChhhchhhhccc
Confidence 122346889999998754 4578999999999999999999999974433211 1111111100 00000000
Q ss_pred -------ccccCC----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 846 -------PVLIGN----VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 846 -------~~l~~~----~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
+..... ........+.+++.+|++.+|++|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 237 EFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred cccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 000000 00112336789999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-33 Score=298.75 Aligned_cols=249 Identities=33% Similarity=0.563 Sum_probs=200.0
Q ss_pred hcccccccccEEEEEEEECC-----CcEEEEEEccCcchh-hhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEe
Q 002336 617 FCKKIGKGSFGSVYYGKMKD-----GKEVAVKIMADSCSH-RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 690 (935)
Q Consensus 617 ~~~~LG~G~fG~Vy~~~~~~-----g~~vAvK~~~~~~~~-~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~ 690 (935)
+.+.||+|+||.||++.+.+ ++.||+|++...... ..+.+..|+++++.++|+||+++++++.+.+..+++|||
T Consensus 3 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~ 82 (258)
T smart00219 3 LGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEY 82 (258)
T ss_pred ccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEec
Confidence 56889999999999998764 488999999765433 567899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccccccc
Q 002336 691 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 770 (935)
Q Consensus 691 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~ 770 (935)
+++++|.+++.... ...+++.++..++.|++.||+|||+ .+++||||||+||++++++.++|+|||++........
T Consensus 83 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lh~---~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (258)
T smart00219 83 MEGGDLLDYLRKNR-PKELSLSDLLSFALQIARGMEYLES---KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY 158 (258)
T ss_pred cCCCCHHHHHHhhh-hccCCHHHHHHHHHHHHHHHHHHhc---CCeeecccccceEEEccCCeEEEcccCCceecccccc
Confidence 99999999987432 1228999999999999999999997 8999999999999999999999999999987654422
Q ss_pred ceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCcccchhHHHHHHHhhhcCCeeeccccccc
Q 002336 771 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 849 (935)
Q Consensus 771 ~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~ 849 (935)
.......++..|+|||.+.+..++.++||||+|+++++|++ |+.||..... ....+. +..+.....
T Consensus 159 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~---~~~~~~----~~~~~~~~~------ 225 (258)
T smart00219 159 YKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN---EEVLEY----LKKGYRLPK------ 225 (258)
T ss_pred cccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHH----HhcCCCCCC------
Confidence 22212336789999999988889999999999999999998 7888863211 122221 111111110
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 002336 850 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAI 885 (935)
Q Consensus 850 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L 885 (935)
+......+.+++.+|+..+|++|||+.|+++.|
T Consensus 226 ---~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 226 ---PENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred ---CCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 111234688999999999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=298.46 Aligned_cols=248 Identities=25% Similarity=0.414 Sum_probs=197.0
Q ss_pred hhcccccccccEEEEEEEECCCcEEEEEEccCcc------hhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEE
Q 002336 616 NFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSC------SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 689 (935)
Q Consensus 616 ~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~~~~~~------~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E 689 (935)
...+.||+|+||.||+|...+++.+|+|.+.... ......+.+|++++++++|+||+++++++.+....++++|
T Consensus 3 ~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 82 (265)
T cd06631 3 TKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFME 82 (265)
T ss_pred cccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEEe
Confidence 4567899999999999998889999999876432 1223568899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccc
Q 002336 690 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 769 (935)
Q Consensus 690 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~ 769 (935)
|+++++|.+++.. ...+++..+..++.|++.||+|||+ .+++|+||+|+||++++++.++|+|||++.......
T Consensus 83 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 156 (265)
T cd06631 83 FVPGGSISSILNR---FGPLPEPVFCKYTKQILDGVAYLHN---NCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVG 156 (265)
T ss_pred cCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHhEEECCCCeEEeccchhhHhhhhcc
Confidence 9999999999873 3468899999999999999999997 899999999999999999999999999987542211
Q ss_pred -----cceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecc
Q 002336 770 -----THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 844 (935)
Q Consensus 770 -----~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~ 844 (935)
........++..|+|||.+.+..++.++||||||+++++|++|+.||...+... .... . ....+..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~--~~~~-~--~~~~~~~---- 227 (265)
T cd06631 157 LHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA--AMFY-I--GAHRGLM---- 227 (265)
T ss_pred ccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHH--HHHH-h--hhccCCC----
Confidence 111123457889999999998889999999999999999999999997322111 1100 0 0000111
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 845 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 845 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
+.+. ......+.+++.+||+.+|++||++.|+++
T Consensus 228 -~~~~----~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 228 -PRLP----DSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred -CCCC----CCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 1111 122346789999999999999999999874
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-33 Score=301.16 Aligned_cols=249 Identities=24% Similarity=0.404 Sum_probs=193.9
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcchhhhHHHHHHHHHHHhc-CCCcccccceeeec------cceEE
Q 002336 614 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEE------EHQRI 685 (935)
Q Consensus 614 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L-~HpnIv~l~g~~~~------~~~~~ 685 (935)
.+++.+.||+|+||.||+|... +++.||+|++.... .....+..|+.+++++ +|+||+++++++.. ....+
T Consensus 7 ~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~ 85 (272)
T cd06637 7 IFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLW 85 (272)
T ss_pred hhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEE
Confidence 4566788999999999999875 58899999986542 3345788999999998 69999999999864 24689
Q ss_pred EEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccc
Q 002336 686 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 765 (935)
Q Consensus 686 lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~ 765 (935)
++|||+.+++|.+++... ....+++..+..++.|++.||+|||+ ++|+|+||||+||++++++.+||+|||++...
T Consensus 86 iv~e~~~~~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~LH~---~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~ 161 (272)
T cd06637 86 LVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 161 (272)
T ss_pred EEEEcCCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHEEECCCCCEEEccCCCceec
Confidence 999999999999998753 23568899999999999999999998 89999999999999999999999999998765
Q ss_pred cccccceeecccCCccccCCCCCC-----CCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCe
Q 002336 766 EEDLTHISSVARGTVGYLDPEYYG-----NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV 840 (935)
Q Consensus 766 ~~~~~~~~~~~~gt~~y~APE~l~-----~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~ 840 (935)
..... ......|+..|+|||++. ...++.++|||||||++|||++|+.||....... ... .......
T Consensus 162 ~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~-----~~~--~~~~~~~ 233 (272)
T cd06637 162 DRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR-----ALF--LIPRNPA 233 (272)
T ss_pred ccccc-cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHH-----HHH--HHhcCCC
Confidence 33222 122345889999999875 3457889999999999999999999996322111 000 1111111
Q ss_pred eecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 841 ISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 841 ~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
.... .......+.+++.+||..+|.+||+++|+++
T Consensus 234 ~~~~--------~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 234 PRLK--------SKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred CCCC--------CCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 1111 1112346889999999999999999999875
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-33 Score=302.83 Aligned_cols=257 Identities=26% Similarity=0.436 Sum_probs=203.7
Q ss_pred HHHHhhcccccccccEEEEEEEEC-CCc----EEEEEEccCcch-hhhHHHHHHHHHHHhcCCCcccccceeeeccceEE
Q 002336 612 EATNNFCKKIGKGSFGSVYYGKMK-DGK----EVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRI 685 (935)
Q Consensus 612 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~----~vAvK~~~~~~~-~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~ 685 (935)
...+++.+.||+|+||.||+|.++ +|+ .+|+|.+..... .....+.+|+.++++++||||+++++++.. ...+
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 84 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ 84 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence 455677899999999999999865 233 689998865533 345678999999999999999999999987 7889
Q ss_pred EEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccc
Q 002336 686 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 765 (935)
Q Consensus 686 lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~ 765 (935)
+||||+++|+|.+++... ...+++..+..++.|++.||+|||+ .+++||||||+||++++++.+||+|||+++..
T Consensus 85 ~v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~ 159 (279)
T cd05057 85 LITQLMPLGCLLDYVRNH--KDNIGSQYLLNWCVQIAKGMSYLEE---KRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (279)
T ss_pred EEEecCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHh---CCEEecccCcceEEEcCCCeEEECCCcccccc
Confidence 999999999999998743 3458999999999999999999998 89999999999999999999999999999875
Q ss_pred ccccccee-ecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCcccchhHHHHHHHhhhcCCeeec
Q 002336 766 EEDLTHIS-SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISI 843 (935)
Q Consensus 766 ~~~~~~~~-~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~ 843 (935)
........ ....++..|+|||.+....++.++|+||||++++||++ |+.||...... .+. ..+..+....
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~----~~~~~~~~~~- 231 (279)
T cd05057 160 DVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAV---EIP----DLLEKGERLP- 231 (279)
T ss_pred cCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHH---HHH----HHHhCCCCCC-
Confidence 43322111 11223568999999988889999999999999999999 99999743221 111 2222221110
Q ss_pred ccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhhhh
Q 002336 844 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 890 (935)
Q Consensus 844 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~~~ 890 (935)
.+......+.+++.+||..+|++||++.++++.|+++..
T Consensus 232 --------~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 232 --------QPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred --------CCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 011122367899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-33 Score=299.44 Aligned_cols=246 Identities=28% Similarity=0.429 Sum_probs=196.7
Q ss_pred hhcccccccccEEEEEEEEC-CCcEEEEEEccCcchh---------hhHHHHHHHHHHHhcCCCcccccceeeeccceEE
Q 002336 616 NFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSH---------RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRI 685 (935)
Q Consensus 616 ~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~~---------~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~ 685 (935)
.+.+.||+|++|.||+|... +++.+|+|.+...... ..+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 3 ~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (267)
T cd06628 3 IKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHLN 82 (267)
T ss_pred cccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCccE
Confidence 45678999999999999875 6889999988643221 2256889999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccc
Q 002336 686 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 765 (935)
Q Consensus 686 lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~ 765 (935)
+||||+++++|.+++.. ...+++..+..++.|++.||+|||+ .+++||||+|+||++++++.+||+|||+++..
T Consensus 83 lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~~l~~~l~~lH~---~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~ 156 (267)
T cd06628 83 IFLEYVPGGSVAALLNN---YGAFEETLVRNFVRQILKGLNYLHN---RGIIHRDIKGANILVDNKGGIKISDFGISKKL 156 (267)
T ss_pred EEEEecCCCCHHHHHHh---ccCccHHHHHHHHHHHHHHHHHHHh---cCcccccCCHHHEEEcCCCCEEecccCCCccc
Confidence 99999999999999973 3568889999999999999999997 89999999999999999999999999998866
Q ss_pred cccccc-----eeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCe
Q 002336 766 EEDLTH-----ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV 840 (935)
Q Consensus 766 ~~~~~~-----~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~ 840 (935)
...... ......|+..|+|||.+.+..++.++||||+|+++|+|++|+.||...... .. +.. +...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~---~~~-~~~~-- 227 (267)
T cd06628 157 EANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL---QA---IFK-IGEN-- 227 (267)
T ss_pred ccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH---HH---HHH-Hhcc--
Confidence 432111 111234788999999998888999999999999999999999999732211 11 111 1111
Q ss_pred eecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 841 ISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 841 ~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
..+.+ +......+.+++.+||+.+|++||++.||++
T Consensus 228 ---~~~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 228 ---ASPEI----PSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred ---CCCcC----CcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 11111 2223347889999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-33 Score=317.98 Aligned_cols=263 Identities=22% Similarity=0.256 Sum_probs=198.7
Q ss_pred HHHHHHhhcccccccccEEEEEEEEC---CCcEEEEEEccCcchhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEE
Q 002336 610 LEEATNNFCKKIGKGSFGSVYYGKMK---DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRIL 686 (935)
Q Consensus 610 l~~~~~~~~~~LG~G~fG~Vy~~~~~---~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~l 686 (935)
+....|.+.+.||+|+||.||++... .++.||+|.+... +...+|++++++++||||+++++++......++
T Consensus 89 ~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~l 163 (392)
T PHA03207 89 VVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCM 163 (392)
T ss_pred hccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEE
Confidence 33456778899999999999999754 3578999987642 345689999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccc
Q 002336 687 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 766 (935)
Q Consensus 687 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~ 766 (935)
|||++. ++|.+++. ....+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 164 v~e~~~-~~l~~~l~---~~~~l~~~~~~~i~~ql~~aL~~LH~---~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~ 236 (392)
T PHA03207 164 VMPKYK-CDLFTYVD---RSGPLPLEQAITIQRRLLEALAYLHG---RGIIHRDVKTENIFLDEPENAVLGDFGAACKLD 236 (392)
T ss_pred EehhcC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEccCccccccC
Confidence 999995 68888884 34678999999999999999999998 899999999999999999999999999987654
Q ss_pred ccccc-eeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCee--e-
Q 002336 767 EDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVI--S- 842 (935)
Q Consensus 767 ~~~~~-~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~--~- 842 (935)
..... ......||+.|+|||++....++.++|||||||++|||++|+.||.............-+.+.+...... .
T Consensus 237 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~ 316 (392)
T PHA03207 237 AHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQN 316 (392)
T ss_pred cccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCc
Confidence 33221 1223468999999999999899999999999999999999999997544322111111111111110000 0
Q ss_pred ----c------ccccccCCCC-------HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002336 843 ----I------VDPVLIGNVK-------IESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 884 (935)
Q Consensus 843 ----~------~d~~l~~~~~-------~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~ 884 (935)
+ ........+. ......+.+++.+||+.+|++||++.|++..
T Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 317 GSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred cchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0 0000000000 0112357789999999999999999999864
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=285.57 Aligned_cols=248 Identities=27% Similarity=0.374 Sum_probs=200.7
Q ss_pred hhcccccccccEEEEEEEEC-CCcEEEEEEccCcch--------hhhHHHHHHHHHHHhc-CCCcccccceeeeccceEE
Q 002336 616 NFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--------HRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRI 685 (935)
Q Consensus 616 ~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~--------~~~~~~~~E~~iL~~L-~HpnIv~l~g~~~~~~~~~ 685 (935)
.-.+.||+|..+.|-+..++ +|++.|+|++..... +-.+.-.+|+.+|+++ .||+|+++.++++.+...+
T Consensus 20 ~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~F 99 (411)
T KOG0599|consen 20 EPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFVF 99 (411)
T ss_pred ChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchhh
Confidence 33578999999999998765 688999998853211 1124456799999998 5999999999999999999
Q ss_pred EEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccc
Q 002336 686 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 765 (935)
Q Consensus 686 lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~ 765 (935)
+|+|.|+.|.|.|+|. ....+++++..+|+.|+.+|++|||. +.||||||||+|||+|++.++||+|||+++..
T Consensus 100 lVFdl~prGELFDyLt---s~VtlSEK~tR~iMrqlfegVeylHa---~~IVHRDLKpENILlddn~~i~isDFGFa~~l 173 (411)
T KOG0599|consen 100 LVFDLMPRGELFDYLT---SKVTLSEKETRRIMRQLFEGVEYLHA---RNIVHRDLKPENILLDDNMNIKISDFGFACQL 173 (411)
T ss_pred hhhhhcccchHHHHhh---hheeecHHHHHHHHHHHHHHHHHHHH---hhhhhcccChhheeeccccceEEeccceeecc
Confidence 9999999999999998 45789999999999999999999998 99999999999999999999999999999987
Q ss_pred cccccceeecccCCccccCCCCC------CCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCC
Q 002336 766 EEDLTHISSVARGTVGYLDPEYY------GNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD 839 (935)
Q Consensus 766 ~~~~~~~~~~~~gt~~y~APE~l------~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~ 839 (935)
..... ....+|||+|+|||.+ ....|+...|+|++|||||-|+.|.+||-... .--+.++|.+|.
T Consensus 174 ~~Gek--LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk-------QmlMLR~ImeGk 244 (411)
T KOG0599|consen 174 EPGEK--LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK-------QMLMLRMIMEGK 244 (411)
T ss_pred CCchh--HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH-------HHHHHHHHHhcc
Confidence 65433 2346799999999987 34578899999999999999999999996211 112334555554
Q ss_pred eeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002336 840 VISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 884 (935)
Q Consensus 840 ~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~ 884 (935)
..-- .| .=.+......+++.+||+.||.+|.|++|.++.
T Consensus 245 yqF~-sp-----eWadis~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 245 YQFR-SP-----EWADISATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred cccC-Cc-----chhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 4110 00 001223367899999999999999999999864
|
|
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-33 Score=298.95 Aligned_cols=247 Identities=30% Similarity=0.498 Sum_probs=197.7
Q ss_pred HHHhhcccccccccEEEEEEEECCCcEEEEEEccCcchhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEecC
Q 002336 613 ATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 692 (935)
Q Consensus 613 ~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~~ 692 (935)
..+++.+.||+|+||.||++.. +++.+|+|.++... ..+.+.+|+.++++++|||++++++++... ..++||||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 4467789999999999999975 48889999986532 346788999999999999999999998654 4799999999
Q ss_pred CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccccce
Q 002336 693 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 772 (935)
Q Consensus 693 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~~ 772 (935)
+++|.+++... ....+++..+++++.|+++||.|||+ .+++||||||+||+++.++.+||+|||++........
T Consensus 82 ~~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~al~~lH~---~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~~-- 155 (254)
T cd05083 82 KGNLVNFLRTR-GRALVSVIQLLQFSLDVAEGMEYLES---KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVD-- 155 (254)
T ss_pred CCCHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCcEEECCCccceeccccCC--
Confidence 99999998754 23468899999999999999999997 8999999999999999999999999999875432211
Q ss_pred eecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccCC
Q 002336 773 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 851 (935)
Q Consensus 773 ~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~~ 851 (935)
....+..|+|||.+.+..++.++|+||||+++|||++ |+.||...... .. ...+..+... +
T Consensus 156 --~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~---~~----~~~~~~~~~~---~------ 217 (254)
T cd05083 156 --NSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLK---EV----KECVEKGYRM---E------ 217 (254)
T ss_pred --CCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHH---HH----HHHHhCCCCC---C------
Confidence 1224567999999988899999999999999999998 99998633221 11 1122222111 1
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhh
Q 002336 852 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 887 (935)
Q Consensus 852 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~ 887 (935)
.+...+..+.+++.+||+.+|++||++++|++.|++
T Consensus 218 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 218 PPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 111223467899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-33 Score=313.37 Aligned_cols=261 Identities=23% Similarity=0.289 Sum_probs=193.5
Q ss_pred HHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCc--chhhhHHHHHHHHHHHhcCCCcccccceeeeccc------e
Q 002336 613 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH------Q 683 (935)
Q Consensus 613 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~--~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~------~ 683 (935)
..|++.+.||+|+||.||++... +|+.||+|++... .......+.+|+.+++.++||||+++++++.... .
T Consensus 21 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 100 (359)
T cd07876 21 KRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQD 100 (359)
T ss_pred hceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccce
Confidence 45667889999999999999875 6899999998643 2234567889999999999999999999885433 4
Q ss_pred EEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccc
Q 002336 684 RILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 763 (935)
Q Consensus 684 ~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~ 763 (935)
.++||||+++ +|.+.+. ..+++..+..++.|+++||+|||+ ++|+||||||+|||++.++.+||+|||+++
T Consensus 101 ~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~---~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~ 171 (359)
T cd07876 101 VYLVMELMDA-NLCQVIH-----MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR 171 (359)
T ss_pred eEEEEeCCCc-CHHHHHh-----ccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEecCCCcc
Confidence 7999999965 5666554 247888899999999999999998 899999999999999999999999999987
Q ss_pred cccccccceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchh------------HH---
Q 002336 764 QAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELN------------IV--- 828 (935)
Q Consensus 764 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~------------l~--- 828 (935)
...... ......||+.|+|||.+.+..++.++||||+||++|+|++|+.||...+..+... ..
T Consensus 172 ~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (359)
T cd07876 172 TACTNF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRL 249 (359)
T ss_pred ccccCc--cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHH
Confidence 643321 1223458999999999999999999999999999999999999997543211100 00
Q ss_pred -HHHHHhhhcCC-e-----eeccccccc---CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002336 829 -HWARSMIKKGD-V-----ISIVDPVLI---GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 884 (935)
Q Consensus 829 -~~~~~~i~~~~-~-----~~~~d~~l~---~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~ 884 (935)
..+........ . .+....... ..........+.+++.+||+.||++|||++|+++.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 250 QPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00011110000 0 000000000 00001112467899999999999999999999864
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=306.94 Aligned_cols=256 Identities=21% Similarity=0.300 Sum_probs=192.6
Q ss_pred hccccccc--ccEEEEEEEEC-CCcEEEEEEccCcc--hhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEec
Q 002336 617 FCKKIGKG--SFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 691 (935)
Q Consensus 617 ~~~~LG~G--~fG~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~ 691 (935)
+.++||+| +||+||++..+ +|+.||+|++.... ....+.+.+|+++++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 45789999 78999999875 78999999986532 233456788999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccccc
Q 002336 692 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 771 (935)
Q Consensus 692 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~ 771 (935)
++|+|.+++... ....+++..+++++.|++.||+|||+ ++|+||||||+|||++.++.++++||+...........
T Consensus 82 ~~~~l~~~~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~---~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~ 157 (327)
T cd08227 82 AYGSAKDLICTH-FMDGMSELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR 157 (327)
T ss_pred CCCcHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence 999999998643 23458999999999999999999998 89999999999999999999999999865432211100
Q ss_pred ------eeecccCCccccCCCCCCC--CCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeec
Q 002336 772 ------ISSVARGTVGYLDPEYYGN--QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISI 843 (935)
Q Consensus 772 ------~~~~~~gt~~y~APE~l~~--~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~ 843 (935)
......++..|+|||++.+ ..++.++|||||||++|||++|+.||....... ...... .+.....
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~~~-----~~~~~~~ 230 (327)
T cd08227 158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQ--MLLEKL-----NGTVPCL 230 (327)
T ss_pred ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhH--HHHHHh-----cCCcccc
Confidence 0112246778999999865 468899999999999999999999997322111 011100 0111100
Q ss_pred cc-------------------ccc-----------------cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 844 VD-------------------PVL-----------------IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 844 ~d-------------------~~l-----------------~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
++ ... ...........+.+++.+||+.||++|||++|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~ 306 (327)
T cd08227 231 LDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN 306 (327)
T ss_pred ccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence 00 000 00011122346889999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=297.27 Aligned_cols=250 Identities=25% Similarity=0.419 Sum_probs=198.1
Q ss_pred hhcccccccccEEEEEEEE-CCCcEEEEEEccCcch------hhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEE
Q 002336 616 NFCKKIGKGSFGSVYYGKM-KDGKEVAVKIMADSCS------HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 688 (935)
Q Consensus 616 ~~~~~LG~G~fG~Vy~~~~-~~g~~vAvK~~~~~~~------~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~ 688 (935)
+..+.||+|++|.||+|.. .+++.+|+|.+..... ...+.+.+|++++++++|+||+++++++.+.+..++||
T Consensus 3 ~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~ 82 (268)
T cd06630 3 LKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFV 82 (268)
T ss_pred cccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEEE
Confidence 4467899999999999986 4689999999864321 13467899999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCC-cEEEeeccccccccc
Q 002336 689 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM-RAKVSDFGLSRQAEE 767 (935)
Q Consensus 689 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~-~vkL~DFGla~~~~~ 767 (935)
||+++++|.+++.. ...+++..+..++.|++.||.|||+ ++++|+||||+||+++.++ .+||+|||.+.....
T Consensus 83 e~~~~~~L~~~l~~---~~~~~~~~~~~~~~ql~~al~~LH~---~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~ 156 (268)
T cd06630 83 EWMAGGSVSHLLSK---YGAFKEAVIINYTEQLLRGLSYLHE---NQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAA 156 (268)
T ss_pred eccCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEccccccccccc
Confidence 99999999999873 3568899999999999999999998 8999999999999998776 599999999877644
Q ss_pred cccc---eeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecc
Q 002336 768 DLTH---ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 844 (935)
Q Consensus 768 ~~~~---~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~ 844 (935)
.... ......++..|+|||.+.+..++.++||||+|+++++|++|+.||......... ....+......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~---~~~~~~~~~~~----- 228 (268)
T cd06630 157 KGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHL---ALIFKIASATT----- 228 (268)
T ss_pred ccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchH---HHHHHHhccCC-----
Confidence 3211 112235788999999998888899999999999999999999999643322111 11111111000
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 845 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 845 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
....+......+.+++.+|++.+|++||++.|+++
T Consensus 229 ----~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 229 ----APSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred ----CCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 11122233457889999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=294.82 Aligned_cols=248 Identities=26% Similarity=0.396 Sum_probs=198.4
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc--hhhhHHHHHHHHHHHhcCCCcccccceeeec-cceEEEEEEe
Q 002336 615 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEE-EHQRILVYEY 690 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~-~~~~~lV~E~ 690 (935)
|++.+.||+|++|.||++..+ +++.+|+|.+.... ....+.+.+|++++++++|+|++++++.+.. ....+++|||
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~ 81 (257)
T cd08223 2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGF 81 (257)
T ss_pred ceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecc
Confidence 567789999999999999875 57899999986432 2345678899999999999999999988764 4467899999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccccccc
Q 002336 691 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 770 (935)
Q Consensus 691 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~ 770 (935)
+++++|.+++... ....+++.++.+++.|++.||++||+ .+++||||||+||+++.++.++|+|||++........
T Consensus 82 ~~~~~l~~~l~~~-~~~~l~~~~~~~~~~~l~~~l~~lH~---~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~ 157 (257)
T cd08223 82 CEGGDLYHKLKEQ-KGKLLPENQVVEWFVQIAMALQYLHE---KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD 157 (257)
T ss_pred cCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCchhEEEecCCcEEEecccceEEecccCC
Confidence 9999999998753 24568999999999999999999997 8999999999999999999999999999876543222
Q ss_pred ceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccC
Q 002336 771 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 850 (935)
Q Consensus 771 ~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~ 850 (935)
......+++.|+|||.+.+..++.++||||+|+++++|++|+.||...+. ...... +..+...
T Consensus 158 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~------~~~~~~-~~~~~~~--------- 220 (257)
T cd08223 158 -MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM------NSLVYR-IIEGKLP--------- 220 (257)
T ss_pred -ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH------HHHHHH-HHhcCCC---------
Confidence 22234578899999999998999999999999999999999999873321 111111 1112111
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 851 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 851 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
..+......+.+++.+|++.+|++||++.|+++
T Consensus 221 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 221 PMPKDYSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred CCccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 111223346889999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=312.92 Aligned_cols=190 Identities=25% Similarity=0.339 Sum_probs=162.0
Q ss_pred HHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcchhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEec
Q 002336 613 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 691 (935)
Q Consensus 613 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~ 691 (935)
..|++.+.||+|+||.||+|... .++.||+|+.... ....|+.++++++||||+++++++......++|||++
T Consensus 66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 139 (357)
T PHA03209 66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY 139 (357)
T ss_pred cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEcc
Confidence 34677899999999999999876 5678999975432 3356999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccccc
Q 002336 692 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 771 (935)
Q Consensus 692 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~ 771 (935)
. ++|.+++.. ....+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 140 ~-~~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~- 212 (357)
T PHA03209 140 S-SDLYTYLTK--RSRPLPIDQALIIEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPA- 212 (357)
T ss_pred C-CcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEecCccccccccCcc-
Confidence 5 688888764 34578999999999999999999998 8999999999999999999999999999875322211
Q ss_pred eeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCC
Q 002336 772 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPV 816 (935)
Q Consensus 772 ~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf 816 (935)
.....||..|+|||++.+..++.++|||||||++|||+++..|+
T Consensus 213 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 213 -FLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred -cccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 12345899999999999989999999999999999999865554
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=304.30 Aligned_cols=258 Identities=27% Similarity=0.449 Sum_probs=200.3
Q ss_pred HHHhhcccccccccEEEEEEEEC-CCc----EEEEEEccCcch-hhhHHHHHHHHHHHhcCCCcccccceeeeccceEEE
Q 002336 613 ATNNFCKKIGKGSFGSVYYGKMK-DGK----EVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRIL 686 (935)
Q Consensus 613 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~----~vAvK~~~~~~~-~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~l 686 (935)
..++..+.||+|+||.||+|.+. +|+ .+|+|.+..... .....+.+|+.+++.++||||+++++++... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~ 85 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL 85 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence 34455688999999999999864 344 578998865433 2345788999999999999999999998754 4679
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccc
Q 002336 687 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 766 (935)
Q Consensus 687 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~ 766 (935)
++||+++|+|.+++... ...+++..+..++.|++.||+|||+ ++|+||||||+||++++++.+||+|||+++...
T Consensus 86 v~e~~~~g~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~ 160 (303)
T cd05110 86 VTQLMPHGCLLDYVHEH--KDNIGSQLLLNWCVQIAKGMMYLEE---RRLVHRDLAARNVLVKSPNHVKITDFGLARLLE 160 (303)
T ss_pred eehhcCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHhh---cCeeccccccceeeecCCCceEEcccccccccc
Confidence 99999999999998743 3468899999999999999999998 899999999999999999999999999998654
Q ss_pred ccccc-eeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCcccchhHHHHHHHhhhcCCeeecc
Q 002336 767 EDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 844 (935)
Q Consensus 767 ~~~~~-~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~ 844 (935)
..... ......++..|+|||.+.+..++.++||||||+++|||++ |+.||..... ....++ +..+....
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~---~~~~~~----~~~~~~~~-- 231 (303)
T cd05110 161 GDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT---REIPDL----LEKGERLP-- 231 (303)
T ss_pred CcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHH----HHCCCCCC--
Confidence 32221 1112335678999999988899999999999999999998 9999863321 112222 22221110
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhhhhhc
Q 002336 845 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 892 (935)
Q Consensus 845 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~~~~~ 892 (935)
. +......+.+++.+||..+|++||+++++++.|+++...+
T Consensus 232 ~-------~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~ 272 (303)
T cd05110 232 Q-------PPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDP 272 (303)
T ss_pred C-------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhch
Confidence 0 1112236789999999999999999999999999865443
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=319.15 Aligned_cols=258 Identities=21% Similarity=0.249 Sum_probs=191.9
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCcchhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEecCC
Q 002336 615 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 693 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~~~ 693 (935)
+.+.+.||+|+||.||++.+. .++.||||... ...+.+|+++|++++|+|||++++++..++..++|||++.
T Consensus 171 y~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~- 243 (461)
T PHA03211 171 FAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR- 243 (461)
T ss_pred eEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccC-
Confidence 455788999999999999886 57889999632 2346789999999999999999999999999999999995
Q ss_pred CCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccccc-e
Q 002336 694 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH-I 772 (935)
Q Consensus 694 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~-~ 772 (935)
++|.+++... ...+++.+++.++.|+++||.|||+ ++|+||||||+|||++.++.+||+|||+++........ .
T Consensus 244 ~~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 318 (461)
T PHA03211 244 SDLYTYLGAR--LRPLGLAQVTAVARQLLSAIDYIHG---EGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPF 318 (461)
T ss_pred CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCEEECcCCHHHEEECCCCCEEEcccCCceeccccccccc
Confidence 6888887642 3469999999999999999999998 89999999999999999999999999999765432211 1
Q ss_pred eecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcc-cchhHHHHHHHhhhcCCe-----eecccc
Q 002336 773 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFG-AELNIVHWARSMIKKGDV-----ISIVDP 846 (935)
Q Consensus 773 ~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~-~~~~l~~~~~~~i~~~~~-----~~~~d~ 846 (935)
.....||..|+|||++.+..++.++|||||||++|||++|..|+-..... .......-+.+.++.... ......
T Consensus 319 ~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~ 398 (461)
T PHA03211 319 HYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGS 398 (461)
T ss_pred ccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcch
Confidence 22345899999999999999999999999999999999988654322111 111111111111111111 000000
Q ss_pred cc------------cCCCCH-------HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002336 847 VL------------IGNVKI-------ESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 884 (935)
Q Consensus 847 ~l------------~~~~~~-------~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~ 884 (935)
.+ ...... .....+.+++.+||+.||++|||++|+++.
T Consensus 399 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 399 RLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred HHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 00 000000 111257899999999999999999999863
|
|
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=294.66 Aligned_cols=245 Identities=28% Similarity=0.395 Sum_probs=197.2
Q ss_pred hhcccccccccEEEEEEEEC-CCcEEEEEEccCcc-----hhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEE
Q 002336 616 NFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-----SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 689 (935)
Q Consensus 616 ~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~-----~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E 689 (935)
+..+.||+|++|.||+|... +++.|++|.+.... ....+.+.+|+++++.++|+||+++++++......++++|
T Consensus 3 ~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 82 (258)
T cd06632 3 RKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLE 82 (258)
T ss_pred cccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEEE
Confidence 45678999999999999876 78999999876432 2345678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccc
Q 002336 690 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 769 (935)
Q Consensus 690 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~ 769 (935)
|+++++|.+++.. ...+++..+..++.|+++||+|||+ .+++|+||+|+||+++.++.+||+|||++.......
T Consensus 83 ~~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~ 156 (258)
T cd06632 83 LVPGGSLAKLLKK---YGSFPEPVIRLYTRQILLGLEYLHD---RNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS 156 (258)
T ss_pred ecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccceeccccc
Confidence 9999999999873 3468899999999999999999998 899999999999999999999999999987654332
Q ss_pred cceeecccCCccccCCCCCCCCC-CCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccccc
Q 002336 770 THISSVARGTVGYLDPEYYGNQQ-LTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 848 (935)
Q Consensus 770 ~~~~~~~~gt~~y~APE~l~~~~-~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l 848 (935)
......++..|++||.+.... ++.++|+||||+++|+|++|+.||..... . ..............
T Consensus 157 --~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~--~----~~~~~~~~~~~~~~------ 222 (258)
T cd06632 157 --FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG--V----AAVFKIGRSKELPP------ 222 (258)
T ss_pred --cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH--H----HHHHHHHhcccCCC------
Confidence 122345788999999887766 89999999999999999999999963221 1 11111111111111
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 849 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 849 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
.+......+.+++.+||+.+|++||+++++++
T Consensus 223 ---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 223 ---IPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred ---cCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 11122346789999999999999999999875
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=312.75 Aligned_cols=261 Identities=22% Similarity=0.291 Sum_probs=194.9
Q ss_pred HHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc--hhhhHHHHHHHHHHHhcCCCcccccceeeecc------ce
Q 002336 613 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE------HQ 683 (935)
Q Consensus 613 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~------~~ 683 (935)
..|++.+.||+|+||.||++... .++.||+|++.... ....+.+.+|+.+++.++||||+++++++... ..
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 96 (355)
T cd07874 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQD 96 (355)
T ss_pred hceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccce
Confidence 45667889999999999999865 68899999986532 23446788899999999999999999987543 35
Q ss_pred EEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccc
Q 002336 684 RILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 763 (935)
Q Consensus 684 ~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~ 763 (935)
.++||||+++ +|.+.+. ..+++..+..++.|+++||+|||+ ++|+||||||+|||++.++.+||+|||+++
T Consensus 97 ~~lv~e~~~~-~l~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDikp~Nill~~~~~~kl~Dfg~~~ 167 (355)
T cd07874 97 VYLVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR 167 (355)
T ss_pred eEEEhhhhcc-cHHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEECCCCCEEEeeCcccc
Confidence 7999999965 6666664 247888999999999999999998 899999999999999999999999999998
Q ss_pred cccccccceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhH-H--------------
Q 002336 764 QAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNI-V-------------- 828 (935)
Q Consensus 764 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l-~-------------- 828 (935)
....... .....|+..|+|||++.+..++.++|||||||++|+|++|+.||...+..+.... .
T Consensus 168 ~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (355)
T cd07874 168 TAGTSFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 245 (355)
T ss_pred cCCCccc--cCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence 6543221 2234689999999999988999999999999999999999999975442211100 0
Q ss_pred -HHHHHhhhcC-Ceeecccccc-----c---CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002336 829 -HWARSMIKKG-DVISIVDPVL-----I---GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 884 (935)
Q Consensus 829 -~~~~~~i~~~-~~~~~~d~~l-----~---~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~ 884 (935)
..+...+... .......+.. . ..........+.+++.+|++.||++|||+.|+++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred cHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 0001111100 0000000000 0 00111123467899999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=296.30 Aligned_cols=249 Identities=22% Similarity=0.362 Sum_probs=201.8
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCc--chhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEec
Q 002336 615 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 691 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~--~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~ 691 (935)
|++.+.||+|+||.||.++.. +++.+++|.+... .....+.+.+|++++++++|+||+++++++.+.+..+++|||+
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~ 81 (256)
T cd08221 2 YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYA 81 (256)
T ss_pred ceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEec
Confidence 456789999999999999765 6889999987543 2344567889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccccc
Q 002336 692 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 771 (935)
Q Consensus 692 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~ 771 (935)
++++|.+++.... ...+++.++..++.|+++||+|||+ .+++||||+|+||+++.++.+||+|||++........
T Consensus 82 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~- 156 (256)
T cd08221 82 NGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHK---AGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS- 156 (256)
T ss_pred CCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChHhEEEeCCCCEEECcCcceEEcccccc-
Confidence 9999999987542 4568999999999999999999997 8999999999999999999999999999876544332
Q ss_pred eeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccCC
Q 002336 772 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 851 (935)
Q Consensus 772 ~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~~ 851 (935)
......+++.|+|||.+.+...+.++||||||++++||++|..||..... .+...... .+.....
T Consensus 157 ~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~------~~~~~~~~-~~~~~~~-------- 221 (256)
T cd08221 157 MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP------LNLVVKIV-QGNYTPV-------- 221 (256)
T ss_pred cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCH------HHHHHHHH-cCCCCCC--------
Confidence 12234588999999999888889999999999999999999999973221 11121111 2221111
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002336 852 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 884 (935)
Q Consensus 852 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~ 884 (935)
+......+.+++.+||..+|++||+++|+++.
T Consensus 222 -~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 222 -VSVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred -ccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 11223468899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=301.87 Aligned_cols=245 Identities=27% Similarity=0.392 Sum_probs=197.1
Q ss_pred cccccccccEEEEEEEEC-CCcEEEEEEccCcchhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEecCCCCH
Q 002336 618 CKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTL 696 (935)
Q Consensus 618 ~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL 696 (935)
...||+|+||.||++... +++.||||.+........+.+.+|+.+++.++|+||+++++.+...+..++||||+++++|
T Consensus 27 ~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L 106 (292)
T cd06658 27 FIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGAL 106 (292)
T ss_pred hhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcH
Confidence 467999999999999875 6889999998765555567789999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccccceeecc
Q 002336 697 RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVA 776 (935)
Q Consensus 697 ~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~ 776 (935)
.+++.. ..+++.++..++.|++.||+|||+ ++++||||||+||++++++.++|+|||++......... ....
T Consensus 107 ~~~~~~----~~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~-~~~~ 178 (292)
T cd06658 107 TDIVTH----TRMNEEQIATVCLSVLRALSYLHN---QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK-RKSL 178 (292)
T ss_pred HHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEccCcchhhccccccc-Ccee
Confidence 998852 358899999999999999999998 89999999999999999999999999998765332221 1224
Q ss_pred cCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccCCCCHHH
Q 002336 777 RGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIES 856 (935)
Q Consensus 777 ~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~~~~~~~ 856 (935)
.|+..|+|||.+.+..++.++||||||++++||++|+.||...+... ... .+... +.+.+.. ....
T Consensus 179 ~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~---~~~----~~~~~-----~~~~~~~--~~~~ 244 (292)
T cd06658 179 VGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQ---AMR----RIRDN-----LPPRVKD--SHKV 244 (292)
T ss_pred ecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHH----HHHhc-----CCCcccc--cccc
Confidence 57899999999988889999999999999999999999997332211 111 11110 1111111 0112
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002336 857 IWRIAEVAIQCVEQRGFSRPKMQEIVLA 884 (935)
Q Consensus 857 ~~~l~~li~~Cl~~dP~~RPs~~ev~~~ 884 (935)
...+.+++.+|+..+|++|||++|+++.
T Consensus 245 ~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 245 SSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 2367899999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-33 Score=302.96 Aligned_cols=262 Identities=23% Similarity=0.332 Sum_probs=196.9
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCcch--hhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEec
Q 002336 615 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 691 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~--~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~ 691 (935)
|++.+.||+|+||.||+|.++ +++.+|+|++..... ...+.+.+|+++++.++||||+++++++..+...++||||+
T Consensus 3 y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 82 (286)
T cd07846 3 YENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFV 82 (286)
T ss_pred eeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEecC
Confidence 456789999999999999986 589999998764322 23457889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccccc
Q 002336 692 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 771 (935)
Q Consensus 692 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~ 771 (935)
++++|.++... ...+++.+++.++.|+++||+|||+ .+++||||+|+||++++++.++|+|||++........
T Consensus 83 ~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~- 155 (286)
T cd07846 83 DHTVLDDLEKY---PNGLDESRVRKYLFQILRGIEFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE- 155 (286)
T ss_pred CccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcc-
Confidence 99999887653 3458999999999999999999998 8999999999999999999999999999876543322
Q ss_pred eeecccCCccccCCCCCCC-CCCCchhHHHHHHHHHHHHHhCCCCCCccCcccch-hHHHHHHH-------hhhcCCe-e
Q 002336 772 ISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAEL-NIVHWARS-------MIKKGDV-I 841 (935)
Q Consensus 772 ~~~~~~gt~~y~APE~l~~-~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~-~l~~~~~~-------~i~~~~~-~ 841 (935)
......++..|+|||++.+ ..++.++||||||++++||++|+.||......+.. ....+... ....... .
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T cd07846 156 VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFA 235 (286)
T ss_pred ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhh
Confidence 1223447889999998865 45788999999999999999999998643321110 01110000 0000000 0
Q ss_pred ecccccccC-----CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 842 SIVDPVLIG-----NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 842 ~~~d~~l~~-----~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
....+.... .........+.+++.+||+.+|++||+++++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 236 GMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred ccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 000000000 001122356889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=301.76 Aligned_cols=246 Identities=22% Similarity=0.345 Sum_probs=206.3
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcchh--hhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEe
Q 002336 614 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSH--RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 690 (935)
Q Consensus 614 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~~--~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~ 690 (935)
.|.+.+.||+|.|+.|-+|++- .|+.||||++.+..-. ....+.+|++.|+.++|||||++|++...+..+|||+|.
T Consensus 19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLEL 98 (864)
T KOG4717|consen 19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILEL 98 (864)
T ss_pred eehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEe
Confidence 3566789999999999999865 7999999999765332 346789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccc-cCCCcEEEeeccccccccccc
Q 002336 691 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL-DINMRAKVSDFGLSRQAEEDL 769 (935)
Q Consensus 691 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILl-d~~~~vkL~DFGla~~~~~~~ 769 (935)
-.+|+|.|++-+. ...+.+....+++.||..|+.|+|+ ..+|||||||+||.+ ..-|-+||.|||++..+....
T Consensus 99 GD~GDl~DyImKH--e~Gl~E~La~kYF~QI~~AI~YCHq---LHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~ 173 (864)
T KOG4717|consen 99 GDGGDLFDYIMKH--EEGLNEDLAKKYFAQIVHAISYCHQ---LHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGK 173 (864)
T ss_pred cCCchHHHHHHhh--hccccHHHHHHHHHHHHHHHHHHhh---hhhhcccCCcceeEEeeecCceEeeeccccccCCCcc
Confidence 9999999998764 5679999999999999999999998 899999999999865 678899999999998776543
Q ss_pred cceeecccCCccccCCCCCCCCCCC-chhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccccc
Q 002336 770 THISSVARGTVGYLDPEYYGNQQLT-EKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 848 (935)
Q Consensus 770 ~~~~~~~~gt~~y~APE~l~~~~~s-~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l 848 (935)
. ....+|...|-|||++.+..|+ ++.||||+|||||.|++|+.||+.....+.. .-++|-..
T Consensus 174 k--L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETL---------------TmImDCKY 236 (864)
T KOG4717|consen 174 K--LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETL---------------TMIMDCKY 236 (864)
T ss_pred h--hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhh---------------hhhhcccc
Confidence 3 2345799999999999988776 7899999999999999999999854443221 12233222
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 849 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 849 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
..|.....++.++|..||..||++|.+.+||+.
T Consensus 237 --tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 237 --TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred --cCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 235556678999999999999999999999864
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-33 Score=311.24 Aligned_cols=253 Identities=23% Similarity=0.296 Sum_probs=194.9
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc---hhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEe
Q 002336 615 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 690 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~ 690 (935)
|++.+.||+|+||.||++++. +++.||+|++.... ......+.+|..++..++|+||+++++++.+.+..++||||
T Consensus 3 y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey 82 (331)
T cd05624 3 FEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDY 82 (331)
T ss_pred ceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeC
Confidence 456789999999999999876 57889999986422 22335578899999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccccccc
Q 002336 691 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 770 (935)
Q Consensus 691 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~ 770 (935)
+++|+|.+++... ...+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||++........
T Consensus 83 ~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~~L~~lH~---~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 157 (331)
T cd05624 83 YVGGDLLTLLSKF--EDRLPEDMARFYIAEMVLAIHSIHQ---LHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT 157 (331)
T ss_pred CCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCc
Confidence 9999999999742 3568899999999999999999998 9999999999999999999999999999976654333
Q ss_pred ceeecccCCccccCCCCCCC-----CCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeeccc
Q 002336 771 HISSVARGTVGYLDPEYYGN-----QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 845 (935)
Q Consensus 771 ~~~~~~~gt~~y~APE~l~~-----~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d 845 (935)
.......|++.|+|||++.+ ..++.++||||||+++|||++|+.||...+.. +............. +.
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~------~~~~~i~~~~~~~~-~p 230 (331)
T cd05624 158 VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV------ETYGKIMNHEERFQ-FP 230 (331)
T ss_pred eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHH------HHHHHHHcCCCccc-CC
Confidence 22334568999999998865 46788999999999999999999999743221 11111111111000 01
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 002336 846 PVLIGNVKIESIWRIAEVAIQCVEQRGFS--RPKMQEIVLA 884 (935)
Q Consensus 846 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~--RPs~~ev~~~ 884 (935)
+.. ......+.+++.+|+...+++ |++++++.+.
T Consensus 231 ~~~-----~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 231 SHI-----TDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred Ccc-----ccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 111 112346788999998865544 4678887654
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-33 Score=311.04 Aligned_cols=253 Identities=25% Similarity=0.323 Sum_probs=194.1
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc---hhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEe
Q 002336 615 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 690 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~ 690 (935)
+++.+.||+|+||.||+++++ .++.+|+|++.... ......+.+|+.++..++|+||+++++.+.+.+..++||||
T Consensus 3 y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey 82 (332)
T cd05623 3 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDY 82 (332)
T ss_pred ceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEec
Confidence 456789999999999999876 47789999986421 22334588899999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccccccc
Q 002336 691 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 770 (935)
Q Consensus 691 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~ 770 (935)
+++|+|.+++... ...+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||++........
T Consensus 83 ~~~g~L~~~l~~~--~~~l~~~~~~~~~~qi~~al~~lH~---~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~ 157 (332)
T cd05623 83 YVGGDLLTLLSKF--EDRLPEDMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT 157 (332)
T ss_pred cCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEeecchheecccCCc
Confidence 9999999999742 3568899999999999999999998 9999999999999999999999999999876543333
Q ss_pred ceeecccCCccccCCCCCC-----CCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeeccc
Q 002336 771 HISSVARGTVGYLDPEYYG-----NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 845 (935)
Q Consensus 771 ~~~~~~~gt~~y~APE~l~-----~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d 845 (935)
.......||+.|+|||++. ...++.++|||||||++|||++|+.||...+. .+..............
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~------~~~~~~i~~~~~~~~~-- 229 (332)
T cd05623 158 VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESL------VETYGKIMNHKERFQF-- 229 (332)
T ss_pred ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCH------HHHHHHHhCCCccccC--
Confidence 2233456899999999875 34678999999999999999999999974322 1111222211110000
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCC--CCCCHHHHHHH
Q 002336 846 PVLIGNVKIESIWRIAEVAIQCVEQRGF--SRPKMQEIVLA 884 (935)
Q Consensus 846 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~--~RPs~~ev~~~ 884 (935)
+.. .......+.+++.+|+..+++ .|++++|+++.
T Consensus 230 p~~----~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 230 PAQ----VTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred CCc----cccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 000 111234577888888765444 37899998766
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=300.99 Aligned_cols=260 Identities=21% Similarity=0.259 Sum_probs=199.4
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc--hhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEec
Q 002336 615 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 691 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~ 691 (935)
|++.+.||+|++|.||+|.++ +++.||+|.++... ....+.+.+|++++++++|+||+++++++...+..++||||+
T Consensus 3 y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~ 82 (288)
T cd07833 3 YEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYV 82 (288)
T ss_pred eeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEecC
Confidence 456789999999999999876 58899999886532 223467899999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccccc
Q 002336 692 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 771 (935)
Q Consensus 692 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~ 771 (935)
+++.+..+.. ....+++.++..++.|++.||+|||+ .+++||||+|+||++++++.+||+|||++.........
T Consensus 83 ~~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~ 156 (288)
T cd07833 83 ERTLLELLEA---SPGGLPPDAVRSYIWQLLQAIAYCHS---HNIIHRDIKPENILVSESGVLKLCDFGFARALRARPAS 156 (288)
T ss_pred CCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEEeeecccccCCCccc
Confidence 9877776654 23558999999999999999999998 89999999999999999999999999998876544332
Q ss_pred eeecccCCccccCCCCCCCC-CCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhh------------hcC
Q 002336 772 ISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMI------------KKG 838 (935)
Q Consensus 772 ~~~~~~gt~~y~APE~l~~~-~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i------------~~~ 838 (935)
......++..|+|||++.+. .++.++||||||+++|+|++|+.||......+. ........ ...
T Consensus 157 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd07833 157 PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQ---LYLIQKCLGPLPPSHQELFSSNP 233 (288)
T ss_pred cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhCCCCHHHhhhcccCc
Confidence 22334578899999999887 889999999999999999999999974322111 00011100 000
Q ss_pred Cee-----eccccc-ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 839 DVI-----SIVDPV-LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 839 ~~~-----~~~d~~-l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
... ...++. ....++......+.+++++||..+|++||+++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 234 RFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred cccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 000 000000 000111122457899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-32 Score=297.57 Aligned_cols=260 Identities=23% Similarity=0.295 Sum_probs=199.7
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc--hhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEec
Q 002336 615 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 691 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~ 691 (935)
|++.+.||+|++|.||+|.+. +|+.||+|++.... ....+.+.+|+.++++++||||+++++++..+...++||||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (286)
T cd07832 2 YKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM 81 (286)
T ss_pred ceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc
Confidence 456788999999999999875 68999999987543 233467899999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccccc
Q 002336 692 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 771 (935)
Q Consensus 692 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~ 771 (935)
+++|.+++... ...+++.+++.++.|+++||+|||+ .+++|+||||+||+++.++.++|+|||++.........
T Consensus 82 -~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~ 155 (286)
T cd07832 82 -PSDLSEVLRDE--ERPLPEAQVKSYMRMLLKGVAYMHA---NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPR 155 (286)
T ss_pred -CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCC
Confidence 99999998743 3668999999999999999999998 89999999999999999999999999998876543322
Q ss_pred eeecccCCccccCCCCCCCC-CCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCC-----------
Q 002336 772 ISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD----------- 839 (935)
Q Consensus 772 ~~~~~~gt~~y~APE~l~~~-~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~----------- 839 (935)
......++..|+|||.+.+. .++.++||||+|++++||++|..||...... ....++........
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07832 156 LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDI---EQLAIVFRTLGTPNEETWPGLTSLP 232 (286)
T ss_pred ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHH---HHHHHHHHHcCCCChHHHhhccCcc
Confidence 22334588999999988654 5689999999999999999998888633221 11111111111000
Q ss_pred -eeeccccccc----CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 840 -VISIVDPVLI----GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 840 -~~~~~d~~l~----~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
...+..+... .....+....+.+++.+|++.+|++||+++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~ 281 (286)
T cd07832 233 DYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR 281 (286)
T ss_pred hhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 0000000000 0001122357889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=296.33 Aligned_cols=253 Identities=27% Similarity=0.394 Sum_probs=200.7
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCc--chhhhHHHHHHHHHHHhcCCCcccccceeeec--cceEEEEEE
Q 002336 615 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEE--EHQRILVYE 689 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~--~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~--~~~~~lV~E 689 (935)
|++.+.||.|+||.||++... +++.+|+|.+... .....+.+.+|++++++++||||+++++++.. +...+++||
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e 81 (265)
T cd08217 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVME 81 (265)
T ss_pred ceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEeh
Confidence 456688999999999999865 6889999988643 23345678899999999999999999997753 456789999
Q ss_pred ecCCCCHHHHhccCC-CCCCCCHHHHHHHHHHHHHHhHHhhhcC--CCceEecCCCCCCccccCCCcEEEeecccccccc
Q 002336 690 YMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGC--NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 766 (935)
Q Consensus 690 ~~~~gsL~~~L~~~~-~~~~l~~~~~~~i~~qia~gL~yLHs~~--~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~ 766 (935)
|+++++|.+++.... ....+++..++.++.|+++||+|||..+ ..+++|+||||+||+++.++.+||+|||++....
T Consensus 82 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~~ 161 (265)
T cd08217 82 YCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILG 161 (265)
T ss_pred hccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccccc
Confidence 999999999986532 3457899999999999999999999321 2899999999999999999999999999998765
Q ss_pred ccccceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccc
Q 002336 767 EDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP 846 (935)
Q Consensus 767 ~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~ 846 (935)
..... .....+++.|+|||.+.+..++.++|+||||+++++|++|+.||...+. ....+ .+..+...
T Consensus 162 ~~~~~-~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~~~~----~~~~~~~~----- 228 (265)
T cd08217 162 HDSSF-AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ---LQLAS----KIKEGKFR----- 228 (265)
T ss_pred CCccc-ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH---HHHHH----HHhcCCCC-----
Confidence 43321 1233588999999999988899999999999999999999999974331 11211 22222111
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002336 847 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 884 (935)
Q Consensus 847 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~ 884 (935)
..+......+.+++.+|++.+|++||++++|++.
T Consensus 229 ----~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 229 ----RIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred ----CCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 1122233578899999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-32 Score=300.51 Aligned_cols=245 Identities=25% Similarity=0.403 Sum_probs=196.9
Q ss_pred cccccccccEEEEEEEEC-CCcEEEEEEccCcchhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEecCCCCH
Q 002336 618 CKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTL 696 (935)
Q Consensus 618 ~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL 696 (935)
...||+|+||.||++... +++.||+|.+........+.+.+|+.+++.++||||+++++++..++..++||||+++++|
T Consensus 26 ~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L 105 (297)
T cd06659 26 YIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL 105 (297)
T ss_pred hhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCH
Confidence 457999999999999875 6899999998654444556788999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccccceeecc
Q 002336 697 RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVA 776 (935)
Q Consensus 697 ~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~ 776 (935)
.+++. ...+++..++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++......... ....
T Consensus 106 ~~~~~----~~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~-~~~~ 177 (297)
T cd06659 106 TDIVS----QTRLNEEQIATVCESVLQALCYLHS---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK-RKSL 177 (297)
T ss_pred HHHHh----hcCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHeEEccCCcEEEeechhHhhccccccc-ccce
Confidence 99875 3458899999999999999999997 89999999999999999999999999998755432221 2234
Q ss_pred cCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccCCCCHHH
Q 002336 777 RGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIES 856 (935)
Q Consensus 777 ~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~~~~~~~ 856 (935)
.++..|+|||++.+..++.++||||||++++||++|+.||...+.. ..... +....... .. .....
T Consensus 178 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~---~~~~~----~~~~~~~~-----~~--~~~~~ 243 (297)
T cd06659 178 VGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPV---QAMKR----LRDSPPPK-----LK--NAHKI 243 (297)
T ss_pred ecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHH----HhccCCCC-----cc--ccCCC
Confidence 5889999999998888999999999999999999999999733221 11111 11111000 00 01112
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002336 857 IWRIAEVAIQCVEQRGFSRPKMQEIVLA 884 (935)
Q Consensus 857 ~~~l~~li~~Cl~~dP~~RPs~~ev~~~ 884 (935)
...+.+++.+|++.+|++||+++++++.
T Consensus 244 ~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 244 SPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred CHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 2357899999999999999999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-32 Score=293.70 Aligned_cols=252 Identities=28% Similarity=0.386 Sum_probs=202.1
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc-hhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEecC
Q 002336 615 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 692 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~-~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~~ 692 (935)
+++.+.||+|++|.||++.++ +++.+|+|.+.... ....+++.+|++++++++||||+++++.+......++++||++
T Consensus 3 ~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (265)
T cd06605 3 LEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMD 82 (265)
T ss_pred chHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecC
Confidence 456688999999999999886 68999999987643 3445678999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccccce
Q 002336 693 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 772 (935)
Q Consensus 693 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~~ 772 (935)
+++|.+++... ...+++..+.+++.|+++||+|||+ ..+++|+||||+||++++++.++|+|||.+.........
T Consensus 83 ~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~--~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~- 157 (265)
T cd06605 83 GGSLDKILKEV--QGRIPERILGKIAVAVLKGLTYLHE--KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK- 157 (265)
T ss_pred CCcHHHHHHHc--cCCCCHHHHHHHHHHHHHHHHHHcC--CCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhh-
Confidence 99999998753 2678899999999999999999996 379999999999999999999999999998765432221
Q ss_pred eecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccCCC
Q 002336 773 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNV 852 (935)
Q Consensus 773 ~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~~~ 852 (935)
...++..|+|||.+.+..++.++||||||+++++|++|+.||...+. ......+.++..... .. +.+...
T Consensus 158 --~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~-~~-----~~~~~~- 227 (265)
T cd06605 158 --TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPEND-PPDGIFELLQYIVNE-PP-----PRLPSG- 227 (265)
T ss_pred --cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccc-ccccHHHHHHHHhcC-CC-----CCCChh-
Confidence 14578899999999888999999999999999999999999973322 112222222222221 11 111111
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 853 KIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 853 ~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
.....+.+++.+||..+|++||++.+++.
T Consensus 228 --~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 228 --KFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred --hcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 13346889999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-32 Score=296.98 Aligned_cols=248 Identities=28% Similarity=0.412 Sum_probs=200.3
Q ss_pred HHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc-hhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEe
Q 002336 613 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 690 (935)
Q Consensus 613 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~-~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~ 690 (935)
..+++.+.||+|+||.||+|... +++.+|+|++.... ....+.+.+|+.++++++||||+++++++..++..++||||
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 83 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence 45667789999999999999865 68899999876432 33456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccccccc
Q 002336 691 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 770 (935)
Q Consensus 691 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~ 770 (935)
+++++|.+++.. ..+++..+..++.|++.++.|||+ .+++|+||||+||+++.++.++|+|||++........
T Consensus 84 ~~~~~l~~~i~~----~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06641 84 LGGGSALDLLEP----GPLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHcc---CCeecCCCCHHhEEECCCCCEEEeecccceecccchh
Confidence 999999999863 458899999999999999999997 9999999999999999999999999999876543221
Q ss_pred ceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccC
Q 002336 771 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 850 (935)
Q Consensus 771 ~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~ 850 (935)
......++..|+|||.+.+...+.++|+||||+++++|++|..||..... . .+.. .+..+.. +.+
T Consensus 157 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~---~---~~~~-~~~~~~~-----~~~-- 221 (277)
T cd06641 157 -KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHP---M---KVLF-LIPKNNP-----PTL-- 221 (277)
T ss_pred -hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccch---H---HHHH-HHhcCCC-----CCC--
Confidence 12233578899999999888889999999999999999999999863221 1 1111 1111111 111
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002336 851 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 884 (935)
Q Consensus 851 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~ 884 (935)
+......+.+++.+|++.+|++||+++++++.
T Consensus 222 --~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 222 --EGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred --CcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 11223467899999999999999999999884
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=303.72 Aligned_cols=196 Identities=26% Similarity=0.393 Sum_probs=159.2
Q ss_pred cccccccccEEEEEEEEC---CCcEEEEEEccCcchhhhHHHHHHHHHHHhcCCCcccccceeee--ccceEEEEEEecC
Q 002336 618 CKKIGKGSFGSVYYGKMK---DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCE--EEHQRILVYEYMH 692 (935)
Q Consensus 618 ~~~LG~G~fG~Vy~~~~~---~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~--~~~~~~lV~E~~~ 692 (935)
..+||+|+||.||+|..+ +++.||+|.+.... ....+.+|++++++++||||+++++++. .+...++||||++
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 357999999999999875 35789999886532 2346788999999999999999999884 3567899999986
Q ss_pred CCCHHHHhccCC------CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccc----cCCCcEEEeecccc
Q 002336 693 NGTLRDRLHGSV------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL----DINMRAKVSDFGLS 762 (935)
Q Consensus 693 ~gsL~~~L~~~~------~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILl----d~~~~vkL~DFGla 762 (935)
+ +|.+.+.... ....+++..+..++.|++.||.|||+ .+|+||||||+|||+ ++++.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 4 7777664211 22358899999999999999999998 899999999999999 56678999999999
Q ss_pred ccccccccc--eeecccCCccccCCCCCCC-CCCCchhHHHHHHHHHHHHHhCCCCCCcc
Q 002336 763 RQAEEDLTH--ISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVE 819 (935)
Q Consensus 763 ~~~~~~~~~--~~~~~~gt~~y~APE~l~~-~~~s~ksDVwS~Gvil~eLltG~~Pf~~~ 819 (935)
+........ ......+|+.|+|||.+.+ ..++.++|||||||++|||+||+.||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 876443221 1223457899999998866 46899999999999999999999999743
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=316.68 Aligned_cols=205 Identities=27% Similarity=0.360 Sum_probs=175.2
Q ss_pred hhhHHHHHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcchhhhHHHHHHHHHHHhcC-C-----Ccccccceeee
Q 002336 607 LPELEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIH-H-----RNLVPLIGYCE 679 (935)
Q Consensus 607 ~~~l~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~-H-----pnIv~l~g~~~ 679 (935)
..|...-+|.+.+.||+|.||.|-+|... +++.||||+++.. .....+-..|+.+|..|+ | -|+|+++++|.
T Consensus 180 ~~d~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~ 258 (586)
T KOG0667|consen 180 VNDHIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFY 258 (586)
T ss_pred ecceeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccc
Confidence 33444447788999999999999999754 6999999999764 344567778999999996 4 48999999999
Q ss_pred ccceEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCC--cEEEe
Q 002336 680 EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM--RAKVS 757 (935)
Q Consensus 680 ~~~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~--~vkL~ 757 (935)
..++.|||+|.+ ..+|+++++.. ...+++...+..++.||+.||.+||+ .+|||+||||+||||.+.+ .+||+
T Consensus 259 fr~HlciVfELL-~~NLYellK~n-~f~Glsl~~ir~~~~Qil~~L~~L~~---l~IIHcDLKPENILL~~~~r~~vKVI 333 (586)
T KOG0667|consen 259 FRNHLCIVFELL-STNLYELLKNN-KFRGLSLPLVRKFAQQILTALLFLHE---LGIIHCDLKPENILLKDPKRSRIKVI 333 (586)
T ss_pred cccceeeeehhh-hhhHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCChhheeeccCCcCceeEE
Confidence 999999999999 56999999876 45669999999999999999999998 9999999999999997543 59999
Q ss_pred eccccccccccccceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCc
Q 002336 758 DFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDF 821 (935)
Q Consensus 758 DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~ 821 (935)
|||.++....... ....+..|+|||++.+.+|+.+.||||||||+.||++|.+-|.+++.
T Consensus 334 DFGSSc~~~q~vy----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne 393 (586)
T KOG0667|consen 334 DFGSSCFESQRVY----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNE 393 (586)
T ss_pred ecccccccCCcce----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCH
Confidence 9999987654322 34567899999999999999999999999999999999988875543
|
|
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=295.96 Aligned_cols=248 Identities=27% Similarity=0.395 Sum_probs=200.1
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCc--chhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEec
Q 002336 615 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 691 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~--~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~ 691 (935)
|++.+.||+|+||.+|++... +|+.+|+|.+... .....+++.+|+.++++++||||+++++++...+..++|+||+
T Consensus 2 y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd08218 2 YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYC 81 (256)
T ss_pred ceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecC
Confidence 456789999999999999865 6899999998643 2234467899999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccccc
Q 002336 692 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 771 (935)
Q Consensus 692 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~ 771 (935)
++++|.+.+... ....+++.++++++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++.........
T Consensus 82 ~~~~l~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~ 157 (256)
T cd08218 82 EGGDLYKKINAQ-RGVLFPEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVEL 157 (256)
T ss_pred CCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhh
Confidence 999999988743 23457899999999999999999997 89999999999999999999999999998765443221
Q ss_pred eeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccCC
Q 002336 772 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 851 (935)
Q Consensus 772 ~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~~ 851 (935)
.....|++.|+|||.+.+...+.++|+||||+++++|++|+.||...+. .+.+...+ .+....
T Consensus 158 -~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~------~~~~~~~~-~~~~~~--------- 220 (256)
T cd08218 158 -ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM------KNLVLKII-RGSYPP--------- 220 (256)
T ss_pred -hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCH------HHHHHHHh-cCCCCC---------
Confidence 2233578899999999888899999999999999999999999863221 11122222 111111
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 852 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 852 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
.+......+.+++.+|++.+|++||++.||++
T Consensus 221 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 221 VSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred CcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 11122346889999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=316.89 Aligned_cols=250 Identities=22% Similarity=0.349 Sum_probs=192.9
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc---hhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEe
Q 002336 615 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 690 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~ 690 (935)
+++.+.||+|+||.||++..+ +++.||+|++.... ......+.+|+.++..++||||+++++.+.+.+..++||||
T Consensus 3 f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~ 82 (360)
T cd05627 3 FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEF 82 (360)
T ss_pred ceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeC
Confidence 345789999999999999876 68999999986432 22345788899999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccccccc
Q 002336 691 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 770 (935)
Q Consensus 691 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~ 770 (935)
+++|+|.+++.. ...+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||++........
T Consensus 83 ~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~~L~~lH~---~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~ 156 (360)
T cd05627 83 LPGGDMMTLLMK---KDTLSEEATQFYIAETVLAIDAIHQ---LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHR 156 (360)
T ss_pred CCCccHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEeeccCCcccccccc
Confidence 999999999873 4568999999999999999999998 9999999999999999999999999999875422100
Q ss_pred ----------------------------------ceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCC
Q 002336 771 ----------------------------------HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPV 816 (935)
Q Consensus 771 ----------------------------------~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf 816 (935)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf 236 (360)
T cd05627 157 TEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236 (360)
T ss_pred cccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCC
Confidence 0011245899999999999999999999999999999999999999
Q ss_pred CccCcccchhHHHHHHHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCC---HHHHHHH
Q 002336 817 SVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPK---MQEIVLA 884 (935)
Q Consensus 817 ~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs---~~ev~~~ 884 (935)
....... ............ .+.+ .. .....+.+++.+|+. +|++|++ ++|+.+.
T Consensus 237 ~~~~~~~------~~~~i~~~~~~~-~~p~----~~--~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~h 293 (360)
T cd05627 237 CSETPQE------TYRKVMNWKETL-VFPP----EV--PISEKAKDLILRFCT-DSENRIGSNGVEEIKSH 293 (360)
T ss_pred CCCCHHH------HHHHHHcCCCce-ecCC----CC--CCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcC
Confidence 7433211 111111110000 0111 00 112356778888764 9999995 5665543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=313.36 Aligned_cols=240 Identities=27% Similarity=0.310 Sum_probs=186.0
Q ss_pred ccccccEEEEEEEEC-CCcEEEEEEccCcch---hhhHHHHHHHHHHHhc---CCCcccccceeeeccceEEEEEEecCC
Q 002336 621 IGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRI---HHRNLVPLIGYCEEEHQRILVYEYMHN 693 (935)
Q Consensus 621 LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~---~~~~~~~~E~~iL~~L---~HpnIv~l~g~~~~~~~~~lV~E~~~~ 693 (935)
||+|+||.||+|+.. +++.||+|++..... .....+..|..++... +||||+++++.+.+....++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999876 589999999864321 1223455677777665 699999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccccccccee
Q 002336 694 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 773 (935)
Q Consensus 694 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~~~ 773 (935)
|+|.+++.. ...+++..+..++.||++||+|||+ ++|+||||||+|||++.++.+||+|||+++....... ..
T Consensus 81 g~L~~~l~~---~~~~~~~~~~~~~~qil~al~~LH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~-~~ 153 (330)
T cd05586 81 GELFWHLQK---EGRFSEDRAKFYIAELVLALEHLHK---YDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK-TT 153 (330)
T ss_pred ChHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC-Cc
Confidence 999998873 4568999999999999999999998 8999999999999999999999999999875432221 12
Q ss_pred ecccCCccccCCCCCCCC-CCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccCCC
Q 002336 774 SVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNV 852 (935)
Q Consensus 774 ~~~~gt~~y~APE~l~~~-~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~~~ 852 (935)
....||+.|+|||.+.+. .++.++||||+||++|||++|+.||...... + ..+.+..+.. .+...
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~------~-~~~~i~~~~~------~~~~~- 219 (330)
T cd05586 154 NTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQ------Q-MYRNIAFGKV------RFPKN- 219 (330)
T ss_pred cCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHH------H-HHHHHHcCCC------CCCCc-
Confidence 334689999999988654 5789999999999999999999999743221 1 1112222211 01100
Q ss_pred CHHHHHHHHHHHHHccccCCCCCC----CHHHHHH
Q 002336 853 KIESIWRIAEVAIQCVEQRGFSRP----KMQEIVL 883 (935)
Q Consensus 853 ~~~~~~~l~~li~~Cl~~dP~~RP----s~~ev~~ 883 (935)
.....+.+++.+||+.+|++|| +++++++
T Consensus 220 --~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 220 --VLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred --cCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 1123677999999999999998 4555544
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-32 Score=296.86 Aligned_cols=262 Identities=23% Similarity=0.283 Sum_probs=197.2
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCcch--hhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEec
Q 002336 615 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 691 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~--~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~ 691 (935)
|++.+.||+|++|.||+|.++ +|+.||+|++..... ...+.+.+|++++++++|||++++++++......++||||+
T Consensus 3 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~ 82 (286)
T cd07847 3 YEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYC 82 (286)
T ss_pred eeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEecc
Confidence 456788999999999999886 589999998864321 23356889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccccc
Q 002336 692 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 771 (935)
Q Consensus 692 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~ 771 (935)
+++.|..++.. ...+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++.........
T Consensus 83 ~~~~l~~~~~~---~~~~~~~~~~~~~~ql~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 156 (286)
T cd07847 83 DHTVLNELEKN---PRGVPEHLIKKIIWQTLQAVNFCHK---HNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDD 156 (286)
T ss_pred CccHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCChhhEEEcCCCcEEECccccceecCCCccc
Confidence 99988887652 3468999999999999999999998 89999999999999999999999999999876443211
Q ss_pred eeecccCCccccCCCCCCC-CCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchh-HHHHHHHhhh-------cCC-ee
Q 002336 772 ISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELN-IVHWARSMIK-------KGD-VI 841 (935)
Q Consensus 772 ~~~~~~gt~~y~APE~l~~-~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~-l~~~~~~~i~-------~~~-~~ 841 (935)
.....++..|+|||.+.+ ..++.++||||||+++++|++|+.||......+... ........+. ... ..
T Consensus 157 -~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T cd07847 157 -YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFK 235 (286)
T ss_pred -ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccc
Confidence 122346788999998765 567899999999999999999999997433221111 1100000000 000 00
Q ss_pred ecccccccCCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 842 SIVDPVLIGNVK-----IESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 842 ~~~d~~l~~~~~-----~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
....+......+ ......+.+++.+||+.+|++||++.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 236 GLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred cccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 000111110001 112346889999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-32 Score=293.74 Aligned_cols=254 Identities=26% Similarity=0.367 Sum_probs=202.1
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc-hhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEecC
Q 002336 615 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 692 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~-~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~~ 692 (935)
+++.+.||.|++|.||+|... +++.+++|++.... ....+.+.+|+++++.++|+||+++++.+...+..++|||+++
T Consensus 3 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~ 82 (267)
T cd06610 3 YELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLS 82 (267)
T ss_pred ceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEeccC
Confidence 566789999999999999865 68899999986432 3356789999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccccc-
Q 002336 693 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH- 771 (935)
Q Consensus 693 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~- 771 (935)
+++|.+.+........+++..+..++.|++.||+|||+ .+++||||||+||++++++.++|+|||++.........
T Consensus 83 ~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~---~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~ 159 (267)
T cd06610 83 GGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHS---NGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRT 159 (267)
T ss_pred CCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcccc
Confidence 99999999754334568999999999999999999997 89999999999999999999999999998765443222
Q ss_pred --eeecccCCccccCCCCCCCC-CCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccccc
Q 002336 772 --ISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 848 (935)
Q Consensus 772 --~~~~~~gt~~y~APE~l~~~-~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l 848 (935)
......|+..|+|||.+... ..+.++|+||||+++++|++|+.||...... ....+ ..... .+.+
T Consensus 160 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~--~~~~~----~~~~~------~~~~ 227 (267)
T cd06610 160 RKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPM--KVLML----TLQND------PPSL 227 (267)
T ss_pred ccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChh--hhHHH----HhcCC------CCCc
Confidence 22334578899999998776 7899999999999999999999999733221 11111 11111 0111
Q ss_pred cCCC-CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 849 IGNV-KIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 849 ~~~~-~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
.... .......+.+++.+|++.+|++||++++|++
T Consensus 228 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 228 ETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred CCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 1110 1123346889999999999999999999975
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-32 Score=309.88 Aligned_cols=261 Identities=23% Similarity=0.292 Sum_probs=194.1
Q ss_pred HHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc--hhhhHHHHHHHHHHHhcCCCcccccceeeecc------ce
Q 002336 613 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE------HQ 683 (935)
Q Consensus 613 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~------~~ 683 (935)
..|.+.+.||+|+||.||++... .++.||||++.... ....+.+.+|+.+++.++||||+++++++... ..
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~ 103 (364)
T cd07875 24 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQD 103 (364)
T ss_pred cceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCe
Confidence 45667889999999999999865 68899999987532 23446788999999999999999999987543 35
Q ss_pred EEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccc
Q 002336 684 RILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 763 (935)
Q Consensus 684 ~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~ 763 (935)
.++||||+++ +|.+.+. ..+++..+..++.|+++||+|||+ ++|+||||||+|||++.++.+||+|||+++
T Consensus 104 ~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~ 174 (364)
T cd07875 104 VYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR 174 (364)
T ss_pred EEEEEeCCCC-CHHHHHH-----hcCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEECCCCcEEEEeCCCcc
Confidence 7999999965 6777664 247888999999999999999998 899999999999999999999999999997
Q ss_pred cccccccceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHH---------HH----
Q 002336 764 QAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIV---------HW---- 830 (935)
Q Consensus 764 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~---------~~---- 830 (935)
....... .....++..|+|||++.+..++.++|||||||++|||++|+.||...+..+....+ ++
T Consensus 175 ~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (364)
T cd07875 175 TAGTSFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL 252 (364)
T ss_pred ccCCCCc--ccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhh
Confidence 6543221 22345899999999999999999999999999999999999999754322111000 00
Q ss_pred ---HHHhhhcCC-ee-----ecccccc---cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002336 831 ---ARSMIKKGD-VI-----SIVDPVL---IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 884 (935)
Q Consensus 831 ---~~~~i~~~~-~~-----~~~d~~l---~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~ 884 (935)
+........ .. ....... ...........+.+++.+|++.||++|||+.|+++.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 253 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred hHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 000000000 00 0000000 000011122467899999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=295.95 Aligned_cols=247 Identities=25% Similarity=0.387 Sum_probs=191.3
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc-----hhhhHHHHHHHHHHHhcCCCcccccceeeec--cceEEE
Q 002336 615 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-----SHRTQQFVTEVALLSRIHHRNLVPLIGYCEE--EHQRIL 686 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~-----~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~--~~~~~l 686 (935)
+...+.||+|+||.||+|... .++.|++|++.... ......+.+|+.++++++||||+++++++.+ ....++
T Consensus 4 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 83 (266)
T cd06651 4 WRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTI 83 (266)
T ss_pred ccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEE
Confidence 345689999999999999875 58999999875321 2234578899999999999999999998865 356789
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccc
Q 002336 687 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 766 (935)
Q Consensus 687 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~ 766 (935)
++||+++++|.+.+.. ...+++.....++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++....
T Consensus 84 ~~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~LH~---~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~ 157 (266)
T cd06651 84 FMEYMPGGSVKDQLKA---YGALTESVTRKYTRQILEGMSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQ 157 (266)
T ss_pred EEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCCCccccc
Confidence 9999999999999873 3458899999999999999999997 899999999999999999999999999987543
Q ss_pred cccc--ceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecc
Q 002336 767 EDLT--HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 844 (935)
Q Consensus 767 ~~~~--~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~ 844 (935)
.... .......++..|+|||.+.+..++.++||||+|+++|||++|+.||...+. ...+........
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~------~~~~~~~~~~~~----- 226 (266)
T cd06651 158 TICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA------MAAIFKIATQPT----- 226 (266)
T ss_pred cccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccch------HHHHHHHhcCCC-----
Confidence 2111 111223478899999999888899999999999999999999999973221 111111111111
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 845 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 845 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
.+. .+......+.+++ +||..+|++||+++||++
T Consensus 227 ~~~----~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 227 NPQ----LPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred CCC----CchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 111 1222223456666 688899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=319.83 Aligned_cols=256 Identities=26% Similarity=0.410 Sum_probs=209.1
Q ss_pred HHHhhcccccccccEEEEEEEEC-CC----cEEEEEEccCc-chhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEE
Q 002336 613 ATNNFCKKIGKGSFGSVYYGKMK-DG----KEVAVKIMADS-CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRIL 686 (935)
Q Consensus 613 ~~~~~~~~LG~G~fG~Vy~~~~~-~g----~~vAvK~~~~~-~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~l 686 (935)
...+-.++||+|+||+||+|.|- +| -+||+|++... ..+..+++.+|+.+|.+|.|||+++++|+|.... ..|
T Consensus 696 telkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~ql 774 (1177)
T KOG1025|consen 696 TELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQL 774 (1177)
T ss_pred hhhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHH
Confidence 33444689999999999999863 44 46899988654 3345678999999999999999999999998765 789
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccc
Q 002336 687 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 766 (935)
Q Consensus 687 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~ 766 (935)
|++||+.|.|.++++.. +..+-.+..+.|..|||+||.|||. ++++||||.++||||..-.++||.|||+++...
T Consensus 775 vtq~mP~G~LlDyvr~h--r~~igsq~lLnw~~QIAkgM~YLe~---qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~ 849 (1177)
T KOG1025|consen 775 VTQLMPLGCLLDYVREH--RDNIGSQDLLNWCYQIAKGMKYLEE---QRLVHRDLAARNVLVKSPNHVKITDFGLAKLLA 849 (1177)
T ss_pred HHHhcccchHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHh---cchhhhhhhhhheeecCCCeEEEEecchhhccC
Confidence 99999999999999864 5668888999999999999999997 999999999999999999999999999999876
Q ss_pred cccccee-ecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCcccchhHHHHHHHhhhcCCeeecc
Q 002336 767 EDLTHIS-SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 844 (935)
Q Consensus 767 ~~~~~~~-~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~ 844 (935)
.+..... ....-.+.|||-|.+....++.++|||||||++||++| |..|+++....+..+ .++.|+.
T Consensus 850 ~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~d-------lle~geR---- 918 (1177)
T KOG1025|consen 850 PDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPD-------LLEKGER---- 918 (1177)
T ss_pred cccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhH-------HHhcccc----
Confidence 5443322 22234678999999999999999999999999999999 999998555443322 2333322
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhhhh
Q 002336 845 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 890 (935)
Q Consensus 845 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~~~ 890 (935)
| ..|+-...++..++.+||..|+..||+++++...+.+...
T Consensus 919 ---L--sqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ar 959 (1177)
T KOG1025|consen 919 ---L--SQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMAR 959 (1177)
T ss_pred ---C--CCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhc
Confidence 1 2344455678899999999999999999999988776543
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-32 Score=303.29 Aligned_cols=250 Identities=26% Similarity=0.331 Sum_probs=197.3
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCcch---hhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEe
Q 002336 615 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 690 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~---~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~ 690 (935)
+++.+.||+|++|.||++... +++.+|+|.+..... ...+.+.+|+++++.++|+||+++++.+......++||||
T Consensus 3 y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 82 (316)
T cd05574 3 FKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDY 82 (316)
T ss_pred eEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEe
Confidence 455688999999999999876 489999999875432 2446788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccccccc
Q 002336 691 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 770 (935)
Q Consensus 691 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~ 770 (935)
+.+++|.+++... ....+++..+..++.|+++||+|||+ .+++||||||+||+++.++.++|+|||++........
T Consensus 83 ~~~~~L~~~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~ 158 (316)
T cd05574 83 CPGGELFRLLQRQ-PGKCLSEEVARFYAAEVLLALEYLHL---LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPP 158 (316)
T ss_pred cCCCCHHHHHHhC-CCCccCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChHHeEEcCCCCEEEeecchhhccccccc
Confidence 9999999998743 34578999999999999999999997 8999999999999999999999999999875432111
Q ss_pred c----------------------------eeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcc
Q 002336 771 H----------------------------ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFG 822 (935)
Q Consensus 771 ~----------------------------~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~ 822 (935)
. ......|+..|+|||.+.+..++.++||||||+++|+|++|+.||...+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~ 238 (316)
T cd05574 159 PVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRD 238 (316)
T ss_pred ccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchH
Confidence 0 011235788999999998888999999999999999999999999743321
Q ss_pred cchhHHHHHHHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCC----HHHHHH
Q 002336 823 AELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPK----MQEIVL 883 (935)
Q Consensus 823 ~~~~l~~~~~~~i~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs----~~ev~~ 883 (935)
. .+. .... ... ... ........+.+++.+|+..+|++||+ ++|+++
T Consensus 239 ~--~~~----~~~~-~~~------~~~--~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 239 E--TFS----NILK-KEV------TFP--GSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred H--HHH----HHhc-CCc------cCC--CccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 1 111 1111 110 000 01113457899999999999999999 555544
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-32 Score=296.56 Aligned_cols=253 Identities=26% Similarity=0.379 Sum_probs=194.5
Q ss_pred HHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcchhhhHHHHHHHHHHHhc-CCCcccccceeee-----ccceEE
Q 002336 613 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGYCE-----EEHQRI 685 (935)
Q Consensus 613 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L-~HpnIv~l~g~~~-----~~~~~~ 685 (935)
..+++.+.||+|+||.||++... +++.+|+|++... ......+.+|+.+++++ +||||+++++++. .+...+
T Consensus 18 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~ 96 (286)
T cd06638 18 DTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI-HDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLW 96 (286)
T ss_pred cceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccc-cchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEE
Confidence 34566789999999999999875 5889999987643 22345688899999999 6999999999873 345689
Q ss_pred EEEEecCCCCHHHHhccCC-CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccc
Q 002336 686 LVYEYMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 764 (935)
Q Consensus 686 lV~E~~~~gsL~~~L~~~~-~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~ 764 (935)
+||||+++++|.+++.... ....+++..+..++.|+++||.|||+ .+++||||||+||++++++.+||+|||++..
T Consensus 97 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~kl~dfg~~~~ 173 (286)
T cd06638 97 LVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHV---NKTIHRDVKGNNILLTTEGGVKLVDFGVSAQ 173 (286)
T ss_pred EEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHh---CCccccCCCHHhEEECCCCCEEEccCCceee
Confidence 9999999999999876422 34568899999999999999999998 8999999999999999999999999999876
Q ss_pred ccccccceeecccCCccccCCCCCCC-----CCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCC
Q 002336 765 AEEDLTHISSVARGTVGYLDPEYYGN-----QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD 839 (935)
Q Consensus 765 ~~~~~~~~~~~~~gt~~y~APE~l~~-----~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~ 839 (935)
...... ......|+..|+|||++.. ..++.++||||+||++|||++|+.||....... .+.. ...+.
T Consensus 174 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~--~~~~-----~~~~~ 245 (286)
T cd06638 174 LTSTRL-RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR--ALFK-----IPRNP 245 (286)
T ss_pred cccCCC-ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhH--HHhh-----ccccC
Confidence 543221 1223458899999998753 457889999999999999999999986332111 1110 11111
Q ss_pred eeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002336 840 VISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 884 (935)
Q Consensus 840 ~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~ 884 (935)
.....++ ......+.+++.+||+.+|++||+++||++.
T Consensus 246 ~~~~~~~-------~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 246 PPTLHQP-------ELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred CCcccCC-------CCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 1111111 1112368899999999999999999999864
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-32 Score=290.62 Aligned_cols=250 Identities=29% Similarity=0.442 Sum_probs=198.8
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCcch--hhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEec
Q 002336 615 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 691 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~--~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~ 691 (935)
|+..+.||+|++|.||+|... +++.+++|.+..... ...+.+.+|++++++++|+||+++++.+...+..++|+||+
T Consensus 2 y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (264)
T cd06626 2 WQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYC 81 (264)
T ss_pred ceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecC
Confidence 445689999999999999865 689999999875543 35678999999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccccc
Q 002336 692 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 771 (935)
Q Consensus 692 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~ 771 (935)
++++|.+++.. ...+++..+..++.|+++||.|||+ .+++|+||+|+||++++++.+||+|||++.........
T Consensus 82 ~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~ 155 (264)
T cd06626 82 SGGTLEELLEH---GRILDEHVIRVYTLQLLEGLAYLHS---HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTT 155 (264)
T ss_pred CCCcHHHHHhh---cCCCChHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCc
Confidence 99999999873 3457889999999999999999998 89999999999999999999999999998876443222
Q ss_pred eee---cccCCccccCCCCCCCCC---CCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeeccc
Q 002336 772 ISS---VARGTVGYLDPEYYGNQQ---LTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 845 (935)
Q Consensus 772 ~~~---~~~gt~~y~APE~l~~~~---~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d 845 (935)
... ...++..|+|||++.... .+.++||||||+++++|++|+.||...+. ....... +..+. .
T Consensus 156 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~--~~~~~~~----~~~~~-----~ 224 (264)
T cd06626 156 MGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDN--EFQIMFH----VGAGH-----K 224 (264)
T ss_pred ccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcc--hHHHHHH----HhcCC-----C
Confidence 111 245788999999987765 88999999999999999999999973321 1111111 11111 1
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 846 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 846 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
+.+... ......+.+++.+|++.+|++||++.|++.
T Consensus 225 ~~~~~~--~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 225 PPIPDS--LQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred CCCCcc--cccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 111110 111346789999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-32 Score=304.99 Aligned_cols=255 Identities=22% Similarity=0.323 Sum_probs=192.1
Q ss_pred HHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcch--hhhHHHHHHHHHHHhcCCCcccccceeeecc------ce
Q 002336 613 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEE------HQ 683 (935)
Q Consensus 613 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~--~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~------~~ 683 (935)
..|.+.+.||+|+||.||+|... +++.||||++..... ...+.+.+|++++++++||||+++++++... ..
T Consensus 15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 94 (343)
T cd07878 15 ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNE 94 (343)
T ss_pred hhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCc
Confidence 45667889999999999999865 688999999865322 2345678899999999999999999987532 35
Q ss_pred EEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccc
Q 002336 684 RILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 763 (935)
Q Consensus 684 ~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~ 763 (935)
.++++|++ +++|.+++. ...+++..+..++.|+++||.|||+ ++|+||||||+|||++.++.+||+|||+++
T Consensus 95 ~~~~~~~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~ 166 (343)
T cd07878 95 VYLVTNLM-GADLNNIVK----CQKLSDEHVQFLIYQLLRGLKYIHS---AGIIHRDLKPSNVAVNEDCELRILDFGLAR 166 (343)
T ss_pred EEEEeecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecccCChhhEEECCCCCEEEcCCccce
Confidence 68999988 789988875 3468999999999999999999998 899999999999999999999999999998
Q ss_pred cccccccceeecccCCccccCCCCCCC-CCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeee
Q 002336 764 QAEEDLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVIS 842 (935)
Q Consensus 764 ~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~ 842 (935)
...... ....|++.|+|||.+.+ ..++.++|||||||++|+|++|+.||...+.... +.. ....... ....
T Consensus 167 ~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~-~~~~~~~-~~~~ 238 (343)
T cd07878 167 QADDEM----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQ--LKR-IMEVVGT-PSPE 238 (343)
T ss_pred ecCCCc----CCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHH--HHH-HHHHhCC-CCHH
Confidence 654321 23458999999999876 5788999999999999999999999974332111 111 0000000 0000
Q ss_pred ccc-----------ccccCCCCH--------HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002336 843 IVD-----------PVLIGNVKI--------ESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 884 (935)
Q Consensus 843 ~~d-----------~~l~~~~~~--------~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~ 884 (935)
... ..+. ..+. .....+.+++.+|++.||++|||++|+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 239 VLKKISSEHARKYIQSLP-HMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred HHHhcchhhHHHHhhccc-cccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000 0000 0000 011246799999999999999999999854
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-32 Score=297.74 Aligned_cols=242 Identities=26% Similarity=0.365 Sum_probs=197.6
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc---hhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEe
Q 002336 615 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 690 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~ 690 (935)
|.+.+.||+|++|.||++.+. +++.+|+|++.... ....+.+.+|++++++++||||+++++++.+++..++||||
T Consensus 3 y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 82 (290)
T cd05580 3 FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEY 82 (290)
T ss_pred eEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEec
Confidence 456789999999999999876 58999999986532 22346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccccccc
Q 002336 691 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 770 (935)
Q Consensus 691 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~ 770 (935)
+++++|.+++.. ...+++..+..++.|+++||.|||+ .+++||||+|+||++++++.+||+|||++......
T Consensus 83 ~~~~~L~~~~~~---~~~l~~~~~~~~~~qil~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~-- 154 (290)
T cd05580 83 VPGGELFSHLRK---SGRFPEPVARFYAAQVVLALEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-- 154 (290)
T ss_pred CCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC--
Confidence 999999999874 3578999999999999999999998 99999999999999999999999999998876443
Q ss_pred ceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccC
Q 002336 771 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 850 (935)
Q Consensus 771 ~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~ 850 (935)
.....+++.|+|||.+.+...+.++||||||+++++|++|+.||...+.. . ..+.+..+.. .+
T Consensus 155 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~----~~~~~~~~~~------~~-- 217 (290)
T cd05580 155 --TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPI---Q----IYEKILEGKV------RF-- 217 (290)
T ss_pred --CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH---H----HHHHHhcCCc------cC--
Confidence 22345889999999998888899999999999999999999999743311 1 1111111111 11
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 002336 851 NVKIESIWRIAEVAIQCVEQRGFSRP-----KMQEIVL 883 (935)
Q Consensus 851 ~~~~~~~~~l~~li~~Cl~~dP~~RP-----s~~ev~~ 883 (935)
+......+.+++.+||+.+|.+|| +++|+++
T Consensus 218 --~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 218 --PSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred --CccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 111234778999999999999999 6666653
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-32 Score=319.56 Aligned_cols=260 Identities=20% Similarity=0.310 Sum_probs=188.5
Q ss_pred HHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcchhhhHHHHHHHHHHHhcCC------Ccccccceeeecc-ceE
Q 002336 613 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHH------RNLVPLIGYCEEE-HQR 684 (935)
Q Consensus 613 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~H------pnIv~l~g~~~~~-~~~ 684 (935)
..|++.+.||+|+||+||+|.+. .++.||||+++... ...+.+..|+++++.++| .+++++++++... .+.
T Consensus 129 ~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~ 207 (467)
T PTZ00284 129 QRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHM 207 (467)
T ss_pred CcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceE
Confidence 45667889999999999999875 57889999986432 233456667888777754 4588888888654 578
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCC------------
Q 002336 685 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM------------ 752 (935)
Q Consensus 685 ~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~------------ 752 (935)
++|||++ +++|.+++.. ...+++..+..++.||+.||+|||+ +.+|+||||||+|||++.++
T Consensus 208 ~iv~~~~-g~~l~~~l~~---~~~l~~~~~~~i~~qi~~aL~yLH~--~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~ 281 (467)
T PTZ00284 208 CIVMPKY-GPCLLDWIMK---HGPFSHRHLAQIIFQTGVALDYFHT--ELHLMHTDLKPENILMETSDTVVDPVTNRALP 281 (467)
T ss_pred EEEEecc-CCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHh--cCCeecCCCCHHHEEEecCCcccccccccccC
Confidence 8999988 7788888863 4568999999999999999999996 25999999999999998765
Q ss_pred ----cEEEeeccccccccccccceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHH
Q 002336 753 ----RAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIV 828 (935)
Q Consensus 753 ----~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~ 828 (935)
.+||+|||.+...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+.....
T Consensus 282 ~~~~~vkl~DfG~~~~~~~~----~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i 357 (467)
T PTZ00284 282 PDPCRVRICDLGGCCDERHS----RTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLM 357 (467)
T ss_pred CCCceEEECCCCccccCccc----cccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence 4999999987643221 23356899999999999999999999999999999999999999754432211111
Q ss_pred H---------HHHH--------hhh-cCCeeecccccc-----cCC-C-CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 829 H---------WARS--------MIK-KGDVISIVDPVL-----IGN-V-KIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 829 ~---------~~~~--------~i~-~~~~~~~~d~~l-----~~~-~-~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
. |... ... .+......++.. ... . .......+.+++.+||+.||++|||++|+++
T Consensus 358 ~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~ 437 (467)
T PTZ00284 358 EKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTT 437 (467)
T ss_pred HHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhc
Confidence 1 1100 000 000000000000 000 0 0011235779999999999999999999986
|
|
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-32 Score=299.30 Aligned_cols=253 Identities=23% Similarity=0.290 Sum_probs=197.5
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCcch---hhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEe
Q 002336 615 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 690 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~---~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~ 690 (935)
+++.+.||+|+||.||++.+. .++.|++|.+..... ...+.+.+|+++++.++||||+++++.+..++..++||||
T Consensus 3 y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 82 (305)
T cd05609 3 FETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEY 82 (305)
T ss_pred ceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEec
Confidence 455789999999999999876 578999998865432 2345788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccc-
Q 002336 691 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL- 769 (935)
Q Consensus 691 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~- 769 (935)
+++++|.+++.. ...+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||+++......
T Consensus 83 ~~g~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~ 156 (305)
T cd05609 83 VEGGDCATLLKN---IGALPVDMARMYFAETVLALEYLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLT 156 (305)
T ss_pred CCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHEEECCCCCEEEeeCCCccccCcCcc
Confidence 999999999973 3568999999999999999999998 899999999999999999999999999886421100
Q ss_pred -------------cceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhh
Q 002336 770 -------------THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIK 836 (935)
Q Consensus 770 -------------~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~ 836 (935)
........++..|+|||.+....++.++|+||||+++|||++|+.||.+.... ++......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~------~~~~~~~~ 230 (305)
T cd05609 157 TNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE------ELFGQVIS 230 (305)
T ss_pred ccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHh
Confidence 00111234788999999998888999999999999999999999999633211 11111111
Q ss_pred cCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhh
Q 002336 837 KGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 887 (935)
Q Consensus 837 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~ 887 (935)
+.. ..+.... .....+.+++.+||+.+|++||+..++.+.|+.
T Consensus 231 -~~~---~~~~~~~----~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 231 -DDI---EWPEGDE----ALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred -ccc---CCCCccc----cCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 111 0111111 122367899999999999999997666666654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-32 Score=294.05 Aligned_cols=247 Identities=23% Similarity=0.326 Sum_probs=192.8
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc-----hhhhHHHHHHHHHHHhcCCCcccccceeeecc--ceEEE
Q 002336 615 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-----SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE--HQRIL 686 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~-----~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~--~~~~l 686 (935)
+++.+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|++++++++||||+++++++.+. ...++
T Consensus 4 ~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (265)
T cd06652 4 WRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSI 83 (265)
T ss_pred ceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEE
Confidence 445789999999999999875 58999999875321 22346788899999999999999999988653 46789
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccc
Q 002336 687 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 766 (935)
Q Consensus 687 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~ 766 (935)
+|||+++++|.+++.. ...+++....+++.|++.||+|||+ .+++|+||||+||+++.++.++|+|||++....
T Consensus 84 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~ 157 (265)
T cd06652 84 FMEHMPGGSIKDQLKS---YGALTENVTRKYTRQILEGVSYLHS---NMIVHRDIKGANILRDSVGNVKLGDFGASKRLQ 157 (265)
T ss_pred EEEecCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEecCCCCEEECcCccccccc
Confidence 9999999999999873 3457888999999999999999998 899999999999999999999999999987643
Q ss_pred ccccc--eeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecc
Q 002336 767 EDLTH--ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 844 (935)
Q Consensus 767 ~~~~~--~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~ 844 (935)
..... ......++..|+|||.+.+..++.++||||||+++|||++|+.||....... . ........
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~-----~-~~~~~~~~------ 225 (265)
T cd06652 158 TICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMA-----A-IFKIATQP------ 225 (265)
T ss_pred cccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHH-----H-HHHHhcCC------
Confidence 22111 1122357889999999988889999999999999999999999996321110 1 11111110
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 845 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 845 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
.....+......+.+++.+|+. +|++||+++||++
T Consensus 226 ---~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 226 ---TNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred ---CCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 0111233344567889999995 9999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=307.21 Aligned_cols=246 Identities=26% Similarity=0.407 Sum_probs=200.4
Q ss_pred cccccccEEEEEEEECC-CcEEEEEEccCcchhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEecCCCCHHH
Q 002336 620 KIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRD 698 (935)
Q Consensus 620 ~LG~G~fG~Vy~~~~~~-g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL~~ 698 (935)
+||+|.||+||.|++.+ ...+|||-+........+.+.+|+...++|+|+|||+++|.|.++++.-+.||.++||+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 69999999999998764 55789999877666677889999999999999999999999999999999999999999999
Q ss_pred HhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCcccc-CCCcEEEeeccccccccccccceeeccc
Q 002336 699 RLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD-INMRAKVSDFGLSRQAEEDLTHISSVAR 777 (935)
Q Consensus 699 ~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld-~~~~vkL~DFGla~~~~~~~~~~~~~~~ 777 (935)
+|+..-..-.-++..+-.+.+||++||.|||. ..|||||||-.||||+ -.|.+||+|||-++....-.. .....-
T Consensus 662 LLrskWGPlKDNEstm~fYtkQILeGLkYLHe---n~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP-~TETFT 737 (1226)
T KOG4279|consen 662 LLRSKWGPLKDNESTMNFYTKQILEGLKYLHE---NKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINP-CTETFT 737 (1226)
T ss_pred HHHhccCCCccchhHHHHHHHHHHHHhhhhhh---cceeeccccCCcEEEeeccceEEecccccchhhccCCc-cccccc
Confidence 99865433233788888999999999999997 8999999999999996 679999999999887643222 233456
Q ss_pred CCccccCCCCCCCC--CCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccCCCCHH
Q 002336 778 GTVGYLDPEYYGNQ--QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIE 855 (935)
Q Consensus 778 gt~~y~APE~l~~~--~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~~~~~~ 855 (935)
||..|||||++..+ .|+.++|||||||++.||.||++||..-... .. .+.+-|-. ......|.+
T Consensus 738 GTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgsp-qA-------AMFkVGmy------KvHP~iPee 803 (1226)
T KOG4279|consen 738 GTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSP-QA-------AMFKVGMY------KVHPPIPEE 803 (1226)
T ss_pred cchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCCh-hH-------hhhhhcce------ecCCCCcHH
Confidence 99999999999654 6889999999999999999999999722111 10 01111111 012234556
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 856 SIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 856 ~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
...+...++.+|+.++|.+||+++++++
T Consensus 804 lsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 804 LSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred HHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 6678899999999999999999999975
|
|
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-32 Score=329.54 Aligned_cols=255 Identities=24% Similarity=0.348 Sum_probs=195.6
Q ss_pred HHHHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCc--chhhhHHHHHHHHHHHhcCCCcccccceeeec--cceEE
Q 002336 611 EEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEE--EHQRI 685 (935)
Q Consensus 611 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~--~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~--~~~~~ 685 (935)
....|.+.+.||+|+||.||++.+. .++.+|+|.+... .......+..|+.+++.++|||||++++++.. ....+
T Consensus 11 ~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ly 90 (1021)
T PTZ00266 11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLY 90 (1021)
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEE
Confidence 3345777899999999999999876 5778999988643 22345678999999999999999999998744 45689
Q ss_pred EEEEecCCCCHHHHhccCC-CCCCCCHHHHHHHHHHHHHHhHHhhhcC----CCceEecCCCCCCccccC----------
Q 002336 686 LVYEYMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGC----NPGIIHRDVKSSNILLDI---------- 750 (935)
Q Consensus 686 lV~E~~~~gsL~~~L~~~~-~~~~l~~~~~~~i~~qia~gL~yLHs~~----~~~ivH~DLkp~NILld~---------- 750 (935)
+||||+++|+|.++|.... ....+++..++.|+.||+.||+|||+.. .++|+||||||+||||+.
T Consensus 91 IVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~ 170 (1021)
T PTZ00266 91 ILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITA 170 (1021)
T ss_pred EEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccc
Confidence 9999999999999987532 2356999999999999999999999722 145999999999999964
Q ss_pred -------CCcEEEeeccccccccccccceeecccCCccccCCCCCCC--CCCCchhHHHHHHHHHHHHHhCCCCCCccCc
Q 002336 751 -------NMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN--QQLTEKSDVYSFGVVLLELISGKKPVSVEDF 821 (935)
Q Consensus 751 -------~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~--~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~ 821 (935)
...+||+|||++........ .....||+.|+|||++.. ..++.++|||||||+||||++|+.||.....
T Consensus 171 ~~~n~ng~~iVKLsDFGlAr~l~~~s~--~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~ 248 (1021)
T PTZ00266 171 QANNLNGRPIAKIGDFGLSKNIGIESM--AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANN 248 (1021)
T ss_pred cccccCCCCceEEccCCcccccccccc--ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCc
Confidence 23489999999976543221 223468999999998853 4688999999999999999999999963221
Q ss_pred ccchhHHHHHHHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 822 GAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 822 ~~~~~l~~~~~~~i~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
....+ ..+..+.. ..+ . .....+.+++.+||+.+|++||++.|+++
T Consensus 249 -----~~qli-~~lk~~p~-----lpi-~----~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 249 -----FSQLI-SELKRGPD-----LPI-K----GKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred -----HHHHH-HHHhcCCC-----CCc-C----CCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 11111 12222111 000 0 11236889999999999999999999984
|
|
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.4e-32 Score=294.39 Aligned_cols=251 Identities=25% Similarity=0.409 Sum_probs=195.0
Q ss_pred hhcccccccccEEEEEEEEC-CCcEEEEEEccCcch----------hhhHHHHHHHHHHHhcCCCcccccceeeeccceE
Q 002336 616 NFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS----------HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQR 684 (935)
Q Consensus 616 ~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~----------~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~ 684 (935)
...+.||+|++|.||+|... +|+.+|+|.++.... ...+.+.+|+.+++.++|||++++++++...+..
T Consensus 4 ~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (272)
T cd06629 4 VKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEYL 83 (272)
T ss_pred eecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCce
Confidence 34678999999999999765 689999998753211 1124678899999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccc
Q 002336 685 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 764 (935)
Q Consensus 685 ~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~ 764 (935)
++||||+++++|.+.+.. ...+++..+..++.|++.||.|||+ ++++||||+|+||+++.++.++|+|||++..
T Consensus 84 ~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~ 157 (272)
T cd06629 84 SIFLEYVPGGSIGSCLRT---YGRFEEQLVRFFTEQVLEGLAYLHS---KGILHRDLKADNLLVDADGICKISDFGISKK 157 (272)
T ss_pred EEEEecCCCCcHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhh---CCeeecCCChhhEEEcCCCeEEEeecccccc
Confidence 999999999999999874 3568999999999999999999997 8999999999999999999999999999876
Q ss_pred ccccccc-eeecccCCccccCCCCCCCCC--CCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCee
Q 002336 765 AEEDLTH-ISSVARGTVGYLDPEYYGNQQ--LTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVI 841 (935)
Q Consensus 765 ~~~~~~~-~~~~~~gt~~y~APE~l~~~~--~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~ 841 (935)
....... ......++..|+|||.+.... ++.++|+||||++++||++|..||...+.. ....+.... ...
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~------~~~~~~~~~-~~~ 230 (272)
T cd06629 158 SDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI------AAMFKLGNK-RSA 230 (272)
T ss_pred ccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH------HHHHHhhcc-ccC
Confidence 5432211 122335788999999887644 789999999999999999999998622211 111111111 111
Q ss_pred ecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 842 SIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 842 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
..+.+.. .......+.+++.+|+..+|++||++++|++
T Consensus 231 ~~~~~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 231 PPIPPDV----SMNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred CcCCccc----cccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 1111111 1122357889999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.8e-32 Score=289.86 Aligned_cols=247 Identities=26% Similarity=0.384 Sum_probs=198.0
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCc--chhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEec
Q 002336 615 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 691 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~--~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~ 691 (935)
|++.+.||+|++|.||++... +++.+|+|.+... .....+.+.+|++++++++|||++++++.+...+..++||||+
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd08220 2 YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYA 81 (256)
T ss_pred ceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecC
Confidence 456788999999999999875 6889999998643 2334567899999999999999999999999899999999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCC-CcEEEeecccccccccccc
Q 002336 692 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN-MRAKVSDFGLSRQAEEDLT 770 (935)
Q Consensus 692 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~-~~vkL~DFGla~~~~~~~~ 770 (935)
++++|.+++... ....+++..+.+++.|++++|+|||+ ++++||||||+||+++++ +.+||+|||++........
T Consensus 82 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (256)
T cd08220 82 PGGTLAEYIQKR-CNSLLDEDTILHFFVQILLALHHVHT---KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK 157 (256)
T ss_pred CCCCHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc
Confidence 999999999753 24458999999999999999999998 899999999999999855 4589999999887644321
Q ss_pred ceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccC
Q 002336 771 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 850 (935)
Q Consensus 771 ~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~ 850 (935)
.....++..|+|||.+.+...+.++||||||+++++|++|+.||...+.. .. +.... .+....+
T Consensus 158 --~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~---~~---~~~~~-~~~~~~~------- 221 (256)
T cd08220 158 --AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP---AL---VLKIM-SGTFAPI------- 221 (256)
T ss_pred --ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchH---HH---HHHHH-hcCCCCC-------
Confidence 12245788999999998888899999999999999999999999743321 11 11111 1111111
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 851 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 851 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
+......+.+++.+||+.+|++|||+.|+++
T Consensus 222 --~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 222 --SDRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred --CCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 1112336889999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=289.95 Aligned_cols=251 Identities=29% Similarity=0.408 Sum_probs=204.2
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCcch-hhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEecC
Q 002336 615 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 692 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~-~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~~ 692 (935)
+++.+.||+|++|.||+|... +++.|++|++..... ...+.+.+|+..+.+++|+|++++++++......++||||++
T Consensus 3 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (264)
T cd06623 3 LERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMD 82 (264)
T ss_pred ceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecC
Confidence 456789999999999999887 599999999876543 445789999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccccce
Q 002336 693 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 772 (935)
Q Consensus 693 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~~ 772 (935)
+++|.+++.. ...+++..++.++.|+++||+|||+ ..+++||||+|+||+++.++.++|+|||++.........
T Consensus 83 ~~~L~~~l~~---~~~l~~~~~~~~~~~l~~~l~~lh~--~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~- 156 (264)
T cd06623 83 GGSLADLLKK---VGKIPEPVLAYIARQILKGLDYLHT--KRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ- 156 (264)
T ss_pred CCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHhc--cCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCc-
Confidence 9999999974 3678999999999999999999995 289999999999999999999999999998866433222
Q ss_pred eecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccCCC
Q 002336 773 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNV 852 (935)
Q Consensus 773 ~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~~~ 852 (935)
.....++..|+|||.+.+..++.++|+||||+++|+|++|+.||.............+.. .... +.+
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~----~~~~-----~~~---- 223 (264)
T cd06623 157 CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAIC----DGPP-----PSL---- 223 (264)
T ss_pred ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHh----cCCC-----CCC----
Confidence 123357889999999998899999999999999999999999997443212222222221 1111 111
Q ss_pred CHH-HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002336 853 KIE-SIWRIAEVAIQCVEQRGFSRPKMQEIVLA 884 (935)
Q Consensus 853 ~~~-~~~~l~~li~~Cl~~dP~~RPs~~ev~~~ 884 (935)
+.. ....+.+++.+|+..+|++||++.|+++.
T Consensus 224 ~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 224 PAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred CcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 111 33478999999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.6e-32 Score=297.76 Aligned_cols=250 Identities=26% Similarity=0.394 Sum_probs=200.6
Q ss_pred HHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcchhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEec
Q 002336 613 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 691 (935)
Q Consensus 613 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~ 691 (935)
..+.+.+.||+|+||.||++... +++.||+|.+........+.+.+|+.++++++||||+++++.+...+..++|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 45667889999999999999764 68899999986544445577899999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccccc
Q 002336 692 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 771 (935)
Q Consensus 692 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~ 771 (935)
++++|.+++.. ..+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||++.........
T Consensus 99 ~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~---~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~ 171 (293)
T cd06647 99 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 171 (293)
T ss_pred CCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHh---CCEeeccCCHHHEEEcCCCCEEEccCcceecccccccc
Confidence 99999999863 357889999999999999999998 89999999999999999999999999988765433222
Q ss_pred eeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccCC
Q 002336 772 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 851 (935)
Q Consensus 772 ~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~~ 851 (935)
.....+++.|+|||.+....++.++||||||+++|+|++|+.||......... . .....+. +.. .
T Consensus 172 -~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~--~----~~~~~~~------~~~--~ 236 (293)
T cd06647 172 -RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL--Y----LIATNGT------PEL--Q 236 (293)
T ss_pred -cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhe--e----ehhcCCC------CCC--C
Confidence 22235788999999998888899999999999999999999999743221110 0 0000000 000 0
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002336 852 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 884 (935)
Q Consensus 852 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~ 884 (935)
.+......+.+++.+||..+|++||++.+++.+
T Consensus 237 ~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 237 NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111223468899999999999999999999865
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.1e-34 Score=290.31 Aligned_cols=251 Identities=25% Similarity=0.392 Sum_probs=208.3
Q ss_pred HHHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcchhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEe
Q 002336 612 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 690 (935)
Q Consensus 612 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~ 690 (935)
+....+.++||+|.||.||+|.++ .|+.+|+|.+.. ..+.+++.+|+.+|++.+.|++|+++|.+-....+|+||||
T Consensus 32 EEVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV--~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEY 109 (502)
T KOG0574|consen 32 EEVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV--DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEY 109 (502)
T ss_pred HHHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc--cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhh
Confidence 455667889999999999999886 699999998743 45678899999999999999999999988888889999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccccccc
Q 002336 691 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 770 (935)
Q Consensus 691 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~ 770 (935)
|..|++.++++. .++++.+.++..++...++||+|||- ..-+|||||+.|||++-+|.+||+|||.+-...+...
T Consensus 110 CGAGSiSDI~R~--R~K~L~E~EIs~iL~~TLKGL~YLH~---~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMA 184 (502)
T KOG0574|consen 110 CGAGSISDIMRA--RRKPLSEQEISAVLRDTLKGLQYLHD---LKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMA 184 (502)
T ss_pred cCCCcHHHHHHH--hcCCccHHHHHHHHHHHHhHHHHHHH---HHHHHhhcccccEEEcccchhhhhhccccchhhhhHH
Confidence 999999999885 47889999999999999999999997 7889999999999999999999999999987665433
Q ss_pred ceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccC
Q 002336 771 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 850 (935)
Q Consensus 771 ~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~ 850 (935)
. .....||+.|||||++..-.|..++||||+|++..||..|++||..-.. .+ +.-++.. .|...-
T Consensus 185 K-RNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHP------MR-AIFMIPT-------~PPPTF 249 (502)
T KOG0574|consen 185 K-RNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHP------MR-AIFMIPT-------KPPPTF 249 (502)
T ss_pred h-hCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccc------cc-eeEeccC-------CCCCCC
Confidence 3 3456799999999999999999999999999999999999999972111 00 0000000 111111
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002336 851 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 884 (935)
Q Consensus 851 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~ 884 (935)
..+......+.+++++||..+|++|-|+-++.+.
T Consensus 250 ~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 250 KKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred CChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 2345566789999999999999999999888764
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.7e-32 Score=297.65 Aligned_cols=260 Identities=22% Similarity=0.293 Sum_probs=193.0
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCcch--hhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEec
Q 002336 615 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 691 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~--~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~ 691 (935)
|++.+.||+|+||.||+|... +|+.+|+|.+..... .....+.+|++++++++||||+++++++.+....++|+||+
T Consensus 2 y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (284)
T cd07839 2 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYC 81 (284)
T ss_pred ceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecC
Confidence 456788999999999999876 689999999864322 22356788999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccccc
Q 002336 692 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 771 (935)
Q Consensus 692 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~ 771 (935)
+ ++|.+.+... ...+++..++.++.||++||.|||+ ++++||||||+||+++.++.+||+|||+++........
T Consensus 82 ~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~ 155 (284)
T cd07839 82 D-QDLKKYFDSC--NGDIDPEIVKSFMFQLLKGLAFCHS---HNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRC 155 (284)
T ss_pred C-CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCC
Confidence 7 5787776532 4568999999999999999999998 89999999999999999999999999998765432221
Q ss_pred eeecccCCccccCCCCCCCC-CCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCC------eeecc
Q 002336 772 ISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD------VISIV 844 (935)
Q Consensus 772 ~~~~~~gt~~y~APE~l~~~-~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~------~~~~~ 844 (935)
.....++..|+|||.+.+. .++.++||||||+++|+|++|+.|+...... . ...+.+.+.....+ .....
T Consensus 156 -~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~-~-~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd07839 156 -YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV-D-DQLKRIFRLLGTPTEESWPGVSKLP 232 (284)
T ss_pred -cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCH-H-HHHHHHHHHhCCCChHHhHHhhhcc
Confidence 1223468899999987664 4789999999999999999999886422211 1 11111111110000 00000
Q ss_pred cc----cccC-----CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 845 DP----VLIG-----NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 845 d~----~l~~-----~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
+. .... .........+.+++.+||+.+|++|||++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 233 DYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred cccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 00 0000 001112346789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.9e-32 Score=288.97 Aligned_cols=257 Identities=25% Similarity=0.292 Sum_probs=205.8
Q ss_pred hHHHHHHhhcccccccccEEEEEEEECC-CcEEEEEEccCcchh---hhHHHHHHHHHHHhcCCCcccccceeeeccceE
Q 002336 609 ELEEATNNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSH---RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQR 684 (935)
Q Consensus 609 ~l~~~~~~~~~~LG~G~fG~Vy~~~~~~-g~~vAvK~~~~~~~~---~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~ 684 (935)
.+.-...++.+.||.|.-|+||++++++ +..+|+|++.+..-. ...+...|-+||+.+.||.++.+++.++.++..
T Consensus 73 ~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~ 152 (459)
T KOG0610|consen 73 SLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYS 152 (459)
T ss_pred ccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeecccee
Confidence 3444555678899999999999999874 588999999765333 345677899999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccc
Q 002336 685 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 764 (935)
Q Consensus 685 ~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~ 764 (935)
|++||||+||+|...+++. .++.+++..+.-++.+++-||+|||. .|||.|||||+||||.++|++-|+||.++..
T Consensus 153 cl~meyCpGGdL~~LrqkQ-p~~~fse~~aRFYaAEvl~ALEYLHm---lGivYRDLKPENILvredGHIMLsDFDLS~~ 228 (459)
T KOG0610|consen 153 CLVMEYCPGGDLHSLRQKQ-PGKRFSESAARFYAAEVLLALEYLHM---LGIVYRDLKPENILVREDGHIMLSDFDLSLR 228 (459)
T ss_pred EEEEecCCCccHHHHHhhC-CCCccchhhHHHHHHHHHHHHHHHHh---hceeeccCCcceeEEecCCcEEeeecccccc
Confidence 9999999999999988755 67789999999999999999999997 9999999999999999999999999998753
Q ss_pred cccc---------------------------------cc----------------------ceeecccCCccccCCCCCC
Q 002336 765 AEED---------------------------------LT----------------------HISSVARGTVGYLDPEYYG 789 (935)
Q Consensus 765 ~~~~---------------------------------~~----------------------~~~~~~~gt~~y~APE~l~ 789 (935)
.... .. ..+....||-.|+|||++.
T Consensus 229 ~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~ 308 (459)
T KOG0610|consen 229 CPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIR 308 (459)
T ss_pred CCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeee
Confidence 2100 00 0011235899999999999
Q ss_pred CCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccc
Q 002336 790 NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVE 869 (935)
Q Consensus 790 ~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~ 869 (935)
+..-+.+.|-|+|||++|||+.|+.||.+....+ .+.. ++-+.+.--..+.....+.+||++.|.
T Consensus 309 G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~--Tl~N-------------Iv~~~l~Fp~~~~vs~~akDLIr~LLv 373 (459)
T KOG0610|consen 309 GEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKE--TLRN-------------IVGQPLKFPEEPEVSSAAKDLIRKLLV 373 (459)
T ss_pred cCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchh--hHHH-------------HhcCCCcCCCCCcchhHHHHHHHHHhc
Confidence 9999999999999999999999999998654432 2221 111111111122445578899999999
Q ss_pred cCCCCCCC----HHHHHHH
Q 002336 870 QRGFSRPK----MQEIVLA 884 (935)
Q Consensus 870 ~dP~~RPs----~~ev~~~ 884 (935)
+||++|-. +.||-+.
T Consensus 374 KdP~kRlg~~rGA~eIK~H 392 (459)
T KOG0610|consen 374 KDPSKRLGSKRGAAEIKRH 392 (459)
T ss_pred cChhhhhccccchHHhhcC
Confidence 99999998 7777553
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.3e-32 Score=293.32 Aligned_cols=254 Identities=28% Similarity=0.434 Sum_probs=196.1
Q ss_pred hhcccccccccEEEEEEEEC----CCcEEEEEEccCcc--hhhhHHHHHHHHHHHhcCCCcccccceeeeccc------e
Q 002336 616 NFCKKIGKGSFGSVYYGKMK----DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH------Q 683 (935)
Q Consensus 616 ~~~~~LG~G~fG~Vy~~~~~----~g~~vAvK~~~~~~--~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~------~ 683 (935)
.+.+.||+|+||.||+|.+. .++.||||++.... ....+++.+|++++++++||||+++++++.... .
T Consensus 2 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 81 (273)
T cd05074 2 TLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPI 81 (273)
T ss_pred cchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccc
Confidence 45678999999999999864 36889999986542 334567899999999999999999999875432 2
Q ss_pred EEEEEEecCCCCHHHHhccCC---CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecc
Q 002336 684 RILVYEYMHNGTLRDRLHGSV---NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFG 760 (935)
Q Consensus 684 ~~lV~E~~~~gsL~~~L~~~~---~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFG 760 (935)
.++++||+++|+|.+++.... ....+++..+.+++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||
T Consensus 82 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~nili~~~~~~kl~dfg 158 (273)
T cd05074 82 PMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSS---KNFIHRDLAARNCMLNENMTVCVADFG 158 (273)
T ss_pred eEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccchhhEEEcCCCCEEECccc
Confidence 378899999999988765322 22357889999999999999999998 899999999999999999999999999
Q ss_pred ccccccccccc-eeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCcccchhHHHHHHHhhhcC
Q 002336 761 LSRQAEEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKG 838 (935)
Q Consensus 761 la~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~i~~~ 838 (935)
+++........ ......++..|++||.+....++.++||||||+++|||++ |+.||...+. ..+..+. . .+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~---~~~~~~~---~-~~ 231 (273)
T cd05074 159 LSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN---SEIYNYL---I-KG 231 (273)
T ss_pred ccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH---HHHHHHH---H-cC
Confidence 98865432211 1112235678999999988889999999999999999999 8888863322 1122211 1 11
Q ss_pred CeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhh
Q 002336 839 DVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 888 (935)
Q Consensus 839 ~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~ 888 (935)
.... .+......+.+++.+|++.+|++||++.|+++.|+++
T Consensus 232 ~~~~---------~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 232 NRLK---------QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred CcCC---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 1100 0112234789999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.9e-32 Score=297.73 Aligned_cols=259 Identities=20% Similarity=0.234 Sum_probs=196.3
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCcchh-----hhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEE
Q 002336 615 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSH-----RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 688 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~~-----~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~ 688 (935)
|++.+.||+|++|.||+|... +++.||+|.+...... ....+..|++++++++|+||+++++++.+.+..++||
T Consensus 2 y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 81 (298)
T cd07841 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVF 81 (298)
T ss_pred ceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEE
Confidence 445678999999999999875 6899999998754322 2345778999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccccc
Q 002336 689 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 768 (935)
Q Consensus 689 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~ 768 (935)
||+ +++|.+++... ...+++..++.++.|+++||.|||+ ++++||||||+||+++.++.++|+|||+++.....
T Consensus 82 e~~-~~~L~~~i~~~--~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~ 155 (298)
T cd07841 82 EFM-ETDLEKVIKDK--SIVLTPADIKSYMLMTLRGLEYLHS---NWILHRDLKPNNLLIASDGVLKLADFGLARSFGSP 155 (298)
T ss_pred ccc-CCCHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCChhhEEEcCCCCEEEccceeeeeccCC
Confidence 999 89999999743 2368999999999999999999998 89999999999999999999999999999876443
Q ss_pred ccceeecccCCccccCCCCCCC-CCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhc---------C
Q 002336 769 LTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKK---------G 838 (935)
Q Consensus 769 ~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~---------~ 838 (935)
... .....++..|+|||.+.+ ..++.++||||||++++||++|..||......+ .+.. ....... .
T Consensus 156 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~--~~~~-~~~~~~~~~~~~~~~~~ 231 (298)
T cd07841 156 NRK-MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDID--QLGK-IFEALGTPTEENWPGVT 231 (298)
T ss_pred Ccc-ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHH--HHHH-HHHHcCCCchhhhhhcc
Confidence 221 122346788999998754 567899999999999999999988876433211 1111 1110000 0
Q ss_pred CeeecccccccCCC-----CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 839 DVISIVDPVLIGNV-----KIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 839 ~~~~~~d~~l~~~~-----~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
.............. .......+.+++.+||+.+|++||+++|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~ 281 (298)
T cd07841 232 SLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE 281 (298)
T ss_pred cccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 00000000000001 1122357889999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.4e-32 Score=298.21 Aligned_cols=261 Identities=22% Similarity=0.324 Sum_probs=193.6
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcchh-hhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEec
Q 002336 614 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSH-RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 691 (935)
Q Consensus 614 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~~-~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~ 691 (935)
.|++.+.||+|++|.||+|..+ +++.||+|.+...... ....+.+|++++++++|+||+++++++.+.+..++||||+
T Consensus 6 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (291)
T cd07844 6 TYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYL 85 (291)
T ss_pred ceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecC
Confidence 3556789999999999999876 6899999998653322 2345778999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccccc
Q 002336 692 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 771 (935)
Q Consensus 692 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~ 771 (935)
.+ +|.+++... ...+++..+..++.|+++||.|||+ .+++||||||+||++++++.+||+|||+++........
T Consensus 86 ~~-~L~~~~~~~--~~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~ 159 (291)
T cd07844 86 DT-DLKQYMDDC--GGGLSMHNVRLFLFQLLRGLAYCHQ---RRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKT 159 (291)
T ss_pred CC-CHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCHHHEEEcCCCCEEECccccccccCCCCcc
Confidence 74 899988643 3468899999999999999999997 89999999999999999999999999998754322111
Q ss_pred eeecccCCccccCCCCCCC-CCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhc---CC--------
Q 002336 772 ISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKK---GD-------- 839 (935)
Q Consensus 772 ~~~~~~gt~~y~APE~l~~-~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~---~~-------- 839 (935)
.....++..|+|||.+.+ ..++.++||||+|+++|+|++|+.||....... .......+.... ..
T Consensus 160 -~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (291)
T cd07844 160 -YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVE--DQLHKIFRVLGTPTEETWPGVSSNP 236 (291)
T ss_pred -ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHH--HHHHHHHHhcCCCChhhhhhhhhcc
Confidence 112236788999998865 567899999999999999999999996433110 111101010000 00
Q ss_pred -eeecc-----cccccCCC-CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 840 -VISIV-----DPVLIGNV-KIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 840 -~~~~~-----d~~l~~~~-~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
..... ...+.... .......+.+++.+|++.+|++||++.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 237 EFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred ccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 00000 00000000 0011246789999999999999999999874
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.98 E-value=6e-32 Score=295.80 Aligned_cols=250 Identities=25% Similarity=0.433 Sum_probs=193.5
Q ss_pred HHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcchhhhHHHHHHHHHHHhc-CCCcccccceeeec------cceE
Q 002336 613 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEE------EHQR 684 (935)
Q Consensus 613 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L-~HpnIv~l~g~~~~------~~~~ 684 (935)
..+++.+.||+|+||.||+|.+. +++.+|+|.+.... .....+..|+.+++++ +|+||+++++++.. ....
T Consensus 16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 94 (282)
T cd06636 16 GIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQL 94 (282)
T ss_pred hhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEE
Confidence 45666789999999999999875 68899999875442 3346788899999998 69999999998842 4578
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccc
Q 002336 685 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 764 (935)
Q Consensus 685 ~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~ 764 (935)
+++|||+++|+|.+++... ....+++..+..++.|+++||+|||+ .+++|+||||+||++++++.++|+|||++..
T Consensus 95 ~iv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dl~~~nili~~~~~~~l~dfg~~~~ 170 (282)
T cd06636 95 WLVMEFCGAGSVTDLVKNT-KGNALKEDWIAYICREILRGLAHLHA---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 170 (282)
T ss_pred EEEEEeCCCCcHHHHHHHc-cCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCcchhh
Confidence 9999999999999988753 23457888899999999999999998 8999999999999999999999999999875
Q ss_pred ccccccceeecccCCccccCCCCCC-----CCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCC
Q 002336 765 AEEDLTHISSVARGTVGYLDPEYYG-----NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD 839 (935)
Q Consensus 765 ~~~~~~~~~~~~~gt~~y~APE~l~-----~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~ 839 (935)
....... .....|+..|+|||.+. ...++.++||||||+++|||++|+.||......... . .+....
T Consensus 171 ~~~~~~~-~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~--~-----~~~~~~ 242 (282)
T cd06636 171 LDRTVGR-RNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRAL--F-----LIPRNP 242 (282)
T ss_pred hhccccC-CCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhh--h-----hHhhCC
Confidence 5322211 22345788999999875 346788999999999999999999999632211100 0 011110
Q ss_pred eeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 840 VISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 840 ~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
. +... .......+.+++.+||+.+|.+||++.|+++
T Consensus 243 ~-----~~~~---~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 243 P-----PKLK---SKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred C-----CCCc---ccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 0 1110 1122346889999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=7e-32 Score=295.40 Aligned_cols=260 Identities=20% Similarity=0.280 Sum_probs=193.9
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCcch--hhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEec
Q 002336 615 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 691 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~--~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~ 691 (935)
|+..+.||+|++|.||+|... +|+.||||.+..... ...+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (284)
T cd07860 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL 81 (284)
T ss_pred ceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeecc
Confidence 345688999999999999875 689999998864322 23357889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccccc
Q 002336 692 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 771 (935)
Q Consensus 692 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~ 771 (935)
. ++|.+++... ....+++..+..++.|+++||+|||+ .+++||||+|+||++++++.+||+|||++.........
T Consensus 82 ~-~~l~~~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lh~---~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~ 156 (284)
T cd07860 82 H-QDLKKFMDAS-PLSGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT 156 (284)
T ss_pred c-cCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEeeccchhhcccCccc
Confidence 5 6898888643 34568999999999999999999997 89999999999999999999999999998765432211
Q ss_pred eeecccCCccccCCCCCCCC-CCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhc-------------
Q 002336 772 ISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKK------------- 837 (935)
Q Consensus 772 ~~~~~~gt~~y~APE~l~~~-~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~------------- 837 (935)
.....++..|+|||.+.+. .++.++||||||+++|||+||+.||...+... ...+..+..-..
T Consensus 157 -~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07860 157 -YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID--QLFRIFRTLGTPDEVVWPGVTSLPD 233 (284)
T ss_pred -cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHHHHhCCCChhhhhhhhHHHH
Confidence 1223467889999987654 46889999999999999999999997433211 111111100000
Q ss_pred --CCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 838 --GDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 838 --~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
..........+.. ........+.+++.+|++.||++||+++|+++
T Consensus 234 ~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 234 YKPSFPKWARQDFSK-VVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred HHhhcccccccCHHH-HcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 0000000000000 00111235779999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2e-31 Score=292.63 Aligned_cols=244 Identities=25% Similarity=0.374 Sum_probs=197.6
Q ss_pred cccccccccEEEEEEEEC-CCcEEEEEEccCcchhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEecCCCCH
Q 002336 618 CKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTL 696 (935)
Q Consensus 618 ~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL 696 (935)
.+.||+|++|.||++... +++.+++|++........+.+.+|+.+++.++||||+++++++...+..++++||+++++|
T Consensus 24 ~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L 103 (285)
T cd06648 24 FVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGAL 103 (285)
T ss_pred ceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCH
Confidence 578999999999999864 6889999988655445556789999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccccceeecc
Q 002336 697 RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVA 776 (935)
Q Consensus 697 ~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~ 776 (935)
.+++.. ..+++..+..++.|++.||+|||+ ++++||||+|+||+++.++.++|+|||++........ .....
T Consensus 104 ~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~-~~~~~ 175 (285)
T cd06648 104 TDIVTH----TRMNEEQIATVCLAVLKALSFLHA---QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP-RRKSL 175 (285)
T ss_pred HHHHHh----CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChhhEEEcCCCcEEEcccccchhhccCCc-ccccc
Confidence 999873 458899999999999999999998 8999999999999999999999999998765433222 12234
Q ss_pred cCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccCCCCHHH
Q 002336 777 RGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIES 856 (935)
Q Consensus 777 ~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~~~~~~~ 856 (935)
.|+..|+|||.+.+..++.++||||||++++||++|+.||...+. ...... +..+....... ....
T Consensus 176 ~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~------~~~~~~-~~~~~~~~~~~-------~~~~ 241 (285)
T cd06648 176 VGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP------LQAMKR-IRDNLPPKLKN-------LHKV 241 (285)
T ss_pred cCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH------HHHHHH-HHhcCCCCCcc-------cccC
Confidence 588999999999888899999999999999999999999863221 111111 11111111100 1112
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 857 IWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 857 ~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
...+.+++.+||+.+|++||+++++++
T Consensus 242 ~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 242 SPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred CHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 346889999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.7e-33 Score=304.37 Aligned_cols=241 Identities=32% Similarity=0.459 Sum_probs=197.6
Q ss_pred cccccccccEEEEEEEEC-CCcEEEEEEccCcch---hhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEecCC
Q 002336 618 CKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 693 (935)
Q Consensus 618 ~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~---~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~~~ 693 (935)
.+.||.|.||.||.|+.. +.+.||||++.-... +.-.++.+|+..|++++|||+|.+-|++-.+...||||||| -
T Consensus 31 LrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYC-l 109 (948)
T KOG0577|consen 31 LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYC-L 109 (948)
T ss_pred HHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHH-h
Confidence 467999999999999865 678899999865433 34468999999999999999999999999999999999999 5
Q ss_pred CCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccccccccee
Q 002336 694 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 773 (935)
Q Consensus 694 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~~~ 773 (935)
|+-.|++.- ..+++-+.++..|+.+.+.||+|||+ .+.||||||+.|||+++.|.|||+|||.+......
T Consensus 110 GSAsDlleV--hkKplqEvEIAAi~~gaL~gLaYLHS---~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA----- 179 (948)
T KOG0577|consen 110 GSASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHS---HNRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA----- 179 (948)
T ss_pred ccHHHHHHH--HhccchHHHHHHHHHHHHHHHHHHHH---hhHHhhhccccceEecCCCeeeeccccchhhcCch-----
Confidence 688887764 35789999999999999999999998 89999999999999999999999999998776443
Q ss_pred ecccCCccccCCCCC---CCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccC
Q 002336 774 SVARGTVGYLDPEYY---GNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 850 (935)
Q Consensus 774 ~~~~gt~~y~APE~l---~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~ 850 (935)
....|||.|||||++ ..+.|+-|.||||+|++..||.-.++|.-. +..-..+. .|..++. |.|.
T Consensus 180 nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFn--MNAMSALY-----HIAQNes-----PtLq- 246 (948)
T KOG0577|consen 180 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN--MNAMSALY-----HIAQNES-----PTLQ- 246 (948)
T ss_pred hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccC--chHHHHHH-----HHHhcCC-----CCCC-
Confidence 335699999999986 468999999999999999999999999742 21111111 1222211 1221
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002336 851 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 884 (935)
Q Consensus 851 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~ 884 (935)
..++...+.+++..||+.-|++|||.+++++.
T Consensus 247 --s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 247 --SNEWSDYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred --CchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 34566789999999999999999999987654
|
|
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-31 Score=292.95 Aligned_cols=255 Identities=25% Similarity=0.325 Sum_probs=198.7
Q ss_pred hhcccccccccEEEEEEEEC-CCcEEEEEEccCcch-hhhHHHHHHHHHHHhcCCCcccccceeeec--cceEEEEEEec
Q 002336 616 NFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEE--EHQRILVYEYM 691 (935)
Q Consensus 616 ~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~-~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~--~~~~~lV~E~~ 691 (935)
++.+.||.|++|.||++... +++.+|+|.+..... .....+.+|++++++++||||+++++++.+ ....++||||+
T Consensus 4 ~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~ 83 (287)
T cd06621 4 VELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYC 83 (287)
T ss_pred EEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEec
Confidence 45678999999999999885 588999999875432 345678999999999999999999998854 34689999999
Q ss_pred CCCCHHHHhccCC-CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccccccc
Q 002336 692 HNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 770 (935)
Q Consensus 692 ~~gsL~~~L~~~~-~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~ 770 (935)
++++|.+++.... ....+++..+..++.|+++||+|||+ .+++|+||+|+||+++.++.++|+|||++........
T Consensus 84 ~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 160 (287)
T cd06621 84 EGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHS---RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLA 160 (287)
T ss_pred CCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEecCCeEEEeecccccccccccc
Confidence 9999998875322 34568889999999999999999998 8999999999999999999999999999875433221
Q ss_pred ceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCc--ccchhHHHHHHHhhhcCCeeecccccc
Q 002336 771 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDF--GAELNIVHWARSMIKKGDVISIVDPVL 848 (935)
Q Consensus 771 ~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~--~~~~~l~~~~~~~i~~~~~~~~~d~~l 848 (935)
....++..|+|||.+.+..++.++||||+|+++|+|++|+.||..... ........+... .....+.+. .
T Consensus 161 ---~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~-~ 232 (287)
T cd06621 161 ---GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVN----MPNPELKDE-P 232 (287)
T ss_pred ---ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhc----CCchhhccC-C
Confidence 123468899999999988999999999999999999999999985432 112223333221 111111110 0
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 849 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 849 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
. ........+.+++.+||+.+|++|||+.|+++
T Consensus 233 ~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 233 G--NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred C--CCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 0 00123457889999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=292.78 Aligned_cols=246 Identities=27% Similarity=0.420 Sum_probs=196.9
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCc-chhhhHHHHHHHHHHHhcC---CCcccccceeeeccceEEEEEE
Q 002336 615 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS-CSHRTQQFVTEVALLSRIH---HRNLVPLIGYCEEEHQRILVYE 689 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~-~~~~~~~~~~E~~iL~~L~---HpnIv~l~g~~~~~~~~~lV~E 689 (935)
|++.+.||+|+||.||+|.+. +++.+|+|.+... .....+++.+|+.++++++ |||++++++++..+...++|||
T Consensus 3 y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e 82 (277)
T cd06917 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIME 82 (277)
T ss_pred hhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEe
Confidence 456788999999999999874 6899999998654 2334567889999999996 9999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccc
Q 002336 690 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 769 (935)
Q Consensus 690 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~ 769 (935)
|+++++|.+++.. ..+++..++.++.|++.||.|||+ .+++||||+|+||++++++.++|+|||++.......
T Consensus 83 ~~~~~~L~~~~~~----~~l~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06917 83 YAEGGSVRTLMKA----GPIAEKYISVIIREVLVALKYIHK---VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS 155 (277)
T ss_pred cCCCCcHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc
Confidence 9999999998863 368999999999999999999998 899999999999999999999999999987765433
Q ss_pred cceeecccCCccccCCCCCCC-CCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccccc
Q 002336 770 THISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 848 (935)
Q Consensus 770 ~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l 848 (935)
.. .....|+..|+|||.+.+ ..++.++||||||+++|+|++|+.||...... .+.. .+... ..+.+
T Consensus 156 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~------~~~~-~~~~~-----~~~~~ 222 (277)
T cd06917 156 SK-RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAF------RAMM-LIPKS-----KPPRL 222 (277)
T ss_pred cc-cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChh------hhhh-ccccC-----CCCCC
Confidence 22 223358889999998765 45689999999999999999999999743221 1110 11111 01111
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 849 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 849 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
... .....+.+++.+||+.+|++||++.|+++
T Consensus 223 ~~~---~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 223 EDN---GYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred Ccc---cCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 111 12346889999999999999999999975
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.2e-32 Score=295.00 Aligned_cols=259 Identities=23% Similarity=0.270 Sum_probs=196.2
Q ss_pred hhcccccccccEEEEEEEEC-CCcEEEEEEccCcc--hhhhHHHHHHHHHHHhcCCCcccccceeeecc--ceEEEEEEe
Q 002336 616 NFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE--HQRILVYEY 690 (935)
Q Consensus 616 ~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~--~~~~lV~E~ 690 (935)
++.+.||+|++|.||+|... +++.+|+|.+.... ....+.+.+|++++++++|+|++++++++... ...++||||
T Consensus 2 ~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~ 81 (287)
T cd07840 2 EKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEY 81 (287)
T ss_pred eeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEecc
Confidence 45678999999999999876 58899999997653 23345788999999999999999999999887 789999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccccccc
Q 002336 691 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 770 (935)
Q Consensus 691 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~ 770 (935)
+++ +|.+++... ...+++..++.++.|+++||+|||+ .+++|+||||+||++++++.+||+|||++........
T Consensus 82 ~~~-~l~~~~~~~--~~~~~~~~~~~i~~~i~~al~~LH~---~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~ 155 (287)
T cd07840 82 MDH-DLTGLLDSP--EVKFTESQIKCYMKQLLEGLQYLHS---NGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS 155 (287)
T ss_pred ccc-cHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEEcCCCCEEEccccceeeccCCCc
Confidence 974 888887643 2578999999999999999999997 8999999999999999999999999999887654432
Q ss_pred ceeecccCCccccCCCCCCC-CCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhc---CCeeec---
Q 002336 771 HISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKK---GDVISI--- 843 (935)
Q Consensus 771 ~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~---~~~~~~--- 843 (935)
.......++..|+|||.+.+ ..++.++||||||+++|||++|+.||....... ....+.+.... ......
T Consensus 156 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07840 156 ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELE---QLEKIFELCGSPTDENWPGVSKL 232 (287)
T ss_pred ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHhCCCchhhccccccc
Confidence 22223346788999997654 467899999999999999999999997433211 11111111100 000000
Q ss_pred -----------ccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 844 -----------VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 844 -----------~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
....+...........+.+++.+|+..+|++||+++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 233 PWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred hhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 0000000000111457889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-31 Score=293.90 Aligned_cols=263 Identities=21% Similarity=0.302 Sum_probs=196.9
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCcchh-hhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEecC
Q 002336 615 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSH-RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 692 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~~-~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~~ 692 (935)
|++.+.||+|++|.||+|+.. +|+.||+|++...... ..+.+.+|++++++++||||+++++++.+.+..++||||++
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 81 (284)
T cd07836 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMD 81 (284)
T ss_pred ceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCC
Confidence 345789999999999999986 6889999998754332 34567889999999999999999999999999999999998
Q ss_pred CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccccce
Q 002336 693 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 772 (935)
Q Consensus 693 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~~ 772 (935)
+ +|.+++........+++..+.+++.|+++||+|||+ .+++||||||+||++++++.++|+|||++.........
T Consensus 82 ~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~- 156 (284)
T cd07836 82 K-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHE---NRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNT- 156 (284)
T ss_pred c-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCccc-
Confidence 5 888887654344578999999999999999999998 89999999999999999999999999998755332211
Q ss_pred eecccCCccccCCCCCCC-CCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchh-HHHHHH-------Hhhhc-CCe--
Q 002336 773 SSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELN-IVHWAR-------SMIKK-GDV-- 840 (935)
Q Consensus 773 ~~~~~gt~~y~APE~l~~-~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~-l~~~~~-------~~i~~-~~~-- 840 (935)
.....++..|++||.+.+ ..++.++||||||+++|+|++|+.||...+..+... ..+... +.+.. ...
T Consensus 157 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd07836 157 FSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKP 236 (284)
T ss_pred cccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcc
Confidence 122346889999998765 457899999999999999999999997544321110 000000 00000 000
Q ss_pred --eecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 841 --ISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 841 --~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
....+... ....+.....+.+++.+|++.+|.+||+++|+++
T Consensus 237 ~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 237 TFPRYPPQDL-QQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred cccCCChHHH-HHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00000000 0011122346789999999999999999999874
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.3e-32 Score=292.05 Aligned_cols=246 Identities=26% Similarity=0.335 Sum_probs=199.7
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc---hhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEe
Q 002336 615 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 690 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~ 690 (935)
|++.+.||.|+||.||++... +++.+|+|.+.... ....+.+.+|++++++++||||+++++.+.+....++|+||
T Consensus 2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 81 (258)
T cd05578 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDL 81 (258)
T ss_pred ceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeC
Confidence 456789999999999999876 58999999986432 23457899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccccccc
Q 002336 691 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 770 (935)
Q Consensus 691 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~ 770 (935)
+++++|.+++.. ...+++..+..++.|+++||.|||+ .+++|+||+|+||++++++.++|+|||++.......
T Consensus 82 ~~~~~L~~~l~~---~~~l~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~- 154 (258)
T cd05578 82 LLGGDLRYHLSQ---KVKFSEEQVKFWICEIVLALEYLHS---KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT- 154 (258)
T ss_pred CCCCCHHHHHHh---cCCcCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc-
Confidence 999999999874 3578999999999999999999997 899999999999999999999999999987654432
Q ss_pred ceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccC
Q 002336 771 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 850 (935)
Q Consensus 771 ~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~ 850 (935)
......|+..|+|||.+.+..++.++|+||+|+++|+|++|+.||...... ...+........ ..
T Consensus 155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----~~~~~~~~~~~~----------~~ 219 (258)
T cd05578 155 -LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT----IRDQIRAKQETA----------DV 219 (258)
T ss_pred -cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc----HHHHHHHHhccc----------cc
Confidence 122345788999999998888999999999999999999999999744332 111122111110 01
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCH--HHHH
Q 002336 851 NVKIESIWRIAEVAIQCVEQRGFSRPKM--QEIV 882 (935)
Q Consensus 851 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~--~ev~ 882 (935)
..+......+.+++.+||+.+|.+||++ +|+.
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 220 LYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred cCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 1122233578899999999999999999 6654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-31 Score=284.79 Aligned_cols=247 Identities=29% Similarity=0.488 Sum_probs=201.4
Q ss_pred hhcccccccccEEEEEEEEC-CCcEEEEEEccCcchhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEecCCC
Q 002336 616 NFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNG 694 (935)
Q Consensus 616 ~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~~~g 694 (935)
...+.||+|++|.||++... +++.+++|++........+.+.+|++++++++|+|++++++++......++++||++++
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~ 82 (253)
T cd05122 3 EILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGG 82 (253)
T ss_pred eeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCCC
Confidence 45678999999999999886 68999999997765556678999999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccccceee
Q 002336 695 TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISS 774 (935)
Q Consensus 695 sL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~ 774 (935)
+|.+++... ...+++..+..++.|+++||++||. .+++||||+|+||++++++.++|+|||.+........ ..
T Consensus 83 ~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~~ 155 (253)
T cd05122 83 SLKDLLKST--NQTLTESQIAYVCKELLKGLEYLHS---NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--RN 155 (253)
T ss_pred cHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHhhc---CCEecCCCCHHHEEEccCCeEEEeecccccccccccc--cc
Confidence 999998743 2578999999999999999999997 9999999999999999999999999999877654322 23
Q ss_pred cccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccCCCCH
Q 002336 775 VARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKI 854 (935)
Q Consensus 775 ~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~~~~~ 854 (935)
...++..|++||.+.+...+.++||||||+++++|++|+.||...+... . ..... ........++ .
T Consensus 156 ~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~---~~~~~-~~~~~~~~~~-------~ 221 (253)
T cd05122 156 TMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMK---A---LFKIA-TNGPPGLRNP-------E 221 (253)
T ss_pred ceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHH---H---HHHHH-hcCCCCcCcc-------c
Confidence 3457889999999988888999999999999999999999997332111 1 11111 1111111111 1
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 855 ESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 855 ~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
.....+.+++.+|++.+|++|||+.|+++
T Consensus 222 ~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 222 KWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred ccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 11346889999999999999999999875
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-31 Score=289.72 Aligned_cols=245 Identities=29% Similarity=0.382 Sum_probs=195.5
Q ss_pred ccccccEEEEEEEEC-CCcEEEEEEccCcch---hhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEecCCCCH
Q 002336 621 IGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTL 696 (935)
Q Consensus 621 LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~---~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL 696 (935)
||+|+||.||++++. +|+.+++|.+..... ...+.+.+|++++++++||||+++++.+......+++|||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999987 499999999865433 3456788999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccccccc------
Q 002336 697 RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT------ 770 (935)
Q Consensus 697 ~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~------ 770 (935)
.+++.. ...+++..+..++.|+++||+|||+ .+++||||+|+||++++++.++|+|||++........
T Consensus 81 ~~~l~~---~~~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 154 (265)
T cd05579 81 ASLLEN---VGSLDEDVARIYIAEIVLALEYLHS---NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD 154 (265)
T ss_pred HHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---cCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence 999974 2478999999999999999999997 8999999999999999999999999999876433211
Q ss_pred -ceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeeccccccc
Q 002336 771 -HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 849 (935)
Q Consensus 771 -~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~ 849 (935)
.......++..|++||.......+.++||||||+++++|++|+.||...... .... . +..+.... +
T Consensus 155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~---~~~~---~-~~~~~~~~---~--- 221 (265)
T cd05579 155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE---EIFQ---N-ILNGKIEW---P--- 221 (265)
T ss_pred cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH---HHHH---H-HhcCCcCC---C---
Confidence 1122345788999999998888899999999999999999999999743321 1111 1 11111100 0
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 002336 850 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 886 (935)
Q Consensus 850 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~ 886 (935)
.. ......+.+++.+|++.+|++||++.++.+.|+
T Consensus 222 ~~--~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 222 ED--VEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred cc--ccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 00 001346889999999999999999976666555
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=290.59 Aligned_cols=252 Identities=28% Similarity=0.417 Sum_probs=196.8
Q ss_pred HHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcchhhhHHHHHHHHHHHhc-CCCcccccceeeeccc------eE
Q 002336 613 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEH------QR 684 (935)
Q Consensus 613 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L-~HpnIv~l~g~~~~~~------~~ 684 (935)
..|++.+.||+|++|.||+|..+ +++.+++|++..... ..+.+.+|+.+++++ +|+||+++++++.... ..
T Consensus 6 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 84 (275)
T cd06608 6 GIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQL 84 (275)
T ss_pred hheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEE
Confidence 45667899999999999999885 578999999875433 346789999999999 6999999999986544 48
Q ss_pred EEEEEecCCCCHHHHhccCC-CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccc
Q 002336 685 ILVYEYMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 763 (935)
Q Consensus 685 ~lV~E~~~~gsL~~~L~~~~-~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~ 763 (935)
++||||+++++|.+++.... ....+++..+..++.|+++||.|||+ .+++||||+|+||++++++.+||+|||++.
T Consensus 85 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~ 161 (275)
T cd06608 85 WLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHE---NKVIHRDIKGQNILLTKNAEVKLVDFGVSA 161 (275)
T ss_pred EEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEEccCCeEEECCCccce
Confidence 99999999999999886432 24578999999999999999999997 899999999999999999999999999987
Q ss_pred cccccccceeecccCCccccCCCCCCC-----CCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcC
Q 002336 764 QAEEDLTHISSVARGTVGYLDPEYYGN-----QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG 838 (935)
Q Consensus 764 ~~~~~~~~~~~~~~gt~~y~APE~l~~-----~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~ 838 (935)
........ .....++..|+|||.+.. ..++.++||||||+++++|++|+.||..... ...+. + +..+
T Consensus 162 ~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--~~~~~----~-~~~~ 233 (275)
T cd06608 162 QLDSTLGR-RNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHP--MRALF----K-IPRN 233 (275)
T ss_pred ecccchhh-hcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccch--HHHHH----H-hhcc
Confidence 65432221 223457889999998743 3567899999999999999999999963211 11111 1 1111
Q ss_pred CeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 839 DVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 839 ~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
.... + ..+......+.+++.+||..||++|||++|+++
T Consensus 234 ~~~~-----~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 234 PPPT-----L--KSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred CCCC-----C--CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 1111 1 111223457889999999999999999999975
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-31 Score=294.17 Aligned_cols=263 Identities=22% Similarity=0.266 Sum_probs=196.3
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcchh--hhHHHHHHHHHHHhcCCCcccccceeeecc--ceEEEEE
Q 002336 614 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSH--RTQQFVTEVALLSRIHHRNLVPLIGYCEEE--HQRILVY 688 (935)
Q Consensus 614 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~~--~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~--~~~~lV~ 688 (935)
.|++.+.||+|++|.||+|.++ +++.+|+|.++..... ....+.+|+.++++++||||+++++++... ...++||
T Consensus 6 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~ 85 (293)
T cd07843 6 EYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVM 85 (293)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEe
Confidence 4667789999999999999886 5889999998654322 224577899999999999999999998776 8899999
Q ss_pred EecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccccc
Q 002336 689 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 768 (935)
Q Consensus 689 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~ 768 (935)
||+. ++|.+.+... ...+++..++.++.|+++||+|||+ .+++||||||+||+++.++.+||+|||++......
T Consensus 86 e~~~-~~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 159 (293)
T cd07843 86 EYVE-HDLKSLMETM--KQPFLQSEVKCLMLQLLSGVAHLHD---NWILHRDLKTSNLLLNNRGILKICDFGLAREYGSP 159 (293)
T ss_pred hhcC-cCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCcEEEeecCceeeccCC
Confidence 9997 5999888743 2368999999999999999999998 89999999999999999999999999998876543
Q ss_pred ccceeecccCCccccCCCCCCCC-CCCchhHHHHHHHHHHHHHhCCCCCCccCcccchh-HHH---------HHH--Hhh
Q 002336 769 LTHISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELN-IVH---------WAR--SMI 835 (935)
Q Consensus 769 ~~~~~~~~~gt~~y~APE~l~~~-~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~-l~~---------~~~--~~i 835 (935)
... .....++..|+|||.+.+. .++.++|+||+|+++++|++|+.||.......... +.. |.. ...
T Consensus 160 ~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (293)
T cd07843 160 LKP-YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELP 238 (293)
T ss_pred ccc-cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccc
Confidence 221 1223468889999988654 46899999999999999999999997443211110 000 000 000
Q ss_pred --hcCCeeecccccccCCCCHH-HHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 836 --KKGDVISIVDPVLIGNVKIE-SIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 836 --~~~~~~~~~d~~l~~~~~~~-~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
............+....+.. ....+.+++.+||+.+|++||+++|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 239 GAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred hhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 00000000011111111111 2446789999999999999999999975
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=287.52 Aligned_cols=242 Identities=24% Similarity=0.332 Sum_probs=195.2
Q ss_pred ccccccEEEEEEEEC-CCcEEEEEEccCcc---hhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEecCCCCH
Q 002336 621 IGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTL 696 (935)
Q Consensus 621 LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL 696 (935)
||.|++|.||++... .++.+|+|++.... ....+.+.+|+++++.++||||+++++.+.++...++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 799999999999876 48999999986532 23446799999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccccceeecc
Q 002336 697 RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVA 776 (935)
Q Consensus 697 ~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~ 776 (935)
.+++.. ...+++..+..++.|+++||+|||+ .+++|+||+|+||+++.++.++|+|||++....... .....
T Consensus 81 ~~~l~~---~~~l~~~~~~~~~~~i~~~l~~lH~---~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~~ 152 (262)
T cd05572 81 WTILRD---RGLFDEYTARFYIACVVLAFEYLHN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWTF 152 (262)
T ss_pred HHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--ccccc
Confidence 999974 3458899999999999999999998 999999999999999999999999999988765432 12233
Q ss_pred cCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccCCCCHHH
Q 002336 777 RGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIES 856 (935)
Q Consensus 777 ~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~~~~~~~ 856 (935)
.++..|++||.+.+..++.++|+||+|+++|+|++|+.||.....+ ..+.......... ....+...
T Consensus 153 ~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~~~~~~---------~~~~~~~~ 219 (262)
T cd05572 153 CGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDED----PMEIYNDILKGNG---------KLEFPNYI 219 (262)
T ss_pred cCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCC----HHHHHHHHhccCC---------CCCCCccc
Confidence 5788999999998888999999999999999999999999744321 1121222111000 01112222
Q ss_pred HHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 002336 857 IWRIAEVAIQCVEQRGFSRPK-----MQEIVL 883 (935)
Q Consensus 857 ~~~l~~li~~Cl~~dP~~RPs-----~~ev~~ 883 (935)
...+.+++.+||+.+|++||+ ++|+++
T Consensus 220 ~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 220 DKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred CHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 447899999999999999999 677654
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=292.85 Aligned_cols=250 Identities=27% Similarity=0.375 Sum_probs=194.0
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCcchhhhHHHHHHHHHHHhc-CCCcccccceeeecc-----ceEEEE
Q 002336 615 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEE-----HQRILV 687 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L-~HpnIv~l~g~~~~~-----~~~~lV 687 (935)
+.+.+.||+|+||.||++... +++.+|+|.+.... .....+.+|+.+++++ +|||++++++++... ...++|
T Consensus 24 y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv 102 (291)
T cd06639 24 WEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLV 102 (291)
T ss_pred eEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEEE
Confidence 455788999999999999875 68899999986532 2345678899999999 799999999998643 358999
Q ss_pred EEecCCCCHHHHhccCC-CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccc
Q 002336 688 YEYMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 766 (935)
Q Consensus 688 ~E~~~~gsL~~~L~~~~-~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~ 766 (935)
|||+++++|.++++... ....+++..++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++....
T Consensus 103 ~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~nili~~~~~~kl~dfg~~~~~~ 179 (291)
T cd06639 103 LELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHN---NRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLT 179 (291)
T ss_pred EEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCCEEEeecccchhcc
Confidence 99999999999886432 34568999999999999999999997 899999999999999999999999999987654
Q ss_pred ccccceeecccCCccccCCCCCCCC-----CCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCee
Q 002336 767 EDLTHISSVARGTVGYLDPEYYGNQ-----QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVI 841 (935)
Q Consensus 767 ~~~~~~~~~~~gt~~y~APE~l~~~-----~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~ 841 (935)
..... .....|+..|+|||.+... .++.++||||||+++|||++|+.||..... ...+.+ +..+...
T Consensus 180 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~--~~~~~~-----~~~~~~~ 251 (291)
T cd06639 180 STRLR-RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHP--VKTLFK-----IPRNPPP 251 (291)
T ss_pred ccccc-ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcH--HHHHHH-----HhcCCCC
Confidence 32211 2234578899999987543 367899999999999999999999963221 111111 1111111
Q ss_pred ecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 842 SIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 842 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
.+.+ +......+.+++.+|++.+|++||++.|+++
T Consensus 252 ~~~~-------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 252 TLLH-------PEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred CCCc-------ccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 1111 1122346889999999999999999999975
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=294.27 Aligned_cols=254 Identities=28% Similarity=0.367 Sum_probs=193.5
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc-hhhhHHHHHHHHHHHhcC-CCcccccceeeeccceEEEEEEec
Q 002336 615 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQRILVYEYM 691 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~-~~~~~~~~~E~~iL~~L~-HpnIv~l~g~~~~~~~~~lV~E~~ 691 (935)
+...+.||+|+||.||++... +++.+|+|.+.... ......+.+|+.++.++. |+||+++++++..+...+++|||+
T Consensus 6 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~ 85 (288)
T cd06616 6 LKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELM 85 (288)
T ss_pred hHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEecc
Confidence 334578999999999999875 58999999986532 234567889999999996 999999999998888999999998
Q ss_pred CCCCHHHHhcc--CCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccc
Q 002336 692 HNGTLRDRLHG--SVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 769 (935)
Q Consensus 692 ~~gsL~~~L~~--~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~ 769 (935)
. +++.++... ......+++..+.+++.|+++||+|||+ ..+++||||||+||+++.++.+||+|||++.......
T Consensus 86 ~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 162 (288)
T cd06616 86 D-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSI 162 (288)
T ss_pred c-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh--cCCeeccCCCHHHEEEccCCcEEEeecchhHHhccCC
Confidence 6 455543321 1124568999999999999999999997 3599999999999999999999999999987654322
Q ss_pred cceeecccCCccccCCCCCCCC---CCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccc
Q 002336 770 THISSVARGTVGYLDPEYYGNQ---QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP 846 (935)
Q Consensus 770 ~~~~~~~~gt~~y~APE~l~~~---~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~ 846 (935)
.. ....|+..|+|||.+.+. .++.++||||||+++|||++|+.||.... ...+-+.+... +.. +
T Consensus 163 ~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-----~~~~~~~~~~~-~~~-----~ 229 (288)
T cd06616 163 AK--TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN-----SVFDQLTQVVK-GDP-----P 229 (288)
T ss_pred cc--ccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc-----hHHHHHhhhcC-CCC-----C
Confidence 21 223578899999998765 68899999999999999999999997322 11111221111 111 1
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002336 847 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 884 (935)
Q Consensus 847 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~ 884 (935)
.+...........+.+++.+|++.+|++||+++||++.
T Consensus 230 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 230 ILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred cCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11111112234478899999999999999999999763
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=286.89 Aligned_cols=248 Identities=29% Similarity=0.430 Sum_probs=198.6
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc--hhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEec
Q 002336 615 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 691 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~ 691 (935)
+.+.+.||+|+||.||+|..+ +|+.+|+|.+.... ....+.+.+|+++++.++|+||+++++.+......++|+||+
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (257)
T cd08225 2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYC 81 (257)
T ss_pred ceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecC
Confidence 345788999999999999876 58899999986431 233467889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCc-EEEeecccccccccccc
Q 002336 692 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMR-AKVSDFGLSRQAEEDLT 770 (935)
Q Consensus 692 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~-vkL~DFGla~~~~~~~~ 770 (935)
++++|.+.+... ....+++..+..++.|+++||.|||+ .+++|+||||+||++++++. +||+|||.+........
T Consensus 82 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (257)
T cd08225 82 DGGDLMKRINRQ-RGVLFSEDQILSWFVQISLGLKHIHD---RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME 157 (257)
T ss_pred CCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence 999999988743 23457899999999999999999998 89999999999999998754 69999999876644322
Q ss_pred ceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccC
Q 002336 771 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 850 (935)
Q Consensus 771 ~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~ 850 (935)
. .....|++.|+|||.+.+..++.++||||||++++||++|+.||.... ..++...... +.....
T Consensus 158 ~-~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~------~~~~~~~~~~-~~~~~~------- 222 (257)
T cd08225 158 L-AYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN------LHQLVLKICQ-GYFAPI------- 222 (257)
T ss_pred c-ccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc------HHHHHHHHhc-ccCCCC-------
Confidence 2 223458889999999988889999999999999999999999986322 2222322222 111111
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 851 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 851 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
.......+.+++.+|+..+|++||++.|+++
T Consensus 223 --~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 223 --SPNFSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred --CCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 1122346889999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=297.52 Aligned_cols=264 Identities=21% Similarity=0.272 Sum_probs=194.3
Q ss_pred HhhcccccccccEEEEEEEECC---CcEEEEEEccCcc---hhhhHHHHHHHHHHHhcCCCcccccceeeecc--ceEEE
Q 002336 615 NNFCKKIGKGSFGSVYYGKMKD---GKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE--HQRIL 686 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~~---g~~vAvK~~~~~~---~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~--~~~~l 686 (935)
|++.+.||+|++|.||+|.... ++.||+|.+.... ....+.+.+|+.++++++||||+++++++.+. ...++
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 81 (316)
T cd07842 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYL 81 (316)
T ss_pred ceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEE
Confidence 4567889999999999998754 7899999987632 33346678899999999999999999999887 78999
Q ss_pred EEEecCCCCHHHHhccCC--CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccC----CCcEEEeecc
Q 002336 687 VYEYMHNGTLRDRLHGSV--NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI----NMRAKVSDFG 760 (935)
Q Consensus 687 V~E~~~~gsL~~~L~~~~--~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~----~~~vkL~DFG 760 (935)
||||+++ +|.+.+.... ....+++..+..++.|++.||+|||+ ++|+||||||+||+++. ++.+||+|||
T Consensus 82 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg 157 (316)
T cd07842 82 LFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHS---NWVLHRDLKPANILVMGEGPERGVVKIGDLG 157 (316)
T ss_pred EEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence 9999975 6666654322 22368899999999999999999998 89999999999999999 9999999999
Q ss_pred cccccccccc--ceeecccCCccccCCCCCCC-CCCCchhHHHHHHHHHHHHHhCCCCCCccCcccc-------hhHHHH
Q 002336 761 LSRQAEEDLT--HISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAE-------LNIVHW 830 (935)
Q Consensus 761 la~~~~~~~~--~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~-------~~l~~~ 830 (935)
++........ .......++..|+|||.+.+ ..++.++||||||+++++|++|+.||........ ..+...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (316)
T cd07842 158 LARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERI 237 (316)
T ss_pred cccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHH
Confidence 9886543322 11223457889999998765 4578999999999999999999999975443220 011111
Q ss_pred HHHhhhc------------CCeeecccccccCCCC---------H--HHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 831 ARSMIKK------------GDVISIVDPVLIGNVK---------I--ESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 831 ~~~~i~~------------~~~~~~~d~~l~~~~~---------~--~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
+. .+.. .......+.......+ . .....+.+++.+|++.+|++|||+.|+++
T Consensus 238 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 238 FE-VLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HH-HhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 10 0000 0000000000000001 0 12236889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-32 Score=308.19 Aligned_cols=246 Identities=27% Similarity=0.443 Sum_probs=194.4
Q ss_pred hhcccccccccEEEEEEEEC-CCcEEEEEEccC----cchhhhHHHHHHHHHHHhcCCCcccccceeeeccce--EEEEE
Q 002336 616 NFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMAD----SCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQ--RILVY 688 (935)
Q Consensus 616 ~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~----~~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~--~~lV~ 688 (935)
+|.++||+|+|-+||+|.+. +|.+||--.++- ......++|..|+.+|+.|+|||||+++.++.+... .-+|+
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 35678999999999999875 577776443321 123345789999999999999999999998876554 67999
Q ss_pred EecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCcccc-CCCcEEEeeccccccccc
Q 002336 689 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD-INMRAKVSDFGLSRQAEE 767 (935)
Q Consensus 689 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld-~~~~vkL~DFGla~~~~~ 767 (935)
|.|..|+|..++++ .+.++.+.+..|++||++||.|||+. +++|+|||||..||+|+ ..|.|||+|+|+|.....
T Consensus 123 EL~TSGtLr~Y~kk---~~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~ 198 (632)
T KOG0584|consen 123 ELFTSGTLREYRKK---HRRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK 198 (632)
T ss_pred ecccCCcHHHHHHH---hccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhc
Confidence 99999999999984 45688899999999999999999984 78999999999999997 568999999999987644
Q ss_pred cccceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeeccccc
Q 002336 768 DLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 847 (935)
Q Consensus 768 ~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~ 847 (935)
... ....|||.|||||++. ..|.+..||||||+.|+||+|+.+||. +.. ....+.+-+..-++...+..+-||
T Consensus 199 s~a---ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYs-EC~-n~AQIYKKV~SGiKP~sl~kV~dP- 271 (632)
T KOG0584|consen 199 SHA---KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYS-ECT-NPAQIYKKVTSGIKPAALSKVKDP- 271 (632)
T ss_pred ccc---ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChh-hhC-CHHHHHHHHHcCCCHHHhhccCCH-
Confidence 322 2367999999999987 689999999999999999999999997 222 122232222222222222223333
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002336 848 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 884 (935)
Q Consensus 848 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~ 884 (935)
.+.++|.+|+.. .++|||+.|+++.
T Consensus 272 -----------evr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 272 -----------EVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred -----------HHHHHHHHHhcC-chhccCHHHHhhC
Confidence 578999999999 9999999999763
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=291.47 Aligned_cols=259 Identities=22% Similarity=0.296 Sum_probs=194.3
Q ss_pred hhcccccccccEEEEEEEEC-CCcEEEEEEccCcc--hhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEecC
Q 002336 616 NFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 692 (935)
Q Consensus 616 ~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~~ 692 (935)
++.+.||+|++|.||+|.+. +|+.||+|++.... ......+.+|+++++.++|||++++++++.+....+++|||++
T Consensus 2 ~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~ 81 (283)
T cd07835 2 QKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFLD 81 (283)
T ss_pred chheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEeccC
Confidence 45678999999999999875 79999999986432 2223568889999999999999999999999999999999995
Q ss_pred CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccccce
Q 002336 693 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 772 (935)
Q Consensus 693 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~~ 772 (935)
++|.+++.... ...+++..+++++.|+++||+|||+ ++++||||+|+||+++.++.++|+|||++.........
T Consensus 82 -~~l~~~~~~~~-~~~~~~~~~~~~~~~i~~~L~~lH~---~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~- 155 (283)
T cd07835 82 -LDLKKYMDSSP-LTGLDPPLIKSYLYQLLQGIAYCHS---HRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT- 155 (283)
T ss_pred -cCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc-
Confidence 68999887432 2468999999999999999999998 89999999999999999999999999998765332211
Q ss_pred eecccCCccccCCCCCCC-CCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcC-----------C-
Q 002336 773 SSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG-----------D- 839 (935)
Q Consensus 773 ~~~~~gt~~y~APE~l~~-~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~-----------~- 839 (935)
.....++..|+|||++.+ ..++.++||||||+++|+|++|+.||...+... .+.+..+...... +
T Consensus 156 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd07835 156 YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEID--QLFRIFRTLGTPDEDVWPGVTSLPDY 233 (283)
T ss_pred cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCChHHhhhhhhchhh
Confidence 112246788999998765 457899999999999999999999997433211 1111111000000 0
Q ss_pred ---eeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 840 ---VISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 840 ---~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
......+.. ..........+.+++.+|++.+|++||+++|+++
T Consensus 234 ~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 234 KPTFPKWARQDL-SKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hhhcccccccch-hhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 000000000 0011122246889999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=291.07 Aligned_cols=250 Identities=22% Similarity=0.351 Sum_probs=190.6
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc-hhhhHHHHHHHHH-HHhcCCCcccccceeeeccceEEEEEEec
Q 002336 615 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVAL-LSRIHHRNLVPLIGYCEEEHQRILVYEYM 691 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~-~~~~~~~~~E~~i-L~~L~HpnIv~l~g~~~~~~~~~lV~E~~ 691 (935)
+++.+.||+|+||.||++.++ +|+.||+|++.... .....++..|+.. ++.++||||+++++++..+...+++|||+
T Consensus 3 ~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~ 82 (283)
T cd06617 3 LEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVM 82 (283)
T ss_pred ceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhh
Confidence 456788999999999999876 68999999987543 2334456666665 56678999999999999999999999999
Q ss_pred CCCCHHHHhccCC-CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccccccc
Q 002336 692 HNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 770 (935)
Q Consensus 692 ~~gsL~~~L~~~~-~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~ 770 (935)
+ |+|.+++.... ....+++..++.++.|++.||+|||+ +.+++||||||+||+++.++.+||+|||++........
T Consensus 83 ~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~--~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~ 159 (283)
T cd06617 83 D-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS--KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVA 159 (283)
T ss_pred c-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhh--cCCeecCCCCHHHEEECCCCCEEEeecccccccccccc
Confidence 6 68887775422 34578999999999999999999997 23999999999999999999999999999876543221
Q ss_pred ceeecccCCccccCCCCCCC----CCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccc
Q 002336 771 HISSVARGTVGYLDPEYYGN----QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP 846 (935)
Q Consensus 771 ~~~~~~~gt~~y~APE~l~~----~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~ 846 (935)
.....++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||..... . .+....... +....+..
T Consensus 160 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-~----~~~~~~~~~-~~~~~~~~- 230 (283)
T cd06617 160 --KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKT-P----FQQLKQVVE-EPSPQLPA- 230 (283)
T ss_pred --cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCcccc-C----HHHHHHHHh-cCCCCCCc-
Confidence 122357889999998754 4568899999999999999999999962211 1 111111111 11111110
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 847 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 847 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
......+.+++.+||..+|++||+++++++
T Consensus 231 -------~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 231 -------EKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred -------cccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 012246889999999999999999999976
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=295.15 Aligned_cols=246 Identities=30% Similarity=0.425 Sum_probs=195.0
Q ss_pred HHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc---hhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEE
Q 002336 613 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 688 (935)
Q Consensus 613 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~ 688 (935)
..|++.+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 44777889999999999999875 68999999886432 233467889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccccc
Q 002336 689 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 768 (935)
Q Consensus 689 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~ 768 (935)
||+. |+|.+.+... ...+++..+..++.|++.||.|||+ .+++||||+|+||++++++.+||+|||++......
T Consensus 95 e~~~-g~l~~~~~~~--~~~l~~~~~~~~~~ql~~~L~~LH~---~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~ 168 (307)
T cd06607 95 EYCL-GSASDILEVH--KKPLQEVEIAAICHGALQGLAYLHS---HERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA 168 (307)
T ss_pred HhhC-CCHHHHHHHc--ccCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEECCCCCEEEeecCcceecCCC
Confidence 9996 5777766532 3468999999999999999999998 89999999999999999999999999998764332
Q ss_pred ccceeecccCCccccCCCCCC---CCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeeccc
Q 002336 769 LTHISSVARGTVGYLDPEYYG---NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 845 (935)
Q Consensus 769 ~~~~~~~~~gt~~y~APE~l~---~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d 845 (935)
....++..|+|||.+. ...++.++||||||+++|||++|+.||...+... . ... +.....
T Consensus 169 -----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~---~---~~~-~~~~~~----- 231 (307)
T cd06607 169 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS---A---LYH-IAQNDS----- 231 (307)
T ss_pred -----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHH---H---HHH-HhcCCC-----
Confidence 1234788999999874 4568899999999999999999999986332211 0 111 111111
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002336 846 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 884 (935)
Q Consensus 846 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~ 884 (935)
+.+ ........+.+++.+||..+|++||++.+|+..
T Consensus 232 ~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 232 PTL---SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred CCC---CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 011 112234578999999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-31 Score=289.78 Aligned_cols=249 Identities=25% Similarity=0.384 Sum_probs=200.4
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcchhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEecC
Q 002336 614 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 692 (935)
Q Consensus 614 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~~ 692 (935)
.+++.+.||+|++|.||+|.++ +++.+++|++..... ....+.+|+++++.++|+|++++++.+......++|+||++
T Consensus 20 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 98 (286)
T cd06614 20 LYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMD 98 (286)
T ss_pred cchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccC
Confidence 3556788999999999999887 689999999876544 45678899999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccccce
Q 002336 693 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 772 (935)
Q Consensus 693 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~~ 772 (935)
+++|.+++.... ..+++..+..++.|+++||+|||+ .+++|+||+|+||+++.++.++|+|||++........ .
T Consensus 99 ~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~---~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~ 172 (286)
T cd06614 99 GGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHS---QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS-K 172 (286)
T ss_pred CCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCChhhEEEcCCCCEEECccchhhhhccchh-h
Confidence 999999998532 379999999999999999999997 9999999999999999999999999998765433221 1
Q ss_pred eecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccCCC
Q 002336 773 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNV 852 (935)
Q Consensus 773 ~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~~~ 852 (935)
.....++..|++||.+.+..++.++||||||+++|+|++|+.||....... . ..... ........+
T Consensus 173 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~---~---~~~~~-~~~~~~~~~------- 238 (286)
T cd06614 173 RNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLR---A---LFLIT-TKGIPPLKN------- 238 (286)
T ss_pred hccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHH---H---HHHHH-hcCCCCCcc-------
Confidence 122347889999999988889999999999999999999999986322111 1 11111 111111100
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 853 KIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 853 ~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
.......+.+++.+|++.+|.+||++.++++
T Consensus 239 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 239 PEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred hhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 1112346889999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.1e-32 Score=306.33 Aligned_cols=267 Identities=27% Similarity=0.414 Sum_probs=201.2
Q ss_pred cccccccccEEEEEEEEC-CCcEEEEEEccCcc-hhhhHHHHHHHHHHHhcCCCcccccceeeeccc------eEEEEEE
Q 002336 618 CKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH------QRILVYE 689 (935)
Q Consensus 618 ~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~-~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~------~~~lV~E 689 (935)
.+.||+|+||.||+|+++ .|+.||||.++... ....+...+|+++|++++|+|||+++++-++.. ...+|||
T Consensus 18 ~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmE 97 (732)
T KOG4250|consen 18 DERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVME 97 (732)
T ss_pred hhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEe
Confidence 578999999999999965 79999999987643 234567889999999999999999999875543 5689999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCcccc--CCCc--EEEeeccccccc
Q 002336 690 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD--INMR--AKVSDFGLSRQA 765 (935)
Q Consensus 690 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld--~~~~--vkL~DFGla~~~ 765 (935)
||.+|||+..|....+..++++.+.+.++.+++.||.|||+ ++|+||||||.||++- .+|+ .||+|||.|+..
T Consensus 98 yC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrE---n~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel 174 (732)
T KOG4250|consen 98 YCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRE---NGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAAREL 174 (732)
T ss_pred ecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHH---cCceeccCCCCcEEEeecCCCceEEeeecccccccC
Confidence 99999999999988888999999999999999999999998 9999999999999983 3344 699999999988
Q ss_pred cccccceeecccCCccccCCCCCC-CCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecc
Q 002336 766 EEDLTHISSVARGTVGYLDPEYYG-NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 844 (935)
Q Consensus 766 ~~~~~~~~~~~~gt~~y~APE~l~-~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~ 844 (935)
.++. ......||..|++||.+. .+.++...|.|||||++||++||..||..........-+.|....-+...+....
T Consensus 175 ~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~~ 252 (732)
T KOG4250|consen 175 DDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAIGA 252 (732)
T ss_pred CCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeEee
Confidence 7655 334567999999999998 4899999999999999999999999997333222111122221111111111112
Q ss_pred ccccc------------CCCCHHHHHHHHHHHHHccccCCCCCC--CHHHHHHHHhhhh
Q 002336 845 DPVLI------------GNVKIESIWRIAEVAIQCVEQRGFSRP--KMQEIVLAIQDSI 889 (935)
Q Consensus 845 d~~l~------------~~~~~~~~~~l~~li~~Cl~~dP~~RP--s~~ev~~~L~~~~ 889 (935)
++... ..........+-.++..+|..+|++|- ...+....+.+++
T Consensus 253 ~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL 311 (732)
T KOG4250|consen 253 QEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDIL 311 (732)
T ss_pred ecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHH
Confidence 21111 111223334566777788888888888 4444444443333
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-31 Score=290.32 Aligned_cols=260 Identities=22% Similarity=0.310 Sum_probs=191.1
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCcchh-hhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEecC
Q 002336 615 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSH-RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 692 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~~-~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~~ 692 (935)
|.+.+.||+|+||.||+|... +|+.||+|.+...... ....+.+|+++++.++|+||+++++++..+...++||||+.
T Consensus 7 y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~ 86 (291)
T cd07870 7 YLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMH 86 (291)
T ss_pred eEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEeccc
Confidence 456789999999999999865 6899999998654322 23467889999999999999999999999999999999995
Q ss_pred CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccccce
Q 002336 693 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 772 (935)
Q Consensus 693 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~~ 772 (935)
++|.+.+... ...+++..+..++.|++.||.|||+ .+|+|+||||+||+++.++.+||+|||+++........
T Consensus 87 -~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~- 159 (291)
T cd07870 87 -TDLAQYMIQH--PGGLHPYNVRLFMFQLLRGLAYIHG---QHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQT- 159 (291)
T ss_pred -CCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEEcCCCcEEEeccccccccCCCCCC-
Confidence 6777666432 3457888899999999999999998 89999999999999999999999999998754332211
Q ss_pred eecccCCccccCCCCCCC-CCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhh---cC------Ceee
Q 002336 773 SSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIK---KG------DVIS 842 (935)
Q Consensus 773 ~~~~~gt~~y~APE~l~~-~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~---~~------~~~~ 842 (935)
.....++..|+|||.+.+ ..++.++||||||+++|||++|+.||........ .+.+ ....+. .. ....
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~-~~~~-~~~~~~~~~~~~~~~~~~~~~ 237 (291)
T cd07870 160 YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFE-QLEK-IWTVLGVPTEDTWPGVSKLPN 237 (291)
T ss_pred CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHH-HHHH-HHHHcCCCChhhhhhhhhccc
Confidence 122346889999999865 4578899999999999999999999974332111 1100 000000 00 0000
Q ss_pred cccccc----cCCC-----CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 843 IVDPVL----IGNV-----KIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 843 ~~d~~l----~~~~-----~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
...... .... .......+.+++.+|+..+|++|||++|++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 238 YKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred ccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 000000 0000 0011346789999999999999999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=290.19 Aligned_cols=242 Identities=22% Similarity=0.279 Sum_probs=186.7
Q ss_pred cccccccEEEEEEEEC-CCcEEEEEEccCcch---hhhHHHHHHHHHHHh---cCCCcccccceeeeccceEEEEEEecC
Q 002336 620 KIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSR---IHHRNLVPLIGYCEEEHQRILVYEYMH 692 (935)
Q Consensus 620 ~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~---~~~~~~~~E~~iL~~---L~HpnIv~l~g~~~~~~~~~lV~E~~~ 692 (935)
.||+|+||.||++... +++.+|+|.+..... .....+.+|..+++. .+||||+.+++++..++..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999875 589999998865321 122334455544443 479999999999998899999999999
Q ss_pred CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccccce
Q 002336 693 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 772 (935)
Q Consensus 693 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~~ 772 (935)
+++|.+++.. ...+++..+..++.|++.||+|||+ .+|+||||||+|||+++++.++|+|||++........
T Consensus 81 ~~~L~~~i~~---~~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~-- 152 (279)
T cd05633 81 GGDLHYHLSQ---HGVFSEKEMRFYATEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP-- 152 (279)
T ss_pred CCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCcCCCCCCHHHEEECCCCCEEEccCCcceeccccCc--
Confidence 9999998873 4569999999999999999999998 8999999999999999999999999999875533221
Q ss_pred eecccCCccccCCCCCC-CCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccCC
Q 002336 773 SSVARGTVGYLDPEYYG-NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 851 (935)
Q Consensus 773 ~~~~~gt~~y~APE~l~-~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~~ 851 (935)
....|+..|+|||.+. +..++.++||||+||++++|++|+.||.......... ....... ....
T Consensus 153 -~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~----~~~~~~~------~~~~---- 217 (279)
T cd05633 153 -HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE----IDRMTLT------VNVE---- 217 (279)
T ss_pred -cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHH----HHHHhhc------CCcC----
Confidence 2235899999999886 4568899999999999999999999997433221111 1111110 0111
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 002336 852 VKIESIWRIAEVAIQCVEQRGFSRP-----KMQEIVLA 884 (935)
Q Consensus 852 ~~~~~~~~l~~li~~Cl~~dP~~RP-----s~~ev~~~ 884 (935)
.+......+.+++.+|+..+|++|| +++|+++.
T Consensus 218 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 218 LPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred CccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 1222334788999999999999999 59988774
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-31 Score=282.09 Aligned_cols=248 Identities=27% Similarity=0.401 Sum_probs=201.4
Q ss_pred hhcccccccccEEEEEEEEC-CCcEEEEEEccCcch--hhhHHHHHHHHHHHhcCCCcccccceeeecc--ceEEEEEEe
Q 002336 616 NFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEE--HQRILVYEY 690 (935)
Q Consensus 616 ~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~--~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~--~~~~lV~E~ 690 (935)
...+.||+|++|.||+|... +++.|++|++..... ...+.+.+|++++++++||||+++++.+... ...++++||
T Consensus 3 ~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~ 82 (260)
T cd06606 3 TRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEY 82 (260)
T ss_pred eeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEe
Confidence 34678999999999999887 689999999865542 4567899999999999999999999999888 889999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccccccc
Q 002336 691 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 770 (935)
Q Consensus 691 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~ 770 (935)
+++++|.+++... ..+++..+..++.|+++||+|||+ .+++|+||+|+||+++.++.++|+|||.+........
T Consensus 83 ~~~~~L~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~---~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 156 (260)
T cd06606 83 VSGGSLSSLLKKF---GKLPEPVIRKYTRQILEGLAYLHS---NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIET 156 (260)
T ss_pred cCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEcccccEEecccccc
Confidence 9999999998743 378999999999999999999998 8999999999999999999999999999887654432
Q ss_pred c-eeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeeccccccc
Q 002336 771 H-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 849 (935)
Q Consensus 771 ~-~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~ 849 (935)
. ......++..|+|||.+.....+.++||||||+++++|++|+.||...+. ...........+..
T Consensus 157 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~~--------- 222 (260)
T cd06606 157 GEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN-----PMAALYKIGSSGEP--------- 222 (260)
T ss_pred cccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc-----hHHHHHhccccCCC---------
Confidence 1 12234578899999999888899999999999999999999999974431 11111111110111
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 850 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 850 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
...+......+.+++.+|++.+|++||++.|+++
T Consensus 223 ~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 223 PEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred cCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 1122222457889999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-31 Score=295.27 Aligned_cols=249 Identities=31% Similarity=0.431 Sum_probs=196.3
Q ss_pred HHHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCc---chhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEE
Q 002336 612 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS---CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILV 687 (935)
Q Consensus 612 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~---~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV 687 (935)
++.+...+.||+|+||.||+|... +++.+|+|++... .....+.+.+|++++++++|||++++++++.+++..++|
T Consensus 24 ~~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 103 (317)
T cd06635 24 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLV 103 (317)
T ss_pred hhhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEE
Confidence 344667789999999999999875 6889999998643 223345788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccc
Q 002336 688 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 767 (935)
Q Consensus 688 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~ 767 (935)
|||+. |+|.+.+.. ....+++.++..++.|++.||.|||+ .+++||||+|+||+++.++.+||+|||++.....
T Consensus 104 ~e~~~-g~l~~~~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~---~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~ 177 (317)
T cd06635 104 MEYCL-GSASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASIASP 177 (317)
T ss_pred EeCCC-CCHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcccEEECCCCCEEEecCCCccccCC
Confidence 99996 577777653 24568999999999999999999998 8999999999999999999999999998875433
Q ss_pred cccceeecccCCccccCCCCCC---CCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecc
Q 002336 768 DLTHISSVARGTVGYLDPEYYG---NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 844 (935)
Q Consensus 768 ~~~~~~~~~~gt~~y~APE~l~---~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~ 844 (935)
. ....++..|+|||.+. ...++.++||||||+++|||++|+.||...... .... .....+..
T Consensus 178 ~-----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~--~~~~----~~~~~~~~---- 242 (317)
T cd06635 178 A-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--SALY----HIAQNESP---- 242 (317)
T ss_pred c-----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHH--HHHH----HHHhccCC----
Confidence 2 1234788999999873 457889999999999999999999998632211 1111 11111110
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 002336 845 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 886 (935)
Q Consensus 845 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~ 886 (935)
.. ........+.+++.+|++.+|++||++.+|++.+-
T Consensus 243 --~~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~ 279 (317)
T cd06635 243 --TL---QSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMF 279 (317)
T ss_pred --CC---CCccccHHHHHHHHHHccCCcccCcCHHHHHhChh
Confidence 00 01122346889999999999999999999987654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-32 Score=300.61 Aligned_cols=252 Identities=22% Similarity=0.358 Sum_probs=204.4
Q ss_pred HHHhhcccccccccEEEEEEEECCCc-EEEEEEccCcchhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEec
Q 002336 613 ATNNFCKKIGKGSFGSVYYGKMKDGK-EVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 691 (935)
Q Consensus 613 ~~~~~~~~LG~G~fG~Vy~~~~~~g~-~vAvK~~~~~~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~ 691 (935)
.-++++-.||.|+||.||+|..++.. ..|.|++.....+...+++-|++||....||+||++++.|..++.++++.|||
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC 111 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC 111 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence 44566778999999999999887543 45778877777777889999999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccccc
Q 002336 692 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 771 (935)
Q Consensus 692 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~ 771 (935)
.||-+..++-. -+..+.+.++.-++.|++.||.|||+ ++|||||||+.|||++-+|.++|+|||.+....... .
T Consensus 112 ~GGAVDaimlE--L~r~LtE~QIqvvc~q~ldALn~LHs---~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~-q 185 (1187)
T KOG0579|consen 112 GGGAVDAIMLE--LGRVLTEDQIQVVCYQVLDALNWLHS---QNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTR-Q 185 (1187)
T ss_pred CCchHhHHHHH--hccccchHHHHHHHHHHHHHHHHHhh---cchhhhhccccceEEEecCcEeeecccccccchhHH-h
Confidence 99999887654 46789999999999999999999998 999999999999999999999999999876533222 1
Q ss_pred eeecccCCccccCCCCC-----CCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccc
Q 002336 772 ISSVARGTVGYLDPEYY-----GNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP 846 (935)
Q Consensus 772 ~~~~~~gt~~y~APE~l-----~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~ 846 (935)
......|||.|||||+. ...+|+.++||||||++|.||..+.+|-.. .+..+-+. ++.......++.
T Consensus 186 kRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhe------lnpMRVll-KiaKSePPTLlq- 257 (1187)
T KOG0579|consen 186 KRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHE------LNPMRVLL-KIAKSEPPTLLQ- 257 (1187)
T ss_pred hhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccc------cchHHHHH-HHhhcCCCcccC-
Confidence 23345799999999986 456899999999999999999999999751 12222111 223333333333
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002336 847 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 884 (935)
Q Consensus 847 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~ 884 (935)
|..+...+.+++.+||..+|..||++.++++.
T Consensus 258 ------PS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 258 ------PSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred ------cchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 23445578999999999999999999998764
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-31 Score=292.79 Aligned_cols=263 Identities=23% Similarity=0.276 Sum_probs=194.9
Q ss_pred HHHHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcch--hhhHHHHHHHHHHHhcCCCcccccceeeeccc-----
Q 002336 611 EEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH----- 682 (935)
Q Consensus 611 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~--~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~----- 682 (935)
....+++.+.||+|+||.||+|.++ +|+.||+|.++.... .....+.+|++++++++||||+++++++.+..
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~ 84 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF 84 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence 3455677899999999999999986 588999999865422 22356788999999999999999999887654
Q ss_pred -----eEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEe
Q 002336 683 -----QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVS 757 (935)
Q Consensus 683 -----~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~ 757 (935)
..++|+||+++ ++.+.+... ...+++..+..++.|++.||+|||+ .+|+||||||+||++++++.+||+
T Consensus 85 ~~~~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~kl~ 158 (302)
T cd07864 85 KKDKGAFYLVFEYMDH-DLMGLLESG--LVHFSEDHIKSFMKQLLEGLNYCHK---KNFLHRDIKCSNILLNNKGQIKLA 158 (302)
T ss_pred cccCCcEEEEEcccCc-cHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCcEEeC
Confidence 78999999976 677766532 3468999999999999999999998 899999999999999999999999
Q ss_pred eccccccccccccceeecccCCccccCCCCCCC-CCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhh
Q 002336 758 DFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIK 836 (935)
Q Consensus 758 DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~ 836 (935)
|||++...............++..|+|||.+.+ ...+.++||||||++++||++|+.||....... .+ ..+.+...
T Consensus 159 dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~--~~-~~~~~~~~ 235 (302)
T cd07864 159 DFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELA--QL-ELISRLCG 235 (302)
T ss_pred cccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHH--HH-HHHHHHhC
Confidence 999987654433222222345778999998754 457899999999999999999999997432211 11 11111111
Q ss_pred cC---Ceeecc--------cc------cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 837 KG---DVISIV--------DP------VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 837 ~~---~~~~~~--------d~------~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
.. ....+. ++ ..... .......+.+++.+||+.+|++||++++++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 236 SPCPAVWPDVIKLPYFNTMKPKKQYRRRLREE-FSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred CCChhhcccccccccccccccccccccchhhh-cCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 00 000000 00 00000 0012347889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.5e-31 Score=289.32 Aligned_cols=244 Identities=26% Similarity=0.371 Sum_probs=196.1
Q ss_pred cccccccccEEEEEEEEC-CCcEEEEEEccCcchhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEecCCCCH
Q 002336 618 CKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTL 696 (935)
Q Consensus 618 ~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL 696 (935)
...||+|+||.||++..+ +++.||+|++..........+.+|+.+++.++|+||+++++.+...+..++||||+++++|
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 104 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence 468999999999999875 6899999998655445567799999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccccceeecc
Q 002336 697 RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVA 776 (935)
Q Consensus 697 ~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~ 776 (935)
.+++. ...+++..+..++.|++.||+|||+ .+++||||+|+||+++.++.++|+|||++........ .....
T Consensus 105 ~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~---~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~-~~~~~ 176 (292)
T cd06657 105 TDIVT----HTRMNEEQIAAVCLAVLKALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRKSL 176 (292)
T ss_pred HHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEcccccceecccccc-ccccc
Confidence 99875 2357899999999999999999998 8999999999999999999999999998876543221 12234
Q ss_pred cCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccCCCCHHH
Q 002336 777 RGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIES 856 (935)
Q Consensus 777 ~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~~~~~~~ 856 (935)
.++..|+|||.+.+..++.++|+||+|+++|+|++|+.||...... .......... .+.+.. ....
T Consensus 177 ~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~---~~~~~~~~~~---------~~~~~~--~~~~ 242 (292)
T cd06657 177 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL---KAMKMIRDNL---------PPKLKN--LHKV 242 (292)
T ss_pred ccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHhhC---------CcccCC--cccC
Confidence 5788999999998888899999999999999999999998733221 1111111111 011100 0111
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 857 IWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 857 ~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
...+.+++.+||+.+|.+||++.++++
T Consensus 243 ~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 243 SPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred CHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 235778999999999999999999876
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-31 Score=289.18 Aligned_cols=256 Identities=22% Similarity=0.262 Sum_probs=191.8
Q ss_pred hhcccccccccEEEEEEEEC-CCcEEEEEEccCcch-hhhHHHHHHHHHHHhcC-CCcccccceeeecc--ceEEEEEEe
Q 002336 616 NFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIH-HRNLVPLIGYCEEE--HQRILVYEY 690 (935)
Q Consensus 616 ~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~-~~~~~~~~E~~iL~~L~-HpnIv~l~g~~~~~--~~~~lV~E~ 690 (935)
++.+.||+|+||.||+|... +++.+|+|+++.... .......+|+.++.++. |+|++++++++.+. +..++||||
T Consensus 2 ~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~ 81 (282)
T cd07831 2 KILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFEL 81 (282)
T ss_pred ceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEec
Confidence 45688999999999999865 689999999875422 22234567899999885 99999999999877 889999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccccccc
Q 002336 691 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 770 (935)
Q Consensus 691 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~ 770 (935)
++ ++|.+.+... ...+++.++..++.|++.||+|||+ .+++||||||+||+++. +.+||+|||++........
T Consensus 82 ~~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~ 154 (282)
T cd07831 82 MD-MNLYELIKGR--KRPLPEKRVKSYMYQLLKSLDHMHR---NGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP 154 (282)
T ss_pred CC-ccHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEcC-CCeEEEecccccccccCCC
Confidence 97 5888877642 3568999999999999999999998 89999999999999999 9999999999976543322
Q ss_pred ceeecccCCccccCCCCCC-CCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhh-----------cC
Q 002336 771 HISSVARGTVGYLDPEYYG-NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIK-----------KG 838 (935)
Q Consensus 771 ~~~~~~~gt~~y~APE~l~-~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~-----------~~ 838 (935)
. ....++..|+|||.+. +..++.++||||+||++|||++|+.||...+.. ....+...... ..
T Consensus 155 ~--~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~ 229 (282)
T cd07831 155 Y--TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNEL---DQIAKIHDVLGTPDAEVLKKFRKS 229 (282)
T ss_pred c--CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHH---HHHHHHHHHcCCCCHHHHHhhccc
Confidence 1 2234788999999764 456789999999999999999999999744321 11222221111 00
Q ss_pred CeeecccccccC----CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 839 DVISIVDPVLIG----NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 839 ~~~~~~d~~l~~----~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
.......+.... .........+.+++.+||+.+|++||+++++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 230 RHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred ccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 000000000000 001123457899999999999999999999875
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=292.32 Aligned_cols=261 Identities=21% Similarity=0.273 Sum_probs=191.3
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCcch--hhhHHHHHHHHHHHhcC-CCcccccceeeeccce-----EE
Q 002336 615 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQ-----RI 685 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~--~~~~~~~~E~~iL~~L~-HpnIv~l~g~~~~~~~-----~~ 685 (935)
|++.+.||+|+||.||+|.+. +++.||+|.+..... .....+.+|+.+++.++ ||||+++++++...+. .+
T Consensus 3 y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~ 82 (295)
T cd07837 3 YEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLY 82 (295)
T ss_pred ceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEE
Confidence 455788999999999999876 689999998765322 23357888999999995 6999999999876655 79
Q ss_pred EEEEecCCCCHHHHhccCCC--CCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccC-CCcEEEeecccc
Q 002336 686 LVYEYMHNGTLRDRLHGSVN--QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI-NMRAKVSDFGLS 762 (935)
Q Consensus 686 lV~E~~~~gsL~~~L~~~~~--~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~-~~~vkL~DFGla 762 (935)
+||||+++ +|.+++..... ...+++..++.++.||++||.|||+ ++++||||||+||+++. ++.+||+|||++
T Consensus 83 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~~~nil~~~~~~~~kl~dfg~~ 158 (295)
T cd07837 83 LVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK---HGVMHRDLKPQNLLVDKQKGLLKIADLGLG 158 (295)
T ss_pred EEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEecCCCeEEEeecccc
Confidence 99999985 78887764321 3568999999999999999999998 89999999999999998 889999999998
Q ss_pred ccccccccceeecccCCccccCCCCCCC-CCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCe-
Q 002336 763 RQAEEDLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV- 840 (935)
Q Consensus 763 ~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~- 840 (935)
......... .....+++.|+|||.+.+ ..++.++||||||+++|+|++|..||....... .+.... ..+.....
T Consensus 159 ~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~--~~~~~~-~~~~~~~~~ 234 (295)
T cd07837 159 RAFSIPVKS-YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQ--QLLHIF-KLLGTPTEQ 234 (295)
T ss_pred eecCCCccc-cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHH--HHHHHH-HHhCCCChh
Confidence 765332111 112246788999998754 567899999999999999999999997432211 111100 11100000
Q ss_pred --eecc---c----cccc----CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 841 --ISIV---D----PVLI----GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 841 --~~~~---d----~~l~----~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
.... + +... ....+.....+.+++.+||..+|++||+++|++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 235 VWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred hCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 0000 0 0000 0000123346889999999999999999999874
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=316.21 Aligned_cols=268 Identities=18% Similarity=0.227 Sum_probs=186.7
Q ss_pred HHHHhhcccccccccEEEEEEEECC--CcEEEEE------------------EccCcchhhhHHHHHHHHHHHhcCCCcc
Q 002336 612 EATNNFCKKIGKGSFGSVYYGKMKD--GKEVAVK------------------IMADSCSHRTQQFVTEVALLSRIHHRNL 671 (935)
Q Consensus 612 ~~~~~~~~~LG~G~fG~Vy~~~~~~--g~~vAvK------------------~~~~~~~~~~~~~~~E~~iL~~L~HpnI 671 (935)
...|++.+.||+|+||.||++.++. +...++| .+. ........+.+|+++|++++||||
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCCCCc
Confidence 4567788999999999999987642 2222222 111 111234568899999999999999
Q ss_pred cccceeeeccceEEEEEEecCCCCHHHHhccCC--CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCcccc
Q 002336 672 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSV--NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD 749 (935)
Q Consensus 672 v~l~g~~~~~~~~~lV~E~~~~gsL~~~L~~~~--~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld 749 (935)
+++++++...+..++|+|++. ++|.+++.... ........++..++.|++.||+|||+ ++|+||||||+|||++
T Consensus 226 v~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~---~gIiHrDLKP~NILl~ 301 (501)
T PHA03210 226 LKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHD---KKLIHRDIKLENIFLN 301 (501)
T ss_pred CcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEC
Confidence 999999999999999999985 56776664321 11223456678899999999999998 8999999999999999
Q ss_pred CCCcEEEeeccccccccccccceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCc-ccchhHH
Q 002336 750 INMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDF-GAELNIV 828 (935)
Q Consensus 750 ~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~-~~~~~l~ 828 (935)
.++.+||+|||+++..............|+..|+|||++.+..++.++|||||||++|||++|..++..... .....+.
T Consensus 302 ~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~ 381 (501)
T PHA03210 302 CDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLL 381 (501)
T ss_pred CCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHH
Confidence 999999999999987654433333345689999999999999999999999999999999998754322221 1111111
Q ss_pred HHHHHhhh-cCCee-------eccccc-c---cCCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002336 829 HWARSMIK-KGDVI-------SIVDPV-L---IGNVK-----IESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 884 (935)
Q Consensus 829 ~~~~~~i~-~~~~~-------~~~d~~-l---~~~~~-----~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~ 884 (935)
+.+..... ..... ..++.. + ....+ ......+.+++.+||+.||++|||++|+++.
T Consensus 382 ~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 382 KIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 11110000 00000 000000 0 00000 0112356788999999999999999999864
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.6e-31 Score=281.38 Aligned_cols=246 Identities=26% Similarity=0.435 Sum_probs=200.3
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCcch--hhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEec
Q 002336 615 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 691 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~--~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~ 691 (935)
|.+.+.||+|++|.||++... +++.+++|.+..... ...+.+.+|++++++++|+|++++++++.++...+++|||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (254)
T cd06627 2 YQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYA 81 (254)
T ss_pred ceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecC
Confidence 456789999999999999876 678999999876543 35578999999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccccc
Q 002336 692 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 771 (935)
Q Consensus 692 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~ 771 (935)
++++|.+++.. ...+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++.........
T Consensus 82 ~~~~L~~~~~~---~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 155 (254)
T cd06627 82 ENGSLRQIIKK---FGPFPESLVAVYVYQVLQGLAYLHE---QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD 155 (254)
T ss_pred CCCcHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEECCCCCEEEeccccceecCCCccc
Confidence 99999999874 3678999999999999999999997 89999999999999999999999999999876543322
Q ss_pred eeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccCC
Q 002336 772 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 851 (935)
Q Consensus 772 ~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~~ 851 (935)
.....++..|+|||.+.+...+.++|||++|+++++|++|+.||..... . ...|. .. .... +.+
T Consensus 156 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~--~--~~~~~--~~-~~~~-----~~~--- 219 (254)
T cd06627 156 -DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP--M--AALFR--IV-QDDH-----PPL--- 219 (254)
T ss_pred -ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH--H--HHHHH--Hh-ccCC-----CCC---
Confidence 2234578899999999887789999999999999999999999863321 1 11111 11 1111 111
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 852 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 852 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
+......+.+++.+||..+|++||++.+++.
T Consensus 220 -~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 220 -PEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred -CCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 1122346789999999999999999999874
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-31 Score=284.68 Aligned_cols=247 Identities=25% Similarity=0.382 Sum_probs=200.9
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc--hhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEec
Q 002336 615 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 691 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~ 691 (935)
+++.+.||+|++|.||++..+ +++.+++|.+.... ......+.+|+++++.++|+||+++++++......++||||+
T Consensus 2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (256)
T cd08530 2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYA 81 (256)
T ss_pred ceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhc
Confidence 355788999999999999765 68899999986532 234567888999999999999999999999989999999999
Q ss_pred CCCCHHHHhccCC-CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccccccc
Q 002336 692 HNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 770 (935)
Q Consensus 692 ~~gsL~~~L~~~~-~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~ 770 (935)
++++|.+++.... ....+++..++.++.|+++||+|||+ .+++|+||+|+||++++++.+||+|||++.......
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~---~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~- 157 (256)
T cd08530 82 PFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHE---QKILHRDLKSANILLVANDLVKIGDLGISKVLKKNM- 157 (256)
T ss_pred CCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEEecCCcEEEeeccchhhhccCC-
Confidence 9999999886432 23568999999999999999999997 899999999999999999999999999998765441
Q ss_pred ceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccC
Q 002336 771 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 850 (935)
Q Consensus 771 ~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~ 850 (935)
.....++..|++||.+.+..++.++|+||+|++++||++|+.||...+.. .+. ..+..+....
T Consensus 158 --~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~---~~~----~~~~~~~~~~-------- 220 (256)
T cd08530 158 --AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ---DLR----YKVQRGKYPP-------- 220 (256)
T ss_pred --cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHH----HHHhcCCCCC--------
Confidence 22245788999999999888999999999999999999999999743321 111 1111111111
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 851 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 851 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
.+......+.+++.+|+..+|++||++.|+++
T Consensus 221 -~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 221 -IPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred -CchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 11233457899999999999999999999975
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-31 Score=288.75 Aligned_cols=244 Identities=23% Similarity=0.284 Sum_probs=190.9
Q ss_pred ccccccEEEEEEEEC-CCcEEEEEEccCcc---hhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEecCCCCH
Q 002336 621 IGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTL 696 (935)
Q Consensus 621 LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL 696 (935)
||+|+||+||++... +|+.+|+|.+.... ......+.+|+++++.++||||+++++.+...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 699999999999765 68999999986432 12334577899999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccccceeecc
Q 002336 697 RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVA 776 (935)
Q Consensus 697 ~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~ 776 (935)
.+++.... ...+++..+..++.|++.||.|||+ .+++||||+|+||+++.++.+||+|||.+....... .....
T Consensus 81 ~~~l~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~ 154 (277)
T cd05577 81 KYHIYNVG-EPGFPEARAIFYAAQIICGLEHLHQ---RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK--KIKGR 154 (277)
T ss_pred HHHHHHcC-cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEccCcchhhhccCC--ccccc
Confidence 99987432 2468999999999999999999998 899999999999999999999999999987654321 12233
Q ss_pred cCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccCCCCHHH
Q 002336 777 RGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIES 856 (935)
Q Consensus 777 ~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~~~~~~~ 856 (935)
.++..|+|||.+.+..++.++||||+|+++++|++|+.||......... ..+...+... .. ..+...
T Consensus 155 ~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---~~~~~~~~~~------~~----~~~~~~ 221 (277)
T cd05577 155 AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEK---EELKRRTLEM------AV----EYPDKF 221 (277)
T ss_pred cCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccH---HHHHhccccc------cc----cCCccC
Confidence 4788999999998888999999999999999999999999743321111 1111111100 00 111122
Q ss_pred HHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 002336 857 IWRIAEVAIQCVEQRGFSRP-----KMQEIVL 883 (935)
Q Consensus 857 ~~~l~~li~~Cl~~dP~~RP-----s~~ev~~ 883 (935)
...+.+++.+||+.+|++|| ++.++++
T Consensus 222 ~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 222 SPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred CHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 34678999999999999999 5555543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-31 Score=295.07 Aligned_cols=266 Identities=20% Similarity=0.260 Sum_probs=194.1
Q ss_pred cccccc--ccEEEEEEEEC-CCcEEEEEEccCcc--hhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEecCC
Q 002336 619 KKIGKG--SFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 693 (935)
Q Consensus 619 ~~LG~G--~fG~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~~~ 693 (935)
+.||+| +||+||++.+. +|+.||+|++.... ....+.+.+|+.+++.++||||+++++++..++..++|+||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 456666 99999999875 79999999986432 23446788999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccccce-
Q 002336 694 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI- 772 (935)
Q Consensus 694 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~~- 772 (935)
++|.+.+.... ...+++..+..++.|++.||+|||+ .+++||||||+||+++.++.++++||+.+..........
T Consensus 84 ~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (328)
T cd08226 84 GSANSLLKTYF-PEGMSEALIGNILFGALRGLNYLHQ---NGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK 159 (328)
T ss_pred CCHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence 99999887542 3458899999999999999999997 899999999999999999999999997543321111000
Q ss_pred -----eecccCCccccCCCCCCC--CCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHh-----------
Q 002336 773 -----SSVARGTVGYLDPEYYGN--QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSM----------- 834 (935)
Q Consensus 773 -----~~~~~gt~~y~APE~l~~--~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~----------- 834 (935)
.....++..|+|||++.+ ..++.++||||||++++||++|+.||...... ..........
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 237 (328)
T cd08226 160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRT--QMLLQKLKGPPYSPLDITTFP 237 (328)
T ss_pred ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChH--HHHHHHhcCCCCCCccccccc
Confidence 011224567999999866 35789999999999999999999999743221 1111100000
Q ss_pred ---------------------hhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--Hhhhhh
Q 002336 835 ---------------------IKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA--IQDSIK 890 (935)
Q Consensus 835 ---------------------i~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~--L~~~~~ 890 (935)
+..+......+..+...........+.+++.+||+.+|++|||++|+++. ++..+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~ 316 (328)
T cd08226 238 CEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKE 316 (328)
T ss_pred hhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHH
Confidence 00000000111111111122345678999999999999999999999753 444444
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=301.25 Aligned_cols=260 Identities=23% Similarity=0.329 Sum_probs=193.1
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc-hhhhHHHHHHHHHHHhcCCCcccccceeeecc-----ceEEE
Q 002336 614 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE-----HQRIL 686 (935)
Q Consensus 614 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~-~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~-----~~~~l 686 (935)
.|++.+.||+|++|.||+|.+. +|+.||+|++.... ......+.+|+.++++++||||+++++++... ...++
T Consensus 6 ~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 85 (336)
T cd07849 6 RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYI 85 (336)
T ss_pred ceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEE
Confidence 3566789999999999999865 68999999986432 23346688899999999999999999987543 35799
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccc
Q 002336 687 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 766 (935)
Q Consensus 687 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~ 766 (935)
|+||+. ++|.+.+. ...+++..+..++.|+++||+|||+ .+|+||||||+||+++.++.+||+|||++....
T Consensus 86 v~e~~~-~~l~~~~~----~~~l~~~~~~~i~~ql~~aL~~LH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~ 157 (336)
T cd07849 86 VQELME-TDLYKLIK----TQHLSNDHIQYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLARIAD 157 (336)
T ss_pred Eehhcc-cCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEECcccceeecc
Confidence 999996 48887775 3468999999999999999999998 899999999999999999999999999987654
Q ss_pred ccccc--eeecccCCccccCCCCCCC-CCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCC---e
Q 002336 767 EDLTH--ISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD---V 840 (935)
Q Consensus 767 ~~~~~--~~~~~~gt~~y~APE~l~~-~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~---~ 840 (935)
..... ......|+..|+|||.+.+ ..++.++||||+|+++|+|++|+.||...+... ....+...+.... .
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~---~~~~~~~~~~~~~~~~~ 234 (336)
T cd07849 158 PEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLH---QLNLILGVLGTPSQEDL 234 (336)
T ss_pred ccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHcCCCCHHHH
Confidence 32211 1122457889999998644 568899999999999999999999997433211 1111111111100 0
Q ss_pred eeccccc-------c--cCCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002336 841 ISIVDPV-------L--IGNVK-----IESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 884 (935)
Q Consensus 841 ~~~~d~~-------l--~~~~~-----~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~ 884 (935)
..+.+.. . ....+ +.....+.+++.+||+.+|++||+++|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 235 NCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred HHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0000000 0 00000 1123468899999999999999999999875
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=292.87 Aligned_cols=260 Identities=19% Similarity=0.234 Sum_probs=185.1
Q ss_pred hhHHHHHHhhcccccccccEEEEEEEECC----CcEEEEEEccCcchhh-----------hHHHHHHHHHHHhcCCCccc
Q 002336 608 PELEEATNNFCKKIGKGSFGSVYYGKMKD----GKEVAVKIMADSCSHR-----------TQQFVTEVALLSRIHHRNLV 672 (935)
Q Consensus 608 ~~l~~~~~~~~~~LG~G~fG~Vy~~~~~~----g~~vAvK~~~~~~~~~-----------~~~~~~E~~iL~~L~HpnIv 672 (935)
.++....|.+.+.||+|+||.||+|.+.+ +..+|+|+........ ......+...+..+.|+|++
T Consensus 7 ~~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~ 86 (294)
T PHA02882 7 IDITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIP 86 (294)
T ss_pred eccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCC
Confidence 34455567888999999999999998764 3456666543221110 01122344455667899999
Q ss_pred ccceeeeccc----eEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccc
Q 002336 673 PLIGYCEEEH----QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL 748 (935)
Q Consensus 673 ~l~g~~~~~~----~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILl 748 (935)
++++.+.... ..++++|++. .++.+.+.. ....++..+..++.|+++||+|||+ ++|+||||||+|||+
T Consensus 87 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~---~~iiHrDiKp~Nill 159 (294)
T PHA02882 87 KYYGCGSFKRCRMYYRFILLEKLV-ENTKEIFKR---IKCKNKKLIKNIMKDMLTTLEYIHE---HGISHGDIKPENIMV 159 (294)
T ss_pred cEEEeeeEecCCceEEEEEEehhc-cCHHHHHHh---hccCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEE
Confidence 9998765433 3467788763 466666653 2335678889999999999999998 899999999999999
Q ss_pred cCCCcEEEeeccccccccccccc------eeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcc
Q 002336 749 DINMRAKVSDFGLSRQAEEDLTH------ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFG 822 (935)
Q Consensus 749 d~~~~vkL~DFGla~~~~~~~~~------~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~ 822 (935)
+.++.++|+|||+++........ ......||+.|+|||++.+..++.++|||||||+++||++|+.||......
T Consensus 160 ~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~ 239 (294)
T PHA02882 160 DGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHN 239 (294)
T ss_pred cCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccc
Confidence 99999999999999865322111 112235899999999999999999999999999999999999999754222
Q ss_pred cch-h--HHHHHHHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 002336 823 AEL-N--IVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 886 (935)
Q Consensus 823 ~~~-~--l~~~~~~~i~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~ 886 (935)
... . ..++..+ +..+.. . .......+.+++..|++.+|++||++.++.+.|+
T Consensus 240 ~~~~~~~~~~~~~~-~~~~~~--------~---~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 240 GNLIHAAKCDFIKR-LHEGKI--------K---IKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred hHHHHHhHHHHHHH-hhhhhh--------c---cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 111 0 1112111 111111 0 0112346889999999999999999999998763
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-31 Score=289.43 Aligned_cols=258 Identities=21% Similarity=0.272 Sum_probs=197.5
Q ss_pred hhcccccccccEEEEEEEEC-CCcEEEEEEccCcchh--hhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEecC
Q 002336 616 NFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSH--RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 692 (935)
Q Consensus 616 ~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~~--~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~~ 692 (935)
+..+.||+|++|.||++... +++.+++|.+...... ....+.+|++++++++|+||+++++++..+...++|+||++
T Consensus 2 ~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 81 (283)
T cd05118 2 QKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMD 81 (283)
T ss_pred ccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccC
Confidence 34678999999999999875 6899999998654332 45678899999999999999999999999999999999997
Q ss_pred CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccccce
Q 002336 693 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 772 (935)
Q Consensus 693 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~~ 772 (935)
+ +|.+.+... ...+++..+..++.|+++||.|||+ .+++|+||||+||+++.++.+||+|||.+....... ..
T Consensus 82 ~-~l~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-~~ 154 (283)
T cd05118 82 T-DLYKLIKDR--QRGLPESLIKSYLYQLLQGLAFCHS---HGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-RP 154 (283)
T ss_pred C-CHHHHHHhh--cccCCHHHHHHHHHHHHHHHHHHHH---CCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-cc
Confidence 5 888887643 3578999999999999999999998 899999999999999999999999999987765433 11
Q ss_pred eecccCCccccCCCCCCCC-CCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcC---Ceeeccc---
Q 002336 773 SSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG---DVISIVD--- 845 (935)
Q Consensus 773 ~~~~~gt~~y~APE~l~~~-~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~---~~~~~~d--- 845 (935)
.....++..|+|||.+.+. ..+.++|+||+|+++|+|++|+.||...+..+. .....+.+... ......+
T Consensus 155 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd05118 155 YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQ---LFKIFRTLGTPDPEVWPKFTSLAR 231 (283)
T ss_pred ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHcCCCchHhcccchhhhh
Confidence 2223478889999998776 789999999999999999999999964332111 11111111100 0000000
Q ss_pred ---cccc-------CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 846 ---PVLI-------GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 846 ---~~l~-------~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
.... ..........+.+++.+||+.+|.+||++++++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 232 NYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 0000 0011223457899999999999999999999975
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.9e-31 Score=283.24 Aligned_cols=244 Identities=27% Similarity=0.305 Sum_probs=188.6
Q ss_pred ccccccccEEEEEEEEC-CCcEEEEEEccCcch---hhhHHHHHHHHHHH-hcCCCcccccceeeeccceEEEEEEecCC
Q 002336 619 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLS-RIHHRNLVPLIGYCEEEHQRILVYEYMHN 693 (935)
Q Consensus 619 ~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~---~~~~~~~~E~~iL~-~L~HpnIv~l~g~~~~~~~~~lV~E~~~~ 693 (935)
+.||+|++|.||+|... +|+.||+|.+..... .....+..|..++. ..+|+|++++++.+...+..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 57999999999999875 589999999865322 22234455555544 45899999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccccccccee
Q 002336 694 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 773 (935)
Q Consensus 694 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~~~ 773 (935)
++|.+++.. ...+++..+..++.|+++||.|||+ .+++||||+|+||++++++.+||+|||++..... .
T Consensus 82 ~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----~ 150 (260)
T cd05611 82 GDCASLIKT---LGGLPEDWAKQYIAEVVLGVEDLHQ---RGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----N 150 (260)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEeecccceeccc-----c
Confidence 999999873 3568899999999999999999998 8999999999999999999999999998875433 1
Q ss_pred ecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccCCCC
Q 002336 774 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVK 853 (935)
Q Consensus 774 ~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~~~~ 853 (935)
....++..|+|||.+.+..++.++||||+|+++|+|++|..||....... .. ..+..+... ..... .
T Consensus 151 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~~----~~~~~~~~~--~~~~~----~ 217 (260)
T cd05611 151 KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDA---VF----DNILSRRIN--WPEEV----K 217 (260)
T ss_pred ccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHH---HH----HHHHhcccC--CCCcc----c
Confidence 22347889999999988888999999999999999999999997332211 11 111111110 00001 1
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 002336 854 IESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 886 (935)
Q Consensus 854 ~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~ 886 (935)
......+.+++.+||+.+|++||++.++.+.|.
T Consensus 218 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~ 250 (260)
T cd05611 218 EFCSPEAVDLINRLLCMDPAKRLGANGYQEIKS 250 (260)
T ss_pred ccCCHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence 122346889999999999999998776655443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-31 Score=284.23 Aligned_cols=249 Identities=30% Similarity=0.454 Sum_probs=202.7
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCcch--hhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEec
Q 002336 615 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 691 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~--~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~ 691 (935)
|.+.+.||+|++|.||++.+. +++.+++|++..... ...+.+.+|+++++.++|||++++++.+......++|+||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~ 81 (258)
T cd08215 2 YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYA 81 (258)
T ss_pred ceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEec
Confidence 345678999999999999876 689999999875433 45577899999999999999999999999889999999999
Q ss_pred CCCCHHHHhccCC-CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccccccc
Q 002336 692 HNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 770 (935)
Q Consensus 692 ~~gsL~~~L~~~~-~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~ 770 (935)
++++|.+.+.... ....+++..+..++.++++||.|||+ .+++|+||+|+||++++++.++|+|||++.......
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~---~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~- 157 (258)
T cd08215 82 DGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHS---RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV- 157 (258)
T ss_pred CCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHHeEEcCCCcEEECCccceeecccCc-
Confidence 9999999987532 24679999999999999999999998 899999999999999999999999999987765433
Q ss_pred ceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccC
Q 002336 771 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 850 (935)
Q Consensus 771 ~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~ 850 (935)
.......|++.|+|||.+....++.++||||+|+++++|++|+.||...+.. +....... ..... +
T Consensus 158 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~------~~~~~~~~-~~~~~-----~-- 223 (258)
T cd08215 158 DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLL------ELALKILK-GQYPP-----I-- 223 (258)
T ss_pred ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHH------HHHHHHhc-CCCCC-----C--
Confidence 1223345788999999998888999999999999999999999998733311 11111111 11111 1
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 851 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 851 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
+......+.+++.+||..+|++||++.|+++
T Consensus 224 --~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 224 --PSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred --CCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 1122347889999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-31 Score=289.21 Aligned_cols=255 Identities=22% Similarity=0.308 Sum_probs=198.8
Q ss_pred HhhcccccccccEEEEEEEEC----CCcEEEEEEccCcc----hhhhHHHHHHHHHHHhc-CCCcccccceeeeccceEE
Q 002336 615 NNFCKKIGKGSFGSVYYGKMK----DGKEVAVKIMADSC----SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRI 685 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~----~g~~vAvK~~~~~~----~~~~~~~~~E~~iL~~L-~HpnIv~l~g~~~~~~~~~ 685 (935)
+++.+.||+|++|.||++... +++.+|||+++... ....+.+.+|++++.++ +||||+++++.+......+
T Consensus 2 ~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~ 81 (288)
T cd05583 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLH 81 (288)
T ss_pred ceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEE
Confidence 345788999999999999753 57889999986432 12345688999999999 5999999999999999999
Q ss_pred EEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccc
Q 002336 686 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 765 (935)
Q Consensus 686 lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~ 765 (935)
+||||+++++|.+.+.. ...+++..+..++.|++++|.|||+ .+++||||||+||+++.++.++|+|||+++..
T Consensus 82 lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~---~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 155 (288)
T cd05583 82 LILDYVNGGELFTHLYQ---REHFTESEVRVYIAEIVLALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (288)
T ss_pred EEEecCCCCcHHHHHhh---cCCcCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEEECcccccc
Confidence 99999999999998863 3568899999999999999999997 89999999999999999999999999998765
Q ss_pred cccccceeecccCCccccCCCCCCCCC--CCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeec
Q 002336 766 EEDLTHISSVARGTVGYLDPEYYGNQQ--LTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISI 843 (935)
Q Consensus 766 ~~~~~~~~~~~~gt~~y~APE~l~~~~--~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~ 843 (935)
............|+..|+|||.+.+.. .+.++||||||++++||++|..||...... ....+..+.....
T Consensus 156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~--~~~~~~~~~~~~~------ 227 (288)
T cd05583 156 LAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQ--NSQSEISRRILKS------ 227 (288)
T ss_pred ccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCccc--chHHHHHHHHHcc------
Confidence 433222222345788999999987654 788999999999999999999999632211 1111222222211
Q ss_pred ccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhh
Q 002336 844 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 888 (935)
Q Consensus 844 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~ 888 (935)
.+.. +......+.+++.+||+.+|++|||++++.+.|+..
T Consensus 228 -~~~~----~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 228 -KPPF----PKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP 267 (288)
T ss_pred -CCCC----CcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence 0111 111223678999999999999999999888877653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-31 Score=293.79 Aligned_cols=260 Identities=22% Similarity=0.226 Sum_probs=192.5
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcchh--hhHHHHHHHHHHHhcCCCcccccceeeecc--ceEEEEE
Q 002336 614 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSH--RTQQFVTEVALLSRIHHRNLVPLIGYCEEE--HQRILVY 688 (935)
Q Consensus 614 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~~--~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~--~~~~lV~ 688 (935)
.+++.+.||+|+||.||+|... +|+.||+|.++..... ....+.+|+.++++++|+||+++++++... +..++||
T Consensus 8 ~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~ 87 (309)
T cd07845 8 EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVM 87 (309)
T ss_pred ceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEE
Confidence 4566789999999999999875 6899999998643222 223567899999999999999999998654 4689999
Q ss_pred EecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccccc
Q 002336 689 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 768 (935)
Q Consensus 689 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~ 768 (935)
||+. ++|.+.+... ...+++.++..++.|+++||+|||+ .+++||||||+||+++.++.+||+|||++......
T Consensus 88 e~~~-~~l~~~l~~~--~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~ 161 (309)
T cd07845 88 EYCE-QDLASLLDNM--PTPFSESQVKCLMLQLLRGLQYLHE---NFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLP 161 (309)
T ss_pred ecCC-CCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccceeeecCCc
Confidence 9996 4888887643 3568999999999999999999998 89999999999999999999999999999876433
Q ss_pred ccceeecccCCccccCCCCCCC-CCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhc--CCee----
Q 002336 769 LTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKK--GDVI---- 841 (935)
Q Consensus 769 ~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~--~~~~---- 841 (935)
... .....++..|+|||.+.+ ..++.++||||+|+++|||++|+.||...+... ...-+...... ....
T Consensus 162 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 237 (309)
T cd07845 162 AKP-MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIE---QLDLIIQLLGTPNESIWPGFS 237 (309)
T ss_pred cCC-CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHhcCCCChhhchhhh
Confidence 211 122335788999998865 567899999999999999999999997433211 11111111100 0000
Q ss_pred -----ecc--c-ccccC--CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 842 -----SIV--D-PVLIG--NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 842 -----~~~--d-~~l~~--~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
... . ..... .........+.+++.+|++.||++|||++|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 238 DLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred cccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 000 0 00000 000012346789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.1e-31 Score=296.59 Aligned_cols=261 Identities=22% Similarity=0.281 Sum_probs=194.7
Q ss_pred HHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCc--chhhhHHHHHHHHHHHhcCCCcccccceeeecc------ce
Q 002336 613 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE------HQ 683 (935)
Q Consensus 613 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~--~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~------~~ 683 (935)
..|+..+.||+|+||.||+|... +|+.||+|.+... .....+.+.+|+.++++++||||+++++++... ..
T Consensus 16 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 95 (353)
T cd07850 16 KRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQD 95 (353)
T ss_pred cceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCc
Confidence 45666789999999999999875 7899999998643 223445678899999999999999999987543 35
Q ss_pred EEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccc
Q 002336 684 RILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 763 (935)
Q Consensus 684 ~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~ 763 (935)
.++||||+. ++|.+.+.. .+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++
T Consensus 96 ~~lv~e~~~-~~l~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 166 (353)
T cd07850 96 VYLVMELMD-ANLCQVIQM-----DLDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR 166 (353)
T ss_pred EEEEEeccC-CCHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCccce
Confidence 799999995 588887752 28888999999999999999998 899999999999999999999999999998
Q ss_pred cccccccceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchh-H--------HHH----
Q 002336 764 QAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELN-I--------VHW---- 830 (935)
Q Consensus 764 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~-l--------~~~---- 830 (935)
....... .....++..|+|||.+.+..++.++||||||+++++|++|+.||...+...... + .++
T Consensus 167 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (353)
T cd07850 167 TAGTSFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRL 244 (353)
T ss_pred eCCCCCC--CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHh
Confidence 6543322 223357889999999998899999999999999999999999997443211100 0 000
Q ss_pred ---HHHhhhcCC------eeecccc----cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002336 831 ---ARSMIKKGD------VISIVDP----VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 884 (935)
Q Consensus 831 ---~~~~i~~~~------~~~~~d~----~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~ 884 (935)
......... ....... .............+.+++.+||+.||++||++.|+++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 245 QPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred hhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000000000 0000000 00001111234567899999999999999999999853
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-31 Score=291.85 Aligned_cols=264 Identities=20% Similarity=0.235 Sum_probs=191.1
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcch--hhhHHHHHHHHHHHhcCCCcccccceeeeccc--------
Q 002336 614 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH-------- 682 (935)
Q Consensus 614 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~--~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~-------- 682 (935)
.|++.+.||+|+||.||+|... +++.||+|.+..... .....+.+|++++++++||||+++++++....
T Consensus 13 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 92 (310)
T cd07865 13 KYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKG 92 (310)
T ss_pred heEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCc
Confidence 4667889999999999999876 689999998864322 22345678999999999999999999986543
Q ss_pred eEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccc
Q 002336 683 QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS 762 (935)
Q Consensus 683 ~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla 762 (935)
..++||||+. ++|.+.+... ...+++.+++.++.|++.||+|||+ ++++|+||||+||+++.++.+||+|||++
T Consensus 93 ~~~lv~e~~~-~~l~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~ 166 (310)
T cd07865 93 SFYLVFEFCE-HDLAGLLSNK--NVKFTLSEIKKVMKMLLNGLYYIHR---NKILHRDMKAANILITKDGILKLADFGLA 166 (310)
T ss_pred eEEEEEcCCC-cCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEECCCCcEEECcCCCc
Confidence 3599999996 4788877642 3468999999999999999999998 89999999999999999999999999998
Q ss_pred ccccccccc---eeecccCCccccCCCCCCCC-CCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcC
Q 002336 763 RQAEEDLTH---ISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG 838 (935)
Q Consensus 763 ~~~~~~~~~---~~~~~~gt~~y~APE~l~~~-~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~ 838 (935)
......... ......++..|+|||.+.+. .++.++||||||+++|||++|+.||...+..........+...+...
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (310)
T cd07865 167 RAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPE 246 (310)
T ss_pred ccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence 765432211 11223467889999987654 47889999999999999999999997443222111111111100000
Q ss_pred Ceeec-----ccc-cccCCC---------CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 839 DVISI-----VDP-VLIGNV---------KIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 839 ~~~~~-----~d~-~l~~~~---------~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
..... .+. .+.... +......+.+++.+||..+|++||+++|+++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 247 VWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred hcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 00000 000 000000 0001235679999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=282.80 Aligned_cols=239 Identities=23% Similarity=0.320 Sum_probs=184.9
Q ss_pred hhccc--ccccccEEEEEEEEC-CCcEEEEEEccCcchhhhHHHHHHHHHHHhc-CCCcccccceeeeccceEEEEEEec
Q 002336 616 NFCKK--IGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEYM 691 (935)
Q Consensus 616 ~~~~~--LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L-~HpnIv~l~g~~~~~~~~~lV~E~~ 691 (935)
.+.+. ||+|+||.||++..+ +++.+|+|.+....... .|......+ +||||+++++.+...+..++||||+
T Consensus 17 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~ 91 (267)
T PHA03390 17 EIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYI 91 (267)
T ss_pred ccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcC
Confidence 34455 499999999999865 68889999876432111 123233223 6999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCC-cEEEeecccccccccccc
Q 002336 692 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM-RAKVSDFGLSRQAEEDLT 770 (935)
Q Consensus 692 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~-~vkL~DFGla~~~~~~~~ 770 (935)
++++|.+++.. ...+++.++..++.|+++||.|||+ .+++||||||+||+++.++ .++|+|||++.......
T Consensus 92 ~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~- 164 (267)
T PHA03390 92 KDGDLFDLLKK---EGKLSEAEVKKIIRQLVEALNDLHK---HNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPS- 164 (267)
T ss_pred CCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCCc-
Confidence 99999999974 3478999999999999999999998 8999999999999999988 99999999987654321
Q ss_pred ceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccC
Q 002336 771 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 850 (935)
Q Consensus 771 ~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~ 850 (935)
...++..|+|||.+.+..++.++||||+|++++||++|+.||.... ........+.... . ... . .
T Consensus 165 ----~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~-~~~~~~~~~~~~~-~-~~~-~-----~-- 229 (267)
T PHA03390 165 ----CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDE-DEELDLESLLKRQ-Q-KKL-P-----F-- 229 (267)
T ss_pred ----cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCC-cchhhHHHHHHhh-c-ccC-C-----c--
Confidence 2357899999999998889999999999999999999999997332 2222223332221 1 000 0 0
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCC-HHHHHH
Q 002336 851 NVKIESIWRIAEVAIQCVEQRGFSRPK-MQEIVL 883 (935)
Q Consensus 851 ~~~~~~~~~l~~li~~Cl~~dP~~RPs-~~ev~~ 883 (935)
.......+.+++.+||+.+|.+||+ ++|+++
T Consensus 230 --~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 230 --IKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred --ccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 1122336889999999999999995 688764
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=288.40 Aligned_cols=261 Identities=21% Similarity=0.243 Sum_probs=192.3
Q ss_pred hcccccccccEEEEEEEECCCcEEEEEEccCc--chhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEecCCC
Q 002336 617 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNG 694 (935)
Q Consensus 617 ~~~~LG~G~fG~Vy~~~~~~g~~vAvK~~~~~--~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~~~g 694 (935)
+.+.+|.|+++.||++.. +++.||+|++... .....+.+.+|+++++.++|+||+++++++.+.+..+++|||++++
T Consensus 6 i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~ 84 (314)
T cd08216 6 IGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG 84 (314)
T ss_pred hhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence 445566666666666655 5999999998654 3345578999999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccccccc----
Q 002336 695 TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT---- 770 (935)
Q Consensus 695 sL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~---- 770 (935)
+|.+++.... ...+++..+..++.|+++||+|||+ ++|+||||||+||+++.++.+||+|||.+........
T Consensus 85 ~l~~~l~~~~-~~~~~~~~~~~~~~~l~~~L~~LH~---~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~ 160 (314)
T cd08216 85 SCEDLLKTHF-PEGLPELAIAFILKDVLNALDYIHS---KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRV 160 (314)
T ss_pred CHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCcceEEEecCCceEEecCccceeeccccccccc
Confidence 9999987542 3458899999999999999999998 8999999999999999999999999998865432111
Q ss_pred --ceeecccCCccccCCCCCCC--CCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhh----hc-----
Q 002336 771 --HISSVARGTVGYLDPEYYGN--QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMI----KK----- 837 (935)
Q Consensus 771 --~~~~~~~gt~~y~APE~l~~--~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i----~~----- 837 (935)
.......++..|+|||.+.. ..++.++||||||+++|||++|+.||...... ....+...... ..
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 238 (314)
T cd08216 161 VHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPAT--QMLLEKVRGTVPCLLDKSTYPL 238 (314)
T ss_pred cccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhccCccccccCchhh
Confidence 01122346778999999865 35789999999999999999999999743211 11111111000 00
Q ss_pred --CCeee----cccccc----cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002336 838 --GDVIS----IVDPVL----IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 884 (935)
Q Consensus 838 --~~~~~----~~d~~l----~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~ 884 (935)
..... ..++.. ...........+.+++.+||+.+|++|||++++++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 239 YEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred hcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 00000 000000 001112233468899999999999999999999864
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.6e-31 Score=284.35 Aligned_cols=247 Identities=23% Similarity=0.334 Sum_probs=193.5
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCc-----chhhhHHHHHHHHHHHhcCCCcccccceeeecc--ceEEE
Q 002336 615 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS-----CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE--HQRIL 686 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~-----~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~--~~~~l 686 (935)
+++.+.||+|++|.||+|... +++.+|+|.+... .....+.+.+|++++++++|+||+++++++.+. ...++
T Consensus 4 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (264)
T cd06653 4 WRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSI 83 (264)
T ss_pred eeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEE
Confidence 456789999999999999875 6899999987432 123446788999999999999999999988653 46789
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccc
Q 002336 687 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 766 (935)
Q Consensus 687 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~ 766 (935)
++||+++++|.+.+.. ...+++..+.+++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||+++...
T Consensus 84 v~e~~~~~~L~~~~~~---~~~l~~~~~~~~~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 157 (264)
T cd06653 84 FVEYMPGGSIKDQLKA---YGALTENVTRRYTRQILQGVSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRIQ 157 (264)
T ss_pred EEEeCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECccccccccc
Confidence 9999999999999873 3458899999999999999999998 899999999999999999999999999987653
Q ss_pred cccc--ceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecc
Q 002336 767 EDLT--HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 844 (935)
Q Consensus 767 ~~~~--~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~ 844 (935)
.... .......++..|+|||.+.+...+.++|+||||+++++|++|+.||...... .. +.+..... .
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~----~~~~~~~~-~---- 226 (264)
T cd06653 158 TICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM--AA----IFKIATQP-T---- 226 (264)
T ss_pred cccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHH--HH----HHHHHcCC-C----
Confidence 2111 1112245788999999998888899999999999999999999999632111 11 11111111 0
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 845 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 845 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
....+......+.+++.+|++ +|..||+..+++.
T Consensus 227 ----~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 227 ----KPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred ----CCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 111223334578899999999 5799999998764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=286.93 Aligned_cols=250 Identities=26% Similarity=0.360 Sum_probs=194.7
Q ss_pred HhhcccccccccEEEEEEEE----CCCcEEEEEEccCcch----hhhHHHHHHHHHHHhc-CCCcccccceeeeccceEE
Q 002336 615 NNFCKKIGKGSFGSVYYGKM----KDGKEVAVKIMADSCS----HRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRI 685 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~----~~g~~vAvK~~~~~~~----~~~~~~~~E~~iL~~L-~HpnIv~l~g~~~~~~~~~ 685 (935)
+++.+.||+|+||.||++.. .+|+.||+|++..... ...+.+.+|+++++++ +|+||+++++.+..+...+
T Consensus 2 y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (290)
T cd05613 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLH 81 (290)
T ss_pred ceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEE
Confidence 34578899999999999986 3689999999865322 2346688899999999 5999999999999988999
Q ss_pred EEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccc
Q 002336 686 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 765 (935)
Q Consensus 686 lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~ 765 (935)
+||||+++++|.+++.. ...+++..+..++.|+++||.|||+ .+++||||+|+|||++.++.+||+|||++...
T Consensus 82 lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 155 (290)
T cd05613 82 LILDYINGGELFTHLSQ---RERFKEQEVQIYSGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 155 (290)
T ss_pred EEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEECCCCCEEEeeCccceec
Confidence 99999999999999873 3568899999999999999999998 89999999999999999999999999998765
Q ss_pred cccccceeecccCCccccCCCCCCCC--CCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeec
Q 002336 766 EEDLTHISSVARGTVGYLDPEYYGNQ--QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISI 843 (935)
Q Consensus 766 ~~~~~~~~~~~~gt~~y~APE~l~~~--~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~ 843 (935)
............|+..|+|||.+... .++.++||||||+++|+|++|+.||...... ..............
T Consensus 156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~--~~~~~~~~~~~~~~----- 228 (290)
T cd05613 156 HEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEK--NSQAEISRRILKSE----- 228 (290)
T ss_pred ccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcc--ccHHHHHHHhhccC-----
Confidence 43322222234578899999998653 4678999999999999999999999633221 11222222221111
Q ss_pred ccccccCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 002336 844 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRP-----KMQEIVL 883 (935)
Q Consensus 844 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----s~~ev~~ 883 (935)
+. .+......+.+++.+|++.+|++|| +++++..
T Consensus 229 --~~----~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 229 --PP----YPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred --CC----CCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 00 1112233678999999999999997 6777655
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-31 Score=295.79 Aligned_cols=265 Identities=25% Similarity=0.329 Sum_probs=194.7
Q ss_pred HHHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCc--chhhhHHHHHHHHHHHhc-CCCcccccceeeecc--ceEE
Q 002336 612 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEE--HQRI 685 (935)
Q Consensus 612 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~--~~~~~~~~~~E~~iL~~L-~HpnIv~l~g~~~~~--~~~~ 685 (935)
...+.+.+.||+|+||.||+|.+. +++.+|+|++... .......+.+|+.+++++ +||||+++++++... ...+
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 85 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY 85 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence 345677899999999999999876 5889999988542 223345677899999999 999999999988643 4679
Q ss_pred EEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccc
Q 002336 686 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 765 (935)
Q Consensus 686 lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~ 765 (935)
+||||++ ++|.+.+.. ..+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||++...
T Consensus 86 lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~---~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~ 157 (337)
T cd07852 86 LVFEYME-TDLHAVIRA----NILEDVHKRYIMYQLLKALKYIHS---GNVIHRDLKPSNILLNSDCRVKLADFGLARSL 157 (337)
T ss_pred EEecccc-cCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccchhcc
Confidence 9999997 599888863 268899999999999999999998 89999999999999999999999999998765
Q ss_pred cccccc----eeecccCCccccCCCCCCC-CCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHH-------
Q 002336 766 EEDLTH----ISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARS------- 833 (935)
Q Consensus 766 ~~~~~~----~~~~~~gt~~y~APE~l~~-~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~------- 833 (935)
...... ......|+..|+|||.+.+ ..++.++||||||+++|+|++|+.||.................
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 237 (337)
T cd07852 158 SELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDI 237 (337)
T ss_pred ccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 432211 1223357889999998754 5678999999999999999999999974432211100000000
Q ss_pred -hhhcCCeeeccccccc------CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002336 834 -MIKKGDVISIVDPVLI------GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 884 (935)
Q Consensus 834 -~i~~~~~~~~~d~~l~------~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~ 884 (935)
.+.......+++.... ..........+.+++.+||+.+|++||++.++++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 238 ESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 0000000001110000 00001123468899999999999999999999864
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=298.66 Aligned_cols=258 Identities=23% Similarity=0.315 Sum_probs=193.8
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCc--chhhhHHHHHHHHHHHhcCCCcccccceeeecc-----ceEEE
Q 002336 615 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE-----HQRIL 686 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~--~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~-----~~~~l 686 (935)
|.+.+.||+|+||.||+|... +++.||||.+... .......+.+|+.+++.++|+||+++++++... ...++
T Consensus 7 y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~l 86 (337)
T cd07858 7 YVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYI 86 (337)
T ss_pred eeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEEE
Confidence 556789999999999999865 6899999998653 223345678899999999999999999987644 34799
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccc
Q 002336 687 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 766 (935)
Q Consensus 687 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~ 766 (935)
|+||+. ++|.+.+.. ...+++..+..++.|++.||.|||+ ++++||||||+||+++.++.+||+|||+++...
T Consensus 87 v~e~~~-~~L~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~ 159 (337)
T cd07858 87 VYELMD-TDLHQIIRS---SQTLSDDHCQYFLYQLLRGLKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLARTTS 159 (337)
T ss_pred EEeCCC-CCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECcCccccccC
Confidence 999995 689888863 4569999999999999999999998 899999999999999999999999999998654
Q ss_pred ccccceeecccCCccccCCCCCCC-CCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhh---------
Q 002336 767 EDLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIK--------- 836 (935)
Q Consensus 767 ~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~--------- 836 (935)
.... ......++..|+|||.+.. ..++.++||||||+++|+|++|+.||...+...... .......
T Consensus 160 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~---~~~~~~~~~~~~~~~~ 235 (337)
T cd07858 160 EKGD-FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLK---LITELLGSPSEEDLGF 235 (337)
T ss_pred CCcc-cccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHH---HHHHHhCCCChHHhhh
Confidence 3321 1223357889999998754 568899999999999999999999997543211110 0000000
Q ss_pred --cCCee-------ecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002336 837 --KGDVI-------SIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 884 (935)
Q Consensus 837 --~~~~~-------~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~ 884 (935)
..... ...++.... ........+.+++.+||+.+|++||+++|+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h 291 (337)
T cd07858 236 IRNEKARRYIRSLPYTPRQSFAR-LFPHANPLAIDLLEKMLVFDPSKRITVEEALAH 291 (337)
T ss_pred cCchhhhHHHHhcCcccccCHHH-HcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence 00000 000000000 011223467899999999999999999999876
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=298.46 Aligned_cols=261 Identities=20% Similarity=0.314 Sum_probs=195.1
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcch--hhhHHHHHHHHHHHhcCCCcccccceeeec----cceEEE
Q 002336 614 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEE----EHQRIL 686 (935)
Q Consensus 614 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~--~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~----~~~~~l 686 (935)
.+.+.+.||+|++|.||+|... +|+.||+|++..... ...+.+.+|+.++++++||||+++++++.. ....++
T Consensus 6 ~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 85 (334)
T cd07855 6 RYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYV 85 (334)
T ss_pred ceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEE
Confidence 4556788999999999999865 689999999875422 334677889999999999999999998753 346899
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccc
Q 002336 687 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 766 (935)
Q Consensus 687 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~ 766 (935)
||||+. ++|.+++.. ...+++..+..++.|+++||.|||+ ++++||||||+||++++++.+||+|||++....
T Consensus 86 v~e~~~-~~l~~~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 158 (334)
T cd07855 86 VMDLME-SDLHHIIHS---DQPLTEEHIRYFLYQLLRGLKYIHS---ANVIHRDLKPSNLLVNEDCELRIGDFGMARGLS 158 (334)
T ss_pred EEehhh-hhHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEecccccceeec
Confidence 999995 689988863 4558999999999999999999998 899999999999999999999999999987654
Q ss_pred ccccc---eeecccCCccccCCCCCCC-CCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhh-------
Q 002336 767 EDLTH---ISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMI------- 835 (935)
Q Consensus 767 ~~~~~---~~~~~~gt~~y~APE~l~~-~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i------- 835 (935)
..... ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...+..... ..+....
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~---~~~~~~~g~~~~~~ 235 (334)
T cd07855 159 SSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQL---KLILSVLGSPSEEV 235 (334)
T ss_pred ccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHH---HHHHHHhCCChhHh
Confidence 32211 1123357889999998755 56889999999999999999999999754322111 1111100
Q ss_pred ----hcCCeeeccccc-ccCCC-----CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002336 836 ----KKGDVISIVDPV-LIGNV-----KIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 884 (935)
Q Consensus 836 ----~~~~~~~~~d~~-l~~~~-----~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~ 884 (935)
......+..+.. ..... .......+.+++.+||+.+|++||+++++++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 236 LNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred hhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 000000000000 00000 11234578999999999999999999998763
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-31 Score=296.35 Aligned_cols=266 Identities=22% Similarity=0.320 Sum_probs=201.1
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc--hhhhHHHHHHHHHHHhcCCCcccccceeeeccc-----eEEE
Q 002336 615 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH-----QRIL 686 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~-----~~~l 686 (935)
|++.+.||+|++|.||+|... +++.+|+|++.... ....+.+.+|+.+++.++|+||+++++++.... ..++
T Consensus 2 y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~l 81 (330)
T cd07834 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYI 81 (330)
T ss_pred ceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEE
Confidence 456789999999999999876 58999999987643 334567999999999999999999999987765 7899
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccc
Q 002336 687 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 766 (935)
Q Consensus 687 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~ 766 (935)
+|||++ ++|.+.+.. ...+++..+..++.|+++||+|||+ .+|+||||||+|||++.++.++|+|||++....
T Consensus 82 v~e~~~-~~l~~~l~~---~~~l~~~~~~~i~~~l~~~l~~LH~---~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~ 154 (330)
T cd07834 82 VTELME-TDLHKVIKS---PQPLTDDHIQYFLYQILRGLKYLHS---ANVIHRDLKPSNILVNSNCDLKICDFGLARGVD 154 (330)
T ss_pred Eecchh-hhHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEcccCceEeec
Confidence 999997 589888873 3479999999999999999999998 899999999999999999999999999998765
Q ss_pred cccc--ceeecccCCccccCCCCCCCC-CCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhc------
Q 002336 767 EDLT--HISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKK------ 837 (935)
Q Consensus 767 ~~~~--~~~~~~~gt~~y~APE~l~~~-~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~------ 837 (935)
.... .......++..|+|||.+.+. .++.++|+||+|+++++|++|+.||......+. ...+......
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~---~~~i~~~~~~~~~~~~ 231 (330)
T cd07834 155 PDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQ---LNLIVEVLGTPSEEDL 231 (330)
T ss_pred ccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHH---HHHHHHhcCCCChhHh
Confidence 4321 112233478899999999877 889999999999999999999999974432211 1111110000
Q ss_pred -----CCeeeccc---ccc---cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--Hhhhhh
Q 002336 838 -----GDVISIVD---PVL---IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA--IQDSIK 890 (935)
Q Consensus 838 -----~~~~~~~d---~~l---~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~--L~~~~~ 890 (935)
......+. ..- ...........+.+++.+||+.+|++||+++++++. +++...
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~ 297 (330)
T cd07834 232 KFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD 297 (330)
T ss_pred hhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence 00000000 000 000011123468899999999999999999999874 554433
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=284.74 Aligned_cols=241 Identities=22% Similarity=0.274 Sum_probs=186.2
Q ss_pred cccccccEEEEEEEEC-CCcEEEEEEccCcch---hhhHHHHHHHHH---HHhcCCCcccccceeeeccceEEEEEEecC
Q 002336 620 KIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVAL---LSRIHHRNLVPLIGYCEEEHQRILVYEYMH 692 (935)
Q Consensus 620 ~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~---~~~~~~~~E~~i---L~~L~HpnIv~l~g~~~~~~~~~lV~E~~~ 692 (935)
.||+|+||.||++... +++.||+|.+..... .....+..|..+ ++...||||+++++++...+..++||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999875 588999999865321 112234444444 444579999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccccce
Q 002336 693 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 772 (935)
Q Consensus 693 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~~ 772 (935)
+++|.+++.. ...+++..+..++.|+++||.|||+ .+++||||||+||+++.++.+||+|||++........
T Consensus 81 g~~L~~~l~~---~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~-- 152 (278)
T cd05606 81 GGDLHYHLSQ---HGVFSEAEMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP-- 152 (278)
T ss_pred CCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCEEcCCCCHHHEEECCCCCEEEccCcCccccCccCC--
Confidence 9999998863 4579999999999999999999998 8999999999999999999999999999875533221
Q ss_pred eecccCCccccCCCCCCCC-CCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccCC
Q 002336 773 SSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 851 (935)
Q Consensus 773 ~~~~~gt~~y~APE~l~~~-~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~~ 851 (935)
....|+..|+|||.+.++ .++.++||||+|+++|||++|+.||.......... ....... ..+.+
T Consensus 153 -~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~----~~~~~~~------~~~~~--- 218 (278)
T cd05606 153 -HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE----IDRMTLT------MAVEL--- 218 (278)
T ss_pred -cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHH----HHHHhhc------cCCCC---
Confidence 223589999999998754 68899999999999999999999997432221111 1111111 01111
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 002336 852 VKIESIWRIAEVAIQCVEQRGFSRP-----KMQEIVL 883 (935)
Q Consensus 852 ~~~~~~~~l~~li~~Cl~~dP~~RP-----s~~ev~~ 883 (935)
+......+.+++.+|+..+|++|| +++|+++
T Consensus 219 -~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 219 -PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred -CCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 111234788999999999999999 9999875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.4e-31 Score=289.07 Aligned_cols=259 Identities=20% Similarity=0.274 Sum_probs=191.6
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCcch--hhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEec
Q 002336 615 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 691 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~--~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~ 691 (935)
+++.+.||+|.+|.||+|..+ +|+.||+|.+..... ...+.+.+|++++++++||||+++++++......++||||+
T Consensus 4 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (294)
T PLN00009 4 YEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYL 83 (294)
T ss_pred eEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEecc
Confidence 456788999999999999876 689999999864322 23356889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccC-CCcEEEeecccccccccccc
Q 002336 692 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI-NMRAKVSDFGLSRQAEEDLT 770 (935)
Q Consensus 692 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~-~~~vkL~DFGla~~~~~~~~ 770 (935)
+ ++|.+.+... ....+++..+..++.|++.||+|||+ ++++||||+|+||+++. ++.+||+|||++........
T Consensus 84 ~-~~l~~~~~~~-~~~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~ 158 (294)
T PLN00009 84 D-LDLKKHMDSS-PDFAKNPRLIKTYLYQILRGIAYCHS---HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR 158 (294)
T ss_pred c-ccHHHHHHhC-CCCCcCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCcceEEEECCCCEEEEcccccccccCCCcc
Confidence 6 5788777533 23346788889999999999999997 89999999999999985 56799999999976543221
Q ss_pred ceeecccCCccccCCCCCCC-CCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecc-----
Q 002336 771 HISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIV----- 844 (935)
Q Consensus 771 ~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~----- 844 (935)
. .....+++.|+|||.+.+ ..++.++||||+|+++|+|++|+.||......+. +.+ ........ .....
T Consensus 159 ~-~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~--~~~-~~~~~~~~-~~~~~~~~~~ 233 (294)
T PLN00009 159 T-FTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDE--LFK-IFRILGTP-NEETWPGVTS 233 (294)
T ss_pred c-cccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHH-HHHHhCCC-Chhhcccccc
Confidence 1 122346889999998765 4678999999999999999999999974322111 111 00000000 00000
Q ss_pred --c-----ccccC----CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 845 --D-----PVLIG----NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 845 --d-----~~l~~----~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
+ +.... ...+.....+.+++.+|++.+|++||++.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 234 LPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred chhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 00000 001112345789999999999999999999975
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=293.65 Aligned_cols=256 Identities=20% Similarity=0.205 Sum_probs=192.2
Q ss_pred hcccccccccEEEEEEEEC-CCcEEEEEEccCcchhh--------------hHHHHHHHHHHHhcCCCcccccceeeecc
Q 002336 617 FCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHR--------------TQQFVTEVALLSRIHHRNLVPLIGYCEEE 681 (935)
Q Consensus 617 ~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~~~--------------~~~~~~E~~iL~~L~HpnIv~l~g~~~~~ 681 (935)
+.+.||+|+||.||+|... +++.||+|+++...... ...+.+|+++++.++|+||+++++++..+
T Consensus 13 ~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 92 (335)
T PTZ00024 13 KGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEG 92 (335)
T ss_pred hhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecC
Confidence 4577999999999999865 68999999986432211 12477899999999999999999999999
Q ss_pred ceEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccc
Q 002336 682 HQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGL 761 (935)
Q Consensus 682 ~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGl 761 (935)
+..++||||+. |+|.+++.. ...+++.....++.|++.||+|||+ .+++||||+|+||+++.++.+||+|||+
T Consensus 93 ~~~~lv~e~~~-~~l~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH~---~~i~H~dl~~~nill~~~~~~kl~dfg~ 165 (335)
T PTZ00024 93 DFINLVMDIMA-SDLKKVVDR---KIRLTESQVKCILLQILNGLNVLHK---WYFMHRDLSPANIFINSKGICKIADFGL 165 (335)
T ss_pred CcEEEEEeccc-cCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHeEECCCCCEEECCccc
Confidence 99999999996 689998863 4568899999999999999999997 8999999999999999999999999999
Q ss_pred cccccccc-------------cceeecccCCccccCCCCCCCC-CCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhH
Q 002336 762 SRQAEEDL-------------THISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNI 827 (935)
Q Consensus 762 a~~~~~~~-------------~~~~~~~~gt~~y~APE~l~~~-~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l 827 (935)
+....... ........++..|+|||.+.+. .++.++||||+|++++||++|+.||...+..+ .
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~---~ 242 (335)
T PTZ00024 166 ARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEID---Q 242 (335)
T ss_pred eeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---H
Confidence 87654111 0111123467889999988664 46899999999999999999999997443221 1
Q ss_pred HHHHHHhhhcCCe---eecc------------cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 828 VHWARSMIKKGDV---ISIV------------DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 828 ~~~~~~~i~~~~~---~~~~------------d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
...+......... .... .+.... ........+.+++.+|++.+|++||+++|++.
T Consensus 243 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 243 LGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKT-IFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred HHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHH-hCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 1111111111000 0000 000000 00112346889999999999999999999975
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.6e-31 Score=286.35 Aligned_cols=246 Identities=27% Similarity=0.391 Sum_probs=198.2
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCc---chhhhHHHHHHHHHHHhcC-CCcccccceeeeccceEEEEEE
Q 002336 615 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS---CSHRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQRILVYE 689 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~---~~~~~~~~~~E~~iL~~L~-HpnIv~l~g~~~~~~~~~lV~E 689 (935)
|.+.+.||+|++|.||+|... +|+.||+|++... .....+.+.+|++++++++ ||||+++++.+...+..++|||
T Consensus 3 y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 82 (280)
T cd05581 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLE 82 (280)
T ss_pred ceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEc
Confidence 456788999999999999876 6999999998652 1233467889999999998 9999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccc
Q 002336 690 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 769 (935)
Q Consensus 690 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~ 769 (935)
++++++|.+.+.. ...+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++.......
T Consensus 83 ~~~~~~L~~~l~~---~~~l~~~~~~~i~~ql~~~l~~Lh~---~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~ 156 (280)
T cd05581 83 YAPNGELLQYIRK---YGSLDEKCTRFYAAEILLALEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNS 156 (280)
T ss_pred CCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEecCCccccccCCcc
Confidence 9999999999974 3479999999999999999999997 899999999999999999999999999987654332
Q ss_pred c-------------------ceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHH
Q 002336 770 T-------------------HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHW 830 (935)
Q Consensus 770 ~-------------------~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~ 830 (935)
. .......++..|+|||......++.++||||||+++++|++|+.||..... ....+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~~~~~- 232 (280)
T cd05581 157 SPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE---YLTFQ- 232 (280)
T ss_pred ccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccH---HHHHH-
Confidence 1 112223478899999999888899999999999999999999999974331 11111
Q ss_pred HHHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCH----HHHHH
Q 002336 831 ARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKM----QEIVL 883 (935)
Q Consensus 831 ~~~~i~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~----~ev~~ 883 (935)
.... . ....+......+.+++.+||+.+|++||++ +++++
T Consensus 233 --~~~~-~----------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 233 --KILK-L----------EYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred --HHHh-c----------CCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 1111 0 001112223468899999999999999999 66653
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=292.91 Aligned_cols=251 Identities=25% Similarity=0.362 Sum_probs=198.8
Q ss_pred HHHHhhcccccccccEEEEEEEECCCcEEEEEEccCc--chhhhHHHHHHHHHHHhcC-CCcccccceeeeccceEEEEE
Q 002336 612 EATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADS--CSHRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQRILVY 688 (935)
Q Consensus 612 ~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~~~~~--~~~~~~~~~~E~~iL~~L~-HpnIv~l~g~~~~~~~~~lV~ 688 (935)
...|++.++||.||.+.||++.-.+.+.+|+|++... .......|.+|+..|.+|+ |.+||++++|-..++.+||||
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm 439 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM 439 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence 4567788999999999999999988888999887543 2334577999999999995 999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccccc
Q 002336 689 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 768 (935)
Q Consensus 689 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~ 768 (935)
|+- ..+|..+|+... .....| .++.+..|++.++.+.|+ .||||.||||.|+|+- .|.+||+|||.|.....+
T Consensus 440 E~G-d~DL~kiL~k~~-~~~~~~-~lk~ywkqML~aV~~IH~---~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~D 512 (677)
T KOG0596|consen 440 ECG-DIDLNKILKKKK-SIDPDW-FLKFYWKQMLLAVKTIHQ---HGIVHSDLKPANFLLV-KGRLKLIDFGIANAIQPD 512 (677)
T ss_pred ecc-cccHHHHHHhcc-CCCchH-HHHHHHHHHHHHHHHHHH---hceeecCCCcccEEEE-eeeEEeeeechhcccCcc
Confidence 987 469999998542 222334 778899999999999998 9999999999999985 578999999999887655
Q ss_pred ccce-eecccCCccccCCCCCCCC-----------CCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHH-HHHHHhh
Q 002336 769 LTHI-SSVARGTVGYLDPEYYGNQ-----------QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIV-HWARSMI 835 (935)
Q Consensus 769 ~~~~-~~~~~gt~~y~APE~l~~~-----------~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~-~~~~~~i 835 (935)
.... .....||+.||+||.+... ..++++||||+|||||+|+-|+.||. ++. .|.
T Consensus 513 TTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~--------~~~n~~a---- 580 (677)
T KOG0596|consen 513 TTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFG--------QIINQIA---- 580 (677)
T ss_pred ccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchH--------HHHHHHH----
Confidence 4433 4456799999999987321 36789999999999999999999997 222 121
Q ss_pred hcCCeeecccccccCCCCH-HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002336 836 KKGDVISIVDPVLIGNVKI-ESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 884 (935)
Q Consensus 836 ~~~~~~~~~d~~l~~~~~~-~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~ 884 (935)
.+..+.||.-.=+++. ...+.++++++.||..||++||++.|+++.
T Consensus 581 ---Kl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 581 ---KLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred ---HHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 1334555533222221 223349999999999999999999999864
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=286.01 Aligned_cols=259 Identities=22% Similarity=0.273 Sum_probs=192.8
Q ss_pred hhcccccccccEEEEEEEEC-CCcEEEEEEccCcch--hhhHHHHHHHHHHHhc---CCCcccccceeeeccce-----E
Q 002336 616 NFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRI---HHRNLVPLIGYCEEEHQ-----R 684 (935)
Q Consensus 616 ~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~--~~~~~~~~E~~iL~~L---~HpnIv~l~g~~~~~~~-----~ 684 (935)
++.+.||+|+||.||+|+++ +++.+|+|++..... .....+.+|+.+++++ +|+|++++++++...+. .
T Consensus 2 ~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~ 81 (287)
T cd07838 2 EELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKL 81 (287)
T ss_pred eEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCcee
Confidence 45678999999999999987 489999999864322 2234566788877766 59999999999987766 8
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccc
Q 002336 685 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 764 (935)
Q Consensus 685 ~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~ 764 (935)
+++|||+. ++|.+++... ....+++..++.++.|+++||+|||+ .+++|+||+|+||+++.++.+||+|||++..
T Consensus 82 ~l~~e~~~-~~l~~~l~~~-~~~~l~~~~~~~~~~~i~~al~~LH~---~~i~h~~l~~~nili~~~~~~~l~dfg~~~~ 156 (287)
T cd07838 82 TLVFEHVD-QDLATYLSKC-PKPGLPPETIKDLMRQLLRGVDFLHS---HRIVHRDLKPQNILVTSDGQVKIADFGLARI 156 (287)
T ss_pred EEEehhcc-cCHHHHHHHc-cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhEEEccCCCEEEeccCccee
Confidence 99999997 4898888643 23368999999999999999999998 8999999999999999999999999999877
Q ss_pred ccccccceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCee---
Q 002336 765 AEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVI--- 841 (935)
Q Consensus 765 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~--- 841 (935)
....... ....++..|+|||.+.+..++.++|+||||+++|||++|+.||......+ .+..+.......+...
T Consensus 157 ~~~~~~~--~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07838 157 YSFEMAL--TSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEAD--QLDKIFDVIGLPSEEEWPR 232 (287)
T ss_pred ccCCccc--ccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHH--HHHHHHHHcCCCChHhcCC
Confidence 6433221 12346888999999988889999999999999999999999987433211 1111111100000000
Q ss_pred ------eccccccc---CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 842 ------SIVDPVLI---GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 842 ------~~~d~~l~---~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
........ ....+.....+.+++.+||+.+|++||+++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 233 NVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred CcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 00000000 0111223457789999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-31 Score=297.74 Aligned_cols=244 Identities=28% Similarity=0.415 Sum_probs=202.8
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcchh--hhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEe
Q 002336 614 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSH--RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 690 (935)
Q Consensus 614 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~~--~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~ 690 (935)
.|.+.+.||+|.|+.|.+|++. .+.+||+|.+.+..-+ ..+.+.+|+++|..|+|||||+++.+.+.+..+|+||||
T Consensus 57 ~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~ey 136 (596)
T KOG0586|consen 57 LYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVMEY 136 (596)
T ss_pred ceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEEe
Confidence 3556789999999999999876 6999999999775433 335588999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccccccc
Q 002336 691 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 770 (935)
Q Consensus 691 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~ 770 (935)
+.+|.+++++.. .+...+..+..++.|+..|++|||+ +.|+|||||++|||++.+.++||+|||++..+.. .
T Consensus 137 a~~ge~~~yl~~---~gr~~e~~ar~~F~q~vsaveYcH~---k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~--~ 208 (596)
T KOG0586|consen 137 ASGGELFDYLVK---HGRMKEKEARAKFRQIVSAVEYCHS---KNIVHRDLKAENILLDENMNIKIADFGFSTFFDY--G 208 (596)
T ss_pred ccCchhHHHHHh---cccchhhhhhhhhHHHHHHHHHHhh---cceeccccchhhcccccccceeeeccccceeecc--c
Confidence 999999999984 4456668888999999999999998 9999999999999999999999999999988763 3
Q ss_pred ceeecccCCccccCCCCCCCCCC-CchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeeccccccc
Q 002336 771 HISSVARGTVGYLDPEYYGNQQL-TEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 849 (935)
Q Consensus 771 ~~~~~~~gt~~y~APE~l~~~~~-s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~ 849 (935)
......+|++.|.|||++.+..+ ++++|+||+|+++|-|+.|..||++.... ++-++.+.
T Consensus 209 ~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk-------------------~Lr~rvl~ 269 (596)
T KOG0586|consen 209 LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLK-------------------ELRPRVLR 269 (596)
T ss_pred ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccc-------------------cccchhee
Confidence 34556789999999999988654 68999999999999999999999854332 11122222
Q ss_pred CCCC--HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002336 850 GNVK--IESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 884 (935)
Q Consensus 850 ~~~~--~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~ 884 (935)
+.+. ....-+..+++++++..+|.+|++++++.+.
T Consensus 270 gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 270 GKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred eeecccceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence 2221 1122357799999999999999999998654
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=283.49 Aligned_cols=261 Identities=23% Similarity=0.320 Sum_probs=194.6
Q ss_pred hhcccccccccEEEEEEEEC-CCcEEEEEEccCcch-hhhHHHHHHHHHHHhcC-CCcccccceeeeccceEEEEEEecC
Q 002336 616 NFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQRILVYEYMH 692 (935)
Q Consensus 616 ~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~-~~~~~~~~E~~iL~~L~-HpnIv~l~g~~~~~~~~~lV~E~~~ 692 (935)
.+.+.||+|++|.||+|... +++.|++|++..... .......+|+..+++++ |+|++++++++..++..++||||+
T Consensus 2 ~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~- 80 (283)
T cd07830 2 KVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM- 80 (283)
T ss_pred eeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC-
Confidence 45688999999999999986 578999999865422 22334567999999998 999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccccce
Q 002336 693 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 772 (935)
Q Consensus 693 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~~ 772 (935)
+|+|.+.+.... ...+++..++.++.|++.+|.|||+ ++++|+||+|+||++++++.++|+|||++........
T Consensus 81 ~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~-- 154 (283)
T cd07830 81 EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHK---HGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP-- 154 (283)
T ss_pred CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCCEEEeecccceeccCCCC--
Confidence 889999887532 3468999999999999999999998 8999999999999999999999999999876543222
Q ss_pred eecccCCccccCCCCCC-CCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchh-HH---------HHHHHhhhcCCee
Q 002336 773 SSVARGTVGYLDPEYYG-NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELN-IV---------HWARSMIKKGDVI 841 (935)
Q Consensus 773 ~~~~~gt~~y~APE~l~-~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~-l~---------~~~~~~i~~~~~~ 841 (935)
.....++..|+|||.+. ...++.++|+||||++++||++|+.||......+... .. .|...........
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd07830 155 YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLG 234 (283)
T ss_pred cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccc
Confidence 12234788999999874 4567899999999999999999999996443211110 00 0111110000000
Q ss_pred eccccccc---CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 842 SIVDPVLI---GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 842 ~~~d~~l~---~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
..+..... ..........+.+++.+||+.+|++||+++|++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 235 FRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred ccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 00000000 0000111356889999999999999999999875
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=286.66 Aligned_cols=252 Identities=25% Similarity=0.375 Sum_probs=192.9
Q ss_pred HHHhhcccccccccEEEEEEEECC-CcEEEEEEccCcc-hhhhHHHHHHHHHHHhcC-CCcccccceeeeccceEEEEEE
Q 002336 613 ATNNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSC-SHRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQRILVYE 689 (935)
Q Consensus 613 ~~~~~~~~LG~G~fG~Vy~~~~~~-g~~vAvK~~~~~~-~~~~~~~~~E~~iL~~L~-HpnIv~l~g~~~~~~~~~lV~E 689 (935)
..+.+.+.||+|++|.||+|.+++ ++.||||.++... ......+..|+.++.+.. ||||+++++++.+....+++||
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e 94 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME 94 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence 345678899999999999999875 8999999987543 233456777887777775 9999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccc
Q 002336 690 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 769 (935)
Q Consensus 690 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~ 769 (935)
|+. ++|.+.+... ...+++..+.+++.|+++||+|||+ ..+|+||||+|+||++++++.+||+|||++.......
T Consensus 95 ~~~-~~l~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~--~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~ 169 (296)
T cd06618 95 LMS-TCLDKLLKRI--QGPIPEDILGKMTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK 169 (296)
T ss_pred ccC-cCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHh--hCCEecCCCcHHHEEEcCCCCEEECccccchhccCCC
Confidence 985 4777766532 3478999999999999999999996 3589999999999999999999999999987654322
Q ss_pred cceeecccCCccccCCCCCCCCC----CCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeeccc
Q 002336 770 THISSVARGTVGYLDPEYYGNQQ----LTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 845 (935)
Q Consensus 770 ~~~~~~~~gt~~y~APE~l~~~~----~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d 845 (935)
.. ....++..|+|||.+.+.. ++.++||||||+++|+|++|+.||...... .+......... ....-.
T Consensus 170 ~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~~~~~~~~~~~-~~~~~~ 241 (296)
T cd06618 170 AK--TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE-----FEVLTKILQEE-PPSLPP 241 (296)
T ss_pred cc--cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH-----HHHHHHHhcCC-CCCCCC
Confidence 21 2234778999999986543 788999999999999999999999632111 11111112111 111000
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002336 846 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 884 (935)
Q Consensus 846 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~ 884 (935)
.......+.+++.+||..+|++||+++++++.
T Consensus 242 -------~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 242 -------NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred -------CCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00123468899999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-32 Score=324.79 Aligned_cols=245 Identities=27% Similarity=0.391 Sum_probs=195.1
Q ss_pred cccccccccEEEEEEEE-CCCcEEEEEEccCcc--hhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEecCCC
Q 002336 618 CKKIGKGSFGSVYYGKM-KDGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNG 694 (935)
Q Consensus 618 ~~~LG~G~fG~Vy~~~~-~~g~~vAvK~~~~~~--~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~~~g 694 (935)
...||.|.||.||-|.. .+|+-.|+|-++... ....+.+.+|+.++..++|||+|+.+|+-.+.+..++.||||++|
T Consensus 1240 g~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~G 1319 (1509)
T KOG4645|consen 1240 GNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGG 1319 (1509)
T ss_pred ccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccC
Confidence 35699999999999974 578999999876432 233467889999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccccc---
Q 002336 695 TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH--- 771 (935)
Q Consensus 695 sL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~--- 771 (935)
+|.+.++ .+.-.++.....+..|++.|++|||+ .|||||||||.||+++.+|.+|++|||.|.........
T Consensus 1320 sLa~ll~---~gri~dE~vt~vyt~qll~gla~LH~---~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~ 1393 (1509)
T KOG4645|consen 1320 SLASLLE---HGRIEDEMVTRVYTKQLLEGLAYLHE---HGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPG 1393 (1509)
T ss_pred cHHHHHH---hcchhhhhHHHHHHHHHHHHHHHHHh---cCceecCCCccceeeecCCcEEeecccceeEecCchhcCCH
Confidence 9999997 34556777777889999999999998 99999999999999999999999999999886554322
Q ss_pred eeecccCCccccCCCCCCCC---CCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccccc
Q 002336 772 ISSVARGTVGYLDPEYYGNQ---QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 848 (935)
Q Consensus 772 ~~~~~~gt~~y~APE~l~~~---~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l 848 (935)
.-+...||+.|||||++.+. .-..++||||+|||+.||+||+.||.. .+.++.+.. .+..|....+..
T Consensus 1394 el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~--~dne~aIMy----~V~~gh~Pq~P~--- 1464 (1509)
T KOG4645|consen 1394 ELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAE--LDNEWAIMY----HVAAGHKPQIPE--- 1464 (1509)
T ss_pred HHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhh--ccchhHHHh----HHhccCCCCCch---
Confidence 12345699999999998653 346789999999999999999999973 222222222 222333322222
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 849 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 849 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
.....=.+++.+|++.||++|.++.|+++
T Consensus 1465 ------~ls~~g~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1465 ------RLSSEGRDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred ------hhhHhHHHHHHHHHhcCchhhhHHHHHHH
Confidence 22234568999999999999998887764
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.8e-31 Score=271.41 Aligned_cols=250 Identities=24% Similarity=0.381 Sum_probs=198.4
Q ss_pred cccccccccEEEEEEE-ECCCcEEEEEEccCcchhhhHHHHHHHHHHHhcC-CCcccccceeeeccceEEEEEEecCCCC
Q 002336 618 CKKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQRILVYEYMHNGT 695 (935)
Q Consensus 618 ~~~LG~G~fG~Vy~~~-~~~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~-HpnIv~l~g~~~~~~~~~lV~E~~~~gs 695 (935)
.+.||+|+++.|--++ +.+|.++|||++.+...+...++.+|++++...+ |+||+.++++|+++...|||||.|.||+
T Consensus 83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGp 162 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGP 162 (463)
T ss_pred HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCch
Confidence 4789999999999885 6789999999998887778889999999999985 9999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCc---EEEeeccccccccccc--c
Q 002336 696 LRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMR---AKVSDFGLSRQAEEDL--T 770 (935)
Q Consensus 696 L~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~---vkL~DFGla~~~~~~~--~ 770 (935)
|.++++ .++.+++.++.++.++|+.||.+||. +||.|||+||+|||-.+... +|||||.+........ .
T Consensus 163 lLshI~---~~~~F~E~EAs~vvkdia~aLdFlH~---kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~s 236 (463)
T KOG0607|consen 163 LLSHIQ---KRKHFNEREASRVVKDIASALDFLHT---KGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCS 236 (463)
T ss_pred HHHHHH---HhhhccHHHHHHHHHHHHHHHHHHhh---cCcccccCCccceeecCCCCcCceeeeccccccccccCCCCC
Confidence 999998 46789999999999999999999997 99999999999999965544 8999998876532211 1
Q ss_pred ce----eecccCCccccCCCCC-----CCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcc----cchhHH----HHHHH
Q 002336 771 HI----SSVARGTVGYLDPEYY-----GNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFG----AELNIV----HWARS 833 (935)
Q Consensus 771 ~~----~~~~~gt~~y~APE~l-----~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~----~~~~l~----~~~~~ 833 (935)
.. .....|+..|||||+. ....|+.+.|.||+|||+|-|+.|..||.+.... +..... +-+-+
T Consensus 237 pastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFe 316 (463)
T KOG0607|consen 237 PASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFE 316 (463)
T ss_pred CCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHH
Confidence 11 1224588899999975 3357889999999999999999999999854331 111111 11223
Q ss_pred hhhcCCeeecccccccCCCCHHH----HHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 834 MIKKGDVISIVDPVLIGNVKIES----IWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 834 ~i~~~~~~~~~d~~l~~~~~~~~----~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
.|++|.+ ++|.++ .....+++...+..++.+|-++..++.
T Consensus 317 sIQEGkY----------eFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 317 SIQEGKY----------EFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred HHhccCC----------cCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 3444432 223222 234568888899999999999998876
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=313.97 Aligned_cols=264 Identities=26% Similarity=0.425 Sum_probs=210.8
Q ss_pred hHHHHHHhhcccccccccEEEEEEEEC----C----CcEEEEEEccCcch-hhhHHHHHHHHHHHhc-CCCcccccceee
Q 002336 609 ELEEATNNFCKKIGKGSFGSVYYGKMK----D----GKEVAVKIMADSCS-HRTQQFVTEVALLSRI-HHRNLVPLIGYC 678 (935)
Q Consensus 609 ~l~~~~~~~~~~LG~G~fG~Vy~~~~~----~----g~~vAvK~~~~~~~-~~~~~~~~E~~iL~~L-~HpnIv~l~g~~ 678 (935)
++......+.+.||+|.||.|++|... . ...||||+++.... .+.+.+..|+++|+.+ +|+||+.++|.|
T Consensus 292 e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~ 371 (609)
T KOG0200|consen 292 EIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGAC 371 (609)
T ss_pred eechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeee
Confidence 444444566779999999999999754 1 45799999986533 4567899999999999 699999999999
Q ss_pred eccceEEEEEEecCCCCHHHHhccCC-----CC--------CCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCC
Q 002336 679 EEEHQRILVYEYMHNGTLRDRLHGSV-----NQ--------KPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSN 745 (935)
Q Consensus 679 ~~~~~~~lV~E~~~~gsL~~~L~~~~-----~~--------~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~N 745 (935)
...+..++|+||++.|+|.++|+... .. ..+.....+.++.|||.|++||++ ++++||||.++|
T Consensus 372 t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~---~~~vHRDLAaRN 448 (609)
T KOG0200|consen 372 TQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLAS---VPCVHRDLAARN 448 (609)
T ss_pred ccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhh---CCccchhhhhhh
Confidence 99999999999999999999998653 01 238899999999999999999998 899999999999
Q ss_pred ccccCCCcEEEeeccccccccccccceeeccc--CCccccCCCCCCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCcc
Q 002336 746 ILLDINMRAKVSDFGLSRQAEEDLTHISSVAR--GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFG 822 (935)
Q Consensus 746 ILld~~~~vkL~DFGla~~~~~~~~~~~~~~~--gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~ 822 (935)
||+.++..+||+|||+++...+.......... -...|||||.+....++.|+|||||||+||||+| |..||.+..
T Consensus 449 VLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~-- 526 (609)
T KOG0200|consen 449 VLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP-- 526 (609)
T ss_pred EEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC--
Confidence 99999999999999999975554433322222 2456999999999999999999999999999999 889986411
Q ss_pred cchhHHHHHHHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhhhh
Q 002336 823 AELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 890 (935)
Q Consensus 823 ~~~~l~~~~~~~i~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~~~ 890 (935)
...++.+ .+++|...+ .|.....++.++++.||..+|++||++.++++.++..+.
T Consensus 527 ~~~~l~~----~l~~G~r~~---------~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~ 581 (609)
T KOG0200|consen 527 PTEELLE----FLKEGNRME---------QPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ 581 (609)
T ss_pred cHHHHHH----HHhcCCCCC---------CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence 1222233 344443211 122234467799999999999999999999999998543
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-31 Score=269.17 Aligned_cols=248 Identities=23% Similarity=0.384 Sum_probs=194.5
Q ss_pred hcccccccccEEEEEEEEC-CCcEEEEEEccCc-chhhhHHHHHHHHHHHhcC-CCcccccceeeeccceEEEEEEecCC
Q 002336 617 FCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS-CSHRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQRILVYEYMHN 693 (935)
Q Consensus 617 ~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~-~~~~~~~~~~E~~iL~~L~-HpnIv~l~g~~~~~~~~~lV~E~~~~ 693 (935)
+...||.|.-|.|++++.+ .|..+|||.+... ..+..++++..++++.+-+ .|+||+.+|+|..+...++.||.|.
T Consensus 96 ~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs- 174 (391)
T KOG0983|consen 96 NLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMS- 174 (391)
T ss_pred hHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHH-
Confidence 4567999999999999876 5899999998765 3455678888888877664 8999999999999988999999884
Q ss_pred CCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccccccccee
Q 002336 694 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 773 (935)
Q Consensus 694 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~~~ 773 (935)
.-++.++.. ..+++++..+-++...+..||.||.+ +++|+|||+||+|||+|+.|++||||||.+-...+...+
T Consensus 175 ~C~ekLlkr--ik~piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAh-- 248 (391)
T KOG0983|consen 175 TCAEKLLKR--IKGPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAH-- 248 (391)
T ss_pred HHHHHHHHH--hcCCchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeecccccceeeccccc--
Confidence 334555543 34668888888999999999999998 799999999999999999999999999999876554433
Q ss_pred ecccCCccccCCCCCC---CCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccC
Q 002336 774 SVARGTVGYLDPEYYG---NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 850 (935)
Q Consensus 774 ~~~~gt~~y~APE~l~---~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~ 850 (935)
....|.+.|||||.+. ...|+.++||||||+.++||.||+.||.+-+.+ ... +...+++. . ..++....
T Consensus 249 trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td--Fe~---ltkvln~e-P-P~L~~~~g- 320 (391)
T KOG0983|consen 249 TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTD--FEV---LTKVLNEE-P-PLLPGHMG- 320 (391)
T ss_pred ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCcc--HHH---HHHHHhcC-C-CCCCcccC-
Confidence 3456899999999985 457899999999999999999999999853332 111 11222211 1 22222111
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002336 851 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 884 (935)
Q Consensus 851 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~ 884 (935)
....+.+++..||+.|+.+||...++++.
T Consensus 321 -----FSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 321 -----FSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred -----cCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 22368899999999999999999998764
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-30 Score=286.26 Aligned_cols=249 Identities=29% Similarity=0.393 Sum_probs=194.8
Q ss_pred HHHHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCc---chhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEE
Q 002336 611 EEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS---CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRIL 686 (935)
Q Consensus 611 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~---~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~l 686 (935)
...++...+.||+|++|.||+|... +++.+|+|.+... .....+++.+|+++++.++|+|++++++++......++
T Consensus 13 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 92 (308)
T cd06634 13 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWL 92 (308)
T ss_pred cHHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEE
Confidence 4455666788999999999999875 5788999987632 22334678899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccc
Q 002336 687 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 766 (935)
Q Consensus 687 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~ 766 (935)
||||+. |+|.+.+... ...+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++....
T Consensus 93 v~e~~~-~~l~~~~~~~--~~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 166 (308)
T cd06634 93 VMEYCL-GSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA 166 (308)
T ss_pred EEEccC-CCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHhEEECCCCcEEECCcccceeec
Confidence 999996 6887776532 3458899999999999999999997 899999999999999999999999999987654
Q ss_pred ccccceeecccCCccccCCCCCC---CCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeec
Q 002336 767 EDLTHISSVARGTVGYLDPEYYG---NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISI 843 (935)
Q Consensus 767 ~~~~~~~~~~~gt~~y~APE~l~---~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~ 843 (935)
... ...++..|+|||.+. ...++.++||||||+++|+|++|+.||...... ........ +....
T Consensus 167 ~~~-----~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~~~~~~~~-~~~~~- 233 (308)
T cd06634 167 PAN-----XFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SALYHIAQ-NESPA- 233 (308)
T ss_pred Ccc-----cccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHH------HHHHHHhh-cCCCC-
Confidence 321 234788999999874 356788999999999999999999998632111 11111111 11111
Q ss_pred ccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 002336 844 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAI 885 (935)
Q Consensus 844 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L 885 (935)
. ........+.+++.+||+.+|++||+++++++.-
T Consensus 234 ----~---~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~ 268 (308)
T cd06634 234 ----L---QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 268 (308)
T ss_pred ----c---CcccccHHHHHHHHHHhhCCcccCCCHHHHhhCc
Confidence 0 0112234678999999999999999999998653
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-29 Score=282.18 Aligned_cols=244 Identities=30% Similarity=0.423 Sum_probs=191.6
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc---hhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEe
Q 002336 615 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 690 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~ 690 (935)
+...+.||+|+||.||+|... +++.|++|++.... ....+.+.+|+++++.++|||++++++++.+....++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 344578999999999999875 68899999986432 23345788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccccccc
Q 002336 691 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 770 (935)
Q Consensus 691 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~ 770 (935)
+. |+|.+.+... ...+++.+++.++.|++.||.|||+ .+++||||+|+||++++++.+||+|||++......
T Consensus 103 ~~-~~l~~~l~~~--~~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~-- 174 (313)
T cd06633 103 CL-GSASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPA-- 174 (313)
T ss_pred CC-CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChhhEEECCCCCEEEeecCCCcccCCC--
Confidence 95 5777777532 3568999999999999999999998 89999999999999999999999999988643221
Q ss_pred ceeecccCCccccCCCCCC---CCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeeccccc
Q 002336 771 HISSVARGTVGYLDPEYYG---NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 847 (935)
Q Consensus 771 ~~~~~~~gt~~y~APE~l~---~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~ 847 (935)
....|+..|+|||.+. ...++.++||||||+++|+|++|..||...+. .......... ......
T Consensus 175 ---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~------~~~~~~~~~~-~~~~~~--- 241 (313)
T cd06633 175 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MSALYHIAQN-DSPTLQ--- 241 (313)
T ss_pred ---CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHHhc-CCCCCC---
Confidence 2235788999999874 45688999999999999999999999863321 1111111111 111111
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002336 848 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 884 (935)
Q Consensus 848 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~ 884 (935)
.......+.+++.+||+.+|.+||++.++++.
T Consensus 242 -----~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 242 -----SNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred -----ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11122357899999999999999999999853
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-30 Score=281.66 Aligned_cols=258 Identities=24% Similarity=0.307 Sum_probs=196.1
Q ss_pred hhcccccccccEEEEEEEEC-CCcEEEEEEccCcc--hhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEecC
Q 002336 616 NFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 692 (935)
Q Consensus 616 ~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~~ 692 (935)
++.+.||+|++|.||+|... +++.+|+|++.... ....+.+..|+.++++++|+|++++++++.+....++||||++
T Consensus 2 ~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 81 (282)
T cd07829 2 EKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD 81 (282)
T ss_pred eeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC
Confidence 34578999999999999876 58999999987643 2234678889999999999999999999999999999999997
Q ss_pred CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccccce
Q 002336 693 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 772 (935)
Q Consensus 693 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~~ 772 (935)
++|.+++... ...+++..+.+++.|+++||+|||+ .+|+||||+|+||++++++.+||+|||++.........
T Consensus 82 -~~l~~~i~~~--~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~- 154 (282)
T cd07829 82 -MDLKKYLDKR--PGPLSPNLIKSIMYQLLRGLAYCHS---HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT- 154 (282)
T ss_pred -cCHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChheEEEcCCCCEEEecCCcccccCCCccc-
Confidence 5899998743 2468999999999999999999998 89999999999999999999999999998765443221
Q ss_pred eecccCCccccCCCCCCCC-CCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcC---------Ce--
Q 002336 773 SSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG---------DV-- 840 (935)
Q Consensus 773 ~~~~~gt~~y~APE~l~~~-~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~---------~~-- 840 (935)
.....++..|+|||.+.+. .++.++||||||++++||++|+.||......+. ...+.+..... ..
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~ 231 (282)
T cd07829 155 YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQ---LFKIFQILGTPTEESWPGVTKLPD 231 (282)
T ss_pred cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH---HHHHHHHhCCCcHHHHHhhccccc
Confidence 1223357789999988766 889999999999999999999999974432211 11111110000 00
Q ss_pred -eeccccc---ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 841 -ISIVDPV---LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 841 -~~~~d~~---l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
....... ......+.....+.+++.+||+.+|++||++++++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 232 YKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred ccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 0000000 000000112347899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.1e-30 Score=273.15 Aligned_cols=236 Identities=30% Similarity=0.396 Sum_probs=191.9
Q ss_pred ccccccEEEEEEEEC-CCcEEEEEEccCcch---hhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEecCCCCH
Q 002336 621 IGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTL 696 (935)
Q Consensus 621 LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~---~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL 696 (935)
||+|++|.||++... +++.+|+|.+..... ...+.+..|++++++++||||+++++.+..+...++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999876 589999999865422 2446788999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccccceeecc
Q 002336 697 RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVA 776 (935)
Q Consensus 697 ~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~ 776 (935)
.+++.. ...+++..+..++.|+++||.|||+ .+++|+||+|+||+++.++.++|+|||++........ .....
T Consensus 81 ~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lh~---~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~ 153 (250)
T cd05123 81 FSHLSK---EGRFSEERARFYAAEIVLALEYLHS---LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS-RTNTF 153 (250)
T ss_pred HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcceEEEcCCCcEEEeecCcceecccCCC-cccCC
Confidence 999974 3468999999999999999999998 9999999999999999999999999999876543321 12234
Q ss_pred cCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccCCCCHHH
Q 002336 777 RGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIES 856 (935)
Q Consensus 777 ~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~~~~~~~ 856 (935)
.++..|++||...+...+.++|+||||+++|+|++|+.||...+. ....+ .... +.. ..+...
T Consensus 154 ~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~---~~~~~---~~~~-~~~----------~~~~~~ 216 (250)
T cd05123 154 CGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR---KEIYE---KILK-DPL----------RFPEFL 216 (250)
T ss_pred cCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---HHHHH---HHhc-CCC----------CCCCCC
Confidence 578899999999888889999999999999999999999974332 11111 1111 100 111112
Q ss_pred HHHHHHHHHHccccCCCCCCCHHH
Q 002336 857 IWRIAEVAIQCVEQRGFSRPKMQE 880 (935)
Q Consensus 857 ~~~l~~li~~Cl~~dP~~RPs~~e 880 (935)
...+.+++.+||..+|++||++++
T Consensus 217 ~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 217 SPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CHHHHHHHHHHhcCCHhhCCCccc
Confidence 346789999999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=275.22 Aligned_cols=261 Identities=24% Similarity=0.363 Sum_probs=207.1
Q ss_pred HHHHHHhhcccccccccEEEEEEEECC------CcEEEEEEccCcch-hhhHHHHHHHHHHHhcCCCcccccceeeec-c
Q 002336 610 LEEATNNFCKKIGKGSFGSVYYGKMKD------GKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEE-E 681 (935)
Q Consensus 610 l~~~~~~~~~~LG~G~fG~Vy~~~~~~------g~~vAvK~~~~~~~-~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~-~ 681 (935)
+.+...++.-.+-+|.||.||+|.|.+ .+.|.+|.+++... -+...+..|...+..+.|||+..+.+++.+ .
T Consensus 281 v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~ 360 (563)
T KOG1024|consen 281 VQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDY 360 (563)
T ss_pred hhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeecc
Confidence 344444456678999999999997653 45678888776433 345678899999999999999999998754 4
Q ss_pred ceEEEEEEecCCCCHHHHhc-----cCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEE
Q 002336 682 HQRILVYEYMHNGTLRDRLH-----GSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKV 756 (935)
Q Consensus 682 ~~~~lV~E~~~~gsL~~~L~-----~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL 756 (935)
...++++.++.-|+|..+|. +......+...+...++.|++.|++|||. ++|+|.||.++|++||+..++||
T Consensus 361 ~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~---~~ViHkDiAaRNCvIdd~LqVkl 437 (563)
T KOG1024|consen 361 ATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHN---HGVIHKDIAARNCVIDDQLQVKL 437 (563)
T ss_pred CcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHh---cCcccchhhhhcceehhheeEEe
Confidence 56788999999999999998 33345568888999999999999999997 99999999999999999999999
Q ss_pred eeccccccccccc-cceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCcccchhHHHHHHHh
Q 002336 757 SDFGLSRQAEEDL-THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSM 834 (935)
Q Consensus 757 ~DFGla~~~~~~~-~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~ 834 (935)
+|=.+++..-..+ .........+..||+||.+.+..++.++|||||||+||||+| |+.|+..-+..+ +...
T Consensus 438 tDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfE-------m~~y 510 (563)
T KOG1024|consen 438 TDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFE-------MEHY 510 (563)
T ss_pred ccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHH-------HHHH
Confidence 9999998754332 223333446789999999999999999999999999999999 999997333221 1222
Q ss_pred hhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhhh
Q 002336 835 IKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI 889 (935)
Q Consensus 835 i~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~~ 889 (935)
++.|.. + ..|...++++..++.-||...|++||+.++++.-|.+.-
T Consensus 511 lkdGyR-------l--aQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~ 556 (563)
T KOG1024|consen 511 LKDGYR-------L--AQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFH 556 (563)
T ss_pred Hhccce-------e--cCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHH
Confidence 333321 1 224455668999999999999999999999998887643
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-30 Score=287.00 Aligned_cols=265 Identities=22% Similarity=0.270 Sum_probs=190.2
Q ss_pred HHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcchh--hhHHHHHHHHHHHhcCCCcccccceeeecc--------
Q 002336 613 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSH--RTQQFVTEVALLSRIHHRNLVPLIGYCEEE-------- 681 (935)
Q Consensus 613 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~~--~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~-------- 681 (935)
..|++.+.||+|++|.||+|.++ +++.+|+|++...... ....+.+|++++++++||||+++++++.+.
T Consensus 8 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 87 (311)
T cd07866 8 RDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKR 87 (311)
T ss_pred ccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccC
Confidence 34566789999999999999876 6899999988543222 234677899999999999999999987443
Q ss_pred ceEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccc
Q 002336 682 HQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGL 761 (935)
Q Consensus 682 ~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGl 761 (935)
...++|+||+.+ +|...+.. ....+++..+..++.|+++||+|||+ .+++||||||+||++++++.+||+|||+
T Consensus 88 ~~~~lv~~~~~~-~l~~~~~~--~~~~~~~~~~~~i~~~l~~al~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~ 161 (311)
T cd07866 88 GSVYMVTPYMDH-DLSGLLEN--PSVKLTESQIKCYMLQLLEGINYLHE---NHILHRDIKAANILIDNQGILKIADFGL 161 (311)
T ss_pred ceEEEEEecCCc-CHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECcCcc
Confidence 346999999965 67766653 24569999999999999999999998 8999999999999999999999999999
Q ss_pred cccccccccce----------eecccCCccccCCCCCCC-CCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHH
Q 002336 762 SRQAEEDLTHI----------SSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHW 830 (935)
Q Consensus 762 a~~~~~~~~~~----------~~~~~gt~~y~APE~l~~-~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~ 830 (935)
+.......... .....+++.|+|||.+.+ ..++.++||||||+++|||++|+.||..............
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~ 241 (311)
T cd07866 162 ARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFK 241 (311)
T ss_pred chhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 87653322111 112346788999998754 4688999999999999999999999974433211111100
Q ss_pred HHHhhhc------CCeeecccccccCCCC-------HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 831 ARSMIKK------GDVISIVDPVLIGNVK-------IESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 831 ~~~~i~~------~~~~~~~d~~l~~~~~-------~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
....... .......+.......+ ......+.+++.+|++.+|++|||+.|++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 242 LCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 0000000 0000000000000000 011246889999999999999999999874
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-30 Score=277.53 Aligned_cols=248 Identities=26% Similarity=0.364 Sum_probs=192.5
Q ss_pred HhhcccccccccEEEEEEEECC-CcEEEEEEccCc-----chhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEE
Q 002336 615 NNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADS-----CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 688 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~~-g~~vAvK~~~~~-----~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~ 688 (935)
|.+.+.||+|+||.||++.+.. +..+++|+++.. ......++..|+.++++++||||+++++++.+....++||
T Consensus 2 y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (260)
T cd08222 2 YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIIT 81 (260)
T ss_pred ceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEE
Confidence 4567899999999999998763 445666665432 1223345778999999999999999999999888999999
Q ss_pred EecCCCCHHHHhccCC-CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccc
Q 002336 689 EYMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 767 (935)
Q Consensus 689 E~~~~gsL~~~L~~~~-~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~ 767 (935)
||+++++|.+.+.... ....+++..++.++.|+++||.|||+ .+++|+||||+||++++ +.+||+|||++.....
T Consensus 82 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~ 157 (260)
T cd08222 82 EYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ---RRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMG 157 (260)
T ss_pred EeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHH---cCccccCCChhheEeec-CCEeecccCceeecCC
Confidence 9999999999886422 34578999999999999999999998 89999999999999975 5699999999876543
Q ss_pred cccceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeeccccc
Q 002336 768 DLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 847 (935)
Q Consensus 768 ~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~ 847 (935)
... ......|+..|+|||.+.+..++.++|+||||+++|+|++|..||..... ...... +..+.. +.
T Consensus 158 ~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~------~~~~~~-~~~~~~-----~~ 224 (260)
T cd08222 158 SCD-LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF------LSVVLR-IVEGPT-----PS 224 (260)
T ss_pred Ccc-cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH------HHHHHH-HHcCCC-----CC
Confidence 322 12234578899999998888889999999999999999999999863211 111111 111111 11
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 848 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 848 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
.+......+.+++.+|++.+|++||++.|+++
T Consensus 225 ----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 225 ----LPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred ----CcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 12233347889999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-31 Score=285.19 Aligned_cols=242 Identities=24% Similarity=0.288 Sum_probs=195.4
Q ss_pred hcccccccccEEEEEEEEC-CCcEEEEEEccCcc---hhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEecC
Q 002336 617 FCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 692 (935)
Q Consensus 617 ~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~~ 692 (935)
.-++||+|+||.||-...+ +|+.+|.|++.+.. ..+....++|-.+|++++.+.||.+-..++..+.+++|+..|.
T Consensus 189 ~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlMN 268 (591)
T KOG0986|consen 189 VYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLMN 268 (591)
T ss_pred eeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEeec
Confidence 3578999999999999765 69999999885432 2233457889999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccccce
Q 002336 693 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 772 (935)
Q Consensus 693 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~~ 772 (935)
||+|.-+|... ....+++.+++-++.+|+.||++||. .+||.||+||+|||+|+.|+++|+|+|+|..+.+.....
T Consensus 269 GGDLkfHiyn~-g~~gF~e~ra~FYAAEi~cGLehlH~---~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~~~ 344 (591)
T KOG0986|consen 269 GGDLKFHIYNH-GNPGFDEQRARFYAAEIICGLEHLHR---RRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKPIR 344 (591)
T ss_pred CCceeEEeecc-CCCCCchHHHHHHHHHHHhhHHHHHh---cceeeccCChhheeeccCCCeEeeccceEEecCCCCccc
Confidence 99999888754 34679999999999999999999997 999999999999999999999999999999887665543
Q ss_pred eecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccCCC
Q 002336 773 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNV 852 (935)
Q Consensus 773 ~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~~~ 852 (935)
. ..||.+|||||++++..|+...|-||+||++|||+.|+.||....... ..+-+.+.+.+.. .++
T Consensus 345 ~--rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKv---k~eEvdrr~~~~~----------~ey 409 (591)
T KOG0986|consen 345 G--RVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKV---KREEVDRRTLEDP----------EEY 409 (591)
T ss_pred c--ccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhh---hHHHHHHHHhcch----------hhc
Confidence 3 379999999999999999999999999999999999999997221111 1111222222111 122
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCC
Q 002336 853 KIESIWRIAEVAIQCVEQRGFSRPK 877 (935)
Q Consensus 853 ~~~~~~~l~~li~~Cl~~dP~~RPs 877 (935)
+..-.++..++.+..|+.||++|--
T Consensus 410 ~~kFS~eakslc~~LL~Kdp~~RLG 434 (591)
T KOG0986|consen 410 SDKFSEEAKSLCEGLLTKDPEKRLG 434 (591)
T ss_pred ccccCHHHHHHHHHHHccCHHHhcc
Confidence 3333346678888888999998864
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=292.71 Aligned_cols=260 Identities=21% Similarity=0.257 Sum_probs=189.7
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcchhhhHHHHHHHHHHHhcCCCcccccceeeecc-----------
Q 002336 614 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE----------- 681 (935)
Q Consensus 614 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~----------- 681 (935)
.|.+.+.||+|+||.||+|... +|+.||+|++........+.+.+|++++++++||||+++++.+...
T Consensus 6 ~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~ 85 (342)
T cd07854 6 RYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSL 85 (342)
T ss_pred ceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccccc
Confidence 3556789999999999999875 6899999998765555567789999999999999999999876543
Q ss_pred ---ceEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCcccc-CCCcEEEe
Q 002336 682 ---HQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD-INMRAKVS 757 (935)
Q Consensus 682 ---~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld-~~~~vkL~ 757 (935)
...++||||++ ++|.+.+. ...+++..+..++.|+++||.|||+ .+++||||||+||+++ +++.+||+
T Consensus 86 ~~~~~~~lv~e~~~-~~L~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~---~givH~dikp~Nili~~~~~~~kl~ 157 (342)
T cd07854 86 TELNSVYIVQEYME-TDLANVLE----QGPLSEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANVFINTEDLVLKIG 157 (342)
T ss_pred cccceEEEEeeccc-ccHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCCceEEEC
Confidence 35789999997 58988875 3458899999999999999999997 8999999999999997 45678999
Q ss_pred eccccccccccccce--eecccCCccccCCCCCCC-CCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHh
Q 002336 758 DFGLSRQAEEDLTHI--SSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSM 834 (935)
Q Consensus 758 DFGla~~~~~~~~~~--~~~~~gt~~y~APE~l~~-~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~ 834 (935)
|||+++......... .....++..|+|||.+.. ..++.++|||||||++|+|++|+.||......... .......
T Consensus 158 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~--~~~~~~~ 235 (342)
T cd07854 158 DFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQM--QLILESV 235 (342)
T ss_pred CcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHHhc
Confidence 999987653322111 122347889999997644 56788999999999999999999999743321110 0000000
Q ss_pred ----------hhcCCeeecccccccCCC-----CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 835 ----------IKKGDVISIVDPVLIGNV-----KIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 835 ----------i~~~~~~~~~d~~l~~~~-----~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
.................. .......+.+++.+||+.+|++||++.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 236 PVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred CCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 000000000000000000 0112246789999999999999999999974
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-30 Score=288.64 Aligned_cols=261 Identities=22% Similarity=0.288 Sum_probs=189.1
Q ss_pred HhhcccccccccEEEEEEEEC-C--CcEEEEEEccCcc--hhhhHHHHHHHHHHHhc-CCCcccccceeeec----cceE
Q 002336 615 NNFCKKIGKGSFGSVYYGKMK-D--GKEVAVKIMADSC--SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEE----EHQR 684 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~-~--g~~vAvK~~~~~~--~~~~~~~~~E~~iL~~L-~HpnIv~l~g~~~~----~~~~ 684 (935)
+++.+.||+|+||.||++... . ++.+|+|++.... ....+.+.+|+++++++ +||||+++++.+.. ....
T Consensus 2 y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 81 (332)
T cd07857 2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNEL 81 (332)
T ss_pred ceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcE
Confidence 456788999999999999876 3 7789999986432 22345788899999999 59999999987532 2456
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccc
Q 002336 685 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 764 (935)
Q Consensus 685 ~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~ 764 (935)
++++|++. ++|.+.+. ....+++..+..++.|++.||+|||+ .+++||||||+||++++++.+||+|||+++.
T Consensus 82 ~~~~e~~~-~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~---~givH~dlkp~Nili~~~~~~kl~Dfg~a~~ 154 (332)
T cd07857 82 YLYEELME-ADLHQIIR---SGQPLTDAHFQSFIYQILCGLKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGLARG 154 (332)
T ss_pred EEEEeccc-CCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHeEEcCCCCEEeCcCCCcee
Confidence 88888885 68988886 34578999999999999999999997 8999999999999999999999999999976
Q ss_pred ccccccc---eeecccCCccccCCCCCCC-CCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhH-H--------HHH
Q 002336 765 AEEDLTH---ISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNI-V--------HWA 831 (935)
Q Consensus 765 ~~~~~~~---~~~~~~gt~~y~APE~l~~-~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l-~--------~~~ 831 (935)
....... ......|+..|+|||.+.+ ..++.++||||+|+++++|++|+.||...+....... . ++.
T Consensus 155 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 234 (332)
T cd07857 155 FSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETL 234 (332)
T ss_pred cccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 5432211 1122358899999998755 5688999999999999999999999975432111000 0 000
Q ss_pred HHhhhcC------CeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 832 RSMIKKG------DVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 832 ~~~i~~~------~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
....... .....-...+. .........+.+++.+|++.+|++||+++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 235 SRIGSPKAQNYIRSLPNIPKKPFE-SIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred HhhhhhhHHHHHHhccccCCcchH-hhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0000000 00000000000 000111346889999999999999999999864
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-30 Score=290.09 Aligned_cols=264 Identities=23% Similarity=0.340 Sum_probs=191.9
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc--hhhhHHHHHHHHHHHhcCCCcccccceeeecc------ceEE
Q 002336 615 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE------HQRI 685 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~------~~~~ 685 (935)
+...+.||+|+||.||+|... +|+.||+|++.... ......+.+|+.+++.++||||+++++++... ...+
T Consensus 17 y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~ 96 (342)
T cd07879 17 YTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFY 96 (342)
T ss_pred eEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceEE
Confidence 445688999999999999865 68999999986532 22235688999999999999999999988653 3468
Q ss_pred EEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccc
Q 002336 686 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 765 (935)
Q Consensus 686 lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~ 765 (935)
+|+||+. .+|.+.+. ..+++..+..++.|+++||+|||+ .+++||||||+||+++.++.+||+|||+++..
T Consensus 97 lv~e~~~-~~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~ 167 (342)
T cd07879 97 LVMPYMQ-TDLQKIMG-----HPLSEDKVQYLVYQMLCGLKYIHS---AGIIHRDLKPGNLAVNEDCELKILDFGLARHA 167 (342)
T ss_pred EEecccc-cCHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCCCCcCC
Confidence 9999996 47776542 358899999999999999999998 89999999999999999999999999998764
Q ss_pred cccccceeecccCCccccCCCCCCC-CCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHH--------Hhhh
Q 002336 766 EEDLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWAR--------SMIK 836 (935)
Q Consensus 766 ~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~--------~~i~ 836 (935)
.... ....++..|+|||.+.+ ..++.++||||||+++|||++|+.||...+............ ....
T Consensus 168 ~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (342)
T cd07879 168 DAEM----TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLE 243 (342)
T ss_pred CCCC----CCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhc
Confidence 3221 22346888999998866 468899999999999999999999997443211110000000 0000
Q ss_pred cCCeeeccc--cccc-CCC---CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--Hhhhhhh
Q 002336 837 KGDVISIVD--PVLI-GNV---KIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA--IQDSIKI 891 (935)
Q Consensus 837 ~~~~~~~~d--~~l~-~~~---~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~--L~~~~~~ 891 (935)
.......+. +... ... .+.....+.+++.+||+.+|++||+++|++.. ++.....
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~ 306 (342)
T cd07879 244 DKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDA 306 (342)
T ss_pred ccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcccc
Confidence 000000000 0000 000 01122357899999999999999999999854 7666543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-29 Score=283.66 Aligned_cols=258 Identities=22% Similarity=0.324 Sum_probs=191.8
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc--hhhhHHHHHHHHHHHhcCCCcccccceeeec-cceEEEEEE
Q 002336 614 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEE-EHQRILVYE 689 (935)
Q Consensus 614 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~-~~~~~lV~E 689 (935)
.|.+.+.||+|+||.||++... +++.||+|++.... ....+.+.+|+++++.++||||+++++++.. ....++++|
T Consensus 11 ~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e 90 (328)
T cd07856 11 RYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTE 90 (328)
T ss_pred ceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEee
Confidence 3556789999999999999865 78999999875432 2234678899999999999999999998865 567889999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccc
Q 002336 690 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 769 (935)
Q Consensus 690 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~ 769 (935)
|+ +++|.+++. ..++++..+..++.|+++||+|||+ ++++||||+|+||++++++.+||+|||++.......
T Consensus 91 ~~-~~~L~~~~~----~~~~~~~~~~~~~~ql~~aL~~LH~---~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~~ 162 (328)
T cd07856 91 LL-GTDLHRLLT----SRPLEKQFIQYFLYQILRGLKYVHS---AGVVHRDLKPSNILINENCDLKICDFGLARIQDPQM 162 (328)
T ss_pred hh-ccCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEeECCCCCEEeCccccccccCCCc
Confidence 98 568988876 3457888888999999999999998 899999999999999999999999999987543221
Q ss_pred cceeecccCCccccCCCCCCC-CCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchh-HH--------HHHHHhhhcCC
Q 002336 770 THISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELN-IV--------HWARSMIKKGD 839 (935)
Q Consensus 770 ~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~-l~--------~~~~~~i~~~~ 839 (935)
....++..|+|||.+.+ ..++.++||||||+++++|++|+.||.......... +. +|...... +.
T Consensus 163 ----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 237 (328)
T cd07856 163 ----TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICS-EN 237 (328)
T ss_pred ----CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccc-hh
Confidence 22346788999998765 578999999999999999999999997443211110 11 11111000 00
Q ss_pred eeecccc-cccCCCCH-----HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002336 840 VISIVDP-VLIGNVKI-----ESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 884 (935)
Q Consensus 840 ~~~~~d~-~l~~~~~~-----~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~ 884 (935)
..+.+.. ......+. .....+.+++.+|++.+|++||++++++..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 238 TLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred hHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000000 00001111 123478899999999999999999998653
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.4e-31 Score=267.01 Aligned_cols=251 Identities=25% Similarity=0.347 Sum_probs=194.3
Q ss_pred ccccccccEEEEEEEEC-CCcEEEEEEccCcch-hhhHHHHHHHHHHHhc-CCCcccccceeeeccceEEEEEEecCCCC
Q 002336 619 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS-HRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEYMHNGT 695 (935)
Q Consensus 619 ~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~-~~~~~~~~E~~iL~~L-~HpnIv~l~g~~~~~~~~~lV~E~~~~gs 695 (935)
..||.|.||+|++-.++ .|+..|||+++.... ...++++.|.+...+- +.||||+++|.+-.++..|+.||.|. .|
T Consensus 70 g~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd-~S 148 (361)
T KOG1006|consen 70 GEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMD-IS 148 (361)
T ss_pred HHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHh-hh
Confidence 46999999999999886 699999999987654 4567788888876554 79999999999999999999999994 56
Q ss_pred HHHHhccC--CCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccccccccee
Q 002336 696 LRDRLHGS--VNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 773 (935)
Q Consensus 696 L~~~L~~~--~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~~~ 773 (935)
|..+-..- .....+++...-+|......||.||.+ ...|+|||+||+|||++..|.+||||||.+-...+... .
T Consensus 149 lDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~SiA--k 224 (361)
T KOG1006|consen 149 LDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSIA--K 224 (361)
T ss_pred HHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecCCCEeeecccchHhHHHHHH--h
Confidence 65433211 135568888888999999999999998 58999999999999999999999999999876654322 2
Q ss_pred ecccCCccccCCCCCCC--CCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccCC
Q 002336 774 SVARGTVGYLDPEYYGN--QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 851 (935)
Q Consensus 774 ~~~~gt~~y~APE~l~~--~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~~ 851 (935)
+...|...|||||.+.. ..|+.++||||+|++|+|+.||+.|+...+. ..+.+.+.. .|+...+..+.
T Consensus 225 T~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s-----vfeql~~Vv-~gdpp~l~~~~---- 294 (361)
T KOG1006|consen 225 TVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS-----VFEQLCQVV-IGDPPILLFDK---- 294 (361)
T ss_pred hhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH-----HHHHHHHHH-cCCCCeecCcc----
Confidence 33458889999999854 3588999999999999999999999973322 223333333 34433332211
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002336 852 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 884 (935)
Q Consensus 852 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~ 884 (935)
...+....+...+.-|+..|-..||...++.++
T Consensus 295 ~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 295 ECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred cccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 112334478899999999999999999998754
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-30 Score=265.86 Aligned_cols=205 Identities=26% Similarity=0.374 Sum_probs=170.2
Q ss_pred HHHhhcccccccccEEEEEEEECC-----CcEEEEEEccCcchh--hhHHHHHHHHHHHhcCCCcccccceeeec-cceE
Q 002336 613 ATNNFCKKIGKGSFGSVYYGKMKD-----GKEVAVKIMADSCSH--RTQQFVTEVALLSRIHHRNLVPLIGYCEE-EHQR 684 (935)
Q Consensus 613 ~~~~~~~~LG~G~fG~Vy~~~~~~-----g~~vAvK~~~~~~~~--~~~~~~~E~~iL~~L~HpnIv~l~g~~~~-~~~~ 684 (935)
..|+.+..||+|.||.||+|.-++ .+.+|+|+++..... -.....+|+.+++.++|||++.+..++-. +...
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v 103 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV 103 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence 346678899999999999996432 347899999765322 23567899999999999999999998866 7788
Q ss_pred EEEEEecCCCCHHHHhccCC--CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCC----CcEEEee
Q 002336 685 ILVYEYMHNGTLRDRLHGSV--NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN----MRAKVSD 758 (935)
Q Consensus 685 ~lV~E~~~~gsL~~~L~~~~--~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~----~~vkL~D 758 (935)
++++||.+. +|.++++-.. ..+.++...+..|+.||+.|+.|||+ +=|+||||||.|||+..+ |.+||+|
T Consensus 104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~---NWvlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHS---NWVLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhh---hheeeccCCcceEEEeccCCccCeeEeec
Confidence 999999976 7877775433 44679999999999999999999998 789999999999999877 9999999
Q ss_pred ccccccccccccce--eecccCCccccCCCCCCC-CCCCchhHHHHHHHHHHHHHhCCCCCCccCc
Q 002336 759 FGLSRQAEEDLTHI--SSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDF 821 (935)
Q Consensus 759 FGla~~~~~~~~~~--~~~~~gt~~y~APE~l~~-~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~ 821 (935)
+|+++.+.+..... .....-|..|+|||++.+ ..|+.+.|||+.|||+.||+|-++-|.+...
T Consensus 180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~ 245 (438)
T KOG0666|consen 180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREE 245 (438)
T ss_pred ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhh
Confidence 99999887654332 334567999999998766 6899999999999999999999988875543
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-29 Score=283.62 Aligned_cols=257 Identities=24% Similarity=0.349 Sum_probs=190.6
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc--hhhhHHHHHHHHHHHhcCCCcccccceeeeccc------eE
Q 002336 614 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH------QR 684 (935)
Q Consensus 614 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~------~~ 684 (935)
.|.+.+.||+|+||.||++... +++.||||++.... ......+.+|++++++++||||+++++++.... ..
T Consensus 16 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 95 (343)
T cd07880 16 RYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDF 95 (343)
T ss_pred ceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceE
Confidence 3556789999999999999765 78999999985432 223456889999999999999999999886543 45
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccc
Q 002336 685 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 764 (935)
Q Consensus 685 ~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~ 764 (935)
++||||+ +++|.+++. ...+++..+..++.|+++||+|||+ .+|+||||||+||+++.++.+||+|||++..
T Consensus 96 ~lv~e~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~al~~LH~---~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~ 167 (343)
T cd07880 96 YLVMPFM-GTDLGKLMK----HEKLSEDRIQFLVYQMLKGLKYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQ 167 (343)
T ss_pred EEEEecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccccc
Confidence 8999998 779988875 3468999999999999999999997 8999999999999999999999999999876
Q ss_pred ccccccceeecccCCccccCCCCCCC-CCCCchhHHHHHHHHHHHHHhCCCCCCccCcccch-hH--------HHHHHHh
Q 002336 765 AEEDLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAEL-NI--------VHWARSM 834 (935)
Q Consensus 765 ~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~-~l--------~~~~~~~ 834 (935)
..... ....+++.|+|||.+.+ ..++.++|+||+|+++++|++|+.||...+..... .. ..+...
T Consensus 168 ~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~- 242 (343)
T cd07880 168 TDSEM----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQK- 242 (343)
T ss_pred cccCc----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHh-
Confidence 54322 22346889999998765 46889999999999999999999999743321100 00 000000
Q ss_pred hhcCCeeeccc--ccccC----CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 835 IKKGDVISIVD--PVLIG----NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 835 i~~~~~~~~~d--~~l~~----~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
+.......... +.... .........+.+++.+|+..+|++||++.++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 243 LQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred hcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00000000000 00000 000112235789999999999999999999984
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-29 Score=284.58 Aligned_cols=254 Identities=21% Similarity=0.306 Sum_probs=191.3
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc--hhhhHHHHHHHHHHHhcCCCcccccceeeeccce------EE
Q 002336 615 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQ------RI 685 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~------~~ 685 (935)
|.+.+.||+|++|.||+|.+. +++.||+|++.... ....+.+.+|+.++++++|||++++++++...+. .+
T Consensus 17 y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 96 (343)
T cd07851 17 YQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVY 96 (343)
T ss_pred eEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccEE
Confidence 556789999999999999886 58899999986532 2334667889999999999999999998765554 89
Q ss_pred EEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccc
Q 002336 686 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 765 (935)
Q Consensus 686 lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~ 765 (935)
+|+||+ +++|.+++.. ..+++..+..++.|+++||.|||+ .+|+||||||+||++++++.+||+|||++...
T Consensus 97 lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~ 168 (343)
T cd07851 97 LVTHLM-GADLNNIVKC----QKLSDDHIQFLVYQILRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLARHT 168 (343)
T ss_pred EEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEccccccccc
Confidence 999998 6799998863 468999999999999999999998 89999999999999999999999999998765
Q ss_pred cccccceeecccCCccccCCCCCCC-CCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhh--------
Q 002336 766 EEDLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIK-------- 836 (935)
Q Consensus 766 ~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~-------- 836 (935)
... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||....... ..........
T Consensus 169 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~---~~~~i~~~~~~~~~~~~~ 241 (343)
T cd07851 169 DDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHID---QLKRIMNLVGTPDEELLQ 241 (343)
T ss_pred ccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHhcCCCCHHHHh
Confidence 432 122357888999998754 467899999999999999999999997433211 1111100000
Q ss_pred ---cCCeeecccccc---cCCC---CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 837 ---KGDVISIVDPVL---IGNV---KIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 837 ---~~~~~~~~d~~l---~~~~---~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
.......+.... ...+ .......+.+++.+|+..+|++|||+.||++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 242 KISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred hccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 000000000000 0000 0011347889999999999999999999875
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-29 Score=286.45 Aligned_cols=255 Identities=22% Similarity=0.307 Sum_probs=188.4
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc--hhhhHHHHHHHHHHHhcCCCcccccceeeecc------ceEE
Q 002336 615 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE------HQRI 685 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~------~~~~ 685 (935)
|.+.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++... ...+
T Consensus 19 y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 98 (345)
T cd07877 19 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY 98 (345)
T ss_pred eEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccccEE
Confidence 445778999999999999764 68999999986532 22346688899999999999999999987542 3467
Q ss_pred EEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccc
Q 002336 686 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 765 (935)
Q Consensus 686 lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~ 765 (935)
++++++ +++|.+++.. ..+++..+..++.|+++||+|||+ .+|+||||||+||++++++.+||+|||++...
T Consensus 99 lv~~~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~ 170 (345)
T cd07877 99 LVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHT 170 (345)
T ss_pred EEehhc-ccCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEcCCCCEEEecccccccc
Confidence 888876 7899888762 358999999999999999999998 89999999999999999999999999998764
Q ss_pred cccccceeecccCCccccCCCCCCC-CCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHh----------
Q 002336 766 EEDLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSM---------- 834 (935)
Q Consensus 766 ~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~---------- 834 (935)
... .....++..|+|||.+.+ ..++.++||||||++++||++|+.||...+.... +....+..
T Consensus 171 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~ 244 (345)
T cd07877 171 DDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ--LKLILRLVGTPGAELLKK 244 (345)
T ss_pred ccc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCCCHHHHhh
Confidence 332 223457889999998765 5678999999999999999999999964322111 11000000
Q ss_pred hhcCC-------eeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002336 835 IKKGD-------VISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 884 (935)
Q Consensus 835 i~~~~-------~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~ 884 (935)
+.... .......... .........+.+++.+|++.+|.+||++.+++..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 245 ISSESARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred cccHhHHHHHHHhcccCCcchh-hhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 00000 0000000000 0000112357899999999999999999998754
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-29 Score=267.91 Aligned_cols=220 Identities=22% Similarity=0.207 Sum_probs=175.1
Q ss_pred cccEEEEEEEEC-CCcEEEEEEccCcchhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEecCCCCHHHHhcc
Q 002336 624 GSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHG 702 (935)
Q Consensus 624 G~fG~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL~~~L~~ 702 (935)
|.+|.||++... +++.+|+|++.... .+.+|...+....||||+++++++.+.+..++||||+++|+|.+.+..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 899999999875 68999999986542 233455555566799999999999999999999999999999998864
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccccceeecccCCccc
Q 002336 703 SVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGY 782 (935)
Q Consensus 703 ~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y 782 (935)
...+++..+..++.|+++||.|||+ ++++||||||+||+++.++.++++|||.+....... ....++..|
T Consensus 79 ---~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~----~~~~~~~~y 148 (237)
T cd05576 79 ---FLNIPEECVKRWAAEMVVALDALHR---EGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC----DGEAVENMY 148 (237)
T ss_pred ---hcCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCCEEEecccchhcccccc----ccCCcCccc
Confidence 3458999999999999999999997 899999999999999999999999999876554321 123356789
Q ss_pred cCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccCCCCHHHHHHHHH
Q 002336 783 LDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAE 862 (935)
Q Consensus 783 ~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~~~~~~~~~~l~~ 862 (935)
+|||.+....++.++||||+|+++|||++|+.|+...... +.. ..... .+......+.+
T Consensus 149 ~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~------------~~~-----~~~~~----~~~~~~~~~~~ 207 (237)
T cd05576 149 CAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG------------INT-----HTTLN----IPEWVSEEARS 207 (237)
T ss_pred cCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh------------ccc-----ccccC----CcccCCHHHHH
Confidence 9999998888899999999999999999999887521110 000 00000 11112246789
Q ss_pred HHHHccccCCCCCCCHH
Q 002336 863 VAIQCVEQRGFSRPKMQ 879 (935)
Q Consensus 863 li~~Cl~~dP~~RPs~~ 879 (935)
++.+|++.||++||++.
T Consensus 208 li~~~l~~dp~~R~~~~ 224 (237)
T cd05576 208 LLQQLLQFNPTERLGAG 224 (237)
T ss_pred HHHHHccCCHHHhcCCC
Confidence 99999999999999973
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.9e-30 Score=264.13 Aligned_cols=246 Identities=25% Similarity=0.339 Sum_probs=197.9
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcch---hhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEE
Q 002336 614 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 689 (935)
Q Consensus 614 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~---~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E 689 (935)
..+|.++||+|.||.|.+++-+ .++.+|+|++++... .....-..|-++|+.-+||.+..+-..|...+++|+|||
T Consensus 169 dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMe 248 (516)
T KOG0690|consen 169 DFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVME 248 (516)
T ss_pred hhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEE
Confidence 3467899999999999999866 799999999987533 233456679999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccc
Q 002336 690 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 769 (935)
Q Consensus 690 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~ 769 (935)
|..||.|.-+|. ....+++....-+..+|..||.|||+ ++||.||||.+|.|+|.+|++||+|||+++.--...
T Consensus 249 yanGGeLf~HLs---rer~FsE~RtRFYGaEIvsAL~YLHs---~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g 322 (516)
T KOG0690|consen 249 YANGGELFFHLS---RERVFSEDRTRFYGAEIVSALGYLHS---RNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYG 322 (516)
T ss_pred EccCceEeeehh---hhhcccchhhhhhhHHHHHHhhhhhh---CCeeeeechhhhheeccCCceEeeecccchhccccc
Confidence 999999998887 35678888888899999999999998 999999999999999999999999999998633222
Q ss_pred cceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeeccccccc
Q 002336 770 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 849 (935)
Q Consensus 770 ~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~ 849 (935)
...+..+|||.|+|||++....|+.+.|-|.+||++|||++|+.||-..+.+.-..++ --+ |-.+
T Consensus 323 -~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLI-------l~e------d~kF- 387 (516)
T KOG0690|consen 323 -DTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELI-------LME------DLKF- 387 (516)
T ss_pred -ceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHH-------Hhh------hccC-
Confidence 2245578999999999999999999999999999999999999999744433222111 111 1111
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 002336 850 GNVKIESIWRIAEVAIQCVEQRGFSRP-----KMQEIVL 883 (935)
Q Consensus 850 ~~~~~~~~~~l~~li~~Cl~~dP~~RP-----s~~ev~~ 883 (935)
|.....+...++...|..||.+|- +++||.+
T Consensus 388 ---Pr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~ 423 (516)
T KOG0690|consen 388 ---PRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMR 423 (516)
T ss_pred ---CccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHh
Confidence 111222456788899999999996 4555544
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.8e-30 Score=264.03 Aligned_cols=242 Identities=24% Similarity=0.351 Sum_probs=193.6
Q ss_pred cccccccccEEEEEEEEC-CCcEEEEEEccCcchhhhHHHHHHHHHHHhc-CCCcccccceeeec----cceEEEEEEec
Q 002336 618 CKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEE----EHQRILVYEYM 691 (935)
Q Consensus 618 ~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L-~HpnIv~l~g~~~~----~~~~~lV~E~~ 691 (935)
.++||-|-.|.|-.+.++ +++.+|+|++... ....+|++..-.. .|||||+++++++. ...+.+|||.|
T Consensus 67 ~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~m 141 (400)
T KOG0604|consen 67 WQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECM 141 (400)
T ss_pred hhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeecc
Confidence 468999999999999876 6899999998753 3455777775554 59999999998754 44567999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCcccc---CCCcEEEeecccccccccc
Q 002336 692 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD---INMRAKVSDFGLSRQAEED 768 (935)
Q Consensus 692 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld---~~~~vkL~DFGla~~~~~~ 768 (935)
+||.|.+.++.. ....+++.++..|+.||+.|+.|||+ .+|.||||||+|+|.. .+..+||+|||+|+.....
T Consensus 142 eGGeLfsriq~~-g~~afTErea~eI~~qI~~Av~~lH~---~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~ 217 (400)
T KOG0604|consen 142 EGGELFSRIQDR-GDQAFTEREASEIMKQIGLAVRYLHS---MNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEP 217 (400)
T ss_pred cchHHHHHHHHc-ccccchHHHHHHHHHHHHHHHHHHHh---cchhhccCChhheeeecCCCCcceEecccccccccCCC
Confidence 999999999865 45679999999999999999999998 9999999999999996 4566999999999976543
Q ss_pred ccceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccccc
Q 002336 769 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 848 (935)
Q Consensus 769 ~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l 848 (935)
.. ....+-|+.|.|||++....|+...|+||+||++|-|+.|.+||=. ..+ ..+.--++..|+.|..
T Consensus 218 ~~--L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS-~hg--~aispgMk~rI~~gqy-------- 284 (400)
T KOG0604|consen 218 GD--LMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYS-NHG--LAISPGMKRRIRTGQY-------- 284 (400)
T ss_pred cc--ccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccc-cCC--ccCChhHHhHhhccCc--------
Confidence 22 2334579999999999999999999999999999999999999952 111 2222234445554433
Q ss_pred cCCCCH----HHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 849 IGNVKI----ESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 849 ~~~~~~----~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
.++. ...+...++|++.|..+|.+|-|+.|+..
T Consensus 285 --~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 285 --EFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred --cCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence 2222 23456789999999999999999999864
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-29 Score=298.76 Aligned_cols=245 Identities=28% Similarity=0.401 Sum_probs=183.1
Q ss_pred cccccccccEEEEEEEEC-CCcEEEEEEccCcc-hhhhHHHHHHHHHHHhcCCCcccccceeeec---------------
Q 002336 618 CKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEE--------------- 680 (935)
Q Consensus 618 ~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~-~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~--------------- 680 (935)
.+.||+||||.||+++.+ ||+.+|||++.-.. ......+.+|+..|.+|+|||||+++..+.+
T Consensus 484 L~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei~~~~~ 563 (1351)
T KOG1035|consen 484 LELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEIVASDS 563 (1351)
T ss_pred HHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccccccch
Confidence 467999999999999987 89999999986543 3344678999999999999999998621100
Q ss_pred --------------------------------------------------------------------------------
Q 002336 681 -------------------------------------------------------------------------------- 680 (935)
Q Consensus 681 -------------------------------------------------------------------------------- 680 (935)
T Consensus 564 ~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~~~~~d 643 (1351)
T KOG1035|consen 564 ESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEGSVILD 643 (1351)
T ss_pred hhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCCccccC
Confidence
Q ss_pred ----------------c--------ceEEEEEEecCCCCHHHHhccCCCCCCC-CHHHHHHHHHHHHHHhHHhhhcCCCc
Q 002336 681 ----------------E--------HQRILVYEYMHNGTLRDRLHGSVNQKPL-DWLTRLQIAHDAAKGLEYLHTGCNPG 735 (935)
Q Consensus 681 ----------------~--------~~~~lV~E~~~~gsL~~~L~~~~~~~~l-~~~~~~~i~~qia~gL~yLHs~~~~~ 735 (935)
+ ..+|+-||||+...|+++++... .. .....++++.+|++||+|+|+ .|
T Consensus 644 ~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~---~~~~~d~~wrLFreIlEGLaYIH~---~g 717 (1351)
T KOG1035|consen 644 DTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNH---FNSQRDEAWRLFREILEGLAYIHD---QG 717 (1351)
T ss_pred cchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcc---cchhhHHHHHHHHHHHHHHHHHHh---Cc
Confidence 0 12578899999988888887432 11 467789999999999999997 89
Q ss_pred eEecCCCCCCccccCCCcEEEeecccccccc------cc-----------ccceeecccCCccccCCCCCCCC---CCCc
Q 002336 736 IIHRDVKSSNILLDINMRAKVSDFGLSRQAE------ED-----------LTHISSVARGTVGYLDPEYYGNQ---QLTE 795 (935)
Q Consensus 736 ivH~DLkp~NILld~~~~vkL~DFGla~~~~------~~-----------~~~~~~~~~gt~~y~APE~l~~~---~~s~ 795 (935)
||||||||.||++|+++.|||+|||++.... +. .....+...||.-|+|||++.+. .|+.
T Consensus 718 iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~ 797 (1351)
T KOG1035|consen 718 IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNS 797 (1351)
T ss_pred eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccc
Confidence 9999999999999999999999999998621 00 01112345699999999998654 5999
Q ss_pred hhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCC
Q 002336 796 KSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSR 875 (935)
Q Consensus 796 ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~R 875 (935)
|+|+||+|||++||+. ||. ..++ . ..+...++.+.+..- .++.......=..+|++++++||.+|
T Consensus 798 KiDmYSLGIVlFEM~y---PF~-TsME-R----a~iL~~LR~g~iP~~------~~f~~~~~~~e~slI~~Ll~hdP~kR 862 (1351)
T KOG1035|consen 798 KIDMYSLGIVLFEMLY---PFG-TSME-R----ASILTNLRKGSIPEP------ADFFDPEHPEEASLIRWLLSHDPSKR 862 (1351)
T ss_pred hhhhHHHHHHHHHHhc---cCC-chHH-H----HHHHHhcccCCCCCC------cccccccchHHHHHHHHHhcCCCccC
Confidence 9999999999999984 454 1111 1 112223344444332 11222233345689999999999999
Q ss_pred CCHHHHHH
Q 002336 876 PKMQEIVL 883 (935)
Q Consensus 876 Ps~~ev~~ 883 (935)
||+.|++.
T Consensus 863 PtA~eLL~ 870 (1351)
T KOG1035|consen 863 PTATELLN 870 (1351)
T ss_pred CCHHHHhh
Confidence 99999874
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-30 Score=280.30 Aligned_cols=243 Identities=26% Similarity=0.385 Sum_probs=194.3
Q ss_pred cccccccccEEEEEEEEC-CCcEEEEEEccCcc--hhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEecCCC
Q 002336 618 CKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNG 694 (935)
Q Consensus 618 ~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~~~g 694 (935)
.+.||.|-||+||-|+++ +|+.||||++.+.. ..+..++.+|+.||++++||.||.+..-|+..+..++|||.+.|.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 688999999999999875 79999999986532 234467899999999999999999999999999999999999765
Q ss_pred CHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccC---CCcEEEeeccccccccccccc
Q 002336 695 TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI---NMRAKVSDFGLSRQAEEDLTH 771 (935)
Q Consensus 695 sL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~---~~~vkL~DFGla~~~~~~~~~ 771 (935)
=|+.+|.. ..+.+++....-++.||+.||+|||. ++|+|+||||+|||+.+ --++||||||+|+..++..-
T Consensus 649 MLEMILSs--EkgRL~er~TkFlvtQIL~ALr~LH~---knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF- 722 (888)
T KOG4236|consen 649 MLEMILSS--EKGRLPERITKFLVTQILVALRYLHF---KNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF- 722 (888)
T ss_pred HHHHHHHh--hcccchHHHHHHHHHHHHHHHHHhhh---cceeeccCCchheeeccCCCCCceeeccccceeecchhhh-
Confidence 56666653 45678988889999999999999997 99999999999999964 34699999999999876432
Q ss_pred eeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccCC
Q 002336 772 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 851 (935)
Q Consensus 772 ~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~~ 851 (935)
.....||+.|+|||+++++.|...-|+||.|||+|.-++|..||..+.. +.++|++..+ +..+.-..
T Consensus 723 -RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd---------IndQIQNAaF--MyPp~PW~- 789 (888)
T KOG4236|consen 723 -RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDED---------INDQIQNAAF--MYPPNPWS- 789 (888)
T ss_pred -hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccc---------hhHHhhcccc--ccCCCchh-
Confidence 3456799999999999999999999999999999999999999973221 1222332211 11111111
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 002336 852 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIV 882 (935)
Q Consensus 852 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~ 882 (935)
+.....+++|...|+..-++|-+...-+
T Consensus 790 ---eis~~AidlIn~LLqVkm~kRysvdk~l 817 (888)
T KOG4236|consen 790 ---EISPEAIDLINNLLQVKMRKRYSVDKSL 817 (888)
T ss_pred ---hcCHHHHHHHHHHHHHHHHHhcchHhhc
Confidence 2223567888888888888888877654
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-29 Score=284.81 Aligned_cols=238 Identities=26% Similarity=0.360 Sum_probs=193.2
Q ss_pred HHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcchhhhHHHHHHHHHHHhc-CCCcccccceeeeccceEEEEEEe
Q 002336 613 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEY 690 (935)
Q Consensus 613 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L-~HpnIv~l~g~~~~~~~~~lV~E~ 690 (935)
..|.+...+|.|+|+.|-++.+. +++..++|++... ..+-.+|+.++... +||||+++.+.+.+..+.++|||.
T Consensus 322 ~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~----~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~ 397 (612)
T KOG0603|consen 322 ESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR----ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMEL 397 (612)
T ss_pred hhhccccccCCCCccceeeeeccccccchhheecccc----ccccccccchhhhhcCCCcceeecceecCCceeeeeehh
Confidence 45667778999999999999875 6888999998754 23344677777666 699999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccc-cCCCcEEEeeccccccccccc
Q 002336 691 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL-DINMRAKVSDFGLSRQAEEDL 769 (935)
Q Consensus 691 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILl-d~~~~vkL~DFGla~~~~~~~ 769 (935)
+.++-+.+.+... +....++..|+.+|+.|+.|||+ +|++||||||+|||+ ++.++++|+|||.++.....
T Consensus 398 l~g~ell~ri~~~----~~~~~e~~~w~~~lv~Av~~LH~---~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~- 469 (612)
T KOG0603|consen 398 LDGGELLRRIRSK----PEFCSEASQWAAELVSAVDYLHE---QGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS- 469 (612)
T ss_pred ccccHHHHHHHhc----chhHHHHHHHHHHHHHHHHHHHh---cCeeecCCChhheeecCCCCcEEEEEechhhhCchh-
Confidence 9999887777632 22237788899999999999998 999999999999999 69999999999999877654
Q ss_pred cceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeeccccccc
Q 002336 770 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 849 (935)
Q Consensus 770 ~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~ 849 (935)
....+-|..|.|||++....+++++|+||||++||+|++|+.||.....+ .-+..++..+...
T Consensus 470 ---~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~------~ei~~~i~~~~~s-------- 532 (612)
T KOG0603|consen 470 ---CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG------IEIHTRIQMPKFS-------- 532 (612)
T ss_pred ---hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch------HHHHHhhcCCccc--------
Confidence 11223588999999999999999999999999999999999999844433 1233444444332
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 850 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 850 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
........+|+.+||+.||.+||+|.++..
T Consensus 533 ----~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 533 ----ECVSDEAKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred ----cccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence 222336789999999999999999999864
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=300.70 Aligned_cols=143 Identities=32% Similarity=0.463 Sum_probs=127.9
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc---hhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEe
Q 002336 615 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 690 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~ 690 (935)
|.+.+.||+|+||.||+|.+. +++.||||+++... ......+..|+.+++.++||||+++++.+......++||||
T Consensus 6 y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmEy 85 (669)
T cd05610 6 FVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVMEY 85 (669)
T ss_pred EEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEeC
Confidence 456789999999999999876 68999999986532 22346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccc
Q 002336 691 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 763 (935)
Q Consensus 691 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~ 763 (935)
+.+++|.+++.. ...+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++
T Consensus 86 ~~g~~L~~li~~---~~~l~~~~~~~i~~qil~aL~yLH~---~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 86 LIGGDVKSLLHI---YGYFDEEMAVKYISEVALALDYLHR---HGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred CCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999999873 3468889999999999999999998 899999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-28 Score=257.93 Aligned_cols=238 Identities=32% Similarity=0.442 Sum_probs=192.4
Q ss_pred ccEEEEEEEEC-CCcEEEEEEccCcchhh-hHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEecCCCCHHHHhcc
Q 002336 625 SFGSVYYGKMK-DGKEVAVKIMADSCSHR-TQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHG 702 (935)
Q Consensus 625 ~fG~Vy~~~~~-~g~~vAvK~~~~~~~~~-~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL~~~L~~ 702 (935)
+||.||+|.+. +|+.+++|++....... .+.+.+|++.+++++|+|++++++++......++++|++++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999987 48999999987654444 67899999999999999999999999998999999999999999999874
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccccceeecccCCccc
Q 002336 703 SVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGY 782 (935)
Q Consensus 703 ~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y 782 (935)
. ..+++..+..++.++++++.+||+ .+++|+||+|+||++++++.++|+|||.+....... ......++..|
T Consensus 81 ~---~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~ 152 (244)
T smart00220 81 R---GRLSEDEARFYARQILSALEYLHS---NGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPEY 152 (244)
T ss_pred c---cCCCHHHHHHHHHHHHHHHHHHHH---cCeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcCC
Confidence 2 338899999999999999999998 899999999999999999999999999988765432 22334578899
Q ss_pred cCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccCCCCHHHHHHHHH
Q 002336 783 LDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAE 862 (935)
Q Consensus 783 ~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~~~~~~~~~~l~~ 862 (935)
++||.+.....+.++|||++|+++++|++|..||.... ......++ +..+...... ........+.+
T Consensus 153 ~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~--~~~~~~~~----~~~~~~~~~~-------~~~~~~~~~~~ 219 (244)
T smart00220 153 MAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDD--QLLELFKK----IGKPKPPFPP-------PEWKISPEAKD 219 (244)
T ss_pred CCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--cHHHHHHH----HhccCCCCcc-------ccccCCHHHHH
Confidence 99999988888999999999999999999999996321 11112221 1111111000 00002347889
Q ss_pred HHHHccccCCCCCCCHHHHHH
Q 002336 863 VAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 863 li~~Cl~~dP~~RPs~~ev~~ 883 (935)
++.+|+..+|++||++.++++
T Consensus 220 ~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 220 LIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHccCCchhccCHHHHhh
Confidence 999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.5e-29 Score=286.47 Aligned_cols=251 Identities=24% Similarity=0.362 Sum_probs=204.0
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcchhhhHHHHHHHHHHHhc-CCCcccccceeee-----ccceEEE
Q 002336 614 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGYCE-----EEHQRIL 686 (935)
Q Consensus 614 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L-~HpnIv~l~g~~~-----~~~~~~l 686 (935)
+..|.+.||.|.+|.||+++.. +++.+|+|++.... ....+++.|.++|+.+ +|||++.++|++. .++.+||
T Consensus 20 ~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~-d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWL 98 (953)
T KOG0587|consen 20 IFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE-DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWL 98 (953)
T ss_pred ccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc-cccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEE
Confidence 3456889999999999999754 68889999876543 3456788999999988 6999999999874 3668999
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccc
Q 002336 687 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 766 (935)
Q Consensus 687 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~ 766 (935)
|||||.+||.-|+++... +..+.|..+..|+..++.||.|||. ..++|||||-.|||++.++.+||+|||.+....
T Consensus 99 VMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~---nkviHRDikG~NiLLT~e~~VKLvDFGvSaQld 174 (953)
T KOG0587|consen 99 VMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHN---NKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD 174 (953)
T ss_pred EeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhh---cceeeecccCceEEEeccCcEEEeeeeeeeeee
Confidence 999999999999999775 7789999999999999999999997 899999999999999999999999999998765
Q ss_pred ccccceeecccCCccccCCCCCC-----CCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCee
Q 002336 767 EDLTHISSVARGTVGYLDPEYYG-----NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVI 841 (935)
Q Consensus 767 ~~~~~~~~~~~gt~~y~APE~l~-----~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~ 841 (935)
... .......||+.|||||++. ...|+.++|+||+|++..||..|.+|+..... ...+-...
T Consensus 175 sT~-grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHP------mraLF~Ip------ 241 (953)
T KOG0587|consen 175 STV-GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHP------MRALFLIP------ 241 (953)
T ss_pred ccc-ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcch------hhhhccCC------
Confidence 432 2234456999999999874 34577899999999999999999999872211 11111111
Q ss_pred ecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002336 842 SIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 884 (935)
Q Consensus 842 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~ 884 (935)
-+|...-..+....+++.+.|..||..|.++||++.++++.
T Consensus 242 --RNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 242 --RNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred --CCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 12222223356677899999999999999999999998754
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-28 Score=235.37 Aligned_cols=259 Identities=20% Similarity=0.278 Sum_probs=198.2
Q ss_pred cccccccccEEEEEEEEC-CCcEEEEEEccCcch--hhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEecCCC
Q 002336 618 CKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNG 694 (935)
Q Consensus 618 ~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~--~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~~~g 694 (935)
-++||+|.||+||+|+.. .++.||+|.++-... .-.....+|+-+|+.++|+|||++++....+...-+|+|||. .
T Consensus 7 mekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~cd-q 85 (292)
T KOG0662|consen 7 MEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCD-Q 85 (292)
T ss_pred HHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHhh-H
Confidence 468999999999999865 578899999864322 223568899999999999999999999999999999999995 4
Q ss_pred CHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccccceee
Q 002336 695 TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISS 774 (935)
Q Consensus 695 sL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~ 774 (935)
+|..+... -.+.++......++.|+++||.++|+ +.+.|||+||.|.||+.+|.+||+|||+++-++-.....+.
T Consensus 86 dlkkyfds--lng~~d~~~~rsfmlqllrgl~fchs---hnvlhrdlkpqnllin~ngelkladfglarafgipvrcysa 160 (292)
T KOG0662|consen 86 DLKKYFDS--LNGDLDPEIVRSFMLQLLRGLGFCHS---HNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSA 160 (292)
T ss_pred HHHHHHHh--cCCcCCHHHHHHHHHHHHhhhhhhhh---hhhhhccCCcceEEeccCCcEEecccchhhhcCCceEeeec
Confidence 77777654 35678889999999999999999998 99999999999999999999999999999987655443332
Q ss_pred cccCCccccCCCCCCC-CCCCchhHHHHHHHHHHHHHh-CCCCCCccCcccchhHHHHHHHhhhcCCeeec---cccccc
Q 002336 775 VARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISI---VDPVLI 849 (935)
Q Consensus 775 ~~~gt~~y~APE~l~~-~~~s~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~---~d~~l~ 849 (935)
...|..|++|+++.+ .-|+...|+||-||++.|+.. |++-|.+.+..++..-+-|......+.....+ .|-...
T Consensus 161 -evvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~y 239 (292)
T KOG0662|consen 161 -EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPY 239 (292)
T ss_pred -eeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCccc
Confidence 346899999998866 568999999999999999988 66667665555544444444443433332222 221122
Q ss_pred CCCCHHHH---------HHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 850 GNVKIESI---------WRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 850 ~~~~~~~~---------~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
..++.... ..=.+++++.+.-+|.+|.++++.++
T Consensus 240 p~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 240 PIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred CCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 22222111 12357888888889999999998765
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4e-29 Score=294.52 Aligned_cols=201 Identities=30% Similarity=0.377 Sum_probs=180.4
Q ss_pred HHHHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc---hhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEE
Q 002336 611 EEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRIL 686 (935)
Q Consensus 611 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~l 686 (935)
....+.+.++||+|+||.|..++++ .++.+|+|++.++. .....-|.+|-.+|..-+.+-|+.++-.|.+..++|+
T Consensus 73 ~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYl 152 (1317)
T KOG0612|consen 73 KAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYL 152 (1317)
T ss_pred CHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEE
Confidence 4566778899999999999999987 57889999997743 2334678999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccc
Q 002336 687 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 766 (935)
Q Consensus 687 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~ 766 (935)
|||||+||+|-.++... ..+++..+..++..|.-||.-||+ .|+|||||||+|||||.+|++||+|||.+..+.
T Consensus 153 VMdY~pGGDlltLlSk~---~~~pE~~ArFY~aEiVlAldslH~---mgyVHRDiKPDNvLld~~GHikLADFGsClkm~ 226 (1317)
T KOG0612|consen 153 VMDYMPGGDLLTLLSKF---DRLPEDWARFYTAEIVLALDSLHS---MGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMD 226 (1317)
T ss_pred EEecccCchHHHHHhhc---CCChHHHHHHHHHHHHHHHHHHHh---ccceeccCCcceeEecccCcEeeccchhHHhcC
Confidence 99999999999999854 378999999999999999999998 999999999999999999999999999998887
Q ss_pred ccccceeecccCCccccCCCCCC----C-CCCCchhHHHHHHHHHHHHHhCCCCCC
Q 002336 767 EDLTHISSVARGTVGYLDPEYYG----N-QQLTEKSDVYSFGVVLLELISGKKPVS 817 (935)
Q Consensus 767 ~~~~~~~~~~~gt~~y~APE~l~----~-~~~s~ksDVwS~Gvil~eLltG~~Pf~ 817 (935)
.+..-.+....|||.|++||+++ + +.|+..+|-||+||++|||+.|..||-
T Consensus 227 ~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFY 282 (1317)
T KOG0612|consen 227 ADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFY 282 (1317)
T ss_pred CCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcch
Confidence 76666777788999999999884 3 679999999999999999999999996
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.4e-28 Score=287.92 Aligned_cols=258 Identities=20% Similarity=0.257 Sum_probs=167.0
Q ss_pred HHhhcccccccccEEEEEEEEC-C----CcEEEEEEccCcchhhhHHHHHHHHHHHhcCCCccccccee------eeccc
Q 002336 614 TNNFCKKIGKGSFGSVYYGKMK-D----GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY------CEEEH 682 (935)
Q Consensus 614 ~~~~~~~LG~G~fG~Vy~~~~~-~----g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~HpnIv~l~g~------~~~~~ 682 (935)
.+.+.+.||+|+||.||+|.+. + ++.||+|++...... +....| .+....+.++..++.. +....
T Consensus 133 ~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~~~ 208 (566)
T PLN03225 133 DFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSKKED 208 (566)
T ss_pred CeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccccCC
Confidence 4566789999999999999886 4 689999987643211 111111 1222223333332221 24566
Q ss_pred eEEEEEEecCCCCHHHHhccCCCC-----------------CCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCC
Q 002336 683 QRILVYEYMHNGTLRDRLHGSVNQ-----------------KPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSN 745 (935)
Q Consensus 683 ~~~lV~E~~~~gsL~~~L~~~~~~-----------------~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~N 745 (935)
..++||||+.+++|.+++...... .......+..++.|++.||+|||+ ++|+||||||+|
T Consensus 209 ~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~---~gIiHRDLKP~N 285 (566)
T PLN03225 209 EYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHS---TGIVHRDVKPQN 285 (566)
T ss_pred ceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHH---CCEEeCcCCHHH
Confidence 789999999999999988643110 011233456799999999999998 899999999999
Q ss_pred ccccC-CCcEEEeeccccccccccccceeecccCCccccCCCCCCCC----------------------CCCchhHHHHH
Q 002336 746 ILLDI-NMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ----------------------QLTEKSDVYSF 802 (935)
Q Consensus 746 ILld~-~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~----------------------~~s~ksDVwS~ 802 (935)
||+++ ++.+||+|||+++..............+++.|+|||.+... .+..++||||+
T Consensus 286 ILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSl 365 (566)
T PLN03225 286 IIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSA 365 (566)
T ss_pred EEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHH
Confidence 99985 57899999999986544333334455689999999965321 23456799999
Q ss_pred HHHHHHHHhCCCCCCccCcc-------cchhHHHHHHHhhhcCCeeecccccccCCCC--HHHHHHHHHHHHHccccCCC
Q 002336 803 GVVLLELISGKKPVSVEDFG-------AELNIVHWARSMIKKGDVISIVDPVLIGNVK--IESIWRIAEVAIQCVEQRGF 873 (935)
Q Consensus 803 Gvil~eLltG~~Pf~~~~~~-------~~~~l~~~~~~~i~~~~~~~~~d~~l~~~~~--~~~~~~l~~li~~Cl~~dP~ 873 (935)
||++|||+++..+++..... .......|....... ..+.+...+. ........+++.+||+.||+
T Consensus 366 GviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~ 439 (566)
T PLN03225 366 GLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPR------ASPDLRRGFEVLDLDGGAGWELLKSMMRFKGR 439 (566)
T ss_pred HHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccc------cchhhhhhhhhccccchHHHHHHHHHccCCcc
Confidence 99999999987765421100 011122221111000 0000000000 00112345899999999999
Q ss_pred CCCCHHHHHHH
Q 002336 874 SRPKMQEIVLA 884 (935)
Q Consensus 874 ~RPs~~ev~~~ 884 (935)
+|||++|+++.
T Consensus 440 kR~ta~e~L~H 450 (566)
T PLN03225 440 QRISAKAALAH 450 (566)
T ss_pred cCCCHHHHhCC
Confidence 99999999864
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.4e-29 Score=264.09 Aligned_cols=244 Identities=25% Similarity=0.355 Sum_probs=196.0
Q ss_pred hHHHHHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcchhh---hHHHHHHHHHHHhc-CCCcccccceeeeccce
Q 002336 609 ELEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHR---TQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQ 683 (935)
Q Consensus 609 ~l~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~~~---~~~~~~E~~iL~~L-~HpnIv~l~g~~~~~~~ 683 (935)
.+.....+|..+||+|.||.|-+|+-+ ..+.+|||++++....+ .+--+.|-++|... +-|.+++++..|...++
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR 424 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR 424 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence 345566788999999999999999876 45679999998764332 23345677777766 57899999999999999
Q ss_pred EEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccc
Q 002336 684 RILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 763 (935)
Q Consensus 684 ~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~ 763 (935)
+|+||||+.||+|--+++. -+.+.+..++-++.+||-||-+||+ ++|+.||||..|||+|.+|++||+|||+++
T Consensus 425 LyFVMEyvnGGDLMyhiQQ---~GkFKEp~AvFYAaEiaigLFFLh~---kgIiYRDLKLDNvmLd~eGHiKi~DFGmcK 498 (683)
T KOG0696|consen 425 LYFVMEYVNGGDLMYHIQQ---VGKFKEPVAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCK 498 (683)
T ss_pred eeeEEEEecCchhhhHHHH---hcccCCchhhhhhHHHHHHhhhhhc---CCeeeeeccccceEeccCCceEeeeccccc
Confidence 9999999999999888873 4567888899999999999999998 999999999999999999999999999998
Q ss_pred cccccccceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeec
Q 002336 764 QAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISI 843 (935)
Q Consensus 764 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~ 843 (935)
.---. .......+||+.|+|||++...+|+.+.|-|||||+||||+.|+.||++++.++ +.+ .|
T Consensus 499 Eni~~-~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~e---lF~----aI-------- 562 (683)
T KOG0696|consen 499 ENIFD-GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE---LFQ----AI-------- 562 (683)
T ss_pred ccccC-CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHH---HHH----HH--------
Confidence 63222 122445689999999999999999999999999999999999999999655432 221 11
Q ss_pred ccccccCCCCHHHHHHHHHHHHHccccCCCCCC
Q 002336 844 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRP 876 (935)
Q Consensus 844 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP 876 (935)
.+... .+|.....+.+.+....+...|.+|-
T Consensus 563 ~ehnv--syPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 563 MEHNV--SYPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred HHccC--cCcccccHHHHHHHHHHhhcCCcccc
Confidence 11111 34444555677888888999998884
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.3e-27 Score=275.85 Aligned_cols=257 Identities=22% Similarity=0.319 Sum_probs=176.7
Q ss_pred HHhhcccccccccEEEEEEEE-----------------CCCcEEEEEEccCcchhhhHH--------------HHHHHHH
Q 002336 614 TNNFCKKIGKGSFGSVYYGKM-----------------KDGKEVAVKIMADSCSHRTQQ--------------FVTEVAL 662 (935)
Q Consensus 614 ~~~~~~~LG~G~fG~Vy~~~~-----------------~~g~~vAvK~~~~~~~~~~~~--------------~~~E~~i 662 (935)
.+++.++||+|+||.||+|.+ ..++.||||++........++ ...|+.+
T Consensus 146 ~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~ 225 (507)
T PLN03224 146 DFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYM 225 (507)
T ss_pred CceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHH
Confidence 455678999999999999964 235689999986543322222 3347777
Q ss_pred HHhcCCCcc-----cccceeeec--------cceEEEEEEecCCCCHHHHhccCC---------------------CCCC
Q 002336 663 LSRIHHRNL-----VPLIGYCEE--------EHQRILVYEYMHNGTLRDRLHGSV---------------------NQKP 708 (935)
Q Consensus 663 L~~L~HpnI-----v~l~g~~~~--------~~~~~lV~E~~~~gsL~~~L~~~~---------------------~~~~ 708 (935)
+.+++|.++ ++++++|.. ....++||||+++++|.++++... ....
T Consensus 226 l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~ 305 (507)
T PLN03224 226 CAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDK 305 (507)
T ss_pred HHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccccc
Confidence 777766554 677787743 356899999999999999887421 1123
Q ss_pred CCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccccceeecccCCccccCCCCC
Q 002336 709 LDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY 788 (935)
Q Consensus 709 l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l 788 (935)
+++..+..++.|++++|.|||+ .+|+||||||+|||++.++.+||+|||++...............+++.|+|||.+
T Consensus 306 ~~~~~~~~i~~ql~~aL~~lH~---~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l 382 (507)
T PLN03224 306 RDINVIKGVMRQVLTGLRKLHR---IGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEEL 382 (507)
T ss_pred CCHHHHHHHHHHHHHHHHHHHH---CCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhh
Confidence 5677889999999999999998 8999999999999999999999999999876543222111222357899999987
Q ss_pred CCCCC----------------------CchhHHHHHHHHHHHHHhCCC-CCCccCc-cc-----chhHHHHHHHhhhcCC
Q 002336 789 GNQQL----------------------TEKSDVYSFGVVLLELISGKK-PVSVEDF-GA-----ELNIVHWARSMIKKGD 839 (935)
Q Consensus 789 ~~~~~----------------------s~ksDVwS~Gvil~eLltG~~-Pf~~~~~-~~-----~~~l~~~~~~~i~~~~ 839 (935)
..... ..+.||||+||+++||++|.. |+..... .. ...+..|.. .....
T Consensus 383 ~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~--~~~~~ 460 (507)
T PLN03224 383 VMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRM--YKGQK 460 (507)
T ss_pred cCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHh--hcccC
Confidence 54321 134799999999999999875 6642111 10 111222211 11111
Q ss_pred eeecccccccCCCCHHHHHHHHHHHHHccccCC---CCCCCHHHHHH
Q 002336 840 VISIVDPVLIGNVKIESIWRIAEVAIQCVEQRG---FSRPKMQEIVL 883 (935)
Q Consensus 840 ~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP---~~RPs~~ev~~ 883 (935)
. +-... ........+++.+|+..+| .+|+|++|+++
T Consensus 461 ~----~~~~~----d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 461 Y----DFSLL----DRNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred C----Ccccc----cccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 1 10000 1112356789999999766 68999999875
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-28 Score=261.68 Aligned_cols=267 Identities=21% Similarity=0.282 Sum_probs=202.4
Q ss_pred hhhHHHHHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcchhhhHHHHHHHHHHHhcC-C-C----cccccceeee
Q 002336 607 LPELEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIH-H-R----NLVPLIGYCE 679 (935)
Q Consensus 607 ~~~l~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~-H-p----nIv~l~g~~~ 679 (935)
..|.....|.+...+|+|.||.|-..... .+..||||+++.- ....+..+-|+++|+++. + | -+|.+.++|+
T Consensus 83 ~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V-~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFd 161 (415)
T KOG0671|consen 83 VGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV-DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFD 161 (415)
T ss_pred eccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH-HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhh
Confidence 45666788888999999999999999765 4789999998753 334556777999999993 2 3 3678888999
Q ss_pred ccceEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccC---------
Q 002336 680 EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI--------- 750 (935)
Q Consensus 680 ~~~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~--------- 750 (935)
-.++.++|+|.+ |-|+.++|... +-.+++...+..++.|+++++++||+ .+++|-||||+|||+-+
T Consensus 162 yrghiCivfell-G~S~~dFlk~N-~y~~fpi~~ir~m~~QL~~sv~fLh~---~kl~HTDLKPENILfvss~~~~~~~~ 236 (415)
T KOG0671|consen 162 YRGHICIVFELL-GLSTFDFLKEN-NYIPFPIDHIRHMGYQLLESVAFLHD---LKLTHTDLKPENILFVSSEYFKTYNP 236 (415)
T ss_pred ccCceEEEEecc-ChhHHHHhccC-CccccchHHHHHHHHHHHHHHHHHHh---cceeecCCChheEEEeccceEEEecc
Confidence 999999999998 66999999864 45678899999999999999999998 99999999999999932
Q ss_pred -----------CCcEEEeeccccccccccccceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCcc
Q 002336 751 -----------NMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVE 819 (935)
Q Consensus 751 -----------~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~ 819 (935)
+..++|+|||.|....+.. .....|..|+|||++.+..++..+||||+||||.||.||..-|...
T Consensus 237 k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtH 312 (415)
T KOG0671|consen 237 KKKVCFIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTH 312 (415)
T ss_pred CCccceeccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccC
Confidence 3458999999998654432 3445799999999999999999999999999999999999998755
Q ss_pred CcccchhHHHHHH-----Hhh---------hcCCe-----------eeccccc--cc--CCCCHHHHHHHHHHHHHcccc
Q 002336 820 DFGAELNIVHWAR-----SMI---------KKGDV-----------ISIVDPV--LI--GNVKIESIWRIAEVAIQCVEQ 870 (935)
Q Consensus 820 ~~~~~~~l~~~~~-----~~i---------~~~~~-----------~~~~d~~--l~--~~~~~~~~~~l~~li~~Cl~~ 870 (935)
+..+.....+-+. .++ ..+.+ ....++. +. -.....+..+|.+|+++||..
T Consensus 313 en~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~f 392 (415)
T KOG0671|consen 313 ENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEF 392 (415)
T ss_pred CcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHcc
Confidence 4222211111110 000 01100 0000100 00 011234556899999999999
Q ss_pred CCCCCCCHHHHHH
Q 002336 871 RGFSRPKMQEIVL 883 (935)
Q Consensus 871 dP~~RPs~~ev~~ 883 (935)
||.+|+|+.|++.
T Consensus 393 DP~~RiTl~EAL~ 405 (415)
T KOG0671|consen 393 DPARRITLREALS 405 (415)
T ss_pred CccccccHHHHhc
Confidence 9999999999875
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.4e-29 Score=250.35 Aligned_cols=265 Identities=21% Similarity=0.313 Sum_probs=190.7
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccC-cchh-hhHHHHHHHHHHHhcCCCcccccceeeec--------cc
Q 002336 614 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMAD-SCSH-RTQQFVTEVALLSRIHHRNLVPLIGYCEE--------EH 682 (935)
Q Consensus 614 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~-~~~~-~~~~~~~E~~iL~~L~HpnIv~l~g~~~~--------~~ 682 (935)
.|.-..+||+|.||.||+|+.+ +|+.||+|++-- .... ......+|+++|+.++|+|++.+++.|.. ..
T Consensus 18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~ 97 (376)
T KOG0669|consen 18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRA 97 (376)
T ss_pred HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccc
Confidence 3344578999999999999876 577889887532 1122 22456789999999999999999998843 23
Q ss_pred eEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccc
Q 002336 683 QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS 762 (935)
Q Consensus 683 ~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla 762 (935)
..++|+.+|+. +|.-+|... ...++..++.+++.++..||.|+|. ..|+|||+||.|+||+.++.+||+|||++
T Consensus 98 t~ylVf~~ceh-DLaGlLsn~--~vr~sls~Ikk~Mk~Lm~GL~~iHr---~kilHRDmKaaNvLIt~dgilklADFGla 171 (376)
T KOG0669|consen 98 TFYLVFDFCEH-DLAGLLSNR--KVRFSLSEIKKVMKGLMNGLYYIHR---NKILHRDMKAANVLITKDGILKLADFGLA 171 (376)
T ss_pred eeeeeHHHhhh-hHHHHhcCc--cccccHHHHHHHHHHHHHHHHHHHH---hhHHhhcccHhhEEEcCCceEEeeccccc
Confidence 47999999976 787777642 3568889999999999999999998 89999999999999999999999999999
Q ss_pred ccccccccc---eeecccCCccccCCCCCCC-CCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcC
Q 002336 763 RQAEEDLTH---ISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG 838 (935)
Q Consensus 763 ~~~~~~~~~---~~~~~~gt~~y~APE~l~~-~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~ 838 (935)
+.+...... ....+..|..|++||.+.+ ..++++.|||+-|||+.||.|+.+-+.+........++..+-..+..+
T Consensus 172 r~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tke 251 (376)
T KOG0669|consen 172 RAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKE 251 (376)
T ss_pred cceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcc
Confidence 765433221 1233456999999997654 689999999999999999999998876433222222222221111111
Q ss_pred Ceeec--------c--cccccCCCC--HHHHH------HHHHHHHHccccCCCCCCCHHHHHHH
Q 002336 839 DVISI--------V--DPVLIGNVK--IESIW------RIAEVAIQCVEQRGFSRPKMQEIVLA 884 (935)
Q Consensus 839 ~~~~~--------~--d~~l~~~~~--~~~~~------~l~~li~~Cl~~dP~~RPs~~ev~~~ 884 (935)
-.... + .|...+.+. .+..+ ...+++.+++..||.+|+++.+++..
T Consensus 252 vWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh 315 (376)
T KOG0669|consen 252 VWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH 315 (376)
T ss_pred cCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence 11110 0 110111110 01111 56789999999999999999988753
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.9e-28 Score=257.51 Aligned_cols=259 Identities=24% Similarity=0.358 Sum_probs=195.4
Q ss_pred HHHHHHhhcccccccccEEEEEEE-ECCCcEEEEEEccC---cch----hhhHHHHHHHHHHHhcCCCcccccceeee-c
Q 002336 610 LEEATNNFCKKIGKGSFGSVYYGK-MKDGKEVAVKIMAD---SCS----HRTQQFVTEVALLSRIHHRNLVPLIGYCE-E 680 (935)
Q Consensus 610 l~~~~~~~~~~LG~G~fG~Vy~~~-~~~g~~vAvK~~~~---~~~----~~~~~~~~E~~iL~~L~HpnIv~l~g~~~-~ 680 (935)
.....|-+.+.||+|+|+.||+|. +.+.+.||||+-.- +.. ...+...+|.+|.+.|.||.||++++++. +
T Consensus 460 tLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslD 539 (775)
T KOG1151|consen 460 TLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLD 539 (775)
T ss_pred chHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeec
Confidence 345667778899999999999996 45688899997432 111 12356788999999999999999999985 4
Q ss_pred cceEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCcccc---CCCcEEEe
Q 002336 681 EHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD---INMRAKVS 757 (935)
Q Consensus 681 ~~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld---~~~~vkL~ 757 (935)
.+..|-|+|||+|.+|.-+|+ ..+.++++++..|++||+.||.||.+. +.+|+|-||||.|||+- ..|.+||.
T Consensus 540 tdsFCTVLEYceGNDLDFYLK---QhklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKIT 615 (775)
T KOG1151|consen 540 TDSFCTVLEYCEGNDLDFYLK---QHKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKIT 615 (775)
T ss_pred cccceeeeeecCCCchhHHHH---hhhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEee
Confidence 567889999999999999998 456789999999999999999999974 57999999999999994 46889999
Q ss_pred eccccccccccccc------eeecccCCccccCCCCCC----CCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhH
Q 002336 758 DFGLSRQAEEDLTH------ISSVARGTVGYLDPEYYG----NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNI 827 (935)
Q Consensus 758 DFGla~~~~~~~~~------~~~~~~gt~~y~APE~l~----~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l 827 (935)
|||+++.+.++... ......||.+|++||.+. ....+.|.||||+|||+|+++-|+.||... ... ..
T Consensus 616 DFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhn-qsQ-Qd- 692 (775)
T KOG1151|consen 616 DFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHN-QSQ-QD- 692 (775)
T ss_pred ecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCc-hhH-HH-
Confidence 99999987654221 233456999999999763 246789999999999999999999999722 211 11
Q ss_pred HHHHHHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 828 VHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 828 ~~~~~~~i~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
.+++..+...-+-.+. ..+........+|++||+..-++|.+..++..
T Consensus 693 ------ILqeNTIlkAtEVqFP--~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 693 ------ILQENTILKATEVQFP--PKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred ------HHhhhchhcceeccCC--CCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 1112211111110110 01122235678999999999999988777653
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.5e-28 Score=265.91 Aligned_cols=239 Identities=23% Similarity=0.333 Sum_probs=196.5
Q ss_pred hhcccccccccEEEEEEEECCCc-EEEEEEccCcc---hhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEec
Q 002336 616 NFCKKIGKGSFGSVYYGKMKDGK-EVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 691 (935)
Q Consensus 616 ~~~~~LG~G~fG~Vy~~~~~~g~-~vAvK~~~~~~---~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~ 691 (935)
+....||-|+||.|=++..+... .+|+|++++.. ..+...+..|-++|...+.|.||+++..|.+....|+.||-|
T Consensus 423 ~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaC 502 (732)
T KOG0614|consen 423 KRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEAC 502 (732)
T ss_pred hhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhh
Confidence 34567999999999999877433 48888886532 334567889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccccc
Q 002336 692 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 771 (935)
Q Consensus 692 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~ 771 (935)
-||.|..+|+ .++.++.....-++..+.+|++|||+ ++||.|||||+|.++|.+|=+||.|||+|+.......
T Consensus 503 lGGElWTiLr---dRg~Fdd~tarF~~acv~EAfeYLH~---k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~K- 575 (732)
T KOG0614|consen 503 LGGELWTILR---DRGSFDDYTARFYVACVLEAFEYLHR---KGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRK- 575 (732)
T ss_pred cCchhhhhhh---hcCCcccchhhhhHHHHHHHHHHHHh---cCceeccCChhheeeccCCceEEeehhhHHHhccCCc-
Confidence 9999999998 56788999999999999999999998 9999999999999999999999999999998766543
Q ss_pred eeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccCC
Q 002336 772 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 851 (935)
Q Consensus 772 ~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~~ 851 (935)
.-..+||+.|.|||++.++.-+.+.|.||+|++++||++|.+||.+.+.-...+++- +| +|.. .
T Consensus 576 -TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~IL-------kG-----id~i---~ 639 (732)
T KOG0614|consen 576 -TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLIL-------KG-----IDKI---E 639 (732)
T ss_pred -eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHH-------hh-----hhhh---h
Confidence 345679999999999999888999999999999999999999998665432222221 11 1110 1
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCC
Q 002336 852 VKIESIWRIAEVAIQCVEQRGFSRPK 877 (935)
Q Consensus 852 ~~~~~~~~l~~li~~Cl~~dP~~RPs 877 (935)
+|....+...+++++.+..+|.+|--
T Consensus 640 ~Pr~I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 640 FPRRITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred cccccchhHHHHHHHHHhcCcHhhhc
Confidence 22223345678999999999999975
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.7e-28 Score=235.74 Aligned_cols=197 Identities=24% Similarity=0.387 Sum_probs=164.4
Q ss_pred hhcccccccccEEEEEEEEC-CCcEEEEEEccCcch-hhhHHHHHHHHHHHh-cCCCcccccceeeeccceEEEEEEecC
Q 002336 616 NFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS-HRTQQFVTEVALLSR-IHHRNLVPLIGYCEEEHQRILVYEYMH 692 (935)
Q Consensus 616 ~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~-~~~~~~~~E~~iL~~-L~HpnIv~l~g~~~~~~~~~lV~E~~~ 692 (935)
.-.+.||+|++|.|=+-++. +|+..|+|.++.... +..++.+.|+.+..+ ..+|.+|+++|....+...++.||.|.
T Consensus 49 ~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~ 128 (282)
T KOG0984|consen 49 VGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMD 128 (282)
T ss_pred hhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhh
Confidence 34578999999999888775 799999999976543 345678888887655 479999999999888899999999994
Q ss_pred CCCHHHHhccC-CCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccccc
Q 002336 693 NGTLRDRLHGS-VNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 771 (935)
Q Consensus 693 ~gsL~~~L~~~-~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~ 771 (935)
.||..+-..- ..+..+++..+-+|+..+..||.|||+ +..++|||+||+||||+.+|++|+||||.+-...+...
T Consensus 129 -tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiA- 204 (282)
T KOG0984|consen 129 -TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIA- 204 (282)
T ss_pred -hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEcccccceeehhhhH-
Confidence 5776654322 156789999999999999999999999 68999999999999999999999999999877654332
Q ss_pred eeecccCCccccCCCCCC----CCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 002336 772 ISSVARGTVGYLDPEYYG----NQQLTEKSDVYSFGVVLLELISGKKPVS 817 (935)
Q Consensus 772 ~~~~~~gt~~y~APE~l~----~~~~s~ksDVwS~Gvil~eLltG~~Pf~ 817 (935)
.+...|...|||||.+. ...|+.|+||||+|+.+.||.+++.||+
T Consensus 205 -kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~ 253 (282)
T KOG0984|consen 205 -KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYE 253 (282)
T ss_pred -HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccc
Confidence 22245888999999874 3478999999999999999999999997
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.9e-27 Score=239.56 Aligned_cols=254 Identities=19% Similarity=0.328 Sum_probs=192.6
Q ss_pred HHHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcchhhhHHHHHHHHHHHhc-CCCccccccee-eeccceEEEEE
Q 002336 612 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGY-CEEEHQRILVY 688 (935)
Q Consensus 612 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L-~HpnIv~l~g~-~~~~~~~~lV~ 688 (935)
+..|++.+.||+|.||.+-+++++ ..+.+++|.+... ....++|.+|..---.| .|.||+..++. |+..+.+++++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q 101 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ 101 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence 356788999999999999999997 5678999988654 33467899998876666 59999998874 67778889999
Q ss_pred EecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCcccc--CCCcEEEeecccccccc
Q 002336 689 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD--INMRAKVSDFGLSRQAE 766 (935)
Q Consensus 689 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld--~~~~vkL~DFGla~~~~ 766 (935)
||++.|+|.+-+.. .++.+....+++.|++.||.|+|+ +.+||||||.+||||- +.-++||||||+++..+
T Consensus 102 E~aP~gdL~snv~~----~GigE~~~K~v~~ql~SAi~fMHs---knlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g 174 (378)
T KOG1345|consen 102 EFAPRGDLRSNVEA----AGIGEANTKKVFAQLLSAIEFMHS---KNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVG 174 (378)
T ss_pred ccCccchhhhhcCc----ccccHHHHHHHHHHHHHHHHHhhc---cchhhcccccceEEEecCCccEEEeeecccccccC
Confidence 99999999988863 567788889999999999999998 9999999999999993 34579999999988655
Q ss_pred ccccceeecccCCccccCCCCCCC-----CCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCee
Q 002336 767 EDLTHISSVARGTVGYLDPEYYGN-----QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVI 841 (935)
Q Consensus 767 ~~~~~~~~~~~gt~~y~APE~l~~-----~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~ 841 (935)
..... ..-+..|.+||.... -...+.+|||.||++++.++||+.||+ ........+++|..-.-+..
T Consensus 175 ~tV~~----~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQ-ka~~~d~~Y~~~~~w~~rk~--- 246 (378)
T KOG1345|consen 175 TTVKY----LEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQ-KASIMDKPYWEWEQWLKRKN--- 246 (378)
T ss_pred ceehh----hhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcch-hhhccCchHHHHHHHhcccC---
Confidence 43222 224567999997643 245678999999999999999999998 44444444555544322211
Q ss_pred ecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 002336 842 SIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 886 (935)
Q Consensus 842 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~ 886 (935)
+.+...+.. ...+++.+.++-+..+|++|-...++.++.+
T Consensus 247 ----~~~P~~F~~-fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk 286 (378)
T KOG1345|consen 247 ----PALPKKFNP-FSEKALRLFKKSLTPRFKDRCKIWTAKKMRK 286 (378)
T ss_pred ----ccCchhhcc-cCHHHHHHHHHhcCCcccccchhHHHHHHHH
Confidence 111111111 1125778889999999999977777666543
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.7e-27 Score=274.14 Aligned_cols=243 Identities=25% Similarity=0.410 Sum_probs=184.9
Q ss_pred cccccccccEE-EEEEEECCCcEEEEEEccCcchhhhHHHHHHHHHHHhc-CCCcccccceeeeccceEEEEEEecCCCC
Q 002336 618 CKKIGKGSFGS-VYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEYMHNGT 695 (935)
Q Consensus 618 ~~~LG~G~fG~-Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L-~HpnIv~l~g~~~~~~~~~lV~E~~~~gs 695 (935)
.+.+|.|+.|+ ||+|... |++||||++-.. ..+-..+|+..|+.- +|||||++++.-.++++.|+..|.|. .+
T Consensus 514 ~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~-~s 588 (903)
T KOG1027|consen 514 KEILGYGSNGTVVFRGVYE-GREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA-CS 588 (903)
T ss_pred HHHcccCCCCcEEEEEeeC-CceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh-hh
Confidence 35789998865 6899987 899999987543 334567899999888 59999999999999999999999994 69
Q ss_pred HHHHhccC-CCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccC---C--CcEEEeeccccccccccc
Q 002336 696 LRDRLHGS-VNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI---N--MRAKVSDFGLSRQAEEDL 769 (935)
Q Consensus 696 L~~~L~~~-~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~---~--~~vkL~DFGla~~~~~~~ 769 (935)
|.++++.. ...........+.++.|++.||+|||+ .+||||||||.||||+. + ..++|+|||+++......
T Consensus 589 L~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHs---l~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~ 665 (903)
T KOG1027|consen 589 LQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHS---LKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGK 665 (903)
T ss_pred HHHHHhccccchhhcccccHHHHHHHHHHHHHHHHh---cccccccCCCceEEEEccCCCcceeEEecccccccccCCCc
Confidence 99999863 111111114457789999999999998 89999999999999975 3 468999999999876544
Q ss_pred cce--eecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhC-CCCCCccCcccchhHHHHHHHhhhcCCeeecccc
Q 002336 770 THI--SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISG-KKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP 846 (935)
Q Consensus 770 ~~~--~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG-~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~ 846 (935)
... .....||-+|+|||++....-+.+.||||+||++|+.++| ..||. +....+.++.. .+-.+..
T Consensus 666 sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFG-d~~~R~~NIl~------~~~~L~~---- 734 (903)
T KOG1027|consen 666 SSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFG-DSLERQANILT------GNYTLVH---- 734 (903)
T ss_pred chhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCC-chHHhhhhhhc------Cccceee----
Confidence 332 3345699999999999998888899999999999999985 99997 22222222211 0000100
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002336 847 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 884 (935)
Q Consensus 847 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~ 884 (935)
+.. ..++ ...++|.+|+..+|..||++.+|+..
T Consensus 735 -L~~--~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~H 767 (903)
T KOG1027|consen 735 -LEP--LPDC--EAKDLISRMLNPDPQLRPSATDVLNH 767 (903)
T ss_pred -ecc--CchH--HHHHHHHHhcCCCcccCCCHHHHhCC
Confidence 110 0111 56799999999999999999999743
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.5e-27 Score=242.55 Aligned_cols=245 Identities=22% Similarity=0.350 Sum_probs=196.3
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCcch---hhhHHHHHHHHHHHhc-CCCcccccceeeeccceEEEEEE
Q 002336 615 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYE 689 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~---~~~~~~~~E~~iL~~L-~HpnIv~l~g~~~~~~~~~lV~E 689 (935)
.++.++||+|.|+.|-+++++ ..+.+|+|++++... ++.+-.+.|-.+..+. +||.+|-++..|..+..+++|.|
T Consensus 252 f~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvie 331 (593)
T KOG0695|consen 252 FDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIE 331 (593)
T ss_pred ceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEE
Confidence 345788999999999999876 567899999876432 3345567777777776 79999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccc
Q 002336 690 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 769 (935)
Q Consensus 690 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~ 769 (935)
|++||+|--+++ .+..++++.+.-+..+|+-||.|||+ +||+.||||..|+|+|..|++||.|+|+++.--...
T Consensus 332 yv~ggdlmfhmq---rqrklpeeharfys~ei~lal~flh~---rgiiyrdlkldnvlldaeghikltdygmcke~l~~g 405 (593)
T KOG0695|consen 332 YVNGGDLMFHMQ---RQRKLPEEHARFYSAEICLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPG 405 (593)
T ss_pred EecCcceeeehh---hhhcCcHHHhhhhhHHHHHHHHHHhh---cCeeeeeccccceEEccCCceeecccchhhcCCCCC
Confidence 999999976666 46679999999999999999999998 999999999999999999999999999998643332
Q ss_pred cceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcc-cchhHHHHHHHhhhcCCeeecccccc
Q 002336 770 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFG-AELNIVHWARSMIKKGDVISIVDPVL 848 (935)
Q Consensus 770 ~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~-~~~~l~~~~~~~i~~~~~~~~~d~~l 848 (935)
. ..+..+||+.|+|||++.+..|+...|-|++||+++||+.|+.||+.-... .+.+--+++-+.+-+..+.
T Consensus 406 d-~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqir------- 477 (593)
T KOG0695|consen 406 D-TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIR------- 477 (593)
T ss_pred c-ccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhccc-------
Confidence 2 244567999999999999999999999999999999999999999854443 3334444554444332220
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCC
Q 002336 849 IGNVKIESIWRIAEVAIQCVEQRGFSRP 876 (935)
Q Consensus 849 ~~~~~~~~~~~l~~li~~Cl~~dP~~RP 876 (935)
.|.....+...+++..+..||.+|-
T Consensus 478 ---iprslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 478 ---IPRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred ---ccceeehhhHHHHHHhhcCCcHHhc
Confidence 1112222456788889999998875
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-25 Score=232.18 Aligned_cols=210 Identities=38% Similarity=0.612 Sum_probs=182.5
Q ss_pred ccccccEEEEEEEECC-CcEEEEEEccCcchh-hhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEecCCCCHHH
Q 002336 621 IGKGSFGSVYYGKMKD-GKEVAVKIMADSCSH-RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRD 698 (935)
Q Consensus 621 LG~G~fG~Vy~~~~~~-g~~vAvK~~~~~~~~-~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL~~ 698 (935)
||+|.+|.||++...+ ++++++|++...... ..+.+.+|++.++.++|++++++++++......++++|++.+++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999998864 899999998765332 34679999999999999999999999999899999999999999999
Q ss_pred HhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccC-CCcEEEeeccccccccccccceeeccc
Q 002336 699 RLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI-NMRAKVSDFGLSRQAEEDLTHISSVAR 777 (935)
Q Consensus 699 ~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~-~~~vkL~DFGla~~~~~~~~~~~~~~~ 777 (935)
++.... ..+++..+..++.++++++++||+ .+++|+||+|.||+++. ++.++|+|||.+........ ......
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~---~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~ 154 (215)
T cd00180 81 LLKENE--GKLSEDEILRILLQILEGLEYLHS---NGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTIV 154 (215)
T ss_pred HHHhcc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhccc
Confidence 987431 468899999999999999999998 89999999999999999 89999999999876544321 122234
Q ss_pred CCccccCCCCCCCC-CCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccCCCCHHH
Q 002336 778 GTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIES 856 (935)
Q Consensus 778 gt~~y~APE~l~~~-~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~~~~~~~ 856 (935)
+...|++||..... ..+.+.|+|++|+++++|
T Consensus 155 ~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------------------------- 187 (215)
T cd00180 155 GTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------------------------------- 187 (215)
T ss_pred CCCCccChhHhcccCCCCchhhhHHHHHHHHHH-----------------------------------------------
Confidence 67889999998877 888999999999999998
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002336 857 IWRIAEVAIQCVEQRGFSRPKMQEIVLA 884 (935)
Q Consensus 857 ~~~l~~li~~Cl~~dP~~RPs~~ev~~~ 884 (935)
..+.+++.+|++.+|++||++.++++.
T Consensus 188 -~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 -PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred -HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 267899999999999999999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.2e-28 Score=245.38 Aligned_cols=260 Identities=22% Similarity=0.291 Sum_probs=190.4
Q ss_pred cccccccccEEEEEEEEC-CCcEEEEEEccCcc--hhhhHHHHHHHHHHHhcCCCcccccceeeecc-----ceEEEEEE
Q 002336 618 CKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE-----HQRILVYE 689 (935)
Q Consensus 618 ~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~-----~~~~lV~E 689 (935)
.+.||-|+||.||.+++. +|+.||+|++.... -...+.+.+|+++|...+|.|++..+++..-. ++.|+++|
T Consensus 58 DRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TE 137 (449)
T KOG0664|consen 58 DRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTE 137 (449)
T ss_pred CCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHH
Confidence 478999999999999865 89999999986432 23457899999999999999999998876433 24678888
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccc
Q 002336 690 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 769 (935)
Q Consensus 690 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~ 769 (935)
.| ..+|..++- ....++...+.-++.||++||+|||+ .+|.||||||.|.|++.+..+||||||+++..+.+.
T Consensus 138 Lm-QSDLHKIIV---SPQ~Ls~DHvKVFlYQILRGLKYLHs---A~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~ 210 (449)
T KOG0664|consen 138 LM-QSDLHKIIV---SPQALTPDHVKVFVYQILRGLKYLHT---ANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRD 210 (449)
T ss_pred HH-Hhhhhheec---cCCCCCcchhhhhHHHHHhhhHHHhh---cchhhccCCCccEEeccCceEEecccccccccchhh
Confidence 88 457777665 45678888888999999999999998 899999999999999999999999999999765443
Q ss_pred cceeecccCCccccCCCCCCC-CCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHH---------HHHhhhcCC
Q 002336 770 THISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHW---------ARSMIKKGD 839 (935)
Q Consensus 770 ~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~---------~~~~i~~~~ 839 (935)
........-|..|+|||++++ ..|+.+.||||.|||+.||+..+.-|.........+++.- ++..- +|.
T Consensus 211 ~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~AC-EGA 289 (449)
T KOG0664|consen 211 RLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYAC-EGA 289 (449)
T ss_pred hhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHh-hhh
Confidence 332223346889999999876 5799999999999999999999988874433222221110 01000 111
Q ss_pred eeeccc-----ccccCCC----CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 002336 840 VISIVD-----PVLIGNV----KIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAI 885 (935)
Q Consensus 840 ~~~~~d-----~~l~~~~----~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L 885 (935)
..-++. |.+..-+ +...-..-..+.++++..||+.|.+.++.+..+
T Consensus 290 k~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 290 KNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred HHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 111111 1111000 111222456888899999999999988887654
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.7e-26 Score=256.56 Aligned_cols=199 Identities=25% Similarity=0.377 Sum_probs=167.3
Q ss_pred cccccccccEEEEEEEE-CCCcEEEEEEccCcc---hhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEecCC
Q 002336 618 CKKIGKGSFGSVYYGKM-KDGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 693 (935)
Q Consensus 618 ~~~LG~G~fG~Vy~~~~-~~g~~vAvK~~~~~~---~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~~~ 693 (935)
++.||-|+||.|.++.. +....+|+|.+++.. ..+....+.|..||.....+-||+++-.|.+.+.+|+||+|++|
T Consensus 634 ik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPG 713 (1034)
T KOG0608|consen 634 IKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPG 713 (1034)
T ss_pred EeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCC
Confidence 56799999999999964 446678999987642 23446688899999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccc------
Q 002336 694 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE------ 767 (935)
Q Consensus 694 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~------ 767 (935)
|++-.+|-+ -+-+++..+..++.++.+|+++.|. .|+|||||||+|||||.+|++||.||||+.-+..
T Consensus 714 GDmMSLLIr---mgIFeE~LARFYIAEltcAiesVHk---mGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskY 787 (1034)
T KOG0608|consen 714 GDMMSLLIR---MGIFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY 787 (1034)
T ss_pred ccHHHHHHH---hccCHHHHHHHHHHHHHHHHHHHHh---ccceecccCccceEEccCCceeeeeccccccceecccccc
Confidence 999998873 4567788888889999999999997 9999999999999999999999999999854211
Q ss_pred --cccc---------------------------------eeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhC
Q 002336 768 --DLTH---------------------------------ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISG 812 (935)
Q Consensus 768 --~~~~---------------------------------~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG 812 (935)
...+ ......||+.|+|||++....++..+|-||.|||||||+.|
T Consensus 788 Yq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g 867 (1034)
T KOG0608|consen 788 YQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVG 867 (1034)
T ss_pred ccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhC
Confidence 0000 00123499999999999999999999999999999999999
Q ss_pred CCCCCccCcc
Q 002336 813 KKPVSVEDFG 822 (935)
Q Consensus 813 ~~Pf~~~~~~ 822 (935)
+.||......
T Consensus 868 ~~pf~~~tp~ 877 (1034)
T KOG0608|consen 868 QPPFLADTPG 877 (1034)
T ss_pred CCCccCCCCC
Confidence 9999844443
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.5e-25 Score=222.91 Aligned_cols=256 Identities=19% Similarity=0.322 Sum_probs=193.2
Q ss_pred HHHHhhcccccccccEEEEEEE-ECCCcEEEEEEccCcchhhhHHHHHHHHHHHhcC-CCcccccceeeecc--ceEEEE
Q 002336 612 EATNNFCKKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIH-HRNLVPLIGYCEEE--HQRILV 687 (935)
Q Consensus 612 ~~~~~~~~~LG~G~fG~Vy~~~-~~~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~-HpnIv~l~g~~~~~--~~~~lV 687 (935)
...|++.+++|+|-++.||.|. ..+++.++||++++ ...+.+.+|+.+|+.|. ||||+++++...+. ....||
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP---VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi 113 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP---VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI 113 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeech---HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence 3567888999999999999996 45788999999985 34578999999999997 99999999998664 456799
Q ss_pred EEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCC-CcEEEeecccccccc
Q 002336 688 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN-MRAKVSDFGLSRQAE 766 (935)
Q Consensus 688 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~-~~vkL~DFGla~~~~ 766 (935)
+||+++.+...+.. .++...+...+.+++.||.|+|+ .||.|||+||.|++||.. ..++|+|+|+|.++.
T Consensus 114 FE~v~n~Dfk~ly~------tl~d~dIryY~~elLkALdyCHS---~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH 184 (338)
T KOG0668|consen 114 FEYVNNTDFKQLYP------TLTDYDIRYYIYELLKALDYCHS---MGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 184 (338)
T ss_pred hhhhccccHHHHhh------hhchhhHHHHHHHHHHHHhHHHh---cCcccccCCcceeeechhhceeeeeecchHhhcC
Confidence 99999988776543 46677889999999999999998 999999999999999964 569999999999876
Q ss_pred ccccceeecccCCccccCCCCCCC-CCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcC-------
Q 002336 767 EDLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG------- 838 (935)
Q Consensus 767 ~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~------- 838 (935)
..... ..+..+..|--||.+-. ..++..-|+|||||++..|+..+.||- ...+...+++..++- +...
T Consensus 185 p~~eY--nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFF-hG~dN~DQLVkIakV-LGt~el~~Yl~ 260 (338)
T KOG0668|consen 185 PGKEY--NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFF-HGHDNYDQLVKIAKV-LGTDELYAYLN 260 (338)
T ss_pred CCcee--eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCccc-CCCCCHHHHHHHHHH-hChHHHHHHHH
Confidence 55432 23345677888998754 567889999999999999999999985 333333344443321 1000
Q ss_pred CeeecccccccC---CCC------------H-HHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 839 DVISIVDPVLIG---NVK------------I-ESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 839 ~~~~~~d~~l~~---~~~------------~-~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
...-.+||.+.+ ... . -...+.++++.+.|..|-++|||++|...
T Consensus 261 KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 261 KYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred HHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 011112222211 000 0 01135789999999999999999999864
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.6e-26 Score=250.79 Aligned_cols=278 Identities=22% Similarity=0.265 Sum_probs=215.0
Q ss_pred cCcccccCChhhHHHHHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcchhhhHHHHHHHHHHHhcC------CCc
Q 002336 598 DEGVAYFIPLPELEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIH------HRN 670 (935)
Q Consensus 598 ~~~~~~~~~~~~l~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~------Hpn 670 (935)
+..-.+...+.|+....|.+.-..|+|-|++|.+|... -|.+||||++..... -.+.=+.|+++|++|+ --|
T Consensus 417 DaEGYYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~-M~KtGl~EleiLkKL~~AD~Edk~H 495 (752)
T KOG0670|consen 417 DAEGYYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV-MHKTGLKELEILKKLNDADPEDKFH 495 (752)
T ss_pred cccceEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH-HhhhhhHHHHHHHHhhccCchhhhH
Confidence 33445667788999999999899999999999999865 588999999986532 3355678999999995 347
Q ss_pred ccccceeeeccceEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccC
Q 002336 671 LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI 750 (935)
Q Consensus 671 Iv~l~g~~~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~ 750 (935)
.++++-.|...+++|||+|-+ ..+|.++|+......+|....+..++.|+.-||..|.. -+|+|.||||.|||+++
T Consensus 496 clrl~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~---c~vlHaDIKPDNiLVNE 571 (752)
T KOG0670|consen 496 CLRLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKK---CGVLHADIKPDNILVNE 571 (752)
T ss_pred HHHHHHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHh---cCeeecccCccceEecc
Confidence 999999999999999999988 57999999987777889999999999999999999997 89999999999999987
Q ss_pred CCc-EEEeeccccccccccccceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHH
Q 002336 751 NMR-AKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVH 829 (935)
Q Consensus 751 ~~~-vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~ 829 (935)
... +||||||.|....++.. ..+..+..|.|||++.+..|+...|+||.||.||||.||+..|.+..-..-..+..
T Consensus 572 ~k~iLKLCDfGSA~~~~enei---tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~m 648 (752)
T KOG0670|consen 572 SKNILKLCDFGSASFASENEI---TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFM 648 (752)
T ss_pred CcceeeeccCccccccccccc---cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHH
Confidence 654 79999999987765433 22334667999999999999999999999999999999999998554332211111
Q ss_pred HH-----HHhhhcCCeee-ccc--------------------------c------cccC--CCCH---HHHHHHHHHHHH
Q 002336 830 WA-----RSMIKKGDVIS-IVD--------------------------P------VLIG--NVKI---ESIWRIAEVAIQ 866 (935)
Q Consensus 830 ~~-----~~~i~~~~~~~-~~d--------------------------~------~l~~--~~~~---~~~~~l~~li~~ 866 (935)
-+ ..+++.|.+.. -+| | .+.+ .++. .....+.+|+.+
T Consensus 649 e~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdk 728 (752)
T KOG0670|consen 649 ELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDK 728 (752)
T ss_pred HhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHH
Confidence 11 12222221110 011 1 0111 1222 334578899999
Q ss_pred ccccCCCCCCCHHHHHH
Q 002336 867 CVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 867 Cl~~dP~~RPs~~ev~~ 883 (935)
|+..||++|.|..+.++
T Consensus 729 ml~LdP~KRit~nqAL~ 745 (752)
T KOG0670|consen 729 MLILDPEKRITVNQALK 745 (752)
T ss_pred HhccChhhcCCHHHHhc
Confidence 99999999999998765
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.8e-25 Score=229.43 Aligned_cols=196 Identities=37% Similarity=0.618 Sum_probs=170.8
Q ss_pred hhcccccccccEEEEEEEECC-CcEEEEEEccCcchh-hhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEecCC
Q 002336 616 NFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSH-RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 693 (935)
Q Consensus 616 ~~~~~LG~G~fG~Vy~~~~~~-g~~vAvK~~~~~~~~-~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~~~ 693 (935)
.+.+.||+|++|.||++...+ ++.+++|.+...... ..+.+.+|++.+++++|+|++++++++......++++|++++
T Consensus 2 ~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~ 81 (225)
T smart00221 2 ELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEG 81 (225)
T ss_pred ceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCC
Confidence 356789999999999999875 899999999766544 567899999999999999999999999998999999999999
Q ss_pred CCHHHHhccCCCCCC-CCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccccce
Q 002336 694 GTLRDRLHGSVNQKP-LDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 772 (935)
Q Consensus 694 gsL~~~L~~~~~~~~-l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~~ 772 (935)
++|.+++... .. +++..+..++.+++.++.+||+ .+++|+||+|+||+++.++.++|+|||.+..........
T Consensus 82 ~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~ 155 (225)
T smart00221 82 GDLFDYLRKK---GGKLSEEEARFYLRQILEALEYLHS---LGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAAL 155 (225)
T ss_pred CCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccc
Confidence 9999998743 23 8899999999999999999998 899999999999999999999999999988765432111
Q ss_pred eecccCCccccCCCCC-CCCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 002336 773 SSVARGTVGYLDPEYY-GNQQLTEKSDVYSFGVVLLELISGKKPVS 817 (935)
Q Consensus 773 ~~~~~gt~~y~APE~l-~~~~~s~ksDVwS~Gvil~eLltG~~Pf~ 817 (935)
.....++..|++||.+ ....++.++|||+||++++||++|+.||.
T Consensus 156 ~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~ 201 (225)
T smart00221 156 LKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFS 201 (225)
T ss_pred ccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCcc
Confidence 2234577889999998 66777889999999999999999999996
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.2e-26 Score=249.97 Aligned_cols=193 Identities=25% Similarity=0.437 Sum_probs=164.0
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCcch--------hhhHHHHHHHHHHHhcC---CCcccccceeeeccc
Q 002336 615 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--------HRTQQFVTEVALLSRIH---HRNLVPLIGYCEEEH 682 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~--------~~~~~~~~E~~iL~~L~---HpnIv~l~g~~~~~~ 682 (935)
|...+.+|+|+||.|+++.++ +..+|+||++.+... .+...+-.|++||..|+ |+||++++++|++++
T Consensus 563 yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd 642 (772)
T KOG1152|consen 563 YTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDD 642 (772)
T ss_pred ceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCC
Confidence 445788999999999999987 467899999865311 11123567999999997 999999999999999
Q ss_pred eEEEEEEec-CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccc
Q 002336 683 QRILVYEYM-HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGL 761 (935)
Q Consensus 683 ~~~lV~E~~-~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGl 761 (935)
.+||+||.. ++.+|.++++ -...+++.++..|++|++.|+++||+ .+|+|||||-+||.++.+|-+||+|||.
T Consensus 643 ~yyl~te~hg~gIDLFd~IE---~kp~m~E~eAk~IFkQV~agi~hlh~---~~ivhrdikdenvivd~~g~~klidfgs 716 (772)
T KOG1152|consen 643 YYYLETEVHGEGIDLFDFIE---FKPRMDEPEAKLIFKQVVAGIKHLHD---QGIVHRDIKDENVIVDSNGFVKLIDFGS 716 (772)
T ss_pred eeEEEecCCCCCcchhhhhh---ccCccchHHHHHHHHHHHhccccccc---cCceecccccccEEEecCCeEEEeeccc
Confidence 999999976 5568999998 35679999999999999999999997 9999999999999999999999999999
Q ss_pred cccccccccceeecccCCccccCCCCCCCCCC-CchhHHHHHHHHHHHHHhCCCCC
Q 002336 762 SRQAEEDLTHISSVARGTVGYLDPEYYGNQQL-TEKSDVYSFGVVLLELISGKKPV 816 (935)
Q Consensus 762 a~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~-s~ksDVwS~Gvil~eLltG~~Pf 816 (935)
+....... .....||..|.|||++.+..| +..-|||++|++||-++....||
T Consensus 717 aa~~ksgp---fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpy 769 (772)
T KOG1152|consen 717 AAYTKSGP---FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPY 769 (772)
T ss_pred hhhhcCCC---cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCC
Confidence 87654432 233569999999999988765 56789999999999998888776
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1e-25 Score=234.92 Aligned_cols=255 Identities=24% Similarity=0.294 Sum_probs=189.4
Q ss_pred cccccccccEEEEEEEEC-CCcEEEEEEccCcc--hhhhHHHHHHHHHHHhcCCCcccccceeeec------cceEEEEE
Q 002336 618 CKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEE------EHQRILVY 688 (935)
Q Consensus 618 ~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~------~~~~~lV~ 688 (935)
.+.+|.|.- .|..+.+. .+++||+|+..... ....++..+|...+..++|+||++++.++.- ....|+||
T Consensus 22 L~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~ 100 (369)
T KOG0665|consen 22 LKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVM 100 (369)
T ss_pred ecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHH
Confidence 356888888 66666543 68999999876531 2344678899999999999999999998843 34579999
Q ss_pred EecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccccc
Q 002336 689 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 768 (935)
Q Consensus 689 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~ 768 (935)
|+| ..+|...+. ..++...+..++.|+++|++|||+ .+|+||||||+||++..+..+||.|||+++.....
T Consensus 101 e~m-~~nl~~vi~-----~elDH~tis~i~yq~~~~ik~lhs---~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~ 171 (369)
T KOG0665|consen 101 ELM-DANLCQVIL-----MELDHETISYILYQMLCGIKHLHS---AGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD 171 (369)
T ss_pred Hhh-hhHHHHHHH-----HhcchHHHHHHHHHHHHHHHHHHh---cceeecccCcccceecchhheeeccchhhcccCcc
Confidence 999 568888776 346778899999999999999998 99999999999999999999999999999875443
Q ss_pred ccceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHH----------------HHHH
Q 002336 769 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIV----------------HWAR 832 (935)
Q Consensus 769 ~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~----------------~~~~ 832 (935)
...+....|..|.|||++.+..+.+..||||+||++.||++|+.-|.+.+..+.+..+ .-++
T Consensus 172 --~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r 249 (369)
T KOG0665|consen 172 --FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVR 249 (369)
T ss_pred --cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHH
Confidence 3445567899999999998888999999999999999999999998855543222111 1111
Q ss_pred HhhhcC------Ceeecc-cccccC--CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002336 833 SMIKKG------DVISIV-DPVLIG--NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 884 (935)
Q Consensus 833 ~~i~~~------~~~~~~-d~~l~~--~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~ 884 (935)
...+.. ...+.+ |..... +.+.-......+++.+||..+|++|-+++++++.
T Consensus 250 ~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 250 NYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred HHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 111100 000000 100000 1111223356799999999999999999999865
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.5e-24 Score=232.20 Aligned_cols=140 Identities=26% Similarity=0.431 Sum_probs=116.0
Q ss_pred cCChhhHHH-HHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcchhhhHHHHHHHHHHHhcC-----C---Ccccc
Q 002336 604 FIPLPELEE-ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIH-----H---RNLVP 673 (935)
Q Consensus 604 ~~~~~~l~~-~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~-----H---pnIv~ 673 (935)
...+.|.-. ..|-+.++||-|.|++||++.+. ..+.||+|+.+. .....+..+.|+++|++++ | .+||+
T Consensus 68 pV~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKS-AqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~ 146 (590)
T KOG1290|consen 68 PVRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKS-AQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQ 146 (590)
T ss_pred eeeccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEeh-hhHHHHHHHHHHHHHHHHHhcCCCCCCCceeee
Confidence 334445444 66777899999999999999764 678899999764 3455677889999999984 2 47999
Q ss_pred cceeeec----cceEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccc
Q 002336 674 LIGYCEE----EHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL 748 (935)
Q Consensus 674 l~g~~~~----~~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILl 748 (935)
++++|.. +.+.+||+|++ |.+|..++... .-+.++...+.+|+.||+.||.|||.. -+|||-||||+|||+
T Consensus 147 LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s-~YrGlpl~~VK~I~~qvL~GLdYLH~e--cgIIHTDlKPENvLl 221 (590)
T KOG1290|consen 147 LLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYS-NYRGLPLSCVKEICRQVLTGLDYLHRE--CGIIHTDLKPENVLL 221 (590)
T ss_pred eeccceecCCCCcEEEEEehhh-hhHHHHHHHHh-CCCCCcHHHHHHHHHHHHHHHHHHHHh--cCccccCCCcceeee
Confidence 9999854 56899999999 77888888755 466799999999999999999999994 699999999999999
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.7e-25 Score=249.83 Aligned_cols=251 Identities=25% Similarity=0.387 Sum_probs=202.0
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcchhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEecC
Q 002336 614 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 692 (935)
Q Consensus 614 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~~ 692 (935)
.|++.+++|.|.+|.||+++.+ .++..|+|+++-....+.+-+.+|+-+++.-+|||||.++|.+...+..++.||||.
T Consensus 16 dyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycg 95 (829)
T KOG0576|consen 16 DYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCG 95 (829)
T ss_pred chhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecC
Confidence 4567789999999999999865 789999999987666677788899999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccccce
Q 002336 693 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 772 (935)
Q Consensus 693 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~~ 772 (935)
+|+|+++-+ ..+++++.++..++++.++||+|||+ .+-+|||||-.|||+++.|.+|++|||.+..+......
T Consensus 96 ggslQdiy~---~TgplselqiayvcRetl~gl~ylhs---~gk~hRdiKGanilltd~gDvklaDfgvsaqitati~K- 168 (829)
T KOG0576|consen 96 GGSLQDIYH---VTGPLSELQIAYVCRETLQGLKYLHS---QGKIHRDIKGANILLTDEGDVKLADFGVSAQITATIAK- 168 (829)
T ss_pred CCcccceee---ecccchhHHHHHHHhhhhccchhhhc---CCcccccccccceeecccCceeecccCchhhhhhhhhh-
Confidence 999999887 45789999999999999999999998 89999999999999999999999999998776554333
Q ss_pred eecccCCccccCCCCC---CCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeeccccccc
Q 002336 773 SSVARGTVGYLDPEYY---GNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 849 (935)
Q Consensus 773 ~~~~~gt~~y~APE~l---~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~ 849 (935)
.....||+.|||||+. ..+.|..++|||++|+...|+---+.|.- + .+..+-..-+-+ +..+|.-.
T Consensus 169 rksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplf----d--lhpmr~l~LmTk-----S~~qpp~l 237 (829)
T KOG0576|consen 169 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLF----D--LHPMRALFLMTK-----SGFQPPTL 237 (829)
T ss_pred hhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCccc----c--cchHHHHHHhhc-----cCCCCCcc
Confidence 3345699999999975 45678999999999999999987776642 1 111111111111 11222111
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 850 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 850 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
+-+......+.++++.|+..+|++||+++.+++
T Consensus 238 -kDk~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 238 -KDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred -cCCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 112334456889999999999999999988765
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.4e-23 Score=258.50 Aligned_cols=195 Identities=19% Similarity=0.274 Sum_probs=137.8
Q ss_pred hcCC-Ccccccceee-------eccceEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCce
Q 002336 665 RIHH-RNLVPLIGYC-------EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 736 (935)
Q Consensus 665 ~L~H-pnIv~l~g~~-------~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~i 736 (935)
.++| +||++++++| .+....++++|++ +++|.++|.. ....+++.+++.++.||++||+|||+ ++|
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~---~gI 101 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN--PDRSVDAFECFHVFRQIVEIVNAAHS---QGI 101 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc--ccccccHHHHHHHHHHHHHHHHHHHh---CCe
Confidence 4455 6888888877 2234567788887 6699999974 24569999999999999999999998 999
Q ss_pred EecCCCCCCccccCCC-------------------cEEEeeccccccccccc--------c-------ceeecccCCccc
Q 002336 737 IHRDVKSSNILLDINM-------------------RAKVSDFGLSRQAEEDL--------T-------HISSVARGTVGY 782 (935)
Q Consensus 737 vH~DLkp~NILld~~~-------------------~vkL~DFGla~~~~~~~--------~-------~~~~~~~gt~~y 782 (935)
+||||||+||||+..+ .+|++|||+++...... . .......||+.|
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 181 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY 181 (793)
T ss_pred eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence 9999999999996544 45556666654321100 0 000113478889
Q ss_pred cCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccCCCCHHHHHHHHH
Q 002336 783 LDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAE 862 (935)
Q Consensus 783 ~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~~~~~~~~~~l~~ 862 (935)
||||++.+..++.++|||||||+||||++|..|+.... .. ... +... .+.+.. ........+
T Consensus 182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~-----~~---~~~-~~~~----~~~~~~-----~~~~~~~~~ 243 (793)
T PLN00181 182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS-----RT---MSS-LRHR----VLPPQI-----LLNWPKEAS 243 (793)
T ss_pred EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH-----HH---HHH-HHHh----hcChhh-----hhcCHHHHH
Confidence 99999999999999999999999999999988865211 00 100 1000 011111 011224568
Q ss_pred HHHHccccCCCCCCCHHHHHH
Q 002336 863 VAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 863 li~~Cl~~dP~~RPs~~ev~~ 883 (935)
++.+||+.+|.+||++.|+++
T Consensus 244 ~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 244 FCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred HHHHhCCCChhhCcChHHHhh
Confidence 888999999999999999975
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.4e-22 Score=203.98 Aligned_cols=169 Identities=22% Similarity=0.213 Sum_probs=126.4
Q ss_pred CCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccccccccee
Q 002336 694 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 773 (935)
Q Consensus 694 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~~~ 773 (935)
|+|.++++.. +..+++.+++.++.|+++||+|||+ .+ ||+|||++.++.+|+ ||+++......
T Consensus 1 GsL~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~lH~---~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~---- 63 (176)
T smart00750 1 VSLADILEVR--GRPLNEEEIWAVCLQCLRALRELHR---QA------KSGNILLTWDGLLKL--DGSVAFKTPEQ---- 63 (176)
T ss_pred CcHHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHh---cC------CcccEeEcCccceee--ccceEeecccc----
Confidence 6899998742 4569999999999999999999997 44 999999999999999 99987654322
Q ss_pred ecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccCCCC
Q 002336 774 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVK 853 (935)
Q Consensus 774 ~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~~~~ 853 (935)
..|++.|+|||++.+..++.++|||||||++|||++|+.||..... ....+..+..... .. ++.- ....
T Consensus 64 --~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~-~~~~~~~~~~~~~-~~------~~~~-~~~~ 132 (176)
T smart00750 64 --SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERE-LSAILEILLNGMP-AD------DPRD-RSNL 132 (176)
T ss_pred --CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccch-hcHHHHHHHHHhc-cC------Cccc-cccH
Confidence 2478999999999999999999999999999999999999963221 1111111111111 10 0000 0011
Q ss_pred HHHH--HHHHHHHHHccccCCCCCCCHHHHHHHHhhhhh
Q 002336 854 IESI--WRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 890 (935)
Q Consensus 854 ~~~~--~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~~~ 890 (935)
.... ..+.+++.+||..+|++||++.|+++.+.....
T Consensus 133 ~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~ 171 (176)
T smart00750 133 ESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFA 171 (176)
T ss_pred HHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHH
Confidence 1122 258999999999999999999999998876543
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.88 E-value=8.5e-23 Score=220.89 Aligned_cols=259 Identities=25% Similarity=0.344 Sum_probs=190.3
Q ss_pred HHhhcccccccccEEEEEEEEC----CCcEEEEEEccCcchhhhHHHHHHHHHHHhcC-CCcccccceeeeccceEEEEE
Q 002336 614 TNNFCKKIGKGSFGSVYYGKMK----DGKEVAVKIMADSCSHRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQRILVY 688 (935)
Q Consensus 614 ~~~~~~~LG~G~fG~Vy~~~~~----~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~-HpnIv~l~g~~~~~~~~~lV~ 688 (935)
.+...++||+|.|++||++.+. ..+.||+|.+...+ ....+.+|+++|..+. +.||+++.+++..++...+|+
T Consensus 37 ~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivl 114 (418)
T KOG1167|consen 37 AYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVL 114 (418)
T ss_pred hhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEe
Confidence 3455789999999999999754 36789999986543 3456899999999994 999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccC-CCcEEEeeccccccccc
Q 002336 689 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI-NMRAKVSDFGLSRQAEE 767 (935)
Q Consensus 689 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~-~~~vkL~DFGla~~~~~ 767 (935)
||++.....++... ++..++..++..++.||+++|+ +|||||||||+|+|.+. -+.-.|+|||++.....
T Consensus 115 p~~~H~~f~~l~~~------l~~~~i~~Yl~~ll~Al~~~h~---~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~ 185 (418)
T KOG1167|consen 115 PYFEHDRFRDLYRS------LSLAEIRWYLRNLLKALAHLHK---NGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDG 185 (418)
T ss_pred cccCccCHHHHHhc------CCHHHHHHHHHHHHHHhhhhhc---cCccccCCCccccccccccCCceEEechhHHHHHh
Confidence 99999999888763 5678899999999999999998 99999999999999984 46689999999872110
Q ss_pred c-------c------c------------------------------ceeecccCCccccCCCCCCC-CCCCchhHHHHHH
Q 002336 768 D-------L------T------------------------------HISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFG 803 (935)
Q Consensus 768 ~-------~------~------------------------------~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwS~G 803 (935)
. . . .......||++|+|||++.. +..+.+.||||.|
T Consensus 186 ~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~G 265 (418)
T KOG1167|consen 186 YQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAG 265 (418)
T ss_pred hhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeecc
Confidence 0 0 0 00112359999999998754 5778999999999
Q ss_pred HHHHHHHhCCCCCCccCcccchhHHHHH--------HHh-hhcCC--eee------ccc----------ccc-cCCC---
Q 002336 804 VVLLELISGKKPVSVEDFGAELNIVHWA--------RSM-IKKGD--VIS------IVD----------PVL-IGNV--- 852 (935)
Q Consensus 804 vil~eLltG~~Pf~~~~~~~~~~l~~~~--------~~~-i~~~~--~~~------~~d----------~~l-~~~~--- 852 (935)
||++.+++++.||-....+ -..+.+.+ ++. .-.|. +.+ +.+ ..+ ....
T Consensus 266 VI~Lslls~~~PFf~a~dd-~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~ 344 (418)
T KOG1167|consen 266 VILLSLLSRRYPFFKAKDD-ADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNT 344 (418)
T ss_pred ceeehhhccccccccCccc-cchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccce
Confidence 9999999999998644332 11111111 110 01111 111 100 000 0001
Q ss_pred -----CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002336 853 -----KIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 884 (935)
Q Consensus 853 -----~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~ 884 (935)
.......+.+++.+|++.+|.+|.|++|.++.
T Consensus 345 ~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH 381 (418)
T KOG1167|consen 345 EREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH 381 (418)
T ss_pred eeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence 01111257899999999999999999998864
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.1e-22 Score=206.63 Aligned_cols=251 Identities=22% Similarity=0.356 Sum_probs=191.8
Q ss_pred HHHhhcccccccccEEEEEEEECCCcEEEEEEccCc--chhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEe
Q 002336 613 ATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 690 (935)
Q Consensus 613 ~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~~~~~--~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~ 690 (935)
...++..+|.+...|..|+|+|. |..+++|++.-. .....++|.+|.-.|+.+.||||+.++|.|....+..++..|
T Consensus 190 ~~lnl~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~ 268 (448)
T KOG0195|consen 190 SSLNLITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQY 268 (448)
T ss_pred hhhhhhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeee
Confidence 44566778999999999999999 666777776532 222346899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEe--ecccccccccc
Q 002336 691 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVS--DFGLSRQAEED 768 (935)
Q Consensus 691 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~--DFGla~~~~~~ 768 (935)
|+.|+|+..|++. .....+..++.+++.++|+|++|||+- .+-|..--|..+.++||++..++|+ |--++..
T Consensus 269 mp~gslynvlhe~-t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarismad~kfsfq---- 342 (448)
T KOG0195|consen 269 MPFGSLYNVLHEQ-TSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ---- 342 (448)
T ss_pred ccchHHHHHHhcC-ccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheecccceeeee----
Confidence 9999999999965 345577889999999999999999983 3344445689999999999998875 3222211
Q ss_pred ccceeecccCCccccCCCCCCCCCC---CchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeeccc
Q 002336 769 LTHISSVARGTVGYLDPEYYGNQQL---TEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 845 (935)
Q Consensus 769 ~~~~~~~~~gt~~y~APE~l~~~~~---s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d 845 (935)
.....-.+.||+||.++..+- -.++|+|||++++|||.|...||.....-+- ..++ .-
T Consensus 343 ----e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmec-------gmki--------al 403 (448)
T KOG0195|consen 343 ----EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMEC-------GMKI--------AL 403 (448)
T ss_pred ----ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhh-------hhhh--------hh
Confidence 112234788999999876543 3689999999999999999999973221110 0011 11
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhhh
Q 002336 846 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI 889 (935)
Q Consensus 846 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~~ 889 (935)
+.+.-..++.....+..++.-|+.+||.+||.+..|+-.|++++
T Consensus 404 eglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 404 EGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred ccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 12333444555557788999999999999999999999988764
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=8.5e-21 Score=212.15 Aligned_cols=262 Identities=24% Similarity=0.320 Sum_probs=196.3
Q ss_pred HHhhcccccccccEEEEEEEECCC--cEEEEEEccCcchhhhHHHHHHHHHHHhcCC----Ccccccceee-eccceEEE
Q 002336 614 TNNFCKKIGKGSFGSVYYGKMKDG--KEVAVKIMADSCSHRTQQFVTEVALLSRIHH----RNLVPLIGYC-EEEHQRIL 686 (935)
Q Consensus 614 ~~~~~~~LG~G~fG~Vy~~~~~~g--~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~H----pnIv~l~g~~-~~~~~~~l 686 (935)
.+.+.+.||+|+||.||++..... +.+|+|............+..|..++..+.+ +++..+++.. ..+...++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 567789999999999999987653 5789888765433333378889999998863 5888888888 47778899
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCC-----CcEEEeeccc
Q 002336 687 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN-----MRAKVSDFGL 761 (935)
Q Consensus 687 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~-----~~vkL~DFGl 761 (935)
||+.+ |.+|.++..... .+.++..+.++++.|++.+|++||+ .|++||||||.|++++.. ..+.|.|||+
T Consensus 99 VM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~---~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl 173 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHS---KGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGL 173 (322)
T ss_pred EEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHh---cCcccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence 99987 889999876543 5779999999999999999999998 999999999999999865 4699999999
Q ss_pred cc--ccccccc----ce---eecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHH
Q 002336 762 SR--QAEEDLT----HI---SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWAR 832 (935)
Q Consensus 762 a~--~~~~~~~----~~---~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~ 832 (935)
++ .+..... .. .....||..|++++...+...+.+.|+||++.++.|++.|..||.............
T Consensus 174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~--- 250 (322)
T KOG1164|consen 174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFE--- 250 (322)
T ss_pred CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHH---
Confidence 98 3221111 11 123459999999999999999999999999999999999999996444322211111
Q ss_pred HhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhhhhhc
Q 002336 833 SMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 892 (935)
Q Consensus 833 ~~i~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~~~~~ 892 (935)
+.... ..... .....+. .+.++...+-..+..++|....+...|++....+
T Consensus 251 ~~~~~----~~~~~--~~~~~~~---~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~ 301 (322)
T KOG1164|consen 251 KDPRK----LLTDR--FGDLKPE---EFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE 301 (322)
T ss_pred HHhhh----hcccc--ccCCChH---HHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence 11110 00110 1112223 4455555555689999999999999988877655
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=5.8e-21 Score=199.85 Aligned_cols=262 Identities=19% Similarity=0.248 Sum_probs=204.9
Q ss_pred HHhhcccccccccEEEEEEE-ECCCcEEEEEEccCcchhhhHHHHHHHHHHHhcC-CCcccccceeeeccceEEEEEEec
Q 002336 614 TNNFCKKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQRILVYEYM 691 (935)
Q Consensus 614 ~~~~~~~LG~G~fG~Vy~~~-~~~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~-HpnIv~l~g~~~~~~~~~lV~E~~ 691 (935)
-|+++++||+|.||.++.|+ +-++++||||.-. ......++..|.+..+.|. .++|..++.|..++.+..||+|.+
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEP--rkS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL 106 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEP--RKSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL 106 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEecc--ccCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh
Confidence 35678999999999999996 4579999999743 3345578889999999985 799999998888898999999998
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccC-----CCcEEEeecccccccc
Q 002336 692 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI-----NMRAKVSDFGLSRQAE 766 (935)
Q Consensus 692 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~-----~~~vkL~DFGla~~~~ 766 (935)
|-||+|+..- .+..++.+++..+|.|++.-++|+|+ +.+|.|||||+|+||.. ...+.|+|||+|+.+.
T Consensus 107 -GPSLEDLFD~--CgR~FSvKTV~miA~Qmi~rie~vH~---k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Yr 180 (449)
T KOG1165|consen 107 -GPSLEDLFDL--CGRRFSVKTVAMIAKQMITRIEYVHE---KDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYR 180 (449)
T ss_pred -CcCHHHHHHH--hcCcccHHhHHHHHHHHHHHHHHHHh---cceeecccCccceeecCCCCCCCceEEEEeccchhhhc
Confidence 8899998875 46789999999999999999999998 99999999999999964 3448999999999987
Q ss_pred ccccce------eecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCe
Q 002336 767 EDLTHI------SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV 840 (935)
Q Consensus 767 ~~~~~~------~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~ 840 (935)
+..... .+...||.+||+-....+...+.+.|+-|+|-++++.+-|..||.+-..+......+-+.+.-+...+
T Consensus 181 Dp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T~i 260 (449)
T KOG1165|consen 181 DPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRSTPI 260 (449)
T ss_pred CccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccCCH
Confidence 654432 23456999999999999999999999999999999999999999976665443333322222222222
Q ss_pred eecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhhhhhc
Q 002336 841 ISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 892 (935)
Q Consensus 841 ~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~~~~~ 892 (935)
.++.+ .-+ +++...+.-.-..+..+-|+.+-+...+.+++...
T Consensus 261 ~~Lc~------g~P---~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~ 303 (449)
T KOG1165|consen 261 EVLCE------GFP---EEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRL 303 (449)
T ss_pred HHHHh------cCH---HHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhc
Confidence 22211 122 34445555555778889999998888877766443
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=8.8e-21 Score=212.22 Aligned_cols=162 Identities=19% Similarity=0.154 Sum_probs=125.3
Q ss_pred HHHhhcccccccccEEEEEEEEC--CCcEEEEEEccCcc-----hhhhHHHHHHHHHHHhcCCCcccccceeeeccceEE
Q 002336 613 ATNNFCKKIGKGSFGSVYYGKMK--DGKEVAVKIMADSC-----SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRI 685 (935)
Q Consensus 613 ~~~~~~~~LG~G~fG~Vy~~~~~--~g~~vAvK~~~~~~-----~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~ 685 (935)
..|.+.+.||+|+||+||+|.++ +++.+|||++.... ....+.+.+|+++|++++|+|++..+..+ ...+
T Consensus 18 ~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---~~~~ 94 (365)
T PRK09188 18 ARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---GKDG 94 (365)
T ss_pred CCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---CCcE
Confidence 34667889999999999999875 57778999865321 22345689999999999999998633222 4579
Q ss_pred EEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCC-CCCCccccCCCcEEEeecccccc
Q 002336 686 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDV-KSSNILLDINMRAKVSDFGLSRQ 764 (935)
Q Consensus 686 lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DL-kp~NILld~~~~vkL~DFGla~~ 764 (935)
+||||++|++|... .. .. ...++.|++++|.|||+ ++|+|||| ||+|||++.++.+||+|||+++.
T Consensus 95 LVmE~~~G~~L~~~-~~---~~------~~~~~~~i~~aL~~lH~---~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~ 161 (365)
T PRK09188 95 LVRGWTEGVPLHLA-RP---HG------DPAWFRSAHRALRDLHR---AGITHNDLAKPQNWLMGPDGEAAVIDFQLASV 161 (365)
T ss_pred EEEEccCCCCHHHh-Cc---cc------hHHHHHHHHHHHHHHHH---CCCeeCCCCCcceEEEcCCCCEEEEECcccee
Confidence 99999999999732 11 11 14678999999999998 99999999 99999999999999999999987
Q ss_pred cccccccee-------ecccCCccccCCCCCCC
Q 002336 765 AEEDLTHIS-------SVARGTVGYLDPEYYGN 790 (935)
Q Consensus 765 ~~~~~~~~~-------~~~~gt~~y~APE~l~~ 790 (935)
......... ....+++.|+|||.+..
T Consensus 162 ~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 162 FRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred cccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 644321111 23457888999999854
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.4e-20 Score=187.37 Aligned_cols=262 Identities=21% Similarity=0.282 Sum_probs=199.2
Q ss_pred HHHHHhhcccccccccEEEEEEE-ECCCcEEEEEEccCcchhhhHHHHHHHHHHHhcCC-CcccccceeeeccceEEEEE
Q 002336 611 EEATNNFCKKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHH-RNLVPLIGYCEEEHQRILVY 688 (935)
Q Consensus 611 ~~~~~~~~~~LG~G~fG~Vy~~~-~~~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~H-pnIv~l~g~~~~~~~~~lV~ 688 (935)
....|.+.++||.|+||.+|.|. ..+|++||||+-+.. ....++..|..+.+.|+| ..|..+.-+..+.....+||
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~--a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM 90 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSK--AKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM 90 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeeccc--CCCcchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence 34557778999999999999996 568999999986543 334578889999999974 67888888888888999999
Q ss_pred EecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccC---CCcEEEeeccccccc
Q 002336 689 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI---NMRAKVSDFGLSRQA 765 (935)
Q Consensus 689 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~---~~~vkL~DFGla~~~ 765 (935)
+.+ |.+|++++.- ....++.++.+-++-|++.-++|+|. ++++||||||+|+|+.- ...+.|+|||+++.+
T Consensus 91 dLL-GPsLEdLfnf--C~R~ftmkTvLMLaDQml~RiEyvH~---r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky 164 (341)
T KOG1163|consen 91 DLL-GPSLEDLFNF--CSRRFTMKTVLMLADQMLSRIEYVHL---RNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY 164 (341)
T ss_pred ecc-CccHHHHHHH--HhhhhhHHhHHHHHHHHHHHHHHHHh---hccccccCCccceeeccccccceEEEEeccchhhh
Confidence 998 8899998874 35668889999999999999999997 99999999999999963 456899999999987
Q ss_pred cccccce------eecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCC
Q 002336 766 EEDLTHI------SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD 839 (935)
Q Consensus 766 ~~~~~~~------~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~ 839 (935)
-+..... .....||..|.+-....+...+.+.|+-|+|.+|...-.|..||++-......+..+-+.++ .
T Consensus 165 ~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~Ek----K 240 (341)
T KOG1163|consen 165 RDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEK----K 240 (341)
T ss_pred ccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHh----h
Confidence 5543221 22345899999988888888899999999999999999999999865554433333322221 1
Q ss_pred eeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhhh
Q 002336 840 VISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI 889 (935)
Q Consensus 840 ~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~~ 889 (935)
....++. +-..+ +.++.-.+..|-..-.++-|+..-+-+.++-+.
T Consensus 241 ~s~~ie~-LC~G~----P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLf 285 (341)
T KOG1163|consen 241 MSTPIEV-LCKGF----PAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILF 285 (341)
T ss_pred cCCCHHH-HhCCC----cHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHH
Confidence 1111111 11112 235667777888888888898887777665443
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.82 E-value=4.8e-19 Score=194.25 Aligned_cols=259 Identities=29% Similarity=0.442 Sum_probs=196.1
Q ss_pred hhcccccccccEEEEEEEECCCcEEEEEEccCcchh---hhHHHHHHHHHHHhcCCC-cccccceeeeccceEEEEEEec
Q 002336 616 NFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSH---RTQQFVTEVALLSRIHHR-NLVPLIGYCEEEHQRILVYEYM 691 (935)
Q Consensus 616 ~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~~~~~~~~---~~~~~~~E~~iL~~L~Hp-nIv~l~g~~~~~~~~~lV~E~~ 691 (935)
.+.+.||.|.||.||++... +.+++|.+...... ....+.+|..+++.+.|+ +++++.+.+......+++++++
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 80 (384)
T COG0515 3 RILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYV 80 (384)
T ss_pred eeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecC
Confidence 45678999999999999887 88999998764333 357799999999999988 7999999997777789999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCC-cEEEeecccccccccccc
Q 002336 692 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM-RAKVSDFGLSRQAEEDLT 770 (935)
Q Consensus 692 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~-~vkL~DFGla~~~~~~~~ 770 (935)
.++++.+.+........+.......++.|++.++.|+|+ .+++|||+||+||+++..+ .++++|||.++.......
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~---~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~ 157 (384)
T COG0515 81 DGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS---KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGS 157 (384)
T ss_pred CCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCc
Confidence 999999777632111368899999999999999999998 8899999999999999988 799999999986544332
Q ss_pred c-----eeecccCCccccCCCCCCC---CCCCchhHHHHHHHHHHHHHhCCCCCCccCcc-cchhHHHHHHHhhhcCCee
Q 002336 771 H-----ISSVARGTVGYLDPEYYGN---QQLTEKSDVYSFGVVLLELISGKKPVSVEDFG-AELNIVHWARSMIKKGDVI 841 (935)
Q Consensus 771 ~-----~~~~~~gt~~y~APE~l~~---~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~-~~~~l~~~~~~~i~~~~~~ 841 (935)
. ......|+..|+|||.+.+ .......|+|++|++++++++|..||...... ......+ .+......
T Consensus 158 ~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~----~~~~~~~~ 233 (384)
T COG0515 158 TSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLK----IILELPTP 233 (384)
T ss_pred cccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHH----HHHhcCCc
Confidence 1 2345679999999999887 68899999999999999999999997633321 0111111 11111110
Q ss_pred ecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002336 842 SIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 884 (935)
Q Consensus 842 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~ 884 (935)
.................+.+++.+|+..+|..|.++.+....
T Consensus 234 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 234 -SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred -ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 000000000001223467899999999999999999987764
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.79 E-value=7.6e-20 Score=217.62 Aligned_cols=252 Identities=22% Similarity=0.261 Sum_probs=184.0
Q ss_pred hcccccccccEEEEEEEEC-CCcEEEEEEcc----Ccch--hhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEE
Q 002336 617 FCKKIGKGSFGSVYYGKMK-DGKEVAVKIMA----DSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 689 (935)
Q Consensus 617 ~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~----~~~~--~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E 689 (935)
..+.+|.|.+|.|+..... ..+..+.|..+ .... .....+..|+-+-..++|+|++..+..+.+.....-+||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 4578999999988777543 34444444432 2111 112236678888888999999998888777666666699
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccc
Q 002336 690 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 769 (935)
Q Consensus 690 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~ 769 (935)
|+++ +|..++.. ...+...++-.+++|++.|++|||+ .||.|||+|++|+++..+|.+||+|||.+..+.-..
T Consensus 402 ~~~~-Dlf~~~~~---~~~~~~~e~~c~fKqL~~Gv~y~h~---~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~ 474 (601)
T KOG0590|consen 402 YCPY-DLFSLVMS---NGKLTPLEADCFFKQLLRGVKYLHS---MGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPW 474 (601)
T ss_pred cccH-HHHHHHhc---ccccchhhhhHHHHHHHHHHHHHHh---cCceeccCccccEEEecCCceEEeecCcceeeccCc
Confidence 9999 99999873 3467788889999999999999998 999999999999999999999999999987654332
Q ss_pred c---ceeecccCCccccCCCCCCCCCCCc-hhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeeccc
Q 002336 770 T---HISSVARGTVGYLDPEYYGNQQLTE-KSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 845 (935)
Q Consensus 770 ~---~~~~~~~gt~~y~APE~l~~~~~s~-ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d 845 (935)
. .......|...|+|||.+....|.+ ..||||.|+++..|++|+.||..+...+... ......+.. .+..
T Consensus 475 e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~-----~~~~~~~~~-~~~~ 548 (601)
T KOG0590|consen 475 EKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF-----KTNNYSDQR-NIFE 548 (601)
T ss_pred chhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch-----hhhcccccc-cccc
Confidence 2 4455667999999999999888875 6799999999999999999998554433211 000000000 0000
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 846 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 846 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
-....-...+.....++-+|++.+|.+|-|+++|++
T Consensus 549 --~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 549 --GPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred --ChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 000011233446678999999999999999999875
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.78 E-value=5.9e-19 Score=181.64 Aligned_cols=140 Identities=18% Similarity=0.187 Sum_probs=109.4
Q ss_pred cccccccccEEEEEEEECCCcEEEEEEccCcchh--h-------h-----------------HHHHHHHHHHHhcCCCcc
Q 002336 618 CKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSH--R-------T-----------------QQFVTEVALLSRIHHRNL 671 (935)
Q Consensus 618 ~~~LG~G~fG~Vy~~~~~~g~~vAvK~~~~~~~~--~-------~-----------------~~~~~E~~iL~~L~HpnI 671 (935)
...||+|++|.||+|...+|+.||||+++..... . . .....|++.+.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4679999999999999888999999998754211 0 1 122349999999988877
Q ss_pred cccceeeeccceEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHh-hhcCCCceEecCCCCCCccccC
Q 002336 672 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYL-HTGCNPGIIHRDVKSSNILLDI 750 (935)
Q Consensus 672 v~l~g~~~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yL-Hs~~~~~ivH~DLkp~NILld~ 750 (935)
.....+.. ...++||||++++++..... ....++.....+++.|++.+|.+| |+ .+|+||||||+|||++
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~---~~~~~~~~~~~~i~~qi~~~L~~l~H~---~giiHrDlkP~NIli~- 152 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRL---KDAPLSESKARELYLQVIQIMRILYQD---CRLVHADLSEYNLLYH- 152 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhh---hcCCCCHHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEE-
Confidence 54443322 22389999999887765432 235688899999999999999999 56 8999999999999998
Q ss_pred CCcEEEeecccccccc
Q 002336 751 NMRAKVSDFGLSRQAE 766 (935)
Q Consensus 751 ~~~vkL~DFGla~~~~ 766 (935)
++.++|+|||++....
T Consensus 153 ~~~v~LiDFG~a~~~~ 168 (190)
T cd05147 153 DGKLYIIDVSQSVEHD 168 (190)
T ss_pred CCcEEEEEccccccCC
Confidence 4789999999987543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=3.1e-19 Score=186.28 Aligned_cols=175 Identities=15% Similarity=0.187 Sum_probs=135.3
Q ss_pred hhhHHHHHHhhcccccccccEEEEEEEECCCcEEEEEEccCcchhhhH---------HHHHHHHHHHhcCCCccccccee
Q 002336 607 LPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQ---------QFVTEVALLSRIHHRNLVPLIGY 677 (935)
Q Consensus 607 ~~~l~~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~~~~~~~~~~~---------~~~~E~~iL~~L~HpnIv~l~g~ 677 (935)
.+++....++..+.+|.|+||.||+... ++..+|+|++++......+ .+.+|++.+.+++|++|..+.++
T Consensus 25 ~~~~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~ 103 (232)
T PRK10359 25 FDDFLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDF 103 (232)
T ss_pred HHHHhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEe
Confidence 4566677788899999999999999766 5778999999754332222 26889999999999999999887
Q ss_pred eecc--------ceEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCcccc
Q 002336 678 CEEE--------HQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD 749 (935)
Q Consensus 678 ~~~~--------~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld 749 (935)
+... ...+++|||++|.+|.+... ++. ....+++.+|..||. .+++|||+||+||+++
T Consensus 104 ~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~---~gi~H~Dikp~Nili~ 169 (232)
T PRK10359 104 YLLAERKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQ---HGMVSGDPHKGNFIVS 169 (232)
T ss_pred eeecccccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHH---cCCccCCCChHHEEEe
Confidence 5432 35789999999999988742 222 245699999999998 9999999999999999
Q ss_pred CCCcEEEeeccccccccccccceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHH
Q 002336 750 INMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELI 810 (935)
Q Consensus 750 ~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLl 810 (935)
.++ ++|+|||........... ..+.....+..++|+|+||+.+....
T Consensus 170 ~~g-i~liDfg~~~~~~e~~a~-------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 170 KNG-LRIIDLSGKRCTAQRKAK-------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CCC-EEEEECCCcccccchhhH-------------HHHHHHhHhcccccccceeEeehHHH
Confidence 988 999999988655322111 00333445667999999999987654
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.6e-19 Score=211.46 Aligned_cols=247 Identities=21% Similarity=0.304 Sum_probs=177.8
Q ss_pred HhhcccccccccEEEEEEEECCCcEEEEEEccCcc-hhhhHHHH---HHHHHHHhcCCCcccccceeeeccceEEEEEEe
Q 002336 615 NNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSC-SHRTQQFV---TEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 690 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~~~~~~-~~~~~~~~---~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~ 690 (935)
+.+.+.||.+.|=+|.+|++++|. |+||++.+.. .-..+.|. +|++ ...++|||.+.+.-....+...|||-+|
T Consensus 25 ~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 25 CHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred eeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 344688999999999999999888 9999986543 22233343 3444 5556899999998887777777888888
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccc--ccc
Q 002336 691 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA--EED 768 (935)
Q Consensus 691 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~--~~~ 768 (935)
..+ +|+|.|. .+.-+...+.+.|+.|++.||..+|. .+|+|||||.+||||+.-.=+.|+||..-+.. .++
T Consensus 103 vkh-nLyDRlS---TRPFL~~iEKkWiaFQLL~al~qcH~---~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeD 175 (1431)
T KOG1240|consen 103 VKH-NLYDRLS---TRPFLVLIEKKWIAFQLLKALSQCHK---LGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPED 175 (1431)
T ss_pred Hhh-hhhhhhc---cchHHHHHHHHHHHHHHHHHHHHHHH---cCccccccccceEEEeeechhhhhcccccCCccCCCC
Confidence 855 8999987 45667888899999999999999997 99999999999999998877999999765442 111
Q ss_pred ccc----eeecccCCccccCCCCCCC-----------CCCCchhHHHHHHHHHHHHHh-CCCCCCccCcccchhHHHHHH
Q 002336 769 LTH----ISSVARGTVGYLDPEYYGN-----------QQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWAR 832 (935)
Q Consensus 769 ~~~----~~~~~~gt~~y~APE~l~~-----------~~~s~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~ 832 (935)
... .......-..|+|||.+.. ...+++.||||+||++.||++ |++||. +.+...
T Consensus 176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~---------LSQL~a 246 (1431)
T KOG1240|consen 176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT---------LSQLLA 246 (1431)
T ss_pred CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc---------HHHHHh
Confidence 111 1112223457999997632 126789999999999999988 788886 222222
Q ss_pred HhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 002336 833 SMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 886 (935)
Q Consensus 833 ~~i~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~ 886 (935)
..-.+ .......+.. .+. ..+.+++..|++.||++|-++++.++..+
T Consensus 247 Yr~~~---~~~~e~~Le~-Ied---~~~Rnlil~Mi~rdPs~RlSAedyL~~yr 293 (1431)
T KOG1240|consen 247 YRSGN---ADDPEQLLEK-IED---VSLRNLILSMIQRDPSKRLSAEDYLQKYR 293 (1431)
T ss_pred HhccC---ccCHHHHHHh-CcC---ccHHHHHHHHHccCchhccCHHHHHHhhh
Confidence 11111 0000011110 000 15779999999999999999999998743
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.2e-17 Score=172.25 Aligned_cols=141 Identities=21% Similarity=0.253 Sum_probs=111.7
Q ss_pred cccccccccEEEEEEEECCCcEEEEEEccCcchh--------------------------hhHHHHHHHHHHHhcCCCcc
Q 002336 618 CKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSH--------------------------RTQQFVTEVALLSRIHHRNL 671 (935)
Q Consensus 618 ~~~LG~G~fG~Vy~~~~~~g~~vAvK~~~~~~~~--------------------------~~~~~~~E~~iL~~L~HpnI 671 (935)
...||+|++|.||+|...+|+.||||+++..... ....+..|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 4679999999999999888999999998754211 01124578999999999987
Q ss_pred cccceeeeccceEEEEEEecCCCCHHHH-hccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccC
Q 002336 672 VPLIGYCEEEHQRILVYEYMHNGTLRDR-LHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI 750 (935)
Q Consensus 672 v~l~g~~~~~~~~~lV~E~~~~gsL~~~-L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~ 750 (935)
.....+... ..++||||++++++... +. ...++.....+++.|++.++.+||+ ..+|+||||||+|||++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~----~~~~~~~~~~~i~~~l~~~l~~lH~--~~givHrDlkP~NIll~- 152 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLK----DVPLEEEEAEELYEQVVEQMRRLYQ--EAGLVHGDLSEYNILYH- 152 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhh----hccCCHHHHHHHHHHHHHHHHHHHH--hCCEecCCCChhhEEEE-
Confidence 655444333 24899999998855433 33 3457788899999999999999996 37999999999999999
Q ss_pred CCcEEEeeccccccccc
Q 002336 751 NMRAKVSDFGLSRQAEE 767 (935)
Q Consensus 751 ~~~vkL~DFGla~~~~~ 767 (935)
++.++|+|||++....+
T Consensus 153 ~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 153 DGKPYIIDVSQAVELDH 169 (190)
T ss_pred CCCEEEEEcccceecCC
Confidence 88999999999976543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=8.2e-18 Score=191.53 Aligned_cols=218 Identities=28% Similarity=0.414 Sum_probs=164.2
Q ss_pred HHhcCCCcccccceeeeccceEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCC
Q 002336 663 LSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVK 742 (935)
Q Consensus 663 L~~L~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLk 742 (935)
|+.+.|.|+.+++|.+.++...+.|.+||..|+|.|.+.. ....+++.-...++++++.||.|||.. .--+|+.++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~--~~~~~d~~F~~s~~rdi~~Gl~ylh~s--~i~~hg~l~ 76 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN--EDIKLDYFFILSFIRDISKGLAYLHNS--PIGYHGALK 76 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc--cccCccHHHHHHHHHHHHHHHHHHhcC--cceeeeeec
Confidence 3567899999999999999999999999999999999985 356789999999999999999999982 333999999
Q ss_pred CCCccccCCCcEEEeecccccccccc-ccceeecccCCccccCCCCCCCC-------CCCchhHHHHHHHHHHHHHhCCC
Q 002336 743 SSNILLDINMRAKVSDFGLSRQAEED-LTHISSVARGTVGYLDPEYYGNQ-------QLTEKSDVYSFGVVLLELISGKK 814 (935)
Q Consensus 743 p~NILld~~~~vkL~DFGla~~~~~~-~~~~~~~~~gt~~y~APE~l~~~-------~~s~ksDVwS~Gvil~eLltG~~ 814 (935)
.+|+++|..+.+||+|||+....... .........-..-|.|||.+... ..+.+.||||||++++|+++.+.
T Consensus 77 s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~ 156 (484)
T KOG1023|consen 77 SSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG 156 (484)
T ss_pred cccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence 99999999999999999998765421 11111112234569999988653 24678999999999999999999
Q ss_pred CCCccCcccc-hhHHHHHHHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhhhhh
Q 002336 815 PVSVEDFGAE-LNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 891 (935)
Q Consensus 815 Pf~~~~~~~~-~~l~~~~~~~i~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~~~~ 891 (935)
||+....... ..++..++. .+ ...+-|.+.... +....+..++.+||..+|++||+++.|-..++.+...
T Consensus 157 ~~~~~~~~~~~~eii~~~~~---~~--~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~ 227 (484)
T KOG1023|consen 157 PFDLRNLVEDPDEIILRVKK---GG--SNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKG 227 (484)
T ss_pred ccccccccCChHHHHHHHHh---cC--CCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhccc
Confidence 9985444322 234443332 01 111222221111 2333689999999999999999999998887766553
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.71 E-value=5.8e-17 Score=165.78 Aligned_cols=182 Identities=15% Similarity=0.145 Sum_probs=137.9
Q ss_pred cccccccccEEEEEEEECCCcEEEEEEccCcchh----hhHHHHHHHHHHHhcC-CCcccccceeeeccceEEEEEEecC
Q 002336 618 CKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSH----RTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQRILVYEYMH 692 (935)
Q Consensus 618 ~~~LG~G~fG~Vy~~~~~~g~~vAvK~~~~~~~~----~~~~~~~E~~iL~~L~-HpnIv~l~g~~~~~~~~~lV~E~~~ 692 (935)
...|++|+||+||.+.- .+.+++.+.+...... ....+.+|+++|++|+ |+++++++++ ...+++|||++
T Consensus 7 ~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~ 81 (218)
T PRK12274 7 NEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLA 81 (218)
T ss_pred ceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeec
Confidence 46899999999997766 5888887777654321 1235889999999995 5889999886 34699999999
Q ss_pred CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCC-CCCCccccCCCcEEEeeccccccccccccc
Q 002336 693 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDV-KSSNILLDINMRAKVSDFGLSRQAEEDLTH 771 (935)
Q Consensus 693 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DL-kp~NILld~~~~vkL~DFGla~~~~~~~~~ 771 (935)
|.+|.+.+.. ....++.|++++|+++|+ .||+|||| ||.|||++.++.++|+|||++.........
T Consensus 82 G~~L~~~~~~----------~~~~~~~qi~~~L~~lH~---~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~ 148 (218)
T PRK12274 82 GAAMYQRPPR----------GDLAYFRAARRLLQQLHR---CGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARW 148 (218)
T ss_pred CccHHhhhhh----------hhHHHHHHHHHHHHHHHH---CcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchH
Confidence 9998765421 113578899999999998 99999999 799999999999999999999865433210
Q ss_pred ----e--------eecccCCccccCCCCCCC-CCCC-chhHHHHHHHHHHHHHhCCCCCC
Q 002336 772 ----I--------SSVARGTVGYLDPEYYGN-QQLT-EKSDVYSFGVVLLELISGKKPVS 817 (935)
Q Consensus 772 ----~--------~~~~~gt~~y~APE~l~~-~~~s-~ksDVwS~Gvil~eLltG~~Pf~ 817 (935)
. ......++.|++|+...- ...+ .+.+-++-|.-+|.++|+..+.-
T Consensus 149 ~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~ 208 (218)
T PRK12274 149 MRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHW 208 (218)
T ss_pred HHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcc
Confidence 0 112235777888874322 1233 67788899999999999998875
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.71 E-value=1.5e-17 Score=178.69 Aligned_cols=229 Identities=21% Similarity=0.305 Sum_probs=147.7
Q ss_pred cccccccccEEEEEEEEC-CCcEEEEEEccCcc---hhhhHHHHHHHHHHHhcC----------CCcccccceeee----
Q 002336 618 CKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIH----------HRNLVPLIGYCE---- 679 (935)
Q Consensus 618 ~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~iL~~L~----------HpnIv~l~g~~~---- 679 (935)
.+.||.|+++.||.+++. +|+++|||++.-.. ....+++++|.-....+. |-.++-.++...
T Consensus 17 ~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~~ 96 (288)
T PF14531_consen 17 GRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPGK 96 (288)
T ss_dssp EEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETTS
T ss_pred ccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcCC
Confidence 578999999999999987 58999999975432 223456666665554432 223333333221
Q ss_pred -----cc---c-----eEEEEEEecCCCCHHHHhcc---C-CCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCC
Q 002336 680 -----EE---H-----QRILVYEYMHNGTLRDRLHG---S-VNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVK 742 (935)
Q Consensus 680 -----~~---~-----~~~lV~E~~~~gsL~~~L~~---~-~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLk 742 (935)
.. . ..+++|+-+ .++|.+++.. . .....+....++.+..|+++.+++||+ .|++|+|||
T Consensus 97 ~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~---~GlVHgdi~ 172 (288)
T PF14531_consen 97 PPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHS---YGLVHGDIK 172 (288)
T ss_dssp -SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH---TTEEEST-S
T ss_pred CcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhh---cceEecccc
Confidence 11 1 236788887 5688887542 1 112234455667788999999999998 999999999
Q ss_pred CCCccccCCCcEEEeeccccccccccccceeecccCCccccCCCCCCC--------CCCCchhHHHHHHHHHHHHHhCCC
Q 002336 743 SSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN--------QQLTEKSDVYSFGVVLLELISGKK 814 (935)
Q Consensus 743 p~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~--------~~~s~ksDVwS~Gvil~eLltG~~ 814 (935)
|+|++++.+|.++|+||+.....+..... ...+..|.+||.... ..++.+.|.|++|+++|.|.++..
T Consensus 173 ~~nfll~~~G~v~Lg~F~~~~r~g~~~~~----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~l 248 (288)
T PF14531_consen 173 PENFLLDQDGGVFLGDFSSLVRAGTRYRC----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRL 248 (288)
T ss_dssp GGGEEE-TTS-EEE--GGGEEETTEEEEG----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-
T ss_pred eeeEEEcCCCCEEEcChHHHeecCceeec----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccC
Confidence 99999999999999999877665543221 234577899986522 357889999999999999999999
Q ss_pred CCCccCcccchhHHHHHHHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCC
Q 002336 815 PVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSR 875 (935)
Q Consensus 815 Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~R 875 (935)
||........... ....+. +.++.+..+|..+|+.+|++|
T Consensus 249 Pf~~~~~~~~~~~--------------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 249 PFGLSSPEADPEW--------------------DFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp STCCCGGGSTSGG--------------------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred CCCCCCccccccc--------------------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 9984433211110 112334 666789999999999999988
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.70 E-value=7.2e-17 Score=195.52 Aligned_cols=250 Identities=22% Similarity=0.245 Sum_probs=179.7
Q ss_pred HHHHHHhhcccccccccEEEEEEEECCCcEEEEEEccCcchhhhHHHHHHHHHHHhcC---CCcccccceeeeccceEEE
Q 002336 610 LEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIH---HRNLVPLIGYCEEEHQRIL 686 (935)
Q Consensus 610 l~~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~---HpnIv~l~g~~~~~~~~~l 686 (935)
+....+.+.+.||+|+||.||+|...+|+.||+|+-++.+... |.--.+++.+|+ -+-|..+.....-.+.-++
T Consensus 695 ~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~l 771 (974)
T KOG1166|consen 695 VGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSAHVFQNASVL 771 (974)
T ss_pred ecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHHHccCCccee
Confidence 3344556678899999999999999889999999977655432 222233344444 2345555555555667789
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCcccc-------CCCcEEEeec
Q 002336 687 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD-------INMRAKVSDF 759 (935)
Q Consensus 687 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld-------~~~~vkL~DF 759 (935)
|+||.+.|+|.+++. ..+.++|.-.+.++.|+++.+++||. .+||||||||+|.||. +...++|+||
T Consensus 772 v~ey~~~Gtlld~~N---~~~~m~e~lv~~~~~qml~ive~lH~---~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDf 845 (974)
T KOG1166|consen 772 VSEYSPYGTLLDLIN---TNKVMDEYLVMFFSCQMLRIVEHLHA---MGIIHGDIKPDNFLLRREICADSDSKGLYLIDF 845 (974)
T ss_pred eeeccccccHHHhhc---cCCCCCchhhhHHHHHHHHHHHHHHh---cceecccCCcceeEeecccCCCCcccceEEEec
Confidence 999999999999998 56789999999999999999999998 8999999999999993 2345899999
Q ss_pred ccccccccccc-ceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcC
Q 002336 760 GLSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG 838 (935)
Q Consensus 760 Gla~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~ 838 (935)
|.+..+.--.. ..-....+|-.+-.+|...++.++..+|.|.++-+++.|+.|++.- ..+|
T Consensus 846 G~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q------------------~~~g 907 (974)
T KOG1166|consen 846 GRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME------------------VKNG 907 (974)
T ss_pred ccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH------------------hcCC
Confidence 98865321111 1233456888999999999999999999999999999999997531 1122
Q ss_pred CeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhhhh
Q 002336 839 DVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 890 (935)
Q Consensus 839 ~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~~~ 890 (935)
.. ..++..+.+....+... +++..+|..+-..=|.+.++...|++...
T Consensus 908 ~~-~~~~~~~~Ry~~~~~W~---~~F~~lLN~~~~~~p~l~~lr~~~~~~~~ 955 (974)
T KOG1166|consen 908 SS-WMVKTNFPRYWKRDMWN---KFFDLLLNPDCDTLPNLQELRTELEEVLA 955 (974)
T ss_pred cc-eeccccchhhhhHHHHH---HHHHHHhCcCcccchhHHHHHHHHHHHHH
Confidence 21 22222233333333333 44444555666666777888777776654
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.67 E-value=2.7e-16 Score=163.66 Aligned_cols=134 Identities=16% Similarity=0.166 Sum_probs=104.5
Q ss_pred cccccccccEEEEEEEECCCcEEEEEEccCcchhhhHHHHHHHHHHHhc-----CCCcccccceeeeccc---e-EEEEE
Q 002336 618 CKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRI-----HHRNLVPLIGYCEEEH---Q-RILVY 688 (935)
Q Consensus 618 ~~~LG~G~fG~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L-----~HpnIv~l~g~~~~~~---~-~~lV~ 688 (935)
.+.||+|+||.||. +.+....+||++........+.+.+|+.+++.+ .||||++++|+++++. . ..+|+
T Consensus 7 ~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~ 84 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIA 84 (210)
T ss_pred cceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEe
Confidence 36899999999996 443333478987654444567899999999999 5799999999998764 3 33789
Q ss_pred Ee--cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHh-HHhhhcCCCceEecCCCCCCccccC----CCcEEEeeccc
Q 002336 689 EY--MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGL-EYLHTGCNPGIIHRDVKSSNILLDI----NMRAKVSDFGL 761 (935)
Q Consensus 689 E~--~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL-~yLHs~~~~~ivH~DLkp~NILld~----~~~vkL~DFGl 761 (935)
|| +.+++|.+++.. ..+++. ..++.|++.++ +|||+ ++|+||||||+|||++. +..++|+||+.
T Consensus 85 e~~G~~~~tL~~~l~~----~~~~e~--~~~~~~~L~~l~~yLh~---~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G 155 (210)
T PRK10345 85 DFDGKPSITLTEFAEQ----CRYEED--VAQLRQLLKKLKRYLLD---NRIVTMELKPQNILCQRISESEVIPVVCDNIG 155 (210)
T ss_pred cCCCCcchhHHHHHHc----ccccHh--HHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEeccCCCCCcEEEEECCC
Confidence 99 557999999963 235544 35678888777 99998 99999999999999974 34799999553
Q ss_pred c
Q 002336 762 S 762 (935)
Q Consensus 762 a 762 (935)
+
T Consensus 156 ~ 156 (210)
T PRK10345 156 E 156 (210)
T ss_pred C
Confidence 3
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.67 E-value=2.4e-17 Score=187.31 Aligned_cols=225 Identities=26% Similarity=0.344 Sum_probs=176.4
Q ss_pred cccccccEEEEEEE----ECCCcEEEEEEccCcchh--hhHHHHHHHHHHHhcC-CCcccccceeeeccceEEEEEEecC
Q 002336 620 KIGKGSFGSVYYGK----MKDGKEVAVKIMADSCSH--RTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQRILVYEYMH 692 (935)
Q Consensus 620 ~LG~G~fG~Vy~~~----~~~g~~vAvK~~~~~~~~--~~~~~~~E~~iL~~L~-HpnIv~l~g~~~~~~~~~lV~E~~~ 692 (935)
.+|+|.||.|+++. .+.|+-+|+|+.++.... .......|..++...+ ||.+|++...+..+...++++++..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 37999999999763 345778899987654221 1124566888999997 9999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccccce
Q 002336 693 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 772 (935)
Q Consensus 693 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~~ 772 (935)
+|.|...+. .....++.........++-+++++|+ .+++|||+|++||+++.+|++++.|||+++..-+....
T Consensus 81 gg~lft~l~---~~~~f~~~~~~~~~aelaLald~lh~---l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~- 153 (612)
T KOG0603|consen 81 GGDLFTRLS---KEVMFDELDVAFYLAELALALDHLHK---LGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA- 153 (612)
T ss_pred cchhhhccc---cCCchHHHHHHHHHHHHHHHHhhcch---hHHHHhcccccceeecccCccccCCchhhhHhHhhhhc-
Confidence 999998887 34556777777888899999999997 99999999999999999999999999999875443222
Q ss_pred eecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccCCC
Q 002336 773 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNV 852 (935)
Q Consensus 773 ~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~~~ 852 (935)
+||..|||||++. ....+.|-||||++++||+||..||.. +-++..++. .-..
T Consensus 154 ----cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----------~~~~~Il~~-----------~~~~ 206 (612)
T KOG0603|consen 154 ----CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----------DTMKRILKA-----------ELEM 206 (612)
T ss_pred ----ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----------HHHHHHhhh-----------ccCC
Confidence 7899999999998 457889999999999999999999983 111111111 1122
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCH
Q 002336 853 KIESIWRIAEVAIQCVEQRGFSRPKM 878 (935)
Q Consensus 853 ~~~~~~~l~~li~~Cl~~dP~~RPs~ 878 (935)
+.+......+++..++..+|..|--.
T Consensus 207 p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 207 PRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred chhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 33444456678888888888888654
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.65 E-value=6.5e-16 Score=164.52 Aligned_cols=141 Identities=21% Similarity=0.244 Sum_probs=109.4
Q ss_pred HhhcccccccccEEEEEEE--ECCCcEEEEEEccCcchh------------------------hhHHHHHHHHHHHhcCC
Q 002336 615 NNFCKKIGKGSFGSVYYGK--MKDGKEVAVKIMADSCSH------------------------RTQQFVTEVALLSRIHH 668 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~--~~~g~~vAvK~~~~~~~~------------------------~~~~~~~E~~iL~~L~H 668 (935)
+.+.+.||+|++|.||+|. ..+|+.||+|+++..... ....+..|++.+.++.+
T Consensus 30 ~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~ 109 (237)
T smart00090 30 SAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYE 109 (237)
T ss_pred HHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence 5678899999999999998 468999999998643210 01235689999999975
Q ss_pred Cc--ccccceeeeccceEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCc-eEecCCCCCC
Q 002336 669 RN--LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG-IIHRDVKSSN 745 (935)
Q Consensus 669 pn--Iv~l~g~~~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~-ivH~DLkp~N 745 (935)
.. +.+++++ ...++||||+++.+|..... ....+...+...++.|++.++++||+ .+ ++||||||+|
T Consensus 110 ~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~---~g~iiH~Dikp~N 179 (237)
T smart00090 110 AGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRL---KDVEPEEEEEFELYDDILEEMRKLYK---EGELVHGDLSEYN 179 (237)
T ss_pred cCCCCCeeeEe----cCceEEEEEecCCccccccc---ccCCcchHHHHHHHHHHHHHHHHHHh---cCCEEeCCCChhh
Confidence 32 3333432 23589999999988876542 23345666778999999999999998 88 9999999999
Q ss_pred ccccCCCcEEEeecccccccc
Q 002336 746 ILLDINMRAKVSDFGLSRQAE 766 (935)
Q Consensus 746 ILld~~~~vkL~DFGla~~~~ 766 (935)
|+++ ++.++|+|||.+....
T Consensus 180 Ili~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 180 ILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred EEEE-CCCEEEEEChhhhccC
Confidence 9999 8899999999887543
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.5e-15 Score=159.07 Aligned_cols=134 Identities=25% Similarity=0.407 Sum_probs=113.5
Q ss_pred ccccccccEEEEEEEECCCcEEEEEEccCcch--------hhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEe
Q 002336 619 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCS--------HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 690 (935)
Q Consensus 619 ~~LG~G~fG~Vy~~~~~~g~~vAvK~~~~~~~--------~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~ 690 (935)
+.||+|++|.||+|.+ .|..+++|+...... .....+.+|++++..++|+++.....++......+++|||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999988 578899998654221 1124578899999999999998888887777788999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccc
Q 002336 691 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 764 (935)
Q Consensus 691 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~ 764 (935)
++|++|.+.+... . . .+..++.+++.+|.+||+ .+++|||++|.|||++ ++.++|+|||++..
T Consensus 81 ~~G~~L~~~~~~~---~---~-~~~~i~~~i~~~l~~lH~---~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSN---G---M-EELELSREIGRLVGKLHS---AGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhc---c---H-HHHHHHHHHHHHHHHHHh---CCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999988632 1 1 788999999999999998 8999999999999999 78899999998764
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.61 E-value=3e-15 Score=155.36 Aligned_cols=130 Identities=25% Similarity=0.418 Sum_probs=107.3
Q ss_pred cccccccEEEEEEEECCCcEEEEEEccCcch--------hhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEec
Q 002336 620 KIGKGSFGSVYYGKMKDGKEVAVKIMADSCS--------HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 691 (935)
Q Consensus 620 ~LG~G~fG~Vy~~~~~~g~~vAvK~~~~~~~--------~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~ 691 (935)
.||+|++|.||+|.+. |+.+++|+...... ....++.+|++++..++|+++.....++......++||||+
T Consensus 1 ~ig~G~~~~vy~~~~~-~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFL-GLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeecC-CccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 4899999999999965 78899998653211 12356788999999999888766666666666779999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccc
Q 002336 692 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 764 (935)
Q Consensus 692 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~ 764 (935)
+|++|.+.+... . ..++.+++++|.+||+ .+++|||++|+||+++ ++.++++|||++..
T Consensus 80 ~g~~l~~~~~~~---~-------~~~~~~i~~~l~~lH~---~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEG---N-------DELLREIGRLVGKLHK---AGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhc---H-------HHHHHHHHHHHHHHHH---CCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 999999987532 1 0789999999999998 9999999999999999 88999999998865
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.61 E-value=3.5e-15 Score=154.88 Aligned_cols=136 Identities=21% Similarity=0.239 Sum_probs=107.8
Q ss_pred HhhcccccccccEEEEEEEECCCcEEEEEEccCcchh----------------------hhHHHHHHHHHHHhcCCCc--
Q 002336 615 NNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSH----------------------RTQQFVTEVALLSRIHHRN-- 670 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~~~~~~~~----------------------~~~~~~~E~~iL~~L~Hpn-- 670 (935)
+.+.+.||+|+||.||++..++|+.||||++...... ....+..|+.++..+.|++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 96 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP 96 (198)
T ss_pred hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence 6667899999999999999888999999986542200 1123667899999998774
Q ss_pred ccccceeeeccceEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccC
Q 002336 671 LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI 750 (935)
Q Consensus 671 Iv~l~g~~~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~ 750 (935)
+...++. ...++||||+++++|.+.... .....++.++++++.++|+ .+++||||||+||++++
T Consensus 97 v~~~~~~----~~~~lv~e~~~g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh~---~gi~H~Dl~p~Nill~~ 160 (198)
T cd05144 97 VPKPIDW----NRHAVVMEYIDGVELYRVRVL---------EDPEEVLDEILEEIVKAYK---HGIIHGDLSEFNILVDD 160 (198)
T ss_pred CCceeec----CCceEEEEEeCCcchhhcccc---------ccHHHHHHHHHHHHHHHHH---CCCCcCCCCcccEEEcC
Confidence 4444432 345899999999998765431 2346788999999999998 89999999999999999
Q ss_pred CCcEEEeecccccccc
Q 002336 751 NMRAKVSDFGLSRQAE 766 (935)
Q Consensus 751 ~~~vkL~DFGla~~~~ 766 (935)
++.++|+|||++....
T Consensus 161 ~~~~~liDfg~~~~~~ 176 (198)
T cd05144 161 DEKIYIIDWPQMVSTD 176 (198)
T ss_pred CCcEEEEECCccccCC
Confidence 9999999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.57 E-value=9e-15 Score=156.75 Aligned_cols=197 Identities=21% Similarity=0.247 Sum_probs=135.6
Q ss_pred CCCcccccceeeec---------------------------cceEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHH
Q 002336 667 HHRNLVPLIGYCEE---------------------------EHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAH 719 (935)
Q Consensus 667 ~HpnIv~l~g~~~~---------------------------~~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~ 719 (935)
+|||||++.++|.+ ....|+||..++ .+|.+++- ....+.....-++.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~----~~~~s~r~~~~~la 348 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLW----TRHRSYRTGRVILA 348 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHh----cCCCchHHHHHHHH
Confidence 59999999876632 345789998885 48888875 33455666778899
Q ss_pred HHHHHhHHhhhcCCCceEecCCCCCCccc--cCCCc--EEEeecccccccccc-----ccceeecccCCccccCCCCCCC
Q 002336 720 DAAKGLEYLHTGCNPGIIHRDVKSSNILL--DINMR--AKVSDFGLSRQAEED-----LTHISSVARGTVGYLDPEYYGN 790 (935)
Q Consensus 720 qia~gL~yLHs~~~~~ivH~DLkp~NILl--d~~~~--vkL~DFGla~~~~~~-----~~~~~~~~~gt~~y~APE~l~~ 790 (935)
|+++|+.|||+ +||.|||+|.+|||+ |+|+. +.|+|||++.--... .....-...|...-||||+...
T Consensus 349 QlLEav~hL~~---hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta 425 (598)
T KOG4158|consen 349 QLLEAVTHLHK---HGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA 425 (598)
T ss_pred HHHHHHHHHHH---ccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence 99999999997 999999999999999 34443 678999987532221 1111122347788999998754
Q ss_pred CC------CCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccCCCCHHHHHHHHHHH
Q 002336 791 QQ------LTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVA 864 (935)
Q Consensus 791 ~~------~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~~~~~~~~~~l~~li 864 (935)
.+ .-.|+|.|+.|-+.||+++...||=.... ...+... .++.. -|.+....++ .+.+++
T Consensus 426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGe-m~L~~r~-----Yqe~q-----LPalp~~vpp----~~rqlV 490 (598)
T KOG4158|consen 426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGE-MLLDTRT-----YQESQ-----LPALPSRVPP----VARQLV 490 (598)
T ss_pred CCCCceeeccchhhhhhhhhhHHHHhccCCcccccch-heechhh-----hhhhh-----CCCCcccCCh----HHHHHH
Confidence 21 23699999999999999999999853110 0001111 11111 1233333333 567888
Q ss_pred HHccccCCCCCCCHHHHHHHHh
Q 002336 865 IQCVEQRGFSRPKMQEIVLAIQ 886 (935)
Q Consensus 865 ~~Cl~~dP~~RPs~~ev~~~L~ 886 (935)
...++.+|++|++..-....|.
T Consensus 491 ~~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 491 FDLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred HHHhcCCccccCCccHHHhHHH
Confidence 8999999999999876665554
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.57 E-value=8.3e-15 Score=175.03 Aligned_cols=133 Identities=24% Similarity=0.363 Sum_probs=109.1
Q ss_pred hcccccccccEEEEEEEECCCcEEEEEEc-cCc-ch------hhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEE
Q 002336 617 FCKKIGKGSFGSVYYGKMKDGKEVAVKIM-ADS-CS------HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 688 (935)
Q Consensus 617 ~~~~LG~G~fG~Vy~~~~~~g~~vAvK~~-~~~-~~------~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~ 688 (935)
..+.||+|+||.||+|.+.+. .+++|+. ... .. ...+.+.+|+++++.++|++++....++......++||
T Consensus 337 ~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~ 415 (535)
T PRK09605 337 PDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVM 415 (535)
T ss_pred ccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEE
Confidence 367899999999999988744 3444432 211 11 12356889999999999999998888877777789999
Q ss_pred EecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccc
Q 002336 689 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 765 (935)
Q Consensus 689 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~ 765 (935)
||+++++|.+.+. ....++.|++++|.+||+ .+++||||||+|||+ +++.++|+|||+++..
T Consensus 416 E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~---~giiHrDlkp~NILl-~~~~~~liDFGla~~~ 477 (535)
T PRK09605 416 EYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHK---AGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS 477 (535)
T ss_pred EecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHh---CCCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence 9999999999875 356799999999999998 899999999999999 6788999999998753
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.56 E-value=9.9e-14 Score=167.73 Aligned_cols=129 Identities=26% Similarity=0.476 Sum_probs=99.4
Q ss_pred CCcEEEEEccCCCCcccCCccccCcccccccccccccCCCCCC-CccccccccccccccccccCCCCCccCcc-cccccc
Q 002336 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPSYMGSL-PNLQEL 489 (935)
Q Consensus 412 ~~~l~~L~Ls~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p-~~~~l~~L~~L~L~~N~l~g~iP~~l~~l-~~L~~L 489 (935)
.++|+.|+|++|+|+|.+|+.+++|++|+.|+|++|+|+|.+| .+++|++|+.|+|++|+|+|.+|..++.+ .++..+
T Consensus 441 L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~~~~~~~l 520 (623)
T PLN03150 441 LRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASF 520 (623)
T ss_pred CCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHHhhccccCceE
Confidence 3589999999999999999999999999999999999999999 58999999999999999999999998774 467889
Q ss_pred ccccccCCCCCCccccCCceeeeecCCCCCcccc-cccceeEEEeccchhHHHHHHHHHhhhheeee
Q 002336 490 HIENNSFVGEIPPALLTGKVIFKYDNNPKLHKES-RRRMRFKLILGTSIGVLAILLVLFLCSLIVLR 555 (935)
Q Consensus 490 ~l~~N~l~g~iP~~l~~~~~~~~~~~n~~~~~~~-~~~~~~~iiv~~~v~~~~~lvll~~~~~~~~r 555 (935)
++.+|...+.+|. + ..|... .......++++++++++++++.++ +++..++
T Consensus 521 ~~~~N~~lc~~p~-l-------------~~C~~~~~~~~~i~~~~~~~~~~l~~~~~~~-~~~~~r~ 572 (623)
T PLN03150 521 NFTDNAGLCGIPG-L-------------RACGPHLSVGAKIGIAFGVSVAFLFLVICAM-CWWKRRQ 572 (623)
T ss_pred EecCCccccCCCC-C-------------CCCcccCCCceEEEEEhHHHHHHHHHHHHHh-hheeehh
Confidence 9999986544543 1 123222 233456666666666555555444 4444443
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.55 E-value=1.4e-15 Score=169.96 Aligned_cols=174 Identities=27% Similarity=0.376 Sum_probs=132.4
Q ss_pred eEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccc
Q 002336 683 QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS 762 (935)
Q Consensus 683 ~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla 762 (935)
..++.|++|+..+|.++|.........++.....++.|++.|++| ++.+|+|+||.||+...+..+||.|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhhhe
Confidence 467999999999999999876667778889999999999999999 58999999999999999999999999998
Q ss_pred ccccccc-----cceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCcccchhHHHHHHHhhh
Q 002336 763 RQAEEDL-----THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIK 836 (935)
Q Consensus 763 ~~~~~~~-----~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~i~ 836 (935)
....... ........||..||+||.+.+..|+.|+||||||++|+||+. =..++. .. -...-++
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~e-----r~-----~t~~d~r 473 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFE-----RI-----ATLTDIR 473 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHH-----HH-----Hhhhhhh
Confidence 7654433 122344569999999999999999999999999999999997 222221 00 0011122
Q ss_pred cCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHH
Q 002336 837 KGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEI 881 (935)
Q Consensus 837 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev 881 (935)
.|. ++|....+++.+ ..++++++...|.+||++.++
T Consensus 474 ~g~----ip~~~~~d~p~e-----~~ll~~lls~~p~~RP~~~~~ 509 (516)
T KOG1033|consen 474 DGI----IPPEFLQDYPEE-----YTLLQQLLSPSPEERPSAIEV 509 (516)
T ss_pred cCC----CChHHhhcCcHH-----HHHHHHhcCCCcccCchHHHH
Confidence 222 222333333332 478899999999999955443
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.51 E-value=1e-13 Score=135.53 Aligned_cols=134 Identities=22% Similarity=0.207 Sum_probs=113.5
Q ss_pred cccccccccEEEEEEEECCCcEEEEEEccCcchhhhHHHHHHHHHHHhcCC--CcccccceeeeccceEEEEEEecCCCC
Q 002336 618 CKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHH--RNLVPLIGYCEEEHQRILVYEYMHNGT 695 (935)
Q Consensus 618 ~~~LG~G~fG~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~H--pnIv~l~g~~~~~~~~~lV~E~~~~gs 695 (935)
.+.||+|.++.||++...+ +.+++|....... ...+.+|+..++.++| .++++++++....+..+++|||++++.
T Consensus 3 ~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~ 79 (155)
T cd05120 3 IKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGET 79 (155)
T ss_pred ceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCee
Confidence 4679999999999999874 7899999865433 4678899999999976 588999988888788999999998876
Q ss_pred HHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccc
Q 002336 696 LRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 764 (935)
Q Consensus 696 L~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~ 764 (935)
+... +......++.+++++|++||.....+++|||++|+||++++.+.+++.|||.+..
T Consensus 80 ~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 80 LDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred cccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 6543 4566778899999999999974445899999999999999989999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.48 E-value=1.5e-13 Score=140.90 Aligned_cols=137 Identities=23% Similarity=0.316 Sum_probs=98.0
Q ss_pred cccccccccEEEEEEEECCCcEEEEEEccCcchh--hhHH----------------------HHHHHHHHHhcCCCc--c
Q 002336 618 CKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSH--RTQQ----------------------FVTEVALLSRIHHRN--L 671 (935)
Q Consensus 618 ~~~LG~G~fG~Vy~~~~~~g~~vAvK~~~~~~~~--~~~~----------------------~~~E~~iL~~L~Hpn--I 671 (935)
.+.||+|+||.||+|...+|++||||++...... .... ...|.+.+..+.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4689999999999999888999999998653221 1111 134666666664432 3
Q ss_pred cccceeeeccceEEEEEEecCCCCHHH-HhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccC
Q 002336 672 VPLIGYCEEEHQRILVYEYMHNGTLRD-RLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI 750 (935)
Q Consensus 672 v~l~g~~~~~~~~~lV~E~~~~gsL~~-~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~ 750 (935)
.+.++. ...++||||++++.+.. .+... ... .+..+++.+++.++.++|+ ..+|+||||||+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~----~~~-~~~~~~~~~~~~~l~~lh~--~~~ivH~Dl~p~Nili~- 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDV----RLL-EDPEELYDQILELMRKLYR--EAGLVHGDLSEYNILVD- 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhh----hhc-ccHHHHHHHHHHHHHHHhh--ccCcCcCCCChhhEEEE-
Confidence 333332 23589999999854321 11110 011 5678899999999999996 37999999999999999
Q ss_pred CCcEEEeecccccccc
Q 002336 751 NMRAKVSDFGLSRQAE 766 (935)
Q Consensus 751 ~~~vkL~DFGla~~~~ 766 (935)
++.++|+|||.+....
T Consensus 150 ~~~~~liDfg~a~~~~ 165 (187)
T cd05119 150 DGKVYIIDVPQAVEID 165 (187)
T ss_pred CCcEEEEECccccccc
Confidence 8999999999987543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.45 E-value=4.1e-13 Score=143.38 Aligned_cols=136 Identities=18% Similarity=0.243 Sum_probs=105.5
Q ss_pred ccccc-ccccEEEEEEEECCCcEEEEEEccCcc-------------hhhhHHHHHHHHHHHhcCCCcc--cccceeeecc
Q 002336 618 CKKIG-KGSFGSVYYGKMKDGKEVAVKIMADSC-------------SHRTQQFVTEVALLSRIHHRNL--VPLIGYCEEE 681 (935)
Q Consensus 618 ~~~LG-~G~fG~Vy~~~~~~g~~vAvK~~~~~~-------------~~~~~~~~~E~~iL~~L~HpnI--v~l~g~~~~~ 681 (935)
...|| .|+.|+||++... +..++||.+.... ......+.+|++++.+|+|++| ++.+++....
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 35687 8999999999886 7789999874311 1223567889999999998775 6677764432
Q ss_pred c----eEEEEEEecCC-CCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEE
Q 002336 682 H----QRILVYEYMHN-GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKV 756 (935)
Q Consensus 682 ~----~~~lV~E~~~~-gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL 756 (935)
. ..++|||++++ .+|.+++.. ..++.. .+.+++++|.+||+ .||+||||||.|||++.++.++|
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~----~~l~~~----~~~~i~~~l~~lH~---~GI~HrDlkp~NILv~~~~~v~L 183 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE----APLSEE----QWQAIGQLIARFHD---AGVYHADLNAHNILLDPDGKFWL 183 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc----CCCCHH----HHHHHHHHHHHHHH---CCCCCCCCCchhEEEcCCCCEEE
Confidence 2 22599999997 699988763 234433 36789999999998 99999999999999999899999
Q ss_pred eeccccccc
Q 002336 757 SDFGLSRQA 765 (935)
Q Consensus 757 ~DFGla~~~ 765 (935)
+|||.+...
T Consensus 184 IDfg~~~~~ 192 (239)
T PRK01723 184 IDFDRGELR 192 (239)
T ss_pred EECCCcccC
Confidence 999988653
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.43 E-value=1.9e-14 Score=171.74 Aligned_cols=252 Identities=22% Similarity=0.307 Sum_probs=186.1
Q ss_pred HhhcccccccccEEEEEEEECC--CcEEEEEEccCcc--hhhhHHHHHHHHHHHhcC-CCcccccceeeeccceEEEEEE
Q 002336 615 NNFCKKIGKGSFGSVYYGKMKD--GKEVAVKIMADSC--SHRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQRILVYE 689 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~~--g~~vAvK~~~~~~--~~~~~~~~~E~~iL~~L~-HpnIv~l~g~~~~~~~~~lV~E 689 (935)
+++.+.||+|.|+.|-...... ...+|+|.+.... .........|..+-..+. |+|++++++.....+..+++++
T Consensus 22 ~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~ 101 (601)
T KOG0590|consen 22 YKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLS 101 (601)
T ss_pred ccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccccC
Confidence 4456679999999998887643 3446666554432 222344555777777776 9999999999999999999999
Q ss_pred ecCCCCHHHHh-ccCCCCCCCCHHHHHHHHHHHHHHhHHhh-hcCCCceEecCCCCCCccccCCC-cEEEeecccccccc
Q 002336 690 YMHNGTLRDRL-HGSVNQKPLDWLTRLQIAHDAAKGLEYLH-TGCNPGIIHRDVKSSNILLDINM-RAKVSDFGLSRQAE 766 (935)
Q Consensus 690 ~~~~gsL~~~L-~~~~~~~~l~~~~~~~i~~qia~gL~yLH-s~~~~~ivH~DLkp~NILld~~~-~vkL~DFGla~~~~ 766 (935)
+..++++.+.+ +.. ....+....-.++.|+..++.|+| . .++.|+||||+|.+++..+ ..+++|||++..+.
T Consensus 102 ~s~g~~~f~~i~~~~--~~~~~~~~~~~~~~ql~s~l~~~H~~---~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~ 176 (601)
T KOG0590|consen 102 YSDGGSLFSKISHPD--STGTSSSSASRYLPQLNSGLSYLHPE---NGVTHRDIKPSNSLLDESGSALKIADFGLATAYR 176 (601)
T ss_pred cccccccccccccCC--ccCCCCcchhhhhhhhccCccccCcc---cccccCCCCCccchhccCCCcccCCCchhhcccc
Confidence 99999999888 422 224555667778999999999999 6 8999999999999999999 99999999998765
Q ss_pred c--cccceeecccC-CccccCCCCCCC-CCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeee
Q 002336 767 E--DLTHISSVARG-TVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVIS 842 (935)
Q Consensus 767 ~--~~~~~~~~~~g-t~~y~APE~l~~-~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~ 842 (935)
. ..........| ++.|+|||...+ ....+..|+||.|+++.-+++|..|++...... .....|....- ...
T Consensus 177 ~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~-~~~~~~~~~~~---~~~- 251 (601)
T KOG0590|consen 177 NKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKD-GRYSSWKSNKG---RFT- 251 (601)
T ss_pred ccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccc-ccceeeccccc---ccc-
Confidence 5 33334445567 999999999877 456788999999999999999999998544432 22222222110 000
Q ss_pred cccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 843 IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 843 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
.... ........+++.+++..+|..|.+.+++..
T Consensus 252 ---~~~~----~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 252 ---QLPW----NSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred ---cCcc----ccCChhhhhcccccccCCchhccccccccc
Confidence 0011 111225678888999999999999998753
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.40 E-value=3.1e-13 Score=160.88 Aligned_cols=206 Identities=26% Similarity=0.350 Sum_probs=136.8
Q ss_pred hhcccccccccEEEEEEEECC-CcEEEEEEccCcchhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEecCCC
Q 002336 616 NFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNG 694 (935)
Q Consensus 616 ~~~~~LG~G~fG~Vy~~~~~~-g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~~~g 694 (935)
+.++.|..|++|.||..++++ .+++|+|+-++. -+.+- ++.....|.+| |
T Consensus 86 ~~IklisngAygavylvrh~~trqrfa~kiNkq~------lilRn--ilt~a~npfvv---------------------g 136 (1205)
T KOG0606|consen 86 NTIKLISNGAYGAVYLVRHKETRQRFAMKINKQN------LILRN--ILTFAGNPFVV---------------------G 136 (1205)
T ss_pred ceeEeeccCCCCceeeeeccccccchhhcccccc------hhhhc--cccccCCccee---------------------c
Confidence 347889999999999999884 667888542211 11110 22222333332 3
Q ss_pred CHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccc-----
Q 002336 695 TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL----- 769 (935)
Q Consensus 695 sL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~----- 769 (935)
+=...++ .-++++.. ++.+++|||+ .+|+|||+||+|.+|+.-|++|+.|||+.+......
T Consensus 137 Dc~tllk---~~g~lPvd--------mvla~Eylh~---ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~ 202 (1205)
T KOG0606|consen 137 DCATLLK---NIGPLPVD--------MVLAVEYLHS---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLK 202 (1205)
T ss_pred hhhhhcc---cCCCCcch--------hhHHhHhhcc---CCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhh
Confidence 3333333 22333322 2778999997 999999999999999999999999999987521110
Q ss_pred ---------cceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcC-C
Q 002336 770 ---------THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG-D 839 (935)
Q Consensus 770 ---------~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~-~ 839 (935)
....+..+||+.|+|||++....|+.-.|-|++|+|+||.+.|+.||.++..++- +...+... .
T Consensus 203 eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeel------fg~visd~i~ 276 (1205)
T KOG0606|consen 203 EGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEEL------FGQVISDDIE 276 (1205)
T ss_pred hcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHH------Hhhhhhhhcc
Confidence 0112345799999999999999999999999999999999999999985433211 11112110 0
Q ss_pred eeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHH
Q 002336 840 VISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQ 879 (935)
Q Consensus 840 ~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ 879 (935)
..+- | .....+..+++.+.|+++|.+|--..
T Consensus 277 wpE~-d--------ea~p~Ea~dli~~LL~qnp~~Rlgt~ 307 (1205)
T KOG0606|consen 277 WPEE-D--------EALPPEAQDLIEQLLRQNPLCRLGTG 307 (1205)
T ss_pred cccc-C--------cCCCHHHHHHHHHHHHhChHhhcccc
Confidence 1111 1 12223677888899999999997433
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.34 E-value=9.3e-13 Score=138.68 Aligned_cols=203 Identities=26% Similarity=0.357 Sum_probs=142.9
Q ss_pred HHHHHhcCCCcccccceeeec-----cceEEEEEEecCCCCHHHHhccCC-CCCCCCHHHHHHHHHHHHHHhHHhhhcCC
Q 002336 660 VALLSRIHHRNLVPLIGYCEE-----EHQRILVYEYMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCN 733 (935)
Q Consensus 660 ~~iL~~L~HpnIv~l~g~~~~-----~~~~~lV~E~~~~gsL~~~L~~~~-~~~~l~~~~~~~i~~qia~gL~yLHs~~~ 733 (935)
+..|-.+-|-|||+++.|+.+ ..+..++.|||..|++..+|++.. .++.+......+|+.||+.||.|||+ |+
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs-~~ 196 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS-CD 196 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-cC
Confidence 334455579999999998754 335789999999999999998654 56778899999999999999999998 78
Q ss_pred CceEecCCCCCCccccCCCcEEEeeccccccc---cccccceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHH
Q 002336 734 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQA---EEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELI 810 (935)
Q Consensus 734 ~~ivH~DLkp~NILld~~~~vkL~DFGla~~~---~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLl 810 (935)
+.|+|+++..+-|++..++-+|+.---..... ............+-++|.+||.-.....+..+|||+||.-.+||.
T Consensus 197 PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema 276 (458)
T KOG1266|consen 197 PPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA 276 (458)
T ss_pred CccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence 99999999999999999998888521111100 000111122234678999999987778888999999999999998
Q ss_pred hCCCCC-CccCccc-chhHHHHHHHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002336 811 SGKKPV-SVEDFGA-ELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 884 (935)
Q Consensus 811 tG~~Pf-~~~~~~~-~~~l~~~~~~~i~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~ 884 (935)
.+..-- .....-. +.+. ...+ -.+...+ =.+.+.+|++..|..||+|.+++..
T Consensus 277 ilEiq~tnseS~~~~ee~i----a~~i------~~len~l-----------qr~~i~kcl~~eP~~rp~ar~llfH 331 (458)
T KOG1266|consen 277 ILEIQSTNSESKVEVEENI----ANVI------IGLENGL-----------QRGSITKCLEGEPNGRPDARLLLFH 331 (458)
T ss_pred HheeccCCCcceeehhhhh----hhhe------eeccCcc-----------ccCcCcccccCCCCCCcchhhhhcC
Confidence 876432 1111100 0000 0000 0011111 1256779999999999999998765
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.34 E-value=3.3e-12 Score=147.97 Aligned_cols=141 Identities=24% Similarity=0.310 Sum_probs=100.6
Q ss_pred ccccccccEEEEEEEECCCcEEEEEEccCcchhhh----------------------------------------HHHHH
Q 002336 619 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRT----------------------------------------QQFVT 658 (935)
Q Consensus 619 ~~LG~G~fG~Vy~~~~~~g~~vAvK~~~~~~~~~~----------------------------------------~~~~~ 658 (935)
+.||.|++|.||+|++++|+.||||+.++...... -+|.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 56999999999999999999999999865421110 02445
Q ss_pred HHHHHHhcC----CCcccccceee-eccceEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHH-HhHHhhhcC
Q 002336 659 EVALLSRIH----HRNLVPLIGYC-EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK-GLEYLHTGC 732 (935)
Q Consensus 659 E~~iL~~L~----HpnIv~l~g~~-~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~-gL~yLHs~~ 732 (935)
|++.+.+++ |.+-+.+-..+ ......++||||++|++|.+..... .... .+.+++.++++ .+..+|.
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~--~~~~---~~~~ia~~~~~~~l~ql~~-- 275 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALD--EAGL---DRKALAENLARSFLNQVLR-- 275 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHH--hcCC---CHHHHHHHHHHHHHHHHHh--
Confidence 666666552 22223332233 2344579999999999998876421 1112 23456666666 4678887
Q ss_pred CCceEecCCCCCCccccCCCcEEEeeccccccccc
Q 002336 733 NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 767 (935)
Q Consensus 733 ~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~ 767 (935)
.|++|+|+||.||+++.++.++++|||++....+
T Consensus 276 -~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 276 -DGFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred -CCceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 8999999999999999999999999999876643
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.30 E-value=4.6e-12 Score=162.77 Aligned_cols=136 Identities=29% Similarity=0.554 Sum_probs=96.7
Q ss_pred ccCchhhHHHHHHHHhhcCCC--CCCCCC-CCCCCCCCCceEEEeCCCCCcEEEEEccCCCCcccCCccccCcccccccc
Q 002336 367 AKTEWQDVMVLEALRSISDES--ERTNDR-GDPCVPVPWEWVTCSTTTPPRITKIALSGKNLKGEIPPELKNMEALTELW 443 (935)
Q Consensus 367 ~~t~~~d~~~l~~l~~~~~~~--~~~~w~-~dpC~~~~w~~v~c~~~~~~~l~~L~Ls~n~l~g~ip~~i~~L~~L~~L~ 443 (935)
..+.++|..+|.++|+.+.++ ...+|+ .+.|| .|.|+.|+.. .+|+.|+|++|+++|.+|+.|..|++|+.|+
T Consensus 24 ~~~~~~~~~~l~~~~~~~~~~~~~~~~w~~~~~~c--~w~gv~c~~~--~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~ 99 (968)
T PLN00113 24 SMLHAEELELLLSFKSSINDPLKYLSNWNSSADVC--LWQGITCNNS--SRVVSIDLSGKNISGKISSAIFRLPYIQTIN 99 (968)
T ss_pred cCCCHHHHHHHHHHHHhCCCCcccCCCCCCCCCCC--cCcceecCCC--CcEEEEEecCCCccccCChHHhCCCCCCEEE
Confidence 455778999999999888542 345675 34454 6999999753 4899999999999988888888888888888
Q ss_pred cccccCCCCCC-C-ccccccccccccccccccC----------------------CCCCccCccccccccccccccCCCC
Q 002336 444 LDGNFLTGPLP-D-MSRLIDLRIVHLENNELTG----------------------SLPSYMGSLPNLQELHIENNSFVGE 499 (935)
Q Consensus 444 Ls~N~l~g~~p-~-~~~l~~L~~L~L~~N~l~g----------------------~iP~~l~~l~~L~~L~l~~N~l~g~ 499 (935)
|++|+++|.+| + +.++++|++|+|++|+++| .+|..++++++|+.|+|++|.+.+.
T Consensus 100 Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~ 179 (968)
T PLN00113 100 LSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRGSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGK 179 (968)
T ss_pred CCCCccCCcCChHHhccCCCCCEEECcCCccccccCccccCCCCEEECcCCcccccCChHHhcCCCCCEEECccCccccc
Confidence 88888888777 3 3366666666666666554 4555555566666666666666656
Q ss_pred CCccccC
Q 002336 500 IPPALLT 506 (935)
Q Consensus 500 iP~~l~~ 506 (935)
+|..+.+
T Consensus 180 ~p~~~~~ 186 (968)
T PLN00113 180 IPNSLTN 186 (968)
T ss_pred CChhhhh
Confidence 6655443
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.15 E-value=1.1e-10 Score=117.64 Aligned_cols=129 Identities=18% Similarity=0.168 Sum_probs=95.6
Q ss_pred ccccccccEEEEEEEECCCcEEEEEEccCcchhhhHHHHHHHHHHHhcCCCccc-ccceeeeccceEEEEEEecCCCCHH
Q 002336 619 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLV-PLIGYCEEEHQRILVYEYMHNGTLR 697 (935)
Q Consensus 619 ~~LG~G~fG~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~HpnIv-~l~g~~~~~~~~~lV~E~~~~gsL~ 697 (935)
+.|+.|.++.||+++.. ++.+++|+...... ....+..|+++++.+.+.+++ +++.+.. ...++||||++|.++.
T Consensus 4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~l~ 79 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSELL 79 (170)
T ss_pred eecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCccc
Confidence 57899999999999876 78899998765422 234567899999998655544 4444432 3458999999998775
Q ss_pred HHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcC--CCceEecCCCCCCccccCCCcEEEeeccccc
Q 002336 698 DRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC--NPGIIHRDVKSSNILLDINMRAKVSDFGLSR 763 (935)
Q Consensus 698 ~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~--~~~ivH~DLkp~NILld~~~~vkL~DFGla~ 763 (935)
+.. .....++.+++++|+.||+.. ..+++|||++|.||+++ ++.++++||+.+.
T Consensus 80 ~~~-----------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 80 TED-----------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred ccc-----------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 430 011345789999999999721 12369999999999999 6789999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.14 E-value=7.1e-11 Score=138.56 Aligned_cols=139 Identities=20% Similarity=0.283 Sum_probs=90.3
Q ss_pred ccccccccEEEEEEEECC-CcEEEEEEccCcchhh----------------------------------hH------HHH
Q 002336 619 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHR----------------------------------TQ------QFV 657 (935)
Q Consensus 619 ~~LG~G~fG~Vy~~~~~~-g~~vAvK~~~~~~~~~----------------------------------~~------~~~ 657 (935)
+.||.|++|.||+|++++ |+.||||+.++..... .+ ++.
T Consensus 125 ~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~ 204 (537)
T PRK04750 125 KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLM 204 (537)
T ss_pred hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHH
Confidence 579999999999999987 9999999987542110 11 233
Q ss_pred HHHHHHHhcC----CCcccccceeeec-cceEEEEEEecCCCCHHHHh--ccCC-CCCCCCHHHHHHHHHHHHHHhHHhh
Q 002336 658 TEVALLSRIH----HRNLVPLIGYCEE-EHQRILVYEYMHNGTLRDRL--HGSV-NQKPLDWLTRLQIAHDAAKGLEYLH 729 (935)
Q Consensus 658 ~E~~iL~~L~----HpnIv~l~g~~~~-~~~~~lV~E~~~~gsL~~~L--~~~~-~~~~l~~~~~~~i~~qia~gL~yLH 729 (935)
+|+..+.+++ +.+.+.+-.++.+ ....+|||||++|+.+.+.. .... +...+.......++.|+ +
T Consensus 205 ~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi-------f 277 (537)
T PRK04750 205 REAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV-------F 277 (537)
T ss_pred HHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH-------H
Confidence 4444444442 3333333333322 44568999999999998742 2110 01112222222333333 3
Q ss_pred hcCCCceEecCCCCCCccccCCC----cEEEeeccccccccc
Q 002336 730 TGCNPGIIHRDVKSSNILLDINM----RAKVSDFGLSRQAEE 767 (935)
Q Consensus 730 s~~~~~ivH~DLkp~NILld~~~----~vkL~DFGla~~~~~ 767 (935)
. .|++|+|+||.||+++.++ .++++|||++.....
T Consensus 278 ~---~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 278 R---DGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred h---CCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 3 7999999999999999888 999999999877644
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.11 E-value=8.2e-11 Score=134.67 Aligned_cols=252 Identities=23% Similarity=0.244 Sum_probs=182.5
Q ss_pred hHHHHHHhhcccccc--cccEEEEEEEE---CCCcEEEEEEccCcch--hhhHHHHHHHHHHHhcC-CCcccccceeeec
Q 002336 609 ELEEATNNFCKKIGK--GSFGSVYYGKM---KDGKEVAVKIMADSCS--HRTQQFVTEVALLSRIH-HRNLVPLIGYCEE 680 (935)
Q Consensus 609 ~l~~~~~~~~~~LG~--G~fG~Vy~~~~---~~g~~vAvK~~~~~~~--~~~~~~~~E~~iL~~L~-HpnIv~l~g~~~~ 680 (935)
+.......+.+.+|. |.+|.||.+.. .+++.+|+|.-+.... .....-.+|+...++++ |+|.++....+..
T Consensus 110 s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~ 189 (524)
T KOG0601|consen 110 SFFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEG 189 (524)
T ss_pred chhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccccc
Confidence 455566667889999 99999999977 3688899998443322 33344556777777774 9999998888999
Q ss_pred cceEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHH----HhHHhhhcCCCceEecCCCCCCccccCC-CcEE
Q 002336 681 EHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK----GLEYLHTGCNPGIIHRDVKSSNILLDIN-MRAK 755 (935)
Q Consensus 681 ~~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~----gL~yLHs~~~~~ivH~DLkp~NILld~~-~~vk 755 (935)
.+..++-+|.+. .+|.++.+.. ...++....+..+.+..+ ||.++|+ ..++|-|+||.||++..+ ...+
T Consensus 190 ~~~lfiqtE~~~-~sl~~~~~~~--~~~~p~~~l~~~~~~~~~~~~~al~~~hs---~~~~~~~~kp~~i~~~~~~~s~~ 263 (524)
T KOG0601|consen 190 SGILFIQTELCG-ESLQSYCHTP--CNFLPDNLLWNSLRDWLSRDVTALSHLHS---NNIVHDDLKPANIFTTSDWTSCK 263 (524)
T ss_pred CCcceeeecccc-chhHHhhhcc--cccCCchhhhhHHhhhhhcccccccccCC---Ccccccccchhheecccccceee
Confidence 999999999984 6777776632 233677788888888888 9999998 899999999999999999 8899
Q ss_pred Eeeccccccccccccc----eeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHH
Q 002336 756 VSDFGLSRQAEEDLTH----ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWA 831 (935)
Q Consensus 756 L~DFGla~~~~~~~~~----~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~ 831 (935)
+.|||+...+.+.... ......|...|++||..++ .++.+.|+|++|.+..+-.++........... |.
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~------W~ 336 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKNSS------WS 336 (524)
T ss_pred cCCcceeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCCCC------cc
Confidence 9999998877654321 1222257788999998766 56899999999999999998876654221110 10
Q ss_pred HHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 832 RSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 832 ~~~i~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
.++.+- +-+ ++.......+...+..|++.+|..|++.+++..
T Consensus 337 --~~r~~~---ip~-----e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 337 --QLRQGY---IPL-----EFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred --cccccc---Cch-----hhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 001100 000 111111123445889999999999999887754
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.08 E-value=8.4e-12 Score=120.20 Aligned_cols=165 Identities=25% Similarity=0.416 Sum_probs=130.6
Q ss_pred EeeecCCCcchhhhhhhhhceeecccc---cCchhhHHHHHHHHhhcCCCCCCCCCCCCCCCCCCceEEEeCCCCCcEEE
Q 002336 341 SFVKTRDSTLGPLLNAIEISKYQKIAA---KTEWQDVMVLEALRSISDESERTNDRGDPCVPVPWEWVTCSTTTPPRITK 417 (935)
Q Consensus 341 ~~~~~~~s~l~p~ina~e~~~~~~~~~---~t~~~d~~~l~~l~~~~~~~~~~~w~~dpC~~~~w~~v~c~~~~~~~l~~ 417 (935)
++....-+.+||-|..+.+++++.+.. ...+..+..|..++..-......+- - | .|. +..+.++.
T Consensus 39 tLSHNKl~~vppnia~l~nlevln~~nnqie~lp~~issl~klr~lnvgmnrl~~--l---p---rgf----gs~p~lev 106 (264)
T KOG0617|consen 39 TLSHNKLTVVPPNIAELKNLEVLNLSNNQIEELPTSISSLPKLRILNVGMNRLNI--L---P---RGF----GSFPALEV 106 (264)
T ss_pred hcccCceeecCCcHHHhhhhhhhhcccchhhhcChhhhhchhhhheecchhhhhc--C---c---ccc----CCCchhhh
Confidence 344666778899999999988888764 3556666667666643222122111 1 1 111 23568999
Q ss_pred EEccCCCCcc-cCCccccCcccccccccccccCCCCCCCccccccccccccccccccCCCCCccCccccccccccccccC
Q 002336 418 IALSGKNLKG-EIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSF 496 (935)
Q Consensus 418 L~Ls~n~l~g-~ip~~i~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~l~~N~l 496 (935)
|||+.|+|+- .+|..|..++.|+-|+|+.|.|.-.+|++++|++|+.|.|.+|.|- ++|.+++.|+.|++|++.+|++
T Consensus 107 ldltynnl~e~~lpgnff~m~tlralyl~dndfe~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgnrl 185 (264)
T KOG0617|consen 107 LDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFEILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGNRL 185 (264)
T ss_pred hhccccccccccCCcchhHHHHHHHHHhcCCCcccCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhccccee
Confidence 9999999974 5899999999999999999999999999999999999999999999 9999999999999999999999
Q ss_pred CCCCCccccC-----CceeeeecCCCCC
Q 002336 497 VGEIPPALLT-----GKVIFKYDNNPKL 519 (935)
Q Consensus 497 ~g~iP~~l~~-----~~~~~~~~~n~~~ 519 (935)
+ .+|+++++ ....+....|||.
T Consensus 186 ~-vlppel~~l~l~~~k~v~r~E~NPwv 212 (264)
T KOG0617|consen 186 T-VLPPELANLDLVGNKQVMRMEENPWV 212 (264)
T ss_pred e-ecChhhhhhhhhhhHHHHhhhhCCCC
Confidence 9 99999876 2345567888885
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.06 E-value=1.5e-09 Score=125.40 Aligned_cols=168 Identities=20% Similarity=0.216 Sum_probs=127.3
Q ss_pred ECCCcEEEEEEccCcchhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEecCCCCHHHHhccCCCCCCCCHHH
Q 002336 634 MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLT 713 (935)
Q Consensus 634 ~~~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~ 713 (935)
..++.+|.|+..+...........+-++.|+.++||||++++...+.++..|+|+|.+. .|...++. +....
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~------l~~~~ 105 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE------LGKEE 105 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH------hHHHH
Confidence 34688888888776555445667788899999999999999999999999999999984 56666653 22455
Q ss_pred HHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccccceeecccCCccccCCCCCCCCCC
Q 002336 714 RLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQL 793 (935)
Q Consensus 714 ~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~ 793 (935)
....+.||+.||.|||. +.+++|++|....|+++..|+.||++|.++........ ......--..|..|+.+....
T Consensus 106 v~~Gl~qIl~AL~FL~~--d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s~- 181 (690)
T KOG1243|consen 106 VCLGLFQILAALSFLND--DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPSE- 181 (690)
T ss_pred HHHHHHHHHHHHHHHhc--cCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCccc-
Confidence 66678999999999997 58999999999999999999999999988754332111 111111223456666543322
Q ss_pred CchhHHHHHHHHHHHHHhCCC
Q 002336 794 TEKSDVYSFGVVLLELISGKK 814 (935)
Q Consensus 794 s~ksDVwS~Gvil~eLltG~~ 814 (935)
-..|.|.||++++|++.|..
T Consensus 182 -~s~D~~~Lg~li~el~ng~~ 201 (690)
T KOG1243|consen 182 -WSIDSWGLGCLIEELFNGSL 201 (690)
T ss_pred -cchhhhhHHHHHHHHhCccc
Confidence 45699999999999999943
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.99 E-value=2.9e-09 Score=111.89 Aligned_cols=142 Identities=21% Similarity=0.319 Sum_probs=111.0
Q ss_pred ccccccccEEEEEEEECCCcEEEEEEccCcch-hhhHHHHHHHHHHHhcCC--Ccccccceeeeccc---eEEEEEEecC
Q 002336 619 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHH--RNLVPLIGYCEEEH---QRILVYEYMH 692 (935)
Q Consensus 619 ~~LG~G~fG~Vy~~~~~~g~~vAvK~~~~~~~-~~~~~~~~E~~iL~~L~H--pnIv~l~g~~~~~~---~~~lV~E~~~ 692 (935)
+.|+.|..+.||+++..+|+.+++|+...... .....+..|+++++.+++ .++.+++.+..... ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 56899999999999988778999998764322 134578899999999975 34566777766542 5689999999
Q ss_pred CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhc-----------------------------------------
Q 002336 693 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG----------------------------------------- 731 (935)
Q Consensus 693 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~----------------------------------------- 731 (935)
|.++.+.+.. ..++..++..++.+++++|..||+.
T Consensus 84 G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 84 GRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred CEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 9888775531 3467778888899999999999852
Q ss_pred ------------CCCceEecCCCCCCccccC--CCcEEEeecccccc
Q 002336 732 ------------CNPGIIHRDVKSSNILLDI--NMRAKVSDFGLSRQ 764 (935)
Q Consensus 732 ------------~~~~ivH~DLkp~NILld~--~~~vkL~DFGla~~ 764 (935)
....++|||+++.||+++. ++.+.|+||+.+..
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 1356899999999999998 66789999997754
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=98.97 E-value=5.2e-09 Score=107.38 Aligned_cols=136 Identities=15% Similarity=0.181 Sum_probs=97.9
Q ss_pred ccccccccEEEEEEEECC-------CcEEEEEEccCcch----------------------hhhHHHH----HHHHHHHh
Q 002336 619 KKIGKGSFGSVYYGKMKD-------GKEVAVKIMADSCS----------------------HRTQQFV----TEVALLSR 665 (935)
Q Consensus 619 ~~LG~G~fG~Vy~~~~~~-------g~~vAvK~~~~~~~----------------------~~~~~~~----~E~~iL~~ 665 (935)
-.||.|--+.||.|.-.+ +..+|||+.+.... ...+.+. +|++.|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999997543 57999998642110 0112233 79999999
Q ss_pred cCC--CcccccceeeeccceEEEEEEecCCCCHHH-HhccCCCCCCCCHHHHHHHHHHHHHHhHHh-hhcCCCceEecCC
Q 002336 666 IHH--RNLVPLIGYCEEEHQRILVYEYMHNGTLRD-RLHGSVNQKPLDWLTRLQIAHDAAKGLEYL-HTGCNPGIIHRDV 741 (935)
Q Consensus 666 L~H--pnIv~l~g~~~~~~~~~lV~E~~~~gsL~~-~L~~~~~~~~l~~~~~~~i~~qia~gL~yL-Hs~~~~~ivH~DL 741 (935)
+.. -++.+++++ ...++||||+.+..+.. .++ ...++..+...+..+++.+|..| |. .+++||||
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk----d~~~~~~~~~~i~~~i~~~l~~l~H~---~glVHGDL 151 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLK----DAKLNDEEMKNAYYQVLSMMKQLYKE---CNLVHADL 151 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhh----ccccCHHHHHHHHHHHHHHHHHHHHh---CCeecCCC
Confidence 853 445555554 45689999997654422 222 22344556678889999999999 76 89999999
Q ss_pred CCCCccccCCCcEEEeecccccccc
Q 002336 742 KSSNILLDINMRAKVSDFGLSRQAE 766 (935)
Q Consensus 742 kp~NILld~~~~vkL~DFGla~~~~ 766 (935)
++.|||++ ++.+.|+|||.+....
T Consensus 152 s~~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 152 SEYNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred CHHHEEEE-CCcEEEEECCCceeCC
Confidence 99999997 4679999999876553
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.96 E-value=1e-10 Score=112.76 Aligned_cols=84 Identities=31% Similarity=0.481 Sum_probs=81.1
Q ss_pred CCcEEEEEccCCCCcccCCccccCcccccccccccccCCCCCCCccccccccccccccccccCCCCCccCcccccccccc
Q 002336 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 491 (935)
Q Consensus 412 ~~~l~~L~Ls~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~l 491 (935)
..+++.|.||+|+|+ .+|+.|+.|.+|+.|+|++|+++..+++++.|++|+.|+++-|+|. .+|..||.++.|+.|||
T Consensus 32 ~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levldl 109 (264)
T KOG0617|consen 32 MSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIEELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLDL 109 (264)
T ss_pred hhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhhhcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhhc
Confidence 457899999999999 9999999999999999999999999999999999999999999999 99999999999999999
Q ss_pred ccccCC
Q 002336 492 ENNSFV 497 (935)
Q Consensus 492 ~~N~l~ 497 (935)
..|+++
T Consensus 110 tynnl~ 115 (264)
T KOG0617|consen 110 TYNNLN 115 (264)
T ss_pred cccccc
Confidence 999997
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.90 E-value=1.1e-08 Score=101.67 Aligned_cols=131 Identities=24% Similarity=0.367 Sum_probs=101.1
Q ss_pred ccccccccEEEEEEEECCCcEEEEEEccCc-ch-------hhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEe
Q 002336 619 KKIGKGSFGSVYYGKMKDGKEVAVKIMADS-CS-------HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 690 (935)
Q Consensus 619 ~~LG~G~fG~Vy~~~~~~g~~vAvK~~~~~-~~-------~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~ 690 (935)
..+++|+-+.+|.+.+. |.++++|.-.+. -. -...+-.+|++++.+++--.|...+=+..+.....++|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 46889999999999886 555677753221 11 1224567799999998766666655566677778899999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccc
Q 002336 691 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 764 (935)
Q Consensus 691 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~ 764 (935)
.+|..|.+.+... ...++..+=.-+.-||. .+|+||||.++||++..++ +.++|||++..
T Consensus 81 I~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~---~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA----------RPDLLREVGRLVGKLHK---AGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc----------chHHHHHHHHHHHHHHh---cCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9999999988743 24567777778889997 9999999999999998665 99999999874
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.85 E-value=5.1e-10 Score=126.13 Aligned_cols=178 Identities=22% Similarity=0.311 Sum_probs=144.2
Q ss_pred eeeeEEEEEeeecCCCcchhhhhhhhhceeecccccCchhhHHHHHHHHhhcCCCCCCCCCC--CCCCCCCCceEEEeCC
Q 002336 333 TLNFVLSFSFVKTRDSTLGPLLNAIEISKYQKIAAKTEWQDVMVLEALRSISDESERTNDRG--DPCVPVPWEWVTCSTT 410 (935)
Q Consensus 333 ~~~~~~~~~~~~~~~s~l~p~ina~e~~~~~~~~~~t~~~d~~~l~~l~~~~~~~~~~~w~~--dpC~~~~w~~v~c~~~ 410 (935)
++-.++.++-+....+.+||-|..+.++.-+.++....+.=..+|-.+..+...+...|--. .-|. ..|
T Consensus 197 tsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp~vPecly~l~~LrrLNLS~N~iteL~~~~-~~W-------- 267 (1255)
T KOG0444|consen 197 TSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLPIVPECLYKLRNLRRLNLSGNKITELNMTE-GEW-------- 267 (1255)
T ss_pred hhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCCcchHHHhhhhhhheeccCcCceeeeeccH-HHH--------
Confidence 33345566667777889999999999999999999888888888888877665433333221 1121 122
Q ss_pred CCCcEEEEEccCCCCcccCCccccCcccccccccccccCC--CCCCCccccccccccccccccccCCCCCccCccccccc
Q 002336 411 TPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLT--GPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQE 488 (935)
Q Consensus 411 ~~~~l~~L~Ls~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~--g~~p~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~ 488 (935)
.+|.+|+||.|+|+ .+|..+.+|+.|+.|++.+|+|+ |++..|+.|..|+++++++|+|. .+|++++.|.+|+.
T Consensus 268 --~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~k 343 (1255)
T KOG0444|consen 268 --ENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQK 343 (1255)
T ss_pred --hhhhhhccccchhc-cchHHHhhhHHHHHHHhccCcccccCCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHH
Confidence 38999999999999 99999999999999999999875 55558999999999999999999 99999999999999
Q ss_pred cccccccCCCCCCccc--cCCceeeeecCCCCCccccc
Q 002336 489 LHIENNSFVGEIPPAL--LTGKVIFKYDNNPKLHKESR 524 (935)
Q Consensus 489 L~l~~N~l~g~iP~~l--~~~~~~~~~~~n~~~~~~~~ 524 (935)
|.|++|.|- ++|+.+ ......+.+-.||.+-..++
T Consensus 344 L~L~~NrLi-TLPeaIHlL~~l~vLDlreNpnLVMPPK 380 (1255)
T KOG0444|consen 344 LKLDHNRLI-TLPEAIHLLPDLKVLDLRENPNLVMPPK 380 (1255)
T ss_pred hccccccee-echhhhhhcCCcceeeccCCcCccCCCC
Confidence 999999998 999975 44666778888988765444
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.79 E-value=3.9e-08 Score=97.05 Aligned_cols=142 Identities=20% Similarity=0.234 Sum_probs=103.6
Q ss_pred cccccccccEEEEEEEECCCcEEEEEEcc-Ccch-------hhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEE
Q 002336 618 CKKIGKGSFGSVYYGKMKDGKEVAVKIMA-DSCS-------HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 689 (935)
Q Consensus 618 ~~~LG~G~fG~Vy~~~~~~g~~vAvK~~~-~~~~-------~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E 689 (935)
...|-+|+-+.|+++.+. |+..+||.-. +.-. -..++..+|++.|.+++--.|.-..=++.+...-.++||
T Consensus 12 l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME 90 (229)
T KOG3087|consen 12 LELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYME 90 (229)
T ss_pred ceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEE
Confidence 357889999999999998 7777777532 1111 123567889999998865555554445666666789999
Q ss_pred ecCC-CCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCc---EEEeecccccc
Q 002336 690 YMHN-GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMR---AKVSDFGLSRQ 764 (935)
Q Consensus 690 ~~~~-gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~---vkL~DFGla~~ 764 (935)
|+++ -++.+++.... ...........++.+|-+.+.-||. ..|+||||..+||++..++. +.++|||++..
T Consensus 91 ~~~g~~~vk~~i~~~~-~~~~~d~~~~~~~~~iG~~igklH~---ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 91 FIDGASTVKDFILSTM-EDESEDEGLAELARRIGELIGKLHD---NDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred eccchhHHHHHHHHHc-cCcccchhHHHHHHHHHHHHHHhhh---CCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 9977 36777776442 2223333347788999999999997 89999999999999965443 58999999864
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.76 E-value=6.4e-09 Score=119.36 Aligned_cols=240 Identities=22% Similarity=0.232 Sum_probs=167.8
Q ss_pred hcccccccccEEEEEEEEC--CCcEEEEEEccCcchhhhHH--HHHHHHHHHhc-CCCcccccceeeeccceEEEEEEec
Q 002336 617 FCKKIGKGSFGSVYYGKMK--DGKEVAVKIMADSCSHRTQQ--FVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEYM 691 (935)
Q Consensus 617 ~~~~LG~G~fG~Vy~~~~~--~g~~vAvK~~~~~~~~~~~~--~~~E~~iL~~L-~HpnIv~l~g~~~~~~~~~lV~E~~ 691 (935)
+...||.|.|+.|+....+ ++..+++|.+.+.......+ -..|+.+...+ .|.++++....+..-...++=-||+
T Consensus 269 ~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~~ 348 (524)
T KOG0601|consen 269 LVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEFC 348 (524)
T ss_pred eeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchhhh
Confidence 3568999999999988644 57788998876543332222 23466666666 4888888777776666777999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCC-CcEEEeecccccccccccc
Q 002336 692 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN-MRAKVSDFGLSRQAEEDLT 770 (935)
Q Consensus 692 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~-~~vkL~DFGla~~~~~~~~ 770 (935)
+++++..... ....+++..++++..|++.++.++|+ +.++|+|+||+||++..+ +..++.|||+.....-.
T Consensus 349 ~~~s~~l~~~---~~~~~d~~~~~~~~~q~~~~l~~i~s---~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~-- 420 (524)
T KOG0601|consen 349 EGGSSSLRSV---TSQMLDEDPRLRLTAQILTALNVIHS---KLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFS-- 420 (524)
T ss_pred cCcchhhhhH---HHHhcCcchhhhhHHHHHhccccccc---hhhhcccccccceeeccchhhhhcccccccccccee--
Confidence 9998876552 23457778889999999999999998 999999999999999876 77899999988642111
Q ss_pred ceeecccCCcccc--CCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccccc
Q 002336 771 HISSVARGTVGYL--DPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 848 (935)
Q Consensus 771 ~~~~~~~gt~~y~--APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l 848 (935)
........++. +++......+..+.|+++||.-+.+.+++..--. ...+|.. ++.+... .+
T Consensus 421 --~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~--------~~~~~~~--i~~~~~p-----~~ 483 (524)
T KOG0601|consen 421 --SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSE--------SGVQSLT--IRSGDTP-----NL 483 (524)
T ss_pred --cccccccccccccchhhccccccccccccccccccccccccCcccCc--------cccccee--eeccccc-----CC
Confidence 11111233344 4555556678899999999999999998875432 1111111 1122111 11
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 002336 849 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 886 (935)
Q Consensus 849 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~ 886 (935)
+.. ...+..+.+.+...++..||.+.++..+.+
T Consensus 484 ----~~~-~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~ 516 (524)
T KOG0601|consen 484 ----PGL-KLQLQVLLKVMINPDRKRRPSAVELSLHSE 516 (524)
T ss_pred ----Cch-HHhhhhhhhhhcCCccccchhhhhhcccch
Confidence 111 146778888999999999999998876544
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.71 E-value=1.4e-07 Score=102.21 Aligned_cols=141 Identities=16% Similarity=0.161 Sum_probs=101.8
Q ss_pred ccccccccEEEEEEEECCCcEEEEEEccCcchh-hh----------HHHHHHHHHHHhcCCCcc--cccceeeec-----
Q 002336 619 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSH-RT----------QQFVTEVALLSRIHHRNL--VPLIGYCEE----- 680 (935)
Q Consensus 619 ~~LG~G~fG~Vy~~~~~~g~~vAvK~~~~~~~~-~~----------~~~~~E~~iL~~L~HpnI--v~l~g~~~~----- 680 (935)
+.+-+-....|++.++. |+.+.||........ .. ..+.+|+..+.++...+| ..++++...
T Consensus 28 e~v~~~~~rrvvr~~~~-g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFELA-GKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEEC-CEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 44444445557787775 889999976443211 11 147889999988854443 344555533
Q ss_pred cceEEEEEEecCCC-CHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccC-------CC
Q 002336 681 EHQRILVYEYMHNG-TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI-------NM 752 (935)
Q Consensus 681 ~~~~~lV~E~~~~g-sL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~-------~~ 752 (935)
....++|+|++++. +|.+++.... ....+...+..++.++++.+..||. .||+|||++++|||++. +.
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~~LH~---~Gi~HgDL~~~NiLl~~~~~~~~~~~ 182 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWA-TNPPDPRLKRMLIKRVATMVRDMHA---AGINHRDCYICHFLLHLPFPGREEDL 182 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHH---CcCccCCCChhhEEEeccccCCCCCc
Confidence 23568999999886 8999875321 2345566778999999999999998 99999999999999975 46
Q ss_pred cEEEeecccccc
Q 002336 753 RAKVSDFGLSRQ 764 (935)
Q Consensus 753 ~vkL~DFGla~~ 764 (935)
.+.|+||+.+..
T Consensus 183 ~~~LIDl~r~~~ 194 (268)
T PRK15123 183 KLSVIDLHRAQI 194 (268)
T ss_pred eEEEEECCcccc
Confidence 799999997753
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.66 E-value=7.4e-07 Score=100.30 Aligned_cols=170 Identities=21% Similarity=0.292 Sum_probs=128.7
Q ss_pred ccEEEEEEEEC-CCcEEEEEEccCcchhhhHHHHHHHHHHHhcCCCcccccceeee----ccceEEEEEEecCC-CCHHH
Q 002336 625 SFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCE----EEHQRILVYEYMHN-GTLRD 698 (935)
Q Consensus 625 ~fG~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~----~~~~~~lV~E~~~~-gsL~~ 698 (935)
.-.+.|++... +|..+++|+++............-+++++++.|+|+|++.+++. .+..+++||+|+++ ++|.+
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d 367 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD 367 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence 34678899765 89999999995543333334445688899999999999999875 34568899999986 57777
Q ss_pred HhccCC------------CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccc
Q 002336 699 RLHGSV------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 766 (935)
Q Consensus 699 ~L~~~~------------~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~ 766 (935)
.--... .+...++..++.++.|+..||.++|+ .|+.-+-|.+++||++.+.+++|+..|......
T Consensus 368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHs---sGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~ 444 (655)
T KOG3741|consen 368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHS---SGLACKTLDLKKILVTGKMRIRISGCGIMDVLQ 444 (655)
T ss_pred HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHh---cCceeecccHhHeEeeCcceEEEecccceeeec
Confidence 543211 23457789999999999999999998 899999999999999999999999887665443
Q ss_pred ccccceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCC
Q 002336 767 EDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 815 (935)
Q Consensus 767 ~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~P 815 (935)
.+.. |.+. --.+-|.=.||.+++.|.||..-
T Consensus 445 ~d~~---------------~~le---~~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 445 EDPT---------------EPLE---SQQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CCCC---------------cchh---HHhhhhHHHHHHHHHHHhhcccc
Confidence 3220 1111 12467999999999999999654
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.63 E-value=7.2e-07 Score=97.85 Aligned_cols=269 Identities=16% Similarity=0.156 Sum_probs=165.3
Q ss_pred hcccccccccEEEEEEEECCCcEEEEEEccCcchhhhHHHHHHHHHHHhc-CCCccccccee----e---eccceEEEEE
Q 002336 617 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGY----C---EEEHQRILVY 688 (935)
Q Consensus 617 ~~~~LG~G~fG~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L-~HpnIv~l~g~----~---~~~~~~~lV~ 688 (935)
.++.||+|+.+.+|-.-. -...+.|+.+..-.....+ .+..|... .||-+-.-+.+ . ..+....+.|
T Consensus 15 ~gr~LgqGgea~ly~l~e--~~d~VAKIYh~Pppa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm 89 (637)
T COG4248 15 PGRPLGQGGEADLYTLGE--VRDQVAKIYHAPPPAAQAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM 89 (637)
T ss_pred CCccccCCccceeeecch--hhchhheeecCCCchHHHH---HHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence 357899999999995422 1223556665443322222 22333333 46544331211 1 1223366888
Q ss_pred EecCCC-CHHHHhccCC---CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccc
Q 002336 689 EYMHNG-TLRDRLHGSV---NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 764 (935)
Q Consensus 689 E~~~~g-sL~~~L~~~~---~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~ 764 (935)
..+.+. .+.++++... .-...+|.-.++.+..+|.+.+-||. .|.+-||+.++|+|+++++.+.|.|=..-..
T Consensus 90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~---~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi 166 (637)
T COG4248 90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHE---HGHVVGDVNQNSFLVSDDSKVVLVDSDSFQI 166 (637)
T ss_pred ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHh---cCCcccccCccceeeecCceEEEEcccceee
Confidence 888764 3344443222 22346799999999999999999997 8999999999999999999999997654333
Q ss_pred ccccccceeecccCCccccCCCCCC-----CCCCCchhHHHHHHHHHHHHHhC-CCCCCccCccc-chhHHHHHHHhhhc
Q 002336 765 AEEDLTHISSVARGTVGYLDPEYYG-----NQQLTEKSDVYSFGVVLLELISG-KKPVSVEDFGA-ELNIVHWARSMIKK 837 (935)
Q Consensus 765 ~~~~~~~~~~~~~gt~~y~APE~l~-----~~~~s~ksDVwS~Gvil~eLltG-~~Pf~~~~~~~-~~~l~~~~~~~i~~ 837 (935)
..+...+ ..-.|...|.+||.-. +-.-+...|-|.+|+++++++.| +.||.+-.... ..+..+ ..|..
T Consensus 167 ~~ng~~~--~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E---~~Ia~ 241 (637)
T COG4248 167 NANGTLH--LCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLE---TDIAH 241 (637)
T ss_pred ccCCceE--ecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcch---hhhhc
Confidence 2222222 2235888999999643 34556789999999999999886 99998654421 111111 01112
Q ss_pred CCeeecccccc-----cCCCCHH-HHHHHHHHHHHccccC--CCCCCCHHHHHHHHhhhhhhccCCCCC
Q 002336 838 GDVISIVDPVL-----IGNVKIE-SIWRIAEVAIQCVEQR--GFSRPKMQEIVLAIQDSIKIEKGGDQK 898 (935)
Q Consensus 838 ~~~~~~~d~~l-----~~~~~~~-~~~~l~~li~~Cl~~d--P~~RPs~~ev~~~L~~~~~~~~~~~~~ 898 (935)
|.+...-|..- ....+-+ .+..+.-+..+|+... +.-||+++..+..|..+.....+....
T Consensus 242 g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~~C~v~ 310 (637)
T COG4248 242 GRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLKKCTVS 310 (637)
T ss_pred ceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhhhhhhc
Confidence 22222222111 0111111 1235667788888764 568999999999988777766655443
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.62 E-value=1.9e-07 Score=95.49 Aligned_cols=126 Identities=25% Similarity=0.317 Sum_probs=82.3
Q ss_pred EEEEEEECCCcEEEEEEccCcch--------------------------hhhHHHHHHHHHHHhcCCC--cccccceeee
Q 002336 628 SVYYGKMKDGKEVAVKIMADSCS--------------------------HRTQQFVTEVALLSRIHHR--NLVPLIGYCE 679 (935)
Q Consensus 628 ~Vy~~~~~~g~~vAvK~~~~~~~--------------------------~~~~~~~~E~~iL~~L~Hp--nIv~l~g~~~ 679 (935)
.||.|...+|..+|||+.+.... .......+|++.|.++..- ++.+++++-
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 48999998999999998642100 0113467899999999755 455555442
Q ss_pred ccceEEEEEEecC--CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHH-hhhcCCCceEecCCCCCCccccCCCcEEE
Q 002336 680 EEHQRILVYEYMH--NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEY-LHTGCNPGIIHRDVKSSNILLDINMRAKV 756 (935)
Q Consensus 680 ~~~~~~lV~E~~~--~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~y-LHs~~~~~ivH~DLkp~NILld~~~~vkL 756 (935)
..++||||++ |..+..+.... ++......++.++++.+.. +|. .||+||||.+.|||++++ .+.|
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~~-----~~~~~~~~~~~~il~~~~~~~~~---~givHGDLs~~NIlv~~~-~~~i 147 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDVD-----LSPEEPKELLEEILEEIIKMLHK---AGIVHGDLSEYNILVDDG-KVYI 147 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHCG-----GGGSTHHHHHHHHHHHHHHHHHC---TTEEESS-STTSEEEETT-CEEE
T ss_pred ---CCEEEEEecCCCccchhhHHhcc-----ccchhHHHHHHHHHHHHHHHHHh---cCceecCCChhhEEeecc-eEEE
Confidence 3479999998 65554433311 1133456678888886666 465 899999999999999987 8999
Q ss_pred eecccccccc
Q 002336 757 SDFGLSRQAE 766 (935)
Q Consensus 757 ~DFGla~~~~ 766 (935)
+|||.+....
T Consensus 148 IDf~qav~~~ 157 (188)
T PF01163_consen 148 IDFGQAVDSS 157 (188)
T ss_dssp --GTTEEETT
T ss_pred EecCcceecC
Confidence 9999876543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.60 E-value=1.3e-08 Score=115.13 Aligned_cols=153 Identities=18% Similarity=0.275 Sum_probs=84.0
Q ss_pred ecCCCcchhhhhhhhhceeecccccCchhhHHHHHHHHhhcCCCCCCCCCCCCCCCCCCceEEEeCCCCCcEEEEEccCC
Q 002336 344 KTRDSTLGPLLNAIEISKYQKIAAKTEWQDVMVLEALRSISDESERTNDRGDPCVPVPWEWVTCSTTTPPRITKIALSGK 423 (935)
Q Consensus 344 ~~~~s~l~p~ina~e~~~~~~~~~~t~~~d~~~l~~l~~~~~~~~~~~w~~dpC~~~~w~~v~c~~~~~~~l~~L~Ls~n 423 (935)
.-.+|.+||-|-.++-+.++.++.....+=..-|+.-|.++-.+...|.... .|.+ -|-+...|..||||+|
T Consensus 89 ~LKnsGiP~diF~l~dLt~lDLShNqL~EvP~~LE~AKn~iVLNLS~N~Iet--IPn~------lfinLtDLLfLDLS~N 160 (1255)
T KOG0444|consen 89 NLKNSGIPTDIFRLKDLTILDLSHNQLREVPTNLEYAKNSIVLNLSYNNIET--IPNS------LFINLTDLLFLDLSNN 160 (1255)
T ss_pred ccccCCCCchhcccccceeeecchhhhhhcchhhhhhcCcEEEEcccCcccc--CCch------HHHhhHhHhhhccccc
Confidence 3456778999999999999888765443333334444433322111111100 0000 0112234556666666
Q ss_pred CCcccCCccccCcccccccccccccCCCC-CCCcccccccccccccccccc-CCCCCccCccccccccccccccCCCCCC
Q 002336 424 NLKGEIPPELKNMEALTELWLDGNFLTGP-LPDMSRLIDLRIVHLENNELT-GSLPSYMGSLPNLQELHIENNSFVGEIP 501 (935)
Q Consensus 424 ~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~-~p~~~~l~~L~~L~L~~N~l~-g~iP~~l~~l~~L~~L~l~~N~l~g~iP 501 (935)
.|. .+|+.+..|..|+.|+||+|-|.-- +-.+..|++|++|++++.+-+ ..+|.++..|.+|..+|||.|+|. .+|
T Consensus 161 rLe-~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vP 238 (1255)
T KOG0444|consen 161 RLE-MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVP 238 (1255)
T ss_pred hhh-hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCC-cch
Confidence 666 6666666666666666666655431 113334444444444444411 256777777777777777777777 777
Q ss_pred ccccC
Q 002336 502 PALLT 506 (935)
Q Consensus 502 ~~l~~ 506 (935)
+.+.+
T Consensus 239 ecly~ 243 (1255)
T KOG0444|consen 239 ECLYK 243 (1255)
T ss_pred HHHhh
Confidence 76654
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.53 E-value=2.8e-08 Score=119.45 Aligned_cols=242 Identities=21% Similarity=0.244 Sum_probs=159.3
Q ss_pred cccccccccEEEEEEEEC-CCcEEEEEEccCc---chhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEecCC
Q 002336 618 CKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS---CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 693 (935)
Q Consensus 618 ~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~---~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~~~ 693 (935)
.+.+-+|.++.++.+.-. .|...+.|+.... ...+.+....+-.++-..+||-+++...-+.-....+|+++|..+
T Consensus 809 ~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~~~~~~ 888 (1205)
T KOG0606|consen 809 TKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVGHYLNG 888 (1205)
T ss_pred cccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhhHHhcc
Confidence 457888999999877543 3433444433211 111122233333333334556666665555556678999999999
Q ss_pred CCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccc------
Q 002336 694 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE------ 767 (935)
Q Consensus 694 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~------ 767 (935)
++|...|+.. .+.+..........+.+++++||+ ..+.|+|++|.|.++..+++.++.|||.....+.
T Consensus 889 ~~~~Skl~~~---~~~saepaRs~i~~~vqs~e~L~s---~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~ 962 (1205)
T KOG0606|consen 889 GDLPSKLHNS---GCLSAEPARSPILERVQSLESLHS---SLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTTD 962 (1205)
T ss_pred CCchhhhhcC---CCcccccccchhHHHHhhhhcccc---chhhcccccccchhhcccCCcccCccccccccccccCcCC
Confidence 9999999843 345555566677788899999997 5689999999999999999999999983322100
Q ss_pred c--------------------cc----ceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCccc
Q 002336 768 D--------------------LT----HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGA 823 (935)
Q Consensus 768 ~--------------------~~----~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~ 823 (935)
. .. .......||+.|.+||.+.+..-...+|.|++|+.++|.++|..||.......
T Consensus 963 ~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq~ 1042 (1205)
T KOG0606|consen 963 LSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETPQQ 1042 (1205)
T ss_pred cccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcchhh
Confidence 0 00 01123458999999999999999999999999999999999999997332211
Q ss_pred chhHHHHHHHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHH
Q 002336 824 ELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQ 879 (935)
Q Consensus 824 ~~~l~~~~~~~i~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ 879 (935)
.. +..+ .++ -+. ...+.+......+++.+.+..+|.+|-.+.
T Consensus 1043 ---~f---~ni~-~~~-----~~~--p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1043 ---IF---ENIL-NRD-----IPW--PEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred ---hh---hccc-cCC-----CCC--CCCccccChhhhhhhhhhhccCchhccCcc
Confidence 11 0001 111 111 111222233556777788889999998776
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.50 E-value=1.2e-08 Score=110.50 Aligned_cols=102 Identities=22% Similarity=0.335 Sum_probs=80.7
Q ss_pred CcEEEEEccCCCCcccCCccccCcccccccccccccCCCCCCCc-cccccccccccccccccCCCCCccCcccccccccc
Q 002336 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 491 (935)
Q Consensus 413 ~~l~~L~Ls~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~~-~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~l 491 (935)
.++.-|+|.+|++. .+| +|..+..|.+|+++.|++.-.+.+. .+|.+|.+|||.+|++. +.|+++.-|.+|..||+
T Consensus 206 ~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDl 282 (565)
T KOG0472|consen 206 ESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIEMLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSLERLDL 282 (565)
T ss_pred hhhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHHhhHHHHhcccccceeeeccccccc-cCchHHHHhhhhhhhcc
Confidence 45666777777777 666 7777777777777777777655554 48899999999999999 89999999999999999
Q ss_pred ccccCCCCCCccccCC-ceeeeecCCCC
Q 002336 492 ENNSFVGEIPPALLTG-KVIFKYDNNPK 518 (935)
Q Consensus 492 ~~N~l~g~iP~~l~~~-~~~~~~~~n~~ 518 (935)
|||.++ .+|.++++. ...+.+.|||.
T Consensus 283 SNN~is-~Lp~sLgnlhL~~L~leGNPl 309 (565)
T KOG0472|consen 283 SNNDIS-SLPYSLGNLHLKFLALEGNPL 309 (565)
T ss_pred cCCccc-cCCcccccceeeehhhcCCch
Confidence 999998 889888874 33445678875
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.49 E-value=3.4e-08 Score=107.16 Aligned_cols=136 Identities=21% Similarity=0.227 Sum_probs=97.5
Q ss_pred CchhhHHHHHHHHhhcCC-CCCCCCCCCCCCCCCCceEEEeCCCCCcEEEEEccCCCCcccCCccccCcccccccccccc
Q 002336 369 TEWQDVMVLEALRSISDE-SERTNDRGDPCVPVPWEWVTCSTTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGN 447 (935)
Q Consensus 369 t~~~d~~~l~~l~~~~~~-~~~~~w~~dpC~~~~w~~v~c~~~~~~~l~~L~Ls~n~l~g~ip~~i~~L~~L~~L~Ls~N 447 (935)
+.+.+...|..+...... ....+|-+ -.-...++++-|+|+||-|. .+|.+++.|..|+.||||+|
T Consensus 402 elPk~L~~lkelvT~l~lsnn~isfv~------------~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~N 468 (565)
T KOG0472|consen 402 ELPKRLVELKELVTDLVLSNNKISFVP------------LELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFN 468 (565)
T ss_pred hhhhhhHHHHHHHHHHHhhcCccccch------------HHHHhhhcceeeecccchhh-hcchhhhhhhhhheeccccc
Confidence 556666666666654432 33444433 22223568999999999888 99999999999999999999
Q ss_pred cCCCCCCCccccccccccccccccccCCCCCc-cCccccccccccccccCCCCCCccccC--CceeeeecCCCCC
Q 002336 448 FLTGPLPDMSRLIDLRIVHLENNELTGSLPSY-MGSLPNLQELHIENNSFVGEIPPALLT--GKVIFKYDNNPKL 519 (935)
Q Consensus 448 ~l~g~~p~~~~l~~L~~L~L~~N~l~g~iP~~-l~~l~~L~~L~l~~N~l~g~iP~~l~~--~~~~~~~~~n~~~ 519 (935)
+|.-.+--+..+..|+.+-.++|++. .+|.+ +++|.+|..|||.+|.+. .||+.+++ ....+.++|||+.
T Consensus 469 rFr~lP~~~y~lq~lEtllas~nqi~-~vd~~~l~nm~nL~tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr 541 (565)
T KOG0472|consen 469 RFRMLPECLYELQTLETLLASNNQIG-SVDPSGLKNMRNLTTLDLQNNDLQ-QIPPILGNMTNLRHLELDGNPFR 541 (565)
T ss_pred ccccchHHHhhHHHHHHHHhcccccc-ccChHHhhhhhhcceeccCCCchh-hCChhhccccceeEEEecCCccC
Confidence 88754445566667777777777777 55554 888888888888888887 88887776 4455667788764
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.48 E-value=8.1e-07 Score=93.44 Aligned_cols=134 Identities=23% Similarity=0.236 Sum_probs=95.1
Q ss_pred HhhcccccccccEEEEEEEECCCcEEEEEEccCcc----------------------hhhhHHHHHHHHHHHhcCCC--c
Q 002336 615 NNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSC----------------------SHRTQQFVTEVALLSRIHHR--N 670 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~~~~~~----------------------~~~~~~~~~E~~iL~~L~Hp--n 670 (935)
+.+++.||.|--+.||.|...+|.++|||.=+... .......++|+++|++|... .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 45678999999999999999999999999632110 00123467899999999754 6
Q ss_pred ccccceeeeccceEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccC
Q 002336 671 LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI 750 (935)
Q Consensus 671 Iv~l~g~~~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~ 750 (935)
+.+.+++ +...+|||+++|-.|...- ++....-.++..|++-+..+-. .||+|||+++-||++++
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~---~GiVHGDlSefNIlV~~ 237 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYR---RGIVHGDLSEFNILVTE 237 (304)
T ss_pred CCCcccc----ccceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHH---cCccccCCchheEEEec
Confidence 6666643 4568999999986665421 1122233344444444444443 79999999999999999
Q ss_pred CCcEEEeeccccc
Q 002336 751 NMRAKVSDFGLSR 763 (935)
Q Consensus 751 ~~~vkL~DFGla~ 763 (935)
+|.+.++||--+.
T Consensus 238 dg~~~vIDwPQ~v 250 (304)
T COG0478 238 DGDIVVIDWPQAV 250 (304)
T ss_pred CCCEEEEeCcccc
Confidence 9999999996443
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.45 E-value=5.4e-08 Score=80.56 Aligned_cols=59 Identities=39% Similarity=0.515 Sum_probs=31.8
Q ss_pred cccccccccccCCCCCC-CccccccccccccccccccCCCCCccCccccccccccccccC
Q 002336 438 ALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSF 496 (935)
Q Consensus 438 ~L~~L~Ls~N~l~g~~p-~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~l~~N~l 496 (935)
+|+.|+|++|+|+...+ .|.++++|++|+|++|+++...|..|..|++|++|++++|+|
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 45555555555554444 345555555555555555533334555555666666655553
|
... |
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.38 E-value=1.2e-07 Score=78.36 Aligned_cols=60 Identities=35% Similarity=0.482 Sum_probs=54.2
Q ss_pred CcEEEEEccCCCCcccCCccccCcccccccccccccCCCCCC-Cccccccccccccccccc
Q 002336 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNEL 472 (935)
Q Consensus 413 ~~l~~L~Ls~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p-~~~~l~~L~~L~L~~N~l 472 (935)
++|+.|+|++|+|+..-+..|.++++|++|+|++|.++...| .|.+|++|+.|+|++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 478999999999995544688999999999999999998888 689999999999999986
|
... |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.38 E-value=1.6e-06 Score=101.46 Aligned_cols=147 Identities=22% Similarity=0.280 Sum_probs=94.8
Q ss_pred HHHhhc-ccccccccEEEEEEEECCCcEEEEEEccCcchhhhH-------------------------------------
Q 002336 613 ATNNFC-KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQ------------------------------------- 654 (935)
Q Consensus 613 ~~~~~~-~~LG~G~fG~Vy~~~~~~g~~vAvK~~~~~~~~~~~------------------------------------- 654 (935)
.-.+|. +.|+.++-|.||+|++++|+.||||+.++......+
T Consensus 124 ~F~eF~~~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~ 203 (517)
T COG0661 124 LFSEFEPEPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLR 203 (517)
T ss_pred HHHHcCCCchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHH
Confidence 334453 679999999999999999999999998654322110
Q ss_pred ---HHHHHHHHHHhcC-----CCcccccceeee-ccceEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHh
Q 002336 655 ---QFVTEVALLSRIH-----HRNLVPLIGYCE-EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGL 725 (935)
Q Consensus 655 ---~~~~E~~iL~~L~-----HpnIv~l~g~~~-~~~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL 725 (935)
++.+|+..+.+++ .+++ ++=..++ -.....|+|||++|-.+.+...-. ..+.+.+.+.....++. +
T Consensus 204 ~ElDy~~EA~n~~~~~~nf~~~~~v-~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~--~~g~d~k~ia~~~~~~f--~ 278 (517)
T COG0661 204 EELDYRREAANAERFRENFKDDPDV-YVPKVYWEYTTRRVLTMEWIDGIKISDIAALK--SAGIDRKELAELLVRAF--L 278 (517)
T ss_pred HHhCHHHHHHHHHHHHHHcCCCCCe-EeceeehhccCCcEEEEEeeCCEecccHHHHH--hcCCCHHHHHHHHHHHH--H
Confidence 1333444444442 2222 2222332 345678999999999888874321 23344333333222221 1
Q ss_pred HHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccc
Q 002336 726 EYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 767 (935)
Q Consensus 726 ~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~ 767 (935)
..+- ..|+.|+|.+|.||+++.++.+.+.|||+.....+
T Consensus 279 ~q~~---~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 279 RQLL---RDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred HHHH---hcCccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 1111 26899999999999999999999999999876654
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.38 E-value=1.3e-07 Score=112.21 Aligned_cols=105 Identities=29% Similarity=0.409 Sum_probs=92.7
Q ss_pred CCcEEEEEccCCCCcccCCc-cccCcccccccccccccCCCCCCCccccccccccccccccccCCCCCccCccccccccc
Q 002336 412 PPRITKIALSGKNLKGEIPP-ELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 490 (935)
Q Consensus 412 ~~~l~~L~Ls~n~l~g~ip~-~i~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~ 490 (935)
..+|+.|+|++|.|. ++|. .+.+|..|++|+||+|+|+..+-.+.++..|++|-..+|+|. .+| ++.+++.|+.+|
T Consensus 382 ~~hLKVLhLsyNrL~-~fpas~~~kle~LeeL~LSGNkL~~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lD 458 (1081)
T KOG0618|consen 382 FKHLKVLHLSYNRLN-SFPASKLRKLEELEELNLSGNKLTTLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLD 458 (1081)
T ss_pred ccceeeeeecccccc-cCCHHHHhchHHhHHHhcccchhhhhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEe
Confidence 368999999999998 8885 689999999999999999988878999999999999999999 899 899999999999
Q ss_pred cccccCC-CCCCcccc-CCceeeeecCCCCC
Q 002336 491 IENNSFV-GEIPPALL-TGKVIFKYDNNPKL 519 (935)
Q Consensus 491 l~~N~l~-g~iP~~l~-~~~~~~~~~~n~~~ 519 (935)
++.|+|+ +.+|..+. .....+.+.||+++
T Consensus 459 lS~N~L~~~~l~~~~p~p~LkyLdlSGN~~l 489 (1081)
T KOG0618|consen 459 LSCNNLSEVTLPEALPSPNLKYLDLSGNTRL 489 (1081)
T ss_pred cccchhhhhhhhhhCCCcccceeeccCCccc
Confidence 9999998 55666665 45667788888854
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=98.36 E-value=1.2e-07 Score=95.55 Aligned_cols=101 Identities=29% Similarity=0.480 Sum_probs=37.6
Q ss_pred CcEEEEEccCCCCcccCCcccc-CcccccccccccccCCCCCCCccccccccccccccccccCCCCCcc-Cccccccccc
Q 002336 413 PRITKIALSGKNLKGEIPPELK-NMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYM-GSLPNLQELH 490 (935)
Q Consensus 413 ~~l~~L~Ls~n~l~g~ip~~i~-~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~iP~~l-~~l~~L~~L~ 490 (935)
.++++|+|.+|+|+ .|. .++ .|++|+.|||++|.|+. ++.+..|++|+.|+|++|+++ .+++.+ ..+++|+.|+
T Consensus 19 ~~~~~L~L~~n~I~-~Ie-~L~~~l~~L~~L~Ls~N~I~~-l~~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~L~~L~ 94 (175)
T PF14580_consen 19 VKLRELNLRGNQIS-TIE-NLGATLDKLEVLDLSNNQITK-LEGLPGLPRLKTLDLSNNRIS-SISEGLDKNLPNLQELY 94 (175)
T ss_dssp -------------------S--TT-TT--EEE-TTS--S---TT----TT--EEE--SS----S-CHHHHHH-TT--EEE
T ss_pred cccccccccccccc-ccc-chhhhhcCCCEEECCCCCCcc-ccCccChhhhhhcccCCCCCC-ccccchHHhCCcCCEEE
Confidence 37899999999998 553 566 58899999999999996 467888999999999999999 676555 4689999999
Q ss_pred cccccCCCCCCc--cc--cCCceeeeecCCCC
Q 002336 491 IENNSFVGEIPP--AL--LTGKVIFKYDNNPK 518 (935)
Q Consensus 491 l~~N~l~g~iP~--~l--~~~~~~~~~~~n~~ 518 (935)
|++|++. .+-+ .+ +.....+.+.+||.
T Consensus 95 L~~N~I~-~l~~l~~L~~l~~L~~L~L~~NPv 125 (175)
T PF14580_consen 95 LSNNKIS-DLNELEPLSSLPKLRVLSLEGNPV 125 (175)
T ss_dssp -TTS----SCCCCGGGGG-TT--EEE-TT-GG
T ss_pred CcCCcCC-ChHHhHHHHcCCCcceeeccCCcc
Confidence 9999997 4432 11 22455677788875
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.31 E-value=6.6e-06 Score=84.86 Aligned_cols=137 Identities=20% Similarity=0.233 Sum_probs=102.2
Q ss_pred cccccEEEEEEEECCCcEEEEEEccCcc------hhhhHHHHHHHHHHHhcCCC--cccccceeeec-----cceEEEEE
Q 002336 622 GKGSFGSVYYGKMKDGKEVAVKIMADSC------SHRTQQFVTEVALLSRIHHR--NLVPLIGYCEE-----EHQRILVY 688 (935)
Q Consensus 622 G~G~fG~Vy~~~~~~g~~vAvK~~~~~~------~~~~~~~~~E~~iL~~L~Hp--nIv~l~g~~~~-----~~~~~lV~ 688 (935)
|+||-+.|++..+. |+.+-+|.-.... ......|.+|+..+++|... .+.+++ ++.. ....+||+
T Consensus 27 ~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 27 RRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLVT 104 (216)
T ss_pred CCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEEE
Confidence 55888999998876 5578888754211 23457899999999999532 244444 3321 22457999
Q ss_pred EecCC-CCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCc--EEEeecccccc
Q 002336 689 EYMHN-GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMR--AKVSDFGLSRQ 764 (935)
Q Consensus 689 E~~~~-gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~--vkL~DFGla~~ 764 (935)
|-+.+ -+|.+++... ...+.+...+..++.++++.++-||. .|+.|+|+.++||+++.++. ++++||.-++.
T Consensus 105 e~L~g~~~L~~~l~~~-~~~~~~~~~k~~il~~va~~ia~LH~---~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 105 EDMAGFISIADWYAQH-AVSPYSDEVRQAMLKAVALAFKKMHS---VNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EeCCCCccHHHHHhcC-CcCCcchHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 98864 5898888643 22356777888999999999999998 99999999999999986667 99999976543
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.29 E-value=2.9e-06 Score=88.63 Aligned_cols=106 Identities=27% Similarity=0.312 Sum_probs=83.2
Q ss_pred HHHHHHHHHHHhcCCCc--ccccceeeecc----ceEEEEEEecCCC-CHHHHhccCCCCCCCCHHHHHHHHHHHHHHhH
Q 002336 654 QQFVTEVALLSRIHHRN--LVPLIGYCEEE----HQRILVYEYMHNG-TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLE 726 (935)
Q Consensus 654 ~~~~~E~~iL~~L~Hpn--Iv~l~g~~~~~----~~~~lV~E~~~~g-sL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~ 726 (935)
....+|...+..+.... ..+.+++.... ...++|+|++++. +|.+++... ...+......++.++++.++
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~---~~~~~~~~~~ll~~l~~~i~ 132 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQW---EQLDPSQRRELLRALARLIA 132 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhh---cccchhhHHHHHHHHHHHHH
Confidence 46788999888885333 45556665442 2458999999884 899988742 22566678899999999999
Q ss_pred HhhhcCCCceEecCCCCCCccccCCC---cEEEeeccccccc
Q 002336 727 YLHTGCNPGIIHRDVKSSNILLDINM---RAKVSDFGLSRQA 765 (935)
Q Consensus 727 yLHs~~~~~ivH~DLkp~NILld~~~---~vkL~DFGla~~~ 765 (935)
-||. .||+|+|++++|||++.+. .+.++||+-++..
T Consensus 133 ~lH~---~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 133 KLHD---AGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHH---CcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 9998 9999999999999999887 8999999977643
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.27 E-value=1.5e-07 Score=109.46 Aligned_cols=151 Identities=18% Similarity=0.279 Sum_probs=103.8
Q ss_pred HHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccc--------cceeecccCCccccCCCCCC
Q 002336 718 AHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL--------THISSVARGTVGYLDPEYYG 789 (935)
Q Consensus 718 ~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~--------~~~~~~~~gt~~y~APE~l~ 789 (935)
+.+++.|+.|+|. ..++||++|.|++|.++..+..||+.|+.+....... ........-...|.|||++.
T Consensus 105 l~~v~dgl~flh~--sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 105 LGNVADGLAFLHR--SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hhcccchhhhhcc--CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 3455699999998 6899999999999999999999999998765433211 11111122456799999999
Q ss_pred CCCCCchhHHHHHHHHHHHHHh-CCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHcc
Q 002336 790 NQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCV 868 (935)
Q Consensus 790 ~~~~s~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl 868 (935)
+...+.++|+||+|+++|-+.. |+.-+............. . .+..-...+..+.+.++.+-+.+++
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~---~----------~~~~~~~~~s~~~p~el~~~l~k~l 249 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSR---N----------LLNAGAFGYSNNLPSELRESLKKLL 249 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhh---c----------ccccccccccccCcHHHHHHHHHHh
Confidence 9888999999999999999984 544444222211111110 0 0111111222344557888899999
Q ss_pred ccCCCCCCCHHHHHH
Q 002336 869 EQRGFSRPKMQEIVL 883 (935)
Q Consensus 869 ~~dP~~RPs~~ev~~ 883 (935)
..++.-||++.++..
T Consensus 250 ~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 250 NGDSAVRPTLDLLLS 264 (700)
T ss_pred cCCcccCcchhhhhc
Confidence 999999998877653
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.25 E-value=1.4e-07 Score=106.61 Aligned_cols=105 Identities=21% Similarity=0.320 Sum_probs=86.3
Q ss_pred CcEEEEEccCCCCcccCCccccCcccccccccccccCCCCCC-CccccccccccccccccccCCCCC---ccCccccccc
Q 002336 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPS---YMGSLPNLQE 488 (935)
Q Consensus 413 ~~l~~L~Ls~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p-~~~~l~~L~~L~L~~N~l~g~iP~---~l~~l~~L~~ 488 (935)
++|.+|+|++|+|+.--+.+|..|..|+.|+|++|+++..-. .|-.|++|+.|||++|.|++.|-+ .+..|++|+.
T Consensus 317 qkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~Lrk 396 (873)
T KOG4194|consen 317 QKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRK 396 (873)
T ss_pred ccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhh
Confidence 489999999999995566789999999999999999987765 688899999999999999988876 3667899999
Q ss_pred cccccccCCCCCCccccCC---ceeeeecCCCC
Q 002336 489 LHIENNSFVGEIPPALLTG---KVIFKYDNNPK 518 (935)
Q Consensus 489 L~l~~N~l~g~iP~~l~~~---~~~~~~~~n~~ 518 (935)
|.|.+|+|. .||...+.+ ...+.+.+|+-
T Consensus 397 L~l~gNqlk-~I~krAfsgl~~LE~LdL~~Nai 428 (873)
T KOG4194|consen 397 LRLTGNQLK-SIPKRAFSGLEALEHLDLGDNAI 428 (873)
T ss_pred eeecCceee-ecchhhhccCcccceecCCCCcc
Confidence 999999998 899876654 34455566654
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.22 E-value=1.2e-05 Score=85.32 Aligned_cols=132 Identities=14% Similarity=0.132 Sum_probs=85.2
Q ss_pred ccccccccEEEEEEEECCCcEEEEEEccCcchhhhHHHHHHHHHHHhcCCCc--ccccceeeeccceEEEEEEecCCCC-
Q 002336 619 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRN--LVPLIGYCEEEHQRILVYEYMHNGT- 695 (935)
Q Consensus 619 ~~LG~G~fG~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~Hpn--Iv~l~g~~~~~~~~~lV~E~~~~gs- 695 (935)
..||+|..+.||+. .|..+++|...... ......+|.++++.+..-. +.+.+++....+...+|||+++|..
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 57899999999983 25568889876532 3345788999999986433 4667777777777889999999863
Q ss_pred HHHHhccCCCCCCCCHHHHHHHHHHHHHHhH---------------------------------------Hhhh-cCCCc
Q 002336 696 LRDRLHGSVNQKPLDWLTRLQIAHDAAKGLE---------------------------------------YLHT-GCNPG 735 (935)
Q Consensus 696 L~~~L~~~~~~~~l~~~~~~~i~~qia~gL~---------------------------------------yLHs-~~~~~ 735 (935)
+...+.. +......++.++++.+. +|.. .....
T Consensus 82 ~~~~~~~-------~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~ 154 (226)
T TIGR02172 82 FSRIISD-------NPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTST 154 (226)
T ss_pred hhhhhcC-------CHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCc
Confidence 2111110 00111111111111111 1111 11346
Q ss_pred eEecCCCCCCccccCCCcEEEeeccccc
Q 002336 736 IIHRDVKSSNILLDINMRAKVSDFGLSR 763 (935)
Q Consensus 736 ivH~DLkp~NILld~~~~vkL~DFGla~ 763 (935)
++|+|+.|.||++++++ +.++||+.+.
T Consensus 155 ~~HgD~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 155 CLHGDFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred eEecCCCCCcEEEcCCC-cEEEechhcC
Confidence 79999999999999888 9999999765
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF11721 Malectin: Di-glucose binding within endoplasmic reticulum; InterPro: IPR021720 Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan | Back alignment and domain information |
|---|
Probab=98.18 E-value=6e-06 Score=83.70 Aligned_cols=135 Identities=20% Similarity=0.396 Sum_probs=73.7
Q ss_pred EEEecCCCCCccCCCCCeEEecCCccccCCcee--e-------ecCC-----CCCcccccccccccCCCCcceEEeeecC
Q 002336 26 ISIDCGSTSNYTDPSTGLAWISDIGIMNNGKSV--K-------VENP-----SGNWMQYRTRRDLPIDNKKYCYNLITKE 91 (935)
Q Consensus 26 ~~idcg~~~~~~~~~~~~~~~~d~~~~~~g~~~--~-------~~~~-----~~~~~~~~tlr~fp~~~~~~cy~l~~~~ 91 (935)
+.|+||+... +| ..|+.|.+|..|..++..- . .... ....+.+.|-|+=| ...-|.+|..+
T Consensus 3 ~~IN~Gg~~~-~~-~~g~~w~~D~~~~~g~~~y~~~~~~~~~~~~~~~~i~~t~d~~Lyqt~R~g~---~~f~Y~ip~~~ 77 (174)
T PF11721_consen 3 LRINAGGPAY-TD-SSGIVWEADQYYTGGSWGYYVSSDNNGSTSSTNSSIPGTTDDPLYQTERYGP---SSFSYDIPVVP 77 (174)
T ss_dssp EEEEETSSSE-EE-TTTEEE-SSSSSTTSS-----------SSTTS--TTS-HHHHHTTT-----S---SSEEEEEE--S
T ss_pred EEEECCCCcc-cC-CCCCEEcCCCCCCCCCcccccccccccccccccccccCCCchhhhHhhcCCC---CceEEEEecCC
Confidence 5799998777 55 8899999999996555510 0 0000 00123456777744 35799999999
Q ss_pred CceeEEEEEe---eecCCCCCCCCC---eEEEEEcCce-eEEEEecC---Ccc-ceEEEE-EEecCCCCcccceec----
Q 002336 92 RRRYLVRATF---QYGSLGSEASYP---KFQLYLDATL-WSTVTVLD---ASR-VYAKEM-IIRAPSDSIDVCICC---- 155 (935)
Q Consensus 92 ~~~ylvr~~~---~yg~yd~~~~~p---~fd~~~~~~~-w~~v~~~~---~~~-~~~~e~-~~~~~~~~~~vcl~~---- 155 (935)
.+.|-||.-| +++. ++..+.| +||+.++|+. ...+++.. ... ....+. -+...+..+.++|..
T Consensus 78 ~G~Y~V~L~FaE~~~~~-~~~~~~~G~RvFdV~v~g~~vl~~~Di~~~~G~~~~~~~~~~~~v~v~dg~L~i~f~~~~~~ 156 (174)
T PF11721_consen 78 NGTYTVRLHFAELYFGA-SGGASGPGQRVFDVYVNGETVLKNFDIYAEAGGFNKAAVRRFFNVTVTDGTLNIQFVWAGKG 156 (174)
T ss_dssp -EEEEEEEEEE-SSS---------SSSS-EEEEETTEEEEEEE-HHHHHSSSS---EEEEEEEEEETTEEETTEEEE--S
T ss_pred CcEEEEEEEeccccccc-cccccCCCceEEEEEecceEEEeccCHHHHcCCCceEEEEEEEEEEEeCCcEEEEEEecCCC
Confidence 9999999999 3333 4444444 7999999954 33333311 111 233333 223477789999986
Q ss_pred -------cCCCCceeeee
Q 002336 156 -------AVTGSPFISTL 166 (935)
Q Consensus 156 -------~~~~~pfis~l 166 (935)
...|.|.||+|
T Consensus 157 ~~~i~~~~~~~~p~IsaI 174 (174)
T PF11721_consen 157 TLCIPFIGSYGNPLISAI 174 (174)
T ss_dssp EEEEEEESSSSSSSEEEE
T ss_pred cEEeeccccCCCcEEeeC
Confidence 44567888886
|
It carries a signal peptide from residues 1-26, a C-terminal transmembrane helix from residues 255-274, and a highly conserved central part of approximately 190 residues followed by an acidic, glutamate-rich region. Carbohydrate-binding is mediated by the four aromatic residues, Y67, Y89, Y116, and F117 and the aspartate at D186. NMR-based ligand-screening studies has shown binding of the protein to maltose and related oligosaccharides, on the basis of which the protein has been designated "malectin", and its endogenous ligand is found to be Glc2-high-mannose N-glycan [. This entry represents a malectin domain, and can also be found in probable receptor-like serine/threonine-protein kinases from plants [] and in proteins described as glycoside hydrolases. ; PDB: 2KR2_A 2JWP_A 2K46_A. |
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=98.10 E-value=9e-07 Score=89.22 Aligned_cols=82 Identities=24% Similarity=0.392 Sum_probs=42.2
Q ss_pred CcEEEEEccCCCCcccCCccccCcccccccccccccCCCCCCCc-cccccccccccccccccCCCC--CccCcccccccc
Q 002336 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNELTGSLP--SYMGSLPNLQEL 489 (935)
Q Consensus 413 ~~l~~L~Ls~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~~-~~l~~L~~L~L~~N~l~g~iP--~~l~~l~~L~~L 489 (935)
.+++.|+|++|+|+ .++ .+..|+.|+.|+|++|+|+...+.+ ..+++|+.|+|++|++. .+- ..+..|++|+.|
T Consensus 42 ~~L~~L~Ls~N~I~-~l~-~l~~L~~L~~L~L~~N~I~~i~~~l~~~lp~L~~L~L~~N~I~-~l~~l~~L~~l~~L~~L 118 (175)
T PF14580_consen 42 DKLEVLDLSNNQIT-KLE-GLPGLPRLKTLDLSNNRISSISEGLDKNLPNLQELYLSNNKIS-DLNELEPLSSLPKLRVL 118 (175)
T ss_dssp TT--EEE-TTS--S---T-T----TT--EEE--SS---S-CHHHHHH-TT--EEE-TTS----SCCCCGGGGG-TT--EE
T ss_pred cCCCEEECCCCCCc-ccc-CccChhhhhhcccCCCCCCccccchHHhCCcCCEEECcCCcCC-ChHHhHHHHcCCCccee
Confidence 58999999999999 565 5888999999999999999865555 46899999999999998 443 357789999999
Q ss_pred ccccccCC
Q 002336 490 HIENNSFV 497 (935)
Q Consensus 490 ~l~~N~l~ 497 (935)
+|.+|.++
T Consensus 119 ~L~~NPv~ 126 (175)
T PF14580_consen 119 SLEGNPVC 126 (175)
T ss_dssp E-TT-GGG
T ss_pred eccCCccc
Confidence 99999998
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.09 E-value=8.5e-07 Score=96.48 Aligned_cols=110 Identities=25% Similarity=0.310 Sum_probs=86.3
Q ss_pred CCCCCCCCCCceEEEeCC----------CCCcEEEEEccCCCCcccCCccccCcccccccccccccCCCCCC-Ccccccc
Q 002336 393 RGDPCVPVPWEWVTCSTT----------TPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLID 461 (935)
Q Consensus 393 ~~dpC~~~~w~~v~c~~~----------~~~~l~~L~Ls~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p-~~~~l~~ 461 (935)
...||.+..-+|..++|. -|+..++|.|..|+|+-.-|..|+.|.+|+.||||+|+|+.+-| .|.+|++
T Consensus 37 CP~pC~Cs~~~g~~VdCr~~GL~eVP~~LP~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~ 116 (498)
T KOG4237|consen 37 CPAPCTCSDVEGGIVDCRGKGLTEVPANLPPETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLAS 116 (498)
T ss_pred CCCCcccCCCCCceEEccCCCcccCcccCCCcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHh
Confidence 346776544445555553 25678999999999994444589999999999999999999988 6999999
Q ss_pred cccccccc-ccccCCCCC-ccCccccccccccccccCCCCCCccc
Q 002336 462 LRIVHLEN-NELTGSLPS-YMGSLPNLQELHIENNSFVGEIPPAL 504 (935)
Q Consensus 462 L~~L~L~~-N~l~g~iP~-~l~~l~~L~~L~l~~N~l~g~iP~~l 504 (935)
|..|-|.+ |+++ .+|. .|++|.+|+.|.+.-|++. .++...
T Consensus 117 l~~Lvlyg~NkI~-~l~k~~F~gL~slqrLllNan~i~-Cir~~a 159 (498)
T KOG4237|consen 117 LLSLVLYGNNKIT-DLPKGAFGGLSSLQRLLLNANHIN-CIRQDA 159 (498)
T ss_pred hhHHHhhcCCchh-hhhhhHhhhHHHHHHHhcChhhhc-chhHHH
Confidence 88877766 8899 7876 5888999998888888887 665544
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.09 E-value=3.4e-05 Score=80.71 Aligned_cols=136 Identities=24% Similarity=0.311 Sum_probs=95.8
Q ss_pred cccccccEEEEEEEECCCcEEEEEEccCcchhhh------------------------HHHHHHHHHHHhcC--CCcccc
Q 002336 620 KIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRT------------------------QQFVTEVALLSRIH--HRNLVP 673 (935)
Q Consensus 620 ~LG~G~fG~Vy~~~~~~g~~vAvK~~~~~~~~~~------------------------~~~~~E~~iL~~L~--HpnIv~ 673 (935)
.|+.|--+.||+|.-.++..+|+|+++....... .-..+|+..|.++. +=.+.+
T Consensus 55 ~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~ 134 (268)
T COG1718 55 CISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVPE 134 (268)
T ss_pred eecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCCC
Confidence 5788999999999988899999999864321110 11345788888774 444555
Q ss_pred cceeeeccceEEEEEEecCCCC-HHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCC
Q 002336 674 LIGYCEEEHQRILVYEYMHNGT-LRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM 752 (935)
Q Consensus 674 l~g~~~~~~~~~lV~E~~~~gs-L~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~ 752 (935)
.+++. ...|||||+.... -.-.| ...++...+...+..++++.+.-|-. ..++||+||+.-|||+. ++
T Consensus 135 Pi~~~----~nVLvMEfIg~~g~pAP~L----kDv~~e~~e~~~~~~~~v~~~~~l~~--~a~LVHgDLSEyNiL~~-~~ 203 (268)
T COG1718 135 PIAFR----NNVLVMEFIGDDGLPAPRL----KDVPLELEEAEGLYEDVVEYMRRLYK--EAGLVHGDLSEYNILVH-DG 203 (268)
T ss_pred ceeec----CCeEEEEeccCCCCCCCCc----ccCCcCchhHHHHHHHHHHHHHHHHH--hcCcccccchhhheEEE-CC
Confidence 55554 3479999995431 11112 22333444677788888888888875 47999999999999999 88
Q ss_pred cEEEeecccccccc
Q 002336 753 RAKVSDFGLSRQAE 766 (935)
Q Consensus 753 ~vkL~DFGla~~~~ 766 (935)
.+.|+|||-+....
T Consensus 204 ~p~iID~~QaV~~~ 217 (268)
T COG1718 204 EPYIIDVSQAVTID 217 (268)
T ss_pred eEEEEECccccccC
Confidence 99999999776543
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.08 E-value=4.7e-07 Score=85.02 Aligned_cols=105 Identities=26% Similarity=0.327 Sum_probs=88.4
Q ss_pred CCcEEEEEccCCCCcccCCccccCc-ccccccccccccCCCCCCCccccccccccccccccccCCCCCccCccccccccc
Q 002336 412 PPRITKIALSGKNLKGEIPPELKNM-EALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 490 (935)
Q Consensus 412 ~~~l~~L~Ls~n~l~g~ip~~i~~L-~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~ 490 (935)
..+|+.++|++|++. .+|+.|... +.++.|+|++|.|+..+-++..++.|+.|+++.|.|. ..|.-+..|.+|-.|+
T Consensus 52 ~~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neisdvPeE~Aam~aLr~lNl~~N~l~-~~p~vi~~L~~l~~Ld 129 (177)
T KOG4579|consen 52 GYELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEISDVPEELAAMPALRSLNLRFNPLN-AEPRVIAPLIKLDMLD 129 (177)
T ss_pred CceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhhhchHHHhhhHHhhhcccccCccc-cchHHHHHHHhHHHhc
Confidence 357999999999999 888877654 6999999999999998889999999999999999999 8888888899999999
Q ss_pred cccccCCCCCCccccCCce--eeeecCCCCC
Q 002336 491 IENNSFVGEIPPALLTGKV--IFKYDNNPKL 519 (935)
Q Consensus 491 l~~N~l~g~iP~~l~~~~~--~~~~~~n~~~ 519 (935)
..+|.+. +||..++.... .....++|+.
T Consensus 130 s~~na~~-eid~dl~~s~~~al~~lgnepl~ 159 (177)
T KOG4579|consen 130 SPENARA-EIDVDLFYSSLPALIKLGNEPLG 159 (177)
T ss_pred CCCCccc-cCcHHHhccccHHHHHhcCCccc
Confidence 9999998 99988765322 2333445543
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.08 E-value=2e-05 Score=81.57 Aligned_cols=138 Identities=17% Similarity=0.198 Sum_probs=87.5
Q ss_pred HHHHHHhhcccccccccEEEEEEEECCCcEEEEEEccCcchhhhHH---------HHHHHHHHHhcCCCc---cccccee
Q 002336 610 LEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQ---------FVTEVALLSRIHHRN---LVPLIGY 677 (935)
Q Consensus 610 l~~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~~~~~~~~~~~~---------~~~E~~iL~~L~Hpn---Iv~l~g~ 677 (935)
+....+...+.+-......|.+-..+ |+.+++|..+.......+. ..+++..+.+++... ...++..
T Consensus 28 i~~~~~~~~kv~k~~~r~~ValIei~-~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~ 106 (229)
T PF06176_consen 28 ILDNNYKIIKVFKNTKRNYVALIEID-GKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA 106 (229)
T ss_pred HHhCCceEEEeecCCCccEEEEEEEC-CcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence 33444444555665555556555554 7889999876543322222 234455555553322 2222222
Q ss_pred e-----eccceEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCC
Q 002336 678 C-----EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM 752 (935)
Q Consensus 678 ~-----~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~ 752 (935)
. ......+++|||++|..|.+... +++ .++..+.+++.-||+ .|++|||.+|.|+++++++
T Consensus 107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~~-------i~e----~~~~ki~~~ikqlH~---~G~~HGD~hpgNFlv~~~~ 172 (229)
T PF06176_consen 107 AEKKIFRYTSSYVLLMEYIEGVELNDIED-------IDE----DLAEKIVEAIKQLHK---HGFYHGDPHPGNFLVSNNG 172 (229)
T ss_pred eeeeeccceeEEEEEEEEecCeecccchh-------cCH----HHHHHHHHHHHHHHH---cCCccCCCCcCcEEEECCc
Confidence 2 22344578999999988766542 222 245667788999998 9999999999999998655
Q ss_pred cEEEeeccccc
Q 002336 753 RAKVSDFGLSR 763 (935)
Q Consensus 753 ~vkL~DFGla~ 763 (935)
+++.||+..+
T Consensus 173 -i~iID~~~k~ 182 (229)
T PF06176_consen 173 -IRIIDTQGKR 182 (229)
T ss_pred -EEEEECcccc
Confidence 9999998654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=98.06 E-value=1.7e-06 Score=105.54 Aligned_cols=73 Identities=29% Similarity=0.407 Sum_probs=37.8
Q ss_pred cccccccccccCCCCCCCccccccccccccccccccCCCCCccCccccccccccccccCCCCCCccccC--CceeeeecC
Q 002336 438 ALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLT--GKVIFKYDN 515 (935)
Q Consensus 438 ~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~l~~N~l~g~iP~~l~~--~~~~~~~~~ 515 (935)
+|+.|+|++|+|++.++. .++|+.|+|++|+|+ .+|.. ..+|+.|+|++|+|+ .||..++. ....+.+.+
T Consensus 383 ~L~~LdLs~N~Lt~LP~l---~s~L~~LdLS~N~Ls-sIP~l---~~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~ 454 (788)
T PRK15387 383 GLKELIVSGNRLTSLPVL---PSELKELMVSGNRLT-SLPML---PSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEG 454 (788)
T ss_pred ccceEEecCCcccCCCCc---ccCCCEEEccCCcCC-CCCcc---hhhhhhhhhccCccc-ccChHHhhccCCCeEECCC
Confidence 455566666666543222 134555666666665 35543 234555666666665 56655443 233445555
Q ss_pred CCC
Q 002336 516 NPK 518 (935)
Q Consensus 516 n~~ 518 (935)
|+.
T Consensus 455 N~L 457 (788)
T PRK15387 455 NPL 457 (788)
T ss_pred CCC
Confidence 554
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.06 E-value=9.1e-07 Score=100.21 Aligned_cols=102 Identities=23% Similarity=0.340 Sum_probs=90.8
Q ss_pred cEEEEEccCCCCcccCCccccCcccccccccccccCCCCCCCccccccccccccccccccCCCCCccCcccccccccccc
Q 002336 414 RITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIEN 493 (935)
Q Consensus 414 ~l~~L~Ls~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~l~~ 493 (935)
-|..|-++||+++ .+|++|+.+..|..||.+.|.+-..++.++.|.+|+.|++..|++. .+|++++.| .|..||+|+
T Consensus 144 pLkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~slpsql~~l~slr~l~vrRn~l~-~lp~El~~L-pLi~lDfSc 220 (722)
T KOG0532|consen 144 PLKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQSLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSL-PLIRLDFSC 220 (722)
T ss_pred cceeEEEecCccc-cCCcccccchhHHHhhhhhhhhhhchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCC-ceeeeeccc
Confidence 3778889999998 9999999889999999999999999999999999999999999999 899998854 688999999
Q ss_pred ccCCCCCCccccC--CceeeeecCCCCC
Q 002336 494 NSFVGEIPPALLT--GKVIFKYDNNPKL 519 (935)
Q Consensus 494 N~l~g~iP~~l~~--~~~~~~~~~n~~~ 519 (935)
|+++ .||-.+.. ....+.+++||..
T Consensus 221 Nkis-~iPv~fr~m~~Lq~l~LenNPLq 247 (722)
T KOG0532|consen 221 NKIS-YLPVDFRKMRHLQVLQLENNPLQ 247 (722)
T ss_pred Ccee-ecchhhhhhhhheeeeeccCCCC
Confidence 9999 99998876 5667788999864
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=98.02 E-value=4.4e-06 Score=102.52 Aligned_cols=95 Identities=24% Similarity=0.360 Sum_probs=60.0
Q ss_pred CcEEEEEccCCCCcccCCccccCcccccccccccccCCCCCCCccccccccccccccccccCCCCCccCccccccccccc
Q 002336 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIE 492 (935)
Q Consensus 413 ~~l~~L~Ls~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~l~ 492 (935)
..++.|+|++|+|+ .+|..+. ++|+.|+|++|+|+..+..+. .+|+.|+|++|++. .+|..+. ++|+.|+|+
T Consensus 199 ~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~LtsLP~~l~--~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls 270 (754)
T PRK15370 199 EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLTSIPATLP--DTIQEMELSINRIT-ELPERLP--SALQSLDLF 270 (754)
T ss_pred cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccccCChhhh--ccccEEECcCCccC-cCChhHh--CCCCEEECc
Confidence 46778888888887 6776554 477777888877775433332 35666666666666 5666553 356666666
Q ss_pred cccCCCCCCccccCCceeeeecCC
Q 002336 493 NNSFVGEIPPALLTGKVIFKYDNN 516 (935)
Q Consensus 493 ~N~l~g~iP~~l~~~~~~~~~~~n 516 (935)
+|+|+ .||..+......+.+++|
T Consensus 271 ~N~L~-~LP~~l~~sL~~L~Ls~N 293 (754)
T PRK15370 271 HNKIS-CLPENLPEELRYLSVYDN 293 (754)
T ss_pred CCccC-ccccccCCCCcEEECCCC
Confidence 66666 566655544444455554
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.99 E-value=6.8e-06 Score=93.36 Aligned_cols=121 Identities=21% Similarity=0.326 Sum_probs=78.8
Q ss_pred hhHHHHHHHHhhcCCCCCCCCCCCCCCCCCCceEEEeCCCCCcEEEEEccCCCCcccCCccccCcccccccccccccCCC
Q 002336 372 QDVMVLEALRSISDESERTNDRGDPCVPVPWEWVTCSTTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTG 451 (935)
Q Consensus 372 ~d~~~l~~l~~~~~~~~~~~w~~dpC~~~~w~~v~c~~~~~~~l~~L~Ls~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g 451 (935)
++..++.++...-...+...--..||.|.. .++++|+|++|.|+..--..|.+|.+|..|.|++|.++.
T Consensus 143 e~L~~l~alrslDLSrN~is~i~~~sfp~~-----------~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNritt 211 (873)
T KOG4194|consen 143 EELSALPALRSLDLSRNLISEIPKPSFPAK-----------VNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITT 211 (873)
T ss_pred HHHHhHhhhhhhhhhhchhhcccCCCCCCC-----------CCceEEeeccccccccccccccccchheeeecccCcccc
Confidence 344445444433222223333456666532 367888888888875555678888888888888888887
Q ss_pred CCC-CccccccccccccccccccCCC-CCccCccccccccccccccCCCCCCcccc
Q 002336 452 PLP-DMSRLIDLRIVHLENNELTGSL-PSYMGSLPNLQELHIENNSFVGEIPPALL 505 (935)
Q Consensus 452 ~~p-~~~~l~~L~~L~L~~N~l~g~i-P~~l~~l~~L~~L~l~~N~l~g~iP~~l~ 505 (935)
.++ .|.+|++|+.|+|..|++. .+ --.|.+|++|+.|.|..|.++ .+-++.+
T Consensus 212 Lp~r~Fk~L~~L~~LdLnrN~ir-ive~ltFqgL~Sl~nlklqrN~I~-kL~DG~F 265 (873)
T KOG4194|consen 212 LPQRSFKRLPKLESLDLNRNRIR-IVEGLTFQGLPSLQNLKLQRNDIS-KLDDGAF 265 (873)
T ss_pred cCHHHhhhcchhhhhhcccccee-eehhhhhcCchhhhhhhhhhcCcc-cccCcce
Confidence 777 6777888888888888876 33 335666777777777777776 5555443
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.96 E-value=2.1e-06 Score=102.41 Aligned_cols=90 Identities=28% Similarity=0.461 Sum_probs=84.8
Q ss_pred cEEEEEccCCCCcccCCccccCcccccccccccccCCCCCCCccccccccccccccccccCCCCCccCcccccccccccc
Q 002336 414 RITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIEN 493 (935)
Q Consensus 414 ~l~~L~Ls~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~l~~ 493 (935)
+|.+|||++|.++ ..|..|..+.+|+.|+++.|.+...+-+.+++.+|++|+|.+|++. .+|.++..+++|++|+++.
T Consensus 46 ~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i~~vp~s~~~~~~l~~lnL~~n~l~-~lP~~~~~lknl~~LdlS~ 123 (1081)
T KOG0618|consen 46 KLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYIRSVPSSCSNMRNLQYLNLKNNRLQ-SLPASISELKNLQYLDLSF 123 (1081)
T ss_pred eeEEeeccccccc-cCCchhhhHHHHhhcccchhhHhhCchhhhhhhcchhheeccchhh-cCchhHHhhhcccccccch
Confidence 5999999999997 9999999999999999999999998889999999999999999999 9999999999999999999
Q ss_pred ccCCCCCCccccC
Q 002336 494 NSFVGEIPPALLT 506 (935)
Q Consensus 494 N~l~g~iP~~l~~ 506 (935)
|+|. .+|.-+..
T Consensus 124 N~f~-~~Pl~i~~ 135 (1081)
T KOG0618|consen 124 NHFG-PIPLVIEV 135 (1081)
T ss_pred hccC-CCchhHHh
Confidence 9998 99986643
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=97.95 E-value=6.4e-05 Score=79.31 Aligned_cols=142 Identities=20% Similarity=0.266 Sum_probs=84.5
Q ss_pred ccccccccEEEEEEEECCCcEEEEEEccCcchhhhHHHHHHHHHHHhcCCC--cccccceeee---ccceEEEEEEecCC
Q 002336 619 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHR--NLVPLIGYCE---EEHQRILVYEYMHN 693 (935)
Q Consensus 619 ~~LG~G~fG~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~Hp--nIv~l~g~~~---~~~~~~lV~E~~~~ 693 (935)
+.|+.|..+.||+....+ ..+++|..... .....+.+|..+++.+... .+.+++.+.. .....+++|+++++
T Consensus 3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g 79 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPG 79 (239)
T ss_dssp EEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESS
T ss_pred ccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecc
Confidence 578999999999999986 69999987554 4556788899999888533 3456665442 23346899999999
Q ss_pred CCHHH----------------Hh---ccC-CCCCCCCHHH---------HHHH------------HHHHHH-HhHHhhh-
Q 002336 694 GTLRD----------------RL---HGS-VNQKPLDWLT---------RLQI------------AHDAAK-GLEYLHT- 730 (935)
Q Consensus 694 gsL~~----------------~L---~~~-~~~~~l~~~~---------~~~i------------~~qia~-gL~yLHs- 730 (935)
..+.. .+ +.. ....+..... .... ...+.+ .+..+++
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (239)
T PF01636_consen 80 RPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEAL 159 (239)
T ss_dssp EEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhh
Confidence 87776 11 111 0111111110 0000 111222 2333332
Q ss_pred ---cCCCceEecCCCCCCcccc-CCCcEEEeeccccc
Q 002336 731 ---GCNPGIIHRDVKSSNILLD-INMRAKVSDFGLSR 763 (935)
Q Consensus 731 ---~~~~~ivH~DLkp~NILld-~~~~vkL~DFGla~ 763 (935)
.....++|+|+.+.|||++ +++.+-|+||+.+.
T Consensus 160 ~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 160 LPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred hccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 1246799999999999999 66666899998764
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=97.94 E-value=7.8e-06 Score=99.91 Aligned_cols=92 Identities=27% Similarity=0.436 Sum_probs=60.3
Q ss_pred CcEEEEEccCCCCcccCCccccCcccccccccccccCCCCCCCccccccccccccccccccCCCCCccCccccccccccc
Q 002336 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIE 492 (935)
Q Consensus 413 ~~l~~L~Ls~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~l~ 492 (935)
.+|+.|+|++|+|+ .+|... .+|+.|++++|+|++ +|.+ +.+|+.|+|++|+|+ .+|... ++|+.|+++
T Consensus 342 ~~Lq~LdLS~N~Ls-~LP~lp---~~L~~L~Ls~N~L~~-LP~l--~~~L~~LdLs~N~Lt-~LP~l~---s~L~~LdLS 410 (788)
T PRK15387 342 SGLQELSVSDNQLA-SLPTLP---SELYKLWAYNNRLTS-LPAL--PSGLKELIVSGNRLT-SLPVLP---SELKELMVS 410 (788)
T ss_pred cccceEecCCCccC-CCCCCC---cccceehhhcccccc-Cccc--ccccceEEecCCccc-CCCCcc---cCCCEEEcc
Confidence 36778888888887 466532 456667788888775 4433 246788888888888 566543 567888888
Q ss_pred cccCCCCCCccccCCceeeeecCCC
Q 002336 493 NNSFVGEIPPALLTGKVIFKYDNNP 517 (935)
Q Consensus 493 ~N~l~g~iP~~l~~~~~~~~~~~n~ 517 (935)
+|+|+ .||... .....+.+.+|.
T Consensus 411 ~N~Ls-sIP~l~-~~L~~L~Ls~Nq 433 (788)
T PRK15387 411 GNRLT-SLPMLP-SGLLSLSVYRNQ 433 (788)
T ss_pred CCcCC-CCCcch-hhhhhhhhccCc
Confidence 88888 677532 223334444443
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=97.92 E-value=8.1e-06 Score=100.22 Aligned_cols=95 Identities=23% Similarity=0.392 Sum_probs=56.1
Q ss_pred cEEEEEccCCCCcccCCccccCcccccccccccccCCCCCCCccccccccccccccccccCCCCCccCcccccccccccc
Q 002336 414 RITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIEN 493 (935)
Q Consensus 414 ~l~~L~Ls~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~l~~ 493 (935)
+|+.|+|++|+|+ .+|..+. ++|+.|+|++|+|+..++.+. ++|+.|++++|+|+ .+|..+. ++|+.|+|++
T Consensus 284 sL~~L~Ls~N~Lt-~LP~~lp--~sL~~L~Ls~N~Lt~LP~~l~--~sL~~L~Ls~N~Lt-~LP~~l~--~sL~~L~Ls~ 355 (754)
T PRK15370 284 ELRYLSVYDNSIR-TLPAHLP--SGITHLNVQSNSLTALPETLP--PGLKTLEAGENALT-SLPASLP--PELQVLDVSK 355 (754)
T ss_pred CCcEEECCCCccc-cCcccch--hhHHHHHhcCCccccCCcccc--ccceeccccCCccc-cCChhhc--CcccEEECCC
Confidence 5777777777777 4555443 456667777777765433332 45666666666666 3665543 4666666666
Q ss_pred ccCCCCCCccccCCceeeeecCCC
Q 002336 494 NSFVGEIPPALLTGKVIFKYDNNP 517 (935)
Q Consensus 494 N~l~g~iP~~l~~~~~~~~~~~n~ 517 (935)
|+|+ .+|..+......+.+.+|.
T Consensus 356 N~L~-~LP~~lp~~L~~LdLs~N~ 378 (754)
T PRK15370 356 NQIT-VLPETLPPTITTLDVSRNA 378 (754)
T ss_pred CCCC-cCChhhcCCcCEEECCCCc
Confidence 6666 5665554444444555543
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.89 E-value=6.4e-05 Score=87.94 Aligned_cols=142 Identities=22% Similarity=0.265 Sum_probs=91.0
Q ss_pred ccccccccEEEEEEEECCCcEEEEEEccCcchhhh-------------------------------------HHHHHHHH
Q 002336 619 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRT-------------------------------------QQFVTEVA 661 (935)
Q Consensus 619 ~~LG~G~fG~Vy~~~~~~g~~vAvK~~~~~~~~~~-------------------------------------~~~~~E~~ 661 (935)
+.||.-..|.||+|++++|+.||||+-++...... -+|.+|++
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 67999999999999999999999999655322210 02444555
Q ss_pred HHHhc----CCCcc---cccceeee-ccceEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCC
Q 002336 662 LLSRI----HHRNL---VPLIGYCE-EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 733 (935)
Q Consensus 662 iL~~L----~HpnI---v~l~g~~~-~~~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~ 733 (935)
...+. +|-+. |.+=.+++ -.....|+||||+|..+.|.-.- ....++...+..- +.++ |++....
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i--~~~gi~~~~i~~~---l~~~--~~~qIf~ 319 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAI--DKRGISPHDILNK---LVEA--YLEQIFK 319 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHH--HHcCCCHHHHHHH---HHHH--HHHHHHh
Confidence 44443 34441 11222222 23467999999999877664321 1234554444333 3332 2222223
Q ss_pred CceEecCCCCCCccccC----CCcEEEeeccccccccc
Q 002336 734 PGIIHRDVKSSNILLDI----NMRAKVSDFGLSRQAEE 767 (935)
Q Consensus 734 ~~ivH~DLkp~NILld~----~~~vkL~DFGla~~~~~ 767 (935)
.|++|+|=+|.||+++. ++.+.+.|||+.....+
T Consensus 320 ~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 320 TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred cCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 68999999999999984 67899999999876544
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.85 E-value=0.00012 Score=78.59 Aligned_cols=140 Identities=19% Similarity=0.171 Sum_probs=85.2
Q ss_pred ccccccc-EEEEEEEECCCcEEEEEEccCcchhhhHHHHHHHHHHHhcC-CCcccccceeeeccceEEEEEEecCCCCHH
Q 002336 620 KIGKGSF-GSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQRILVYEYMHNGTLR 697 (935)
Q Consensus 620 ~LG~G~f-G~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~-HpnIv~l~g~~~~~~~~~lV~E~~~~gsL~ 697 (935)
.|..|.. ..||+.... +..+++|...... ...+.+|+++++.+. +--+.+++++....+..++|||+++|.+|.
T Consensus 5 ~~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~ 80 (244)
T cd05150 5 RVTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA 80 (244)
T ss_pred ecCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence 4555555 888998765 5788888875432 345778999998884 434556777776666779999999998776
Q ss_pred HHh-------------------ccCCC-CCCCCH--HHHHHHHHH--------------------HHHHhHHhhh----c
Q 002336 698 DRL-------------------HGSVN-QKPLDW--LTRLQIAHD--------------------AAKGLEYLHT----G 731 (935)
Q Consensus 698 ~~L-------------------~~~~~-~~~l~~--~~~~~i~~q--------------------ia~gL~yLHs----~ 731 (935)
... +.... ..+... ......... +.+.+..|-. .
T Consensus 81 ~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 160 (244)
T cd05150 81 ALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAE 160 (244)
T ss_pred HhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCc
Confidence 432 11100 001110 000000000 1111111111 1
Q ss_pred CCCceEecCCCCCCccccCCCcEEEeeccccc
Q 002336 732 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 763 (935)
Q Consensus 732 ~~~~ivH~DLkp~NILld~~~~vkL~DFGla~ 763 (935)
....++|+|+.|.|||+++++.+.|+||+.+.
T Consensus 161 ~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 161 EDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred CceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 13569999999999999998778899998764
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=97.83 E-value=1.9e-05 Score=102.98 Aligned_cols=105 Identities=18% Similarity=0.307 Sum_probs=86.8
Q ss_pred CCcEEEEEccCCCCcccCCccccCcccccccccccccCCCCCCCccccccccccccccccccCCCCCccCcccccccccc
Q 002336 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 491 (935)
Q Consensus 412 ~~~l~~L~Ls~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~l 491 (935)
+.+|+.|+|++|+|. .+|..+..|++|+.|+|++|...+.+|+++.+++|+.|+|++|.....+|.++++|++|+.|++
T Consensus 610 ~~~L~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip~ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L 688 (1153)
T PLN03210 610 PENLVKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIPDLSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDM 688 (1153)
T ss_pred ccCCcEEECcCcccc-ccccccccCCCCCEEECCCCCCcCcCCccccCCcccEEEecCCCCccccchhhhccCCCCEEeC
Confidence 458999999999988 7888899999999999999887788899999999999999998877799999999999999999
Q ss_pred ccccCCCCCCcccc-CCceeeeecCCC
Q 002336 492 ENNSFVGEIPPALL-TGKVIFKYDNNP 517 (935)
Q Consensus 492 ~~N~l~g~iP~~l~-~~~~~~~~~~n~ 517 (935)
++|..-+.+|..+. .....+.+.++.
T Consensus 689 ~~c~~L~~Lp~~i~l~sL~~L~Lsgc~ 715 (1153)
T PLN03210 689 SRCENLEILPTGINLKSLYRLNLSGCS 715 (1153)
T ss_pred CCCCCcCccCCcCCCCCCCEEeCCCCC
Confidence 98765558887652 233344555554
|
syringae 6; Provisional |
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=97.78 E-value=5.6e-06 Score=86.99 Aligned_cols=83 Identities=25% Similarity=0.489 Sum_probs=46.9
Q ss_pred CCcEEEEEccCCCCcccCCccccCcccccccccccccCCCCCC----------------------Ccccccccccccccc
Q 002336 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP----------------------DMSRLIDLRIVHLEN 469 (935)
Q Consensus 412 ~~~l~~L~Ls~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p----------------------~~~~l~~L~~L~L~~ 469 (935)
.|.+..|+||+|+|. .+.. ++.|.+|+.||||+|.|+..-- .++.|-+|..||+++
T Consensus 306 ~Pkir~L~lS~N~i~-~v~n-La~L~~L~~LDLS~N~Ls~~~Gwh~KLGNIKtL~La~N~iE~LSGL~KLYSLvnLDl~~ 383 (490)
T KOG1259|consen 306 APKLRRLILSQNRIR-TVQN-LAELPQLQLLDLSGNLLAECVGWHLKLGNIKTLKLAQNKIETLSGLRKLYSLVNLDLSS 383 (490)
T ss_pred ccceeEEecccccee-eehh-hhhcccceEeecccchhHhhhhhHhhhcCEeeeehhhhhHhhhhhhHhhhhheeccccc
Confidence 456777777777776 4433 6667777777777777653211 122334455555555
Q ss_pred ccccCCCC--CccCccccccccccccccCC
Q 002336 470 NELTGSLP--SYMGSLPNLQELHIENNSFV 497 (935)
Q Consensus 470 N~l~g~iP--~~l~~l~~L~~L~l~~N~l~ 497 (935)
|++. .+- .+||+|+.|+.|.|.+|.+.
T Consensus 384 N~Ie-~ldeV~~IG~LPCLE~l~L~~NPl~ 412 (490)
T KOG1259|consen 384 NQIE-ELDEVNHIGNLPCLETLRLTGNPLA 412 (490)
T ss_pred cchh-hHHHhcccccccHHHHHhhcCCCcc
Confidence 5554 232 24555566666666666555
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.78 E-value=7.5e-05 Score=76.69 Aligned_cols=105 Identities=24% Similarity=0.218 Sum_probs=83.7
Q ss_pred HHHHHHHHhcCC-CcccccceeeeccceEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCc
Q 002336 657 VTEVALLSRIHH-RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 735 (935)
Q Consensus 657 ~~E~~iL~~L~H-pnIv~l~g~~~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ 735 (935)
..|.-+|+.+++ +++.+++|+|.. ++|.||...+++...-.....-...+|..|.+|+.++++.+.+|++.....
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 358888999976 699999999943 789999987766432110001234689999999999999999999866567
Q ss_pred eEecCCCCCCccccCCCcEEEeeccccccc
Q 002336 736 IIHRDVKSSNILLDINMRAKVSDFGLSRQA 765 (935)
Q Consensus 736 ivH~DLkp~NILld~~~~vkL~DFGla~~~ 765 (935)
+.-.|++++|+-+++++++|+.|.+.+...
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 899999999999999999999999876543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.77 E-value=6e-06 Score=95.24 Aligned_cols=184 Identities=20% Similarity=0.230 Sum_probs=135.6
Q ss_pred hcccccccccEEEEEEEECCCcEEEEEEccCcchhhhHHHHHHHHHHHhcCCCc-ccccceeeeccceEEEEEEecCCC-
Q 002336 617 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRN-LVPLIGYCEEEHQRILVYEYMHNG- 694 (935)
Q Consensus 617 ~~~~LG~G~fG~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~Hpn-Iv~l~g~~~~~~~~~lV~E~~~~g- 694 (935)
+.+-+++|+++.++|.+-...+....+.+... ....-++++|.+++||| .++.++-++.+...+++++++.++
T Consensus 246 ~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~r 320 (829)
T KOG0576|consen 246 FFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGR 320 (829)
T ss_pred HHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCc
Confidence 34667889999999987654444445655433 34456899999999999 777777777788889999999877
Q ss_pred CHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccccceee
Q 002336 695 TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISS 774 (935)
Q Consensus 695 sL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~ 774 (935)
+...... .....+...+...+...-++++++||+ ..-+|+| ||+..+ +..|..||+....+.... ...
T Consensus 321 s~~~~~~--~se~~~~~~~~~~~~r~et~~l~~l~~---~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~--~~~ 388 (829)
T KOG0576|consen 321 SSALEMT--VSEIALEQYQFAYPLRKETRPLAELHS---SYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM--KPR 388 (829)
T ss_pred cccccCC--hhhHhhhhhhhhhhhhhhccccccccc---ccccCcc----cccccc-cccccccccCCcccCccc--ccc
Confidence 2221111 123344555666777888899999997 3347888 777654 678999999887665543 233
Q ss_pred cccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 002336 775 VARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVS 817 (935)
Q Consensus 775 ~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~ 817 (935)
...+++.++|||......+..+-|+|+.|+-..+|--|..|-.
T Consensus 389 t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 389 TAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred cCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence 4568999999999999999999999999998788887877755
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.74 E-value=0.00016 Score=71.87 Aligned_cols=129 Identities=20% Similarity=0.276 Sum_probs=88.7
Q ss_pred hcccccccccEEEEEEEECCCcEEEEEEccCcchhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEecCCCCH
Q 002336 617 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTL 696 (935)
Q Consensus 617 ~~~~LG~G~fG~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL 696 (935)
..+.|++|.+|.||++.+. |.++|+|+-+.+ .....+..|+++|..++--++.+=+-++. .-++.|||..|-+|
T Consensus 26 v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~d--s~r~~l~kEakiLeil~g~~~~p~vy~yg---~~~i~me~i~G~~L 99 (201)
T COG2112 26 VEKELAKGTTSVVYLGEWR-GGEVALKVRRRD--SPRRNLEKEAKILEILAGEGVTPEVYFYG---EDFIRMEYIDGRPL 99 (201)
T ss_pred hhhhhhcccccEEEEeecc-CceEEEEEecCC--cchhhHHHHHHHHHHhhhcCCCceEEEec---hhhhhhhhhcCcch
Confidence 3578999999999999998 668999986554 33567899999999987655544332222 12455999999888
Q ss_pred HHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCC-CCCccccCCCcEEEeecccccc
Q 002336 697 RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVK-SSNILLDINMRAKVSDFGLSRQ 764 (935)
Q Consensus 697 ~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLk-p~NILld~~~~vkL~DFGla~~ 764 (935)
.+.-... +..++ ..+++.---|.. .||-|+.|+ |...+|-.++.+.|+||..|+.
T Consensus 100 ~~~~~~~------~rk~l----~~vlE~a~~LD~---~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 100 GKLEIGG------DRKHL----LRVLEKAYKLDR---LGIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred hhhhhcc------cHHHH----HHHHHHHHHHHH---hccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 7765421 22333 344444344444 789999987 4444444455899999998863
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=97.73 E-value=5e-06 Score=94.39 Aligned_cols=103 Identities=26% Similarity=0.414 Sum_probs=92.1
Q ss_pred CCcEEEEEccCCCCcccCCccccCcccccccccccccCCCCCCCccccccccccccccccccCCCCCccCcccccccccc
Q 002336 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 491 (935)
Q Consensus 412 ~~~l~~L~Ls~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~l 491 (935)
...++.|||+.|+++ .+|..+..|+ |+.|-++||+++-.+++++.+..|..||.+.|++. .+|..++.|.+|+.|++
T Consensus 120 L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli~sNNkl~~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~v 196 (722)
T KOG0532|consen 120 LEALTFLDLSSNQLS-HLPDGLCDLP-LKVLIVSNNKLTSLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNV 196 (722)
T ss_pred hhHHHHhhhccchhh-cCChhhhcCc-ceeEEEecCccccCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHH
Confidence 347899999999999 9999998886 89999999999999999999999999999999999 99999999999999999
Q ss_pred ccccCCCCCCccccC-CceeeeecCCCC
Q 002336 492 ENNSFVGEIPPALLT-GKVIFKYDNNPK 518 (935)
Q Consensus 492 ~~N~l~g~iP~~l~~-~~~~~~~~~n~~ 518 (935)
..|++. .+|++++. ....+.|+.|.-
T Consensus 197 rRn~l~-~lp~El~~LpLi~lDfScNki 223 (722)
T KOG0532|consen 197 RRNHLE-DLPEELCSLPLIRLDFSCNKI 223 (722)
T ss_pred hhhhhh-hCCHHHhCCceeeeecccCce
Confidence 999999 99999985 334566677753
|
|
| >PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B | Back alignment and domain information |
|---|
Probab=97.72 E-value=9.2e-06 Score=62.25 Aligned_cols=36 Identities=39% Similarity=0.704 Sum_probs=21.1
Q ss_pred cccccccccccccCCCCCccCccccccccccccccCC
Q 002336 461 DLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFV 497 (935)
Q Consensus 461 ~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~l~~N~l~ 497 (935)
+|++|+|++|+++ .+|..+++|++|+.|++++|+++
T Consensus 2 ~L~~L~l~~N~i~-~l~~~l~~l~~L~~L~l~~N~i~ 37 (44)
T PF12799_consen 2 NLEELDLSNNQIT-DLPPELSNLPNLETLNLSNNPIS 37 (44)
T ss_dssp T-SEEEETSSS-S-SHGGHGTTCTTSSEEEETSSCCS
T ss_pred cceEEEccCCCCc-ccCchHhCCCCCCEEEecCCCCC
Confidence 4556666666666 55555666666666666666665
|
... |
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=97.70 E-value=1.6e-05 Score=91.62 Aligned_cols=102 Identities=28% Similarity=0.506 Sum_probs=86.9
Q ss_pred CcEEEEEccCCCCcccCCccccCcc-cccccccccccCCCCCCCccccccccccccccccccCCCCCccCcccccccccc
Q 002336 413 PRITKIALSGKNLKGEIPPELKNME-ALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 491 (935)
Q Consensus 413 ~~l~~L~Ls~n~l~g~ip~~i~~L~-~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~l 491 (935)
..++.|++.+|+++ .||+.+..++ +|+.|++++|++...+..+..+++|+.|++++|+++ .+|...+.+++|+.|++
T Consensus 116 ~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L~l 193 (394)
T COG4886 116 TNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIESLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDL 193 (394)
T ss_pred cceeEEecCCcccc-cCccccccchhhcccccccccchhhhhhhhhccccccccccCCchhh-hhhhhhhhhhhhhheec
Confidence 46899999999998 8898888885 999999999999988778899999999999999999 88888888899999999
Q ss_pred ccccCCCCCCcc--ccCCceeeeecCCC
Q 002336 492 ENNSFVGEIPPA--LLTGKVIFKYDNNP 517 (935)
Q Consensus 492 ~~N~l~g~iP~~--l~~~~~~~~~~~n~ 517 (935)
++|+++ .||.. .......+...+|+
T Consensus 194 s~N~i~-~l~~~~~~~~~L~~l~~~~N~ 220 (394)
T COG4886 194 SGNKIS-DLPPEIELLSALEELDLSNNS 220 (394)
T ss_pred cCCccc-cCchhhhhhhhhhhhhhcCCc
Confidence 999998 88886 44445566666664
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.68 E-value=1.9e-06 Score=99.86 Aligned_cols=126 Identities=23% Similarity=0.274 Sum_probs=93.3
Q ss_pred CCCCCCCCCCce---EEEeCCC----------CCcEEEEEccCCCCcccCCccccCcccccccccccccCCCCCC-Cccc
Q 002336 393 RGDPCVPVPWEW---VTCSTTT----------PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSR 458 (935)
Q Consensus 393 ~~dpC~~~~w~~---v~c~~~~----------~~~l~~L~Ls~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p-~~~~ 458 (935)
.||-|...+|.- ..|+|.. .+.+..|||++|++... . .+..|++|++|||+.|.|.-.+- ....
T Consensus 154 ggd~~ns~~Wn~L~~a~fsyN~L~~mD~SLqll~ale~LnLshNk~~~v-~-~Lr~l~~LkhLDlsyN~L~~vp~l~~~g 231 (1096)
T KOG1859|consen 154 GGDISNSPVWNKLATASFSYNRLVLMDESLQLLPALESLNLSHNKFTKV-D-NLRRLPKLKHLDLSYNCLRHVPQLSMVG 231 (1096)
T ss_pred ccccccchhhhhHhhhhcchhhHHhHHHHHHHHHHhhhhccchhhhhhh-H-HHHhcccccccccccchhccccccchhh
Confidence 467777666653 4566642 46789999999999843 3 88899999999999999986554 4455
Q ss_pred cccccccccccccccCCCCCccCccccccccccccccCCCCC---CccccCCceeeeecCCCCCcccc
Q 002336 459 LIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEI---PPALLTGKVIFKYDNNPKLHKES 523 (935)
Q Consensus 459 l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~l~~N~l~g~i---P~~l~~~~~~~~~~~n~~~~~~~ 523 (935)
+. |+.|.|.||-++ ++- .+.+|++|+.|||+.|-|++-- |-+.......+.+.|||.-|...
T Consensus 232 c~-L~~L~lrnN~l~-tL~-gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c~p~ 296 (1096)
T KOG1859|consen 232 CK-LQLLNLRNNALT-TLR-GIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCCAPW 296 (1096)
T ss_pred hh-heeeeecccHHH-hhh-hHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccccCHH
Confidence 55 999999999988 443 4789999999999999998431 22222334556789999888543
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.63 E-value=0.00037 Score=87.90 Aligned_cols=78 Identities=13% Similarity=0.299 Sum_probs=56.8
Q ss_pred cccccccccEEEEEEEECCC---cEEEEEEccCcc-hhhhHHHHHHHHHHHhcC-CCcc--cccceeeecc---ceEEEE
Q 002336 618 CKKIGKGSFGSVYYGKMKDG---KEVAVKIMADSC-SHRTQQFVTEVALLSRIH-HRNL--VPLIGYCEEE---HQRILV 687 (935)
Q Consensus 618 ~~~LG~G~fG~Vy~~~~~~g---~~vAvK~~~~~~-~~~~~~~~~E~~iL~~L~-HpnI--v~l~g~~~~~---~~~~lV 687 (935)
.+.++.|.+..+|+....++ ..+++|+..... ......+.+|+++|+.+. |.++ .+++++|.+. +..++|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 45689999999999887654 467777754322 122356889999999995 6665 7777777664 457899
Q ss_pred EEecCCCC
Q 002336 688 YEYMHNGT 695 (935)
Q Consensus 688 ~E~~~~gs 695 (935)
|||++|..
T Consensus 123 ME~v~G~~ 130 (822)
T PLN02876 123 MEYLEGRI 130 (822)
T ss_pred EEecCCcc
Confidence 99998764
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.61 E-value=0.00064 Score=70.26 Aligned_cols=127 Identities=24% Similarity=0.310 Sum_probs=90.9
Q ss_pred ccccccccEEEEEEEECCCcEEEEEEccCcc----------------hhhhHHHHHHHHHHHhcC------CCcccccce
Q 002336 619 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSC----------------SHRTQQFVTEVALLSRIH------HRNLVPLIG 676 (935)
Q Consensus 619 ~~LG~G~fG~Vy~~~~~~g~~vAvK~~~~~~----------------~~~~~~~~~E~~iL~~L~------HpnIv~l~g 676 (935)
..||+|+.-.||. +.+.....||+..... ....++..+|+.-...+. +.+|.+++|
T Consensus 7 ~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G 84 (199)
T PF10707_consen 7 DLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYG 84 (199)
T ss_pred cccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeE
Confidence 5799999999995 5556678888876654 122456667777666655 889999999
Q ss_pred eeeccceEEEEEEecCC--C----CHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccC
Q 002336 677 YCEEEHQRILVYEYMHN--G----TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI 750 (935)
Q Consensus 677 ~~~~~~~~~lV~E~~~~--g----sL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~ 750 (935)
+.+++....+|+|.+.+ | +|.+++. ...++. ...+.+.++. +||-. ..|+.+|++|+||++..
T Consensus 85 ~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~----~~~~~~-~~~~~L~~f~---~~l~~---~~Iv~~dl~~~NIv~~~ 153 (199)
T PF10707_consen 85 FVETNLGLGLVVELIRDADGNISPTLEDYLK----EGGLTE-ELRQALDEFK---RYLLD---HHIVIRDLNPHNIVVQR 153 (199)
T ss_pred EEecCCceEEEEEEEECCCCCcCccHHHHHH----cCCccH-HHHHHHHHHH---HHHHH---cCCeecCCCcccEEEEe
Confidence 99999999999998754 2 5777775 334555 4445555544 45554 77999999999999953
Q ss_pred C--C--cEEEee
Q 002336 751 N--M--RAKVSD 758 (935)
Q Consensus 751 ~--~--~vkL~D 758 (935)
. + .+.|+|
T Consensus 154 ~~~~~~~lvlID 165 (199)
T PF10707_consen 154 RDSGEFRLVLID 165 (199)
T ss_pred cCCCceEEEEEe
Confidence 2 2 467776
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=97.61 E-value=5.7e-05 Score=98.63 Aligned_cols=91 Identities=21% Similarity=0.317 Sum_probs=70.8
Q ss_pred CCcEEEEEccCCCCcccCCccccCcccccccccccccCCCCCCCccccccccccccccccccCCCCCccCcccccccccc
Q 002336 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 491 (935)
Q Consensus 412 ~~~l~~L~Ls~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~l 491 (935)
+++|+.|+|++|...+.+|.++++|++|+.|+|++|...+.+|...++++|+.|+|++|.....+|.. .++|+.|+|
T Consensus 777 ~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~L 853 (1153)
T PLN03210 777 SPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGINLESLESLDLSGCSRLRTFPDI---STNISDLNL 853 (1153)
T ss_pred cccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCCCccccCEEECCCCCcccccccc---ccccCEeEC
Confidence 35799999999998889999999999999999999876667775557888888888887655566653 356777777
Q ss_pred ccccCCCCCCccccC
Q 002336 492 ENNSFVGEIPPALLT 506 (935)
Q Consensus 492 ~~N~l~g~iP~~l~~ 506 (935)
++|.++ .+|.++..
T Consensus 854 s~n~i~-~iP~si~~ 867 (1153)
T PLN03210 854 SRTGIE-EVPWWIEK 867 (1153)
T ss_pred CCCCCc-cChHHHhc
Confidence 777777 67765543
|
syringae 6; Provisional |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.58 E-value=0.00054 Score=70.33 Aligned_cols=125 Identities=28% Similarity=0.433 Sum_probs=89.6
Q ss_pred HHHhhccccccccc-EEEEEEEECCCcEEEEEEccCc-----------ch----------hhhHHHHHHHHHHHhcC---
Q 002336 613 ATNNFCKKIGKGSF-GSVYYGKMKDGKEVAVKIMADS-----------CS----------HRTQQFVTEVALLSRIH--- 667 (935)
Q Consensus 613 ~~~~~~~~LG~G~f-G~Vy~~~~~~g~~vAvK~~~~~-----------~~----------~~~~~~~~E~~iL~~L~--- 667 (935)
...++.+.||.|.. |.||++++. |+.+|+|+++.. .. .....|..|.+...+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~-g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEID-GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEEC-CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 45567899999999 999999998 889999993210 00 12346889999988885
Q ss_pred CCcc--cccceeeecc------------------ceEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHH
Q 002336 668 HRNL--VPLIGYCEEE------------------HQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEY 727 (935)
Q Consensus 668 HpnI--v~l~g~~~~~------------------~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~y 727 (935)
+.++ |+++||..-. ....+|.||.+... .+ ..+-+.+|.+-|..
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~----~~~~~~~~~~dl~~ 179 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PL----QIRDIPQMLRDLKI 179 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------cc----chhHHHHHHHHHHH
Confidence 4455 9999987211 12356777765432 12 23345667777888
Q ss_pred hhhcCCCceEecCCCCCCccccCCCcEEEeecccc
Q 002336 728 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS 762 (935)
Q Consensus 728 LHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla 762 (935)
+|. .||+-+|+++.|.. .-||+|||.+
T Consensus 180 ~~k---~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 180 LHK---LGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHH---CCeeeccCcccccc-----CCEEEecccC
Confidence 997 99999999999986 3589999854
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 935 | ||||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 3e-59 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-58 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 6e-56 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-55 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-37 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 8e-37 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-36 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 6e-35 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-34 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-34 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-25 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-24 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-24 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 3e-24 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 3e-24 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 3e-24 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 4e-24 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 5e-24 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 9e-24 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-23 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-23 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-23 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 4e-23 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-23 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 9e-23 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 9e-23 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-22 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-22 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-22 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-22 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-22 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-22 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-22 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-22 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-22 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-22 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-22 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-22 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-22 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 1e-22 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-22 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-22 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-22 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-22 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-22 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-22 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-22 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-22 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-22 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-22 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-22 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-22 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-22 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-22 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-22 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-22 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-22 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-22 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-22 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-22 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-22 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-22 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-22 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 3e-22 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 3e-22 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 3e-22 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 3e-22 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 3e-22 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-22 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 6e-22 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 7e-22 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 7e-22 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 8e-22 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 8e-22 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 9e-22 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 9e-22 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 9e-22 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-22 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-21 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-21 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-21 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-21 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-21 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-21 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-21 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-21 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-21 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-21 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-21 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-21 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-21 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-21 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-21 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-21 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-21 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-21 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-21 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-21 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 3e-21 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 6e-21 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 6e-21 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-21 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 8e-21 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 8e-21 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-21 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-21 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 9e-21 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 9e-21 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-20 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-20 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-20 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-20 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-20 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-20 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-20 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-20 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-20 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-20 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-20 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-20 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-20 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 3e-20 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 3e-20 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 3e-20 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 3e-20 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 3e-20 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 3e-20 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 3e-20 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 3e-20 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 3e-20 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 3e-20 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 3e-20 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 3e-20 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 3e-20 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-20 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 4e-20 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 4e-20 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 4e-20 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 4e-20 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 5e-20 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 5e-20 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 6e-20 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 7e-20 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 7e-20 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 7e-20 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 8e-20 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 8e-20 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 8e-20 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 8e-20 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 8e-20 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 9e-20 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 9e-20 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 9e-20 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-19 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-19 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-19 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-19 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-19 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-19 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-19 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-19 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-19 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-19 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 1e-19 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-19 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-19 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-19 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-19 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-19 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 3e-19 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 3e-19 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 4e-19 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 4e-19 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 6e-19 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 7e-19 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 8e-19 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 8e-19 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 9e-19 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 9e-19 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 9e-19 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 9e-19 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 9e-19 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-18 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 1e-18 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-18 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 1e-18 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-18 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 1e-18 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-18 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 1e-18 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-18 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-18 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-18 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-18 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-18 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-18 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 3e-18 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-18 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 3e-18 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-18 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 3e-18 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 3e-18 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-18 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-18 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 4e-18 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 5e-18 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 5e-18 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 6e-18 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 6e-18 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 6e-18 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 8e-18 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-18 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-17 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-17 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-17 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-17 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-17 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-17 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-17 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-17 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-17 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-17 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 3e-17 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 3e-17 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-17 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-17 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 5e-17 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 5e-17 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 6e-17 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 7e-17 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 7e-17 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 7e-17 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 7e-17 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 7e-17 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 8e-17 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 8e-17 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 8e-17 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 9e-17 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 9e-17 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 1e-16 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-16 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 1e-16 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-16 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-16 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-16 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-16 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-16 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-16 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-16 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-16 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-16 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-16 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-16 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-16 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-16 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-16 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-16 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 1e-16 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-16 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 1e-16 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-16 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-16 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-16 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-16 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-16 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-16 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-16 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-16 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-16 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-16 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-16 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-16 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-16 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-16 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-16 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-16 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-16 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-16 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-16 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-16 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-16 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-16 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-16 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-16 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-16 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-16 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-16 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-16 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-16 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-16 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-16 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-16 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-16 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-16 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-16 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 3e-16 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 3e-16 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 3e-16 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 3e-16 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 3e-16 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 3e-16 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 3e-16 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 3e-16 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 4e-16 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-16 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 4e-16 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 4e-16 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 5e-16 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 5e-16 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 5e-16 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-16 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 5e-16 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 5e-16 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 5e-16 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-16 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 6e-16 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 6e-16 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 6e-16 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 6e-16 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 7e-16 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 7e-16 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 7e-16 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 8e-16 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 8e-16 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 8e-16 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 8e-16 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-15 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-15 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 1e-15 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-15 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 1e-15 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 1e-15 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 1e-15 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 1e-15 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 1e-15 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 2e-15 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-15 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 2e-15 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-15 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-15 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-15 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 2e-15 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-15 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 3e-15 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 3e-15 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 3e-15 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 3e-15 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 3e-15 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-15 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 4e-15 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-15 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 4e-15 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 4e-15 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-15 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 4e-15 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 4e-15 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 4e-15 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 4e-15 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-15 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 5e-15 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 5e-15 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-15 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-15 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-15 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-15 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 5e-15 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 5e-15 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 6e-15 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 6e-15 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 6e-15 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 6e-15 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-15 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 6e-15 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 6e-15 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 7e-15 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 7e-15 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 7e-15 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 7e-15 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 8e-15 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 8e-15 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 8e-15 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 8e-15 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 9e-15 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 9e-15 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 9e-15 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 9e-15 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-15 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 9e-15 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 9e-15 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-14 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-14 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-14 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-14 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-14 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-14 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-14 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-14 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 1e-14 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 1e-14 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-14 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-14 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-14 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-14 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-14 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-14 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-14 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-14 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-14 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 2e-14 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-14 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-14 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-14 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-14 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-14 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-14 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-14 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-14 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-14 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-14 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-14 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-14 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-14 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 3e-14 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 3e-14 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 3e-14 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 3e-14 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-14 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 3e-14 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 3e-14 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-14 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-14 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 3e-14 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 3e-14 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 3e-14 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 3e-14 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-14 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-14 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 3e-14 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 3e-14 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 3e-14 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 3e-14 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 4e-14 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 4e-14 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-14 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-14 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 4e-14 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 4e-14 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 4e-14 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 4e-14 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 4e-14 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 5e-14 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 5e-14 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 5e-14 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 5e-14 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 6e-14 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 7e-14 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 7e-14 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 8e-14 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 8e-14 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 8e-14 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 8e-14 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 9e-14 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 1e-13 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-13 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 1e-13 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 1e-13 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-13 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-13 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 1e-13 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-13 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-13 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-13 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-13 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-13 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-13 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-13 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-13 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-13 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 3e-13 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 3e-13 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 3e-13 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 3e-13 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 3e-13 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 4e-13 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 4e-13 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-13 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 5e-13 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 5e-13 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 5e-13 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 6e-13 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 6e-13 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 6e-13 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 6e-13 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 7e-13 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 7e-13 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 7e-13 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 7e-13 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 7e-13 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 7e-13 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 9e-13 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 9e-13 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 9e-13 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 9e-13 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-12 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-12 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-12 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-12 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-12 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-12 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-12 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-12 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-12 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-12 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-12 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-12 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-12 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-12 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 1e-12 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-12 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-12 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-12 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-12 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-12 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-12 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 1e-12 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 1e-12 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-12 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-12 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-12 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-12 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-12 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-12 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-12 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-12 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-12 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-12 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-12 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-12 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-12 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-12 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-12 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-12 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-12 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-12 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-12 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-12 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-12 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 3e-12 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 3e-12 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 3e-12 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 3e-12 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 3e-12 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-12 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 3e-12 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 4e-12 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-12 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 4e-12 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-12 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 4e-12 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 4e-12 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-12 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 4e-12 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-12 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 4e-12 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 4e-12 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 4e-12 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 4e-12 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 4e-12 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 4e-12 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 5e-12 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 5e-12 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 5e-12 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-12 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-12 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 5e-12 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 5e-12 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 5e-12 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-12 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 5e-12 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-12 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 5e-12 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 5e-12 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-12 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 5e-12 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 5e-12 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 5e-12 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 6e-12 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-12 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 6e-12 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 6e-12 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 6e-12 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 6e-12 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 6e-12 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 6e-12 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 6e-12 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 7e-12 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 7e-12 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 7e-12 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 7e-12 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 7e-12 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 7e-12 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 7e-12 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 8e-12 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 8e-12 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 9e-12 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 9e-12 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-11 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-11 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-11 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-11 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-11 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-11 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-11 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-11 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 2e-11 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-11 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-11 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-11 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-11 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-11 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-11 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-11 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-11 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-11 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 3e-11 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-11 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 3e-11 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 3e-11 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-11 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-11 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-11 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-11 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 3e-11 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-11 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 3e-11 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 3e-11 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 3e-11 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 3e-11 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 3e-11 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-11 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 3e-11 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 3e-11 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 4e-11 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-11 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 4e-11 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 4e-11 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 4e-11 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 4e-11 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 4e-11 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 4e-11 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 4e-11 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 4e-11 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 4e-11 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 5e-11 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 5e-11 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 5e-11 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 6e-11 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 6e-11 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 6e-11 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 7e-11 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-11 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 8e-11 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 8e-11 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 9e-11 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 9e-11 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 1e-10 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 1e-10 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-10 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-10 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-10 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-10 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-10 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 1e-10 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-10 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-10 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-10 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 1e-10 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-10 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-10 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-10 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-10 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-10 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-10 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-10 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-10 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-10 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-10 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-10 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-10 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-10 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-10 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-10 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-10 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-10 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-10 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-10 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-10 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-10 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-10 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-10 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-10 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-10 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-10 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-10 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-10 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-10 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-10 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-10 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-10 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-10 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-10 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-10 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-10 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-10 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-10 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-10 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-10 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-10 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-10 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-10 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-10 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-10 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-10 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-10 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-10 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-10 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-10 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-10 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-10 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-10 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-10 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-10 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-10 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-10 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-10 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-10 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-10 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-10 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-10 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 3e-10 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 3e-10 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 3e-10 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 3e-10 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 3e-10 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 3e-10 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 3e-10 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 3e-10 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 3e-10 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 3e-10 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 3e-10 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 3e-10 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 3e-10 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 3e-10 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 3e-10 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-10 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 4e-10 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 4e-10 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 4e-10 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 4e-10 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 4e-10 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 4e-10 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 4e-10 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 4e-10 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 4e-10 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 5e-10 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 5e-10 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 5e-10 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 5e-10 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 5e-10 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 5e-10 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 5e-10 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 6e-10 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 6e-10 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 6e-10 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-10 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 6e-10 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 6e-10 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 6e-10 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 6e-10 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-10 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 6e-10 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 6e-10 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 7e-10 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 7e-10 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 7e-10 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 8e-10 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 8e-10 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 8e-10 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 8e-10 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 8e-10 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 9e-10 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 9e-10 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 9e-10 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 1e-09 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 1e-09 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-09 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 1e-09 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 1e-09 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 1e-09 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 1e-09 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 1e-09 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 1e-09 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-09 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-09 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-09 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 1e-09 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 1e-09 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-09 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-09 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-09 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-09 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-09 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-09 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-09 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-09 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-09 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-09 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-09 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-09 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-09 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-09 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-09 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-09 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-09 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-09 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-09 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-09 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-09 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 3e-09 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 3e-09 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-09 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-09 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 4e-09 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 4e-09 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 4e-09 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 4e-09 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 4e-09 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 4e-09 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 4e-09 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 4e-09 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 4e-09 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 4e-09 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 5e-09 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 5e-09 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 5e-09 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 5e-09 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 5e-09 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 5e-09 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 5e-09 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 6e-09 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 6e-09 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 6e-09 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 6e-09 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 6e-09 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 6e-09 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 6e-09 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 6e-09 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 6e-09 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 7e-09 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 7e-09 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 7e-09 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 8e-09 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 9e-09 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 9e-09 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 9e-09 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-08 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-08 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-08 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-08 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 1e-08 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-08 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-08 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-08 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 1e-08 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 1e-08 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 1e-08 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 1e-08 | ||
| 3uys_A | 296 | Crystal Structure Of Apo Human Ck1d Length = 296 | 1e-08 | ||
| 4hni_A | 296 | Crystal Structure Of Ck1e In Complex With Pf4800567 | 1e-08 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-08 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-08 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-08 | ||
| 1ckj_A | 317 | Casein Kinase I Delta Truncation Mutant Containing | 2e-08 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-08 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 2e-08 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-08 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 2e-08 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 3e-08 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 3e-08 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-08 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-08 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 3e-08 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-08 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 3e-08 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 3e-08 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 3e-08 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 4e-08 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 4e-08 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 4e-08 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 4e-08 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 5e-08 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 6e-08 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 6e-08 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 7e-08 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 7e-08 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 7e-08 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 8e-08 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 8e-08 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 8e-08 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 8e-08 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 8e-08 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 8e-08 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 9e-08 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 9e-08 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 9e-08 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 9e-08 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 9e-08 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-07 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-07 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-07 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-07 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-07 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-07 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 1e-07 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-07 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 1e-07 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-07 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-07 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 1e-07 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 1e-07 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 1e-07 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 1e-07 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-07 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-07 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-07 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 1e-07 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 1e-07 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-07 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-07 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 1e-07 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 1e-07 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-07 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 1e-07 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-07 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 2e-07 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 2e-07 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-07 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 2e-07 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 2e-07 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-07 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 3e-07 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 3e-07 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 3e-07 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 3e-07 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 3e-07 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 3e-07 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 4e-07 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 4e-07 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 4e-07 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 5e-07 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 5e-07 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 5e-07 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 6e-07 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 6e-07 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 7e-07 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 7e-07 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 8e-07 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 8e-07 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 9e-07 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 9e-07 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 1e-06 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-06 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 1e-06 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-06 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-06 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 2e-06 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 3e-06 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 3e-06 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 3e-06 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 3e-06 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 4e-06 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 4e-06 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 5e-06 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 5e-06 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 7e-06 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 7e-06 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 8e-06 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 9e-06 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 9e-06 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 9e-06 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 9e-06 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 9e-06 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 9e-06 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 1e-05 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 1e-05 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-05 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-05 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-05 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 1e-05 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 1e-05 |
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296 | Back alignment and structure |
|
| >pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 457 bits (1179), Expect = e-155
Identities = 127/319 (39%), Positives = 193/319 (60%), Gaps = 7/319 (2%)
Query: 579 TSTKPSNTAYSIARGGHFMDEGVAYFIPLPELEEATNNFCKK--IGKGSFGSVYYGKMKD 636
+ + + + A ++ +Y +PL +LEEATNNF K IG G FG VY G ++D
Sbjct: 3 SKYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRD 62
Query: 637 GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTL 696
G +VA+K S ++F TE+ LS H +LV LIG+C+E ++ IL+Y+YM NG L
Sbjct: 63 GAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNL 122
Query: 697 RDRLHGSVNQK-PLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAK 755
+ L+GS + W RL+I AA+GL YLHT IIHRDVKS NILLD N K
Sbjct: 123 KRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPK 179
Query: 756 VSDFGLSRQA-EEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKK 814
++DFG+S++ E D TH+S+V +GT+GY+DPEY+ +LTEKSDVYSFGVVL E++ +
Sbjct: 180 ITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARS 239
Query: 815 PVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFS 874
+ +N+ WA G + IVDP L ++ ES+ + + A++C+
Sbjct: 240 AIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSED 299
Query: 875 RPKMQEIVLAIQDSIKIEK 893
RP M +++ ++ ++++++
Sbjct: 300 RPSMGDVLWKLEYALRLQE 318
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 384 bits (989), Expect = e-126
Identities = 112/282 (39%), Positives = 173/282 (61%), Gaps = 6/282 (2%)
Query: 609 ELEEATNNFCK--KIGKGSFGSVYYGKMKDGKEVAVK-IMADSCSHRTQQFVTEVALLSR 665
EL+ A++NF +G+G FG VY G++ DG VAVK + + QF TEV ++S
Sbjct: 24 ELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISM 83
Query: 666 IHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKP-LDWLTRLQIAHDAAKG 724
HRNL+ L G+C +R+LVY YM NG++ L +P LDW R +IA +A+G
Sbjct: 84 AVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARG 143
Query: 725 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLD 784
L YLH C+P IIHRDVK++NILLD A V DFGL++ + TH+++ RGT+G++
Sbjct: 144 LAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIA 203
Query: 785 PEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAE--LNIVHWARSMIKKGDVIS 842
PEY + +EK+DV+ +GV+LLELI+G++ + + + ++ W + ++K+ + +
Sbjct: 204 PEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEA 263
Query: 843 IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 884
+VD L GN K E + ++ +VA+ C + RPKM E+V
Sbjct: 264 LVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRM 305
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 369 bits (951), Expect = e-121
Identities = 102/292 (34%), Positives = 153/292 (52%), Gaps = 26/292 (8%)
Query: 609 ELEEATNNF--------CKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQ----F 656
EL+ TNNF K+G+G FG VY G + + VAVK +A T++ F
Sbjct: 19 ELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQF 77
Query: 657 VTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQ 716
E+ ++++ H NLV L+G+ + LVY YM NG+L DRL PL W R +
Sbjct: 78 DQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCK 137
Query: 717 IAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA-EEDLTHISSV 775
IA AA G+ +LH IHRD+KS+NILLD AK+SDFGL+R + + T ++S
Sbjct: 138 IAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSR 194
Query: 776 ARGTVGYLDPEYY-GNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFG-AELNIVHWARS 833
GT Y+ PE G ++T KSD+YSFGVVLLE+I+G V D ++
Sbjct: 195 IVGTTAYMAPEALRG--EITPKSDIYSFGVVLLEIITGLPAV---DEHREPQLLLDIKEE 249
Query: 834 MIK-KGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 884
+ + + +D + + S+ + VA QC+ ++ RP ++++
Sbjct: 250 IEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 278 bits (712), Expect = 3e-86
Identities = 74/308 (24%), Positives = 118/308 (38%), Gaps = 31/308 (10%)
Query: 605 IPLPELEEATNNFC--KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVAL 662
+ L + + +G FG V+ ++ + VAVKI ++ Q EV
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQ-DKQSWQNEYEVYS 71
Query: 663 LSRIHHRNLVPLIGYCEE----EHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA 718
L + H N++ IG + + L+ + G+L D L + W IA
Sbjct: 72 LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA----NVVSWNELCHIA 127
Query: 719 HDAAKGLEYLHT-------GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 771
A+GL YLH G P I HRD+KS N+LL N+ A ++DFGL+ + E +
Sbjct: 128 ETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSA 187
Query: 772 ISSVAR-GTVGYLDPEY-----YGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAEL 825
+ + GT Y+ PE + + D+Y+ G+VL EL S L
Sbjct: 188 GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYML 247
Query: 826 NIVHWARSMIKKGDVISIV-----DPVLIGNV-KIESIWRIAEVAIQCVEQRGFSRPKMQ 879
D+ +V PVL K + + E +C + +R
Sbjct: 248 PFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAG 307
Query: 880 EIVLAIQD 887
+ I
Sbjct: 308 CVGERITQ 315
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 242 bits (621), Expect = 3e-73
Identities = 86/213 (40%), Positives = 123/213 (57%), Gaps = 10/213 (4%)
Query: 605 IPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSH--RTQQFVTEVAL 662
IP +L +KIG GSFG+V+ + G +VAVKI+ + H R +F+ EVA+
Sbjct: 34 IPWCDLN-----IKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAI 87
Query: 663 LSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAA 722
+ R+ H N+V +G + +V EY+ G+L LH S ++ LD RL +A+D A
Sbjct: 88 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVA 147
Query: 723 KGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGY 782
KG+ YLH NP I+HR++KS N+L+D KV DFGLSR S A GT +
Sbjct: 148 KGMNYLHN-RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAA-GTPEW 205
Query: 783 LDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 815
+ PE ++ EKSDVYSFGV+L EL + ++P
Sbjct: 206 MAPEVLRDEPSNEKSDVYSFGVILWELATLQQP 238
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 240 bits (614), Expect = 2e-72
Identities = 84/328 (25%), Positives = 144/328 (43%), Gaps = 39/328 (11%)
Query: 603 YFIPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVAL 662
+ I E+E + +G+G+FG V K + K+VA+K + + F+ E+
Sbjct: 3 HMIDYKEIE-----VEEVVGRGAFGVVCKAKWR-AKDVAIKQIESESE--RKAFIVELRQ 54
Query: 663 LSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAA 722
LSR++H N+V L G C LV EY G+L + LHG+ + +
Sbjct: 55 LSRVNHPNIVKLYGACLNPV--CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCS 112
Query: 723 KGLEYLHTGCNPGIIHRDVKSSNILLDINMR-AKVSDFGLSRQAEEDLTHISSVARGTVG 781
+G+ YLH+ +IHRD+K N+LL K+ DFG + + +T+ +G+
Sbjct: 113 QGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTN----NKGSAA 168
Query: 782 YLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG--- 838
++ PE + +EK DV+S+G++L E+I+ +KP ++ G + WA + G
Sbjct: 169 WMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKP--FDEIGGPAFRIMWA---VHNGTRP 223
Query: 839 DVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKGGDQK 898
+I + I + +C + RP M+EIV + ++ G D+
Sbjct: 224 PLIKNLPK------------PIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEP 271
Query: 899 F----SSSSSKGQSSRKTLLTSFLEIES 922
S G+ R F E
Sbjct: 272 LQYPCQHSLPPGEDGRVEPYVDFAEFYR 299
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 229 bits (585), Expect = 2e-68
Identities = 75/240 (31%), Positives = 120/240 (50%), Gaps = 29/240 (12%)
Query: 591 ARGGHFMDEGVAYFIPLPELEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC 649
A GG + + E+E + K+IGKG FG V+ G++ D VA+K +
Sbjct: 2 AMGGSEFPKSRLPTLADNEIE-----YEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGD 56
Query: 650 SH-------RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHG 702
S + Q+F EV ++S ++H N+V L G +V E++ G L RL
Sbjct: 57 SEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLLD 114
Query: 703 SVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD-----INMRAKVS 757
P+ W +L++ D A G+EY+ NP I+HRD++S NI L + AKV+
Sbjct: 115 --KAHPIKWSVKLRLMLDIALGIEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVA 171
Query: 758 DFGLSRQAEEDLTHISSVARGTVGYLDPE--YYGNQQLTEKSDVYSFGVVLLELISGKKP 815
DFGLS+Q+ ++ G ++ PE + TEK+D YSF ++L +++G+ P
Sbjct: 172 DFGLSQQSVHSVSG----LLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGP 227
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 220 bits (564), Expect = 8e-66
Identities = 48/218 (22%), Positives = 97/218 (44%), Gaps = 21/218 (9%)
Query: 605 IPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSH--RTQQFVTEVAL 662
I +L F K+ + G ++ G+ + G ++ VK++ +++ F E
Sbjct: 7 IDFKQLN-----FLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPR 60
Query: 663 LSRIHHRNLVPLIGYCEEEHQRIL--VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHD 720
L H N++P++G C+ + +M G+L + LH +D ++ A D
Sbjct: 61 LRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLH-EGTNFVVDQSQAVKFALD 119
Query: 721 AAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTV 780
A+G+ +LHT P I + S ++++D +M A++S + + S
Sbjct: 120 MARGMAFLHT-LEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ------SPGRMYAP 172
Query: 781 GYLDPEYYGNQQL---TEKSDVYSFGVVLLELISGKKP 815
++ PE + +D++SF V+L EL++ + P
Sbjct: 173 AWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVP 210
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 220 bits (563), Expect = 1e-65
Identities = 75/223 (33%), Positives = 103/223 (46%), Gaps = 25/223 (11%)
Query: 605 IPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIM----ADSCSHRTQQFVTEV 660
I EL + IG G FG VY G EVAVK + S + E
Sbjct: 4 IDFAELT-----LEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEA 57
Query: 661 ALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHD 720
L + + H N++ L G C +E LV E+ G L L G K + + A
Sbjct: 58 KLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSG----KRIPPDILVNWAVQ 113
Query: 721 AAKGLEYLHTGCNPGIIHRDVKSSNILLD--------INMRAKVSDFGLSRQAEEDLTHI 772
A+G+ YLH IIHRD+KSSNIL+ N K++DFGL+R E T
Sbjct: 114 IARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR--EWHRTTK 171
Query: 773 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 815
S A G ++ PE ++ SDV+S+GV+L EL++G+ P
Sbjct: 172 MSAA-GAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVP 213
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 222 bits (567), Expect = 2e-65
Identities = 72/339 (21%), Positives = 128/339 (37%), Gaps = 48/339 (14%)
Query: 605 IPLPELEEATNNFC--KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTE--V 660
E +N + IG+G +G+VY G + D + VAVK+ + Q F+ E +
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFS---FANRQNFINEKNI 58
Query: 661 ALLSRIHHRNLVPLIGYCEE-----EHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRL 715
+ + H N+ I E + +LV EY NG+L L DW++
Sbjct: 59 YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLS----LHTSDWVSSC 114
Query: 716 QIAHDAAKGLEYLHT------GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR------ 763
++AH +GL YLHT P I HRD+ S N+L+ + +SDFGLS
Sbjct: 115 RLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNR 174
Query: 764 -QAEEDLTHISSVARGTVGYLDPEY-------YGNQQLTEKSDVYSFGVVLLELISGKKP 815
+ + + GT+ Y+ PE + ++ D+Y+ G++ E+
Sbjct: 175 LVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTD 234
Query: 816 VSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNV--KIESIWR--------IAEVAI 865
+ + E + + + + V K W+ + E
Sbjct: 235 LFPGESVPEYQMA-FQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIE 293
Query: 866 QCVEQRGFSRPKMQEIVLAIQDSIKIEKGGDQKFSSSSS 904
C +Q +R Q + + + I + ++
Sbjct: 294 DCWDQDAEARLTAQXAEERMAELMMIWERNKSVSPTAHH 332
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 214 bits (547), Expect = 3e-63
Identities = 68/217 (31%), Positives = 113/217 (52%), Gaps = 19/217 (8%)
Query: 605 IPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSH--RTQQFVTEVAL 662
IP ++ ++IG GSFG+VY GK +VAVK++ + + Q F EV +
Sbjct: 21 IPDGQIT-----VGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGV 73
Query: 663 LSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAA 722
L + H N++ +GY I V ++ +L LH ++ + + IA A
Sbjct: 74 LRKTRHVNILLFMGYSTAPQLAI-VTQWCEGSSLYHHLH--ASETKFEMKKLIDIARQTA 130
Query: 723 KGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR-QAEEDLTHISSVARGTVG 781
+G++YLH IIHRD+KS+NI L + K+ DFGL+ ++ +H G++
Sbjct: 131 RGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSIL 187
Query: 782 YLDPE---YYGNQQLTEKSDVYSFGVVLLELISGKKP 815
++ PE + + +SDVY+FG+VL EL++G+ P
Sbjct: 188 WMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLP 224
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 215 bits (549), Expect = 4e-63
Identities = 60/226 (26%), Positives = 96/226 (42%), Gaps = 28/226 (12%)
Query: 605 IPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIM--ADSCSHRTQQFVTEVAL 662
IP +LE + IGKG FG VY+G+ EVA++++ + + F EV
Sbjct: 30 IPFEQLE-----IGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMA 82
Query: 663 LSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAA 722
+ H N+V +G C ++ TL + + LD QIA +
Sbjct: 83 YRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRD--AKIVLDVNKTRQIAQEIV 140
Query: 723 KGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR----QAEEDLTHISSVARG 778
KG+ YLH GI+H+D+KS N+ D N + ++DFGL + G
Sbjct: 141 KGMGYLHA---KGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNG 196
Query: 779 TVGYLDPEYYGNQQL---------TEKSDVYSFGVVLLELISGKKP 815
+ +L PE ++ SDV++ G + EL + + P
Sbjct: 197 WLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWP 242
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 209 bits (533), Expect = 6e-61
Identities = 59/213 (27%), Positives = 96/213 (45%), Gaps = 19/213 (8%)
Query: 617 FCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLI 675
+ +GKG FG ++ G+ + +K + + F+ EV ++ + H N++ I
Sbjct: 14 HGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFI 73
Query: 676 GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 735
G ++ + + EY+ GTLR + W R+ A D A G+ YLH +
Sbjct: 74 GVLYKDKRLNFITEYIKGGTLRGIIKS--MDSQYPWSQRVSFAKDIASGMAYLH---SMN 128
Query: 736 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR-------------GTVGY 782
IIHRD+ S N L+ N V+DFGL+R ++ T + G +
Sbjct: 129 IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYW 188
Query: 783 LDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 815
+ PE + EK DV+SFG+VL E+I
Sbjct: 189 MAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNA 221
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 207 bits (529), Expect = 3e-60
Identities = 77/324 (23%), Positives = 130/324 (40%), Gaps = 44/324 (13%)
Query: 607 LPELEEATNN----FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVAL 662
LP L + T K+IGKG +G V+ GK + G++VAVK+ + + TE+
Sbjct: 27 LPLLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE-EASWFRETEIYQ 84
Query: 663 LSRIHHRNLVPLIGYCEEEHQRI----LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA 718
+ H N++ I + L+ +Y NG+L D L LD + L++A
Sbjct: 85 TVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLK----STTLDAKSMLKLA 140
Query: 719 HDAAKGLEYLHT-----GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 773
+ + GL +LHT P I HRD+KS NIL+ N ++D GL+ + D +
Sbjct: 141 YSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVD 200
Query: 774 SVARGTVG---YLDPE------YYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAE 824
VG Y+ PE + Q +D+YSFG++L E+ E
Sbjct: 201 IPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVS----GGIVE 256
Query: 825 LNIVHWARSMIKKGDVISIVDPVLIGNV--KIESIWR-------IAEVAIQCVEQRGFSR 875
+ + + + + V I + + W + ++ +C SR
Sbjct: 257 EYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASR 316
Query: 876 PKMQEIVLAIQDSIKIEKGGDQKF 899
+ + K+ + D K
Sbjct: 317 LTALRVKKTLA---KMSESQDIKL 337
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 201 bits (512), Expect = 8e-58
Identities = 78/318 (24%), Positives = 136/318 (42%), Gaps = 40/318 (12%)
Query: 607 LPELEEATN----NFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVAL 662
LP L + T + IGKG FG V+ GK + G+EVAVKI S R+ E+
Sbjct: 32 LPLLVQRTIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIF-SSREERSWFREAEIYQ 89
Query: 663 LSRIHHRNLVPLIGYCEEEHQRI----LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA 718
+ H N++ I +++ LV +Y +G+L D L+ + + +++A
Sbjct: 90 TVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN----RYTVTVEGMIKLA 145
Query: 719 HDAAKGLEYLH-----TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR---QAEEDLT 770
A GL +LH T P I HRD+KS NIL+ N ++D GL+ A + +
Sbjct: 146 LSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTID 205
Query: 771 HISSVARGTVGYLDPE------YYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAE 824
+ GT Y+ PE + + +++D+Y+ G+V E+ + + +
Sbjct: 206 IAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHE-DYQ 264
Query: 825 LNIVHWARSMIKKGDVISIVD------PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKM 878
L S ++ +V + E++ +A++ +C G +R
Sbjct: 265 LPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTA 324
Query: 879 QEIV-----LAIQDSIKI 891
I L+ Q+ IK+
Sbjct: 325 LRIKKTLSQLSQQEGIKM 342
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 198 bits (506), Expect = 2e-57
Identities = 61/224 (27%), Positives = 99/224 (44%), Gaps = 28/224 (12%)
Query: 617 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFV--TEVALLSRIHHRNLVPL 674
+ +GKG +G V+ G + G+ VAVKI + S + + TE+ + H N++
Sbjct: 12 LLECVGKGRYGEVWRGSWQ-GENVAVKIFS---SRDEKSWFRETELYNTVMLRHENILGF 67
Query: 675 IGYC----EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 730
I Q L+ Y G+L D L LD ++ L+I A GL +LH
Sbjct: 68 IASDMTSRHSSTQLWLITHYHEMGSLYDYLQ----LTTLDTVSCLRIVLSIASGLAHLHI 123
Query: 731 -----GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR---QAEEDLTHISSVARGTVGY 782
P I HRD+KS NIL+ N + ++D GL+ Q+ L ++ GT Y
Sbjct: 124 EIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRY 183
Query: 783 LDPE------YYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 820
+ PE ++ D+++FG+VL E+ + +
Sbjct: 184 MAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVE 227
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 2e-43
Identities = 66/207 (31%), Positives = 101/207 (48%), Gaps = 20/207 (9%)
Query: 619 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPLI 675
+IG+GSF +VY G + EVA + D ++ Q+F E +L + H N+V
Sbjct: 32 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 91
Query: 676 GY----CEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLH 729
+ + +LV E M +GTL+ L + K L R QI KGL++LH
Sbjct: 92 DSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCR-QIL----KGLQFLH 146
Query: 730 TGCNPGIIHRDVKSSNILLD-INMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY 788
T P IIHRD+K NI + K+ D GL+ + +V GT ++ PE Y
Sbjct: 147 T-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA--SFAKAV-IGTPEFMAPEMY 202
Query: 789 GNQQLTEKSDVYSFGVVLLELISGKKP 815
++ E DVY+FG+ +LE+ + + P
Sbjct: 203 -EEKYDESVDVYAFGMCMLEMATSEYP 228
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 158 bits (403), Expect = 1e-42
Identities = 64/207 (30%), Positives = 101/207 (48%), Gaps = 17/207 (8%)
Query: 617 FCKKIGKGSFGSVYYGKMKDGK-EVAVKIMADSCSHRTQQ-FVTEVALLSRIHHRNLVPL 674
++IG+G+FG V+ G+++ VAVK ++ + F+ E +L + H N+V L
Sbjct: 118 LGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRL 177
Query: 675 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 734
IG C ++ +V E + G L L T LQ+ DAA G+EYL +
Sbjct: 178 IGVCTQKQPIYIVMELVQGGDFLTFLRT--EGARLRVKTLLQMVGDAAAGMEYLE---SK 232
Query: 735 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYL-----DPEYYG 789
IHRD+ + N L+ K+SDFG+SR+ + A G + + PE
Sbjct: 233 CCIHRDLAARNCLVTEKNVLKISDFGMSREEADG----VYAASGGLRQVPVKWTAPEALN 288
Query: 790 NQQLTEKSDVYSFGVVLLELIS-GKKP 815
+ + +SDV+SFG++L E S G P
Sbjct: 289 YGRYSSESDVWSFGILLWETFSLGASP 315
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 7e-42
Identities = 64/200 (32%), Positives = 107/200 (53%), Gaps = 7/200 (3%)
Query: 617 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 676
K++G G FG V GK K +VAVK++ + +F E + ++ H LV G
Sbjct: 12 LLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSE-DEFFQEAQTMMKLSHPKLVKFYG 70
Query: 677 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 736
C +E+ +V EY+ NG L + L + K L+ L++ +D +G+ +L +
Sbjct: 71 VCSKEYPIYIVTEYISNGCLLNYLRS--HGKGLEPSQLLEMCYDVCEGMAFLE---SHQF 125
Query: 737 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEK 796
IHRD+ + N L+D ++ KVSDFG++R +D S + V + PE + + + K
Sbjct: 126 IHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSK 185
Query: 797 SDVYSFGVVLLELIS-GKKP 815
SDV++FG+++ E+ S GK P
Sbjct: 186 SDVWAFGILMWEVFSLGKMP 205
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 1e-41
Identities = 66/200 (33%), Positives = 104/200 (52%), Gaps = 7/200 (3%)
Query: 617 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 676
F ++IG G FG V+ G + +VA+K + + + F+ E ++ ++ H LV L G
Sbjct: 12 FVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE-EDFIEEAEVMMKLSHPKLVQLYG 70
Query: 677 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 736
C E+ LV E+M +G L D L + L L + D +G+ YL +
Sbjct: 71 VCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETL--LGMCLDVCEGMAYL---EEACV 125
Query: 737 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEK 796
IHRD+ + N L+ N KVSDFG++R +D S+ + V + PE + + + K
Sbjct: 126 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSK 185
Query: 797 SDVYSFGVVLLELIS-GKKP 815
SDV+SFGV++ E+ S GK P
Sbjct: 186 SDVWSFGVLMWEVFSEGKIP 205
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 2e-41
Identities = 65/201 (32%), Positives = 101/201 (50%), Gaps = 7/201 (3%)
Query: 617 FCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLI 675
K+G G +G VY G K VAVK + + ++F+ E A++ I H NLV L+
Sbjct: 224 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLL 282
Query: 676 GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 735
G C E ++ E+M G L D L N++ + + L +A + +EYL
Sbjct: 283 GVCTREPPFYIITEFMTYGNLLDYLR-ECNRQEVSAVVLLYMATQISSAMEYLE---KKN 338
Query: 736 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTE 795
IHR++ + N L+ N KV+DFGLSR D + A+ + + PE + +
Sbjct: 339 FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 398
Query: 796 KSDVYSFGVVLLELIS-GKKP 815
KSDV++FGV+L E+ + G P
Sbjct: 399 KSDVWAFGVLLWEIATYGMSP 419
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 2e-41
Identities = 65/200 (32%), Positives = 101/200 (50%), Gaps = 7/200 (3%)
Query: 617 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 676
K+G+G FG V+ G VA+K + + F+ E ++ ++ H LV L
Sbjct: 188 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYA 246
Query: 677 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 736
EE I V EYM G+L D L G K L + +A A G+ Y+
Sbjct: 247 VVSEEPIYI-VTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVE---RMNY 301
Query: 737 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEK 796
+HRD++++NIL+ N+ KV+DFGL+R E++ A+ + + PE + T K
Sbjct: 302 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 361
Query: 797 SDVYSFGVVLLELIS-GKKP 815
SDV+SFG++L EL + G+ P
Sbjct: 362 SDVWSFGILLTELTTKGRVP 381
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 151 bits (385), Expect = 4e-41
Identities = 63/200 (31%), Positives = 104/200 (52%), Gaps = 7/200 (3%)
Query: 617 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 676
F K++G G FG V YGK + +VA+K++ + +F+ E ++ + H LV L G
Sbjct: 28 FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQLYG 86
Query: 677 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 736
C ++ ++ EYM NG L + L + L++ D + +EYL +
Sbjct: 87 VCTKQRPIFIITEYMANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLE---SKQF 141
Query: 737 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEK 796
+HRD+ + N L++ KVSDFGLSR +D S ++ V + PE + + K
Sbjct: 142 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSK 201
Query: 797 SDVYSFGVVLLELIS-GKKP 815
SD+++FGV++ E+ S GK P
Sbjct: 202 SDIWAFGVLMWEIYSLGKMP 221
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 5e-41
Identities = 56/214 (26%), Positives = 96/214 (44%), Gaps = 27/214 (12%)
Query: 619 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 677
+ IG G FG V+ K + DGK +K + + ++ EV L+++ H N+V G
Sbjct: 17 ELIGSGGFGQVFKAKHRIDGKTYVIKRV----KYNNEKAEREVKALAKLDHVNIVHYNGC 72
Query: 678 CEEEHQRI----------------LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDA 721
+ + E+ GTL + + LD + L++
Sbjct: 73 WDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR-RGEKLDKVLALELFEQI 131
Query: 722 AKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVG 781
KG++Y+H + +I+RD+K SNI L + K+ DFGL + D S GT+
Sbjct: 132 TKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSK--GTLR 186
Query: 782 YLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 815
Y+ PE +Q ++ D+Y+ G++L EL+
Sbjct: 187 YMSPEQISSQDYGKEVDLYALGLILAELLHVCDT 220
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 158 bits (400), Expect = 5e-41
Identities = 65/200 (32%), Positives = 101/200 (50%), Gaps = 7/200 (3%)
Query: 617 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 676
K+G+G FG V+ G VA+K + + F+ E ++ ++ H LV L
Sbjct: 271 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYA 329
Query: 677 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 736
EE I V EYM G+L D L G K L + +A A G+ Y+
Sbjct: 330 VVSEEPIYI-VTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVE---RMNY 384
Query: 737 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEK 796
+HRD++++NIL+ N+ KV+DFGL+R E++ A+ + + PE + T K
Sbjct: 385 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 444
Query: 797 SDVYSFGVVLLELIS-GKKP 815
SDV+SFG++L EL + G+ P
Sbjct: 445 SDVWSFGILLTELTTKGRVP 464
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 5e-41
Identities = 61/200 (30%), Positives = 102/200 (51%), Gaps = 7/200 (3%)
Query: 617 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 676
+++G G FG V+ G +VAVK + F+ E L+ ++ H+ LV L
Sbjct: 17 LVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVRLYA 75
Query: 677 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 736
+E I + EYM NG+L D L + L L +A A+G+ ++
Sbjct: 76 VVTQEPIYI-ITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIE---ERNY 130
Query: 737 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEK 796
IHRD++++NIL+ + K++DFGL+R E++ A+ + + PE T K
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIK 190
Query: 797 SDVYSFGVVLLELIS-GKKP 815
SDV+SFG++L E+++ G+ P
Sbjct: 191 SDVWSFGILLTEIVTHGRIP 210
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 1e-40
Identities = 66/201 (32%), Positives = 101/201 (50%), Gaps = 7/201 (3%)
Query: 617 FCKKIGKGSFGSVYYGKMKDGK-EVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLI 675
K+G G +G VY G K VAVK + + ++F+ E A++ I H NLV L+
Sbjct: 17 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLL 75
Query: 676 GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 735
G C E ++ E+M G L D L N++ + + L +A + +EYL
Sbjct: 76 GVCTREPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLE---KKN 131
Query: 736 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTE 795
IHRD+ + N L+ N KV+DFGLSR D + A+ + + PE + +
Sbjct: 132 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 191
Query: 796 KSDVYSFGVVLLELIS-GKKP 815
KSDV++FGV+L E+ + G P
Sbjct: 192 KSDVWAFGVLLWEIATYGMSP 212
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 1e-40
Identities = 57/200 (28%), Positives = 98/200 (49%), Gaps = 7/200 (3%)
Query: 617 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 676
KK+G G FG V+ +VAVK M + F+ E ++ + H LV L
Sbjct: 192 LEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSV-EAFLAEANVMKTLQHDKLVKLHA 250
Query: 677 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 736
+E I + E+M G+L D L + + A+G+ ++
Sbjct: 251 VVTKEPIYI-ITEFMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIE---QRNY 305
Query: 737 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEK 796
IHRD++++NIL+ ++ K++DFGL+R E++ A+ + + PE T K
Sbjct: 306 IHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIK 365
Query: 797 SDVYSFGVVLLELIS-GKKP 815
SDV+SFG++L+E+++ G+ P
Sbjct: 366 SDVWSFGILLMEIVTYGRIP 385
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 2e-40
Identities = 53/226 (23%), Positives = 109/226 (48%), Gaps = 19/226 (8%)
Query: 598 DEGVAYFIPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKE-----VAVKIMADSCSHR 652
++ + + E + K +G G+FG+VY G E VA+K + ++ S +
Sbjct: 5 NQALLRILKETEFK-----KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK 59
Query: 653 TQQ-FVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDW 711
+ + E +++ + + ++ L+G C L+ + M G L D + ++ +
Sbjct: 60 ANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVRE--HKDNIGS 116
Query: 712 LTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ-AEEDLT 770
L AKG+ YL + ++HRD+ + N+L+ K++DFGL++ E+
Sbjct: 117 QYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 173
Query: 771 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 815
+ + + + ++ E ++ T +SDV+S+GV + EL++ G KP
Sbjct: 174 YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 2e-40
Identities = 66/201 (32%), Positives = 108/201 (53%), Gaps = 13/201 (6%)
Query: 617 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 676
+ IGKG FG V G + G +VAVK + + + Q F+ E ++++++ H NLV L+G
Sbjct: 197 LLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLG 253
Query: 677 YCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 735
EE + +V EYM G+L D L + L L+ + D + +EYL
Sbjct: 254 VIVEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLE---GNN 309
Query: 736 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTE 795
+HRD+ + N+L+ + AKVSDFGL++ + + + V + PE ++ +
Sbjct: 310 FVHRDLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVKWTAPEALREKKFST 365
Query: 796 KSDVYSFGVVLLELIS-GKKP 815
KSDV+SFG++L E+ S G+ P
Sbjct: 366 KSDVWSFGILLWEIYSFGRVP 386
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 1e-39
Identities = 58/203 (28%), Positives = 104/203 (51%), Gaps = 13/203 (6%)
Query: 620 KIGKGSFGSVYYGKMKDGKE---VAVKIMADSCSHRTQQ-FVTEVALLSRIHHRNLVPLI 675
++G G+FGSV G + K+ VA+K++ + + E ++ ++ + +V LI
Sbjct: 17 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76
Query: 676 GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 735
G C+ E +LV E G L L G ++ + ++ H + G++YL
Sbjct: 77 GVCQAE-ALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYL---EEKN 130
Query: 736 IIHRDVKSSNILLDINMRAKVSDFGLSR--QAEEDLTHISSVARGTVGYLDPEYYGNQQL 793
+HRD+ + N+LL AK+SDFGLS+ A++ S + + + PE ++
Sbjct: 131 FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKF 190
Query: 794 TEKSDVYSFGVVLLELIS-GKKP 815
+ +SDV+S+GV + E +S G+KP
Sbjct: 191 SSRSDVWSYGVTMWEALSYGQKP 213
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 2e-39
Identities = 53/217 (24%), Positives = 98/217 (45%), Gaps = 28/217 (12%)
Query: 619 KKIGKGSFGSVYYGKMK-DGKEVAVKIMA-DSCSHRTQQFVTEVALLSRIHHRNLVPLIG 676
+ +G+G FG V+ K K D A+K + + ++ + EV L+++ H +V
Sbjct: 11 QCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFN 70
Query: 677 YCEEEH---------QRILVY---EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKG 724
E++ ++ +Y + L+D ++G + + L I A+
Sbjct: 71 AWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEA 130
Query: 725 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR------- 777
+E+LH + G++HRD+K SNI ++ KV DFGL ++D + +
Sbjct: 131 VEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARH 187
Query: 778 ----GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELI 810
GT Y+ PE + K D++S G++L EL+
Sbjct: 188 TGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 3e-39
Identities = 59/203 (29%), Positives = 98/203 (48%), Gaps = 12/203 (5%)
Query: 619 KKIGKGSFGSVYYGKMKDGKE----VAVKIMADSCSHRTQQ-FVTEVALLSRIHHRNLVP 673
+ IG+G FG V+ G + VA+K + S ++ F+ E + + H ++V
Sbjct: 21 RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 80
Query: 674 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 733
LIG E I + E G LR L + LD + + A+ + L YL +
Sbjct: 81 LIGVITENPVWI-IMELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAYLE---S 134
Query: 734 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQL 793
+HRD+ + N+L+ N K+ DFGLSR E+ + +S + + ++ PE ++
Sbjct: 135 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 194
Query: 794 TEKSDVYSFGVVLLELIS-GKKP 815
T SDV+ FGV + E++ G KP
Sbjct: 195 TSASDVWMFGVCMWEILMHGVKP 217
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 3e-39
Identities = 60/209 (28%), Positives = 108/209 (51%), Gaps = 17/209 (8%)
Query: 617 FCKKIGKGSFGSVYYGKMKDGKE----VAVKIMADSCSHRTQQ-FVTEVALLSRIHHRNL 671
K IG G G V YG+++ + VA+K + + R ++ F++E +++ + H N+
Sbjct: 53 IEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNI 112
Query: 672 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 731
+ L G ++V EYM NG+L L + + + + G+ YL
Sbjct: 113 IRLEGVVTRGRLAMIVTEYMENGSLDTFLRT--HDGQFTIMQLVGMLRGVGAGMRYLSD- 169
Query: 732 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSR--QAEEDLTHISSVARGTVGYLDPE--Y 787
G +HRD+ + N+L+D N+ KVSDFGLSR + + D + ++ + + + PE
Sbjct: 170 --LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIA 227
Query: 788 YGNQQLTEKSDVYSFGVVLLELIS-GKKP 815
+ + SDV+SFGVV+ E+++ G++P
Sbjct: 228 FR--TFSSASDVWSFGVVMWEVLAYGERP 254
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 3e-39
Identities = 65/213 (30%), Positives = 104/213 (48%), Gaps = 12/213 (5%)
Query: 609 ELEEATNNFCKKIGKGSFGSVYYGKMKDGKE----VAVKIMADSCSHRTQQ-FVTEVALL 663
+ + +G+G FG VY G + K VAVK C+ ++ F++E ++
Sbjct: 8 GIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIM 67
Query: 664 SRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK 723
+ H ++V LIG EEE I + E G L L N+ L LT + + K
Sbjct: 68 KNLDHPHIVKLIGIIEEEPTWI-IMELYPYGELGHYLER--NKNSLKVLTLVLYSLQICK 124
Query: 724 GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYL 783
+ YL + +HRD+ NIL+ K+ DFGLSR E++ + +SV R + ++
Sbjct: 125 AMAYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWM 181
Query: 784 DPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 815
PE ++ T SDV+ F V + E++S GK+P
Sbjct: 182 SPESINFRRFTTASDVWMFAVCMWEILSFGKQP 214
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 3e-39
Identities = 52/214 (24%), Positives = 87/214 (40%), Gaps = 20/214 (9%)
Query: 619 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 677
+K+G+G F V + + DG A+K + ++ E + +H N++ L+ Y
Sbjct: 35 QKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAY 94
Query: 678 CEEEHQR----ILVYEYMHNGTLRDRL-HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 732
C E L+ + GTL + + L L + +GLE +H
Sbjct: 95 CLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH--- 151
Query: 733 NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR--------GTVGYLD 784
G HRD+K +NILL + + D G QA + T+ Y
Sbjct: 152 AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRA 211
Query: 785 PE---YYGNQQLTEKSDVYSFGVVLLELISGKKP 815
PE + + E++DV+S G VL ++ G+ P
Sbjct: 212 PELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGP 245
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 9e-39
Identities = 66/228 (28%), Positives = 98/228 (42%), Gaps = 21/228 (9%)
Query: 598 DEGVAYFIPLPELEEATNNFCKKIGKGSFGSVYYG--KMKDGKE--VAVKIM-ADSCSHR 652
+ + I +L +K+G GSFG V G GK VAVK + D S
Sbjct: 8 LQSLTCLIGEKDLR-----LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQP 62
Query: 653 TQQ--FVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLD 710
F+ EV + + HRNL+ L G ++ V E G+L DRL L
Sbjct: 63 EAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLG 121
Query: 711 WLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR--QAEED 768
L + A A+G+ YL + IHRD+ + N+LL K+ DFGL R +D
Sbjct: 122 TL--SRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDD 176
Query: 769 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 815
+ + + PE + + SD + FGV L E+ + G++P
Sbjct: 177 HYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 224
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 9e-39
Identities = 65/219 (29%), Positives = 103/219 (47%), Gaps = 15/219 (6%)
Query: 607 LPELEEATNNFCKKIGKGSFGSVYYGKMKDGKE----VAVKIMADSCSHRTQQ-FVTEVA 661
+ +F + IG+G FG VY+G + D AVK + F+TE
Sbjct: 19 VIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGI 78
Query: 662 LLSRIHHRNLVPLIGYC-EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHD 720
++ H N++ L+G C E ++V YM +G LR+ + +
Sbjct: 79 IMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQ 136
Query: 721 AAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED---LTHISSVAR 777
AKG++YL + +HRD+ + N +LD KV+DFGL+R + H + A+
Sbjct: 137 VAKGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAK 193
Query: 778 GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 815
V ++ E Q+ T KSDV+SFGV+L EL++ G P
Sbjct: 194 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 232
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 2e-38
Identities = 67/201 (33%), Positives = 108/201 (53%), Gaps = 13/201 (6%)
Query: 617 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 676
+ IGKG FG V G + G +VAVK + + + Q F+ E ++++++ H NLV L+G
Sbjct: 25 LLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLG 81
Query: 677 YCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 735
EE + +V EYM G+L D L + L L+ + D + +EYL
Sbjct: 82 VIVEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLE---GNN 137
Query: 736 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTE 795
+HRD+ + N+L+ + AKVSDFGL+++A + V + PE ++ +
Sbjct: 138 FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST----QDTGKLPVKWTAPEALREKKFST 193
Query: 796 KSDVYSFGVVLLELIS-GKKP 815
KSDV+SFG++L E+ S G+ P
Sbjct: 194 KSDVWSFGILLWEIYSFGRVP 214
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 2e-38
Identities = 61/205 (29%), Positives = 105/205 (51%), Gaps = 15/205 (7%)
Query: 619 KKIGKGSFGSVYYGKMKDGK---EVAVKIM-ADSCSHRTQQ-FVTEVALLSRIHHRNLVP 673
K++G G+FG+V G + K VAVKI+ ++ + + E ++ ++ + +V
Sbjct: 23 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 82
Query: 674 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 733
+IG CE E + V E G L L + + +++ H + G++YL
Sbjct: 83 MIGICEAESWML-VMEMAELGPLNKYLQ---QNRHVKDKNIIELVHQVSMGMKYLE---E 135
Query: 734 PGIIHRDVKSSNILLDINMRAKVSDFGLSR--QAEEDLTHISSVARGTVGYLDPEYYGNQ 791
+HRD+ + N+LL AK+SDFGLS+ +A+E+ + + V + PE
Sbjct: 136 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 195
Query: 792 QLTEKSDVYSFGVVLLELIS-GKKP 815
+ + KSDV+SFGV++ E S G+KP
Sbjct: 196 KFSSKSDVWSFGVLMWEAFSYGQKP 220
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 3e-38
Identities = 68/212 (32%), Positives = 108/212 (50%), Gaps = 14/212 (6%)
Query: 609 ELEEATNNFCKKIGKGSFGSVYYGKMK-----DGKEVAVKIMADSCSHRTQQFVTEVALL 663
+ EE F +++GKG+FGSV + G+ VAVK + S + F E+ +L
Sbjct: 6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 65
Query: 664 SRIHHRNLVPLIGYCEEEHQR--ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDA 721
+ H N+V G C +R L+ EY+ G+LRD L +++ +D + LQ
Sbjct: 66 KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK--HKERIDHIKLLQYTSQI 123
Query: 722 AKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR--QAEEDLTHISSVARGT 779
KG+EYL T IHRD+ + NIL++ R K+ DFGL++ +++ +
Sbjct: 124 CKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESP 180
Query: 780 VGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS 811
+ + PE + + SDV+SFGVVL EL +
Sbjct: 181 IFWYAPESLTESKFSVASDVWSFGVVLYELFT 212
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 3e-38
Identities = 53/226 (23%), Positives = 109/226 (48%), Gaps = 19/226 (8%)
Query: 598 DEGVAYFIPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKE-----VAVKIMADSCSHR 652
++ + + E + K +G G+FG+VY G E VA+K + ++ S +
Sbjct: 5 NQALLRILKETEFK-----KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK 59
Query: 653 TQQ-FVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDW 711
+ + E +++ + + ++ L+G C L+ + M G L D + ++ +
Sbjct: 60 ANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVRE--HKDNIGS 116
Query: 712 LTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ-AEEDLT 770
L AKG+ YL + ++HRD+ + N+L+ K++DFGL++ E+
Sbjct: 117 QYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 173
Query: 771 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 815
+ + + + ++ E ++ T +SDV+S+GV + EL++ G KP
Sbjct: 174 YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 4e-38
Identities = 62/207 (29%), Positives = 99/207 (47%), Gaps = 22/207 (10%)
Query: 619 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRT----QQFVTEVALLSRIHHRNLVP 673
+KIG+GSFG K DG++ +K + + S + ++ EVA+L+ + H N+V
Sbjct: 30 QKIGEGSFGKAILVKSTEDGRQYVIKEI--NISRMSSKEREESRREVAVLANMKHPNIVQ 87
Query: 674 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQ-----KPLDWLTRLQIAHDAAKGLEYL 728
EE +V +Y G L R++ + LDW QI L+++
Sbjct: 88 YRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFV--QICL----ALKHV 141
Query: 729 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY 788
H + I+HRD+KS NI L + ++ DFG++R + + GT YL PE
Sbjct: 142 H---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACI-GTPYYLSPEIC 197
Query: 789 GNQQLTEKSDVYSFGVVLLELISGKKP 815
N+ KSD+++ G VL EL + K
Sbjct: 198 ENKPYNNKSDIWALGCVLYELCTLKHA 224
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 5e-38
Identities = 63/208 (30%), Positives = 107/208 (51%), Gaps = 14/208 (6%)
Query: 617 FCKKIGKGSFGSVYYGKMKDGKE-----VAVKIMADSCSHRTQQ-FVTEVALLSRIHHRN 670
K IG G FG VY G +K VA+K + + + + F+ E ++ + H N
Sbjct: 48 RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHN 107
Query: 671 LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 730
++ L G + +++ EYM NG L L L + + A G++YL
Sbjct: 108 IIRLEGVISKYKPMMIITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYLA- 164
Query: 731 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR--QAEEDLTHISSVARGTVGYLDPEYY 788
N +HRD+ + NIL++ N+ KVSDFGLSR + + + T+ +S + + + PE
Sbjct: 165 --NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAI 222
Query: 789 GNQQLTEKSDVYSFGVVLLELIS-GKKP 815
++ T SDV+SFG+V+ E+++ G++P
Sbjct: 223 SYRKFTSASDVWSFGIVMWEVMTYGERP 250
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 5e-38
Identities = 71/296 (23%), Positives = 129/296 (43%), Gaps = 20/296 (6%)
Query: 534 GTSIGVLAILLVLFLCSLI----VLRKLRRKISNQKSYEKVCPLADSLRTSTKPSNTAYS 589
+I L+ C L+ +R + +++ + LA++ + + + S
Sbjct: 303 SLTIAENMADLIDGYCRLVNGATQSFIIRPQKEGERALPSIPKLANNEKQGVRSHTVSVS 362
Query: 590 IARG-GHFMDEGVAYFIPLP---ELEEATNNFCKKIGKGSFGSVYYGKMKDGKE----VA 641
+DE Y +P E++ + IG+G FG V+ G + VA
Sbjct: 363 ETDDYAEIIDEEDTYTMPSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVA 422
Query: 642 VKIMADSCSHRTQQ-FVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRL 700
+K + S ++ F+ E + + H ++V LIG E ++ E G LR L
Sbjct: 423 IKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFL 481
Query: 701 HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFG 760
+ LD + + A+ + L YL + +HRD+ + N+L+ N K+ DFG
Sbjct: 482 QV--RKFSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFG 536
Query: 761 LSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 815
LSR E+ + +S + + ++ PE ++ T SDV+ FGV + E++ G KP
Sbjct: 537 LSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP 592
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 6e-38
Identities = 54/229 (23%), Positives = 101/229 (44%), Gaps = 32/229 (13%)
Query: 607 LPELEEATNNFCKKIGKGSFGSVYYGKMKDGK--------EVAVKIMADSCSHRTQQFVT 658
++ F + +G+G+F ++ G ++ EV +K++ + + ++ F
Sbjct: 2 FHKIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFE 61
Query: 659 EVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA 718
+++S++ H++LV G C + ILV E++ G+L L + N + W L++A
Sbjct: 62 AASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWK--LEVA 119
Query: 719 HDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI--------NMRAKVSDFGLSRQAEEDLT 770
A + +L +IH +V + NILL K+SD G+S
Sbjct: 120 KQLAAAMHFLE---ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK-- 174
Query: 771 HISSVARGTVGYLDPE---YYGNQQLTEKSDVYSFGVVLLELIS-GKKP 815
+ + + ++ PE N L +D +SFG L E+ S G KP
Sbjct: 175 ---DILQERIPWVPPECIENPKN--LNLATDKWSFGTTLWEICSGGDKP 218
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 7e-38
Identities = 55/220 (25%), Positives = 104/220 (47%), Gaps = 16/220 (7%)
Query: 609 ELEEATNNFCKKIGKGSFGSVYYGKMK-----DGKEVAVKIMADSCSHRTQQ-FVTEVAL 662
E+ + +G+G FG V + G++VAVK + E+ +
Sbjct: 17 HFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEI 76
Query: 663 LSRIHHRNLVPLIGYCEEEHQR--ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHD 720
L ++H N+V G C E+ L+ E++ +G+L++ L N+ ++ +L+ A
Sbjct: 77 LRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPK--NKNKINLKQQLKYAVQ 134
Query: 721 AAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR--QAEEDLTHISSVARG 778
KG++YL + +HRD+ + N+L++ + K+ DFGL++ + +++ +
Sbjct: 135 ICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDS 191
Query: 779 TVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVS 817
V + PE + SDV+SFGV L EL++ S
Sbjct: 192 PVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSS 231
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 8e-38
Identities = 57/204 (27%), Positives = 104/204 (50%), Gaps = 13/204 (6%)
Query: 619 KKIGKGSFGSVYYGKMKDGKE---VAVKIMADSCSHRTQQ-FVTEVALLSRIHHRNLVPL 674
++G G+FGSV G + K+ VA+K++ + + E ++ ++ + +V L
Sbjct: 342 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRL 401
Query: 675 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 734
IG C+ E +LV E G L L G ++ + ++ H + G++YL
Sbjct: 402 IGVCQAE-ALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYL---EEK 455
Query: 735 GIIHRDVKSSNILLDINMRAKVSDFGLSR--QAEEDLTHISSVARGTVGYLDPEYYGNQQ 792
+HR++ + N+LL AK+SDFGLS+ A++ S + + + PE ++
Sbjct: 456 NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK 515
Query: 793 LTEKSDVYSFGVVLLELIS-GKKP 815
+ +SDV+S+GV + E +S G+KP
Sbjct: 516 FSSRSDVWSYGVTMWEALSYGQKP 539
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 8e-38
Identities = 57/235 (24%), Positives = 100/235 (42%), Gaps = 32/235 (13%)
Query: 619 KKIGKGSFGSVYYGKMK-DGKEVAVKI--MADSCSHRT-QQFVTEVALLSRIHHRNLVPL 674
KKIG+G F VY DG VA+K + D + + E+ LL +++H N++
Sbjct: 38 KKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKY 97
Query: 675 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKP-------LDWLTRLQIAHDAAKGLEY 727
E+++ +V E G L + QK + Q+ LE+
Sbjct: 98 YASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFV--QLCS----ALEH 151
Query: 728 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVG---YLD 784
+H + ++HRD+K +N+ + K+ D GL R + ++ A VG Y+
Sbjct: 152 MH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRF----FSSKTTAAHSLVGTPYYMS 204
Query: 785 PEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD 839
PE KSD++S G +L E+ + + P F + ++ I++ D
Sbjct: 205 PERIHENGYNFKSDIWSLGCLLYEMAALQSP-----FYGDKMNLYSLCKKIEQCD 254
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 8e-38
Identities = 64/217 (29%), Positives = 104/217 (47%), Gaps = 15/217 (6%)
Query: 609 ELEEATNNFCKKIGKGSFGSVYYG-----KMKDGKEVAVKIMADSCSHRTQQFVTEVALL 663
EE + ++GKG+FGSV G VAVK + S + + F E+ +L
Sbjct: 19 IFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQIL 78
Query: 664 SRIHHRNLVPLIGYCEEEHQR--ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDA 721
+H +V G ++ LV EY+ +G LRD L ++ LD L +
Sbjct: 79 KALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQR--HRARLDASRLLLYSSQI 136
Query: 722 AKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR--QAEEDLTHISSVARGT 779
KG+EYL + +HRD+ + NIL++ K++DFGL++ ++D + +
Sbjct: 137 CKGMEYLGS---RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSP 193
Query: 780 VGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 815
+ + PE + + +SDV+SFGVVL EL + K
Sbjct: 194 IFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKS 230
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 1e-37
Identities = 68/212 (32%), Positives = 108/212 (50%), Gaps = 14/212 (6%)
Query: 609 ELEEATNNFCKKIGKGSFGSVYYG-----KMKDGKEVAVKIMADSCSHRTQQFVTEVALL 663
+ EE F +++GKG+FGSV + G+ VAVK + S + F E+ +L
Sbjct: 37 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 96
Query: 664 SRIHHRNLVPLIGYCEEEHQR--ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDA 721
+ H N+V G C +R L+ EY+ G+LRD L +++ +D + LQ
Sbjct: 97 KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK--HKERIDHIKLLQYTSQI 154
Query: 722 AKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR--QAEEDLTHISSVARGT 779
KG+EYL T IHRD+ + NIL++ R K+ DFGL++ +++ +
Sbjct: 155 CKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESP 211
Query: 780 VGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS 811
+ + PE + + SDV+SFGVVL EL +
Sbjct: 212 IFWYAPESLTESKFSVASDVWSFGVVLYELFT 243
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 1e-37
Identities = 62/205 (30%), Positives = 93/205 (45%), Gaps = 9/205 (4%)
Query: 619 KKIGKGSFGSVYYGKMK-DGKEVAVK-IMADSCSHRT-QQFVTEVALLSRIHHRNLVPLI 675
IG GS+G + K DGK + K + S + Q V+EV LL + H N+V
Sbjct: 12 YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 71
Query: 676 GYCEEEHQRIL--VYEYMHNGTLRDRL-HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 732
+ L V EY G L + G+ ++ LD L++ L+ H
Sbjct: 72 DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 131
Query: 733 NPG--IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN 790
+ G ++HRD+K +N+ LD K+ DFGL+R D + + GT Y+ PE
Sbjct: 132 DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV-GTPYYMSPEQMNR 190
Query: 791 QQLTEKSDVYSFGVVLLELISGKKP 815
EKSD++S G +L EL + P
Sbjct: 191 MSYNEKSDIWSLGCLLYELCALMPP 215
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 1e-37
Identities = 67/219 (30%), Positives = 105/219 (47%), Gaps = 15/219 (6%)
Query: 607 LPELEEATNNFCKKIGKGSFGSVYYGKMKDGKE----VAVKIMADSCSHRT-QQFVTEVA 661
+ +F + IG+G FG VY+G + D AVK + QF+TE
Sbjct: 83 VIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGI 142
Query: 662 LLSRIHHRNLVPLIGYC-EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHD 720
++ H N++ L+G C E ++V YM +G LR+ + +
Sbjct: 143 IMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQ 200
Query: 721 AAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR---QAEEDLTHISSVAR 777
AKG+++L + +HRD+ + N +LD KV+DFGL+R E D H + A+
Sbjct: 201 VAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAK 257
Query: 778 GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 815
V ++ E Q+ T KSDV+SFGV+L EL++ G P
Sbjct: 258 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 296
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 1e-37
Identities = 58/231 (25%), Positives = 96/231 (41%), Gaps = 48/231 (20%)
Query: 617 FCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLI 675
+G+G+FG V + D + A+K + + ++EV LL+ ++H+ +V
Sbjct: 10 EIAVLGQGAFGQVVKARNALDSRYYAIKKI-RHTEEKLSTILSEVMLLASLNHQYVVRYY 68
Query: 676 G-YCEEEHQRI------------LVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHD 720
+ E + + EY NGTL D + Q+ W QI
Sbjct: 69 AAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQIL-- 126
Query: 721 AAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR--- 777
+ L Y+H + GIIHRD+K NI +D + K+ DFGL++ L + ++
Sbjct: 127 --EALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLP 181
Query: 778 ----------GTVGYLDPE------YYGNQQLTEKSDVYSFGVVLLELISG 812
GT Y+ E +Y EK D+YS G++ E+I
Sbjct: 182 GSSDNLTSAIGTAMYVATEVLDGTGHYN-----EKIDMYSLGIIFFEMIYP 227
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 1e-37
Identities = 54/205 (26%), Positives = 102/205 (49%), Gaps = 14/205 (6%)
Query: 619 KKIGKGSFGSVYYGKMKDGKE-----VAVKIMADSCSHRTQQ-FVTEVALLSRIHHRNLV 672
K +G G FG+V+ G E V +K++ D ++ Q + + + H ++V
Sbjct: 19 KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78
Query: 673 PLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 732
L+G C ++ V +Y+ G+L D + ++ L L AKG+ YL
Sbjct: 79 RLLGLCPGSSLQL-VTQYLPLGSLLDHVRQ--HRGALGPQLLLNWGVQIAKGMYYLE--- 132
Query: 733 NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE-EDLTHISSVARGTVGYLDPEYYGNQ 791
G++HR++ + N+LL + +V+DFG++ +D + S A+ + ++ E
Sbjct: 133 EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFG 192
Query: 792 QLTEKSDVYSFGVVLLELIS-GKKP 815
+ T +SDV+S+GV + EL++ G +P
Sbjct: 193 KYTHQSDVWSYGVTVWELMTFGAEP 217
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 1e-37
Identities = 59/207 (28%), Positives = 109/207 (52%), Gaps = 13/207 (6%)
Query: 617 FCKKIGKGSFGSVYYGKMKDGKE----VAVKIMADSCSHRTQQ-FVTEVALLSRIHHRNL 671
K +G G FG V G++K + VA+K + + + ++ F+ E +++ + H N+
Sbjct: 49 IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNI 108
Query: 672 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 731
+ L G + ++V EYM NG+L L + + + + A G++YL
Sbjct: 109 IRLEGVVTKSKPVMIVTEYMENGSLDSFLRK--HDAQFTVIQLVGMLRGIASGMKYLSD- 165
Query: 732 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSR--QAEEDLTHISSVARGTVGYLDPEYYG 789
G +HRD+ + NIL++ N+ KVSDFGL R + + + + + + + + PE
Sbjct: 166 --MGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIA 223
Query: 790 NQQLTEKSDVYSFGVVLLELIS-GKKP 815
++ T SDV+S+G+VL E++S G++P
Sbjct: 224 YRKFTSASDVWSYGIVLWEVMSYGERP 250
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 2e-37
Identities = 61/207 (29%), Positives = 99/207 (47%), Gaps = 15/207 (7%)
Query: 619 KKIGKGSFGSVYYGKMKDGKE----VAVKIMADSCSHRT-QQFVTEVALLSRIHHRNLVP 673
+ IGKG FG VY+G+ D + A+K ++ + + F+ E L+ ++H N++
Sbjct: 27 RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLA 86
Query: 674 LIGYC-EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 732
LIG E ++ YM +G L + Q+ + A+G+EYL
Sbjct: 87 LIGIMLPPEGLPHVLLPYMCHGDLLQFIRS--PQRNPTVKDLISFGLQVARGMEYLA--- 141
Query: 733 NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGT---VGYLDPEYYG 789
+HRD+ + N +LD + KV+DFGL+R + + R V + E
Sbjct: 142 EQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQ 201
Query: 790 NQQLTEKSDVYSFGVVLLELIS-GKKP 815
+ T KSDV+SFGV+L EL++ G P
Sbjct: 202 TYRFTTKSDVWSFGVLLWELLTRGAPP 228
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 2e-37
Identities = 62/203 (30%), Positives = 103/203 (50%), Gaps = 14/203 (6%)
Query: 619 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVT----EVALLSRIHHRNLVP 673
K+G G +VY + +VA+K + ++ + EV S++ H+N+V
Sbjct: 17 DKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPR-EKEETLKRFEREVHNSSQLSHQNIVS 75
Query: 674 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 733
+I EE+ LV EY+ TL + + + PL T + + G+++ H +
Sbjct: 76 MIDVDEEDDCYYLVMEYIEGPTLSEYIE---SHGPLSVDTAINFTNQILDGIKHAH---D 129
Query: 734 PGIIHRDVKSSNILLDINMRAKVSDFGLSR-QAEEDLTHISSVARGTVGYLDPEYYGNQQ 792
I+HRD+K NIL+D N K+ DFG+++ +E LT + V GTV Y PE +
Sbjct: 130 MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVL-GTVQYFSPEQAKGEA 188
Query: 793 LTEKSDVYSFGVVLLELISGKKP 815
E +D+YS G+VL E++ G+ P
Sbjct: 189 TDECTDIYSIGIVLYEMLVGEPP 211
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 2e-37
Identities = 53/209 (25%), Positives = 89/209 (42%), Gaps = 22/209 (10%)
Query: 619 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGY 677
+G G+ G++ Y M D ++VAVK + C + EV LL H N++
Sbjct: 30 DVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADR---EVQLLRESDEHPNVIRYFCT 86
Query: 678 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGII 737
++ + + E TL++ + L + + GL +LH + I+
Sbjct: 87 EKDRQFQYIAIELC-AATLQEYVEQ--KDFAHLGLEPITLLQQTTSGLAHLH---SLNIV 140
Query: 738 HRDVKSSNILL-----DINMRAKVSDFGLSRQAEED---LTHISSVARGTVGYLDPEYY- 788
HRD+K NIL+ ++A +SDFGL ++ + S V GT G++ PE
Sbjct: 141 HRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVP-GTEGWIAPEMLS 199
Query: 789 --GNQQLTEKSDVYSFGVVLLELISGKKP 815
+ T D++S G V +IS
Sbjct: 200 EDCKENPTYTVDIFSAGCVFYYVISEGSH 228
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 6e-37
Identities = 56/251 (22%), Positives = 97/251 (38%), Gaps = 46/251 (18%)
Query: 619 KKIGKGSFGSVYYGKMKDGKEVAVKIM-----------------ADSCSHRTQQFVTEVA 661
+ + +G F + + KD K A+K S + F E+
Sbjct: 37 RTLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQ 95
Query: 662 LLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQ--- 716
+++ I + + G + ++YEYM N ++ +++ ++
Sbjct: 96 IITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKC 155
Query: 717 IAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVA 776
I Y+H I HRDVK SNIL+D N R K+SDFG S + S
Sbjct: 156 IIKSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGS--- 210
Query: 777 RGTVGYLDPE-------YYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVH 829
RGT ++ PE Y G K D++S G+ L + P F ++++V
Sbjct: 211 RGTYEFMPPEFFSNESSYNG-----AKVDIWSLGICLYVMFYNVVP-----FSLKISLVE 260
Query: 830 WARSMIKKGDV 840
+ I+ ++
Sbjct: 261 -LFNNIRTKNI 270
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 1e-36
Identities = 57/220 (25%), Positives = 94/220 (42%), Gaps = 18/220 (8%)
Query: 609 ELEEATNNFCKKIGKGSFGSVYYGKMKDGKE-----VAVKIMADSCSHRTQQ-FVTEVAL 662
+ + +G+G FG V + VAVK + + + + E+ +
Sbjct: 27 VFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDI 86
Query: 663 LSRIHHRNLVPLIGYCEEEHQR--ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHD 720
L ++H +++ G CE+ LV EY+ G+LRD L + + L A
Sbjct: 87 LRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLP----RHSIGLAQLLLFAQQ 142
Query: 721 AAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR--QAEEDLTHISSVARG 778
+G+ YLH IHRD+ + N+LLD + K+ DFGL++ + +
Sbjct: 143 ICEGMAYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDS 199
Query: 779 TVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVS 817
V + PE + SDV+SFGV L EL++ S
Sbjct: 200 PVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQS 239
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 1e-36
Identities = 67/237 (28%), Positives = 105/237 (44%), Gaps = 19/237 (8%)
Query: 595 HFMDEGVAYFIPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGK------EVAVKIMADS 648
+ + L E+ + +G G+FG VY G++ +VAVK + +
Sbjct: 12 YCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV 71
Query: 649 CSHRTQQ-FVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGT----LRDRLHGS 703
CS + + F+ E ++S+ +H+N+V IG + R ++ E M G LR+
Sbjct: 72 CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRP 131
Query: 704 VNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI---NMRAKVSDFG 760
L L L +A D A G +YL IHRD+ + N LL AK+ DFG
Sbjct: 132 SQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFG 188
Query: 761 LSRQ-AEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 815
++R A V ++ PE + T K+D +SFGV+L E+ S G P
Sbjct: 189 MARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 245
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 2e-36
Identities = 58/215 (26%), Positives = 103/215 (47%), Gaps = 19/215 (8%)
Query: 617 FCKKIGKGSFGSVYYGKMKDGKE------VAVKIMADSCSHRTQQ-FVTEVALLSRIHHR 669
+++G+GSFG VY G K + VA+K + ++ S R + F+ E +++ +
Sbjct: 29 MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 88
Query: 670 NLVPLIGYCEEEHQRILVYEYMHNGT----LRDRLHGSVNQKPLDWLTR---LQIAHDAA 722
++V L+G + +++ E M G LR N L + +Q+A + A
Sbjct: 89 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 148
Query: 723 KGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ-AEEDLTHISSVARGTVG 781
G+ YL+ +HRD+ + N ++ + K+ DFG++R E D V
Sbjct: 149 DGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 205
Query: 782 YLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 815
++ PE + T SDV+SFGVVL E+ + ++P
Sbjct: 206 WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP 240
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 2e-36
Identities = 60/201 (29%), Positives = 91/201 (45%), Gaps = 13/201 (6%)
Query: 619 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHR---TQQFVTEVALLSRIHHRNLVPL 674
+ +GKG FG+VY + K +A+K++ + + Q EV + S + H N++ L
Sbjct: 15 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74
Query: 675 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 734
GY + + L+ EY GT+ L D + A L Y H +
Sbjct: 75 YGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALSYCH---SK 128
Query: 735 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLT 794
+IHRD+K N+LL K++DFG S A GT+ YL PE +
Sbjct: 129 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC---GTLDYLPPEMIEGRMHD 185
Query: 795 EKSDVYSFGVVLLELISGKKP 815
EK D++S GV+ E + GK P
Sbjct: 186 EKVDLWSLGVLCYEFLVGKPP 206
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 2e-36
Identities = 69/218 (31%), Positives = 104/218 (47%), Gaps = 24/218 (11%)
Query: 617 FCKKIGKGSFGSVYYGKMKDGKE---VAVKIMADSCSHRTQQ-FVTEVALLSRI-HHRNL 671
F IG+G+FG V ++K A+K M + S + F E+ +L ++ HH N+
Sbjct: 29 FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 88
Query: 672 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGS-------------VNQKPLDWLTRLQIA 718
+ L+G CE L EY +G L D L S L L A
Sbjct: 89 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 148
Query: 719 HDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARG 778
D A+G++YL IHRD+ + NIL+ N AK++DFGLSR +++ ++ R
Sbjct: 149 ADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKTMGRL 203
Query: 779 TVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 815
V ++ E T SDV+S+GV+L E++S G P
Sbjct: 204 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 241
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 2e-36
Identities = 65/213 (30%), Positives = 103/213 (48%), Gaps = 19/213 (8%)
Query: 619 KKIGKGSFGSVYYGKMKDGKE----VAVKIM-ADSCSHRTQQ-FVTEVALLSRIHHRNLV 672
K +G+G FGSV G +K VAVK M D+ S R + F++E A + H N++
Sbjct: 40 KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99
Query: 673 PLIGYCEEEHQRI-----LVYEYMHNGTLRDRLHGSVNQKPLDWLTR---LQIAHDAAKG 724
L+G C E + ++ +M G L L S + + L+ D A G
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159
Query: 725 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ-AEEDLTHISSVARGTVGYL 783
+EYL +HRD+ + N +L +M V+DFGLS++ D +A+ V ++
Sbjct: 160 MEYLSNR---NFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI 216
Query: 784 DPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 815
E ++ T KSDV++FGV + E+ + G P
Sbjct: 217 AIESLADRVYTSKSDVWAFGVTMWEIATRGMTP 249
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 2e-36
Identities = 69/255 (27%), Positives = 111/255 (43%), Gaps = 19/255 (7%)
Query: 577 LRTSTKPSNTAYSIARGGHFMDEGVAYFIPLPELEEATNNFCKKIGKGSFGSVYYGKMKD 636
+ S ++T + + + L E+ + +G G+FG VY G++
Sbjct: 35 YKLSKLRTSTIMTDYNPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSG 94
Query: 637 GK------EVAVKIMADSCSHRTQQ-FVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 689
+VAVK + + CS + + F+ E ++S+ +H+N+V IG + R ++ E
Sbjct: 95 MPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLE 154
Query: 690 YMHNGT----LRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSN 745
M G LR+ L L L +A D A G +YL IHRD+ + N
Sbjct: 155 LMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARN 211
Query: 746 ILLDI---NMRAKVSDFGLSRQ-AEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYS 801
LL AK+ DFG++R A V ++ PE + T K+D +S
Sbjct: 212 CLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWS 271
Query: 802 FGVVLLELIS-GKKP 815
FGV+L E+ S G P
Sbjct: 272 FGVLLWEIFSLGYMP 286
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 5e-36
Identities = 62/214 (28%), Positives = 102/214 (47%), Gaps = 20/214 (9%)
Query: 619 KKIGKGSFGSVYYGKMKDGKE----VAVKIM-ADSCSHR-TQQFVTEVALLSRIHHRNLV 672
+ +GKG FGSV ++K VAVK++ AD + ++F+ E A + H ++
Sbjct: 29 RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVA 88
Query: 673 PLIGYCEEEHQRI------LVYEYMHNGTLRDRLHGS---VNQKPLDWLTRLQIAHDAAK 723
L+G + ++ +M +G L L S N L T ++ D A
Sbjct: 89 KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIAC 148
Query: 724 GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ-AEEDLTHISSVARGTVGY 782
G+EYL + IHRD+ + N +L +M V+DFGLSR+ D ++ V +
Sbjct: 149 GMEYLSSR---NFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKW 205
Query: 783 LDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 815
L E + T SDV++FGV + E+++ G+ P
Sbjct: 206 LALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP 239
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 5e-36
Identities = 55/203 (27%), Positives = 93/203 (45%), Gaps = 14/203 (6%)
Query: 619 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVT----EVALLSRIHHRNLVP 673
+ +G+G G VY + + VA+K+M+++ S F T E R+ ++VP
Sbjct: 40 RLVGRGGMGDVYEAEDTVRERIVALKLMSETLS-SDPVFRTRMQREARTAGRLQEPHVVP 98
Query: 674 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 733
+ + E + Q + ++ L L Q PL + I L+ H
Sbjct: 99 IHDFGEIDGQLYVDMRLINGVDLAAMLR---RQGPLAPPRAVAIVRQIGSALDAAHAA-- 153
Query: 734 PGIIHRDVKSSNILLDINMRAKVSDFGLSR-QAEEDLTHISSVARGTVGYLDPEYYGNQQ 792
G HRDVK NIL+ + A + DFG++ +E LT + + GT+ Y+ PE +
Sbjct: 154 -GATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTV-GTLYYMAPERFSESH 211
Query: 793 LTEKSDVYSFGVVLLELISGKKP 815
T ++D+Y+ VL E ++G P
Sbjct: 212 ATYRADIYALTCVLYECLTGSPP 234
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 1e-35
Identities = 51/220 (23%), Positives = 91/220 (41%), Gaps = 24/220 (10%)
Query: 619 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIG 676
+ + +G F VY + + G+E A+K + + + + + EV + ++ H N+V
Sbjct: 34 RVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCS 93
Query: 677 YCEEEHQR-------ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 729
+ L+ + G L + L ++ PL T L+I + + ++++H
Sbjct: 94 AASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH 153
Query: 730 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVA-----------RG 778
P IIHRD+K N+LL K+ DFG + + S
Sbjct: 154 R-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNT 212
Query: 779 TVGYLDPE---YYGNQQLTEKSDVYSFGVVLLELISGKKP 815
T Y PE Y N + EK D+++ G +L L + P
Sbjct: 213 TPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP 252
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 2e-35
Identities = 58/243 (23%), Positives = 103/243 (42%), Gaps = 33/243 (13%)
Query: 619 KKIGKGSFGSVYYGKMKDGKEVAVKIMA-DSCSHRT-QQFVTEVALLSRIHHRNL--VPL 674
K+IG G V+ + + A+K + + ++T + E+A L+++ + + L
Sbjct: 34 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93
Query: 675 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 734
Y + +V E N L L +K +D R + + + +H
Sbjct: 94 YDYEITDQYIYMVMEC-GNIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHTIH---QH 146
Query: 735 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI---SSVARGTVGYLDPE----- 786
GI+H D+K +N L+ + K+ DFG++ Q + D T + S V GTV Y+ PE
Sbjct: 147 GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQV--GTVNYMPPEAIKDM 203
Query: 787 ------YYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV 840
+++ KSDV+S G +L + GK P F +N + ++I
Sbjct: 204 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP-----FQQIINQISKLHAIIDPNHE 258
Query: 841 ISI 843
I
Sbjct: 259 IEF 261
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 3e-35
Identities = 54/202 (26%), Positives = 86/202 (42%), Gaps = 15/202 (7%)
Query: 619 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADS---CSHRTQQFVTEVALLSRIHHRNLVPL 674
+ +GKG FG+VY + K +A+K++ S Q E+ + S + H N++ +
Sbjct: 20 RPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRM 79
Query: 675 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLD-WLTRLQIAHDAAKGLEYLHTGCN 733
Y + + L+ E+ G L L D + + A L Y H
Sbjct: 80 YNYFHDRKRIYLMLEFAPRGELYKEL---QKHGRFDEQRSA-TFMEELADALHYCH---E 132
Query: 734 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQL 793
+IHRD+K N+L+ K++DFG S A GT+ YL PE +
Sbjct: 133 RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMC---GTLDYLPPEMIEGKTH 189
Query: 794 TEKSDVYSFGVVLLELISGKKP 815
EK D++ GV+ E + G P
Sbjct: 190 DEKVDLWCAGVLCYEFLVGMPP 211
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 4e-35
Identities = 65/208 (31%), Positives = 97/208 (46%), Gaps = 24/208 (11%)
Query: 619 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADS---CSHRTQQFVTEVALLSRIHHRNLVPL 674
+GKGSF VY + + G EVA+K++ + Q+ EV + ++ H +++ L
Sbjct: 17 NLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILEL 76
Query: 675 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLD-WLTR---LQIAHDAAKGLEYLHT 730
Y E+ + LV E HNG + L KP R QI G+ YLH
Sbjct: 77 YNYFEDSNYVYLVLEMCHNGEMNRYLK--NRVKPFSENEARHFMHQII----TGMLYLH- 129
Query: 731 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR---GTVGYLDPEY 787
+ GI+HRD+ SN+LL NM K++DFGL+ Q + GT Y+ PE
Sbjct: 130 --SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP----HEKHYTLCGTPNYISPEI 183
Query: 788 YGNQQLTEKSDVYSFGVVLLELISGKKP 815
+SDV+S G + L+ G+ P
Sbjct: 184 ATRSAHGLESDVWSLGCMFYTLLIGRPP 211
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 5e-35
Identities = 59/241 (24%), Positives = 98/241 (40%), Gaps = 41/241 (17%)
Query: 619 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGY 677
K +G GS G+V + G+ VAVK M E+ LL+ H N++
Sbjct: 21 KILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALM---EIKLLTESDDHPNVIRYYCS 77
Query: 678 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK-------GLEYLHT 730
+ + E N L+D + ++ D +LQ ++ G+ +LH
Sbjct: 78 ETTDRFLYIALELC-NLNLQDLV---ESKNVSDENLKLQKEYNPISLLRQIASGVAHLH- 132
Query: 731 GCNPGIIHRDVKSSNILLDI-------------NMRAKVSDFGLSRQAEEDLTHISSVAR 777
+ IIHRD+K NIL+ N+R +SDFGL ++ + + +
Sbjct: 133 --SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLN 190
Query: 778 ---GTVGYLDPE-------YYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNI 827
GT G+ PE ++LT D++S G V ++S K + + E NI
Sbjct: 191 NPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNI 250
Query: 828 V 828
+
Sbjct: 251 I 251
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 6e-35
Identities = 57/206 (27%), Positives = 100/206 (48%), Gaps = 18/206 (8%)
Query: 619 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 677
+GKG++G VY G+ +A+K + + S +Q E+AL + H+N+V +G
Sbjct: 28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGS 87
Query: 678 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLD-----WLTRLQIAHDAAKGLEYLHTGC 732
E + E + G+L L + + T+ QI GL+YLH
Sbjct: 88 FSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTK-QILE----GLKYLH--- 139
Query: 733 NPGIIHRDVKSSNILLDI-NMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE--YYG 789
+ I+HRD+K N+L++ + K+SDFG S++ + GT+ Y+ PE G
Sbjct: 140 DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETF-TGTLQYMAPEIIDKG 198
Query: 790 NQQLTEKSDVYSFGVVLLELISGKKP 815
+ + +D++S G ++E+ +GK P
Sbjct: 199 PRGYGKAADIWSLGCTIIEMATGKPP 224
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 6e-35
Identities = 54/205 (26%), Positives = 90/205 (43%), Gaps = 21/205 (10%)
Query: 619 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 677
++G+GSFG V+ K K G + AVK + E+ + + +VPL G
Sbjct: 64 PRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE-----ELVACAGLSSPRIVPLYGA 118
Query: 678 CEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 735
E + E + G+L + G + + + Q +GLEYLH
Sbjct: 119 VREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLG-QAL----EGLEYLH---TRR 170
Query: 736 IIHRDVKSSNILLDIN-MRAKVSDFGLSRQAEEDLTHISSVAR----GTVGYLDPEYYGN 790
I+H DVK+ N+LL + RA + DFG + + D S + GT ++ PE
Sbjct: 171 ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMG 230
Query: 791 QQLTEKSDVYSFGVVLLELISGKKP 815
+ K D++S ++L +++G P
Sbjct: 231 KPCDAKVDIWSSCCMMLHMLNGCHP 255
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 8e-35
Identities = 66/231 (28%), Positives = 107/231 (46%), Gaps = 27/231 (11%)
Query: 607 LPELEEATNNFCKKIGKGSFGSVYYGKMKDGKE------VAVKIMADSCSHRTQQFVTEV 660
+ ++ ++G+G+FG V+ + + VAVK + ++ Q F E
Sbjct: 35 VHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREA 94
Query: 661 ALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRD--RLHG----------SVNQKP 708
LL+ + H+++V G C E ++V+EYM +G L R HG V P
Sbjct: 95 ELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGP 154
Query: 709 LDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ-AEE 767
L L +A A G+ YL +HRD+ + N L+ + K+ DFG+SR
Sbjct: 155 LGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYST 211
Query: 768 DLTHISSVARGTVGYLDPE--YYGNQQLTEKSDVYSFGVVLLELIS-GKKP 815
D + + ++ PE Y + T +SDV+SFGVVL E+ + GK+P
Sbjct: 212 DYYRVGGRTMLPIRWMPPESILYR--KFTTESDVWSFGVVLWEIFTYGKQP 260
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 9e-35
Identities = 59/243 (24%), Positives = 104/243 (42%), Gaps = 33/243 (13%)
Query: 619 KKIGKGSFGSVYYGKMKDGKEVAVKIMA-DSCSHRT-QQFVTEVALLSRI--HHRNLVPL 674
K+IG G V+ + + A+K + + ++T + E+A L+++ H ++ L
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 675 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 734
Y + +V E N L L +K +D R + + + +H
Sbjct: 75 YDYEITDQYIYMVMEC-GNIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHTIH---QH 127
Query: 735 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI---SSVARGTVGYLDPE----- 786
GI+H D+K +N L+ + K+ DFG++ Q + D T + S V GTV Y+ PE
Sbjct: 128 GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQV--GTVNYMPPEAIKDM 184
Query: 787 ------YYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV 840
+++ KSDV+S G +L + GK P F +N + ++I
Sbjct: 185 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP-----FQQIINQISKLHAIIDPNHE 239
Query: 841 ISI 843
I
Sbjct: 240 IEF 242
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 1e-34
Identities = 65/222 (29%), Positives = 104/222 (46%), Gaps = 28/222 (12%)
Query: 617 FCKKIGKGSFGSVYYGKMKDGKE------VAVKIMADSCSHRTQQFVTEVALLSRIHHRN 670
+++G+G+FG V+ + + VAVK + D + F E LL+ + H +
Sbjct: 19 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 78
Query: 671 LVPLIGYCEEEHQRILVYEYMHNGTLRD--RLHG-----------SVNQKPLDWLTRLQI 717
+V G C + I+V+EYM +G L R HG + L L I
Sbjct: 79 IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 138
Query: 718 AHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ-AEEDLTHISSVA 776
A A G+ YL + +HRD+ + N L+ N+ K+ DFG+SR D +
Sbjct: 139 ASQIASGMVYLA---SQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHT 195
Query: 777 RGTVGYLDPE--YYGNQQLTEKSDVYSFGVVLLELIS-GKKP 815
+ ++ PE Y + T +SDV+SFGV+L E+ + GK+P
Sbjct: 196 MLPIRWMPPESIMYR--KFTTESDVWSFGVILWEIFTYGKQP 235
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 1e-34
Identities = 57/233 (24%), Positives = 108/233 (46%), Gaps = 29/233 (12%)
Query: 607 LPELEEATNNFCKKIGKGSFGSVYYGKMKDGKE------VAVKIMADSCSHRTQQ-FVTE 659
L E+ + F +++G+ FG VY G + VA+K + D ++ F E
Sbjct: 3 LKEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHE 62
Query: 660 VALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRD--RLHG-----------SVNQ 706
L +R+ H N+V L+G ++ +++ Y +G L + + +
Sbjct: 63 AMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVK 122
Query: 707 KPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ-A 765
L+ + + A G+EYL + ++H+D+ + N+L+ + K+SD GL R+
Sbjct: 123 SALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFREVY 179
Query: 766 EEDLTHISSVARGTVGYLDPE--YYGNQQLTEKSDVYSFGVVLLELIS-GKKP 815
D + + + ++ PE YG + + SD++S+GVVL E+ S G +P
Sbjct: 180 AADYYKLLGNSLLPIRWMAPEAIMYG--KFSIDSDIWSYGVVLWEVFSYGLQP 230
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 1e-34
Identities = 63/209 (30%), Positives = 104/209 (49%), Gaps = 20/209 (9%)
Query: 619 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVT----EVALLSRIHHRNLVP 673
+ +G G V+ + ++D ++VAVK++ + R F E + ++H +V
Sbjct: 18 EILGFGGMSEVHLARDLRDHRDVAVKVLRADLA-RDPSFYLRFRREAQNAAALNHPAIVA 76
Query: 674 LIGYCEEEHQRI----LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 729
+ E E +V EY+ TLRD +H + P+ +++ DA + L + H
Sbjct: 77 VYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQALNFSH 133
Query: 730 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR---QAEEDLTHISSVARGTVGYLDPE 786
GIIHRDVK +NI++ KV DFG++R + +T ++V GT YL PE
Sbjct: 134 ---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVI-GTAQYLSPE 189
Query: 787 YYGNQQLTEKSDVYSFGVVLLELISGKKP 815
+ +SDVYS G VL E+++G+ P
Sbjct: 190 QARGDSVDARSDVYSLGCVLYEVLTGEPP 218
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 1e-34
Identities = 57/216 (26%), Positives = 95/216 (43%), Gaps = 21/216 (9%)
Query: 616 NFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMA-DSCSHRTQQFVTEVALLSRIHHRNLVP 673
+G+G+ +V+ G+ K G A+K+ S + E +L +++H+N+V
Sbjct: 12 LLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVK 71
Query: 674 LIGYCEEEHQR--ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 731
L EE R +L+ E+ G+L L N L L + D G+ +L
Sbjct: 72 LFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR-- 129
Query: 732 CNPGIIHRDVKSSNILL----DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 787
GI+HR++K NI+ D K++DFG +R+ E+D +S GT YL P+
Sbjct: 130 -ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY--GTEEYLHPDM 186
Query: 788 Y--------GNQQLTEKSDVYSFGVVLLELISGKKP 815
Y ++ D++S GV +G P
Sbjct: 187 YERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 2e-34
Identities = 65/224 (29%), Positives = 103/224 (45%), Gaps = 28/224 (12%)
Query: 617 FCKKIGKGSFGSVYYGKMKDGKE------VAVKIMADSCSHRTQQ-FVTEVALLSRI-HH 668
F K +G G+FG V + VAVK++ S ++ ++E+ +LS + +H
Sbjct: 27 FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 86
Query: 669 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRL---------------HGSVNQKPLDWLT 713
N+V L+G C +++ EY G L + L ++ LD
Sbjct: 87 MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 146
Query: 714 RLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ-AEEDLTHI 772
L ++ AKG+ +L + IHRD+ + NILL K+ DFGL+R + +
Sbjct: 147 LLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVV 203
Query: 773 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 815
AR V ++ PE N T +SDV+S+G+ L EL S G P
Sbjct: 204 KGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 2e-34
Identities = 54/205 (26%), Positives = 93/205 (45%), Gaps = 19/205 (9%)
Query: 619 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPL 674
+ +GKG F + + A KI+ S H+ ++ E+++ + H+++V
Sbjct: 47 RFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 106
Query: 675 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLD-WLTR---LQIAHDAAKGLEYLHT 730
G+ E+ +V E +L + +K L R QI G +YLH
Sbjct: 107 HGFFEDNDFVFVVLELCRRRSLLELH---KRRKALTEPEARYYLRQIV----LGCQYLH- 158
Query: 731 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN 790
+IHRD+K N+ L+ ++ K+ DFGL+ + E D V GT Y+ PE
Sbjct: 159 --RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD-GERKKVLCGTPNYIAPEVLSK 215
Query: 791 QQLTEKSDVYSFGVVLLELISGKKP 815
+ + + DV+S G ++ L+ GK P
Sbjct: 216 KGHSFEVDVWSIGCIMYTLLVGKPP 240
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 2e-34
Identities = 54/205 (26%), Positives = 93/205 (45%), Gaps = 19/205 (9%)
Query: 619 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPL 674
+ +GKG F + + A KI+ S H+ ++ E+++ + H+++V
Sbjct: 21 RFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 80
Query: 675 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLD-WLTR---LQIAHDAAKGLEYLHT 730
G+ E+ +V E +L + +K L R QI G +YLH
Sbjct: 81 HGFFEDNDFVFVVLELCRRRSLLELH---KRRKALTEPEARYYLRQIV----LGCQYLH- 132
Query: 731 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN 790
+IHRD+K N+ L+ ++ K+ DFGL+ + E D V GT Y+ PE
Sbjct: 133 --RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD-GERKKVLCGTPNYIAPEVLSK 189
Query: 791 QQLTEKSDVYSFGVVLLELISGKKP 815
+ + + DV+S G ++ L+ GK P
Sbjct: 190 KGHSFEVDVWSIGCIMYTLLVGKPP 214
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 2e-34
Identities = 57/243 (23%), Positives = 102/243 (41%), Gaps = 33/243 (13%)
Query: 619 KKIGKGSFGSVYYGKMKDGKEVAVKIMA-DSCSHRT-QQFVTEVALLSRIHHRNL--VPL 674
K+IG G V+ + + A+K + + ++T + E+A L+++ + + L
Sbjct: 62 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121
Query: 675 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 734
Y + +V E N L L +K +D R + + + +H
Sbjct: 122 YDYEITDQYIYMVMEC-GNIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHTIH---QH 174
Query: 735 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI---SSVARGTVGYLDPE----- 786
GI+H D+K +N L+ + K+ DFG++ Q + D T + S V G V Y+ PE
Sbjct: 175 GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQV--GAVNYMPPEAIKDM 231
Query: 787 ------YYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV 840
+++ KSDV+S G +L + GK P F +N + ++I
Sbjct: 232 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP-----FQQIINQISKLHAIIDPNHE 286
Query: 841 ISI 843
I
Sbjct: 287 IEF 289
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-34
Identities = 56/201 (27%), Positives = 103/201 (51%), Gaps = 15/201 (7%)
Query: 619 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 677
+KIG+G+ G+VY G+EVA++ M + + + E+ ++ + N+V +
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 678 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA---HDAAKGLEYLHTGCNP 734
+ +V EY+ G+L D + + + QIA + + LE+LH+
Sbjct: 86 YLVGDELWVVMEYLAGGSLTDVVTETC-------MDEGQIAAVCRECLQALEFLHSN--- 135
Query: 735 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLT 794
+IHRD+KS NILL ++ K++DFG Q + + S++ GT ++ PE +
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYG 194
Query: 795 EKSDVYSFGVVLLELISGKKP 815
K D++S G++ +E+I G+ P
Sbjct: 195 PKVDIWSLGIMAIEMIEGEPP 215
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 3e-34
Identities = 62/228 (27%), Positives = 111/228 (48%), Gaps = 36/228 (15%)
Query: 617 FCKKIGKGSFGSVYYGKMKDGKE--------VAVKIMADSCSHRTQQ-FVTEVALLSRI- 666
K +G+G+FG V + + VAVK++ D + + V+E+ ++ I
Sbjct: 39 LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 98
Query: 667 HHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRL-------------HGSVNQKPLDWLT 713
H+N++ L+G C ++ ++ EY G LR+ L V ++ + +
Sbjct: 99 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 714 RLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 773
+ + A+G+EYL + IHRD+ + N+L+ N K++DFGL+R D+ +I
Sbjct: 159 LVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLAR----DINNID 211
Query: 774 SVARGTVGYL-----DPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 815
+ T G L PE ++ T +SDV+SFGV++ E+ + G P
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 3e-34
Identities = 73/289 (25%), Positives = 131/289 (45%), Gaps = 42/289 (14%)
Query: 558 RRKISNQKSYEKVCPLADSLRTSTKPSNTAYSIARGGHFMDEGVAYFIPLPELEEATNN- 616
R+ + +S + +R +T+ S+TA + P+ E +
Sbjct: 28 RQVTVSAESSSSMNSNTPLVRITTRLSSTADT----PMLAGVSEYELPEDPKWEFPRDKL 83
Query: 617 -FCKKIGKGSFGSVYYG--------KMKDGKEVAVKIMADSCSHRTQQ-FVTEVALLSRI 666
K +G+G FG V K K+ VAVK++ D + + V+E+ ++ I
Sbjct: 84 TLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMI 143
Query: 667 -HHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRL-------------HGSVNQKPLDWL 712
H+N++ L+G C ++ ++ EY G LR+ L V ++ + +
Sbjct: 144 GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 203
Query: 713 TRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 772
+ + A+G+EYL + IHRD+ + N+L+ N K++DFGL+R D+ +I
Sbjct: 204 DLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLAR----DINNI 256
Query: 773 SSVARGTVGYL-----DPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 815
+ T G L PE ++ T +SDV+SFGV++ E+ + G P
Sbjct: 257 DYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 305
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 3e-34
Identities = 67/252 (26%), Positives = 110/252 (43%), Gaps = 21/252 (8%)
Query: 617 FCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVT-EVALLSRIHHRNLVPL 674
+++G G FG V +D G++VA+K S + ++ E+ ++ +++H N+V
Sbjct: 18 MKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSA 77
Query: 675 IGYCEEE------HQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYL 728
+ +L EY G LR L+ N L + D + L YL
Sbjct: 78 REVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYL 137
Query: 729 HTGCNPGIIHRDVKSSNILLDIN---MRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDP 785
H IIHRD+K NI+L + K+ D G +++ ++ V GT+ YL P
Sbjct: 138 H---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFV--GTLQYLAP 192
Query: 786 EYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 845
E ++ T D +SFG + E I+G +P F V W + +K + +V
Sbjct: 193 ELLEQKKYTVTVDYWSFGTLAFECITGFRP-----FLPNWQPVQWHGKVREKSNEHIVVY 247
Query: 846 PVLIGNVKIESI 857
L G VK S+
Sbjct: 248 DDLTGAVKFSSV 259
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 4e-34
Identities = 60/233 (25%), Positives = 107/233 (45%), Gaps = 41/233 (17%)
Query: 617 FCKKIGKGSFGSVYYGKMKDGKE------VAVKIMADSCSHRTQQ-FVTEVALLSRIHHR 669
K +G+G FG V K VAVK++ ++ S + ++E +L +++H
Sbjct: 27 LGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHP 86
Query: 670 NLVPLIGYCEEEHQRILVYEYMHNGTLRDRL---------------------HGSVNQKP 708
+++ L G C ++ +L+ EY G+LR L +++
Sbjct: 87 HVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERA 146
Query: 709 LDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 768
L + A ++G++YL ++HRD+ + NIL+ + K+SDFGLSR D
Sbjct: 147 LTMGDLISFAWQISQGMQYLA---EMKLVHRDLAARNILVAEGRKMKISDFGLSR----D 199
Query: 769 LTHISSVARGTVGYL-----DPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 815
+ S + + G + E + T +SDV+SFGV+L E+++ G P
Sbjct: 200 VYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 252
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 4e-34
Identities = 63/227 (27%), Positives = 101/227 (44%), Gaps = 35/227 (15%)
Query: 617 FCKKIGKGSFGSVYYGKMKDGKE------VAVKIMADSCSHRTQQ-FVTEVALLSRI-HH 668
K +G+G+FG V + VAVK++ + +H + ++E+ +L I HH
Sbjct: 31 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 90
Query: 669 RNLVPLIGYC-EEEHQRILVYEYMHNGTLRDRL-------------HGSVNQKPLDWLTR 714
N+V L+G C + +++ E+ G L L + + L
Sbjct: 91 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 150
Query: 715 LQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISS 774
+ + AKG+E+L + IHRD+ + NILL K+ DFGL+R D+
Sbjct: 151 ICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLAR----DIYKDPD 203
Query: 775 VARGTVGYL-----DPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 815
R L PE ++ T +SDV+SFGV+L E+ S G P
Sbjct: 204 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 5e-34
Identities = 50/201 (24%), Positives = 76/201 (37%), Gaps = 13/201 (6%)
Query: 619 KKIGKGSFGSVYYGKMK-DGKEVAVKI--MADSCSHRTQQFVTEVALLSRI-HHRNLVPL 674
++G GS+G V+ + K DG+ AVK + + EV ++ H V L
Sbjct: 63 SRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRL 122
Query: 675 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 734
EE L E +L+ L D L +LH +
Sbjct: 123 EQAWEEGGILYLQTELC-GPSLQQHC--EAWGASLPEAQVWGYLRDTLLALAHLH---SQ 176
Query: 735 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLT 794
G++H DVK +NI L R K+ DFGL + G Y+ PE
Sbjct: 177 GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQE--GDPRYMAPELL-QGSYG 233
Query: 795 EKSDVYSFGVVLLELISGKKP 815
+DV+S G+ +LE+ +
Sbjct: 234 TAADVFSLGLTILEVACNMEL 254
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 5e-34
Identities = 57/216 (26%), Positives = 95/216 (43%), Gaps = 21/216 (9%)
Query: 616 NFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMA-DSCSHRTQQFVTEVALLSRIHHRNLVP 673
+G+G+ +V+ G+ K G A+K+ S + E +L +++H+N+V
Sbjct: 12 LLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVK 71
Query: 674 LIGYCEEEHQR--ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 731
L EE R +L+ E+ G+L L N L L + D G+ +L
Sbjct: 72 LFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR-- 129
Query: 732 CNPGIIHRDVKSSNILL----DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 787
GI+HR++K NI+ D K++DFG +R+ E+D +S GT YL P+
Sbjct: 130 -ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY--GTEEYLHPDM 186
Query: 788 Y--------GNQQLTEKSDVYSFGVVLLELISGKKP 815
Y ++ D++S GV +G P
Sbjct: 187 YERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 1e-33
Identities = 60/220 (27%), Positives = 101/220 (45%), Gaps = 24/220 (10%)
Query: 617 FCKKIGKGSFGSVYYGKMKDGKE------VAVKIMADSCSHRTQQ-FVTEVALLSRI-HH 668
F K +G G+FG V + VAVK++ + ++ ++E+ ++S + H
Sbjct: 50 FGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQH 109
Query: 669 RNLVPLIGYCEEEHQRILVYEYMHNGTLRD--RLHGSVNQ---------KPLDWLTRLQI 717
N+V L+G C +++ EY G L + R V + L
Sbjct: 110 ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHF 169
Query: 718 AHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ-AEEDLTHISSVA 776
+ A+G+ +L + IHRDV + N+LL AK+ DFGL+R + + A
Sbjct: 170 SSQVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNA 226
Query: 777 RGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 815
R V ++ PE + T +SDV+S+G++L E+ S G P
Sbjct: 227 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP 266
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 2e-33
Identities = 68/246 (27%), Positives = 101/246 (41%), Gaps = 67/246 (27%)
Query: 617 FCKKIGKGSFGSVYYGKMKDGKE------VAVKIMADSCSHRTQQ-FVTEVALLSRIHHR 669
+ + IG+G+FG V+ + VAVK++ + S Q F E AL++ +
Sbjct: 51 YVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNP 110
Query: 670 NLVPLIGYCEEEHQRILVYEYMHNGTLRDRL---------------------HGSVNQKP 708
N+V L+G C L++EYM G L + L S P
Sbjct: 111 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPP 170
Query: 709 LDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 768
L +L IA A G+ YL +HRD+ + N L+ NM K++DFGLSR
Sbjct: 171 LSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSA 227
Query: 769 LTHISSVARGTVGYLDPEYY---GNQQL---------------TEKSDVYSFGVVLLELI 810
+YY GN + T +SDV+++GVVL E+
Sbjct: 228 -----------------DYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIF 270
Query: 811 S-GKKP 815
S G +P
Sbjct: 271 SYGLQP 276
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 2e-33
Identities = 62/229 (27%), Positives = 105/229 (45%), Gaps = 33/229 (14%)
Query: 617 FCKKIGKGSFGSVYYGKMKDGKE------VAVKIMADSCSHRTQQ-FVTEVALLSRI-HH 668
F K +G G+FG V + VAVK++ + ++ ++E+ +++++ H
Sbjct: 49 FGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSH 108
Query: 669 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRL-----------------HGSVNQKPLDW 711
N+V L+G C L++EY G L + L ++ L+
Sbjct: 109 ENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 168
Query: 712 LTR---LQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ-AEE 767
LT L A+ AKG+E+L +HRD+ + N+L+ K+ DFGL+R +
Sbjct: 169 LTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSD 225
Query: 768 DLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 815
+ AR V ++ PE T KSDV+S+G++L E+ S G P
Sbjct: 226 SNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 274
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-33
Identities = 61/201 (30%), Positives = 99/201 (49%), Gaps = 15/201 (7%)
Query: 619 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 677
KIG+GS G V + K G++VAVK+M R + EV ++ H N+V +
Sbjct: 51 VKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKS 110
Query: 678 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA---HDAAKGLEYLHTGCNP 734
+ ++ E++ G L D + L QIA + L YLH
Sbjct: 111 YLVGEELWVLMEFLQGGALTDIVSQVR-------LNEEQIATVCEAVLQALAYLH---AQ 160
Query: 735 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLT 794
G+IHRD+KS +ILL ++ R K+SDFG Q +D+ S+ GT ++ PE
Sbjct: 161 GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWMAPEVISRSLYA 219
Query: 795 EKSDVYSFGVVLLELISGKKP 815
+ D++S G++++E++ G+ P
Sbjct: 220 TEVDIWSLGIMVIEMVDGEPP 240
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 7e-33
Identities = 62/226 (27%), Positives = 109/226 (48%), Gaps = 36/226 (15%)
Query: 619 KKIGKGSFGSVYYGKMKDGK--------EVAVKIMADSCSHRTQQ-FVTEVALLSRI-HH 668
K +G+G+FG V + +VAVK++ + + ++E+ ++ I H
Sbjct: 75 KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 134
Query: 669 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRL-------------HGSVNQKPLDWLTRL 715
+N++ L+G C ++ ++ EY G LR+ L ++ L +
Sbjct: 135 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 194
Query: 716 QIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSV 775
A+ A+G+EYL + IHRD+ + N+L+ + K++DFGL+R D+ HI
Sbjct: 195 SCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHIDYY 247
Query: 776 ARGTVGYL-----DPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 815
+ T G L PE ++ T +SDV+SFGV+L E+ + G P
Sbjct: 248 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 293
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 130 bits (327), Expect = 7e-33
Identities = 42/270 (15%), Positives = 84/270 (31%), Gaps = 32/270 (11%)
Query: 572 PLADSLR----TSTKPSNTAYSIARGGHFMDEGVAYFIPLPELEEATNNFC--KKIGKGS 625
P D L + ++Y + P E + + +G+G+
Sbjct: 21 PWDDKLIFKLLSGLSKPVSSYP---NTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGA 77
Query: 626 FGSVYYGKMKD------GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCE 679
F VY D ++ +K+ + + L +
Sbjct: 78 FAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHL 137
Query: 680 EEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGII 737
++ +LV E GTL + + + + +K + + A +E +H II
Sbjct: 138 FQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EII 194
Query: 738 HRDVKSSNILL-----------DINMRAKVSDFGLSRQAEEDLTHISSVAR-GTVGYLDP 785
H D+K N +L D++ + D G S + A+ T G+
Sbjct: 195 HGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCV 254
Query: 786 EYYGNQQLTEKSDVYSFGVVLLELISGKKP 815
E N+ + D + + ++ G
Sbjct: 255 EMLSNKPWNYQIDYFGVAATVYCMLFGTYM 284
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 3e-32
Identities = 61/205 (29%), Positives = 98/205 (47%), Gaps = 22/205 (10%)
Query: 619 KKIGKGSFGSVYYGKMKD-GKEVAVKIMA-DSCSHRTQQFVTEVALLSRIHHRNLVPLIG 676
+KIGKGSFG V+ G K VA+KI+ + + E+ +LS+ + G
Sbjct: 28 EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 87
Query: 677 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA---HDAAKGLEYLHTGCN 733
++ + ++ EY+ G+ D L L QIA + KGL+YLH +
Sbjct: 88 SYLKDTKLWIIMEYLGGGSALDLLEPGP-------LDETQIATILREILKGLDYLH---S 137
Query: 734 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVG---YLDPEYYGN 790
IHRD+K++N+LL + K++DFG++ Q LT VG ++ PE
Sbjct: 138 EKKIHRDIKAANVLLSEHGEVKLADFGVAGQ----LTDTQIKRNTFVGTPFWMAPEVIKQ 193
Query: 791 QQLTEKSDVYSFGVVLLELISGKKP 815
K+D++S G+ +EL G+ P
Sbjct: 194 SAYDSKADIWSLGITAIELARGEPP 218
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 4e-32
Identities = 59/214 (27%), Positives = 97/214 (45%), Gaps = 25/214 (11%)
Query: 619 KKIGKGSFGSVYYGKMKD-GKEVAVKIMA-DSCSHRTQQFVTEVALLSRIHHRNLVPLIG 676
+ IG G+ V ++VA+K + + C + + E+ +S+ HH N+V
Sbjct: 21 EVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYT 80
Query: 677 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDW--LTRLQIA---HDAAKGLEYLHTG 731
+ + LV + + G++ D + V + L IA + +GLEYLH
Sbjct: 81 SFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH-- 138
Query: 732 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGT-VG---YLDPE- 786
G IHRDVK+ NILL + +++DFG+S + R T VG ++ PE
Sbjct: 139 -KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEV 197
Query: 787 -----YYGNQQLTEKSDVYSFGVVLLELISGKKP 815
Y K+D++SFG+ +EL +G P
Sbjct: 198 MEQVRGYD-----FKADIWSFGITAIELATGAAP 226
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 9e-32
Identities = 43/204 (21%), Positives = 77/204 (37%), Gaps = 23/204 (11%)
Query: 620 KIGKGSFGSVYYGK--MKDGKEVAVKIMADSCSHRTQQ-FVTEVALLSRIHHRNLVPLIG 676
I G G +Y +G+ V +K + S Q + E L+ + H ++V +
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146
Query: 677 YCEEEHQRI-----LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 731
+ E + +V EY+ +L+ L + + L YLH
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLH-- 199
Query: 732 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ 791
+ G+++ D+K NI+L + K+ D G + + + GT G+ PE
Sbjct: 200 -SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSR----INSFGYLY-GTPGFQAPEIVRTG 252
Query: 792 QLTEKSDVYSFGVVLLELISGKKP 815
T +D+Y+ G L L
Sbjct: 253 P-TVATDIYTVGRTLAALTLDLPT 275
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 1e-31
Identities = 51/206 (24%), Positives = 98/206 (47%), Gaps = 18/206 (8%)
Query: 619 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 677
++G G+FG VY K K+ G A K++ + ++ E+ +L+ H +V L+G
Sbjct: 25 GELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGA 84
Query: 678 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA---HDAAKGLEYLHTGCNP 734
+ + ++ E+ G + + LT QI + L +LH+
Sbjct: 85 YYHDGKLWIMIEFCPGGAVDAIMLELDRG-----LTEPQIQVVCRQMLEALNFLHSK--- 136
Query: 735 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLT 794
IIHRD+K+ N+L+ + +++DFG+S + + L S GT ++ PE + +
Sbjct: 137 RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI-GTPYWMAPEVVMCETMK 195
Query: 795 E-----KSDVYSFGVVLLELISGKKP 815
+ K+D++S G+ L+E+ + P
Sbjct: 196 DTPYDYKADIWSLGITLIEMAQIEPP 221
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 125 bits (314), Expect = 4e-31
Identities = 24/232 (10%), Positives = 59/232 (25%), Gaps = 42/232 (18%)
Query: 619 KKIGKGSFGSVYYGKMKD-GKEVAVKIM---ADSCSHRTQQFVTEVALLSRIHHRNLVPL 674
+ + G V+ + + ++ A+K+ A++ ++ +R+ +
Sbjct: 68 EPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEA 127
Query: 675 IGYC--------------------------EEEHQRILVYEYMH--NGTLRDRLH-GSVN 705
+L+ L L V
Sbjct: 128 RDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVF 187
Query: 706 QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 765
+ L + + L + G++H N+ + + R + D +
Sbjct: 188 RGDEGILALHILTAQLIRLAANLQS---KGLVHGHFTPDNLFIMPDGRLMLGDVSALWKV 244
Query: 766 EEDLTHISSVARGTVGYLDPEYYG--NQQLTEKSDVYSFGVVLLELISGKKP 815
S V Y E+ T + + G+ + + P
Sbjct: 245 GTRGPASS----VPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP 292
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 4e-31
Identities = 60/201 (29%), Positives = 103/201 (51%), Gaps = 15/201 (7%)
Query: 619 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 677
+K+G+GS+GSVY K+ G+ VA+K + Q+ + E++++ + ++V G
Sbjct: 35 EKLGEGSYGSVYKAIHKETGQIVAIKQV--PVESDLQEIIKEISIMQQCDSPHVVKYYGS 92
Query: 678 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA---HDAAKGLEYLHTGCNP 734
+ +V EY G++ D + + K L +IA KGLEYLH
Sbjct: 93 YFKNTDLWIVMEYCGAGSVSDIIR--LRNKTLT---EDEIATILQSTLKGLEYLHFM--- 144
Query: 735 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLT 794
IHRD+K+ NILL+ AK++DFG++ Q + + ++V GT ++ PE
Sbjct: 145 RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI-GTPFWMAPEVIQEIGYN 203
Query: 795 EKSDVYSFGVVLLELISGKKP 815
+D++S G+ +E+ GK P
Sbjct: 204 CVADIWSLGITAIEMAEGKPP 224
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 5e-31
Identities = 43/222 (19%), Positives = 79/222 (35%), Gaps = 33/222 (14%)
Query: 619 KKIGKGSFGSVYYGKMK-DGKEVAVKI--MADSCSHRTQQFVTEVALLSRI-HHRNLVPL 674
+KIG G FGSV+ + DG A+K + S Q + EV + + H ++V
Sbjct: 17 EKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRY 76
Query: 675 IGYCEEEHQRILVYEYMHNGTLRDRL-HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 733
E+ ++ EY + G+L D + + +GL Y+H +
Sbjct: 77 FSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH---S 133
Query: 734 PGIIHRDVKSSNILLDIN-------------------MRAKVSDFGLSRQAEEDLTHISS 774
++H D+K SNI + + K+ D G +
Sbjct: 134 MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEE-- 191
Query: 775 VARGTVGYLDPE-YYGNQQLTEKSDVYSFGVVLLELISGKKP 815
G +L E N K+D+++ + ++ +
Sbjct: 192 ---GDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPL 230
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 125 bits (314), Expect = 7e-31
Identities = 52/220 (23%), Positives = 91/220 (41%), Gaps = 33/220 (15%)
Query: 617 FCKKIGKG--SFGSVYYGKMKD-GKEVAVKIMA-DSCSHRTQQFV-TEVALLSRIHHRNL 671
IGKG +V + K G+ V V+ + ++CS+ F+ E+ + +H N+
Sbjct: 29 LLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNI 88
Query: 672 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA---HDAAKGLEYL 728
VP +++ +V +M G+ +D + + L IA K L+Y+
Sbjct: 89 VPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDG----MNELAIAYILQGVLKALDYI 144
Query: 729 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR------GTVGY 782
H + G +HR VK+S+IL+ ++ + +S + V + +
Sbjct: 145 H---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPW 201
Query: 783 LDPE-------YYGNQQLTEKSDVYSFGVVLLELISGKKP 815
L PE Y KSD+YS G+ EL +G P
Sbjct: 202 LSPEVLQQNLQGYD-----AKSDIYSVGITACELANGHVP 236
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 1e-30
Identities = 56/232 (24%), Positives = 104/232 (44%), Gaps = 23/232 (9%)
Query: 598 DEGVAYFIPLPELEEATNNFCKKIGKGSFGSVYYGKMKD---GKEVAVKIM-ADSCSHRT 653
+ + + E+ ++G G+ G V+ K+ G +A K++ +
Sbjct: 23 QKQKVGELKDDDFEK-----ISELGAGNGGVVF--KVSHKPSGLVMARKLIHLEIKPAIR 75
Query: 654 QQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLT 713
Q + E+ +L + +V G + + + E+M G+L D++ + P L
Sbjct: 76 NQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILG 134
Query: 714 RLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL--TH 771
+ ++ KGL YL I+HRDVK SNIL++ K+ DFG+S Q + + +
Sbjct: 135 K--VSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF 190
Query: 772 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGA 823
+ GT Y+ PE + +SD++S G+ L+E+ G+ P+ D
Sbjct: 191 V-----GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKE 237
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 3e-30
Identities = 64/209 (30%), Positives = 98/209 (46%), Gaps = 20/209 (9%)
Query: 616 NFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMA---DSCSHRTQQFVTEVALLSRIHHRNL 671
+ +GKGSFG V K K G+E AVK+++ + + EV LL ++ H N+
Sbjct: 29 KGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNI 88
Query: 672 VPLIGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLH 729
+ L + E++ LV E G L D + ++ + R Q+ G+ Y+H
Sbjct: 89 MKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIR-QV----LSGITYMH 143
Query: 730 TGCNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE 786
I+HRD+K N+LL + ++ DFGLS E + GT Y+ PE
Sbjct: 144 ---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKI--GTAYYIAPE 198
Query: 787 YYGNQQLTEKSDVYSFGVVLLELISGKKP 815
+ EK DV+S GV+L L+SG P
Sbjct: 199 VL-HGTYDEKCDVWSTGVILYILLSGCPP 226
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 4e-30
Identities = 58/216 (26%), Positives = 96/216 (44%), Gaps = 31/216 (14%)
Query: 619 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIG 676
+ +G G++G VY G+ G+ A+K+M D ++ E+ +L + HHRN+ G
Sbjct: 30 ELVGNGTYGQVYKGRHVKTGQLAAIKVM-DVTGDEEEEIKQEINMLKKYSHHRNIATYYG 88
Query: 677 ------YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA---HDAAKGLEY 727
+ Q LV E+ G++ D + + L IA + +GL +
Sbjct: 89 AFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNT----LKEEWIAYICREILRGLSH 144
Query: 728 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVG---YLD 784
LH +IHRD+K N+LL N K+ DFG+S Q L +G ++
Sbjct: 145 LH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ----LDRTVGRRNTFIGTPYWMA 197
Query: 785 PEYYGNQQLTE-----KSDVYSFGVVLLELISGKKP 815
PE + + KSD++S G+ +E+ G P
Sbjct: 198 PEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 233
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 4e-30
Identities = 41/272 (15%), Positives = 88/272 (32%), Gaps = 61/272 (22%)
Query: 619 KKIGKGSFGSVYYGK-MKDGKEVAVKIM------ADSCSHRTQQFVTEVALLSRIHH--- 668
+G+ + + G+ V + + + ++ V + LL I +
Sbjct: 79 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 138
Query: 669 -----RNLVPLIGYCEEEHQRI----------------LVYEYMH--NGTLRDRL-HGSV 704
R + P + + +++ +Y M T + L S
Sbjct: 139 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 198
Query: 705 NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 764
K L RLQ+ + L LH + G++H ++ +I+LD ++ F +
Sbjct: 199 THKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVR 255
Query: 765 AEEDLTHISSVARGTVGYLDPEY-----------YGNQQLTEKSDVYSFGVVLLELISGK 813
+ + + G+ PE +T D ++ G+V+ +
Sbjct: 256 DGARVV-----SSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310
Query: 814 KP--------VSVEDFGAELNIVHWARSMIKK 837
P S F + NI R++++
Sbjct: 311 LPITKDAALGGSEWIFRSCKNIPQPVRALLEG 342
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 6e-30
Identities = 59/214 (27%), Positives = 101/214 (47%), Gaps = 31/214 (14%)
Query: 619 KKIGKGSFGSVYYGKMKD---GKEVAVKIM-ADSCSHRTQQFVTEVA-LLSRIHHRNLVP 673
++G+G++G V KM+ G+ +AVK + A S ++ + ++ + + V
Sbjct: 13 MELGRGAYGVVE--KMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVT 70
Query: 674 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQK----PLDWLTRLQIAHDAAKGLEYLH 729
G E + E M + +L D+ + V K P D L + IA K LE+LH
Sbjct: 71 FYGALFREGDVWICMELM-DTSL-DKFYKQVIDKGQTIPEDILGK--IAVSIVKALEHLH 126
Query: 730 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR----GTVGYLDP 785
+ +IHRDVK SN+L++ + K+ DFG+S + VA+ G Y+ P
Sbjct: 127 S--KLSVIHRDVKPSNVLINALGQVKMCDFGISGYL------VDDVAKDIDAGCKPYMAP 178
Query: 786 E----YYGNQQLTEKSDVYSFGVVLLELISGKKP 815
E + + KSD++S G+ ++EL + P
Sbjct: 179 ERINPELNQKGYSVKSDIWSLGITMIELAILRFP 212
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 7e-30
Identities = 62/207 (29%), Positives = 99/207 (47%), Gaps = 19/207 (9%)
Query: 617 FCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVP 673
KK+G G++G V + K E A+KI+ + + + + EVA+L + H N++
Sbjct: 41 RVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMK 100
Query: 674 LIGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 731
L + E++ LV E G L D + N+ + + Q+ G+ YLH
Sbjct: 101 LYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIK-QV----LSGVTYLH-- 153
Query: 732 CNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY 788
I+HRD+K N+LL + + K+ DFGLS E + GT Y+ PE
Sbjct: 154 -KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERL--GTAYYIAPEVL 210
Query: 789 GNQQLTEKSDVYSFGVVLLELISGKKP 815
++ EK DV+S GV+L L++G P
Sbjct: 211 -RKKYDEKCDVWSIGVILFILLAGYPP 236
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-29
Identities = 60/249 (24%), Positives = 90/249 (36%), Gaps = 53/249 (21%)
Query: 617 FCKKIGKGSFGSVYYGKMKD-GKEVAVKI-----MADSCSHRTQQFVTEVALLSRIHHRN 670
IG+GS+G V A+KI + ++ TEV L+ ++HH N
Sbjct: 30 LKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPN 89
Query: 671 LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAH----------- 719
+ L E+E LV E H G L D+L+ ++ +
Sbjct: 90 IARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEA 149
Query: 720 -------------------DAAK-------GLEYLHTGCNPGIIHRDVKSSNILL--DIN 751
+ L YLH N GI HRD+K N L + +
Sbjct: 150 INGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH---NQGICHRDIKPENFLFSTNKS 206
Query: 752 MRAKVSDFGLSRQAEEDLTHISSVAR---GTVGYLDPE--YYGNQQLTEKSDVYSFGVVL 806
K+ DFGLS++ + GT ++ PE N+ K D +S GV+L
Sbjct: 207 FEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLL 266
Query: 807 LELISGKKP 815
L+ G P
Sbjct: 267 HLLLMGAVP 275
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-29
Identities = 61/206 (29%), Positives = 101/206 (49%), Gaps = 17/206 (8%)
Query: 616 NFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPL 674
F + +G G+F V+ K + GK A+K + S + R E+A+L +I H N+V L
Sbjct: 12 IFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTL 71
Query: 675 IGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 732
E LV + + G L DR+ G +K + + Q+ ++YLH
Sbjct: 72 EDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQ-QV----LSAVKYLH--- 123
Query: 733 NPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYG 789
GI+HRD+K N+L + N + ++DFGLS+ + + +S+ GT GY+ PE
Sbjct: 124 ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI--MSTAC-GTPGYVAPEVLA 180
Query: 790 NQQLTEKSDVYSFGVVLLELISGKKP 815
+ ++ D +S GV+ L+ G P
Sbjct: 181 QKPYSKAVDCWSIGVITYILLCGYPP 206
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 4e-29
Identities = 59/218 (27%), Positives = 98/218 (44%), Gaps = 30/218 (13%)
Query: 617 FCKKIGKGSFGSVYYGKMK-DGKEVAVKI-------------MADSCSHRTQQFVTEVAL 662
+K+G G++G V K K E A+K+ + ++ E++L
Sbjct: 40 KVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISL 99
Query: 663 LSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHD 720
L + H N++ L E++ LV E+ G L +++ ++ + + QI
Sbjct: 100 LKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMK-QI--- 155
Query: 721 AAKGLEYLHTGCNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVAR 777
G+ YLH I+HRD+K NILL + + K+ DFGLS +D +
Sbjct: 156 -LSGICYLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRL-- 209
Query: 778 GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 815
GT Y+ PE ++ EK DV+S GV++ L+ G P
Sbjct: 210 GTAYYIAPEVL-KKKYNEKCDVWSCGVIMYILLCGYPP 246
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 4e-29
Identities = 59/238 (24%), Positives = 99/238 (41%), Gaps = 34/238 (14%)
Query: 619 KKIGKGSFGSVYYGKMKD-GKEVAVKIMA--------DSCSHRTQQFVTEVALLSRIHHR 669
K +G G+ G V + K+VA++I++ + TE+ +L +++H
Sbjct: 141 KTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHP 200
Query: 670 NLVPLIGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEY 727
++ + + + E +V E M G L D++ + + + Q+ ++Y
Sbjct: 201 CIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFY-QMLL----AVQY 254
Query: 728 LHTGCNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLD 784
LH GIIHRD+K N+LL + + K++DFG S+ E + GT YL
Sbjct: 255 LH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLC--GTPTYLA 309
Query: 785 PE---YYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD 839
PE G D +S GV+L +SG P S L + I G
Sbjct: 310 PEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL------KDQITSGK 361
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 4e-29
Identities = 68/207 (32%), Positives = 100/207 (48%), Gaps = 24/207 (11%)
Query: 619 KKIGKGSFGSVYYGKMKD-GKEVAVKIM---ADSCSHRTQQFVTEVALLSRIHHRNLVPL 674
++IG GSFG+VY+ + + VA+K M + + Q + EV L ++ H N +
Sbjct: 60 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 119
Query: 675 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA---HDAAKGLEYLHTG 731
G EH LV EY G+ D L V++KPL ++IA H A +GL YLH+
Sbjct: 120 RGCYLREHTAWLVMEYC-LGSASDLLE--VHKKPLQ---EVEIAAVTHGALQGLAYLHSH 173
Query: 732 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ 791
+IHRDVK+ NILL K+ DFG + + + GT ++ PE
Sbjct: 174 ---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV-----GTPYWMAPEVILAM 225
Query: 792 QLTE---KSDVYSFGVVLLELISGKKP 815
+ K DV+S G+ +EL K P
Sbjct: 226 DEGQYDGKVDVWSLGITCIELAERKPP 252
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 5e-29
Identities = 28/236 (11%), Positives = 66/236 (27%), Gaps = 42/236 (17%)
Query: 619 KKIGKGSFGSVYYGKMK-DGKEVAVKIM------ADSCSHRTQQFVTEVALLSRIHHRNL 671
+G+ + + G+ V + + + ++ V + LL I ++
Sbjct: 84 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 143
Query: 672 ------------------VPLIGYCEEEHQRILVYEY--------MHNGTLRDRLHGSV- 704
+ + + + V + T + L
Sbjct: 144 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 203
Query: 705 NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 764
K L RLQ+ + L LH + G++H ++ +I+LD ++ F +
Sbjct: 204 THKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVR 260
Query: 765 AEEDLTHISSVARGTVGYLDPE-----YYGNQQLTEKSDVYSFGVVLLELISGKKP 815
+ +T D ++ G+ + + P
Sbjct: 261 DGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP 316
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 5e-29
Identities = 59/216 (27%), Positives = 96/216 (44%), Gaps = 29/216 (13%)
Query: 619 KKIGKGSFGSVYYGKMKD-GKEVAVKIM---------ADSCSHRTQQFVTEVALLSRI-H 667
+ +G+G V K KE AVKI+ A+ + + EV +L ++
Sbjct: 23 EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSG 82
Query: 668 HRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGL 725
H N++ L E LV++ M G L D L ++++K + R + + +
Sbjct: 83 HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMR-ALL----EVI 137
Query: 726 EYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDP 785
LH I+HRD+K NILLD +M K++DFG S Q + GT YL P
Sbjct: 138 CALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVC--GTPSYLAP 192
Query: 786 E------YYGNQQLTEKSDVYSFGVVLLELISGKKP 815
E + ++ D++S GV++ L++G P
Sbjct: 193 EIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 9e-29
Identities = 60/214 (28%), Positives = 95/214 (44%), Gaps = 30/214 (14%)
Query: 619 KKIGKGSFGSVYYGKMKD---GKEVAVKIM-ADSCSHRTQQFVTEVA-LLSRIHHRNLVP 673
+IG+G++GSV KM G+ +AVK + + +Q + ++ ++ +V
Sbjct: 28 GEIGRGAYGSVN--KMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQ 85
Query: 674 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQK----PLDWLTRLQIAHDAAKGLEYLH 729
G E + E M + + + P + L + I K L +L
Sbjct: 86 FYGALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILGK--ITLATVKALNHLK 142
Query: 730 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR----GTVGYLDP 785
N IIHRD+K SNILLD + K+ DFG+S Q + S+A+ G Y+ P
Sbjct: 143 E--NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQL------VDSIAKTRDAGCRPYMAP 194
Query: 786 E----YYGNQQLTEKSDVYSFGVVLLELISGKKP 815
E Q +SDV+S G+ L EL +G+ P
Sbjct: 195 ERIDPSASRQGYDVRSDVWSLGITLYELATGRFP 228
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-28
Identities = 48/210 (22%), Positives = 81/210 (38%), Gaps = 25/210 (11%)
Query: 616 NFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPL 674
IG+GS+G V K A K + +F E+ ++ + H N++ L
Sbjct: 12 TLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRL 71
Query: 675 IGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 732
E+ LV E G L +R+ + + + + + Y H
Sbjct: 72 YETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMK-DV----LSAVAYCH--- 123
Query: 733 NPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE--- 786
+ HRD+K N L + K+ DFGL+ + + + V GT Y+ P+
Sbjct: 124 KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKV--GTPYYVSPQVLE 181
Query: 787 -YYGNQQLTEKSDVYSFGVVLLELISGKKP 815
YG + D +S GV++ L+ G P
Sbjct: 182 GLYG-----PECDEWSAGVMMYVLLCGYPP 206
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-28
Identities = 63/208 (30%), Positives = 98/208 (47%), Gaps = 19/208 (9%)
Query: 616 NFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLV 672
N +GKGSFG V K + +E AVK++ + + T + EV LL ++ H N++
Sbjct: 25 NIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIM 84
Query: 673 PLIGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 730
L E+ +V E G L D + ++ + + Q+ G+ Y+H
Sbjct: 85 KLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIK-QV----FSGITYMH- 138
Query: 731 GCNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 787
I+HRD+K NILL + + K+ DFGLS +++ + GT Y+ PE
Sbjct: 139 --KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI--GTAYYIAPEV 194
Query: 788 YGNQQLTEKSDVYSFGVVLLELISGKKP 815
EK DV+S GV+L L+SG P
Sbjct: 195 L-RGTYDEKCDVWSAGVILYILLSGTPP 221
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-28
Identities = 60/238 (25%), Positives = 99/238 (41%), Gaps = 36/238 (15%)
Query: 594 GHFMDEGVAYFIPLPELEEATNNFCKKIGKGSFGSVYYGKMKD---GKEVAVKIM-ADSC 649
G+ G Y + +LE ++G G+ G V+ KM+ G +AVK M
Sbjct: 11 GYLTIGGQRYQAEINDLEN-----LGEMGSGTCGQVW--KMRFRKTGHVIAVKQMRRSGN 63
Query: 650 SHRTQQFVTEVA-LLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRD--RLHGSVNQ 706
++ + ++ +L +V G + E M + R+ G + +
Sbjct: 64 KEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPE 123
Query: 707 KPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 766
+ L ++ K L YL G+IHRDVK SNILLD + K+ DFG+S +
Sbjct: 124 RILG-----KMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGQIKLCDFGISGRL- 175
Query: 767 EDLTHISSVAR----GTVGYLDPE-----YYGNQQLTEKSDVYSFGVVLLELISGKKP 815
+ A+ G Y+ PE ++DV+S G+ L+EL +G+ P
Sbjct: 176 -----VDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFP 228
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 2e-28
Identities = 55/212 (25%), Positives = 98/212 (46%), Gaps = 24/212 (11%)
Query: 616 NFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMA-DSCSHRTQQFVTEVALLSRIHHRNLVP 673
F +K+G G+FG V+ + + G E +K + D +Q E+ +L + H N++
Sbjct: 25 IFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIK 84
Query: 674 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK-------GLE 726
+ E+ H +V E G L +R+ + + L+ A+ L
Sbjct: 85 IFEVFEDYHNMYIVMETCEGGELLERIVSAQARG--KALSE----GYVAELMKQMMNALA 138
Query: 727 YLHTGCNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYL 783
Y H + ++H+D+K NIL + K+ DFGL+ + D ++ GT Y+
Sbjct: 139 YFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAA--GTALYM 193
Query: 784 DPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 815
PE + + +T K D++S GVV+ L++G P
Sbjct: 194 APEVF-KRDVTFKCDIWSAGVVMYFLLTGCLP 224
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 3e-28
Identities = 64/212 (30%), Positives = 99/212 (46%), Gaps = 27/212 (12%)
Query: 616 NFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLV 672
N +GKGSFG V K + +E AVK++ + + T + EV LL ++ H N++
Sbjct: 25 NIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIM 84
Query: 673 PLIGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 730
L E+ +V E G L D + ++ + + Q+ G+ Y+H
Sbjct: 85 KLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIK-QV----FSGITYMH- 138
Query: 731 GCNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE- 786
I+HRD+K NILL + + K+ DFGLS +++ + GT Y+ PE
Sbjct: 139 --KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI--GTAYYIAPEV 194
Query: 787 ---YYGNQQLTEKSDVYSFGVVLLELISGKKP 815
Y EK DV+S GV+L L+SG P
Sbjct: 195 LRGTYD-----EKCDVWSAGVILYILLSGTPP 221
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 6e-28
Identities = 53/217 (24%), Positives = 86/217 (39%), Gaps = 30/217 (13%)
Query: 617 FCKKIGKGSFGSVYYGKMKD-GKEVAVKI-----MADSCSHRTQQFVTEVALLSRIHHRN 670
C+ IGKG F V ++ G++ AVKI S T+ E ++ + H +
Sbjct: 28 LCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPH 87
Query: 671 LVPLIGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAK----- 723
+V L+ + +V+E+M L + + A+
Sbjct: 88 IVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFV----YSE----AVASHYMRQI 139
Query: 724 --GLEYLHTGCNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVARG 778
L Y H + IIHRDVK +LL + + K+ FG++ Q E G
Sbjct: 140 LEALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV-G 195
Query: 779 TVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 815
T ++ PE + + DV+ GV+L L+SG P
Sbjct: 196 TPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLP 232
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 1e-27
Identities = 59/228 (25%), Positives = 100/228 (43%), Gaps = 19/228 (8%)
Query: 619 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIG 676
K +G+GSF K + AVKI++ TQ+ E+ L H N+V L
Sbjct: 17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQK---EITALKLCEGHPNIVKLHE 73
Query: 677 YCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 734
++ LV E ++ G L +R+ ++ ++ R ++ + ++H +
Sbjct: 74 VFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMR-KL----VSAVSHMH---DV 125
Query: 735 GIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ 791
G++HRD+K N+L + N+ K+ DFG +R D + + T+ Y PE
Sbjct: 126 GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC-FTLHYAAPELLNQN 184
Query: 792 QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD 839
E D++S GV+L ++SG+ P D IKKGD
Sbjct: 185 GYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGD 232
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 1e-27
Identities = 56/208 (26%), Positives = 95/208 (45%), Gaps = 18/208 (8%)
Query: 616 NFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMA-DSCSHRTQQFV-TEVALLSRIHHRNLV 672
+ +++GKG+F V K G E A KI+ S R Q + E + ++ H N+V
Sbjct: 9 DVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIV 68
Query: 673 PLIGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 730
L +EE LV++ + G L + + ++ + QI + + Y H
Sbjct: 69 RLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQ-QI----LESIAYCH- 122
Query: 731 GCNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 787
+ GI+HR++K N+LL K++DFGL+ + + GT GYL PE
Sbjct: 123 --SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA--GTPGYLSPEV 178
Query: 788 YGNQQLTEKSDVYSFGVVLLELISGKKP 815
++ D+++ GV+L L+ G P
Sbjct: 179 LKKDPYSKPVDIWACGVILYILLVGYPP 206
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 3e-27
Identities = 60/215 (27%), Positives = 95/215 (44%), Gaps = 28/215 (13%)
Query: 619 KKIGKGSFGSVYYGKMKD-GKEVAVKIMA--------DSCSHRTQQFVTEVALLSRIH-H 668
IG+G V + G E AVKIM + + E +L ++ H
Sbjct: 100 DVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGH 159
Query: 669 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLE 726
+++ LI E LV++ M G L D L ++++K + R + + +
Sbjct: 160 PHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMR-SLL----EAVS 214
Query: 727 YLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE 786
+LH I+HRD+K NILLD NM+ ++SDFG S E GT GYL PE
Sbjct: 215 FLH---ANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELC--GTPGYLAPE 269
Query: 787 ------YYGNQQLTEKSDVYSFGVVLLELISGKKP 815
+ ++ D+++ GV+L L++G P
Sbjct: 270 ILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPP 304
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 3e-27
Identities = 48/206 (23%), Positives = 98/206 (47%), Gaps = 16/206 (7%)
Query: 616 NFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPL 674
+ +++G G+FG V+ K G+ K + E+++++++HH L+ L
Sbjct: 54 DILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINL 113
Query: 675 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAH---DAAKGLEYLHTG 731
E++++ +L+ E++ G L DR+ + ++ ++ + A +GL+++H
Sbjct: 114 HDAFEDKYEMVLILEFLSGGELFDRI---AAED--YKMSEAEVINYMRQACEGLKHMH-- 166
Query: 732 CNPGIIHRDVKSSNILL--DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYG 789
I+H D+K NI+ K+ DFGL+ + D I V T + PE
Sbjct: 167 -EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD--EIVKVTTATAEFAAPEIVD 223
Query: 790 NQQLTEKSDVYSFGVVLLELISGKKP 815
+ + +D+++ GV+ L+SG P
Sbjct: 224 REPVGFYTDMWAIGVLGYVLLSGLSP 249
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 4e-27
Identities = 56/213 (26%), Positives = 94/213 (44%), Gaps = 23/213 (10%)
Query: 616 NFCKKIGKGSFGSVYYGKMKD-GKEVAVKIM------ADSCSHRTQQFVTEVALLSRIHH 668
+ +++G G F V + K G E A K + A ++ EV++L ++ H
Sbjct: 15 DIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLH 74
Query: 669 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLE 726
N++ L E +L+ E + G L D L S++++ + QI G+
Sbjct: 75 HNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIK-QI----LDGVN 129
Query: 727 YLHTGCNPGIIHRDVKSSNILL----DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGY 782
YLH I H D+K NI+L K+ DFGL+ + E+ GT +
Sbjct: 130 YLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG--VEFKNIFGTPEF 184
Query: 783 LDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 815
+ PE + L ++D++S GV+ L+SG P
Sbjct: 185 VAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 4e-27
Identities = 58/234 (24%), Positives = 100/234 (42%), Gaps = 50/234 (21%)
Query: 619 KKIGKGSFGSVYYGK-MKDGKEVAVKIM--------ADSCSHRTQQFVT----------- 658
+IGKGS+G V D A+K++ A +
Sbjct: 19 DEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRG 78
Query: 659 -------EVALLSRIHHRNLVPLIGYCEEEHQR--ILVYEYMHNGTLRDRLHGSVNQKPL 709
E+A+L ++ H N+V L+ ++ ++ +V+E ++ G + + KPL
Sbjct: 79 PIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEV----PTLKPL 134
Query: 710 DWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 769
D KG+EYLH IIHRD+K SN+L+ + K++DFG+S + +
Sbjct: 135 SEDQARFYFQDLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSD 191
Query: 770 THISSVARGTVGYLDPE--------YYGNQQLTEKSDVYSFGVVLLELISGKKP 815
+S+ GT ++ PE + G + DV++ GV L + G+ P
Sbjct: 192 ALLSNTV-GTPAFMAPESLSETRKIFSG-----KALDVWAMGVTLYCFVFGQCP 239
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 5e-27
Identities = 60/238 (25%), Positives = 99/238 (41%), Gaps = 34/238 (14%)
Query: 619 KKIGKGSFGSVYYGKMKD-GKEVAVKIMA--------DSCSHRTQQFVTEVALLSRIHHR 669
K +G G+ G V + K+VA+KI++ + TE+ +L +++H
Sbjct: 16 KTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHP 75
Query: 670 NLVPLIGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEY 727
++ + + + E +V E M G L D++ + + + Q+ ++Y
Sbjct: 76 CIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFY-QML----LAVQY 129
Query: 728 LHTGCNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLD 784
LH GIIHRD+K N+LL + + K++DFG S+ E + GT YL
Sbjct: 130 LH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLC--GTPTYLA 184
Query: 785 PE---YYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD 839
PE G D +S GV+L +SG P S L + I G
Sbjct: 185 PEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL------KDQITSGK 236
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 6e-27
Identities = 51/207 (24%), Positives = 90/207 (43%), Gaps = 17/207 (8%)
Query: 617 FCKKIGKGSFGSVYYGKMKD-GKEVAVKIM--ADSCSHRTQQFVTEVALLSRIHHRNLVP 673
+++GKG+F V G+E A I+ + Q+ E + + H N+V
Sbjct: 15 LFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVR 74
Query: 674 LIGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 731
L EE L+++ + G L + + ++ + QI + + + H
Sbjct: 75 LHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQ-QI----LEAVLHCH-- 127
Query: 732 CNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY 788
G++HR++K N+LL K++DFGL+ + E + A GT GYL PE
Sbjct: 128 -QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA-GTPGYLSPEVL 185
Query: 789 GNQQLTEKSDVYSFGVVLLELISGKKP 815
+ D+++ GV+L L+ G P
Sbjct: 186 RKDPYGKPVDLWACGVILYILLVGYPP 212
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 7e-27
Identities = 58/215 (26%), Positives = 93/215 (43%), Gaps = 26/215 (12%)
Query: 619 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIG 676
+G+G+ V +E AVKI+ H + EV +L + HRN++ LI
Sbjct: 19 DVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIE 78
Query: 677 YCEEEHQRILVYEYMHNGTLRDRLH--GSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 734
+ EEE + LV+E M G++ +H N+ + + + A L++LH N
Sbjct: 79 FFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQ-DV----ASALDFLH---NK 130
Query: 735 GIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVAR------GTVGYLDP 785
GI HRD+K NIL + K+ DF L + + G+ Y+ P
Sbjct: 131 GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAP 190
Query: 786 E-----YYGNQQLTEKSDVYSFGVVLLELISGKKP 815
E ++ D++S GV+L L+SG P
Sbjct: 191 EVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP 225
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 7e-27
Identities = 58/213 (27%), Positives = 93/213 (43%), Gaps = 23/213 (10%)
Query: 616 NFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMA------DSCSHRTQQFVTEVALLSRIHH 668
+++G G F V + K GKE A K + ++ EV +L I H
Sbjct: 8 EMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRH 67
Query: 669 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLE 726
N++ L E + +L+ E + G L D L S+ + + QI G+
Sbjct: 68 PNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLK-QI----LDGVH 122
Query: 727 YLHTGCNPGIIHRDVKSSNILL----DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGY 782
YLH + I H D+K NI+L N R K+ DFG++ + E + GT +
Sbjct: 123 YLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAG--NEFKNIFGTPEF 177
Query: 783 LDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 815
+ PE + L ++D++S GV+ L+SG P
Sbjct: 178 VAPEIVNYEPLGLEADMWSIGVITYILLSGASP 210
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 9e-27
Identities = 50/267 (18%), Positives = 90/267 (33%), Gaps = 73/267 (27%)
Query: 619 KKIGKGSFGSVYYGKMK-DG-----KEVA--------------VKIMA------------ 646
+ +G+G FG V+ K K D K + VK +A
Sbjct: 12 QCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFN 71
Query: 647 ---------------------------DSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCE 679
S ++ + +N V +
Sbjct: 72 AWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSS 131
Query: 680 EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHR 739
+ + + L+D ++ + + + L I A+ +E+LH + G++HR
Sbjct: 132 PKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLH---SKGLMHR 188
Query: 740 DVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR-----------GTVGYLDPEYY 788
D+K SNI ++ KV DFGL ++D + + GT Y+ PE
Sbjct: 189 DLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQI 248
Query: 789 GNQQLTEKSDVYSFGVVLLELISGKKP 815
+ K D++S G++L EL+
Sbjct: 249 HGNNYSHKVDIFSLGLILFELLYSFST 275
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 9e-27
Identities = 56/213 (26%), Positives = 93/213 (43%), Gaps = 23/213 (10%)
Query: 616 NFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMA------DSCSHRTQQFVTEVALLSRIHH 668
+ +++G G F V + K G + A K + + EV++L I H
Sbjct: 14 DTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQH 73
Query: 669 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLE 726
N++ L E + IL+ E + G L D L S+ ++ + QI G+
Sbjct: 74 PNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLK-QI----LNGVY 128
Query: 727 YLHTGCNPGIIHRDVKSSNILL----DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGY 782
YLH + I H D+K NI+L R K+ DFGL+ + + + GT +
Sbjct: 129 YLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF--GTPEF 183
Query: 783 LDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 815
+ PE + L ++D++S GV+ L+SG P
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 1e-26
Identities = 56/207 (27%), Positives = 94/207 (45%), Gaps = 18/207 (8%)
Query: 617 FCKKIGKGSFGSVYYGKMKD-GKEVAVKIMA-DSCSHRTQQFV-TEVALLSRIHHRNLVP 673
+++GKG+F V K G E A KI+ S R Q + E + ++ H N+V
Sbjct: 33 VKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVR 92
Query: 674 LIGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 731
L +EE LV++ + G L + + ++ + QI + + Y H
Sbjct: 93 LHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQ-QI----LESIAYCH-- 145
Query: 732 CNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY 788
+ GI+HR++K N+LL K++DFGL+ + + GT GYL PE
Sbjct: 146 -SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA--GTPGYLSPEVL 202
Query: 789 GNQQLTEKSDVYSFGVVLLELISGKKP 815
++ D+++ GV+L L+ G P
Sbjct: 203 KKDPYSKPVDIWACGVILYILLVGYPP 229
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 1e-26
Identities = 50/206 (24%), Positives = 93/206 (45%), Gaps = 16/206 (7%)
Query: 616 NFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPL 674
+ +++G G+FG V+ + G A K + + E+ +S + H LV L
Sbjct: 160 DIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNL 219
Query: 675 IGYCEEEHQRILVYEYMHNGTLRDRL---HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 731
E++++ +++YE+M G L +++ H +++ R Q+ KGL ++H
Sbjct: 220 HDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMR-QV----CKGLCHMH-- 272
Query: 732 CNPGIIHRDVKSSNILLDINMRA--KVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYG 789
+H D+K NI+ K+ DFGL+ + V GT + PE
Sbjct: 273 -ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK--QSVKVTTGTAEFAAPEVAE 329
Query: 790 NQQLTEKSDVYSFGVVLLELISGKKP 815
+ + +D++S GV+ L+SG P
Sbjct: 330 GKPVGYYTDMWSVGVLSYILLSGLSP 355
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 3e-26
Identities = 57/222 (25%), Positives = 96/222 (43%), Gaps = 28/222 (12%)
Query: 616 NFCKKIGKGSFGSVYYGKMKD-GKEVAVKIM------ADSCSHRTQQFVTEVALLSRIHH 668
+ +++G G F V + K G E A K + A ++ EV++L ++ H
Sbjct: 15 DIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLH 74
Query: 669 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLE 726
N++ L E +L+ E + G L D L S++++ + QI G+
Sbjct: 75 PNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIK-QI----LDGVN 129
Query: 727 YLHTGCNPGIIHRDVKSSNILL----DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGY 782
YLH I H D+K NI+L K+ DFGL+ + E+ GT +
Sbjct: 130 YLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG--VEFKNIFGTPEF 184
Query: 783 LDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAE 824
+ PE + L ++D++S GV+ L+SG P F +
Sbjct: 185 VAPEIVNYEPLGLEADMWSIGVITYILLSGASP-----FLGD 221
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 3e-26
Identities = 43/207 (20%), Positives = 92/207 (44%), Gaps = 19/207 (9%)
Query: 616 NFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFV-TEVALLSRIHHRNLVP 673
+ +G+G FG V+ K K + Q V E+++L+ HRN++
Sbjct: 8 MIAEDLGRGEFGIVHRCVETSSKKTYMAKFV--KVKGTDQVLVKKEISILNIARHRNILH 65
Query: 674 LIGYCEEEHQRILVYEYMHNGTLRDRL---HGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 730
L E + ++++E++ + +R+ +N++ + Q+ + L++LH
Sbjct: 66 LHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVH-QV----CEALQFLH- 119
Query: 731 GCNPGIIHRDVKSSNILL--DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY 788
+ I H D++ NI+ + K+ +FG +RQ + + Y PE +
Sbjct: 120 --SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG--DNFRLLFTAPEYYAPEVH 175
Query: 789 GNQQLTEKSDVYSFGVVLLELISGKKP 815
+ ++ +D++S G ++ L+SG P
Sbjct: 176 QHDVVSTATDMWSLGTLVYVLLSGINP 202
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 6e-26
Identities = 60/222 (27%), Positives = 94/222 (42%), Gaps = 45/222 (20%)
Query: 619 KKIGKGSFGSVYYGK-MKDGKEVAVKIMA----DSCSHRTQQFVTEVALLSRIHHRNLVP 673
+G+GS+G V + AVKI+ + E+ LL R+ H+N++
Sbjct: 11 DLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQ 70
Query: 674 L--IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK-------G 724
L + Y EE+ + +V EY G + SV +K R + A G
Sbjct: 71 LVDVLYNEEKQKMYMVMEYCVCGM--QEMLDSVPEK------RFPV-CQAHGYFCQLIDG 121
Query: 725 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS----RQAEEDLTHISSVARGTV 780
LEYLH + GI+H+D+K N+LL K+S G++ A +D S G+
Sbjct: 122 LEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQ---GSP 175
Query: 781 GYLDPE-------YYGNQQLTEKSDVYSFGVVLLELISGKKP 815
+ PE + G K D++S GV L + +G P
Sbjct: 176 AFQPPEIANGLDTFSG-----FKVDIWSAGVTLYNITTGLYP 212
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 9e-26
Identities = 57/257 (22%), Positives = 100/257 (38%), Gaps = 52/257 (20%)
Query: 619 KKIGKGSFGSVYYGK-MKDGKEVAVKIM--------ADSCSHRTQQFVTEVALLSRIHHR 669
+G G+FG V+ + KEV VK + + + E+A+LSR+ H
Sbjct: 30 SPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHA 89
Query: 670 NLVPLIGYCEEEHQRILVYEYMHNGT-LRDRL--HGSVNQKPLDWLTRL---QIAHDAAK 723
N++ ++ E + LV E +G L + H +++ L Q+
Sbjct: 90 NIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEP----LASYIFRQLVS---- 141
Query: 724 GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYL 783
+ YL IIHRD+K NI++ + K+ DFG + E + GT+ Y
Sbjct: 142 AVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERG--KLFYTFCGTIEYC 196
Query: 784 DPE------YYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDF----GAELNIVHW--- 830
PE Y G + +++S GV L L+ + P + A ++ +
Sbjct: 197 APEVLMGNPYRG-----PELEMWSLGVTLYTLVFEENP--FCELEETVEAAIHPPYLVSK 249
Query: 831 -ARSMIKKGDVISIVDP 846
S++ + P
Sbjct: 250 ELMSLVSG---LLQPVP 263
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 60/216 (27%), Positives = 95/216 (43%), Gaps = 40/216 (18%)
Query: 619 KKIGKGSFGSVYYGK-MKDGKEVAVKIMA-DSCSHRTQQFVTEVALLSRIHHRNLVPLIG 676
+ +G+G++G V + VAVKI+ + E+ + ++H N+V G
Sbjct: 13 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 677 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK-------GLEYLH 729
+ E + + L EY G L DR+ + DA + G+ YLH
Sbjct: 73 HRREGNIQYLFLEYCSGGELFDRI---EPDIGMP-------EPDAQRFFHQLMAGVVYLH 122
Query: 730 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS----RQAEEDLTHISSVARGTVGYLDP 785
GI HRD+K N+LLD K+SDFGL+ E L + GT+ Y+ P
Sbjct: 123 ---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC---GTLPYVAP 176
Query: 786 E------YYGNQQLTEKSDVYSFGVVLLELISGKKP 815
E ++ E DV+S G+VL +++G+ P
Sbjct: 177 ELLKRREFHA-----EPVDVWSCGIVLTAMLAGELP 207
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 2e-25
Identities = 54/222 (24%), Positives = 89/222 (40%), Gaps = 36/222 (16%)
Query: 619 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQ----QFVTEVALLSRI-HHRNLV 672
K++G+G F V K G+E A K + R Q + + E+A+L ++
Sbjct: 35 KELGRGKFAVVRQCISKSTGQEYAAKFL--KKRRRGQDCRAEILHEIAVLELAKSCPRVI 92
Query: 673 PLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK-------GL 725
L E + IL+ EY G + + + ++ +D + G+
Sbjct: 93 NLHEVYENTSEIILILEYAAGGEIFSL----CLPELAEMVSE----NDVIRLIKQILEGV 144
Query: 726 EYLHTGCNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGY 782
YLH I+H D+K NILL K+ DFG+SR+ GT Y
Sbjct: 145 YYLH---QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHA--CELREIMGTPEY 199
Query: 783 LDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAE 824
L PE +T +D+++ G++ L++ P F E
Sbjct: 200 LAPEILNYDPITTATDMWNIGIIAYMLLTHTSP-----FVGE 236
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 4e-25
Identities = 67/208 (32%), Positives = 98/208 (47%), Gaps = 26/208 (12%)
Query: 619 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLI 675
K IGKG+F V + + G+EVA+KI+ + Q+ EV ++ ++H N+V L
Sbjct: 21 KTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLF 80
Query: 676 GYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 733
E E L+ EY G + D L HG + +K R QI ++Y H
Sbjct: 81 EVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFR-QIVS----AVQYCH---Q 132
Query: 734 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE------Y 787
I+HRD+K+ N+LLD +M K++DFG S + G Y PE Y
Sbjct: 133 KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG--GKLDAFCGAPPYAAPELFQGKKY 190
Query: 788 YGNQQLTEKSDVYSFGVVLLELISGKKP 815
G + DV+S GV+L L+SG P
Sbjct: 191 DG-----PEVDVWSLGVILYTLVSGSLP 213
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 5e-25
Identities = 56/207 (27%), Positives = 99/207 (47%), Gaps = 24/207 (11%)
Query: 619 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 677
+ +G G FG V+ + G ++A KI+ ++ E+++++++ H NL+ L
Sbjct: 95 EILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDA 154
Query: 678 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAH---DAAKGLEYLHTGCNP 734
E ++ +LV EY+ G L DR+ +++ LT L +G+ ++H
Sbjct: 155 FESKNDIVLVMEYVDGGELFDRI---IDES--YNLTELDTILFMKQICEGIRHMH---QM 206
Query: 735 GIIHRDVKSSNILL------DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY 788
I+H D+K NIL I K+ DFGL+R+ + V GT +L PE
Sbjct: 207 YILHLDLKPENILCVNRDAKQI----KIIDFGLARRYKPR--EKLKVNFGTPEFLAPEVV 260
Query: 789 GNQQLTEKSDVYSFGVVLLELISGKKP 815
++ +D++S GV+ L+SG P
Sbjct: 261 NYDFVSFPTDMWSVGVIAYMLLSGLSP 287
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 6e-25
Identities = 60/216 (27%), Positives = 95/216 (43%), Gaps = 40/216 (18%)
Query: 619 KKIGKGSFGSVYYGK-MKDGKEVAVKIMA-DSCSHRTQQFVTEVALLSRIHHRNLVPLIG 676
+ +G+G++G V + VAVKI+ + E+ + ++H N+V G
Sbjct: 13 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 677 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK-------GLEYLH 729
+ E + + L EY G L DR+ + DA + G+ YLH
Sbjct: 73 HRREGNIQYLFLEYCSGGELFDRI---EPDIGMP-------EPDAQRFFHQLMAGVVYLH 122
Query: 730 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS----RQAEEDLTHISSVARGTVGYLDP 785
GI HRD+K N+LLD K+SDFGL+ E L + GT+ Y+ P
Sbjct: 123 ---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC---GTLPYVAP 176
Query: 786 E------YYGNQQLTEKSDVYSFGVVLLELISGKKP 815
E ++ E DV+S G+VL +++G+ P
Sbjct: 177 ELLKRREFHA-----EPVDVWSCGIVLTAMLAGELP 207
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 7e-25
Identities = 49/209 (23%), Positives = 93/209 (44%), Gaps = 27/209 (12%)
Query: 619 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIG 676
+ +G G G V + G++ A+K++ DS R EV + ++V ++
Sbjct: 35 QVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQ-----EVDHHWQASGGPHIVCILD 89
Query: 677 YCEEEHQRI----LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQ---IAHDAAKGLEYLH 729
E H ++ E M G L R+ ++ T + I D +++LH
Sbjct: 90 VYENMHHGKRCLLIIMECMEGGELFSRIQ----ERGDQAFTEREAAEIMRDIGTAIQFLH 145
Query: 730 TGCNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE 786
+ I HRDVK N+L + + K++DFG +++ ++ + + T Y+ PE
Sbjct: 146 ---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA--LQTPC-YTPYYVAPE 199
Query: 787 YYGNQQLTEKSDVYSFGVVLLELISGKKP 815
G ++ + D++S GV++ L+ G P
Sbjct: 200 VLGPEKYDKSCDMWSLGVIMYILLCGFPP 228
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 8e-25
Identities = 53/209 (25%), Positives = 88/209 (42%), Gaps = 23/209 (11%)
Query: 616 NFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADS-CSHRTQQFVTEVALLSR-IHHRNLV 672
+ IG GS+ K E AVKI+ S E+ +L R H N++
Sbjct: 25 EVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTE-----EIEILLRYGQHPNII 79
Query: 673 PLIGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 730
L ++ +V E M G L D++ +++ + I K +EYLH
Sbjct: 80 TLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLF-TI----TKTVEYLH- 133
Query: 731 GCNPGIIHRDVKSSNILL----DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE 786
G++HRD+K SNIL ++ DFG ++Q + + + T ++ PE
Sbjct: 134 --AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPC-YTANFVAPE 190
Query: 787 YYGNQQLTEKSDVYSFGVVLLELISGKKP 815
Q D++S GV+L +++G P
Sbjct: 191 VLERQGYDAACDIWSLGVLLYTMLTGYTP 219
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-24
Identities = 57/219 (26%), Positives = 94/219 (42%), Gaps = 41/219 (18%)
Query: 619 KKIGKGSFGSVYYGK-MKDGKEVAVKIMA-----DSCSHRTQQFVT-EVALLSRIHHR-- 669
+G G FGSVY G + D VA+K + D V EV LL ++
Sbjct: 49 PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 108
Query: 670 NLVPLIGYCEEEHQRILVYEYMHN-GTLRDRL--HGSVNQKPLDWLTRL---QIAHDAAK 723
++ L+ + E +L+ E L D + G++ ++ L R Q+
Sbjct: 109 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEE----LARSFFWQVLE---- 160
Query: 724 GLEYLHTGCNPGIIHRDVKSSNILLDIN-MRAKVSDFGLSRQAEEDLTHISSVARGTVGY 782
+ + H N G++HRD+K NIL+D+N K+ DFG ++ + GT Y
Sbjct: 161 AVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD---GTRVY 214
Query: 783 LDPE------YYGNQQLTEKSDVYSFGVVLLELISGKKP 815
PE Y+G + V+S G++L +++ G P
Sbjct: 215 SPPEWIRYHRYHG-----RSAAVWSLGILLYDMVCGDIP 248
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-24
Identities = 60/237 (25%), Positives = 99/237 (41%), Gaps = 38/237 (16%)
Query: 617 FCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLI 675
++G+G+ VY K K K A+K++ + + TE+ +L R+ H N++ L
Sbjct: 57 VESELGRGATSIVYRCKQKGTQKPYALKVLKKT--VDKKIVRTEIGVLLRLSHPNIIKLK 114
Query: 676 GYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAK-------GLE 726
E + LV E + G L DR+ G +++ DAA +
Sbjct: 115 EIFETPTEISLVLELVTGGELFDRIVEKGYYSER------------DAADAVKQILEAVA 162
Query: 727 YLHTGCNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYL 783
YLH GI+HRD+K N+L + K++DFGLS+ E + + GT GY
Sbjct: 163 YLH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVC--GTPGYC 217
Query: 784 DPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV 840
PE + D++S G++ L+ G +P E + I +
Sbjct: 218 APEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMF------RRILNCEY 268
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 60/209 (28%), Positives = 92/209 (44%), Gaps = 27/209 (12%)
Query: 619 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRT---QQFVTEVALLSRIHHRNLVPL 674
+G G+FG V G+ G +VAVKI+ + E+ L H +++ L
Sbjct: 17 DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL 76
Query: 675 IGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 732
+V EY+ G L D + HG V + L + QI ++Y H
Sbjct: 77 YQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQ-QILS----AVDYCH--- 128
Query: 733 NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE------ 786
++HRD+K N+LLD +M AK++DFGLS + + G+ Y PE
Sbjct: 129 RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG--EFLRTSCGSPNYAAPEVISGRL 186
Query: 787 YYGNQQLTEKSDVYSFGVVLLELISGKKP 815
Y G + D++S GV+L L+ G P
Sbjct: 187 YAG-----PEVDIWSCGVILYALLCGTLP 210
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-24
Identities = 34/119 (28%), Positives = 58/119 (48%), Gaps = 6/119 (5%)
Query: 391 NDRGDPCVPVPWEWVTCSTTT-PPRITKIALSGKNLKGE--IPPELKNMEALTELWL-DG 446
D C W V C T T R+ + LSG NL IP L N+ L L++
Sbjct: 28 LPTTDCC-NRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGI 86
Query: 447 NFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 504
N L GP+P +++L L +++ + ++G++P ++ + L L N+ G +PP++
Sbjct: 87 NNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSI 145
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 95.7 bits (239), Expect = 1e-21
Identities = 28/106 (26%), Positives = 46/106 (43%), Gaps = 1/106 (0%)
Query: 415 ITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTG 474
+ + LS L+G+ + + ++ L N L L + +L + L NN + G
Sbjct: 199 LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYG 258
Query: 475 SLPSYMGSLPNLQELHIENNSFVGEIPPAL-LTGKVIFKYDNNPKL 519
+LP + L L L++ N+ GEIP L + Y NN L
Sbjct: 259 TLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCL 304
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 87.2 bits (217), Expect = 1e-18
Identities = 27/91 (29%), Positives = 40/91 (43%), Gaps = 3/91 (3%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEAL-TELWLDGNFLTGPLP-DMSRLIDLRIVHLENN 470
P + I G + G IP + L T + + N LTG +P + L +L V L N
Sbjct: 149 PNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL-NLAFVDLSRN 207
Query: 471 ELTGSLPSYMGSLPNLQELHIENNSFVGEIP 501
L G GS N Q++H+ NS ++
Sbjct: 208 MLEGDASVLFGSDKNTQKIHLAKNSLAFDLG 238
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 2e-17
Identities = 24/93 (25%), Positives = 41/93 (44%), Gaps = 7/93 (7%)
Query: 416 TKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD----MSRLIDLRIVHLENNE 471
+ S L G +PP + ++ L + DGN ++G +PD S+L + + N
Sbjct: 128 VTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKL--FTSMTISRNR 185
Query: 472 LTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 504
LTG +P +L NL + + N G+
Sbjct: 186 LTGKIPPTFANL-NLAFVDLSRNMLEGDASVLF 217
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 65.6 bits (161), Expect = 1e-11
Identities = 22/88 (25%), Positives = 39/88 (44%), Gaps = 3/88 (3%)
Query: 415 ITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELT 473
KI L+ +L ++ ++ + L L L N + G LP +++L L +++ N L
Sbjct: 223 TQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLC 281
Query: 474 GSLPSYMGSLPNLQELHIENNSFVGEIP 501
G +P G+L NN + P
Sbjct: 282 GEIPQ-GGNLQRFDVSAYANNKCLCGSP 308
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 50.2 bits (121), Expect = 2e-06
Identities = 17/69 (24%), Positives = 27/69 (39%), Gaps = 2/69 (2%)
Query: 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLE-NN 470
+ + L + G +P L ++ L L + N L G +P L + N
Sbjct: 243 SKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNK 302
Query: 471 ELTGS-LPS 478
L GS LP+
Sbjct: 303 CLCGSPLPA 311
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 3e-24
Identities = 23/214 (10%), Positives = 58/214 (27%), Gaps = 40/214 (18%)
Query: 620 KIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSH---RTQQFVTEVALLSRIHHRNLVPLI 675
G + ++VA+ + Q+ ++ LSRI + ++
Sbjct: 38 FHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVL 97
Query: 676 GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 735
++V E++ G+L++ + ++ A + H G
Sbjct: 98 DVVHTRAGGLVVAEWIRGGSLQEVADT-----SPSPVGAIRAMQSLAAAADAAHRA---G 149
Query: 736 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTE 795
+ S + + I+ ++ +
Sbjct: 150 VALSIDHPSRVRVSIDGDVVLAYP---------------------ATMPDA-------NP 181
Query: 796 KSDVYSFGVVLLELISGKKPVSVEDFGAELNIVH 829
+ D+ G L L+ + P+ + L
Sbjct: 182 QDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAE 215
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 6e-24
Identities = 59/258 (22%), Positives = 106/258 (41%), Gaps = 52/258 (20%)
Query: 619 KKIGKGSFGSVYYGK-MKDGKEVAVKIMA-----DSCSHRTQQFVT-EVALLSRIH---- 667
+GKG FG+V+ G + D +VA+K++ EVALL ++
Sbjct: 37 PLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGG 96
Query: 668 HRNLVPLIGYCEEEHQRILVYEYMHNGT-LRDRL--HGSVNQKPLDWLTRL---QIAHDA 721
H ++ L+ + E + +LV E L D + G + + +R Q+
Sbjct: 97 HPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEG----PSRCFFGQVVA-- 150
Query: 722 AKGLEYLHTGCNPGIIHRDVKSSNILLDINM-RAKVSDFGLSRQAEEDLTHISSVARGTV 780
+++ H + G++HRD+K NIL+D+ AK+ DFG ++ GT
Sbjct: 151 --AIQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFD---GTR 202
Query: 781 GYLDPE------YYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED--FGAELNIVHW-- 830
Y PE Y+ + V+S G++L +++ G P + AEL+
Sbjct: 203 VYSPPEWISRHQYHA-----LPATVWSLGILLYDMVCGDIPFERDQEILEAELHFPAHVS 257
Query: 831 --ARSMIKKGDVISIVDP 846
++I++ P
Sbjct: 258 PDCCALIRR---CLAPKP 272
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 7e-24
Identities = 56/218 (25%), Positives = 97/218 (44%), Gaps = 37/218 (16%)
Query: 616 NFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQF---VTEVALLSRIHHRNL 671
F K +G+GSF +V + +E A+KI+ + + E ++SR+ H
Sbjct: 33 KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 92
Query: 672 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQI-AHDAAK------- 723
V L +++ + Y NG L L ++ ++ +
Sbjct: 93 VKLYFTFQDDEKLYFGLSYAKNGEL------------LKYIRKIGSFDETCTRFYTAEIV 140
Query: 724 -GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR----- 777
LEYLH GIIHRD+K NILL+ +M +++DFG ++ + S AR
Sbjct: 141 SALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE----SKQARANSFV 193
Query: 778 GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 815
GT Y+ PE + + SD+++ G ++ +L++G P
Sbjct: 194 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-23
Identities = 50/209 (23%), Positives = 88/209 (42%), Gaps = 26/209 (12%)
Query: 619 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIG 676
+ +G G G V K ++ A+K++ D R EV L R ++V ++
Sbjct: 68 QVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR-----EVELHWRASQCPHIVRIVD 122
Query: 677 YCEEEHQRI----LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQ---IAHDAAKGLEYLH 729
E + +V E + G L R+ + T + I + ++YLH
Sbjct: 123 VYENLYAGRKCLLIVMECLDGGELFSRIQ----DRGDQAFTEREASEIMKSIGEAIQYLH 178
Query: 730 TGCNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE 786
+ I HRDVK N+L N K++DFG +++ + + T Y+ PE
Sbjct: 179 ---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPC--YTPYYVAPE 233
Query: 787 YYGNQQLTEKSDVYSFGVVLLELISGKKP 815
G ++ + D++S GV++ L+ G P
Sbjct: 234 VLGPEKYDKSCDMWSLGVIMYILLCGYPP 262
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 4e-23
Identities = 63/211 (29%), Positives = 101/211 (47%), Gaps = 31/211 (14%)
Query: 618 CKKIGKGSFGSVYYGKMKDGKEVAVK-IMADSC-SHRTQQFVTEVALLSRIHHRNLVPLI 675
CK IG GSFG V+ K+ + EVA+K ++ D +R E+ ++ + H N+V L
Sbjct: 45 CKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNR------ELQIMRIVKHPNVVDLK 98
Query: 676 ------GYCEEEHQRILVYEYMHNGTLRD--RLHGSVNQKPLDWLTRL---QIAHDAAKG 724
G ++E LV EY+ T+ R + + Q L +L Q+ +
Sbjct: 99 AFFYSNGDKKDEVFLNLVLEYV-PETVYRASRHYAKLKQTMPMLLIKLYMYQL----LRS 153
Query: 725 LEYLHTGCNPGIIHRDVKSSNILLDINMRA-KVSDFGLSRQAEEDLTHISSVARGTVGYL 783
L Y+H+ GI HRD+K N+LLD K+ DFG ++ ++S + + Y
Sbjct: 154 LAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYIC--SRYYR 208
Query: 784 DPE-YYGNQQLTEKSDVYSFGVVLLELISGK 813
PE +G T D++S G V+ EL+ G+
Sbjct: 209 APELIFGATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 9e-23
Identities = 61/212 (28%), Positives = 89/212 (41%), Gaps = 18/212 (8%)
Query: 616 NFCKKIGKGSFGSVYYGKMKDGKEV-AVKIMA-DSCSHRTQ--QFVTEVALLSRIHHRNL 671
K IG+G+F V KMK +V A+KIM R + F E +L R +
Sbjct: 64 EILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWI 123
Query: 672 VPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 730
L + ++ + LV EY G L L + P + R +A + ++ +H
Sbjct: 124 TQLH-FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEM-ARFYLA-EIVMAIDSVH- 179
Query: 731 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN 790
G +HRD+K NILLD +++DFG + D T S VA GT YL PE
Sbjct: 180 --RLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQA 237
Query: 791 QQLTEKSDVY-------SFGVVLLELISGKKP 815
+ Y + GV E+ G+ P
Sbjct: 238 VGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 1e-22
Identities = 61/208 (29%), Positives = 101/208 (48%), Gaps = 17/208 (8%)
Query: 616 NFCKKIGKGSFGSVYYGKMKDGKEV-AVKIMA-DSCSHRTQQF--VTEVALLSRIHHRNL 671
+ IGKGSFG V + D K++ A+K M C R + E+ ++ + H L
Sbjct: 18 EILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFL 77
Query: 672 VPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 730
V L Y ++ + + +V + + G LR L N + +L I + L+YL
Sbjct: 78 VNLW-YSFQDEEDMFMVVDLLLGGDLRYHL--QQNVHFKEETVKLFIC-ELVMALDYLQ- 132
Query: 731 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN 790
N IIHRD+K NILLD + ++DF ++ + +++A GT Y+ PE + +
Sbjct: 133 --NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQI-TTMA-GTKPYMAPEMFSS 188
Query: 791 QQLTEKS---DVYSFGVVLLELISGKKP 815
++ S D +S GV EL+ G++P
Sbjct: 189 RKGAGYSFAVDWWSLGVTAYELLRGRRP 216
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-22
Identities = 59/210 (28%), Positives = 96/210 (45%), Gaps = 12/210 (5%)
Query: 616 NFCKKIGKGSFGSVYYGKMKDGKEV-AVKIMA-DSCSHRTQQFVT--EVALLSRIHHRNL 671
+ +GKG FG V +++ ++ A K + R + + E +L +++ R +
Sbjct: 187 RQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFV 246
Query: 672 VPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 730
V L Y E + LV M+ G L+ ++ + A GLE LH
Sbjct: 247 VSLA-YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAE-ICCGLEDLH- 303
Query: 731 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN 790
I++RD+K NILLD + ++SD GL+ E T V GTVGY+ PE N
Sbjct: 304 --RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRV--GTVGYMAPEVVKN 359
Query: 791 QQLTEKSDVYSFGVVLLELISGKKPVSVED 820
++ T D ++ G +L E+I+G+ P
Sbjct: 360 ERYTFSPDWWALGCLLYEMIAGQSPFQQRK 389
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 1e-22
Identities = 56/208 (26%), Positives = 89/208 (42%), Gaps = 27/208 (12%)
Query: 619 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 677
K IG G+FG + + VAVK + + + + E+ + H N+V
Sbjct: 26 KDIGSGNFGVARLMRDKLTKELVAVKYI-ERGAAIDENVQREIINHRSLRHPNIVRFKEV 84
Query: 678 CEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 735
++ EY G L +R+ G ++ + + Q+ G+ Y H +
Sbjct: 85 ILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQ-QLLS----GVSYCH---SMQ 136
Query: 736 IIHRDVKSSNILLDIN--MRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE------Y 787
I HRD+K N LLD + R K+ DFG S+ + S+V GT Y+ PE Y
Sbjct: 137 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV--GTPAYIAPEVLLRQEY 194
Query: 788 YGNQQLTEKSDVYSFGVVLLELISGKKP 815
G + +DV+S GV L ++ G P
Sbjct: 195 DG-----KIADVWSCGVTLYVMLVGAYP 217
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 2e-22
Identities = 56/209 (26%), Positives = 94/209 (44%), Gaps = 28/209 (13%)
Query: 619 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPL 674
+ +G+GSFG V K ++VA+K ++ S + E++ L + H +++ L
Sbjct: 15 ETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKL 74
Query: 675 IGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 732
++V EY G L D + + + + QI +EY H
Sbjct: 75 YDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQ-QIIC----AIEYCH--- 125
Query: 733 NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE------ 786
I+HRD+K N+LLD N+ K++DFGLS + + + G+ Y PE
Sbjct: 126 RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG--NFLKTSCGSPNYAAPEVINGKL 183
Query: 787 YYGNQQLTEKSDVYSFGVVLLELISGKKP 815
Y G + DV+S G+VL ++ G+ P
Sbjct: 184 YAG-----PEVDVWSCGIVLYVMLVGRLP 207
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 2e-22
Identities = 61/239 (25%), Positives = 106/239 (44%), Gaps = 29/239 (12%)
Query: 593 GGHFMDEGVAYFIPLPELEEATN-NFCKKIGKGSFGSVYYGKMKD-GKEVAVK-IMAD-S 648
G M A +E + G+G+FG+V GK K G VA+K ++ D
Sbjct: 2 PGSMMSLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR 61
Query: 649 CSHRTQQFVTEVALLSRIHHRNLVPLIGY----CEEEHQRI---LVYEYMHNGTLRD--R 699
+R Q + L+ +HH N+V L Y E + + I +V EY+ TL R
Sbjct: 62 FRNRELQ---IMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYV-PDTLHRCCR 117
Query: 700 LHGSVNQKPLDWLTRL---QIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD-INMRAK 755
+ P L ++ Q+ + + LH + HRD+K N+L++ + K
Sbjct: 118 NYYRRQVAPPPILIKVFLFQLI----RSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLK 172
Query: 756 VSDFGLSRQAEEDLTHISSVARGTVGYLDPEY-YGNQQLTEKSDVYSFGVVLLELISGK 813
+ DFG +++ +++ + + Y PE +GNQ T D++S G + E++ G+
Sbjct: 173 LCDFGSAKKLSPSEPNVAYIC--SRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-22
Identities = 57/206 (27%), Positives = 94/206 (45%), Gaps = 11/206 (5%)
Query: 616 NFCKKIGKGSFGSVYYGKMKDGKEV-AVKIMA-DSCSHRTQQFVT--EVALLSRIHHRNL 671
+ +G+G FG V+ +MK ++ A K + R E +L+++H R +
Sbjct: 188 LDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFI 247
Query: 672 VPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQI-AHDAAKGLEYLH 729
V L Y E + LV M+ G +R ++ P R GLE+LH
Sbjct: 248 VSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH 306
Query: 730 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYG 789
II+RD+K N+LLD + ++SD GL+ + + T A GT G++ PE
Sbjct: 307 ---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYA-GTPGFMAPELLL 362
Query: 790 NQQLTEKSDVYSFGVVLLELISGKKP 815
++ D ++ GV L E+I+ + P
Sbjct: 363 GEEYDFSVDYFALGVTLYEMIAARGP 388
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-22
Identities = 62/210 (29%), Positives = 97/210 (46%), Gaps = 29/210 (13%)
Query: 619 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPL 674
+G G+FG V GK G +VAVKI+ + E+ L H +++ L
Sbjct: 22 DTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL 81
Query: 675 IGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 732
+V EY+ G L D + +G +++K L + QI G++Y H
Sbjct: 82 YQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQ-QILS----GVDYCH--- 133
Query: 733 NPGIIHRDVKSSNILLDINMRAKVSDFGLSR-QAEEDLTHISSVARGTVGYLDPE----- 786
++HRD+K N+LLD +M AK++DFGLS ++ + S G+ Y PE
Sbjct: 134 RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC---GSPNYAAPEVISGR 190
Query: 787 -YYGNQQLTEKSDVYSFGVVLLELISGKKP 815
Y G + D++S GV+L L+ G P
Sbjct: 191 LYAG-----PEVDIWSSGVILYALLCGTLP 215
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 4e-22
Identities = 63/212 (29%), Positives = 101/212 (47%), Gaps = 32/212 (15%)
Query: 618 CKKIGKGSFGSVYYGKMKD-GKEVAVK-IMADSC-SHRTQQFVTEVALLSRIHHRNLVPL 674
K IG GSFG VY K+ D G+ VA+K ++ D +R E+ ++ ++ H N+V L
Sbjct: 59 TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR------ELQIMRKLDHCNIVRL 112
Query: 675 IGYCEEEHQRI------LVYEYMHNGTLRD--RLHGSVNQKPLDWLTRL---QIAHDAAK 723
+ ++ LV +Y+ T+ R + Q +L Q+ +
Sbjct: 113 RYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLPVIYVKLYMYQLF----R 167
Query: 724 GLEYLHTGCNPGIIHRDVKSSNILLDINMRA-KVSDFGLSRQAEEDLTHISSVARGTVGY 782
L Y+H+ GI HRD+K N+LLD + K+ DFG ++Q ++S + + Y
Sbjct: 168 SLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC--SRYY 222
Query: 783 LDPEY-YGNQQLTEKSDVYSFGVVLLELISGK 813
PE +G T DV+S G VL EL+ G+
Sbjct: 223 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 2e-21
Identities = 41/107 (38%), Positives = 57/107 (53%), Gaps = 6/107 (5%)
Query: 399 PVPWEWVTCSTTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MS 457
+P + S ++ + L L+GEIP EL ++ L L LD N LTG +P +S
Sbjct: 433 TIPSSLGSLS-----KLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLS 487
Query: 458 RLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 504
+L + L NN LTG +P ++G L NL L + NNSF G IP L
Sbjct: 488 NCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAEL 534
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 7e-21
Identities = 39/150 (26%), Positives = 64/150 (42%), Gaps = 14/150 (9%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNE 471
+ + L +L GEIP L N L + L N LTG +P + RL +L I+ L NN
Sbjct: 466 KTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNS 525
Query: 472 LTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL-----------LTGKVIFKYDNNPKLH 520
+G++P+ +G +L L + N F G IP A+ + GK N+
Sbjct: 526 FSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKK 585
Query: 521 K--ESRRRMRFKLILGTSIGVLAILLVLFL 548
+ + + F+ I + L+ +
Sbjct: 586 ECHGAGNLLEFQGIRSEQLNRLSTRNPCNI 615
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 1e-20
Identities = 26/119 (21%), Positives = 50/119 (42%), Gaps = 5/119 (4%)
Query: 399 PVPWEWVTCSTTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSR 458
WV + +A+SG + G++ + L L + N + +P +
Sbjct: 166 ANVVGWVLSDGCG--ELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIPFLGD 221
Query: 459 LIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG-KVIFKYDNN 516
L+ + + N+L+G + + L+ L+I +N FVG IPP L + + +N
Sbjct: 222 CSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLPLKSLQYLSLAENK 280
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 1e-20
Identities = 30/96 (31%), Positives = 45/96 (46%), Gaps = 1/96 (1%)
Query: 410 TTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLE 468
+ ++ L G+IPP L N L L L N+L+G +P + L LR + L
Sbjct: 391 NPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLW 450
Query: 469 NNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 504
N L G +P + + L+ L ++ N GEIP L
Sbjct: 451 LNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGL 486
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 9e-19
Identities = 30/95 (31%), Positives = 49/95 (51%), Gaps = 3/95 (3%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD--MSRLIDLRIVHLENN 470
+T + LSG + G +PP + L L L N +G LP + ++ L+++ L N
Sbjct: 294 DTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFN 353
Query: 471 ELTGSLPSYMGSL-PNLQELHIENNSFVGEIPPAL 504
E +G LP + +L +L L + +N+F G I P L
Sbjct: 354 EFSGELPESLTNLSASLLTLDLSSNNFSGPILPNL 388
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 1e-18
Identities = 35/96 (36%), Positives = 49/96 (51%), Gaps = 3/96 (3%)
Query: 412 PPRITKIALSGKNLKGEIPPELKN--MEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLE 468
+ + LS N G I P L L EL+L N TG +P +S +L +HL
Sbjct: 367 SASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLS 426
Query: 469 NNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 504
N L+G++PS +GSL L++L + N GEIP L
Sbjct: 427 FNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQEL 462
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 6e-18
Identities = 26/120 (21%), Positives = 49/120 (40%), Gaps = 11/120 (9%)
Query: 391 NDRGDPCVPVPWEWVTCSTTTPPRITKIALSGKNLK---GEIPPELKNMEALTELWLDGN 447
+ +PC ++ VTC ++T I LS K L + L ++ L L+L +
Sbjct: 34 SSNKNPCT---FDGVTCRDD---KVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNS 87
Query: 448 FLTGPLPDMSRLIDLRIVHLENNELTGSLPSYM--GSLPNLQELHIENNSFVGEIPPALL 505
+ G + L + L N L+G + + GS L+ L++ +N+ +
Sbjct: 88 HINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGG 147
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 7e-18
Identities = 28/95 (29%), Positives = 44/95 (46%), Gaps = 4/95 (4%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD--MSRLIDLRIVHLENN 470
+ + +S G IPP +++L L L N TG +PD L + L N
Sbjct: 247 TELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGN 304
Query: 471 ELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALL 505
G++P + GS L+ L + +N+F GE+P L
Sbjct: 305 HFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTL 339
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 2e-17
Identities = 28/95 (29%), Positives = 43/95 (45%), Gaps = 3/95 (3%)
Query: 413 PRITKIALSGKNLKGEIPPELK-NMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENN 470
+ ++L+ GEIP L + LT L L GN G +P L + L +N
Sbjct: 269 KSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSN 328
Query: 471 ELTGSLP-SYMGSLPNLQELHIENNSFVGEIPPAL 504
+G LP + + L+ L + N F GE+P +L
Sbjct: 329 NFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESL 363
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 8e-17
Identities = 33/97 (34%), Positives = 50/97 (51%), Gaps = 5/97 (5%)
Query: 413 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPD-MSRL-IDLRIVHLEN 469
+ +ALS N GE+P + L M L L L N +G LP+ ++ L L + L +
Sbjct: 318 SLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSS 377
Query: 470 NELTGSLPSYMG--SLPNLQELHIENNSFVGEIPPAL 504
N +G + + LQEL+++NN F G+IPP L
Sbjct: 378 NNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTL 414
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 1e-16
Identities = 31/133 (23%), Positives = 56/133 (42%), Gaps = 26/133 (19%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNE 471
++ + G P N ++ L + N L+G +P + + L I++L +N+
Sbjct: 608 STRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHND 667
Query: 472 LTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL---------------LTGKV----IFK 512
++GS+P +G L L L + +N G IP A+ L+G + F+
Sbjct: 668 ISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFE 727
Query: 513 ------YDNNPKL 519
+ NNP L
Sbjct: 728 TFPPAKFLNNPGL 740
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 2e-15
Identities = 20/101 (19%), Positives = 37/101 (36%), Gaps = 7/101 (6%)
Query: 413 PRITKIALSGKNLKGEIPP--ELKNMEALTELWLDGNFLTG--PLPDMSRLIDLRIVHLE 468
+T + LS +L G + L + L L + N L + +L L ++ L
Sbjct: 100 ASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLS 159
Query: 469 NNELTGSLPS---YMGSLPNLQELHIENNSFVGEIPPALLT 506
N ++G+ L+ L I N G++ +
Sbjct: 160 ANSISGANVVGWVLSDGCGELKHLAISGNKISGDVDVSRCV 200
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 4e-14
Identities = 17/88 (19%), Positives = 33/88 (37%), Gaps = 1/88 (1%)
Query: 418 IALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSL 476
A + +G +L + + G + + + N L+G +
Sbjct: 589 GAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYI 648
Query: 477 PSYMGSLPNLQELHIENNSFVGEIPPAL 504
P +GS+P L L++ +N G IP +
Sbjct: 649 PKEIGSMPYLFILNLGHNDISGSIPDEV 676
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 72.2 bits (178), Expect = 4e-13
Identities = 15/89 (16%), Positives = 30/89 (33%), Gaps = 3/89 (3%)
Query: 419 ALSGKNLKGEIPPELKNMEALTELWLDGNF--LTGPLP-DMSRLIDLRIVHLENNELTGS 475
++ + G+ +KN E GN G ++RL ++ + G
Sbjct: 564 KIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGH 623
Query: 476 LPSYMGSLPNLQELHIENNSFVGEIPPAL 504
+ ++ L + N G IP +
Sbjct: 624 TSPTFDNNGSMMFLDMSYNMLSGYIPKEI 652
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 2e-21
Identities = 60/210 (28%), Positives = 99/210 (47%), Gaps = 16/210 (7%)
Query: 616 NFCKKIGKGSFGSVYYGKMKDGKEV-AVKIM--ADSCSHR-TQQFVTEVALLSRIHHRNL 671
K IG+G+FG V K+K+ +V A+KI+ + T F E +L + +
Sbjct: 77 EILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWI 136
Query: 672 VPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 730
L Y ++ + LV +Y G L L ++ P + R +A + ++ +H
Sbjct: 137 TTLH-YAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEM-ARFYLA-EMVIAIDSVH- 192
Query: 731 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN 790
+HRD+K NIL+D+N +++DFG + ED T SSVA GT Y+ PE
Sbjct: 193 --QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQA 250
Query: 791 QQLTEKS-----DVYSFGVVLLELISGKKP 815
+ + D +S GV + E++ G+ P
Sbjct: 251 MEGGKGRYGPECDWWSLGVCMYEMLYGETP 280
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 3e-21
Identities = 52/208 (25%), Positives = 96/208 (46%), Gaps = 29/208 (13%)
Query: 619 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPLI 675
+G G++GSV + G++VA+K ++ ++ E+ LL + H N++ L+
Sbjct: 30 THVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLL 89
Query: 676 -----GYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRL---QIAHDAAKGLE 726
LV +M D L + K + + Q+ KGL+
Sbjct: 90 DVFTPASSLRNFYDFYLVMPFMQT----D-LQKIMGLKFSEEKIQYLVYQML----KGLK 140
Query: 727 YLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE 786
Y+H+ G++HRD+K N+ ++ + K+ DFGL+R A+ ++T V T Y PE
Sbjct: 141 YIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTG--YVV--TRWYRAPE 193
Query: 787 -YYGNQQLTEKSDVYSFGVVLLELISGK 813
+ D++S G ++ E+++GK
Sbjct: 194 VILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 97.2 bits (242), Expect = 3e-21
Identities = 64/268 (23%), Positives = 109/268 (40%), Gaps = 37/268 (13%)
Query: 619 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPLI 675
K IG G+ G V + VA+K ++ ++T ++ E+ L+ ++H+N++ L+
Sbjct: 68 KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 127
Query: 676 ------GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 729
EE LV E M + L V Q LD + + G+++LH
Sbjct: 128 NVFTPQKTLEEFQDVYLVMELMDA----N-LC-QVIQMELDHERMSYLLYQMLCGIKHLH 181
Query: 730 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYG 789
+ GIIHRD+K SNI++ + K+ DFGL+R A V T Y PE
Sbjct: 182 SA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV--TRYYRAPEVIL 236
Query: 790 NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 849
E D++S G ++ E++ K D+ + N +++ +
Sbjct: 237 GMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNK---------------VIE--QL 279
Query: 850 GNVKIESIWRIAEVAIQCVEQRGFSRPK 877
G E + ++ VE R
Sbjct: 280 GTPCPEFMKKLQPTVRNYVENRPKYAGL 307
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 98.0 bits (244), Expect = 5e-21
Identities = 57/211 (27%), Positives = 99/211 (46%), Gaps = 23/211 (10%)
Query: 616 NFCKKIGKGSFGSVYYGKMKDGKEV-AVKIMA-DSCSHRTQQF--VTEVALLSRIH---H 668
+ + IG+G FG VY + D ++ A+K + + + + E +LS +
Sbjct: 192 SVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDC 251
Query: 669 RNLVPLIGYCEEEHQRI-LVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGL 725
+V + Y ++ + + M+ G L L HG ++ R A + GL
Sbjct: 252 PFIVCMS-YAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA----DMRFYAA-EIILGL 305
Query: 726 EYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDP 785
E++H N +++RD+K +NILLD + ++SD GL+ + H +SV GT GY+ P
Sbjct: 306 EHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH-ASV--GTHGYMAP 359
Query: 786 EYYGNQQLTEKS-DVYSFGVVLLELISGKKP 815
E + S D +S G +L +L+ G P
Sbjct: 360 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 6e-21
Identities = 65/268 (24%), Positives = 110/268 (41%), Gaps = 37/268 (13%)
Query: 619 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPLI 675
K IG G+ G V + VA+K ++ ++T ++ E+ L+ ++H+N++ L+
Sbjct: 31 KPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 90
Query: 676 -----GYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 729
EE Q + +V E M + L V Q LD + + G+++LH
Sbjct: 91 NVFTPQKSLEEFQDVYIVMELMDA----N-LC-QVIQMELDHERMSYLLYQMLCGIKHLH 144
Query: 730 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYG 789
+ GIIHRD+K SNI++ + K+ DFGL+R A V T Y PE
Sbjct: 145 SA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV--TRYYRAPEVIL 199
Query: 790 NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 849
E D++S G ++ E+I G D + N +++ +
Sbjct: 200 GMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNK---------------VIE--QL 242
Query: 850 GNVKIESIWRIAEVAIQCVEQRGFSRPK 877
G E + ++ VE R
Sbjct: 243 GTPCPEFMKKLQPTVRTYVENRPKYAGY 270
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 7e-21
Identities = 55/211 (26%), Positives = 96/211 (45%), Gaps = 34/211 (16%)
Query: 619 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPLI 675
+G G++GSV K G VAVK ++ ++ E+ LL + H N++ L+
Sbjct: 35 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 94
Query: 676 -----GYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 729
EE + LV M G D L+ V + L + + +GL+Y+H
Sbjct: 95 DVFTPARSLEEFNDVYLVTHLM--GA--D-LNNIVKCQKLTDDHVQFLIYQILRGLKYIH 149
Query: 730 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY- 788
+ IIHRD+K SN+ ++ + K+ DFGL+R +++T GY+ +Y
Sbjct: 150 SA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMT----------GYVATRWYR 196
Query: 789 ------GNQQLTEKSDVYSFGVVLLELISGK 813
+ D++S G ++ EL++G+
Sbjct: 197 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 1e-20
Identities = 55/205 (26%), Positives = 97/205 (47%), Gaps = 22/205 (10%)
Query: 619 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPLI 675
+ +G G++G+V + G +VA+K + ++ E+ LL + H N++ L+
Sbjct: 31 QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLL 90
Query: 676 -----GYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 729
++ LV +M D L + + L + + KGL Y+H
Sbjct: 91 DVFTPDETLDDFTDFYLVMPFMGT----D-LGKLMKHEKLGEDRIQFLVYQMLKGLRYIH 145
Query: 730 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY-Y 788
GIIHRD+K N+ ++ + K+ DFGL+RQA+ ++T V T Y PE
Sbjct: 146 AA---GIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTG--YVV--TRWYRAPEVIL 198
Query: 789 GNQQLTEKSDVYSFGVVLLELISGK 813
+ T+ D++S G ++ E+I+GK
Sbjct: 199 NWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 1e-20
Identities = 54/216 (25%), Positives = 94/216 (43%), Gaps = 31/216 (14%)
Query: 616 NFCKKIGKGSFGSVYYGKMKDGKEV-AVKIMADSCSHRTQQ---FVTEVALLSRIHHRNL 671
K IG+G+FG V + K ++V A+K+++ + F E +++ + +
Sbjct: 72 EVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWV 131
Query: 672 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK-------- 723
V L +++ +V EYM G L ++ ++ + A+
Sbjct: 132 VQLFYAFQDDRYLYMVMEYMPGGDL------------VNLMSNYDVPEKWARFYTAEVVL 179
Query: 724 GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYL 783
L+ +H + G IHRDVK N+LLD + K++DFG + ++ A GT Y+
Sbjct: 180 ALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYI 236
Query: 784 DPE---YYGNQQLTEKS-DVYSFGVVLLELISGKKP 815
PE G + D +S GV L E++ G P
Sbjct: 237 SPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 2e-20
Identities = 55/215 (25%), Positives = 89/215 (41%), Gaps = 31/215 (14%)
Query: 619 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVT-----------EVALLSRIH 667
+ I GS+G+V G +G VA+K + ++ S + E+ LL+ H
Sbjct: 28 RFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFH 87
Query: 668 HRNLVPL----IGYCEEEHQRI-LVYEYMHNGTLRDRLHG--SVNQKPLDWLTRLQ-IAH 719
H N++ L + + E ++ LV E M D L + + +Q +
Sbjct: 88 HPNILGLRDIFVHFEEPAMHKLYLVTELMRT----D-LAQVIHDQRIVIS-PQHIQYFMY 141
Query: 720 DAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGT 779
GL LH G++HRD+ NILL N + DF L+R+ D V
Sbjct: 142 HILLGLHVLHEA---GVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVT--H 196
Query: 780 VGYLDPEY-YGNQQLTEKSDVYSFGVVLLELISGK 813
Y PE + T+ D++S G V+ E+ + K
Sbjct: 197 RWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 93.3 bits (232), Expect = 4e-20
Identities = 60/210 (28%), Positives = 98/210 (46%), Gaps = 12/210 (5%)
Query: 616 NFCKKIGKGSFGSVYYGKMKDGKEV-AVKIMA-DSCSHR--TQQFVTEVALLSRIHHRNL 671
+ K +GKG+FG V K K A+KI+ + + +TE +L H L
Sbjct: 151 EYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFL 210
Query: 672 VPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 730
L Y + H R+ V EY + G L H S + + R A + L+YLH+
Sbjct: 211 TALK-YSFQTHDRLCFVMEYANGGELF--FHLSRERVFSEDRARFYGA-EIVSALDYLHS 266
Query: 731 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN 790
+++RD+K N++LD + K++DFGL ++ +D + + GT YL PE +
Sbjct: 267 --EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFC-GTPEYLAPEVLED 323
Query: 791 QQLTEKSDVYSFGVVLLELISGKKPVSVED 820
D + GVV+ E++ G+ P +D
Sbjct: 324 NDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 353
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 2e-19
Identities = 50/206 (24%), Positives = 97/206 (47%), Gaps = 26/206 (12%)
Query: 619 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPL-- 674
+K+G+G + V+ + + ++V VKI+ + ++ E+ +L + N++ L
Sbjct: 42 RKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKR---EIKILENLRGGPNIITLAD 98
Query: 675 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA---HDAAKGLEYLHTG 731
I LV+E+++N + + LT I ++ K L+Y H+
Sbjct: 99 IVKDPVSRTPALVFEHVNNTDFK---------QLYQTLTDYDIRFYMYEILKALDYCHSM 149
Query: 732 CNPGIIHRDVKSSNILLDINMRA-KVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN 790
GI+HRDVK N+++D R ++ D+GL+ + VA + + PE +
Sbjct: 150 ---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVA--SRYFKGPELLVD 204
Query: 791 QQLTEKS-DVYSFGVVLLELISGKKP 815
Q+ + S D++S G +L +I K+P
Sbjct: 205 YQMYDYSLDMWSLGCMLASMIFRKEP 230
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 4e-19
Identities = 59/213 (27%), Positives = 100/213 (46%), Gaps = 40/213 (18%)
Query: 619 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQF-----VT---EVALLSRIHHRN 670
+K+G+G++G VY K G+ VA+K + R T E++LL +HH N
Sbjct: 27 EKVGEGTYGVVYKAKDSQGRIVALKRI------RLDAEDEGIPSTAIREISLLKELHHPN 80
Query: 671 LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTR------LQIAHDAAKG 724
+V LI E LV+E+M D L +++ Q+ +G
Sbjct: 81 IVSLIDVIHSERCLTLVFEFMEK----D-LKKVLDENKTGLQDSQIKIYLYQLL----RG 131
Query: 725 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ---AEEDLTHISSVARGTVG 781
+ + H I+HRD+K N+L++ + K++DFGL+R TH V T+
Sbjct: 132 VAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHE--VV--TLW 184
Query: 782 YLDPEY-YGNQQLTEKSDVYSFGVVLLELISGK 813
Y P+ G+++ + D++S G + E+I+GK
Sbjct: 185 YRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 4e-19
Identities = 47/211 (22%), Positives = 80/211 (37%), Gaps = 47/211 (22%)
Query: 617 FCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPL 674
+ +G G G V K ++ A+K++ D R EV L R ++V +
Sbjct: 22 TSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR-----EVELHWRASQCPHIVRI 76
Query: 675 IGYCEEEHQRI----LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQ---IAHDAAKGLEY 727
+ E + +V E + G L R+ + T + I + ++Y
Sbjct: 77 VDVYENLYAGRKCLLIVMECLDGGELFSRIQ----DRGDQAFTEREASEIMKSIGEAIQY 132
Query: 728 LHTGCNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLD 784
LH + I HRDVK N+L N K++DFG +++
Sbjct: 133 LH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE------------------TT 171
Query: 785 PEYYGNQQLTEKSDVYSFGVVLLELISGKKP 815
E Y + D++S GV++ L+ G P
Sbjct: 172 GEKYD-----KSCDMWSLGVIMYILLCGYPP 197
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 4e-19
Identities = 56/208 (26%), Positives = 95/208 (45%), Gaps = 27/208 (12%)
Query: 620 KIGKGSFGSVYYGKMKD-GKEVAVKIM-------ADSCSHRTQQFVTEVALLSRIHHRNL 671
K+G G++ +VY G K G VA+K + S + R E++L+ + H N+
Sbjct: 12 KLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIR------EISLMKELKHENI 65
Query: 672 VPLIGYCEEEHQRILVYEYMHN--GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 729
V L E++ LV+E+M N D + L+ +GL + H
Sbjct: 66 VRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH 125
Query: 730 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ---AEEDLTHISSVARGTVGYLDPE 786
I+HRD+K N+L++ + K+ DFGL+R + V T+ Y P+
Sbjct: 126 EN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSE--VV--TLWYRAPD 178
Query: 787 Y-YGNQQLTEKSDVYSFGVVLLELISGK 813
G++ + D++S G +L E+I+GK
Sbjct: 179 VLMGSRTYSTSIDIWSCGCILAEMITGK 206
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 88.4 bits (219), Expect = 7e-19
Identities = 60/270 (22%), Positives = 105/270 (38%), Gaps = 71/270 (26%)
Query: 617 FCKKIGKGSFGSVYYG------KMKDGKEVAVKIMADSCSHR-TQQFVTEVALLSRI-HH 668
K +G+G+FG V K + VAVK++ + +H + ++E+ +L I HH
Sbjct: 26 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 85
Query: 669 RNLVPLIGYC-EEEHQRILVYEYMHNGTLRDRLHGSVNQ--------------------- 706
N+V L+G C + +++ E+ G L L N+
Sbjct: 86 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAI 145
Query: 707 -----KPLDWLTRLQIAHDAA----KGLEYLHTGCNPGIIHRDVKSSNILLDI------- 750
+ LD +T Q + + K L + P +++D + L+
Sbjct: 146 PVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKG 205
Query: 751 -----------------------NMRAKVSDFGLSRQAEEDLTHI-SSVARGTVGYLDPE 786
K+ DFGL+R +D ++ AR + ++ PE
Sbjct: 206 MEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPE 265
Query: 787 YYGNQQLTEKSDVYSFGVVLLELIS-GKKP 815
++ T +SDV+SFGV+L E+ S G P
Sbjct: 266 TIFDRVYTIQSDVWSFGVLLWEIFSLGASP 295
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 86.8 bits (216), Expect = 1e-18
Identities = 59/208 (28%), Positives = 91/208 (43%), Gaps = 29/208 (13%)
Query: 619 KKIGKGSFGSVYYGKMKD-GKEVAVKIM--------ADSCSHRTQQFVTEVALLSRIHHR 669
KIG+GS+G V+ + +D G+ VA+K + R E+ +L ++ H
Sbjct: 9 GKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALR------EIRMLKQLKHP 62
Query: 670 NLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 729
NLV L+ + + LV+EY + T+ L Q+ + I + + + H
Sbjct: 63 NLVNLLEVFRRKRRLHLVFEYCDH-TVLHEL--DRYQRGVPEHLVKSITWQTLQAVNFCH 119
Query: 730 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ---AEEDLTHISSVARGTVGYLDPE 786
IHRDVK NIL+ + K+ DFG +R + VA T Y PE
Sbjct: 120 KH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDD--EVA--TRWYRSPE 172
Query: 787 Y-YGNQQLTEKSDVYSFGVVLLELISGK 813
G+ Q DV++ G V EL+SG
Sbjct: 173 LLVGDTQYGPPVDVWAIGCVFAELLSGV 200
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 2e-18
Identities = 50/243 (20%), Positives = 91/243 (37%), Gaps = 62/243 (25%)
Query: 618 CKKIGKGSFGSVYYGKMKD-GKEVAVK-IMADSCSHRTQQFVTEVALLSRIHHRNLVPL- 674
K +G GSFG V + GK A+K ++ D + E+ ++ + H N++ L
Sbjct: 12 GKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP--RYKNR---ELDIMKVLDHVNIIKLV 66
Query: 675 -IGYCEEEHQRI------------------------------------LVYEYMHNGTLR 697
Y + + ++ EY+ TL
Sbjct: 67 DYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV-PDTLH 125
Query: 698 D--RLHGSVNQKPLDWLTRL---QIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM 752
+ + L + Q+ + + ++H+ GI HRD+K N+L++
Sbjct: 126 KVLKSFIRSGRSIPMNLISIYIYQLF----RAVGFIHSL---GICHRDIKPQNLLVNSKD 178
Query: 753 -RAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE-YYGNQQLTEKSDVYSFGVVLLELI 810
K+ DFG +++ ++ + + Y PE G + T D++S G V ELI
Sbjct: 179 NTLKLCDFGSAKKLIPSEPSVAYIC--SRFYRAPELMLGATEYTPSIDLWSIGCVFGELI 236
Query: 811 SGK 813
GK
Sbjct: 237 LGK 239
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 3e-18
Identities = 58/208 (27%), Positives = 98/208 (47%), Gaps = 29/208 (13%)
Query: 619 KKIGKGSFGSVYYGKMKD-GKEVAVKIM--------ADSCSHRTQQFVTEVALLSRIHHR 669
+G+GS+G V + KD G+ VA+K + R E+ LL ++ H
Sbjct: 31 GLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMR------EIKLLKQLRHE 84
Query: 670 NLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 729
NLV L+ C+++ + LV+E++ + T+ D L + LD+ + G+ + H
Sbjct: 85 NLVNLLEVCKKKKRWYLVFEFVDH-TILDDL--ELFPNGLDYQVVQKYLFQIINGIGFCH 141
Query: 730 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ---AEEDLTHISSVARGTVGYLDPE 786
+ IIHRD+K NIL+ + K+ DFG +R E VA T Y PE
Sbjct: 142 SH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDE--VA--TRWYRAPE 194
Query: 787 Y-YGNQQLTEKSDVYSFGVVLLELISGK 813
G+ + + DV++ G ++ E+ G+
Sbjct: 195 LLVGDVKYGKAVDVWAIGCLVTEMFMGE 222
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 85.3 bits (212), Expect = 3e-18
Identities = 51/212 (24%), Positives = 97/212 (45%), Gaps = 40/212 (18%)
Query: 620 KIGKGSFGSVYYGKMKDGKEVAVKIM--------ADSCSHRTQQFVTEVALLSRIHHRNL 671
KIG+G++G VY + G+ A+K + S + R E+++L + H N+
Sbjct: 9 KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIR------EISILKELKHSNI 62
Query: 672 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTR------LQIAHDAAKGL 725
V L + + +LV+E++ D L ++ + LQ+ G+
Sbjct: 63 VKLYDVIHTKKRLVLVFEHLDQ----D-LKKLLDVCEGGLESVTAKSFLLQLL----NGI 113
Query: 726 EYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ---AEEDLTHISSVARGTVGY 782
Y H ++HRD+K N+L++ K++DFGL+R TH + T+ Y
Sbjct: 114 AYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHE--IV--TLWY 166
Query: 783 LDPEY-YGNQQLTEKSDVYSFGVVLLELISGK 813
P+ G+++ + D++S G + E+++G
Sbjct: 167 RAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 3e-18
Identities = 51/216 (23%), Positives = 95/216 (43%), Gaps = 31/216 (14%)
Query: 619 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLI-- 675
K +G G G V+ K VA+K + + + + E+ ++ R+ H N+V +
Sbjct: 17 KPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEI 76
Query: 676 ------------GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK 723
G E + +V EYM T D L + Q PL + +
Sbjct: 77 LGPSGSQLTDDVGSLTELNSVYIVQEYM--ET--D-LANVLEQGPLLEEHARLFMYQLLR 131
Query: 724 GLEYLHTGCNPGIIHRDVKSSNILLD-INMRAKVSDFGLSRQAEEDLTHISS----VARG 778
GL+Y+H+ ++HRD+K +N+ ++ ++ K+ DFGL+R + +H +
Sbjct: 132 GLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLV-- 186
Query: 779 TVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGK 813
T Y P + T+ D+++ G + E+++GK
Sbjct: 187 TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 84.9 bits (211), Expect = 4e-18
Identities = 52/215 (24%), Positives = 96/215 (44%), Gaps = 41/215 (19%)
Query: 620 KIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQF-----VT---EVALLSRIHHRN 670
KIG+G++G+V+ K ++ + VA+K + R + E+ LL + H+N
Sbjct: 9 KIGEGTYGTVFKAKNRETHEIVALKRV------RLDDDDEGVPSSALREICLLKELKHKN 62
Query: 671 LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTR------LQIAHDAAKG 724
+V L + + LV+E+ D L + D Q+ KG
Sbjct: 63 IVRLHDVLHSDKKLTLVFEFCDQ----D-LKKYFDSCNGDLDPEIVKSFLFQLL----KG 113
Query: 725 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ---AEEDLTHISSVARGTVG 781
L + H+ ++HRD+K N+L++ N K+++FGL+R + V T+
Sbjct: 114 LGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSA--EVV--TLW 166
Query: 782 YLDPEY-YGNQQLTEKSDVYSFGVVLLELISGKKP 815
Y P+ +G + + D++S G + EL + +P
Sbjct: 167 YRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP 201
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 9e-18
Identities = 50/217 (23%), Positives = 90/217 (41%), Gaps = 35/217 (16%)
Query: 619 KKIGKGSFGSVYYGK-MKDGKEVAVK-IMADSCSHRTQQFVTEVALLSRIHHRNLVPLI- 675
+G+G++G V G+ VA+K I + + E+ +L H N++ +
Sbjct: 17 SLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFN 76
Query: 676 ----GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLD-----WLTRLQIAHDAAKGLE 726
E ++ ++ E M T D LH ++ + L + Q + ++
Sbjct: 77 IQRPDSFENFNEVYIIQELM--QT--D-LHRVISTQMLSDDHIQYFIY-QTL----RAVK 126
Query: 727 YLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTV---GYL 783
LH +IHRD+K SN+L++ N KV DFGL+R +E S ++
Sbjct: 127 VLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFV 183
Query: 784 DPEYY-------GNQQLTEKSDVYSFGVVLLELISGK 813
+Y + + + DV+S G +L EL +
Sbjct: 184 ATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 1e-17
Identities = 63/227 (27%), Positives = 106/227 (46%), Gaps = 45/227 (19%)
Query: 619 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRT--QQFVTEVALLSRIH-HRNLVPL 674
KK+GKG++G V+ + G+ VAVK + D+ + T Q+ E+ +L+ + H N+V L
Sbjct: 15 KKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNL 74
Query: 675 --IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLD-----WLTRLQIAHDAAKGLEY 727
+ + + LV++YM T D LH + L+ ++ Q+ K ++Y
Sbjct: 75 LNVLRADNDRDVYLVFDYM--ET--D-LHAVIRANILEPVHKQYVVY-QLI----KVIKY 124
Query: 728 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 787
LH+G G++HRD+K SNILL+ KV+DFGLSR +++ +
Sbjct: 125 LHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFD 181
Query: 788 YGNQQLTE---------------------KSDVYSFGVVLLELISGK 813
LT+ D++S G +L E++ GK
Sbjct: 182 DDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 1e-17
Identities = 58/210 (27%), Positives = 99/210 (47%), Gaps = 28/210 (13%)
Query: 619 KKIGKGSFGSVYYGK-MKDGKEVAVK-IMA-DSCSH--RTQQFVTEVALLSRIHHRNLVP 673
IG+G++G V + VA+K I + ++ RT + E+ +L R H N++
Sbjct: 33 SYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRT---LREIKILLRFRHENIIG 89
Query: 674 LI-----GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYL 728
+ E+ +V + M T D L+ + + L + +GL+Y+
Sbjct: 90 INDIIRAPTIEQMKDVYIVQDLM--ET--D-LYKLLKTQHLSNDHICYFLYQILRGLKYI 144
Query: 729 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISS----VARGTVGYLD 784
H+ ++HRD+K SN+LL+ K+ DFGL+R A+ D H VA T Y
Sbjct: 145 HSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA--TRWYRA 199
Query: 785 PEYYGN-QQLTEKSDVYSFGVVLLELISGK 813
PE N + T+ D++S G +L E++S +
Sbjct: 200 PEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 1e-17
Identities = 54/212 (25%), Positives = 86/212 (40%), Gaps = 27/212 (12%)
Query: 619 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVP-LIG 676
+KIG GSFG +Y G + G+EVA+K+ H Q E + + +P +
Sbjct: 15 RKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRW 72
Query: 677 YCEEEHQRILVYEYMHNG----TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 732
E ++V E + G L + + K T L +A +EY+H
Sbjct: 73 CGAEGDYNVMVMELL--GPSLEDLFNFCSRKFSLK-----TVLLLADQMISRIEYIH--- 122
Query: 733 NPGIIHRDVKSSNILLDINMRAK---VSDFGLSRQ--AEEDLTHISSVA----RGTVGYL 783
+ IHRDVK N L+ + + + DFGL+++ HI GT Y
Sbjct: 123 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 182
Query: 784 DPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 815
+ + + + D+ S G VL+ G P
Sbjct: 183 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLP 214
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 85.2 bits (211), Expect = 1e-17
Identities = 56/213 (26%), Positives = 93/213 (43%), Gaps = 26/213 (12%)
Query: 620 KIGKGSFGSVYYGKMKD---GKEVAVK-IMADSCSHRTQQFVTEVALLSRIHHRNLVPLI 675
K+G+G++G VY K KD K+ A+K I S E+ALL + H N++ L
Sbjct: 28 KVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSA---CREIALLRELKHPNVISLQ 84
Query: 676 GYCEEEHQRI--LVYEYMHN--GTLRDRLHGSVNQKPLDWLTRLQI---AHDAAKGLEYL 728
R L+++Y + + S K L R + + G+ YL
Sbjct: 85 KVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYL 144
Query: 729 HTGCNPGIIHRDVKSSNILLDI----NMRAKVSDFGLSRQ---AEEDLTHISSVARGTVG 781
H ++HRD+K +NIL+ R K++D G +R + L + V T
Sbjct: 145 HAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV-TFW 200
Query: 782 YLDPEY-YGNQQLTEKSDVYSFGVVLLELISGK 813
Y PE G + T+ D+++ G + EL++ +
Sbjct: 201 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 233
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 1e-17
Identities = 59/225 (26%), Positives = 97/225 (43%), Gaps = 43/225 (19%)
Query: 616 NFCKKIGKGSFGSVYYGKMKDGKEV-AVKIMA-DSCSHRTQQF--VTEVALLSRIHHRNL 671
++ K +GKG+FG V + K A+KI+ + + + VTE +L H L
Sbjct: 8 DYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFL 67
Query: 672 VPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAH----DAAK--- 723
L Y + H R+ V EY + G L L + A+
Sbjct: 68 TALK-YAFQTHDRLCFVMEYANGGEL---------------FFHLSRERVFTEERARFYG 111
Query: 724 -----GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR- 777
LEYLH + +++RD+K N++LD + K++DFGL + E ++ + +
Sbjct: 112 AEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK---EGISD-GATMKT 164
Query: 778 --GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 820
GT YL PE + D + GVV+ E++ G+ P +D
Sbjct: 165 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 209
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 83.7 bits (208), Expect = 2e-17
Identities = 56/216 (25%), Positives = 98/216 (45%), Gaps = 38/216 (17%)
Query: 616 NFCKKIGKGSFGSVYYGKMKDGKEV-AVKIMADSCSHRTQQF---VTEVALLSRIHHRNL 671
+ +G GSFG V+ + + A+K++ R +Q E +LS + H +
Sbjct: 9 QILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFI 68
Query: 672 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAH----DAAK---- 723
+ + G ++ Q ++ +Y+ G L + L+ + AK
Sbjct: 69 IRMWGTFQDAQQIFMIMDYIEGGEL---------------FSLLRKSQRFPNPVAKFYAA 113
Query: 724 ----GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGT 779
LEYLH + II+RD+K NILLD N K++DFG ++ D+T+ GT
Sbjct: 114 EVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKY-VPDVTY---TLCGT 166
Query: 780 VGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 815
Y+ PE + + D +SFG+++ E+++G P
Sbjct: 167 PDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTP 202
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 2e-17
Identities = 55/226 (24%), Positives = 97/226 (42%), Gaps = 55/226 (24%)
Query: 620 KIGKGSFGSVYYGKMKD-GKEVAVK------------IMADSCSHRTQQFVTEVALLSRI 666
KIG+G+FG V+ + + G++VA+K I A + E+ +L +
Sbjct: 24 KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITA----------LREIKILQLL 73
Query: 667 HHRNLVPLIGYCEEEHQRI--------LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA 718
H N+V LI C + LV+++ + D L G ++ + T +I
Sbjct: 74 KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH----D-LAGLLSNVLVK-FTLSEIK 127
Query: 719 HDAA---KGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR-------QAEED 768
GL Y+H I+HRD+K++N+L+ + K++DFGL+R
Sbjct: 128 RVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNR 184
Query: 769 LTHISSVARGTVGYLDPEY-YGNQQLTEKSDVYSFGVVLLELISGK 813
T+ V T+ Y PE G + D++ G ++ E+ +
Sbjct: 185 YTNR--VV--TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 226
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 2e-17
Identities = 51/216 (23%), Positives = 91/216 (42%), Gaps = 38/216 (17%)
Query: 616 NFCKKIGKGSFGSVYYGKMKDGKEV-AVKIMADSCSHRTQQF---VTEVALLSRIHHRNL 671
+ K +G GSFG V K K+ A+KI+ + +Q + E +L ++ L
Sbjct: 44 DRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFL 103
Query: 672 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAH----DAAK---- 723
V L ++ +V EY+ G + + L+ A+
Sbjct: 104 VKLEFSFKDNSNLYMVMEYVAGGEM---------------FSHLRRIGRFSEPHARFYAA 148
Query: 724 ----GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGT 779
EYLH + +I+RD+K N+L+D +V+DFG +++ + T GT
Sbjct: 149 QIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR-VKGRTW---TLCGT 201
Query: 780 VGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 815
L PE ++ + D ++ GV++ E+ +G P
Sbjct: 202 PEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 3e-17
Identities = 62/224 (27%), Positives = 104/224 (46%), Gaps = 39/224 (17%)
Query: 616 NFCKKIGKGSFGSVYYGKMKDGKEV----AVKIM--ADSCSHRTQQFVTEVALLSRIHHR 669
K +G+GSFG V+ K G + A+K++ A + E +L ++H
Sbjct: 27 ELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHP 86
Query: 670 NLVPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAH----DAAK- 723
+V L Y + ++ L+ +++ G L TRL + K
Sbjct: 87 FIVKLH-YAFQTEGKLYLILDFLRGGDL---------------FTRLSKEVMFTEEDVKF 130
Query: 724 -------GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVA 776
L++LH + GII+RD+K NILLD K++DFGLS+++ + S
Sbjct: 131 YLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC 187
Query: 777 RGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 820
GTV Y+ PE + T+ +D +SFGV++ E+++G P +D
Sbjct: 188 -GTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKD 230
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 4e-17
Identities = 58/214 (27%), Positives = 93/214 (43%), Gaps = 38/214 (17%)
Query: 619 KKIGKGSFGSVYYGK-MKDGKEVAVK-IMADSCSHRTQQF-VT---EVALLSRIHHRNLV 672
+G+G F +VY + + VA+K I S T E+ LL + H N++
Sbjct: 16 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 75
Query: 673 PLIGYCEEEHQRILVYEYMHN---GTLRDRLHGSVNQKPLD------WLTRLQIAHDAAK 723
L+ + LV+++M ++D N L ++ L +
Sbjct: 76 GLLDAFGHKSNISLVFDFMETDLEVIIKD------NSLVLTPSHIKAYM--LMTL----Q 123
Query: 724 GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ---AEEDLTHISSVARGTV 780
GLEYLH I+HRD+K +N+LLD N K++DFGL++ TH V T
Sbjct: 124 GLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQ--VV--TR 176
Query: 781 GYLDPEY-YGNQQLTEKSDVYSFGVVLLELISGK 813
Y PE +G + D+++ G +L EL+
Sbjct: 177 WYRAPELLFGARMYGVGVDMWAVGCILAELLLRV 210
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 83.3 bits (206), Expect = 7e-17
Identities = 52/243 (21%), Positives = 87/243 (35%), Gaps = 55/243 (22%)
Query: 619 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPLI 675
IG+GS+G VY K VA+K + ++ + E+ +L+R+ ++ L
Sbjct: 32 HLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLY 91
Query: 676 GYCEEEHQRI-----LVYEYMHNGTLRDRLHGSV--NQKPLDWLTRL-------QIAHDA 721
+ +V E + D L LT +
Sbjct: 92 DLIIPDDLLKFDELYIVLEIA--DS--D-LKKLFKTPIF----LTEEHIKTILYNLL--- 139
Query: 722 AKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL-THISSVARGTV 780
G ++H GIIHRD+K +N LL+ + KV DFGL+R + T+I +
Sbjct: 140 -LGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENE 195
Query: 781 GYLDPEYYGNQQLTE--------------------KS-DVYSFGVVLLELISGKKPVSVE 819
+QLT KS D++S G + EL++ + +
Sbjct: 196 EPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHIND 255
Query: 820 DFG 822
Sbjct: 256 PTN 258
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 81.4 bits (202), Expect = 9e-17
Identities = 52/228 (22%), Positives = 97/228 (42%), Gaps = 45/228 (19%)
Query: 616 NFCKKIGKGSFGSVY---YGKMKDGKEV-AVKIMA-DSCSHRTQQFV---TEVALLSRIH 667
+ +GKG +G V+ + ++ A+K++ + E +L +
Sbjct: 20 ELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVK 79
Query: 668 HRNLVPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAH----DAA 722
H +V LI Y + ++ L+ EY+ G L +L+ D A
Sbjct: 80 HPFIVDLI-YAFQTGGKLYLILEYLSGGEL---------------FMQLEREGIFMEDTA 123
Query: 723 K--------GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA--EEDLTHI 772
L +LH GII+RD+K NI+L+ K++DFGL +++ + +TH
Sbjct: 124 CFYLAEISMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTH- 179
Query: 773 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 820
+ GT+ Y+ PE D +S G ++ ++++G P + E+
Sbjct: 180 -TFC-GTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGEN 225
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 1e-16
Identities = 54/219 (24%), Positives = 95/219 (43%), Gaps = 42/219 (19%)
Query: 615 NNFCK--KIGKGSFGSVYYGK-MKDGKEVAVKIM-------ADSCSHRTQQFVTEVALLS 664
+ K K+G+G++ +VY GK VA+K + A + R EV+LL
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIR------EVSLLK 55
Query: 665 RIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTR------LQIA 718
+ H N+V L E LV+EY+ +D L ++ Q+
Sbjct: 56 DLKHANIVTLHDIIHTEKSLTLVFEYLD----KD-LKQYLDDCGNIINMHNVKLFLFQLL 110
Query: 719 HDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ---AEEDLTHISSV 775
+GL Y H ++HRD+K N+L++ K++DFGL+R + + V
Sbjct: 111 ----RGLAYCH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNE--V 161
Query: 776 ARGTVGYLDPEY-YGNQQLTEKSDVYSFGVVLLELISGK 813
T+ Y P+ G+ + + D++ G + E+ +G+
Sbjct: 162 V--TLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGR 198
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 82.9 bits (205), Expect = 1e-16
Identities = 44/197 (22%), Positives = 80/197 (40%), Gaps = 33/197 (16%)
Query: 619 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPLI 675
IG GS+G V + + VA+K + ++ + E+A+L+R++H ++V ++
Sbjct: 59 HLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVL 118
Query: 676 -----GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAH------DAAKG 724
E+ + +V E D K L H + G
Sbjct: 119 DIVIPKDVEKFDELYVVLEIAD----SD-FK-----KLFRTPVYLTELHIKTLLYNLLVG 168
Query: 725 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARG------ 778
++Y+H+ GI+HRD+K +N L++ + KV DFGL+R + S +
Sbjct: 169 VKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDM 225
Query: 779 TVGYLDPEYYGNQQLTE 795
+ +QLT
Sbjct: 226 NLVTFPHTKNLKRQLTG 242
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 1e-16
Identities = 38/157 (24%), Positives = 63/157 (40%), Gaps = 23/157 (14%)
Query: 619 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVP-LIG 676
KKIG G+FG + GK + + VA+K+ Q E ++ + +P +
Sbjct: 15 KKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA--PQLHLEYRFYKQLGSGDGIPQVYY 72
Query: 677 YCEEEHQRILVYEYMHNG----TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 732
+ +V E + G L D + + K T L IA +EY+H
Sbjct: 73 FGPCGKYNAMVLELL--GPSLEDLFDLCDRTFSLK-----TVLMIAIQLISRMEYVH--- 122
Query: 733 NPGIIHRDVKSSNILLDINMRAKVS-----DFGLSRQ 764
+ +I+RDVK N L+ DF L+++
Sbjct: 123 SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE 159
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 2e-16
Identities = 61/226 (26%), Positives = 93/226 (41%), Gaps = 44/226 (19%)
Query: 616 NFCKKIGKGSFGSVYYGKMKDGKEV-AVKIMA-DSCSHRTQQFVTEV---ALLSRIHHRN 670
+F K IGKGSFG V + K + AVK++ + + ++ LL + H
Sbjct: 41 HFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPF 100
Query: 671 LVPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAH----DAAK-- 723
LV L + + ++ V +Y++ G L LQ A+
Sbjct: 101 LVGLH-FSFQTADKLYFVLDYINGGEL---------------FYHLQRERCFLEPRARFY 144
Query: 724 ------GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR 777
L YLH + I++RD+K NILLD ++DFGL + E++ H +S
Sbjct: 145 AAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCK---ENIEH-NSTTS 197
Query: 778 ---GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 820
GT YL PE Q D + G VL E++ G P +
Sbjct: 198 TFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN 243
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 2e-16
Identities = 43/214 (20%), Positives = 84/214 (39%), Gaps = 29/214 (13%)
Query: 619 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVP-LIG 676
++IG+GSFG ++ G + + ++VA+K Q E + +P +
Sbjct: 16 RRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYY 73
Query: 677 YCEEEHQRILVYEYMHNG----TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 732
+ +E +LV + + G L D + K T A ++ +H
Sbjct: 74 FGQEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVK-----TVAMAAKQMLARVQSIH--- 123
Query: 733 NPGIIHRDVKSSNILLDINMRAK-----VSDFGLSRQAEEDLT--HISSVA----RGTVG 781
+++RD+K N L+ V DFG+ + + +T HI GT
Sbjct: 124 EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTAR 183
Query: 782 YLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 815
Y+ + ++ + + D+ + G V + + G P
Sbjct: 184 YMSINTHLGREQSRRDDLEALGHVFMYFLRGSLP 217
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 2e-16
Identities = 49/212 (23%), Positives = 89/212 (41%), Gaps = 35/212 (16%)
Query: 620 KIGKGSFGSVYYGKMKD-GKEVAVKIM--------ADSCSHRTQQFVTEVALLSRIHHRN 670
K+G+G++G VY + VA+K + + R EV+LL + HRN
Sbjct: 41 KLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIR------EVSLLKELQHRN 94
Query: 671 LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 730
++ L H+ L++EY N L+ + + + G+ + H+
Sbjct: 95 IIELKSVIHHNHRLHLIFEYAEN-DLKKYMD---KNPDVSMRVIKSFLYQLINGVNFCHS 150
Query: 731 GCNPGIIHRDVKSSNILLDINMRA-----KVSDFGLSRQ---AEEDLTHISSVARGTVGY 782
+HRD+K N+LL ++ + K+ DFGL+R TH + T+ Y
Sbjct: 151 ---RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHE--II--TLWY 203
Query: 783 LDPEY-YGNQQLTEKSDVYSFGVVLLELISGK 813
PE G++ + D++S + E++
Sbjct: 204 RPPEILLGSRHYSTSVDIWSIACIWAEMLMKT 235
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 4e-16
Identities = 52/220 (23%), Positives = 95/220 (43%), Gaps = 37/220 (16%)
Query: 619 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIH---------- 667
+K+G G F +V+ K M + VA+KI+ + + E+ LL R++
Sbjct: 25 RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYT-EAAEDEIKLLQRVNDADNTKEDSM 83
Query: 668 -HRNLVPLIGY-----CEEEHQRILVYEYMHNGTLRDRLHGSVNQK-PLDWLTRLQIAHD 720
+++ L+ + H ++V+E + L + ++ PL + QI+
Sbjct: 84 GANHILKLLDHFNHKGPNGVHV-VMVFEVLGE-NLLALIKKYEHRGIPLI-YVK-QISKQ 139
Query: 721 AAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRA------KVSDFGLSRQAEEDLT-HIS 773
GL+Y+H C IIH D+K N+L++I K++D G + +E T I
Sbjct: 140 LLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQ 197
Query: 774 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGK 813
+ Y PE +D++S ++ ELI+G
Sbjct: 198 TRE-----YRSPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 80.8 bits (199), Expect = 5e-16
Identities = 53/212 (25%), Positives = 93/212 (43%), Gaps = 27/212 (12%)
Query: 619 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVP-LIG 676
+KIG GSFG +Y G ++ +EVA+K+ H Q + E + + +P +
Sbjct: 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRW 70
Query: 677 YCEEEHQRILVYEYMHNG----TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 732
+ E +LV + + G L + ++ K T L +A +E++H
Sbjct: 71 FGVEGDYNVLVMDLL--GPSLEDLFNFCSRKLSLK-----TVLMLADQMINRVEFVH--- 120
Query: 733 NPGIIHRDVKSSNILLDINMRAK---VSDFGLSRQAEEDLT--HISSVA----RGTVGYL 783
+ +HRD+K N L+ + RA + DFGL+++ + T HI GT Y
Sbjct: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 180
Query: 784 DPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 815
+ + + + D+ S G VL+ + G P
Sbjct: 181 SVNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 6e-16
Identities = 60/232 (25%), Positives = 101/232 (43%), Gaps = 49/232 (21%)
Query: 616 NFCKKIGKGSFGSVYYGKMKDGKEV----AVKIMA-DSCSHRTQQFV---TEVALLSRI- 666
K +G G++G V+ + G + A+K++ + + + TE +L I
Sbjct: 57 ELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIR 116
Query: 667 HHRNLVPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAH----DA 721
LV L Y + ++ L+ +Y++ G L T L
Sbjct: 117 QSPFLVTLH-YAFQTETKLHLILDYINGGEL---------------FTHLSQRERFTEHE 160
Query: 722 AK--------GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 773
+ LE+LH GII+RD+K NILLD N ++DFGLS+ E + +
Sbjct: 161 VQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSK---EFVADET 214
Query: 774 SVAR---GTVGYLDPE-YYGNQQLTEKS-DVYSFGVVLLELISGKKPVSVED 820
A GT+ Y+ P+ G +K+ D +S GV++ EL++G P +V+
Sbjct: 215 ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDG 266
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 9e-16
Identities = 58/212 (27%), Positives = 96/212 (45%), Gaps = 29/212 (13%)
Query: 620 KIGKGSFGSVYYGK-MKDGKEVAVK-IMADSCSHRTQQF-VT---EVALLSRIH---HRN 670
+IG G++G+VY + G VA+K + + ++ EVALL R+ H N
Sbjct: 16 EIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPN 75
Query: 671 LVPLI-----GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQI---AHDAA 722
+V L+ + E + LV+E++ +D L +++ P L I
Sbjct: 76 VVRLMDVCATSRTDREIKVTLVFEHVD----QD-LRTYLDKAPPPGLPAETIKDLMRQFL 130
Query: 723 KGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGY 782
+GL++LH I+HRD+K NIL+ K++DFGL+R + V T+ Y
Sbjct: 131 RGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVV--TLWY 185
Query: 783 LDPEY-YGNQQLTEKSDVYSFGVVLLELISGK 813
PE + T D++S G + E+ K
Sbjct: 186 RAPEVLLQSTYATP-VDMWSVGCIFAEMFRRK 216
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 1e-15
Identities = 57/212 (26%), Positives = 96/212 (45%), Gaps = 26/212 (12%)
Query: 616 NFCKKIGKGSFGSVYYGKMKDGKEV-AVK------IMADSCSHRTQQFVTEVALLSRI-H 667
+ + IG+GS+ V ++K + A+K + D Q TE + + +
Sbjct: 12 DLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQ---TEKHVFEQASN 68
Query: 668 HRNLVPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLD-WLTRLQIAHDAAKGL 725
H LV L C + R+ V EY++ G L + Q+ L R A + + L
Sbjct: 69 HPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQ---RQRKLPEEHARFYSA-EISLAL 123
Query: 726 EYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ--AEEDLTHISSVARGTVGYL 783
YLH GII+RD+K N+LLD K++D+G+ ++ D T GT Y+
Sbjct: 124 NYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC---GTPNYI 177
Query: 784 DPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 815
PE + D ++ GV++ E+++G+ P
Sbjct: 178 APEILRGEDYGFSVDWWALGVLMFEMMAGRSP 209
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 80.5 bits (198), Expect = 1e-15
Identities = 63/214 (29%), Positives = 98/214 (45%), Gaps = 20/214 (9%)
Query: 616 NFCKKIGKGSFGSVYYGKMKDGKEV-AVK------IMADSCSHRTQQFVTEVALLSRI-H 667
NF +GKGSFG V + K E+ AVK ++ D T E +L+
Sbjct: 344 NFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTM---VEKRVLALPGK 400
Query: 668 HRNLVPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLE 726
L L C + R+ V EY++ G L H + + A + A GL
Sbjct: 401 PPFLTQLH-SCFQTMDRLYFVMEYVNGGDLM--YHIQQVGRFKEPHAVFYAA-EIAIGLF 456
Query: 727 YLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE 786
+L + GII+RD+K N++LD K++DFG+ ++ D + GT Y+ PE
Sbjct: 457 FLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFC-GTPDYIAPE 512
Query: 787 YYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 820
Q + D ++FGV+L E+++G+ P ED
Sbjct: 513 IIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED 546
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 1e-15
Identities = 56/212 (26%), Positives = 96/212 (45%), Gaps = 26/212 (12%)
Query: 616 NFCKKIGKGSFGSVYYGKMKDGKEV-AVK------IMADSCSHRTQQFVTEVALLSRI-H 667
+ + IG+GS+ V ++K + A++ + D Q TE + + +
Sbjct: 55 DLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQ---TEKHVFEQASN 111
Query: 668 HRNLVPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLD-WLTRLQIAHDAAKGL 725
H LV L C + R+ V EY++ G L + Q+ L R A + + L
Sbjct: 112 HPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQ---RQRKLPEEHARFYSA-EISLAL 166
Query: 726 EYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ--AEEDLTHISSVARGTVGYL 783
YLH GII+RD+K N+LLD K++D+G+ ++ D T GT Y+
Sbjct: 167 NYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC---GTPNYI 220
Query: 784 DPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 815
PE + D ++ GV++ E+++G+ P
Sbjct: 221 APEILRGEDYGFSVDWWALGVLMFEMMAGRSP 252
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 1e-15
Identities = 62/216 (28%), Positives = 100/216 (46%), Gaps = 24/216 (11%)
Query: 616 NFCKKIGKGSFGSVYYGKMKDGKEV-AVK------IMADSCSHRTQQFVTEVALLSRI-H 667
F + +GKGSFG V ++K+ ++ AVK I+ D T TE +LS +
Sbjct: 26 EFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTM---TEKRILSLARN 82
Query: 668 HRNLVPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLE 726
H L L C + R+ V E+++ G L H +++ + R A + L
Sbjct: 83 HPFLTQLF-CCFQTPDRLFFVMEFVNGGDLM--FHIQKSRRFDEARARFYAA-EIISALM 138
Query: 727 YLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ--AEEDLTHISSVARGTVGYLD 784
+LH GII+RD+K N+LLD K++DFG+ ++ T ++ GT Y+
Sbjct: 139 FLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTT--ATFC-GTPDYIA 192
Query: 785 PEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 820
PE D ++ GV+L E++ G P E+
Sbjct: 193 PEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAEN 228
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 3e-15
Identities = 59/214 (27%), Positives = 95/214 (44%), Gaps = 20/214 (9%)
Query: 616 NFCKKIGKGSFGSVYYGKMKDGKEV-AVKIMA-DSCSHRTQQFVTEV---ALLSRIHHRN 670
K +GKGSFG V+ + K + A+K + D T V L H
Sbjct: 20 ILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPF 79
Query: 671 LVPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 729
L + + + + V EY++ G L + K A + GL++LH
Sbjct: 80 LTHMF-CTFQTKENLFFVMEYLNGGDLMYHIQSC--HKFDLSRATFYAA-EIILGLQFLH 135
Query: 730 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR---GTVGYLDPE 786
+ GI++RD+K NILLD + K++DFG+ + E++ + GT Y+ PE
Sbjct: 136 ---SKGIVYRDLKLDNILLDKDGHIKIADFGMCK---ENMLG-DAKTNTFCGTPDYIAPE 188
Query: 787 YYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 820
Q+ D +SFGV+L E++ G+ P +D
Sbjct: 189 ILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD 222
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 4e-15
Identities = 63/217 (29%), Positives = 99/217 (45%), Gaps = 26/217 (11%)
Query: 616 NFCKKIGKGSFGSVYYGKMKDGKEV-AVK------IMADSCSHRTQQFVTEVALLSRI-H 667
NF +GKGSFG V + K E+ AVK ++ D T E +L+
Sbjct: 23 NFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTM---VEKRVLALPGK 79
Query: 668 HRNLVPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLE 726
L L C + R+ V EY++ G L + V + A + A GL
Sbjct: 80 PPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQ-QVGRFKEPH-AVFYAA-EIAIGLF 135
Query: 727 YLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR---GTVGYL 783
+L + GII+RD+K N++LD K++DFG+ + E++ + GT Y+
Sbjct: 136 FLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCK---ENIWD-GVTTKTFCGTPDYI 188
Query: 784 DPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 820
PE Q + D ++FGV+L E+++G+ P ED
Sbjct: 189 APEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED 225
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 7e-15
Identities = 40/231 (17%), Positives = 80/231 (34%), Gaps = 45/231 (19%)
Query: 619 KKIGKGSFGSVYYGK---------MKDGKEVAVKI-MADSCSHRTQQF------VTEVAL 662
+ + G +Y ++ ++K+ D Q F +V
Sbjct: 48 SFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNK 107
Query: 663 LSRIHHRNL--VPLIGYC--EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA 718
+++ L +P ++ R LV + G + L + LQ+A
Sbjct: 108 WKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQSALDVSPKHVLSERSVLQVA 165
Query: 719 HDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKV--SDFGLSRQAEEDLTHI---- 772
LE+LH +H +V + NI +D +++V + +G + + H+
Sbjct: 166 CRLLDALEFLH---ENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVE 222
Query: 773 --SSVARGTVGYLDPEY------YGNQQLTEKSDVYSFGVVLLELISGKKP 815
S G + E+ G + +SD+ S G +L+ + G P
Sbjct: 223 GSRSPHEGDL-----EFISMDLHKGCGP-SRRSDLQSLGYCMLKWLYGFLP 267
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 9e-15
Identities = 53/254 (20%), Positives = 92/254 (36%), Gaps = 60/254 (23%)
Query: 605 IPLPELEEATNNFC------KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFV 657
+P PE + + KKIG G FG +Y ++ A ++
Sbjct: 23 MPFPEGKVLDDMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVE-YQENGPLF 81
Query: 658 TEVALLSRIHHRNL--------------VPLIGYC-----EEEHQRILVYEYMHNGT-LR 697
+E+ R+ ++ +PL + R +V E + G L+
Sbjct: 82 SELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQ 139
Query: 698 D--RLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAK 755
+G+ + T LQ+ LEY+H +H D+K++N+LL +
Sbjct: 140 KISGQNGTFKKS-----TVLQLGIRMLDVLEYIH---ENEYVHGDIKAANLLLGYKNPDQ 191
Query: 756 V--SDFGLSRQAEEDLTHISSVAR------GTVGYLDPEY------YGNQQLTEKSDVYS 801
V +D+GLS + + H GT+ E+ G + +SDV
Sbjct: 192 VYLADYGLSYRYCPNGNHKQYQENPRKGHNGTI-----EFTSLDAHKGVAL-SRRSDVEI 245
Query: 802 FGVVLLELISGKKP 815
G +L + GK P
Sbjct: 246 LGYCMLRWLCGKLP 259
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 1e-14
Identities = 20/136 (14%), Positives = 41/136 (30%), Gaps = 12/136 (8%)
Query: 391 NDRGDPCVPVPWEWVTCSTTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLT 450
N + + V+ ++ R+T ++L G G +P + + L L L +
Sbjct: 61 NFNKELDMWGAQPGVSLNSNG--RVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEK 118
Query: 451 GP-----LPDMSRLIDLRIVHLENNELTGSLPSYMG--SLPNLQELHIENNSFVGEIPPA 503
+S + + Y +L + I ++ I +
Sbjct: 119 VNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKS 178
Query: 504 ---LLTGKVIFKYDNN 516
L I + NN
Sbjct: 179 SRITLKDTQIGQLSNN 194
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 1e-14
Identities = 24/95 (25%), Positives = 37/95 (38%), Gaps = 2/95 (2%)
Query: 415 ITKIALSGKNLK-GEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELT 473
I I + NLK + L+ M+ L L N L G LP I L ++L N++T
Sbjct: 307 IQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLPAFGSEIKLASLNLAYNQIT 366
Query: 474 GSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGK 508
++ G ++ L +N IP
Sbjct: 367 EIPANFCGFTEQVENLSFAHNKL-KYIPNIFDAKS 400
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 1e-13
Identities = 16/98 (16%), Positives = 36/98 (36%), Gaps = 10/98 (10%)
Query: 414 RITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGP---------LPDMSRLIDLRI 464
+T + + ++P LK + + + + N L D ++I
Sbjct: 250 DLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQI 309
Query: 465 VHLENNEL-TGSLPSYMGSLPNLQELHIENNSFVGEIP 501
+++ N L T + + + + L L N G++P
Sbjct: 310 IYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLP 347
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 3e-11
Identities = 16/126 (12%), Positives = 38/126 (30%), Gaps = 22/126 (17%)
Query: 416 TKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP--------------------D 455
T+I N+ + + + L + ++ +
Sbjct: 186 TQIGQLSNNI-TFVSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLK 244
Query: 456 MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDN 515
L DL V + N LP+++ +LP +Q +++ N + + +
Sbjct: 245 WDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGIS-GEQLKDDWQALADAPV 303
Query: 516 NPKLHK 521
K+
Sbjct: 304 GEKIQI 309
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 5e-11
Identities = 15/110 (13%), Positives = 36/110 (32%), Gaps = 19/110 (17%)
Query: 414 RITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELT 473
+ K ++ + I + T++ N +T + RL LR ++ N+
Sbjct: 160 DLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITFVSKAVMRLTKLRQFYMGNSPFV 219
Query: 474 G-------------------SLPSYMGSLPNLQELHIENNSFVGEIPPAL 504
+ +L +L ++ + N + ++P L
Sbjct: 220 AENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFL 269
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 5e-11
Identities = 18/103 (17%), Positives = 33/103 (32%), Gaps = 12/103 (11%)
Query: 413 PRITKIALSGKNLKGEIPPELK--NMEALTELWLDGNFLTGPLPD----MSRLIDLRIVH 466
+T I L L + + + + L + L N + P S L I +
Sbjct: 488 YLLTSIDLRFNKLTK-LSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRN 545
Query: 467 ---LENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLT 506
+ N P + P+L +L I +N + +
Sbjct: 546 QRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRK-VNEKITP 587
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 2e-10
Identities = 21/98 (21%), Positives = 32/98 (32%), Gaps = 10/98 (10%)
Query: 416 TKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTG--------PLPDMSRLIDLRIVHL 467
+ I LS + L+ + L GN LT + L + L
Sbjct: 436 SSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDL 495
Query: 468 ENNELTGSLPS-YMGSLPNLQELHIENNSFVGEIPPAL 504
N+LT +LP L + + NSF + P
Sbjct: 496 RFNKLTKLSDDFRATTLPYLVGIDLSYNSF-SKFPTQP 532
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 3e-10
Identities = 20/116 (17%), Positives = 42/116 (36%), Gaps = 19/116 (16%)
Query: 409 TTTPPRI-------TKIALSGKNLKGEIPP--ELKNMEALTELWLDGNFLTG-------P 452
T P ++ + LK IP + K++ ++ + N + P
Sbjct: 366 TEIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDP 424
Query: 453 LP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 507
L + I++ ++L NN+++ + L +++ N EIP L
Sbjct: 425 LDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNML-TEIPKNSLKD 479
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 5e-10
Identities = 11/89 (12%), Positives = 31/89 (34%), Gaps = 4/89 (4%)
Query: 420 LSGKNLKGEIPPELK--NMEALTELWLDGNFLTGPLPDMSRL-IDLRIVHLENNELTGSL 476
+ + + L + ++ + + SR+ + + +N +T +
Sbjct: 140 KMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNIT-FV 198
Query: 477 PSYMGSLPNLQELHIENNSFVGEIPPALL 505
+ L L++ ++ N+ FV E
Sbjct: 199 SKAVMRLTKLRQFYMGNSPFVAENICEAW 227
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 1e-09
Identities = 11/95 (11%), Positives = 32/95 (33%), Gaps = 10/95 (10%)
Query: 420 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELT----- 473
+ N++ LT++ + LP + L +++++++ N
Sbjct: 232 SEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQL 291
Query: 474 ---GSLPSYMGSLPNLQELHIENNSF-VGEIPPAL 504
+ +Q ++I N+ + +L
Sbjct: 292 KDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSL 326
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 2e-09
Identities = 20/118 (16%), Positives = 39/118 (33%), Gaps = 15/118 (12%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTEL------WLDGNFLTGPLPD-MSRLIDLRIV 465
P + I LS + P + N L GN P+ ++ L +
Sbjct: 513 PYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQL 571
Query: 466 HLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLT----GKVIFKYDNNPKL 519
+ +N++ + PN+ L I++N + + G + YD +
Sbjct: 572 QIGSNDIR-KVNE--KITPNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDKTQDI 626
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 2e-14
Identities = 58/218 (26%), Positives = 100/218 (45%), Gaps = 43/218 (19%)
Query: 620 KIGKGSFGSVYYGKMKDGKE----VAVKIMADSCSHRTQQF-----VT---EVALL---S 664
+IG+G++G V+ K +D K VA+K + R Q ++ EVA+L
Sbjct: 18 EIGEGAYGKVF--KARDLKNGGRFVALKRV------RVQTGEEGMPLSTIREVAVLRHLE 69
Query: 665 RIHHRNLVPLI-----GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQI-- 717
H N+V L + E + LV+E++ +D L +++ P + I
Sbjct: 70 TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD----QD-LTTYLDKVPEPGVPTETIKD 124
Query: 718 -AHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVA 776
+GL++LH+ ++HRD+K NIL+ + + K++DFGL+R + S V
Sbjct: 125 MMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV 181
Query: 777 RGTVGYLDPEY-YGNQQLTEKSDVYSFGVVLLELISGK 813
T+ Y PE + T D++S G + E+ K
Sbjct: 182 --TLWYRAPEVLLQSSYATP-VDLWSVGCIFAEMFRRK 216
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 72.5 bits (178), Expect = 1e-13
Identities = 48/253 (18%), Positives = 84/253 (33%), Gaps = 57/253 (22%)
Query: 606 PLPELEEATNNFC------KKIGKGSFGSVYYGKMKDGKEVAVKI--MADSCSHRTQQFV 657
E T+ IG+G FG +Y M + V +
Sbjct: 22 QFAVGEIITDMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLF 81
Query: 658 TEVALLSRIHHRNL--------------VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGS 703
TE+ R VP + Y +M + DR
Sbjct: 82 TELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFM----IMDRFGSD 137
Query: 704 VNQKPLDWLTR-------LQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKV 756
+ QK + + LQ++ LEY+H +H D+K+SN+LL+ +V
Sbjct: 138 L-QKIYEANAKRFSRKTVLQLSLRILDILEYIH---EHEYVHGDIKASNLLLNYKNPDQV 193
Query: 757 --SDFGLSRQAEEDLTHISSVAR------GTVGYLDPEY------YGNQQLTEKSDVYSF 802
D+GL+ + + H + A GT+ E+ G + + D+
Sbjct: 194 YLVDYGLAYRYCPEGVHKAYAADPKRCHDGTI-----EFTSIDAHNGVAP-SRRGDLEIL 247
Query: 803 GVVLLELISGKKP 815
G +++ ++G P
Sbjct: 248 GYCMIQWLTGHLP 260
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 6e-13
Identities = 56/213 (26%), Positives = 91/213 (42%), Gaps = 37/213 (17%)
Query: 619 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHR------NL 671
K IGKGSFG V K + VA+K++ + Q E+ +L + + N+
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAE-EIRILEHLRKQDKDNTMNV 161
Query: 672 VPLIGY-------CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQ-IAHDAAK 723
+ ++ C + +E + L + + + + L ++ AH +
Sbjct: 162 IHMLENFTFRNHIC-------MTFELLSM-NLYELIKKN-KFQGFS-LPLVRKFAHSILQ 211
Query: 724 GLEYLHTGCNPGIIHRDVKSSNILLDINMRA--KVSDFGLSRQAEEDL-THISSVARGTV 780
L+ LH IIH D+K NILL R+ KV DFG S + + T+I S R
Sbjct: 212 CLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQS--R--- 263
Query: 781 GYLDPEYYGNQQLTEKSDVYSFGVVLLELISGK 813
Y PE + D++S G +L EL++G
Sbjct: 264 FYRAPEVILGARYGMPIDMWSLGCILAELLTGY 296
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 1e-12
Identities = 19/96 (19%), Positives = 36/96 (37%), Gaps = 1/96 (1%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNE 471
P + + LS ++ +++ L+ L L GN + S L L+ +
Sbjct: 52 PELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETN 111
Query: 472 LTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 507
L +G L L+EL++ +N P +
Sbjct: 112 LASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSN 147
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 1e-12
Identities = 17/87 (19%), Positives = 32/87 (36%), Gaps = 2/87 (2%)
Query: 420 LSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNELTGSLP 477
++G + + P+ + LT L L L P + L L+++++ +N
Sbjct: 452 MAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDT 511
Query: 478 SYMGSLPNLQELHIENNSFVGEIPPAL 504
L +LQ L N + L
Sbjct: 512 FPYKCLNSLQVLDYSLNHIMTSKKQEL 538
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 1e-12
Identities = 17/94 (18%), Positives = 36/94 (38%), Gaps = 2/94 (2%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNE 471
++ + L+G ++ + +L +L L L L+ +++ +N
Sbjct: 76 SHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNL 135
Query: 472 LTG-SLPSYMGSLPNLQELHIENNSFVGEIPPAL 504
+ LP Y +L NL+ L + +N L
Sbjct: 136 IQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDL 169
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 2e-12
Identities = 16/97 (16%), Positives = 31/97 (31%), Gaps = 3/97 (3%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD--MSRLIDLRIVHLENN 470
+ + LS + + +E L L + L L +L + + +
Sbjct: 373 TSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHT 431
Query: 471 ELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 507
+ L +L+ L + NSF P + T
Sbjct: 432 HTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTE 468
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 1e-11
Identities = 17/91 (18%), Positives = 32/91 (35%), Gaps = 2/91 (2%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNE 471
+T + LS L+ P ++ +L L + N L L+++ N
Sbjct: 470 RNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNH 529
Query: 472 LTGSLPSYMGSLP-NLQELHIENNSFVGEIP 501
+ S + P +L L++ N F
Sbjct: 530 IMTSKKQELQHFPSSLAFLNLTQNDFACTCE 560
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 8e-11
Identities = 16/82 (19%), Positives = 25/82 (30%), Gaps = 1/82 (1%)
Query: 424 NLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLP-SYMGS 482
+ KG +L L L N + + L L + +++ L S S
Sbjct: 360 SFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLS 419
Query: 483 LPNLQELHIENNSFVGEIPPAL 504
L NL L I +
Sbjct: 420 LRNLIYLDISHTHTRVAFNGIF 441
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 2e-10
Identities = 17/86 (19%), Positives = 26/86 (30%), Gaps = 4/86 (4%)
Query: 420 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPS 478
N +IP L + L L N L +L+++ L E+
Sbjct: 14 CMELNFY-KIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDG 70
Query: 479 YMGSLPNLQELHIENNSFVGEIPPAL 504
SL +L L + N A
Sbjct: 71 AYQSLSHLSTLILTGNPIQSLALGAF 96
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 8e-10
Identities = 19/98 (19%), Positives = 37/98 (37%), Gaps = 6/98 (6%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTG-PLPDM-SRLIDLRIVHLENN 470
+ K+ NL + +++ L EL + N + LP+ S L +L + L +N
Sbjct: 100 SSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSN 159
Query: 471 ELTGSLPSYMGSLPNLQ----ELHIENNSFVGEIPPAL 504
++ + + L + L + N P A
Sbjct: 160 KIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAF 197
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 4e-07
Identities = 12/96 (12%), Positives = 30/96 (31%), Gaps = 4/96 (4%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLI--DLRIVHLENN 470
+ + +S N K + +L L N + + L ++L N
Sbjct: 494 SSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQN 553
Query: 471 ELTGSLPS--YMGSLPNLQELHIENNSFVGEIPPAL 504
+ + ++ + + ++L +E P
Sbjct: 554 DFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDK 589
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 8e-07
Identities = 16/94 (17%), Positives = 33/94 (35%), Gaps = 5/94 (5%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALT----ELWLDGNFLTGPLPDMSRLIDLRIVHLE 468
+ + LS ++ +L+ + + L L N + P + I L + L
Sbjct: 149 TNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLR 208
Query: 469 NNELTGSLPSY-MGSLPNLQELHIENNSFVGEIP 501
NN + ++ + L L+ + F E
Sbjct: 209 NNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGN 242
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 2e-06
Identities = 15/114 (13%), Positives = 30/114 (26%), Gaps = 11/114 (9%)
Query: 414 RITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTG----PLPDMSRLIDLRIVHLE 468
R+ K+ L + ++ + L L D S L L + +E
Sbjct: 201 RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIE 260
Query: 469 NNELT------GSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNN 516
L + L N+ + + + + G + N
Sbjct: 261 EFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNC 314
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 69.6 bits (170), Expect = 2e-12
Identities = 54/258 (20%), Positives = 91/258 (35%), Gaps = 73/258 (28%)
Query: 619 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIH--------HR 669
+K+G G F +V+ ++ K VA+K++ S H T+ + E+ LL +
Sbjct: 43 RKLGWGHFSTVWLSWDIQGKKFVAMKVVK-SAEHYTETALDEIRLLKSVRNSDPNDPNRE 101
Query: 670 NLVPLIGY-----CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKG 724
+V L+ H +V+E + + L + S N + L +I +G
Sbjct: 102 MVVQLLDDFKISGVNGTHI-CMVFEVLGH-HLLKWIIKS-NYQGLPLPCVKKIIQQVLQG 158
Query: 725 LEYLHTGCNPGIIHRDVKSSNILLDIN--------------------------------- 751
L+YLHT C IIH D+K NILL +N
Sbjct: 159 LDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPAT 216
Query: 752 ----------------MRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTE 795
++ K++D G + + T T Y E
Sbjct: 217 AGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQ----TRQYRSLEVLIGSGYNT 272
Query: 796 KSDVYSFGVVLLELISGK 813
+D++S + EL +G
Sbjct: 273 PADIWSTACMAFELATGD 290
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 68.4 bits (166), Expect = 2e-12
Identities = 33/193 (17%), Positives = 57/193 (29%), Gaps = 54/193 (27%)
Query: 618 CKKIGKGSFGSVYYGKMKDGKEVAVKIMA--------DSCSHRTQQFVTEVALLSRIH-- 667
C+KIG+G FG V+ D VA+KI+A S ++ + E+ + +
Sbjct: 25 CEKIGEGVFGEVFQTI-ADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLL 83
Query: 668 -------HRNLVPLIGYC------------------------------EEEHQRILVYEY 690
+ L ++ Q +V E+
Sbjct: 84 SGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEF 143
Query: 691 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI 750
G +++ K T I H L + HRD+ N+LL
Sbjct: 144 EFGGIDLEQMR----TKLSSLATAKSILHQLTASLAVAEA--SLRFEHRDLHWGNVLLKK 197
Query: 751 NMRAKVSDFGLSR 763
K+ +
Sbjct: 198 TSLKKLHYTLNGK 210
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 69.1 bits (168), Expect = 5e-12
Identities = 101/679 (14%), Positives = 188/679 (27%), Gaps = 208/679 (30%)
Query: 269 NLEDFPANARAFAYFAEIQDLGPSETRKFKL--------EQPY--F------ADYSNAVV 312
+++D P + + I + + +L E+ F +Y +
Sbjct: 37 DVQDMPKSILSKEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMS 96
Query: 313 NIAENAN---GSYTLYEPSYMNVTLNFVLSFS--FVKTRDSTLGPLLNAI-EISKYQKI- 365
I +Y + N F+ V +R L A+ E+ + +
Sbjct: 97 PIKTEQRQPSMMTRMYI-EQRDRLYNDNQVFAKYNV-SRLQPYLKLRQALLELRPAKNVL 154
Query: 366 ------AAKTEWQDVMVLEALRSISDESERTNDRGDPCVPVPWEWVTCSTTTPPRITKIA 419
+ KT + L+ S + + D + W +
Sbjct: 155 IDGVLGSGKT----WVALDVCL--SYKVQCKMDFK-----IFW---------------LN 188
Query: 420 LSGKNLKGEIPPELKNMEALTELW--LDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLP 477
L N + +E L +L +D N+ D S I LRI + + L
Sbjct: 189 LKNCNSPETV------LEMLQKLLYQIDPNWT--SRSDHSSNIKLRI-----HSIQAELR 235
Query: 478 SYMGSLPNLQEL----HIEN----NSF--------------VGEIPPALLTGKVIFKYDN 515
+ S P L +++N N+F V + A T + + +
Sbjct: 236 RLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHS 295
Query: 516 NPKLHKESRRRMRFKLILGTSIGVL---AILLVLFLCSLIVLRKLRRKISNQKSYEKVCP 572
E + L L + S+I +R ++ +++ V
Sbjct: 296 MTLTPDEVKS--LLLKYLDCRPQDLPREVLTTNPRRLSIIA-ESIRDGLATWDNWKHV-- 350
Query: 573 LADSLRTSTKPS-NTAYSIARGGHFMDEGVAYF-----IPLP------------ELEEAT 614
D L T + S N F V F IP ++
Sbjct: 351 NCDKLTTIIESSLNVLEPAEYRKMFDRLSV--FPPSAHIPTILLSLIWFDVIKSDVMVVV 408
Query: 615 NNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPL 674
N K S+ K KE + I + L ++ N L
Sbjct: 409 NKLHKY-------SLV---EKQPKESTISI------P-------SIYLELKVKLENEYAL 445
Query: 675 IGYCEEEHQRIL-VYEYMHNGTLRDRLHGSVNQKPLD--WLTRLQIAHDAAKGLEYLH-T 730
H+ I+ Y + + LD + + I H H
Sbjct: 446 -------HRSIVDHYNI-----PKTFDSDDLIPPYLDQYFYS--HIGH---------HLK 482
Query: 731 GCNPGIIHRDVKSSNILLDIN-MRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYG 789
R + LD + K+ + A + + ++Y
Sbjct: 483 NIEHP--ERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILNT---------LQQLKFYK 531
Query: 790 NQQLTEKSDVYSFGVVLLELISGKKPVSVEDF--GAELNIVHWARSMIKKGDVISIVDPV 847
+ + Y L++ ++ DF E N++ S K D++ I
Sbjct: 532 -PYICDNDPKYE------RLVN-----AILDFLPKIEENLI---CS--KYTDLLRI---A 571
Query: 848 LIGNVKIESIWRIAEVAIQ 866
L + E+I+ A +Q
Sbjct: 572 L--MAEDEAIFEEAHKQVQ 588
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 51.0 bits (121), Expect = 2e-06
Identities = 101/635 (15%), Positives = 189/635 (29%), Gaps = 228/635 (35%)
Query: 10 IYLLF---LSSVVSQVTEFISIDCGSTSNYTDPSTGLAWISDIGIMNNGKSVKVEN--PS 64
LF LS V +F+ + NY ++ +K E PS
Sbjct: 64 TLRLFWTLLSKQEEMVQKFV--EEVLRINY-------KFLMS--------PIKTEQRQPS 106
Query: 65 GNWMQYRTRRD-LPIDNKKYC-YNLITKERRRYLVRATFQ---------YGSLGSEASYP 113
Y +RD L DN+ + YN+ + L +A + G LGS
Sbjct: 107 MMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSG---- 162
Query: 114 KFQLYLDATLWSTVTVLDASRVYAKEMIIRAPSDSI---DVCICCAVTGSPFISTLELRP 170
K T + A V + I ++ + L
Sbjct: 163 K-------------TWV-ALDVCLSYKVQCKMDFKIFWLNL-------KNCNSPETVLEM 201
Query: 171 L-NLSMYAT-DFEDNFFLKVAARVNFGALTKDALR-------YP------DDPYDRIWDS 215
L L ++ ++ ++ + LR Y + + ++
Sbjct: 202 LQKLLYQIDPNWTSRSDHSSNIKLRIHSI-QAELRRLLKSKPYENCLLVLLN----VQNA 256
Query: 216 DLDRRPNFVVGAASGTVRI-NTTKNIE------TRTREYPPVKVMQTAVVGTE--GVLSY 266
A + + +I TT+ + T + + + E +L
Sbjct: 257 K-------AWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLK 309
Query: 267 RLNL--EDFPANA-----RAFAYFAE---------------------------IQDLGPS 292
L+ +D P R + AE + L P+
Sbjct: 310 YLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPA 369
Query: 293 ETRKFKLEQPYFADYSNAV----VNIAEN------ANGSYTLYEPSYMNVTLNFVLSFSF 342
E RK F +V +I + + + +N + +S
Sbjct: 370 EYRK------MFDRL--SVFPPSAHIPTILLSLIWFDVIK--SDVMVV---VNKLHKYSL 416
Query: 343 VKTR--DSTLGPLLNAIEISKYQKIAAKTEWQDVMVLEALRSISD--ESERTNDRGDPCV 398
V+ + +ST+ + +I Y ++ K E + L RSI D +T D D
Sbjct: 417 VEKQPKESTIS--IPSI----YLELKVKLE--NEYALH--RSIVDHYNIPKTFDSDDL-- 464
Query: 399 PVPWEWVTCSTTTPPRITKIALS--GKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM 456
PP + + S G +LK PE + ++LD F
Sbjct: 465 ------------IPPYLDQYFYSHIGHHLKNIEHPERMTL--FRMVFLDFRF-------- 502
Query: 457 SRLIDLRIVHLENNELTGSLPSYMGSLPN-LQEL-----HIENNS------------FVG 498
++ +I H + + GS+ N LQ+L +I +N F+
Sbjct: 503 ---LEQKIRH------DSTAWNASGSILNTLQQLKFYKPYICDNDPKYERLVNAILDFLP 553
Query: 499 EIPPALLTGK------VIFKYDNNPKLHKESRRRM 527
+I L+ K + ++ + +E+ +++
Sbjct: 554 KIEENLICSKYTDLLRIALMAEDEA-IFEEAHKQV 587
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 49.5 bits (117), Expect = 5e-06
Identities = 50/319 (15%), Positives = 88/319 (27%), Gaps = 101/319 (31%)
Query: 644 IMADSCSHRTQQFVTEVA------LLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLR 697
+ Q+FV EV L+S I P + Y R
Sbjct: 70 TLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRM--------YIEQ-----R 116
Query: 698 DRLHGSVNQKPLDWLTRLQIAHDAAKGLE--------YLH--TGCNPGIIHRDVKSS--- 744
DRL+ ++RLQ + L + G G K+
Sbjct: 117 DRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGS--G------KTWVAL 168
Query: 745 NILLDINMRAKVSD------FGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSD 798
++ L ++ K+ E L + + +DP + T +SD
Sbjct: 169 DVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLY----QIDPNW------TSRSD 218
Query: 799 VYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVIS--IVDPVLIGNVKIES 856
S + + AEL R + K ++ NV+
Sbjct: 219 -----------HSSNIKLRIHSIQAELR-----RLLKSKPYENCLLVLL-----NVQNAK 257
Query: 857 IWRIAEVAIQCVEQRGFSRPKMQEIVL----AIQDSIKIEKGGD---QKFSSSSSKGQSS 909
W + C K+ ++ + D + S + + +
Sbjct: 258 AWN--AFNLSC---------KI--LLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEV- 303
Query: 910 RKTLLTSFLEIESPDLSNE 928
K+LL +L+ DL E
Sbjct: 304 -KSLLLKYLDCRPQDLPRE 321
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 49.1 bits (116), Expect = 8e-06
Identities = 67/469 (14%), Positives = 135/469 (28%), Gaps = 134/469 (28%)
Query: 16 SSVVSQVTEFISIDCGSTSNYTDPSTGLAWISDIGIMNNGKSV--KVENPSGNWMQYRTR 73
+ V V + C + W++ + N+ ++V ++ T
Sbjct: 164 TWVALDVCLSYKVQCK-------MDFKIFWLN-LKNCNSPETVLEMLQKLLYQIDPNWTS 215
Query: 74 RDLPIDNKKYCYNLITKERRRYLVRATFQYGSLGSEASYPKFQLYLDATLWSTVTVLDAS 133
R N K + I E RR L Y L L + + +A
Sbjct: 216 RSDHSSNIKLRIHSIQAELRRLL-----------KSKPYENCLLVLL-NVQNA-KAWNAF 262
Query: 134 RVYAKEMII---RAPSDSIDVCICCAVTGSPFISTL------------------ELR--- 169
+ K ++ + +D + ++ TL +L
Sbjct: 263 NLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREV 322
Query: 170 ----PLNLSMYATDFED-----NFFLKV-------AARVNFGALTKDALR--------YP 205
P LS+ A D + + V + L R +P
Sbjct: 323 LTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFP 382
Query: 206 DD---PYD---RIWD-----------------SDLDRRPNFVVGAASGTVRINTTKNIET 242
P IW S ++++P T+ I +I
Sbjct: 383 PSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPK------ESTISIP---SIYL 433
Query: 243 RTREYPPVKVMQTAVVGTEGVLSYRL----NLEDFPANARAFAYFAE-----IQDLGPSE 293
+ K+ + V Y + + +D YF ++++ E
Sbjct: 434 ELKV----KLENEYALHRSIVDHYNIPKTFDSDDLIPP-YLDQYFYSHIGHHLKNIEHPE 488
Query: 294 TRKFKLEQPYFADYS---NAVVNIAENANGSYTLYEPSYMNVTLNFVLSFSFVKTRDSTL 350
+ L + F D+ + + + N S S +N ++ D
Sbjct: 489 --RMTLFRMVFLDFRFLEQKIRHDSTAWNAS-----GSILNTLQQLKFYKPYICDNDPKY 541
Query: 351 GPLLNAIE--ISKYQKIAAKTEWQDVMVLEAL----RSISDESERTNDR 393
L+NAI + K ++ +++ D++ + AL +I +E+ + R
Sbjct: 542 ERLVNAILDFLPKIEENLICSKYTDLLRI-ALMAEDEAIFEEAHKQVQR 589
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 5e-12
Identities = 27/95 (28%), Positives = 41/95 (43%), Gaps = 4/95 (4%)
Query: 411 TPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLEN 469
T P + L L + P + + L + +D L LPD M + L + L
Sbjct: 79 TQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLME-LPDTMQQFAGLETLTLAR 136
Query: 470 NELTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 504
N L +LP+ + SL L+EL I + E+P L
Sbjct: 137 NPLR-ALPASIASLNRLRELSIRACPELTELPEPL 170
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 5e-11
Identities = 21/95 (22%), Positives = 41/95 (43%), Gaps = 12/95 (12%)
Query: 420 LSGKNLKGEIPPELKNMEA---------LTELWLDGNFLTGPLPD-MSRLIDLRIVHLEN 469
+ E+P L + +A L L L+ + LP ++ L +L+ + + N
Sbjct: 157 IRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIRS-LPASIANLQNLKSLKIRN 215
Query: 470 NELTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 504
+ L+ +L + LP L+EL + + + PP
Sbjct: 216 SPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIF 249
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 5e-11
Identities = 19/106 (17%), Positives = 39/106 (36%), Gaps = 3/106 (2%)
Query: 416 TKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGS 475
+ L ++ +P + N++ L L + + L+ P + L L + L +
Sbjct: 186 QSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSALGPAIHHLPKLEELDLRGCTALRN 244
Query: 476 LPSYMGSLPNLQELHIENNSFVGEIPPAL--LTGKVIFKYDNNPKL 519
P G L+ L +++ S + +P + LT L
Sbjct: 245 YPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNL 290
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 8e-11
Identities = 20/89 (22%), Positives = 29/89 (32%), Gaps = 4/89 (4%)
Query: 420 LSGKNLKGEIPPELKNMEALTELWL-DGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLP 477
L G PP L L L D + L LP + RL L + L LP
Sbjct: 236 LRGCTALRNYPPIFGGRAPLKRLILKDCSNLLT-LPLDIHRLTQLEKLDLRGCVNLSRLP 294
Query: 478 SYMGSLPNLQELHIENNSFVGEIPPALLT 506
S + LP + + + ++
Sbjct: 295 SLIAQLPANCIILVPPH-LQAQLDQHRPV 322
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 1e-08
Identities = 26/100 (26%), Positives = 40/100 (40%), Gaps = 15/100 (15%)
Query: 416 TKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHL-ENNELT 473
+ + L E+P ++ L L L N L LP ++ L LR + + ELT
Sbjct: 107 QHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLRA-LPASIASLNRLRELSIRACPELT 164
Query: 474 GSLPSYMGS---------LPNLQELHIENNSFVGEIPPAL 504
LP + S L NLQ L +E +P ++
Sbjct: 165 -ELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASI 202
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 4e-05
Identities = 13/69 (18%), Positives = 27/69 (39%), Gaps = 4/69 (5%)
Query: 420 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENN---ELTGS 475
L + +P ++ + L +L L G LP +++L I+ + + +L
Sbjct: 260 LKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQH 319
Query: 476 LPSYMGSLP 484
P + P
Sbjct: 320 RPVARPAEP 328
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 1e-04
Identities = 11/107 (10%), Positives = 23/107 (21%), Gaps = 24/107 (22%)
Query: 420 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRL-------------------- 459
G L + + + +
Sbjct: 19 FQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRALKATADLLEDA 78
Query: 460 --IDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 504
+ L + L P L +LQ + I+ + E+P +
Sbjct: 79 TQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTM 123
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 1e-11
Identities = 17/98 (17%), Positives = 34/98 (34%), Gaps = 6/98 (6%)
Query: 413 PRITKIALSGKNLKGEIPPELK---NMEALTELWLDGNFLTGPLPDM---SRLIDLRIVH 466
R+ + L+ L + +L ++ L L + L+ + +L ++
Sbjct: 195 GRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLD 254
Query: 467 LENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 504
L N L LP L+ +E N+ +L
Sbjct: 255 LSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSL 292
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 2e-11
Identities = 18/111 (16%), Positives = 33/111 (29%), Gaps = 9/111 (8%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM---SRLIDLRIVHLEN 469
+ + LS L +E L EL L N + + L+ + L +
Sbjct: 121 KNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSS 180
Query: 470 NELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNNPKLH 520
N++ P ++ L L + N + L N +
Sbjct: 181 NQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKL------CLELANTSIR 225
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 4e-11
Identities = 22/93 (23%), Positives = 33/93 (35%), Gaps = 1/93 (1%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNE 471
P + + L L LTEL L N + + + +L + L +N
Sbjct: 73 PMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNG 132
Query: 472 LTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 504
L+ + L NLQEL + NN L
Sbjct: 133 LSSTKLGTQVQLENLQELLLSNNKIQALKSEEL 165
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 4e-11
Identities = 23/94 (24%), Positives = 41/94 (43%), Gaps = 1/94 (1%)
Query: 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENN 470
P IT + L+ L+ LT L + N ++ P++ +L L++++L++N
Sbjct: 24 PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHN 83
Query: 471 ELTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 504
EL+ NL ELH+ +NS
Sbjct: 84 ELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPF 117
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 8e-11
Identities = 15/93 (16%), Positives = 31/93 (33%), Gaps = 1/93 (1%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNE 471
++T + + + P + + L L L N L+ + +L +HL +N
Sbjct: 49 SQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNS 108
Query: 472 LTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 504
+ + NL L + +N
Sbjct: 109 IQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQ 141
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 2e-10
Identities = 18/89 (20%), Positives = 31/89 (34%), Gaps = 1/89 (1%)
Query: 420 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNELTGSLPS 478
L G LK + L L L+ N ++ L +L+I+ L N L S
Sbjct: 519 LWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPAS 578
Query: 479 YMGSLPNLQELHIENNSFVGEIPPALLTG 507
+ +L+ L+++ N
Sbjct: 579 VFNNQVSLKSLNLQKNLITSVEKKVFGPA 607
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 2e-10
Identities = 27/139 (19%), Positives = 44/139 (31%), Gaps = 4/139 (2%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTG---PLPDMSRLIDLRIVHLEN 469
I +I LS + +L L L L L +L I+ L N
Sbjct: 430 ENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSN 489
Query: 470 NELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNNPKLHKESRRRMRF 529
N + + L L+ L +++N+ + G I+ LH + F
Sbjct: 490 NNIANINDDMLEGLEKLEILDLQHNNLA-RLWKHANPGGPIYFLKGLSHLHILNLESNGF 548
Query: 530 KLILGTSIGVLAILLVLFL 548
I L L ++ L
Sbjct: 549 DEIPVEVFKDLFELKIIDL 567
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 3e-10
Identities = 16/96 (16%), Positives = 37/96 (38%), Gaps = 3/96 (3%)
Query: 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENN 470
+T++ L +++ + L L L N L+ +L +L+ + L NN
Sbjct: 96 CTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNN 155
Query: 471 ELTGSLPS--YMGSLPNLQELHIENNSFVGEIPPAL 504
++ + + +L++L + +N P
Sbjct: 156 KIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCF 191
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 3e-10
Identities = 19/99 (19%), Positives = 36/99 (36%), Gaps = 6/99 (6%)
Query: 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM----SRLIDLRIVHL 467
+ K+ LS +K P + L L+L+ L L + +R + L
Sbjct: 170 NSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSL 229
Query: 468 ENNELTGSLPSYMGSL--PNLQELHIENNSFVGEIPPAL 504
N++L+ + + L NL L + N+ +
Sbjct: 230 SNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSF 268
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 3e-10
Identities = 16/103 (15%), Positives = 33/103 (32%), Gaps = 4/103 (3%)
Query: 406 TCSTTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM--SRLIDLR 463
T + + + L+ + + L L L N + L L ++
Sbjct: 374 TFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIF 433
Query: 464 IVHLENNELTGSLPSYMGSLPNLQELHIENNSF--VGEIPPAL 504
++L N+ + +P+LQ L + + V P
Sbjct: 434 EIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPF 476
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 4e-10
Identities = 22/101 (21%), Positives = 36/101 (35%), Gaps = 9/101 (8%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLT---------GPLPDMSRLIDLR 463
+T + LS N+ L+ +E L L L N L GP+ + L L
Sbjct: 480 RNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLH 539
Query: 464 IVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 504
I++LE+N L L+ + + N+
Sbjct: 540 ILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVF 580
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 6e-10
Identities = 15/100 (15%), Positives = 32/100 (32%), Gaps = 5/100 (5%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMS-----RLIDLRIVHL 467
+ + + ++ G + L L L +F + L I++L
Sbjct: 329 KCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNL 388
Query: 468 ENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 507
N+++ L +L+ L + N E+ G
Sbjct: 389 TKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRG 428
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 1e-09
Identities = 19/90 (21%), Positives = 35/90 (38%), Gaps = 7/90 (7%)
Query: 420 LSGKNLKGEIPPEL-KNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLP 477
S L ++P +L N +T L L N L + +R L + + N ++ P
Sbjct: 11 CSHLKLT-QVPDDLPTN---ITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEP 66
Query: 478 SYMGSLPNLQELHIENNSFVGEIPPALLTG 507
LP L+ L++++N +
Sbjct: 67 ELCQKLPMLKVLNLQHNELSQ-LSDKTFAF 95
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 4e-09
Identities = 26/146 (17%), Positives = 49/146 (33%), Gaps = 15/146 (10%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD----------MSRLIDL 462
P++ L N++ L + + L L +F + L L
Sbjct: 272 PQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCL 331
Query: 463 RIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNNPKLHKE 522
+++E+N++ G + L NL+ L + N+ F + LH
Sbjct: 332 EHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNE-----TFVSLAHSPLHIL 386
Query: 523 SRRRMRFKLILGTSIGVLAILLVLFL 548
+ + + I + L L VL L
Sbjct: 387 NLTKNKISKIESDAFSWLGHLEVLDL 412
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 6e-04
Identities = 18/110 (16%), Positives = 31/110 (28%), Gaps = 5/110 (4%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM--SRLIDLRIVHLENN 470
+ I L NL N +L L L N +T + +L + + N
Sbjct: 560 FELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFN 619
Query: 471 ELTGSLPSYMGSLPNLQELHIENNSFVGEIP---PALLTGKVIFKYDNNP 517
+ S + + E H P G + +D +
Sbjct: 620 PFDCTCESIAWFVNWINETHTNIPELSSHYLCNTPPHYHGFPVRLFDTSS 669
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 67.2 bits (164), Expect = 2e-11
Identities = 10/81 (12%), Positives = 29/81 (35%), Gaps = 4/81 (4%)
Query: 424 NLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSL 483
N I ++ + L ++ + T +D + + + + +L
Sbjct: 435 NRITFISKAIQRLTKLQIIYFANSPFTYDNI----AVDWEDANSDYAKQYENEELSWSNL 490
Query: 484 PNLQELHIENNSFVGEIPPAL 504
+L ++ + N + ++P L
Sbjct: 491 KDLTDVELYNCPNMTQLPDFL 511
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 64.1 bits (156), Expect = 2e-10
Identities = 17/103 (16%), Positives = 31/103 (30%), Gaps = 13/103 (12%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGP---------LPDM-SRLIDL 462
+T + L ++P L ++ L L + N L D +
Sbjct: 491 KDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKI 550
Query: 463 RIVHLENNELTGSLPSY-MGSLPNLQELHIENNSFVGEIPPAL 504
+I ++ N L S + + L L +N A
Sbjct: 551 QIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKV--RHLEAF 591
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 61.8 bits (150), Expect = 7e-10
Identities = 21/110 (19%), Positives = 41/110 (37%), Gaps = 12/110 (10%)
Query: 420 LSGKNLKGEIPPELK--NMEALTELWLDGNFLTGPLPD----MSRLIDLRIVH---LENN 470
L L + + + + L+ + + N + P S+L I H E N
Sbjct: 735 LRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGN 792
Query: 471 ELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNNPKLH 520
+ P+ + + P+L +L I +N ++ L I +NP +
Sbjct: 793 RILRQWPTGITTCPSLIQLQIGSNDI-RKVDEKLTPQLYILDIADNPNIS 841
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 61.8 bits (150), Expect = 8e-10
Identities = 22/100 (22%), Positives = 35/100 (35%), Gaps = 14/100 (14%)
Query: 414 RITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD---MSRLIDLRIVHLENN 470
+T I +N KN LT + L N LT L D + L L + + N
Sbjct: 708 LMTSIP---ENSLKPKDGNYKNTYLLTTIDLRFNKLTS-LSDDFRATTLPYLSNMDVSYN 763
Query: 471 ELTGSLPSYMGSLPNLQELHIE------NNSFVGEIPPAL 504
+ S P+ + L+ I N + + P +
Sbjct: 764 CFS-SFPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGI 802
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 61.8 bits (150), Expect = 8e-10
Identities = 13/108 (12%), Positives = 32/108 (29%), Gaps = 4/108 (3%)
Query: 391 NDRGDPCVPVPWEWVTCSTTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLT 450
N + + V R+T ++L+G KG +P + + L L + T
Sbjct: 303 NFNKELDMWGDQPGVDLDNNG--RVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSET 360
Query: 451 GPLPDMSRL-IDLRIVHLENNELTGSLPS-YMGSLPNLQELHIENNSF 496
+ + + + ++ L + ++
Sbjct: 361 VSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAI 408
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 61.0 bits (148), Expect = 2e-09
Identities = 19/104 (18%), Positives = 36/104 (34%), Gaps = 10/104 (9%)
Query: 413 PRITKIALSGKNLKGEIPP--ELKNMEALTELWLDGNFLTGPLPDMS------RLIDLRI 464
++ + S LK IP K++ + + N + ++S + I+
Sbjct: 619 DQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINAST 677
Query: 465 VHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGK 508
V L NE+ + + + + NN IP L K
Sbjct: 678 VTLSYNEIQKFPTELFATGSPISTIILSNNLM-TSIPENSLKPK 720
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 60.3 bits (146), Expect = 2e-09
Identities = 20/99 (20%), Positives = 35/99 (35%), Gaps = 7/99 (7%)
Query: 413 PRITKIALSGKNLKGEIPPE--LKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENN 470
P+I + NL+ E P L+ M L L N + L + L + L+ N
Sbjct: 548 PKIQIFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKVRH-LEAFGTNVKLTDLKLDYN 605
Query: 471 ELTGSLPSYMGS-LPNLQELHIENNSFVGEIPPALLTGK 508
++ +P + ++ L +N IP
Sbjct: 606 QIE-EIPEDFCAFTDQVEGLGFSHNKL-KYIPNIFNAKS 642
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 59.5 bits (144), Expect = 4e-09
Identities = 20/118 (16%), Positives = 41/118 (34%), Gaps = 15/118 (12%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTEL------WLDGNFLTGPLPD-MSRLIDLRIV 465
P ++ + +S P + N L +GN + P ++ L +
Sbjct: 753 PYLSNMDVSYNCFS-SFPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQL 811
Query: 466 HLENNELTGSLPSYMGSLPNLQELHIENNSF----VGEIPPALLTGKVIFKYDNNPKL 519
+ +N++ + + P L L I +N V + P + G + YD +
Sbjct: 812 QIGSNDIR-KVDEKL--TPQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQDI 866
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 50.3 bits (120), Expect = 3e-06
Identities = 11/94 (11%), Positives = 29/94 (30%), Gaps = 8/94 (8%)
Query: 420 LSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTG---- 474
++ L + L L + + P+M + + L++ ++
Sbjct: 378 ERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINR-NPEMKPIKKDSRISLKDTQIGNLTNR 436
Query: 475 --SLPSYMGSLPNLQELHIENNSFVGEIPPALLT 506
+ + L LQ ++ N+ F +
Sbjct: 437 ITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWE 470
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 46.8 bits (111), Expect = 3e-05
Identities = 24/148 (16%), Positives = 43/148 (29%), Gaps = 8/148 (5%)
Query: 417 KIALSGKNLK-----GEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNE 471
AL GKN + N EL + G+ L + R+ L L
Sbjct: 278 WEALDGKNWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNNGRVTGL---SLAGFG 334
Query: 472 LTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNNPKLHKESRRRMRFKL 531
G +P +G L L+ L +S + + ++M
Sbjct: 335 AKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDY 394
Query: 532 ILGTSIGVLAILLVLFLCSLIVLRKLRR 559
++ L + + ++K R
Sbjct: 395 DQRLNLSDLLQDAINRNPEMKPIKKDSR 422
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 1e-10
Identities = 14/97 (14%), Positives = 24/97 (24%), Gaps = 3/97 (3%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTG--PLPDMSRLIDLRIVHLENN 470
+ + LS + +E L L + L L L + +
Sbjct: 376 NSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYT 434
Query: 471 ELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 507
L +L L + NSF +
Sbjct: 435 NTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFAN 471
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 8e-10
Identities = 19/97 (19%), Positives = 38/97 (39%), Gaps = 3/97 (3%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNE 471
++ + L+G ++ P + +L L L +LI L+ +++ +N
Sbjct: 80 HHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNF 139
Query: 472 LTG-SLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 507
+ LP+Y +L NL + + N I L
Sbjct: 140 IHSCKLPAYFSNLTNLVHVDLSYNYIQT-ITVNDLQF 175
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 2e-09
Identities = 18/88 (20%), Positives = 30/88 (34%), Gaps = 3/88 (3%)
Query: 420 LSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNELTGSLP 477
++G + K N LT L L L + L L+++++ +N L
Sbjct: 455 MAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDS 514
Query: 478 SYMGSLPNLQELHIENNSFVGEIPPALL 505
S+ L +L L N L
Sbjct: 515 SHYNQLYSLSTLDCSFNRIET-SKGILQ 541
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 5e-09
Identities = 15/89 (16%), Positives = 29/89 (32%), Gaps = 5/89 (5%)
Query: 420 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPS 478
+ L ++P ++ + + L N L S +L+ + L E+
Sbjct: 18 CMDQKLS-KVPDDI--PSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDK 74
Query: 479 YMGSLPNLQELHIENNSFVGEIPPALLTG 507
L +L L + N P +G
Sbjct: 75 AWHGLHHLSNLILTGNPIQS-FSPGSFSG 102
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 6e-09
Identities = 19/96 (19%), Positives = 35/96 (36%), Gaps = 1/96 (1%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNE 471
+ + LS ++ + L+ L L GN + P S L L + +
Sbjct: 56 SELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETK 115
Query: 472 LTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 507
L +G L L++L++ +N PA +
Sbjct: 116 LASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSN 151
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 1e-08
Identities = 18/94 (19%), Positives = 24/94 (25%), Gaps = 1/94 (1%)
Query: 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENN 470
P I LS LK N L L L + L L + L N
Sbjct: 31 PSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGN 90
Query: 471 ELTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 504
+ P L +L+ L +
Sbjct: 91 PIQSFSPGSFSGLTSLENLVAVETKLASLESFPI 124
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 3e-08
Identities = 16/86 (18%), Positives = 28/86 (32%), Gaps = 1/86 (1%)
Query: 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENN 470
+T + LS L+ + L L + N L ++L L + N
Sbjct: 472 TTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFN 531
Query: 471 ELTGSLPSYMGSLPNLQELHIENNSF 496
+ S +L ++ NNS
Sbjct: 532 RIETSKGILQHFPKSLAFFNLTNNSV 557
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 2e-07
Identities = 18/101 (17%), Positives = 30/101 (29%), Gaps = 7/101 (6%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTG-PLPD-MSRLIDLRIVHLENN 470
+ + L + + L +L + NF+ LP S L +L V L N
Sbjct: 104 TSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYN 163
Query: 471 ELTGSLPSYMGSLPNL----QELHIENNSFVGEIPPALLTG 507
+ + + L L + N I G
Sbjct: 164 YIQTITVNDLQFLRENPQVNLSLDMSLNPI-DFIQDQAFQG 203
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 2e-06
Identities = 16/85 (18%), Positives = 29/85 (34%), Gaps = 4/85 (4%)
Query: 426 KGEIPPELKNMEALTELWLDGNFLTGPLPD---MSRLIDLRIVHLENNELTGSLPSYMGS 482
KG I + + +L+ L L N L+ LR + L N + +
Sbjct: 339 KGSISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMG 397
Query: 483 LPNLQELHIENNSFVGEIPPALLTG 507
L LQ L ++++ +
Sbjct: 398 LEELQHLDFQHSTLKRVTEFSAFLS 422
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 9e-06
Identities = 13/77 (16%), Positives = 30/77 (38%), Gaps = 4/77 (5%)
Query: 420 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSY 479
L+ N + + + ++ + L G + L D+ + + + + +L P+
Sbjct: 268 LTYTNDFSDDIVKFHCLANVSAMSLAGVSIKY-LEDVPKHFKWQSLSIIRCQLK-QFPT- 324
Query: 480 MGSLPNLQELHIENNSF 496
LP L+ L + N
Sbjct: 325 -LDLPFLKSLTLTMNKG 340
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 2e-10
Identities = 65/247 (26%), Positives = 101/247 (40%), Gaps = 25/247 (10%)
Query: 578 RTSTKPSNTAYSIARGGHFMDEGVAYFIPLPELEEATNNFCKKIGKGSFGSVYYGK-MKD 636
+S K Y+ + D+ Y + E IGKGSFG V +
Sbjct: 23 MSSHKKERKVYN----DGYDDDNYDYIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVE 78
Query: 637 GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHR------NLVPLIGYCEEEHQRILVYEY 690
+ VA+KI+ + + Q EV LL ++ +V L + + LV+E
Sbjct: 79 QEWVAIKIIKNKKAFL-NQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEM 137
Query: 691 MHNGTLRDRLHGSVNQKPLDWLTRLQ-IAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD 749
+ L D L + N + + L + A L +L T IIH D+K NILL
Sbjct: 138 LSY-NLYDLLRNT-NFRGVS-LNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLC 193
Query: 750 INMRA--KVSDFGLSRQAEEDL-THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVL 806
R+ K+ DFG S Q + + +I S R Y PE D++S G +L
Sbjct: 194 NPKRSAIKIVDFGSSCQLGQRIYQYIQS--R---FYRSPEVLLGMPYDLAIDMWSLGCIL 248
Query: 807 LELISGK 813
+E+ +G+
Sbjct: 249 VEMHTGE 255
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 62.9 bits (153), Expect = 3e-10
Identities = 22/154 (14%), Positives = 46/154 (29%), Gaps = 6/154 (3%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 472
+ + L + ++ ++ L L L N L P+ + + L NN+L
Sbjct: 169 DTLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKL 226
Query: 473 TGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKY---DNNPKLHKESRRRMRF 529
+ + NL+ + N F + + KL ++
Sbjct: 227 V-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTV 285
Query: 530 KLILGTSIGVLAILLVLFLCSLIVLRKLRRKISN 563
+ L F LI L++ + +
Sbjct: 286 PTLGHYGAYCCEDLPAPFADRLIALKRKEHALLS 319
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 61.4 bits (149), Expect = 8e-10
Identities = 24/95 (25%), Positives = 37/95 (38%), Gaps = 7/95 (7%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 472
+ ++ LSG L +L L L L N L D+ L LR + L NN +
Sbjct: 34 WNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYE-TLDLESLSTLRTLDLNNNYV 92
Query: 473 TGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 507
L P+++ LH NN+ + + G
Sbjct: 93 Q-ELL----VGPSIETLHAANNNI-SRVSCSRGQG 121
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 53.7 bits (129), Expect = 2e-07
Identities = 20/91 (21%), Positives = 37/91 (40%), Gaps = 4/91 (4%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNE 471
R ++ +LK + ++ + EL L GN L+ + L +++L +N
Sbjct: 10 NRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNV 69
Query: 472 LTGSLPSYMGSLPNLQELHIENNSFVGEIPP 502
L + SL L+ L + NN E+
Sbjct: 70 LY-ETLD-LESLSTLRTLDLNNNYV-QELLV 97
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 50.2 bits (120), Expect = 2e-06
Identities = 16/76 (21%), Positives = 30/76 (39%), Gaps = 3/76 (3%)
Query: 432 ELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 491
EL ++ L N ++ + SR + ++L NN++T G +Q L +
Sbjct: 94 ELLVGPSIETLHAANNNISR-VSC-SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDL 151
Query: 492 ENNSFVGEIPPALLTG 507
+ N + A L
Sbjct: 152 KLNEID-TVNFAELAA 166
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 49.5 bits (118), Expect = 4e-06
Identities = 11/87 (12%), Positives = 29/87 (33%), Gaps = 5/87 (5%)
Query: 420 LSGKNLKGEIPPELKNMEALTELWLDGNFLTG-PLPDM-SRLIDLRIVHLENNELTGSLP 477
L+ + + + L L N + ++ + L ++L+ N + +
Sbjct: 127 LANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVK 185
Query: 478 SYMGSLPNLQELHIENNSFVGEIPPAL 504
+ L+ L + +N + P
Sbjct: 186 GQV-VFAKLKTLDLSSNKLA-FMGPEF 210
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 48.7 bits (116), Expect = 6e-06
Identities = 10/69 (14%), Positives = 24/69 (34%), Gaps = 2/69 (2%)
Query: 435 NMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIEN 493
N + + L L + +++ + L N L+ + + L+ L++ +
Sbjct: 8 NGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSS 67
Query: 494 NSFVGEIPP 502
N E
Sbjct: 68 NVLY-ETLD 75
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 3e-10
Identities = 18/94 (19%), Positives = 29/94 (30%)
Query: 414 RITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELT 473
+ I L L EL L L+ + L L+ + L N+
Sbjct: 255 SVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSELPSGLVGLSTLKKLVLSANKFE 314
Query: 474 GSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 507
+ P+L L I+ N+ E+ L
Sbjct: 315 NLCQISASNFPSLTHLSIKGNTKRLELGTGCLEN 348
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 2e-09
Identities = 19/91 (20%), Positives = 30/91 (32%), Gaps = 2/91 (2%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM--SRLIDLRIVHLENN 470
+ + LS K L L L L L L++++L ++
Sbjct: 376 SHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHS 435
Query: 471 ELTGSLPSYMGSLPNLQELHIENNSFVGEIP 501
L S LP LQ L+++ N F
Sbjct: 436 LLDISSEQLFDGLPALQHLNLQGNHFPKGNI 466
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 2e-09
Identities = 19/99 (19%), Positives = 38/99 (38%), Gaps = 4/99 (4%)
Query: 413 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTG-PLPDMS--RLIDLRIVHLE 468
P +T +++ G + E+ L+N+E L EL L + + ++ L L+ ++L
Sbjct: 325 PSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLS 384
Query: 469 NNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 507
NE P L+ L + + +
Sbjct: 385 YNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQN 423
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 2e-09
Identities = 16/97 (16%), Positives = 23/97 (23%), Gaps = 2/97 (2%)
Query: 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENN 470
P + S L + LT L L + D L + L N
Sbjct: 32 PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTAN 91
Query: 471 ELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 507
L + + L+ L I L
Sbjct: 92 PLIFMAETALSGPKALKHLFFIQTGISS-IDFIPLHN 127
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 8e-09
Identities = 15/84 (17%), Positives = 35/84 (41%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 472
R+ + LS +L +++ + + L N LT + + ++L +N +
Sbjct: 476 GRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIYLNLASNHI 535
Query: 473 TGSLPSYMGSLPNLQELHIENNSF 496
+ LPS + L + +++ N
Sbjct: 536 SIILPSLLPILSQQRTINLRQNPL 559
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 8e-09
Identities = 14/96 (14%), Positives = 32/96 (33%), Gaps = 2/96 (2%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNE 471
R+ + L+ L L +AL L+ ++ L ++L +N
Sbjct: 81 HRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNH 140
Query: 472 LTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 507
++ L+ L +NN+ + ++
Sbjct: 141 ISSIKLPKGFPTEKLKVLDFQNNAIH-YLSKEDMSS 175
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 1e-08
Identities = 13/93 (13%), Positives = 29/93 (31%), Gaps = 1/93 (1%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNE 471
+T + L+ + ++ L L L N L S L+ +
Sbjct: 57 INLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTG 116
Query: 472 LTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 504
++ + + L+ L++ +N P
Sbjct: 117 ISSIDFIPLHNQKTLESLYLGSNHISSIKLPKG 149
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 2e-08
Identities = 20/89 (22%), Positives = 29/89 (32%), Gaps = 5/89 (5%)
Query: 420 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPS 478
L EIP L + L N L SRLI+L + L ++
Sbjct: 19 CENLGLN-EIPGTL--PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHED 75
Query: 479 YMGSLPNLQELHIENNSFVGEIPPALLTG 507
S L L + N + + L+G
Sbjct: 76 TFQSQHRLDTLVLTANPLIF-MAETALSG 103
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 4e-08
Identities = 17/99 (17%), Positives = 31/99 (31%), Gaps = 4/99 (4%)
Query: 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENN 470
P + + + L N + L L+L N ++ L+++ +NN
Sbjct: 104 PKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNN 163
Query: 471 ELTGSLPSYMGSLPNLQ--ELHIENNSFVGEIPPALLTG 507
+ M SL L++ N I P
Sbjct: 164 AIHYLSKEDMSSLQQATNLSLNLNGNDI-AGIEPGAFDS 201
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 1e-07
Identities = 18/97 (18%), Positives = 30/97 (30%), Gaps = 4/97 (4%)
Query: 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLID----LRIVHL 467
+ + LS L + AL L L GN + + L I+ L
Sbjct: 424 LHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVL 483
Query: 468 ENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 504
+L+ SL + + + +N AL
Sbjct: 484 SFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEAL 520
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 5e-07
Identities = 20/99 (20%), Positives = 39/99 (39%), Gaps = 5/99 (5%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD--MSRLIDLRIVHLENN 470
+ K+ LS + N +LT L + GN L + L +LR + L ++
Sbjct: 301 STLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHD 360
Query: 471 ELTGSLPSYM--GSLPNLQELHIENNSFVGEIPPALLTG 507
++ S + +L +LQ L++ N + +
Sbjct: 361 DIETSDCCNLQLRNLSHLQSLNLSYNEPLS-LKTEAFKE 398
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 9e-06
Identities = 15/97 (15%), Positives = 30/97 (30%), Gaps = 6/97 (6%)
Query: 413 PRITKIALSGKNLKGEIPPELKN--MEALTELWLDGNFLTGPLPDM---SRLIDLRIVHL 467
+ G I LKN +++L + P + + + ++L
Sbjct: 202 AVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINL 261
Query: 468 ENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 504
+ + + LQEL + E+P L
Sbjct: 262 QKHYFFNISSNTFHCFSGLQELDLTATHL-SELPSGL 297
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 5e-04
Identities = 13/99 (13%), Positives = 32/99 (32%), Gaps = 7/99 (7%)
Query: 414 RITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM---SRLIDLRIVHLENN 470
+ L+G ++ I P + L G + S + L + E+
Sbjct: 180 TNLSLNLNGNDIA-GIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDM 238
Query: 471 ELTGSLPSYMGSLP--NLQELHIENNSFVGEIPPALLTG 507
+ P+ L +++ ++++ + F I
Sbjct: 239 DDEDISPAVFEGLCEMSVESINLQKHYFFN-ISSNTFHC 276
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 5e-10
Identities = 17/99 (17%), Positives = 35/99 (35%), Gaps = 7/99 (7%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMS---RLIDLRIVHLEN 469
+ + LS + + +E L L + L + + S L +L + + +
Sbjct: 78 TSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQ-MSEFSVFLSLRNLIYLDISH 135
Query: 470 NELTGSLPSYM-GSLPNLQELHIENNSFVGEIPPALLTG 507
+ + L +L+ L + NSF P + T
Sbjct: 136 THTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTE 173
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 7e-08
Identities = 18/95 (18%), Positives = 37/95 (38%), Gaps = 7/95 (7%)
Query: 412 PPRITKIALSGKNLKGEIPP-ELKNMEALTELWLDGNFLTG---PLPDMSRLIDLRIVHL 467
P T++ L L+ +P + LT+L L N L+ L+ + L
Sbjct: 27 PSSATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDL 85
Query: 468 ENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPP 502
N + ++ S L L+ L ++++ ++
Sbjct: 86 SFNGVI-TMSSNFLGLEQLEHLDFQHSNLK-QMSE 118
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 3e-06
Identities = 13/100 (13%), Positives = 31/100 (31%), Gaps = 8/100 (8%)
Query: 413 PRITKIALSGKNLKGEIPPE--LKNMEALTELWLDGNFLTGPLPDM--SRLIDLRIVHLE 468
++ + NLK ++ ++ L L + + + L L ++ +
Sbjct: 101 EQLEHLDFQHSNLK-QMSEFSVFLSLRNLIYLDISHTHTRV-AFNGIFNGLSSLEVLKMA 158
Query: 469 NNELTGSLPSYM-GSLPNLQELHIENNSFVGEIPPALLTG 507
N + + L NL L + ++ P
Sbjct: 159 GNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNS 197
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 3e-05
Identities = 14/80 (17%), Positives = 25/80 (31%), Gaps = 4/80 (5%)
Query: 430 PPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYM--GSLPNLQ 487
+L L L N + + L L + +++ L + + SL NL
Sbjct: 71 SQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLSLRNLI 129
Query: 488 ELHIENNSFVGEIPPALLTG 507
L I + + G
Sbjct: 130 YLDISHTHTR-VAFNGIFNG 148
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 4e-05
Identities = 18/88 (20%), Positives = 35/88 (39%), Gaps = 6/88 (6%)
Query: 413 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDM--SRLIDLRIVHLEN 469
+T + LS L+ ++ P ++ +L L + N L L L+++
Sbjct: 175 RNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMSHNNFFS-LDTFPYKCLNSLQVLDYSL 232
Query: 470 NELTGSLPSYMGSLP-NLQELHIENNSF 496
N + S + P +L L++ N F
Sbjct: 233 NHIMTSKKQELQHFPSSLAFLNLTQNDF 260
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 60.2 bits (147), Expect = 9e-10
Identities = 20/91 (21%), Positives = 36/91 (39%), Gaps = 11/91 (12%)
Query: 414 RITKI-ALSG-KNLKG--------EIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLR 463
+IT + L+ L +K++ L L + N ++ + ++ L L
Sbjct: 232 KITDLSPLANLSQLTWLEIGTNQISDINAVKDLTKLKMLNVGSNQISD-ISVLNNLSQLN 290
Query: 464 IVHLENNELTGSLPSYMGSLPNLQELHIENN 494
+ L NN+L +G L NL L + N
Sbjct: 291 SLFLNNNQLGNEDMEVIGGLTNLTTLFLSQN 321
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 57.6 bits (140), Expect = 7e-09
Identities = 16/83 (19%), Positives = 31/83 (37%), Gaps = 5/83 (6%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNE 471
++ + + + L N+ L L+L+ N L ++ L +L + L N
Sbjct: 265 TKLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNH 322
Query: 472 LTGSLPSYMGSLPNLQELHIENN 494
+T P + SL + N
Sbjct: 323 ITDIRP--LASLSKMDSADFANQ 343
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 57.2 bits (139), Expect = 9e-09
Identities = 18/92 (19%), Positives = 42/92 (45%), Gaps = 5/92 (5%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 472
R+ + + + + P L N+ LT L + N ++ + + L L+++++ +N++
Sbjct: 221 TRLNSLKIGNNKITD-LSP-LANLSQLTWLEIGTNQISD-INAVKDLTKLKMLNVGSNQI 277
Query: 473 TGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 504
+ S + +L L L + NN E +
Sbjct: 278 SD--ISVLNNLSQLNSLFLNNNQLGNEDMEVI 307
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 56.4 bits (137), Expect = 2e-08
Identities = 17/92 (18%), Positives = 38/92 (41%), Gaps = 15/92 (16%)
Query: 414 RITKI-ALSG-KNLK---------GEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDL 462
++ + ++ +L +I P L ++ +L N +T + ++ + L
Sbjct: 166 KVKDVTPIANLTDLYSLSLNYNQIEDISP-LASLTSLHYFTAYVNQITD-ITPVANMTRL 223
Query: 463 RIVHLENNELTGSLPSYMGSLPNLQELHIENN 494
+ + NN++T P + +L L L I N
Sbjct: 224 NSLKIGNNKITDLSP--LANLSQLTWLEIGTN 253
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 56.0 bits (136), Expect = 2e-08
Identities = 23/90 (25%), Positives = 48/90 (53%), Gaps = 6/90 (6%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 472
ITK+ ++G+ + ++ + L L L+GN +T + +S L+ L +++ N++
Sbjct: 44 ESITKLVVAGEKVAS--IQGIEYLTNLEYLNLNGNQITD-ISPLSNLVKLTNLYIGTNKI 100
Query: 473 TGSLPSYMGSLPNLQELHIENNSFVGEIPP 502
T S + +L NL+EL++ ++ I P
Sbjct: 101 TD--ISALQNLTNLRELYLNEDNISD-ISP 127
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 54.5 bits (132), Expect = 7e-08
Identities = 14/82 (17%), Positives = 37/82 (45%), Gaps = 4/82 (4%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 472
++T + + + L+N+ L EL+L+ + ++ + ++ L + ++L N
Sbjct: 88 VKLTNLYIGTNKIT--DISALQNLTNLRELYLNEDNISD-ISPLANLTKMYSLNLGANHN 144
Query: 473 TGSLPSYMGSLPNLQELHIENN 494
S S + ++ L L + +
Sbjct: 145 L-SDLSPLSNMTGLNYLTVTES 165
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 53.7 bits (130), Expect = 1e-07
Identities = 21/94 (22%), Positives = 39/94 (41%), Gaps = 4/94 (4%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 472
+ ++ L+ N+ I P L N+ + L L N L +S + L + + +++
Sbjct: 110 TNLRELYLNEDNISD-ISP-LANLTKMYSLNLGANHNLSDLSPLSNMTGLNYLTVTESKV 167
Query: 473 TGSLPSYMGSLPNLQELHIENNSFVGEIPPALLT 506
P + +L +L L + N P A LT
Sbjct: 168 KDVTP--IANLTDLYSLSLNYNQIEDISPLASLT 199
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 53.3 bits (129), Expect = 2e-07
Identities = 18/76 (23%), Positives = 31/76 (40%), Gaps = 3/76 (3%)
Query: 431 PELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 490
+ N+ L L L+ N + + ++ L L N++T P + ++ L L
Sbjct: 171 TPIANLTDLYSLSLNYNQIED-ISPLASLTSLHYFTAYVNQITDITP--VANMTRLNSLK 227
Query: 491 IENNSFVGEIPPALLT 506
I NN P A L+
Sbjct: 228 IGNNKITDLSPLANLS 243
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 49.5 bits (119), Expect = 3e-06
Identities = 13/80 (16%), Positives = 29/80 (36%), Gaps = 4/80 (5%)
Query: 427 GEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNL 486
+I P ++ L +T + L + + + ++ S+ + L NL
Sbjct: 13 NQIFP-DADLAEGIRAVLQKASVTDVVT-QEELESITKLVVAGEKVA-SIQG-IEYLTNL 68
Query: 487 QELHIENNSFVGEIPPALLT 506
+ L++ N P + L
Sbjct: 69 EYLNLNGNQITDISPLSNLV 88
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 46.0 bits (110), Expect = 3e-05
Identities = 11/61 (18%), Positives = 24/61 (39%), Gaps = 1/61 (1%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 472
++ + L+ L E + + LT L+L N +T + ++ L + N +
Sbjct: 287 SQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITD-IRPLASLSKMDSADFANQVI 345
Query: 473 T 473
Sbjct: 346 K 346
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 1e-09
Identities = 18/105 (17%), Positives = 36/105 (34%), Gaps = 5/105 (4%)
Query: 406 TCSTTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMS---RLIDL 462
+ S + + LS + + +E L L + L + + S L +L
Sbjct: 366 SQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQ-MSEFSVFLSLRNL 423
Query: 463 RIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 507
+ + + + L +L+ L + NSF P + T
Sbjct: 424 IYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTE 468
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 5e-08
Identities = 19/99 (19%), Positives = 41/99 (41%), Gaps = 7/99 (7%)
Query: 413 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPD--MSRLIDLRIVHLEN 469
++ + L+G ++ + + +L +L L L + + L L+ +++ +
Sbjct: 76 SHLSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLAS-LENFPIGHLKTLKELNVAH 133
Query: 470 NELT-GSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 507
N + LP Y +L NL+ L + +N I L
Sbjct: 134 NLIQSFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRV 171
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 7e-08
Identities = 18/87 (20%), Positives = 41/87 (47%), Gaps = 4/87 (4%)
Query: 413 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENN 470
+ + ++G + + P+ + LT L L L P + L L+++++ +N
Sbjct: 445 SSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASN 504
Query: 471 ELTGSLPSYM-GSLPNLQELHIENNSF 496
+L S+P + L +LQ++ + N +
Sbjct: 505 QLK-SVPDGIFDRLTSLQKIWLHTNPW 530
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 3e-07
Identities = 17/89 (19%), Positives = 28/89 (31%), Gaps = 5/89 (5%)
Query: 420 LSGKNLKGEIPPELKNMEALTELWLDGNFLTG-PLPDMSRLIDLRIVHLENNELTGSLPS 478
N +IP L + L L N L +L+++ L E+
Sbjct: 14 CMELNFY-KIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDG 70
Query: 479 YMGSLPNLQELHIENNSFVGEIPPALLTG 507
SL +L L + N + +G
Sbjct: 71 AYQSLSHLSTLILTGNPIQ-SLALGAFSG 98
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 8e-07
Identities = 16/99 (16%), Positives = 30/99 (30%), Gaps = 6/99 (6%)
Query: 412 PPRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDMS--RLIDLRIVHLE 468
P + LS L+ + + L L L + + D + L L + L
Sbjct: 27 PFSTKNLDLSFNPLR-HLGSYSFFSFPELQVLDLSRCEIQT-IEDGAYQSLSHLSTLILT 84
Query: 469 NNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 507
N + L +LQ+L + + +
Sbjct: 85 GNPIQSLALGAFSGLSSLQKLVAVETNLA-SLENFPIGH 122
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 3e-06
Identities = 19/101 (18%), Positives = 37/101 (36%), Gaps = 7/101 (6%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLT-GPLPD-MSRLIDLRIVHLENN 470
+ K+ NL + +++ L EL + N + LP+ S L +L + L +N
Sbjct: 100 SSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSN 159
Query: 471 ELTGSLPSYMGSLPNLQ----ELHIENNSFVGEIPPALLTG 507
++ + + L + L + N I P
Sbjct: 160 KIQSIYCTDLRVLHQMPLLNLSLDLSLNPM-NFIQPGAFKE 199
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 5e-06
Identities = 20/97 (20%), Positives = 37/97 (38%), Gaps = 3/97 (3%)
Query: 413 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENN 470
P + + LS ++ I +++ L+ L L GN + S L L+ +
Sbjct: 52 PELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVET 110
Query: 471 ELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 507
L +G L L+EL++ +N P +
Sbjct: 111 NLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSN 147
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 2e-05
Identities = 16/95 (16%), Positives = 37/95 (38%), Gaps = 7/95 (7%)
Query: 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTG-PLPDMS--RLIDLRIVHLE 468
+ ++ + N G E+ ++ +L L L N L+ S L+ + L
Sbjct: 324 LKSLKRLTFTS-NKGGNAFSEV-DLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLS 381
Query: 469 NNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPA 503
N + ++ S L L+ L ++++ ++
Sbjct: 382 FNGVI-TMSSNFLGLEQLEHLDFQHSNLK-QMSEF 414
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 4e-05
Identities = 21/99 (21%), Positives = 33/99 (33%), Gaps = 6/99 (6%)
Query: 413 PRITKIALSGKNL--KGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENN 470
P + + LS L KG +L L L N + + L L + +++
Sbjct: 347 PSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHS 406
Query: 471 ELTGSLP--SYMGSLPNLQELHIENNSFVGEIPPALLTG 507
L + S SL NL L I + + G
Sbjct: 407 NLK-QMSEFSVFLSLRNLIYLDISHTHTR-VAFNGIFNG 443
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 1e-09
Identities = 28/93 (30%), Positives = 47/93 (50%), Gaps = 8/93 (8%)
Query: 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNE 471
PP + + +S L+ ++P EL+N L + +D N L LPD+ L + NN+
Sbjct: 130 PPLLEYLGVSNNQLE-KLP-ELQNSSFLKIIDVDNNSLKK-LPDL--PPSLEFIAAGNNQ 184
Query: 472 LTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 504
L LP + +LP L ++ +NNS ++P
Sbjct: 185 LE-ELPE-LQNLPFLTAIYADNNSLK-KLPDLP 214
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 4e-08
Identities = 29/99 (29%), Positives = 40/99 (40%), Gaps = 10/99 (10%)
Query: 409 TTTPPRI---TKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIV 465
P I L E PEL+N+ LT ++ D N L LPD+ L +
Sbjct: 208 KKLPDLPLSLESIVAGNNIL--EELPELQNLPFLTTIYADNNLLKT-LPDL--PPSLEAL 262
Query: 466 HLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 504
++ +N LT LP SL L + E+PP L
Sbjct: 263 NVRDNYLT-DLPELPQSLTFLDVSENIFSGLS-ELPPNL 299
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 2e-07
Identities = 22/96 (22%), Positives = 36/96 (37%), Gaps = 12/96 (12%)
Query: 409 TTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLE 468
+ PP + + S ++ + + L EL + N L LP + L +
Sbjct: 293 SELPPNLYYLNASSNEIR-SLCDLPPS---LEELNVSNNKLIE-LPAL--PPRLERLIAS 345
Query: 469 NNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 504
N L +P NL++LH+E N E P
Sbjct: 346 FNHLA-EVPE---LPQNLKQLHVEYNPLR-EFPDIP 376
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 3e-06
Identities = 26/110 (23%), Positives = 42/110 (38%), Gaps = 25/110 (22%)
Query: 411 TPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENN 470
PP + ++ +S L E+P L L N L +P++ +L+ +H+E N
Sbjct: 315 LPPSLEELNVSNNKLI-ELPALPPR---LERLIASFNHLAE-VPEL--PQNLKQLHVEYN 367
Query: 471 ELTGSLPSYMGSL----------------PNLQELHIENNSFVGEIPPAL 504
L P S+ NL++LH+E N E P
Sbjct: 368 PLR-EFPDIPESVEDLRMNSHLAEVPELPQNLKQLHVETNPLR-EFPDIP 415
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 3e-06
Identities = 26/99 (26%), Positives = 39/99 (39%), Gaps = 20/99 (20%)
Query: 420 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP---------DMSRLID-----LRIV 465
NL E+P E +N+++ TE + + P +SRL D +
Sbjct: 18 RHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHEL 76
Query: 466 HLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 504
L N L+ SLP P+L+ L NS E+P
Sbjct: 77 ELNNLGLS-SLPE---LPPHLESLVASCNSLT-ELPELP 110
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 2e-05
Identities = 21/105 (20%), Positives = 33/105 (31%), Gaps = 18/105 (17%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEA-------------LTELWLDGNFLTGPLPDMSRL 459
T+ + + PP EL L+ L+ LP+
Sbjct: 34 KSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLS-SLPE--LP 90
Query: 460 IDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 504
L + N LT LP SL +L + + ++PP L
Sbjct: 91 PHLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKAL-SDLPPLL 133
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 4e-05
Identities = 16/88 (18%), Positives = 32/88 (36%), Gaps = 9/88 (10%)
Query: 409 TTTPPRITKI-ALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVH 466
P + L + E+P +N L +L ++ N L PD + DLR
Sbjct: 370 REFPDIPESVEDLRMNSHLAEVPELPQN---LKQLHVETNPLRE-FPDIPESVEDLR--- 422
Query: 467 LENNELTGSLPSYMGSLPNLQELHIENN 494
+ + + + L++ E++
Sbjct: 423 MNSERVVDPYEFAHETTDKLEDDVFEHH 450
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 6e-05
Identities = 26/129 (20%), Positives = 49/129 (37%), Gaps = 28/129 (21%)
Query: 411 TPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRI----- 464
PPR+ ++ S +L E+P +N L +L ++ N L PD + DLR+
Sbjct: 335 LPPRLERLIASFNHLA-EVPELPQN---LKQLHVEYNPLRE-FPDIPESVEDLRMNSHLA 389
Query: 465 -----------VHLENNELTGSLPSYMGSLPNLQELHIENNSFVG--EIPPALLTGKVIF 511
+H+E N L P ++++L + + V E
Sbjct: 390 EVPELPQNLKQLHVETNPLR-EFPD---IPESVEDLRMNSERVVDPYEFAHETTDKLEDD 445
Query: 512 KYDNNPKLH 520
++++ H
Sbjct: 446 VFEHHHHHH 454
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 1e-09
Identities = 15/104 (14%), Positives = 42/104 (40%), Gaps = 6/104 (5%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 472
+T + L N+ P + ++ L L+ N ++ + ++ L ++ + +N++
Sbjct: 309 KNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSD-VSSLANLTNINWLSAGHNQI 365
Query: 473 TGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNN 516
+ P + +L + +L + + ++ P I N
Sbjct: 366 SDLTP--LANLTRITQLGLNDQAWTN-APVNYKANVSIPNTVKN 406
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 4e-09
Identities = 22/89 (24%), Positives = 39/89 (43%), Gaps = 5/89 (5%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 472
+ +++L+G LK L ++ LT+L L N ++ L +S L L + L N++
Sbjct: 221 TNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISN-LAPLSGLTKLTELKLGANQI 277
Query: 473 TGSLPSYMGSLPNLQELHIENNSFVGEIP 501
+ P + L L L + N P
Sbjct: 278 SNISP--LAGLTALTNLELNENQLEDISP 304
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 1e-08
Identities = 24/94 (25%), Positives = 41/94 (43%), Gaps = 5/94 (5%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 472
+T + L+ + P L + LTEL L N ++ + ++ L L + L N+L
Sbjct: 243 TNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISN-ISPLAGLTALTNLELNENQL 299
Query: 473 TGSLPSYMGSLPNLQELHIENNSFVGEIPPALLT 506
S + +L NL L + N+ P + LT
Sbjct: 300 ED--ISPISNLKNLTYLTLYFNNISDISPVSSLT 331
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 2e-08
Identities = 24/82 (29%), Positives = 38/82 (46%), Gaps = 5/82 (6%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 472
++T++ L + P L + ALT L L+ N L + +S L +L + L N +
Sbjct: 265 TKLTELKLGANQISNISP--LAGLTALTNLELNENQLED-ISPISNLKNLTYLTLYFNNI 321
Query: 473 TGSLPSYMGSLPNLQELHIENN 494
+ P + SL LQ L NN
Sbjct: 322 SDISP--VSSLTKLQRLFFYNN 341
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 3e-08
Identities = 20/94 (21%), Positives = 37/94 (39%), Gaps = 5/94 (5%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 472
+ ++ +S + L + L L N ++ + + L +L + L N+L
Sbjct: 177 TTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQISD-ITPLGILTNLDELSLNGNQL 233
Query: 473 TGSLPSYMGSLPNLQELHIENNSFVGEIPPALLT 506
+ SL NL +L + NN P + LT
Sbjct: 234 KD--IGTLASLTNLTDLDLANNQISNLAPLSGLT 265
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 5e-08
Identities = 20/94 (21%), Positives = 39/94 (41%), Gaps = 5/94 (5%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 472
++T + +K ++ + LT++ N LT + + L L + + NN++
Sbjct: 46 DQVTTLQADRLGIK--SIDGVEYLNNLTQINFSNNQLTD-ITPLKNLTKLVDILMNNNQI 102
Query: 473 TGSLPSYMGSLPNLQELHIENNSFVGEIPPALLT 506
+ + +L NL L + NN P LT
Sbjct: 103 AD--ITPLANLTNLTGLTLFNNQITDIDPLKNLT 134
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 3e-07
Identities = 21/89 (23%), Positives = 37/89 (41%), Gaps = 5/89 (5%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 472
+ + + + P L + L EL L+GN L + ++ L +L + L NN++
Sbjct: 199 TNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD-IGTLASLTNLTDLDLANNQI 255
Query: 473 TGSLPSYMGSLPNLQELHIENNSFVGEIP 501
+ P + L L EL + N P
Sbjct: 256 SNLAP--LSGLTKLTELKLGANQISNISP 282
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 6e-07
Identities = 21/92 (22%), Positives = 39/92 (42%), Gaps = 5/92 (5%)
Query: 415 ITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTG 474
K L N+ + +++ +T L D + + + L +L ++ NN+LT
Sbjct: 26 KMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS-IDGVEYLNNLTQINFSNNQLTD 82
Query: 475 SLPSYMGSLPNLQELHIENNSFVGEIPPALLT 506
P + +L L ++ + NN P A LT
Sbjct: 83 ITP--LKNLTKLVDILMNNNQIADITPLANLT 112
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 7e-07
Identities = 23/81 (28%), Positives = 43/81 (53%), Gaps = 5/81 (6%)
Query: 415 ITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTG 474
+T+I S L I P LKN+ L ++ ++ N + + ++ L +L + L NN++T
Sbjct: 70 LTQINFSNNQLTD-ITP-LKNLTKLVDILMNNNQIAD-ITPLANLTNLTGLTLFNNQITD 126
Query: 475 SLPSYMGSLPNLQELHIENNS 495
P + +L NL L + +N+
Sbjct: 127 IDP--LKNLTNLNRLELSSNT 145
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 1e-06
Identities = 19/94 (20%), Positives = 37/94 (39%), Gaps = 6/94 (6%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 472
+ ++ LS + L + +L +L L ++ L L + + +N++
Sbjct: 134 TNLNRLELSSNTISD--ISALSGLTSLQQLSFGNQVTD--LKPLANLTTLERLDISSNKV 189
Query: 473 TGSLPSYMGSLPNLQELHIENNSFVGEIPPALLT 506
+ S + L NL+ L NN P +LT
Sbjct: 190 SD--ISVLAKLTNLESLIATNNQISDITPLGILT 221
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 2e-04
Identities = 14/107 (13%), Positives = 31/107 (28%), Gaps = 10/107 (9%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 472
I ++ + P L N+ +T+L L+ T + + +
Sbjct: 353 TNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGA 410
Query: 473 TGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNNPKL 519
P+ + + E I N T +V + + +
Sbjct: 411 L-IAPATISDGGSYTEPDITWNL-------PSYTNEVSYTFSQPVTI 449
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 2e-09
Identities = 25/98 (25%), Positives = 41/98 (41%), Gaps = 7/98 (7%)
Query: 412 PPRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLEN 469
PP + L + EI KN++ L L L N ++ P + L+ L ++L
Sbjct: 51 PPDTALLDLQNNKIT-EIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSK 109
Query: 470 NELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 507
N+L LP LQEL + N ++ ++ G
Sbjct: 110 NQLK-ELPE--KMPKTLQELRVHENEIT-KVRKSVFNG 143
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 2e-09
Identities = 23/112 (20%), Positives = 46/112 (41%), Gaps = 9/112 (8%)
Query: 411 TPPRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPD--MSRLIDLRIVHL 467
PP +T++ L G + ++ LK + L +L L N ++ + + ++ LR +HL
Sbjct: 190 LPPSLTELHLDGNKIT-KVDAASLKGLNNLAKLGLSFNSISA-VDNGSLANTPHLRELHL 247
Query: 468 ENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNNPKL 519
NN+L +P + +Q +++ NN+ I
Sbjct: 248 NNNKLV-KVPGGLADHKYIQVVYLHNNNIS-AIGSNDFCPPGYN--TKKASY 295
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 3e-08
Identities = 17/101 (16%), Positives = 41/101 (40%), Gaps = 9/101 (8%)
Query: 411 TPPRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLT-GPLPDM--SRLIDLRIVH 466
P + ++ + + ++ + + + L N L + + + L +
Sbjct: 119 MPKTLQELRVHENEIT-KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIR 177
Query: 467 LENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 507
+ + +T ++P G P+L ELH++ N ++ A L G
Sbjct: 178 IADTNIT-TIPQ--GLPPSLTELHLDGNKI-TKVDAASLKG 214
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 1e-07
Identities = 12/91 (13%), Positives = 33/91 (36%), Gaps = 10/91 (10%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLT-------GPLPDMSRLIDLRIV 465
P + ++ L+ L ++P L + + + ++L N ++ P ++ V
Sbjct: 240 PHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGV 298
Query: 466 HLENNELT-GSLPSYM-GSLPNLQELHIENN 494
L +N + + + + + N
Sbjct: 299 SLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 7e-07
Identities = 21/103 (20%), Positives = 40/103 (38%), Gaps = 9/103 (8%)
Query: 413 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNE 471
+ K+ LS ++ + L N L EL L+ N L ++ +++V+L NN
Sbjct: 216 NNLAKLGLSFNSIS-AVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNN 274
Query: 472 LTG------SLPSYMGSLPNLQELHIENNSF-VGEIPPALLTG 507
++ P Y + + + +N EI P+
Sbjct: 275 ISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRC 317
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 4e-09
Identities = 22/98 (22%), Positives = 42/98 (42%), Gaps = 7/98 (7%)
Query: 412 PPRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLEN 469
P T + L ++ E+ + K ++ L L L N ++ S L L+ +++
Sbjct: 53 SPDTTLLDLQNNDIS-ELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISK 111
Query: 470 NELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 507
N L +P +L EL I +N ++P + +G
Sbjct: 112 NHLV-EIPP--NLPSSLVELRIHDNRIR-KVPKGVFSG 145
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 5e-08
Identities = 14/91 (15%), Positives = 32/91 (35%), Gaps = 10/91 (10%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLT-------GPLPDMSRLIDLRIV 465
P + ++ L L +P L +++ L ++L N +T P+ + +
Sbjct: 241 PTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGI 299
Query: 466 HLENNELT-GSLPSYM-GSLPNLQELHIENN 494
L NN + + + + + N
Sbjct: 300 SLFNNPVPYWEVQPATFRCVTDRLAIQFGNY 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 2e-06
Identities = 28/87 (32%), Positives = 42/87 (48%), Gaps = 7/87 (8%)
Query: 420 LSGKNLKGEIPPELKNMEALTELWLDGNFLTG-PLPDMSRLIDLRIVHLENNELTGSLPS 478
+S L IP +L E L EL LD N + L D+ R L + L +N++ + +
Sbjct: 179 ISEAKLT-GIPKDL--PETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIR-MIEN 234
Query: 479 YM-GSLPNLQELHIENNSFVGEIPPAL 504
LP L+ELH++NN +P L
Sbjct: 235 GSLSFLPTLRELHLDNNKLS-RVPAGL 260
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 2e-05
Identities = 16/98 (16%), Positives = 34/98 (34%), Gaps = 7/98 (7%)
Query: 413 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNE 471
+ + L N +I + + L +L++ N L +P L + + +N
Sbjct: 78 QHLYALVLVN-NKISKIHEKAFSPLRKLQKLYISKNHLVE-IPPNL-PSSLVELRIHDNR 134
Query: 472 LTGSLPSYM-GSLPNLQELHIENNSF-VGEIPPALLTG 507
+ +P + L N+ + + N P G
Sbjct: 135 IR-KVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDG 171
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 9e-09
Identities = 14/71 (19%), Positives = 35/71 (49%), Gaps = 1/71 (1%)
Query: 433 LKNMEALTELWLDGNFLTG-PLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 491
+ + L L + G +T +P++S L L ++ + ++ S+ + + +LP + + +
Sbjct: 84 ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDL 143
Query: 492 ENNSFVGEIPP 502
N + +I P
Sbjct: 144 SYNGAITDIMP 154
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 1e-07
Identities = 15/90 (16%), Positives = 38/90 (42%), Gaps = 3/90 (3%)
Query: 415 ITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTG 474
+T I L+ N+ ++ ++ + +L ++ T +S L +L + + ++T
Sbjct: 46 LTYITLANINVT-DLTG-IEYAHNIKDLTINNIHATN-YNPISGLSNLERLRIMGKDVTS 102
Query: 475 SLPSYMGSLPNLQELHIENNSFVGEIPPAL 504
+ L +L L I +++ I +
Sbjct: 103 DKIPNLSGLTSLTLLDISHSAHDDSILTKI 132
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 2e-07
Identities = 10/82 (12%), Positives = 32/82 (39%), Gaps = 2/82 (2%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 472
+T + +S I ++ + + + L N + + L +L+ ++++ + +
Sbjct: 112 TSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMPLKTLPELKSLNIQFDGV 171
Query: 473 TGSLPSYMGSLPNLQELHIENN 494
+ P L +L+ +
Sbjct: 172 HDY--RGIEDFPKLNQLYAFSQ 191
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 9e-09
Identities = 15/95 (15%), Positives = 31/95 (32%), Gaps = 3/95 (3%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 472
+ + L + ++ ++ L L L N L P+ + + L NN+L
Sbjct: 169 DTLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKL 226
Query: 473 TGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 507
+ + NL+ + N F +
Sbjct: 227 V-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSK 260
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 2e-07
Identities = 15/93 (16%), Positives = 35/93 (37%), Gaps = 8/93 (8%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD--MSRLIDLRIVHLENN 470
P I + + N+ + + ++L N +T L D ++ + L+ N
Sbjct: 99 PSIETLHAANNNIS-RVSCS--RGQGKKNIYLANNKITM-LRDLDEGCRSRVQYLDLKLN 154
Query: 471 ELTG-SLPSYMGSLPNLQELHIENNSFVGEIPP 502
E+ + S L+ L+++ N ++
Sbjct: 155 EIDTVNFAELAASSDTLEHLNLQYNFIY-DVKG 186
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 3e-07
Identities = 21/91 (23%), Positives = 39/91 (42%), Gaps = 4/91 (4%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTG-PLPDMSRLIDLRIVHLENNE 471
R ++ +LK + ++ + EL L GN L+ D++ L +++L +N
Sbjct: 10 NRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNV 69
Query: 472 LTGSLPSYMGSLPNLQELHIENNSFVGEIPP 502
L + SL L+ L + NN E+
Sbjct: 70 LY-ETLD-LESLSTLRTLDLNNNYV-QELLV 97
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 3e-06
Identities = 16/77 (20%), Positives = 30/77 (38%), Gaps = 3/77 (3%)
Query: 432 ELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 491
EL ++ L N ++ + SR + ++L NN++T G +Q L +
Sbjct: 94 ELLVGPSIETLHAANNNISR-VSC-SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDL 151
Query: 492 ENNSFVGEIPPALLTGK 508
+ N + A L
Sbjct: 152 KLNEID-TVNFAELAAS 167
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 4e-06
Identities = 11/75 (14%), Positives = 26/75 (34%), Gaps = 2/75 (2%)
Query: 429 IPPELKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNELTGSLPSYMGSLPNLQ 487
I +N + + L L + +++ + L N L+ + + L+
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 488 ELHIENNSFVGEIPP 502
L++ +N E
Sbjct: 62 LLNLSSNVLY-ETLD 75
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 1e-08
Identities = 21/86 (24%), Positives = 35/86 (40%), Gaps = 5/86 (5%)
Query: 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNE 471
P + + +S NL L L EL++ N L LPD S L ++ + N+
Sbjct: 430 PQTLEVLDVSNNNLD-SFSLFLPR---LQELYISRNKLKT-LPDASLFPVLLVMKISRNQ 484
Query: 472 LTGSLPSYMGSLPNLQELHIENNSFV 497
L L +LQ++ + N +
Sbjct: 485 LKSVPDGIFDRLTSLQKIWLHTNPWD 510
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 7e-08
Identities = 22/154 (14%), Positives = 47/154 (30%), Gaps = 4/154 (2%)
Query: 413 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTG-PLPDMSRLIDLRIVHLENN 470
+ + + EI + +L EL + L + + D+ + L +
Sbjct: 123 TNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLS 182
Query: 471 ELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNNPKLHKESRRRMRFK 530
E L + L +++ L + + + + L + F
Sbjct: 183 ESAFLLEIFADILSSVRYLELRDTNL-ARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFN 241
Query: 531 LILGTSIGVLAILLVLFL-CSLIVLRKLRRKISN 563
+L +L + V F C+L L S+
Sbjct: 242 ELLKLLRYILELSEVEFDDCTLNGLGDFNPSESD 275
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 5e-07
Identities = 21/100 (21%), Positives = 37/100 (37%), Gaps = 7/100 (7%)
Query: 412 PPRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPD--MSRLIDLRIVHLE 468
+ + LS + I L+ L L L + + + L L + L
Sbjct: 25 TAAMKSLDLSFNKIT-YIGHGDLRACANLQVLILKSSRINT-IEGDAFYSLGSLEHLDLS 82
Query: 469 NNELTGSLPSYM-GSLPNLQELHIENNSFVGEIPPALLTG 507
+N L+ SL S G L +L+ L++ N + +L
Sbjct: 83 DNHLS-SLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPN 121
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 1e-05
Identities = 11/98 (11%), Positives = 29/98 (29%), Gaps = 4/98 (4%)
Query: 413 PRITKIALSGKNLKG-EIPPELKNMEALTELWLDGNFLTGPLP--DMSRLIDLRIVHLEN 469
+ + L G + + N+ L L + + D + L L + ++
Sbjct: 98 SSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKA 157
Query: 470 NELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 507
L + S+ ++ L + + +
Sbjct: 158 LSLRNYQSQSLKSIRDIHHLTLHLSES-AFLLEIFADI 194
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 1e-05
Identities = 16/101 (15%), Positives = 35/101 (34%), Gaps = 6/101 (5%)
Query: 406 TCSTTTPPRITKIALSGKNLK--GEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLR 463
+ P + + LS +L+ + L ++ LT L + N +R
Sbjct: 354 SACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFHPMPDSCQWPEKMR 413
Query: 464 IVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 504
++L + + + + L+ L + NN+ L
Sbjct: 414 FLNLSSTGIR-VVKT--CIPQTLEVLDVSNNNL-DSFSLFL 450
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 3e-05
Identities = 20/100 (20%), Positives = 39/100 (39%), Gaps = 11/100 (11%)
Query: 413 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDMSRLID----LRIVHL 467
++ +I + + +P +++++L L L N + S L+ + L
Sbjct: 310 EKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVL 368
Query: 468 ENNELTGSLPSYMG---SLPNLQELHIENNSFVGEIPPAL 504
N L S+ +L NL L I N+F +P +
Sbjct: 369 SQNHLR-SMQKTGEILLTLKNLTSLDISRNTF-HPMPDSC 406
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 1e-08
Identities = 34/111 (30%), Positives = 43/111 (38%), Gaps = 11/111 (9%)
Query: 405 VTCS----TTTPPRI----TKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM 456
V C T PP + T + LS L L LT+L LD LT L
Sbjct: 15 VNCDKRNLTALPPDLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK-LQVD 73
Query: 457 SRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 507
L L + L +N+L SLP +LP L L + N +P L G
Sbjct: 74 GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT-SLPLGALRG 122
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 9e-05
Identities = 27/86 (31%), Positives = 41/86 (47%), Gaps = 7/86 (8%)
Query: 413 PRITKIALSGKNLKGEIPPEL-KNMEALTELWLDGNFLTGPLPD--MSRLIDLRIVHLEN 469
P +T + +S L +P + + L EL+L GN L LP ++ L + L N
Sbjct: 100 PALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELKT-LPPGLLTPTPKLEKLSLAN 157
Query: 470 NELTGSLPSYM-GSLPNLQELHIENN 494
N LT LP+ + L NL L ++ N
Sbjct: 158 NNLT-ELPAGLLNGLENLDTLLLQEN 182
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 57.1 bits (137), Expect = 2e-08
Identities = 22/84 (26%), Positives = 37/84 (44%), Gaps = 5/84 (5%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 472
+T + LS L+ +PP L + L L N L + ++ L L+ + L NN L
Sbjct: 463 LLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VDGVANLPRLQELLLCNNRL 520
Query: 473 TGSLPS--YMGSLPNLQELHIENN 494
+ + S P L L+++ N
Sbjct: 521 Q-QSAAIQPLVSCPRLVLLNLQGN 543
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 53.6 bits (128), Expect = 2e-07
Identities = 22/87 (25%), Positives = 40/87 (45%), Gaps = 4/87 (4%)
Query: 408 STTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHL 467
+ + L+ K+L + L+ + +T L L N L P ++ L L ++
Sbjct: 436 LKMEYADVRVLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQA 493
Query: 468 ENNELTGSLPSYMGSLPNLQELHIENN 494
+N L ++ + +LP LQEL + NN
Sbjct: 494 SDNALE-NVDG-VANLPRLQELLLCNN 518
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 42.8 bits (100), Expect = 5e-04
Identities = 13/65 (20%), Positives = 24/65 (36%), Gaps = 7/65 (10%)
Query: 431 PELKNMEALTELWLDGNFLTGP--LPDMSRLIDLRIVHLENNELTGSLPSY----MGSLP 484
+ N+ L EL L N L + + L +++L+ N L LP
Sbjct: 502 DGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLC-QEEGIQERLAEMLP 560
Query: 485 NLQEL 489
++ +
Sbjct: 561 SVSSI 565
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 3e-08
Identities = 17/97 (17%), Positives = 36/97 (37%), Gaps = 5/97 (5%)
Query: 413 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNE 471
P + ++ L I + + L L L + +P+++ L+ L + + N
Sbjct: 171 PSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKD-MPNLTPLVGLEELEMSGNH 229
Query: 472 LTGSLPSYM-GSLPNLQELHIENNSFVGEIPPALLTG 507
+ L +L++L + N+ V I G
Sbjct: 230 FP-EIRPGSFHGLSSLKKLWVMNSQ-VSLIERNAFDG 264
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 4e-07
Identities = 23/98 (23%), Positives = 39/98 (39%), Gaps = 5/98 (5%)
Query: 413 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENN 470
+ + L +++ +I + +L L L N+LT L LR + L NN
Sbjct: 99 HHLEVLQLGRNSIR-QIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNN 157
Query: 471 ELTGSLPSYM-GSLPNLQELHIENNSFVGEIPPALLTG 507
+ S+PSY +P+L L + + I G
Sbjct: 158 PIE-SIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEG 194
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 7e-06
Identities = 21/91 (23%), Positives = 43/91 (47%), Gaps = 11/91 (12%)
Query: 413 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLT----GPLPDMSRLIDLRIVHL 467
+ ++ +SG + EI P + +L +LW+ + ++ ++ L ++L
Sbjct: 218 VGLEELEMSGNHFP-EIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASL---VELNL 273
Query: 468 ENNELTGSLPSYM-GSLPNLQELHIENNSFV 497
+N L+ SLP + L L ELH+ +N +
Sbjct: 274 AHNNLS-SLPHDLFTPLRYLVELHLHHNPWN 303
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 2e-05
Identities = 19/79 (24%), Positives = 35/79 (44%), Gaps = 4/79 (5%)
Query: 431 PELKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNELTGSLPSYM-GSLPNLQE 488
P L + L EL + GN P L L+ + + N++++ + L +L E
Sbjct: 212 PNLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVS-LIERNAFDGLASLVE 270
Query: 489 LHIENNSFVGEIPPALLTG 507
L++ +N+ +P L T
Sbjct: 271 LNLAHNNLS-SLPHDLFTP 288
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 3e-08
Identities = 19/97 (19%), Positives = 36/97 (37%), Gaps = 5/97 (5%)
Query: 413 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNE 471
P + ++ L I + + L L L L +P+++ LI L + L N
Sbjct: 160 PSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLRE-IPNLTPLIKLDELDLSGNH 218
Query: 472 LTGSLPSYM-GSLPNLQELHIENNSFVGEIPPALLTG 507
L+ ++ L +LQ+L + + I
Sbjct: 219 LS-AIRPGSFQGLMHLQKLWMIQSQIQ-VIERNAFDN 253
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 1e-06
Identities = 24/99 (24%), Positives = 41/99 (41%), Gaps = 7/99 (7%)
Query: 413 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPD--MSRLIDLRIVHLEN 469
+ + LS +++ I + L L L N LT +P+ L L+ + L N
Sbjct: 88 RHLEILQLSRNHIR-TIEIGAFNGLANLNTLELFDNRLTT-IPNGAFVYLSKLKELWLRN 145
Query: 470 NELTGSLPSYM-GSLPNLQELHIENNSFVGEIPPALLTG 507
N + S+PSY +P+L+ L + + I G
Sbjct: 146 NPIE-SIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEG 183
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 7e-06
Identities = 21/88 (23%), Positives = 43/88 (48%), Gaps = 5/88 (5%)
Query: 413 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENN 470
++ ++ LSG +L I P + + L +LW+ + + + L L ++L +N
Sbjct: 207 IKLDELDLSGNHLS-AIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHN 265
Query: 471 ELTGSLPSYM-GSLPNLQELHIENNSFV 497
LT LP + L +L+ +H+ +N +
Sbjct: 266 NLT-LLPHDLFTPLHHLERIHLHHNPWN 292
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 47.1 bits (112), Expect = 2e-05
Identities = 24/94 (25%), Positives = 38/94 (40%), Gaps = 9/94 (9%)
Query: 413 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDM--SRLIDLRIVHL-E 468
+ + L L IP + L ELWL N + +P +R+ LR + L E
Sbjct: 112 ANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIES-IPSYAFNRIPSLRRLDLGE 169
Query: 469 NNELTGSLPSYM-GSLPNLQELHIENNSFVGEIP 501
L+ + L NL+ L++ + EIP
Sbjct: 170 LKRLS-YISEGAFEGLSNLRYLNLAMCNLR-EIP 201
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 46.7 bits (111), Expect = 3e-05
Identities = 19/82 (23%), Positives = 35/82 (42%), Gaps = 10/82 (12%)
Query: 431 PELKNMEALTELWLDGNFLT----GPLPDMSRLIDLRIVHLENNELTGSLPSYM-GSLPN 485
P L + L EL L GN L+ G + L L + +++ + +L +
Sbjct: 201 PNLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKL---WMIQSQIQ-VIERNAFDNLQS 256
Query: 486 LQELHIENNSFVGEIPPALLTG 507
L E+++ +N+ +P L T
Sbjct: 257 LVEINLAHNNLT-LLPHDLFTP 277
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 5e-08
Identities = 19/110 (17%), Positives = 44/110 (40%), Gaps = 8/110 (7%)
Query: 408 STTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHL 467
S +T + ++ ++ ++ + LT+L N +T D+S+ +L +
Sbjct: 37 SEEQLATLTSLDCHNSSIT-DMTG-IEKLTGLTKLICTSNNITT--LDLSQNTNLTYLAC 92
Query: 468 ENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNNP 517
++N+LT +L + L L L+ + N ++ + N
Sbjct: 93 DSNKLT-NLD--VTPLTKLTYLNCDTNKL-TKLDVSQNPLLTYLNCARNT 138
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 3e-06
Identities = 24/107 (22%), Positives = 39/107 (36%), Gaps = 9/107 (8%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 472
+ ++ N+ ++ L LT L N LT D++ L L N L
Sbjct: 191 KLLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNKLTE--IDVTPLTQLTYFDCSVNPL 245
Query: 473 TGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNNPKL 519
T L + +L L LH + EI T + F+ + K+
Sbjct: 246 T-ELD--VSTLSKLTTLHCIQTDLL-EIDLTHNTQLIYFQAEGCRKI 288
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 4e-06
Identities = 15/82 (18%), Positives = 30/82 (36%), Gaps = 7/82 (8%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 472
++T++ ++ LT L N +T D+S+ L ++ + N +
Sbjct: 148 TQLTELDCHLNKKIT--KLDVTPQTQLTTLDCSFNKITE--LDVSQNKLLNRLNCDTNNI 203
Query: 473 TGSLPSYMGSLPNLQELHIENN 494
T L + L L +N
Sbjct: 204 T-KLD--LNQNIQLTFLDCSSN 222
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 8e-06
Identities = 16/75 (21%), Positives = 28/75 (37%), Gaps = 5/75 (6%)
Query: 420 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSY 479
+ + ++ + L L +T L D+S+ L ++L N ELT L
Sbjct: 280 FQAEGCRKIKELDVTHNTQLYLLDCQAAGIT-EL-DLSQNPKLVYLYLNNTELT-ELD-- 334
Query: 480 MGSLPNLQELHIENN 494
+ L+ L N
Sbjct: 335 VSHNTKLKSLSCVNA 349
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 4e-05
Identities = 19/94 (20%), Positives = 34/94 (36%), Gaps = 8/94 (8%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 472
++ + + E+ L L L+L+ LT L D+S L+ + N +
Sbjct: 297 TQLYLLDCQAAGIT-ELD--LSQNPKLVYLYLNNTELTE-L-DVSHNTKLKSLSCVNAHI 351
Query: 473 TGSLPSYMGSLPNLQELHIENNSFVGEIPPALLT 506
S +G +P L + +P LT
Sbjct: 352 Q-DFSS-VGKIPALNNNFEAEGQTI-TMPKETLT 382
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 9e-05
Identities = 19/97 (19%), Positives = 37/97 (38%), Gaps = 8/97 (8%)
Query: 410 TTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLEN 469
+T ++T + +L EI L + L +G L D++ L ++ +
Sbjct: 251 STLSKLTTLHCIQTDLL-EID--LTHNTQLIYFQAEGCRKIKEL-DVTHNTQLYLLDCQA 306
Query: 470 NELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLT 506
+T L + P L L++ N E+ + T
Sbjct: 307 AGIT-ELD--LSQNPKLVYLYLNNTELT-ELDVSHNT 339
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 5e-04
Identities = 16/84 (19%), Positives = 26/84 (30%), Gaps = 7/84 (8%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 472
++T + L ++ + LT L N LT D+S L + N+
Sbjct: 106 TKLTYLNCDTNKLT-KLD--VSQNPLLTYLNCARNTLT--EIDVSHNTQLTELDCHLNKK 160
Query: 473 TGSLPSYMGSLPNLQELHIENNSF 496
L + L L N
Sbjct: 161 ITKLD--VTPQTQLTTLDCSFNKI 182
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 5e-08
Identities = 25/115 (21%), Positives = 39/115 (33%), Gaps = 10/115 (8%)
Query: 412 PPRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLEN 469
+ + LS + I L+ L L L N + D S L L + L
Sbjct: 51 TEAVKSLDLSNNRIT-YISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSY 109
Query: 470 NELTGSLPSYM-GSLPNLQELHIENNSFVGEIPPA----LLTGKVIFKYDNNPKL 519
N L+ +L S L +L L++ N + + LT I + N
Sbjct: 110 NYLS-NLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTF 162
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 2e-05
Identities = 11/65 (16%), Positives = 27/65 (41%), Gaps = 2/65 (3%)
Query: 433 LKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYM-GSLPNLQELHI 491
L + + L + ++++ L + N+L S+P + L +LQ++ +
Sbjct: 250 LIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWL 308
Query: 492 ENNSF 496
N +
Sbjct: 309 HTNPW 313
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 4e-05
Identities = 23/99 (23%), Positives = 36/99 (36%), Gaps = 6/99 (6%)
Query: 413 PRITKIALSGKNLKGEIPPEL-KNMEALTELWLDGNFLT--GPLPDMSRLIDLRIVHLEN 469
+ + LS L + K + +LT L L GN G S L L+I+ + N
Sbjct: 100 GSLEHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGN 158
Query: 470 NELTGSLPSYM-GSLPNLQELHIENNSFVGEIPPALLTG 507
+ + L L+EL I+ + P L
Sbjct: 159 MDTFTKIQRKDFAGLTFLEELEIDASDLQ-SYEPKSLKS 196
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 6e-08
Identities = 20/99 (20%), Positives = 37/99 (37%), Gaps = 8/99 (8%)
Query: 413 PRITKIALSGKNLKGEIPPEL-KNMEALTELWLDGNFLTGPLPDM--SRLIDLRIVHLEN 469
+TK+ +S + + + +++ L L + N L + S L L + LE
Sbjct: 104 SNLTKLDISENKIV-ILLDYMFQDLYNLKSLEVGDNDLVY-ISHRAFSGLNSLEQLTLEK 161
Query: 470 NELTGSLPSYM-GSLPNLQELHIENNSFVGEIPPALLTG 507
LT S+P+ L L L + + + I
Sbjct: 162 CNLT-SIPTEALSHLHGLIVLRLRHLNIN-AIRDYSFKR 198
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 8e-08
Identities = 22/100 (22%), Positives = 40/100 (40%), Gaps = 8/100 (8%)
Query: 412 PPRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDM--SRLIDLRIVHLE 468
P + L +K + + + L EL L+ N ++ + + L +LR + L
Sbjct: 31 PTETRLLDLGKNRIK-TLNQDEFASFPHLEELELNENIVSA-VEPGAFNNLFNLRTLGLR 88
Query: 469 NNELTGSLPSYM-GSLPNLQELHIENNSFVGEIPPALLTG 507
+N L +P + L NL +L I N V + +
Sbjct: 89 SNRLK-LIPLGVFTGLSNLTKLDISENKIV-ILLDYMFQD 126
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 1e-07
Identities = 18/97 (18%), Positives = 35/97 (36%), Gaps = 4/97 (4%)
Query: 413 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENN 470
+ ++ L NL IP E L ++ L L L + RL L+++ + +
Sbjct: 152 NSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHW 210
Query: 471 ELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 507
++ NL L I + + +P +
Sbjct: 211 PYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRH 246
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 5e-07
Identities = 20/91 (21%), Positives = 39/91 (42%), Gaps = 11/91 (12%)
Query: 413 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLT----GPLPDMSRLIDLRIVHL 467
+ + LS + I L + L E+ L G L ++ L R++++
Sbjct: 248 VYLRFLNLSYNPIS-TIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYL---RVLNV 303
Query: 468 ENNELTGSLPSYM-GSLPNLQELHIENNSFV 497
N+LT +L + S+ NL+ L +++N
Sbjct: 304 SGNQLT-TLEESVFHSVGNLETLILDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 6e-05
Identities = 18/98 (18%), Positives = 41/98 (41%), Gaps = 6/98 (6%)
Query: 413 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENN 470
+T ++++ NL +P ++++ L L L N ++ M L+ L+ + L
Sbjct: 224 LNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGG 282
Query: 471 ELTGSLPSYM-GSLPNLQELHIENNSFVGEIPPALLTG 507
+L + Y L L+ L++ N + ++
Sbjct: 283 QLA-VVEPYAFRGLNYLRVLNVSGNQLT-TLEESVFHS 318
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 52.1 bits (125), Expect = 7e-08
Identities = 22/85 (25%), Positives = 36/85 (42%), Gaps = 2/85 (2%)
Query: 411 TPPRITKIALSG-KNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLEN 469
TP + ++ L K+ G+I L L L L + ++ +L L+ + L
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLIS-VSNLPKLPKLKKLELSE 80
Query: 470 NELTGSLPSYMGSLPNLQELHIENN 494
N + G L LPNL L++ N
Sbjct: 81 NRIFGGLDMLAEKLPNLTHLNLSGN 105
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 54.9 bits (132), Expect = 9e-08
Identities = 15/84 (17%), Positives = 36/84 (42%), Gaps = 4/84 (4%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 472
R+ ++ +S L + + + L L L N L + + L ++L++N +
Sbjct: 278 QRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLLHVERNQPQFDRLENLYLDHNSI 336
Query: 473 TGSLPSYMGSLPNLQELHIENNSF 496
+L + + L+ L + +N +
Sbjct: 337 V-TLK--LSTHHTLKNLTLSHNDW 357
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 54.9 bits (132), Expect = 9e-08
Identities = 22/99 (22%), Positives = 42/99 (42%), Gaps = 8/99 (8%)
Query: 413 PRITKIALSGKNLKGEIPPEL-KNMEALTELWLDGNFLTGPLPDM--SRLIDLRIVHLEN 469
I K+ + ++ +PP + +N+ LT L L+ N L+ LP L + + N
Sbjct: 99 HTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLSS-LPRGIFHNTPKLTTLSMSN 156
Query: 470 NELTGSLPSYM-GSLPNLQELHIENNSFVGEIPPALLTG 507
N L + + +LQ L + +N + +L+
Sbjct: 157 NNLE-RIEDDTFQATTSLQNLQLSSNRLT-HVDLSLIPS 193
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 53.8 bits (129), Expect = 2e-07
Identities = 14/100 (14%), Positives = 37/100 (37%), Gaps = 6/100 (6%)
Query: 411 TPPRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLE 468
T + ++ ++P L + + L L+ + + ++ +++
Sbjct: 49 TLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMG 107
Query: 469 NNELTGSLPSYM-GSLPNLQELHIENNSFVGEIPPALLTG 507
N + LP ++ ++P L L +E N +P +
Sbjct: 108 FNAIR-YLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHN 145
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 53.0 bits (127), Expect = 3e-07
Identities = 21/99 (21%), Positives = 41/99 (41%), Gaps = 8/99 (8%)
Query: 413 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDM--SRLIDLRIVHLEN 469
++ + L+ ++ EI + +L++ N + LP + L ++ LE
Sbjct: 75 RQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRY-LPPHVFQNVPLLTVLVLER 132
Query: 470 NELTGSLPSYM-GSLPNLQELHIENNSFVGEIPPALLTG 507
N+L+ SLP + + P L L + NN+ I
Sbjct: 133 NDLS-SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQA 169
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 49.9 bits (119), Expect = 3e-06
Identities = 21/94 (22%), Positives = 35/94 (37%), Gaps = 7/94 (7%)
Query: 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNE 471
P + ++ S ++ + + LT L L N LT + L V L NE
Sbjct: 210 PIAVEELDASHNSIN-VVRGPV--NVELTILKLQHNNLT-DTAWLLNYPGLVEVDLSYNE 265
Query: 472 LTGSLPSYM-GSLPNLQELHIENNSFVGEIPPAL 504
L + + + L+ L+I NN V +
Sbjct: 266 LE-KIMYHPFVKMQRLERLYISNNRLV-ALNLYG 297
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 48.8 bits (116), Expect = 8e-06
Identities = 20/87 (22%), Positives = 35/87 (40%), Gaps = 8/87 (9%)
Query: 413 PRITKIALSGKNLKGEIPPEL-KNMEALTELWLDGNFLTGPLPDM--SRLIDLRIVHLEN 469
P +T + L +L +P + N LT L + N L + D L+ + L +
Sbjct: 123 PLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLER-IEDDTFQATTSLQNLQLSS 180
Query: 470 NELTGSLPSYMGSLPNLQELHIENNSF 496
N LT + +P+L ++ N
Sbjct: 181 NRLT-HVDL--SLIPSLFHANVSYNLL 204
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 47.2 bits (112), Expect = 2e-05
Identities = 19/98 (19%), Positives = 35/98 (35%), Gaps = 10/98 (10%)
Query: 410 TTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLEN 469
+ P + +S L L A+ EL N + + ++L I+ L++
Sbjct: 189 SLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSINV-VRGPV-NVELTILKLQH 241
Query: 470 NELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 507
N LT + + P L E+ + N +I
Sbjct: 242 NNLT-DTAW-LLNYPGLVEVDLSYNELE-KIMYHPFVK 276
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 45.7 bits (108), Expect = 7e-05
Identities = 10/80 (12%), Positives = 31/80 (38%), Gaps = 6/80 (7%)
Query: 431 PELKNMEALTELWLDGNFLTGPLPD--MSRLIDLRIVHLENNELTGSLPSYM-GSLPNLQ 487
E + + + + LP + + +++L + ++ + +Y +Q
Sbjct: 45 FEDITLNNQKIVTFKNSTMRK-LPAALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQ 102
Query: 488 ELHIENNSFVGEIPPALLTG 507
+L++ N+ +PP +
Sbjct: 103 KLYMGFNAIR-YLPPHVFQN 121
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 1e-07
Identities = 20/85 (23%), Positives = 39/85 (45%), Gaps = 2/85 (2%)
Query: 411 TPPRITKIALSG-KNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLEN 469
TP + ++ L ++ +G++ E L L LT + ++ +L L+ + L +
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTS-IANLPKLNKLKKLELSD 73
Query: 470 NELTGSLPSYMGSLPNLQELHIENN 494
N ++G L PNL L++ N
Sbjct: 74 NRVSGGLEVLAEKCPNLTHLNLSGN 98
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 5e-04
Identities = 22/83 (26%), Positives = 37/83 (44%), Gaps = 7/83 (8%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGP--LPDMSRLIDLRIVHLENN 470
++ K+ LS + G + + LT L L GN + + + +L +L+ + L N
Sbjct: 64 NKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
Query: 471 ELTGSLPSY----MGSLPNLQEL 489
E+T +L Y LP L L
Sbjct: 124 EVT-NLNDYRENVFKLLPQLTYL 145
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 53.6 bits (128), Expect = 2e-07
Identities = 22/115 (19%), Positives = 39/115 (33%), Gaps = 13/115 (11%)
Query: 395 DPCVPVPWEWVTCS----TTTPPRI------TKIALSGKNLKGEIPPE-LKNMEALTELW 443
D C P + C+ + + T++ + + + L+ + L L
Sbjct: 3 DACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLT 62
Query: 444 LDGNFLTGPLPDM-SRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFV 497
+ + L PD L ++L N L SL +LQEL + N
Sbjct: 63 IVKSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 46.7 bits (110), Expect = 2e-05
Identities = 18/95 (18%), Positives = 33/95 (34%), Gaps = 7/95 (7%)
Query: 428 EIPPELKNMEALTELWLDGNFLTGPLPD--MSRLIDLRIVHLENNELTGSLPSYMGS-LP 484
+ L E LTEL+++ L + L +LR + + + L + P
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTP 80
Query: 485 NLQELHIENNSFVGEIPPALLTGK--VIFKYDNNP 517
L L++ N+ + + G NP
Sbjct: 81 RLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNP 114
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 52.9 bits (127), Expect = 3e-07
Identities = 22/88 (25%), Positives = 35/88 (39%), Gaps = 8/88 (9%)
Query: 412 PPRITKIALSGKNLKGEIPPE--LKNMEALTELWLDGNFLTGPLPDM--SRLIDLRIVHL 467
P + LS NL + E + L L L N L + + +LR + L
Sbjct: 38 PSYTALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLNF-ISSEAFVPVPNLRYLDL 95
Query: 468 ENNELTGSLPSYM-GSLPNLQELHIENN 494
+N L +L ++ L L+ L + NN
Sbjct: 96 SSNHLH-TLDEFLFSDLQALEVLLLYNN 122
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 51.8 bits (124), Expect = 5e-07
Identities = 35/172 (20%), Positives = 59/172 (34%), Gaps = 25/172 (14%)
Query: 413 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDM--SRLIDLRIVHLEN 469
+ + LS +L I E + L L L N L L + S L L ++ L N
Sbjct: 64 TNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSNHLHT-LDEFLFSDLQALEVLLLYN 121
Query: 470 NELTGSLPSYM-GSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNNPKLHKESRRRMR 528
N + + + LQ+L++ N P L+ + PKL +
Sbjct: 122 NHIV-VVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKD-----GNKLPKLMLLDLSSNK 174
Query: 529 FKLILGTSIGVLAILLVLFL----------CSLIVLRK--LRRKISNQKSYE 568
K + T + L + L C L L R++S+ ++
Sbjct: 175 LKKLPLTDLQKLPAWVKNGLYLHNNPLECDCKLYQLFSHWQYRQLSSVMDFQ 226
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 3e-07
Identities = 13/99 (13%), Positives = 37/99 (37%), Gaps = 8/99 (8%)
Query: 413 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDMS--RLIDLRIVHLEN 469
+ ++ ++P L + + L L+ + + + ++ +++
Sbjct: 45 NNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEE-IDTYAFAYAHTIQKLYMGF 102
Query: 470 NELTGSLPSYM-GSLPNLQELHIENNSFVGEIPPALLTG 507
N + LP ++ ++P L L +E N +P +
Sbjct: 103 NAIR-YLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHN 139
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 2e-06
Identities = 21/93 (22%), Positives = 36/93 (38%), Gaps = 5/93 (5%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTG-PLPDMSRLIDLRIVHLENNE 471
+T + L NL L N L E+ L N L ++ L +++ NN
Sbjct: 226 VELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNR 283
Query: 472 LTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 504
L +L Y +P L+ L + +N + +
Sbjct: 284 LV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQ 314
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 5e-06
Identities = 20/87 (22%), Positives = 35/87 (40%), Gaps = 8/87 (9%)
Query: 413 PRITKIALSGKNLKGEIPPEL-KNMEALTELWLDGNFLTGPLPD--MSRLIDLRIVHLEN 469
P +T + L +L +P + N LT L + N L + D L+ + L +
Sbjct: 117 PLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLER-IEDDTFQATTSLQNLQLSS 174
Query: 470 NELTGSLPSYMGSLPNLQELHIENNSF 496
N LT + +P+L ++ N
Sbjct: 175 NRLT-HVDL--SLIPSLFHANVSYNLL 198
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 9e-06
Identities = 19/98 (19%), Positives = 35/98 (35%), Gaps = 10/98 (10%)
Query: 410 TTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLEN 469
+ P + +S L L A+ EL N + + ++L I+ L++
Sbjct: 183 SLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSINV-VRGPV-NVELTILKLQH 235
Query: 470 NELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 507
N LT + + P L E+ + N +I
Sbjct: 236 NNLT-DTAW-LLNYPGLVEVDLSYNELE-KIMYHPFVK 270
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 4e-04
Identities = 19/95 (20%), Positives = 37/95 (38%), Gaps = 5/95 (5%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 472
P + + LS +L + + L L+LD N + L +S L+ + L +N+
Sbjct: 295 PTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLK-LSTHHTLKNLTLSHNDW 351
Query: 473 TGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 507
+ S N+ +++ +I L G
Sbjct: 352 DCN--SLRALFRNVARPAVDDADQHCKIDYQLEHG 384
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 4e-07
Identities = 25/99 (25%), Positives = 40/99 (40%), Gaps = 8/99 (8%)
Query: 413 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDM--SRLIDLRIVHLEN 469
R+ + L L+ E+ P + + AL L+L N L LPD L +L + L
Sbjct: 105 GRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQA-LPDDTFRDLGNLTHLFLHG 162
Query: 470 NELTGSLPSYM-GSLPNLQELHIENNSFVGEIPPALLTG 507
N ++ S+P L +L L + N + P
Sbjct: 163 NRIS-SVPERAFRGLHSLDRLLLHQNRVA-HVHPHAFRD 199
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 9e-07
Identities = 21/84 (25%), Positives = 31/84 (36%), Gaps = 7/84 (8%)
Query: 428 EIPPE-LKNMEALTELWLDGNFLTGPLPDM--SRLIDLRIVHLENNELTGSLPSYM-GSL 483
+ P + L L LD L L L L+ ++L++N L +LP L
Sbjct: 95 SVDPATFHGLGRLHTLHLDRCGLQE-LGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRDL 152
Query: 484 PNLQELHIENNSFVGEIPPALLTG 507
NL L + N +P G
Sbjct: 153 GNLTHLFLHGNRIS-SVPERAFRG 175
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 1e-06
Identities = 20/104 (19%), Positives = 41/104 (39%), Gaps = 9/104 (8%)
Query: 406 TCSTTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTG-PLPDMSRLIDLRI 464
C + + L+ +P + A ++L GN ++ P +L I
Sbjct: 7 VCYNEPK---VTTSCPQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTI 60
Query: 465 VHLENNELTGSLPSYM-GSLPNLQELHIENNSFVGEIPPALLTG 507
+ L +N L + + L L++L + +N+ + + PA G
Sbjct: 61 LWLHSNVLA-RIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHG 103
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 6e-06
Identities = 21/89 (23%), Positives = 39/89 (43%), Gaps = 7/89 (7%)
Query: 413 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPD--MSRLIDLRIVHLEN 469
+T + L G + +P + + +L L L N + + L L ++L
Sbjct: 153 GNLTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQNRVAH-VHPHAFRDLGRLMTLYLFA 210
Query: 470 NELTGSLPSY-MGSLPNLQELHIENNSFV 497
N L+ +LP+ + L LQ L + +N +V
Sbjct: 211 NNLS-ALPTEALAPLRALQYLRLNDNPWV 238
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 53.0 bits (127), Expect = 4e-07
Identities = 26/96 (27%), Positives = 38/96 (39%), Gaps = 12/96 (12%)
Query: 409 TTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLE 468
P + K+ + G L +P L EL + N L LP + +L +
Sbjct: 117 PALPSGLCKLWIFGNQLT-SLPVLPPG---LQELSVSDNQLAS-LPAL--PSELCKLWAY 169
Query: 469 NNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 504
NN+LT SLP LQEL + +N +P
Sbjct: 170 NNQLT-SLPM---LPSGLQELSVSDNQLA-SLPTLP 200
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 52.6 bits (126), Expect = 5e-07
Identities = 22/89 (24%), Positives = 32/89 (35%), Gaps = 8/89 (8%)
Query: 416 TKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGS 475
+ + L +P L +T L + N LT LP +LR + + N+LT S
Sbjct: 43 AVLNVGESGLT-TLPDCLPA--HITTLVIPDNNLTS-LPA--LPPELRTLEVSGNQLT-S 95
Query: 476 LPSYMGSLPNLQELHIENNSFVGEIPPAL 504
LP L L +P L
Sbjct: 96 LPVLPPGLLELSIFSNPLTHLP-ALPSGL 123
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 48.7 bits (116), Expect = 8e-06
Identities = 26/95 (27%), Positives = 38/95 (40%), Gaps = 12/95 (12%)
Query: 410 TTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLEN 469
T P + K+ L +P L EL + GN LT LP + +L+ + +
Sbjct: 198 TLPSELYKLWAYNNRLT-SLPALPSG---LKELIVSGNRLTS-LPVL--PSELKELMVSG 250
Query: 470 NELTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 504
N LT SLP L L + N +P +L
Sbjct: 251 NRLT-SLPM---LPSGLLSLSVYRNQLT-RLPESL 280
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 44.9 bits (106), Expect = 1e-04
Identities = 26/110 (23%), Positives = 41/110 (37%), Gaps = 26/110 (23%)
Query: 412 PPRITKIALSGKNLKGEIPPELKNM-----------------EALTELWLDGNFLTGPLP 454
PP + + +SG L +P + L +LW+ GN LT LP
Sbjct: 80 PPELRTLEVSGNQLT-SLPVLPPGLLELSIFSNPLTHLPALPSGLCKLWIFGNQLTS-LP 137
Query: 455 DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 504
L+ + + +N+L SLP+ L +L NN +P
Sbjct: 138 V--LPPGLQELSVSDNQLA-SLPA---LPSELCKLWAYNNQLT-SLPMLP 180
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 6e-07
Identities = 28/108 (25%), Positives = 40/108 (37%), Gaps = 22/108 (20%)
Query: 406 TCSTTT---------------PPRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFL 449
TCS P IT+I L +K IPP + L + L N +
Sbjct: 10 TCSNNIVDCRGKGLTEIPTNLPETITEIRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQI 68
Query: 450 TGPLPDM--SRLIDLRIVHLENNELTGSLPSYM-GSLPNLQELHIENN 494
+ L L L + L N++T LP + L +LQ L + N
Sbjct: 69 SE-LAPDAFQGLRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNAN 114
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 5e-05
Identities = 20/84 (23%), Positives = 36/84 (42%), Gaps = 5/84 (5%)
Query: 416 TKIALSGKNLKGEIPPEL-KNMEALTELWLDGNFLTGPLPD--MSRLIDLRIVHLENNEL 472
+ L G + E+P L + + +L L L+ N + L L +L ++ L +N+L
Sbjct: 83 NSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKINC-LRVDAFQDLHNLNLLSLYDNKL 140
Query: 473 TGSLPSYMGSLPNLQELHIENNSF 496
L +Q +H+ N F
Sbjct: 141 QTIAKGTFSPLRAIQTMHLAQNPF 164
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 8e-07
Identities = 47/236 (19%), Positives = 87/236 (36%), Gaps = 65/236 (27%)
Query: 619 KKIGKGSFGSVY--YGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHR------N 670
+G+G+FG V + +VA+KI+ + +R + E+ +L +I +
Sbjct: 25 GNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARL-EINVLKKIKEKDKENKFL 83
Query: 671 LVPLIGY-------CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQ-IAHDAA 722
V + + C + +E + + L + N +P L ++ +A+
Sbjct: 84 CVLMSDWFNFHGHMC-------IAFELLGK-NTFEFLKEN-NFQPYP-LPHVRHMAYQLC 133
Query: 723 KGLEYLHTGCNPGIIHRDVKSSNILLDINMRA-------------------KVSDFGLSR 763
L +LH + H D+K NIL + +V+DFG +
Sbjct: 134 HALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSAT 190
Query: 764 QAEEDL-THISSVARGTVGYLDPE-----YYGNQQLTEKSDVYSFGVVLLELISGK 813
E T +++ R Y PE + + DV+S G +L E G
Sbjct: 191 FDHEHHTTIVAT--R---HYRPPEVILELGWA-----QPCDVWSIGCILFEYYRGF 236
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 8e-07
Identities = 20/82 (24%), Positives = 41/82 (50%), Gaps = 5/82 (6%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 472
++ ++L + +I L ++ L L+L N +T + +SRL L + LE+N++
Sbjct: 112 KKLKSLSLEHNGIS-DING-LVHLPQLESLYLGNNKITD-ITVLSRLTKLDTLSLEDNQI 168
Query: 473 TGSLPSYMGSLPNLQELHIENN 494
+ + + L LQ L++ N
Sbjct: 169 S-DIVP-LAGLTKLQNLYLSKN 188
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 2e-04
Identities = 17/62 (27%), Positives = 33/62 (53%), Gaps = 3/62 (4%)
Query: 433 LKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIE 492
LK+++ L L L+ N ++ + + L L ++L NN++T + + L L L +E
Sbjct: 108 LKDLKKLKSLSLEHNGISD-INGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLE 164
Query: 493 NN 494
+N
Sbjct: 165 DN 166
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 2e-04
Identities = 21/82 (25%), Positives = 45/82 (54%), Gaps = 5/82 (6%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 472
I +I + ++K + ++ + +T+L+L+GN LT + ++ L +L + L+ N++
Sbjct: 46 NSIDQIIANNSDIK-SVQG-IQYLPNVTKLFLNGNKLTD-IKPLANLKNLGWLFLDENKV 102
Query: 473 TGSLPSYMGSLPNLQELHIENN 494
L S + L L+ L +E+N
Sbjct: 103 K-DLSS-LKDLKKLKSLSLEHN 122
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 2e-04
Identities = 16/85 (18%), Positives = 37/85 (43%), Gaps = 3/85 (3%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 472
++ ++L + +I P L + L L+L N ++ L ++ L +L ++ L + E
Sbjct: 156 TKLDTLSLEDNQIS-DIVP-LAGLTKLQNLYLSKNHISD-LRALAGLKNLDVLELFSQEC 212
Query: 473 TGSLPSYMGSLPNLQELHIENNSFV 497
++ +L + + S V
Sbjct: 213 LNKPINHQSNLVVPNTVKNTDGSLV 237
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 3e-04
Identities = 27/82 (32%), Positives = 46/82 (56%), Gaps = 5/82 (6%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 472
P +TK+ L+G L +I P L N++ L L+LD N + L + L L+ + LE+N +
Sbjct: 68 PNVTKLFLNGNKLT-DIKP-LANLKNLGWLFLDENKVKD-LSSLKDLKKLKSLSLEHNGI 124
Query: 473 TGSLPSYMGSLPNLQELHIENN 494
+ + + LP L+ L++ NN
Sbjct: 125 S-DING-LVHLPQLESLYLGNN 144
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 1e-06
Identities = 23/105 (21%), Positives = 44/105 (41%), Gaps = 5/105 (4%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 472
+ + L + I P L + L L + ++ L ++ L L + ++N++
Sbjct: 129 SNLQVLYLDLNQIT-NISP-LAGLTNLQYLSIGNAQVSD-LTPLANLSKLTTLKADDNKI 185
Query: 473 TGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNNP 517
+ + + SLPNL E+H++NN P A + I N
Sbjct: 186 S-DISP-LASLPNLIEVHLKNNQISDVSPLANTSNLFIVTLTNQT 228
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 1e-06
Identities = 21/106 (19%), Positives = 46/106 (43%), Gaps = 6/106 (5%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 472
+ +++ + ++ P L N+ LT L D N ++ + ++ L +L VHL+NN++
Sbjct: 151 TNLQYLSIGNAQVS-DLTP-LANLSKLTTLKADDNKISD-ISPLASLPNLIEVHLKNNQI 207
Query: 473 TGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNNPK 518
+ + + + NL + + N + P V+ P
Sbjct: 208 S-DVSP-LANTSNLFIVTLTNQTIT-NQPVFYNNNLVVPNVVKGPS 250
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 3e-06
Identities = 18/82 (21%), Positives = 39/82 (47%), Gaps = 5/82 (6%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 472
I + L+ ++ P L + L L+LD N +T + ++ L +L+ + + N ++
Sbjct: 107 QSIKTLDLTS-TQITDVTP-LAGLSNLQVLYLDLNQITN-ISPLAGLTNLQYLSIGNAQV 163
Query: 473 TGSLPSYMGSLPNLQELHIENN 494
+ L + +L L L ++N
Sbjct: 164 S-DLTP-LANLSKLTTLKADDN 183
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 3e-05
Identities = 17/90 (18%), Positives = 39/90 (43%), Gaps = 6/90 (6%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 472
IT ++ G + I ++ + L L L N +T L + L + + L N L
Sbjct: 41 DGITTLSAFGTGVT-TIEG-VQYLNNLIGLELKDNQITD-LAPLKNLTKITELELSGNPL 97
Query: 473 TGSLPSYMGSLPNLQELHIENNSFVGEIPP 502
++ + + L +++ L + + + ++ P
Sbjct: 98 K-NVSA-IAGLQSIKTLDLTSTQ-ITDVTP 124
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 3e-05
Identities = 23/90 (25%), Positives = 45/90 (50%), Gaps = 6/90 (6%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 472
+ + L + ++ P LKN+ +TEL L GN L + ++ L ++ + L + ++
Sbjct: 63 NNLIGLELKDNQIT-DLAP-LKNLTKITELELSGNPLKN-VSAIAGLQSIKTLDLTSTQI 119
Query: 473 TGSLPSYMGSLPNLQELHIENNSFVGEIPP 502
T + + L NLQ L+++ N + I P
Sbjct: 120 TD--VTPLAGLSNLQVLYLDLNQ-ITNISP 146
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 2e-04
Identities = 18/82 (21%), Positives = 37/82 (45%), Gaps = 5/82 (6%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 472
KIA N+ + +++ +T L G +T + + L +L + L++N++
Sbjct: 19 ANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTT-IEGVQYLNNLIGLELKDNQI 75
Query: 473 TGSLPSYMGSLPNLQELHIENN 494
T L + +L + EL + N
Sbjct: 76 T-DLAP-LKNLTKITELELSGN 95
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 4e-04
Identities = 21/103 (20%), Positives = 43/103 (41%), Gaps = 6/103 (5%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 472
++T + + +I P L ++ L E+ L N ++ + ++ +L IV L N +
Sbjct: 173 SKLTTLKADDNKIS-DISP-LASLPNLIEVHLKNNQISD-VSPLANTSNLFIVTLTNQTI 229
Query: 473 TGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDN 515
T + P + NL ++ I PA ++ + N
Sbjct: 230 T-NQPVFY--NNNLVVPNVVKGPSGAPIAPATISDNGTYASPN 269
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 1e-06
Identities = 18/106 (16%), Positives = 37/106 (34%), Gaps = 16/106 (15%)
Query: 402 WEWVTCS----TTTPPRI----TKIALSGKNLKGEIPPE--LKNMEALTELWLDGNFLTG 451
V CS P I ++ L+ + K + L ++ N +T
Sbjct: 13 GTTVDCSNQKLNKIPEHIPQYTAELRLNNNEFT-VLEATGIFKKLPQLRKINFSNNKITD 71
Query: 452 PLPDM--SRLIDLRIVHLENNELTGSLPSYM-GSLPNLQELHIENN 494
+ + + + L +N L ++ M L +L+ L + +N
Sbjct: 72 -IEEGAFEGASGVNEILLTSNRLE-NVQHKMFKGLESLKTLMLRSN 115
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 7e-05
Identities = 22/86 (25%), Positives = 43/86 (50%), Gaps = 9/86 (10%)
Query: 416 TKIALSGKNLKGEIPPEL-KNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNELT 473
+I L+ L+ + ++ K +E+L L L N +T D L +R++ L +N++T
Sbjct: 84 NEILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQIT 142
Query: 474 GSLPSYMG---SLPNLQELHIENNSF 496
++ G +L +L L++ N F
Sbjct: 143 -TVAP--GAFDTLHSLSTLNLLANPF 165
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 51.0 bits (122), Expect = 1e-06
Identities = 15/87 (17%), Positives = 33/87 (37%), Gaps = 6/87 (6%)
Query: 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMS--RLIDLRIVHLEN 469
+ T + +S + ++ ++ L L + N + L +L + L +
Sbjct: 20 SQKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQY-LDISVFKFNQELEYLDLSH 78
Query: 470 NELTGSLPSYMGSLPNLQELHIENNSF 496
N+L + NL+ L + N+F
Sbjct: 79 NKLV-KISC--HPTVNLKHLDLSFNAF 102
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 48.3 bits (115), Expect = 9e-06
Identities = 15/100 (15%), Positives = 31/100 (31%), Gaps = 6/100 (6%)
Query: 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLID----LRIVHL 467
+ S L + ++ L L L N L L ++ + L+ + +
Sbjct: 323 ISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKE-LSKIAEMTTQMKSLQQLDI 381
Query: 468 ENNELTGSLPSYM-GSLPNLQELHIENNSFVGEIPPALLT 506
N ++ +L L++ +N I L
Sbjct: 382 SQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLPP 421
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 45.2 bits (107), Expect = 8e-05
Identities = 17/86 (19%), Positives = 37/86 (43%), Gaps = 4/86 (4%)
Query: 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNE 471
+ + +S L I L + L L N + + +L L+ +++ +N+
Sbjct: 398 TKSLLSLNMSSNILTDTIFRCL--PPRIKVLDLHSNKIKSIPKQVVKLEALQELNVASNQ 455
Query: 472 LTGSLPSYM-GSLPNLQELHIENNSF 496
L S+P + L +LQ++ + N +
Sbjct: 456 LK-SVPDGIFDRLTSLQKIWLHTNPW 480
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 1e-06
Identities = 17/90 (18%), Positives = 33/90 (36%), Gaps = 7/90 (7%)
Query: 420 LSGKNLKGEIPPELKNMEALTELWLDGNFLTG-PLPDMSRLIDLRIVHLENNELTGSLPS 478
NL ++P L L L N++ L L+++ L + ++
Sbjct: 11 YRFCNLT-QVPQVLNT---TERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDK 66
Query: 479 YM-GSLPNLQELHIENNSFVGEIPPALLTG 507
+LPNL+ L + ++ + P G
Sbjct: 67 EAFRNLPNLRILDLGSSKIY-FLHPDAFQG 95
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 51.0 bits (122), Expect = 2e-06
Identities = 27/112 (24%), Positives = 44/112 (39%), Gaps = 9/112 (8%)
Query: 412 PPRITKIALSGKNLKGEIPPEL-----KNMEALTELWLDGNFLTGPLPDM-SRLIDLRIV 465
P + ++ L L+ EL + + L L+L+ N+L P + S L LR +
Sbjct: 450 NPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGL 509
Query: 466 HLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNNP 517
L +N LT L NL+ L I N + P + + +N
Sbjct: 510 SLNSNRLT-VLSHND-LPANLEILDISRNQLL-APNPDVFVSLSVLDITHNK 558
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 49.4 bits (118), Expect = 5e-06
Identities = 18/100 (18%), Positives = 35/100 (35%), Gaps = 7/100 (7%)
Query: 413 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPD---MSRLIDLRIVHLE 468
P + + L + + P+ + + L EL L L+ + L L + L
Sbjct: 73 PNLRILDLGSSKIY-FLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLS 131
Query: 469 NNELTG-SLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 507
N++ L G L +L+ + +N + L
Sbjct: 132 KNQIRSLYLHPSFGKLNSLKSIDFSSNQIF-LVCEHELEP 170
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 46.7 bits (111), Expect = 3e-05
Identities = 16/85 (18%), Positives = 34/85 (40%), Gaps = 5/85 (5%)
Query: 415 ITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNEL 472
+ + LS + + + ++ L L L N + + L +L++++L N L
Sbjct: 268 VRHLDLSHGFVF-SLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLL 326
Query: 473 TGSLPSYM-GSLPNLQELHIENNSF 496
L S LP + + ++ N
Sbjct: 327 G-ELYSSNFYGLPKVAYIDLQKNHI 350
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 46.3 bits (110), Expect = 5e-05
Identities = 18/103 (17%), Positives = 34/103 (33%), Gaps = 10/103 (9%)
Query: 413 PRITKIALSGKNLKGEIPPE--LKNMEALTELWLDGNFLTG------PLPDMSRLIDLRI 464
P + + L+ + +L +L+L N L L L++
Sbjct: 426 PHLQILILNQNRFS-SCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQV 484
Query: 465 VHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 507
++L +N L P L L+ L + +N + L
Sbjct: 485 LYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLT-VLSHNDLPA 526
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 44.8 bits (106), Expect = 1e-04
Identities = 22/146 (15%), Positives = 44/146 (30%), Gaps = 10/146 (6%)
Query: 420 LSGKNLKGEIPPE--LKNMEALTELWLDGNFLT--GPLPDMSRLIDLRIVHLENNELTGS 475
L L + + +N++ALT L L N + P +L L+ + +N++
Sbjct: 104 LYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLV 163
Query: 476 LPSYMGSL--PNLQELHIENNSFVGEIPPALLTGKVIFKYDNNPKLHKESRRRMRFKLIL 533
+ L L + NS + F+ N L + + +
Sbjct: 164 CEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFR---NMVLEILDVSGNGWTVDI 220
Query: 534 -GTSIGVLAILLVLFLCSLIVLRKLR 558
G ++ L +
Sbjct: 221 TGNFSNAISKSQAFSLILAHHIMGAG 246
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 42.1 bits (99), Expect = 8e-04
Identities = 16/86 (18%), Positives = 31/86 (36%), Gaps = 3/86 (3%)
Query: 413 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTG-PLPDMSRLIDLRIVHLENN 470
+ + L+ + +I E ++ L L L N L + L + + L+ N
Sbjct: 290 KDLKVLNLAYNKIN-KIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKN 348
Query: 471 ELTGSLPSYMGSLPNLQELHIENNSF 496
+ L LQ L + +N+
Sbjct: 349 HIAIIQDQTFKFLEKLQTLDLRDNAL 374
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 50.3 bits (120), Expect = 1e-06
Identities = 18/92 (19%), Positives = 30/92 (32%), Gaps = 5/92 (5%)
Query: 408 STTTPPRITKIALSGKNLKGEIPPEL-KNMEALTELWLDGNFLTGPLPDMSRLIDLRIVH 466
++ + LS +L+ L L L L + L ++
Sbjct: 223 LAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQVPKGLPA--KLSVLD 280
Query: 467 LENNELTGSLPSYMGSLPNLQELHIENNSFVG 498
L N L PS LP + L ++ N F+
Sbjct: 281 LSYNRLD-RNPS-PDELPQVGNLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 48.4 bits (115), Expect = 6e-06
Identities = 15/99 (15%), Positives = 32/99 (32%), Gaps = 8/99 (8%)
Query: 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP--------DMSRLIDLR 463
P + ++++ + +++ AL+ L L N G L L
Sbjct: 148 KPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLA 207
Query: 464 IVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPP 502
+ + +G + + LQ L + +NS
Sbjct: 208 LRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGA 246
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 45.7 bits (108), Expect = 4e-05
Identities = 32/187 (17%), Positives = 56/187 (29%), Gaps = 20/187 (10%)
Query: 395 DPCVPVPWEWVTCSTTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP 454
+PC + P + E+ +++E L +D G
Sbjct: 4 EPCELDEESCSCNFSDPKPDWSSAFNCLGAADVELYGGGRSLEYL-LKRVDTEADLGQFT 62
Query: 455 DMSRLIDLRIVHLENNELTGSLPSYM---GSLPNLQELHIENNSFVGEIPPALLTGKVIF 511
D+ + + L+ + + + + + LQEL +EN G PP LL
Sbjct: 63 DIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEA---- 118
Query: 512 KYDNNPKLHKESRRRMRFKLILGTSIGVLAILLVLFLCSLIVLRKLRRKISNQKSYEKVC 571
P L+ + R + + A L L L+ L I+ S C
Sbjct: 119 ---TGPDLNILNLRNVSW-------ATRDAWLAELQQWLKPGLKVLS--IAQAHSLNFSC 166
Query: 572 PLADSLR 578
Sbjct: 167 EQVRVFP 173
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 45.7 bits (108), Expect = 4e-05
Identities = 16/96 (16%), Positives = 30/96 (31%), Gaps = 7/96 (7%)
Query: 413 PRITKIALSGKNLKGEIPPELKN--MEALTELWLDGNFLTGPLPDMSRLID-----LRIV 465
+ ++ L + G PP L L L L ++ L L+++
Sbjct: 95 SGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVL 154
Query: 466 HLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIP 501
+ + P L L + +N +GE
Sbjct: 155 SIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERG 190
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 2e-06
Identities = 52/241 (21%), Positives = 91/241 (37%), Gaps = 71/241 (29%)
Query: 619 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRI-----HHRNLV 672
+K+G G+FG V + + + K AVK++ + + + E +L +I ++ N+V
Sbjct: 41 RKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYT-RSAKIEADILKKIQNDDINNNNIV 99
Query: 673 PLIGY-------CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQ-IAHDAAKG 724
G C L++E + +L + + + N + ++ + K
Sbjct: 100 KYHGKFMYYDHMC-------LIFEPLGP-SLYEIITRN-NYNGFH-IEDIKLYCIEILKA 149
Query: 725 LEYLHTGCNPGIIHRDVKSSNILLDINMRA-------------------------KVSDF 759
L YL + H D+K NILLD K+ DF
Sbjct: 150 LNYLR---KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDF 206
Query: 760 GLSRQAEEDL-THISSVARGTVGYLDPE------YYGNQQLTEKSDVYSFGVVLLELISG 812
G + + + I++ R Y PE + SD++SFG VL EL +G
Sbjct: 207 GCATFKSDYHGSIINT--R---QYRAPEVILNLGW------DVSSDMWSFGCVLAELYTG 255
Query: 813 K 813
Sbjct: 256 S 256
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 3e-06
Identities = 20/115 (17%), Positives = 38/115 (33%), Gaps = 17/115 (14%)
Query: 395 DPCVPVPWEWVTCSTTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTG-PL 453
DP CS + L ++P + + + L N +
Sbjct: 2 DPGTS------ECSVIG----YNAICINRGLH-QVPELPAH---VNYVDLSLNSIAELNE 47
Query: 454 PDMSRLIDLRIVHLENNELTGSLPSYM-GSLPNLQELHIENNSFVGEIPPALLTG 507
SRL DL+ + +E + + L +L L ++ N F+ ++ G
Sbjct: 48 TSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFL-QLETGAFNG 101
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 2e-05
Identities = 20/86 (23%), Positives = 36/86 (41%), Gaps = 7/86 (8%)
Query: 413 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDMS--RLIDLRIVHLEN 469
+ ++ L+ + +I + L +L L NFL + L L ++ L
Sbjct: 299 TDLEQLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQNFLGS-IDSRMFENLDKLEVLDLSY 356
Query: 470 NELTGSLPSYM-GSLPNLQELHIENN 494
N + +L LPNL+EL ++ N
Sbjct: 357 NHIR-ALGDQSFLGLPNLKELALDTN 381
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 9e-05
Identities = 24/85 (28%), Positives = 42/85 (49%), Gaps = 7/85 (8%)
Query: 416 TKIALSGKNLKGEIPPEL-KNMEALTELWLDGNFLTGPLPDMS--RLIDLRIVHLENNEL 472
K+ LS L I + +N++ L L L N + L D S L +L+ + L+ N+L
Sbjct: 326 LKLNLSQNFLG-SIDSRMFENLDKLEVLDLSYNHIRA-LGDQSFLGLPNLKELALDTNQL 383
Query: 473 TGSLPSYM-GSLPNLQELHIENNSF 496
S+P + L +LQ++ + N +
Sbjct: 384 K-SVPDGIFDRLTSLQKIWLHTNPW 407
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 43.6 bits (103), Expect = 3e-04
Identities = 14/87 (16%), Positives = 27/87 (31%), Gaps = 6/87 (6%)
Query: 413 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTG-PLPDMS--RLIDLRIVHLE 468
+ + L ++ + L L L L G L L L ++ L
Sbjct: 79 SSLIILKLDYNQFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLR 137
Query: 469 NNELTGSLPSYM-GSLPNLQELHIENN 494
+N + P+ ++ L + N
Sbjct: 138 DNNIKKIQPASFFLNMRRFHVLDLTFN 164
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 4e-06
Identities = 22/100 (22%), Positives = 39/100 (39%), Gaps = 6/100 (6%)
Query: 413 PRITKIALSGKNLKGEIPPEL-KNMEALTELWLDGN-FLTGPLPDM-SRLIDLRIVHLEN 469
P I++I +S ++ N+ +T + + LT PD L L+ + + N
Sbjct: 55 PNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFN 114
Query: 470 NELTGSLP--SYMGSLPNLQELHIENNSFVGEIPPALLTG 507
L P + + S L I +N ++ IP G
Sbjct: 115 TGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQG 153
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 1e-04
Identities = 19/108 (17%), Positives = 37/108 (34%), Gaps = 19/108 (17%)
Query: 406 TCSTTTPPRITKIALSGKNLKG--EIPPELKNMEALTELWLDGNFLTGPLPDM--SRLID 461
C ++ K+++ +PP L L L +P S L +
Sbjct: 9 ECHQEE-----DFRVTCKDIQRIPSLPPST------QTLKLIETHLRT-IPSHAFSNLPN 56
Query: 462 LRIVHL-ENNELTGSLPSYM-GSLPNLQELHIENNSFVGEIPPALLTG 507
+ +++ + L L S+ +L + + I N + I P L
Sbjct: 57 ISRIYVSIDVTLQ-QLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKE 103
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 49.3 bits (117), Expect = 4e-06
Identities = 21/82 (25%), Positives = 41/82 (50%), Gaps = 5/82 (6%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 472
++ ++L + +I L ++ L L+L N +T + +SRL L + LE+N++
Sbjct: 109 KKLKSLSLEHNGIS-DING-LVHLPQLESLYLGNNKITD-ITVLSRLTKLDTLSLEDNQI 165
Query: 473 TGSLPSYMGSLPNLQELHIENN 494
+ + G L LQ L++ N
Sbjct: 166 S-DIVPLAG-LTKLQNLYLSKN 185
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 45.1 bits (106), Expect = 1e-04
Identities = 19/82 (23%), Positives = 40/82 (48%), Gaps = 5/82 (6%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 472
+ + L +K ++ LK+++ L L L+ N ++ + + L L ++L NN++
Sbjct: 87 KNLGWLFLDENKIK-DLSS-LKDLKKLKSLSLEHNGISD-INGLVHLPQLESLYLGNNKI 143
Query: 473 TGSLPSYMGSLPNLQELHIENN 494
T + + L L L +E+N
Sbjct: 144 TD--ITVLSRLTKLDTLSLEDN 163
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 44.7 bits (105), Expect = 1e-04
Identities = 13/82 (15%), Positives = 35/82 (42%), Gaps = 5/82 (6%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 472
K L K++ + + ++ ++ + + + + + L ++ + L N+L
Sbjct: 21 AETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKS-VQGIQYLPNVTKLFLNGNKL 77
Query: 473 TGSLPSYMGSLPNLQELHIENN 494
T + + +L NL L ++ N
Sbjct: 78 T-DI-KPLTNLKNLGWLFLDEN 97
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 43.9 bits (103), Expect = 2e-04
Identities = 17/92 (18%), Positives = 39/92 (42%), Gaps = 5/92 (5%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 472
P++ + L + +I L + L L L+ N ++ + ++ L L+ ++L N +
Sbjct: 131 PQLESLYLGNNKIT-DITV-LSRLTKLDTLSLEDNQISD-IVPLAGLTKLQNLYLSKNHI 187
Query: 473 TGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 504
+ L + L NL L + + + +
Sbjct: 188 S-DL-RALAGLKNLDVLELFSQECLNKPINHQ 217
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 43.6 bits (102), Expect = 3e-04
Identities = 27/82 (32%), Positives = 47/82 (57%), Gaps = 5/82 (6%)
Query: 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 472
P +TK+ L+G L +I P L N++ L L+LD N + L + L L+ + LE+N +
Sbjct: 65 PNVTKLFLNGNKLT-DIKP-LTNLKNLGWLFLDENKIKD-LSSLKDLKKLKSLSLEHNGI 121
Query: 473 TGSLPSYMGSLPNLQELHIENN 494
+ + + + LP L+ L++ NN
Sbjct: 122 S-DI-NGLVHLPQLESLYLGNN 141
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 49.6 bits (118), Expect = 4e-06
Identities = 23/104 (22%), Positives = 34/104 (32%), Gaps = 16/104 (15%)
Query: 409 TTTPPRI---TKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIV 465
T P I L +P + L L + N LT LP++ L +
Sbjct: 133 TMLPELPALLEYINADNNQLT-MLPELPTS---LEVLSVRNNQLTF-LPEL--PESLEAL 185
Query: 466 HLENNELTGSLPSYMGSLPNLQE----LHIENNSFVGEIPPALL 505
+ N L SLP+ + +E N IP +L
Sbjct: 186 DVSTNLLE-SLPAVPVRNHHSEETEIFFRCRENRIT-HIPENIL 227
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 49.6 bits (118), Expect = 4e-06
Identities = 21/101 (20%), Positives = 40/101 (39%), Gaps = 16/101 (15%)
Query: 409 TTTPPRI-----TKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLR 463
+ +++ L+ NL +P L +T L + N L LP++ L
Sbjct: 50 VSLLKECLINQFSELQLNRLNLS-SLPDNLPP--QITVLEITQNALI-SLPEL--PASLE 103
Query: 464 IVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 504
+ +N L+ +LP +L+ L ++NN +P
Sbjct: 104 YLDACDNRLS-TLPE---LPASLKHLDVDNNQLT-MLPELP 139
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 7e-06
Identities = 49/236 (20%), Positives = 90/236 (38%), Gaps = 65/236 (27%)
Query: 619 KKIGKGSFGSVY--YGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHR------N 670
+G+G+FG V G+ VAVKI+ + + + +E+ +L ++
Sbjct: 20 DTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYC-EAARSEIQVLEHLNTTDPNSTFR 78
Query: 671 LVPLIGY-------CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQ-IAHDAA 722
V ++ + C +V+E + + D + + P L ++ +A+
Sbjct: 79 CVQMLEWFEHHGHIC-------IVFELLGL-STYDFIKEN-GFLPFR-LDHIRKMAYQIC 128
Query: 723 KGLEYLHTGCNPGIIHRDVKSSNILLDINMRA-------------------KVSDFGLSR 763
K + +LH + + H D+K NIL + KV DFG +
Sbjct: 129 KSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSAT 185
Query: 764 QAEEDL-THISSVARGTVGYLDPE-----YYGNQQLTEKSDVYSFGVVLLELISGK 813
+E T +S+ R Y PE + + DV+S G +L+E G
Sbjct: 186 YDDEHHSTLVST--R---HYRAPEVILALGWS-----QPCDVWSIGCILIEYYLGF 231
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 2e-05
Identities = 24/83 (28%), Positives = 40/83 (48%), Gaps = 7/83 (8%)
Query: 416 TKIALSGKNLKGEIPPEL-KNMEALTELWLDGNFLTGPLPD--MSRLIDLRIVHLENNEL 472
+ L+ L+ +P + K ++ L LW+ N L LP +L++L + L+ N+L
Sbjct: 64 RLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQA-LPIGVFDQLVNLAELRLDRNQL 121
Query: 473 TGSLPSYM-GSLPNLQELHIENN 494
SLP + SL L L + N
Sbjct: 122 K-SLPPRVFDSLTKLTYLSLGYN 143
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 3e-05
Identities = 29/102 (28%), Positives = 44/102 (43%), Gaps = 15/102 (14%)
Query: 405 VTCS----TTTPPRI----TKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPD 455
V CS T P I K+ L L +P + + L L+L+ N L LP
Sbjct: 21 VDCSSKKLTAIPSNIPADTKKLDLQSNKLS-SLPSKAFHRLTKLRLLYLNDNKLQT-LPA 78
Query: 456 M--SRLIDLRIVHLENNELTGSLPSYM-GSLPNLQELHIENN 494
L +L + + +N+L +LP + L NL EL ++ N
Sbjct: 79 GIFKELKNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRN 119
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 2e-04
Identities = 27/108 (25%), Positives = 46/108 (42%), Gaps = 19/108 (17%)
Query: 406 TCSTTTPPRITKIALSGKNLK---GEIPPELKNMEALTELWLDGNFLTGPLPDM--SRLI 460
+C+ + S K L IP + +L L N L+ LP RL
Sbjct: 13 SCNNNK----NSVDCSSKKLTAIPSNIPADT------KKLDLQSNKLSS-LPSKAFHRLT 61
Query: 461 DLRIVHLENNELTGSLPSYM-GSLPNLQELHIENNSFVGEIPPALLTG 507
LR+++L +N+L +LP+ + L NL+ L + +N +P +
Sbjct: 62 KLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQ-ALPIGVFDQ 107
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 2e-05
Identities = 18/100 (18%), Positives = 39/100 (39%), Gaps = 9/100 (9%)
Query: 413 PRITKIALSGKNLKGEIPPEL-KNMEALTELWLDGNFLTGPLPDM--SRLIDLRIVHLEN 469
++ + L+G ++ + + +L +L L L + L L+ +++ +
Sbjct: 76 SHLSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLAS-LENFPIGHLKTLKELNVAH 133
Query: 470 NELTGSLPS--YMGSLPNLQELHIENNSFVGEIPPALLTG 507
N + S Y +L NL+ L + +N I L
Sbjct: 134 NLIQ-SFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRV 171
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 45.3 bits (108), Expect = 4e-05
Identities = 22/119 (18%), Positives = 33/119 (27%), Gaps = 28/119 (23%)
Query: 395 DPCVPVPWEWVTCSTTT---------------PPRITKIALSGKNLKGEIPPE-LKNMEA 438
+PCV T P + LS L+ + +
Sbjct: 1 EPCV------EVVPNITYQCMELNFYKIPDNLPFSTKNLDLSFNPLR-HLGSYSFFSFPE 53
Query: 439 LTELWLDGNFLTGPLPDM--SRLIDLRIVHLENNELTGSLPSYM-GSLPNLQELHIENN 494
L L L + + D L L + L N + SL L +LQ+L
Sbjct: 54 LQVLDLSRCEIQT-IEDGAYQSLSHLSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVET 110
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 4e-05
Identities = 17/83 (20%), Positives = 31/83 (37%), Gaps = 2/83 (2%)
Query: 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNE 471
R ++ L G + I ++ + N + L L L+ + + NN
Sbjct: 18 AVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLDGFPLLRRLKTLLVNNNR 75
Query: 472 LTGSLPSYMGSLPNLQELHIENN 494
+ +LP+L EL + NN
Sbjct: 76 ICRIGEGLDQALPDLTELILTNN 98
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 6e-05
Identities = 17/56 (30%), Positives = 29/56 (51%), Gaps = 2/56 (3%)
Query: 440 TELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYM-GSLPNLQELHIENN 494
TEL+LDGN T ++S L ++ L NN ++ +L + ++ L L + N
Sbjct: 34 TELYLDGNQFTLVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLTLILSYN 88
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 9e-05
Identities = 27/101 (26%), Positives = 41/101 (40%), Gaps = 14/101 (13%)
Query: 405 VTCS----TTTPPRI----TKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD- 455
V CS P I T++ L G +P EL N + LT + L N ++ L +
Sbjct: 15 VRCSNKGLKVLPKGIPRDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRIS-TLSNQ 72
Query: 456 -MSRLIDLRIVHLENNELTGSLPSYM-GSLPNLQELHIENN 494
S + L + L N L +P L +L+ L + N
Sbjct: 73 SFSNMTQLLTLILSYNRLR-CIPPRTFDGLKSLRLLSLHGN 112
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 7e-05
Identities = 29/103 (28%), Positives = 39/103 (37%), Gaps = 17/103 (16%)
Query: 405 VTCS----TTTPPRI----TKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD- 455
V C + P I K+ L L + + LT L LD N L L
Sbjct: 19 VDCQGKSLDSVPSGIPADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQT-LSAG 77
Query: 456 -MSRLIDLRIVHLENNELTGSLPSYMG---SLPNLQELHIENN 494
L +L + L NN+L SLP G L L +L++ N
Sbjct: 78 VFDDLTELGTLGLANNQLA-SLPL--GVFDHLTQLDKLYLGGN 117
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 45.2 bits (107), Expect = 9e-05
Identities = 19/88 (21%), Positives = 37/88 (42%), Gaps = 8/88 (9%)
Query: 412 PPRITKIALSGKNLKGEIPP-ELKNMEALTELWLDGNFLTGPLPDMS--RLIDLRIVHLE 468
PPR ++LS ++ E+ ++ + L L L N + L DL + +
Sbjct: 51 PPRTKALSLSQNSIS-ELRMPDISFLSELRVLRLSHNRIRS-LDFHVFLFNQDLEYLDVS 108
Query: 469 NNELTGSLPSYMGSLPNLQELHIENNSF 496
+N L ++ + +L+ L + N F
Sbjct: 109 HNRLQ-NISC--CPMASLRHLDLSFNDF 133
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 44.1 bits (104), Expect = 2e-04
Identities = 15/77 (19%), Positives = 24/77 (31%), Gaps = 2/77 (2%)
Query: 420 LSGKNLKGEIPPELKNMEALTELWLDGNFLTG-PLPDMSRLIDLRIVHLENNELTGSLPS 478
LS + + + T L N T S L L+ + L+ N L +
Sbjct: 336 LSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK-NFFK 394
Query: 479 YMGSLPNLQELHIENNS 495
N+ L + S
Sbjct: 395 VALMTKNMSSLETLDVS 411
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 42.6 bits (100), Expect = 5e-04
Identities = 20/91 (21%), Positives = 39/91 (42%), Gaps = 4/91 (4%)
Query: 407 CSTTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVH 466
+ I + LS L G + L + L L N + D++ L L+ ++
Sbjct: 422 RTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIMSIPKDVTHLQALQELN 479
Query: 467 LENNELTGSLP-SYMGSLPNLQELHIENNSF 496
+ +N+L S+P L +LQ + + +N +
Sbjct: 480 VASNQLK-SVPDGVFDRLTSLQYIWLHDNPW 509
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 42.6 bits (100), Expect = 6e-04
Identities = 22/91 (24%), Positives = 39/91 (42%), Gaps = 11/91 (12%)
Query: 420 LSGKNLKGEIPPELKNMEALTELWLDGNFLTG-PLPDMSRLIDLRIVHLENNELTGSLPS 478
S +NL +P +L L L N ++ +PD+S L +LR++ L +N + SL
Sbjct: 38 YSNRNLT-HVPKDLP--PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIR-SLDF 93
Query: 479 YMG---SLPNLQELHIENNSFVGEIPPALLT 506
+L+ L + +N I +
Sbjct: 94 --HVFLFNQDLEYLDVSHNRLQ-NISCCPMA 121
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 44.4 bits (105), Expect = 1e-04
Identities = 20/99 (20%), Positives = 37/99 (37%), Gaps = 5/99 (5%)
Query: 413 PRITKIALSGKNLKGEIPPE-LKNMEALTELWL-DGNFLTGPLPDM-SRLIDLRIVHLEN 469
+ KI +S ++ I + N+ L E+ + N L P+ L +L+ + + N
Sbjct: 54 GDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISN 113
Query: 470 NELTGSLPSYM-GSLPNLQELHIENNSFVGEIPPALLTG 507
+ LP L I++N + I G
Sbjct: 114 TGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVG 151
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 1e-04
Identities = 32/103 (31%), Positives = 48/103 (46%), Gaps = 17/103 (16%)
Query: 405 VTCS----TTTPPRI----TKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD- 455
V C T+ P I T + L +LK + +LT+L+L GN L LP+
Sbjct: 12 VECYSQGRTSVPTGIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQS-LPNG 70
Query: 456 -MSRLIDLRIVHLENNELTGSLPSYMG---SLPNLQELHIENN 494
++L L ++L N+L SLP+ G L L+EL + N
Sbjct: 71 VFNKLTSLTYLNLSTNQLQ-SLPN--GVFDKLTQLKELALNTN 110
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 2e-04
Identities = 16/100 (16%), Positives = 38/100 (38%), Gaps = 13/100 (13%)
Query: 405 VTCS----TTTPPRI----TKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM 456
+T S P K L K++ + + + ++ ++ + + + + +
Sbjct: 3 ITVSTPIKQIFPDDAFAETIKANLKKKSVT-DAVTQ-NELNSIDQIIANNSDIKS-VQGI 59
Query: 457 SRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSF 496
L ++R + L N+L + + L NL L + N
Sbjct: 60 QYLPNVRYLALGGNKLH-DISAL-KELTNLTYLILTGNQL 97
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 3e-04
Identities = 24/83 (28%), Positives = 37/83 (44%), Gaps = 7/83 (8%)
Query: 415 ITKIALSGKNLKGEIP-PELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELT 473
I +I + ++K L N + L L GN L + + L +L + L N+L
Sbjct: 43 IDQIIANNSDIKSVQGIQYLPN---VRYLALGGNKLH-DISALKELTNLTYLILTGNQLQ 98
Query: 474 GSLPS-YMGSLPNLQELHIENNS 495
SLP+ L NL+EL + N
Sbjct: 99 -SLPNGVFDKLTNLKELVLVENQ 120
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 4e-04
Identities = 28/103 (27%), Positives = 40/103 (38%), Gaps = 17/103 (16%)
Query: 405 VTCS----TTTPPRI----TKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD- 455
V C + P I + L + P ++ L EL+L N L LP
Sbjct: 24 VDCRSKRHASVPAGIPTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGA-LPVG 82
Query: 456 -MSRLIDLRIVHLENNELTGSLPSYMG---SLPNLQELHIENN 494
L L ++ L N+LT LPS L +L+EL + N
Sbjct: 83 VFDSLTQLTVLDLGTNQLT-VLPS--AVFDRLVHLKELFMCCN 122
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 6e-04
Identities = 26/102 (25%), Positives = 50/102 (49%), Gaps = 15/102 (14%)
Query: 414 RITKIA-LSG-KNLK---------GEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDL 462
I KI+ LSG +NL+ +I + L ELW+ N + L + +L++L
Sbjct: 59 NIEKISSLSGMENLRILSLGRNLIKKIENLDAVADTLEELWISYNQIAS-LSGIEKLVNL 117
Query: 463 RIVHLENNELT--GSLPSYMGSLPNLQELHIENNSFVGEIPP 502
R++++ NN++T G + + +L L++L + N +
Sbjct: 118 RVLYMSNNKITNWGEI-DKLAALDKLEDLLLAGNPLYNDYKE 158
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 935 | |||
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.97 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.97 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.97 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.93 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.88 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.82 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.7 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.64 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.58 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.54 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.51 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.46 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.4 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.38 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.35 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.32 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.3 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.3 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.29 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.27 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.21 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.21 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.21 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.21 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.2 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.18 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.17 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.16 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.15 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.15 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.14 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.13 | |
| 2jwp_A | 174 | Malectin, MGC80075; sugar binding, sugar binding p | 99.12 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.11 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.11 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.11 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.1 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.1 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.08 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.08 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.06 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.05 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.05 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.05 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.05 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.02 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.01 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.0 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.0 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 98.99 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 98.98 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 98.97 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 98.97 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 98.96 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 98.96 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 98.96 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 98.96 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 98.96 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 98.96 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 98.95 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 98.95 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 98.94 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.94 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 98.94 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 98.94 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 98.93 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 98.93 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 98.92 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 98.91 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 98.9 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 98.89 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 98.89 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 98.89 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 98.87 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 98.87 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 98.86 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 98.86 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 98.86 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 98.85 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 98.85 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 98.85 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 98.85 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 98.85 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 98.84 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 98.84 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 98.84 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 98.83 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 98.82 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 98.81 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 98.81 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 98.79 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 98.79 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 98.78 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 98.78 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 98.77 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.76 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 98.76 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 98.75 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 98.75 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 98.75 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 98.75 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 98.75 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 98.73 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 98.73 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 98.73 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 98.73 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 98.7 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 98.69 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 98.68 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 98.68 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 98.68 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 98.68 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 98.67 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 98.66 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 98.65 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 98.64 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 98.61 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 98.58 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 98.57 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 98.57 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.57 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 98.57 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 98.56 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 98.56 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 98.54 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 98.54 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 98.53 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 98.51 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 98.5 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 98.5 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 98.49 | |
| 2jwp_A | 174 | Malectin, MGC80075; sugar binding, sugar binding p | 98.48 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 98.42 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 98.42 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 98.42 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 98.41 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 98.4 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 98.36 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 98.34 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 98.33 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.26 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 98.25 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 98.25 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 98.21 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.2 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.19 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.19 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 98.18 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.15 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.12 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 98.12 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 97.98 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.95 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 97.95 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 97.92 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 97.89 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 97.66 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 97.64 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.59 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.54 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 97.45 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.35 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 97.34 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.32 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.29 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 97.13 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 96.92 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 96.79 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 96.71 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.7 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.67 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.64 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.55 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.51 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.45 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 96.38 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.36 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 96.31 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 96.26 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.19 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.11 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 96.04 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 95.85 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 95.82 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 95.79 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 95.43 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.38 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 95.28 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 95.12 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 93.83 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 93.82 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 93.28 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 90.75 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 88.02 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 87.11 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 83.86 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 83.83 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 82.71 |
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-49 Score=437.66 Aligned_cols=259 Identities=26% Similarity=0.429 Sum_probs=207.5
Q ss_pred HHhhcccccccccEEEEEEEEC------CCcEEEEEEccCcchhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEE
Q 002336 614 TNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILV 687 (935)
Q Consensus 614 ~~~~~~~LG~G~fG~Vy~~~~~------~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV 687 (935)
...+.++||+|+||.||+|+++ +++.||||+++.......++|.+|+++|++++|||||+++|+|.+.+..++|
T Consensus 42 d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV 121 (329)
T 4aoj_A 42 DIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMV 121 (329)
T ss_dssp GEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEE
T ss_pred HeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 3456789999999999999875 4788999999877666778899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhccCC------------CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEE
Q 002336 688 YEYMHNGTLRDRLHGSV------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAK 755 (935)
Q Consensus 688 ~E~~~~gsL~~~L~~~~------------~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vk 755 (935)
||||++|+|.++++... ...+++|.++++|+.|+|+||+|||+ ++|+||||||+||||++++.+|
T Consensus 122 ~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLKp~NILl~~~~~~K 198 (329)
T 4aoj_A 122 FEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG---LHFVHRDLATRNCLVGQGLVVK 198 (329)
T ss_dssp EECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTTEEE
T ss_pred EEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHhhEEECCCCcEE
Confidence 99999999999997542 23469999999999999999999998 8999999999999999999999
Q ss_pred Eeeccccccccccc-cceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCcccchhHHHHHHH
Q 002336 756 VSDFGLSRQAEEDL-THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARS 833 (935)
Q Consensus 756 L~DFGla~~~~~~~-~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~ 833 (935)
|+|||+++...... ........||+.|||||++.+..++.++|||||||++|||+| |+.||..... ..+. .
T Consensus 199 i~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~---~~~~----~ 271 (329)
T 4aoj_A 199 IGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN---TEAI----D 271 (329)
T ss_dssp ECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH---HHHH----H
T ss_pred EcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCH---HHHH----H
Confidence 99999998754332 222344569999999999999999999999999999999999 8999974322 1122 2
Q ss_pred hhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhhhhh
Q 002336 834 MIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 891 (935)
Q Consensus 834 ~i~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~~~~ 891 (935)
.+..+.... .+......+.+++.+||+.||++|||++||++.|+.+...
T Consensus 272 ~i~~g~~~~---------~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 272 CITQGRELE---------RPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp HHHHTCCCC---------CCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred HHHcCCCCC---------CcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 232332111 1222234688999999999999999999999999987653
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-49 Score=435.15 Aligned_cols=261 Identities=28% Similarity=0.446 Sum_probs=214.3
Q ss_pred HHHHhhcccccccccEEEEEEEEC------CCcEEEEEEccCcchhhhHHHHHHHHHHHhcCCCcccccceeeeccceEE
Q 002336 612 EATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRI 685 (935)
Q Consensus 612 ~~~~~~~~~LG~G~fG~Vy~~~~~------~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~ 685 (935)
...+.+.+.||+|+||.||+|++. +++.||||+++.......++|.+|+++|++++|||||+++|+|.+++..+
T Consensus 12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~ 91 (299)
T 4asz_A 12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 91 (299)
T ss_dssp GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEE
Confidence 344567889999999999999874 47789999998776667788999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhccCC----------CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEE
Q 002336 686 LVYEYMHNGTLRDRLHGSV----------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAK 755 (935)
Q Consensus 686 lV~E~~~~gsL~~~L~~~~----------~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vk 755 (935)
+|||||++|+|.++|+... ....++|.++++++.|+|+||+|||+ ++|+||||||+|||+++++.+|
T Consensus 92 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDlKp~NILl~~~~~~K 168 (299)
T 4asz_A 92 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLVK 168 (299)
T ss_dssp EEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEE
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccCHhhEEECCCCcEE
Confidence 9999999999999997531 34579999999999999999999998 8999999999999999999999
Q ss_pred Eeeccccccccccccc-eeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCcccchhHHHHHHH
Q 002336 756 VSDFGLSRQAEEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARS 833 (935)
Q Consensus 756 L~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~ 833 (935)
|+|||+++........ ......||+.|||||++.+..++.++|||||||++|||+| |+.||..... ..+ ..
T Consensus 169 i~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~---~~~----~~ 241 (299)
T 4asz_A 169 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN---NEV----IE 241 (299)
T ss_dssp ECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH---HHH----HH
T ss_pred ECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH---HHH----HH
Confidence 9999999875443322 2233458999999999999999999999999999999999 8999974322 112 22
Q ss_pred hhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhhhhh
Q 002336 834 MIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 891 (935)
Q Consensus 834 ~i~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~~~~ 891 (935)
.+..+.... .+...+..+.+++.+||+.||++|||++||++.|+++...
T Consensus 242 ~i~~~~~~~---------~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~ 290 (299)
T 4asz_A 242 CITQGRVLQ---------RPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA 290 (299)
T ss_dssp HHHHTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHcCCCCC---------CCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 233333211 1222334688999999999999999999999999987653
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-49 Score=435.30 Aligned_cols=262 Identities=24% Similarity=0.415 Sum_probs=213.8
Q ss_pred hHHHHHHhhcccccccccEEEEEEEEC------CCcEEEEEEccCcch-hhhHHHHHHHHHHHhcCCCcccccceeeecc
Q 002336 609 ELEEATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEE 681 (935)
Q Consensus 609 ~l~~~~~~~~~~LG~G~fG~Vy~~~~~------~g~~vAvK~~~~~~~-~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~ 681 (935)
++...+.+|.++||+|+||+||+|.+. +++.||||+++.... ...++|.+|+.+|++++|||||+++|+|.++
T Consensus 22 ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~ 101 (308)
T 4gt4_A 22 EISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKD 101 (308)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEEC
Confidence 444456678899999999999999873 467899999975433 3357899999999999999999999999999
Q ss_pred ceEEEEEEecCCCCHHHHhccCC-------------CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccc
Q 002336 682 HQRILVYEYMHNGTLRDRLHGSV-------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL 748 (935)
Q Consensus 682 ~~~~lV~E~~~~gsL~~~L~~~~-------------~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILl 748 (935)
+..++|||||++|+|.++|.... ....++|.++++++.|||+||+|||+ ++|+||||||+||||
T Consensus 102 ~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLK~~NILl 178 (308)
T 4gt4_A 102 QPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSS---HHVVHKDLATRNVLV 178 (308)
T ss_dssp SSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEE
T ss_pred CEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCccccceEE
Confidence 99999999999999999996432 12468999999999999999999998 899999999999999
Q ss_pred cCCCcEEEeeccccccccccc-cceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCcccchh
Q 002336 749 DINMRAKVSDFGLSRQAEEDL-THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELN 826 (935)
Q Consensus 749 d~~~~vkL~DFGla~~~~~~~-~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~ 826 (935)
++++.+||+|||+++...... ........||+.|||||++.+..++.++|||||||++|||+| |+.||.+... ..
T Consensus 179 ~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~---~~ 255 (308)
T 4gt4_A 179 YDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN---QD 255 (308)
T ss_dssp CGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH---HH
T ss_pred CCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH---HH
Confidence 999999999999998754332 222344568999999999999999999999999999999999 8999974322 12
Q ss_pred HHHHHHHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhhh
Q 002336 827 IVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI 889 (935)
Q Consensus 827 l~~~~~~~i~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~~ 889 (935)
+. ..+..+.... .+...+..+.+++.+||+.||++||||+||++.|+...
T Consensus 256 ~~----~~i~~~~~~~---------~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~ 305 (308)
T 4gt4_A 256 VV----EMIRNRQVLP---------CPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWG 305 (308)
T ss_dssp HH----HHHHTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred HH----HHHHcCCCCC---------CcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhcc
Confidence 22 2333333221 12233446889999999999999999999999998653
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-47 Score=420.24 Aligned_cols=257 Identities=31% Similarity=0.505 Sum_probs=202.2
Q ss_pred HhhcccccccccEEEEEEEECCCcEEEEEEccCc--chhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEecC
Q 002336 615 NNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 692 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~~~~~--~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~~ 692 (935)
..+.++||+|+||+||+|++++ .||||+++.. .....+.|.+|+++|++++|||||+++|++.+ +..++|||||+
T Consensus 38 l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy~~ 114 (307)
T 3omv_A 38 VMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQWCE 114 (307)
T ss_dssp CCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCS
T ss_pred eEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEcCC
Confidence 4578899999999999999763 5999998643 33456789999999999999999999999865 46899999999
Q ss_pred CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccc-cc
Q 002336 693 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL-TH 771 (935)
Q Consensus 693 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~-~~ 771 (935)
+|+|.++|+.. ...+++.+++.|+.|||+||+|||+ ++|+||||||+||||++++.+||+|||+|+...... ..
T Consensus 115 gGsL~~~l~~~--~~~l~~~~~~~i~~qia~gL~yLH~---~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~ 189 (307)
T 3omv_A 115 GSSLYKHLHVQ--ETKFQMFQLIDIARQTAQGMDYLHA---KNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQ 189 (307)
T ss_dssp SCBHHHHHHTS--CCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCCSSSEEEETTEEEEECCCSSCBC--------
T ss_pred CCCHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCccCHHHEEECCCCcEEEeeccCceecccCCcce
Confidence 99999999743 4579999999999999999999998 899999999999999999999999999998754322 22
Q ss_pred eeecccCCccccCCCCCC---CCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccccc
Q 002336 772 ISSVARGTVGYLDPEYYG---NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 848 (935)
Q Consensus 772 ~~~~~~gt~~y~APE~l~---~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l 848 (935)
......||+.|||||++. ...++.++|||||||++|||+||+.||...... ..+...+..+.. .|.+
T Consensus 190 ~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~------~~~~~~~~~~~~----~p~~ 259 (307)
T 3omv_A 190 QVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNR------DQIIFMVGRGYA----SPDL 259 (307)
T ss_dssp ----CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH------HHHHHHHHTTCC----CCCS
T ss_pred eecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChH------HHHHHHHhcCCC----CCCc
Confidence 233457999999999885 346899999999999999999999999743221 112222222211 1111
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhhhh
Q 002336 849 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 890 (935)
Q Consensus 849 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~~~ 890 (935)
...+...+..+.+++.+||+.+|++|||++||++.|+.+..
T Consensus 260 -~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~ 300 (307)
T 3omv_A 260 -SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQH 300 (307)
T ss_dssp -TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHT
T ss_pred -ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 11222334578899999999999999999999999987654
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-47 Score=420.56 Aligned_cols=261 Identities=24% Similarity=0.263 Sum_probs=209.2
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCcchhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEecCC
Q 002336 615 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 693 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~~~ 693 (935)
+.+.++||+|+||.||+|+++ +|+.||||+++... ...+|+.+|+.++|||||++++++.+++..|||||||+|
T Consensus 60 ~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~-----~~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~g 134 (336)
T 4g3f_A 60 MTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV-----FRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEG 134 (336)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT-----CCTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTT
T ss_pred eEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHH-----hHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCC
Confidence 445678999999999999986 68999999986432 234799999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCC-cEEEeeccccccccccccc-
Q 002336 694 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM-RAKVSDFGLSRQAEEDLTH- 771 (935)
Q Consensus 694 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~-~vkL~DFGla~~~~~~~~~- 771 (935)
|+|.++++. .+.+++.++..++.||+.||+|||+ ++|+||||||+||||+.++ ++||+|||+|+........
T Consensus 135 g~L~~~l~~---~~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~ 208 (336)
T 4g3f_A 135 GSLGQLIKQ---MGCLPEDRALYYLGQALEGLEYLHT---RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGK 208 (336)
T ss_dssp CBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-------
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCccc
Confidence 999999974 4579999999999999999999998 8999999999999999987 6999999999876543211
Q ss_pred ---eeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccccc
Q 002336 772 ---ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 848 (935)
Q Consensus 772 ---~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l 848 (935)
......||+.|||||++.+..++.++|||||||++|||++|+.||........ ... +..+... +
T Consensus 209 ~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~---~~~----i~~~~~~------~ 275 (336)
T 4g3f_A 209 SLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPL---CLK----IASEPPP------I 275 (336)
T ss_dssp -----CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCC---HHH----HHHSCCG------G
T ss_pred ceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH---HHH----HHcCCCC------c
Confidence 12234699999999999999999999999999999999999999975433221 111 1111110 0
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhhhhhccCCCCCcc
Q 002336 849 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKGGDQKFS 900 (935)
Q Consensus 849 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~~~~~~~~~~~~~ 900 (935)
...+......+.+++.+||+.||++|||++|+++.|...+.....-..+|-
T Consensus 276 -~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~ 326 (336)
T 4g3f_A 276 -REIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWK 326 (336)
T ss_dssp -GGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSS
T ss_pred -hhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCc
Confidence 011222334688999999999999999999999999887766555445543
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=419.74 Aligned_cols=247 Identities=25% Similarity=0.347 Sum_probs=205.9
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCcchhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEecCC
Q 002336 615 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 693 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~~~ 693 (935)
|++.++||+|+||.||+|.++ +|+.||||++........+.+.+|+++|++++|||||++++++.+++..|||||||++
T Consensus 76 y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~g 155 (346)
T 4fih_A 76 LDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 155 (346)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCTT
T ss_pred cEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCC
Confidence 566788999999999999986 6999999999765455567789999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccccccccee
Q 002336 694 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 773 (935)
Q Consensus 694 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~~~ 773 (935)
|+|.+++.. ..+++.++..++.||+.||+|||+ ++|+||||||+||||+.++.+||+|||+|+........ .
T Consensus 156 g~L~~~l~~----~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~-~ 227 (346)
T 4fih_A 156 GALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR-R 227 (346)
T ss_dssp EEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCC-B
T ss_pred CcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEECCCCCEEEecCcCceecCCCCCc-c
Confidence 999999973 459999999999999999999998 99999999999999999999999999999876544332 3
Q ss_pred ecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccCCCC
Q 002336 774 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVK 853 (935)
Q Consensus 774 ~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~~~~ 853 (935)
....||+.|||||++.+..|+.++||||+||++|||++|+.||...... ... ..+..+.... +. ..
T Consensus 228 ~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~---~~~----~~i~~~~~~~-----~~--~~ 293 (346)
T 4fih_A 228 KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL---KAM----KMIRDNLPPR-----LK--NL 293 (346)
T ss_dssp CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHH----HHHHHSSCCC-----CS--CG
T ss_pred cccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH---HHH----HHHHcCCCCC-----CC--cc
Confidence 3457999999999999999999999999999999999999999743221 111 1222221111 10 11
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 854 IESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 854 ~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
......+.+++.+||+.||++|||++|+++
T Consensus 294 ~~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 294 HKVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp GGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 122346889999999999999999999875
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=420.34 Aligned_cols=249 Identities=26% Similarity=0.376 Sum_probs=201.1
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCc--chhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEe
Q 002336 614 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 690 (935)
Q Consensus 614 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~--~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~ 690 (935)
.|++.+.||+|+||+||+|++. +|+.||||++... .....+.+.+|+++|++++|||||++++++.+++..|+||||
T Consensus 25 ~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy 104 (350)
T 4b9d_A 25 KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDY 104 (350)
T ss_dssp CEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred ceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeC
Confidence 3677899999999999999875 6999999998653 233457899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccccccc
Q 002336 691 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 770 (935)
Q Consensus 691 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~ 770 (935)
|+||+|.+++... ....+++.+++.++.||+.||+|||+ ++|+||||||+||||+.++.+||+|||+++.......
T Consensus 105 ~~gg~L~~~i~~~-~~~~~~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~ 180 (350)
T 4b9d_A 105 CEGGDLFKRINAQ-KGVLFQEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVE 180 (350)
T ss_dssp CTTCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHH---TTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHHH
T ss_pred CCCCcHHHHHHHc-CCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCCEEEcccccceeecCCcc
Confidence 9999999999743 34567899999999999999999998 9999999999999999999999999999987654322
Q ss_pred ceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccC
Q 002336 771 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 850 (935)
Q Consensus 771 ~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~ 850 (935)
......||+.|||||++.+..++.++|||||||++|||++|+.||..... .+.... +..+.... +..
T Consensus 181 -~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~------~~~~~~-i~~~~~~~-----~~~ 247 (350)
T 4b9d_A 181 -LARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSM------KNLVLK-IISGSFPP-----VSL 247 (350)
T ss_dssp -HHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHH-HHHTCCCC-----CCT
T ss_pred -cccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH------HHHHHH-HHcCCCCC-----CCc
Confidence 12345699999999999999999999999999999999999999974332 111222 22222211 111
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 851 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 851 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
. ....+.+++.+||+.||++|||++|+++
T Consensus 248 ~----~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 248 H----YSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp T----SCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred c----CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 2 2236889999999999999999999976
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-46 Score=406.35 Aligned_cols=244 Identities=28% Similarity=0.422 Sum_probs=196.7
Q ss_pred hhcccccccccEEEEEEEEC-CCcEEEEEEccCc--chhhhHHHHHHHHHHHhcCCCcccccceeeec----cceEEEEE
Q 002336 616 NFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEE----EHQRILVY 688 (935)
Q Consensus 616 ~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~--~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~----~~~~~lV~ 688 (935)
++.++||+|+||.||+|.+. +++.||+|++... .....+.|.+|+++|++++|||||++++++.+ +...+|||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 45678999999999999876 6889999998643 23345679999999999999999999999864 45689999
Q ss_pred EecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCc--eEecCCCCCCcccc-CCCcEEEeeccccccc
Q 002336 689 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG--IIHRDVKSSNILLD-INMRAKVSDFGLSRQA 765 (935)
Q Consensus 689 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~--ivH~DLkp~NILld-~~~~vkL~DFGla~~~ 765 (935)
|||++|+|.+++.. ...+++..+..++.||+.||+|||+ ++ |+||||||+||||+ .++.+||+|||+|+..
T Consensus 109 Ey~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~ylH~---~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~ 182 (290)
T 3fpq_A 109 ELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 182 (290)
T ss_dssp ECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred eCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCCCEEecccChhheeEECCCCCEEEEeCcCCEeC
Confidence 99999999999974 4679999999999999999999997 66 99999999999997 4799999999999864
Q ss_pred cccccceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeeccc
Q 002336 766 EEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 845 (935)
Q Consensus 766 ~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d 845 (935)
... ......||+.|||||++.+ .++.++|||||||++|||+||+.||...... .. +...+..+.....++
T Consensus 183 ~~~---~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~--~~----~~~~i~~~~~~~~~~ 252 (290)
T 3fpq_A 183 RAS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA--AQ----IYRRVTSGVKPASFD 252 (290)
T ss_dssp CTT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH--HH----HHHHHTTTCCCGGGG
T ss_pred CCC---ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcH--HH----HHHHHHcCCCCCCCC
Confidence 332 2334579999999998875 5999999999999999999999999632211 11 222333332211111
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 846 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 846 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
+ ..+ ..+.+++.+||+.||++|||++|+++
T Consensus 253 ~----~~~----~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 253 K----VAI----PEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp G----CCC----HHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred c----cCC----HHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1 112 25789999999999999999999875
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-46 Score=412.60 Aligned_cols=267 Identities=25% Similarity=0.362 Sum_probs=201.5
Q ss_pred HhhcccccccccEEEEEEEECCCcEEEEEEccCcchhhhHHHHHHHHHHHhcCCCcccccceeeeccc----eEEEEEEe
Q 002336 615 NNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH----QRILVYEY 690 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~----~~~lV~E~ 690 (935)
+.+.++||+|+||+||+|+++ |+.||||++.... .....+..|+..+.+++|||||+++|+|.+++ ..+|||||
T Consensus 5 i~L~~~iG~G~fG~Vy~~~~~-g~~VAvK~l~~~~-~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey 82 (303)
T 3hmm_A 5 IVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSRE-ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDY 82 (303)
T ss_dssp EEEEEEEEECSSSEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEEC
T ss_pred EEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccc-hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecC
Confidence 345789999999999999985 8999999986532 22223345666667889999999999997653 57999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcC-----CCceEecCCCCCCccccCCCcEEEeeccccccc
Q 002336 691 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC-----NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 765 (935)
Q Consensus 691 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~-----~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~ 765 (935)
|++|+|.++|+. .++++..+++++.|+++||+|||+.+ .++|+||||||+||||+.++++||+|||+++..
T Consensus 83 ~~~gsL~~~l~~----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~ 158 (303)
T 3hmm_A 83 HEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH 158 (303)
T ss_dssp CTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred CCCCcHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccc
Confidence 999999999974 46899999999999999999999721 249999999999999999999999999999876
Q ss_pred cccccc---eeecccCCccccCCCCCCCC------CCCchhHHHHHHHHHHHHHhCCCCCCccCcccc--------hhHH
Q 002336 766 EEDLTH---ISSVARGTVGYLDPEYYGNQ------QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAE--------LNIV 828 (935)
Q Consensus 766 ~~~~~~---~~~~~~gt~~y~APE~l~~~------~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~--------~~l~ 828 (935)
...... ......||+.|||||++.+. .++.++|||||||++|||+||+.|+........ ....
T Consensus 159 ~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~ 238 (303)
T 3hmm_A 159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV 238 (303)
T ss_dssp ETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred cCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchH
Confidence 543322 12235699999999998654 467899999999999999999887753322110 0111
Q ss_pred HHHHHhhhcCCeeecccccccCCC-CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhhhhh
Q 002336 829 HWARSMIKKGDVISIVDPVLIGNV-KIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 891 (935)
Q Consensus 829 ~~~~~~i~~~~~~~~~d~~l~~~~-~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~~~~ 891 (935)
+.+...+..+. ++|.+.... ..+....+.+++.+||+.||++||||+||++.|+++...
T Consensus 239 ~~~~~~~~~~~----~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~ 298 (303)
T 3hmm_A 239 EEMRKVVCEQK----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp HHHHHHHTTSC----CCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHHHHhccc----CCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence 22222222211 222222211 235567889999999999999999999999999987654
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=421.77 Aligned_cols=266 Identities=26% Similarity=0.401 Sum_probs=214.7
Q ss_pred hHHHHHHhhcccccccccEEEEEEEECC------CcEEEEEEccCcch-hhhHHHHHHHHHHHhcCC-Ccccccceeeec
Q 002336 609 ELEEATNNFCKKIGKGSFGSVYYGKMKD------GKEVAVKIMADSCS-HRTQQFVTEVALLSRIHH-RNLVPLIGYCEE 680 (935)
Q Consensus 609 ~l~~~~~~~~~~LG~G~fG~Vy~~~~~~------g~~vAvK~~~~~~~-~~~~~~~~E~~iL~~L~H-pnIv~l~g~~~~ 680 (935)
|+....+++.+.||+|+||.||+|.+.. ++.||||++..... ...+.|.+|+++|.+++| ||||+++|+|.+
T Consensus 60 Ei~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~ 139 (353)
T 4ase_A 60 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK 139 (353)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred EecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEe
Confidence 3444567788999999999999998752 36899999976543 345779999999999965 999999999966
Q ss_pred -cceEEEEEEecCCCCHHHHhccCC-------------CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCc
Q 002336 681 -EHQRILVYEYMHNGTLRDRLHGSV-------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNI 746 (935)
Q Consensus 681 -~~~~~lV~E~~~~gsL~~~L~~~~-------------~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NI 746 (935)
++..++|||||++|+|.++|+... ....+++.+++.++.|||+||+|||+ ++|+||||||+||
T Consensus 140 ~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~---~~iiHRDLK~~NI 216 (353)
T 4ase_A 140 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNI 216 (353)
T ss_dssp TTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGE
T ss_pred cCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhh---CCeecCccCccce
Confidence 456899999999999999997532 13458999999999999999999998 8999999999999
Q ss_pred cccCCCcEEEeeccccccccccccc-eeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCcccc
Q 002336 747 LLDINMRAKVSDFGLSRQAEEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAE 824 (935)
Q Consensus 747 Lld~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~ 824 (935)
|+++++.+||+|||+|+........ ......||+.|||||++.+..++.++|||||||++|||+| |+.||.+.....
T Consensus 217 Ll~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~- 295 (353)
T 4ase_A 217 LLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE- 295 (353)
T ss_dssp EECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH-
T ss_pred eeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHH-
Confidence 9999999999999999876544332 2334568999999999999999999999999999999998 999997433221
Q ss_pred hhHHHHHHHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhhhhhc
Q 002336 825 LNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 892 (935)
Q Consensus 825 ~~l~~~~~~~i~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~~~~~ 892 (935)
.+...+.++..... +......+.+++.+||+.||++|||++||++.|+++++..
T Consensus 296 -----~~~~~i~~g~~~~~---------p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~~ 349 (353)
T 4ase_A 296 -----EFCRRLKEGTRMRA---------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 349 (353)
T ss_dssp -----HHHHHHHHTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred -----HHHHHHHcCCCCCC---------CccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHHh
Confidence 12233333322111 1122346889999999999999999999999999987644
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=421.47 Aligned_cols=247 Identities=25% Similarity=0.347 Sum_probs=206.1
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCcchhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEecCC
Q 002336 615 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 693 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~~~ 693 (935)
|++.++||+|+||.||+|.+. +|+.||||++........+.+.+|+.+|+.++|||||++++++.+++..|||||||+|
T Consensus 153 y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~g 232 (423)
T 4fie_A 153 LDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 232 (423)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred cEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCCCC
Confidence 566789999999999999986 6999999999765555567899999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccccccccee
Q 002336 694 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 773 (935)
Q Consensus 694 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~~~ 773 (935)
|+|.+++.. ..+++.++..++.||+.||+|||+ ++|+||||||+||||+.+|.+||+|||+|+........ .
T Consensus 233 G~L~~~i~~----~~l~e~~~~~~~~qil~aL~ylH~---~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~-~ 304 (423)
T 4fie_A 233 GALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR-R 304 (423)
T ss_dssp EEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCC-B
T ss_pred CcHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEecCccceECCCCCcc-c
Confidence 999999973 459999999999999999999998 99999999999999999999999999999876544322 3
Q ss_pred ecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccCCCC
Q 002336 774 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVK 853 (935)
Q Consensus 774 ~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~~~~ 853 (935)
...+||+.|||||++.+..|+.++|||||||++|||++|+.||...... ... ..+..+.... +. ..
T Consensus 305 ~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~---~~~----~~i~~~~~~~-----~~--~~ 370 (423)
T 4fie_A 305 KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL---KAM----KMIRDNLPPR-----LK--NL 370 (423)
T ss_dssp CCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHH----HHHHHSCCCC-----CS--CT
T ss_pred cccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH---HHH----HHHHcCCCCC-----Cc--cc
Confidence 3457999999999999999999999999999999999999999743221 111 1222221111 11 01
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 854 IESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 854 ~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
......+.+++.+||+.||++|||++|+++
T Consensus 371 ~~~s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 371 HKVSPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp TSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 112236789999999999999999999875
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=411.51 Aligned_cols=246 Identities=24% Similarity=0.375 Sum_probs=205.5
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc---hhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEE
Q 002336 614 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 689 (935)
Q Consensus 614 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E 689 (935)
.|++.+.||+|+||+||+|++. +|+.||||++.... ....+.+.+|+++|++++|||||++++++.+++..|+|||
T Consensus 33 dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmE 112 (311)
T 4aw0_A 33 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLS 112 (311)
T ss_dssp GEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 3778999999999999999876 69999999986532 2234678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccc
Q 002336 690 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 769 (935)
Q Consensus 690 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~ 769 (935)
|++||+|.+++.. .+.+++.++..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+|+......
T Consensus 113 y~~gG~L~~~i~~---~~~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~ 186 (311)
T 4aw0_A 113 YAKNGELLKYIRK---IGSFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 186 (311)
T ss_dssp CCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTT
T ss_pred cCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCC
Confidence 9999999999973 4679999999999999999999998 999999999999999999999999999998765332
Q ss_pred -cceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccccc
Q 002336 770 -THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 848 (935)
Q Consensus 770 -~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l 848 (935)
.......+||+.|||||++.+..++.++||||+||++|||++|+.||...+.. .+ ...+..+.+ .+
T Consensus 187 ~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~---~~----~~~i~~~~~------~~ 253 (311)
T 4aw0_A 187 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEG---LI----FAKIIKLEY------DF 253 (311)
T ss_dssp TCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HH----HHHHHHTCC------CC
T ss_pred CcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH---HH----HHHHHcCCC------CC
Confidence 22334567999999999999999999999999999999999999999743321 11 122222222 11
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 002336 849 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIV 882 (935)
Q Consensus 849 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~ 882 (935)
.... ...+.+++.+||+.||++|||++|+.
T Consensus 254 p~~~----s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 254 PEKF----FPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp CTTC----CHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred Cccc----CHHHHHHHHHHccCCHhHCcChHHHc
Confidence 1122 23678999999999999999999863
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=397.23 Aligned_cols=244 Identities=25% Similarity=0.373 Sum_probs=189.9
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc---hhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEE
Q 002336 614 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 689 (935)
Q Consensus 614 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E 689 (935)
.|++.+.||+|+||+||+|.+. +|+.||||++.... ....+.+.+|+++|++++|||||++++++.+++..++|||
T Consensus 14 ~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE 93 (275)
T 3hyh_A 14 NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIE 93 (275)
T ss_dssp CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEe
Confidence 3677899999999999999875 69999999986542 2234679999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccc
Q 002336 690 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 769 (935)
Q Consensus 690 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~ 769 (935)
|+ +|+|.+.+.. ...+++.++..++.||+.||+|||+ ++|+||||||+|||+++++++||+|||+|+...+..
T Consensus 94 y~-~g~L~~~l~~---~~~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~ 166 (275)
T 3hyh_A 94 YA-GNELFDYIVQ---RDKMSEQEARRFFQQIISAVEYCHR---HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN 166 (275)
T ss_dssp CC-CEEHHHHHHH---SCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTCCEEECCSSCC-------
T ss_pred CC-CCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCChHHeEECCCCCEEEeecCCCeecCCCC
Confidence 99 6899999874 4679999999999999999999998 999999999999999999999999999998754432
Q ss_pred cceeecccCCccccCCCCCCCCCC-CchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccccc
Q 002336 770 THISSVARGTVGYLDPEYYGNQQL-TEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 848 (935)
Q Consensus 770 ~~~~~~~~gt~~y~APE~l~~~~~-s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l 848 (935)
. .....||+.|||||++.+..+ +.++||||+||++|||++|+.||...... .+ .+.+..+.. .+
T Consensus 167 ~--~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~---~~----~~~i~~~~~------~~ 231 (275)
T 3hyh_A 167 F--LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIP---VL----FKNISNGVY------TL 231 (275)
T ss_dssp ----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HH----HHHHHHTCC------CC
T ss_pred c--cCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHH---HH----HHHHHcCCC------CC
Confidence 2 234579999999999988765 58999999999999999999999743221 11 122222221 11
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 849 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 849 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
.... ...+.+++.+||+.||++|||++|+++
T Consensus 232 p~~~----s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 232 PKFL----SPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp CTTS----CHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCCC----CHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 1112 236789999999999999999999976
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=403.64 Aligned_cols=246 Identities=26% Similarity=0.336 Sum_probs=194.6
Q ss_pred HHhhcccccccccEEEEEEEEC----CCcEEEEEEccCcch--hhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEE
Q 002336 614 TNNFCKKIGKGSFGSVYYGKMK----DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILV 687 (935)
Q Consensus 614 ~~~~~~~LG~G~fG~Vy~~~~~----~g~~vAvK~~~~~~~--~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV 687 (935)
.|++.+.||+|+||+||+|+.. .++.||||+++.... .....+.+|+++|++++|||||++++++.+++..|+|
T Consensus 25 ~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv 104 (304)
T 3ubd_A 25 QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLI 104 (304)
T ss_dssp GEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEEE
T ss_pred ccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 4678899999999999999863 478999999875422 2335688999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccc
Q 002336 688 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 767 (935)
Q Consensus 688 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~ 767 (935)
||||+||+|.+++.. .+.+++.++..++.|++.||+|||+ ++|+||||||+|||+++++.+||+|||+|+....
T Consensus 105 mEy~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 178 (304)
T 3ubd_A 105 LDFLRGGDLFTRLSK---EVMFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESID 178 (304)
T ss_dssp ECCCTTCEEHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTSCEEEESSEEEEC---
T ss_pred EEcCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHeEEcCCCCEEecccccceeccC
Confidence 999999999999974 4679999999999999999999998 9999999999999999999999999999986543
Q ss_pred cccceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeeccccc
Q 002336 768 DLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 847 (935)
Q Consensus 768 ~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~ 847 (935)
... ......||+.|||||++.+..++.++||||+||++|||++|+.||.+.+.. .+ . ..+.++.. .
T Consensus 179 ~~~-~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~---~~---~-~~i~~~~~------~ 244 (304)
T 3ubd_A 179 HEK-KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRK---ET---M-TMILKAKL------G 244 (304)
T ss_dssp --C-CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HH---H-HHHHHCCC------C
T ss_pred CCc-cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHH---HH---H-HHHHcCCC------C
Confidence 322 223457999999999999999999999999999999999999999743321 11 1 12222221 1
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCCCH-----HHHHH
Q 002336 848 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKM-----QEIVL 883 (935)
Q Consensus 848 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~-----~ev~~ 883 (935)
+ +......+.+++.+||+.||++|||+ +|+++
T Consensus 245 ~----p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 245 M----PQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp C----CTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred C----CCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 1 11122367899999999999999984 56653
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-44 Score=392.15 Aligned_cols=249 Identities=23% Similarity=0.356 Sum_probs=187.9
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcch-hhhHHHHHHHHHHHhcCCCcccccceeeeccc---------
Q 002336 614 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH--------- 682 (935)
Q Consensus 614 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~-~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~--------- 682 (935)
.|++.+.||+|+||+||+|+++ +|+.||||+++.... ...+.+.+|+++|++++|||||++++++.+.+
T Consensus 6 dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~ 85 (299)
T 4g31_A 6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSS 85 (299)
T ss_dssp HEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC---------
T ss_pred hCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccC
Confidence 3667899999999999999876 689999999865433 34567999999999999999999999986543
Q ss_pred ---eEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeec
Q 002336 683 ---QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDF 759 (935)
Q Consensus 683 ---~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DF 759 (935)
..|+|||||++|+|.+++.........++..++.++.||++||+|||+ ++|+||||||+|||++.++.+||+||
T Consensus 86 ~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~---~~IiHRDlKp~NILl~~~~~vKl~DF 162 (299)
T 4g31_A 86 PKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDF 162 (299)
T ss_dssp -CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCC
T ss_pred CCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHH---CcCccccCcHHHeEECCCCcEEEccC
Confidence 368999999999999999854333445677789999999999999998 89999999999999999999999999
Q ss_pred cccccccccccc-----------eeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHH
Q 002336 760 GLSRQAEEDLTH-----------ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIV 828 (935)
Q Consensus 760 Gla~~~~~~~~~-----------~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~ 828 (935)
|+|+........ ......||+.|||||++.+..++.++|||||||++|||++ ||.... +..
T Consensus 163 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~-----~~~ 234 (299)
T 4g31_A 163 GLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM-----ERV 234 (299)
T ss_dssp CCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH-----HHH
T ss_pred ccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc-----HHH
Confidence 999876543211 1123469999999999999999999999999999999996 775211 111
Q ss_pred HHHHHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 829 HWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 829 ~~~~~~i~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
..+ ..+........ .......+.+++.+||+.||++|||+.|+++
T Consensus 235 ~~~-~~~~~~~~p~~---------~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 235 RTL-TDVRNLKFPPL---------FTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp HHH-HHHHTTCCCHH---------HHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHH-HHHhcCCCCCC---------CcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 111 11222221111 1122235678999999999999999999876
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-42 Score=380.55 Aligned_cols=276 Identities=41% Similarity=0.718 Sum_probs=242.3
Q ss_pred HhhcccccccccEEEEEEEECCCcEEEEEEccCcchhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEecCCC
Q 002336 615 NNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNG 694 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~~~g 694 (935)
|++.+.||+|+||.||+|.+++|+.||||++........+.+.+|+++++.++||||+++++++.+.+..++||||+++|
T Consensus 41 y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 120 (321)
T 2qkw_B 41 FDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENG 120 (321)
T ss_dssp CSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECCTTC
T ss_pred cCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcCCCC
Confidence 44578899999999999999889999999988766666788999999999999999999999999999999999999999
Q ss_pred CHHHHhccCC-CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccc-cce
Q 002336 695 TLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL-THI 772 (935)
Q Consensus 695 sL~~~L~~~~-~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~-~~~ 772 (935)
+|.+++.... ....+++..++.++.|+++||+|||+ ++|+||||||+||+++.++.+||+|||+++...... ...
T Consensus 121 ~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 197 (321)
T 2qkw_B 121 NLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHT---RAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHL 197 (321)
T ss_dssp BTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCCC
T ss_pred cHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcC---CCeecCCCCHHHEEECCCCCEEEeeccccccccccccccc
Confidence 9999987543 23468999999999999999999998 899999999999999999999999999998654322 222
Q ss_pred eecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccCCC
Q 002336 773 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNV 852 (935)
Q Consensus 773 ~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~~~ 852 (935)
.....||+.|+|||.+.+..++.++||||||+++|||++|+.||.............|.......+.+...+++.+....
T Consensus 198 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (321)
T 2qkw_B 198 STVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKI 277 (321)
T ss_dssp BCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSCTTCS
T ss_pred ccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChhhcccc
Confidence 23345899999999998888999999999999999999999999866555666778888777778888888888887778
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhhhhhcc
Q 002336 853 KIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 893 (935)
Q Consensus 853 ~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~~~~~~ 893 (935)
+.+....+.+++.+||+.||++|||++||++.|+.++...+
T Consensus 278 ~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~~ 318 (321)
T 2qkw_B 278 RPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQE 318 (321)
T ss_dssp CHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSC
T ss_pred CHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhccc
Confidence 88889999999999999999999999999999999887654
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-42 Score=390.56 Aligned_cols=260 Identities=19% Similarity=0.311 Sum_probs=198.6
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc--hhhhHHHHHHHHHHHhcCCCcccccceeeec------cceE
Q 002336 614 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEE------EHQR 684 (935)
Q Consensus 614 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~------~~~~ 684 (935)
.|++.+.||+|+||+||+|.+. +|+.||||+++... ....+.+.+|+++|+.++|||||++++++.. .+..
T Consensus 55 ~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~ 134 (398)
T 4b99_A 55 EYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSV 134 (398)
T ss_dssp SEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCE
T ss_pred CeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEE
Confidence 3677899999999999999876 79999999996542 2345678899999999999999999998753 4678
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccc
Q 002336 685 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 764 (935)
Q Consensus 685 ~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~ 764 (935)
|+|||||+ |+|.+++. ..+.+++.++..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++.
T Consensus 135 ~ivmE~~~-g~L~~~i~---~~~~l~~~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~ 207 (398)
T 4b99_A 135 YVVLDLME-SDLHQIIH---SSQPLTLEHVRYFLYQLLRGLKYMHS---AQVIHRDLKPSNLLVNENCELKIGDFGMARG 207 (398)
T ss_dssp EEEEECCS-EEHHHHHT---SSSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred EEEEeCCC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHH---CcCcCCCcCccccccCCCCCEEEeecceeee
Confidence 99999996 68999987 35679999999999999999999998 9999999999999999999999999999987
Q ss_pred ccccc---cceeecccCCccccCCCCCCCC-CCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCe
Q 002336 765 AEEDL---THISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV 840 (935)
Q Consensus 765 ~~~~~---~~~~~~~~gt~~y~APE~l~~~-~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~ 840 (935)
..... ........||+.|+|||++.+. .++.++||||+||++|||++|+.||.+.+..+.. ..+........
T Consensus 208 ~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l---~~I~~~~g~p~- 283 (398)
T 4b99_A 208 LCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQL---QLIMMVLGTPS- 283 (398)
T ss_dssp C-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHH---HHHHHHHCCCC-
T ss_pred cccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHH---HHHHHhcCCCC-
Confidence 54321 1223446799999999987764 5799999999999999999999999854432211 11111110000
Q ss_pred eeccc-----------ccccCCC--C-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002336 841 ISIVD-----------PVLIGNV--K-----IESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 884 (935)
Q Consensus 841 ~~~~d-----------~~l~~~~--~-----~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~ 884 (935)
..... ..+.... + +.....+.+++.+||+.||++|||++|+++.
T Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 284 PAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp GGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred hHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00000 0000000 0 0112367899999999999999999998763
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=378.57 Aligned_cols=287 Identities=39% Similarity=0.705 Sum_probs=242.8
Q ss_pred CChhhHHHHHH--hhcccccccccEEEEEEEECCCcEEEEEEccCcchh-hhHHHHHHHHHHHhcCCCcccccceeeecc
Q 002336 605 IPLPELEEATN--NFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSH-RTQQFVTEVALLSRIHHRNLVPLIGYCEEE 681 (935)
Q Consensus 605 ~~~~~l~~~~~--~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~~~~~~~~-~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~ 681 (935)
+++.++..... ++.+.||+|+||.||+|.+.+|+.||||++...... ....+.+|+++++.++||||+++++++...
T Consensus 20 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 99 (326)
T 3uim_A 20 FSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTP 99 (326)
T ss_dssp CCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECCS
T ss_pred ecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEecC
Confidence 44556655444 447899999999999999888999999998764332 234789999999999999999999999999
Q ss_pred ceEEEEEEecCCCCHHHHhccCC-CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecc
Q 002336 682 HQRILVYEYMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFG 760 (935)
Q Consensus 682 ~~~~lV~E~~~~gsL~~~L~~~~-~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFG 760 (935)
+..++||||+++|+|.+++.... ....+++..+..++.|++.||+|||+.+..+|+||||||+|||++.++.+||+|||
T Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg 179 (326)
T 3uim_A 100 TERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG 179 (326)
T ss_dssp SCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCS
T ss_pred CceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCc
Confidence 99999999999999999998653 34459999999999999999999998322399999999999999999999999999
Q ss_pred ccccccccccceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCc--ccchhHHHHHHHhhhcC
Q 002336 761 LSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDF--GAELNIVHWARSMIKKG 838 (935)
Q Consensus 761 la~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~--~~~~~l~~~~~~~i~~~ 838 (935)
+++..............||+.|+|||.+.+..++.++||||||+++|+|++|+.||..... .......+|+.......
T Consensus 180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 259 (326)
T 3uim_A 180 LAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 259 (326)
T ss_dssp SCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSC
T ss_pred cccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhch
Confidence 9987765544445556699999999999888899999999999999999999999973322 23446778888888888
Q ss_pred CeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhhhhh
Q 002336 839 DVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 891 (935)
Q Consensus 839 ~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~~~~ 891 (935)
......+..+....+......+.+++.+||+.+|++|||++||+++|++....
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~~ 312 (326)
T 3uim_A 260 KLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLA 312 (326)
T ss_dssp CSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSCS
T ss_pred hhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcchh
Confidence 88888888888888888899999999999999999999999999999875443
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=375.68 Aligned_cols=194 Identities=25% Similarity=0.416 Sum_probs=166.5
Q ss_pred HHhhcccccccccEEEEEEEEC----CCcEEEEEEccCcchhhhHHHHHHHHHHHhc-CCCcccccceeeeccceEEEEE
Q 002336 614 TNNFCKKIGKGSFGSVYYGKMK----DGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVY 688 (935)
Q Consensus 614 ~~~~~~~LG~G~fG~Vy~~~~~----~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L-~HpnIv~l~g~~~~~~~~~lV~ 688 (935)
.|++.+.||+|+||+||+|+.+ .++.||+|++.... ...++.+|+++|+.+ +|||||++++++.+.++.++||
T Consensus 22 ~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvm 99 (361)
T 4f9c_A 22 VFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAM 99 (361)
T ss_dssp TCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEE
T ss_pred cEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEE
Confidence 3677889999999999999764 46789999986542 345688999999998 6999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCC-CcEEEeeccccccccc
Q 002336 689 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN-MRAKVSDFGLSRQAEE 767 (935)
Q Consensus 689 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~-~~vkL~DFGla~~~~~ 767 (935)
||+++|+|.+++. .+++.++..++.|++.||+|||+ ++|+||||||+|||++.+ +.+||+|||+|+...+
T Consensus 100 E~~~g~~L~~~~~------~l~~~~~~~~~~qll~al~ylH~---~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~ 170 (361)
T 4f9c_A 100 PYLEHESFLDILN------SLSFQEVREYMLNLFKALKRIHQ---FGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHD 170 (361)
T ss_dssp ECCCCCCHHHHHT------TCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTCEECTT
T ss_pred eCCCcccHHHHHc------CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCC
Confidence 9999999999984 38899999999999999999998 999999999999999876 7999999999976543
Q ss_pred cccc---------------------------eeecccCCccccCCCCCCCC-CCCchhHHHHHHHHHHHHHhCCCCCCc
Q 002336 768 DLTH---------------------------ISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSV 818 (935)
Q Consensus 768 ~~~~---------------------------~~~~~~gt~~y~APE~l~~~-~~s~ksDVwS~Gvil~eLltG~~Pf~~ 818 (935)
.... ......||+.|+|||++.+. .++.++||||+||++|||++|+.||..
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~ 249 (361)
T 4f9c_A 171 TKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYK 249 (361)
T ss_dssp CSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSC
T ss_pred ccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCC
Confidence 2110 11234699999999988764 589999999999999999999999963
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=397.59 Aligned_cols=250 Identities=21% Similarity=0.334 Sum_probs=207.0
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcchhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEecC
Q 002336 614 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 692 (935)
Q Consensus 614 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~~ 692 (935)
.|++.+.||+|+||.||+|.++ +|+.||+|++........+.+.+|+++|+.++|||||++++++.+....++|||||+
T Consensus 158 ~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~ 237 (573)
T 3uto_A 158 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMS 237 (573)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred ccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeecC
Confidence 3677899999999999999886 699999999977666667789999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCC--CcEEEeecccccccccccc
Q 002336 693 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN--MRAKVSDFGLSRQAEEDLT 770 (935)
Q Consensus 693 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~--~~vkL~DFGla~~~~~~~~ 770 (935)
||+|.+++.. ....+++.++..++.||+.||+|||+ ++|+||||||+|||++.+ +.+||+|||+++.......
T Consensus 238 gg~L~~~i~~--~~~~l~e~~~~~~~~qi~~al~ylH~---~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~ 312 (573)
T 3uto_A 238 GGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS 312 (573)
T ss_dssp CCBHHHHHTC--TTSCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSE
T ss_pred CCcHHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhccccCCCCCCEEEeeccceeEccCCCc
Confidence 9999999864 24569999999999999999999998 999999999999999854 8999999999988754332
Q ss_pred ceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccC
Q 002336 771 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 850 (935)
Q Consensus 771 ~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~ 850 (935)
.....||+.|||||++.+..++.++||||+||++|||++|+.||.+....+ .. ..+..+... +.+....
T Consensus 313 --~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~---~~----~~i~~~~~~--~~~~~~~ 381 (573)
T 3uto_A 313 --VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE---TL----RNVKSCDWN--MDDSAFS 381 (573)
T ss_dssp --EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH---HH----HHHHTTCCC--CCSGGGT
T ss_pred --eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH---HH----HHHHhCCCC--CCccccc
Confidence 234569999999999999999999999999999999999999997443211 11 122222110 1111111
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 851 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 851 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
. ....+.+++.+||+.||++|||++|+++
T Consensus 382 ~----~s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 382 G----ISEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp T----SCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred C----CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1 2236789999999999999999999987
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=391.27 Aligned_cols=247 Identities=22% Similarity=0.272 Sum_probs=196.8
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCcch---hhhHHHHH---HHHHHHhcCCCcccccceeeeccceEEEE
Q 002336 615 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVT---EVALLSRIHHRNLVPLIGYCEEEHQRILV 687 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~---~~~~~~~~---E~~iL~~L~HpnIv~l~g~~~~~~~~~lV 687 (935)
|++.+.||+|+||.||+|+++ +|+.||||++..... .....+.+ ++.+++.++|||||++++++.+.+.+|+|
T Consensus 191 f~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~lylV 270 (689)
T 3v5w_A 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFI 270 (689)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEE
T ss_pred eEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEEEE
Confidence 566789999999999999886 699999999864321 11223333 45666677899999999999999999999
Q ss_pred EEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccc
Q 002336 688 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 767 (935)
Q Consensus 688 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~ 767 (935)
|||++||+|.++|.. .+.+++..+..++.||+.||+|||+ ++|+||||||+||||+.+|++||+|||+|+....
T Consensus 271 mEy~~GGdL~~~l~~---~~~l~E~~a~~y~~qIl~aL~yLH~---~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~ 344 (689)
T 3v5w_A 271 LDLMNGGDLHYHLSQ---HGVFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSK 344 (689)
T ss_dssp ECCCCSCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred EecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHeEEeCCCCEEecccceeeecCC
Confidence 999999999999974 4679999999999999999999998 9999999999999999999999999999987654
Q ss_pred cccceeecccCCccccCCCCCC-CCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccc
Q 002336 768 DLTHISSVARGTVGYLDPEYYG-NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP 846 (935)
Q Consensus 768 ~~~~~~~~~~gt~~y~APE~l~-~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~ 846 (935)
.. ....+||+.|||||++. +..++.++|+||+||++|||++|+.||......+...+. ..+.....
T Consensus 345 ~~---~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~----~~i~~~~~------ 411 (689)
T 3v5w_A 345 KK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID----RMTLTMAV------ 411 (689)
T ss_dssp CC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHH----HHHHHCCC------
T ss_pred CC---CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH----HhhcCCCC------
Confidence 32 23457999999999986 457999999999999999999999999744332221111 12211111
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 002336 847 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPK-----MQEIVLA 884 (935)
Q Consensus 847 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs-----~~ev~~~ 884 (935)
.+ +......+.+++.+||+.||++|++ ++||.++
T Consensus 412 ~~----p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H 450 (689)
T 3v5w_A 412 EL----PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 450 (689)
T ss_dssp CC----CTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred CC----CccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence 11 1122236789999999999999998 6777553
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=363.86 Aligned_cols=259 Identities=25% Similarity=0.387 Sum_probs=212.7
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcchhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEecC
Q 002336 614 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 692 (935)
Q Consensus 614 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~~ 692 (935)
.+.+.+.||+|+||.||+|.+. +++.||+|++........+.+.+|++++++++||||+++++++.+++..++||||++
T Consensus 11 ~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 90 (310)
T 3s95_A 11 DLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIK 90 (310)
T ss_dssp GEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred HeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEecC
Confidence 4566789999999999999886 689999999877666677889999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccccce
Q 002336 693 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 772 (935)
Q Consensus 693 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~~ 772 (935)
+|+|.+++... ...+++.+++.++.|+++||+|||+ ++|+||||||+|||++.++.+||+|||+++.........
T Consensus 91 ~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 165 (310)
T 3s95_A 91 GGTLRGIIKSM--DSQYPWSQRVSFAKDIASGMAYLHS---MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQP 165 (310)
T ss_dssp TCBHHHHHHHC--CTTSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEECTTSCEEECCCTTCEECC------
T ss_pred CCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCcCeEEECCCCCEEEeecccceecccccccc
Confidence 99999999753 4569999999999999999999998 899999999999999999999999999998754332211
Q ss_pred -------------eecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccc---hhHHHHHHHhhh
Q 002336 773 -------------SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAE---LNIVHWARSMIK 836 (935)
Q Consensus 773 -------------~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~---~~l~~~~~~~i~ 836 (935)
.....||+.|+|||.+.+..++.++||||||+++|||++|..|+........ ........
T Consensus 166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~---- 241 (310)
T 3s95_A 166 EGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLD---- 241 (310)
T ss_dssp --------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHH----
T ss_pred cccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcccc----
Confidence 1134689999999999999999999999999999999999999864322211 11111111
Q ss_pred cCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhhhhhccC
Q 002336 837 KGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKG 894 (935)
Q Consensus 837 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~~~~~~~ 894 (935)
....... ...+.+++.+||+.||++|||++|+++.|+++......
T Consensus 242 ---------~~~~~~~----~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~~ 286 (310)
T 3s95_A 242 ---------RYCPPNC----PPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAG 286 (310)
T ss_dssp ---------HTCCTTC----CTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHH
T ss_pred ---------ccCCCCC----CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhccC
Confidence 1111111 23578999999999999999999999999988765543
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=358.90 Aligned_cols=261 Identities=34% Similarity=0.509 Sum_probs=202.7
Q ss_pred HHHHhhcccccccccEEEEEEEECCCcEEEEEEccCcc--hhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEE
Q 002336 612 EATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 689 (935)
Q Consensus 612 ~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~~~~~~--~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E 689 (935)
...+++.+.||+|+||.||+|++. |+.||||++.... ....+.+.+|++++++++||||+++++++.+....++|||
T Consensus 36 ~~~y~i~~~lG~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 114 (309)
T 3p86_A 36 WCDLNIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTE 114 (309)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEE
T ss_pred hhHceeeeEeecCCCeEEEEEEEC-CCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEe
Confidence 345677899999999999999885 8899999986543 3345679999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCc--eEecCCCCCCccccCCCcEEEeeccccccccc
Q 002336 690 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG--IIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 767 (935)
Q Consensus 690 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~--ivH~DLkp~NILld~~~~vkL~DFGla~~~~~ 767 (935)
|+++|+|.+++........+++..++.++.|+++||+|||+ ++ |+||||||+|||++.++.+||+|||+++....
T Consensus 115 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~ 191 (309)
T 3p86_A 115 YLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN---RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAS 191 (309)
T ss_dssp CCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHT---SSSCCCCTTCCGGGEEECTTCCEEECCCC-------
T ss_pred cCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHc---CCCCEECCCCChhhEEEeCCCcEEECCCCCCccccc
Confidence 99999999999854323348999999999999999999998 78 99999999999999999999999999976543
Q ss_pred cccceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeeccccc
Q 002336 768 DLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 847 (935)
Q Consensus 768 ~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~ 847 (935)
... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...... .....+ .......
T Consensus 192 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~---~~~~~~---~~~~~~~------ 258 (309)
T 3p86_A 192 TFL-SSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPA---QVVAAV---GFKCKRL------ 258 (309)
T ss_dssp -----------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHH---HHHHHH---HHSCCCC------
T ss_pred ccc-ccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHH---HhcCCCC------
Confidence 322 123356899999999999999999999999999999999999999743221 111111 1111110
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhhhhhc
Q 002336 848 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 892 (935)
Q Consensus 848 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~~~~~ 892 (935)
..+......+.+++.+||+.+|++|||++|+++.|+.++...
T Consensus 259 ---~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~ 300 (309)
T 3p86_A 259 ---EIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA 300 (309)
T ss_dssp ---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred ---CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhC
Confidence 111222336889999999999999999999999999887643
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=349.28 Aligned_cols=279 Identities=37% Similarity=0.589 Sum_probs=224.7
Q ss_pred cCChhhHHHHHHhhc--------ccccccccEEEEEEEECCCcEEEEEEccCcc----hhhhHHHHHHHHHHHhcCCCcc
Q 002336 604 FIPLPELEEATNNFC--------KKIGKGSFGSVYYGKMKDGKEVAVKIMADSC----SHRTQQFVTEVALLSRIHHRNL 671 (935)
Q Consensus 604 ~~~~~~l~~~~~~~~--------~~LG~G~fG~Vy~~~~~~g~~vAvK~~~~~~----~~~~~~~~~E~~iL~~L~HpnI 671 (935)
.+.+.++.+++.+|. +.||+|+||.||+|.+. ++.||+|++.... ....+.+.+|++++++++||||
T Consensus 14 ~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 92 (307)
T 2nru_A 14 SFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN-NTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENL 92 (307)
T ss_dssp ECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEESS-SCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTB
T ss_pred cccHHHHHHHHcccccccccccCCccccCCCeEEEEEEEC-CceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCe
Confidence 456788888888874 56999999999999874 8999999986532 2345679999999999999999
Q ss_pred cccceeeeccceEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCC
Q 002336 672 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN 751 (935)
Q Consensus 672 v~l~g~~~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~ 751 (935)
+++++++.+.+..++||||+++++|.+++........+++..++.++.|+++||+|||+ ++|+||||||+||+++.+
T Consensus 93 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Nili~~~ 169 (307)
T 2nru_A 93 VELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHE---NHHIHRDIKSANILLDEA 169 (307)
T ss_dssp CCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTT
T ss_pred EEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecCCCCHHHEEEcCC
Confidence 99999999999999999999999999998755445679999999999999999999998 899999999999999999
Q ss_pred CcEEEeeccccccccccccc-eeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHH
Q 002336 752 MRAKVSDFGLSRQAEEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHW 830 (935)
Q Consensus 752 ~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~ 830 (935)
+.+||+|||++......... ......|++.|+|||.+.+ .++.++||||||+++|+|++|+.||........ ...+
T Consensus 170 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~~~~ 246 (307)
T 2nru_A 170 FTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQL--LLDI 246 (307)
T ss_dssp CCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSB--TTHH
T ss_pred CcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHH--HHHH
Confidence 99999999999875443222 2233468999999998765 578999999999999999999999975433221 1122
Q ss_pred HHHhhh-cCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhhhh
Q 002336 831 ARSMIK-KGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 890 (935)
Q Consensus 831 ~~~~i~-~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~~~ 890 (935)
...... ...+...+++.+ ...+......+.+++.+||+.+|++||+++||++.|+++..
T Consensus 247 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 247 KEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp HHHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred HHHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 222111 112333344433 23456677789999999999999999999999999998753
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-39 Score=351.75 Aligned_cols=248 Identities=24% Similarity=0.370 Sum_probs=204.2
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcchhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEecC
Q 002336 614 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 692 (935)
Q Consensus 614 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~~ 692 (935)
.|++.+.||+|+||.||+|... +|+.||+|++........+.+.+|+.+++.++||||+++++++...+..++||||++
T Consensus 21 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 100 (297)
T 3fxz_A 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLA 100 (297)
T ss_dssp TBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred ceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECCC
Confidence 3566789999999999999864 789999999876555556778999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccccce
Q 002336 693 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 772 (935)
Q Consensus 693 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~~ 772 (935)
+|+|.+++.. ..+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||++.........
T Consensus 101 ~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~- 172 (297)
T 3fxz_A 101 GGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK- 172 (297)
T ss_dssp TCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC-
T ss_pred CCCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccc-
Confidence 9999999974 358999999999999999999998 89999999999999999999999999998876543322
Q ss_pred eecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccCCC
Q 002336 773 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNV 852 (935)
Q Consensus 773 ~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~~~ 852 (935)
.....||+.|+|||.+.+..++.++||||||+++|||++|+.||....... ........+.. .. ..
T Consensus 173 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~------~~~~~~~~~~~-~~-------~~ 238 (297)
T 3fxz_A 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR------ALYLIATNGTP-EL-------QN 238 (297)
T ss_dssp BCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHHHHHCSC-CC-------SC
T ss_pred cCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHhCCCC-CC-------CC
Confidence 234569999999999998899999999999999999999999997432211 11111111111 00 01
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 853 KIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 853 ~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
+......+.+++.+||+.||++|||++|+++
T Consensus 239 ~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 239 PEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 1222346889999999999999999999975
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-39 Score=363.82 Aligned_cols=264 Identities=24% Similarity=0.454 Sum_probs=212.9
Q ss_pred HHHHhhcccccccccEEEEEEEEC--------CCcEEEEEEccCcch-hhhHHHHHHHHHHHhc-CCCcccccceeeecc
Q 002336 612 EATNNFCKKIGKGSFGSVYYGKMK--------DGKEVAVKIMADSCS-HRTQQFVTEVALLSRI-HHRNLVPLIGYCEEE 681 (935)
Q Consensus 612 ~~~~~~~~~LG~G~fG~Vy~~~~~--------~g~~vAvK~~~~~~~-~~~~~~~~E~~iL~~L-~HpnIv~l~g~~~~~ 681 (935)
...+.+.+.||+|+||.||+|++. ++..||||+++.... ...+.+.+|+.+++++ +||||+++++++.+.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 345667889999999999999863 356799999976533 3456899999999999 899999999999999
Q ss_pred ceEEEEEEecCCCCHHHHhccCC-------------CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccc
Q 002336 682 HQRILVYEYMHNGTLRDRLHGSV-------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL 748 (935)
Q Consensus 682 ~~~~lV~E~~~~gsL~~~L~~~~-------------~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILl 748 (935)
+..++||||+++|+|.+++.... ....+++.+++.++.||++||+|||+ ++|+||||||+|||+
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchhhEEE
Confidence 99999999999999999997542 12458999999999999999999998 899999999999999
Q ss_pred cCCCcEEEeeccccccccccccc-eeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCcccchh
Q 002336 749 DINMRAKVSDFGLSRQAEEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELN 826 (935)
Q Consensus 749 d~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~ 826 (935)
+.++.+||+|||+++........ ......+++.|+|||++.+..++.++|||||||++|||++ |+.||...... .
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~---~ 313 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE---E 313 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---G
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH---H
Confidence 99999999999999865443221 1223346789999999988899999999999999999999 99999744322 1
Q ss_pred HHHHHHHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhhhhhccC
Q 002336 827 IVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKG 894 (935)
Q Consensus 827 l~~~~~~~i~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~~~~~~~ 894 (935)
+.. .+..+... ..+......+.+++.+||+.+|++||+++|+++.|++++.....
T Consensus 314 ~~~----~~~~~~~~---------~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~~~ 368 (370)
T 2psq_A 314 LFK----LLKEGHRM---------DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTN 368 (370)
T ss_dssp HHH----HHHTTCCC---------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred HHH----HHhcCCCC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhcc
Confidence 221 22222111 11122234688999999999999999999999999998876543
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=349.70 Aligned_cols=259 Identities=27% Similarity=0.444 Sum_probs=211.7
Q ss_pred HHHHhhcccccccccEEEEEEEECCCcEEEEEEccCcchhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEec
Q 002336 612 EATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 691 (935)
Q Consensus 612 ~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~ 691 (935)
...+++.+.||+|+||.||+|.++++..||+|++..... ..+++.+|++++++++||||+++++++.+....++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI 85 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence 345677899999999999999999888999999875432 3467899999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccccc
Q 002336 692 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 771 (935)
Q Consensus 692 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~ 771 (935)
++++|.+++... ...+++..++.++.|+++||+|||+ .+|+||||||+||+++.++.+||+|||++.........
T Consensus 86 ~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~ 160 (268)
T 3sxs_A 86 SNGCLLNYLRSH--GKGLEPSQLLEMCYDVCEGMAFLES---HQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYV 160 (268)
T ss_dssp TTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEE
T ss_pred CCCcHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCcceEEECCCCCEEEccCccceecchhhhh
Confidence 999999998742 3468999999999999999999998 89999999999999999999999999999876554433
Q ss_pred eeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccC
Q 002336 772 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 850 (935)
Q Consensus 772 ~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~ 850 (935)
......+++.|+|||.+.+..++.++||||+|+++|+|++ |+.||....... ... .+..+.. ...
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~------~~~-~~~~~~~--~~~----- 226 (268)
T 3sxs_A 161 SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSE------VVL-KVSQGHR--LYR----- 226 (268)
T ss_dssp ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHH------HHH-HHHTTCC--CCC-----
T ss_pred cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHH------HHH-HHHcCCC--CCC-----
Confidence 3334456778999999988889999999999999999999 999997332211 111 1111111 001
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhhhhhc
Q 002336 851 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 892 (935)
Q Consensus 851 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~~~~~ 892 (935)
+......+.+++.+||+.+|++|||++|+++.|+.+...+
T Consensus 227 --~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~~ 266 (268)
T 3sxs_A 227 --PHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREKD 266 (268)
T ss_dssp --CTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC--
T ss_pred --CCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhcc
Confidence 1111236889999999999999999999999999887644
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=359.67 Aligned_cols=264 Identities=27% Similarity=0.499 Sum_probs=211.6
Q ss_pred hHHHHHHhhcccccccccEEEEEEEEC----CCcEEEEEEccCcc-hhhhHHHHHHHHHHHhcCCCcccccceeeeccce
Q 002336 609 ELEEATNNFCKKIGKGSFGSVYYGKMK----DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQ 683 (935)
Q Consensus 609 ~l~~~~~~~~~~LG~G~fG~Vy~~~~~----~g~~vAvK~~~~~~-~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~ 683 (935)
++....+++.+.||+|+||.||+|.+. .+..||||+++... ....+.+.+|+.++++++||||+++++++.+.+.
T Consensus 45 ~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 124 (325)
T 3kul_A 45 EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRL 124 (325)
T ss_dssp BCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGC
T ss_pred ccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCc
Confidence 344556777899999999999999985 35569999997643 3445789999999999999999999999999999
Q ss_pred EEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccc
Q 002336 684 RILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 763 (935)
Q Consensus 684 ~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~ 763 (935)
.++||||+++|+|.+++... ...+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++
T Consensus 125 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 199 (325)
T 3kul_A 125 AMIVTEYMENGSLDTFLRTH--DGQFTIMQLVGMLRGVGAGMRYLSD---LGYVHRDLAARNVLVDSNLVCKVSDFGLSR 199 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCSSCE
T ss_pred cEEEeeCCCCCcHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEECCCCCEEECCCCccc
Confidence 99999999999999999743 4569999999999999999999998 899999999999999999999999999998
Q ss_pred cccccccc--eeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCcccchhHHHHHHHhhhcCCe
Q 002336 764 QAEEDLTH--ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDV 840 (935)
Q Consensus 764 ~~~~~~~~--~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~i~~~~~ 840 (935)
........ ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...... ... ..+..+..
T Consensus 200 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~---~~~----~~~~~~~~ 272 (325)
T 3kul_A 200 VLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNR---DVI----SSVEEGYR 272 (325)
T ss_dssp ECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHH---HHH----HHHHTTCC
T ss_pred ccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHH---HHH----HHHHcCCC
Confidence 76543222 1222346778999999988889999999999999999999 99999733221 111 11222211
Q ss_pred eecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhhhhhcc
Q 002336 841 ISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 893 (935)
Q Consensus 841 ~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~~~~~~ 893 (935)
. ..+......+.+++.+||+.+|++||+++||++.|+.+....+
T Consensus 273 ~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~ 316 (325)
T 3kul_A 273 L---------PAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPE 316 (325)
T ss_dssp C---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC
T ss_pred C---------CCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCcc
Confidence 0 1112223468899999999999999999999999999887544
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=347.99 Aligned_cols=256 Identities=29% Similarity=0.461 Sum_probs=210.8
Q ss_pred HHHhhcccccccccEEEEEEEECCCcEEEEEEccCcchhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEecC
Q 002336 613 ATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 692 (935)
Q Consensus 613 ~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~~ 692 (935)
..+++.+.||+|+||.||+|.+.+++.||+|++..... ..+++.+|++++++++||||+++++++.+....++||||++
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 88 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 88 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred hhceeeheecCCCccEEEEEEecCCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence 34667889999999999999998899999999875432 34679999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccccce
Q 002336 693 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 772 (935)
Q Consensus 693 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~~ 772 (935)
+++|.+++... ...+++..++.++.|+++||+|||+ ++|+||||||+||+++.++.+||+|||+++.........
T Consensus 89 ~~~L~~~l~~~--~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 163 (269)
T 4hcu_A 89 HGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 163 (269)
T ss_dssp TCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHS
T ss_pred CCcHHHHHHhc--CcccCHHHHHHHHHHHHHHHHHHHh---CCeecCCcchheEEEcCCCCEEecccccccccccccccc
Confidence 99999999743 4568999999999999999999998 899999999999999999999999999998765433333
Q ss_pred eecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccCC
Q 002336 773 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 851 (935)
Q Consensus 773 ~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~~ 851 (935)
.....+++.|+|||.+.+..++.++||||+|+++|+|++ |+.||...... .... .+..+.. ...
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~---~~~~----~~~~~~~-----~~~--- 228 (269)
T 4hcu_A 164 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS---EVVE----DISTGFR-----LYK--- 228 (269)
T ss_dssp TTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHH----HHHTTCC-----CCC---
T ss_pred ccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH---HHHH----HHhcCcc-----CCC---
Confidence 334456788999999988889999999999999999999 99999743221 1111 1221110 011
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhhhh
Q 002336 852 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 890 (935)
Q Consensus 852 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~~~ 890 (935)
+......+.+++.+||+.+|++||+++|+++.|+++..
T Consensus 229 -~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~ 266 (269)
T 4hcu_A 229 -PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 266 (269)
T ss_dssp -CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -CCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence 11123368899999999999999999999999998765
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=360.51 Aligned_cols=264 Identities=26% Similarity=0.353 Sum_probs=206.5
Q ss_pred HHhhcccccccccEEEEEEEECCCcEEEEEEccCcchhhhHHHHHHHHHHHhcCCCcccccceeeeccc----eEEEEEE
Q 002336 614 TNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH----QRILVYE 689 (935)
Q Consensus 614 ~~~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~----~~~lV~E 689 (935)
.+++.+.||+|+||.||+|++. ++.||||++.... .....+..|+.++++++||||+++++++.... ..++|||
T Consensus 25 ~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e 102 (322)
T 3soc_A 25 PLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITA 102 (322)
T ss_dssp EEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred hchhhheecccCceEEEEEEEC-CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEe
Confidence 4567889999999999999987 8999999986542 33455667999999999999999999997744 4699999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCC----------ceEecCCCCCCccccCCCcEEEeec
Q 002336 690 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP----------GIIHRDVKSSNILLDINMRAKVSDF 759 (935)
Q Consensus 690 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~----------~ivH~DLkp~NILld~~~~vkL~DF 759 (935)
|+++|+|.++++. ..+++..++.++.|+++||+|||+ . +|+||||||+|||++.++.+||+||
T Consensus 103 ~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~al~~LH~---~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DF 175 (322)
T 3soc_A 103 FHEKGSLSDFLKA----NVVSWNELCHIAETMARGLAYLHE---DIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADF 175 (322)
T ss_dssp CCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHTC---CEEEETTEEECEEECSCCSGGGEEECTTCCEEECCC
T ss_pred cCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHh---hccccccccCCCEEeCCCChHhEEECCCCeEEEccC
Confidence 9999999999974 358999999999999999999997 6 9999999999999999999999999
Q ss_pred cccccccccccc-eeecccCCccccCCCCCCC-----CCCCchhHHHHHHHHHHHHHhCCCCCCccCcccch--------
Q 002336 760 GLSRQAEEDLTH-ISSVARGTVGYLDPEYYGN-----QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAEL-------- 825 (935)
Q Consensus 760 Gla~~~~~~~~~-~~~~~~gt~~y~APE~l~~-----~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~-------- 825 (935)
|+++........ ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||.........
T Consensus 176 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~ 255 (322)
T 3soc_A 176 GLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQ 255 (322)
T ss_dssp TTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCS
T ss_pred CcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhcc
Confidence 999775443222 1223468999999999876 35567899999999999999999999754332111
Q ss_pred --hHHHHHHHhhhcCCeeecccccccCCC-CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhhhhh
Q 002336 826 --NIVHWARSMIKKGDVISIVDPVLIGNV-KIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 891 (935)
Q Consensus 826 --~l~~~~~~~i~~~~~~~~~d~~l~~~~-~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~~~~ 891 (935)
....+...... .... +.+.... .......+.+++.+||+.||++|||++||++.|+++...
T Consensus 256 ~~~~~~~~~~~~~-~~~~----~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~ 319 (322)
T 3soc_A 256 HPSLEDMQEVVVH-KKKR----PVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL 319 (322)
T ss_dssp SCCHHHHHHHHTT-SCCC----CCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCchhhhhhhhhc-ccCC----CCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 11111111111 1111 1111111 223456799999999999999999999999999988764
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=350.19 Aligned_cols=264 Identities=27% Similarity=0.409 Sum_probs=208.0
Q ss_pred HHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCc---chhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEE
Q 002336 613 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS---CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 688 (935)
Q Consensus 613 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~---~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~ 688 (935)
..|++.+.||+|+||.||+|.+. +++.||+|++... .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 90 (294)
T 4eqm_A 11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVM 90 (294)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEE
Confidence 34667899999999999999875 6899999998543 2334567999999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccccc
Q 002336 689 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 768 (935)
Q Consensus 689 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~ 768 (935)
||+++++|.+++.. ...+++..++.++.|+++||+|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 91 e~~~g~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 164 (294)
T 4eqm_A 91 EYIEGPTLSEYIES---HGPLSVDTAINFTNQILDGIKHAHD---MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSET 164 (294)
T ss_dssp ECCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCSSSTTC---
T ss_pred eCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEEeCCCccccccc
Confidence 99999999999974 4579999999999999999999998 89999999999999999999999999999876544
Q ss_pred ccceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccccc
Q 002336 769 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 848 (935)
Q Consensus 769 ~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l 848 (935)
.........||+.|+|||.+.+..++.++||||+|+++|||++|+.||...... ......+... .... ..
T Consensus 165 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~------~~~~~~~~~~-~~~~-~~-- 234 (294)
T 4eqm_A 165 SLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAV------SIAIKHIQDS-VPNV-TT-- 234 (294)
T ss_dssp ----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHH------HHHHHHHSSC-CCCH-HH--
T ss_pred cccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHhhcc-CCCc-ch--
Confidence 333334456899999999999888999999999999999999999999743221 1111222211 1111 01
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHHhhhhhhccC
Q 002336 849 IGNVKIESIWRIAEVAIQCVEQRGFSRP-KMQEIVLAIQDSIKIEKG 894 (935)
Q Consensus 849 ~~~~~~~~~~~l~~li~~Cl~~dP~~RP-s~~ev~~~L~~~~~~~~~ 894 (935)
......+..+.+++.+|++.+|++|| +++++.+.|+.+......
T Consensus 235 --~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~~ 279 (294)
T 4eqm_A 235 --DVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENRA 279 (294)
T ss_dssp --HSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSST
T ss_pred --hcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhccC
Confidence 11122234788999999999999999 999999999987765443
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-38 Score=349.31 Aligned_cols=257 Identities=24% Similarity=0.392 Sum_probs=208.9
Q ss_pred CChhhHHHHHH------------hhcccccccccEEEEEEEEC-CCcEEEEEEccCcchhhhHHHHHHHHHHHhcCCCcc
Q 002336 605 IPLPELEEATN------------NFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNL 671 (935)
Q Consensus 605 ~~~~~l~~~~~------------~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~HpnI 671 (935)
++..++.+++. +..+.||+|+||.||+|... +|+.||||++........+.+.+|+.++++++||||
T Consensus 25 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni 104 (321)
T 2c30_A 25 VTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNV 104 (321)
T ss_dssp CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTB
T ss_pred CcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCc
Confidence 34556666554 33568999999999999987 799999999876555556789999999999999999
Q ss_pred cccceeeeccceEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCC
Q 002336 672 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN 751 (935)
Q Consensus 672 v~l~g~~~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~ 751 (935)
+++++++...+..++||||+++++|.+++. ...+++..+..++.|+++||+|||+ ++|+||||||+|||++.+
T Consensus 105 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~----~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~ 177 (321)
T 2c30_A 105 VEMYKSYLVGEELWVLMEFLQGGALTDIVS----QVRLNEEQIATVCEAVLQALAYLHA---QGVIHRDIKSDSILLTLD 177 (321)
T ss_dssp CCEEEEEEETTEEEEEECCCCSCBHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTT
T ss_pred ceEEEEEEECCEEEEEEecCCCCCHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCC
Confidence 999999999999999999999999999986 3469999999999999999999998 899999999999999999
Q ss_pred CcEEEeeccccccccccccceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHH
Q 002336 752 MRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWA 831 (935)
Q Consensus 752 ~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~ 831 (935)
+.+||+|||++......... .....||+.|+|||++.+..++.++||||||+++|||++|+.||...... ....
T Consensus 178 ~~~kl~Dfg~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~---~~~~-- 251 (321)
T 2c30_A 178 GRVKLSDFGFCAQISKDVPK-RKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPV---QAMK-- 251 (321)
T ss_dssp CCEEECCCTTCEECCSSSCC-BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHHH--
T ss_pred CcEEEeeeeeeeecccCccc-cccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHH--
Confidence 99999999999876543222 23456899999999999999999999999999999999999999743221 1111
Q ss_pred HHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 832 RSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 832 ~~~i~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
.+.......... .......+.+++.+||+.||++|||++|+++
T Consensus 252 --~~~~~~~~~~~~-------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 294 (321)
T 2c30_A 252 --RLRDSPPPKLKN-------SHKVSPVLRDFLERMLVRDPQERATAQELLD 294 (321)
T ss_dssp --HHHHSSCCCCTT-------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred --HHhcCCCCCcCc-------cccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 111111111100 1112236889999999999999999999976
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-39 Score=348.06 Aligned_cols=259 Identities=27% Similarity=0.450 Sum_probs=209.6
Q ss_pred HHHHhhcccccccccEEEEEEEECCCcEEEEEEccCcchhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEec
Q 002336 612 EATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 691 (935)
Q Consensus 612 ~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~ 691 (935)
...+++.+.||+|+||.||+|.+.+++.||+|++..... ..+++.+|++++++++||||+++++++.+.+..++||||+
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 101 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 101 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCC
T ss_pred HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEecc
Confidence 345677899999999999999999888999999975432 3467899999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccccc
Q 002336 692 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 771 (935)
Q Consensus 692 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~ 771 (935)
++++|.+++... ...+++..++.++.|+++||+|||+ ++|+||||||+||+++.++.+||+|||+++........
T Consensus 102 ~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 176 (283)
T 3gen_A 102 ANGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT 176 (283)
T ss_dssp TTCBHHHHHHCG--GGCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHH
T ss_pred CCCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCccceEEEcCCCCEEEccccccccccccccc
Confidence 999999999742 3569999999999999999999998 89999999999999999999999999999876543322
Q ss_pred eeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccC
Q 002336 772 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 850 (935)
Q Consensus 772 ~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~ 850 (935)
......+++.|+|||.+.+..++.++||||+|+++|||++ |+.||...... ... ..+..+.. ..
T Consensus 177 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~---~~~----~~~~~~~~-----~~--- 241 (283)
T 3gen_A 177 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS---ETA----EHIAQGLR-----LY--- 241 (283)
T ss_dssp STTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHH---HHH----HHHHTTCC-----CC---
T ss_pred cccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChh---HHH----HHHhcccC-----CC---
Confidence 2333456788999999988889999999999999999998 99999743321 111 11221110 00
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhhhhhc
Q 002336 851 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 892 (935)
Q Consensus 851 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~~~~~ 892 (935)
.+......+.+++.+||+.+|++|||++|+++.|+++...+
T Consensus 242 -~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~e 282 (283)
T 3gen_A 242 -RPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDEE 282 (283)
T ss_dssp -CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred -CCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhcc
Confidence 11111246889999999999999999999999999887654
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-40 Score=359.80 Aligned_cols=267 Identities=28% Similarity=0.451 Sum_probs=208.7
Q ss_pred HHHHHhhcccccccccEEEEEEEE-----CCCcEEEEEEccCcchhhhHHHHHHHHHHHhcCCCcccccceeeec--cce
Q 002336 611 EEATNNFCKKIGKGSFGSVYYGKM-----KDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEE--EHQ 683 (935)
Q Consensus 611 ~~~~~~~~~~LG~G~fG~Vy~~~~-----~~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~--~~~ 683 (935)
....+++.+.||+|+||.||+|++ .+++.||||++........+.+.+|++++++++||||+++++++.. ...
T Consensus 8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 87 (295)
T 3ugc_A 8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 87 (295)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTS
T ss_pred CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCc
Confidence 345567789999999999999985 2688999999987766667889999999999999999999999854 355
Q ss_pred EEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccc
Q 002336 684 RILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 763 (935)
Q Consensus 684 ~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~ 763 (935)
.++||||+++|+|.+++... ...+++..++.++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++
T Consensus 88 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~ 162 (295)
T 3ugc_A 88 LKLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTK 162 (295)
T ss_dssp CEEEEECCTTCBHHHHHHHC--GGGCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred eEEEEEeCCCCCHHHHHHhc--ccccCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHhhEEEcCCCeEEEccCcccc
Confidence 89999999999999999753 3458999999999999999999998 899999999999999999999999999998
Q ss_pred ccccccc--ceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcc---------cchhHHHHHH
Q 002336 764 QAEEDLT--HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFG---------AELNIVHWAR 832 (935)
Q Consensus 764 ~~~~~~~--~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~---------~~~~l~~~~~ 832 (935)
....... .......++..|+|||.+.+..++.++||||||+++|||++|..|+...... ..........
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (295)
T 3ugc_A 163 VLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 242 (295)
T ss_dssp -------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHH
T ss_pred cccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHH
Confidence 7644322 1222344677899999998888999999999999999999999998733211 0011111222
Q ss_pred HhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhhhhh
Q 002336 833 SMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 891 (935)
Q Consensus 833 ~~i~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~~~~ 891 (935)
..+..+... ..+......+.+++.+||+.+|++|||++|+++.|+++...
T Consensus 243 ~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~ 292 (295)
T 3ugc_A 243 ELLKNNGRL---------PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN 292 (295)
T ss_dssp HHHHTTCCC---------CCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHhccCcC---------CCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence 222222111 11222334788999999999999999999999999988653
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=345.95 Aligned_cols=259 Identities=25% Similarity=0.380 Sum_probs=199.7
Q ss_pred HHhhcccccccccEEEEEEEECCCcEEEEEEccCcchhhhHHHHHHHHHHHh--cCCCcccccceeeec----cceEEEE
Q 002336 614 TNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSR--IHHRNLVPLIGYCEE----EHQRILV 687 (935)
Q Consensus 614 ~~~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~--L~HpnIv~l~g~~~~----~~~~~lV 687 (935)
.+++.+.||+|+||.||+|++ +++.||||++... ..+.+..|.+++.. ++||||+++++++.. ....++|
T Consensus 9 ~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv 84 (301)
T 3q4u_A 9 DITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLI 84 (301)
T ss_dssp GCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred cEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEe
Confidence 456788999999999999998 4999999998643 33456667777766 789999999998644 3568999
Q ss_pred EEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhh--------hcCCCceEecCCCCCCccccCCCcEEEeec
Q 002336 688 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH--------TGCNPGIIHRDVKSSNILLDINMRAKVSDF 759 (935)
Q Consensus 688 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH--------s~~~~~ivH~DLkp~NILld~~~~vkL~DF 759 (935)
|||+++|+|.++++ ...+++..+++++.|+++||+||| + ++|+||||||+|||++.++.+||+||
T Consensus 85 ~e~~~~g~L~~~l~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~---~~ivH~Dlkp~Nill~~~~~~kl~Df 157 (301)
T 3q4u_A 85 THYHEMGSLYDYLQ----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGK---PAIAHRDLKSKNILVKKNGQCCIADL 157 (301)
T ss_dssp ECCCTTCBHHHHHT----TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCB---CEEECSCCCGGGEEECTTSCEEECCC
T ss_pred hhhccCCCHHHHHh----hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCC---CCeecCCCChHhEEEcCCCCEEEeeC
Confidence 99999999999996 346999999999999999999999 6 89999999999999999999999999
Q ss_pred cccccccccccce---eecccCCccccCCCCCCCC------CCCchhHHHHHHHHHHHHHhC----------CCCCCccC
Q 002336 760 GLSRQAEEDLTHI---SSVARGTVGYLDPEYYGNQ------QLTEKSDVYSFGVVLLELISG----------KKPVSVED 820 (935)
Q Consensus 760 Gla~~~~~~~~~~---~~~~~gt~~y~APE~l~~~------~~s~ksDVwS~Gvil~eLltG----------~~Pf~~~~ 820 (935)
|+++......... .....||+.|+|||.+.+. .++.++||||||+++|||++| +.||....
T Consensus 158 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~ 237 (301)
T 3q4u_A 158 GLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVV 237 (301)
T ss_dssp TTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred CCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccC
Confidence 9997654433221 2234689999999998776 455799999999999999999 78876332
Q ss_pred cccchhHHHHHHHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhh
Q 002336 821 FGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 888 (935)
Q Consensus 821 ~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~ 888 (935)
... ..................... ...+......+.+++.+||+.||++|||++||++.|+++
T Consensus 238 ~~~-~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 238 PND-PSFEDMRKVVCVDQQRPNIPN----RWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp CSS-CCHHHHHHHHTTSCCCCCCCG----GGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred CCC-cchhhhhHHHhccCCCCCCCh----hhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 221 111111111111111111111 112234567899999999999999999999999999875
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=354.80 Aligned_cols=245 Identities=26% Similarity=0.418 Sum_probs=202.3
Q ss_pred HhhcccccccccEEEEEEEE-CCCcEEEEEEccCc--chhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEec
Q 002336 615 NNFCKKIGKGSFGSVYYGKM-KDGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 691 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~-~~g~~vAvK~~~~~--~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~ 691 (935)
|++.+.||+|+||.||+|.+ .+|+.||||++... .....+.+.+|+++|+.++||||+++++++...+..++||||+
T Consensus 17 y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~ 96 (328)
T 3fe3_A 17 YRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYA 96 (328)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred EEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEECC
Confidence 56678999999999999998 47999999998654 2334567889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccccc
Q 002336 692 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 771 (935)
Q Consensus 692 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~ 771 (935)
++|+|.+++.. ...+++..+..++.|+++||+|||+ ++|+||||||+|||++.++.+||+|||++........
T Consensus 97 ~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~- 169 (328)
T 3fe3_A 97 SGGEVFDYLVA---HGRMKEKEARSKFRQIVSAVQYCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK- 169 (328)
T ss_dssp TTCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSCG-
T ss_pred CCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCCc-
Confidence 99999999874 3568999999999999999999998 8999999999999999999999999999986543322
Q ss_pred eeecccCCccccCCCCCCCCCCC-chhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccC
Q 002336 772 ISSVARGTVGYLDPEYYGNQQLT-EKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 850 (935)
Q Consensus 772 ~~~~~~gt~~y~APE~l~~~~~s-~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~ 850 (935)
.....||+.|+|||++.+..+. .++||||+||++|+|++|+.||...... + ....+..+...
T Consensus 170 -~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~------~-~~~~i~~~~~~--------- 232 (328)
T 3fe3_A 170 -LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLK------E-LRERVLRGKYR--------- 232 (328)
T ss_dssp -GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHH------H-HHHHHHHCCCC---------
T ss_pred -cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHH------H-HHHHHHhCCCC---------
Confidence 2345699999999998877664 8999999999999999999999744321 1 11222222110
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002336 851 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 884 (935)
Q Consensus 851 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~ 884 (935)
.+......+.+++.+||+.||++|||++|+++.
T Consensus 233 -~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 233 -IPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp -CCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred -CCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 111122367899999999999999999999763
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=361.46 Aligned_cols=273 Identities=24% Similarity=0.430 Sum_probs=217.4
Q ss_pred hHHHHHHhhcccccccccEEEEEEEEC--------CCcEEEEEEccCcch-hhhHHHHHHHHHHHhc-CCCcccccceee
Q 002336 609 ELEEATNNFCKKIGKGSFGSVYYGKMK--------DGKEVAVKIMADSCS-HRTQQFVTEVALLSRI-HHRNLVPLIGYC 678 (935)
Q Consensus 609 ~l~~~~~~~~~~LG~G~fG~Vy~~~~~--------~g~~vAvK~~~~~~~-~~~~~~~~E~~iL~~L-~HpnIv~l~g~~ 678 (935)
++....+.+.+.||+|+||.||+|++. .++.||||++..... ...+.+.+|+++++++ +||||+++++++
T Consensus 65 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~ 144 (382)
T 3tt0_A 65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC 144 (382)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeee
Confidence 344456777899999999999999863 246799999876533 3457899999999999 899999999999
Q ss_pred eccceEEEEEEecCCCCHHHHhccCCC-------------CCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCC
Q 002336 679 EEEHQRILVYEYMHNGTLRDRLHGSVN-------------QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSN 745 (935)
Q Consensus 679 ~~~~~~~lV~E~~~~gsL~~~L~~~~~-------------~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~N 745 (935)
...+..++||||+++|+|.+++..... ...+++..+++++.|+++||+|||+ ++|+||||||+|
T Consensus 145 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~N 221 (382)
T 3tt0_A 145 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARN 221 (382)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGG
T ss_pred ccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCcce
Confidence 999999999999999999999975421 2469999999999999999999998 899999999999
Q ss_pred ccccCCCcEEEeecccccccccccc-ceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCccc
Q 002336 746 ILLDINMRAKVSDFGLSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGA 823 (935)
Q Consensus 746 ILld~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~ 823 (935)
||++.++.+||+|||+++....... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||......
T Consensus 222 Ill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~- 300 (382)
T 3tt0_A 222 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE- 300 (382)
T ss_dssp EEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-
T ss_pred EEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-
Confidence 9999999999999999987644322 12233457889999999998899999999999999999999 99999743321
Q ss_pred chhHHHHHHHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhhhhhccCCCCCcc
Q 002336 824 ELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKGGDQKFS 900 (935)
Q Consensus 824 ~~~l~~~~~~~i~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~~~~~~~~~~~~~ 900 (935)
.+ ...+..+.... .+......+.+++.+||+.+|++|||++||++.|+++............
T Consensus 301 --~~----~~~~~~~~~~~---------~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~~~~ 362 (382)
T 3tt0_A 301 --EL----FKLLKEGHRMD---------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQEMGYY 362 (382)
T ss_dssp --HH----HHHHHTTCCCC---------CCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSCC----
T ss_pred --HH----HHHHHcCCCCC---------CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcCCCCCC
Confidence 11 12222222111 1112233688999999999999999999999999999987766655443
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=351.76 Aligned_cols=250 Identities=24% Similarity=0.374 Sum_probs=199.7
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCcch-hhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEecC
Q 002336 615 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 692 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~-~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~~ 692 (935)
|++.+.||+|+||.||+|.+. +++.||||++..... ...+.+.+|+.+++.++||||+++++++.+++..++||||++
T Consensus 9 y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~ 88 (323)
T 3tki_A 9 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCS 88 (323)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred ceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEcCC
Confidence 566789999999999999876 789999999864432 234678999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccc-cc
Q 002336 693 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL-TH 771 (935)
Q Consensus 693 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~-~~ 771 (935)
+|+|.+++. ....+++..+..++.|+++||+|||+ ++|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 89 ~~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 162 (323)
T 3tki_A 89 GGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 162 (323)
T ss_dssp TEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred CCcHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccccchHHEEEeCCCCEEEEEeeccceeccCCccc
Confidence 999999997 35679999999999999999999998 899999999999999999999999999998654322 12
Q ss_pred eeecccCCccccCCCCCCCCCC-CchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccC
Q 002336 772 ISSVARGTVGYLDPEYYGNQQL-TEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 850 (935)
Q Consensus 772 ~~~~~~gt~~y~APE~l~~~~~-s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~ 850 (935)
......||+.|+|||++.+..+ +.++||||||+++|+|++|+.||...... ......|... ... ..+
T Consensus 163 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~~~~~~----~~~---~~~---- 230 (323)
T 3tki_A 163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS-CQEYSDWKEK----KTY---LNP---- 230 (323)
T ss_dssp CBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTT-SHHHHHHHTT----CTT---STT----
T ss_pred ccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchH-HHHHHHHhcc----ccc---CCc----
Confidence 2234568999999999877665 78999999999999999999999743322 1222222111 000 000
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002336 851 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 884 (935)
Q Consensus 851 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~ 884 (935)
.......+.+++.+||+.||++|||++|+++.
T Consensus 231 --~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 231 --WKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp --GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred --cccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 01122367899999999999999999998764
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=366.51 Aligned_cols=258 Identities=29% Similarity=0.444 Sum_probs=209.3
Q ss_pred HHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcch-hhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEe
Q 002336 613 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 690 (935)
Q Consensus 613 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~-~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~ 690 (935)
..+.+.+.||+|+||.||+|.+. +++.||||+++.... ...+.+.+|+++|++++||||+++++++...+..++||||
T Consensus 114 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 193 (377)
T 3cbl_A 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMEL 193 (377)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEc
Confidence 34567889999999999999987 789999999875432 3446789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccccccc
Q 002336 691 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 770 (935)
Q Consensus 691 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~ 770 (935)
+++|+|.+++... +..+++..++.++.|+++||+|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 194 ~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~ 268 (377)
T 3cbl_A 194 VQGGDFLTFLRTE--GARLRVKTLLQMVGDAAAGMEYLES---KCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVY 268 (377)
T ss_dssp CTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEE
T ss_pred CCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCce
Confidence 9999999999742 3468999999999999999999998 8999999999999999999999999999986543221
Q ss_pred cee-ecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCcccchhHHHHHHHhhhcCCeeecccccc
Q 002336 771 HIS-SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 848 (935)
Q Consensus 771 ~~~-~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l 848 (935)
... ....+++.|+|||.+.+..++.++||||||+++|||++ |..||...... . +...+..+....
T Consensus 269 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~---~----~~~~~~~~~~~~------ 335 (377)
T 3cbl_A 269 AASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQ---Q----TREFVEKGGRLP------ 335 (377)
T ss_dssp ECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHH---H----HHHHHHTTCCCC------
T ss_pred eecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---H----HHHHHHcCCCCC------
Confidence 111 12235678999999988889999999999999999998 99999743221 1 122222222111
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhhhhh
Q 002336 849 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 891 (935)
Q Consensus 849 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~~~~ 891 (935)
.+...+..+.+++.+||+.+|++|||+++|++.|+++...
T Consensus 336 ---~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 336 ---CPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp ---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 1112234688999999999999999999999999987653
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-39 Score=373.99 Aligned_cols=259 Identities=24% Similarity=0.429 Sum_probs=210.2
Q ss_pred HHHHhhcccccccccEEEEEEEECCCcEEEEEEccCcchhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEec
Q 002336 612 EATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 691 (935)
Q Consensus 612 ~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~ 691 (935)
...+++.+.||+|+||.||+|.+++++.||||+++... ...+.|.+|+++|++++||||+++++++. .+..++||||+
T Consensus 187 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~ 264 (454)
T 1qcf_A 187 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFM 264 (454)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCC
T ss_pred hHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeec
Confidence 34466788999999999999999989999999997543 34678999999999999999999999987 56789999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccccc
Q 002336 692 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 771 (935)
Q Consensus 692 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~ 771 (935)
++|+|.+++... ....+++..++.++.|+++||+|||+ ++|+||||||+|||++.++.+||+|||+++........
T Consensus 265 ~~g~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~ 340 (454)
T 1qcf_A 265 AKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT 340 (454)
T ss_dssp TTCBHHHHHHSH-HHHTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHH
T ss_pred CCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCcee
Confidence 999999999743 22358899999999999999999998 89999999999999999999999999999876443222
Q ss_pred eeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccC
Q 002336 772 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 850 (935)
Q Consensus 772 ~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~ 850 (935)
......++..|+|||.+....++.++||||||+++|||++ |+.||...... ...+ .+..+...
T Consensus 341 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~---~~~~----~i~~~~~~--------- 404 (454)
T 1qcf_A 341 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP---EVIR----ALERGYRM--------- 404 (454)
T ss_dssp TTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---HHHH----HHHHTCCC---------
T ss_pred ccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHH---HHHH----HHHcCCCC---------
Confidence 2233346788999999988889999999999999999999 99999743221 1222 12222110
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhhhhhc
Q 002336 851 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 892 (935)
Q Consensus 851 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~~~~~ 892 (935)
..+......+.+++.+||+.+|++|||+++|++.|+++....
T Consensus 405 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~ 446 (454)
T 1qcf_A 405 PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTAT 446 (454)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSS
T ss_pred CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhcc
Confidence 011222346889999999999999999999999999876543
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=340.47 Aligned_cols=263 Identities=16% Similarity=0.193 Sum_probs=211.7
Q ss_pred HHhhcccccccccEEEEEEEE-CCCcEEEEEEccCcchhhhHHHHHHHHHHHhc-CCCcccccceeeeccceEEEEEEec
Q 002336 614 TNNFCKKIGKGSFGSVYYGKM-KDGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEYM 691 (935)
Q Consensus 614 ~~~~~~~LG~G~fG~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L-~HpnIv~l~g~~~~~~~~~lV~E~~ 691 (935)
.|++.+.||+|+||.||+|.. .+|+.||||++... ...+.+.+|+.+++.+ +|+|++++++++.+....++||||+
T Consensus 11 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~ 88 (298)
T 1csn_A 11 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL 88 (298)
T ss_dssp TEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECC--TTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC
T ss_pred ceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccC--CccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec
Confidence 456778999999999999986 47899999998643 2345788999999999 7999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCc-----EEEeecccccccc
Q 002336 692 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMR-----AKVSDFGLSRQAE 766 (935)
Q Consensus 692 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~-----vkL~DFGla~~~~ 766 (935)
+++|.+++... +..+++..+..++.|+++||+|||+ ++|+||||||+|||++.++. +||+|||+++...
T Consensus 89 -~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~ 162 (298)
T 1csn_A 89 -GPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 162 (298)
T ss_dssp -CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred -CCCHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEeccCCCCCCCeEEEEECccccccc
Confidence 99999999753 4469999999999999999999997 89999999999999987776 9999999998765
Q ss_pred ccccc------eeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCe
Q 002336 767 EDLTH------ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV 840 (935)
Q Consensus 767 ~~~~~------~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~ 840 (935)
..... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||..............+.........
T Consensus 163 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 242 (298)
T 1csn_A 163 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL 242 (298)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCH
T ss_pred cccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccH
Confidence 43221 123456899999999999999999999999999999999999999854433322222222221111111
Q ss_pred eecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhhhhhcc
Q 002336 841 ISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 893 (935)
Q Consensus 841 ~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~~~~~~ 893 (935)
.. +... ....+.+++.+||+.+|++||++++|++.|+++.....
T Consensus 243 ~~-----~~~~----~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~ 286 (298)
T 1csn_A 243 RE-----LCAG----FPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLN 286 (298)
T ss_dssp HH-----HTTT----SCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred HH-----HHhh----CcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcC
Confidence 11 1111 22468899999999999999999999999999876543
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=343.37 Aligned_cols=269 Identities=22% Similarity=0.318 Sum_probs=211.4
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCcch-hhhHHHHHHHHHHHhcCCCcccccceeeeccc--eEEEEEEe
Q 002336 615 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH--QRILVYEY 690 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~-~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~--~~~lV~E~ 690 (935)
|.+.+.||+|+||.||+|.+. +++.||||++..... ...+.+.+|++++++++||||+++++++.... ..++||||
T Consensus 11 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~ 90 (319)
T 4euu_A 11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEF 90 (319)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEEC
T ss_pred EEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEeC
Confidence 556789999999999999887 589999999875432 33567889999999999999999999987655 77999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccc----cCCCcEEEeecccccccc
Q 002336 691 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL----DINMRAKVSDFGLSRQAE 766 (935)
Q Consensus 691 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILl----d~~~~vkL~DFGla~~~~ 766 (935)
+++++|.+++........+++..++.++.|+++||+|||+ .+|+||||||+|||+ +.++.+||+|||+++...
T Consensus 91 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~ 167 (319)
T 4euu_A 91 CPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE 167 (319)
T ss_dssp CTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEECC
T ss_pred CCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEeccCCCCceEEEccCCCceecC
Confidence 9999999999865444559999999999999999999998 899999999999999 788889999999998765
Q ss_pred ccccceeecccCCccccCCCCCC--------CCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcC
Q 002336 767 EDLTHISSVARGTVGYLDPEYYG--------NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG 838 (935)
Q Consensus 767 ~~~~~~~~~~~gt~~y~APE~l~--------~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~ 838 (935)
.... .....||+.|+|||++. +..++.++||||||+++|||++|+.||........ ..+.+...+...
T Consensus 168 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~ 243 (319)
T 4euu_A 168 DDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRR--NKEVMYKIITGK 243 (319)
T ss_dssp TTCC--BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGG--CHHHHHHHHHHC
T ss_pred CCCc--eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccch--hHHHHHHHhcCC
Confidence 4332 22345899999999874 57889999999999999999999999964332211 111122222111
Q ss_pred ---Ceeecc-----------cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhhhh
Q 002336 839 ---DVISIV-----------DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 890 (935)
Q Consensus 839 ---~~~~~~-----------d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~~~ 890 (935)
....+. +..............+.+++.+||+.||++|||++|+++...+...
T Consensus 244 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~ 309 (319)
T 4euu_A 244 PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309 (319)
T ss_dssp CTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC
T ss_pred CcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhh
Confidence 111100 0011123445667789999999999999999999999998876554
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-39 Score=378.25 Aligned_cols=258 Identities=29% Similarity=0.449 Sum_probs=212.4
Q ss_pred HHHHhhcccccccccEEEEEEEECC-CcEEEEEEccCcchhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEe
Q 002336 612 EATNNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 690 (935)
Q Consensus 612 ~~~~~~~~~LG~G~fG~Vy~~~~~~-g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~ 690 (935)
...+++.+.||+|+||.||+|.++. ++.||||+++... ...+.|.+|+.+|++++||||++++++|......++||||
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~ 297 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 297 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEc
Confidence 3446678899999999999999874 8899999997543 3457899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccccccc
Q 002336 691 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 770 (935)
Q Consensus 691 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~ 770 (935)
+++|+|.+++... ....+++..++.++.|+++||+|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 298 ~~~g~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 373 (495)
T 1opk_A 298 MTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTY 373 (495)
T ss_dssp CTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCE
T ss_pred cCCCCHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChhhEEECCCCcEEEeecccceeccCCce
Confidence 9999999999754 34568999999999999999999998 8999999999999999999999999999987654332
Q ss_pred ceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCcccchhHHHHHHHhhhcCCeeeccccccc
Q 002336 771 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 849 (935)
Q Consensus 771 ~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~ 849 (935)
.......+++.|+|||.+....++.++||||||+++|||++ |+.||...+.. ...+. +..+..
T Consensus 374 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~---~~~~~----~~~~~~--------- 437 (495)
T 1opk_A 374 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS---QVYEL----LEKDYR--------- 437 (495)
T ss_dssp ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---GHHHH----HHTTCC---------
T ss_pred eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH---HHHHH----HHcCCC---------
Confidence 22333446789999999988889999999999999999999 99999744322 12221 222111
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhhhh
Q 002336 850 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 890 (935)
Q Consensus 850 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~~~ 890 (935)
...+......+.+++.+||+.+|++|||++||++.|+.+..
T Consensus 438 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~ 478 (495)
T 1opk_A 438 MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 478 (495)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred CCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence 01122233468899999999999999999999999998753
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-39 Score=365.28 Aligned_cols=261 Identities=26% Similarity=0.481 Sum_probs=200.0
Q ss_pred HHHHHhhcccccccccEEEEEEEEC----CCcEEEEEEccCcc-hhhhHHHHHHHHHHHhcCCCcccccceeeeccceEE
Q 002336 611 EEATNNFCKKIGKGSFGSVYYGKMK----DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRI 685 (935)
Q Consensus 611 ~~~~~~~~~~LG~G~fG~Vy~~~~~----~g~~vAvK~~~~~~-~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~ 685 (935)
....+++.+.||+|+||.||+|++. ++..||||+++... ....+.|.+|+.++++++||||+++++++.+.+..+
T Consensus 43 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 122 (373)
T 2qol_A 43 DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVM 122 (373)
T ss_dssp CGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred CHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceE
Confidence 3345667889999999999999875 57789999987643 334568999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccc
Q 002336 686 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 765 (935)
Q Consensus 686 lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~ 765 (935)
+||||+++|+|.++++.. ...+++.+++.++.|+++||+|||+ ++|+||||||+|||++.++.+||+|||+++..
T Consensus 123 lv~e~~~~~sL~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 197 (373)
T 2qol_A 123 IVTEYMENGSLDSFLRKH--DAQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLGRVL 197 (373)
T ss_dssp EEEECCTTCBHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred EEEeCCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEEcCCCCEEECcCcccccc
Confidence 999999999999999743 4568999999999999999999998 89999999999999999999999999999876
Q ss_pred cccccce--eecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCcccchhHHHHHHHhhhcCCeee
Q 002336 766 EEDLTHI--SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVIS 842 (935)
Q Consensus 766 ~~~~~~~--~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~ 842 (935)
....... .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||...... ... ..+..+..
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~---~~~----~~i~~~~~-- 268 (373)
T 2qol_A 198 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ---DVI----KAVDEGYR-- 268 (373)
T ss_dssp ----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHH---HHH----HHHHTTEE--
T ss_pred ccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHH---HHH----HHHHcCCC--
Confidence 5432221 112235678999999988899999999999999999998 99999733221 111 12222111
Q ss_pred cccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhhhhhc
Q 002336 843 IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 892 (935)
Q Consensus 843 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~~~~~ 892 (935)
...+......+.+++.+||+.+|++||+++||++.|++++...
T Consensus 269 -------~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~ 311 (373)
T 2qol_A 269 -------LPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP 311 (373)
T ss_dssp -------CCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCG
T ss_pred -------CCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCc
Confidence 0111223347889999999999999999999999999887643
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-38 Score=348.77 Aligned_cols=260 Identities=19% Similarity=0.235 Sum_probs=208.9
Q ss_pred HhhcccccccccEEEEEEEE-CCCcEEEEEEccCcchhhhHHHHHHHHHHHhc-CCCcccccceeeeccceEEEEEEecC
Q 002336 615 NNFCKKIGKGSFGSVYYGKM-KDGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEYMH 692 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L-~HpnIv~l~g~~~~~~~~~lV~E~~~ 692 (935)
|++.+.||+|+||.||+|.. .+|+.||||++.... ..+.+.+|+++++++ +||||+++++++...+..++||||+
T Consensus 11 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~- 87 (330)
T 2izr_A 11 FRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL- 87 (330)
T ss_dssp EEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC--SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC-
T ss_pred eEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC-
Confidence 55678999999999999987 478999999986532 235688999999999 8999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCc-----EEEeeccccccccc
Q 002336 693 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMR-----AKVSDFGLSRQAEE 767 (935)
Q Consensus 693 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~-----vkL~DFGla~~~~~ 767 (935)
+++|.+++... ...+++..++.++.|++.||+|||+ .+|+||||||+|||++.++. +||+|||+++....
T Consensus 88 ~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~---~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~ 162 (330)
T 2izr_A 88 GPSLEDLFDLC--DRTFSLKTVLMIAIQLISRMEYVHS---KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYID 162 (330)
T ss_dssp CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBC
T ss_pred CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeec
Confidence 99999999753 4579999999999999999999998 89999999999999998887 99999999987644
Q ss_pred cccc------eeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCee
Q 002336 768 DLTH------ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVI 841 (935)
Q Consensus 768 ~~~~------~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~ 841 (935)
.... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||..............+.........
T Consensus 163 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~- 241 (330)
T 2izr_A 163 PETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPI- 241 (330)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCH-
T ss_pred CCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCCH-
Confidence 3221 123456999999999999999999999999999999999999999854433322222222111111000
Q ss_pred ecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhhhhhc
Q 002336 842 SIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 892 (935)
Q Consensus 842 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~~~~~ 892 (935)
..+.. ..+ .+.+++.+||+.+|.+||++++|.+.|+++....
T Consensus 242 ----~~~~~----~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~ 283 (330)
T 2izr_A 242 ----EVLCE----NFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRK 283 (330)
T ss_dssp ----HHHTT----TCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred ----HHHhc----cCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHc
Confidence 00000 112 7889999999999999999999999999776543
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-38 Score=345.72 Aligned_cols=261 Identities=30% Similarity=0.510 Sum_probs=202.8
Q ss_pred HHhhcccccccccEEEEEEEECCCcEEEEEEccCcchhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEecCC
Q 002336 614 TNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 693 (935)
Q Consensus 614 ~~~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~~~ 693 (935)
.+++.+.||+|+||.||+|.+. ++.||+|++... ...+.+.+|++++++++||||+++++++.+ ..++||||+++
T Consensus 9 ~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~~ 83 (307)
T 2eva_A 9 EIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAEG 83 (307)
T ss_dssp GEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCTT
T ss_pred HeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCCC
Confidence 4566789999999999999987 889999998643 345789999999999999999999999874 47899999999
Q ss_pred CCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCc-EEEeeccccccccccccce
Q 002336 694 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMR-AKVSDFGLSRQAEEDLTHI 772 (935)
Q Consensus 694 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~-vkL~DFGla~~~~~~~~~~ 772 (935)
|+|.+++........+++..++.++.|+++||+|||+...++|+||||||+|||++.++. +||+|||++.......
T Consensus 84 ~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~~--- 160 (307)
T 2eva_A 84 GSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHM--- 160 (307)
T ss_dssp CBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-----------
T ss_pred CCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccccc---
Confidence 999999985433345789999999999999999999743368999999999999998886 7999999997654321
Q ss_pred eecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccCCC
Q 002336 773 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNV 852 (935)
Q Consensus 773 ~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~~~ 852 (935)
....||+.|+|||.+.+..++.++||||||+++|||++|+.||....... ....|. ...+... ......
T Consensus 161 -~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--~~~~~~---~~~~~~~-----~~~~~~ 229 (307)
T 2eva_A 161 -TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPA--FRIMWA---VHNGTRP-----PLIKNL 229 (307)
T ss_dssp -----CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSH--HHHHHH---HHTTCCC-----CCBTTC
T ss_pred -ccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccH--HHHHHH---HhcCCCC-----Cccccc
Confidence 22358999999999999899999999999999999999999997332211 111111 1112111 111122
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhhhhhccCCCC
Q 002336 853 KIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKGGDQ 897 (935)
Q Consensus 853 ~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~~~~~~~~~~ 897 (935)
...+.+++.+||+.+|++|||++|+++.|+.+.........
T Consensus 230 ----~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~~ 270 (307)
T 2eva_A 230 ----PKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADE 270 (307)
T ss_dssp ----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCTTS
T ss_pred ----CHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccCCCC
Confidence 23688999999999999999999999999998876654443
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-38 Score=349.65 Aligned_cols=246 Identities=24% Similarity=0.358 Sum_probs=202.0
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc---hhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEe
Q 002336 615 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 690 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~ 690 (935)
+++.+.||+|+||.||+|+.+ +|+.||+|+++... ......+.+|+++++.++||||+++++++...+..++||||
T Consensus 7 y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E~ 86 (337)
T 1o6l_A 7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEY 86 (337)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred eEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEEeC
Confidence 556789999999999999886 68999999986532 22346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccccccc
Q 002336 691 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 770 (935)
Q Consensus 691 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~ 770 (935)
+++|+|.+++.. ...+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 87 ~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~ 160 (337)
T 1o6l_A 87 ANGGELFFHLSR---ERVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA 160 (337)
T ss_dssp CTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC
T ss_pred CCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCCHHHEEECCCCCEEEeeccchhhcccCCC
Confidence 999999999873 4568999999999999999999998 8999999999999999999999999999986432221
Q ss_pred ceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccC
Q 002336 771 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 850 (935)
Q Consensus 771 ~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~ 850 (935)
......||+.|+|||++.+..++.++||||||+++|||++|+.||...+.. .+. ..+..+.. .+
T Consensus 161 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~---~~~----~~i~~~~~------~~-- 224 (337)
T 1o6l_A 161 -TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---RLF----ELILMEEI------RF-- 224 (337)
T ss_dssp -CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---HHH----HHHHHCCC------CC--
T ss_pred -cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHH---HHH----HHHHcCCC------CC--
Confidence 223456899999999999999999999999999999999999999743221 111 11211111 11
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 002336 851 NVKIESIWRIAEVAIQCVEQRGFSRP-----KMQEIVLA 884 (935)
Q Consensus 851 ~~~~~~~~~l~~li~~Cl~~dP~~RP-----s~~ev~~~ 884 (935)
+......+.+++.+||+.||++|| +++|+++.
T Consensus 225 --p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 225 --PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp --CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred --CCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 112233678999999999999999 89998764
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-38 Score=338.97 Aligned_cols=255 Identities=29% Similarity=0.453 Sum_probs=209.5
Q ss_pred HHhhcccccccccEEEEEEEECCCcEEEEEEccCcchhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEecCC
Q 002336 614 TNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 693 (935)
Q Consensus 614 ~~~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~~~ 693 (935)
.+++.+.||+|+||.||+|.+.+++.||+|++..... ..+.+.+|++++++++||||+++++++.+.+..++||||+++
T Consensus 9 ~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 87 (267)
T 3t9t_A 9 ELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEH 87 (267)
T ss_dssp GEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTT
T ss_pred heeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCC
Confidence 4566889999999999999998899999999876432 346789999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccccccccee
Q 002336 694 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 773 (935)
Q Consensus 694 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~~~ 773 (935)
++|.+++... ...+++..++.++.|+++||+|||+ ++++||||||+||+++.++.+||+|||++...........
T Consensus 88 ~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~ 162 (267)
T 3t9t_A 88 GCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS 162 (267)
T ss_dssp CBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHST
T ss_pred CcHHHHHhhC--cccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEECCCCCEEEccccccccccccccccc
Confidence 9999999753 3568999999999999999999998 8999999999999999999999999999987644322222
Q ss_pred ecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccCCC
Q 002336 774 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNV 852 (935)
Q Consensus 774 ~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~~~ 852 (935)
....++..|+|||.+.+..++.++||||||+++|+|++ |+.||...... .... .+..+.. ...
T Consensus 163 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~~----~i~~~~~-----~~~---- 226 (267)
T 3t9t_A 163 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS---EVVE----DISTGFR-----LYK---- 226 (267)
T ss_dssp TSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHH----HHHTTCC-----CCC----
T ss_pred ccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHH---HHHH----HHhcCCc-----CCC----
Confidence 33457788999999988889999999999999999999 89999743221 1111 1222211 001
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhhhh
Q 002336 853 KIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 890 (935)
Q Consensus 853 ~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~~~ 890 (935)
+......+.+++.+||+.+|++||+++|+++.|+++..
T Consensus 227 ~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 227 PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 11123368899999999999999999999999998765
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=344.48 Aligned_cols=260 Identities=25% Similarity=0.404 Sum_probs=198.6
Q ss_pred HHHHhhcccccccccEEEEEEEECC----CcEEEEEEccCcc-hhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEE
Q 002336 612 EATNNFCKKIGKGSFGSVYYGKMKD----GKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRIL 686 (935)
Q Consensus 612 ~~~~~~~~~LG~G~fG~Vy~~~~~~----g~~vAvK~~~~~~-~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~l 686 (935)
...|++.+.||+|+||.||+|.+.. +..||+|++.... ....+.+.+|+.++++++||||+++++++. ++..++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l 92 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 92 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence 3456778999999999999998753 4579999987543 334567999999999999999999999985 456899
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccc
Q 002336 687 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 766 (935)
Q Consensus 687 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~ 766 (935)
||||+++++|.+++... ...+++..++.++.|+++||+|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 93 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 167 (281)
T 1mp8_A 93 IMELCTLGELRSFLQVR--KYSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 167 (281)
T ss_dssp EEECCTTEEHHHHHHHT--TTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC--------
T ss_pred EEecCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHEEECCCCCEEECccccccccC
Confidence 99999999999999743 4468999999999999999999998 899999999999999999999999999998765
Q ss_pred ccccceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCcccchhHHHHHHHhhhcCCeeeccc
Q 002336 767 EDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 845 (935)
Q Consensus 767 ~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d 845 (935)
...........+++.|+|||.+.+..++.++||||||+++|||++ |..||...... ..... +..+....
T Consensus 168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~---~~~~~----i~~~~~~~--- 237 (281)
T 1mp8_A 168 DSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN---DVIGR----IENGERLP--- 237 (281)
T ss_dssp -----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---GHHHH----HHTTCCCC---
T ss_pred cccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHH---HHHHH----HHcCCCCC---
Confidence 443333333456789999999988889999999999999999997 99999743322 12221 22221111
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhhhhhcc
Q 002336 846 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 893 (935)
Q Consensus 846 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~~~~~~ 893 (935)
+ +......+.+++.+||+.+|++||++.|+++.|+++...+.
T Consensus 238 --~----~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 279 (281)
T 1mp8_A 238 --M----PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEK 279 (281)
T ss_dssp --C----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred --C----CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhc
Confidence 1 11223468899999999999999999999999999876543
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=344.97 Aligned_cols=260 Identities=22% Similarity=0.291 Sum_probs=199.0
Q ss_pred HHhhcccccccccEEEEEEEECCCcEEEEEEccCcchh--hhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEec
Q 002336 614 TNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSH--RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 691 (935)
Q Consensus 614 ~~~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~~~~~~~~--~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~ 691 (935)
.|++.+.||+|+||.||+|.+.+|+.||+|++...... ..+.+.+|++++++++||||+++++++.+++..++||||+
T Consensus 22 ~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 101 (311)
T 3niz_A 22 KYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFM 101 (311)
T ss_dssp EEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEECC
T ss_pred hhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcCC
Confidence 35667899999999999999988999999998654322 3467889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccccc
Q 002336 692 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 771 (935)
Q Consensus 692 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~ 771 (935)
++ +|.+.+.. ....+++..+..++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||+++........
T Consensus 102 ~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~ 175 (311)
T 3niz_A 102 EK-DLKKVLDE--NKTGLQDSQIKIYLYQLLRGVAHCHQ---HRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRS 175 (311)
T ss_dssp SE-EHHHHHHT--CTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC-
T ss_pred CC-CHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCchHhEEECCCCCEEEccCcCceecCCCccc
Confidence 75 88887764 34568999999999999999999998 89999999999999999999999999999876433222
Q ss_pred eeecccCCccccCCCCCCC-CCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCe---ee-----
Q 002336 772 ISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV---IS----- 842 (935)
Q Consensus 772 ~~~~~~gt~~y~APE~l~~-~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~---~~----- 842 (935)
.....||+.|+|||.+.+ ..++.++||||+|+++|+|++|+.||......+. ...+......... ..
T Consensus 176 -~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~---~~~i~~~~~~~~~~~~~~~~~~~ 251 (311)
T 3niz_A 176 -YTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQ---LPKIFSILGTPNPREWPQVQELP 251 (311)
T ss_dssp ---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTH---HHHHHHHHCCCCTTTSGGGTTSH
T ss_pred -ccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHHCCCChHHhhhhhccc
Confidence 233458999999998865 5789999999999999999999999975443322 1111111111100 00
Q ss_pred --------cccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 843 --------IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 843 --------~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
..+..............+.+++.+||+.||++|||++|+++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 252 LWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp HHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred hhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 00000000000112236789999999999999999999986
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-39 Score=351.95 Aligned_cols=266 Identities=24% Similarity=0.400 Sum_probs=207.5
Q ss_pred HHHHHHhhcccccccccEEEEEEEE-----CCCcEEEEEEccCcch-hhhHHHHHHHHHHHhcCCCcccccceeeecc--
Q 002336 610 LEEATNNFCKKIGKGSFGSVYYGKM-----KDGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEE-- 681 (935)
Q Consensus 610 l~~~~~~~~~~LG~G~fG~Vy~~~~-----~~g~~vAvK~~~~~~~-~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~-- 681 (935)
+....+++.+.||+|+||.||+|++ .+++.||+|++..... ...+.+.+|+++++.++||||+++++++...
T Consensus 18 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 97 (302)
T 4e5w_A 18 FEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGG 97 (302)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---
T ss_pred hhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCC
Confidence 3344567789999999999999984 3689999999875432 3346789999999999999999999999776
Q ss_pred ceEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccc
Q 002336 682 HQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGL 761 (935)
Q Consensus 682 ~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGl 761 (935)
...++||||+++++|.+++... ...+++..++.++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+
T Consensus 98 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~ 172 (302)
T 4e5w_A 98 NGIKLIMEFLPSGSLKEYLPKN--KNKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGL 172 (302)
T ss_dssp CCEEEEEECCTTCBHHHHHHHH--TTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTT
T ss_pred ceEEEEEEeCCCCcHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHhhc---CCcccCCCchheEEEcCCCCEEECcccc
Confidence 6689999999999999999642 4568999999999999999999998 8999999999999999999999999999
Q ss_pred ccccccccc--ceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCc--------ccchhHHHHH
Q 002336 762 SRQAEEDLT--HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDF--------GAELNIVHWA 831 (935)
Q Consensus 762 a~~~~~~~~--~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~--------~~~~~l~~~~ 831 (935)
+........ .......||..|+|||.+.+..++.++||||+|+++|+|++|..|+..... ..........
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 252 (302)
T 4e5w_A 173 TKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRL 252 (302)
T ss_dssp CEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHH
T ss_pred cccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHH
Confidence 987654432 223344578889999999888899999999999999999999998652210 0011111111
Q ss_pred HHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhhh
Q 002336 832 RSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI 889 (935)
Q Consensus 832 ~~~i~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~~ 889 (935)
...+..+... ..+......+.+++.+||+.||++|||++|+++.|++++
T Consensus 253 ~~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 253 VNTLKEGKRL---------PCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HHHHHTTCCC---------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHhccCCC---------CCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 2222222111 112223347889999999999999999999999999875
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=344.32 Aligned_cols=261 Identities=29% Similarity=0.444 Sum_probs=215.2
Q ss_pred HHHHHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcchhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEE
Q 002336 610 LEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 688 (935)
Q Consensus 610 l~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~ 688 (935)
+....+++.+.||+|+||.||+|.+. +++.||+|++... ....+.+.+|++++++++||||+++++++.+....++||
T Consensus 10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 88 (288)
T 3kfa_A 10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 88 (288)
T ss_dssp CCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEE
T ss_pred ccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEE
Confidence 34455677899999999999999987 4889999998754 334578999999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccccc
Q 002336 689 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 768 (935)
Q Consensus 689 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~ 768 (935)
||+++++|.+++... ....+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++......
T Consensus 89 e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 164 (288)
T 3kfa_A 89 EFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 164 (288)
T ss_dssp ECCTTEEHHHHHHHC-CTTTSCHHHHHHHHHHHHHHHHHHHH---HTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSS
T ss_pred EcCCCCcHHHHHHhc-ccCCccHhHHHHHHHHHHHHHHHHHH---CCccCCCCCcceEEEcCCCCEEEccCccceeccCC
Confidence 999999999999754 34568999999999999999999998 89999999999999999999999999999876654
Q ss_pred ccceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCcccchhHHHHHHHhhhcCCeeeccccc
Q 002336 769 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 847 (935)
Q Consensus 769 ~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~ 847 (935)
.........+++.|+|||.+.+..++.++||||||+++|+|++ |..||...+... ..+.+ ..+..
T Consensus 165 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~---~~~~~----~~~~~------- 230 (288)
T 3kfa_A 165 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---VYELL----EKDYR------- 230 (288)
T ss_dssp SSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---HHHHH----HTTCC-------
T ss_pred ccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHH----hccCC-------
Confidence 4433444557889999999988889999999999999999999 999997443321 22211 11110
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhhhhh
Q 002336 848 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 891 (935)
Q Consensus 848 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~~~~ 891 (935)
...+......+.+++.+||+.+|++|||++|+++.|+++...
T Consensus 231 --~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~ 272 (288)
T 3kfa_A 231 --MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 272 (288)
T ss_dssp --CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --CCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHh
Confidence 011122234688999999999999999999999999887654
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-38 Score=364.70 Aligned_cols=252 Identities=29% Similarity=0.488 Sum_probs=205.7
Q ss_pred HHHhhcccccccccEEEEEEEECCCcEEEEEEccCcchhhhHHHHHHHHHHHhcCCCcccccceeeeccc-eEEEEEEec
Q 002336 613 ATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH-QRILVYEYM 691 (935)
Q Consensus 613 ~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~-~~~lV~E~~ 691 (935)
..+++.+.||+|+||.||+|.+. |+.||||+++... ..+.|.+|+++|++++||||+++++++.... ..++||||+
T Consensus 193 ~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~ 269 (450)
T 1k9a_A 193 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 269 (450)
T ss_dssp GGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECC
T ss_pred HHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEec
Confidence 34566789999999999999987 8899999997643 4578999999999999999999999986654 789999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccccc
Q 002336 692 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 771 (935)
Q Consensus 692 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~ 771 (935)
++|+|.+++... ....+++..++.++.|+++||+|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 270 ~~g~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-- 343 (450)
T 1k9a_A 270 AKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 343 (450)
T ss_dssp TTCBHHHHHHHH-CTTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred CCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEECCCCCEEEeeCCCcccccccc--
Confidence 999999999753 23447899999999999999999998 899999999999999999999999999998543321
Q ss_pred eeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccC
Q 002336 772 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 850 (935)
Q Consensus 772 ~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~ 850 (935)
....+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+ ... .+..+...
T Consensus 344 --~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~---~~~----~i~~~~~~--------- 405 (450)
T 1k9a_A 344 --DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVP----RVEKGYKM--------- 405 (450)
T ss_dssp -----CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT---HHH----HHHTTCCC---------
T ss_pred --cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHH----HHHcCCCC---------
Confidence 12346889999999998899999999999999999998 999997443221 211 22222111
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhhhhh
Q 002336 851 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 891 (935)
Q Consensus 851 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~~~~ 891 (935)
..+......+.+++.+||+.+|++|||+++|++.|+++...
T Consensus 406 ~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 406 DAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 11222234788999999999999999999999999987754
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=369.99 Aligned_cols=259 Identities=27% Similarity=0.434 Sum_probs=205.0
Q ss_pred HHHhhcccccccccEEEEEEEECCCcEEEEEEccCcchhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEecC
Q 002336 613 ATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 692 (935)
Q Consensus 613 ~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~~ 692 (935)
..+++.+.||+|+||.||+|.++++..||||+++... ...+.|.+|+++|++++||||+++++++.+ +..++||||++
T Consensus 184 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~ 261 (452)
T 1fmk_A 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS 261 (452)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred hHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhc
Confidence 4456788999999999999999988899999997543 234679999999999999999999999876 67899999999
Q ss_pred CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccccce
Q 002336 693 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 772 (935)
Q Consensus 693 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~~ 772 (935)
+|+|.+++... .+..+++..++.++.|+++||+|||+ ++|+||||||+|||++.++.+||+|||+++.........
T Consensus 262 ~gsL~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 337 (452)
T 1fmk_A 262 KGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 337 (452)
T ss_dssp TCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred CCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEECCCCCEEECCCccceecCCCceec
Confidence 99999999742 23458999999999999999999998 899999999999999999999999999998765433222
Q ss_pred eecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccCC
Q 002336 773 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 851 (935)
Q Consensus 773 ~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~~ 851 (935)
.....++..|+|||.+....++.++||||||+++|||++ |+.||...... .. ...+..+... .
T Consensus 338 ~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~---~~----~~~i~~~~~~---------~ 401 (452)
T 1fmk_A 338 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR---EV----LDQVERGYRM---------P 401 (452)
T ss_dssp -----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HH----HHHHHTTCCC---------C
T ss_pred ccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHH---HH----HHHHHcCCCC---------C
Confidence 333456789999999988889999999999999999999 99999743221 11 1222222111 1
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhhhhhcc
Q 002336 852 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 893 (935)
Q Consensus 852 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~~~~~~ 893 (935)
.+......+.+++.+||+.+|++|||+++|++.|+++.....
T Consensus 402 ~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~ 443 (452)
T 1fmk_A 402 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 443 (452)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCC
Confidence 112233468899999999999999999999999998875443
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-38 Score=345.33 Aligned_cols=261 Identities=26% Similarity=0.432 Sum_probs=211.2
Q ss_pred HHHHhhcccccccccEEEEEEEE------CCCcEEEEEEccCcc-hhhhHHHHHHHHHHHhcCCCcccccceeeeccceE
Q 002336 612 EATNNFCKKIGKGSFGSVYYGKM------KDGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQR 684 (935)
Q Consensus 612 ~~~~~~~~~LG~G~fG~Vy~~~~------~~g~~vAvK~~~~~~-~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~ 684 (935)
...+.+.+.||+|+||.||+|.+ .+++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 101 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL 101 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence 34566788999999999999986 245889999987543 34457899999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhccCCC---------------------CCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCC
Q 002336 685 ILVYEYMHNGTLRDRLHGSVN---------------------QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKS 743 (935)
Q Consensus 685 ~lV~E~~~~gsL~~~L~~~~~---------------------~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp 743 (935)
++||||+++++|.+++..... ...+++..++.++.|+++||+|||+ ++|+||||||
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dikp 178 (314)
T 2ivs_A 102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE---MKLVHRDLAA 178 (314)
T ss_dssp EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHH---TTEECCCCSG
T ss_pred EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHH---CCCcccccch
Confidence 999999999999999975432 2348899999999999999999998 8999999999
Q ss_pred CCccccCCCcEEEeeccccccccccccc-eeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCc
Q 002336 744 SNILLDINMRAKVSDFGLSRQAEEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDF 821 (935)
Q Consensus 744 ~NILld~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLlt-G~~Pf~~~~~ 821 (935)
+|||++.++.+||+|||+++........ ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||.....
T Consensus 179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 258 (314)
T 2ivs_A 179 RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP 258 (314)
T ss_dssp GGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred heEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 9999999999999999999876443222 1223356788999999988889999999999999999999 9999974433
Q ss_pred ccchhHHHHHHHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhhhhh
Q 002336 822 GAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 891 (935)
Q Consensus 822 ~~~~~l~~~~~~~i~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~~~~ 891 (935)
.. +.. .+..+.... .+......+.+++.+||+.||++||+++|+++.|+++...
T Consensus 259 ~~---~~~----~~~~~~~~~---------~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 259 ER---LFN----LLKTGHRME---------RPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp GG---HHH----HHHTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred HH---HHH----HhhcCCcCC---------CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence 21 222 222221111 1112234688999999999999999999999999988764
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-38 Score=349.27 Aligned_cols=261 Identities=26% Similarity=0.438 Sum_probs=209.8
Q ss_pred HHHhhcccccccccEEEEEEEEC------CCcEEEEEEccCcc-hhhhHHHHHHHHHHHhcCCCcccccceeeeccceEE
Q 002336 613 ATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRI 685 (935)
Q Consensus 613 ~~~~~~~~LG~G~fG~Vy~~~~~------~g~~vAvK~~~~~~-~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~ 685 (935)
..+++.+.||+|+||.||+|.+. +++.||+|+++... ....+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 47 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 126 (343)
T 1luf_A 47 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMC 126 (343)
T ss_dssp GGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCE
T ss_pred HHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCceE
Confidence 44567889999999999999875 34889999997643 334567999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhccCCC---------------------CCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCC
Q 002336 686 LVYEYMHNGTLRDRLHGSVN---------------------QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSS 744 (935)
Q Consensus 686 lV~E~~~~gsL~~~L~~~~~---------------------~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~ 744 (935)
+||||+++|+|.+++..... ...+++.+++.++.|+++||+|||+ ++|+||||||+
T Consensus 127 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~ 203 (343)
T 1luf_A 127 LLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATR 203 (343)
T ss_dssp EEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGG
T ss_pred EEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcc
Confidence 99999999999999875321 2578999999999999999999998 89999999999
Q ss_pred CccccCCCcEEEeecccccccccccc-ceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCcc
Q 002336 745 NILLDINMRAKVSDFGLSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFG 822 (935)
Q Consensus 745 NILld~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~ 822 (935)
|||++.++.+||+|||+++....... .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||......
T Consensus 204 NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~ 283 (343)
T 1luf_A 204 NCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHE 283 (343)
T ss_dssp GEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH
T ss_pred eEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCChH
Confidence 99999999999999999976543221 12233457899999999988889999999999999999999 99999743221
Q ss_pred cchhHHHHHHHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhhhhhc
Q 002336 823 AELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 892 (935)
Q Consensus 823 ~~~~l~~~~~~~i~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~~~~~ 892 (935)
.. ...+..+..... +......+.+++.+||+.+|++||+++||++.|+++....
T Consensus 284 ---~~----~~~~~~~~~~~~---------~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~ 337 (343)
T 1luf_A 284 ---EV----IYYVRDGNILAC---------PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERA 337 (343)
T ss_dssp ---HH----HHHHHTTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC--
T ss_pred ---HH----HHHHhCCCcCCC---------CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhh
Confidence 11 122333322111 1122346889999999999999999999999999887643
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=346.00 Aligned_cols=252 Identities=22% Similarity=0.305 Sum_probs=204.1
Q ss_pred HHHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcchh------hhHHHHHHHHHHHhcCCCcccccceeeeccceE
Q 002336 612 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSH------RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQR 684 (935)
Q Consensus 612 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~~------~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~ 684 (935)
...|++.+.||+|+||.||+|... +|+.||+|++...... ..+.+.+|+.++++++||||+++++++.+....
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 356778899999999999999886 6899999998654321 346789999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCC----cEEEeecc
Q 002336 685 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM----RAKVSDFG 760 (935)
Q Consensus 685 ~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~----~vkL~DFG 760 (935)
++||||+++++|.+++.. ...+++..+..++.|++.||.|||+ ++|+||||||+|||++.++ .+||+|||
T Consensus 90 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg 163 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFG 163 (326)
T ss_dssp EEEEECCCSCBHHHHHTT---SSCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEcCCCCCHHHHHHh---cCCcCHHHHHHHHHHHHHHHHHHHH---CCeEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence 999999999999999973 4679999999999999999999998 8999999999999999887 79999999
Q ss_pred ccccccccccceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCe
Q 002336 761 LSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV 840 (935)
Q Consensus 761 la~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~ 840 (935)
+++....... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||....... .. .. +.....
T Consensus 164 ~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~---~~-~~~~~~ 234 (326)
T 2y0a_A 164 LAHKIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE---TL---AN-VSAVNY 234 (326)
T ss_dssp TCEECCTTSC--CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH---HH---HH-HHHTCC
T ss_pred CCeECCCCCc--cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH---HH---HH-HHhcCC
Confidence 9987643322 223468999999999998899999999999999999999999997432211 11 11 111110
Q ss_pred eecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002336 841 ISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 884 (935)
Q Consensus 841 ~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~ 884 (935)
. ....... .....+.+++.+||+.||++|||++|+++.
T Consensus 235 ~--~~~~~~~----~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 235 E--FEDEYFS----NTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp C--CCHHHHT----TSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred C--cCccccc----cCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0 0000001 112367899999999999999999999873
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-39 Score=356.88 Aligned_cols=270 Identities=25% Similarity=0.375 Sum_probs=211.0
Q ss_pred HHHHhhcccccccccEEEEEEEE-----CCCcEEEEEEccCcchhhhHHHHHHHHHHHhcCCCcccccceeee--ccceE
Q 002336 612 EATNNFCKKIGKGSFGSVYYGKM-----KDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCE--EEHQR 684 (935)
Q Consensus 612 ~~~~~~~~~LG~G~fG~Vy~~~~-----~~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~--~~~~~ 684 (935)
...+++.+.||+|+||.||+|++ .+++.||||++........+.+.+|++++++++||||+++++++. +....
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 101 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL 101 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence 34567789999999999999985 368899999998776666778999999999999999999999886 45668
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccc
Q 002336 685 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 764 (935)
Q Consensus 685 ~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~ 764 (935)
++||||+++++|.+++... ...+++..++.++.|+++||+|||+ ++|+||||||+|||++.++.+||+|||++..
T Consensus 102 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 176 (327)
T 3lxl_A 102 RLVMEYLPSGCLRDFLQRH--RARLDASRLLLYSSQICKGMEYLGS---RRCVHRDLAARNILVESEAHVKIADFGLAKL 176 (327)
T ss_dssp EEEEECCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred EEEEeecCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChhhEEECCCCCEEEccccccee
Confidence 9999999999999999742 3468999999999999999999998 8999999999999999999999999999987
Q ss_pred ccccccc--eeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCccc--------chhHHHHHHHh
Q 002336 765 AEEDLTH--ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGA--------ELNIVHWARSM 834 (935)
Q Consensus 765 ~~~~~~~--~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~--------~~~l~~~~~~~ 834 (935)
....... ......++..|+|||.+.+..++.++||||||+++|+|++|+.||....... ...........
T Consensus 177 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (327)
T 3lxl_A 177 LPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLEL 256 (327)
T ss_dssp CCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHH
T ss_pred cccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHH
Confidence 6543322 2233457888999999988889999999999999999999999986332210 00011111122
Q ss_pred hhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhhhhhccCC
Q 002336 835 IKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKGG 895 (935)
Q Consensus 835 i~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~~~~~~~~ 895 (935)
+..+.. ...+......+.+++.+||+.+|++|||++|+++.|+.+.......
T Consensus 257 ~~~~~~---------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~ 308 (327)
T 3lxl_A 257 LEEGQR---------LPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGC 308 (327)
T ss_dssp HHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-------
T ss_pred hhcccC---------CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhcCc
Confidence 222111 1112233447889999999999999999999999999887655443
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=353.18 Aligned_cols=257 Identities=23% Similarity=0.409 Sum_probs=201.1
Q ss_pred HHHhhcccccccccEEEEEEEEC-CCc----EEEEEEccCcc-hhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEE
Q 002336 613 ATNNFCKKIGKGSFGSVYYGKMK-DGK----EVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRIL 686 (935)
Q Consensus 613 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~----~vAvK~~~~~~-~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~l 686 (935)
..|++.+.||+|+||.||+|.+. +++ .||+|.+.... ....+.+.+|+.++++++||||+++++++.+.. .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~ 93 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEE
Confidence 44667889999999999999875 344 46888876433 234578999999999999999999999998764 789
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccc
Q 002336 687 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 766 (935)
Q Consensus 687 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~ 766 (935)
|+||+++|+|.+++... ...+++..++.++.|+++||+|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 94 v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 168 (327)
T 3poz_A 94 ITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp EEECCTTCBHHHHHHHS--TTSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred EEEecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence 99999999999998753 4569999999999999999999998 899999999999999999999999999998764
Q ss_pred ccccc-eeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCcccchhHHHHHHHhhhcCCeeecc
Q 002336 767 EDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 844 (935)
Q Consensus 767 ~~~~~-~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~ 844 (935)
..... ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||....... +.. .+..+...
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~~~----~~~~~~~~--- 238 (327)
T 3poz_A 169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISS----ILEKGERL--- 238 (327)
T ss_dssp TTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHH----HHHTTCCC---
T ss_pred CCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH---HHH----HHHcCCCC---
Confidence 43222 2223346889999999998899999999999999999999 999997443322 111 12222111
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhhhhh
Q 002336 845 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 891 (935)
Q Consensus 845 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~~~~ 891 (935)
..+......+.+++.+||+.+|++||+++|+++.|+.+...
T Consensus 239 ------~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 279 (327)
T 3poz_A 239 ------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp ------CCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred ------CCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence 11122234688999999999999999999999999887654
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=348.98 Aligned_cols=249 Identities=24% Similarity=0.323 Sum_probs=202.8
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcchh------hhHHHHHHHHHHHhcCCCcccccceeeeccceEEE
Q 002336 614 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSH------RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRIL 686 (935)
Q Consensus 614 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~~------~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~l 686 (935)
.|++.+.||+|+||.||+|..+ +|+.||+|++...... ..+.+.+|+.+|+.++||||+++++++.+....++
T Consensus 13 ~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 92 (361)
T 2yab_A 13 FYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVL 92 (361)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEEE
Confidence 3567889999999999999886 6899999998754322 24678999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCC----cEEEeecccc
Q 002336 687 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM----RAKVSDFGLS 762 (935)
Q Consensus 687 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~----~vkL~DFGla 762 (935)
||||+++|+|.+++.. ...+++..+..++.||+.||.|||+ .+|+||||||+|||++.++ .+||+|||++
T Consensus 93 v~e~~~gg~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a 166 (361)
T 2yab_A 93 ILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166 (361)
T ss_dssp EEECCCSCBHHHHHTT---CSCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEECCCSSC
T ss_pred EEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEeCCCCCccCEEEEecCCc
Confidence 9999999999999973 4579999999999999999999998 8999999999999998777 7999999999
Q ss_pred ccccccccceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeee
Q 002336 763 RQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVIS 842 (935)
Q Consensus 763 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~ 842 (935)
+....... .....||+.|+|||++.+..++.++||||+||++|+|++|..||...... .. .. .+..+...
T Consensus 167 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~---~~---~~-~i~~~~~~- 236 (361)
T 2yab_A 167 HEIEDGVE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ---ET---LA-NITAVSYD- 236 (361)
T ss_dssp EECCTTCC--CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH---HH---HH-HHHTTCCC-
T ss_pred eEcCCCCc--cccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH---HH---HH-HHHhcCCC-
Confidence 87654322 23356999999999999889999999999999999999999999743221 11 11 12221110
Q ss_pred cccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 843 IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 843 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
+++..... ....+.+++.+||..||++|||++|+++
T Consensus 237 -~~~~~~~~----~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 237 -FDEEFFSQ----TSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp -CCHHHHTT----SCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred -CCchhccC----CCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 11111111 1236789999999999999999999985
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-38 Score=354.08 Aligned_cols=263 Identities=27% Similarity=0.425 Sum_probs=208.9
Q ss_pred HHHHhhcccccccccEEEEEEEEC------CCcEEEEEEccCcch-hhhHHHHHHHHHHHhc-CCCcccccceeeeccc-
Q 002336 612 EATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSCS-HRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEH- 682 (935)
Q Consensus 612 ~~~~~~~~~LG~G~fG~Vy~~~~~------~g~~vAvK~~~~~~~-~~~~~~~~E~~iL~~L-~HpnIv~l~g~~~~~~- 682 (935)
...+++.+.||+|+||.||+|.+. +++.||||++..... ...+.+.+|+++++++ +||||+++++++.+.+
T Consensus 21 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~ 100 (359)
T 3vhe_A 21 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 100 (359)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred ccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCC
Confidence 345667899999999999999742 468899999976433 3456799999999999 7999999999987754
Q ss_pred eEEEEEEecCCCCHHHHhccCCC---------------------------------------------------------
Q 002336 683 QRILVYEYMHNGTLRDRLHGSVN--------------------------------------------------------- 705 (935)
Q Consensus 683 ~~~lV~E~~~~gsL~~~L~~~~~--------------------------------------------------------- 705 (935)
..++||||+++|+|.+++.....
T Consensus 101 ~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (359)
T 3vhe_A 101 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 180 (359)
T ss_dssp CCEEEEECCTTEEHHHHHHTTTTSBCSCC---------------------------------------------------
T ss_pred ceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhcc
Confidence 48999999999999999975421
Q ss_pred ------CCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccccccc-ceeecccC
Q 002336 706 ------QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT-HISSVARG 778 (935)
Q Consensus 706 ------~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~-~~~~~~~g 778 (935)
...+++..++.++.|+++||+|||+ ++|+||||||+|||++.++.+||+|||+++....... .......|
T Consensus 181 ~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~ 257 (359)
T 3vhe_A 181 APEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 257 (359)
T ss_dssp ---CTTTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEE
T ss_pred cccchhccccCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCC
Confidence 1228899999999999999999998 8999999999999999999999999999986543322 22334568
Q ss_pred CccccCCCCCCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccCCCCHHHH
Q 002336 779 TVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESI 857 (935)
Q Consensus 779 t~~y~APE~l~~~~~s~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~~~~~~~~ 857 (935)
|+.|+|||++.+..++.++||||||+++|||++ |+.||....... .. ...+..+.... . +....
T Consensus 258 t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~~----~~~~~~~~~~~-----~----~~~~~ 322 (359)
T 3vhe_A 258 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--EF----CRRLKEGTRMR-----A----PDYTT 322 (359)
T ss_dssp CGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH--HH----HHHHHHTCCCC-----C----CTTCC
T ss_pred CceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhH--HH----HHHHHcCCCCC-----C----CCCCC
Confidence 899999999988889999999999999999998 999997443321 11 11222221111 1 11122
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHHHHhhhhhhc
Q 002336 858 WRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 892 (935)
Q Consensus 858 ~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~~~~~ 892 (935)
..+.+++.+||+.+|++|||++||++.|++++...
T Consensus 323 ~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 357 (359)
T 3vhe_A 323 PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 357 (359)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHHh
Confidence 36889999999999999999999999999887643
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=349.55 Aligned_cols=254 Identities=23% Similarity=0.328 Sum_probs=205.4
Q ss_pred HHHHHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCc--chhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEE
Q 002336 610 LEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRIL 686 (935)
Q Consensus 610 l~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~--~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~l 686 (935)
.....|++.+.||+|+||.||+|.++ +|+.||+|++... .....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l 105 (362)
T 2bdw_A 26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 105 (362)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 34567888999999999999999876 6899999998653 23345678999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCC---CcEEEeeccccc
Q 002336 687 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN---MRAKVSDFGLSR 763 (935)
Q Consensus 687 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~---~~vkL~DFGla~ 763 (935)
||||+++|+|.+.+.. ...+++..+..++.||++||+|||+ ++|+||||||+|||++.+ +.+||+|||++.
T Consensus 106 v~e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~ 179 (362)
T 2bdw_A 106 VFDLVTGGELFEDIVA---REFYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAI 179 (362)
T ss_dssp EECCCCSCBHHHHHTT---CSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEESCSSTTCCEEECCCTTCB
T ss_pred EEecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEeecCcce
Confidence 9999999999998873 4568999999999999999999998 899999999999999865 459999999998
Q ss_pred cccccccceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeec
Q 002336 764 QAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISI 843 (935)
Q Consensus 764 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~ 843 (935)
....... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.. .+. ..+..+....
T Consensus 180 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~---~~~----~~i~~~~~~~- 249 (362)
T 2bdw_A 180 EVNDSEA--WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH---RLY----AQIKAGAYDY- 249 (362)
T ss_dssp CCTTCCS--CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHH----HHHHHTCCCC-
T ss_pred EecCCcc--cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH---HHH----HHHHhCCCCC-
Confidence 7654322 22356999999999999989999999999999999999999999743221 111 1222222110
Q ss_pred ccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002336 844 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 884 (935)
Q Consensus 844 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~ 884 (935)
..+ .. ......+.+++.+||+.||++||+++|+++.
T Consensus 250 ~~~-~~----~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 250 PSP-EW----DTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp CTT-GG----GGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred Ccc-cc----cCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000 00 1123468899999999999999999998754
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=338.46 Aligned_cols=247 Identities=28% Similarity=0.387 Sum_probs=193.7
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcch--------------------------hhhHHHHHHHHHHHhc
Q 002336 614 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--------------------------HRTQQFVTEVALLSRI 666 (935)
Q Consensus 614 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~--------------------------~~~~~~~~E~~iL~~L 666 (935)
.|++.+.||+|+||.||+|... +++.||||++..... ...+.+.+|+++++++
T Consensus 14 ~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 93 (298)
T 2zv2_A 14 QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKL 93 (298)
T ss_dssp TEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHTC
T ss_pred ceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhC
Confidence 3567889999999999999875 688999999865321 1235688999999999
Q ss_pred CCCcccccceeeec--cceEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCC
Q 002336 667 HHRNLVPLIGYCEE--EHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSS 744 (935)
Q Consensus 667 ~HpnIv~l~g~~~~--~~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~ 744 (935)
+||||+++++++.+ ....++||||+++++|.+++. ...+++..+..++.|+++||+|||+ ++|+||||||+
T Consensus 94 ~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~ 166 (298)
T 2zv2_A 94 DHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT----LKPLSEDQARFYFQDLIKGIEYLHY---QKIIHRDIKPS 166 (298)
T ss_dssp CCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC----SSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGG
T ss_pred CCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHH
Confidence 99999999999976 568899999999999988654 4579999999999999999999998 89999999999
Q ss_pred CccccCCCcEEEeeccccccccccccceeecccCCccccCCCCCCCCC---CCchhHHHHHHHHHHHHHhCCCCCCccCc
Q 002336 745 NILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQ---LTEKSDVYSFGVVLLELISGKKPVSVEDF 821 (935)
Q Consensus 745 NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~---~s~ksDVwS~Gvil~eLltG~~Pf~~~~~ 821 (935)
|||++.++.+||+|||+++........ .....||+.|+|||.+.+.. .+.++||||||+++|||++|+.||.....
T Consensus 167 Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 245 (298)
T 2zv2_A 167 NLLVGEDGHIKIADFGVSNEFKGSDAL-LSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERI 245 (298)
T ss_dssp GEEECTTSCEEECCCTTCEECSSSSCE-ECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred HEEECCCCCEEEecCCCcccccccccc-ccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccH
Confidence 999999999999999999876543222 23456899999999987654 47899999999999999999999974322
Q ss_pred ccchhHHHHHHHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 822 GAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 822 ~~~~~l~~~~~~~i~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
. .. ...+....... + .. ......+.+++.+||+.||++||+++|+++
T Consensus 246 ~------~~-~~~~~~~~~~~---~-~~----~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 246 M------CL-HSKIKSQALEF---P-DQ----PDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp H------HH-HHHHHHCCCCC---C-SS----SCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred H------HH-HHHHhcccCCC---C-Cc----cccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 1 11 11222211110 0 00 112236889999999999999999999864
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-38 Score=337.45 Aligned_cols=249 Identities=31% Similarity=0.432 Sum_probs=192.3
Q ss_pred HHhhcccccccccEEEEEEEECCCcEEEEEEccCcchh----hhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEE
Q 002336 614 TNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSH----RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 689 (935)
Q Consensus 614 ~~~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~~~~~~~~----~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E 689 (935)
.+++.+.||+|+||.||+|.+. ++.||||++...... ..+.+.+|+++++.++||||+++++++.+.+..++|||
T Consensus 8 ~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (271)
T 3dtc_A 8 ELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVME 86 (271)
T ss_dssp SEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEE
T ss_pred heeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEE
Confidence 3566789999999999999986 899999998654322 24678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCc---eEecCCCCCCccccC--------CCcEEEee
Q 002336 690 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG---IIHRDVKSSNILLDI--------NMRAKVSD 758 (935)
Q Consensus 690 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~---ivH~DLkp~NILld~--------~~~vkL~D 758 (935)
|+++++|.+++. ...+++..++.++.|+++||+|||+ ++ |+||||||+|||++. ++.+||+|
T Consensus 87 ~~~~~~L~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~---~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~D 159 (271)
T 3dtc_A 87 FARGGPLNRVLS----GKRIPPDILVNWAVQIARGMNYLHD---EAIVPIIHRDLKSSNILILQKVENGDLSNKILKITD 159 (271)
T ss_dssp CCTTEEHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHH---SSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECC
T ss_pred cCCCCCHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHh---CCCCceeecCCchHHEEEecccccccccCcceEEcc
Confidence 999999999986 3568999999999999999999998 66 999999999999986 77899999
Q ss_pred ccccccccccccceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcC
Q 002336 759 FGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG 838 (935)
Q Consensus 759 FGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~ 838 (935)
||++........ ....|++.|+|||.+.+..++.++||||||+++++|++|+.||....... . .......
T Consensus 160 fg~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---~---~~~~~~~- 229 (271)
T 3dtc_A 160 FGLAREWHRTTK---MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLA---V---AYGVAMN- 229 (271)
T ss_dssp CCC----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHH---H---HHHHHTS-
T ss_pred CCcccccccccc---cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---H---HHhhhcC-
Confidence 999986544322 23458999999999988889999999999999999999999997432211 1 1111111
Q ss_pred CeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhh
Q 002336 839 DVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 888 (935)
Q Consensus 839 ~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~ 888 (935)
... ...+......+.+++.+||+.+|++|||++|+++.|+++
T Consensus 230 ~~~--------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 230 KLA--------LPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp CCC--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred CCC--------CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 110 011122234688999999999999999999999999763
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=353.60 Aligned_cols=266 Identities=26% Similarity=0.419 Sum_probs=208.8
Q ss_pred HHHHHHhhcccccccccEEEEEEEE------CCCcEEEEEEccCcc-hhhhHHHHHHHHHHHhc-CCCcccccceeeecc
Q 002336 610 LEEATNNFCKKIGKGSFGSVYYGKM------KDGKEVAVKIMADSC-SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEE 681 (935)
Q Consensus 610 l~~~~~~~~~~LG~G~fG~Vy~~~~------~~g~~vAvK~~~~~~-~~~~~~~~~E~~iL~~L-~HpnIv~l~g~~~~~ 681 (935)
+....+++.+.||+|+||.||+|.+ .+++.||+|++.... ....+.+.+|+.+++++ +||||+++++++...
T Consensus 42 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 121 (344)
T 1rjb_A 42 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS 121 (344)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeC
Confidence 3445667789999999999999986 246689999987542 23457899999999999 899999999999999
Q ss_pred ceEEEEEEecCCCCHHHHhccCCC--------------------CCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCC
Q 002336 682 HQRILVYEYMHNGTLRDRLHGSVN--------------------QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDV 741 (935)
Q Consensus 682 ~~~~lV~E~~~~gsL~~~L~~~~~--------------------~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DL 741 (935)
+..++||||+++|+|.+++..... ...+++..++.++.|+++||+|||+ ++|+||||
T Consensus 122 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Di 198 (344)
T 1rjb_A 122 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDL 198 (344)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEETTC
T ss_pred CccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCC
Confidence 999999999999999999975422 1348999999999999999999998 89999999
Q ss_pred CCCCccccCCCcEEEeeccccccccccccc-eeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHh-CCCCCCcc
Q 002336 742 KSSNILLDINMRAKVSDFGLSRQAEEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVE 819 (935)
Q Consensus 742 kp~NILld~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLlt-G~~Pf~~~ 819 (935)
||+|||++.++.+||+|||++......... ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 199 kp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 278 (344)
T 1rjb_A 199 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 278 (344)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred ChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccC
Confidence 999999999999999999999876443322 2233457889999999988889999999999999999998 99999744
Q ss_pred CcccchhHHHHHHHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhhhhhcc
Q 002336 820 DFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 893 (935)
Q Consensus 820 ~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~~~~~~ 893 (935)
.... .... .+..+... ..+......+.+++.+||+.+|++||+++||++.|+.+.....
T Consensus 279 ~~~~--~~~~----~~~~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~ 337 (344)
T 1rjb_A 279 PVDA--NFYK----LIQNGFKM---------DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAE 337 (344)
T ss_dssp CCSH--HHHH----HHHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC----
T ss_pred CcHH--HHHH----HHhcCCCC---------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHH
Confidence 3221 1111 22222110 1111223468899999999999999999999999998876544
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-38 Score=341.12 Aligned_cols=259 Identities=26% Similarity=0.439 Sum_probs=209.5
Q ss_pred HHHhhcccccccccEEEEEEEECCCcEEEEEEccCcchhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEecC
Q 002336 613 ATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 692 (935)
Q Consensus 613 ~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~~ 692 (935)
..+++.+.||+|+||.||+|.+.+++.||+|++.... ...+.+.+|++++++++||||+++++++.. +..++||||++
T Consensus 13 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~ 90 (279)
T 1qpc_A 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYME 90 (279)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCT
T ss_pred HhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEecCC
Confidence 4567789999999999999999888899999987543 235679999999999999999999999874 45899999999
Q ss_pred CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccccce
Q 002336 693 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 772 (935)
Q Consensus 693 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~~ 772 (935)
+++|.+++... ....+++..++.++.|+++||+|||+ ++|+||||||+||++++++.+||+|||++..........
T Consensus 91 ~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 166 (279)
T 1qpc_A 91 NGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA 166 (279)
T ss_dssp TCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEEC
T ss_pred CCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHhhEEEcCCCCEEECCCcccccccCccccc
Confidence 99999998742 12368999999999999999999998 899999999999999999999999999998765443333
Q ss_pred eecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccCC
Q 002336 773 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 851 (935)
Q Consensus 773 ~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~~ 851 (935)
.....++..|+|||.+.+..++.++||||||++++||++ |+.||...... .... .+..+.. ...
T Consensus 167 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~~~----~~~~~~~-----~~~--- 231 (279)
T 1qpc_A 167 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP---EVIQ----NLERGYR-----MVR--- 231 (279)
T ss_dssp CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HHHH----HHHTTCC-----CCC---
T ss_pred ccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHH---HHHH----HHhcccC-----CCC---
Confidence 333456788999999988889999999999999999999 99999743221 1111 1222211 011
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhhhhhcc
Q 002336 852 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 893 (935)
Q Consensus 852 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~~~~~~ 893 (935)
+......+.+++.+|++.+|++|||++++++.|+++.....
T Consensus 232 -~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 272 (279)
T 1qpc_A 232 -PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATE 272 (279)
T ss_dssp -CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred -cccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhcc
Confidence 11223468899999999999999999999999999876543
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=350.63 Aligned_cols=263 Identities=25% Similarity=0.392 Sum_probs=208.6
Q ss_pred hhcccccccccEEEEEEEEC-----CCcEEEEEEccCcch-hhhHHHHHHHHHHHhcCCCcccccceeeec--cceEEEE
Q 002336 616 NFCKKIGKGSFGSVYYGKMK-----DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEE--EHQRILV 687 (935)
Q Consensus 616 ~~~~~LG~G~fG~Vy~~~~~-----~g~~vAvK~~~~~~~-~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~--~~~~~lV 687 (935)
++.+.||+|+||.||++.+. +++.||||++..... ...+.+.+|++++++++||||+++++++.+ ....++|
T Consensus 34 ~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 113 (318)
T 3lxp_A 34 KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLV 113 (318)
T ss_dssp EEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEE
T ss_pred hhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEE
Confidence 67889999999999998753 588999999976533 345679999999999999999999999977 4678999
Q ss_pred EEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccc
Q 002336 688 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 767 (935)
Q Consensus 688 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~ 767 (935)
|||+++|+|.+++.. ..+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++.....
T Consensus 114 ~e~~~~~~L~~~l~~----~~~~~~~~~~i~~~l~~~l~~LH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 186 (318)
T 3lxp_A 114 MEYVPLGSLRDYLPR----HSIGLAQLLLFAQQICEGMAYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 186 (318)
T ss_dssp ECCCTTCBHHHHGGG----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGGGCEECCT
T ss_pred EecccCCcHHHHHhh----CCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEEcCCCCEEECCccccccccc
Confidence 999999999999974 348999999999999999999998 8999999999999999999999999999987654
Q ss_pred cccc--eeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCccc--------chhHHHHHHHhhhc
Q 002336 768 DLTH--ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGA--------ELNIVHWARSMIKK 837 (935)
Q Consensus 768 ~~~~--~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~--------~~~l~~~~~~~i~~ 837 (935)
.... ......++..|+|||.+.+..++.++||||||+++|+|++|+.||....... ...........+..
T Consensus 187 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (318)
T 3lxp_A 187 GHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLER 266 (318)
T ss_dssp TCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHT
T ss_pred cccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhc
Confidence 3321 2233457888999999988889999999999999999999999986332110 00011111222222
Q ss_pred CCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhhhhhccC
Q 002336 838 GDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKG 894 (935)
Q Consensus 838 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~~~~~~~ 894 (935)
+.. ...+......+.+++.+||+.+|++|||++|+++.|+.+......
T Consensus 267 ~~~---------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~ 314 (318)
T 3lxp_A 267 GER---------LPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQG 314 (318)
T ss_dssp TCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC
T ss_pred ccC---------CCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhcc
Confidence 211 111222334788999999999999999999999999988765543
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-38 Score=346.99 Aligned_cols=263 Identities=29% Similarity=0.449 Sum_probs=212.1
Q ss_pred HHHHhhcccccccccEEEEEEEE------CCCcEEEEEEccCcch-hhhHHHHHHHHHHHhc-CCCcccccceeeeccce
Q 002336 612 EATNNFCKKIGKGSFGSVYYGKM------KDGKEVAVKIMADSCS-HRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQ 683 (935)
Q Consensus 612 ~~~~~~~~~LG~G~fG~Vy~~~~------~~g~~vAvK~~~~~~~-~~~~~~~~E~~iL~~L-~HpnIv~l~g~~~~~~~ 683 (935)
...+.+.+.||+|+||.||+|.+ .+++.||+|++..... ...+.+.+|+.+++++ +||||+++++++...+.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 101 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence 34567789999999999999985 2468899999976433 3457799999999999 89999999999999999
Q ss_pred EEEEEEecCCCCHHHHhccCCC---------------CCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccc
Q 002336 684 RILVYEYMHNGTLRDRLHGSVN---------------QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL 748 (935)
Q Consensus 684 ~~lV~E~~~~gsL~~~L~~~~~---------------~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILl 748 (935)
.++||||+++|+|.+++..... ...+++..+++++.|+++||+|||+ ++|+||||||+||++
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~ 178 (313)
T 1t46_A 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILL 178 (313)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEE
T ss_pred cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccceEEE
Confidence 9999999999999999875421 2358999999999999999999998 899999999999999
Q ss_pred cCCCcEEEeeccccccccccccc-eeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCcccchh
Q 002336 749 DINMRAKVSDFGLSRQAEEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELN 826 (935)
Q Consensus 749 d~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~ 826 (935)
+.++.+||+|||+++........ ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||....... .
T Consensus 179 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~ 256 (313)
T 1t46_A 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS--K 256 (313)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH--H
T ss_pred cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchh--H
Confidence 99999999999999876544322 2233457889999999988889999999999999999999 999997443221 1
Q ss_pred HHHHHHHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhhhhhc
Q 002336 827 IVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 892 (935)
Q Consensus 827 l~~~~~~~i~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~~~~~ 892 (935)
... .+..+.. .. .+......+.+++.+||+.+|++|||++|+++.|+++....
T Consensus 257 ~~~----~~~~~~~-----~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 309 (313)
T 1t46_A 257 FYK----MIKEGFR-----ML----SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES 309 (313)
T ss_dssp HHH----HHHHTCC-----CC----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred HHH----HhccCCC-----CC----CcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHh
Confidence 111 1211111 00 11122346889999999999999999999999999887643
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=345.83 Aligned_cols=249 Identities=24% Similarity=0.323 Sum_probs=181.0
Q ss_pred ccccccccEEEEEEEEC-CCcEEEEEEccCcchhhhHHHHHHHHHHHhcC-CCcccccceeeeccceEEEEEEecCCCCH
Q 002336 619 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQRILVYEYMHNGTL 696 (935)
Q Consensus 619 ~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~-HpnIv~l~g~~~~~~~~~lV~E~~~~gsL 696 (935)
+.||+|+||.||+|.+. +++.||||++... ....+.+|+.+++.+. ||||+++++++.+....++||||+++|+|
T Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L 93 (325)
T 3kn6_A 17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGEL 93 (325)
T ss_dssp CCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcH
Confidence 68999999999999886 6899999998643 3456788999999997 99999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCC---cEEEeecccccccccccccee
Q 002336 697 RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM---RAKVSDFGLSRQAEEDLTHIS 773 (935)
Q Consensus 697 ~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~---~vkL~DFGla~~~~~~~~~~~ 773 (935)
.+++.. ...+++.++..++.|+++||+|||+ ++|+||||||+|||++.++ .+||+|||+++........ .
T Consensus 94 ~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~-~ 166 (325)
T 3kn6_A 94 FERIKK---KKHFSETEASYIMRKLVSAVSHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP-L 166 (325)
T ss_dssp HHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC------
T ss_pred HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCc-c
Confidence 999984 4679999999999999999999998 8999999999999997665 8999999999865433222 2
Q ss_pred ecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccCCCC
Q 002336 774 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVK 853 (935)
Q Consensus 774 ~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~~~~ 853 (935)
....||+.|+|||.+.+..++.++||||||+++|+|++|+.||...+..........+...+..+.... .. ...
T Consensus 167 ~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~--~~----~~~ 240 (325)
T 3kn6_A 167 KTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSF--EG----EAW 240 (325)
T ss_dssp -----------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCC--CS----HHH
T ss_pred cccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCC--Cc----ccc
Confidence 334589999999999999999999999999999999999999985443211111222233333332210 00 000
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 854 IESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 854 ~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
......+.+++.+||+.||++|||++|+++
T Consensus 241 ~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 241 KNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp HTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred cCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 112346889999999999999999999864
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=359.17 Aligned_cols=266 Identities=27% Similarity=0.450 Sum_probs=211.6
Q ss_pred hHHHHHHhhcccccccccEEEEEEEEC------CCcEEEEEEccCcc-hhhhHHHHHHHHHHHhcCCCcccccceeeecc
Q 002336 609 ELEEATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE 681 (935)
Q Consensus 609 ~l~~~~~~~~~~LG~G~fG~Vy~~~~~------~g~~vAvK~~~~~~-~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~ 681 (935)
++....+++.+.||+|+||.||+|.+. +++.||||++.... ......+.+|+.++++++||||+++++++...
T Consensus 67 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 146 (367)
T 3l9p_A 67 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS 146 (367)
T ss_dssp BCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence 444556778899999999999999853 46789999987543 34456789999999999999999999999999
Q ss_pred ceEEEEEEecCCCCHHHHhccCC----CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCC---cE
Q 002336 682 HQRILVYEYMHNGTLRDRLHGSV----NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM---RA 754 (935)
Q Consensus 682 ~~~~lV~E~~~~gsL~~~L~~~~----~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~---~v 754 (935)
...++||||+++|+|.+++.... ....+++..++.++.|+++||+|||+ ++|+||||||+|||++.++ .+
T Consensus 147 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~~~~ 223 (367)
T 3l9p_A 147 LPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVA 223 (367)
T ss_dssp SSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCE
T ss_pred CCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEEecCCCCceE
Confidence 99999999999999999987532 22468999999999999999999998 8999999999999999555 59
Q ss_pred EEeeccccccccccc-cceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCcccchhHHHHHH
Q 002336 755 KVSDFGLSRQAEEDL-THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWAR 832 (935)
Q Consensus 755 kL~DFGla~~~~~~~-~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~ 832 (935)
||+|||+++...... ........||+.|+|||.+.+..++.++|||||||++|||++ |+.||...... ...
T Consensus 224 kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~---~~~---- 296 (367)
T 3l9p_A 224 KIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ---EVL---- 296 (367)
T ss_dssp EECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---HHH----
T ss_pred EECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH---HHH----
Confidence 999999997643221 122233457899999999988899999999999999999998 99999743221 111
Q ss_pred HhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhhhhhcc
Q 002336 833 SMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 893 (935)
Q Consensus 833 ~~i~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~~~~~~ 893 (935)
..+..+.... .+......+.+++.+||+.+|++||+++||++.|+.+.....
T Consensus 297 ~~i~~~~~~~---------~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~~ 348 (367)
T 3l9p_A 297 EFVTSGGRMD---------PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPD 348 (367)
T ss_dssp HHHHTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHH
T ss_pred HHHHcCCCCC---------CCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhChh
Confidence 1222221111 111223368899999999999999999999999998876543
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-37 Score=334.61 Aligned_cols=252 Identities=31% Similarity=0.520 Sum_probs=201.1
Q ss_pred HHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcchhh-------hHHHHHHHHHHHhcCCCcccccceeeeccceE
Q 002336 613 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHR-------TQQFVTEVALLSRIHHRNLVPLIGYCEEEHQR 684 (935)
Q Consensus 613 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~~~-------~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~ 684 (935)
..+++.+.||+|+||.||+|.+. +++.||+|++....... .+.+.+|++++++++||||+++++++.+..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-- 96 (287)
T 4f0f_A 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-- 96 (287)
T ss_dssp TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--
T ss_pred ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--
Confidence 44667889999999999999875 78999999986432211 167899999999999999999999997665
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCc--eEecCCCCCCccccCCCc-----EEEe
Q 002336 685 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG--IIHRDVKSSNILLDINMR-----AKVS 757 (935)
Q Consensus 685 ~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~--ivH~DLkp~NILld~~~~-----vkL~ 757 (935)
++||||+++|+|.+.+.. ....+++..++.++.|+++||+|||+ ++ |+||||||+|||++.++. +||+
T Consensus 97 ~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~l~~~l~~lH~---~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~ 171 (287)
T 4f0f_A 97 RMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIALGIEYMQN---QNPPIVHRDLRSPNIFLQSLDENAPVCAKVA 171 (287)
T ss_dssp EEEEECCTTCBHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCSCCSGGGEEESCCCTTCSCCEEEC
T ss_pred eEEEEecCCCCHHHHHhc--ccCCccHHHHHHHHHHHHHHHHHHHh---CCCCeecCCCCcceEEEeccCCCCceeEEeC
Confidence 699999999999998864 34579999999999999999999998 78 999999999999988776 9999
Q ss_pred eccccccccccccceeecccCCccccCCCCC--CCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhh
Q 002336 758 DFGLSRQAEEDLTHISSVARGTVGYLDPEYY--GNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMI 835 (935)
Q Consensus 758 DFGla~~~~~~~~~~~~~~~gt~~y~APE~l--~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i 835 (935)
|||+++..... .....|++.|+|||.+ ....++.++||||+|+++|||++|+.||........ .......
T Consensus 172 Dfg~~~~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~----~~~~~~~ 243 (287)
T 4f0f_A 172 DFGLSQQSVHS----VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKI----KFINMIR 243 (287)
T ss_dssp CCTTCBCCSSC----EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHH----HHHHHHH
T ss_pred CCCcccccccc----ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHH----HHHHHHh
Confidence 99999754432 2335689999999998 455678999999999999999999999974333211 1111111
Q ss_pred hcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhh
Q 002336 836 KKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 888 (935)
Q Consensus 836 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~ 888 (935)
..+. .+.+ +......+.+++.+||+.||++|||++|+++.|+++
T Consensus 244 ~~~~-----~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 244 EEGL-----RPTI----PEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp HSCC-----CCCC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred ccCC-----CCCC----CcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 1111 1111 122234688999999999999999999999999864
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=344.63 Aligned_cols=250 Identities=22% Similarity=0.327 Sum_probs=197.5
Q ss_pred HHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc-hhhhHHHHHHHHHHHhcCCCcccccceeeeccc--------
Q 002336 613 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH-------- 682 (935)
Q Consensus 613 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~-~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~-------- 682 (935)
..|++.+.||+|+||.||+|++. +|+.||||++.... ....+.+.+|+++|++++||||+++++++.+..
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 85 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEM 85 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhh
Confidence 34667899999999999999987 79999999986533 334578999999999999999999999885543
Q ss_pred -------------------------------------------------eEEEEEEecCCCCHHHHhccCCCCCCCCHHH
Q 002336 683 -------------------------------------------------QRILVYEYMHNGTLRDRLHGSVNQKPLDWLT 713 (935)
Q Consensus 683 -------------------------------------------------~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~ 713 (935)
..++||||+++++|.+++.........++..
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~ 165 (332)
T 3qd2_B 86 DEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGV 165 (332)
T ss_dssp HC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHH
T ss_pred hhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHH
Confidence 3799999999999999998665555567778
Q ss_pred HHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccccccc-----------ceeecccCCccc
Q 002336 714 RLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT-----------HISSVARGTVGY 782 (935)
Q Consensus 714 ~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~-----------~~~~~~~gt~~y 782 (935)
++.++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++....... .......||+.|
T Consensus 166 ~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 242 (332)
T 3qd2_B 166 CLHIFIQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242 (332)
T ss_dssp HHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGG
T ss_pred HHHHHHHHHHHHHHHHh---CCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCc
Confidence 99999999999999998 8999999999999999999999999999987654321 112334689999
Q ss_pred cCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccCCCCHHHHHHHHH
Q 002336 783 LDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAE 862 (935)
Q Consensus 783 ~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~~~~~~~~~~l~~ 862 (935)
+|||.+.+..++.++||||||+++|||++|..|+. .... ............. .......+.+
T Consensus 243 ~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~--------~~~~-~~~~~~~~~~~~~---------~~~~~~~~~~ 304 (332)
T 3qd2_B 243 MSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM--------ERVR-IITDVRNLKFPLL---------FTQKYPQEHM 304 (332)
T ss_dssp SCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHH--------HHHH-HHHHHHTTCCCHH---------HHHHCHHHHH
T ss_pred cChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChh--------HHHH-HHHHhhccCCCcc---------cccCChhHHH
Confidence 99999988899999999999999999999877653 1111 1111111111110 1122346789
Q ss_pred HHHHccccCCCCCCCHHHHHH
Q 002336 863 VAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 863 li~~Cl~~dP~~RPs~~ev~~ 883 (935)
++.+||+.||++|||++|+++
T Consensus 305 li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 305 MVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp HHHHHHCSSGGGSCCHHHHHH
T ss_pred HHHHHccCCCCcCCCHHHHhh
Confidence 999999999999999999986
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-38 Score=347.02 Aligned_cols=264 Identities=26% Similarity=0.412 Sum_probs=196.1
Q ss_pred HHHHHhhcccccccccEEEEEEEECCC----cEEEEEEccCc--chhhhHHHHHHHHHHHhcCCCcccccceeeeccceE
Q 002336 611 EEATNNFCKKIGKGSFGSVYYGKMKDG----KEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQR 684 (935)
Q Consensus 611 ~~~~~~~~~~LG~G~fG~Vy~~~~~~g----~~vAvK~~~~~--~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~ 684 (935)
....|++.+.||+|+||.||+|.+... ..||||+++.. .....+.+.+|++++++++||||+++++++......
T Consensus 21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (323)
T 3qup_A 21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK 100 (323)
T ss_dssp C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence 345677789999999999999987643 27999998754 334567899999999999999999999999876655
Q ss_pred ------EEEEEecCCCCHHHHhccCC---CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEE
Q 002336 685 ------ILVYEYMHNGTLRDRLHGSV---NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAK 755 (935)
Q Consensus 685 ------~lV~E~~~~gsL~~~L~~~~---~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vk 755 (935)
++||||+++|+|.+++.... ....+++..++.++.|+++||+|||+ ++|+||||||+|||++.++.+|
T Consensus 101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~ivH~Dikp~NIli~~~~~~k 177 (323)
T 3qup_A 101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSS---RNFIHRDLAARNCMLAEDMTVC 177 (323)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEE
T ss_pred cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHc---CCcccCCCCcceEEEcCCCCEE
Confidence 99999999999999886432 22368999999999999999999998 8999999999999999999999
Q ss_pred Eeeccccccccccccc-eeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCcccchhHHHHHHH
Q 002336 756 VSDFGLSRQAEEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARS 833 (935)
Q Consensus 756 L~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~ 833 (935)
|+|||+++........ ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||....... ...
T Consensus 178 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~---~~~---- 250 (323)
T 3qup_A 178 VADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE---IYN---- 250 (323)
T ss_dssp ECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHH----
T ss_pred EeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHH---HHH----
Confidence 9999999875443221 1223346788999999988889999999999999999999 999997433321 111
Q ss_pred hhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhhhhhcc
Q 002336 834 MIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 893 (935)
Q Consensus 834 ~i~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~~~~~~ 893 (935)
.+..+... ..+......+.+++.+||+.||++|||+.|+++.|++++.-..
T Consensus 251 ~~~~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~ 301 (323)
T 3qup_A 251 YLIGGNRL---------KQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLS 301 (323)
T ss_dssp HHHTTCCC---------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred HHhcCCCC---------CCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhh
Confidence 11111111 1112223468899999999999999999999999999887544
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=353.02 Aligned_cols=248 Identities=22% Similarity=0.346 Sum_probs=198.7
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc---hhhhHHHHHHHHHHHhc-CCCcccccceeeeccceEEEEE
Q 002336 614 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVY 688 (935)
Q Consensus 614 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~iL~~L-~HpnIv~l~g~~~~~~~~~lV~ 688 (935)
.+++.+.||+|+||.||+|+++ +++.||+|+++... ....+.+.+|..++.++ +||||+++++++.+.+..++||
T Consensus 53 ~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV~ 132 (396)
T 4dc2_A 53 DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVI 132 (396)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEE
T ss_pred HcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEEE
Confidence 3567889999999999999986 57889999987542 22345688999999887 8999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccccc
Q 002336 689 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 768 (935)
Q Consensus 689 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~ 768 (935)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 133 E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~ 206 (396)
T 4dc2_A 133 EYVNGGDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 206 (396)
T ss_dssp ECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EcCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEECCCCCEEEeecceeeecccC
Confidence 99999999999874 4569999999999999999999998 89999999999999999999999999999863322
Q ss_pred ccceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCccc--chhHHHHHHHhhhcCCeeecccc
Q 002336 769 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGA--ELNIVHWARSMIKKGDVISIVDP 846 (935)
Q Consensus 769 ~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~--~~~l~~~~~~~i~~~~~~~~~d~ 846 (935)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+ .....+.+.+.+..+..
T Consensus 207 ~~-~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~------ 279 (396)
T 4dc2_A 207 GD-TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI------ 279 (396)
T ss_dssp TC-CBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCC------
T ss_pred CC-ccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcccc------
Confidence 21 2334569999999999999999999999999999999999999997433221 11122223333333221
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCH
Q 002336 847 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKM 878 (935)
Q Consensus 847 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~ 878 (935)
. .+......+.+++.+||+.||++||++
T Consensus 280 ~----~p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 280 R----IPRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp C----CCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred C----CCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 1 111223367899999999999999985
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=349.86 Aligned_cols=255 Identities=23% Similarity=0.300 Sum_probs=203.6
Q ss_pred HHHHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc-----hhhhHHHHHHHHHHHhcCCCcccccceeeeccceE
Q 002336 611 EEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-----SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQR 684 (935)
Q Consensus 611 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~-----~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~ 684 (935)
....|++.+.||+|+||.||+|.+. +|+.||||++.... ....+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 101 (351)
T 3c0i_A 22 FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGML 101 (351)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred cccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 4567888999999999999999876 68999999985321 11346789999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhccCC-CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCc---EEEeecc
Q 002336 685 ILVYEYMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMR---AKVSDFG 760 (935)
Q Consensus 685 ~lV~E~~~~gsL~~~L~~~~-~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~---vkL~DFG 760 (935)
++||||+++++|.+.+.... .+..+++..+..++.|+++||+|||+ ++|+||||||+|||++.++. +||+|||
T Consensus 102 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg 178 (351)
T 3c0i_A 102 YMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFG 178 (351)
T ss_dssp EEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECSSSTTCCEEECCCT
T ss_pred EEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChHHeEEecCCCCCcEEEecCc
Confidence 99999999999988775432 34468999999999999999999998 89999999999999986654 9999999
Q ss_pred ccccccccccceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCe
Q 002336 761 LSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV 840 (935)
Q Consensus 761 la~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~ 840 (935)
+++....... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.... ..+. ..+..+..
T Consensus 179 ~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~----~~~~----~~i~~~~~ 249 (351)
T 3c0i_A 179 VAIQLGESGL-VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK----ERLF----EGIIKGKY 249 (351)
T ss_dssp TCEECCTTSC-BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH----HHHH----HHHHHTCC
T ss_pred ceeEecCCCe-eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH----HHHH----HHHHcCCC
Confidence 9987654322 1234569999999999998899999999999999999999999997421 1111 11111211
Q ss_pred eecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 841 ISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 841 ~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
. ..+..... ....+.+++.+||+.||++|||+.|+++
T Consensus 250 ~--~~~~~~~~----~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 250 K--MNPRQWSH----ISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp C--CCHHHHTT----SCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred C--CCcccccc----CCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0 01111111 1236889999999999999999999976
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=349.73 Aligned_cols=269 Identities=17% Similarity=0.236 Sum_probs=207.0
Q ss_pred HHHhhcccccccccEEEEEEEECC------CcEEEEEEccCcchhh-----------hHHHHHHHHHHHhcCCCcccccc
Q 002336 613 ATNNFCKKIGKGSFGSVYYGKMKD------GKEVAVKIMADSCSHR-----------TQQFVTEVALLSRIHHRNLVPLI 675 (935)
Q Consensus 613 ~~~~~~~~LG~G~fG~Vy~~~~~~------g~~vAvK~~~~~~~~~-----------~~~~~~E~~iL~~L~HpnIv~l~ 675 (935)
..|++.+.||+|+||.||+|.+.. ++.||||++....... ...+..|+..+..++||||++++
T Consensus 35 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~ 114 (364)
T 3op5_A 35 AAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYW 114 (364)
T ss_dssp CEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEE
T ss_pred CeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEE
Confidence 346678999999999999998864 4789999986543211 12344566677788899999999
Q ss_pred eeeecc----ceEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCcccc--
Q 002336 676 GYCEEE----HQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD-- 749 (935)
Q Consensus 676 g~~~~~----~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld-- 749 (935)
+++... ...++||||+ +++|.+++.. ....+++..++.++.|++.||+|||+ ++|+||||||+|||++
T Consensus 115 ~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~--~~~~l~~~~~~~i~~qi~~~l~~lH~---~~iiHrDlkp~Nill~~~ 188 (364)
T 3op5_A 115 GSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA--NAKRFSRKTVLQLSLRILDILEYIHE---HEYVHGDIKASNLLLNYK 188 (364)
T ss_dssp EEEEEEETTEEEEEEEEECE-EEEHHHHHHH--TTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEESS
T ss_pred eeeeeccCCcceEEEEEeCC-CCCHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHH---CCeEEecCCHHHEEEecC
Confidence 998764 4589999999 9999999975 24679999999999999999999998 8999999999999999
Q ss_pred CCCcEEEeeccccccccccccce------eecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCccc
Q 002336 750 INMRAKVSDFGLSRQAEEDLTHI------SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGA 823 (935)
Q Consensus 750 ~~~~vkL~DFGla~~~~~~~~~~------~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~ 823 (935)
.++.+||+|||+++......... .....||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 189 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~- 267 (364)
T 3op5_A 189 NPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKD- 267 (364)
T ss_dssp CTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC-
T ss_pred CCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccC-
Confidence 88999999999998764432211 12334999999999999989999999999999999999999999743222
Q ss_pred chhHHHHHHHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhhhhhcc
Q 002336 824 ELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 893 (935)
Q Consensus 824 ~~~l~~~~~~~i~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~~~~~~ 893 (935)
.....+...... ..+..++++.+... ..+..+.+++.+||+.+|++||++++|++.|+++.....
T Consensus 268 -~~~~~~~~~~~~-~~~~~~~~~~~~~~---~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~ 332 (364)
T 3op5_A 268 -PKYVRDSKIRYR-ENIASLMDKCFPAA---NAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIG 332 (364)
T ss_dssp -HHHHHHHHHHHH-HCHHHHHHHHSCTT---CCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred -HHHHHHHHHHhh-hhHHHHHHHhcccc---cCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcC
Confidence 222222222221 12333344333211 112368899999999999999999999999998876543
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-37 Score=349.93 Aligned_cols=260 Identities=21% Similarity=0.297 Sum_probs=201.2
Q ss_pred HHhhccccccc--ccEEEEEEEEC-CCcEEEEEEccCcc--hhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEE
Q 002336 614 TNNFCKKIGKG--SFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 688 (935)
Q Consensus 614 ~~~~~~~LG~G--~fG~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~ 688 (935)
.|++.+.||+| +||.||+|+.. +|+.||||++.... ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 26 ~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 105 (389)
T 3gni_B 26 CYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVT 105 (389)
T ss_dssp GEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEEE
Confidence 35678999999 99999999987 69999999986542 334567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccccc
Q 002336 689 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 768 (935)
Q Consensus 689 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~ 768 (935)
||+++|+|.+++... ....+++..+..++.||++||+|||+ ++|+||||||+|||++.++.+||+|||.+......
T Consensus 106 e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~ 181 (389)
T 3gni_B 106 SFMAYGSAKDLICTH-FMDGMNELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMISH 181 (389)
T ss_dssp ECCTTCBHHHHHHHT-CTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCGGGCEECEET
T ss_pred EccCCCCHHHHHhhh-cccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEcccccceeeccc
Confidence 999999999998754 23569999999999999999999998 89999999999999999999999999988654322
Q ss_pred cc------ceeecccCCccccCCCCCCC--CCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCe
Q 002336 769 LT------HISSVARGTVGYLDPEYYGN--QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV 840 (935)
Q Consensus 769 ~~------~~~~~~~gt~~y~APE~l~~--~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~ 840 (935)
.. .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ +..... +..
T Consensus 182 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~~~~-----~~~ 254 (389)
T 3gni_B 182 GQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM--LLEKLN-----GTV 254 (389)
T ss_dssp TEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTH--HHHC----------
T ss_pred cccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHH--HHHHhc-----CCC
Confidence 11 11122368999999999877 6789999999999999999999999974433211 111000 000
Q ss_pred eeccccc-----------------------c-------------cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002336 841 ISIVDPV-----------------------L-------------IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 884 (935)
Q Consensus 841 ~~~~d~~-----------------------l-------------~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~ 884 (935)
..+.+.. + ....+......+.+++.+||+.||++|||++|+++.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 255 PCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp ---------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred CccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence 0000000 0 000111223468899999999999999999999864
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=344.49 Aligned_cols=259 Identities=21% Similarity=0.285 Sum_probs=191.8
Q ss_pred HHHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcchhhhHHHHHHHHHHHhcC-CCcccccceee--------ecc
Q 002336 612 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIH-HRNLVPLIGYC--------EEE 681 (935)
Q Consensus 612 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~-HpnIv~l~g~~--------~~~ 681 (935)
...+++.+.||+|+||.||+|.+. +++.||||++........+.+.+|+.+++++. ||||+++++++ ...
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~ 106 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ 106 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence 345677899999999999999975 68999999987666666778999999999996 99999999998 344
Q ss_pred ceEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCc--eEecCCCCCCccccCCCcEEEeec
Q 002336 682 HQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG--IIHRDVKSSNILLDINMRAKVSDF 759 (935)
Q Consensus 682 ~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~--ivH~DLkp~NILld~~~~vkL~DF 759 (935)
...++||||+. |+|.+++........+++..++.++.|++.||+|||+ .+ |+||||||+|||++.++.+||+||
T Consensus 107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~~~ivH~Dikp~NIl~~~~~~~kl~Df 182 (337)
T 3ll6_A 107 AEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR---QKPPIIHRDLKVENLLLSNQGTIKLCDF 182 (337)
T ss_dssp EEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCCCCCGGGCEECTTSCEEBCCC
T ss_pred ceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHh---CCCCEEEccCCcccEEECCCCCEEEecC
Confidence 56899999995 7999988754445679999999999999999999997 77 999999999999999999999999
Q ss_pred cccccccccccce-----------eecccCCccccCCCCC---CCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccch
Q 002336 760 GLSRQAEEDLTHI-----------SSVARGTVGYLDPEYY---GNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAEL 825 (935)
Q Consensus 760 Gla~~~~~~~~~~-----------~~~~~gt~~y~APE~l---~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~ 825 (935)
|+++......... .....||+.|+|||++ .+..++.++||||||+++|||++|+.||......
T Consensus 183 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~--- 259 (337)
T 3ll6_A 183 GSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL--- 259 (337)
T ss_dssp TTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred ccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH---
Confidence 9998765432211 1134589999999998 5677899999999999999999999999732211
Q ss_pred hHHHHHHHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhhhhhcc
Q 002336 826 NIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 893 (935)
Q Consensus 826 ~l~~~~~~~i~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~~~~~~ 893 (935)
.... +.. ....... ....+.+++.+||+.+|++||+++|+++.|+++.....
T Consensus 260 ---~~~~-----~~~----~~~~~~~----~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~ 311 (337)
T 3ll6_A 260 ---RIVN-----GKY----SIPPHDT----QYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARN 311 (337)
T ss_dssp --------------C----CCCTTCC----SSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred ---Hhhc-----Ccc----cCCcccc----cchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccC
Confidence 0000 000 0000011 11247799999999999999999999999998876543
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-38 Score=341.77 Aligned_cols=255 Identities=22% Similarity=0.392 Sum_probs=202.8
Q ss_pred HHHHHhhcccccccccEEEEEEEECC-C-------cEEEEEEccCcchhhhHHHHHHHHHHHhcCCCcccccceeeeccc
Q 002336 611 EEATNNFCKKIGKGSFGSVYYGKMKD-G-------KEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH 682 (935)
Q Consensus 611 ~~~~~~~~~~LG~G~fG~Vy~~~~~~-g-------~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~ 682 (935)
....+.+.+.||+|+||.||+|.+.. + +.||+|++........+.+.+|++++++++||||+++++++.+.+
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 85 (289)
T 4fvq_A 6 RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGD 85 (289)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTT
T ss_pred chhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCC
Confidence 34456778999999999999998653 3 579999997666666678999999999999999999999999999
Q ss_pred eEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCc--------E
Q 002336 683 QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMR--------A 754 (935)
Q Consensus 683 ~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~--------v 754 (935)
..++||||+++|+|.+++... ...+++..++.++.|+++||+|||+ ++|+||||||+|||++.++. +
T Consensus 86 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~~~~ 160 (289)
T 4fvq_A 86 ENILVQEFVKFGSLDTYLKKN--KNCINILWKLEVAKQLAAAMHFLEE---NTLIHGNVCAKNILLIREEDRKTGNPPFI 160 (289)
T ss_dssp CCEEEEECCTTCBHHHHHHHT--GGGCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred CCEEEEECCCCCCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHhh---CCeECCCcCcceEEEecCCccccccccee
Confidence 999999999999999999753 3448999999999999999999998 89999999999999998887 9
Q ss_pred EEeeccccccccccccceeecccCCccccCCCCCCC-CCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHH
Q 002336 755 KVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARS 833 (935)
Q Consensus 755 kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~ 833 (935)
||+|||++...... ....|++.|+|||.+.+ ..++.++||||||+++|||++|..|+...... .......
T Consensus 161 kl~Dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~--~~~~~~~-- 231 (289)
T 4fvq_A 161 KLSDPGISITVLPK-----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDS--QRKLQFY-- 231 (289)
T ss_dssp EECCCCSCTTTSCH-----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH--HHHHHHH--
T ss_pred eeccCcccccccCc-----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccch--HHHHHHh--
Confidence 99999998765332 12347889999999877 77899999999999999999965444312111 1111111
Q ss_pred hhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhhhhhc
Q 002336 834 MIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 892 (935)
Q Consensus 834 ~i~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~~~~~ 892 (935)
........ .. ...+.+++.+||+.||++|||++|+++.|+++....
T Consensus 232 -~~~~~~~~--------~~----~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~ 277 (289)
T 4fvq_A 232 -EDRHQLPA--------PK----AAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPD 277 (289)
T ss_dssp -HTTCCCCC--------CS----SCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC---
T ss_pred -hccCCCCC--------CC----CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCC
Confidence 11111111 11 125789999999999999999999999999887733
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-37 Score=355.27 Aligned_cols=253 Identities=22% Similarity=0.301 Sum_probs=203.8
Q ss_pred HHHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc--hhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEE
Q 002336 612 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 688 (935)
Q Consensus 612 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~ 688 (935)
...|++.+.||+|+||.||+|... +|+.+|+|++.... ....+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIF 89 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEE
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEE
Confidence 456778899999999999999875 78999999986543 234567899999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCcccc---CCCcEEEeeccccccc
Q 002336 689 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD---INMRAKVSDFGLSRQA 765 (935)
Q Consensus 689 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld---~~~~vkL~DFGla~~~ 765 (935)
||+++|+|.+.+.. ...+++..+..++.|+++||+|||+ ++|+||||||+|||++ .++.+||+|||++...
T Consensus 90 E~~~gg~L~~~i~~---~~~~~e~~~~~i~~qil~aL~~lH~---~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~ 163 (444)
T 3soa_A 90 DLVTGGELFEDIVA---REYYSEADASHCIQQILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEV 163 (444)
T ss_dssp CCCBCCBHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCC
T ss_pred EeCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEeccCCCCcEEEccCceeEEe
Confidence 99999999998874 4569999999999999999999998 8999999999999998 5688999999999876
Q ss_pred cccccceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeeccc
Q 002336 766 EEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 845 (935)
Q Consensus 766 ~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d 845 (935)
...... .....||+.|+|||++.+..++.++||||+||++|+|++|+.||...+.. ... ..+..+.... ..
T Consensus 164 ~~~~~~-~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~---~~~----~~i~~~~~~~-~~ 234 (444)
T 3soa_A 164 EGEQQA-WFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQH---RLY----QQIKAGAYDF-PS 234 (444)
T ss_dssp CTTCCB-CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHH----HHHHHTCCCC-CT
T ss_pred cCCCce-eecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHH---HHH----HHHHhCCCCC-Cc
Confidence 543322 23356999999999999989999999999999999999999999743321 111 1222222110 01
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002336 846 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 884 (935)
Q Consensus 846 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~ 884 (935)
+ ... .....+.+++.+||+.||++|||++|+++.
T Consensus 235 ~-~~~----~~s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 235 P-EWD----TVTPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp T-TTT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred c-ccc----cCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 1 011 122368899999999999999999999874
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-37 Score=340.18 Aligned_cols=250 Identities=19% Similarity=0.293 Sum_probs=203.1
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcchhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEecC
Q 002336 614 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 692 (935)
Q Consensus 614 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~~ 692 (935)
.|.+.+.||+|+||.||+|.+. +++.+|+|.+... ......+.+|+.+++.++||||+++++++.+.+..++||||++
T Consensus 6 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~ 84 (321)
T 1tki_A 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFIS 84 (321)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred ceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCC
Confidence 3566789999999999999876 5889999998754 3445678899999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccC--CCcEEEeecccccccccccc
Q 002336 693 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI--NMRAKVSDFGLSRQAEEDLT 770 (935)
Q Consensus 693 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~--~~~vkL~DFGla~~~~~~~~ 770 (935)
+|+|.+++.. ....+++..+..++.|+++||+|||+ ++|+||||||+|||++. ++.+||+|||+++.......
T Consensus 85 g~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~---~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~ 159 (321)
T 1tki_A 85 GLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN 159 (321)
T ss_dssp CCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE
T ss_pred CCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCc
Confidence 9999999974 23568999999999999999999998 89999999999999987 78999999999987654322
Q ss_pred ceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccC
Q 002336 771 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 850 (935)
Q Consensus 771 ~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~ 850 (935)
.....||+.|+|||++.+..++.++||||+|+++|+|++|+.||...... +...... .+... .++....
T Consensus 160 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~------~~~~~i~-~~~~~--~~~~~~~ 228 (321)
T 1tki_A 160 --FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ------QIIENIM-NAEYT--FDEEAFK 228 (321)
T ss_dssp --EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHH-HTCCC--CCHHHHT
T ss_pred --cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHH------HHHHHHH-cCCCC--CChhhhc
Confidence 23346899999999999888999999999999999999999999743221 1111111 11110 0000001
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002336 851 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 884 (935)
Q Consensus 851 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~ 884 (935)
.....+.+++.+||..||++|||++|+++.
T Consensus 229 ----~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 258 (321)
T 1tki_A 229 ----EISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp ----TSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ----cCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 112368899999999999999999999874
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=338.51 Aligned_cols=259 Identities=19% Similarity=0.289 Sum_probs=197.3
Q ss_pred HhhcccccccccEEEEEEEECCCcEEEEEEccCcchh--hhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEecC
Q 002336 615 NNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSH--RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 692 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~~~~~~~~--~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~~ 692 (935)
|++.+.||+|+||.||+|...+|+.||+|++...... ..+.+.+|++++++++||||+++++++...+..++||||++
T Consensus 4 y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 83 (288)
T 1ob3_A 4 YHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLD 83 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCS
T ss_pred chhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEecC
Confidence 4567899999999999999988999999998654322 23678899999999999999999999999999999999997
Q ss_pred CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccccce
Q 002336 693 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 772 (935)
Q Consensus 693 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~~ 772 (935)
+ +|.+.+... ...+++..+..++.|+++||+|||+ ++|+||||||+|||++.++.+||+|||+++........
T Consensus 84 ~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~- 156 (288)
T 1ob3_A 84 Q-DLKKLLDVC--EGGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK- 156 (288)
T ss_dssp E-EHHHHHHTS--TTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred C-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEeECccccccCccccc-
Confidence 5 999988743 4568999999999999999999998 89999999999999999999999999999765432221
Q ss_pred eecccCCccccCCCCCCC-CCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCC---eee-----c
Q 002336 773 SSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD---VIS-----I 843 (935)
Q Consensus 773 ~~~~~gt~~y~APE~l~~-~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~---~~~-----~ 843 (935)
.....||+.|+|||.+.+ ..++.++||||+|+++|||++|+.||......+ .+.. +.+...... ... .
T Consensus 157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~~~~-~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T 1ob3_A 157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD--QLMR-IFRILGTPNSKNWPNVTELPK 233 (288)
T ss_dssp -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHH-HHHHHCCCCTTTSTTGGGSTT
T ss_pred cccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHH-HHHHHCCCChhhchhhhcccc
Confidence 223458999999998865 468999999999999999999999997433211 1111 111111100 000 0
Q ss_pred cccccc-------CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 844 VDPVLI-------GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 844 ~d~~l~-------~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
.++.+. ..........+.+++.+||+.||++|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 111110 0011122346789999999999999999999875
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-37 Score=349.93 Aligned_cols=249 Identities=24% Similarity=0.338 Sum_probs=202.3
Q ss_pred HHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc---hhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEE
Q 002336 613 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 688 (935)
Q Consensus 613 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~ 688 (935)
..|++.+.||+|+||.||++... +++.||+|++.... ....+.+.+|+++|+.++||||+++++++.+.+..++||
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 34667899999999999999876 58899999986432 223467889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccccc
Q 002336 689 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 768 (935)
Q Consensus 689 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~ 768 (935)
||+.+|+|.+++.. ...+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 95 e~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 168 (384)
T 4fr4_A 95 DLLLGGDLRYHLQQ---NVHFKEETVKLFICELVMALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE 168 (384)
T ss_dssp CCCTTEEHHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred ecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEECCCCCEEEeccceeeeccCC
Confidence 99999999999983 4679999999999999999999998 89999999999999999999999999999876433
Q ss_pred ccceeecccCCccccCCCCCCC---CCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeeccc
Q 002336 769 LTHISSVARGTVGYLDPEYYGN---QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 845 (935)
Q Consensus 769 ~~~~~~~~~gt~~y~APE~l~~---~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d 845 (935)
.. .....||+.|+|||++.. ..++.++|||||||++|||++|+.||............... .....
T Consensus 169 ~~--~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~----~~~~~----- 237 (384)
T 4fr4_A 169 TQ--ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTF----ETTVV----- 237 (384)
T ss_dssp CC--BCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHH----HHCCC-----
T ss_pred Cc--eeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHH----hhccc-----
Confidence 22 234569999999999864 45899999999999999999999999744333222222211 11110
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCC-HHHHHH
Q 002336 846 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPK-MQEIVL 883 (935)
Q Consensus 846 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs-~~ev~~ 883 (935)
.++......+.+++.+||+.+|++||+ +++|.+
T Consensus 238 -----~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 238 -----TYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp -----CCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred -----CCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 112222346889999999999999998 777654
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-37 Score=340.16 Aligned_cols=268 Identities=25% Similarity=0.389 Sum_probs=203.8
Q ss_pred hHHHHHHhhcccccccccEEEEEEEECCCcEEEEEEccCcchhhhHHHHHHHHHHHhc--CCCcccccceeeecc----c
Q 002336 609 ELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRI--HHRNLVPLIGYCEEE----H 682 (935)
Q Consensus 609 ~l~~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L--~HpnIv~l~g~~~~~----~ 682 (935)
+.....|++.+.||+|+||.||+|++. ++.||||++... ....+..|.+++..+ +||||+++++++... .
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 108 (337)
T 3mdy_A 33 RTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWT 108 (337)
T ss_dssp TTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGC
T ss_pred cccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCC
Confidence 445567888999999999999999987 999999998643 234455566666554 899999999998776 6
Q ss_pred eEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCC--------ceEecCCCCCCccccCCCcE
Q 002336 683 QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP--------GIIHRDVKSSNILLDINMRA 754 (935)
Q Consensus 683 ~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~--------~ivH~DLkp~NILld~~~~v 754 (935)
..++||||+++|+|.++++. ..+++..++.++.|++.||+|||+ . +|+||||||+|||++.++.+
T Consensus 109 ~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~---~~~~~~~~~~ivH~Dikp~Nill~~~~~~ 181 (337)
T 3mdy_A 109 QLYLITDYHENGSLYDYLKS----TTLDAKSMLKLAYSSVSGLCHLHT---EIFSTQGKPAIAHRDLKSKNILVKKNGTC 181 (337)
T ss_dssp EEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHS---CBCSTTCBCCEECSCCCGGGEEECTTSCE
T ss_pred ceEEEEeccCCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHH---hhhhhccCCCEEecccchHHEEECCCCCE
Confidence 88999999999999999973 358999999999999999999997 6 99999999999999999999
Q ss_pred EEeeccccccccccccce---eecccCCccccCCCCCCCCCCCch------hHHHHHHHHHHHHHhC----------CCC
Q 002336 755 KVSDFGLSRQAEEDLTHI---SSVARGTVGYLDPEYYGNQQLTEK------SDVYSFGVVLLELISG----------KKP 815 (935)
Q Consensus 755 kL~DFGla~~~~~~~~~~---~~~~~gt~~y~APE~l~~~~~s~k------sDVwS~Gvil~eLltG----------~~P 815 (935)
||+|||+++......... .....||+.|+|||++.+.....+ +|||||||++|||++| +.|
T Consensus 182 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p 261 (337)
T 3mdy_A 182 CIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLP 261 (337)
T ss_dssp EECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred EEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccccccccc
Confidence 999999997654432221 123468999999999877655554 9999999999999999 666
Q ss_pred CCccCcccchhHHHHHHHhhhcCCeeecccccccCCC-CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhhhhhcc
Q 002336 816 VSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNV-KIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 893 (935)
Q Consensus 816 f~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~~~-~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~~~~~~ 893 (935)
|....... ... ......+..... .+.+.... .......+.+++.+||+.||++|||++||++.|+++.....
T Consensus 262 ~~~~~~~~-~~~-~~~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~ 334 (337)
T 3mdy_A 262 YHDLVPSD-PSY-EDMREIVCIKKL----RPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQD 334 (337)
T ss_dssp TTTTSCSS-CCH-HHHHHHHTTSCC----CCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTTT
T ss_pred HhhhcCCC-Cch-hhhHHHHhhhcc----CccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhcc
Confidence 65322211 111 111222211111 11111111 22556789999999999999999999999999998877543
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-37 Score=349.66 Aligned_cols=251 Identities=21% Similarity=0.349 Sum_probs=205.1
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcchhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEecC
Q 002336 614 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 692 (935)
Q Consensus 614 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~~ 692 (935)
.|++.+.||+|+||.||+|... +|+.||+|++..........+.+|+++|+.++||||+++++++.+....++||||++
T Consensus 52 ~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~~ 131 (387)
T 1kob_A 52 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLS 131 (387)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCC
T ss_pred ceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcCC
Confidence 4667889999999999999876 689999999976655566789999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccC--CCcEEEeecccccccccccc
Q 002336 693 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI--NMRAKVSDFGLSRQAEEDLT 770 (935)
Q Consensus 693 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~--~~~vkL~DFGla~~~~~~~~ 770 (935)
+|+|.+++... ...+++..++.++.|++.||+|||+ .+|+||||||+|||++. ++.+||+|||+++.......
T Consensus 132 gg~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~ 206 (387)
T 1kob_A 132 GGELFDRIAAE--DYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI 206 (387)
T ss_dssp CCBHHHHTTCT--TCCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC
T ss_pred CCcHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccchHHeEEecCCCCceEEEecccceecCCCcc
Confidence 99999998742 3468999999999999999999998 89999999999999974 57799999999987654322
Q ss_pred ceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccC
Q 002336 771 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 850 (935)
Q Consensus 771 ~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~ 850 (935)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .... . +...... .++....
T Consensus 207 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~---~~~~---~-i~~~~~~--~~~~~~~ 275 (387)
T 1kob_A 207 --VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL---ETLQ---N-VKRCDWE--FDEDAFS 275 (387)
T ss_dssp --EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH---HHHH---H-HHHCCCC--CCSSTTT
T ss_pred --eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHH---HHHH---H-HHhCCCC--CCccccc
Confidence 23346899999999999989999999999999999999999999743221 1111 1 1111110 1111111
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002336 851 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 884 (935)
Q Consensus 851 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~ 884 (935)
.....+.+++.+||+.||++|||++|+++.
T Consensus 276 ----~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 276 ----SVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp ----TSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred ----cCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 223468899999999999999999999863
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=346.46 Aligned_cols=265 Identities=24% Similarity=0.450 Sum_probs=211.4
Q ss_pred HHHHhhcccccccccEEEEEEEEC--------CCcEEEEEEccCcch-hhhHHHHHHHHHHHhc-CCCcccccceeeecc
Q 002336 612 EATNNFCKKIGKGSFGSVYYGKMK--------DGKEVAVKIMADSCS-HRTQQFVTEVALLSRI-HHRNLVPLIGYCEEE 681 (935)
Q Consensus 612 ~~~~~~~~~LG~G~fG~Vy~~~~~--------~g~~vAvK~~~~~~~-~~~~~~~~E~~iL~~L-~HpnIv~l~g~~~~~ 681 (935)
...+.+.+.||+|+||.||+|.+. +++.||+|++..... ...+.+.+|+++++++ +||||+++++++...
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 345677899999999999999873 467899999976433 3457799999999999 899999999999999
Q ss_pred ceEEEEEEecCCCCHHHHhccCCC-------------CCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccc
Q 002336 682 HQRILVYEYMHNGTLRDRLHGSVN-------------QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL 748 (935)
Q Consensus 682 ~~~~lV~E~~~~gsL~~~L~~~~~-------------~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILl 748 (935)
+..++||||+++|+|.+++..... ...+++..++.++.|+++||+|||+ ++|+||||||+|||+
T Consensus 114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll 190 (334)
T 2pvf_A 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVLV 190 (334)
T ss_dssp SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEE
T ss_pred CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCccceEEE
Confidence 999999999999999999975431 2348999999999999999999998 899999999999999
Q ss_pred cCCCcEEEeeccccccccccccc-eeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCcccchh
Q 002336 749 DINMRAKVSDFGLSRQAEEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELN 826 (935)
Q Consensus 749 d~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~ 826 (935)
+.++.+||+|||+++........ ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||...... .
T Consensus 191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~ 267 (334)
T 2pvf_A 191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE---E 267 (334)
T ss_dssp CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---H
T ss_pred cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHH---H
Confidence 99999999999999876543221 1223346788999999988889999999999999999999 99999743221 1
Q ss_pred HHHHHHHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhhhhhccCC
Q 002336 827 IVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKGG 895 (935)
Q Consensus 827 l~~~~~~~i~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~~~~~~~~ 895 (935)
+.. .+..+.... . +......+.+++.+||+.+|++||+++|+++.|+++.......
T Consensus 268 ~~~----~~~~~~~~~-----~----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~~~ 323 (334)
T 2pvf_A 268 LFK----LLKEGHRMD-----K----PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTNE 323 (334)
T ss_dssp HHH----HHHHTCCCC-----C----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC--
T ss_pred HHH----HHhcCCCCC-----C----CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccccC
Confidence 111 222221111 1 1122346889999999999999999999999999998766543
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-37 Score=345.31 Aligned_cols=248 Identities=23% Similarity=0.344 Sum_probs=199.1
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc---hhhhHHHHHHHHHHHhc-CCCcccccceeeeccceEEEEE
Q 002336 614 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVY 688 (935)
Q Consensus 614 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~iL~~L-~HpnIv~l~g~~~~~~~~~lV~ 688 (935)
.+++.+.||+|+||.||+|+++ +++.||+|++.... ....+.+.+|..+++++ +||||+++++++.+.+..++||
T Consensus 10 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~ 89 (345)
T 3a8x_A 10 DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVI 89 (345)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred heEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEE
Confidence 3566889999999999999986 58899999987542 23456788999999988 8999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccccc
Q 002336 689 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 768 (935)
Q Consensus 689 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~ 768 (935)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+ ++|+||||||+|||++.++++||+|||+++.....
T Consensus 90 e~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~ 163 (345)
T 3a8x_A 90 EYVNGGDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 163 (345)
T ss_dssp CCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT
T ss_pred eCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEEeccccccccCC
Confidence 99999999999874 3569999999999999999999998 89999999999999999999999999999864322
Q ss_pred ccceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccc--hhHHHHHHHhhhcCCeeecccc
Q 002336 769 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAE--LNIVHWARSMIKKGDVISIVDP 846 (935)
Q Consensus 769 ~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~--~~l~~~~~~~i~~~~~~~~~d~ 846 (935)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ......+.+.+..+..
T Consensus 164 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~------ 236 (345)
T 3a8x_A 164 GD-TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI------ 236 (345)
T ss_dssp TC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCC------
T ss_pred CC-cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCC------
Confidence 21 23345699999999999999999999999999999999999999974322111 1112222233332221
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCH
Q 002336 847 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKM 878 (935)
Q Consensus 847 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~ 878 (935)
.+ +......+.+++.+||+.||++||++
T Consensus 237 ~~----p~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 237 RI----PRSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp CC----CTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred CC----CCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 11 11223368899999999999999995
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-37 Score=331.42 Aligned_cols=252 Identities=21% Similarity=0.368 Sum_probs=203.1
Q ss_pred HHHhhcccccccccEEEEEEEECCCcEEEEEEccCcc--hhhhHHHHHHHHHHHhcCCCcccccceeeecc--ceEEEEE
Q 002336 613 ATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE--HQRILVY 688 (935)
Q Consensus 613 ~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~~~~~~--~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~--~~~~lV~ 688 (935)
..+++.+.||+|+||.||+|+++ ++.||||++.... ....+.+.+|+.++++++||||+++++++.+. ...++||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT 88 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred HHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence 34567889999999999999987 8999999987542 34456799999999999999999999999876 7889999
Q ss_pred EecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCc--eEecCCCCCCccccCCCcEEEeecccccccc
Q 002336 689 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG--IIHRDVKSSNILLDINMRAKVSDFGLSRQAE 766 (935)
Q Consensus 689 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~--ivH~DLkp~NILld~~~~vkL~DFGla~~~~ 766 (935)
||+++|+|.+++... ....+++..++.++.|+++||+|||+ ++ ++||||||+||+++.++.++|+|||++....
T Consensus 89 e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~---~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~ 164 (271)
T 3kmu_A 89 HWMPYGSLYNVLHEG-TNFVVDQSQAVKFALDMARGMAFLHT---LEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ 164 (271)
T ss_dssp ECCTTCBHHHHHHSC-SSCCCCHHHHHHHHHHHHHHHHHHTT---SSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS
T ss_pred cccCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhc---CCCceecCCCccceEEEcCCcceeEEeccceeeec
Confidence 999999999999853 23468999999999999999999997 77 9999999999999999999999998875432
Q ss_pred ccccceeecccCCccccCCCCCCCCCCCc---hhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeec
Q 002336 767 EDLTHISSVARGTVGYLDPEYYGNQQLTE---KSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISI 843 (935)
Q Consensus 767 ~~~~~~~~~~~gt~~y~APE~l~~~~~s~---ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~ 843 (935)
. ....||+.|+|||.+.+...+. ++||||||+++|||++|+.||...... +........+..
T Consensus 165 ~------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~~~~~~~~~~~~--- 229 (271)
T 3kmu_A 165 S------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNM------EIGMKVALEGLR--- 229 (271)
T ss_dssp C------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHH------HHHHHHHHSCCC---
T ss_pred c------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChH------HHHHHHHhcCCC---
Confidence 2 1235799999999987654443 899999999999999999999733221 111122222211
Q ss_pred ccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhhhh
Q 002336 844 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 890 (935)
Q Consensus 844 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~~~ 890 (935)
+.+ +......+.+++.+||+.+|++|||++|+++.|+++..
T Consensus 230 --~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 230 --PTI----PPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp --CCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred --CCC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 111 12223468899999999999999999999999998753
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=339.00 Aligned_cols=258 Identities=28% Similarity=0.455 Sum_probs=204.5
Q ss_pred HHhhcccccccccEEEEEEEECC----CcEEEEEEccCcc-hhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEE
Q 002336 614 TNNFCKKIGKGSFGSVYYGKMKD----GKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 688 (935)
Q Consensus 614 ~~~~~~~LG~G~fG~Vy~~~~~~----g~~vAvK~~~~~~-~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~ 688 (935)
.+.+.+.||+|+||.||+|.+.. +..||+|.+.... ....+.+.+|+.++++++||||+++++++.++ ..++||
T Consensus 13 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~v~ 91 (281)
T 3cc6_A 13 DVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTWIIM 91 (281)
T ss_dssp GEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCEEEE
T ss_pred ceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCEEEE
Confidence 45667899999999999998653 3469999987653 34557899999999999999999999998754 568999
Q ss_pred EecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccccc
Q 002336 689 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 768 (935)
Q Consensus 689 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~ 768 (935)
||+++++|.+++... ...+++..+..++.|+++||+|||+ ++|+||||||+||+++.++.+||+|||++......
T Consensus 92 e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 166 (281)
T 3cc6_A 92 ELYPYGELGHYLERN--KNSLKVLTLVLYSLQICKAMAYLES---INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDE 166 (281)
T ss_dssp ECCTTCBHHHHHHHH--TTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEEETTEEEECCCCGGGCC---
T ss_pred ecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEECCCCcEEeCccCCCcccccc
Confidence 999999999999742 4568999999999999999999998 89999999999999999999999999999876544
Q ss_pred ccceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCcccchhHHHHHHHhhhcCCeeeccccc
Q 002336 769 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 847 (935)
Q Consensus 769 ~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~ 847 (935)
.........+++.|+|||.+.+..++.++||||||+++|||++ |+.||....... .... +..+....
T Consensus 167 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~---~~~~----~~~~~~~~----- 234 (281)
T 3cc6_A 167 DYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD---VIGV----LEKGDRLP----- 234 (281)
T ss_dssp ------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG---HHHH----HHHTCCCC-----
T ss_pred cccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH---HHHH----HhcCCCCC-----
Confidence 3333334457889999999988889999999999999999998 999997433221 2211 11111111
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhhhhhcc
Q 002336 848 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 893 (935)
Q Consensus 848 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~~~~~~ 893 (935)
. +......+.+++.+||+.+|++||++.|+++.|+++...+.
T Consensus 235 ~----~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~ 276 (281)
T 3cc6_A 235 K----PDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQMEK 276 (281)
T ss_dssp C----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred C----CCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHhhh
Confidence 1 11122368899999999999999999999999999877654
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=340.66 Aligned_cols=268 Identities=25% Similarity=0.406 Sum_probs=211.0
Q ss_pred hhHHHHHHhhcccccccccEEEEEEEECCCcEEEEEEccCcchhhhHHHHHHHHHHHh--cCCCcccccceeeeccc---
Q 002336 608 PELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSR--IHHRNLVPLIGYCEEEH--- 682 (935)
Q Consensus 608 ~~l~~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~--L~HpnIv~l~g~~~~~~--- 682 (935)
.+.....+.+.+.||+|+||.||+|++. |+.||||++... ..+.+.+|.+++.. ++||||+++++++....
T Consensus 37 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~ 112 (342)
T 1b6c_B 37 QRTIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTW 112 (342)
T ss_dssp HHHHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSC
T ss_pred cccccccEEEEeeecCCCCcEEEEEEEc-CccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCcc
Confidence 4455677888999999999999999985 999999998643 34567889999887 68999999999998765
Q ss_pred -eEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhh--------hcCCCceEecCCCCCCccccCCCc
Q 002336 683 -QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH--------TGCNPGIIHRDVKSSNILLDINMR 753 (935)
Q Consensus 683 -~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH--------s~~~~~ivH~DLkp~NILld~~~~ 753 (935)
..++||||+++|+|.+++.. ..+++..++.++.|+++||+||| + ++|+||||||+|||++.++.
T Consensus 113 ~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~---~~ivH~Dlkp~NIll~~~~~ 185 (342)
T 1b6c_B 113 TQLWLVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGK---PAIAHRDLKSKNILVKKNGT 185 (342)
T ss_dssp CCEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCB---CEEECSCCSGGGEEECTTSC
T ss_pred ceeEEEEeecCCCcHHHHHhc----cCccHHHHHHHHHHHHHHHHHHHHHHhhhccc---CCeeeCCCCHHHEEECCCCC
Confidence 78999999999999999974 35899999999999999999999 6 89999999999999999999
Q ss_pred EEEeeccccccccccccc---eeecccCCccccCCCCCCCC------CCCchhHHHHHHHHHHHHHhC----------CC
Q 002336 754 AKVSDFGLSRQAEEDLTH---ISSVARGTVGYLDPEYYGNQ------QLTEKSDVYSFGVVLLELISG----------KK 814 (935)
Q Consensus 754 vkL~DFGla~~~~~~~~~---~~~~~~gt~~y~APE~l~~~------~~s~ksDVwS~Gvil~eLltG----------~~ 814 (935)
+||+|||++......... ......||+.|+|||.+.+. .++.++||||||+++|||++| +.
T Consensus 186 ~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~ 265 (342)
T 1b6c_B 186 CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL 265 (342)
T ss_dssp EEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCC
T ss_pred EEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCccccccc
Confidence 999999999876543322 12344689999999998765 234789999999999999999 77
Q ss_pred CCCccCcccchhHHHHHHHhhhcCCeeecccccccCC-CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhhhhhc
Q 002336 815 PVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN-VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 892 (935)
Q Consensus 815 Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~~-~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~~~~~ 892 (935)
||...... ......+.. .+..... .+.+... ...+....+.+++.+||+.+|++|||++||++.|+++...+
T Consensus 266 p~~~~~~~-~~~~~~~~~-~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~~ 338 (342)
T 1b6c_B 266 PYYDLVPS-DPSVEEMRK-VVCEQKL----RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 338 (342)
T ss_dssp TTTTTSCS-SCCHHHHHH-HHTTSCC----CCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred CccccCcC-cccHHHHHH-HHHHHHh----CCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHHh
Confidence 87633221 112222222 2222111 1111111 12356678999999999999999999999999999987654
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-37 Score=337.19 Aligned_cols=260 Identities=21% Similarity=0.294 Sum_probs=197.0
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc--hhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEec
Q 002336 615 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 691 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~ 691 (935)
|++.+.||+|+||.||+|.+. +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+++..++||||+
T Consensus 4 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 83 (292)
T 3o0g_A 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC 83 (292)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred ceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEecC
Confidence 456789999999999999886 68999999986543 233467889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccccc
Q 002336 692 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 771 (935)
Q Consensus 692 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~ 771 (935)
++ +|.+.+.. ....+++..+..++.|+++||+|||+ ++|+||||||+|||++.++.+||+|||+++........
T Consensus 84 ~~-~l~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH~---~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 157 (292)
T 3o0g_A 84 DQ-DLKKYFDS--CNGDLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC 157 (292)
T ss_dssp SE-EHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSC
T ss_pred CC-CHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccceecCCcccc
Confidence 76 55555543 34679999999999999999999998 89999999999999999999999999999876433222
Q ss_pred eeecccCCccccCCCCCCCCC-CCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcC---Ceeecc---
Q 002336 772 ISSVARGTVGYLDPEYYGNQQ-LTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG---DVISIV--- 844 (935)
Q Consensus 772 ~~~~~~gt~~y~APE~l~~~~-~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~---~~~~~~--- 844 (935)
.....||+.|+|||.+.+.. ++.++||||+|+++|||++|..|+..... .. .....+.+..... ......
T Consensus 158 -~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~-~~-~~~~~i~~~~~~~~~~~~~~~~~~~ 234 (292)
T 3o0g_A 158 -YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND-VD-DQLKRIFRLLGTPTEEQWPSMTKLP 234 (292)
T ss_dssp -CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSS-HH-HHHHHHHHHHCCCCTTTCTTGGGST
T ss_pred -ccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCC-HH-HHHHHHHHHhCCCChhhhhhhcccc
Confidence 23346899999999987655 79999999999999999998888642221 11 1111111111110 000000
Q ss_pred c---------ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 845 D---------PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 845 d---------~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
+ ..............+.+++.+||+.||++|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 0 00000111223346789999999999999999999975
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=351.59 Aligned_cols=247 Identities=24% Similarity=0.355 Sum_probs=198.3
Q ss_pred HHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc---hhhhHHHHHHHHHHHhc-CCCcccccceeeeccceEEEE
Q 002336 613 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILV 687 (935)
Q Consensus 613 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~iL~~L-~HpnIv~l~g~~~~~~~~~lV 687 (935)
..+++.+.||+|+||.||+|+++ +|+.||||+++... ....+.+.+|.++++.+ +||||+++++++.+.+..++|
T Consensus 23 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv 102 (353)
T 3txo_A 23 DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFV 102 (353)
T ss_dssp CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEE
Confidence 34667899999999999999876 58999999987532 22345688899999988 699999999999999999999
Q ss_pred EEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccc
Q 002336 688 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 767 (935)
Q Consensus 688 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~ 767 (935)
|||+++|+|.+++.. ...+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 103 ~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~ 176 (353)
T 3txo_A 103 MEFVNGGDLMFHIQK---SRRFDEARARFYAAEIISALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC 176 (353)
T ss_dssp EECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred EeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCCHHHEEECCCCCEEEccccceeeccc
Confidence 999999999999974 4569999999999999999999998 8999999999999999999999999999986432
Q ss_pred cccceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeeccccc
Q 002336 768 DLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 847 (935)
Q Consensus 768 ~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~ 847 (935)
... ......||+.|+|||++.+..++.++||||+||++|||++|+.||...+.. .. . ..+..+..
T Consensus 177 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~---~~---~-~~i~~~~~------- 241 (353)
T 3txo_A 177 NGV-TTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENED---DL---F-EAILNDEV------- 241 (353)
T ss_dssp ----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HH---H-HHHHHCCC-------
T ss_pred CCc-cccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHH---HH---H-HHHHcCCC-------
Confidence 222 233456999999999998888999999999999999999999999743321 11 1 12222211
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCCCH------HHHHH
Q 002336 848 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKM------QEIVL 883 (935)
Q Consensus 848 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~------~ev~~ 883 (935)
.++......+.+++.+||+.+|++||++ +|+++
T Consensus 242 ---~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 242 ---VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp ---CCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred ---CCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 1111123367899999999999999998 67665
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-37 Score=356.72 Aligned_cols=253 Identities=24% Similarity=0.300 Sum_probs=202.2
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCcch---hhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEe
Q 002336 615 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 690 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~---~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~ 690 (935)
+++.+.||+|+||.||+|+++ +++.||+|++..... ...+.+.+|..++..++||||+++++++.+.+..++||||
T Consensus 76 y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~Ey 155 (437)
T 4aw2_A 76 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDY 155 (437)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECC
T ss_pred eEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEEec
Confidence 455789999999999999987 478899999865322 1234589999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccccccc
Q 002336 691 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 770 (935)
Q Consensus 691 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~ 770 (935)
+++|+|.+++... ...+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 156 ~~gg~L~~~l~~~--~~~l~e~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~ 230 (437)
T 4aw2_A 156 YVGGDLLTLLSKF--EDRLPEEMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT 230 (437)
T ss_dssp CTTCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSC
T ss_pred CCCCcHHHHHHHc--cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeeEcCCCCEEEcchhhhhhcccCCC
Confidence 9999999999742 4579999999999999999999998 8999999999999999999999999999987655444
Q ss_pred ceeecccCCccccCCCCCC-----CCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeeccc
Q 002336 771 HISSVARGTVGYLDPEYYG-----NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 845 (935)
Q Consensus 771 ~~~~~~~gt~~y~APE~l~-----~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d 845 (935)
.......||+.|+|||++. ...++.++|||||||++|||++|+.||...+..+. ...+......-..
T Consensus 231 ~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~---~~~i~~~~~~~~~----- 302 (437)
T 4aw2_A 231 VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET---YGKIMNHKERFQF----- 302 (437)
T ss_dssp EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH---HHHHHTHHHHCCC-----
T ss_pred cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHH---HHhhhhccccccC-----
Confidence 4444567999999999986 56789999999999999999999999974432211 1111100000001
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 002336 846 PVLIGNVKIESIWRIAEVAIQCVEQRGFS--RPKMQEIVLA 884 (935)
Q Consensus 846 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~--RPs~~ev~~~ 884 (935)
+..... ....+.+++.+||..+|++ ||+++|+++.
T Consensus 303 p~~~~~----~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 303 PTQVTD----VSENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp CSSCCC----SCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred Cccccc----CCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 111011 2236789999999888888 9999999764
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-37 Score=339.89 Aligned_cols=261 Identities=22% Similarity=0.308 Sum_probs=203.7
Q ss_pred HHHhhcccccccccEEEEEEEE-CCCcEEEEEEccCcchhhhHHHHHHHHHHHhcCCCcccccceeee----ccceEEEE
Q 002336 613 ATNNFCKKIGKGSFGSVYYGKM-KDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCE----EEHQRILV 687 (935)
Q Consensus 613 ~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~----~~~~~~lV 687 (935)
..|++.+.||+|+||.||++.. .+|+.||||++........+.+.+|+++++.++||||+++++++. .....++|
T Consensus 29 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv 108 (317)
T 2buj_A 29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLL 108 (317)
T ss_dssp EEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEE
T ss_pred eEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEE
Confidence 3467789999999999999987 479999999987665666778999999999999999999999986 34578999
Q ss_pred EEecCCCCHHHHhccCC-CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccc
Q 002336 688 YEYMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 766 (935)
Q Consensus 688 ~E~~~~gsL~~~L~~~~-~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~ 766 (935)
|||+++|+|.+++.... ....+++..++.++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||++....
T Consensus 109 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~ 185 (317)
T 2buj_A 109 LPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQAC 185 (317)
T ss_dssp EECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCSSCEESC
T ss_pred EEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCCCEEEEecCcchhcc
Confidence 99999999999887422 34679999999999999999999998 899999999999999999999999999987643
Q ss_pred ccccc--------eeecccCCccccCCCCCCCCC---CCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhh
Q 002336 767 EDLTH--------ISSVARGTVGYLDPEYYGNQQ---LTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMI 835 (935)
Q Consensus 767 ~~~~~--------~~~~~~gt~~y~APE~l~~~~---~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i 835 (935)
..... ......|++.|+|||.+.... ++.++||||||+++|||++|+.||....... ...... +
T Consensus 186 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-~~~~~~----~ 260 (317)
T 2buj_A 186 IHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKG-DSVALA----V 260 (317)
T ss_dssp EEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTT-SCHHHH----H
T ss_pred cccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhccc-chhhHH----h
Confidence 21110 011234799999999987553 6899999999999999999999996321111 111111 1
Q ss_pred hcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhhhh
Q 002336 836 KKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 890 (935)
Q Consensus 836 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~~~ 890 (935)
... . . ... .......+.+++.+||+.+|++||+++|+++.|+.+..
T Consensus 261 ~~~-~-~---~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 306 (317)
T 2buj_A 261 QNQ-L-S---IPQ----SPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP 306 (317)
T ss_dssp HCC-------CCC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCC
T ss_pred hcc-C-C---CCc----cccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCC
Confidence 110 0 0 000 11122468899999999999999999999999987754
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=347.45 Aligned_cols=256 Identities=24% Similarity=0.409 Sum_probs=201.8
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcE----EEEEEccCcc-hhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEE
Q 002336 614 TNNFCKKIGKGSFGSVYYGKMK-DGKE----VAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILV 687 (935)
Q Consensus 614 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~----vAvK~~~~~~-~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV 687 (935)
.+++.+.||+|+||.||+|.+. +++. ||+|.+.... ....+.+.+|+.++++++||||+++++++. +...++|
T Consensus 14 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v 92 (325)
T 3kex_A 14 ELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQLV 92 (325)
T ss_dssp TEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEEE
T ss_pred HceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEEE
Confidence 4566789999999999999875 3443 8888875432 233467889999999999999999999986 4568999
Q ss_pred EEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccc
Q 002336 688 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 767 (935)
Q Consensus 688 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~ 767 (935)
|||+++|+|.+++... ...+++..++.++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 93 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 167 (325)
T 3kex_A 93 TQYLPLGSLLDHVRQH--RGALGPQLLLNWGVQIAKGMYYLEE---HGMVHRNLAARNVLLKSPSQVQVADFGVADLLPP 167 (325)
T ss_dssp EECCTTCBSHHHHHSS--GGGSCTTHHHHHHHHHHHHHHHHHH---TTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCC
T ss_pred EEeCCCCCHHHHHHHc--cccCCHHHHHHHHHHHHHHHHHHHh---CCCCCCccchheEEECCCCeEEECCCCcccccCc
Confidence 9999999999999743 3568899999999999999999998 8999999999999999999999999999987654
Q ss_pred cccc-eeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCcccchhHHHHHHHhhhcCCeeeccc
Q 002336 768 DLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 845 (935)
Q Consensus 768 ~~~~-~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d 845 (935)
.... ......++..|+|||.+.+..++.++||||||+++|||++ |+.||....... ... .+..+.....
T Consensus 168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~----~~~~~~~~~~-- 238 (325)
T 3kex_A 168 DDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE---VPD----LLEKGERLAQ-- 238 (325)
T ss_dssp CTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTH---HHH----HHHTTCBCCC--
T ss_pred ccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHH---HHH----HHHcCCCCCC--
Confidence 3322 2334457889999999988889999999999999999999 999997443321 111 2222211111
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhhhhh
Q 002336 846 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 891 (935)
Q Consensus 846 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~~~~ 891 (935)
+......+.+++.+||+.+|++||+++|+++.|+++...
T Consensus 239 -------~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~ 277 (325)
T 3kex_A 239 -------PQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARD 277 (325)
T ss_dssp -------CTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred -------CCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 111112567899999999999999999999999987653
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=346.58 Aligned_cols=244 Identities=23% Similarity=0.325 Sum_probs=198.7
Q ss_pred HhhcccccccccEEEEEEEE-CCCcEEEEEEccCcch---hhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEe
Q 002336 615 NNFCKKIGKGSFGSVYYGKM-KDGKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 690 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~-~~g~~vAvK~~~~~~~---~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~ 690 (935)
|.+.+.||+|+||.||+|.+ .+++.||+|++..... ...+.+.+|+.+++.++||||+++++++......++||||
T Consensus 11 Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 90 (336)
T 3h4j_B 11 YIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEY 90 (336)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred EEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEEC
Confidence 56678999999999999997 4789999999864322 1235789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccccccc
Q 002336 691 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 770 (935)
Q Consensus 691 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~ 770 (935)
+ +|+|.+.+.. ...+++..+..++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||++........
T Consensus 91 ~-~g~l~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~~ 163 (336)
T 3h4j_B 91 A-GGELFDYIVE---KKRMTEDEGRRFFQQIICAIEYCHR---HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNF 163 (336)
T ss_dssp C-CEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHH---HTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSBT
T ss_pred C-CCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCchhhEEEcCCCCEEEEEeccceeccCCcc
Confidence 9 7899888863 4569999999999999999999998 8999999999999999999999999999987654322
Q ss_pred ceeecccCCccccCCCCCCCCCC-CchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeeccccccc
Q 002336 771 HISSVARGTVGYLDPEYYGNQQL-TEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 849 (935)
Q Consensus 771 ~~~~~~~gt~~y~APE~l~~~~~-s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~ 849 (935)
.....||+.|+|||.+.+..+ +.++||||+|+++|+|++|+.||.......... .+..+ .
T Consensus 164 --~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~-------~i~~~----------~ 224 (336)
T 3h4j_B 164 --LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFK-------KVNSC----------V 224 (336)
T ss_dssp --TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBC-------CCCSS----------C
T ss_pred --cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHH-------HHHcC----------C
Confidence 233468999999999988765 789999999999999999999997433221100 00000 0
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002336 850 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 884 (935)
Q Consensus 850 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~ 884 (935)
...+......+.+++.+||+.||++|||++|+++.
T Consensus 225 ~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 225 YVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp CCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred CCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 01122223467899999999999999999999763
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=332.20 Aligned_cols=264 Identities=23% Similarity=0.316 Sum_probs=206.8
Q ss_pred HHHhhcccccccccEEEEEEEE-CCCcEEEEEEccCcchhhhHHHHHHHHHHHhcCCCcccccceee-eccceEEEEEEe
Q 002336 613 ATNNFCKKIGKGSFGSVYYGKM-KDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYC-EEEHQRILVYEY 690 (935)
Q Consensus 613 ~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~-~~~~~~~lV~E~ 690 (935)
..|++.+.||+|+||.||+|.+ .+++.||||++... ...+.+.+|+++++.++|++++..++.+ ...+..++||||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~ 86 (296)
T 4hgt_A 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK--TKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 86 (296)
T ss_dssp --CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccc--ccchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEc
Confidence 4567789999999999999987 47899999986543 2335688999999999988888777766 566778999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccc---cCCCcEEEeeccccccccc
Q 002336 691 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEE 767 (935)
Q Consensus 691 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILl---d~~~~vkL~DFGla~~~~~ 767 (935)
+ +++|.+++... ...+++..++.++.|++.||+|||+ ++|+||||||+|||+ ++++.+||+|||+++....
T Consensus 87 ~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~ 160 (296)
T 4hgt_A 87 L-GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 160 (296)
T ss_dssp C-CCBHHHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred c-CCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeeeeccCCCCeEEEecCccceeccC
Confidence 9 99999998743 4569999999999999999999998 899999999999999 7899999999999987654
Q ss_pred cccc------eeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCee
Q 002336 768 DLTH------ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVI 841 (935)
Q Consensus 768 ~~~~------~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~ 841 (935)
.... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||..............+.........
T Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~- 239 (296)
T 4hgt_A 161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI- 239 (296)
T ss_dssp TTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH-
T ss_pred cccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchh-
Confidence 3221 123456899999999999999999999999999999999999999854443322222222111111110
Q ss_pred ecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhhhhhcc
Q 002336 842 SIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 893 (935)
Q Consensus 842 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~~~~~~ 893 (935)
+.+...+ ...+.+++.+||+.+|++||++++|++.|+++.....
T Consensus 240 ----~~~~~~~----~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~ 283 (296)
T 4hgt_A 240 ----EVLCKGY----PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 283 (296)
T ss_dssp ----HHHTTTS----CHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred ----hhhhccC----CHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhC
Confidence 0011111 2368899999999999999999999999999886544
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-37 Score=336.70 Aligned_cols=264 Identities=21% Similarity=0.311 Sum_probs=201.3
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCc---chhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEE
Q 002336 614 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS---CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 689 (935)
Q Consensus 614 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~---~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E 689 (935)
.|++.+.||+|+||.||+|... +|+.||+|++... .....+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 33 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 112 (310)
T 2wqm_A 33 NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLE 112 (310)
T ss_dssp GEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEEe
Confidence 4677899999999999999874 7999999998742 23445678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCC-CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccccc
Q 002336 690 YMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 768 (935)
Q Consensus 690 ~~~~gsL~~~L~~~~-~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~ 768 (935)
|+++++|.+++.... ....+++..++.++.|+++||.|||+ .+++||||||+||+++.++.+||+|||++......
T Consensus 113 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~ 189 (310)
T 2wqm_A 113 LADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 189 (310)
T ss_dssp CCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCC---------
T ss_pred cCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCcHHHEEEcCCCCEEEEeccceeeecCC
Confidence 999999999886422 34568999999999999999999998 89999999999999999999999999998765433
Q ss_pred ccceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccccc
Q 002336 769 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 848 (935)
Q Consensus 769 ~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l 848 (935)
... .....|++.|+|||.+.+..++.++||||||+++|+|++|+.||...... ...... .+..+.......
T Consensus 190 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~~~-~~~~~~~~~~~~--- 260 (310)
T 2wqm_A 190 TTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSLCK-KIEQCDYPPLPS--- 260 (310)
T ss_dssp ----------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CC----HHHHHH-HHHTTCSCCCCT---
T ss_pred Ccc-ccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchh----HHHHHH-HhhcccCCCCcc---
Confidence 221 22345899999999999889999999999999999999999999743221 112221 222222211111
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhhhhhccC
Q 002336 849 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKG 894 (935)
Q Consensus 849 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~~~~~~~ 894 (935)
. .....+.+++.+||+.||++||++++|++.|+++......
T Consensus 261 -~----~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~ 301 (310)
T 2wqm_A 261 -D----HYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTAS 301 (310)
T ss_dssp -T----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred -c----ccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhh
Confidence 1 1223688999999999999999999999999998876654
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=332.41 Aligned_cols=259 Identities=24% Similarity=0.413 Sum_probs=209.2
Q ss_pred hhcc-cccccccEEEEEEEEC---CCcEEEEEEccCcc-hhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEe
Q 002336 616 NFCK-KIGKGSFGSVYYGKMK---DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 690 (935)
Q Consensus 616 ~~~~-~LG~G~fG~Vy~~~~~---~g~~vAvK~~~~~~-~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~ 690 (935)
.+.+ .||+|+||.||+|.+. +++.||+|+++... ....+.+.+|++++++++||||+++++++ ..+..++||||
T Consensus 12 ~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~ 90 (287)
T 1u59_A 12 LIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEM 90 (287)
T ss_dssp EEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEEEC
T ss_pred hhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEEEe
Confidence 3444 8999999999999864 57889999997643 34567899999999999999999999999 45568999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccccccc
Q 002336 691 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 770 (935)
Q Consensus 691 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~ 770 (935)
+++++|.+++.. ....+++..++.++.|+++||.|||+ .+|+||||||+||+++.++.+||+|||++........
T Consensus 91 ~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 165 (287)
T 1u59_A 91 AGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDS 165 (287)
T ss_dssp CTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSC
T ss_pred CCCCCHHHHHHh--CCccCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCchheEEEcCCCCEEECcccceeeeccCcc
Confidence 999999999864 34569999999999999999999998 8999999999999999999999999999987644322
Q ss_pred ce--eecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCcccchhHHHHHHHhhhcCCeeeccccc
Q 002336 771 HI--SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 847 (935)
Q Consensus 771 ~~--~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~ 847 (935)
.. .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||...... .... .+..+...
T Consensus 166 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~~~~----~i~~~~~~------ 232 (287)
T 1u59_A 166 YYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP---EVMA----FIEQGKRM------ 232 (287)
T ss_dssp EECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH---HHHH----HHHTTCCC------
T ss_pred eeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH---HHHH----HHhcCCcC------
Confidence 21 223346889999999988889999999999999999998 99999743321 1222 22222111
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhhhhhccCCC
Q 002336 848 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKGGD 896 (935)
Q Consensus 848 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~~~~~~~~~ 896 (935)
..+......+.+++.+||+.+|++||+++|+++.|+++........
T Consensus 233 ---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~ 278 (287)
T 1u59_A 233 ---ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKV 278 (287)
T ss_dssp ---CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTTC
T ss_pred ---CCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCcc
Confidence 1112223478899999999999999999999999999887665443
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-38 Score=373.41 Aligned_cols=259 Identities=27% Similarity=0.434 Sum_probs=210.1
Q ss_pred HHHHhhcccccccccEEEEEEEECCCcEEEEEEccCcchhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEec
Q 002336 612 EATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 691 (935)
Q Consensus 612 ~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~ 691 (935)
...+++.+.||+|+||.||+|.++++..||||+++... ...+.|.+|+++|++++||||+++++++.+ +..++||||+
T Consensus 266 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~ 343 (535)
T 2h8h_A 266 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 343 (535)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred hhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehh
Confidence 34466788999999999999999988899999997543 234679999999999999999999999976 6789999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccccc
Q 002336 692 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 771 (935)
Q Consensus 692 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~ 771 (935)
++|+|.+++... ....+++.+++.++.||++||+|||+ ++|+||||||+|||++.++.+||+|||+++........
T Consensus 344 ~~gsL~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 419 (535)
T 2h8h_A 344 SKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 419 (535)
T ss_dssp TTEEHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHH
T ss_pred cCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCcee
Confidence 999999999742 23458999999999999999999998 89999999999999999999999999999876543222
Q ss_pred eeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccC
Q 002336 772 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 850 (935)
Q Consensus 772 ~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~ 850 (935)
......++..|+|||.+....++.++||||||+++|||++ |+.||...... .. ...+..+....
T Consensus 420 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~---~~----~~~i~~~~~~~-------- 484 (535)
T 2h8h_A 420 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR---EV----LDQVERGYRMP-------- 484 (535)
T ss_dssp TTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHH---HH----HHHHHTTCCCC--------
T ss_pred cccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---HH----HHHHHcCCCCC--------
Confidence 2223446789999999988889999999999999999999 99999743221 11 12222221111
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhhhhhc
Q 002336 851 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 892 (935)
Q Consensus 851 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~~~~~ 892 (935)
.+......+.+++.+||+.+|++|||+++|++.|+++....
T Consensus 485 -~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~ 525 (535)
T 2h8h_A 485 -CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 525 (535)
T ss_dssp -CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCC
T ss_pred -CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhcc
Confidence 11222346889999999999999999999999999876543
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=336.81 Aligned_cols=259 Identities=22% Similarity=0.330 Sum_probs=198.7
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcch---hhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEE
Q 002336 614 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 689 (935)
Q Consensus 614 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~---~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E 689 (935)
.|++.+.||+|+||.||+|... +++.||+|++..... ...+.+.+|+.++++++||||+++++++..++..++|||
T Consensus 35 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 114 (309)
T 2h34_A 35 PYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMR 114 (309)
T ss_dssp CEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEEE
Confidence 3667889999999999999976 688999999875422 234678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccc
Q 002336 690 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 769 (935)
Q Consensus 690 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~ 769 (935)
|+++++|.+++.. ...+++..++.++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||++.......
T Consensus 115 ~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 188 (309)
T 2h34_A 115 LINGVDLAAMLRR---QGPLAPPRAVAIVRQIGSALDAAHA---AGATHRDVKPENILVSADDFAYLVDFGIASATTDEK 188 (309)
T ss_dssp CCCCEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSCCC--------
T ss_pred ecCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CcCCcCCCChHHEEEcCCCCEEEecCccCccccccc
Confidence 9999999999974 3568999999999999999999998 899999999999999999999999999998765443
Q ss_pred cceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeeccccccc
Q 002336 770 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 849 (935)
Q Consensus 770 ~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~ 849 (935)
........|++.|+|||.+.+..++.++||||||+++|||++|+.||...... .....+...... +
T Consensus 189 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~~~~~~~~~~~~----~--- 254 (309)
T 2h34_A 189 LTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS-------VMGAHINQAIPR----P--- 254 (309)
T ss_dssp --------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH-------HHHHHHHSCCCC----G---
T ss_pred cccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH-------HHHHHhccCCCC----c---
Confidence 33333456899999999999989999999999999999999999999743221 112222221110 0
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHHhhhhhhc
Q 002336 850 GNVKIESIWRIAEVAIQCVEQRGFSRP-KMQEIVLAIQDSIKIE 892 (935)
Q Consensus 850 ~~~~~~~~~~l~~li~~Cl~~dP~~RP-s~~ev~~~L~~~~~~~ 892 (935)
...+......+.+++.+||+.+|++|| +++++++.|++.....
T Consensus 255 ~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~ 298 (309)
T 2h34_A 255 STVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATA 298 (309)
T ss_dssp GGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred cccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence 001111223688999999999999999 9999999999876544
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-37 Score=339.86 Aligned_cols=250 Identities=23% Similarity=0.305 Sum_probs=196.6
Q ss_pred hhhHHHHHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc--hhhhHHHHHHHHHHHhc-CCCcccccceeeeccc
Q 002336 607 LPELEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEH 682 (935)
Q Consensus 607 ~~~l~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~iL~~L-~HpnIv~l~g~~~~~~ 682 (935)
..++....+++.++||+|+||+||+|.+. +|+.||||++.... ......+..|+..+.++ +||||+++++++.+.+
T Consensus 51 ~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~ 130 (311)
T 3p1a_A 51 PESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGG 130 (311)
T ss_dssp SSCHHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred ccchhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCC
Confidence 34566677888999999999999999987 79999999976532 23334556666666665 8999999999999999
Q ss_pred eEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccc
Q 002336 683 QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS 762 (935)
Q Consensus 683 ~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla 762 (935)
..++||||+ +++|.+++... +..+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++
T Consensus 131 ~~~lv~e~~-~~~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~DFG~a 204 (311)
T 3p1a_A 131 ILYLQTELC-GPSLQQHCEAW--GASLPEAQVWGYLRDTLLALAHLHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLL 204 (311)
T ss_dssp EEEEEEECC-CCBHHHHHHHH--CSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECGGGCEEECCCTTC
T ss_pred EEEEEEecc-CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEccceee
Confidence 999999999 77999888653 4569999999999999999999998 89999999999999999999999999998
Q ss_pred ccccccccceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeee
Q 002336 763 RQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVIS 842 (935)
Q Consensus 763 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~ 842 (935)
........ .....||+.|+|||++.+ .++.++||||||+++|||++|..|+..... | ..+..+...
T Consensus 205 ~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~--------~--~~~~~~~~~- 270 (311)
T 3p1a_A 205 VELGTAGA--GEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG--------W--QQLRQGYLP- 270 (311)
T ss_dssp EECC--------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH--------H--HHHTTTCCC-
T ss_pred eecccCCC--CcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH--------H--HHHhccCCC-
Confidence 77644322 233458999999998876 689999999999999999999776642110 1 112222111
Q ss_pred cccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 843 IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 843 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
+.+.. .....+.+++.+||+.+|++|||++|+++
T Consensus 271 ---~~~~~----~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 271 ---PEFTA----GLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp ---HHHHT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ---ccccc----CCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 11111 12246889999999999999999999975
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=346.14 Aligned_cols=251 Identities=23% Similarity=0.327 Sum_probs=199.0
Q ss_pred cccccccccEEEEEEEEC-CCcEEEEEEccCcchhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEecCCCCH
Q 002336 618 CKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTL 696 (935)
Q Consensus 618 ~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL 696 (935)
.+.||+|+||.||+|... +|+.||+|+++.......+.+.+|++++++++||||+++++++.+.+..++||||+++++|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 467999999999999875 6899999999876656677899999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccc--cCCCcEEEeeccccccccccccceee
Q 002336 697 RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL--DINMRAKVSDFGLSRQAEEDLTHISS 774 (935)
Q Consensus 697 ~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILl--d~~~~vkL~DFGla~~~~~~~~~~~~ 774 (935)
.+++... ...+++..++.++.|+++||+|||+ .+|+||||||+|||+ +.++.+||+|||+++....... ..
T Consensus 174 ~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~--~~ 246 (373)
T 2x4f_A 174 FDRIIDE--SYNLTELDTILFMKQICEGIRHMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK--LK 246 (373)
T ss_dssp HHHHHHT--GGGCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB--CC
T ss_pred HHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc--cc
Confidence 9988642 3568999999999999999999998 899999999999999 5678999999999987654322 22
Q ss_pred cccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccCCCCH
Q 002336 775 VARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKI 854 (935)
Q Consensus 775 ~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~~~~~ 854 (935)
...||+.|+|||++.+..++.++|||||||++|||++|+.||...... +......... . .. .+.....
T Consensus 247 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~------~~~~~i~~~~-~-~~-~~~~~~~--- 314 (373)
T 2x4f_A 247 VNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA------ETLNNILACR-W-DL-EDEEFQD--- 314 (373)
T ss_dssp CCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHHTC-C-CS-CSGGGTT---
T ss_pred cccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhcc-C-CC-Chhhhcc---
Confidence 345899999999999889999999999999999999999999743321 1111122111 0 00 0111111
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHH--HHhhh
Q 002336 855 ESIWRIAEVAIQCVEQRGFSRPKMQEIVL--AIQDS 888 (935)
Q Consensus 855 ~~~~~l~~li~~Cl~~dP~~RPs~~ev~~--~L~~~ 888 (935)
....+.+++.+||+.+|++||+++|+++ .+.+.
T Consensus 315 -~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~ 349 (373)
T 2x4f_A 315 -ISEEAKEFISKLLIKEKSWRISASEALKHPWLSDH 349 (373)
T ss_dssp -SCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred -CCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCC
Confidence 2236889999999999999999999987 45443
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-37 Score=340.44 Aligned_cols=243 Identities=22% Similarity=0.359 Sum_probs=201.4
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCcch---hhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEe
Q 002336 615 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 690 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~---~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~ 690 (935)
+++.+.||+|+||.||+++.. +|+.||+|+++.... ...+.+.+|+.+++.++||||+++++++.+....++||||
T Consensus 8 y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e~ 87 (318)
T 1fot_A 8 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDY 87 (318)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECC
T ss_pred cEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEEeC
Confidence 566889999999999999886 689999999865322 2345688899999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccccccc
Q 002336 691 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 770 (935)
Q Consensus 691 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~ 770 (935)
+++|+|.+++.. ...+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 88 ~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~-- 159 (318)
T 1fot_A 88 IEGGELFSLLRK---SQRFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-- 159 (318)
T ss_dssp CCSCBHHHHHHH---TSSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC--
T ss_pred CCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChheEEEcCCCCEEEeecCcceecCCc--
Confidence 999999999974 4568999999999999999999997 89999999999999999999999999999875432
Q ss_pred ceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccC
Q 002336 771 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 850 (935)
Q Consensus 771 ~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~ 850 (935)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||...... +....... +.. .+
T Consensus 160 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~------~~~~~i~~-~~~------~~-- 222 (318)
T 1fot_A 160 --TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM------KTYEKILN-AEL------RF-- 222 (318)
T ss_dssp --BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHH-CCC------CC--
T ss_pred --cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH------HHHHHHHh-CCC------CC--
Confidence 22356999999999999999999999999999999999999999743221 11111221 111 11
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 002336 851 NVKIESIWRIAEVAIQCVEQRGFSRP-----KMQEIVLA 884 (935)
Q Consensus 851 ~~~~~~~~~l~~li~~Cl~~dP~~RP-----s~~ev~~~ 884 (935)
+......+.+++.+||+.+|++|| +++|+++.
T Consensus 223 --p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h 259 (318)
T 1fot_A 223 --PPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 259 (318)
T ss_dssp --CTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred --CCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence 112223688999999999999999 88888753
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-36 Score=329.86 Aligned_cols=263 Identities=23% Similarity=0.318 Sum_probs=207.5
Q ss_pred HHhhcccccccccEEEEEEEE-CCCcEEEEEEccCcchhhhHHHHHHHHHHHhcCCCcccccceee-eccceEEEEEEec
Q 002336 614 TNNFCKKIGKGSFGSVYYGKM-KDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYC-EEEHQRILVYEYM 691 (935)
Q Consensus 614 ~~~~~~~LG~G~fG~Vy~~~~-~~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~-~~~~~~~lV~E~~ 691 (935)
.|++.+.||+|+||.||+|.+ .+|+.||||++.... ..+.+.+|+.+++.++|++++..++++ ......++||||+
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~ 87 (296)
T 3uzp_A 10 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL 87 (296)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS--SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred EEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc--chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec
Confidence 356678999999999999997 478999999986543 235688999999999998877777765 5567789999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccc---cCCCcEEEeecccccccccc
Q 002336 692 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEED 768 (935)
Q Consensus 692 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILl---d~~~~vkL~DFGla~~~~~~ 768 (935)
+++|.+++... ...+++..++.++.|+++||+|||+ ++|+||||||+|||+ +.++.+||+|||+++.....
T Consensus 88 -~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~ 161 (296)
T 3uzp_A 88 -GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 161 (296)
T ss_dssp -CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred -CCCHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccc
Confidence 99999999743 4569999999999999999999998 899999999999999 48899999999999876543
Q ss_pred ccc------eeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeee
Q 002336 769 LTH------ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVIS 842 (935)
Q Consensus 769 ~~~------~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~ 842 (935)
... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||..............+.........
T Consensus 162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-- 239 (296)
T 3uzp_A 162 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI-- 239 (296)
T ss_dssp TTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH--
T ss_pred ccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCch--
Confidence 321 123456899999999999989999999999999999999999999854433322222222211111110
Q ss_pred cccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhhhhhcc
Q 002336 843 IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 893 (935)
Q Consensus 843 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~~~~~~ 893 (935)
+.+...+ ...+.+++.+||+.+|++||++++|++.|+++.....
T Consensus 240 ---~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~ 283 (296)
T 3uzp_A 240 ---EVLCKGY----PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 283 (296)
T ss_dssp ---HHHTTTS----CHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred ---HHHHhhC----CHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcC
Confidence 0111112 2368899999999999999999999999999876554
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-37 Score=341.94 Aligned_cols=248 Identities=23% Similarity=0.340 Sum_probs=193.0
Q ss_pred HHHhhcccccccccEEEEEEEE----CCCcEEEEEEccCcc----hhhhHHHHHHHHHHHhcCCCcccccceeeeccceE
Q 002336 613 ATNNFCKKIGKGSFGSVYYGKM----KDGKEVAVKIMADSC----SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQR 684 (935)
Q Consensus 613 ~~~~~~~~LG~G~fG~Vy~~~~----~~g~~vAvK~~~~~~----~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~ 684 (935)
..|++.+.||+|+||.||+++. .+|+.||+|+++... ......+.+|+++|+.++||||+++++++...+..
T Consensus 17 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 96 (327)
T 3a62_A 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKL 96 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCE
T ss_pred HHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEE
Confidence 4567789999999999999987 478999999987542 22345688899999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccc
Q 002336 685 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 764 (935)
Q Consensus 685 ~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~ 764 (935)
++||||+++++|.+++.. ...+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++.
T Consensus 97 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 170 (327)
T 3a62_A 97 YLILEYLSGGELFMQLER---EGIFMEDTACFYLAEISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKE 170 (327)
T ss_dssp EEEEECCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTSCEEECCCSCC--
T ss_pred EEEEeCCCCCcHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHh---CCEEcccCCHHHeEECCCCcEEEEeCCcccc
Confidence 999999999999999873 4568899999999999999999998 8999999999999999999999999999876
Q ss_pred ccccccceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecc
Q 002336 765 AEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 844 (935)
Q Consensus 765 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~ 844 (935)
...... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...... +....... +..
T Consensus 171 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~~~~~i~~-~~~---- 238 (327)
T 3a62_A 171 SIHDGT-VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRK------KTIDKILK-CKL---- 238 (327)
T ss_dssp ---------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHH-TCC----
T ss_pred cccCCc-cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHH------HHHHHHHh-CCC----
Confidence 433221 223456899999999998888999999999999999999999999743321 11111111 111
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 002336 845 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRP-----KMQEIVLA 884 (935)
Q Consensus 845 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----s~~ev~~~ 884 (935)
. .+......+.+++.+||+.+|++|| +++|+++.
T Consensus 239 --~----~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h 277 (327)
T 3a62_A 239 --N----LPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH 277 (327)
T ss_dssp --C----CCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred --C----CCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence 1 1112234688999999999999999 77787653
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-37 Score=336.79 Aligned_cols=263 Identities=30% Similarity=0.540 Sum_probs=197.0
Q ss_pred hHHHHHHhhcccccccccEEEEEEEECCCcEEEEEEccCcc--hhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEE
Q 002336 609 ELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRIL 686 (935)
Q Consensus 609 ~l~~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~~~~~~--~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~l 686 (935)
|+....+++.+.||+|+||.||+|++. ..||+|+++... ....+.+.+|++++++++||||+++++++. ....++
T Consensus 20 ei~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~~l 96 (289)
T 3og7_A 20 EIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAI 96 (289)
T ss_dssp BCCTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEE
T ss_pred ccCccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeecc-CCccEE
Confidence 344455677899999999999999875 359999986543 344577999999999999999999999764 456899
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccc
Q 002336 687 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 766 (935)
Q Consensus 687 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~ 766 (935)
||||+++++|.+++... ...+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++....
T Consensus 97 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 171 (289)
T 3og7_A 97 VTQWCEGSSLYHHLHAS--ETKFEMKKLIDIARQTARGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKS 171 (289)
T ss_dssp EEECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTTEEEECCCC------
T ss_pred EEEecCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccccCccceEEECCCCCEEEccceeccccc
Confidence 99999999999999643 4668999999999999999999998 899999999999999999999999999997654
Q ss_pred ccc-cceeecccCCccccCCCCCC---CCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeee
Q 002336 767 EDL-THISSVARGTVGYLDPEYYG---NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVIS 842 (935)
Q Consensus 767 ~~~-~~~~~~~~gt~~y~APE~l~---~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~ 842 (935)
... ........||+.|+|||.+. +..++.++||||||+++|+|++|+.||...... ... ...+..+....
T Consensus 172 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~~~----~~~~~~~~~~~ 245 (289)
T 3og7_A 172 RWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR--DQI----IEMVGRGSLSP 245 (289)
T ss_dssp ------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCH--HHH----HHHHHHTSCCC
T ss_pred cccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchH--HHH----HHHhcccccCc
Confidence 321 11223346899999999876 567889999999999999999999999743221 112 22222222211
Q ss_pred cccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhhhh
Q 002336 843 IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 890 (935)
Q Consensus 843 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~~~ 890 (935)
... .........+.+++.+||+.+|++||+++|+++.|+++..
T Consensus 246 ~~~-----~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 246 DLS-----KVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp CTT-----SSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred chh-----hccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 111 1112223478899999999999999999999999998754
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-37 Score=335.39 Aligned_cols=258 Identities=29% Similarity=0.470 Sum_probs=202.1
Q ss_pred HhhcccccccccEEEEEEEECC----CcEEEEEEccCcch-hhhHHHHHHHHHHHhcCCCcccccceee-eccceEEEEE
Q 002336 615 NNFCKKIGKGSFGSVYYGKMKD----GKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYC-EEEHQRILVY 688 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~~----g~~vAvK~~~~~~~-~~~~~~~~E~~iL~~L~HpnIv~l~g~~-~~~~~~~lV~ 688 (935)
+++.+.||+|+||.||+|.+.+ ...+|+|.+..... ...+.+.+|+.++++++||||+++++++ ..++..++||
T Consensus 27 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~ 106 (298)
T 3f66_A 27 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 106 (298)
T ss_dssp EEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEE
T ss_pred hhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEE
Confidence 4567899999999999998653 23589999875433 3457899999999999999999999986 4556789999
Q ss_pred EecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccccc
Q 002336 689 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 768 (935)
Q Consensus 689 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~ 768 (935)
||+++|+|.+++.. ....+++..++.++.|+++||+|||+ ++|+||||||+||+++.++.+||+|||+++.....
T Consensus 107 e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~ql~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 181 (298)
T 3f66_A 107 PYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKYLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 181 (298)
T ss_dssp ECCTTCBHHHHHHC--TTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCG
T ss_pred eCCCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEECCCCCEEECccccccccccc
Confidence 99999999999974 34568999999999999999999998 89999999999999999999999999999876443
Q ss_pred cc---ceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCcccchhHHHHHHHhhhcCCeeecc
Q 002336 769 LT---HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 844 (935)
Q Consensus 769 ~~---~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~ 844 (935)
.. .......+|+.|+|||.+.+..++.++||||+|+++|+|++ |..||...... ..... +..+...
T Consensus 182 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~---~~~~~----~~~~~~~--- 251 (298)
T 3f66_A 182 EYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF---DITVY----LLQGRRL--- 251 (298)
T ss_dssp GGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTT---THHHH----HHTTCCC---
T ss_pred chhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHH---HHHHH----HhcCCCC---
Confidence 21 11233457889999999988889999999999999999999 55566532221 11111 1111110
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhhhhhcc
Q 002336 845 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 893 (935)
Q Consensus 845 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~~~~~~ 893 (935)
.. +......+.+++.+||+.+|++||+++|+++.|+++.....
T Consensus 252 --~~----~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~ 294 (298)
T 3f66_A 252 --LQ----PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 294 (298)
T ss_dssp --CC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSC
T ss_pred --CC----CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence 00 11122368899999999999999999999999999887544
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-37 Score=331.98 Aligned_cols=256 Identities=24% Similarity=0.381 Sum_probs=206.3
Q ss_pred hHHHHHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcchhhhHHHHHHHHHHHhcCCCcccccceeeec-------
Q 002336 609 ELEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEE------- 680 (935)
Q Consensus 609 ~l~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~------- 680 (935)
......|++.+.||+|+||.||+|.+. +++.||+|++.... +.+.+|++++++++||||+++++++..
T Consensus 7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (284)
T 2a19_B 7 KRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPET 82 (284)
T ss_dssp HHHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---
T ss_pred chhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccc
Confidence 445566778899999999999999986 79999999986542 457789999999999999999998754
Q ss_pred ---------cceEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCC
Q 002336 681 ---------EHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN 751 (935)
Q Consensus 681 ---------~~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~ 751 (935)
....++||||+++++|.+++... ....+++..++.++.|++.||.|||+ ++|+||||||+|||++.+
T Consensus 83 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~ 158 (284)
T 2a19_B 83 SSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR-RGEKLDKVLALELFEQITKGVDYIHS---KKLINRDLKPSNIFLVDT 158 (284)
T ss_dssp ------CCEEEEEEEEECCCCSCBHHHHHHHG-GGSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEET
T ss_pred ccccccccCcceEEEEEeccCCCCHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHEEEcCC
Confidence 45579999999999999999743 24568999999999999999999998 899999999999999999
Q ss_pred CcEEEeeccccccccccccceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHH
Q 002336 752 MRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWA 831 (935)
Q Consensus 752 ~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~ 831 (935)
+.+||+|||++........ .....|++.|+|||.+.+..++.++||||||+++|||++|..|+... ....
T Consensus 159 ~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~--------~~~~ 228 (284)
T 2a19_B 159 KQVKIGDFGLVTSLKNDGK--RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET--------SKFF 228 (284)
T ss_dssp TEEEECCCTTCEESSCCSC--CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH--------HHHH
T ss_pred CCEEECcchhheecccccc--ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH--------HHHH
Confidence 9999999999987654322 22345899999999998888999999999999999999999887411 1111
Q ss_pred HHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhhhhhccCC
Q 002336 832 RSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKGG 895 (935)
Q Consensus 832 ~~~i~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~~~~~~~~ 895 (935)
..+..+.. ...++ ..+.+++.+||+.||++||++.|+++.|+.+....+..
T Consensus 229 -~~~~~~~~--------~~~~~----~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~~~ 279 (284)
T 2a19_B 229 -TDLRDGII--------SDIFD----KKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKN 279 (284)
T ss_dssp -HHHHTTCC--------CTTSC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-----
T ss_pred -HHhhcccc--------cccCC----HHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCCcc
Confidence 11222211 11122 35789999999999999999999999999887655543
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=354.22 Aligned_cols=251 Identities=23% Similarity=0.336 Sum_probs=200.7
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcch---hhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEE
Q 002336 614 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 689 (935)
Q Consensus 614 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~---~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E 689 (935)
.+++.+.||+|+||.||+|+++ +++.||+|++..... ...+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 70 ~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E 149 (410)
T 3v8s_A 70 DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVME 149 (410)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 3455789999999999999986 588999999865321 223458899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccc
Q 002336 690 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 769 (935)
Q Consensus 690 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~ 769 (935)
|+++|+|.++++. ..+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 150 ~~~gg~L~~~l~~----~~~~e~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~ 222 (410)
T 3v8s_A 150 YMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG 222 (410)
T ss_dssp CCTTEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS
T ss_pred CCCCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeeECCCCCEEEeccceeEeeccCC
Confidence 9999999999973 358999999999999999999998 899999999999999999999999999998765543
Q ss_pred cceeecccCCccccCCCCCCCCC----CCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeeccc
Q 002336 770 THISSVARGTVGYLDPEYYGNQQ----LTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 845 (935)
Q Consensus 770 ~~~~~~~~gt~~y~APE~l~~~~----~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d 845 (935)
........||+.|+|||++.+.. ++.++|||||||++|||++|+.||...+... ... ...........
T Consensus 223 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~---~~~---~i~~~~~~~~~-- 294 (410)
T 3v8s_A 223 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG---TYS---KIMNHKNSLTF-- 294 (410)
T ss_dssp EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHH---HHH---HHHTHHHHCCC--
T ss_pred cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhh---HHH---HHHhccccccC--
Confidence 33344567999999999986554 7899999999999999999999997433221 111 11110000000
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 002336 846 PVLIGNVKIESIWRIAEVAIQCVEQRGFS--RPKMQEIVLA 884 (935)
Q Consensus 846 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~--RPs~~ev~~~ 884 (935)
+ . .......+.+++.+||+.+|++ ||+++||.+.
T Consensus 295 p---~--~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 295 P---D--DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp C---T--TCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred C---C--cccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 0 0 0011236789999999999988 9999999865
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-37 Score=339.50 Aligned_cols=262 Identities=21% Similarity=0.309 Sum_probs=189.5
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcch-hhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEec
Q 002336 614 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 691 (935)
Q Consensus 614 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~-~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~ 691 (935)
.|++.+.||+|+||.||+|... +|+.||+|++..... ...+.+.+|++++++++||||+++++++..++..++||||+
T Consensus 6 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 85 (317)
T 2pmi_A 6 QFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFM 85 (317)
T ss_dssp -------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEECC
T ss_pred ceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEec
Confidence 4667889999999999999876 689999999865432 23467889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCC---CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccccc
Q 002336 692 HNGTLRDRLHGSV---NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 768 (935)
Q Consensus 692 ~~gsL~~~L~~~~---~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~ 768 (935)
+ |+|.+++.... ....+++..+..++.|+++||+|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 86 ~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 161 (317)
T 2pmi_A 86 D-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE---NKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIP 161 (317)
T ss_dssp C-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCSSCEETTSC
T ss_pred C-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCChHHeEEcCCCCEEECcCccceecCCC
Confidence 8 59998876421 23468999999999999999999998 89999999999999999999999999999876433
Q ss_pred ccceeecccCCccccCCCCCCC-CCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcC--C-eeec-
Q 002336 769 LTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG--D-VISI- 843 (935)
Q Consensus 769 ~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~--~-~~~~- 843 (935)
... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+ ....+.+..... . ....
T Consensus 162 ~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~i~~~~~~~~~~~~~~~~ 237 (317)
T 2pmi_A 162 VNT-FSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEE---QLKLIFDIMGTPNESLWPSVT 237 (317)
T ss_dssp CCC-CCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCSCCTTTCGGGG
T ss_pred ccc-CCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHhCCCChhHhhhhh
Confidence 221 223458999999998876 468999999999999999999999997443321 111111111100 0 0000
Q ss_pred ----ccccc------------cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 844 ----VDPVL------------IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 844 ----~d~~l------------~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
..+.. ...........+.+++.+||+.||++|||++|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 238 KLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp GCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 00000 00000112236889999999999999999999875
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-37 Score=334.80 Aligned_cols=260 Identities=27% Similarity=0.403 Sum_probs=205.0
Q ss_pred hhcccccccccEEEEEEEECC-C---cEEEEEEccCcch-hhhHHHHHHHHHHHhcCCCcccccceeeeccceE-EEEEE
Q 002336 616 NFCKKIGKGSFGSVYYGKMKD-G---KEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQR-ILVYE 689 (935)
Q Consensus 616 ~~~~~LG~G~fG~Vy~~~~~~-g---~~vAvK~~~~~~~-~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~-~lV~E 689 (935)
+..+.||+|+||.||+|.+.+ + ..+|+|.+..... ...+.+.+|+.++++++||||+++++++.+.+.. ++|||
T Consensus 24 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e 103 (298)
T 3pls_A 24 HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLP 103 (298)
T ss_dssp EEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEEC
T ss_pred ccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEe
Confidence 345889999999999998642 2 3799999875433 3457899999999999999999999999766655 99999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccc
Q 002336 690 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 769 (935)
Q Consensus 690 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~ 769 (935)
|+.+|+|.+++.. ....+++..++.++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 104 ~~~~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 178 (298)
T 3pls_A 104 YMCHGDLLQFIRS--PQRNPTVKDLISFGLQVARGMEYLAE---QKFVHRDLAARNCMLDESFTVKVADFGLARDILDRE 178 (298)
T ss_dssp CCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGG
T ss_pred cccCCCHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCc
Confidence 9999999999975 34678999999999999999999998 899999999999999999999999999998654322
Q ss_pred c---ceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccc
Q 002336 770 T---HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP 846 (935)
Q Consensus 770 ~---~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~ 846 (935)
. .......+++.|+|||.+.+..++.++||||||+++|+|++|..|+..... ....... +..+....
T Consensus 179 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~--~~~~~~~----~~~~~~~~---- 248 (298)
T 3pls_A 179 YYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHID--PFDLTHF----LAQGRRLP---- 248 (298)
T ss_dssp GGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC--GGGHHHH----HHTTCCCC----
T ss_pred ccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCC--HHHHHHH----hhcCCCCC----
Confidence 1 122334578899999999999999999999999999999996655432211 1122221 11111100
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhhhhhccCC
Q 002336 847 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKGG 895 (935)
Q Consensus 847 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~~~~~~~~ 895 (935)
.+......+.+++.+||+.+|++|||++|+++.|+++.......
T Consensus 249 -----~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~~ 292 (298)
T 3pls_A 249 -----QPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGD 292 (298)
T ss_dssp -----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCSC
T ss_pred -----CCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhcc
Confidence 11112246889999999999999999999999999988765543
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-37 Score=342.63 Aligned_cols=272 Identities=24% Similarity=0.384 Sum_probs=196.6
Q ss_pred HHhhcccccccccEEEEEEEECCCcEEEEEEccCcchhhhHHHHHHHHH--HHhcCCCcccccceeee-----ccceEEE
Q 002336 614 TNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVAL--LSRIHHRNLVPLIGYCE-----EEHQRIL 686 (935)
Q Consensus 614 ~~~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~i--L~~L~HpnIv~l~g~~~-----~~~~~~l 686 (935)
.+++.+.||+|+||.||+|++. ++.||||++.... ...+..|.++ +..++||||+++++.+. .....++
T Consensus 14 ~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~l 89 (336)
T 3g2f_A 14 NLKLLELIGRGRYGAVYKGSLD-ERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLL 89 (336)
T ss_dssp SEEEEEEEEECSSEEEEEEEET-TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEE
T ss_pred HhheeeecccCCCeEEEEEEEC-CeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEE
Confidence 3566789999999999999874 8999999986432 2344445444 44589999999998543 3346789
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCC---------ceEecCCCCCCccccCCCcEEEe
Q 002336 687 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP---------GIIHRDVKSSNILLDINMRAKVS 757 (935)
Q Consensus 687 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~---------~ivH~DLkp~NILld~~~~vkL~ 757 (935)
||||+++|+|.+++.. ...++..+.+++.|+++||+|||+ . +|+||||||+|||++.++.+||+
T Consensus 90 v~e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~~L~~LH~---~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~ 162 (336)
T 3g2f_A 90 VMEYYPNGSLXKYLSL----HTSDWVSSCRLAHSVTRGLAYLHT---ELPRGDHYKPAISHRDLNSRNVLVKNDGTCVIS 162 (336)
T ss_dssp EECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHC---CBCCGGGCBCCEECSSCSGGGEEECTTSCEEEC
T ss_pred EEecCCCCcHHHHHhh----cccchhHHHHHHHHHHHHHHHHHh---hhccccccccceeecccccceEEEcCCCcEEEe
Confidence 9999999999999974 345889999999999999999997 6 99999999999999999999999
Q ss_pred ecccccccccccc-------ceeecccCCccccCCCCCCC-------CCCCchhHHHHHHHHHHHHHhCCCCCCccCccc
Q 002336 758 DFGLSRQAEEDLT-------HISSVARGTVGYLDPEYYGN-------QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGA 823 (935)
Q Consensus 758 DFGla~~~~~~~~-------~~~~~~~gt~~y~APE~l~~-------~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~ 823 (935)
|||+++....... .......||+.|+|||++.+ ..++.++||||||+++|||++|..|+.......
T Consensus 163 DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~ 242 (336)
T 3g2f_A 163 DFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVP 242 (336)
T ss_dssp CCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCC
T ss_pred eccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchh
Confidence 9999987543211 11223468999999999876 456679999999999999999977764222211
Q ss_pred c-hh----------HHHHHHHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhhhhhc
Q 002336 824 E-LN----------IVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 892 (935)
Q Consensus 824 ~-~~----------l~~~~~~~i~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~~~~~ 892 (935)
. .. .................+.... .........+.+++.+||+.||++|||++|+++.|++++..-
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~ 320 (336)
T 3g2f_A 243 EYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAW--KENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIW 320 (336)
T ss_dssp CCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTC--CCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCC
T ss_pred HHHHhhhcccCCCchHHHHHhhhcccccCCCCCccc--ccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHH
Confidence 1 00 0011111111111111111111 112235567999999999999999999999999999988765
Q ss_pred cCCCCC
Q 002336 893 KGGDQK 898 (935)
Q Consensus 893 ~~~~~~ 898 (935)
.+....
T Consensus 321 ~~~~~~ 326 (336)
T 3g2f_A 321 ERNKSV 326 (336)
T ss_dssp CC----
T ss_pred HhcccC
Confidence 554433
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=348.85 Aligned_cols=271 Identities=22% Similarity=0.309 Sum_probs=212.1
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCcch-hhhHHHHHHHHHHHhcCCCcccccceeeeccc--eEEEEEEe
Q 002336 615 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH--QRILVYEY 690 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~-~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~--~~~lV~E~ 690 (935)
|.+.+.||+|+||.||+|.+. +|+.||||++..... ...+.+.+|++++++++||||+++++++.... ..++||||
T Consensus 11 y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~ 90 (396)
T 4eut_A 11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEF 90 (396)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEECC
T ss_pred eEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEec
Confidence 556789999999999999886 589999999875432 33467889999999999999999999987655 77999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccc----cCCCcEEEeecccccccc
Q 002336 691 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL----DINMRAKVSDFGLSRQAE 766 (935)
Q Consensus 691 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILl----d~~~~vkL~DFGla~~~~ 766 (935)
+++|+|.+++........+++..++.++.|++.||+|||+ .+|+||||||+|||+ +.++.+||+|||+++...
T Consensus 91 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~ 167 (396)
T 4eut_A 91 CPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE 167 (396)
T ss_dssp CTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEECC
T ss_pred CCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHH---CCEEECCcCHHHEEEeecCCCceeEEEecCCCceEcc
Confidence 9999999999865444559999999999999999999998 899999999999999 778889999999998765
Q ss_pred ccccceeecccCCccccCCCCCCC--------CCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcC
Q 002336 767 EDLTHISSVARGTVGYLDPEYYGN--------QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG 838 (935)
Q Consensus 767 ~~~~~~~~~~~gt~~y~APE~l~~--------~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~ 838 (935)
.... .....||+.|+|||++.. ..++.++|||||||++|||++|+.||........ ..+.+...+...
T Consensus 168 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~--~~~~~~~~~~~~ 243 (396)
T 4eut_A 168 DDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRR--NKEVMYKIITGK 243 (396)
T ss_dssp CGGG--SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTT--CHHHHHHHHHSC
T ss_pred CCCc--cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccc--hHHHHHHHhcCC
Confidence 4322 223458999999998754 4677899999999999999999999964332211 111222222211
Q ss_pred C---eeecc-----------cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhhhhhc
Q 002336 839 D---VISIV-----------DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 892 (935)
Q Consensus 839 ~---~~~~~-----------d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~~~~~ 892 (935)
. ..... +..............+.+++.+||+.||++||+++|+++.+++++...
T Consensus 244 p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~~ 311 (396)
T 4eut_A 244 PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRM 311 (396)
T ss_dssp CTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTCE
T ss_pred CcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhce
Confidence 1 10000 001112334567778899999999999999999999999998877643
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=328.88 Aligned_cols=249 Identities=20% Similarity=0.273 Sum_probs=202.6
Q ss_pred HHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcchhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEec
Q 002336 613 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 691 (935)
Q Consensus 613 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~ 691 (935)
..|.+.+.||+|+||.||+|... +++.+|+|++........+.+.+|++++++++||||+++++++.+....++||||+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 88 (277)
T 3f3z_A 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELC 88 (277)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEecc
Confidence 45777899999999999999876 57799999987665556678999999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccc---cCCCcEEEeecccccccccc
Q 002336 692 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEED 768 (935)
Q Consensus 692 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILl---d~~~~vkL~DFGla~~~~~~ 768 (935)
++++|.+.+.. ...+++..+..++.|+++||+|||+ ++|+||||||+||++ +.++.+||+|||++......
T Consensus 89 ~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~ 162 (277)
T 3f3z_A 89 TGGELFERVVH---KRVFRESDAARIMKDVLSAVAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG 162 (277)
T ss_dssp CSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTT
T ss_pred CCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCc
Confidence 99999998873 4568999999999999999999998 899999999999999 78899999999999876543
Q ss_pred ccceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccccc
Q 002336 769 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 848 (935)
Q Consensus 769 ~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l 848 (935)
.. .....||+.|+|||.+.+. ++.++||||||+++|||++|+.||....... . ...+..+.... ....
T Consensus 163 ~~--~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---~----~~~~~~~~~~~--~~~~ 230 (277)
T 3f3z_A 163 KM--MRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSE---V----MLKIREGTFTF--PEKD 230 (277)
T ss_dssp SC--BCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---H----HHHHHHCCCCC--CHHH
T ss_pred cc--hhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHH---H----HHHHHhCCCCC--Cchh
Confidence 22 2334689999999988664 8999999999999999999999997433211 1 11122221100 0000
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 849 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 849 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
.. .....+.+++.+||+.+|++||++.|+++
T Consensus 231 ~~----~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 231 WL----NVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp HT----TSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred hh----cCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00 11246889999999999999999999975
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-37 Score=339.56 Aligned_cols=259 Identities=24% Similarity=0.372 Sum_probs=195.2
Q ss_pred HHhhcccccccccEEEEEEEE-CCCcEEEEEEccCcc---hhhhHHHHHHHHHHHhcCCCcccccceeeeccce----EE
Q 002336 614 TNNFCKKIGKGSFGSVYYGKM-KDGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQ----RI 685 (935)
Q Consensus 614 ~~~~~~~LG~G~fG~Vy~~~~-~~g~~vAvK~~~~~~---~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~----~~ 685 (935)
.|++.+.||+|+||.||+|.+ .+++.||||++.... ......+.+|++++++++||||+++++++..... .+
T Consensus 13 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~ 92 (311)
T 3ork_A 13 RYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPY 92 (311)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred cEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcccE
Confidence 466789999999999999987 478999999987542 2334678999999999999999999999876543 49
Q ss_pred EEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccc
Q 002336 686 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 765 (935)
Q Consensus 686 lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~ 765 (935)
+||||+++++|.+++.. ...+++..++.++.|+++||+|||+ ++|+||||||+|||++.++.+||+|||+++..
T Consensus 93 lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~ 166 (311)
T 3ork_A 93 IVMEYVDGVTLRDIVHT---EGPMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAI 166 (311)
T ss_dssp EEEECCCEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEETTSCEEECCCSCC---
T ss_pred EEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEcCCCCEEEeeccCcccc
Confidence 99999999999999973 4568999999999999999999998 89999999999999999999999999999875
Q ss_pred cccccc--eeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeec
Q 002336 766 EEDLTH--ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISI 843 (935)
Q Consensus 766 ~~~~~~--~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~ 843 (935)
...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||...... ..............
T Consensus 167 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~------~~~~~~~~~~~~~~- 239 (311)
T 3ork_A 167 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV------SVAYQHVREDPIPP- 239 (311)
T ss_dssp ---------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHHCCCCCH-
T ss_pred cccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHhcCCCCCc-
Confidence 443221 122345899999999999889999999999999999999999999743221 11112222211110
Q ss_pred ccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHH-HHHHHhhhhhh
Q 002336 844 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQE-IVLAIQDSIKI 891 (935)
Q Consensus 844 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~e-v~~~L~~~~~~ 891 (935)
.... ......+.+++.+||+.||++||+..+ +...|......
T Consensus 240 --~~~~----~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~ 282 (311)
T 3ork_A 240 --SARH----EGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNG 282 (311)
T ss_dssp --HHHS----TTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTT
T ss_pred --cccc----CCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcC
Confidence 0000 112236889999999999999996555 44555555443
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=347.38 Aligned_cols=245 Identities=24% Similarity=0.369 Sum_probs=199.8
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc---hhhhHHHHHHHHHHHhc-CCCcccccceeeeccceEEEEE
Q 002336 614 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVY 688 (935)
Q Consensus 614 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~iL~~L-~HpnIv~l~g~~~~~~~~~lV~ 688 (935)
.+.+.+.||+|+||.||+|+++ +|+.||+|+++... ....+.+..|..++..+ +||||+++++++.+.+..++||
T Consensus 18 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv~ 97 (345)
T 1xjd_A 18 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVM 97 (345)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEE
T ss_pred HeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEEE
Confidence 3566889999999999999986 68999999987532 22345678899999887 8999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccccc
Q 002336 689 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 768 (935)
Q Consensus 689 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~ 768 (935)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 98 E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 171 (345)
T 1xjd_A 98 EYLNGGDLMYHIQS---CHKFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG 171 (345)
T ss_dssp ECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred eCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCChhhEEECCCCCEEEeEChhhhhcccC
Confidence 99999999999974 3568999999999999999999998 89999999999999999999999999999864322
Q ss_pred ccceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccccc
Q 002336 769 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 848 (935)
Q Consensus 769 ~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l 848 (935)
.. ......||+.|+|||++.+..++.++||||+||++|||++|+.||...+.. .+. ..+..+.. .+
T Consensus 172 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~---~~~----~~i~~~~~------~~ 237 (345)
T 1xjd_A 172 DA-KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE---ELF----HSIRMDNP------FY 237 (345)
T ss_dssp TC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHH----HHHHHCCC------CC
T ss_pred CC-cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHH---HHH----HHHHhCCC------CC
Confidence 21 233456999999999999989999999999999999999999999743321 111 11222211 11
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHH-HHH
Q 002336 849 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQ-EIV 882 (935)
Q Consensus 849 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~-ev~ 882 (935)
+......+.+++.+||+.+|++||++. |+.
T Consensus 238 ----p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 238 ----PRWLEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp ----CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred ----CcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 111223678999999999999999997 654
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-37 Score=337.74 Aligned_cols=260 Identities=23% Similarity=0.306 Sum_probs=197.0
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCcch--hhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEec
Q 002336 615 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 691 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~--~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~ 691 (935)
|++.+.||+|+||.||+|.+. +|+.||+|++..... ...+.+.+|++++++++||||+++++++...+..++||||+
T Consensus 5 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (311)
T 4agu_A 5 YEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYC 84 (311)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred ceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEeC
Confidence 456789999999999999986 589999998865433 23467889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccccc
Q 002336 692 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 771 (935)
Q Consensus 692 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~ 771 (935)
++++|.+++. ....+++..+..++.|+++||+|||+ ++|+||||||+||+++.++.+||+|||++.........
T Consensus 85 ~~~~l~~~~~---~~~~~~~~~~~~i~~~l~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 158 (311)
T 4agu_A 85 DHTVLHELDR---YQRGVPEHLVKSITWQTLQAVNFCHK---HNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDY 158 (311)
T ss_dssp SEEHHHHHHH---TSSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred CCchHHHHHh---hhcCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccc
Confidence 9999999887 34568999999999999999999998 89999999999999999999999999999876533222
Q ss_pred eeecccCCccccCCCCCCC-CCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhh-----------cCC
Q 002336 772 ISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIK-----------KGD 839 (935)
Q Consensus 772 ~~~~~~gt~~y~APE~l~~-~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~-----------~~~ 839 (935)
.....|++.|+|||.+.+ ..++.++||||+|+++|+|++|+.||......+.... +..... ...
T Consensus 159 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 234 (311)
T 4agu_A 159 -YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYL---IRKTLGDLIPRHQQVFSTNQ 234 (311)
T ss_dssp --------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH---HHHHHCSCCHHHHHHHHTCG
T ss_pred -cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHHhccccccccccccccc
Confidence 223458999999998865 6789999999999999999999999975443222111 111110 000
Q ss_pred ee---ecccccccCC---CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002336 840 VI---SIVDPVLIGN---VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 884 (935)
Q Consensus 840 ~~---~~~d~~l~~~---~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~ 884 (935)
.. ...++.-... ........+.+++.+||+.||++|||++|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 235 YFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp GGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred ccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 00 0000000000 001123368899999999999999999999864
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-37 Score=352.30 Aligned_cols=253 Identities=24% Similarity=0.251 Sum_probs=200.1
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc---hhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEE
Q 002336 614 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 689 (935)
Q Consensus 614 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E 689 (935)
.+++.+.||+|+||.||+++++ +|+.||+|++.... ....+.+.+|..++..++||||+++++++.+.+..++|||
T Consensus 62 ~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVmE 141 (412)
T 2vd5_A 62 DFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVME 141 (412)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEEC
T ss_pred hEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEc
Confidence 3455789999999999999986 69999999986532 1233568899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccc
Q 002336 690 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 769 (935)
Q Consensus 690 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~ 769 (935)
|+++|+|.+++... +..+++..+..++.||+.||+|||+ ++|+||||||+|||++.++++||+|||+++......
T Consensus 142 ~~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~ 216 (412)
T 2vd5_A 142 YYVGGDLLTLLSKF--GERIPAEMARFYLAEIVMAIDSVHR---LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADG 216 (412)
T ss_dssp CCCSCBHHHHHHHH--SSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS
T ss_pred CCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccCHHHeeecCCCCEEEeechhheeccCCC
Confidence 99999999999742 3468999999999999999999998 899999999999999999999999999998765443
Q ss_pred cceeecccCCccccCCCCCC-------CCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeee
Q 002336 770 THISSVARGTVGYLDPEYYG-------NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVIS 842 (935)
Q Consensus 770 ~~~~~~~~gt~~y~APE~l~-------~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~ 842 (935)
........||+.|+|||++. ...++.++|||||||++|||++|+.||...+..+ ....+......-..
T Consensus 217 ~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~---~~~~i~~~~~~~~~-- 291 (412)
T 2vd5_A 217 TVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAE---TYGKIVHYKEHLSL-- 291 (412)
T ss_dssp CEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHH---HHHHHHTHHHHCCC--
T ss_pred ccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHH---HHHHHHhcccCcCC--
Confidence 33334457999999999886 4578999999999999999999999997433221 11111100000000
Q ss_pred cccccccCCCCHHHHHHHHHHHHHccccCCCCC---CCHHHHHHH
Q 002336 843 IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSR---PKMQEIVLA 884 (935)
Q Consensus 843 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~R---Ps~~ev~~~ 884 (935)
+..... ....+.+++.+||. +|++| |+++|+.+.
T Consensus 292 ---p~~~~~----~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 292 ---PLVDEG----VPEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp ---C----C----CCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred ---CccccC----CCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 111111 22367899999999 99998 689998754
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=342.70 Aligned_cols=248 Identities=24% Similarity=0.332 Sum_probs=186.9
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcchhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEecC
Q 002336 614 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 692 (935)
Q Consensus 614 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~~ 692 (935)
.|++.+.||+|+||.||+|.+. +++.||||++.... ..+.+.+|++++++++||||+++++++.+.+..++||||++
T Consensus 54 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 131 (349)
T 2w4o_A 54 FFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVT 131 (349)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred cEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCC
Confidence 4566889999999999999987 58899999987542 34678899999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccC---CCcEEEeeccccccccccc
Q 002336 693 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI---NMRAKVSDFGLSRQAEEDL 769 (935)
Q Consensus 693 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~---~~~vkL~DFGla~~~~~~~ 769 (935)
+|+|.+++.. ...+++.+++.++.|+++||.|||+ .+|+||||||+|||++. ++.+||+|||+++......
T Consensus 132 ~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~ 205 (349)
T 2w4o_A 132 GGELFDRIVE---KGYYSERDAADAVKQILEAVAYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV 205 (349)
T ss_dssp SCBHHHHHTT---CSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESSSSTTCCEEECCCC---------
T ss_pred CCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCcccEEEecCCCCCCEEEccCccccccCccc
Confidence 9999999873 4568999999999999999999998 89999999999999975 8899999999998654322
Q ss_pred cceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeeccccccc
Q 002336 770 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 849 (935)
Q Consensus 770 ~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~ 849 (935)
. .....||+.|+|||++.+..++.++|||||||++|||++|+.||....... .....+..+... ...+
T Consensus 206 ~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~------~~~~~i~~~~~~-~~~~--- 273 (349)
T 2w4o_A 206 L--MKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQ------FMFRRILNCEYY-FISP--- 273 (349)
T ss_dssp ---------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHH------HHHHHHHTTCCC-CCTT---
T ss_pred c--cccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccH------HHHHHHHhCCCc-cCCc---
Confidence 1 233468999999999999899999999999999999999999996332211 111122222111 0111
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 850 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 850 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
........+.+++.+||+.||++|||++|+++
T Consensus 274 --~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 274 --WWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp --TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred --hhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11122346889999999999999999999876
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-37 Score=342.69 Aligned_cols=261 Identities=29% Similarity=0.482 Sum_probs=203.3
Q ss_pred HHHHhhcccccccccEEEEEEEECC-----CcEEEEEEccCcc-hhhhHHHHHHHHHHHhcCCCcccccceeeeccceEE
Q 002336 612 EATNNFCKKIGKGSFGSVYYGKMKD-----GKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRI 685 (935)
Q Consensus 612 ~~~~~~~~~LG~G~fG~Vy~~~~~~-----g~~vAvK~~~~~~-~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~ 685 (935)
...+.+.+.||+|+||.||+|.+.. +..||+|+++... ......+.+|++++++++||||+++++++...+..+
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 122 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 122 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence 3445567899999999999998753 2469999987543 334567999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccc
Q 002336 686 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 765 (935)
Q Consensus 686 lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~ 765 (935)
+||||+++|+|.+++... ...+++..++.++.|+++||+|||+ ++|+||||||+|||++.++.+||+|||+++..
T Consensus 123 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 197 (333)
T 1mqb_A 123 IITEYMENGALDKFLREK--DGEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVL 197 (333)
T ss_dssp EEEECCTTEEHHHHHHHT--TTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EEEeCCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChheEEECCCCcEEECCCCcchhh
Confidence 999999999999999753 4568999999999999999999998 89999999999999999999999999999876
Q ss_pred cccccc--eeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCcccchhHHHHHHHhhhcCCeee
Q 002336 766 EEDLTH--ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVIS 842 (935)
Q Consensus 766 ~~~~~~--~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~ 842 (935)
...... ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||...... ... ..+..+....
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~---~~~----~~~~~~~~~~ 270 (333)
T 1mqb_A 198 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH---EVM----KAINDGFRLP 270 (333)
T ss_dssp -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHH----HHHHTTCCCC
T ss_pred ccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHH---HHH----HHHHCCCcCC
Confidence 543221 1122345788999999988899999999999999999999 99999633221 111 1222221100
Q ss_pred cccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhhhhhcc
Q 002336 843 IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 893 (935)
Q Consensus 843 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~~~~~~ 893 (935)
.+......+.+++.+||+.+|++||++.|+++.|+++.....
T Consensus 271 ---------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~ 312 (333)
T 1mqb_A 271 ---------TPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPD 312 (333)
T ss_dssp ---------CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGG
T ss_pred ---------CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcch
Confidence 111223468899999999999999999999999998876443
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=341.93 Aligned_cols=268 Identities=20% Similarity=0.203 Sum_probs=199.9
Q ss_pred HHHHHHhhcccccccccEEEEEEEEC----CCcEEEEEEccCcchh-----------hhHHHHHHHHHHHhcCCCccccc
Q 002336 610 LEEATNNFCKKIGKGSFGSVYYGKMK----DGKEVAVKIMADSCSH-----------RTQQFVTEVALLSRIHHRNLVPL 674 (935)
Q Consensus 610 l~~~~~~~~~~LG~G~fG~Vy~~~~~----~g~~vAvK~~~~~~~~-----------~~~~~~~E~~iL~~L~HpnIv~l 674 (935)
+....|.+.+.||+|+||.||+|.+. .+..+|+|++...... ....+.+|+..++.++||||+++
T Consensus 34 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~ 113 (345)
T 2v62_A 34 MEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLF 113 (345)
T ss_dssp TTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCE
T ss_pred ccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCccee
Confidence 33345677899999999999999986 5788999998754321 12346788999999999999999
Q ss_pred ceeeec----cceEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccC
Q 002336 675 IGYCEE----EHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI 750 (935)
Q Consensus 675 ~g~~~~----~~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~ 750 (935)
++++.. ....++||||+ +++|.+++... ..+++..++.++.|+++||+|||+ ++|+||||||+|||++.
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~ 186 (345)
T 2v62_A 114 YGSGLTEFKGRSYRFMVMERL-GIDLQKISGQN---GTFKKSTVLQLGIRMLDVLEYIHE---NEYVHGDIKAANLLLGY 186 (345)
T ss_dssp EEEEEEESSSCEEEEEEEECE-EEEHHHHCBGG---GBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEES
T ss_pred ecccccccCCCcEEEEEEecc-CCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCcCHHHEEEcc
Confidence 999877 67899999999 99999999743 379999999999999999999998 89999999999999998
Q ss_pred CC--cEEEeeccccccccccccc------eeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcc
Q 002336 751 NM--RAKVSDFGLSRQAEEDLTH------ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFG 822 (935)
Q Consensus 751 ~~--~vkL~DFGla~~~~~~~~~------~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~ 822 (935)
++ .+||+|||+++........ ......||+.|+|||++.+..++.++||||||+++|||++|+.||......
T Consensus 187 ~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~ 266 (345)
T 2v62_A 187 KNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKD 266 (345)
T ss_dssp SSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTC
T ss_pred CCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccc
Confidence 77 9999999999876433211 113346899999999999889999999999999999999999999632221
Q ss_pred cchhHHHHHHHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhhhh
Q 002336 823 AELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 890 (935)
Q Consensus 823 ~~~~l~~~~~~~i~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~~~ 890 (935)
. ............. ....+..... .......+.+++.+||+.+|++||++++|++.|++...
T Consensus 267 -~-~~~~~~~~~~~~~-~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 267 -P-VAVQTAKTNLLDE-LPQSVLKWAP---SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp -H-HHHHHHHHHHHHT-TTHHHHHHSC---TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred -c-HHHHHHHHhhccc-ccHHHHhhcc---ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 1 1111111111111 1111100000 00122368899999999999999999999999987654
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-36 Score=334.62 Aligned_cols=251 Identities=24% Similarity=0.327 Sum_probs=204.3
Q ss_pred HHHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcchh------hhHHHHHHHHHHHhcCCCcccccceeeeccceE
Q 002336 612 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSH------RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQR 684 (935)
Q Consensus 612 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~~------~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~ 684 (935)
...|++.+.||+|+||.||+|... +|+.||+|++...... ..+.+.+|+.++++++||||+++++++.+....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 456778999999999999999886 6899999998654321 246799999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCC----cEEEeecc
Q 002336 685 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM----RAKVSDFG 760 (935)
Q Consensus 685 ~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~----~vkL~DFG 760 (935)
++||||+++++|.+++.. ...+++..+..++.|+++||+|||+ .+|+||||||+||+++.++ .+||+|||
T Consensus 91 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~---~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg 164 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (321)
T ss_dssp EEEECCCCSCBHHHHHHT---CSCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEECCCT
T ss_pred EEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChHHEEEecCCCCcCCEEEccCc
Confidence 999999999999999973 4568999999999999999999998 8999999999999999888 79999999
Q ss_pred ccccccccccceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCe
Q 002336 761 LSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV 840 (935)
Q Consensus 761 la~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~ 840 (935)
++........ .....||+.|+|||.+.+..++.++||||||+++|+|++|+.||...... +.... +.....
T Consensus 165 ~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~~~~-i~~~~~ 235 (321)
T 2a2a_A 165 LAHEIEDGVE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ------ETLAN-ITSVSY 235 (321)
T ss_dssp TCEECCTTCC--CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH------HHHHH-HHTTCC
T ss_pred cceecCcccc--ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHH------HHHHH-HHhccc
Confidence 9987654322 22345899999999999889999999999999999999999999743221 11111 111111
Q ss_pred eecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 841 ISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 841 ~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
..++...... ...+.+++.+||+.||++|||++|+++
T Consensus 236 --~~~~~~~~~~----~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 236 --DFDEEFFSHT----SELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp --CCCHHHHTTC----CHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred --ccChhhhccc----CHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 0111111111 236889999999999999999999986
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-36 Score=326.09 Aligned_cols=251 Identities=25% Similarity=0.375 Sum_probs=202.7
Q ss_pred HHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc-hhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEe
Q 002336 613 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 690 (935)
Q Consensus 613 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~-~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~ 690 (935)
..|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 86 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 86 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEe
Confidence 45677899999999999999886 68999999986432 23457789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccccccc
Q 002336 691 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 770 (935)
Q Consensus 691 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~ 770 (935)
+++++|.+++. ....+++..+..++.|+++||+|||+ ++++||||||+||+++.++.+||+|||++........
T Consensus 87 ~~~~~L~~~l~---~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 160 (276)
T 2yex_A 87 CSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 160 (276)
T ss_dssp CTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred cCCCcHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcc
Confidence 99999999987 34579999999999999999999998 8999999999999999999999999999976543221
Q ss_pred -ceeecccCCccccCCCCCCCCCC-CchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccccc
Q 002336 771 -HISSVARGTVGYLDPEYYGNQQL-TEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 848 (935)
Q Consensus 771 -~~~~~~~gt~~y~APE~l~~~~~-s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l 848 (935)
.......|++.|+|||.+.+..+ +.++||||||+++|||++|+.||...... ......|.. .... ..+
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~----~~~~---~~~-- 230 (276)
T 2yex_A 161 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS-CQEYSDWKE----KKTY---LNP-- 230 (276)
T ss_dssp ECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTT-SHHHHHHHT----TCTT---STT--
T ss_pred hhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchH-HHHHHHhhh----cccc---cCc--
Confidence 12234568999999999987665 78999999999999999999999743322 112222211 1000 000
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 849 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 849 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
.......+.+++.+||+.+|++|||++|+++
T Consensus 231 ----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 231 ----WKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp ----GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ----hhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 0112236789999999999999999999875
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=329.03 Aligned_cols=246 Identities=27% Similarity=0.424 Sum_probs=180.5
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCcchh---hhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEe
Q 002336 615 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSH---RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 690 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~~---~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~ 690 (935)
|++.+.||+|+||.||+|+.. +|+.||+|++...... ..+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 13 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 92 (278)
T 3cok_A 13 FKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEM 92 (278)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEec
Confidence 566789999999999999874 7999999998643221 236789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccccccc
Q 002336 691 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 770 (935)
Q Consensus 691 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~ 770 (935)
+++++|.+++... ...+++..++.++.|+++||+|||+ .+|+||||||+||+++.++.+||+|||++........
T Consensus 93 ~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 167 (278)
T 3cok_A 93 CHNGEMNRYLKNR--VKPFSENEARHFMHQIITGMLYLHS---HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHE 167 (278)
T ss_dssp CTTEEHHHHHHTC--SSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSSCCGGGEEECTTCCEEECCCTTCEECC----
T ss_pred CCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCC
Confidence 9999999999742 3568999999999999999999998 8999999999999999999999999999987543222
Q ss_pred ceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccC
Q 002336 771 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 850 (935)
Q Consensus 771 ~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~ 850 (935)
. .....|++.|+|||.+.+..++.++||||||+++|||++|+.||......... .... .. +...
T Consensus 168 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~------~~~~-~~------~~~~-- 231 (278)
T 3cok_A 168 K-HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTL------NKVV-LA------DYEM-- 231 (278)
T ss_dssp -------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----------CC-SS------CCCC--
T ss_pred c-ceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHH------HHHh-hc------ccCC--
Confidence 1 22345899999999999888999999999999999999999999743322110 0000 00 0111
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 851 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 851 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
+......+.+++.+||+.||++||+++++++
T Consensus 232 --~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 232 --PSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp --CTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred --ccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 1122346789999999999999999999875
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=341.20 Aligned_cols=264 Identities=16% Similarity=0.197 Sum_probs=205.6
Q ss_pred HHhhcccccccccEEEEEEEECC---------CcEEEEEEccCcchhhhHHHHHHHHHHHhcCCCcccc-----------
Q 002336 614 TNNFCKKIGKGSFGSVYYGKMKD---------GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVP----------- 673 (935)
Q Consensus 614 ~~~~~~~LG~G~fG~Vy~~~~~~---------g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~HpnIv~----------- 673 (935)
.|.+.+.||+|+||.||+|.+.. ++.||+|++... +.+.+|++++++++||||++
T Consensus 43 ~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 117 (352)
T 2jii_A 43 QWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLL 117 (352)
T ss_dssp EEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTTC
T ss_pred eEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCcc
Confidence 45678899999999999998864 789999998643 46889999999999999998
Q ss_pred ----cceeeec-cceEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccc
Q 002336 674 ----LIGYCEE-EHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL 748 (935)
Q Consensus 674 ----l~g~~~~-~~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILl 748 (935)
+++++.. ....++||||+ +++|.+++... ....+++..++.++.|+++||+|||+ ++|+||||||+|||+
T Consensus 118 ~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dikp~NIl~ 192 (352)
T 2jii_A 118 AIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS-PKHVLSERSVLQVACRLLDALEFLHE---NEYVHGNVTAENIFV 192 (352)
T ss_dssp SCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCCGGGEEE
T ss_pred CccchhhccccCCcEEEEEecCC-CcCHHHHHHhC-CcCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCHHHEEE
Confidence 5666655 67889999999 99999999853 23679999999999999999999998 899999999999999
Q ss_pred cCCC--cEEEeeccccccccccccc------eeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccC
Q 002336 749 DINM--RAKVSDFGLSRQAEEDLTH------ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 820 (935)
Q Consensus 749 d~~~--~vkL~DFGla~~~~~~~~~------~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~ 820 (935)
+.++ .+||+|||+++........ ......||+.|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus 193 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 272 (352)
T 2jii_A 193 DPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCL 272 (352)
T ss_dssp ETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred cCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCC
Confidence 9998 8999999999876543221 1133468999999999999899999999999999999999999997443
Q ss_pred cccchhHHHHHHHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhhhhhcc
Q 002336 821 FGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 893 (935)
Q Consensus 821 ~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~~~~~~ 893 (935)
.. ............. ......+..... ......+.+++.+||+.+|++||++++|++.|+++.....
T Consensus 273 ~~-~~~~~~~~~~~~~--~~~~~~~~~~~~---~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~ 339 (352)
T 2jii_A 273 PN-TEDIMKQKQKFVD--KPGPFVGPCGHW---IRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLR 339 (352)
T ss_dssp TC-HHHHHHHHHHHHH--SCCCEECTTSCE---ECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred cC-HHHHHHHHHhccC--Chhhhhhhcccc---CCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcC
Confidence 22 1122222221111 111111111100 0112368899999999999999999999999999886554
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-37 Score=343.37 Aligned_cols=244 Identities=23% Similarity=0.286 Sum_probs=201.7
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcch---hhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEE
Q 002336 614 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 689 (935)
Q Consensus 614 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~---~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E 689 (935)
.+++.+.||+|+||.||++++. +|+.||+|++..... ...+.+.+|+++++.++||||+++++++.+....++|||
T Consensus 42 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 121 (350)
T 1rdq_E 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVME 121 (350)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred HCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEc
Confidence 3556789999999999999986 689999999865322 234678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccc
Q 002336 690 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 769 (935)
Q Consensus 690 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~ 769 (935)
|+++|+|.+++.. ...+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 122 ~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~~ 195 (350)
T 1rdq_E 122 YVAGGEMFSHLRR---IGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT 195 (350)
T ss_dssp CCTTCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCB
T ss_pred CCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCccceEEECCCCCEEEcccccceeccCCc
Confidence 9999999999974 3568999999999999999999998 999999999999999999999999999998764432
Q ss_pred cceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeeccccccc
Q 002336 770 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 849 (935)
Q Consensus 770 ~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~ 849 (935)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...... +.. ..+..+.. .+
T Consensus 196 ----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~------~~~-~~i~~~~~------~~- 257 (350)
T 1rdq_E 196 ----WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI------QIY-EKIVSGKV------RF- 257 (350)
T ss_dssp ----CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHH-HHHHHCCC------CC-
T ss_pred ----ccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHH------HHH-HHHHcCCC------CC-
Confidence 2346899999999999989999999999999999999999999743221 111 12222221 11
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 002336 850 GNVKIESIWRIAEVAIQCVEQRGFSRPK-----MQEIVLA 884 (935)
Q Consensus 850 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs-----~~ev~~~ 884 (935)
+......+.+++.+||+.||++||+ ++||.+.
T Consensus 258 ---p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h 294 (350)
T 1rdq_E 258 ---PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp ---CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred ---CCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence 1122346889999999999999998 8887653
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-37 Score=337.50 Aligned_cols=264 Identities=27% Similarity=0.429 Sum_probs=209.8
Q ss_pred HHHHhhcccccccccEEEEEEEE------CCCcEEEEEEccCcch-hhhHHHHHHHHHHHhc-CCCcccccceeeeccc-
Q 002336 612 EATNNFCKKIGKGSFGSVYYGKM------KDGKEVAVKIMADSCS-HRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEH- 682 (935)
Q Consensus 612 ~~~~~~~~~LG~G~fG~Vy~~~~------~~g~~vAvK~~~~~~~-~~~~~~~~E~~iL~~L-~HpnIv~l~g~~~~~~- 682 (935)
...+++.+.||+|+||.||+|.+ .+++.||||++..... ...+.+.+|+.+++++ +||||+++++++...+
T Consensus 26 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 105 (316)
T 2xir_A 26 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 105 (316)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTS
T ss_pred hhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCC
Confidence 34566789999999999999975 2468899999876433 3456799999999999 7999999999987654
Q ss_pred eEEEEEEecCCCCHHHHhccCCC-------------CCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCcccc
Q 002336 683 QRILVYEYMHNGTLRDRLHGSVN-------------QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD 749 (935)
Q Consensus 683 ~~~lV~E~~~~gsL~~~L~~~~~-------------~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld 749 (935)
..++||||+++++|.+++..... ...+++..++.++.|+++||.|||+ ++|+||||||+||+++
T Consensus 106 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dikp~Nil~~ 182 (316)
T 2xir_A 106 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLS 182 (316)
T ss_dssp CCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEC
T ss_pred ceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHh---CCcccccCccceEEEC
Confidence 58999999999999999985432 2238899999999999999999998 8999999999999999
Q ss_pred CCCcEEEeeccccccccccccc-eeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCcccchhH
Q 002336 750 INMRAKVSDFGLSRQAEEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNI 827 (935)
Q Consensus 750 ~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l 827 (935)
.++.+||+|||+++........ ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||....... ..
T Consensus 183 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~--~~ 260 (316)
T 2xir_A 183 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--EF 260 (316)
T ss_dssp GGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH--HH
T ss_pred CCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhH--HH
Confidence 9999999999999875443222 2233457889999999988889999999999999999998 999997433221 11
Q ss_pred HHHHHHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhhhhhcc
Q 002336 828 VHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 893 (935)
Q Consensus 828 ~~~~~~~i~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~~~~~~ 893 (935)
. ..+..+.... . +......+.+++.+||+.+|++|||++|+++.|++++....
T Consensus 261 ~----~~~~~~~~~~-----~----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 313 (316)
T 2xir_A 261 C----RRLKEGTRMR-----A----PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 313 (316)
T ss_dssp H----HHHHHTCCCC-----C----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred H----HHhccCccCC-----C----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence 1 1222221111 1 11122368899999999999999999999999999886543
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-37 Score=342.72 Aligned_cols=248 Identities=23% Similarity=0.333 Sum_probs=193.9
Q ss_pred HhhcccccccccEEEEEEEECCCcEEEEEEccCc--chhhhHHHHHHHHHHHhcCC--CcccccceeeeccceEEEEEEe
Q 002336 615 NNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHH--RNLVPLIGYCEEEHQRILVYEY 690 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~~~~~--~~~~~~~~~~E~~iL~~L~H--pnIv~l~g~~~~~~~~~lV~E~ 690 (935)
|++.+.||+|+||.||++...+++.||||++... .....+.+.+|+.+|++++| |||+++++++......++|||
T Consensus 11 y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e- 89 (343)
T 3dbq_A 11 YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME- 89 (343)
T ss_dssp EEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC-
T ss_pred EEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEEe-
Confidence 5668899999999999999988999999998643 23345778999999999976 999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccccccc
Q 002336 691 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 770 (935)
Q Consensus 691 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~ 770 (935)
+.+++|.+++.. ...+++.++..++.|+++||+|||+ ++|+||||||+|||++ ++.+||+|||+++.......
T Consensus 90 ~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~---~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~ 162 (343)
T 3dbq_A 90 CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT 162 (343)
T ss_dssp CCSEEHHHHHHH---SCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC-----
T ss_pred CCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEE-CCcEEEeecccccccCcccc
Confidence 568899999984 4678999999999999999999998 8999999999999997 67899999999987654322
Q ss_pred c-eeecccCCccccCCCCCCC-----------CCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcC
Q 002336 771 H-ISSVARGTVGYLDPEYYGN-----------QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG 838 (935)
Q Consensus 771 ~-~~~~~~gt~~y~APE~l~~-----------~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~ 838 (935)
. ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... ........+.
T Consensus 163 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-----~~~~~~~~~~-- 235 (343)
T 3dbq_A 163 SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-----QISKLHAIID-- 235 (343)
T ss_dssp -------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCS-----HHHHHHHHHC--
T ss_pred cccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhh-----HHHHHHHHhc--
Confidence 2 2234569999999998743 6789999999999999999999999973211 1111112221
Q ss_pred CeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002336 839 DVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 884 (935)
Q Consensus 839 ~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~ 884 (935)
+......+......+.+++.+||+.||++|||++|+++.
T Consensus 236 -------~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 236 -------PNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp -------TTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred -------CCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 111111222222468899999999999999999999865
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-37 Score=339.85 Aligned_cols=266 Identities=28% Similarity=0.438 Sum_probs=210.3
Q ss_pred HHHHhhcccccccccEEEEEEEE-----CCCcEEEEEEccCcchhhhHHHHHHHHHHHhcCCCcccccceeeeccc--eE
Q 002336 612 EATNNFCKKIGKGSFGSVYYGKM-----KDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH--QR 684 (935)
Q Consensus 612 ~~~~~~~~~LG~G~fG~Vy~~~~-----~~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~--~~ 684 (935)
...+++.+.||+|+||.||++++ .+++.||+|++........+.+.+|++++++++||||+++++++...+ ..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 34466789999999999999984 368899999998766666788999999999999999999999886544 68
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccc
Q 002336 685 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 764 (935)
Q Consensus 685 ~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~ 764 (935)
++||||+++++|.+++... ...+++..++.++.|+++||+|||+ ++|+||||||+||+++.++.+||+|||++..
T Consensus 120 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~ 194 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKV 194 (326)
T ss_dssp EEEECCCTTCBHHHHHHHS--TTSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEECCCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEEcCCCcEEEecCcchhh
Confidence 9999999999999999753 3568999999999999999999998 8999999999999999999999999999987
Q ss_pred ccccccce--eecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcc---------cchhHHHHHHH
Q 002336 765 AEEDLTHI--SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFG---------AELNIVHWARS 833 (935)
Q Consensus 765 ~~~~~~~~--~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~---------~~~~l~~~~~~ 833 (935)
........ .....++..|+|||.+.+..++.++||||||+++|||++|..|+...... ........+.+
T Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (326)
T 2w1i_A 195 LPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE 274 (326)
T ss_dssp CCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHH
T ss_pred ccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHH
Confidence 65433221 22334677899999998888899999999999999999999998632110 00111111222
Q ss_pred hhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhhhhh
Q 002336 834 MIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 891 (935)
Q Consensus 834 ~i~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~~~~ 891 (935)
.+..+... ..+......+.+++.+||+.+|++||+++||++.|+++...
T Consensus 275 ~~~~~~~~---------~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~ 323 (326)
T 2w1i_A 275 LLKNNGRL---------PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ 323 (326)
T ss_dssp HHHTTCCC---------CCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HhhcCCCC---------CCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 22222111 11122234688999999999999999999999999987653
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-37 Score=337.88 Aligned_cols=265 Identities=24% Similarity=0.287 Sum_probs=197.3
Q ss_pred hHHHHHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcch-----hhhHHHHHHHHHHHhcC---CCcccccceeee
Q 002336 609 ELEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS-----HRTQQFVTEVALLSRIH---HRNLVPLIGYCE 679 (935)
Q Consensus 609 ~l~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~-----~~~~~~~~E~~iL~~L~---HpnIv~l~g~~~ 679 (935)
++....|++.+.||+|+||.||+|.+. +++.||+|++..... .....+.+|++++++++ ||||+++++++.
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~ 84 (308)
T 3g33_A 5 SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCA 84 (308)
T ss_dssp -----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEE
T ss_pred cccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeee
Confidence 444556778899999999999999974 689999999864321 11245677888777764 999999999987
Q ss_pred ccc-----eEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcE
Q 002336 680 EEH-----QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRA 754 (935)
Q Consensus 680 ~~~-----~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~v 754 (935)
... ..++||||+. ++|.+++... ....+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+
T Consensus 85 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~~~ 159 (308)
T 3g33_A 85 TSRTDREIKVTLVFEHVD-QDLRTYLDKA-PPPGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGTV 159 (308)
T ss_dssp ECCSSSEEEEEEEEECCC-CBHHHHHHTC-CTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCTTTEEECTTSCE
T ss_pred ccCCCCceeEEEEehhhh-cCHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCE
Confidence 654 5789999997 6999998854 23449999999999999999999998 899999999999999999999
Q ss_pred EEeeccccccccccccceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHh
Q 002336 755 KVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSM 834 (935)
Q Consensus 755 kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~ 834 (935)
||+|||+++....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+ ....+...
T Consensus 160 kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~i~~~ 234 (308)
T 3g33_A 160 KLADFGLARIYSYQMA--LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD---QLGKIFDL 234 (308)
T ss_dssp EECSCSCTTTSTTCCC--SGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHH---HHHHHHHH
T ss_pred EEeeCccccccCCCcc--cCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHH
Confidence 9999999987643322 234568999999999988889999999999999999999999997433221 11111111
Q ss_pred hhcC---Ceeecc---cccccC-------CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 835 IKKG---DVISIV---DPVLIG-------NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 835 i~~~---~~~~~~---d~~l~~-------~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
+... ...... ...+.. ....+....+.+++.+||+.||++|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 235 IGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp HCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 1110 000000 000000 001122346889999999999999999999875
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=330.71 Aligned_cols=244 Identities=26% Similarity=0.412 Sum_probs=197.6
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCcch---hhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEe
Q 002336 615 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 690 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~---~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~ 690 (935)
|++.+.||+|+||.||+|.+. +++.||+|++..... ...+.+.+|+.++++++||||+++++++.+....++||||
T Consensus 11 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 90 (279)
T 3fdn_A 11 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEY 90 (279)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred EEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEEec
Confidence 566789999999999999876 577999999864322 1245688999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccccccc
Q 002336 691 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 770 (935)
Q Consensus 691 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~ 770 (935)
+++++|.+.+.. ...+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++.......
T Consensus 91 ~~~~~l~~~l~~---~~~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~- 163 (279)
T 3fdn_A 91 APLGTVYRELQK---LSKFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR- 163 (279)
T ss_dssp CTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHT---TTCEECCCCGGGEEECTTSCEEECSCCEESCC-----
T ss_pred CCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHhEEEcCCCCEEEEeccccccCCccc-
Confidence 999999999874 3568999999999999999999997 899999999999999999999999999986543322
Q ss_pred ceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccC
Q 002336 771 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 850 (935)
Q Consensus 771 ~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~ 850 (935)
.....|++.|+|||.+.+..++.++||||||+++|+|++|+.||....... .. ..+.....
T Consensus 164 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~----~~~~~~~~---------- 224 (279)
T 3fdn_A 164 --RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE---TY----KRISRVEF---------- 224 (279)
T ss_dssp ------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH---HH----HHHHHTCC----------
T ss_pred --ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHH---HH----HHHHhCCC----------
Confidence 223468999999999999899999999999999999999999997433211 11 11111111
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002336 851 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 884 (935)
Q Consensus 851 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~ 884 (935)
..+......+.+++.+||+.+|++||+++|+++.
T Consensus 225 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 225 TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp CCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred CCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 1111223467899999999999999999999864
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=343.77 Aligned_cols=258 Identities=23% Similarity=0.402 Sum_probs=199.7
Q ss_pred HHHhhcccccccccEEEEEEEEC-CCc----EEEEEEccCc-chhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEE
Q 002336 613 ATNNFCKKIGKGSFGSVYYGKMK-DGK----EVAVKIMADS-CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRIL 686 (935)
Q Consensus 613 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~----~vAvK~~~~~-~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~l 686 (935)
..|++.+.||+|+||.||+|.+. +++ .||+|.+... .....+.+.+|+.++++++||||+++++++.... .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~ 93 (327)
T 3lzb_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEE
T ss_pred hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceE
Confidence 44667889999999999999875 444 3577777543 2334578999999999999999999999998765 789
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccc
Q 002336 687 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 766 (935)
Q Consensus 687 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~ 766 (935)
|+|++.+|+|.+++... ...+++..++.++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 94 v~~~~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~ 168 (327)
T 3lzb_A 94 ITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp EECCCSSCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCTTC-----
T ss_pred EEEecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHhh---CCCcCCCCCHHHEEEcCCCCEEEccCcceeEcc
Confidence 99999999999998753 4568999999999999999999998 899999999999999999999999999998764
Q ss_pred ccccc-eeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCcccchhHHHHHHHhhhcCCeeecc
Q 002336 767 EDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 844 (935)
Q Consensus 767 ~~~~~-~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~ 844 (935)
..... ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||....... +.. .+..+....
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~---~~~----~~~~~~~~~-- 239 (327)
T 3lzb_A 169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISS----ILEKGERLP-- 239 (327)
T ss_dssp -----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHH----HHHTTCCCC--
T ss_pred CccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH---HHH----HHHcCCCCC--
Confidence 33221 1223346788999999988899999999999999999999 999997443322 111 122221111
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhhhhhc
Q 002336 845 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 892 (935)
Q Consensus 845 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~~~~~ 892 (935)
.+......+.+++.+||+.+|++||+++|+++.|+++....
T Consensus 240 -------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 280 (327)
T 3lzb_A 240 -------QPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDP 280 (327)
T ss_dssp -------CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTSH
T ss_pred -------CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCc
Confidence 11122336889999999999999999999999999887543
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-36 Score=330.61 Aligned_cols=250 Identities=26% Similarity=0.406 Sum_probs=201.6
Q ss_pred HHHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcchhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEe
Q 002336 612 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 690 (935)
Q Consensus 612 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~ 690 (935)
...|.+.+.||+|+||.||++... +|+.||+|++........+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL 87 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence 456778899999999999999886 7899999999865544556789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccc---cCCCcEEEeeccccccccc
Q 002336 691 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEE 767 (935)
Q Consensus 691 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILl---d~~~~vkL~DFGla~~~~~ 767 (935)
+++++|.+.+.. ...+++..+..++.|++.||.|||+ .+|+||||||+||++ +.++.+||+|||++.....
T Consensus 88 ~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 161 (304)
T 2jam_A 88 VSGGELFDRILE---RGVYTEKDASLVIQQVLSAVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN 161 (304)
T ss_dssp CCSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC
T ss_pred CCCccHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEecCCCCCCEEEccCCcceecCC
Confidence 999999998863 3568999999999999999999998 899999999999999 7889999999999876443
Q ss_pred cccceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeeccccc
Q 002336 768 DLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 847 (935)
Q Consensus 768 ~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~ 847 (935)
.. .....|++.|+|||.+.+..++.++||||+|+++|+|++|+.||...... ... ..+..+... ....
T Consensus 162 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~----~~i~~~~~~--~~~~ 229 (304)
T 2jam_A 162 GI---MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETES---KLF----EKIKEGYYE--FESP 229 (304)
T ss_dssp BT---THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHH----HHHHHCCCC--CCTT
T ss_pred Cc---cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH---HHH----HHHHcCCCC--CCcc
Confidence 21 12345899999999999999999999999999999999999999743221 111 122222110 0111
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 848 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 848 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
. .......+.+++.+||+.||++||+++|+++
T Consensus 230 ~----~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 230 F----WDDISESAKDFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp T----TTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred c----cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1 1122346889999999999999999999976
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=342.43 Aligned_cols=261 Identities=24% Similarity=0.418 Sum_probs=209.3
Q ss_pred HHHHhhcccccccccEEEEEEEEC------CCcEEEEEEccCcch-hhhHHHHHHHHHHHhcCCCcccccceeeeccceE
Q 002336 612 EATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQR 684 (935)
Q Consensus 612 ~~~~~~~~~LG~G~fG~Vy~~~~~------~g~~vAvK~~~~~~~-~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~ 684 (935)
...|++.+.||+|+||.||+|.+. .++.||+|++..... .....+.+|+.+++.++||||+++++++.+.+..
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 103 (322)
T 1p4o_A 24 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 103 (322)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred hhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCcc
Confidence 345677899999999999999765 367899999875433 3456789999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhccCC-------CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEe
Q 002336 685 ILVYEYMHNGTLRDRLHGSV-------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVS 757 (935)
Q Consensus 685 ~lV~E~~~~gsL~~~L~~~~-------~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~ 757 (935)
++||||+++|+|.+++.... ....+++..+++++.|+++||.|||+ ++|+||||||+||+++.++.+||+
T Consensus 104 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~NIli~~~~~~kl~ 180 (322)
T 1p4o_A 104 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIG 180 (322)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEECTTCCEEEC
T ss_pred EEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCCccCCCccceEEEcCCCeEEEC
Confidence 99999999999999987421 12457899999999999999999998 899999999999999999999999
Q ss_pred eccccccccccccc-eeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCcccchhHHHHHHHhh
Q 002336 758 DFGLSRQAEEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMI 835 (935)
Q Consensus 758 DFGla~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~i 835 (935)
|||+++........ ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||...... .. ...+
T Consensus 181 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~----~~~~ 253 (322)
T 1p4o_A 181 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE---QV----LRFV 253 (322)
T ss_dssp CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH---HH----HHHH
T ss_pred cCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHH---HH----HHHH
Confidence 99999865433221 1222346889999999988889999999999999999999 89998743221 11 1122
Q ss_pred hcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhhhhh
Q 002336 836 KKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 891 (935)
Q Consensus 836 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~~~~ 891 (935)
..+.... .+......+.+++.+||+.+|++|||++|+++.|++....
T Consensus 254 ~~~~~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~ 300 (322)
T 1p4o_A 254 MEGGLLD---------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 300 (322)
T ss_dssp HTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred HcCCcCC---------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhcc
Confidence 2222111 1112234688999999999999999999999999987653
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-37 Score=346.60 Aligned_cols=260 Identities=29% Similarity=0.464 Sum_probs=197.0
Q ss_pred HhhcccccccccEEEEEEEEC--CC--cEEEEEEccCcc-hhhhHHHHHHHHHHHhcCCCcccccceeee-ccceEEEEE
Q 002336 615 NNFCKKIGKGSFGSVYYGKMK--DG--KEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCE-EEHQRILVY 688 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~--~g--~~vAvK~~~~~~-~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~-~~~~~~lV~ 688 (935)
+++.+.||+|+||.||+|.+. ++ ..||+|.+.... ....+.+.+|+.++++++||||+++++++. .++..++||
T Consensus 91 ~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~ 170 (373)
T 3c1x_A 91 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 170 (373)
T ss_dssp EEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEE
T ss_pred eecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEE
Confidence 445688999999999999864 22 368999986533 345678999999999999999999999875 456789999
Q ss_pred EecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccccc
Q 002336 689 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 768 (935)
Q Consensus 689 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~ 768 (935)
||+++|+|.+++... ...+++..++.++.|+++||+|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 171 e~~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 245 (373)
T 3c1x_A 171 PYMKHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 245 (373)
T ss_dssp ECCTTCBHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred ECCCCCCHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHH---CCEecCccchheEEECCCCCEEEeecccccccccc
Confidence 999999999999742 4568899999999999999999998 89999999999999999999999999999865432
Q ss_pred ccc---eeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCcccchhHHHHHHHhhhcCCeeecc
Q 002336 769 LTH---ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 844 (935)
Q Consensus 769 ~~~---~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~ 844 (935)
... ......+++.|+|||.+.+..++.++||||||+++|||++ |..||......+ .... +..+... .
T Consensus 246 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~---~~~~----~~~~~~~--~ 316 (373)
T 3c1x_A 246 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---ITVY----LLQGRRL--L 316 (373)
T ss_dssp ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC---HHHH----HHTTCCC--C
T ss_pred ccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH---HHHH----HHcCCCC--C
Confidence 211 1223447789999999988899999999999999999999 677776433221 2221 1122110 0
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhhhhhccCC
Q 002336 845 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKGG 895 (935)
Q Consensus 845 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~~~~~~~~ 895 (935)
. +......+.+++.+||+.+|++||+++|+++.|+++.......
T Consensus 317 ~-------p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~~ 360 (373)
T 3c1x_A 317 Q-------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE 360 (373)
T ss_dssp C-------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSC
T ss_pred C-------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcccc
Confidence 1 1122346889999999999999999999999999988755533
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-37 Score=343.79 Aligned_cols=248 Identities=25% Similarity=0.335 Sum_probs=200.5
Q ss_pred HHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc---hhhhHHHHHHHHHHHhc-CCCcccccceeeeccceEEEE
Q 002336 613 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILV 687 (935)
Q Consensus 613 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~iL~~L-~HpnIv~l~g~~~~~~~~~lV 687 (935)
..+++.+.||+|+||.||+|+.+ +|+.||+|+++... ....+.+..|..++..+ +||||+++++++.+.+..++|
T Consensus 20 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 99 (353)
T 2i0e_A 20 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFV 99 (353)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEE
Confidence 34667889999999999999987 47899999987542 22345688899999988 799999999999999999999
Q ss_pred EEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccc
Q 002336 688 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 767 (935)
Q Consensus 688 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~ 767 (935)
|||+++|+|.+++.. ...+++..++.++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 100 ~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 173 (353)
T 2i0e_A 100 MEYVNGGDLMYHIQQ---VGRFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW 173 (353)
T ss_dssp EECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEEcCCCcEEEEeCCccccccc
Confidence 999999999999974 3568999999999999999999998 8999999999999999999999999999986432
Q ss_pred cccceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeeccccc
Q 002336 768 DLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 847 (935)
Q Consensus 768 ~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~ 847 (935)
... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+.. .+. . .+..+.. .
T Consensus 174 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~---~~~---~-~i~~~~~------~ 239 (353)
T 2i0e_A 174 DGV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED---ELF---Q-SIMEHNV------A 239 (353)
T ss_dssp TTC-CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHH---H-HHHHCCC------C
T ss_pred CCc-ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHH---HHH---H-HHHhCCC------C
Confidence 221 233456999999999999999999999999999999999999999743221 111 1 1212211 1
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 002336 848 LIGNVKIESIWRIAEVAIQCVEQRGFSRPK-----MQEIVLA 884 (935)
Q Consensus 848 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs-----~~ev~~~ 884 (935)
++......+.+++.+||+.+|++||+ ++|+.+.
T Consensus 240 ----~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h 277 (353)
T 2i0e_A 240 ----YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 277 (353)
T ss_dssp ----CCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred ----CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 11122346889999999999999995 5666543
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-37 Score=346.17 Aligned_cols=200 Identities=26% Similarity=0.329 Sum_probs=174.6
Q ss_pred HHHHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcchhhhHHHHHHHHHHHhcC-----CCcccccceeeeccceE
Q 002336 611 EEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIH-----HRNLVPLIGYCEEEHQR 684 (935)
Q Consensus 611 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~-----HpnIv~l~g~~~~~~~~ 684 (935)
....|.+.+.||+|+||.||+|.+. +++.||||++... ....+.+..|+.+++.++ ||||+++++++...+..
T Consensus 33 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~ 111 (360)
T 3llt_A 33 LNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHM 111 (360)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEE
T ss_pred ecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCee
Confidence 3456777899999999999999885 6899999998743 344567788999999996 99999999999999999
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccC--------------
Q 002336 685 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI-------------- 750 (935)
Q Consensus 685 ~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~-------------- 750 (935)
++||||+ +++|.+++... ....+++..+..++.|++.||+|||+ ++|+||||||+|||++.
T Consensus 112 ~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~ 186 (360)
T 3llt_A 112 CLIFEPL-GPSLYEIITRN-NYNGFHIEDIKLYCIEILKALNYLRK---MSLTHTDLKPENILLDDPYFEKSLITVRRVT 186 (360)
T ss_dssp EEEECCC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCTTCCEEEEEEECTT
T ss_pred EEEEcCC-CCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCcccEEEccccccccccchhccc
Confidence 9999999 99999999754 23468999999999999999999998 89999999999999975
Q ss_pred -----------CCcEEEeeccccccccccccceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCcc
Q 002336 751 -----------NMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVE 819 (935)
Q Consensus 751 -----------~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~ 819 (935)
++.+||+|||+++...... ....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 187 ~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 262 (360)
T 3llt_A 187 DGKKIQIYRTKSTGIKLIDFGCATFKSDYH----GSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTH 262 (360)
T ss_dssp TCCEEEEEEESCCCEEECCCTTCEETTSCC----CSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccccccccccCCCCEEEEeccCceecCCCC----cCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCC
Confidence 7889999999998654322 2346899999999999999999999999999999999999999754
Q ss_pred C
Q 002336 820 D 820 (935)
Q Consensus 820 ~ 820 (935)
.
T Consensus 263 ~ 263 (360)
T 3llt_A 263 E 263 (360)
T ss_dssp S
T ss_pred c
Confidence 3
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=338.98 Aligned_cols=256 Identities=25% Similarity=0.293 Sum_probs=197.4
Q ss_pred HHHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCc-----chhhhHHHHHHHHHHHhcCCCcccccceeeeccceEE
Q 002336 612 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS-----CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRI 685 (935)
Q Consensus 612 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~-----~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~ 685 (935)
...|++.+.||+|+||.||+|... +++.||+|++... .....+.+.+|++++++++||||+++++++.+.+..+
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 104 (345)
T 3hko_A 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYIC 104 (345)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEE
Confidence 455777899999999999999875 6889999998643 2234568999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhccCC-------------------------------------CCCCCCHHHHHHHHHHHHHHhHHh
Q 002336 686 LVYEYMHNGTLRDRLHGSV-------------------------------------NQKPLDWLTRLQIAHDAAKGLEYL 728 (935)
Q Consensus 686 lV~E~~~~gsL~~~L~~~~-------------------------------------~~~~l~~~~~~~i~~qia~gL~yL 728 (935)
+||||+++|+|.+++.... ....+++..+..++.|+++||+||
T Consensus 105 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~L 184 (345)
T 3hko_A 105 LVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYL 184 (345)
T ss_dssp EEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHH
Confidence 9999999999999985211 012245777889999999999999
Q ss_pred hhcCCCceEecCCCCCCccccCCC--cEEEeecccccccccccc---ceeecccCCccccCCCCCCC--CCCCchhHHHH
Q 002336 729 HTGCNPGIIHRDVKSSNILLDINM--RAKVSDFGLSRQAEEDLT---HISSVARGTVGYLDPEYYGN--QQLTEKSDVYS 801 (935)
Q Consensus 729 Hs~~~~~ivH~DLkp~NILld~~~--~vkL~DFGla~~~~~~~~---~~~~~~~gt~~y~APE~l~~--~~~s~ksDVwS 801 (935)
|+ ++|+||||||+|||++.++ .+||+|||+++....... .......||+.|+|||.+.+ ..++.++||||
T Consensus 185 H~---~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diws 261 (345)
T 3hko_A 185 HN---QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWS 261 (345)
T ss_dssp HH---TTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHH
T ss_pred HH---CCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHH
Confidence 98 8999999999999998776 899999999986543211 12234568999999998865 67899999999
Q ss_pred HHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHH
Q 002336 802 FGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEI 881 (935)
Q Consensus 802 ~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev 881 (935)
||+++|||++|+.||...... +........... ...+. .......+.+++.+||+.+|++||++.|+
T Consensus 262 lG~il~el~~g~~pf~~~~~~------~~~~~~~~~~~~--~~~~~-----~~~~~~~~~~li~~~l~~~p~~Rps~~~~ 328 (345)
T 3hko_A 262 AGVLLHLLLMGAVPFPGVNDA------DTISQVLNKKLC--FENPN-----YNVLSPLARDLLSNLLNRNVDERFDAMRA 328 (345)
T ss_dssp HHHHHHHHHHSSCSSCCSSHH------HHHHHHHHCCCC--TTSGG-----GGGSCHHHHHHHHHHSCSCTTTSCCHHHH
T ss_pred HHHHHHHHHHCCCCCCCCChH------HHHHHHHhcccc--cCCcc-----cccCCHHHHHHHHHHcCCChhHCCCHHHH
Confidence 999999999999999743321 111122221110 00110 01123468899999999999999999999
Q ss_pred HH
Q 002336 882 VL 883 (935)
Q Consensus 882 ~~ 883 (935)
++
T Consensus 329 l~ 330 (345)
T 3hko_A 329 LQ 330 (345)
T ss_dssp HH
T ss_pred hc
Confidence 76
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=345.00 Aligned_cols=264 Identities=26% Similarity=0.411 Sum_probs=209.9
Q ss_pred HHHHhhcccccccccEEEEEEEECC------CcEEEEEEccCcch-hhhHHHHHHHHHHHhc-CCCcccccceeeeccce
Q 002336 612 EATNNFCKKIGKGSFGSVYYGKMKD------GKEVAVKIMADSCS-HRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQ 683 (935)
Q Consensus 612 ~~~~~~~~~LG~G~fG~Vy~~~~~~------g~~vAvK~~~~~~~-~~~~~~~~E~~iL~~L-~HpnIv~l~g~~~~~~~ 683 (935)
...+.+.+.||+|+||.||+|.+.. ++.||+|++..... ...+.+.+|+.+++.+ +||||+++++++.+.+.
T Consensus 45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 124 (333)
T 2i1m_A 45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGP 124 (333)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCc
Confidence 3456678999999999999998752 24799999876433 3456799999999999 89999999999999999
Q ss_pred EEEEEEecCCCCHHHHhccCC-----------CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCC
Q 002336 684 RILVYEYMHNGTLRDRLHGSV-----------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM 752 (935)
Q Consensus 684 ~~lV~E~~~~gsL~~~L~~~~-----------~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~ 752 (935)
.++||||+++|+|.+++.... ....+++..++.++.|++.||+|||+ ++|+||||||+|||++.++
T Consensus 125 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~~~ 201 (333)
T 2i1m_A 125 VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS---KNCIHRDVAARNVLLTNGH 201 (333)
T ss_dssp CEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGCEEEGGG
T ss_pred eEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhc---CCcccCCcccceEEECCCC
Confidence 999999999999999986421 13468999999999999999999998 8999999999999999999
Q ss_pred cEEEeeccccccccccccc-eeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCcccchhHHHH
Q 002336 753 RAKVSDFGLSRQAEEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHW 830 (935)
Q Consensus 753 ~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~ 830 (935)
.+||+|||+++........ ......+++.|+|||.+.+..++.++||||||+++|||++ |..||....... ....
T Consensus 202 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~--~~~~- 278 (333)
T 2i1m_A 202 VAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS--KFYK- 278 (333)
T ss_dssp EEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH--HHHH-
T ss_pred eEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhH--HHHH-
Confidence 9999999999865443222 2233456889999999988889999999999999999999 999997433221 1112
Q ss_pred HHHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhhhhhcc
Q 002336 831 ARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 893 (935)
Q Consensus 831 ~~~~i~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~~~~~~ 893 (935)
.+..+.. .. .+......+.+++.+||+.+|++|||++||++.|+++.....
T Consensus 279 ---~~~~~~~-----~~----~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~ 329 (333)
T 2i1m_A 279 ---LVKDGYQ-----MA----QPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQEDR 329 (333)
T ss_dssp ---HHHHTCC-----CC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred ---HHhcCCC-----CC----CCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHhhh
Confidence 1211111 00 111123468899999999999999999999999998776543
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=336.47 Aligned_cols=262 Identities=26% Similarity=0.429 Sum_probs=198.5
Q ss_pred HHHHhhcccccccccEEEEEEEEC----CCcEEEEEEccCc--chhhhHHHHHHHHHHHhcCCCcccccceeeeccc---
Q 002336 612 EATNNFCKKIGKGSFGSVYYGKMK----DGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH--- 682 (935)
Q Consensus 612 ~~~~~~~~~LG~G~fG~Vy~~~~~----~g~~vAvK~~~~~--~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~--- 682 (935)
...+.+.+.||+|+||.||+|.+. .++.||+|++... .....+.+.+|+.++++++||||+++++++.+..
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 112 (313)
T 3brb_A 33 RNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQG 112 (313)
T ss_dssp GGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-----
T ss_pred HHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccC
Confidence 345667889999999999999764 3458999998754 2334567999999999999999999999987654
Q ss_pred --eEEEEEEecCCCCHHHHhccCC---CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEe
Q 002336 683 --QRILVYEYMHNGTLRDRLHGSV---NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVS 757 (935)
Q Consensus 683 --~~~lV~E~~~~gsL~~~L~~~~---~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~ 757 (935)
..++||||+++|+|.+++.... ....+++..++.++.|+++||.|||+ ++|+||||||+|||++.++.+||+
T Consensus 113 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~~~~~kl~ 189 (313)
T 3brb_A 113 IPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSN---RNFLHRDLAARNCMLRDDMTVCVA 189 (313)
T ss_dssp --CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCSGGGEEECTTSCEEEC
T ss_pred CcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCcEEEe
Confidence 3499999999999999984321 34679999999999999999999998 899999999999999999999999
Q ss_pred ecccccccccccc-ceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCcccchhHHHHHHHhh
Q 002336 758 DFGLSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMI 835 (935)
Q Consensus 758 DFGla~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~i 835 (935)
|||+++....... .......+++.|+|||.+.+..++.++||||||+++|+|++ |..||...... ..... +
T Consensus 190 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~~~~----~ 262 (313)
T 3brb_A 190 DFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNH---EMYDY----L 262 (313)
T ss_dssp SCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---GHHHH----H
T ss_pred ecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHH---HHHHH----H
Confidence 9999986543321 11223457889999999988899999999999999999999 88998743322 12221 1
Q ss_pred hcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhhhhhc
Q 002336 836 KKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 892 (935)
Q Consensus 836 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~~~~~ 892 (935)
..+.... . +......+.+++.+||+.+|++||+++++++.|+++....
T Consensus 263 ~~~~~~~-----~----~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~l 310 (313)
T 3brb_A 263 LHGHRLK-----Q----PEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESL 310 (313)
T ss_dssp HTTCCCC-----C----BTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred HcCCCCC-----C----CccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 1111111 1 1122346889999999999999999999999999887643
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=365.23 Aligned_cols=253 Identities=25% Similarity=0.426 Sum_probs=202.4
Q ss_pred cccccccEEEEEEEEC---CCcEEEEEEccCcc-hhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEecCCCC
Q 002336 620 KIGKGSFGSVYYGKMK---DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGT 695 (935)
Q Consensus 620 ~LG~G~fG~Vy~~~~~---~g~~vAvK~~~~~~-~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~~~gs 695 (935)
.||+|+||.||+|.+. ++..||||+++... ....+.+.+|+++|++++|||||++++++.. +..++||||+++|+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~ 421 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 421 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence 7999999999999874 46679999997643 3356789999999999999999999999976 56899999999999
Q ss_pred HHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccccce--e
Q 002336 696 LRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI--S 773 (935)
Q Consensus 696 L~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~~--~ 773 (935)
|.+++... ...+++..++.++.||++||+|||+ ++|+||||||+|||++.++.+||+|||+++......... .
T Consensus 422 L~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~LH~---~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 496 (613)
T 2ozo_A 422 LHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEE---KNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR 496 (613)
T ss_dssp HHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC---------
T ss_pred HHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHH---CCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeec
Confidence 99999743 4569999999999999999999998 899999999999999999999999999998764332211 1
Q ss_pred ecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccCCC
Q 002336 774 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNV 852 (935)
Q Consensus 774 ~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~~~ 852 (935)
....+++.|+|||++.+..++.++|||||||++|||++ |+.||...... ... ..+..+.... .
T Consensus 497 ~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~---~~~----~~i~~~~~~~---------~ 560 (613)
T 2ozo_A 497 SAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP---EVM----AFIEQGKRME---------C 560 (613)
T ss_dssp -----CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSH---HHH----HHHHTTCCCC---------C
T ss_pred cCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHH---HHH----HHHHcCCCCC---------C
Confidence 22335689999999988899999999999999999998 99999743321 122 2233332111 1
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhhhhhccC
Q 002336 853 KIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKG 894 (935)
Q Consensus 853 ~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~~~~~~~ 894 (935)
+......+.+++.+||+.+|++||++++|++.|+.+......
T Consensus 561 p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~ 602 (613)
T 2ozo_A 561 PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS 602 (613)
T ss_dssp CTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHSC
T ss_pred CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhcc
Confidence 222334788999999999999999999999999987665443
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=328.87 Aligned_cols=257 Identities=24% Similarity=0.305 Sum_probs=203.6
Q ss_pred HHHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcchh------hhHHHHHHHHHHHhcCCCcccccceeeeccceE
Q 002336 612 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSH------RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQR 684 (935)
Q Consensus 612 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~~------~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~ 684 (935)
...|++.+.||+|+||.||+|... +|+.||+|++...... ..+.+.+|+.++++++||||+++++++.+....
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 356778899999999999999987 6899999998653221 246799999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCC----cEEEeecc
Q 002336 685 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM----RAKVSDFG 760 (935)
Q Consensus 685 ~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~----~vkL~DFG 760 (935)
++||||+++++|.+++.. ...+++..+..++.|+++||.|||+ ++++||||||+||+++.++ .+||+|||
T Consensus 84 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg 157 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAE---KESLTEDEATQFLKQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFG 157 (283)
T ss_dssp EEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEeecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChHHEEEecCCCCCCceEEEecc
Confidence 999999999999999973 4568999999999999999999998 8999999999999998877 89999999
Q ss_pred ccccccccccceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCe
Q 002336 761 LSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV 840 (935)
Q Consensus 761 la~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~ 840 (935)
++........ .....|++.|+|||.+.+..++.++||||||+++|+|++|+.||....... . .. .+.....
T Consensus 158 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~---~~-~~~~~~~ 228 (283)
T 3bhy_A 158 IAHKIEAGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQE---T---LT-NISAVNY 228 (283)
T ss_dssp TCEECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH---H---HH-HHHTTCC
T ss_pred cceeccCCCc--ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHH---H---HH-HhHhccc
Confidence 9987644322 223458999999999998899999999999999999999999997433211 1 11 1111111
Q ss_pred eecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH--HHhhhh
Q 002336 841 ISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL--AIQDSI 889 (935)
Q Consensus 841 ~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~--~L~~~~ 889 (935)
. ..+.... .....+.+++.+||+.+|++||+++|+++ .++++.
T Consensus 229 ~--~~~~~~~----~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 273 (283)
T 3bhy_A 229 D--FDEEYFS----NTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIR 273 (283)
T ss_dssp C--CCHHHHT----TCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHH
T ss_pred C--Ccchhcc----cCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHH
Confidence 0 0111111 11236889999999999999999999987 355443
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=332.40 Aligned_cols=258 Identities=26% Similarity=0.428 Sum_probs=204.7
Q ss_pred HHhhcc-cccccccEEEEEEEEC---CCcEEEEEEccCcch--hhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEE
Q 002336 614 TNNFCK-KIGKGSFGSVYYGKMK---DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILV 687 (935)
Q Consensus 614 ~~~~~~-~LG~G~fG~Vy~~~~~---~g~~vAvK~~~~~~~--~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV 687 (935)
.+.+.+ .||+|+||.||+|.+. .++.||||++..... ...+.+.+|+++++.++||||+++++++ ..+..++|
T Consensus 17 ~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~lv 95 (291)
T 1xbb_A 17 LLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLV 95 (291)
T ss_dssp GEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEEE
T ss_pred hhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEEE
Confidence 345555 8999999999999653 468899999875432 2356799999999999999999999999 55678999
Q ss_pred EEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccc
Q 002336 688 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 767 (935)
Q Consensus 688 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~ 767 (935)
|||+++++|.+++.. ...+++..++.++.|+++||+|||+ ++|+||||||+||+++.++.+||+|||++.....
T Consensus 96 ~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 169 (291)
T 1xbb_A 96 MEMAELGPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRA 169 (291)
T ss_dssp EECCTTEEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEECCT
T ss_pred EEeCCCCCHHHHHHh---CcCCCHHHHHHHHHHHHHHHHHHHh---CCeEcCCCCcceEEEeCCCcEEEccCCcceeecc
Confidence 999999999999974 4568999999999999999999998 8999999999999999999999999999987654
Q ss_pred cccce--eecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCcccchhHHHHHHHhhhcCCeeecc
Q 002336 768 DLTHI--SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 844 (935)
Q Consensus 768 ~~~~~--~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~ 844 (935)
..... .....+++.|+|||.+.+..++.++||||||+++|+|++ |+.||...... .. ...+..+....
T Consensus 170 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~----~~~~~~~~~~~-- 240 (291)
T 1xbb_A 170 DENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS---EV----TAMLEKGERMG-- 240 (291)
T ss_dssp TCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HH----HHHHHTTCCCC--
T ss_pred CCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHH---HH----HHHHHcCCCCC--
Confidence 33221 122346788999999988888999999999999999999 99999743221 11 12222222111
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhhhhhccC
Q 002336 845 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKG 894 (935)
Q Consensus 845 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~~~~~~~ 894 (935)
.+......+.+++.+||+.||++||++.|+++.|+++......
T Consensus 241 -------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~ 283 (291)
T 1xbb_A 241 -------CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVN 283 (291)
T ss_dssp -------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHHH
T ss_pred -------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhh
Confidence 1122234688999999999999999999999999998765543
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-36 Score=328.44 Aligned_cols=251 Identities=24% Similarity=0.372 Sum_probs=196.3
Q ss_pred HHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcch-hhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEe
Q 002336 613 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 690 (935)
Q Consensus 613 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~-~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~ 690 (935)
..|.+.+.||+|+||.||++... +++.+|+|++..... ...+.+.+|++++++++||||+++++++.+....++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 101 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET 101 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence 46778899999999999999875 689999999865432 2457789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCC-CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccc---cCCCcEEEeecccccccc
Q 002336 691 MHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAE 766 (935)
Q Consensus 691 ~~~gsL~~~L~~~~-~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILl---d~~~~vkL~DFGla~~~~ 766 (935)
+++|+|.+.+.... ....+++..+..++.|+++||+|||+ ++|+||||||+|||+ +.++.+||+|||++....
T Consensus 102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 178 (285)
T 3is5_A 102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178 (285)
T ss_dssp CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence 99999999885321 34679999999999999999999998 899999999999999 456889999999998654
Q ss_pred ccccceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccc
Q 002336 767 EDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP 846 (935)
Q Consensus 767 ~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~ 846 (935)
.... .....|++.|+|||.+. ..++.++||||||+++|||++|+.||....... ... ............
T Consensus 179 ~~~~--~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~---~~~----~~~~~~~~~~~~- 247 (285)
T 3is5_A 179 SDEH--STNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEE---VQQ----KATYKEPNYAVE- 247 (285)
T ss_dssp ----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHH----HHHHCCCCCCC--
T ss_pred Cccc--CcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHH---HHh----hhccCCcccccc-
Confidence 4322 23346899999999876 468999999999999999999999997433221 111 111111100000
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 847 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 847 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
... ....+.+++.+||+.||++|||++|+++
T Consensus 248 --~~~----~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 248 --CRP----LTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp ---CC----CCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred --cCc----CCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 001 1236789999999999999999999975
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-37 Score=342.68 Aligned_cols=263 Identities=30% Similarity=0.494 Sum_probs=206.9
Q ss_pred HHHHHHhhcccccccccEEEEEEEEC-CCcE--EEEEEccCcc-hhhhHHHHHHHHHHHhc-CCCcccccceeeeccceE
Q 002336 610 LEEATNNFCKKIGKGSFGSVYYGKMK-DGKE--VAVKIMADSC-SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQR 684 (935)
Q Consensus 610 l~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~--vAvK~~~~~~-~~~~~~~~~E~~iL~~L-~HpnIv~l~g~~~~~~~~ 684 (935)
+....+++.+.||+|+||.||+|.+. +++. +|+|.+.... ....+.+.+|+++++++ +||||+++++++.+.+..
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 101 (327)
T 1fvr_A 22 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL 101 (327)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEE
T ss_pred ccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCce
Confidence 33455677899999999999999875 4654 4999886532 33456799999999999 899999999999999999
Q ss_pred EEEEEecCCCCHHHHhccCC-------------CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCC
Q 002336 685 ILVYEYMHNGTLRDRLHGSV-------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN 751 (935)
Q Consensus 685 ~lV~E~~~~gsL~~~L~~~~-------------~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~ 751 (935)
++||||+++++|.+++.... ....+++..++.++.|+++||+|||+ ++|+||||||+|||++.+
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~ 178 (327)
T 1fvr_A 102 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGEN 178 (327)
T ss_dssp EEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGG
T ss_pred EEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCccceEEEcCC
Confidence 99999999999999997532 23478999999999999999999998 899999999999999999
Q ss_pred CcEEEeeccccccccccccceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCcccchhHHHH
Q 002336 752 MRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHW 830 (935)
Q Consensus 752 ~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~ 830 (935)
+.+||+|||+++....... .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||...... +
T Consensus 179 ~~~kL~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~------~- 249 (327)
T 1fvr_A 179 YVAKIADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA------E- 249 (327)
T ss_dssp GCEEECCTTCEESSCEECC--C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------H-
T ss_pred CeEEEcccCcCcccccccc--ccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHH------H-
Confidence 9999999999875432211 222346889999999988889999999999999999998 99999743221 1
Q ss_pred HHHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhhhhhcc
Q 002336 831 ARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 893 (935)
Q Consensus 831 ~~~~i~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~~~~~~ 893 (935)
....+..+.. . ..+......+.+++.+||+.+|++||+++|+++.|+++.....
T Consensus 250 ~~~~~~~~~~-----~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 303 (327)
T 1fvr_A 250 LYEKLPQGYR-----L----EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 303 (327)
T ss_dssp HHHHGGGTCC-----C----CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred HHHHhhcCCC-----C----CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhc
Confidence 1112222211 0 1111223468899999999999999999999999998887543
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=341.17 Aligned_cols=251 Identities=24% Similarity=0.325 Sum_probs=199.6
Q ss_pred HHHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcchhhhHHHHHHHHHHHhc-CCCcccccceeeeccceEEEEEE
Q 002336 612 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYE 689 (935)
Q Consensus 612 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L-~HpnIv~l~g~~~~~~~~~lV~E 689 (935)
...|++.+.||+|+||.||++.++ +|+.||+|++.... ....+|++++.++ +||||+++++++.+.+..++|||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~----~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E 96 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK----RDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTE 96 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTT----CCCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEccc----CChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEe
Confidence 345777899999999999999886 68899999986542 2345788888888 79999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCC----CcEEEeeccccccc
Q 002336 690 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN----MRAKVSDFGLSRQA 765 (935)
Q Consensus 690 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~----~~vkL~DFGla~~~ 765 (935)
|+++|+|.+++.. ...+++..+..++.|++.||+|||+ ++|+||||||+|||+.++ +.+||+|||+++..
T Consensus 97 ~~~gg~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH~---~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~ 170 (342)
T 2qr7_A 97 LMKGGELLDKILR---QKFFSEREASAVLFTITKTVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL 170 (342)
T ss_dssp CCCSCBHHHHHHT---CTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEEC
T ss_pred CCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccC
Confidence 9999999999873 4579999999999999999999998 899999999999998432 35999999999876
Q ss_pred cccccceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeeccc
Q 002336 766 EEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 845 (935)
Q Consensus 766 ~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d 845 (935)
...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||..........+. ..+..+...
T Consensus 171 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~----~~i~~~~~~---- 241 (342)
T 2qr7_A 171 RAENGL-LMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEIL----ARIGSGKFS---- 241 (342)
T ss_dssp BCTTCC-BCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHH----HHHHHCCCC----
T ss_pred cCCCCc-eeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHH----HHHccCCcc----
Confidence 443222 23346899999999998877899999999999999999999999743322222222 222222221
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 846 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 846 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
+...........+.+++.+||+.||++||+++|+++
T Consensus 242 --~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 242 --LSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp --CCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred --cCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 111111122346889999999999999999999876
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=342.27 Aligned_cols=251 Identities=23% Similarity=0.286 Sum_probs=191.9
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcchhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEecC
Q 002336 614 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 692 (935)
Q Consensus 614 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~~ 692 (935)
.|++.+.||+|+||.||++... +++.||||++.... ...+.+.+|+.+++.++||||+++++++.+.+..++||||++
T Consensus 21 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 99 (361)
T 3uc3_A 21 RYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYAS 99 (361)
T ss_dssp TEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred cEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCC
Confidence 4667899999999999999986 78999999987543 234678899999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCc--EEEeecccccccccccc
Q 002336 693 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMR--AKVSDFGLSRQAEEDLT 770 (935)
Q Consensus 693 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~--vkL~DFGla~~~~~~~~ 770 (935)
+|+|.+++.. ...+++..+..++.|+++||+|||+ ++|+||||||+|||++.++. +||+|||+++......
T Consensus 100 ~~~L~~~l~~---~~~~~~~~~~~i~~ql~~~L~~LH~---~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~- 172 (361)
T 3uc3_A 100 GGELYERICN---AGRFSEDEARFFFQQLLSGVSYCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS- 172 (361)
T ss_dssp SCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTCCSCCCCGGGEEECSSSSCCEEECCCCCC--------
T ss_pred CCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCceEEEeecCccccccccC-
Confidence 9999999873 4569999999999999999999998 89999999999999987765 9999999987532221
Q ss_pred ceeecccCCccccCCCCCCCCCCCch-hHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeeccccccc
Q 002336 771 HISSVARGTVGYLDPEYYGNQQLTEK-SDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 849 (935)
Q Consensus 771 ~~~~~~~gt~~y~APE~l~~~~~s~k-sDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~ 849 (935)
......||+.|+|||++.+..+..+ +||||+||++|+|++|+.||....... ............ ... +.
T Consensus 173 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~--~~~~~~~~~~~~-~~~------~~ 242 (361)
T 3uc3_A 173 -QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPR--DYRKTIQRILSV-KYS------IP 242 (361)
T ss_dssp ---------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CC--CHHHHHHHHHTT-CCC------CC
T ss_pred -CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHH--HHHHHHHHHhcC-CCC------CC
Confidence 1233468999999999877777655 899999999999999999997443322 122222222211 110 00
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002336 850 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 884 (935)
Q Consensus 850 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~ 884 (935)
. .......+.+++.+||+.+|++|||++|+++.
T Consensus 243 ~--~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 243 D--DIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp T--TSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred C--cCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 0 00112367899999999999999999999864
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-37 Score=334.98 Aligned_cols=253 Identities=30% Similarity=0.471 Sum_probs=198.2
Q ss_pred HHHhhcccccccccEEEEEEEECCCcEEEEEEccCcchhhhHHHHHHHHHHHhcCCCcccccceeeec-cceEEEEEEec
Q 002336 613 ATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEE-EHQRILVYEYM 691 (935)
Q Consensus 613 ~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~-~~~~~lV~E~~ 691 (935)
..+++.+.||+|+||.||+|++. |+.||+|+++... ..+.+.+|++++++++||||+++++++.+ .+..++||||+
T Consensus 21 ~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~ 97 (278)
T 1byg_A 21 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 97 (278)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred hhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecC
Confidence 34667899999999999999986 8999999987542 45679999999999999999999998754 45789999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccccc
Q 002336 692 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 771 (935)
Q Consensus 692 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~ 771 (935)
++++|.+++... ....+++..++.++.|+++||+|||+ ++++||||||+||+++.++.+||+|||++.......
T Consensus 98 ~~~~L~~~l~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-- 171 (278)
T 1byg_A 98 AKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 171 (278)
T ss_dssp TTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred CCCCHHHHHHhc-ccccCCHHHHHHHHHHHHHHHHHHHh---CCccccCCCcceEEEeCCCcEEEeeccccccccccc--
Confidence 999999998742 12237899999999999999999998 899999999999999999999999999987654322
Q ss_pred eeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccC
Q 002336 772 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 850 (935)
Q Consensus 772 ~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~ 850 (935)
....+++.|+|||.+.+..++.++||||||+++|||++ |+.||...... .... .+..+.. ...
T Consensus 172 --~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~---~~~~----~~~~~~~-----~~~-- 235 (278)
T 1byg_A 172 --DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVVP----RVEKGYK-----MDA-- 235 (278)
T ss_dssp ------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG---GHHH----HHTTTCC-----CCC--
T ss_pred --cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHH---HHHH----HHhcCCC-----CCC--
Confidence 22347889999999988889999999999999999998 99999743322 1111 1222211 111
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhhhhhc
Q 002336 851 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 892 (935)
Q Consensus 851 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~~~~~ 892 (935)
+......+.+++.+||+.+|++||+++|+++.|+++...+
T Consensus 236 --~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~~ 275 (278)
T 1byg_A 236 --PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHE 275 (278)
T ss_dssp --CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred --cccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhhh
Confidence 1222346889999999999999999999999999887644
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=346.75 Aligned_cols=248 Identities=22% Similarity=0.321 Sum_probs=194.7
Q ss_pred HhhcccccccccEEEEEEEECCCcEEEEEEccCc--chhhhHHHHHHHHHHHhcC--CCcccccceeeeccceEEEEEEe
Q 002336 615 NNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADS--CSHRTQQFVTEVALLSRIH--HRNLVPLIGYCEEEHQRILVYEY 690 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~~~~~--~~~~~~~~~~E~~iL~~L~--HpnIv~l~g~~~~~~~~~lV~E~ 690 (935)
|++.+.||+|+||.||++...+++.||||++... .....+.+.+|+.+|++++ ||||+++++++...+..++|||
T Consensus 58 y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E- 136 (390)
T 2zmd_A 58 YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME- 136 (390)
T ss_dssp EEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE-
T ss_pred eEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEe-
Confidence 6678899999999999999888999999998643 2344578999999999996 5999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccccccc
Q 002336 691 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 770 (935)
Q Consensus 691 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~ 770 (935)
+.+++|.+++.. ...+++.++..++.||++||.|||+ .+|+||||||+|||++ ++.+||+|||+++.......
T Consensus 137 ~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~ 209 (390)
T 2zmd_A 137 CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT 209 (390)
T ss_dssp CCSEEHHHHHHH---CSSCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCCGGGEEES-SSCEEECCCSSSCCC-----
T ss_pred cCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCc
Confidence 668899999984 3578999999999999999999998 8999999999999995 58899999999987654322
Q ss_pred c-eeecccCCccccCCCCCCC-----------CCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcC
Q 002336 771 H-ISSVARGTVGYLDPEYYGN-----------QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG 838 (935)
Q Consensus 771 ~-~~~~~~gt~~y~APE~l~~-----------~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~ 838 (935)
. ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... ........+...
T Consensus 210 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~-----~~~~~~~~~~~~ 284 (390)
T 2zmd_A 210 SVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-----QISKLHAIIDPN 284 (390)
T ss_dssp ----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCC-----HHHHHHHHHCTT
T ss_pred cccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhH-----HHHHHHHHhCcc
Confidence 2 2234569999999998754 4689999999999999999999999973211 111122222111
Q ss_pred CeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002336 839 DVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 884 (935)
Q Consensus 839 ~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~ 884 (935)
.....+......+.+++.+||+.||++||+++|+++.
T Consensus 285 ---------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 285 ---------HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp ---------SCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ---------ccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 1111111112368899999999999999999999864
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=339.12 Aligned_cols=242 Identities=23% Similarity=0.308 Sum_probs=199.8
Q ss_pred HHHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcch--------hhhHHHHHHHHHHHhcCCCcccccceeeeccc
Q 002336 612 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--------HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH 682 (935)
Q Consensus 612 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~--------~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~ 682 (935)
...|++.+.||+|+||.||+|.+. +++.||||++..... ...+.+.+|+.++++++||||+++++++.+.+
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 102 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG 102 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence 355677899999999999999865 688999999875421 13346788999999999999999999999999
Q ss_pred eEEEEEEecCCC-CHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccc
Q 002336 683 QRILVYEYMHNG-TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGL 761 (935)
Q Consensus 683 ~~~lV~E~~~~g-sL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGl 761 (935)
..++||||+.+| +|.+++.. ...+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+
T Consensus 103 ~~~lv~e~~~~g~~l~~~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg~ 176 (335)
T 3dls_A 103 FFQLVMEKHGSGLDLFAFIDR---HPRLDEPLASYIFRQLVSAVGYLRL---KDIIHRDIKDENIVIAEDFTIKLIDFGS 176 (335)
T ss_dssp EEEEEEECCTTSCBHHHHHHT---CCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTT
T ss_pred EEEEEEEeCCCCccHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEEeccCHHHEEEcCCCcEEEeeccc
Confidence 999999999777 99999973 4569999999999999999999998 8999999999999999999999999999
Q ss_pred cccccccccceeecccCCccccCCCCCCCCCC-CchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCe
Q 002336 762 SRQAEEDLTHISSVARGTVGYLDPEYYGNQQL-TEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV 840 (935)
Q Consensus 762 a~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~-s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~ 840 (935)
++....... .....||+.|+|||.+.+..+ +.++||||||+++|+|++|+.||...... .
T Consensus 177 a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------------~----- 237 (335)
T 3dls_A 177 AAYLERGKL--FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET------------V----- 237 (335)
T ss_dssp CEECCTTCC--BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG------------T-----
T ss_pred ceECCCCCc--eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH------------H-----
Confidence 987654332 223458999999999887766 88999999999999999999999731110 0
Q ss_pred eecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002336 841 ISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 884 (935)
Q Consensus 841 ~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~ 884 (935)
..... .+......+.+++.+||+.+|++|||++|+++.
T Consensus 238 ----~~~~~--~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 238 ----EAAIH--PPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp ----TTCCC--CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred ----hhccC--CCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000 011122368899999999999999999999875
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-36 Score=352.45 Aligned_cols=244 Identities=25% Similarity=0.376 Sum_probs=201.6
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCcch---hhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEe
Q 002336 615 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 690 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~---~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~ 690 (935)
|.+.+.||+|+||.||+|.+. +|+.||||++..... ...+.+.+|+.+++.++||||+++++++...+..++||||
T Consensus 18 Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~ 97 (476)
T 2y94_A 18 YILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEY 97 (476)
T ss_dssp EEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred EEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeC
Confidence 566789999999999999986 799999999865322 2245788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccccccc
Q 002336 691 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 770 (935)
Q Consensus 691 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~ 770 (935)
+++|+|.+++.. ...+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||++........
T Consensus 98 ~~gg~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~~ 171 (476)
T 2y94_A 98 VSGGELFDYICK---NGRLDEKESRRLFQQILSGVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF 171 (476)
T ss_dssp CSSEEHHHHTTS---SSSCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTCC
T ss_pred CCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCCCcccccHHHEEEecCCCeEEEeccchhhcccccc
Confidence 999999999973 4679999999999999999999998 8999999999999999999999999999987654322
Q ss_pred ceeecccCCccccCCCCCCCCCC-CchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeeccccccc
Q 002336 771 HISSVARGTVGYLDPEYYGNQQL-TEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 849 (935)
Q Consensus 771 ~~~~~~~gt~~y~APE~l~~~~~-s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~ 849 (935)
.....||+.|+|||++.+..+ +.++||||+||++|+|++|+.||...... .+. ..+..+... .
T Consensus 172 --~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~---~~~----~~i~~~~~~------~- 235 (476)
T 2y94_A 172 --LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVP---TLF----KKICDGIFY------T- 235 (476)
T ss_dssp --BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSH---HHH----HHHHTTCCC------C-
T ss_pred --ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHH---HHH----HHHhcCCcC------C-
Confidence 234569999999999887665 78999999999999999999999743321 111 122222110 0
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 850 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 850 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
+......+.+++.+||+.||++|||++|+++
T Consensus 236 ---p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 236 ---PQYLNPSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp ---CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ---CccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 1111236789999999999999999999986
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-36 Score=326.17 Aligned_cols=248 Identities=24% Similarity=0.343 Sum_probs=200.6
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc--hhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEec
Q 002336 615 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 691 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~ 691 (935)
|++.+.||+|+||.||+|.+. +|+.||+|++.... ....+.+.+|+.++++++||||+++++++.+....++||||+
T Consensus 8 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 87 (284)
T 3kk8_A 8 YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLV 87 (284)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred hhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEecC
Confidence 566789999999999999876 68999999986532 334567889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCc---EEEeecccccccccc
Q 002336 692 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMR---AKVSDFGLSRQAEED 768 (935)
Q Consensus 692 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~---vkL~DFGla~~~~~~ 768 (935)
++++|.+.+.. ...+++..+..++.|++.||+|||+ .+|+||||||+||+++.++. +||+|||++......
T Consensus 88 ~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~ 161 (284)
T 3kk8_A 88 TGGELFEDIVA---REFYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 161 (284)
T ss_dssp CSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSS
T ss_pred CCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccC
Confidence 99999988873 4568999999999999999999998 89999999999999986655 999999999766543
Q ss_pred ccceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccccc
Q 002336 769 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 848 (935)
Q Consensus 769 ~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l 848 (935)
.. .....|++.|+|||.+.+..++.++||||+|+++|+|++|+.||...... .... .+..+... ...+ .
T Consensus 162 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~---~~~~----~~~~~~~~-~~~~-~ 230 (284)
T 3kk8_A 162 EA--WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH---RLYA----QIKAGAYD-YPSP-E 230 (284)
T ss_dssp CB--CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHH----HHHHTCCC-CCTT-T
T ss_pred cc--ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchh---HHHH----HHHhcccc-CCch-h
Confidence 22 22346899999999999999999999999999999999999999743221 1111 11111111 0000 0
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 849 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 849 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
. ......+.+++.+||+.+|++|||++|+++
T Consensus 231 ~----~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 231 W----DTVTPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp T----TTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred h----cccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 0 112236889999999999999999999976
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-36 Score=337.16 Aligned_cols=247 Identities=29% Similarity=0.429 Sum_probs=198.9
Q ss_pred HHHHhhcccccccccEEEEEEEE-CCCcEEEEEEccCcc---hhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEE
Q 002336 612 EATNNFCKKIGKGSFGSVYYGKM-KDGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILV 687 (935)
Q Consensus 612 ~~~~~~~~~LG~G~fG~Vy~~~~-~~g~~vAvK~~~~~~---~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV 687 (935)
...++..+.||+|+||.||+|.. .+|+.||||++.... ....+.+.+|++++++++||||+++++++..++..++|
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 132 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 132 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence 34466788999999999999987 478999999986432 23346789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccc
Q 002336 688 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 767 (935)
Q Consensus 688 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~ 767 (935)
|||+. |+|.+.+.. ....+++..+..++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 133 ~e~~~-g~l~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 206 (348)
T 1u5q_A 133 MEYCL-GSASDLLEV--HKKPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 206 (348)
T ss_dssp EECCS-EEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred EecCC-CCHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence 99997 688887753 24578999999999999999999998 8999999999999999999999999999986543
Q ss_pred cccceeecccCCccccCCCCC---CCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecc
Q 002336 768 DLTHISSVARGTVGYLDPEYY---GNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 844 (935)
Q Consensus 768 ~~~~~~~~~~gt~~y~APE~l---~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~ 844 (935)
. ....||+.|+|||++ ....++.++||||||+++|||++|+.||..... ........... .....
T Consensus 207 ~-----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~------~~~~~~~~~~~-~~~~~ 274 (348)
T 1u5q_A 207 A-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MSALYHIAQNE-SPALQ 274 (348)
T ss_dssp B-----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHHHSC-CCCCC
T ss_pred C-----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHHhcC-CCCCC
Confidence 2 234689999999987 356789999999999999999999999963321 11122222221 11111
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002336 845 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 884 (935)
Q Consensus 845 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~ 884 (935)
... ....+.+++.+||+.+|++|||++++++.
T Consensus 275 ----~~~----~~~~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 275 ----SGH----WSEYFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp ----CTT----SCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred ----CCC----CCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 111 22367899999999999999999998753
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-36 Score=329.93 Aligned_cols=246 Identities=24% Similarity=0.352 Sum_probs=201.7
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc---hhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEe
Q 002336 615 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 690 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~ 690 (935)
|.+.+.||+|+||.||++.+. +++.+|+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 17 y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 96 (294)
T 2rku_A 17 YVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLEL 96 (294)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred eEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEEec
Confidence 456789999999999999986 57899999986532 23456789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccccccc
Q 002336 691 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 770 (935)
Q Consensus 691 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~ 770 (935)
+++++|.+++.. ...+++.++..++.|+++||+|||+ ++|+||||||+||+++.++.+||+|||++........
T Consensus 97 ~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 170 (294)
T 2rku_A 97 CRRRSLLELHKR---RKALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE 170 (294)
T ss_dssp CTTCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred CCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEcCCCCEEEEeccCceecccCcc
Confidence 999999998873 4578999999999999999999998 8999999999999999999999999999987543222
Q ss_pred ceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccC
Q 002336 771 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 850 (935)
Q Consensus 771 ~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~ 850 (935)
. .....|++.|+|||.+.+..++.++||||||+++|+|++|+.||......+ ... .+..+.. .+
T Consensus 171 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~------~~~-~~~~~~~------~~-- 234 (294)
T 2rku_A 171 R-KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE------TYL-RIKKNEY------SI-- 234 (294)
T ss_dssp C-BCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHH-HHHTTCC------CC--
T ss_pred c-cccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHH-HHhhccC------CC--
Confidence 1 233468999999999988889999999999999999999999997433211 111 1111111 11
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002336 851 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 884 (935)
Q Consensus 851 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~ 884 (935)
+......+.+++.+||+.+|++||+++|+++.
T Consensus 235 --~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 235 --PKHINPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp --CTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred --ccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 11122367899999999999999999998763
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-37 Score=356.49 Aligned_cols=248 Identities=24% Similarity=0.348 Sum_probs=192.9
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCc---chhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEE
Q 002336 614 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS---CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 689 (935)
Q Consensus 614 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~---~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E 689 (935)
.+++.+.||+|+||.||+|... +|+.||||++... .......+.+|+.+++.++||||+++++++...+..++|||
T Consensus 149 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 228 (446)
T 4ejn_A 149 EFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVME 228 (446)
T ss_dssp GEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEEC
T ss_pred HcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEEe
Confidence 4667889999999999999875 6899999998653 22334567889999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccc
Q 002336 690 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 769 (935)
Q Consensus 690 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~ 769 (935)
|+++|+|.+++.. ...+++..+..++.|++.||+|||+ .++|+||||||+|||++.++.+||+|||+++......
T Consensus 229 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~--~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 303 (446)
T 4ejn_A 229 YANGGELFFHLSR---ERVFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG 303 (446)
T ss_dssp CCSSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHH--HTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC--
T ss_pred eCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHhh--cCCEEECCCCHHHEEECCCCCEEEccCCCceeccCCC
Confidence 9999999999874 4578999999999999999999995 2789999999999999999999999999998643322
Q ss_pred cceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeeccccccc
Q 002336 770 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 849 (935)
Q Consensus 770 ~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~ 849 (935)
.. .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+.. .+.+ .+..+.. .+
T Consensus 304 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~---~~~~----~i~~~~~------~~- 368 (446)
T 4ejn_A 304 AT-MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---KLFE----LILMEEI------RF- 368 (446)
T ss_dssp ----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHH----HHHHCCC------CC-
T ss_pred cc-cccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH---HHHH----HHHhCCC------CC-
Confidence 22 23456999999999999899999999999999999999999999743321 1111 1111111 11
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 002336 850 GNVKIESIWRIAEVAIQCVEQRGFSRP-----KMQEIVLA 884 (935)
Q Consensus 850 ~~~~~~~~~~l~~li~~Cl~~dP~~RP-----s~~ev~~~ 884 (935)
+......+.+++.+||+.||++|| +++|+++.
T Consensus 369 ---p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h 405 (446)
T 4ejn_A 369 ---PRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH 405 (446)
T ss_dssp ---CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred ---CccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence 111223688999999999999999 99999863
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-36 Score=334.89 Aligned_cols=257 Identities=22% Similarity=0.272 Sum_probs=200.7
Q ss_pred hHHHHHHhhc-ccccccccEEEEEEEEC-CCcEEEEEEccCcch--hhhHHHHHHHHHHHhc-CCCcccccceeeeccce
Q 002336 609 ELEEATNNFC-KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQ 683 (935)
Q Consensus 609 ~l~~~~~~~~-~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~--~~~~~~~~E~~iL~~L-~HpnIv~l~g~~~~~~~ 683 (935)
+.-...|.+. +.||+|+||.||+|... +++.||+|++..... .....+.+|+.+++.+ +||||+++++++.+.+.
T Consensus 24 ~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~ 103 (327)
T 3lm5_A 24 ENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSE 103 (327)
T ss_dssp HHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred HhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCe
Confidence 3334455554 88999999999999876 689999999875432 2346789999999999 57999999999999999
Q ss_pred EEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccC---CCcEEEeecc
Q 002336 684 RILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI---NMRAKVSDFG 760 (935)
Q Consensus 684 ~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~---~~~vkL~DFG 760 (935)
.++||||+++|+|.+++... ....+++..++.++.|++.||+|||+ ++|+||||||+|||++. ++.+||+|||
T Consensus 104 ~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~ql~~~L~~LH~---~givH~Dikp~NIl~~~~~~~~~~kL~Dfg 179 (327)
T 3lm5_A 104 IILILEYAAGGEIFSLCLPE-LAEMVSENDVIRLIKQILEGVYYLHQ---NNIVHLDLKPQNILLSSIYPLGDIKIVDFG 179 (327)
T ss_dssp EEEEEECCTTEEGGGGGSSC-C-CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESCBTTBCCEEECCGG
T ss_pred EEEEEEecCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCChHHEEEecCCCCCcEEEeeCc
Confidence 99999999999999998643 34679999999999999999999998 89999999999999987 7899999999
Q ss_pred ccccccccccceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCe
Q 002336 761 LSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV 840 (935)
Q Consensus 761 la~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~ 840 (935)
+++....... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||....... ... .+.....
T Consensus 180 ~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~~----~i~~~~~ 250 (327)
T 3lm5_A 180 MSRKIGHACE--LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQE---TYL----NISQVNV 250 (327)
T ss_dssp GCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHH----HHHHTCC
T ss_pred cccccCCccc--cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH---HHH----HHHhccc
Confidence 9987644322 223468999999999999999999999999999999999999997433211 111 1111110
Q ss_pred eecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002336 841 ISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 884 (935)
Q Consensus 841 ~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~ 884 (935)
.............+.+++.+||+.+|++|||++|+++.
T Consensus 251 ------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 251 ------DYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp ------CCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred ------ccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 00011111223468899999999999999999998753
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-36 Score=332.50 Aligned_cols=257 Identities=24% Similarity=0.341 Sum_probs=195.5
Q ss_pred Hhh-cccccccccEEEEEEEEC-CCcEEEEEEccCcchhhhHHHHHHHHHHHhc-CCCcccccceeeeccceEEEEEEec
Q 002336 615 NNF-CKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEYM 691 (935)
Q Consensus 615 ~~~-~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L-~HpnIv~l~g~~~~~~~~~lV~E~~ 691 (935)
|++ .+.||+|+||.||+|... +++.||||++........+.+.+|++++.++ +||||+++++++.+.+..++||||+
T Consensus 14 y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 93 (316)
T 2ac3_A 14 YQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKM 93 (316)
T ss_dssp CEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred EEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcC
Confidence 344 367999999999999865 7899999999766555567899999999985 7999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCc---EEEeecccccccccc
Q 002336 692 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMR---AKVSDFGLSRQAEED 768 (935)
Q Consensus 692 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~---vkL~DFGla~~~~~~ 768 (935)
++++|.+++.. ...+++..+..++.|+++||+|||+ ++|+||||||+|||++.++. +||+|||++......
T Consensus 94 ~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~ 167 (316)
T 2ac3_A 94 RGGSILSHIHK---RRHFNELEASVVVQDVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLN 167 (316)
T ss_dssp TTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-----
T ss_pred CCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEEccCCCcCceEEEEccCccccccC
Confidence 99999999974 3568999999999999999999998 89999999999999998776 999999998765322
Q ss_pred cc------ceeecccCCccccCCCCCCC-----CCCCchhHHHHHHHHHHHHHhCCCCCCccCcccc-h-------hHHH
Q 002336 769 LT------HISSVARGTVGYLDPEYYGN-----QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAE-L-------NIVH 829 (935)
Q Consensus 769 ~~------~~~~~~~gt~~y~APE~l~~-----~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~-~-------~l~~ 829 (935)
.. .......||+.|+|||.+.. ..++.++||||||+++|||++|+.||......+. . ....
T Consensus 168 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 247 (316)
T 2ac3_A 168 GDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQN 247 (316)
T ss_dssp --------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHH
T ss_pred CccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHH
Confidence 11 11123458999999998864 4578999999999999999999999975432210 0 0011
Q ss_pred HHHHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 830 WARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 830 ~~~~~i~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
-....+..+... ...+ ... .....+.+++.+||+.||++|||++|+++
T Consensus 248 ~~~~~i~~~~~~-~~~~-~~~----~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 248 MLFESIQEGKYE-FPDK-DWA----HISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp HHHHHHHHCCCC-CCHH-HHT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHHHhccCcc-cCch-hcc----cCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 111222222110 0000 000 11236889999999999999999999986
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=325.07 Aligned_cols=245 Identities=29% Similarity=0.428 Sum_probs=195.4
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCc--chhhhHHHHHHHHHHHhcCCCcccccceeeec----cceEEEE
Q 002336 615 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEE----EHQRILV 687 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~--~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~----~~~~~lV 687 (935)
+.+.+.||+|+||.||+|.+. +++.||+|++... .....+.+.+|+.++++++||||+++++++.. ....++|
T Consensus 28 ~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv 107 (290)
T 1t4h_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEE
Confidence 345678999999999999875 6889999998653 23445779999999999999999999998764 4568999
Q ss_pred EEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCc--eEecCCCCCCcccc-CCCcEEEeecccccc
Q 002336 688 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG--IIHRDVKSSNILLD-INMRAKVSDFGLSRQ 764 (935)
Q Consensus 688 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~--ivH~DLkp~NILld-~~~~vkL~DFGla~~ 764 (935)
|||+++++|.+++.. ...+++..++.++.|++.||+|||+ .+ |+||||||+|||++ .++.+||+|||++..
T Consensus 108 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~ 181 (290)
T 1t4h_A 108 TELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp EECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred EEecCCCCHHHHHHH---ccCCCHHHHHHHHHHHHHHHHHHHc---CCCCEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence 999999999999974 3568999999999999999999998 67 99999999999997 789999999999975
Q ss_pred ccccccceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecc
Q 002336 765 AEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 844 (935)
Q Consensus 765 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~ 844 (935)
..... .....|++.|+|||.+.+ .++.++||||+|+++|+|++|+.||...... .... ..+..+......
T Consensus 182 ~~~~~---~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-----~~~~-~~~~~~~~~~~~ 251 (290)
T 1t4h_A 182 KRASF---AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA-----AQIY-RRVTSGVKPASF 251 (290)
T ss_dssp CCTTS---BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH-----HHHH-HHHTTTCCCGGG
T ss_pred ccccc---cccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcH-----HHHH-HHHhccCCcccc
Confidence 44332 223468999999998864 5899999999999999999999999732221 1111 122222111111
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 845 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 845 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
+. . ....+.+++.+||+.+|++|||++|+++
T Consensus 252 ~~----~----~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 252 DK----V----AIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp GG----C----CCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CC----C----CCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 11 1 1236889999999999999999999975
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-36 Score=328.14 Aligned_cols=248 Identities=24% Similarity=0.369 Sum_probs=196.7
Q ss_pred cccccccccEEEEEEEEC-CCcEEEEEEccCcchhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEecCCCCH
Q 002336 618 CKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTL 696 (935)
Q Consensus 618 ~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL 696 (935)
...||+|+||.||+|.+. +++.||+|.+........+.+.+|+.+++.++||||+++++++...+..++||||+++++|
T Consensus 27 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 106 (295)
T 2clq_A 27 RVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSL 106 (295)
T ss_dssp BCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEH
T ss_pred cEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCH
Confidence 358999999999999875 6889999998776555667899999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccC-CCcEEEeeccccccccccccceeec
Q 002336 697 RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI-NMRAKVSDFGLSRQAEEDLTHISSV 775 (935)
Q Consensus 697 ~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~-~~~vkL~DFGla~~~~~~~~~~~~~ 775 (935)
.+++........+++..+..++.|+++||+|||+ ++|+||||||+||+++. ++.+||+|||++........ ....
T Consensus 107 ~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~-~~~~ 182 (295)
T 2clq_A 107 SALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHD---NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP-CTET 182 (295)
T ss_dssp HHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC------CC
T ss_pred HHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHh---CCEEccCCChhhEEEECCCCCEEEeecccccccCCCCC-cccc
Confidence 9999865445567899999999999999999998 89999999999999987 89999999999987543222 1233
Q ss_pred ccCCccccCCCCCCCC--CCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccCCCC
Q 002336 776 ARGTVGYLDPEYYGNQ--QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVK 853 (935)
Q Consensus 776 ~~gt~~y~APE~l~~~--~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~~~~ 853 (935)
..|++.|+|||.+.+. .++.++||||||+++|+|++|+.||........ ... ..... . ..+.+ +
T Consensus 183 ~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~---~~~~~-~-----~~~~~----~ 248 (295)
T 2clq_A 183 FTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQA-AMF---KVGMF-K-----VHPEI----P 248 (295)
T ss_dssp CCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHH-HHH---HHHHH-C-----CCCCC----C
T ss_pred cCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhH-HHH---hhccc-c-----ccccc----c
Confidence 4689999999998654 378999999999999999999999963222111 111 11110 0 11111 1
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 854 IESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 854 ~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
......+.+++.+||+.+|++||+++|+++
T Consensus 249 ~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 249 ESMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp TTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred ccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 222346889999999999999999999875
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=366.41 Aligned_cols=249 Identities=27% Similarity=0.462 Sum_probs=199.4
Q ss_pred ccccccccEEEEEEEEC---CCcEEEEEEccCcch--hhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEecCC
Q 002336 619 KKIGKGSFGSVYYGKMK---DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 693 (935)
Q Consensus 619 ~~LG~G~fG~Vy~~~~~---~g~~vAvK~~~~~~~--~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~~~ 693 (935)
+.||+|+||.||+|.+. .++.||||+++.... ...+++.+|+++|++++|||||++++++.. +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 57999999999999663 467899999976432 235789999999999999999999999965 458899999999
Q ss_pred CCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccccccc--c
Q 002336 694 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT--H 771 (935)
Q Consensus 694 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~--~ 771 (935)
|+|.+++.. ...+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++....... .
T Consensus 454 g~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~yLH~---~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 527 (635)
T 4fl3_A 454 GPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 527 (635)
T ss_dssp EEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC------
T ss_pred CCHHHHHhh---CCCCCHHHHHHHHHHHHHHHHHHHH---CCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccc
Confidence 999999973 4678999999999999999999998 8999999999999999999999999999987644322 1
Q ss_pred eeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccC
Q 002336 772 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 850 (935)
Q Consensus 772 ~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~ 850 (935)
......+|+.|+|||++.+..++.++|||||||++|||++ |+.||...... . +...+..+....
T Consensus 528 ~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~---~----~~~~i~~~~~~~-------- 592 (635)
T 4fl3_A 528 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS---E----VTAMLEKGERMG-------- 592 (635)
T ss_dssp -------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---H----HHHHHHTTCCCC--------
T ss_pred cccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH---H----HHHHHHcCCCCC--------
Confidence 1223346788999999988899999999999999999998 99999743321 1 222233322111
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhhhh
Q 002336 851 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 890 (935)
Q Consensus 851 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~~~ 890 (935)
.+......+.+++.+||+.||++||++++|++.|+++..
T Consensus 593 -~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~ 631 (635)
T 4fl3_A 593 -CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 631 (635)
T ss_dssp -CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred -CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 112233478899999999999999999999999998654
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=342.04 Aligned_cols=254 Identities=26% Similarity=0.354 Sum_probs=202.5
Q ss_pred HHHhhcccccccccEEEEEEEE----CCCcEEEEEEccCcc----hhhhHHHHHHHHHHHhc-CCCcccccceeeeccce
Q 002336 613 ATNNFCKKIGKGSFGSVYYGKM----KDGKEVAVKIMADSC----SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQ 683 (935)
Q Consensus 613 ~~~~~~~~LG~G~fG~Vy~~~~----~~g~~vAvK~~~~~~----~~~~~~~~~E~~iL~~L-~HpnIv~l~g~~~~~~~ 683 (935)
..|++.+.||+|+||.||+++. .+++.||||+++... ....+.+.+|+++++++ +||||+++++++.....
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 133 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 133 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence 3467789999999999999987 368999999986532 12345678899999999 69999999999999999
Q ss_pred EEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccc
Q 002336 684 RILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 763 (935)
Q Consensus 684 ~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~ 763 (935)
.++||||+++|+|.+++.. ...+++..+..++.|+++||.|||+ ++|+||||||+|||++.++.+||+|||+++
T Consensus 134 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 207 (355)
T 1vzo_A 134 LHLILDYINGGELFTHLSQ---RERFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSK 207 (355)
T ss_dssp EEEEECCCCSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred EEEEeecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCcEEEeeCCCCe
Confidence 9999999999999999974 3568999999999999999999998 899999999999999999999999999998
Q ss_pred cccccccceeecccCCccccCCCCCCC--CCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCee
Q 002336 764 QAEEDLTHISSVARGTVGYLDPEYYGN--QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVI 841 (935)
Q Consensus 764 ~~~~~~~~~~~~~~gt~~y~APE~l~~--~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~ 841 (935)
..............||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ .....+......
T Consensus 208 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~--~~~~~~~~~~~~--- 282 (355)
T 1vzo_A 208 EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS--QAEISRRILKSE--- 282 (355)
T ss_dssp ECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC--HHHHHHHHHHCC---
T ss_pred ecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccch--HHHHHHHHhccC---
Confidence 765443333344569999999999875 4578999999999999999999999974433221 222222222111
Q ss_pred ecccccccCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHH
Q 002336 842 SIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRP-----KMQEIVLAI 885 (935)
Q Consensus 842 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----s~~ev~~~L 885 (935)
+. .+......+.+++.+||+.||++|| +++|+++..
T Consensus 283 ----~~----~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 283 ----PP----YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp ----CC----CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred ----CC----CCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 11 1222234678999999999999999 999987653
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-36 Score=338.39 Aligned_cols=253 Identities=16% Similarity=0.166 Sum_probs=203.6
Q ss_pred HHHhhcccccccccEEEEEEE------ECCCcEEEEEEccCcchhhhHHHHHHHHHHHhcC---CCcccccceeeeccce
Q 002336 613 ATNNFCKKIGKGSFGSVYYGK------MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIH---HRNLVPLIGYCEEEHQ 683 (935)
Q Consensus 613 ~~~~~~~~LG~G~fG~Vy~~~------~~~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~---HpnIv~l~g~~~~~~~ 683 (935)
..|.+.+.||+|+||.||+|. ...++.||||++.... ..++..|+++++.++ |+||+++++++...+.
T Consensus 65 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~ 141 (365)
T 3e7e_A 65 KLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNG 141 (365)
T ss_dssp SEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSC
T ss_pred EEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCC
Confidence 345667899999999999994 3468899999987543 346778888888886 9999999999999999
Q ss_pred EEEEEEecCCCCHHHHhccCC--CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccC-----------
Q 002336 684 RILVYEYMHNGTLRDRLHGSV--NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI----------- 750 (935)
Q Consensus 684 ~~lV~E~~~~gsL~~~L~~~~--~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~----------- 750 (935)
.++||||+++|+|.+++.... ....+++..++.++.|+++||+|||+ ++|+||||||+|||++.
T Consensus 142 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~---~~ivHrDiKp~NIll~~~~~~~~~~~~~ 218 (365)
T 3e7e_A 142 SVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDDL 218 (365)
T ss_dssp EEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECGGGTCC------
T ss_pred cEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEecccccCccccccc
Confidence 999999999999999986421 35679999999999999999999998 89999999999999998
Q ss_pred CCcEEEeecccccccccc-ccceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHH
Q 002336 751 NMRAKVSDFGLSRQAEED-LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVH 829 (935)
Q Consensus 751 ~~~vkL~DFGla~~~~~~-~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~ 829 (935)
++.+||+|||+++..... .........||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 219 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~------ 292 (365)
T 3e7e_A 219 SAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE------ 292 (365)
T ss_dssp CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE------
T ss_pred cCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc------
Confidence 899999999999764321 1223344569999999999999899999999999999999999999986322110
Q ss_pred HHHHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCC-CCHHHHHHHHhhhhhhc
Q 002336 830 WARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSR-PKMQEIVLAIQDSIKIE 892 (935)
Q Consensus 830 ~~~~~i~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~R-Ps~~ev~~~L~~~~~~~ 892 (935)
..+...+.... ....+.+++.+|+..+|.+| |+++++.+.|++.....
T Consensus 293 ------------~~~~~~~~~~~---~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~ 341 (365)
T 3e7e_A 293 ------------CKPEGLFRRLP---HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQH 341 (365)
T ss_dssp ------------EEECSCCTTCS---SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHH
T ss_pred ------------eeechhccccC---cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHh
Confidence 01111121111 13367789999999999998 68899999998877653
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=345.64 Aligned_cols=249 Identities=26% Similarity=0.351 Sum_probs=192.2
Q ss_pred HHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcch---hhhHHHHHHHHH-HHhcCCCcccccceeeeccceEEEE
Q 002336 613 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVAL-LSRIHHRNLVPLIGYCEEEHQRILV 687 (935)
Q Consensus 613 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~---~~~~~~~~E~~i-L~~L~HpnIv~l~g~~~~~~~~~lV 687 (935)
..+++.+.||+|+||.||+|+++ +++.||+|+++.... .....+.+|..+ ++.++||||+++++++.+.+..++|
T Consensus 38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv 117 (373)
T 2r5t_A 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFV 117 (373)
T ss_dssp GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEE
Confidence 34677899999999999999986 588999999865432 233456677776 5678999999999999999999999
Q ss_pred EEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccc
Q 002336 688 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 767 (935)
Q Consensus 688 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~ 767 (935)
|||+++|+|.+++.. ...+++..+..++.||+.||+|||+ ++|+||||||+|||++.++++||+|||+++....
T Consensus 118 ~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~ 191 (373)
T 2r5t_A 118 LDYINGGELFYHLQR---ERCFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE 191 (373)
T ss_dssp EECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBC
T ss_pred EeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEeeCcccccccc
Confidence 999999999999874 4568899999999999999999998 8999999999999999999999999999986432
Q ss_pred cccceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeeccccc
Q 002336 768 DLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 847 (935)
Q Consensus 768 ~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~ 847 (935)
... ......||+.|+|||++.+..++.++|+|||||++|||++|+.||...+.. .. ... +..+.. .
T Consensus 192 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~---~~---~~~-i~~~~~------~ 257 (373)
T 2r5t_A 192 HNS-TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA---EM---YDN-ILNKPL------Q 257 (373)
T ss_dssp CCC-CCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHH---HH---HHH-HHHSCC------C
T ss_pred CCC-ccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH---HH---HHH-HHhccc------C
Confidence 221 233456999999999999999999999999999999999999999743221 11 111 111111 1
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 002336 848 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAI 885 (935)
Q Consensus 848 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L 885 (935)
+ +......+.+++.+||+.||++||++.+.++.+
T Consensus 258 ~----~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i 291 (373)
T 2r5t_A 258 L----KPNITNSARHLLEGLLQKDRTKRLGAKDDFMEI 291 (373)
T ss_dssp C----CSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHH
T ss_pred C----CCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHH
Confidence 1 111223678999999999999999986444333
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=338.03 Aligned_cols=259 Identities=21% Similarity=0.305 Sum_probs=192.9
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCcchh-hhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEecC
Q 002336 615 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSH-RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 692 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~~-~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~~ 692 (935)
|.+.+.||+|+||.||+|... +++.||+|++...... ....+.+|++++++++||||+++++++...+..++||||++
T Consensus 4 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 83 (324)
T 3mtl_A 4 YIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD 83 (324)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECCS
T ss_pred eEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecccc
Confidence 456789999999999999986 7899999998654322 22356689999999999999999999999999999999997
Q ss_pred CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccccce
Q 002336 693 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 772 (935)
Q Consensus 693 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~~ 772 (935)
|+|.+++... ...+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++........
T Consensus 84 -~~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~- 156 (324)
T 3mtl_A 84 -KDLKQYLDDC--GNIINMHNVKLFLFQLLRGLAYCHR---QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT- 156 (324)
T ss_dssp -EEHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCCGGGEEECTTCCEEECSSSEEECC-------
T ss_pred -cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCcCHHHEEECCCCCEEEccCcccccccCCccc-
Confidence 5898888753 4568999999999999999999998 89999999999999999999999999999765433222
Q ss_pred eecccCCccccCCCCCCC-CCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcC---Ceeecccc--
Q 002336 773 SSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG---DVISIVDP-- 846 (935)
Q Consensus 773 ~~~~~gt~~y~APE~l~~-~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~---~~~~~~d~-- 846 (935)
.....||+.|+|||.+.+ ..++.++||||+|+++|+|++|+.||......+ ....+.+..... ........
T Consensus 157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~i~~~~~~~~~~~~~~~~~~~~ 233 (324)
T 3mtl_A 157 YDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEE---QLHFIFRILGTPTEETWPGILSNEE 233 (324)
T ss_dssp ------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCCCTTTSTTGGGCHH
T ss_pred cccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCChHhchhhhcchh
Confidence 223458999999998865 678999999999999999999999997543322 222222221110 00000000
Q ss_pred -------cccC----CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 847 -------VLIG----NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 847 -------~l~~----~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
.... .........+.+++.+||+.||++|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 234 FKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp HHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 0000 000112246789999999999999999999976
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-36 Score=327.02 Aligned_cols=244 Identities=23% Similarity=0.353 Sum_probs=200.8
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcch---hhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEE
Q 002336 614 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 689 (935)
Q Consensus 614 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~---~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E 689 (935)
.|++.+.||+|+||.||+|... +++.||+|++..... ...+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 15 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 94 (284)
T 2vgo_A 15 DFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLE 94 (284)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEEE
Confidence 4667889999999999999886 578899999864321 123578899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccc
Q 002336 690 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 769 (935)
Q Consensus 690 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~ 769 (935)
|+++++|.+++.. ...+++..+..++.|+++||.|||+ ++|+||||||+||+++.++.+||+|||++.......
T Consensus 95 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~ 168 (284)
T 2vgo_A 95 FAPRGELYKELQK---HGRFDEQRSATFMEELADALHYCHE---RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR 168 (284)
T ss_dssp CCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTCCEEECCCTTCEECSSSC
T ss_pred eCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEEcCCCCEEEecccccccCcccc
Confidence 9999999999874 3468999999999999999999997 899999999999999999999999999987654322
Q ss_pred cceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeeccccccc
Q 002336 770 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 849 (935)
Q Consensus 770 ~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~ 849 (935)
.....|++.|+|||.+.+..++.++||||||+++|+|++|+.||....... .. ..+..... .+
T Consensus 169 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~------~~-~~~~~~~~------~~- 231 (284)
T 2vgo_A 169 ---RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTE------TH-RRIVNVDL------KF- 231 (284)
T ss_dssp ---BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH------HH-HHHHTTCC------CC-
T ss_pred ---cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhH------HH-HHHhcccc------CC-
Confidence 223468999999999999899999999999999999999999997432211 11 11111111 11
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 850 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 850 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
+......+.+++.+||+.+|++||+++|+++
T Consensus 232 ---~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 232 ---PPFLSDGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp ---CTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ---CCcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 1122346889999999999999999999986
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-36 Score=327.40 Aligned_cols=245 Identities=20% Similarity=0.299 Sum_probs=197.5
Q ss_pred HHHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc--hhhhHHHHHHHHHHHhc-CCCcccccceeeeccceEEEE
Q 002336 612 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILV 687 (935)
Q Consensus 612 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~iL~~L-~HpnIv~l~g~~~~~~~~~lV 687 (935)
...|++.+.||+|+||.||+|.+. +++.||+|++.... ......+.+|+..+..+ +||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 356777899999999999999986 79999999987532 33456788999999999 899999999999999999999
Q ss_pred EEecCCCCHHHHhccCC-CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCC---------------
Q 002336 688 YEYMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN--------------- 751 (935)
Q Consensus 688 ~E~~~~gsL~~~L~~~~-~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~--------------- 751 (935)
|||+++++|.+++.... ....+++..++.++.|+++||+|||+ ++|+||||||+|||++.+
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEC-----------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHh---CCEeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 99999999999987432 12568999999999999999999998 899999999999999844
Q ss_pred ----CcEEEeeccccccccccccceeecccCCccccCCCCCCCC-CCCchhHHHHHHHHHHHHHhCCCCCCccCcccchh
Q 002336 752 ----MRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELN 826 (935)
Q Consensus 752 ----~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~ 826 (935)
..+||+|||++....... ...|++.|+|||.+.+. .++.++||||||+++++|++|..++.... .
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~-----~ 236 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD-----Q 236 (289)
T ss_dssp ---CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH-----H
T ss_pred cCCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh-----H
Confidence 479999999998765432 23489999999998765 66789999999999999999998764211 1
Q ss_pred HHHHHHHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 827 IVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 827 l~~~~~~~i~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
. ..+..+.... +.... ...+.+++.+||+.||++|||++|+++
T Consensus 237 ~-----~~~~~~~~~~-----~~~~~----~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 237 W-----HEIRQGRLPR-----IPQVL----SQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp H-----HHHHTTCCCC-----CSSCC----CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred H-----HHHHcCCCCC-----CCccc----CHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 1 1122222211 11122 236889999999999999999999875
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=342.24 Aligned_cols=264 Identities=21% Similarity=0.293 Sum_probs=201.8
Q ss_pred HHHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc-hhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEE
Q 002336 612 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 689 (935)
Q Consensus 612 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~-~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E 689 (935)
...|++.+.||+|+||.||+|.+. +++.||+|++.... ....+.+.+|+.+++.++||||+++++++..++..++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 345667789999999999999886 68999999987653 3345779999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCC-ceEecCCCCCCccccCCCcEEEeecccccccccc
Q 002336 690 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP-GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 768 (935)
Q Consensus 690 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~-~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~ 768 (935)
|+++++|.+++.. ...+++..+..++.|++.||+|||+ + +|+||||||+|||++.++.+||+|||++......
T Consensus 112 ~~~~~~L~~~l~~---~~~~~~~~~~~i~~~i~~~l~~lh~---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 185 (360)
T 3eqc_A 112 HMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLRE---KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 185 (360)
T ss_dssp CCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---HHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred CCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---hCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc
Confidence 9999999999974 3568999999999999999999997 5 8999999999999999999999999998765332
Q ss_pred ccceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHH-----------------
Q 002336 769 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWA----------------- 831 (935)
Q Consensus 769 ~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~----------------- 831 (935)
. .....||+.|+|||++.+..++.++||||||+++|+|++|+.||...+...........
T Consensus 186 ~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (360)
T 3eqc_A 186 M---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 262 (360)
T ss_dssp C-------CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-------------------
T ss_pred c---ccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCC
Confidence 1 22346899999999999999999999999999999999999999743321110000000
Q ss_pred ------HHhhhcCCeeecccc----cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002336 832 ------RSMIKKGDVISIVDP----VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 884 (935)
Q Consensus 832 ------~~~i~~~~~~~~~d~----~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~ 884 (935)
..........+.++. .............+.+++.+||+.||++|||++|+++.
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 325 (360)
T 3eqc_A 263 PLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 325 (360)
T ss_dssp -----------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred cccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 000000000000000 00000011123368899999999999999999999864
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=338.74 Aligned_cols=266 Identities=27% Similarity=0.454 Sum_probs=207.1
Q ss_pred hHHHHHHhhcccccccccEEEEEEEEC------CCcEEEEEEccCcc-hhhhHHHHHHHHHHHhcCCCcccccceeeecc
Q 002336 609 ELEEATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE 681 (935)
Q Consensus 609 ~l~~~~~~~~~~LG~G~fG~Vy~~~~~------~g~~vAvK~~~~~~-~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~ 681 (935)
++....|++.+.||+|+||.||+|.+. +++.||||++.... ......+.+|+.++++++||||+++++++...
T Consensus 26 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 105 (327)
T 2yfx_A 26 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS 105 (327)
T ss_dssp BCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCC
Confidence 444556778899999999999999842 57789999997543 34456799999999999999999999999999
Q ss_pred ceEEEEEEecCCCCHHHHhccCCC----CCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccC---CCcE
Q 002336 682 HQRILVYEYMHNGTLRDRLHGSVN----QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI---NMRA 754 (935)
Q Consensus 682 ~~~~lV~E~~~~gsL~~~L~~~~~----~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~---~~~v 754 (935)
...++||||+++++|.+++..... ...+++..++.++.|+++||.|||+ .+|+||||||+|||++. +..+
T Consensus 106 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~i~H~dlkp~NIli~~~~~~~~~ 182 (327)
T 2yfx_A 106 LPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVA 182 (327)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCE
T ss_pred CCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeecCcCCHhHEEEecCCCcceE
Confidence 999999999999999999975431 2458999999999999999999998 89999999999999984 4569
Q ss_pred EEeecccccccccccc-ceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCcccchhHHHHHH
Q 002336 755 KVSDFGLSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWAR 832 (935)
Q Consensus 755 kL~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~ 832 (935)
||+|||++........ .......+++.|+|||.+.+..++.++||||||+++|+|++ |+.||...... ...+
T Consensus 183 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~~~~--- 256 (327)
T 2yfx_A 183 KIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ---EVLE--- 256 (327)
T ss_dssp EECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---HHHH---
T ss_pred EECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHH---HHHH---
Confidence 9999999875433221 12223457889999999988889999999999999999998 99999743221 1211
Q ss_pred HhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhhhhhcc
Q 002336 833 SMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 893 (935)
Q Consensus 833 ~~i~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~~~~~~ 893 (935)
.+..+.... . +......+.+++.+||+.+|++||++.|+++.|+.+.....
T Consensus 257 -~~~~~~~~~-----~----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~ 307 (327)
T 2yfx_A 257 -FVTSGGRMD-----P----PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPD 307 (327)
T ss_dssp -HHHTTCCCC-----C----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHH
T ss_pred -HHhcCCCCC-----C----CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCHH
Confidence 222221111 1 11223368899999999999999999999999998776443
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=344.29 Aligned_cols=262 Identities=25% Similarity=0.343 Sum_probs=189.5
Q ss_pred HHHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCc--chhhhHHHHHHHHHHHhcC-CCcccccceeeecc--ceEE
Q 002336 612 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRIH-HRNLVPLIGYCEEE--HQRI 685 (935)
Q Consensus 612 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~--~~~~~~~~~~E~~iL~~L~-HpnIv~l~g~~~~~--~~~~ 685 (935)
...|++.+.||+|+||.||+|.+. +|+.||||++... .....+.+.+|+.+++.+. ||||+++++++... ...+
T Consensus 8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~ 87 (388)
T 3oz6_A 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVY 87 (388)
T ss_dssp HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEE
T ss_pred cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEE
Confidence 345677899999999999999875 6899999998643 2345567889999999997 99999999998654 3789
Q ss_pred EEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccc
Q 002336 686 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 765 (935)
Q Consensus 686 lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~ 765 (935)
+||||++ ++|.+++.. ..+++..+..++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 88 lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 159 (388)
T 3oz6_A 88 LVFDYME-TDLHAVIRA----NILEPVHKQYVVYQLIKVIKYLHS---GGLLHRDMKPSNILLNAECHVKVADFGLSRSF 159 (388)
T ss_dssp EEEECCS-EEHHHHHHH----TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEES
T ss_pred EEecccC-cCHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHeEEcCCCCEEecCCcccccc
Confidence 9999997 689998873 468999999999999999999998 89999999999999999999999999999865
Q ss_pred cccc--------------------cceeecccCCccccCCCCCCC-CCCCchhHHHHHHHHHHHHHhCCCCCCccCcccc
Q 002336 766 EEDL--------------------THISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAE 824 (935)
Q Consensus 766 ~~~~--------------------~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~ 824 (935)
.... ........||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+.+....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~ 239 (388)
T 3oz6_A 160 VNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQ 239 (388)
T ss_dssp SSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred cccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 3210 111233469999999998876 6789999999999999999999999975433211
Q ss_pred hhHHHHHHHhhhcCCeeec-----------c----------cccccCCC------------CHHHHHHHHHHHHHccccC
Q 002336 825 LNIVHWARSMIKKGDVISI-----------V----------DPVLIGNV------------KIESIWRIAEVAIQCVEQR 871 (935)
Q Consensus 825 ~~l~~~~~~~i~~~~~~~~-----------~----------d~~l~~~~------------~~~~~~~l~~li~~Cl~~d 871 (935)
. .-+...+.......+ + .......+ .......+.+++.+||+.|
T Consensus 240 ~---~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~d 316 (388)
T 3oz6_A 240 L---ERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFN 316 (388)
T ss_dssp H---HHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSS
T ss_pred H---HHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccC
Confidence 1 111111100000000 0 00000000 0011236889999999999
Q ss_pred CCCCCCHHHHHHH
Q 002336 872 GFSRPKMQEIVLA 884 (935)
Q Consensus 872 P~~RPs~~ev~~~ 884 (935)
|++|||++|+++.
T Consensus 317 P~~R~t~~e~l~H 329 (388)
T 3oz6_A 317 PNKRISANDALKH 329 (388)
T ss_dssp GGGSCCHHHHTTS
T ss_pred cccCCCHHHHhCC
Confidence 9999999999765
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=339.67 Aligned_cols=245 Identities=22% Similarity=0.320 Sum_probs=188.1
Q ss_pred ccccccccEEEEEEEEC-CCcEEEEEEccCcchhhhHHHHHHHHHHHh-cCCCcccccceeeec----cceEEEEEEecC
Q 002336 619 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSR-IHHRNLVPLIGYCEE----EHQRILVYEYMH 692 (935)
Q Consensus 619 ~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~-L~HpnIv~l~g~~~~----~~~~~lV~E~~~ 692 (935)
+.||+|+||.||++.+. +|+.||||++... ..+.+|++++.+ .+||||+++++++.. ....++||||++
T Consensus 68 ~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~ 142 (400)
T 1nxk_A 68 QVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLD 142 (400)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCC
T ss_pred ceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeCC
Confidence 68999999999999876 6899999998632 456788888754 489999999998865 667899999999
Q ss_pred CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccC---CCcEEEeeccccccccccc
Q 002336 693 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI---NMRAKVSDFGLSRQAEEDL 769 (935)
Q Consensus 693 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~---~~~vkL~DFGla~~~~~~~ 769 (935)
+|+|.+++... ....+++..+..++.||+.||.|||+ .+|+||||||+|||++. ++.+||+|||+++......
T Consensus 143 gg~L~~~l~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~~ 218 (400)
T 1nxk_A 143 GGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN 218 (400)
T ss_dssp SEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC---
T ss_pred CCcHHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCcceEEEecCCCCccEEEEecccccccCCCC
Confidence 99999999853 23469999999999999999999998 89999999999999997 7889999999998654322
Q ss_pred cceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccc-hhHHHHHHHhhhcCCeeecccccc
Q 002336 770 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAE-LNIVHWARSMIKKGDVISIVDPVL 848 (935)
Q Consensus 770 ~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~-~~l~~~~~~~i~~~~~~~~~d~~l 848 (935)
. .....||+.|+|||++.+..++.++|||||||++|||++|+.||........ ..... .+..+... ...+ .
T Consensus 219 ~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~----~i~~~~~~-~~~~-~ 290 (400)
T 1nxk_A 219 S--LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT----RIRMGQYE-FPNP-E 290 (400)
T ss_dssp ----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHH----HHHHTCCC-CCTT-T
T ss_pred c--cccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHH----HHHcCccc-CCCc-c
Confidence 1 2345689999999999999999999999999999999999999974432211 11111 12222111 0000 0
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002336 849 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 884 (935)
Q Consensus 849 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~ 884 (935)
. ......+.+++.+||+.||++|||++|+++.
T Consensus 291 ~----~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 291 W----SEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp T----TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred c----ccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0 1123468899999999999999999999874
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-36 Score=336.18 Aligned_cols=246 Identities=24% Similarity=0.355 Sum_probs=201.8
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc---hhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEE
Q 002336 614 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 689 (935)
Q Consensus 614 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E 689 (935)
.|.+.+.||+|+||.||++.+. +++.+|+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 42 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 121 (335)
T 2owb_A 42 RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLE 121 (335)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEe
Confidence 3556789999999999999886 57899999986532 2345678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccc
Q 002336 690 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 769 (935)
Q Consensus 690 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~ 769 (935)
|+++++|.+++.. ...+++.+++.++.|+++||+|||+ ++|+||||||+|||++.++.+||+|||++.......
T Consensus 122 ~~~~~~L~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 195 (335)
T 2owb_A 122 LCRRRSLLELHKR---RKALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG 195 (335)
T ss_dssp CCTTCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred cCCCCCHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHH---CCCEecCCCchhEEEcCCCCEEEeeccCceecccCc
Confidence 9999999998873 4578999999999999999999998 899999999999999999999999999998754322
Q ss_pred cceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeeccccccc
Q 002336 770 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 849 (935)
Q Consensus 770 ~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~ 849 (935)
. ......|++.|+|||.+.+..++.++||||||+++|||++|+.||......+ ... .+..+.. .+.
T Consensus 196 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~------~~~-~~~~~~~------~~~ 261 (335)
T 2owb_A 196 E-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE------TYL-RIKKNEY------SIP 261 (335)
T ss_dssp C-CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHH-HHHHTCC------CCC
T ss_pred c-cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHH------HHH-HHhcCCC------CCC
Confidence 2 1233468999999999988889999999999999999999999997433211 111 1111111 111
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 850 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 850 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
... ...+.+++.+||+.||++||+++|+++
T Consensus 262 ~~~----~~~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 262 KHI----NPVAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp TTS----CHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred ccC----CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 112 236789999999999999999999976
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-36 Score=354.87 Aligned_cols=251 Identities=25% Similarity=0.312 Sum_probs=203.5
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc---hhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEe
Q 002336 615 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 690 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~ 690 (935)
+++.+.||+|+||.||+|.+. +|+.||+|++.... ......+.+|+++|+.++||||+++++++.+.+..++||||
T Consensus 186 f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmEy 265 (576)
T 2acx_A 186 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 265 (576)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred eEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEEEc
Confidence 456789999999999999886 69999999986532 12345688999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccccccc
Q 002336 691 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 770 (935)
Q Consensus 691 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~ 770 (935)
+++|+|.+++... ....+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 266 ~~gg~L~~~l~~~-~~~~l~e~~~~~i~~qIl~aL~yLH~---~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~~ 341 (576)
T 2acx_A 266 MNGGDLKFHIYHM-GQAGFPEARAVFYAAEICCGLEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT 341 (576)
T ss_dssp CCSCBHHHHHHSS-SSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCC
T ss_pred CCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCchheEEEeCCCCeEEEecccceecccCcc
Confidence 9999999998753 24459999999999999999999998 8999999999999999999999999999987654322
Q ss_pred ceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccC
Q 002336 771 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 850 (935)
Q Consensus 771 ~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~ 850 (935)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.......... .+.+.+.....
T Consensus 342 --~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~---~i~~~i~~~~~---------- 406 (576)
T 2acx_A 342 --IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKRE---EVERLVKEVPE---------- 406 (576)
T ss_dssp --EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHH---HHHHHHHHCCC----------
T ss_pred --ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHH---HHHHHhhcccc----------
Confidence 233469999999999999899999999999999999999999997543321111 11112221111
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 002336 851 NVKIESIWRIAEVAIQCVEQRGFSRP-----KMQEIVLA 884 (935)
Q Consensus 851 ~~~~~~~~~l~~li~~Cl~~dP~~RP-----s~~ev~~~ 884 (935)
.++......+.+++.+||+.||++|| +++||++.
T Consensus 407 ~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 407 EYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred cCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 11112223688999999999999999 78888754
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=347.55 Aligned_cols=260 Identities=22% Similarity=0.284 Sum_probs=192.6
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCc--chhhhHHHHHHHHHHHhcCCCcccccceeeecc------ceE
Q 002336 614 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE------HQR 684 (935)
Q Consensus 614 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~--~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~------~~~ 684 (935)
.|++.+.||+|+||.||+|.+. +|+.||||++... .....+.+.+|+.+|+.++||||+++++++... ...
T Consensus 63 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~ 142 (464)
T 3ttj_A 63 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDV 142 (464)
T ss_dssp TEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEE
T ss_pred CeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeE
Confidence 3566889999999999999876 6899999999754 234457789999999999999999999998554 457
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccc
Q 002336 685 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 764 (935)
Q Consensus 685 ~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~ 764 (935)
++||||+++ +|.+.+. ..+++..+..++.|+++||+|||+ ++|+||||||+|||++.++.+||+|||+++.
T Consensus 143 ~lv~E~~~~-~l~~~~~-----~~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~ 213 (464)
T 3ttj_A 143 YLVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLART 213 (464)
T ss_dssp EEEEECCSE-EHHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCCC--
T ss_pred EEEEeCCCC-CHHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChHhEEEeCCCCEEEEEEEeeee
Confidence 999999976 4666664 238899999999999999999998 8999999999999999999999999999987
Q ss_pred ccccccceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHH-H--------------
Q 002336 765 AEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIV-H-------------- 829 (935)
Q Consensus 765 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~-~-------------- 829 (935)
..... ......||+.|+|||++.+..++.++||||+||++|||++|+.||.+.+..+....+ +
T Consensus 214 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~ 291 (464)
T 3ttj_A 214 AGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 291 (464)
T ss_dssp ---CC--CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSC
T ss_pred cCCCc--ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcc
Confidence 64432 223456899999999999999999999999999999999999999854432111100 0
Q ss_pred -HHHHhhhcCC------eeecccccccCCC---CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002336 830 -WARSMIKKGD------VISIVDPVLIGNV---KIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 884 (935)
Q Consensus 830 -~~~~~i~~~~------~~~~~d~~l~~~~---~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~ 884 (935)
..+..+.... ....+...+.... .......+.+++.+||+.||++|||++|+++.
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 292 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp HHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000010000 0000000000000 01124568999999999999999999999874
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-36 Score=344.81 Aligned_cols=255 Identities=25% Similarity=0.351 Sum_probs=192.6
Q ss_pred hHHHHHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc--------hhhhHHHHHHHHHHHhcCCCcccccceeee
Q 002336 609 ELEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--------SHRTQQFVTEVALLSRIHHRNLVPLIGYCE 679 (935)
Q Consensus 609 ~l~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~--------~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~ 679 (935)
......|.+.+.||+|+||.||+|... +++.||||++.... ......+.+|+++|++++||||+++++++.
T Consensus 131 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~ 210 (419)
T 3i6u_A 131 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD 210 (419)
T ss_dssp HHHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE
T ss_pred hhhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 334556778899999999999999876 68999999986432 112246889999999999999999999986
Q ss_pred ccceEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCC---CcEEE
Q 002336 680 EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN---MRAKV 756 (935)
Q Consensus 680 ~~~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~---~~vkL 756 (935)
. +..++||||+++|+|.+++. ....+++..+..++.|+++||+|||+ ++|+||||||+|||++.+ +.+||
T Consensus 211 ~-~~~~lv~e~~~~g~L~~~l~---~~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~~~~kl 283 (419)
T 3i6u_A 211 A-EDYYIVLELMEGGELFDKVV---GNKRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKI 283 (419)
T ss_dssp S-SEEEEEEECCTTCBGGGGTS---SSCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSSSCCEEE
T ss_pred c-CceEEEEEcCCCCcHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCCCcceEEE
Confidence 5 45799999999999999887 34679999999999999999999998 899999999999999754 45999
Q ss_pred eeccccccccccccceeecccCCccccCCCCCCC---CCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHH
Q 002336 757 SDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN---QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARS 833 (935)
Q Consensus 757 ~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~---~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~ 833 (935)
+|||+++...... ......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||....... .+.+
T Consensus 284 ~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~--~~~~---- 355 (419)
T 3i6u_A 284 TDFGHSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV--SLKD---- 355 (419)
T ss_dssp CCSSTTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSC--CHHH----
T ss_pred eecccceecCCCc--cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchH--HHHH----
Confidence 9999998765432 2234568999999999853 677899999999999999999999997432221 1211
Q ss_pred hhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002336 834 MIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 884 (935)
Q Consensus 834 ~i~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~ 884 (935)
.+..+..... +.... .....+.+++.+||+.||++||+++|+++.
T Consensus 356 ~i~~~~~~~~--~~~~~----~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 356 QITSGKYNFI--PEVWA----EVSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp HHHTTCCCCC--HHHHT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHhcCCCCCC--chhhc----ccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 1222211110 00001 122468899999999999999999999863
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-36 Score=328.32 Aligned_cols=246 Identities=29% Similarity=0.447 Sum_probs=202.7
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc-hhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEecC
Q 002336 615 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 692 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~-~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~~ 692 (935)
+++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+....++||||++
T Consensus 24 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 103 (303)
T 3a7i_A 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG 103 (303)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred HHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeCC
Confidence 556789999999999999875 68999999986543 3345789999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccccce
Q 002336 693 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 772 (935)
Q Consensus 693 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~~ 772 (935)
+++|.+++. ...+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||++.........
T Consensus 104 ~~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~- 175 (303)
T 3a7i_A 104 GGSALDLLE----PGPLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK- 175 (303)
T ss_dssp TEEHHHHHT----TSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCC-
T ss_pred CCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChheEEECCCCCEEEeecccceecCccccc-
Confidence 999999986 3568999999999999999999998 89999999999999999999999999999776543221
Q ss_pred eecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccCCC
Q 002336 773 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNV 852 (935)
Q Consensus 773 ~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~~~ 852 (935)
.....|++.|+|||.+.+..++.++||||||+++|+|++|+.||...... .... .+..+.. +.+...+
T Consensus 176 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~----~~~~~~~-----~~~~~~~ 243 (303)
T 3a7i_A 176 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPM---KVLF----LIPKNNP-----PTLEGNY 243 (303)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHHH----HHHHSCC-----CCCCSSC
T ss_pred cCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHH---HHHH----HhhcCCC-----CCCcccc
Confidence 23346899999999999989999999999999999999999999733211 1111 1111111 1122222
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002336 853 KIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 884 (935)
Q Consensus 853 ~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~ 884 (935)
+ ..+.+++.+||+.+|++|||++|+++.
T Consensus 244 ~----~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 244 S----KPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp C----HHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred C----HHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 2 368899999999999999999999764
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=337.33 Aligned_cols=262 Identities=23% Similarity=0.341 Sum_probs=197.5
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcch--hhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEe
Q 002336 614 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 690 (935)
Q Consensus 614 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~--~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~ 690 (935)
.|++.+.||+|+||.||+|... +|+.||+|++..... ...+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 26 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 105 (331)
T 4aaa_A 26 KYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEF 105 (331)
T ss_dssp GEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEec
Confidence 3667889999999999999886 589999999865432 2346688999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccccccc
Q 002336 691 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 770 (935)
Q Consensus 691 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~ 770 (935)
+++++|.+++. ....+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 106 ~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 179 (331)
T 4aaa_A 106 VDHTILDDLEL---FPNGLDYQVVQKYLFQIINGIGFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE 179 (331)
T ss_dssp CSEEHHHHHHH---STTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred CCcchHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHH---CCEEccCcChheEEEcCCCcEEEEeCCCceeecCCcc
Confidence 99999998876 34569999999999999999999998 8999999999999999999999999999976543322
Q ss_pred ceeecccCCccccCCCCCCCC-CCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHH----------HhhhcCC
Q 002336 771 HISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWAR----------SMIKKGD 839 (935)
Q Consensus 771 ~~~~~~~gt~~y~APE~l~~~-~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~----------~~i~~~~ 839 (935)
......|++.|+|||.+.+. .++.++||||+|+++|+|++|+.||......+. +..... .......
T Consensus 180 -~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 256 (331)
T 4aaa_A 180 -VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQ--LYHIMMCLGNLIPRHQELFNKNP 256 (331)
T ss_dssp -----CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHHHCSCCHHHHHHHHHCG
T ss_pred -ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHH--HHHHHHHhCCCChhhhhHhhhcc
Confidence 12334589999999988765 789999999999999999999999974433211 111110 0000000
Q ss_pred -eeecccccccCCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002336 840 -VISIVDPVLIGNVK-----IESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 884 (935)
Q Consensus 840 -~~~~~d~~l~~~~~-----~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~ 884 (935)
......+.+....+ ......+.+++.+||+.||++|||++|+++.
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 257 VFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp GGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred ccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00000111111111 1223478899999999999999999998763
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-35 Score=345.80 Aligned_cols=262 Identities=21% Similarity=0.294 Sum_probs=206.6
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcchhhhHHHHHHHHHHHhcCC-CcccccceeeeccceEEEEEEec
Q 002336 614 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHH-RNLVPLIGYCEEEHQRILVYEYM 691 (935)
Q Consensus 614 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~H-pnIv~l~g~~~~~~~~~lV~E~~ 691 (935)
.|++.+.||+|+||.||+|.+. +++.||||++.... ...++.+|+++++.++| +++..+..++...+..++||||+
T Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~ 85 (483)
T 3sv0_A 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL 85 (483)
T ss_dssp TEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTC--SSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred cEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccc--ccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC
Confidence 3566889999999999999874 68999999876432 23568899999999987 55555556667788889999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccc---cCCCcEEEeecccccccccc
Q 002336 692 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEED 768 (935)
Q Consensus 692 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILl---d~~~~vkL~DFGla~~~~~~ 768 (935)
+++|.+++... ...+++..++.++.||+.||+|||+ ++|+||||||+|||| +.++.+||+|||+++.....
T Consensus 86 -g~sL~~ll~~~--~~~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (483)
T 3sv0_A 86 -GPSLEDLFNFC--SRKLSLKTVLMLADQMINRVEFVHS---KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (483)
T ss_dssp -CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred -CCCHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCC
Confidence 99999999743 4569999999999999999999998 899999999999999 68899999999999876543
Q ss_pred ccc------eeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeee
Q 002336 769 LTH------ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVIS 842 (935)
Q Consensus 769 ~~~------~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~ 842 (935)
... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||..............+...........
T Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (483)
T 3sv0_A 160 STHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEA 239 (483)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHH
T ss_pred ccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHHH
Confidence 321 12245699999999999999999999999999999999999999985544333333322222211111111
Q ss_pred cccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhhhhhc
Q 002336 843 IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 892 (935)
Q Consensus 843 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~~~~~ 892 (935)
+...+ ...+.+++.+||+.+|++||++++|++.|+++...+
T Consensus 240 -----l~~~~----p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~ 280 (483)
T 3sv0_A 240 -----LCRGY----PTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIRE 280 (483)
T ss_dssp -----HHTTS----CHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred -----HhcCC----cHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHc
Confidence 11112 236889999999999999999999999999886543
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=337.40 Aligned_cols=259 Identities=19% Similarity=0.263 Sum_probs=189.8
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcchh--hhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEe
Q 002336 614 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSH--RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 690 (935)
Q Consensus 614 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~~--~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~ 690 (935)
.|++.+.||+|+||.||+|... +++.||||++...... ..+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 35 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 114 (329)
T 3gbz_A 35 RYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEY 114 (329)
T ss_dssp GEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEec
Confidence 4667899999999999999865 7899999998754322 245678999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccc-----cCCCcEEEeeccccccc
Q 002336 691 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL-----DINMRAKVSDFGLSRQA 765 (935)
Q Consensus 691 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILl-----d~~~~vkL~DFGla~~~ 765 (935)
++ |+|.+++.. ...+++..+..++.|+++||+|||+ ++|+||||||+|||+ +.++.+||+|||+++..
T Consensus 115 ~~-~~L~~~~~~---~~~~~~~~~~~i~~ql~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~ 187 (329)
T 3gbz_A 115 AE-NDLKKYMDK---NPDVSMRVIKSFLYQLINGVNFCHS---RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF 187 (329)
T ss_dssp CS-EEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHH
T ss_pred CC-CCHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCEECCCCCHHHEEEecCCCCccceEEECcCCCcccc
Confidence 97 599999874 4568999999999999999999998 899999999999999 45556999999999865
Q ss_pred cccccceeecccCCccccCCCCCCC-CCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCC---ee
Q 002336 766 EEDLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD---VI 841 (935)
Q Consensus 766 ~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~---~~ 841 (935)
...... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+ .+.... ....... ..
T Consensus 188 ~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--~~~~~~-~~~~~~~~~~~~ 263 (329)
T 3gbz_A 188 GIPIRQ-FTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEID--QLFKIF-EVLGLPDDTTWP 263 (329)
T ss_dssp C------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHH-HHHCCCCTTTST
T ss_pred CCcccc-cCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHH--HHHHHH-HHhCCCchhhhh
Confidence 433222 223457999999999876 458999999999999999999999997433211 111111 1111000 00
Q ss_pred ecc--------cccccCC-----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 842 SIV--------DPVLIGN-----VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 842 ~~~--------d~~l~~~-----~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
... .+..... .+......+.+++.+||+.||++|||++|+++
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 264 GVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp TGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 000 0000000 00012246789999999999999999999975
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-36 Score=327.47 Aligned_cols=253 Identities=26% Similarity=0.373 Sum_probs=200.4
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc--hhhhHHHHHHHHHHHhcCCCcccccceeee--ccceEEEEE
Q 002336 614 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCE--EEHQRILVY 688 (935)
Q Consensus 614 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~--~~~~~~lV~ 688 (935)
.|++.+.||+|+||.||++... +++.||+|++.... ....+.+.+|++++++++||||+++++++. .....++||
T Consensus 7 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~ 86 (279)
T 2w5a_A 7 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVM 86 (279)
T ss_dssp GEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEE
T ss_pred heeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEE
Confidence 3556789999999999999886 68999999986532 344567999999999999999999999874 466889999
Q ss_pred EecCCCCHHHHhccCC-CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCc-----eEecCCCCCCccccCCCcEEEeecccc
Q 002336 689 EYMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG-----IIHRDVKSSNILLDINMRAKVSDFGLS 762 (935)
Q Consensus 689 E~~~~gsL~~~L~~~~-~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~-----ivH~DLkp~NILld~~~~vkL~DFGla 762 (935)
||+++++|.+++.... ....+++..++.++.|+++||+|||+ .+ |+||||||+||+++.++.+||+|||++
T Consensus 87 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~ 163 (279)
T 2w5a_A 87 EYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR---RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 163 (279)
T ss_dssp ECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---HC------CCCCCSGGGEEECSSSCEEECCCCHH
T ss_pred eCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhc---ccCCCCeeEEeccchhhEEEcCCCCEEEecCchh
Confidence 9999999999987432 34458999999999999999999998 66 999999999999999999999999998
Q ss_pred ccccccccceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeee
Q 002336 763 RQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVIS 842 (935)
Q Consensus 763 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~ 842 (935)
+........ .....|++.|+|||.+.+..++.++||||||+++|+|++|+.||..... ... ...+..+....
T Consensus 164 ~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~----~~~i~~~~~~~ 235 (279)
T 2w5a_A 164 RILNHDTSF-AKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ---KEL----AGKIREGKFRR 235 (279)
T ss_dssp HHC---CHH-HHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHH----HHHHHHTCCCC
T ss_pred eeecccccc-ccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH---HHH----HHHHhhccccc
Confidence 765433211 1234589999999999888899999999999999999999999974322 111 12232332211
Q ss_pred cccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 002336 843 IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 886 (935)
Q Consensus 843 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~ 886 (935)
+.. .....+.+++.+||+.+|++||+++||++.+.
T Consensus 236 -----~~~----~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~ 270 (279)
T 2w5a_A 236 -----IPY----RYSDELNEIITRMLNLKDYHRPSVEEILENPL 270 (279)
T ss_dssp -----CCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred -----CCc----ccCHHHHHHHHHHcCCCcccCCCHHHHHhChh
Confidence 111 22346889999999999999999999987543
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-36 Score=323.60 Aligned_cols=246 Identities=24% Similarity=0.392 Sum_probs=193.4
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcch---hhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEE
Q 002336 614 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 689 (935)
Q Consensus 614 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~---~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E 689 (935)
.|.+.+.||+|+||.||+|.+. +|+.||+|++..... ...+.+.+|+++++.++||||+++++++...+..++|||
T Consensus 12 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 91 (276)
T 2h6d_A 12 HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVME 91 (276)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEe
Confidence 3566789999999999999986 799999999865322 234578899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccc
Q 002336 690 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 769 (935)
Q Consensus 690 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~ 769 (935)
|+++++|.+++.. ...+++..+..++.|+++||+|||+ ++++||||||+||+++.++.+||+|||++.......
T Consensus 92 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 165 (276)
T 2h6d_A 92 YVSGGELFDYICK---HGRVEEMEARRLFQQILSAVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 165 (276)
T ss_dssp CCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHH---HCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC--
T ss_pred ccCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChhhEEECCCCCEEEeecccccccCCCc
Confidence 9999999999874 3568999999999999999999998 899999999999999999999999999998764432
Q ss_pred cceeecccCCccccCCCCCCCCCC-CchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccccc
Q 002336 770 THISSVARGTVGYLDPEYYGNQQL-TEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 848 (935)
Q Consensus 770 ~~~~~~~~gt~~y~APE~l~~~~~-s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l 848 (935)
. .....|++.|+|||.+.+..+ +.++||||||+++++|++|+.||...... ... +.+..+.. .+
T Consensus 166 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~----~~~~~~~~------~~ 230 (276)
T 2h6d_A 166 F--LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVP---TLF----KKIRGGVF------YI 230 (276)
T ss_dssp -------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHH----HHHHHCCC------CC
T ss_pred c--eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHH---HHH----HHhhcCcc------cC
Confidence 1 223458999999999987665 68999999999999999999999743221 111 12222211 01
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002336 849 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 884 (935)
Q Consensus 849 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~ 884 (935)
+......+.+++.+||+.+|++|||++|+++.
T Consensus 231 ----~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 231 ----PEYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp ----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred ----chhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 11122368899999999999999999999873
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-35 Score=324.64 Aligned_cols=248 Identities=24% Similarity=0.340 Sum_probs=195.3
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc----hhhhHHHHHHHHHHHhcCCCcccccceee--eccceEEEE
Q 002336 615 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC----SHRTQQFVTEVALLSRIHHRNLVPLIGYC--EEEHQRILV 687 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~----~~~~~~~~~E~~iL~~L~HpnIv~l~g~~--~~~~~~~lV 687 (935)
|++.+.||+|+||.||++... +++.||+|++.... ....+.+.+|++++++++||||+++++++ .+....++|
T Consensus 7 y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (305)
T 2wtk_C 7 YLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMV 86 (305)
T ss_dssp BCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEEE
T ss_pred eeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEEE
Confidence 566789999999999999875 68899999986532 23456799999999999999999999998 455678999
Q ss_pred EEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccc
Q 002336 688 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 767 (935)
Q Consensus 688 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~ 767 (935)
|||++++ |.+.+... ....+++..+..++.|+++||+|||+ ++|+||||||+||+++.++.+||+|||++.....
T Consensus 87 ~e~~~~~-l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~ 161 (305)
T 2wtk_C 87 MEYCVCG-MQEMLDSV-PEKRFPVCQAHGYFCQLIDGLEYLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHP 161 (305)
T ss_dssp EECCSEE-HHHHHHHS-TTCSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred ehhccCC-HHHHHHhC-cccccCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEcCCCcEEeeccccccccCc
Confidence 9999876 77776643 35679999999999999999999998 8999999999999999999999999999987543
Q ss_pred cc-cceeecccCCccccCCCCCCCCC--CCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecc
Q 002336 768 DL-THISSVARGTVGYLDPEYYGNQQ--LTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 844 (935)
Q Consensus 768 ~~-~~~~~~~~gt~~y~APE~l~~~~--~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~ 844 (935)
.. ........|++.|+|||.+.+.. .+.++||||||+++|||++|+.||...... +. ...+..+..
T Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~-~~~i~~~~~---- 230 (305)
T 2wtk_C 162 FAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIY------KL-FENIGKGSY---- 230 (305)
T ss_dssp TCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHH------HH-HHHHHHCCC----
T ss_pred cccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHH------HH-HHHHhcCCC----
Confidence 21 22233456899999999987643 478999999999999999999999743221 11 112222211
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002336 845 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 884 (935)
Q Consensus 845 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~ 884 (935)
.+... ....+.+++.+||+.||++||+++|+++.
T Consensus 231 --~~~~~----~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 231 --AIPGD----CGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp --CCCSS----SCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred --CCCCc----cCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 11112 22367899999999999999999999864
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-36 Score=329.14 Aligned_cols=250 Identities=20% Similarity=0.353 Sum_probs=196.4
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcchhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEecC
Q 002336 614 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 692 (935)
Q Consensus 614 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~~ 692 (935)
.|++.+.||+|+||.||+|.+. +++.||+|++........+.+.+|+++++.++||||+++++++...+..++||||++
T Consensus 20 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 99 (302)
T 2j7t_A 20 VWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCP 99 (302)
T ss_dssp TEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECCT
T ss_pred ceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeCC
Confidence 4567889999999999999986 589999999876655566789999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccccce
Q 002336 693 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 772 (935)
Q Consensus 693 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~~ 772 (935)
+++|.+++... ...+++..+..++.|+++||.|||+ .+++||||||+||+++.++.+||+|||++........ .
T Consensus 100 ~~~l~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~ 173 (302)
T 2j7t_A 100 GGAVDAIMLEL--DRGLTEPQIQVVCRQMLEALNFLHS---KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQ-K 173 (302)
T ss_dssp TEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHH-C
T ss_pred CCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEECCCCCEEEEECCCCcccccccc-c
Confidence 99999988642 4568999999999999999999998 8999999999999999999999999998764322111 1
Q ss_pred eecccCCccccCCCCC-----CCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeeccccc
Q 002336 773 SSVARGTVGYLDPEYY-----GNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 847 (935)
Q Consensus 773 ~~~~~gt~~y~APE~l-----~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~ 847 (935)
.....|++.|+|||.+ ....++.++||||||+++|+|++|+.||...... ........ +.......
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~-~~~~~~~~-- 244 (302)
T 2j7t_A 174 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM------RVLLKIAK-SDPPTLLT-- 244 (302)
T ss_dssp -----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHH-SCCCCCSS--
T ss_pred cccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHH------HHHHHHhc-cCCcccCC--
Confidence 2234589999999987 4677899999999999999999999999743221 11111111 11111111
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 848 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 848 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
+......+.+++.+||+.+|++|||++|+++
T Consensus 245 -----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 245 -----PSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp -----GGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred -----ccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 1122346889999999999999999999874
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=334.05 Aligned_cols=263 Identities=21% Similarity=0.227 Sum_probs=196.6
Q ss_pred HHHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcchh-----hhHHHHHHHHHHHhcCCCcccccceeeeccceEE
Q 002336 612 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSH-----RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRI 685 (935)
Q Consensus 612 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~~-----~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~ 685 (935)
...|++.+.||+|+||.||+|.+. +|+.||||++...... ..+.+.+|+++++.++||||+++++++.+....+
T Consensus 9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 88 (346)
T 1ua2_A 9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNIS 88 (346)
T ss_dssp ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCE
T ss_pred hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceE
Confidence 345777899999999999999986 5899999998653221 1346889999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccc
Q 002336 686 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 765 (935)
Q Consensus 686 lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~ 765 (935)
+||||+++ +|.+.+.. ....+++..+..++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 89 lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~ 162 (346)
T 1ua2_A 89 LVFDFMET-DLEVIIKD--NSLVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSF 162 (346)
T ss_dssp EEEECCSE-EHHHHHTT--CCSSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGGGSTT
T ss_pred EEEEcCCC-CHHHHHHh--cCcCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCCHHHEEEcCCCCEEEEecccceec
Confidence 99999986 88888864 24568889999999999999999998 89999999999999999999999999999876
Q ss_pred cccccceeecccCCccccCCCCCCC-CCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcC---Cee
Q 002336 766 EEDLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG---DVI 841 (935)
Q Consensus 766 ~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~---~~~ 841 (935)
..... ......||+.|+|||.+.+ ..++.++||||||+++|||++|..||......+ .+.. +....... ...
T Consensus 163 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~--~~~~-i~~~~~~~~~~~~~ 238 (346)
T 1ua2_A 163 GSPNR-AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD--QLTR-IFETLGTPTEEQWP 238 (346)
T ss_dssp TSCCC-CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHH-HHHHHCCCCTTTSS
T ss_pred cCCcc-cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH--HHHH-HHHHcCCCChhhhh
Confidence 44322 2233468999999998865 458999999999999999999999997443211 1111 11111100 000
Q ss_pred ec---ccccc---cCCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002336 842 SI---VDPVL---IGNVK-----IESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 884 (935)
Q Consensus 842 ~~---~d~~l---~~~~~-----~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~ 884 (935)
.. .+... ....+ ......+.+++.+||+.||++|||++|+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 239 DMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp STTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 00 00000 00001 1122478999999999999999999999864
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-36 Score=326.74 Aligned_cols=258 Identities=27% Similarity=0.402 Sum_probs=196.3
Q ss_pred HHHhhcccccccccEEEEEEEEC--CCc--EEEEEEccCcc---hhhhHHHHHHHHHHHhcCCCcccccceeeeccceEE
Q 002336 613 ATNNFCKKIGKGSFGSVYYGKMK--DGK--EVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRI 685 (935)
Q Consensus 613 ~~~~~~~~LG~G~fG~Vy~~~~~--~g~--~vAvK~~~~~~---~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~ 685 (935)
..|++.+.||+|+||.||+|++. +++ .||+|+++... ....+.+.+|++++++++||||+++++++.... .+
T Consensus 18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~ 96 (291)
T 1u46_A 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MK 96 (291)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CE
T ss_pred hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ce
Confidence 45677899999999999999864 333 68999987542 334578999999999999999999999998765 88
Q ss_pred EEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccc
Q 002336 686 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 765 (935)
Q Consensus 686 lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~ 765 (935)
+||||+++++|.+++... ...+++..+..++.|+++||.|||+ ++++||||||+||+++.++.+||+|||++...
T Consensus 97 ~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 171 (291)
T 1u46_A 97 MVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRAL 171 (291)
T ss_dssp EEEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred eeEecccCCCHHHHHHhc--cCCcCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEEcCCCCEEEccccccccc
Confidence 999999999999998742 3568999999999999999999998 89999999999999999999999999999876
Q ss_pred cccccc--eeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCcccchhHHHHHHHhhhcCCeee
Q 002336 766 EEDLTH--ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVIS 842 (935)
Q Consensus 766 ~~~~~~--~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~ 842 (935)
...... ......++..|+|||.+.+..++.++||||||+++|+|++ |+.||...... +........+....
T Consensus 172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~------~~~~~~~~~~~~~~ 245 (291)
T 1u46_A 172 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS------QILHKIDKEGERLP 245 (291)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHHHHHHTSCCCCC
T ss_pred cccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHH------HHHHHHHccCCCCC
Confidence 543322 1223457888999999988888999999999999999999 99999743221 11222222211110
Q ss_pred cccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhhhhh
Q 002336 843 IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 891 (935)
Q Consensus 843 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~~~~ 891 (935)
. +......+.+++.+||+.+|++||+++++++.|++....
T Consensus 246 -----~----~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 285 (291)
T 1u46_A 246 -----R----PEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPT 285 (291)
T ss_dssp -----C----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred -----C----CcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCcc
Confidence 1 112234688999999999999999999999999987653
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-36 Score=334.83 Aligned_cols=261 Identities=20% Similarity=0.265 Sum_probs=196.2
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcch--hhhHHHHHHHHHHHhcCCCcccccceeeec--------cc
Q 002336 614 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEE--------EH 682 (935)
Q Consensus 614 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~--~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~--------~~ 682 (935)
.|++.+.||+|+||.||+|.+. +|+.||+|++..... .....+.+|+++++.++||||+++++++.. .+
T Consensus 18 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 97 (351)
T 3mi9_A 18 KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKG 97 (351)
T ss_dssp GEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------C
T ss_pred ceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCCc
Confidence 4667899999999999999984 789999999865432 224578899999999999999999999876 44
Q ss_pred eEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccc
Q 002336 683 QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS 762 (935)
Q Consensus 683 ~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla 762 (935)
..++||||+++ +|.+.+... ...+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||++
T Consensus 98 ~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 171 (351)
T 3mi9_A 98 SIYLVFDFCEH-DLAGLLSNV--LVKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLA 171 (351)
T ss_dssp EEEEEEECCSE-EHHHHHHCT--TSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred eEEEEEeccCC-CHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCCEEEccchhc
Confidence 68999999975 777777643 3569999999999999999999998 89999999999999999999999999999
Q ss_pred ccccccc---cceeecccCCccccCCCCCCC-CCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhc-
Q 002336 763 RQAEEDL---THISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKK- 837 (935)
Q Consensus 763 ~~~~~~~---~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~- 837 (935)
+...... ........||+.|+|||++.+ ..++.++||||||+++|||++|+.||......... ..+......
T Consensus 172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~---~~i~~~~~~~ 248 (351)
T 3mi9_A 172 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQL---ALISQLCGSI 248 (351)
T ss_dssp EECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHHHHCCC
T ss_pred ccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHH---HHHHHHhCCC
Confidence 8654221 112234468999999998865 56899999999999999999999999854332211 111111111
Q ss_pred --CCeeecccccc-------cC-CCCH-HH------HHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 838 --GDVISIVDPVL-------IG-NVKI-ES------IWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 838 --~~~~~~~d~~l-------~~-~~~~-~~------~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
......-+... .. .... +. ...+.+++.+||+.||++|||++|+++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 311 (351)
T 3mi9_A 249 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 311 (351)
T ss_dssp CTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence 00000000000 00 0000 11 135789999999999999999999875
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-37 Score=347.28 Aligned_cols=239 Identities=16% Similarity=0.157 Sum_probs=184.2
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCc---chhhhHHHHHHHH---HHHhcCCCcccccc-------eeeec
Q 002336 615 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS---CSHRTQQFVTEVA---LLSRIHHRNLVPLI-------GYCEE 680 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~---~~~~~~~~~~E~~---iL~~L~HpnIv~l~-------g~~~~ 680 (935)
+.+.+.||+|+||.||+|.+. +|+.||||++... .....+.+.+|+. ++++++|||||+++ +++..
T Consensus 75 y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~ 154 (377)
T 3byv_A 75 LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKD 154 (377)
T ss_dssp EEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEEC
T ss_pred EEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhc
Confidence 455789999999999999974 6999999998632 3344578899995 45555799999998 55544
Q ss_pred cc-----------------eEEEEEEecCCCCHHHHhccCC----CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEec
Q 002336 681 EH-----------------QRILVYEYMHNGTLRDRLHGSV----NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHR 739 (935)
Q Consensus 681 ~~-----------------~~~lV~E~~~~gsL~~~L~~~~----~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~ 739 (935)
.+ ..++||||+ +|+|.+++.... ....+++..++.++.|+++||+|||+ ++|+||
T Consensus 155 ~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHr 230 (377)
T 3byv_A 155 PQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGLVHT 230 (377)
T ss_dssp TTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHH---TTEECS
T ss_pred cCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHh---CCeecC
Confidence 43 278999999 689999987421 11234458888999999999999998 899999
Q ss_pred CCCCCCccccCCCcEEEeeccccccccccccceeecccCCccccCCCCCCCC-----------CCCchhHHHHHHHHHHH
Q 002336 740 DVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ-----------QLTEKSDVYSFGVVLLE 808 (935)
Q Consensus 740 DLkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~-----------~~s~ksDVwS~Gvil~e 808 (935)
||||+|||++.++.+||+|||+++.... ......| +.|+|||++.+. .++.++|||||||++||
T Consensus 231 Dikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~e 305 (377)
T 3byv_A 231 YLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYW 305 (377)
T ss_dssp CCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHH
T ss_pred CCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHH
Confidence 9999999999999999999999986433 2234457 999999998876 89999999999999999
Q ss_pred HHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 809 LISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 809 LltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
|++|+.||......... ..+.. . .... ...+.+++.+||+.||++||++.|+++
T Consensus 306 lltg~~Pf~~~~~~~~~---------------~~~~~-~-~~~~----~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 306 IWCADLPITKDAALGGS---------------EWIFR-S-CKNI----PQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHHSSCCC------CCS---------------GGGGS-S-CCCC----CHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHHCCCCCcccccccch---------------hhhhh-h-ccCC----CHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 99999999733221110 00111 0 0112 236889999999999999999999986
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-35 Score=339.44 Aligned_cols=197 Identities=25% Similarity=0.348 Sum_probs=165.3
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCc--chhhhHHHHHHHHHHHhcCCCcccccceeeecc-----ceEE
Q 002336 614 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE-----HQRI 685 (935)
Q Consensus 614 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~--~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~-----~~~~ 685 (935)
.|.+.+.||+|+||.||+|.+. +++.||||++... .....+.+.+|+++|+.++||||+++++++... ...+
T Consensus 27 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~ 106 (432)
T 3n9x_A 27 NYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELY 106 (432)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEE
T ss_pred CEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEE
Confidence 4667889999999999999876 5889999999753 233457899999999999999999999998765 5789
Q ss_pred EEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccc
Q 002336 686 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 765 (935)
Q Consensus 686 lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~ 765 (935)
+||||++ ++|.+++.. ...+++..+..++.||++||+|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 107 lv~e~~~-~~L~~~~~~---~~~l~~~~~~~i~~qil~aL~~LH~---~givHrDlkp~NILl~~~~~~kL~DFGla~~~ 179 (432)
T 3n9x_A 107 IVLEIAD-SDLKKLFKT---PIFLTEEHIKTILYNLLLGENFIHE---SGIIHRDLKPANCLLNQDCSVKVCDFGLARTI 179 (432)
T ss_dssp EEEECCS-EEHHHHHHS---SCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEecCC-cCHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCHHHeEECCCCCEEEccCCCcccc
Confidence 9999986 699999973 4669999999999999999999998 89999999999999999999999999999876
Q ss_pred cccccc---------------------eeecccCCccccCCCCC-CCCCCCchhHHHHHHHHHHHHHhCCCCCC
Q 002336 766 EEDLTH---------------------ISSVARGTVGYLDPEYY-GNQQLTEKSDVYSFGVVLLELISGKKPVS 817 (935)
Q Consensus 766 ~~~~~~---------------------~~~~~~gt~~y~APE~l-~~~~~s~ksDVwS~Gvil~eLltG~~Pf~ 817 (935)
...... ......||+.|+|||++ ....++.++||||+||++|||++|..||.
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 180 NSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp -------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred cccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 433211 12445689999999975 56679999999999999999998665554
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-36 Score=337.47 Aligned_cols=255 Identities=22% Similarity=0.298 Sum_probs=192.0
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCc--chhhhHHHHHHHHHHHhcCCCcccccceeeeccc------eE
Q 002336 614 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH------QR 684 (935)
Q Consensus 614 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~--~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~------~~ 684 (935)
.|++.+.||+|+||.||+|.+. +|+.||||++... .....+.+.+|+++++.++||||+++++++.... ..
T Consensus 26 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~ 105 (367)
T 1cm8_A 26 VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDF 105 (367)
T ss_dssp SEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCC
T ss_pred eEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceE
Confidence 3566789999999999999875 6999999998543 2234567899999999999999999999987653 46
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccc
Q 002336 685 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 764 (935)
Q Consensus 685 ~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~ 764 (935)
++||||+ +++|.+++.. ..+++..+..++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||+++.
T Consensus 106 ~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 177 (367)
T 1cm8_A 106 YLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQ 177 (367)
T ss_dssp EEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCHHHEEEcCCCCEEEEeeecccc
Confidence 9999999 8899999873 468999999999999999999998 8999999999999999999999999999987
Q ss_pred ccccccceeecccCCccccCCCCCCC-CCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCC----
Q 002336 765 AEEDLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD---- 839 (935)
Q Consensus 765 ~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~---- 839 (935)
.... .....+|+.|+|||++.+ ..++.++||||+||+++||++|+.||.+.+..+.. ..+........
T Consensus 178 ~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l---~~i~~~~g~~~~~~~ 250 (367)
T 1cm8_A 178 ADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQL---KEIMKVTGTPPAEFV 250 (367)
T ss_dssp CCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHHHHHHCCCCHHHH
T ss_pred cccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHhcCCCCHHHH
Confidence 5432 223468999999998866 68999999999999999999999999854432111 11111000000
Q ss_pred --------------eeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002336 840 --------------VISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 884 (935)
Q Consensus 840 --------------~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~ 884 (935)
........+. .........+.+++.+||+.||++|||++|+++.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h 308 (367)
T 1cm8_A 251 QRLQSDEAKNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 308 (367)
T ss_dssp HTCSCHHHHHHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHhhhHHHHHHHHhCCCCCCCCHH-HHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence 0000000000 1111223468899999999999999999999873
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-35 Score=325.60 Aligned_cols=251 Identities=25% Similarity=0.352 Sum_probs=198.3
Q ss_pred HHHHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcchhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEE
Q 002336 611 EEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 689 (935)
Q Consensus 611 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E 689 (935)
....+++.+.||+|+||.||+|.+. +|+.||+|++... ...+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME 104 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETT--SCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCch--HHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence 3445667889999999999999886 5899999998653 234678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccc
Q 002336 690 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 769 (935)
Q Consensus 690 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~ 769 (935)
|+++++|.+++.. ....+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++.......
T Consensus 105 ~~~~~~L~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 179 (314)
T 3com_A 105 YCGAGSVSDIIRL--RNKTLTEDEIATILQSTLKGLEYLHF---MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM 179 (314)
T ss_dssp CCTTEEHHHHHHH--HTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTB
T ss_pred cCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhc
Confidence 9999999999863 24568999999999999999999998 899999999999999999999999999997764432
Q ss_pred cceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeeccccccc
Q 002336 770 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 849 (935)
Q Consensus 770 ~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~ 849 (935)
.. .....|++.|+|||.+.+..++.++||||||+++|+|++|+.||....... . ... +.........
T Consensus 180 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~---~~~-~~~~~~~~~~----- 246 (314)
T 3com_A 180 AK-RNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMR---A---IFM-IPTNPPPTFR----- 246 (314)
T ss_dssp SC-BCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH---H---HHH-HHHSCCCCCS-----
T ss_pred cc-cCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHH---H---HHH-HhcCCCcccC-----
Confidence 22 233458999999999998889999999999999999999999997332211 1 111 1111111110
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 850 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 850 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
.+......+.+++.+||+.+|++||+++++++
T Consensus 247 --~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 247 --KPELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp --SGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred --CcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 11112346889999999999999999999975
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=345.63 Aligned_cols=191 Identities=26% Similarity=0.388 Sum_probs=152.4
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCc--chhhhHHHHHHHHHHHhcCCCcccccceeeec-----cceEE
Q 002336 614 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEE-----EHQRI 685 (935)
Q Consensus 614 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~--~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~-----~~~~~ 685 (935)
.|++.+.||+|+||.||+|.+. +++.||||++... .....+.+.+|+++|++++||||+++++++.. ....+
T Consensus 54 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 133 (458)
T 3rp9_A 54 RYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELY 133 (458)
T ss_dssp TEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEE
T ss_pred CeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceEE
Confidence 4677899999999999999876 6899999998653 23345789999999999999999999999843 35789
Q ss_pred EEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccc
Q 002336 686 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 765 (935)
Q Consensus 686 lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~ 765 (935)
+||||+ +++|.+++. ....+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 134 lv~e~~-~~~L~~~~~---~~~~l~~~~~~~~~~qi~~aL~~LH~---~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~ 206 (458)
T 3rp9_A 134 VVLEIA-DSDFKKLFR---TPVYLTELHIKTLLYNLLVGVKYVHS---AGILHRDLKPANCLVNQDCSVKVCDFGLARTV 206 (458)
T ss_dssp EEECCC-SEEHHHHHH---SSCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCCTTCBCT
T ss_pred EEEecc-ccchhhhcc---cCCCCCHHHHHHHHHHHHHHHHHHHh---CCcCCCCCChhhEEECCCCCEeecccccchhc
Confidence 999998 579999987 34679999999999999999999998 89999999999999999999999999999875
Q ss_pred ccccc--------------------------ceeecccCCccccCCCCC-CCCCCCchhHHHHHHHHHHHHHh
Q 002336 766 EEDLT--------------------------HISSVARGTVGYLDPEYY-GNQQLTEKSDVYSFGVVLLELIS 811 (935)
Q Consensus 766 ~~~~~--------------------------~~~~~~~gt~~y~APE~l-~~~~~s~ksDVwS~Gvil~eLlt 811 (935)
..... .......||+.|+|||++ ....++.++|||||||++|||++
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~ellt 279 (458)
T 3rp9_A 207 DYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLN 279 (458)
T ss_dssp TSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHT
T ss_pred cCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHH
Confidence 43211 112334689999999975 56779999999999999999999
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=337.36 Aligned_cols=266 Identities=22% Similarity=0.270 Sum_probs=202.3
Q ss_pred hhHHHHHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcchhhhHHHHHHHHHHHhcC--------CCcccccceee
Q 002336 608 PELEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIH--------HRNLVPLIGYC 678 (935)
Q Consensus 608 ~~l~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~--------HpnIv~l~g~~ 678 (935)
.++....|++.+.||+|+||.||+|... +++.||||++... ....+.+.+|+++++.++ |+||+++++++
T Consensus 32 g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~ 110 (397)
T 1wak_A 32 GDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDF 110 (397)
T ss_dssp TCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEE
T ss_pred hhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecce
Confidence 3333456778899999999999999875 6889999998754 344567889999999985 78899999998
Q ss_pred e----ccceEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCC-ceEecCCCCCCccccCCC-
Q 002336 679 E----EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP-GIIHRDVKSSNILLDINM- 752 (935)
Q Consensus 679 ~----~~~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~-~ivH~DLkp~NILld~~~- 752 (935)
. .....++||||+ +++|.+.+... ....+++..++.++.||+.||+|||+ + +|+||||||+|||++.++
T Consensus 111 ~~~~~~~~~~~lv~e~~-~~~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~---~~givHrDikp~NIll~~~~~ 185 (397)
T 1wak_A 111 KISGVNGTHICMVFEVL-GHHLLKWIIKS-NYQGLPLPCVKKIIQQVLQGLDYLHT---KCRIIHTDIKPENILLSVNEQ 185 (397)
T ss_dssp EEEETTEEEEEEEECCC-CCBHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHH---TTCEECCCCSGGGEEECCCHH
T ss_pred eecCCCCceEEEEEecc-CccHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHeeEeccch
Confidence 7 566889999999 56666655433 23569999999999999999999998 7 999999999999999775
Q ss_pred ------------------------------------------------cEEEeeccccccccccccceeecccCCccccC
Q 002336 753 ------------------------------------------------RAKVSDFGLSRQAEEDLTHISSVARGTVGYLD 784 (935)
Q Consensus 753 ------------------------------------------------~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~A 784 (935)
.+||+|||+++...... ....||+.|+|
T Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~----~~~~gt~~y~a 261 (397)
T 1wak_A 186 YIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHF----TEDIQTRQYRS 261 (397)
T ss_dssp HHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCS----CSCCSCGGGCC
T ss_pred hhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccC----ccCCCCCcccC
Confidence 79999999998764432 23468999999
Q ss_pred CCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchh---HHHHHHHhhhc--------CC-----------eee
Q 002336 785 PEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELN---IVHWARSMIKK--------GD-----------VIS 842 (935)
Q Consensus 785 PE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~---l~~~~~~~i~~--------~~-----------~~~ 842 (935)
||++.+..++.++|||||||++|||++|+.||.......... ....+.+.... +. ...
T Consensus 262 PE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 341 (397)
T 1wak_A 262 LEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKH 341 (397)
T ss_dssp HHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSS
T ss_pred ChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccc
Confidence 999988889999999999999999999999997544332111 11111111110 00 000
Q ss_pred cccccc---------cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 843 IVDPVL---------IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 843 ~~d~~l---------~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
+.+... .-..+......+.+++.+||+.||++|||++|+++
T Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 342 ITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp CCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred ccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 000000 00234556678999999999999999999999975
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-35 Score=326.08 Aligned_cols=256 Identities=20% Similarity=0.290 Sum_probs=197.0
Q ss_pred HHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcchhhhHHHHHHHHHHHhcC-CCcccccceeeec--cceEEEEE
Q 002336 613 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIH-HRNLVPLIGYCEE--EHQRILVY 688 (935)
Q Consensus 613 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~-HpnIv~l~g~~~~--~~~~~lV~ 688 (935)
..|++.+.||+|+||.||+|... +++.||||++... ..+.+.+|++++++++ ||||+++++++.+ ....++||
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~ 112 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 112 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence 44677899999999999999874 7899999998743 3467899999999997 9999999999987 66789999
Q ss_pred EecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCC-cEEEeeccccccccc
Q 002336 689 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM-RAKVSDFGLSRQAEE 767 (935)
Q Consensus 689 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~-~vkL~DFGla~~~~~ 767 (935)
||+++++|.+++. .+++..+..++.|+++||+|||+ ++|+||||||+|||++.++ .+||+|||+++....
T Consensus 113 e~~~~~~l~~~~~------~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~ 183 (330)
T 3nsz_A 113 EHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 183 (330)
T ss_dssp ECCCCCCHHHHGG------GCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred eccCchhHHHHHH------hCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCC
Confidence 9999999999885 37889999999999999999998 8999999999999999776 899999999986544
Q ss_pred cccceeecccCCccccCCCCCCC-CCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHH--------HhhhcC
Q 002336 768 DLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWAR--------SMIKKG 838 (935)
Q Consensus 768 ~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~--------~~i~~~ 838 (935)
... .....|+..|+|||.+.+ ..++.++||||||+++|||++|+.||...... ...+..... ..+...
T Consensus 184 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~-~~~l~~~~~~~~~~~~~~~~~~~ 260 (330)
T 3nsz_A 184 GQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN-YDQLVRIAKVLGTEDLYDYIDKY 260 (330)
T ss_dssp TCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSH-HHHHHHHHHHHCHHHHHHHHHHT
T ss_pred CCc--cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCch-HHHHHHHHHhcCCchhhhHHHHh
Confidence 322 233468999999999876 67899999999999999999999999532221 111111110 000000
Q ss_pred Ce--------------eecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 839 DV--------------ISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 839 ~~--------------~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
.. ...................+.+++.+||+.||++|||++|+++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 261 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp TCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred ccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00 0000000111111123457899999999999999999999986
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-35 Score=334.26 Aligned_cols=250 Identities=26% Similarity=0.370 Sum_probs=199.2
Q ss_pred HHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcch--------hhhHHHHHHHHHHHhc-CCCcccccceeeeccc
Q 002336 613 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--------HRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEH 682 (935)
Q Consensus 613 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~--------~~~~~~~~E~~iL~~L-~HpnIv~l~g~~~~~~ 682 (935)
..|++.+.||+|+||.||+|.+. +|+.||||++..... ...+.+.+|+.+++++ +||||+++++++....
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 173 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS 173 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence 34555789999999999999986 799999999865321 1235688999999999 7999999999999999
Q ss_pred eEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccc
Q 002336 683 QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS 762 (935)
Q Consensus 683 ~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla 762 (935)
..++||||+++++|.+++.. ...+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++
T Consensus 174 ~~~lv~e~~~g~~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH~---~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~ 247 (365)
T 2y7j_A 174 FMFLVFDLMRKGELFDYLTE---KVALSEKETRSIMRSLLEAVSFLHA---NNIVHRDLKPENILLDDNMQIRLSDFGFS 247 (365)
T ss_dssp EEEEEECCCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEEEeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEEEecCcc
Confidence 99999999999999999873 4568999999999999999999998 89999999999999999999999999999
Q ss_pred ccccccccceeecccCCccccCCCCCC------CCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhh
Q 002336 763 RQAEEDLTHISSVARGTVGYLDPEYYG------NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIK 836 (935)
Q Consensus 763 ~~~~~~~~~~~~~~~gt~~y~APE~l~------~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~ 836 (935)
........ .....||+.|+|||++. ...++.++||||||+++|+|++|+.||...... .... .+.
T Consensus 248 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~---~~~~----~i~ 318 (365)
T 2y7j_A 248 CHLEPGEK--LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQI---LMLR----MIM 318 (365)
T ss_dssp EECCTTCC--BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHH----HHH
T ss_pred cccCCCcc--cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHH---HHHH----HHH
Confidence 87654322 23356899999999874 346889999999999999999999999743211 1111 121
Q ss_pred cCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 837 KGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 837 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
.+.... ..+. ... ....+.+++.+||+.||++||+++|+++
T Consensus 319 ~~~~~~-~~~~-~~~----~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 319 EGQYQF-SSPE-WDD----RSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp HTCCCC-CHHH-HSS----SCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hCCCCC-CCcc-ccc----CCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 221110 0000 011 1236889999999999999999999986
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-36 Score=324.93 Aligned_cols=251 Identities=21% Similarity=0.304 Sum_probs=184.8
Q ss_pred HHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcch-h-hhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEE
Q 002336 613 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS-H-RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 689 (935)
Q Consensus 613 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~-~-~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E 689 (935)
..+++.+.||+|+||.||+|... +|+.||+|++..... . ..+.+.++...++.++||||+++++++.+++..++|||
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e 86 (290)
T 3fme_A 7 DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICME 86 (290)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEE
T ss_pred HhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEe
Confidence 34567889999999999999874 789999999875422 2 22345555556788899999999999999999999999
Q ss_pred ecCCCCHHHHhccCC-CCCCCCHHHHHHHHHHHHHHhHHhhhcCCC-ceEecCCCCCCccccCCCcEEEeeccccccccc
Q 002336 690 YMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNP-GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 767 (935)
Q Consensus 690 ~~~~gsL~~~L~~~~-~~~~l~~~~~~~i~~qia~gL~yLHs~~~~-~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~ 767 (935)
|++ |+|.+++.... ....+++..+..++.|++.||+|||+ + +|+||||||+||+++.++.+||+|||+++....
T Consensus 87 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 162 (290)
T 3fme_A 87 LMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS---KLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVD 162 (290)
T ss_dssp CCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---HSCCCCCCCSGGGCEECTTCCEEBCCC--------
T ss_pred hhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh---cCCeecCCCCHHHEEECCCCCEEEeecCCcccccc
Confidence 997 58877765321 35679999999999999999999998 6 999999999999999999999999999987644
Q ss_pred cccceeecccCCccccCCCCC----CCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeec
Q 002336 768 DLTHISSVARGTVGYLDPEYY----GNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISI 843 (935)
Q Consensus 768 ~~~~~~~~~~gt~~y~APE~l----~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~ 843 (935)
... .....||+.|+|||.+ .+..++.++||||+|+++|+|++|+.||...... . ......+..... ..
T Consensus 163 ~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~----~~~~~~~~~~~~-~~ 234 (290)
T 3fme_A 163 DVA--KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTP-F----QQLKQVVEEPSP-QL 234 (290)
T ss_dssp ---------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCH-H----HHHHHHHHSCCC-CC
T ss_pred ccc--ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCch-H----HHHHHHhccCCC-Cc
Confidence 322 2233589999999985 5667899999999999999999999999732221 1 111222222111 11
Q ss_pred ccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 844 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 844 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
. .......+.+++.+||+.+|++|||++|+++
T Consensus 235 ~--------~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 235 P--------ADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp C--------TTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred c--------cccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 0 1112236889999999999999999999986
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=348.94 Aligned_cols=251 Identities=27% Similarity=0.408 Sum_probs=198.3
Q ss_pred HHHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc--hhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEE
Q 002336 612 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 688 (935)
Q Consensus 612 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~ 688 (935)
...|++.+.||+|+||.||+|.+. +++.||+|++.... ......+.+|+.+++.++||||+++++++.+....++||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 456888999999999999999986 68899999987543 223567899999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccC---CCcEEEeeccccccc
Q 002336 689 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI---NMRAKVSDFGLSRQA 765 (935)
Q Consensus 689 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~---~~~vkL~DFGla~~~ 765 (935)
||+++|+|.+.+.. ...+++..+..++.|+++||+|||+ ++|+||||||+|||++. ++.+||+|||++...
T Consensus 116 e~~~~g~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~ 189 (494)
T 3lij_A 116 ECYKGGELFDEIIH---RMKFNEVDAAVIIKQVLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVF 189 (494)
T ss_dssp ECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred ecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChhhEEEeCCCCCCcEEEEECCCCeEC
Confidence 99999999998863 4568999999999999999999998 89999999999999976 455999999999876
Q ss_pred cccccceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeeccc
Q 002336 766 EEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 845 (935)
Q Consensus 766 ~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d 845 (935)
..... .....||+.|+|||++. ..++.++||||+||++|+|++|+.||...... .+. ..+..+.... +
T Consensus 190 ~~~~~--~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~----~~i~~~~~~~--~ 257 (494)
T 3lij_A 190 ENQKK--MKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQ---EIL----RKVEKGKYTF--D 257 (494)
T ss_dssp BTTBC--BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHH----HHHHHTCCCC--C
T ss_pred CCCcc--ccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHH---HHH----HHHHhCCCCC--C
Confidence 54322 23356999999999886 46899999999999999999999999743321 111 1222222110 1
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002336 846 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 884 (935)
Q Consensus 846 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~ 884 (935)
...... ....+.+++.+||+.+|++|||++|+++.
T Consensus 258 ~~~~~~----~s~~~~~li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 258 SPEWKN----VSEGAKDLIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp SGGGTT----SCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred chhccc----CCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence 111111 12367899999999999999999999864
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-35 Score=348.70 Aligned_cols=247 Identities=23% Similarity=0.301 Sum_probs=199.2
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCcch---hhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEe
Q 002336 615 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 690 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~---~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~ 690 (935)
+.+.+.||+|+||.||+|+++ +|+.||+|++..... ...+.+.+|++++++++||||+++++++.+....++||||
T Consensus 187 f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE~ 266 (543)
T 3c4z_A 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTI 266 (543)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred eEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEEe
Confidence 344578999999999999986 699999999865322 2235788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCC-CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccc
Q 002336 691 MHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 769 (935)
Q Consensus 691 ~~~gsL~~~L~~~~-~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~ 769 (935)
+++|+|.+++.... ....+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 267 ~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~---~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~ 343 (543)
T 3c4z_A 267 MNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ 343 (543)
T ss_dssp CTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTC
T ss_pred ccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHH---cCCcccCCChHHEEEeCCCCEEEeecceeeeccCCC
Confidence 99999999987542 24569999999999999999999998 899999999999999999999999999998765433
Q ss_pred cceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeeccccccc
Q 002336 770 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 849 (935)
Q Consensus 770 ~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~ 849 (935)
.. .....||+.|+|||++.+..++.++|||||||++|||++|+.||....... ...+... .+..+..
T Consensus 344 ~~-~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~--~~~~~~~-~i~~~~~--------- 410 (543)
T 3c4z_A 344 TK-TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV--ENKELKQ-RVLEQAV--------- 410 (543)
T ss_dssp CC-BCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCC--CHHHHHH-HHHHCCC---------
T ss_pred cc-cccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccch--hHHHHHH-HHhhccc---------
Confidence 22 233469999999999999999999999999999999999999997543221 1111111 2211111
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCH
Q 002336 850 GNVKIESIWRIAEVAIQCVEQRGFSRPKM 878 (935)
Q Consensus 850 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~ 878 (935)
.++......+.+++.+||+.+|++||++
T Consensus 411 -~~p~~~s~~~~~li~~lL~~dP~~R~~~ 438 (543)
T 3c4z_A 411 -TYPDKFSPASKDFCEALLQKDPEKRLGF 438 (543)
T ss_dssp -CCCTTSCHHHHHHHHHHSCSSGGGSCCC
T ss_pred -CCCcccCHHHHHHHHHhccCCHhHCCCC
Confidence 1112223467899999999999999975
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-35 Score=327.69 Aligned_cols=254 Identities=26% Similarity=0.353 Sum_probs=197.9
Q ss_pred hHHHHHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcch--------hhhHHHHHHHHHHHhcCCCcccccceeee
Q 002336 609 ELEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--------HRTQQFVTEVALLSRIHHRNLVPLIGYCE 679 (935)
Q Consensus 609 ~l~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~--------~~~~~~~~E~~iL~~L~HpnIv~l~g~~~ 679 (935)
......|.+.+.||+|+||.||+|.+. +++.||||++..... .....+.+|++++++++||||+++++++.
T Consensus 6 ~~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 85 (322)
T 2ycf_A 6 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD 85 (322)
T ss_dssp HHHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred hhhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEc
Confidence 445567888999999999999999876 588999999864321 12346889999999999999999999987
Q ss_pred ccceEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCc---EEE
Q 002336 680 EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMR---AKV 756 (935)
Q Consensus 680 ~~~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~---vkL 756 (935)
.+. .++||||+++++|.+.+.. ...+++..+..++.|+++||+|||+ ++|+||||||+|||++.++. +||
T Consensus 86 ~~~-~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~kl 158 (322)
T 2ycf_A 86 AED-YYIVLELMEGGELFDKVVG---NKRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKI 158 (322)
T ss_dssp SSS-EEEEEECCTTEETHHHHST---TCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSSSCCEEE
T ss_pred CCc-eEEEEecCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEecCCCCCeEEE
Confidence 655 8999999999999998873 4679999999999999999999998 89999999999999987654 999
Q ss_pred eeccccccccccccceeecccCCccccCCCCC---CCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHH
Q 002336 757 SDFGLSRQAEEDLTHISSVARGTVGYLDPEYY---GNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARS 833 (935)
Q Consensus 757 ~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l---~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~ 833 (935)
+|||+++....... .....|++.|+|||++ ....++.++||||||+++|+|++|+.||....... .+...
T Consensus 159 ~Dfg~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~~--- 231 (322)
T 2ycf_A 159 TDFGHSKILGETSL--MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV--SLKDQ--- 231 (322)
T ss_dssp CCCTTCEECCCCHH--HHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSS--CHHHH---
T ss_pred ccCccceecccccc--cccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHH--HHHHH---
Confidence 99999987643221 1234589999999986 45678999999999999999999999997433221 12221
Q ss_pred hhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 834 MIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 834 ~i~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
+..+.... .+..... ....+.+++.+||+.||++||+++|+++
T Consensus 232 -~~~~~~~~--~~~~~~~----~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 232 -ITSGKYNF--IPEVWAE----VSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp -HHHTCCCC--CHHHHTT----SCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred -HHhCcccc--Cchhhhh----cCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 12221110 0111111 2246889999999999999999999985
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=347.88 Aligned_cols=251 Identities=27% Similarity=0.372 Sum_probs=201.2
Q ss_pred HHHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc--hhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEE
Q 002336 612 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 688 (935)
Q Consensus 612 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~ 688 (935)
...|++.+.||+|+||.||+|.+. +++.||||++.... ......+.+|++++++++||||+++++++.+....++||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 466888999999999999999886 78999999986432 223567899999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCcccc---CCCcEEEeeccccccc
Q 002336 689 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD---INMRAKVSDFGLSRQA 765 (935)
Q Consensus 689 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld---~~~~vkL~DFGla~~~ 765 (935)
||+++|+|.+.+.. ...+++..+..++.|++.||.|||+ ++|+||||||+|||++ .++.+||+|||+++..
T Consensus 101 e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 174 (486)
T 3mwu_A 101 ELYTGGELFDEIIK---RKRFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174 (486)
T ss_dssp CCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTB
T ss_pred EcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEEECCcCeEC
Confidence 99999999998863 3569999999999999999999998 8999999999999995 5667999999999876
Q ss_pred cccccceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeeccc
Q 002336 766 EEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 845 (935)
Q Consensus 766 ~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d 845 (935)
..... .....||+.|+|||++.+ .++.++||||+||++|+|++|+.||...... ... ..+..+......
T Consensus 175 ~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~----~~i~~~~~~~~~- 243 (486)
T 3mwu_A 175 QQNTK--MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY---DIL----KRVETGKYAFDL- 243 (486)
T ss_dssp CCC------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHH----HHHHHTCCCSCS-
T ss_pred CCCCc--cCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHH----HHHHhCCCCCCC-
Confidence 44322 233468999999999876 5899999999999999999999999743221 111 112222211100
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002336 846 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 884 (935)
Q Consensus 846 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~ 884 (935)
+ . .......+.+++.+||+.+|++|||+.|+++.
T Consensus 244 ~-~----~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 244 P-Q----WRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp G-G----GGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred c-c----cCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0 0 01122367899999999999999999999874
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=347.76 Aligned_cols=252 Identities=27% Similarity=0.382 Sum_probs=204.2
Q ss_pred HHHHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc---hhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEE
Q 002336 611 EEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRIL 686 (935)
Q Consensus 611 ~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~l 686 (935)
....|++.+.||+|+||.||+|... +|+.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 103 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL 103 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 4467888999999999999999986 78999999986432 2345679999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccc---cCCCcEEEeeccccc
Q 002336 687 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL---DINMRAKVSDFGLSR 763 (935)
Q Consensus 687 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILl---d~~~~vkL~DFGla~ 763 (935)
||||+.+|+|.+.+.. ...+++..+..++.|++.||+|||+ ++|+||||||+|||+ +.++.+||+|||+++
T Consensus 104 v~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 177 (484)
T 3nyv_A 104 VGEVYTGGELFDEIIS---RKRFSEVDAARIIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLST 177 (484)
T ss_dssp EECCCCSCBHHHHHHT---CSCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCTTHHH
T ss_pred EEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeE
Confidence 9999999999998873 4679999999999999999999998 899999999999999 567899999999998
Q ss_pred cccccccceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeec
Q 002336 764 QAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISI 843 (935)
Q Consensus 764 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~ 843 (935)
....... .....||+.|+|||++.+ .++.++||||+||++|+|++|+.||...... ... ..+..+.....
T Consensus 178 ~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~----~~i~~~~~~~~ 247 (484)
T 3nyv_A 178 HFEASKK--MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEY---DIL----KKVEKGKYTFE 247 (484)
T ss_dssp HBCCCCS--HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHH----HHHHHCCCCCC
T ss_pred Ecccccc--cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHH---HHH----HHHHcCCCCCC
Confidence 7644322 223458999999998866 6899999999999999999999999743321 111 12222221110
Q ss_pred ccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002336 844 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 884 (935)
Q Consensus 844 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~ 884 (935)
. + . .......+.+++.+||+.+|++|||++|+++.
T Consensus 248 ~-~-~----~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 282 (484)
T 3nyv_A 248 L-P-Q----WKKVSESAKDLIRKMLTYVPSMRISARDALDH 282 (484)
T ss_dssp S-G-G----GGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred C-c-c----cccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence 0 0 0 01123468899999999999999999999863
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-36 Score=329.44 Aligned_cols=256 Identities=24% Similarity=0.344 Sum_probs=182.7
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc-hhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEec
Q 002336 614 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 691 (935)
Q Consensus 614 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~-~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~ 691 (935)
.|++.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.++++++||||+++++++...+..++||||+
T Consensus 16 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 95 (303)
T 2vwi_A 16 DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLL 95 (303)
T ss_dssp CCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEECC
T ss_pred hhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehhc
Confidence 4566789999999999999865 68999999986432 234567889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccC-----CCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccc
Q 002336 692 HNGTLRDRLHGS-----VNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 766 (935)
Q Consensus 692 ~~gsL~~~L~~~-----~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~ 766 (935)
++++|.+++... .....+++..+..++.|+++||.|||+ .+|+||||||+||+++.++.+||+|||++....
T Consensus 96 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 172 (303)
T 2vwi_A 96 SGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK---NGQIHRDVKAGNILLGEDGSVQIADFGVSAFLA 172 (303)
T ss_dssp TTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTCCEEECCCHHHHHCC
T ss_pred cCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCCChhhEEEcCCCCEEEEeccchheec
Confidence 999999988631 124568999999999999999999998 899999999999999999999999999987654
Q ss_pred cccc----ceeecccCCccccCCCCCCC-CCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCee
Q 002336 767 EDLT----HISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVI 841 (935)
Q Consensus 767 ~~~~----~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~ 841 (935)
.... .......|++.|+|||.+.+ ..++.++||||||+++|||++|+.||....... ... .... +...
T Consensus 173 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~---~~~~-~~~~ 245 (303)
T 2vwi_A 173 TGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMK---VLM---LTLQ-NDPP 245 (303)
T ss_dssp ---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGG---HHH---HHHT-SSCC
T ss_pred cCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhh---HHH---HHhc-cCCC
Confidence 3211 11233468999999998865 568999999999999999999999997433221 111 1111 1111
Q ss_pred e----cccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 842 S----IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 842 ~----~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
. ..++.....+ ...+.+++.+||+.||++||+++|+++
T Consensus 246 ~~~~~~~~~~~~~~~----~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 246 SLETGVQDKEMLKKY----GKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp CTTC-----CCCCCC----CHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred ccccccccchhhhhh----hHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 1 1111111222 236889999999999999999999986
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-36 Score=341.02 Aligned_cols=251 Identities=10% Similarity=0.035 Sum_probs=178.8
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCcch---hhhHHHHHHHHHHHhc--CCCcccccc-------eeeecc
Q 002336 615 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRI--HHRNLVPLI-------GYCEEE 681 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~---~~~~~~~~E~~iL~~L--~HpnIv~l~-------g~~~~~ 681 (935)
+.+.+.||+|+||.||+|.+. +|+.||||++..... ...+.+.+|+.+++.+ +||||++++ +++...
T Consensus 64 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~~ 143 (371)
T 3q60_A 64 LKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQ 143 (371)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEET
T ss_pred eeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheecC
Confidence 456789999999999999976 789999999976432 3445678886555555 699988755 333322
Q ss_pred -----------------ceEEEEEEecCCCCHHHHhccCCCCCCCCHHHH------HHHHHHHHHHhHHhhhcCCCceEe
Q 002336 682 -----------------HQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTR------LQIAHDAAKGLEYLHTGCNPGIIH 738 (935)
Q Consensus 682 -----------------~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~------~~i~~qia~gL~yLHs~~~~~ivH 738 (935)
...++||||++ |+|.+++... +..+++..+ ..++.|+++||+|||+ ++|+|
T Consensus 144 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~---~~ivH 217 (371)
T 3q60_A 144 SQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL--DFVYVFRGDEGILALHILTAQLIRLAANLQS---KGLVH 217 (371)
T ss_dssp TSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH--HHSCCCCHHHHHHHHHHHHHHHHHHHHHHHH---TTEEE
T ss_pred CCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh--ccccchhhhhhhhhHHHHHHHHHHHHHHHHH---CCCcc
Confidence 34799999998 8999999753 223455556 7888999999999998 89999
Q ss_pred cCCCCCCccccCCCcEEEeeccccccccccccceeecccCCccccCCCCCCC--CCCCchhHHHHHHHHHHHHHhCCCCC
Q 002336 739 RDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN--QQLTEKSDVYSFGVVLLELISGKKPV 816 (935)
Q Consensus 739 ~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~--~~~s~ksDVwS~Gvil~eLltG~~Pf 816 (935)
|||||+|||++.++.+||+|||+++...... ....+|+.|+|||++.+ ..++.++|||||||++|||++|+.||
T Consensus 218 rDikp~NIll~~~~~~kL~DFG~a~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf 293 (371)
T 3q60_A 218 GHFTPDNLFIMPDGRLMLGDVSALWKVGTRG----PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPF 293 (371)
T ss_dssp TTCSGGGEEECTTSCEEECCGGGEEETTCEE----EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCST
T ss_pred CcCCHHHEEECCCCCEEEEecceeeecCCCc----cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCC
Confidence 9999999999999999999999998664322 13456799999999987 68999999999999999999999999
Q ss_pred CccCcccchhHHHHHHHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 817 SVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 817 ~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
........... ..............-.........+.+++.+||+.||++|||++|+++
T Consensus 294 ~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 294 GLVTPGIKGSW--------KRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp TBCCTTCTTCC--------CBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CCcCcccccch--------hhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 85432211000 000000000000100001122347889999999999999999999964
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-35 Score=328.51 Aligned_cols=257 Identities=22% Similarity=0.317 Sum_probs=201.8
Q ss_pred HHhhcccccccccEEEEEEEECCCcEEEEEEccCcchhh-----------------hHHHHHHHHHHHhcCCCcccccce
Q 002336 614 TNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHR-----------------TQQFVTEVALLSRIHHRNLVPLIG 676 (935)
Q Consensus 614 ~~~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~~~~~~~~~-----------------~~~~~~E~~iL~~L~HpnIv~l~g 676 (935)
.|.+.+.||+|+||.||+|.. +|+.||+|++....... .+.+.+|+.++++++||||+++++
T Consensus 32 ~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~ 110 (348)
T 2pml_X 32 DYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEG 110 (348)
T ss_dssp TEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCSE
T ss_pred ceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEEE
Confidence 456788999999999999999 79999999986432211 178999999999999999999999
Q ss_pred eeeccceEEEEEEecCCCCHHHH------hccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccC
Q 002336 677 YCEEEHQRILVYEYMHNGTLRDR------LHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI 750 (935)
Q Consensus 677 ~~~~~~~~~lV~E~~~~gsL~~~------L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~ 750 (935)
++.+.+..++||||+++++|.++ +... ....+++..++.++.|++.||+|||+ .++|+||||||+||+++.
T Consensus 111 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~--~~~i~H~dl~p~Nil~~~ 187 (348)
T 2pml_X 111 IITNYDEVYIIYEYMENDSILKFDEYFFVLDKN-YTCFIPIQVIKCIIKSVLNSFSYIHN--EKNICHRDVKPSNILMDK 187 (348)
T ss_dssp EEESSSEEEEEEECCTTCBSSEESSSEESSCSS-SCCCCCHHHHHHHHHHHHHHHHHHHH--TSCEECCCCCGGGEEECT
T ss_pred EEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhc-cccCCCHHHHHHHHHHHHHHHHHHhc--cCCEeecCCChHhEEEcC
Confidence 99999999999999999999998 5432 25679999999999999999999996 379999999999999999
Q ss_pred CCcEEEeeccccccccccccceeecccCCccccCCCCCCCC-CCCc-hhHHHHHHHHHHHHHhCCCCCCccCcccchhHH
Q 002336 751 NMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ-QLTE-KSDVYSFGVVLLELISGKKPVSVEDFGAELNIV 828 (935)
Q Consensus 751 ~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~s~-ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~ 828 (935)
++.+||+|||++...... ......|++.|+|||.+.+. .++. ++||||||+++|||++|+.||...... ....
T Consensus 188 ~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~ 262 (348)
T 2pml_X 188 NGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL--VELF 262 (348)
T ss_dssp TSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS--HHHH
T ss_pred CCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH--HHHH
Confidence 999999999999875443 23345689999999999876 6666 999999999999999999999743321 1122
Q ss_pred HHHHHhhhcCCeeeccc------cccc---CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 829 HWARSMIKKGDVISIVD------PVLI---GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 829 ~~~~~~i~~~~~~~~~d------~~l~---~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
+ .+..+......+ +... ..........+.+++.+||+.+|++||+++|+++
T Consensus 263 ~----~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 263 N----NIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp H----HHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred H----HHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1 122221110000 0000 0000122347889999999999999999999986
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=328.08 Aligned_cols=257 Identities=25% Similarity=0.382 Sum_probs=197.1
Q ss_pred HHHhhcccccccccEEEEEEEECCCcEEEEEEccCcc--hhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEe
Q 002336 613 ATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 690 (935)
Q Consensus 613 ~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~~~~~~--~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~ 690 (935)
..+++.+.||+|+||.||+|.++. .+|+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 33 ~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~ 110 (319)
T 2y4i_B 33 EQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSL 110 (319)
T ss_dssp SCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBC
T ss_pred HHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeec
Confidence 345678999999999999999863 49999986532 22345688899999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccc-
Q 002336 691 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL- 769 (935)
Q Consensus 691 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~- 769 (935)
+++++|.+++... ...+++..++.++.|+++||+|||+ ++|+||||||+|||++ ++.+||+|||+++......
T Consensus 111 ~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~ 184 (319)
T 2y4i_B 111 CKGRTLYSVVRDA--KIVLDVNKTRQIAQEIVKGMGYLHA---KGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQA 184 (319)
T ss_dssp CCSEEHHHHTTSS--CCCCCSHHHHHHHHHHHHHHHHHHH---TTCCCCCCCSTTEEEC---CCEECCCSCCC-------
T ss_pred ccCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChhhEEEe-CCCEEEeecCCccccccccc
Confidence 9999999999742 4568999999999999999999998 8999999999999998 6799999999987643211
Q ss_pred ---cceeecccCCccccCCCCCCC---------CCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhc
Q 002336 770 ---THISSVARGTVGYLDPEYYGN---------QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKK 837 (935)
Q Consensus 770 ---~~~~~~~~gt~~y~APE~l~~---------~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~ 837 (935)
........|++.|+|||.+.. ..++.++||||||+++|||++|+.||...... .. ...+..
T Consensus 185 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~---~~----~~~~~~ 257 (319)
T 2y4i_B 185 GRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAE---AI----IWQMGT 257 (319)
T ss_dssp ---CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHH---HH----HHHHHT
T ss_pred cccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HH----HHHhcc
Confidence 111223458899999998754 45789999999999999999999999743221 11 111222
Q ss_pred CCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhhhhhc
Q 002336 838 GDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 892 (935)
Q Consensus 838 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~~~~~ 892 (935)
+........ .. ...+.+++.+||+.+|++|||++++++.|+++....
T Consensus 258 ~~~~~~~~~----~~----~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~ 304 (319)
T 2y4i_B 258 GMKPNLSQI----GM----GKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRN 304 (319)
T ss_dssp TCCCCCCCS----SC----CTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC----
T ss_pred CCCCCCCcC----CC----CHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhh
Confidence 221111111 11 125789999999999999999999999999887654
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=334.71 Aligned_cols=260 Identities=22% Similarity=0.275 Sum_probs=190.3
Q ss_pred HHhhcccccccccEEEEEEEECCCcEEEEEEccCcchh-----------hhHHHHHHHHHHHhcCCCcccccceeee---
Q 002336 614 TNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSH-----------RTQQFVTEVALLSRIHHRNLVPLIGYCE--- 679 (935)
Q Consensus 614 ~~~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~~~~~~~~-----------~~~~~~~E~~iL~~L~HpnIv~l~g~~~--- 679 (935)
.|.+.+.||+|+||.||+|...+|+.||||++...... ..+.+.+|++++++++||||+++++++.
T Consensus 23 ~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 102 (362)
T 3pg1_A 23 PYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFE 102 (362)
T ss_dssp SCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEECC
T ss_pred ceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEecc
Confidence 35557899999999999999988999999998543221 2367899999999999999999999984
Q ss_pred --ccceEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEe
Q 002336 680 --EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVS 757 (935)
Q Consensus 680 --~~~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~ 757 (935)
.....++||||++ |+|.+.+.. ....+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+
T Consensus 103 ~~~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~ 176 (362)
T 3pg1_A 103 EPAMHKLYLVTELMR-TDLAQVIHD--QRIVISPQHIQYFMYHILLGLHVLHE---AGVVHRDLHPGNILLADNNDITIC 176 (362)
T ss_dssp TTTCCEEEEEEECCS-EEHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEEC
T ss_pred CCCcceEEEEEccCC-CCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHH---CcCEecCCChHHEEEcCCCCEEEE
Confidence 3446899999997 688888764 34579999999999999999999998 899999999999999999999999
Q ss_pred eccccccccccccceeecccCCccccCCCCCCC-CCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhh
Q 002336 758 DFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIK 836 (935)
Q Consensus 758 DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~ 836 (935)
|||+++....... .....|++.|+|||.+.+ ..++.++||||+|+++|+|++|+.||........ ...+.....
T Consensus 177 Dfg~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~---~~~i~~~~~ 251 (362)
T 3pg1_A 177 DFNLAREDTADAN--KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQ---LNKIVEVVG 251 (362)
T ss_dssp CTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHC
T ss_pred ecCcccccccccc--cceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHcC
Confidence 9999975433222 233458999999998876 6789999999999999999999999985432211 111111111
Q ss_pred cCCee-----------eccccccc-------CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002336 837 KGDVI-----------SIVDPVLI-------GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 884 (935)
Q Consensus 837 ~~~~~-----------~~~d~~l~-------~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~ 884 (935)
..... ..+...+. ..........+.+++.+||+.||++|||++|+++.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 252 TPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp CCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 10000 00000000 00011123468899999999999999999999863
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=338.69 Aligned_cols=259 Identities=23% Similarity=0.273 Sum_probs=192.4
Q ss_pred HHhhcccccccccEEEEEEEECCCcEEEEEEccCcchhhhHHHHHHHHHHHhcCCCcccccceeeeccc------eEEEE
Q 002336 614 TNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH------QRILV 687 (935)
Q Consensus 614 ~~~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~------~~~lV 687 (935)
.|.+.+.||+|+||.||+|++..+..+|+|++.... ....+|+++++.++||||+++++++.... ..++|
T Consensus 41 ~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~----~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv 116 (394)
T 4e7w_A 41 AYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDK----RFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLV 116 (394)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEE
T ss_pred eEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCc----chHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEE
Confidence 366789999999999999999877789999886432 22347999999999999999999985433 37899
Q ss_pred EEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCcccc-CCCcEEEeecccccccc
Q 002336 688 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD-INMRAKVSDFGLSRQAE 766 (935)
Q Consensus 688 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld-~~~~vkL~DFGla~~~~ 766 (935)
|||++++.+............+++..+..++.|+++||+|||+ ++|+||||||+|||++ .++.+||+|||+++...
T Consensus 117 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~ 193 (394)
T 4e7w_A 117 LEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILI 193 (394)
T ss_dssp EECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred eeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEcCCCCcEEEeeCCCccccc
Confidence 9999876544433222235679999999999999999999998 8999999999999999 79999999999998764
Q ss_pred ccccceeecccCCccccCCCCCCC-CCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhc--------
Q 002336 767 EDLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKK-------- 837 (935)
Q Consensus 767 ~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~-------- 837 (935)
.... .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+.+..+ .+...++ .+..
T Consensus 194 ~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~--~l~~i~~-~~g~p~~~~~~~ 268 (394)
T 4e7w_A 194 AGEP--NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGID--QLVEIIK-VLGTPSREQIKT 268 (394)
T ss_dssp TTCC--CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHH-HHCCCCHHHHHH
T ss_pred CCCC--CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHH-HhCCCCHHHHHh
Confidence 4322 223468999999998865 468999999999999999999999998543221 1111111 1000
Q ss_pred -------CCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002336 838 -------GDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 884 (935)
Q Consensus 838 -------~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~ 884 (935)
..........+....+......+.+++.+||+.||++|||+.|+++.
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 269 MNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp HCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred hChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 00000000000000111223478899999999999999999999864
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=328.20 Aligned_cols=260 Identities=21% Similarity=0.290 Sum_probs=198.0
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc-hhhhHHHHHHHHHHHhcCCCcccccceeeecc-----ceEEE
Q 002336 614 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE-----HQRIL 686 (935)
Q Consensus 614 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~-~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~-----~~~~l 686 (935)
.|++.+.||+|+||.||+|... +++.||||++.... ....+.+.+|++++++++||||+++++++... ...++
T Consensus 28 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~i 107 (364)
T 3qyz_A 28 RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYI 107 (364)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEE
T ss_pred cEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEE
Confidence 3567889999999999999876 68899999987543 23447789999999999999999999998654 46899
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccc
Q 002336 687 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 766 (935)
Q Consensus 687 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~ 766 (935)
||||++ |+|.+++.. ..+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 108 v~e~~~-~~L~~~l~~----~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~ 179 (364)
T 3qyz_A 108 VQDLME-TDLYKLLKT----QHLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD 179 (364)
T ss_dssp EEECCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEcccC-cCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChHhEEECCCCCEEEEeCcceEecC
Confidence 999997 599998863 458999999999999999999998 899999999999999999999999999998765
Q ss_pred ccccce--eecccCCccccCCCCCC-CCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCee--
Q 002336 767 EDLTHI--SSVARGTVGYLDPEYYG-NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVI-- 841 (935)
Q Consensus 767 ~~~~~~--~~~~~gt~~y~APE~l~-~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~-- 841 (935)
...... .....||+.|+|||++. ...++.++||||+|+++|+|++|+.||......+.. ..+...+......
T Consensus 180 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~---~~i~~~~~~~~~~~~ 256 (364)
T 3qyz_A 180 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQL---NHILGILGSPSQEDL 256 (364)
T ss_dssp GGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHH---HHHHHHHCSCCHHHH
T ss_pred CCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHH---HHHHHHhCCCCHHHH
Confidence 432221 23346899999999764 456899999999999999999999999754433211 1111111100000
Q ss_pred -------------eccccccc--CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002336 842 -------------SIVDPVLI--GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 884 (935)
Q Consensus 842 -------------~~~d~~l~--~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~ 884 (935)
....+.-. ..........+.+++.+||+.||++|||++|+++.
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 257 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp HTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000000 00001122368899999999999999999999863
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-35 Score=326.20 Aligned_cols=260 Identities=21% Similarity=0.274 Sum_probs=197.7
Q ss_pred HHhhcccccccccEEEEEEEE--CCCcEEEEEEccCcch--hhhHHHHHHHHHHHhc---CCCcccccceeee-----cc
Q 002336 614 TNNFCKKIGKGSFGSVYYGKM--KDGKEVAVKIMADSCS--HRTQQFVTEVALLSRI---HHRNLVPLIGYCE-----EE 681 (935)
Q Consensus 614 ~~~~~~~LG~G~fG~Vy~~~~--~~g~~vAvK~~~~~~~--~~~~~~~~E~~iL~~L---~HpnIv~l~g~~~-----~~ 681 (935)
.|++.+.||+|+||.||+|.+ .+|+.||+|++..... .....+.+|+.+++.+ +||||+++++++. ..
T Consensus 12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~ 91 (326)
T 1blx_A 12 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 91 (326)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSE
T ss_pred ceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCC
Confidence 356788999999999999998 3688999999864322 2234677888887776 8999999999987 56
Q ss_pred ceEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccc
Q 002336 682 HQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGL 761 (935)
Q Consensus 682 ~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGl 761 (935)
...++||||++ |+|.+++... ....+++..+..++.|+++||.|||+ ++|+||||||+||+++.++.+||+|||+
T Consensus 92 ~~~~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~---~gi~H~dlkp~Nili~~~~~~kl~Dfg~ 166 (326)
T 1blx_A 92 TKLTLVFEHVD-QDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGL 166 (326)
T ss_dssp EEEEEEEECCS-CBHHHHHHHS-CTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred ceEEEEEecCC-CCHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHHHeEEcCCCCEEEecCcc
Confidence 67899999997 6999998754 23458999999999999999999998 8999999999999999999999999999
Q ss_pred cccccccccceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCC--
Q 002336 762 SRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD-- 839 (935)
Q Consensus 762 a~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~-- 839 (935)
++....... .....|++.|+|||.+.+..++.++||||||+++|+|++|+.||....... ....+........
T Consensus 167 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~i~~~~~~~~~~ 241 (326)
T 1blx_A 167 ARIYSFQMA--LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD---QLGKILDVIGLPGEE 241 (326)
T ss_dssp CCCCCGGGG--GCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCCCGG
T ss_pred cccccCCCC--ccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHH---HHHHHHHHcCCCCcc
Confidence 987643321 233468999999999988889999999999999999999999997443221 1111111111000
Q ss_pred -eeec-------cc---ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 840 -VISI-------VD---PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 840 -~~~~-------~d---~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
.... .. ..............+.+++.+||+.+|++||+++|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 242 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp GSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0000 00 00000111222346789999999999999999999985
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-35 Score=358.72 Aligned_cols=246 Identities=25% Similarity=0.334 Sum_probs=201.3
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc---hhhhHHHHHHHHHHHhc-CCCcccccceeeeccceEEEEE
Q 002336 614 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVY 688 (935)
Q Consensus 614 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~iL~~L-~HpnIv~l~g~~~~~~~~~lV~ 688 (935)
.+++.+.||+|+||.||+|+++ +++.||||+++... ....+.+..|..++..+ +||+|+++++++.+.+..++||
T Consensus 342 ~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV~ 421 (674)
T 3pfq_A 342 DFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 421 (674)
T ss_dssp TEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEEE
T ss_pred ceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEEE
Confidence 4667889999999999999876 58899999987532 23346688899999988 7999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccccc
Q 002336 689 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 768 (935)
Q Consensus 689 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~ 768 (935)
||+++|+|.+++.. ...+++..++.++.||+.||+|||+ ++|+||||||+||||+.++++||+|||+++.....
T Consensus 422 E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~---~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~ 495 (674)
T 3pfq_A 422 EYVNGGDLMYHIQQ---VGRFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD 495 (674)
T ss_dssp ECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TSEECCCCCSTTEEECSSSCEEECCCTTCEECCCT
T ss_pred eCcCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEeccCChhhEEEcCCCcEEEeecceeeccccC
Confidence 99999999999984 3569999999999999999999998 89999999999999999999999999999864332
Q ss_pred ccceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccccc
Q 002336 769 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 848 (935)
Q Consensus 769 ~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l 848 (935)
.. ......||+.|+|||++.+..++.++||||||+++|||++|+.||...+.. .+ . +.+..+..
T Consensus 496 ~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~---~~---~-~~i~~~~~-------- 559 (674)
T 3pfq_A 496 GV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED---EL---F-QSIMEHNV-------- 559 (674)
T ss_dssp TC-CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HH---H-HHHHSSCC--------
T ss_pred Cc-ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHH---HH---H-HHHHhCCC--------
Confidence 22 233456999999999999999999999999999999999999999743321 11 1 12222211
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCH-----HHHHH
Q 002336 849 IGNVKIESIWRIAEVAIQCVEQRGFSRPKM-----QEIVL 883 (935)
Q Consensus 849 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~-----~ev~~ 883 (935)
.++......+.+++.+||+.||++||++ +||.+
T Consensus 560 --~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 560 --AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp --CCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred --CCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 1122233468899999999999999997 66654
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-35 Score=320.57 Aligned_cols=249 Identities=26% Similarity=0.311 Sum_probs=199.6
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc---------hhhhHHHHHHHHHHHhcC-CCcccccceeeeccc
Q 002336 614 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---------SHRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEH 682 (935)
Q Consensus 614 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~---------~~~~~~~~~E~~iL~~L~-HpnIv~l~g~~~~~~ 682 (935)
.|++.+.||+|+||.||+|.+. +|+.||||++.... ....+.+.+|+++++++. ||||+++++++....
T Consensus 18 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 97 (298)
T 1phk_A 18 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNT 97 (298)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred ccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccCC
Confidence 3556789999999999999986 68999999986432 122456889999999995 999999999999999
Q ss_pred eEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccc
Q 002336 683 QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS 762 (935)
Q Consensus 683 ~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla 762 (935)
..++||||+++++|.+++.. ...+++..+..++.|++.||.|||+ ++++||||||+||+++.++.+||+|||++
T Consensus 98 ~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~ 171 (298)
T 1phk_A 98 FFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFS 171 (298)
T ss_dssp EEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEeccCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEcCCCcEEEecccch
Confidence 99999999999999999974 4568999999999999999999998 89999999999999999999999999999
Q ss_pred ccccccccceeecccCCccccCCCCCC------CCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhh
Q 002336 763 RQAEEDLTHISSVARGTVGYLDPEYYG------NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIK 836 (935)
Q Consensus 763 ~~~~~~~~~~~~~~~gt~~y~APE~l~------~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~ 836 (935)
........ .....|++.|+|||.+. ...++.++||||||+++++|++|+.||...... .. . ..+.
T Consensus 172 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~---~-~~~~ 242 (298)
T 1phk_A 172 CQLDPGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM---LM---L-RMIM 242 (298)
T ss_dssp EECCTTCC--BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HH---H-HHHH
T ss_pred hhcCCCcc--cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHH---HH---H-HHHh
Confidence 87644322 22345899999999873 457889999999999999999999999743221 11 1 1122
Q ss_pred cCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 837 KGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 837 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
.+.... ..+ ........+.+++.+||+.+|++||+++|+++
T Consensus 243 ~~~~~~-~~~-----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 243 SGNYQF-GSP-----EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp HTCCCC-CTT-----TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred cCCccc-Ccc-----cccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 221110 000 01122346889999999999999999999875
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-35 Score=358.72 Aligned_cols=261 Identities=25% Similarity=0.403 Sum_probs=206.3
Q ss_pred HHHHHHhhcccccccccEEEEEEEECC----CcEEEEEEccCcc-hhhhHHHHHHHHHHHhcCCCcccccceeeeccceE
Q 002336 610 LEEATNNFCKKIGKGSFGSVYYGKMKD----GKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQR 684 (935)
Q Consensus 610 l~~~~~~~~~~LG~G~fG~Vy~~~~~~----g~~vAvK~~~~~~-~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~ 684 (935)
+....+++.+.||+|+||.||+|.+.. +..||+|.+.... ....+.+.+|+.++++++||||+++++++.+ +..
T Consensus 387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~ 465 (656)
T 2j0j_A 387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPV 465 (656)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-Cce
Confidence 334556778999999999999998752 4679999987543 3344679999999999999999999999854 568
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccc
Q 002336 685 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 764 (935)
Q Consensus 685 ~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~ 764 (935)
++||||+++|+|.+++... ...+++..++.++.|+++||+|||+ ++|+||||||+|||++.++.+||+|||+++.
T Consensus 466 ~lv~E~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDikp~NILl~~~~~vkL~DFG~a~~ 540 (656)
T 2j0j_A 466 WIIMELCTLGELRSFLQVR--KFSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRY 540 (656)
T ss_dssp EEEEECCTTCBHHHHHHHT--TTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCCCCCS
T ss_pred EEEEEcCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchHhEEEeCCCCEEEEecCCCee
Confidence 9999999999999999743 4468999999999999999999998 8999999999999999999999999999987
Q ss_pred ccccccceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCcccchhHHHHHHHhhhcCCeeec
Q 002336 765 AEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISI 843 (935)
Q Consensus 765 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~ 843 (935)
.............+++.|+|||.+.+..++.++||||||+++|||++ |..||...... .... .+..+....
T Consensus 541 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~---~~~~----~i~~~~~~~- 612 (656)
T 2j0j_A 541 MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN---DVIG----RIENGERLP- 612 (656)
T ss_dssp CCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHH----HHHHTCCCC-
T ss_pred cCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHH---HHHH----HHHcCCCCC-
Confidence 65443333333457789999999988889999999999999999997 99999743221 1111 122221111
Q ss_pred ccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhhhhhc
Q 002336 844 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 892 (935)
Q Consensus 844 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~~~~~ 892 (935)
. +......+.+++.+||+.+|++||++.||++.|+++...+
T Consensus 613 ----~----~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~~ 653 (656)
T 2j0j_A 613 ----M----PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 653 (656)
T ss_dssp ----C----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ----C----CccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence 1 1122346889999999999999999999999999987654
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-35 Score=325.63 Aligned_cols=262 Identities=23% Similarity=0.297 Sum_probs=201.2
Q ss_pred HHHhhcccccccccEEEEEEEE-C-CCcEEEEEEccCcchhhhHHHHHHHHHHHhcCCC------cccccceeeeccceE
Q 002336 613 ATNNFCKKIGKGSFGSVYYGKM-K-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHR------NLVPLIGYCEEEHQR 684 (935)
Q Consensus 613 ~~~~~~~~LG~G~fG~Vy~~~~-~-~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~Hp------nIv~l~g~~~~~~~~ 684 (935)
..|++.+.||+|+||.||+|.. . +++.||||++... ....+.+.+|+++++.++|+ +++++++++...+..
T Consensus 14 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~ 92 (339)
T 1z57_A 14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHI 92 (339)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEE
T ss_pred CceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcE
Confidence 4567789999999999999987 3 6889999998754 34456788999999998765 499999999999999
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccC--------------
Q 002336 685 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI-------------- 750 (935)
Q Consensus 685 ~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~-------------- 750 (935)
++||||+ +++|.+++... ....+++..+..++.|+++||+|||+ ++|+||||||+|||++.
T Consensus 93 ~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~ 167 (339)
T 1z57_A 93 CIVFELL-GLSTYDFIKEN-GFLPFRLDHIRKMAYQICKSVNFLHS---NKLTHTDLKPENILFVQSDYTEAYNPKIKRD 167 (339)
T ss_dssp EEEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCCCEEEEEC----CE
T ss_pred EEEEcCC-CCCHHHHHHhc-CCCCCcHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHEEEeccccccccCCccccc
Confidence 9999999 89999998754 23468999999999999999999998 89999999999999987
Q ss_pred -----CCcEEEeeccccccccccccceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccch
Q 002336 751 -----NMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAEL 825 (935)
Q Consensus 751 -----~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~ 825 (935)
++.+||+|||+++..... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||...+..+..
T Consensus 168 ~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~ 243 (339)
T 1z57_A 168 ERTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHL 243 (339)
T ss_dssp EEEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHH
T ss_pred cccccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence 668999999999865432 22346899999999999989999999999999999999999999754332211
Q ss_pred hHHHHHHHh-----hhcCCeeec---------------------ccccc-cCCCCHHHHHHHHHHHHHccccCCCCCCCH
Q 002336 826 NIVHWARSM-----IKKGDVISI---------------------VDPVL-IGNVKIESIWRIAEVAIQCVEQRGFSRPKM 878 (935)
Q Consensus 826 ~l~~~~~~~-----i~~~~~~~~---------------------~d~~l-~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~ 878 (935)
......... ......... ..+.. ...........+.+++.+||+.||++|||+
T Consensus 244 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~ 323 (339)
T 1z57_A 244 AMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITL 323 (339)
T ss_dssp HHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCH
T ss_pred HHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCH
Confidence 111110000 000000000 00000 001123445678999999999999999999
Q ss_pred HHHHHH
Q 002336 879 QEIVLA 884 (935)
Q Consensus 879 ~ev~~~ 884 (935)
+|+++.
T Consensus 324 ~ell~h 329 (339)
T 1z57_A 324 REALKH 329 (339)
T ss_dssp HHHTTS
T ss_pred HHHhcC
Confidence 999753
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=342.77 Aligned_cols=250 Identities=27% Similarity=0.373 Sum_probs=198.3
Q ss_pred HHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcch-------------hhhHHHHHHHHHHHhcCCCcccccceee
Q 002336 613 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS-------------HRTQQFVTEVALLSRIHHRNLVPLIGYC 678 (935)
Q Consensus 613 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~-------------~~~~~~~~E~~iL~~L~HpnIv~l~g~~ 678 (935)
..|.+.+.||+|+||.||+|... +++.||+|++..... ...+.+.+|+.++++++||||+++++++
T Consensus 36 ~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~ 115 (504)
T 3q5i_A 36 ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVF 115 (504)
T ss_dssp GTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred cceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 34677899999999999999986 578999999865321 2246788999999999999999999999
Q ss_pred eccceEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCC---cEE
Q 002336 679 EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM---RAK 755 (935)
Q Consensus 679 ~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~---~vk 755 (935)
.+....++||||+++|+|.+.+.. ...+++..+..++.|++.||+|||+ ++|+||||||+|||++.++ .+|
T Consensus 116 ~~~~~~~lv~e~~~gg~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~k 189 (504)
T 3q5i_A 116 EDKKYFYLVTEFYEGGELFEQIIN---RHKFDECDAANIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLLNIK 189 (504)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESSTTCCSSEE
T ss_pred EcCCEEEEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCcHHHEEEecCCCCccEE
Confidence 999999999999999999998873 4569999999999999999999998 8999999999999998776 699
Q ss_pred EeeccccccccccccceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhh
Q 002336 756 VSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMI 835 (935)
Q Consensus 756 L~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i 835 (935)
|+|||++........ .....||+.|+|||++.+ .++.++||||+||++|+|++|+.||...... .. ...+
T Consensus 190 l~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~----~~~i 259 (504)
T 3q5i_A 190 IVDFGLSSFFSKDYK--LRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQ---DI----IKKV 259 (504)
T ss_dssp ECCCTTCEECCTTSC--BCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HH----HHHH
T ss_pred EEECCCCEEcCCCCc--cccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHH---HH----HHHH
Confidence 999999987654322 233569999999998874 6899999999999999999999999743321 11 1222
Q ss_pred hcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002336 836 KKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 884 (935)
Q Consensus 836 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~ 884 (935)
..+.... +...... ....+.+++.+||+.+|++|||++|+++.
T Consensus 260 ~~~~~~~--~~~~~~~----~s~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 260 EKGKYYF--DFNDWKN----ISDEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp HHCCCCC--CHHHHTT----SCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HcCCCCC--CccccCC----CCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 2222110 0000011 12368899999999999999999999753
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-35 Score=329.65 Aligned_cols=260 Identities=23% Similarity=0.284 Sum_probs=189.6
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCc--chhhhHHHHHHHHHHHhcCCCcccccceeeeccc------eE
Q 002336 614 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH------QR 684 (935)
Q Consensus 614 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~--~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~------~~ 684 (935)
.|++.+.||+|+||.||+|... +++.||||++... .....+.+.+|+.+++.++||||+++++++.... ..
T Consensus 26 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 105 (371)
T 2xrw_A 26 RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDV 105 (371)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEE
T ss_pred heeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccce
Confidence 3566789999999999999875 6889999998653 2334567889999999999999999999987654 78
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccc
Q 002336 685 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 764 (935)
Q Consensus 685 ~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~ 764 (935)
++||||++ ++|.+.+. ..+++..+..++.|+++||+|||+ ++|+||||||+|||++.++.+||+|||+++.
T Consensus 106 ~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~ 176 (371)
T 2xrw_A 106 YIVMELMD-ANLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLART 176 (371)
T ss_dssp EEEEECCS-EEHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCCCC---
T ss_pred EEEEEcCC-CCHHHHHh-----hccCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEEEeecccc
Confidence 99999997 47888875 248899999999999999999998 8999999999999999999999999999986
Q ss_pred ccccccceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHH----------------
Q 002336 765 AEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIV---------------- 828 (935)
Q Consensus 765 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~---------------- 828 (935)
..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+........
T Consensus 177 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 254 (371)
T 2xrw_A 177 AGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ 254 (371)
T ss_dssp ---------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSC
T ss_pred ccccc--ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhh
Confidence 54322 123346899999999999889999999999999999999999999754321110000
Q ss_pred HHHHHhhhcCCe------eecccccccCCC---CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002336 829 HWARSMIKKGDV------ISIVDPVLIGNV---KIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 884 (935)
Q Consensus 829 ~~~~~~i~~~~~------~~~~d~~l~~~~---~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~ 884 (935)
..+......... ............ .......+.+++.+||+.||++|||++|+++.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 255 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp HHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred hHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 000000000000 000000000000 11224578999999999999999999999874
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-35 Score=324.80 Aligned_cols=248 Identities=24% Similarity=0.400 Sum_probs=191.8
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCcchhhhHHHHHHHHHHHhc-CCCcccccceeeec------cceEEE
Q 002336 615 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEE------EHQRIL 686 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L-~HpnIv~l~g~~~~------~~~~~l 686 (935)
|++.+.||+|+||.||+|.+. +|+.||+|++.... ...+.+.+|+.+++++ +||||+++++++.. ....++
T Consensus 26 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~l 104 (326)
T 2x7f_A 26 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWL 104 (326)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEE
T ss_pred EEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEEE
Confidence 556789999999999999985 68999999986542 3456789999999999 79999999999876 467899
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccc
Q 002336 687 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 766 (935)
Q Consensus 687 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~ 766 (935)
||||+++++|.+++... ....+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++....
T Consensus 105 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 180 (326)
T 2x7f_A 105 VMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD 180 (326)
T ss_dssp EEECCTTEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTCCEEECCCTTTC---
T ss_pred EEEcCCCCcHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCcHHHEEEcCCCCEEEeeCcCceecC
Confidence 99999999999999754 23568999999999999999999998 899999999999999999999999999987654
Q ss_pred ccccceeecccCCccccCCCCCC-----CCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCee
Q 002336 767 EDLTHISSVARGTVGYLDPEYYG-----NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVI 841 (935)
Q Consensus 767 ~~~~~~~~~~~gt~~y~APE~l~-----~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~ 841 (935)
.... ......|++.|+|||.+. +..++.++||||||+++|+|++|+.||....... . ... +......
T Consensus 181 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~---~~~-~~~~~~~ 252 (326)
T 2x7f_A 181 RTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR---A---LFL-IPRNPAP 252 (326)
T ss_dssp -----------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH---H---HHH-HHHSCCC
T ss_pred cCcc-ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH---H---HHH-hhcCccc
Confidence 3221 122345899999999886 5678899999999999999999999996332211 1 111 1111111
Q ss_pred ecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 842 SIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 842 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
.... ..+ ...+.+++.+||..+|++||+++|+++
T Consensus 253 ~~~~----~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 253 RLKS----KKW----SKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp CCSC----SCS----CHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred cCCc----ccc----CHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 1111 111 236889999999999999999999987
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=327.59 Aligned_cols=268 Identities=21% Similarity=0.320 Sum_probs=201.0
Q ss_pred HHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcchhhhHHHHHHHHHHHhcC-----------CCcccccceeeec
Q 002336 613 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIH-----------HRNLVPLIGYCEE 680 (935)
Q Consensus 613 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~-----------HpnIv~l~g~~~~ 680 (935)
..|.+.+.||+|+||.||+|... +++.||||++... ....+.+.+|+.++++++ ||||+++++++..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~ 97 (373)
T 1q8y_A 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 97 (373)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence 45677899999999999999874 6899999998753 334567889999999886 8999999999876
Q ss_pred cc----eEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCC-ceEecCCCCCCcccc------
Q 002336 681 EH----QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP-GIIHRDVKSSNILLD------ 749 (935)
Q Consensus 681 ~~----~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~-~ivH~DLkp~NILld------ 749 (935)
.. ..++|||++ +++|.+++... ....+++..+..++.||+.||+|||+ + +|+||||||+|||++
T Consensus 98 ~~~~~~~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~---~~~ivH~Dikp~NIll~~~~~~~ 172 (373)
T 1q8y_A 98 KGPNGVHVVMVFEVL-GENLLALIKKY-EHRGIPLIYVKQISKQLLLGLDYMHR---RCGIIHTDIKPENVLMEIVDSPE 172 (373)
T ss_dssp EETTEEEEEEEECCC-CEEHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHH---TTCEECSCCSGGGEEEEEEETTT
T ss_pred cCCCCceEEEEEecC-CCCHHHHHHHh-hccCCcHHHHHHHHHHHHHHHHHHHh---cCCEEecCCChHHeEEeccCCCc
Confidence 54 789999999 89999998754 24558999999999999999999998 7 999999999999994
Q ss_pred CCCcEEEeeccccccccccccceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHH
Q 002336 750 INMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVH 829 (935)
Q Consensus 750 ~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~ 829 (935)
..+.+||+|||+++...... ....||+.|+|||++.+..++.++||||||+++|||++|+.||.............
T Consensus 173 ~~~~~kl~Dfg~a~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~ 248 (373)
T 1q8y_A 173 NLIQIKIADLGNACWYDEHY----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD 248 (373)
T ss_dssp TEEEEEECCCTTCEETTBCC----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred CcceEEEcccccccccCCCC----CCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHH
Confidence 44579999999998765432 23468999999999988889999999999999999999999998443221111111
Q ss_pred HHHHhhh-cCCeee--------------------cccc--------cc--cCCCCHHHHHHHHHHHHHccccCCCCCCCH
Q 002336 830 WARSMIK-KGDVIS--------------------IVDP--------VL--IGNVKIESIWRIAEVAIQCVEQRGFSRPKM 878 (935)
Q Consensus 830 ~~~~~i~-~~~~~~--------------------~~d~--------~l--~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~ 878 (935)
.+...+. .+.... .+.. .+ ....+......+.+++.+||+.||++|||+
T Consensus 249 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~ 328 (373)
T 1q8y_A 249 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA 328 (373)
T ss_dssp HHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCH
T ss_pred HHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCH
Confidence 1111110 000000 0000 00 012345667789999999999999999999
Q ss_pred HHHHH--HHhhhhh
Q 002336 879 QEIVL--AIQDSIK 890 (935)
Q Consensus 879 ~ev~~--~L~~~~~ 890 (935)
+|+++ .+++...
T Consensus 329 ~ell~hp~f~~~~~ 342 (373)
T 1q8y_A 329 GGLVNHPWLKDTLG 342 (373)
T ss_dssp HHHHTCGGGTTCTT
T ss_pred HHHhhChhhhcccC
Confidence 99987 3444433
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=317.75 Aligned_cols=250 Identities=24% Similarity=0.386 Sum_probs=191.5
Q ss_pred HHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcchhhhHHHHHHHHHHHhcCCCcccccceeeec-----------
Q 002336 613 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEE----------- 680 (935)
Q Consensus 613 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~----------- 680 (935)
..|++.+.||+|+||.||+|... +++.||||++... ....+.+.+|+.++++++||||+++++++.+
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAV 84 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-----
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhccc
Confidence 45667899999999999999975 7999999998643 3445789999999999999999999998754
Q ss_pred --cceEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEee
Q 002336 681 --EHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSD 758 (935)
Q Consensus 681 --~~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~D 758 (935)
....++||||+++|+|.+++... ...+++..++.++.|+++||+|||+ ++|+||||||+|||++.++.+||+|
T Consensus 85 ~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dlkp~Nil~~~~~~~kl~d 159 (303)
T 1zy4_A 85 KKKSTLFIQMEYCENGTLYDLIHSE--NLNQQRDEYWRLFRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGD 159 (303)
T ss_dssp -CEEEEEEEEECCCSCBHHHHHHHS--CGGGCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECC
T ss_pred ccCCceEEEEecCCCCCHHHhhhcc--ccccchHHHHHHHHHHHHHHHHHHh---CCeecccCCHHhEEEcCCCCEEEee
Confidence 45689999999999999999752 3567889999999999999999998 8999999999999999999999999
Q ss_pred ccccccccccc-------------cceeecccCCccccCCCCCCCC-CCCchhHHHHHHHHHHHHHhCCCCCCccCcccc
Q 002336 759 FGLSRQAEEDL-------------THISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAE 824 (935)
Q Consensus 759 FGla~~~~~~~-------------~~~~~~~~gt~~y~APE~l~~~-~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~ 824 (935)
||++....... ........|++.|+|||.+.+. .++.++||||||+++|||++ ||... ..
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~--~~- 233 (303)
T 1zy4_A 160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTG--ME- 233 (303)
T ss_dssp CCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSH--HH-
T ss_pred CcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCc--hh-
Confidence 99998654321 1112234589999999998754 78999999999999999998 55311 11
Q ss_pred hhHHHHHHHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 825 LNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 825 ~~l~~~~~~~i~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
...... .+.... ..+....+......+.+++.+||+.||++|||++|+++
T Consensus 234 --~~~~~~-~~~~~~------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 234 --RVNILK-KLRSVS------IEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp --HHHHHH-HHHSTT------CCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --HHHHHH-hccccc------cccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 111111 121111 11112223333456889999999999999999999986
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-35 Score=336.10 Aligned_cols=258 Identities=22% Similarity=0.244 Sum_probs=192.2
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcchhhhHHHHHHHHHHHhcCCCcccccceeeec------------
Q 002336 614 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEE------------ 680 (935)
Q Consensus 614 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~------------ 680 (935)
.|++.+.||+|+||.||+|.+. +|+.||||++.... ....+|+++|+.++||||+++++++..
T Consensus 8 ~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~ 83 (383)
T 3eb0_A 8 KYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP----RYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPP 83 (383)
T ss_dssp TEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHTTCCCTTBCCEEEEEEEC-----------
T ss_pred eEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHHcCCCCccchhheeeecCcccccccccc
Confidence 4567889999999999999874 78999999986542 233479999999999999999999843
Q ss_pred --------------------------cceEEEEEEecCCCCHHHHhccCC-CCCCCCHHHHHHHHHHHHHHhHHhhhcCC
Q 002336 681 --------------------------EHQRILVYEYMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCN 733 (935)
Q Consensus 681 --------------------------~~~~~lV~E~~~~gsL~~~L~~~~-~~~~l~~~~~~~i~~qia~gL~yLHs~~~ 733 (935)
....++||||++ |+|.+.+.... ....+++..+..++.|+++||+|||+
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~--- 159 (383)
T 3eb0_A 84 DDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS--- 159 (383)
T ss_dssp --------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT---
T ss_pred cccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---
Confidence 334789999998 58777665321 45679999999999999999999997
Q ss_pred CceEecCCCCCCcccc-CCCcEEEeeccccccccccccceeecccCCccccCCCCCCCC-CCCchhHHHHHHHHHHHHHh
Q 002336 734 PGIIHRDVKSSNILLD-INMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELIS 811 (935)
Q Consensus 734 ~~ivH~DLkp~NILld-~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~s~ksDVwS~Gvil~eLlt 811 (935)
.+|+||||||+|||++ .++.+||+|||+++....... .....+|+.|+|||.+.+. .++.++||||+||++|||++
T Consensus 160 ~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~ 237 (383)
T 3eb0_A 160 LGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP--SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELIL 237 (383)
T ss_dssp TTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC--CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHH
T ss_pred CcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC--CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHh
Confidence 8999999999999998 689999999999987644332 2234589999999987664 58999999999999999999
Q ss_pred CCCCCCccCcccchhHHHHHHHhhhc----------CCeeecccccc-----cCCCCHHHHHHHHHHHHHccccCCCCCC
Q 002336 812 GKKPVSVEDFGAELNIVHWARSMIKK----------GDVISIVDPVL-----IGNVKIESIWRIAEVAIQCVEQRGFSRP 876 (935)
Q Consensus 812 G~~Pf~~~~~~~~~~l~~~~~~~i~~----------~~~~~~~d~~l-----~~~~~~~~~~~l~~li~~Cl~~dP~~RP 876 (935)
|+.||......+ .+...++ .... .......-+.. ....+......+.+++.+||+.+|++||
T Consensus 238 g~~pf~~~~~~~--~~~~i~~-~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~ 314 (383)
T 3eb0_A 238 GKPLFSGETSID--QLVRIIQ-IMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRI 314 (383)
T ss_dssp SSCSSCCSSHHH--HHHHHHH-HHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSC
T ss_pred CCCCCCCCChHH--HHHHHHH-HhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCC
Confidence 999997543221 1111111 1100 00000000000 0011122334688999999999999999
Q ss_pred CHHHHHHH
Q 002336 877 KMQEIVLA 884 (935)
Q Consensus 877 s~~ev~~~ 884 (935)
|+.|+++.
T Consensus 315 t~~e~l~h 322 (383)
T 3eb0_A 315 NPYEAMAH 322 (383)
T ss_dssp CHHHHHTS
T ss_pred CHHHHhcC
Confidence 99999853
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-35 Score=325.69 Aligned_cols=259 Identities=21% Similarity=0.281 Sum_probs=190.4
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcchhhhHHHHHHHHHHHhcCCCcccccceeee-------------
Q 002336 614 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCE------------- 679 (935)
Q Consensus 614 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~------------- 679 (935)
.|++.+.||+|+||.||+|... +++.||+|++........+.+.+|++++++++||||+++++++.
T Consensus 12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~ 91 (320)
T 2i6l_A 12 RYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSL 91 (320)
T ss_dssp TEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----C
T ss_pred ceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccccc
Confidence 3556789999999999999987 48999999987766666788999999999999999999998873
Q ss_pred -ccceEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCcccc-CCCcEEEe
Q 002336 680 -EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD-INMRAKVS 757 (935)
Q Consensus 680 -~~~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld-~~~~vkL~ 757 (935)
+....++||||++ |+|.+++. ...+++..+..++.|+++||+|||+ ++|+||||||+|||++ +++.+||+
T Consensus 92 ~~~~~~~lv~e~~~-~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~kl~ 163 (320)
T 2i6l_A 92 TELNSVYIVQEYME-TDLANVLE----QGPLLEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANLFINTEDLVLKIG 163 (320)
T ss_dssp CSCSEEEEEEECCS-EEHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTTEEEEC
T ss_pred cccCceeEEeeccC-CCHHHHhh----cCCccHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCeEEEc
Confidence 4467899999997 69999986 3568999999999999999999998 8999999999999997 56799999
Q ss_pred eccccccccccccc--eeecccCCccccCCCCCCC-CCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHh
Q 002336 758 DFGLSRQAEEDLTH--ISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSM 834 (935)
Q Consensus 758 DFGla~~~~~~~~~--~~~~~~gt~~y~APE~l~~-~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~ 834 (935)
|||+++........ ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||........ ...+...
T Consensus 164 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~---~~~~~~~ 240 (320)
T 2i6l_A 164 DFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQ---MQLILES 240 (320)
T ss_dssp CCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHHH
T ss_pred cCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHh
Confidence 99999876432211 1223457899999998754 6789999999999999999999999974432111 1111000
Q ss_pred hhc----------CCeeeccccccc-CC-----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 835 IKK----------GDVISIVDPVLI-GN-----VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 835 i~~----------~~~~~~~d~~l~-~~-----~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
... ......+..... .. ........+.+++.+||+.||++|||++|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 241 IPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp SCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred cCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 000 000000000000 00 00112346889999999999999999999976
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-35 Score=336.64 Aligned_cols=198 Identities=26% Similarity=0.328 Sum_probs=171.0
Q ss_pred HHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcchhhhHHHHHHHHHHHhc------CCCcccccceeeeccceEE
Q 002336 613 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRI------HHRNLVPLIGYCEEEHQRI 685 (935)
Q Consensus 613 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L------~HpnIv~l~g~~~~~~~~~ 685 (935)
..|++.+.||+|+||.||+|... +++.||||++... ....+.+.+|+++++.+ +|+||+++++++......+
T Consensus 97 ~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~ 175 (429)
T 3kvw_A 97 YRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHIC 175 (429)
T ss_dssp TTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEE
T ss_pred CcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEE
Confidence 34677899999999999999876 5899999999754 33446778899888887 5779999999999999999
Q ss_pred EEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCc--EEEeeccccc
Q 002336 686 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMR--AKVSDFGLSR 763 (935)
Q Consensus 686 lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~--vkL~DFGla~ 763 (935)
+||||+. ++|.+++... ....+++..+..++.||++||+|||+ ++|+||||||+|||++.++. +||+|||+++
T Consensus 176 lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~ 250 (429)
T 3kvw_A 176 MTFELLS-MNLYELIKKN-KFQGFSLPLVRKFAHSILQCLDALHK---NRIIHCDLKPENILLKQQGRSGIKVIDFGSSC 250 (429)
T ss_dssp EEECCCC-CBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHH---HTEECSCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred EEEeccC-CCHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEccCCCcceEEeecccce
Confidence 9999996 6999988754 23458999999999999999999998 89999999999999999887 9999999997
Q ss_pred cccccccceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccC
Q 002336 764 QAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 820 (935)
Q Consensus 764 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~ 820 (935)
..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 251 ~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~ 303 (429)
T 3kvw_A 251 YEHQR----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED 303 (429)
T ss_dssp ETTCC----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ecCCc----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence 65432 223468999999999998899999999999999999999999997544
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=332.06 Aligned_cols=200 Identities=25% Similarity=0.383 Sum_probs=154.0
Q ss_pred Hhh-cccccccccEEEEEEEEC---CCcEEEEEEccCcchhhhHHHHHHHHHHHhcCCCcccccceeee--ccceEEEEE
Q 002336 615 NNF-CKKIGKGSFGSVYYGKMK---DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCE--EEHQRILVY 688 (935)
Q Consensus 615 ~~~-~~~LG~G~fG~Vy~~~~~---~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~--~~~~~~lV~ 688 (935)
+++ .++||+|+||.||+|.++ +++.||||++.... ....+.+|+.+|++++||||+++++++. .....++||
T Consensus 22 y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~ 99 (405)
T 3rgf_A 22 FEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLF 99 (405)
T ss_dssp EECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEE
T ss_pred hhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEE
Confidence 344 568999999999999976 57899999987542 2356889999999999999999999994 477899999
Q ss_pred EecCCCCHHHHhccCC------CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccc----cCCCcEEEee
Q 002336 689 EYMHNGTLRDRLHGSV------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL----DINMRAKVSD 758 (935)
Q Consensus 689 E~~~~gsL~~~L~~~~------~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILl----d~~~~vkL~D 758 (935)
||++ ++|.+.+.... ....+++..++.++.||+.||+|||+ .+|+||||||+|||+ +.++.+||+|
T Consensus 100 e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kl~D 175 (405)
T 3rgf_A 100 DYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIAD 175 (405)
T ss_dssp ECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECCSSTTTTCEEECC
T ss_pred eCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCEeCCCcCHHHeEEecCCCCCCcEEEEE
Confidence 9996 57877765211 22358999999999999999999998 899999999999999 6789999999
Q ss_pred cccccccccccc--ceeecccCCccccCCCCCCC-CCCCchhHHHHHHHHHHHHHhCCCCCCccC
Q 002336 759 FGLSRQAEEDLT--HISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVED 820 (935)
Q Consensus 759 FGla~~~~~~~~--~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~ 820 (935)
||+++....... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus 176 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 240 (405)
T 3rgf_A 176 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 240 (405)
T ss_dssp TTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC
T ss_pred CCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcc
Confidence 999987654321 12234568999999998876 468999999999999999999999997443
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=335.93 Aligned_cols=255 Identities=21% Similarity=0.303 Sum_probs=180.5
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCc--chhhhHHHHHHHHHHHhcCCCcccccceeeecc------ceE
Q 002336 614 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE------HQR 684 (935)
Q Consensus 614 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~--~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~------~~~ 684 (935)
.|++.+.||+|+||.||+|... +|+.||||++... .....+.+.+|+++++.++||||+++++++... ...
T Consensus 30 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~ 109 (367)
T 2fst_X 30 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 109 (367)
T ss_dssp TEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCC
T ss_pred ceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeE
Confidence 4567789999999999999865 6899999998653 233457788999999999999999999998653 567
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccc
Q 002336 685 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 764 (935)
Q Consensus 685 ~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~ 764 (935)
++|+|++ +++|.+++.. ..+++..+..++.||++||+|||+ .+|+||||||+|||++.++.+||+|||+++.
T Consensus 110 ~lv~e~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kL~DFG~a~~ 181 (367)
T 2fst_X 110 YLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARH 181 (367)
T ss_dssp EEEEECC-CEECC---------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECC------
T ss_pred EEEeccc-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHhhEEECCCCCEEEeecccccc
Confidence 9999999 7899888863 569999999999999999999998 8999999999999999999999999999986
Q ss_pred ccccccceeecccCCccccCCCCCCC-CCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeec
Q 002336 765 AEEDLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISI 843 (935)
Q Consensus 765 ~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~ 843 (935)
.... .....||+.|+|||++.+ ..++.++||||+||+++||++|+.||.+.+..+. ...+.+.+... ..+.
T Consensus 182 ~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~---l~~i~~~~g~p-~~~~ 253 (367)
T 2fst_X 182 TADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ---LKLILRLVGTP-GAEL 253 (367)
T ss_dssp -------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCSC-CHHH
T ss_pred cccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhCCC-CHHH
Confidence 5432 223468999999998876 6889999999999999999999999975433211 11111111100 0000
Q ss_pred ccc-----------ccc--CCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002336 844 VDP-----------VLI--GNVK-----IESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 884 (935)
Q Consensus 844 ~d~-----------~l~--~~~~-----~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~ 884 (935)
+.. .+. ...+ ......+.+++.+||+.||++|||++|+++.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 254 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp HTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 000 000 0000 0112367899999999999999999999864
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=319.69 Aligned_cols=250 Identities=22% Similarity=0.316 Sum_probs=193.6
Q ss_pred HHHhhcccccccccEEEEEEEECCCcEEEEEEccCc--chhhhHHHHHHHHHHHhcC--CCcccccceeeeccceEEEEE
Q 002336 613 ATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADS--CSHRTQQFVTEVALLSRIH--HRNLVPLIGYCEEEHQRILVY 688 (935)
Q Consensus 613 ~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~~~~~--~~~~~~~~~~E~~iL~~L~--HpnIv~l~g~~~~~~~~~lV~ 688 (935)
..|++.+.||+|+||.||++...+++.||+|++... .....+.+.+|++++++++ ||||+++++++...+..++||
T Consensus 28 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 107 (313)
T 3cek_A 28 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 107 (313)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEE
T ss_pred ceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEEE
Confidence 346678899999999999999988999999998643 2344578999999999997 599999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccccc
Q 002336 689 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 768 (935)
Q Consensus 689 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~ 768 (935)
| +.+++|.+++.. ...+++..++.++.|+++||.|||+ ++|+||||||+|||+++ +.+||+|||+++.....
T Consensus 108 e-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~ 179 (313)
T 3cek_A 108 E-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPD 179 (313)
T ss_dssp C-CCSEEHHHHHHH---CSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEET-TEEEECCCSSSCC----
T ss_pred e-cCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEEEC-CeEEEeeccccccccCc
Confidence 9 668899999984 4578999999999999999999998 89999999999999964 89999999999876443
Q ss_pred ccc-eeecccCCccccCCCCCCC-----------CCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhh
Q 002336 769 LTH-ISSVARGTVGYLDPEYYGN-----------QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIK 836 (935)
Q Consensus 769 ~~~-~~~~~~gt~~y~APE~l~~-----------~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~ 836 (935)
... ......|++.|+|||.+.+ ..++.++||||||+++|||++|+.||..... ........+.
T Consensus 180 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-----~~~~~~~~~~ 254 (313)
T 3cek_A 180 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-----QISKLHAIID 254 (313)
T ss_dssp ----------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCS-----HHHHHHHHHC
T ss_pred cccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHH-----HHHHHHHHHh
Confidence 221 1233468999999998765 4788999999999999999999999973221 1111222222
Q ss_pred cCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002336 837 KGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 884 (935)
Q Consensus 837 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~ 884 (935)
.... ...+......+.+++.+||+.+|++||+++|+++.
T Consensus 255 ~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 255 PNHE---------IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp TTSC---------CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccc---------cCCcccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 1111 11111112468899999999999999999999863
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-35 Score=338.92 Aligned_cols=259 Identities=24% Similarity=0.264 Sum_probs=191.3
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcchhhhHHHHHHHHHHHhcCCCcccccceeeecc------ceEEE
Q 002336 614 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE------HQRIL 686 (935)
Q Consensus 614 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~------~~~~l 686 (935)
.|++.+.||+|+||.||+|++. +|+.||||++.... ..+.+|+++|+.++||||+++++++... ...++
T Consensus 55 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~l 130 (420)
T 1j1b_A 55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 130 (420)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEE
T ss_pred eEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEe
Confidence 3566789999999999999986 58999999986532 2345799999999999999999988432 23679
Q ss_pred EEEecCCCCHHHHhccC-CCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCC-CcEEEeecccccc
Q 002336 687 VYEYMHNGTLRDRLHGS-VNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN-MRAKVSDFGLSRQ 764 (935)
Q Consensus 687 V~E~~~~gsL~~~L~~~-~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~-~~vkL~DFGla~~ 764 (935)
||||+++ +|.+.+... .....+++..+..++.||++||+|||+ ++|+||||||+|||++.+ +.+||+|||+++.
T Consensus 131 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~ 206 (420)
T 1j1b_A 131 VLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 206 (420)
T ss_dssp EEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred ehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChhhEEEeCCCCeEEeccchhhhh
Confidence 9999975 565554321 135679999999999999999999998 899999999999999965 6689999999987
Q ss_pred ccccccceeecccCCccccCCCCCCCC-CCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHh-------hh
Q 002336 765 AEEDLTHISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSM-------IK 836 (935)
Q Consensus 765 ~~~~~~~~~~~~~gt~~y~APE~l~~~-~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~-------i~ 836 (935)
...... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||...... ..+.+.++.. +.
T Consensus 207 ~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~--~~l~~i~~~lg~p~~~~~~ 282 (420)
T 1j1b_A 207 LVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV--DQLVEIIKVLGTPTREQIR 282 (420)
T ss_dssp CCTTCC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHHHCSCCHHHHH
T ss_pred cccCCC--ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCCCCHHHHH
Confidence 543322 2234689999999988654 7899999999999999999999999754321 1222222110 00
Q ss_pred --cCCeeecccccccC-----CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002336 837 --KGDVISIVDPVLIG-----NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 884 (935)
Q Consensus 837 --~~~~~~~~d~~l~~-----~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~ 884 (935)
.....+..-+.+.. .++......+.+++.+||+.||++||++.|+++.
T Consensus 283 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h 337 (420)
T 1j1b_A 283 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 337 (420)
T ss_dssp HHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence 00111111111100 0111223468899999999999999999999863
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-35 Score=330.73 Aligned_cols=262 Identities=19% Similarity=0.252 Sum_probs=184.5
Q ss_pred HHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcchhhhHHHHHHHHHHHhcCCCcccccceeeeccce-------E
Q 002336 613 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQ-------R 684 (935)
Q Consensus 613 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~-------~ 684 (935)
..|++.+.||+|+||.||+|.+. +|+.||||++... ......+.+|++.++.++||||+++++++..... .
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~ 101 (360)
T 3e3p_A 23 DRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQD-PRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYL 101 (360)
T ss_dssp TTEEEC----------CEEEEETTTCCEEEEEEEECC-TTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEE
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecC-ccccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeE
Confidence 34566889999999999999985 6899999988653 2334567788888999999999999999865333 7
Q ss_pred EEEEEecCCCCHHHHhcc-CCCCCCCCHHHHHHHHHHHHHHhHHhh--hcCCCceEecCCCCCCccccC-CCcEEEeecc
Q 002336 685 ILVYEYMHNGTLRDRLHG-SVNQKPLDWLTRLQIAHDAAKGLEYLH--TGCNPGIIHRDVKSSNILLDI-NMRAKVSDFG 760 (935)
Q Consensus 685 ~lV~E~~~~gsL~~~L~~-~~~~~~l~~~~~~~i~~qia~gL~yLH--s~~~~~ivH~DLkp~NILld~-~~~vkL~DFG 760 (935)
++||||+++ +|.+.+.. ......+++..+..++.|++.||.||| + ++|+||||||+|||++. ++.+||+|||
T Consensus 102 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~ivH~Dlkp~NIll~~~~~~~kl~Dfg 177 (360)
T 3e3p_A 102 NVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPS---VNVCHRDIKPHNVLVNEADGTLKLCDFG 177 (360)
T ss_dssp EEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTT---TCCBCSCCCGGGEEEETTTTEEEECCCT
T ss_pred EEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCC---CCeecCcCCHHHEEEeCCCCcEEEeeCC
Confidence 899999986 44443321 224567899999999999999999999 7 89999999999999996 8999999999
Q ss_pred ccccccccccceeecccCCccccCCCCCCCC-CCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcC-
Q 002336 761 LSRQAEEDLTHISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG- 838 (935)
Q Consensus 761 la~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~- 838 (935)
+++....... .....||+.|+|||++.+. .++.++||||||+++|||++|+.||....... .+....+ .....
T Consensus 178 ~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~--~~~~~~~-~~~~~~ 252 (360)
T 3e3p_A 178 SAKKLSPSEP--NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAG--QLHEIVR-VLGCPS 252 (360)
T ss_dssp TCBCCCTTSC--CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHH-HHCCCC
T ss_pred CceecCCCCC--cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHH--HHHHHHH-HcCCCC
Confidence 9987654332 2234589999999988654 58999999999999999999999997543221 1111111 11000
Q ss_pred -----------Ceeeccc------ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002336 839 -----------DVISIVD------PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 884 (935)
Q Consensus 839 -----------~~~~~~d------~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~ 884 (935)
......+ ..............+.+++.+||+.||++|||++|+++.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 315 (360)
T 3e3p_A 253 REVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315 (360)
T ss_dssp HHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 0000000 000011112234578999999999999999999999763
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-35 Score=327.83 Aligned_cols=258 Identities=21% Similarity=0.249 Sum_probs=194.9
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc-hhhhHHHHHHHHHHHhcCCCcccccceeeecc-----ceEEE
Q 002336 614 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE-----HQRIL 686 (935)
Q Consensus 614 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~-~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~-----~~~~l 686 (935)
.|++.+.||+|+||.||+|.+. +|+.||||++.... ......+.+|++++++++||||+++++++... ...++
T Consensus 12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 91 (353)
T 2b9h_A 12 DFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYI 91 (353)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEE
T ss_pred ceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEE
Confidence 3556789999999999999986 68999999986543 23456788999999999999999999987654 67899
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccc
Q 002336 687 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 766 (935)
Q Consensus 687 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~ 766 (935)
||||+. ++|.+++.. ..+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 92 v~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 163 (353)
T 2b9h_A 92 IQELMQ-TDLHRVIST----QMLSDDHIQYFIYQTLRAVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLARIID 163 (353)
T ss_dssp EECCCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEeccC-ccHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEcCCCcEEEEecccccccc
Confidence 999997 689998873 468999999999999999999998 899999999999999999999999999998764
Q ss_pred ccccc---------eeecccCCccccCCCCCC-CCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhh
Q 002336 767 EDLTH---------ISSVARGTVGYLDPEYYG-NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIK 836 (935)
Q Consensus 767 ~~~~~---------~~~~~~gt~~y~APE~l~-~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~ 836 (935)
..... ......||+.|+|||++. +..++.++||||||+++|+|++|+.||...+..... ..+.....
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~---~~~~~~~~ 240 (353)
T 2b9h_A 164 ESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQL---LLIFGIIG 240 (353)
T ss_dssp ----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHHHHC
T ss_pred cccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHH---HHHHHHhC
Confidence 32211 112245899999999764 478899999999999999999999999754322111 11111110
Q ss_pred cCCeee------------cc-------cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 837 KGDVIS------------IV-------DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 837 ~~~~~~------------~~-------d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
...... .+ ...+. .........+.+++.+||+.||++|||++|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (353)
T 2b9h_A 241 TPHSDNDLRCIESPRAREYIKSLPMYPAAPLE-KMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305 (353)
T ss_dssp CCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHH-HHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCchhccccccccchhhHHhhcccCCCCcchh-hhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 000000 00 00000 000122346789999999999999999999976
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-34 Score=324.14 Aligned_cols=199 Identities=28% Similarity=0.319 Sum_probs=169.0
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcchhhhHHHHHHHHHHHhcC-CC-----cccccceeeeccceEEE
Q 002336 614 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIH-HR-----NLVPLIGYCEEEHQRIL 686 (935)
Q Consensus 614 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~-Hp-----nIv~l~g~~~~~~~~~l 686 (935)
.|++.+.||+|+||.||+|... +++.||||+++.. ......+..|+.+++.++ |+ +|+++++++...+..++
T Consensus 55 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~l 133 (382)
T 2vx3_A 55 RYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCL 133 (382)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEEE
T ss_pred eEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceEE
Confidence 4667889999999999999876 6889999998753 334567788999998885 55 48999999999999999
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCcccc--CCCcEEEeecccccc
Q 002336 687 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD--INMRAKVSDFGLSRQ 764 (935)
Q Consensus 687 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld--~~~~vkL~DFGla~~ 764 (935)
||||+. ++|.+++... ....+++..+..++.|++.||.|||+. +.+|+||||||+|||++ .++.+||+|||+++.
T Consensus 134 v~e~~~-~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~ 210 (382)
T 2vx3_A 134 VFEMLS-YNLYDLLRNT-NFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ 210 (382)
T ss_dssp EEECCC-CBHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTTCEE
T ss_pred EEecCC-CCHHHHHhhc-CcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccCcee
Confidence 999996 5999998754 235689999999999999999999941 37999999999999994 578899999999987
Q ss_pred ccccccceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccC
Q 002336 765 AEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 820 (935)
Q Consensus 765 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~ 820 (935)
..... ....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 211 ~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~ 262 (382)
T 2vx3_A 211 LGQRI----YQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN 262 (382)
T ss_dssp TTCCC----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ccccc----ccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 64432 23468999999999999899999999999999999999999998543
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-34 Score=325.39 Aligned_cols=254 Identities=21% Similarity=0.298 Sum_probs=192.8
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc--hhhhHHHHHHHHHHHhcCCCcccccceeeeccceE------
Q 002336 614 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQR------ 684 (935)
Q Consensus 614 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~------ 684 (935)
.|.+.+.||+|+||.||+|.+. +|+.||||++.... ....+.+.+|+.+++.++||||+++++++...+..
T Consensus 43 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 122 (371)
T 4exu_A 43 TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDF 122 (371)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCC
T ss_pred cEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeE
Confidence 4566789999999999999876 68999999987542 23357789999999999999999999999876654
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccc
Q 002336 685 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 764 (935)
Q Consensus 685 ~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~ 764 (935)
++||||+. ++|.+.+. ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.
T Consensus 123 ~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~ 193 (371)
T 4exu_A 123 YLVMPFMQ-TDLQKIMG-----MEFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLARH 193 (371)
T ss_dssp EEEEECCC-EEHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECSTTCC--
T ss_pred EEEEcccc-ccHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCcCHHHeEECCCCCEEEEecCcccc
Confidence 99999997 68888874 348999999999999999999998 8999999999999999999999999999986
Q ss_pred ccccccceeecccCCccccCCCCCCC-CCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeec
Q 002336 765 AEEDLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISI 843 (935)
Q Consensus 765 ~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~ 843 (935)
.... .....||+.|+|||.+.+ ..++.++||||||+++|+|++|+.||...+..+. ...+....... ..+.
T Consensus 194 ~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~~i~~~~~~~-~~~~ 265 (371)
T 4exu_A 194 ADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ---LTQILKVTGVP-GTEF 265 (371)
T ss_dssp ----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCCC-CHHH
T ss_pred cccC----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHhCCC-cHHH
Confidence 5432 223468999999998876 7889999999999999999999999975432211 11111100000 0000
Q ss_pred c---------------cccccC---CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002336 844 V---------------DPVLIG---NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 884 (935)
Q Consensus 844 ~---------------d~~l~~---~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~ 884 (935)
. ...... .........+.+++.+||+.||++|||++|+++.
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 266 VQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp HTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 0 000000 0001123468899999999999999999999764
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=322.06 Aligned_cols=252 Identities=26% Similarity=0.342 Sum_probs=175.8
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCcch-hhhHHHHHHHH-HHHhcCCCcccccceeeeccceEEEEEEec
Q 002336 615 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS-HRTQQFVTEVA-LLSRIHHRNLVPLIGYCEEEHQRILVYEYM 691 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~-~~~~~~~~E~~-iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~ 691 (935)
+++.+.||+|+||.||+|... +|+.||||++..... ....++..|+. +++.++||||+++++++...+..++||||+
T Consensus 24 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~~ 103 (327)
T 3aln_A 24 LKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELM 103 (327)
T ss_dssp EEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred hhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEeec
Confidence 456789999999999999986 789999999876432 33445666666 677789999999999999999999999999
Q ss_pred CCCCHHHHhccC--CCCCCCCHHHHHHHHHHHHHHhHHhhhcCCC-ceEecCCCCCCccccCCCcEEEeecccccccccc
Q 002336 692 HNGTLRDRLHGS--VNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP-GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 768 (935)
Q Consensus 692 ~~gsL~~~L~~~--~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~-~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~ 768 (935)
++ +|.+++... .....+++..+.+++.|+++||.|||+ . +|+||||||+|||++.++.+||+|||+++.....
T Consensus 104 ~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 179 (327)
T 3aln_A 104 ST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE---NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDS 179 (327)
T ss_dssp SE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHH---HHSCCCSCCCGGGEEEETTTEEEECCCSSSCC----
T ss_pred CC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhc---cCCEeECCCCHHHEEEcCCCCEEEccCCCceecccc
Confidence 75 787776521 124678999999999999999999998 6 9999999999999999999999999999876443
Q ss_pred ccceeecccCCccccCCCCC----CCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecc
Q 002336 769 LTHISSVARGTVGYLDPEYY----GNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 844 (935)
Q Consensus 769 ~~~~~~~~~gt~~y~APE~l----~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~ 844 (935)
.. .....|++.|+|||.+ .+..++.++||||||+++|+|++|+.||...... .+.... +..+..
T Consensus 180 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~~~~~~-~~~~~~---- 247 (327)
T 3aln_A 180 IA--KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSV-----FDQLTQ-VVKGDP---- 247 (327)
T ss_dssp ----------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC------------CC-CCCSCC----
T ss_pred cc--cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchH-----HHHHHH-HhcCCC----
Confidence 22 2223589999999998 4567899999999999999999999999732211 000100 111111
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 845 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 845 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
+.+...........+.+++.+||+.||++||++.|+++
T Consensus 248 -~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 248 -PQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp -CCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred -CCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 11111111122346889999999999999999999976
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-34 Score=324.20 Aligned_cols=259 Identities=20% Similarity=0.264 Sum_probs=197.8
Q ss_pred HHHHhhcccccccccEEEEEEEEC-CC-cEEEEEEccCcchhhhHHHHHHHHHHHhcCCCc------ccccceeeeccce
Q 002336 612 EATNNFCKKIGKGSFGSVYYGKMK-DG-KEVAVKIMADSCSHRTQQFVTEVALLSRIHHRN------LVPLIGYCEEEHQ 683 (935)
Q Consensus 612 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g-~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~Hpn------Iv~l~g~~~~~~~ 683 (935)
...|++.+.||+|+||.||+|... ++ +.||+|+++.. ....+.+.+|+.++++++|++ ++.+++++...+.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 96 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH 96 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence 345777899999999999999875 34 68999998754 344567888999999997665 8889999999999
Q ss_pred EEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccc---------------
Q 002336 684 RILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL--------------- 748 (935)
Q Consensus 684 ~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILl--------------- 748 (935)
.++||||+ +++|.+.+... ....+++.+++.++.|+++||+|||+ ++|+||||||+|||+
T Consensus 97 ~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~ 171 (355)
T 2eu9_A 97 MCIAFELL-GKNTFEFLKEN-NFQPYPLPHVRHMAYQLCHALRFLHE---NQLTHTDLKPENILFVNSEFETLYNEHKSC 171 (355)
T ss_dssp EEEEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred EEEEEecc-CCChHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEecccccccccccccc
Confidence 99999999 66777766543 23568999999999999999999998 899999999999999
Q ss_pred ----cCCCcEEEeeccccccccccccceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccc
Q 002336 749 ----DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAE 824 (935)
Q Consensus 749 ----d~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~ 824 (935)
+.++.+||+|||+++...... ....||+.|+|||++.+..++.++||||||+++|||++|+.||........
T Consensus 172 ~~~~~~~~~~kl~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~ 247 (355)
T 2eu9_A 172 EEKSVKNTSIRVADFGSATFDHEHH----TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREH 247 (355)
T ss_dssp CEEEESCCCEEECCCTTCEETTSCC----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred cccccCCCcEEEeecCccccccccc----cCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 567899999999998654322 234689999999999998999999999999999999999999974432211
Q ss_pred hhHHHHHHHhhhc--------CCeeecc-c-------------------cccc--CCCCHHHHHHHHHHHHHccccCCCC
Q 002336 825 LNIVHWARSMIKK--------GDVISIV-D-------------------PVLI--GNVKIESIWRIAEVAIQCVEQRGFS 874 (935)
Q Consensus 825 ~~l~~~~~~~i~~--------~~~~~~~-d-------------------~~l~--~~~~~~~~~~l~~li~~Cl~~dP~~ 874 (935)
. ..+...... ....... . +.+. ..........+.+++.+||+.||++
T Consensus 248 ~---~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~ 324 (355)
T 2eu9_A 248 L---VMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQ 324 (355)
T ss_dssp H---HHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred H---HHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhh
Confidence 1 111111100 0000000 0 0000 0112233457889999999999999
Q ss_pred CCCHHHHHH
Q 002336 875 RPKMQEIVL 883 (935)
Q Consensus 875 RPs~~ev~~ 883 (935)
|||++|+++
T Consensus 325 Rpt~~e~l~ 333 (355)
T 2eu9_A 325 RITLAEALL 333 (355)
T ss_dssp SCCHHHHTT
T ss_pred CcCHHHHhc
Confidence 999999974
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-34 Score=311.88 Aligned_cols=253 Identities=26% Similarity=0.350 Sum_probs=201.4
Q ss_pred hHHHHHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc--hhhhHHHHHHHHHHHhcCCCcccccceeeeccceEE
Q 002336 609 ELEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRI 685 (935)
Q Consensus 609 ~l~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~ 685 (935)
......|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++......+
T Consensus 18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 97 (287)
T 2wei_A 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY 97 (287)
T ss_dssp HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEE
Confidence 334567788999999999999999986 68999999986532 234567899999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCC---CcEEEeecccc
Q 002336 686 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN---MRAKVSDFGLS 762 (935)
Q Consensus 686 lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~---~~vkL~DFGla 762 (935)
+||||+++++|.+.+.. ...+++..++.++.|+++||.|||+ ++++||||||+||+++.+ +.+||+|||++
T Consensus 98 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~ 171 (287)
T 2wei_A 98 IVGELYTGGELFDEIIK---RKRFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLS 171 (287)
T ss_dssp EEECCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEECSTTGG
T ss_pred EEEEccCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChhhEEEecCCCcccEEEeccCcc
Confidence 99999999999998863 3468999999999999999999998 899999999999999754 46999999998
Q ss_pred ccccccccceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeee
Q 002336 763 RQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVIS 842 (935)
Q Consensus 763 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~ 842 (935)
........ .....|++.|+|||.+.+. ++.++||||||+++|+|++|+.||...... .. . ..+..+....
T Consensus 172 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~---~-~~~~~~~~~~ 241 (287)
T 2wei_A 172 TCFQQNTK--MKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEY---DI---L-KRVETGKYAF 241 (287)
T ss_dssp GTBCCCSS--CSCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HH---H-HHHHHCCCCC
T ss_pred eeecCCCc--cccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCCHH---HH---H-HHHHcCCCCC
Confidence 86544322 1223478899999988764 899999999999999999999999743221 11 1 1222222111
Q ss_pred cccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 843 IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 843 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
.. ..... ....+.+++.+||+.+|++|||++|+++
T Consensus 242 ~~--~~~~~----~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 242 DL--PQWRT----ISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp CS--GGGTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred Cc--hhhhh----cCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 00 00011 1236889999999999999999999987
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-34 Score=324.85 Aligned_cols=253 Identities=21% Similarity=0.294 Sum_probs=192.1
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc--hhhhHHHHHHHHHHHhcCCCcccccceeeeccce------EE
Q 002336 615 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQ------RI 685 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~------~~ 685 (935)
|.+.+.||+|+||.||+|.+. +|+.||||++.... ....+.+.+|+.+++.++||||+++++++..... .+
T Consensus 26 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 105 (353)
T 3coi_A 26 YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFY 105 (353)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCE
T ss_pred EEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeEE
Confidence 556789999999999999875 68999999986532 2335678999999999999999999999977653 49
Q ss_pred EEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccc
Q 002336 686 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 765 (935)
Q Consensus 686 lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~ 765 (935)
+||||++ ++|.+.+. ..+++..+..++.|+++||+|||+ ++|+||||||+|||++.++.+||+|||+++..
T Consensus 106 lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 176 (353)
T 3coi_A 106 LVMPFMQ-TDLQKIMG-----LKFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLARHA 176 (353)
T ss_dssp EEEECCS-EEGGGTTT-----SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTCCEEECSTTCTTC-
T ss_pred EEecccc-CCHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEeECCCCcEEEeecccccCC
Confidence 9999997 68887764 348999999999999999999998 89999999999999999999999999999865
Q ss_pred cccccceeecccCCccccCCCCCCC-CCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcC------
Q 002336 766 EEDLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG------ 838 (935)
Q Consensus 766 ~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~------ 838 (935)
... .....+|+.|+|||.+.+ ..++.++||||||+++|+|++|+.||...+..+. ...+.......
T Consensus 177 ~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~---~~~i~~~~~~~~~~~~~ 249 (353)
T 3coi_A 177 DAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ---LTQILKVTGVPGTEFVQ 249 (353)
T ss_dssp -----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHH---HHHHHHHHCBCCHHHHT
T ss_pred CCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhCCCCHHHHH
Confidence 432 223458999999998876 6789999999999999999999999975432211 11111110000
Q ss_pred ------------CeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002336 839 ------------DVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 884 (935)
Q Consensus 839 ------------~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~ 884 (935)
.......+.+ ..........+.+++.+||+.||++|||++|+++.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 250 KLNDKAAKSYIQSLPQTPRKDF-TQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp TCSCHHHHHHHHTSCBCSSCCT-TTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHhhHHHHHHHHhCcCCCCccH-HHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0000000000 01112233478899999999999999999999753
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-34 Score=318.09 Aligned_cols=249 Identities=20% Similarity=0.273 Sum_probs=169.4
Q ss_pred Hhh-cccccccccEEEEEEEEC-CCcEEEEEEccCcchhhhHHHHHHHHHHHhcCCCcccccceeeec----cceEEEEE
Q 002336 615 NNF-CKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEE----EHQRILVY 688 (935)
Q Consensus 615 ~~~-~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~----~~~~~lV~ 688 (935)
|.+ .+.||+|+||.||+|.+. +|+.||||++.... ....+....++.++||||+++++++.. ....++||
T Consensus 30 y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~ 105 (336)
T 3fhr_A 30 YQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIM 105 (336)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred eEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEE
Confidence 455 346999999999999887 68999999986532 112223334566799999999999865 45589999
Q ss_pred EecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccC---CCcEEEeeccccccc
Q 002336 689 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI---NMRAKVSDFGLSRQA 765 (935)
Q Consensus 689 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~---~~~vkL~DFGla~~~ 765 (935)
||+++|+|.+++... ....+++.+++.++.|+++||+|||+ ++|+||||||+|||++. ++.+||+|||+++..
T Consensus 106 e~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~ql~~~l~~LH~---~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~ 181 (336)
T 3fhr_A 106 ECMEGGELFSRIQER-GDQAFTEREAAEIMRDIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET 181 (336)
T ss_dssp ECCTTEEHHHHHHTC--CCCCBHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred eccCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEEecCCCceEEEeccccceec
Confidence 999999999999854 33579999999999999999999998 89999999999999976 455999999999865
Q ss_pred cccccceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeeccc
Q 002336 766 EEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 845 (935)
Q Consensus 766 ~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d 845 (935)
.... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||........ .......+..+..
T Consensus 182 ~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~~~~~~~~~~~~----- 250 (336)
T 3fhr_A 182 TQNA---LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAI---SPGMKRRIRLGQY----- 250 (336)
T ss_dssp -------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-----------------------------
T ss_pred cccc---cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhh---hhhHHHhhhcccc-----
Confidence 4322 2234579999999999888999999999999999999999999973322111 0000111111100
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 846 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 846 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
.............+.+++.+||+.||++|||++|+++
T Consensus 251 -~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 287 (336)
T 3fhr_A 251 -GFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN 287 (336)
T ss_dssp -CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred -ccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0000001122346889999999999999999999987
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=320.46 Aligned_cols=243 Identities=26% Similarity=0.422 Sum_probs=189.6
Q ss_pred hHHHHHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcch------hhhHHHHHHHHHHHhc----CCCccccccee
Q 002336 609 ELEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS------HRTQQFVTEVALLSRI----HHRNLVPLIGY 677 (935)
Q Consensus 609 ~l~~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~------~~~~~~~~E~~iL~~L----~HpnIv~l~g~ 677 (935)
+.....|++.+.||+|+||.||+|.+. +++.||||++..... .....+.+|+.++.++ +||||++++++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~ 106 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW 106 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence 344566788999999999999999875 689999999865432 1234567899999998 89999999999
Q ss_pred eeccceEEEEEEe-cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCcccc-CCCcEE
Q 002336 678 CEEEHQRILVYEY-MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD-INMRAK 755 (935)
Q Consensus 678 ~~~~~~~~lV~E~-~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld-~~~~vk 755 (935)
+...+..++|||+ +.+++|.+++.. ...+++..++.++.|+++||+|||+ .+|+||||||+||+++ .++.+|
T Consensus 107 ~~~~~~~~~v~e~~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~k 180 (312)
T 2iwi_A 107 FETQEGFMLVLERPLPAQDLFDYITE---KGPLGEGPSRCFFGQVVAAIQHCHS---RGVVHRDIKDENILIDLRRGCAK 180 (312)
T ss_dssp C-----CEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHH---HTEECCCCSGGGEEEETTTTEEE
T ss_pred EecCCeEEEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChhhEEEeCCCCeEE
Confidence 9999999999999 789999999974 4568999999999999999999998 8999999999999999 889999
Q ss_pred EeeccccccccccccceeecccCCccccCCCCCCCCCC-CchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHh
Q 002336 756 VSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQL-TEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSM 834 (935)
Q Consensus 756 L~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~-s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~ 834 (935)
|+|||++....... .....|+..|+|||++.+..+ +.++||||||+++|||++|+.||.... + .
T Consensus 181 l~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--------~----~ 245 (312)
T 2iwi_A 181 LIDFGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ--------E----I 245 (312)
T ss_dssp ECCCSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--------H----H
T ss_pred EEEcchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH--------H----H
Confidence 99999998765432 223458999999998876555 459999999999999999999997211 0 0
Q ss_pred hhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 835 IKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 835 i~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
.. ... .+ +......+.+++.+||+.+|++||+++|+++
T Consensus 246 ~~-~~~------~~----~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 246 LE-AEL------HF----PAHVSPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp HH-TCC------CC----CTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred hh-hcc------CC----cccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11 100 11 1122236789999999999999999999986
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-34 Score=330.18 Aligned_cols=247 Identities=24% Similarity=0.346 Sum_probs=184.3
Q ss_pred cccccccccEEEEEEEECCCcEEEEEEccCcchhhhHHHHHHHHHHHhc-CCCcccccceeeeccceEEEEEEecCCCCH
Q 002336 618 CKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEYMHNGTL 696 (935)
Q Consensus 618 ~~~LG~G~fG~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L-~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL 696 (935)
.+.||+|+||+||.+...+|+.||||++... ..+.+.+|+++++++ +||||+++++++.+++..++||||+. |+|
T Consensus 20 ~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-gsL 95 (434)
T 2rio_A 20 EKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNL 95 (434)
T ss_dssp EEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-EEH
T ss_pred cCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-CCH
Confidence 5789999999998776677999999998643 235678899999887 89999999999999999999999995 699
Q ss_pred HHHhccCCCCC----CCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCC-------------CcEEEeec
Q 002336 697 RDRLHGSVNQK----PLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN-------------MRAKVSDF 759 (935)
Q Consensus 697 ~~~L~~~~~~~----~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~-------------~~vkL~DF 759 (935)
.+++....... ...+..++.++.||+.||+|||+ ++|+||||||+|||++.+ +.+||+||
T Consensus 96 ~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DF 172 (434)
T 2rio_A 96 QDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDF 172 (434)
T ss_dssp HHHHHTC------------CCHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCC
T ss_pred HHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCcccccccccCCCceEEEEccc
Confidence 99997542111 11333467899999999999998 899999999999999754 48999999
Q ss_pred cccccccccccc---eeecccCCccccCCCCCCC-------CCCCchhHHHHHHHHHHHHHh-CCCCCCccCcccchhHH
Q 002336 760 GLSRQAEEDLTH---ISSVARGTVGYLDPEYYGN-------QQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIV 828 (935)
Q Consensus 760 Gla~~~~~~~~~---~~~~~~gt~~y~APE~l~~-------~~~s~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~ 828 (935)
|+++........ ......||+.|+|||++.+ ..++.++|||||||++|||++ |+.||...... . .
T Consensus 173 G~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~-~---~ 248 (434)
T 2rio_A 173 GLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR-E---S 248 (434)
T ss_dssp TTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTH-H---H
T ss_pred ccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhh-H---H
Confidence 999876543221 1223469999999998865 678999999999999999999 99999632211 1 1
Q ss_pred HHHHHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 829 HWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 829 ~~~~~~i~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
........ . +......+......+.+++.+||+.||++|||+.||++
T Consensus 249 ~i~~~~~~---~-----~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 249 NIIRGIFS---L-----DEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp HHHHTCCC---C-----CCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHhcCCCC---c-----ccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 11111110 0 11111123445568899999999999999999999986
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-34 Score=343.03 Aligned_cols=268 Identities=22% Similarity=0.314 Sum_probs=204.5
Q ss_pred HHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCc-chhhhHHHHHHHHHHHhcCCCcccccceeeec------cceE
Q 002336 613 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS-CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEE------EHQR 684 (935)
Q Consensus 613 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~-~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~------~~~~ 684 (935)
..|++.+.||+|+||.||+|.+. +|+.||||++... .....+.+.+|++++++++||||+++++++.. .+..
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~ 93 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP 93 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence 45788999999999999999875 6899999998764 33445779999999999999999999998765 6678
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCc---EEEeeccc
Q 002336 685 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMR---AKVSDFGL 761 (935)
Q Consensus 685 ~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~---vkL~DFGl 761 (935)
++||||+++|+|.+++........+++..++.++.|++.||+|||+ .+|+||||||+||+++.++. +||+|||+
T Consensus 94 ~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs---~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~ 170 (676)
T 3qa8_A 94 LLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGY 170 (676)
T ss_dssp CCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHH---TTBCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred EEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEeecCCCceeEEEccccc
Confidence 9999999999999999865555579999999999999999999998 89999999999999997665 99999999
Q ss_pred cccccccccceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCee
Q 002336 762 SRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVI 841 (935)
Q Consensus 762 a~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~ 841 (935)
+........ .....|++.|+|||.+.+..++.++||||||+++|+|++|+.||..... ...|.......+...
T Consensus 171 a~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~-----~~~~~~~i~~~~~~~ 243 (676)
T 3qa8_A 171 AKELDQGEL--CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQ-----PVQWHGKVREKSNEH 243 (676)
T ss_dssp CCBTTSCCC--CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCH-----HHHSSTTCC------
T ss_pred ccccccccc--cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccc-----hhhhhhhhhcccchh
Confidence 987654322 2335689999999999999999999999999999999999999973221 122211111111111
Q ss_pred ecccc------------cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHH-----HHHHHhhhhh
Q 002336 842 SIVDP------------VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQE-----IVLAIQDSIK 890 (935)
Q Consensus 842 ~~~d~------------~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~e-----v~~~L~~~~~ 890 (935)
..... .............+.+++.+||..||++|||++| ..+.+++++.
T Consensus 244 ~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~ 309 (676)
T 3qa8_A 244 IVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILS 309 (676)
T ss_dssp CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHC
T ss_pred hhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHh
Confidence 11110 0111233446678999999999999999999987 4455555444
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-33 Score=312.94 Aligned_cols=249 Identities=24% Similarity=0.341 Sum_probs=177.6
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcchh-h-hHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEe
Q 002336 614 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSH-R-TQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 690 (935)
Q Consensus 614 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~~-~-~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~ 690 (935)
.+++.+.||+|+||.||+|.+. +|+.||||++...... . .+.+.++..+++.++||||+++++++.+.+..++||||
T Consensus 26 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e~ 105 (318)
T 2dyl_A 26 DLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMEL 105 (318)
T ss_dssp GEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECC
T ss_pred cccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEec
Confidence 3566789999999999999986 6899999998754322 2 23445555678888999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCC-ceEecCCCCCCccccCCCcEEEeeccccccccccc
Q 002336 691 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP-GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 769 (935)
Q Consensus 691 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~-~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~ 769 (935)
+ ++.+..+... ....+++..+..++.|+++||.|||+ + +|+||||||+||+++.++.+||+|||++.......
T Consensus 106 ~-~~~~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 179 (318)
T 2dyl_A 106 M-GTCAEKLKKR--MQGPIPERILGKMTVAIVKALYYLKE---KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK 179 (318)
T ss_dssp C-SEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHH---HHCCCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred c-CCcHHHHHHH--hccCCCHHHHHHHHHHHHHHHHHHHh---hCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCc
Confidence 9 5566555542 24568999999999999999999997 5 99999999999999999999999999997654332
Q ss_pred cceeecccCCccccCCCCCC-----CCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecc
Q 002336 770 THISSVARGTVGYLDPEYYG-----NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 844 (935)
Q Consensus 770 ~~~~~~~~gt~~y~APE~l~-----~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~ 844 (935)
. .....|++.|+|||.+. ...++.++||||||+++|||++|+.||...... .+......... ...
T Consensus 180 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~~~~~~~~~~~-~~~-- 249 (318)
T 2dyl_A 180 A--KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD-----FEVLTKVLQEE-PPL-- 249 (318)
T ss_dssp ---------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSH-----HHHHHHHHHSC-CCC--
T ss_pred c--ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc-----HHHHHHHhccC-CCC--
Confidence 2 22345899999999984 557889999999999999999999999732211 11122222211 111
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 845 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 845 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
+... ......+.+++.+||+.||++||+++|+++
T Consensus 250 ---~~~~--~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 250 ---LPGH--MGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp ---CCSS--SCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ---CCcc--CCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 1000 011236889999999999999999999976
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-34 Score=318.26 Aligned_cols=239 Identities=24% Similarity=0.386 Sum_probs=195.3
Q ss_pred HHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcchh------hhHHHHHHHHHHHhcC--CCcccccceeeeccce
Q 002336 613 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSH------RTQQFVTEVALLSRIH--HRNLVPLIGYCEEEHQ 683 (935)
Q Consensus 613 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~~------~~~~~~~E~~iL~~L~--HpnIv~l~g~~~~~~~ 683 (935)
..|++.+.||+|+||.||+|... +++.||||++...... ..+.+.+|+.++++++ |+||+++++++...+.
T Consensus 43 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~ 122 (320)
T 3a99_A 43 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 122 (320)
T ss_dssp TTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCCc
Confidence 44667899999999999999865 6899999998654221 2356778999999996 5999999999999999
Q ss_pred EEEEEEecCC-CCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCcccc-CCCcEEEeeccc
Q 002336 684 RILVYEYMHN-GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD-INMRAKVSDFGL 761 (935)
Q Consensus 684 ~~lV~E~~~~-gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld-~~~~vkL~DFGl 761 (935)
.++|||++.+ ++|.+++.. ...+++..++.++.|+++||+|||+ .+|+||||||+|||++ +++.+||+|||+
T Consensus 123 ~~lv~e~~~~~~~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~ 196 (320)
T 3a99_A 123 FVLILERPEPVQDLFDFITE---RGALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGS 196 (320)
T ss_dssp EEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCCTT
T ss_pred EEEEEEcCCCCccHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHH---CCcEeCCCCHHHEEEeCCCCCEEEeeCcc
Confidence 9999999986 899999874 4578999999999999999999998 8999999999999999 789999999999
Q ss_pred cccccccccceeecccCCccccCCCCCCCCCC-CchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCe
Q 002336 762 SRQAEEDLTHISSVARGTVGYLDPEYYGNQQL-TEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV 840 (935)
Q Consensus 762 a~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~-s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~ 840 (935)
++...... .....||+.|+|||++.+..+ +.++||||||+++|||++|+.||.... . ... +..
T Consensus 197 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~--------~----~~~-~~~ 260 (320)
T 3a99_A 197 GALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE--------E----IIR-GQV 260 (320)
T ss_dssp CEECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--------H----HHH-CCC
T ss_pred cccccccc---ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh--------h----hhc-ccc
Confidence 98765432 223458999999998876555 688999999999999999999997321 1 011 110
Q ss_pred eecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 841 ISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 841 ~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
...... ...+.+++.+||+.+|++||+++|+++
T Consensus 261 ------~~~~~~----~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 261 ------FFRQRV----SSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp ------CCSSCC----CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ------cccccC----CHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 011112 236889999999999999999999986
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-33 Score=325.76 Aligned_cols=246 Identities=24% Similarity=0.342 Sum_probs=183.6
Q ss_pred HhhcccccccccEEEEEEEECCCcEEEEEEccCcchhhhHHHHHHHHHHHhc-CCCcccccceeeeccceEEEEEEecCC
Q 002336 615 NNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEYMHN 693 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L-~HpnIv~l~g~~~~~~~~~lV~E~~~~ 693 (935)
+++.+.||+|+||+||.....+|+.||||++.... ...+.+|+++|+.+ +|||||++++++.+....++||||+.
T Consensus 26 y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~- 101 (432)
T 3p23_A 26 FCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA- 101 (432)
T ss_dssp EEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTT---EEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS-
T ss_pred EecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC-
Confidence 45568999999999776666679999999986532 23467899999999 79999999999999999999999996
Q ss_pred CCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccC-----CCcEEEeecccccccccc
Q 002336 694 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI-----NMRAKVSDFGLSRQAEED 768 (935)
Q Consensus 694 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~-----~~~vkL~DFGla~~~~~~ 768 (935)
|+|.+++... .....+..++.++.|+++||+|||+ ++|+||||||+|||++. ...+||+|||+++.....
T Consensus 102 g~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~ 176 (432)
T 3p23_A 102 ATLQEYVEQK--DFAHLGLEPITLLQQTTSGLAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVG 176 (432)
T ss_dssp EEHHHHHHSS--SCCCCSSCHHHHHHHHHHHHHHHHH---TTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC---
T ss_pred CCHHHHHHhc--CCCccchhHHHHHHHHHHHHHHHHH---CcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCC
Confidence 6999998754 2334455678899999999999998 89999999999999953 335889999999876533
Q ss_pred cc--ceeecccCCccccCCCCCC---CCCCCchhHHHHHHHHHHHHHh-CCCCCCccCcccchhHHHHHHHhhhcCCeee
Q 002336 769 LT--HISSVARGTVGYLDPEYYG---NQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVIS 842 (935)
Q Consensus 769 ~~--~~~~~~~gt~~y~APE~l~---~~~~s~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~ 842 (935)
.. .......||+.|+|||++. ...++.++|||||||++|||++ |..||...... . .......... .
T Consensus 177 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~-~------~~~~~~~~~~-~ 248 (432)
T 3p23_A 177 RHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQR-Q------ANILLGACSL-D 248 (432)
T ss_dssp ---------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTH-H------HHHHTTCCCC-T
T ss_pred CcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHH-H------HHHHhccCCc-c
Confidence 21 1223456999999999987 4567889999999999999999 99998522111 0 1111111110 0
Q ss_pred cccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 843 IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 843 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
... ........+.+++.+||+.||++|||++||++
T Consensus 249 ~~~------~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 249 CLH------PEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp TSC------TTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccC------ccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 000 11223445789999999999999999999984
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-32 Score=301.50 Aligned_cols=234 Identities=14% Similarity=0.176 Sum_probs=182.8
Q ss_pred HHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcch---hhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEE
Q 002336 613 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 688 (935)
Q Consensus 613 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~---~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~ 688 (935)
..|++.+.||+|+||.||+|.+. +++.||||++..... ...+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 110 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA 110 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence 34677889999999999999986 489999999976432 33477999999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccccc
Q 002336 689 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 768 (935)
Q Consensus 689 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~ 768 (935)
||+++++|.++++. . ....++.+++.|+++||+|||+ ++|+||||||+|||++.++.+||++++
T Consensus 111 e~~~g~~L~~~l~~----~-~~~~~~~~i~~ql~~aL~~lH~---~givH~Dikp~NIll~~~g~~kl~~~~-------- 174 (286)
T 3uqc_A 111 EWIRGGSLQEVADT----S-PSPVGAIRAMQSLAAAADAAHR---AGVALSIDHPSRVRVSIDGDVVLAYPA-------- 174 (286)
T ss_dssp ECCCEEEHHHHHTT----C-CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEETTSCEEECSCC--------
T ss_pred EecCCCCHHHHHhc----C-CChHHHHHHHHHHHHHHHHHHH---CCCccCCCCcccEEEcCCCCEEEEecc--------
Confidence 99999999999963 2 3556789999999999999998 899999999999999999999998443
Q ss_pred ccceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccccc
Q 002336 769 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 848 (935)
Q Consensus 769 ~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l 848 (935)
|++ .++.++||||||+++|||++|+.||............ ...+ .+... .
T Consensus 175 -------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~---~~~~-~~~~~---~--- 224 (286)
T 3uqc_A 175 -------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA---ERDT-AGQPI---E--- 224 (286)
T ss_dssp -------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEEC---CBCT-TSCBC---C---
T ss_pred -------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHH---HHHh-ccCCC---C---
Confidence 333 3689999999999999999999999854332110000 0000 00000 0
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhhhhhcc
Q 002336 849 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 893 (935)
Q Consensus 849 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~~~~~~ 893 (935)
...........+.+++.+||+.||++| |++|+++.|++......
T Consensus 225 ~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~~ 268 (286)
T 3uqc_A 225 PADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVAD 268 (286)
T ss_dssp HHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC---
T ss_pred hhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccCC
Confidence 000111223468899999999999999 99999999999876554
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-33 Score=341.37 Aligned_cols=239 Identities=18% Similarity=0.280 Sum_probs=192.0
Q ss_pred HHHhhcccccccccEEEEEEEEC--CCcEEEEEEccCcc-hhhhHHHHHHHHHHHhcCCCcccccceeeeccce-----E
Q 002336 613 ATNNFCKKIGKGSFGSVYYGKMK--DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQ-----R 684 (935)
Q Consensus 613 ~~~~~~~~LG~G~fG~Vy~~~~~--~g~~vAvK~~~~~~-~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~-----~ 684 (935)
..|++.+.||+|+||.||+|.+. +|+.||||++.... ......+.+|++++++++||||+++++++...+. .
T Consensus 80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~ 159 (681)
T 2pzi_A 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG 159 (681)
T ss_dssp TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence 45777899999999999999986 58999999986543 3445678999999999999999999999987655 7
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccc
Q 002336 685 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 764 (935)
Q Consensus 685 ~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~ 764 (935)
++||||+++++|.+++.. .+++.+++.++.||++||.|||+ ++|+||||||+|||++.+ .+||+|||+++.
T Consensus 160 ~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~---~giiHrDlkp~NIll~~~-~~kl~DFG~a~~ 230 (681)
T 2pzi_A 160 YIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHS---IGLVYNDLKPENIMLTEE-QLKLIDLGAVSR 230 (681)
T ss_dssp EEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred EEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHH---CCCeecccChHHeEEeCC-cEEEEecccchh
Confidence 999999999999887652 68999999999999999999998 899999999999999975 899999999987
Q ss_pred ccccccceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecc
Q 002336 765 AEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 844 (935)
Q Consensus 765 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~ 844 (935)
.... ....||+.|+|||++.+.. +.++|||||||++++|++|..|+........ .
T Consensus 231 ~~~~-----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~-------------------~ 285 (681)
T 2pzi_A 231 INSF-----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGL-------------------P 285 (681)
T ss_dssp TTCC-----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSSC-------------------C
T ss_pred cccC-----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccccc-------------------c
Confidence 6443 2346899999999886654 8999999999999999999988763211100 0
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHHhhhh
Q 002336 845 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRP-KMQEIVLAIQDSI 889 (935)
Q Consensus 845 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-s~~ev~~~L~~~~ 889 (935)
...........+.+++.+||+.||++|| +++++...|....
T Consensus 286 ----~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 327 (681)
T 2pzi_A 286 ----EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL 327 (681)
T ss_dssp ----TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred ----ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence 0000011234688999999999999999 5677777776554
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=9.5e-32 Score=295.46 Aligned_cols=220 Identities=22% Similarity=0.311 Sum_probs=173.6
Q ss_pred ccccccccEEEEEEEEC-CCcEEEEEEccCcchhhhHHHHHHHHHH-HhcCCCcccccceeeec----cceEEEEEEecC
Q 002336 619 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALL-SRIHHRNLVPLIGYCEE----EHQRILVYEYMH 692 (935)
Q Consensus 619 ~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~iL-~~L~HpnIv~l~g~~~~----~~~~~lV~E~~~ 692 (935)
+.||+|+||.||+|... +++.||+|++.. ...+.+|+.++ +.++||||+++++++.. ....++||||++
T Consensus 24 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~ 98 (299)
T 3m2w_A 24 QVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLD 98 (299)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCCC
T ss_pred cccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeecC
Confidence 77999999999999875 689999999864 24567888888 55589999999999876 677899999999
Q ss_pred CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccC---CCcEEEeeccccccccccc
Q 002336 693 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI---NMRAKVSDFGLSRQAEEDL 769 (935)
Q Consensus 693 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~---~~~vkL~DFGla~~~~~~~ 769 (935)
+|+|.+++... ....+++..++.++.|++.||+|||+ ++|+||||||+|||++. ++.+||+|||++....
T Consensus 99 ~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~--- 171 (299)
T 3m2w_A 99 GGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT--- 171 (299)
T ss_dssp SCBHHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECT---
T ss_pred CCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEecCCCCCcEEEeccccccccc---
Confidence 99999999854 34569999999999999999999998 89999999999999998 7889999999986432
Q ss_pred cceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeeccccccc
Q 002336 770 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 849 (935)
Q Consensus 770 ~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~ 849 (935)
+..++.++||||||+++|||++|+.||........ .......+.....
T Consensus 172 --------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~-----------~~~~~~~~~~~~~- 219 (299)
T 3m2w_A 172 --------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI-----------SPGMKTRIRMGQY- 219 (299)
T ss_dssp --------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC------------------CCSCCSSCTTCC-
T ss_pred --------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhh-----------hHHHHHHHhhccc-
Confidence 23467899999999999999999999973322110 0000000000000
Q ss_pred CCCC----HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 850 GNVK----IESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 850 ~~~~----~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
..+ ......+.+++.+||+.||++|||++|+++
T Consensus 220 -~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~ 256 (299)
T 3m2w_A 220 -EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 256 (299)
T ss_dssp -SSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred -cCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 011 112347889999999999999999999986
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-32 Score=315.69 Aligned_cols=237 Identities=16% Similarity=0.119 Sum_probs=177.3
Q ss_pred hcccccccccEEEEEEEEC-CCcEEEEEEccCcchh---hhHHHHHHHHHHHhcCC-Cccccccee--------------
Q 002336 617 FCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSH---RTQQFVTEVALLSRIHH-RNLVPLIGY-------------- 677 (935)
Q Consensus 617 ~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~~---~~~~~~~E~~iL~~L~H-pnIv~l~g~-------------- 677 (935)
..+.||+|+||.||+|.+. +|+.||||++...... ..+.+.+|+.+++.++| +|......+
T Consensus 82 ~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (413)
T 3dzo_A 82 RGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQ 161 (413)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECCC
T ss_pred EecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccCC
Confidence 4678999999999999965 7999999998743222 35779999999999977 332221111
Q ss_pred -------eec-----cceEEEEEEecCCCCHHHHhcc----CCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCC
Q 002336 678 -------CEE-----EHQRILVYEYMHNGTLRDRLHG----SVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDV 741 (935)
Q Consensus 678 -------~~~-----~~~~~lV~E~~~~gsL~~~L~~----~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DL 741 (935)
+.. ....+++|+.+ +++|.++++. ...+..+++..++.++.|+++||+|||+ ++|+||||
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~iiHrDi 237 (413)
T 3dzo_A 162 KKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGLVHTYL 237 (413)
T ss_dssp ---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH---TTEECSCC
T ss_pred CCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCc
Confidence 111 12346667665 6899988841 1134567888999999999999999998 89999999
Q ss_pred CCCCccccCCCcEEEeeccccccccccccceeecccCCccccCCCCC----------CCCCCCchhHHHHHHHHHHHHHh
Q 002336 742 KSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY----------GNQQLTEKSDVYSFGVVLLELIS 811 (935)
Q Consensus 742 kp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l----------~~~~~s~ksDVwS~Gvil~eLlt 811 (935)
||+|||++.++.+||+|||+++..... .....| +.|+|||++ ....++.++|||||||++|||++
T Consensus 238 Kp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ellt 312 (413)
T 3dzo_A 238 RPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWC 312 (413)
T ss_dssp CGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHH
T ss_pred ccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHH
Confidence 999999999999999999998865443 233457 999999998 66678899999999999999999
Q ss_pred CCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 812 GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 812 G~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
|+.||......... ..++.. .... ...+.+++.+||+.+|++||++.|+++
T Consensus 313 g~~Pf~~~~~~~~~---------------~~~~~~--~~~~----~~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 313 ADLPNTDDAALGGS---------------EWIFRS--CKNI----PQPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp SSCCCCTTGGGSCS---------------GGGGSS--CCCC----CHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCCCCCcchhhhH---------------HHHHhh--cccC----CHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 99999743321110 011110 0112 246889999999999999999877743
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.97 E-value=9.5e-33 Score=308.65 Aligned_cols=242 Identities=18% Similarity=0.215 Sum_probs=182.5
Q ss_pred HHHHHhhcccccccccEEEEEEEECCCcEEEEEEccCcch--------hhhHHHHHHHHHHHhcC---------------
Q 002336 611 EEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCS--------HRTQQFVTEVALLSRIH--------------- 667 (935)
Q Consensus 611 ~~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~~~~~~~--------~~~~~~~~E~~iL~~L~--------------- 667 (935)
....|++.+.||+|+||.||+|++ +|+.||||++..... ...+.+.+|+.+++.++
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 18 PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp CHHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred ccccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 356788899999999999999998 589999999875421 22367889999999886
Q ss_pred -----------CCcccccceeeec-------------cceEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 002336 668 -----------HRNLVPLIGYCEE-------------EHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK 723 (935)
Q Consensus 668 -----------HpnIv~l~g~~~~-------------~~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~ 723 (935)
||||+++++++.+ .+..++||||+++|++.+.+. +..+++..+..++.||+.
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~----~~~~~~~~~~~i~~qi~~ 172 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR----TKLSSLATAKSILHQLTA 172 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT----TTCCCHHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH----hcCCCHHHHHHHHHHHHH
Confidence 5555555555544 678999999999997766664 256899999999999999
Q ss_pred HhHHhh-hcCCCceEecCCCCCCccccCCC--------------------cEEEeeccccccccccccceeecccCCccc
Q 002336 724 GLEYLH-TGCNPGIIHRDVKSSNILLDINM--------------------RAKVSDFGLSRQAEEDLTHISSVARGTVGY 782 (935)
Q Consensus 724 gL~yLH-s~~~~~ivH~DLkp~NILld~~~--------------------~vkL~DFGla~~~~~~~~~~~~~~~gt~~y 782 (935)
||+||| + ++|+||||||+|||++.++ .+||+|||+++..... ...||+.|
T Consensus 173 aL~~lH~~---~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~y 243 (336)
T 2vuw_A 173 SLAVAEAS---LRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDVS 243 (336)
T ss_dssp HHHHHHHH---HCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCCT
T ss_pred HHHHHHHh---CCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeecc
Confidence 999999 7 8999999999999999887 8999999999876532 23589999
Q ss_pred cCCCCCCCCCCCchhHHHHHHHH-HHHHHhCCCCCCccCcccchhHHHHHHHhhh-cCCeeecccccccCCCCHHHHHHH
Q 002336 783 LDPEYYGNQQLTEKSDVYSFGVV-LLELISGKKPVSVEDFGAELNIVHWARSMIK-KGDVISIVDPVLIGNVKIESIWRI 860 (935)
Q Consensus 783 ~APE~l~~~~~s~ksDVwS~Gvi-l~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~-~~~~~~~~d~~l~~~~~~~~~~~l 860 (935)
+|||++.+.. +.++||||++++ .+++++|..||... .........+. ..... ..............+
T Consensus 244 ~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~------~~~~~~~~~~~~~~~~~----~~~~~~~~~~~s~~~ 312 (336)
T 2vuw_A 244 MDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNV------LWLHYLTDKMLKQMTFK----TKCNTPAMKQIKRKI 312 (336)
T ss_dssp TCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH------HHHHHHHHHHHHTCCCS----SCCCSHHHHHHHHHH
T ss_pred cChhhhcCCC-ccceehhhhhCCCCcccccccCCCcch------hhhhHHHHhhhhhhccC----cccchhhhhhcCHHH
Confidence 9999998766 899999998777 77788899988511 00011111111 11110 000111123455689
Q ss_pred HHHHHHccccCCCCCCCHHHHH
Q 002336 861 AEVAIQCVEQRGFSRPKMQEIV 882 (935)
Q Consensus 861 ~~li~~Cl~~dP~~RPs~~ev~ 882 (935)
.+++.+||+.+ |++|++
T Consensus 313 ~dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 313 QEFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHHHGGGSS-----SHHHHH
T ss_pred HHHHHHHhccC-----CHHHHH
Confidence 99999999866 888887
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=5.1e-27 Score=280.19 Aligned_cols=186 Identities=17% Similarity=0.141 Sum_probs=130.5
Q ss_pred ccccccccEEEEEEEE-CCCcEEEEEEccCcc----------hhhhHHHHHHHHHHHhc-CCCcccccceeeeccceEEE
Q 002336 619 KKIGKGSFGSVYYGKM-KDGKEVAVKIMADSC----------SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRIL 686 (935)
Q Consensus 619 ~~LG~G~fG~Vy~~~~-~~g~~vAvK~~~~~~----------~~~~~~~~~E~~iL~~L-~HpnIv~l~g~~~~~~~~~l 686 (935)
...+.|+.|.+..++. --|+.+++|++.... ....++|.+|+++|+++ +|+||+++++++++++..||
T Consensus 240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yL 319 (569)
T 4azs_A 240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWL 319 (569)
T ss_dssp CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEE
T ss_pred hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEE
Confidence 4567777777766543 358999999986531 12335799999999999 79999999999999999999
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccc
Q 002336 687 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 766 (935)
Q Consensus 687 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~ 766 (935)
||||++|++|.++|.. +.+++.. +|+.||+.||+|||+ +|||||||||+|||+++++.+||+|||+++...
T Consensus 320 VMEyv~G~~L~d~i~~---~~~l~~~---~I~~QIl~AL~ylH~---~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~ 390 (569)
T 4azs_A 320 VMEKLPGRLLSDMLAA---GEEIDRE---KILGSLLRSLAALEK---QGFWHDDVRPWNVMVDARQHARLIDFGSIVTTP 390 (569)
T ss_dssp EEECCCSEEHHHHHHT---TCCCCHH---HHHHHHHHHHHHHHH---TTCEESCCCGGGEEECTTSCEEECCCTTEESCC
T ss_pred EEecCCCCcHHHHHHh---CCCCCHH---HHHHHHHHHHHHHHH---CCceeccCchHhEEECCCCCEEEeecccCeeCC
Confidence 9999999999999984 4566654 588999999999998 999999999999999999999999999998765
Q ss_pred ccccceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCC
Q 002336 767 EDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 815 (935)
Q Consensus 767 ~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~P 815 (935)
..... .....||++|+|||++.+ .+..++|+|++|+++++|.++..+
T Consensus 391 ~~~~~-~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 391 QDCSW-PTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp ---CC-SHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred CCCcc-ccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 43322 233569999999999876 467789999999998887665444
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=6.3e-24 Score=252.05 Aligned_cols=183 Identities=17% Similarity=0.204 Sum_probs=146.3
Q ss_pred cccccccccEEEEEEEECCCcEEEEEEccCcch--------hhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEE
Q 002336 618 CKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCS--------HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 689 (935)
Q Consensus 618 ~~~LG~G~fG~Vy~~~~~~g~~vAvK~~~~~~~--------~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E 689 (935)
.+.||+|+||.||+|... ++.+++|+...... ...+++.+|++++++++||||+++..++...+..++|||
T Consensus 341 ~~~LG~G~fg~Vy~~~~~-~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE 419 (540)
T 3en9_A 341 EHLIGKGAEADIKRDSYL-DFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMS 419 (540)
T ss_dssp -------CCEEEEEEECS-SCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEE
T ss_pred CCEEeeCCCEEEEEEEEC-CCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEE
Confidence 568999999999999655 78899998643211 123568999999999999999977777777778899999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccc
Q 002336 690 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 769 (935)
Q Consensus 690 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~ 769 (935)
|+++++|.+++.. +..++.|+++||+|||+ ++|+||||||+|||++. .+||+|||+++......
T Consensus 420 ~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~---~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~ 483 (540)
T 3en9_A 420 YINGKLAKDVIED-----------NLDIAYKIGEIVGKLHK---NDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDE 483 (540)
T ss_dssp CCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHH---TTEECTTCCTTSEEESS--SEEECCCTTCEECCCHH
T ss_pred CCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHH---CcCccCCCCHHHEEECC--eEEEEECccCEECCCcc
Confidence 9999999999973 56899999999999998 89999999999999998 99999999999875532
Q ss_pred cce------eecccCCccccCCCCCCC--CCCCchhHHHHHHHHHHHHHhCCCCCC
Q 002336 770 THI------SSVARGTVGYLDPEYYGN--QQLTEKSDVYSFGVVLLELISGKKPVS 817 (935)
Q Consensus 770 ~~~------~~~~~gt~~y~APE~l~~--~~~s~ksDVwS~Gvil~eLltG~~Pf~ 817 (935)
... .....||+.|+|||++.. ..|+...|+|+..+-..+.+.++.+|.
T Consensus 484 ~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 484 DKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred ccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 211 234568999999999876 567888999999999988888777664
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.82 E-value=5e-21 Score=208.42 Aligned_cols=140 Identities=15% Similarity=0.116 Sum_probs=114.8
Q ss_pred hcccccccccEEEEEEEECCCcEEEEEEccCcch------------------hhhHHHHHHHHHHHhcCCCcccccceee
Q 002336 617 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCS------------------HRTQQFVTEVALLSRIHHRNLVPLIGYC 678 (935)
Q Consensus 617 ~~~~LG~G~fG~Vy~~~~~~g~~vAvK~~~~~~~------------------~~~~~~~~E~~iL~~L~HpnIv~l~g~~ 678 (935)
+.+.||+|+||.||+|.+.+|+.||+|+++.... .....+.+|+++|++++ | +++.+++
T Consensus 94 ~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~~~ 170 (282)
T 1zar_A 94 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPKVY 170 (282)
T ss_dssp EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCCEE
T ss_pred ecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCeEE
Confidence 3588999999999999997799999999864321 13456899999999999 5 7777766
Q ss_pred eccceEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEee
Q 002336 679 EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSD 758 (935)
Q Consensus 679 ~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~D 758 (935)
.. +..++||||+++++|.+ +.. .....++.|+++||.|||+ .+|+||||||+|||++ ++.+||+|
T Consensus 171 ~~-~~~~lvmE~~~g~~L~~-l~~---------~~~~~i~~qi~~~l~~lH~---~giiHrDlkp~NILl~-~~~vkl~D 235 (282)
T 1zar_A 171 AW-EGNAVLMELIDAKELYR-VRV---------ENPDEVLDMILEEVAKFYH---RGIVHGDLSQYNVLVS-EEGIWIID 235 (282)
T ss_dssp EE-ETTEEEEECCCCEEGGG-CCC---------SCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEE-TTEEEECC
T ss_pred ec-cceEEEEEecCCCcHHH-cch---------hhHHHHHHHHHHHHHHHHH---CCCEeCCCCHHHEEEE-CCcEEEEE
Confidence 44 55699999999999998 531 1245799999999999998 9999999999999999 99999999
Q ss_pred ccccccccccccceeecccCCccccCCCCC
Q 002336 759 FGLSRQAEEDLTHISSVARGTVGYLDPEYY 788 (935)
Q Consensus 759 FGla~~~~~~~~~~~~~~~gt~~y~APE~l 788 (935)
||+++. +..+.|||++
T Consensus 236 FG~a~~--------------~~~~~a~e~l 251 (282)
T 1zar_A 236 FPQSVE--------------VGEEGWREIL 251 (282)
T ss_dssp CTTCEE--------------TTSTTHHHHH
T ss_pred CCCCeE--------------CCCCCHHHHH
Confidence 999863 3346777765
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.70 E-value=1.9e-17 Score=177.82 Aligned_cols=137 Identities=23% Similarity=0.228 Sum_probs=105.0
Q ss_pred hhcccccccccEEEEEEEE-CCCcE--EEEEEccCcchh------------------------hhHHHHHHHHHHHhcCC
Q 002336 616 NFCKKIGKGSFGSVYYGKM-KDGKE--VAVKIMADSCSH------------------------RTQQFVTEVALLSRIHH 668 (935)
Q Consensus 616 ~~~~~LG~G~fG~Vy~~~~-~~g~~--vAvK~~~~~~~~------------------------~~~~~~~E~~iL~~L~H 668 (935)
.+.+.||+|+||.||+|.+ .+|+. ||||+++..... ....+.+|+.+|.+++|
T Consensus 50 ~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~ 129 (258)
T 1zth_A 50 AMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAKE 129 (258)
T ss_dssp EEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHHH
T ss_pred hhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHHh
Confidence 3567899999999999998 67999 999987543111 11368889999999988
Q ss_pred CcccccceeeeccceEEEEEEecCC-C----CHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhh-hcCCCceEecCCC
Q 002336 669 RNLVPLIGYCEEEHQRILVYEYMHN-G----TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH-TGCNPGIIHRDVK 742 (935)
Q Consensus 669 pnIv~l~g~~~~~~~~~lV~E~~~~-g----sL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLH-s~~~~~ivH~DLk 742 (935)
+++....-+.. ...++||||+.+ | +|.+.... .++..+..++.|++++|.||| + .+|+|||||
T Consensus 130 ~~i~~p~~~~~--~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~---~givHrDlk 198 (258)
T 1zth_A 130 AGVSVPQPYTY--MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQE---AELVHADLS 198 (258)
T ss_dssp TTCCCCCEEEE--ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHT---SCEECSSCS
T ss_pred CCCCCCeEEEc--CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHH---CCEEeCCCC
Confidence 86532222211 356899999942 4 77776532 124467889999999999999 7 899999999
Q ss_pred CCCccccCCCcEEEeeccccccc
Q 002336 743 SSNILLDINMRAKVSDFGLSRQA 765 (935)
Q Consensus 743 p~NILld~~~~vkL~DFGla~~~ 765 (935)
|+|||+++ .++|+|||++...
T Consensus 199 p~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 199 EYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp TTSEEESS--SEEECCCTTCEET
T ss_pred HHHEEEcC--cEEEEECcccccC
Confidence 99999998 9999999999754
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.64 E-value=2.4e-16 Score=174.02 Aligned_cols=150 Identities=27% Similarity=0.494 Sum_probs=127.7
Q ss_pred CchhhHHHHHHHHhhcCCC-CCCCCCC-CCCCCCCCceEEEeCCC-CCcEEEEEccCCCCcc--cCCccccCcccccccc
Q 002336 369 TEWQDVMVLEALRSISDES-ERTNDRG-DPCVPVPWEWVTCSTTT-PPRITKIALSGKNLKG--EIPPELKNMEALTELW 443 (935)
Q Consensus 369 t~~~d~~~l~~l~~~~~~~-~~~~w~~-dpC~~~~w~~v~c~~~~-~~~l~~L~Ls~n~l~g--~ip~~i~~L~~L~~L~ 443 (935)
+.++|..||.++|+.+.++ ...+|.. .+||.+.|.||.|+... ..+|+.|+|++|+++| .+|+.|++|++|++|+
T Consensus 3 c~~~~~~aL~~~k~~~~~~~~l~~W~~~~~~C~~~w~gv~C~~~~~~~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~ 82 (313)
T 1ogq_A 3 CNPQDKQALLQIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLY 82 (313)
T ss_dssp SCHHHHHHHHHHHHHTTCCGGGTTCCTTSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCSEEE
T ss_pred CCHHHHHHHHHHHHhcCCcccccCCCCCCCCCcCCCcceEeCCCCCCceEEEEECCCCCccCCcccChhHhCCCCCCeee
Confidence 5678999999999988643 3456753 34444469999997642 3689999999999999 9999999999999999
Q ss_pred ccc-ccCCCCCC-CccccccccccccccccccCCCCCccCccccccccccccccCCCCCCccccC--CceeeeecCCCC
Q 002336 444 LDG-NFLTGPLP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLT--GKVIFKYDNNPK 518 (935)
Q Consensus 444 Ls~-N~l~g~~p-~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~l~~N~l~g~iP~~l~~--~~~~~~~~~n~~ 518 (935)
|++ |.+.+.+| .++++++|++|+|++|+++|.+|..++++++|+.|+|++|+++|.+|..+.. ....+.+++|..
T Consensus 83 L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l 161 (313)
T 1ogq_A 83 IGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRI 161 (313)
T ss_dssp EEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCC
T ss_pred CCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHhcCCCCCeEECcCCcc
Confidence 995 99999998 6999999999999999999999999999999999999999999999988765 445566667653
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.58 E-value=1.6e-15 Score=188.32 Aligned_cols=158 Identities=20% Similarity=0.241 Sum_probs=127.6
Q ss_pred hhhhhhceeeccc---ccCchhhHHHHHHHHhhcCCCCCCCCCC-------CCCCCCCC------------ceEEEeCCC
Q 002336 354 LNAIEISKYQKIA---AKTEWQDVMVLEALRSISDESERTNDRG-------DPCVPVPW------------EWVTCSTTT 411 (935)
Q Consensus 354 ina~e~~~~~~~~---~~t~~~d~~~l~~l~~~~~~~~~~~w~~-------dpC~~~~w------------~~v~c~~~~ 411 (935)
-|+++-.+.+++. ..+..+|..||.++|+.+... +|+. +|| +|.| .||.|++.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~d~~ALl~~k~~l~~~---~W~~~~~~~~~~~~-~C~W~~~~~~~~w~~~~GV~C~~~- 322 (876)
T 4ecn_A 248 DNKLTKDANVPIQLKETAEYIKDYKALKAIWEALDGK---NWRYYSGTINNTIH-SLNWNFNKELDMWGDQPGVDLDNN- 322 (876)
T ss_dssp TTSEEEEEEEEECCCCCCHHHHHHHHHHHHHHHTTGG---GCCCCCSSCSSCCC-CCSCCCSSCGGGTTCCTTEEECTT-
T ss_pred ecccccccccceeccccccchHHHHHHHHHHHHcCCC---CCCcCCCcccccCC-ccccccccccccccCcCceEecCC-
Confidence 3443444555543 245567999999999998643 6643 342 2589 99999873
Q ss_pred CCcEEEEEccCCCCcccCCccccCccccccccc-ccccCCCC--------------------------------------
Q 002336 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWL-DGNFLTGP-------------------------------------- 452 (935)
Q Consensus 412 ~~~l~~L~Ls~n~l~g~ip~~i~~L~~L~~L~L-s~N~l~g~-------------------------------------- 452 (935)
.+|+.|+|++|+|.|.+|++|++|++|+.|+| ++|.++|.
T Consensus 323 -~~V~~L~Ls~~~L~G~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s 401 (876)
T 4ecn_A 323 -GRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLS 401 (876)
T ss_dssp -SCEEEEECTTTCCEEEECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSC
T ss_pred -CCEEEEECccCCCCCcCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhh
Confidence 69999999999999999999999999999999 88866554
Q ss_pred --------------------------------------CC-CccccccccccccccccccC-----------------CC
Q 002336 453 --------------------------------------LP-DMSRLIDLRIVHLENNELTG-----------------SL 476 (935)
Q Consensus 453 --------------------------------------~p-~~~~l~~L~~L~L~~N~l~g-----------------~i 476 (935)
+| .+++|++|+.|+|++|+|+| .+
T Consensus 402 ~l~~~~l~~~~~~~~i~~~~~l~l~~l~l~~~~N~L~~IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~i 481 (876)
T 4ecn_A 402 DLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYE 481 (876)
T ss_dssp HHHHHHHHTCTTSCCCCCCCCCCCCTTTTTCCSCEEEEECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHT
T ss_pred HHHHHHhhhCccccccccccccchhhceeccccCcccchhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccC
Confidence 56 68899999999999999998 49
Q ss_pred CCccC--ccccccccccccccCCCCCCccccC--CceeeeecCCC
Q 002336 477 PSYMG--SLPNLQELHIENNSFVGEIPPALLT--GKVIFKYDNNP 517 (935)
Q Consensus 477 P~~l~--~l~~L~~L~l~~N~l~g~iP~~l~~--~~~~~~~~~n~ 517 (935)
|++++ +|++|+.|+|++|++.|.+|..+.. ....+.+++|.
T Consensus 482 P~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~ 526 (876)
T 4ecn_A 482 NEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNR 526 (876)
T ss_dssp TSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCT
T ss_pred ChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCC
Confidence 99988 9999999999999999999988765 45566677776
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.54 E-value=4.6e-15 Score=179.83 Aligned_cols=145 Identities=18% Similarity=0.248 Sum_probs=121.1
Q ss_pred cCchhhHHHHHHHHhhcCCCCCC----------CCCCC-CCCCCCC---ceEEEeCCCCCcEEEEEccCCCCcccCCccc
Q 002336 368 KTEWQDVMVLEALRSISDESERT----------NDRGD-PCVPVPW---EWVTCSTTTPPRITKIALSGKNLKGEIPPEL 433 (935)
Q Consensus 368 ~t~~~d~~~l~~l~~~~~~~~~~----------~w~~d-pC~~~~w---~~v~c~~~~~~~l~~L~Ls~n~l~g~ip~~i 433 (935)
.....|..||.+++.......+. +|+.+ +| |.| .||.|+.. .+|+.|+|++|+++|.+|++|
T Consensus 26 ~~~~~d~~aL~~~~~~~~~~~w~~~~~~~~~~~~W~~~~~~--c~w~~~~GV~C~~~--~~V~~L~L~~~~l~g~lp~~l 101 (636)
T 4eco_A 26 AEYIKDYLALKEIWDALNGKNWSQQGFGTQPGANWNFNKEL--DMWGAQPGVSLNSN--GRVTGLSLEGFGASGRVPDAI 101 (636)
T ss_dssp CHHHHHHHHHHHHHHHTTGGGCCCCC------CCCCCSSCG--GGTTCCTTEEECTT--CCEEEEECTTSCCEEEECGGG
T ss_pred hhHHHHHHHHHHHHHHcCCCCcccCCcCCccCCCCCCCCCc--ccccCCCCeEEcCC--CCEEEEEecCcccCCcCChHH
Confidence 34457999999999887543322 67643 23 269 99999765 699999999999999999999
Q ss_pred cCccccccccccccc-----------------------------------------------------------------
Q 002336 434 KNMEALTELWLDGNF----------------------------------------------------------------- 448 (935)
Q Consensus 434 ~~L~~L~~L~Ls~N~----------------------------------------------------------------- 448 (935)
++|++|+.|+|++|.
T Consensus 102 ~~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~~~~l~l~l~~~~l~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~ 181 (636)
T 4eco_A 102 GQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRI 181 (636)
T ss_dssp GGCTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHHCTTSCCCCCCCCC
T ss_pred hcCccceEEECcCCccccCCccccccccccCchHHHHHHHHhhHHHhhhccCchhhHHHHHHHHhhcCcccccccccccc
Confidence 999999999999994
Q ss_pred -------------CCCCCC-CccccccccccccccccccCC-----------------CCCccC--cccccccccccccc
Q 002336 449 -------------LTGPLP-DMSRLIDLRIVHLENNELTGS-----------------LPSYMG--SLPNLQELHIENNS 495 (935)
Q Consensus 449 -------------l~g~~p-~~~~l~~L~~L~L~~N~l~g~-----------------iP~~l~--~l~~L~~L~l~~N~ 495 (935)
|+| +| .++++++|++|+|++|+|+|. +|.+++ +|++|+.|+|++|+
T Consensus 182 ~l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~ 260 (636)
T 4eco_A 182 TLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCP 260 (636)
T ss_dssp CCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCT
T ss_pred chhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCc
Confidence 445 55 689999999999999999986 999999 99999999999999
Q ss_pred CCCCCCccccC--CceeeeecCCC
Q 002336 496 FVGEIPPALLT--GKVIFKYDNNP 517 (935)
Q Consensus 496 l~g~iP~~l~~--~~~~~~~~~n~ 517 (935)
+.|.+|..+.. ....+.+++|.
T Consensus 261 l~~~~p~~l~~l~~L~~L~Ls~n~ 284 (636)
T 4eco_A 261 NLTKLPTFLKALPEMQLINVACNR 284 (636)
T ss_dssp TCSSCCTTTTTCSSCCEEECTTCT
T ss_pred CCccChHHHhcCCCCCEEECcCCC
Confidence 99999998875 44556667775
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.51 E-value=6.8e-15 Score=164.96 Aligned_cols=136 Identities=16% Similarity=0.148 Sum_probs=97.6
Q ss_pred HhhcccccccccEEEEEEEECCCcEEEEEEccCcchh--------------hhH--------HHHHHHHHHHhcCCCccc
Q 002336 615 NNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSH--------------RTQ--------QFVTEVALLSRIHHRNLV 672 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~~~~~~~~--------------~~~--------~~~~E~~iL~~L~HpnIv 672 (935)
|.+.+.||+|++|.||+|...+|+.||||+++..... ... ...+|...|.++.+.++.
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~ 176 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFP 176 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred EEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 4567889999999999999999999999987532110 001 123466666666544432
Q ss_pred ccceeeeccceEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCC
Q 002336 673 PLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM 752 (935)
Q Consensus 673 ~l~g~~~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~ 752 (935)
...-+.. ...++||||++|++|.+.... .....++.|++.+|.+||+ .+||||||||.|||+++++
T Consensus 177 vp~p~~~--~~~~LVME~i~G~~L~~l~~~---------~~~~~l~~qll~~l~~lH~---~gIVHrDLKp~NILl~~dg 242 (397)
T 4gyi_A 177 VPEPIAQ--SRHTIVMSLVDALPMRQVSSV---------PDPASLYADLIALILRLAK---HGLIHGDFNEFNILIREEK 242 (397)
T ss_dssp CCCEEEE--ETTEEEEECCSCEEGGGCCCC---------SCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEEEEE
T ss_pred CCeeeec--cCceEEEEecCCccHhhhccc---------HHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHEEEeCCC
Confidence 2211111 223799999999888765431 1235688999999999998 8999999999999998776
Q ss_pred ----------cEEEeecccccc
Q 002336 753 ----------RAKVSDFGLSRQ 764 (935)
Q Consensus 753 ----------~vkL~DFGla~~ 764 (935)
.+.|+||+-+..
T Consensus 243 d~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 243 DAEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp CSSCTTSEEEEEEECCCTTCEE
T ss_pred CcccccccccceEEEEeCCccc
Confidence 389999996654
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.46 E-value=1.6e-14 Score=178.98 Aligned_cols=111 Identities=32% Similarity=0.436 Sum_probs=102.2
Q ss_pred CCcEEEEEccCCCCcccCCccccCcccccccccccccCCCCCC-CccccccccccccccccccCCCCCccCccccccccc
Q 002336 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 490 (935)
Q Consensus 412 ~~~l~~L~Ls~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p-~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~ 490 (935)
.+.++.|||++|+++|.+|.+|++|++|+.|+|++|+|+|.+| ++++|++|+.|||++|+|+|.+|.+++++++|+.|+
T Consensus 631 l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ 710 (768)
T 3rgz_A 631 NGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEID 710 (768)
T ss_dssp SBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEE
T ss_pred cccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEE
Confidence 4578999999999999999999999999999999999999999 699999999999999999999999999999999999
Q ss_pred cccccCCCCCCccc-cCCceeeeecCCCCCccc
Q 002336 491 IENNSFVGEIPPAL-LTGKVIFKYDNNPKLHKE 522 (935)
Q Consensus 491 l~~N~l~g~iP~~l-~~~~~~~~~~~n~~~~~~ 522 (935)
|++|+|+|.||..- +.......+.|||.+|+.
T Consensus 711 ls~N~l~g~iP~~~~~~~~~~~~~~gN~~Lcg~ 743 (768)
T 3rgz_A 711 LSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGY 743 (768)
T ss_dssp CCSSEEEEECCSSSSGGGSCGGGGCSCTEEEST
T ss_pred CcCCcccccCCCchhhccCCHHHhcCCchhcCC
Confidence 99999999999853 334455678999999974
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.40 E-value=2.9e-13 Score=138.46 Aligned_cols=120 Identities=23% Similarity=0.307 Sum_probs=103.6
Q ss_pred CCceEEEeCC--------CCCcEEEEEccCCCCcccCCccccCcccccccccccccCCCCCC-Ccccccccccccccccc
Q 002336 401 PWEWVTCSTT--------TPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNE 471 (935)
Q Consensus 401 ~w~~v~c~~~--------~~~~l~~L~Ls~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p-~~~~l~~L~~L~L~~N~ 471 (935)
.|..+.|+.. .+++++.|+|++|+|+ .+|..|.++++|+.|+|++|.|++..+ .|.+|++|+.|+|++|+
T Consensus 11 ~~~~l~~~~~~l~~ip~~~~~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~ 89 (193)
T 2wfh_A 11 LDTVVRCSNKGLKVLPKGIPRDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNR 89 (193)
T ss_dssp ETTEEECTTSCCSSCCSCCCTTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred CCCEEEcCCCCCCcCCCCCCCCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCc
Confidence 4566666542 2457999999999998 899999999999999999999999988 59999999999999999
Q ss_pred ccCCCCCccCccccccccccccccCCCCCCccccC---CceeeeecCCCCCccc
Q 002336 472 LTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLT---GKVIFKYDNNPKLHKE 522 (935)
Q Consensus 472 l~g~iP~~l~~l~~L~~L~l~~N~l~g~iP~~l~~---~~~~~~~~~n~~~~~~ 522 (935)
|++..|..|..+++|+.|+|++|+|+ .+|...+. ....+.+.+|++.|.+
T Consensus 90 l~~i~~~~f~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~L~~N~~~C~c 142 (193)
T 2wfh_A 90 LRCIPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGANPLYCDC 142 (193)
T ss_dssp CCBCCTTTTTTCTTCCEEECCSSCCC-BCCTTTTTTCTTCCEEECCSSCEECSG
T ss_pred cCEeCHHHhCCCCCCCEEECCCCCCC-eeChhhhhcCccccEEEeCCCCeecCC
Confidence 99877888999999999999999999 77775443 4567788999998864
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.38 E-value=3.5e-13 Score=137.65 Aligned_cols=123 Identities=19% Similarity=0.215 Sum_probs=105.5
Q ss_pred CCCceEEEeCC--------CCCcEEEEEccCCCCcccCCc-cccCcccccccccccccCCCCCC-Ccccccccccccccc
Q 002336 400 VPWEWVTCSTT--------TPPRITKIALSGKNLKGEIPP-ELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLEN 469 (935)
Q Consensus 400 ~~w~~v~c~~~--------~~~~l~~L~Ls~n~l~g~ip~-~i~~L~~L~~L~Ls~N~l~g~~p-~~~~l~~L~~L~L~~ 469 (935)
+.|..+.|+.. .+.+++.|+|++|++++..+. .|+++++|+.|+|++|+|++.+| .|.++++|+.|+|++
T Consensus 8 C~~~~l~~s~~~l~~ip~~~~~~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 87 (192)
T 1w8a_A 8 CEGTTVDCTGRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp EETTEEECTTSCCSSCCSCCCTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred ECCCEEEcCCCCcCcCccCCCCCCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence 45777777643 234899999999999966654 48999999999999999999988 699999999999999
Q ss_pred ccccCCCCCccCccccccccccccccCCCCCCccccC--CceeeeecCCCCCccc
Q 002336 470 NELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLT--GKVIFKYDNNPKLHKE 522 (935)
Q Consensus 470 N~l~g~iP~~l~~l~~L~~L~l~~N~l~g~iP~~l~~--~~~~~~~~~n~~~~~~ 522 (935)
|+|++..|..+.++++|+.|+|++|+|++.+|..+.. ....+.+.+|+..|..
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c 142 (192)
T 1w8a_A 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNC 142 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSG
T ss_pred CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcC
Confidence 9999888888999999999999999999888877754 4567788999998753
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.35 E-value=5.5e-13 Score=165.21 Aligned_cols=131 Identities=19% Similarity=0.324 Sum_probs=82.7
Q ss_pred cCchhhHHHHHHHHhhcCCC-CCCCCC-CCCCCCCCCceEEEeCCCCCcEEEEEccCCCCccc---CCccccCccccccc
Q 002336 368 KTEWQDVMVLEALRSISDES-ERTNDR-GDPCVPVPWEWVTCSTTTPPRITKIALSGKNLKGE---IPPELKNMEALTEL 442 (935)
Q Consensus 368 ~t~~~d~~~l~~l~~~~~~~-~~~~w~-~dpC~~~~w~~v~c~~~~~~~l~~L~Ls~n~l~g~---ip~~i~~L~~L~~L 442 (935)
....+|..||.++|+.+.++ ...+|. +..|| .|.||+|+ ..+|+.|+|+++++.|. +|+.|++|+.|+.+
T Consensus 8 ~~~~~~~~all~~k~~~~~~~~l~~W~~~~~~C--~w~gv~C~---~~~v~~L~L~~~~l~g~~~~l~~~l~~L~~L~~l 82 (768)
T 3rgz_A 8 QSLYREIHQLISFKDVLPDKNLLPDWSSNKNPC--TFDGVTCR---DDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESL 82 (768)
T ss_dssp CCHHHHHHHHHHHHTTCSCTTSSTTCCTTSCGG--GSTTEEEE---TTEEEEEECTTSCCCEEHHHHHHHTTTCTTCCEE
T ss_pred cCCHHHHHHHHHHHhhCCCcccccCCCCCCCCc--CCcceEEC---CCcEEEEECCCCCcCCccCccChhHhccCccccc
Confidence 44678999999999988643 456785 34444 79999998 36999999999999998 77655555444444
Q ss_pred ccccccCCCCCCCccccccccccccccccccCCCCC--ccCccccccccccccccCCCCCCcc
Q 002336 443 WLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPS--YMGSLPNLQELHIENNSFVGEIPPA 503 (935)
Q Consensus 443 ~Ls~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~iP~--~l~~l~~L~~L~l~~N~l~g~iP~~ 503 (935)
+++.|.+...++.++++++|++|+|++|+++|.+|. .+++|++|++|+|++|.++|.+|..
T Consensus 83 ~~~~~~~~~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~ 145 (768)
T 3rgz_A 83 FLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVS 145 (768)
T ss_dssp ECTTSCEEECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCC
T ss_pred CCcCCCcCCCchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHH
Confidence 444444433223455555555555555555555554 4555555555555555555554443
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.32 E-value=2.2e-12 Score=129.56 Aligned_cols=125 Identities=20% Similarity=0.314 Sum_probs=104.8
Q ss_pred CCCCCCCCceEEEeCCC--------CCcEEEEEccCCCCcccCCccccCcccccccccccccCCCCCCC-cccccccccc
Q 002336 395 DPCVPVPWEWVTCSTTT--------PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIV 465 (935)
Q Consensus 395 dpC~~~~w~~v~c~~~~--------~~~l~~L~Ls~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L 465 (935)
+.|. |.|.++.|.... +++++.|+|++|++++..+..|.++++|++|+|++|+|++.++. +.++++|+.|
T Consensus 3 ~~C~-C~~~~l~~~~~~l~~~p~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 81 (177)
T 2o6r_A 3 SRCS-CSGTEIRCNSKGLTSVPTGIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTIL 81 (177)
T ss_dssp TTCE-EETTEEECCSSCCSSCCTTCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred CCCE-eCCCEEEecCCCCccCCCCCCCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEE
Confidence 3453 478888887532 45899999999999976666789999999999999999988885 7999999999
Q ss_pred ccccccccCCCCCccCccccccccccccccCCCCCCccccC---CceeeeecCCCCCcc
Q 002336 466 HLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLT---GKVIFKYDNNPKLHK 521 (935)
Q Consensus 466 ~L~~N~l~g~iP~~l~~l~~L~~L~l~~N~l~g~iP~~l~~---~~~~~~~~~n~~~~~ 521 (935)
+|++|++++..+..++.+++|+.|+|++|+|+ .+|...+. ....+.+.+|+..|.
T Consensus 82 ~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~-~~~~~~~~~l~~L~~L~l~~N~~~~~ 139 (177)
T 2o6r_A 82 YLHENKLQSLPNGVFDKLTQLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCS 139 (177)
T ss_dssp ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCS-CCCTTTTTTCTTCCEEECCSSCBCCC
T ss_pred ECCCCCccccCHHHhhCCcccCEEECcCCcce-EeCHHHhcCCcccCEEEecCCCeecc
Confidence 99999999766677899999999999999999 67776533 456678899998874
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.30 E-value=1.9e-12 Score=135.20 Aligned_cols=111 Identities=19% Similarity=0.198 Sum_probs=97.6
Q ss_pred CCcEEEEEccCCCCcccCCccccCcccccccccccccCCCCCCC-ccccccccccccccccccCCCCCccCccccccccc
Q 002336 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 490 (935)
Q Consensus 412 ~~~l~~L~Ls~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~ 490 (935)
.++|+.|+|++|+|++..+..|.++++|+.|+|++|+|++.+|. |.++++|+.|+|++|++++..|..+..+++|+.|+
T Consensus 56 l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 135 (220)
T 2v70_A 56 LPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLS 135 (220)
T ss_dssp CTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEE
T ss_pred CCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEE
Confidence 45899999999999977777999999999999999999998884 89999999999999999988899999999999999
Q ss_pred cccccCCCCCCccccC--CceeeeecCCCCCccc
Q 002336 491 IENNSFVGEIPPALLT--GKVIFKYDNNPKLHKE 522 (935)
Q Consensus 491 l~~N~l~g~iP~~l~~--~~~~~~~~~n~~~~~~ 522 (935)
|++|+|++..|..+.. ....+.+.+|+..|.+
T Consensus 136 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c 169 (220)
T 2v70_A 136 LYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNC 169 (220)
T ss_dssp CTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSG
T ss_pred CCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCC
Confidence 9999999766776654 4566788999988853
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.30 E-value=2.6e-12 Score=134.94 Aligned_cols=122 Identities=22% Similarity=0.308 Sum_probs=95.2
Q ss_pred CCCCCCCCCCCceEEEeCC--------CCCcEEEEEccCCCCcccCCccccCcccccccccccccCCCCCCC-ccccccc
Q 002336 392 DRGDPCVPVPWEWVTCSTT--------TPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDL 462 (935)
Q Consensus 392 w~~dpC~~~~w~~v~c~~~--------~~~~l~~L~Ls~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~-~~~l~~L 462 (935)
|..+.| .|.++.|+.. .+++|+.|+|++|+|++..|..|.++++|+.|+|++|+|++.++. |.++++|
T Consensus 14 ~~~~~C---s~~~v~c~~~~l~~ip~~~~~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L 90 (229)
T 3e6j_A 14 PSQCSC---SGTTVDCRSKRHASVPAGIPTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQL 90 (229)
T ss_dssp CTTCEE---ETTEEECTTSCCSSCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTC
T ss_pred CCCCEE---eCCEeEccCCCcCccCCCCCCCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCc
Confidence 334455 5899999753 245789999999999988888899999999999999999877764 6889999
Q ss_pred cccccccccccCCCCCccCccccccccccccccCCCCCCccccC--CceeeeecCCC
Q 002336 463 RIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLT--GKVIFKYDNNP 517 (935)
Q Consensus 463 ~~L~L~~N~l~g~iP~~l~~l~~L~~L~l~~N~l~g~iP~~l~~--~~~~~~~~~n~ 517 (935)
+.|+|++|+|++..+..+..+++|+.|+|++|+|+ .||..+.. ....+.+.+|.
T Consensus 91 ~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~ 146 (229)
T 3e6j_A 91 TVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQ 146 (229)
T ss_dssp CEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSC
T ss_pred CEEECCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCc
Confidence 99999999998655666788888888888888888 88876643 33444555554
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.29 E-value=5.7e-13 Score=147.94 Aligned_cols=132 Identities=22% Similarity=0.242 Sum_probs=110.8
Q ss_pred cCchhhHHHHHHHHhhcCC-C--CCCCCC------CCCCCCCCCceEEEeC-------CCCCcEEEEEccCCCCcccCCc
Q 002336 368 KTEWQDVMVLEALRSISDE-S--ERTNDR------GDPCVPVPWEWVTCST-------TTPPRITKIALSGKNLKGEIPP 431 (935)
Q Consensus 368 ~t~~~d~~~l~~l~~~~~~-~--~~~~w~------~dpC~~~~w~~v~c~~-------~~~~~l~~L~Ls~n~l~g~ip~ 431 (935)
....+|..+|.+||+.+.. . ....|. ++.| .|.|+.|.. ....+|+.|+|++|+++ .+|+
T Consensus 23 ~~~~~~~~aLl~~k~~~~~~~~~~~~~w~~~~~~~~~~~---~~~g~~~~~~~~~l~~~~~~~l~~L~L~~n~l~-~lp~ 98 (328)
T 4fcg_A 23 TALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIE---TRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPD 98 (328)
T ss_dssp CCCCCHHHHHHHHHHHHHHCCTTHHHHHHHHTTTCTTSC---CSHHHHHHHHHHHHHHHTSTTCCEEEEESSCCS-SCCS
T ss_pred ccCchHHHHHHHHHHhccCCchhhhhhhccccccccccc---ccCCcchhhhHHHHhcccccceeEEEccCCCch-hcCh
Confidence 4556788999999986632 1 123452 2334 699998852 23468999999999999 9999
Q ss_pred cccCcccccccccccccCCCCCC-CccccccccccccccccccCCCCCccCccccccccccccccCCCCCCcccc
Q 002336 432 ELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALL 505 (935)
Q Consensus 432 ~i~~L~~L~~L~Ls~N~l~g~~p-~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~l~~N~l~g~iP~~l~ 505 (935)
.+++|++|++|+|++|.|+ .+| .++++++|++|+|++|+++ .+|..++++++|+.|+|++|++.|.+|..+.
T Consensus 99 ~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~ 171 (328)
T 4fcg_A 99 QAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLA 171 (328)
T ss_dssp CGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSE
T ss_pred hhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHh
Confidence 9999999999999999999 555 7999999999999999999 9999999999999999999999999999874
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.27 E-value=4.6e-12 Score=132.23 Aligned_cols=111 Identities=19% Similarity=0.246 Sum_probs=91.7
Q ss_pred CCcEEEEEccCCCCcccCCccccCcccccccccccccCCCCCCC-ccccccccccccccccccCCCCCccCccccccccc
Q 002336 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 490 (935)
Q Consensus 412 ~~~l~~L~Ls~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~ 490 (935)
.++|+.|+|++|+|++..|..|.+|++|++|+|++|+|++.++. |.++++|+.|+|++|++++..|..+..+++|+.|+
T Consensus 55 l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 134 (220)
T 2v9t_B 55 YKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLS 134 (220)
T ss_dssp CTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCcCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEE
Confidence 35788999999999988888999999999999999999987775 68899999999999999988888899999999999
Q ss_pred cccccCCCCCCccccC--CceeeeecCCCCCccc
Q 002336 491 IENNSFVGEIPPALLT--GKVIFKYDNNPKLHKE 522 (935)
Q Consensus 491 l~~N~l~g~iP~~l~~--~~~~~~~~~n~~~~~~ 522 (935)
|++|+|++..|..+.. ....+.+.+|++.|.+
T Consensus 135 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c 168 (220)
T 2v9t_B 135 LYDNKLQTIAKGTFSPLRAIQTMHLAQNPFICDC 168 (220)
T ss_dssp CCSSCCSCCCTTTTTTCTTCCEEECCSSCEECSG
T ss_pred CCCCcCCEECHHHHhCCCCCCEEEeCCCCcCCCC
Confidence 9999998443333433 4556788999988853
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.21 E-value=1.2e-11 Score=123.67 Aligned_cols=103 Identities=27% Similarity=0.333 Sum_probs=82.3
Q ss_pred EEEEccCCCCcccCCccccCcccccccccccccCCCCCC-CccccccccccccccccccCCCCCccCccccccccccccc
Q 002336 416 TKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENN 494 (935)
Q Consensus 416 ~~L~Ls~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p-~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~l~~N 494 (935)
+.|++++|+|+ .+|..+. ++|+.|+|++|+|++.+| .|.++++|+.|+|++|+|++..|..+..+++|+.|+|++|
T Consensus 12 ~~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N 88 (170)
T 3g39_A 12 TTVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDN 88 (170)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCC
Confidence 57889999988 6887764 788999999999999887 5888999999999999999655556788999999999999
Q ss_pred cCCCCCCcc-ccC--CceeeeecCCCCCccc
Q 002336 495 SFVGEIPPA-LLT--GKVIFKYDNNPKLHKE 522 (935)
Q Consensus 495 ~l~g~iP~~-l~~--~~~~~~~~~n~~~~~~ 522 (935)
+|+ .+|.. +.. ....+.+.+|+..|..
T Consensus 89 ~l~-~~~~~~~~~l~~L~~L~L~~N~~~c~c 118 (170)
T 3g39_A 89 QLK-SIPRGAFDNLKSLTHIWLLNNPWDCAC 118 (170)
T ss_dssp CCC-CCCTTTTTTCTTCCEEECCSSCBCTTB
T ss_pred ccC-EeCHHHhcCCCCCCEEEeCCCCCCCCc
Confidence 998 56554 332 4556778889888754
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.21 E-value=9.2e-12 Score=124.48 Aligned_cols=102 Identities=23% Similarity=0.265 Sum_probs=88.8
Q ss_pred CCCceEEEeCC--------CCCcEEEEEccCCCCcccCCccccCcccccccccccccCCCCCCC-ccccccccccccccc
Q 002336 400 VPWEWVTCSTT--------TPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENN 470 (935)
Q Consensus 400 ~~w~~v~c~~~--------~~~~l~~L~Ls~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~L~~N 470 (935)
+.|..+.|+.. .+.+++.|+|++|+|++..|..|.+|++|+.|+|++|+|++.++. |.++++|++|+|++|
T Consensus 9 C~~~~l~~s~n~l~~ip~~~~~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N 88 (170)
T 3g39_A 9 CSGTTVDCSGKSLASVPTGIPTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDN 88 (170)
T ss_dssp EETTEEECTTSCCSSCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cCCCEEEeCCCCcCccCccCCCCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCC
Confidence 35677777543 245799999999999988899999999999999999999998885 689999999999999
Q ss_pred cccCCCCCccCccccccccccccccCCCCCC
Q 002336 471 ELTGSLPSYMGSLPNLQELHIENNSFVGEIP 501 (935)
Q Consensus 471 ~l~g~iP~~l~~l~~L~~L~l~~N~l~g~iP 501 (935)
+|++..|..+..+++|+.|+|++|.+++..+
T Consensus 89 ~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~ 119 (170)
T 3g39_A 89 QLKSIPRGAFDNLKSLTHIWLLNNPWDCACS 119 (170)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCBCTTBG
T ss_pred ccCEeCHHHhcCCCCCCEEEeCCCCCCCCch
Confidence 9996666679999999999999999995544
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.21 E-value=1.7e-11 Score=128.70 Aligned_cols=109 Identities=23% Similarity=0.227 Sum_probs=94.8
Q ss_pred CCcEEEEEccCCCCcccCCccccCcccccccccccccCCCCCCC-ccccccccccccccccccCCCCCccCccccccccc
Q 002336 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 490 (935)
Q Consensus 412 ~~~l~~L~Ls~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~ 490 (935)
.++|+.|+|++|+|++..+..|.+|++|+.|+|++|+|++.++. +..+++|+.|+|++|+|+ .+|..+..+++|+.|+
T Consensus 63 l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~ 141 (229)
T 3e6j_A 63 LINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLA 141 (229)
T ss_dssp CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEE
T ss_pred ccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEE
Confidence 45899999999999854456679999999999999999998885 789999999999999999 9999999999999999
Q ss_pred cccccCCCCCCccccC---CceeeeecCCCCCccc
Q 002336 491 IENNSFVGEIPPALLT---GKVIFKYDNNPKLHKE 522 (935)
Q Consensus 491 l~~N~l~g~iP~~l~~---~~~~~~~~~n~~~~~~ 522 (935)
|++|+|+ .+|...+. ....+.+.+|+..|.+
T Consensus 142 L~~N~l~-~~~~~~~~~l~~L~~L~l~~N~~~c~c 175 (229)
T 3e6j_A 142 LDQNQLK-SIPHGAFDRLSSLTHAYLFGNPWDCEC 175 (229)
T ss_dssp CCSSCCC-CCCTTTTTTCTTCCEEECTTSCBCTTB
T ss_pred CCCCcCC-ccCHHHHhCCCCCCEEEeeCCCccCCc
Confidence 9999999 66654333 4567788999998864
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.21 E-value=1.9e-12 Score=142.79 Aligned_cols=108 Identities=26% Similarity=0.309 Sum_probs=98.8
Q ss_pred EEEEEccCCCCcccCCccccCcccccccccccccCCCCCCCccccccccccccccccccCCCCCccCccccccccccccc
Q 002336 415 ITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENN 494 (935)
Q Consensus 415 l~~L~Ls~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~l~~N 494 (935)
|+.|+|++|++++.+|..|.++++|+.|+|++|.+++.+|.+..+++|+.|+|++|+++|.+|..++++++|+.|+|++|
T Consensus 199 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N 278 (313)
T 1ogq_A 199 LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFN 278 (313)
T ss_dssp CSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGGCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSS
T ss_pred ccEEECcCCcccCcCCHHHhcCCCCCEEECCCCceeeecCcccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCC
Confidence 89999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cCCCCCCccc-cCCceeeeecCCCCCccc
Q 002336 495 SFVGEIPPAL-LTGKVIFKYDNNPKLHKE 522 (935)
Q Consensus 495 ~l~g~iP~~l-~~~~~~~~~~~n~~~~~~ 522 (935)
+|+|.+|..- ......+.+.+|+++|+.
T Consensus 279 ~l~~~ip~~~~l~~L~~l~l~~N~~lc~~ 307 (313)
T 1ogq_A 279 NLCGEIPQGGNLQRFDVSAYANNKCLCGS 307 (313)
T ss_dssp EEEEECCCSTTGGGSCGGGTCSSSEEEST
T ss_pred cccccCCCCccccccChHHhcCCCCccCC
Confidence 9999999862 123456678999999974
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.20 E-value=1.7e-11 Score=123.02 Aligned_cols=103 Identities=22% Similarity=0.338 Sum_probs=86.2
Q ss_pred EEEEccCCCCcccCCccccCcccccccccccccCCCCCC-CccccccccccccccccccCCCCCccCccccccccccccc
Q 002336 416 TKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENN 494 (935)
Q Consensus 416 ~~L~Ls~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p-~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~l~~N 494 (935)
+.|++++|+|. .+|..+. ++|+.|+|++|+|++.+| .|.++++|+.|+|++|+|++..+..+.++++|+.|+|++|
T Consensus 15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N 91 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN 91 (174)
T ss_dssp SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence 57899999996 8898775 899999999999999988 6899999999999999999644455789999999999999
Q ss_pred cCCCCCCcc-ccC--CceeeeecCCCCCccc
Q 002336 495 SFVGEIPPA-LLT--GKVIFKYDNNPKLHKE 522 (935)
Q Consensus 495 ~l~g~iP~~-l~~--~~~~~~~~~n~~~~~~ 522 (935)
+|+ .+|.. +.. ....+.+.+|+..|..
T Consensus 92 ~l~-~l~~~~~~~l~~L~~L~L~~N~~~c~~ 121 (174)
T 2r9u_A 92 HLK-SIPRGAFDNLKSLTHIYLYNNPWDCEC 121 (174)
T ss_dssp CCC-CCCTTTTTTCTTCSEEECCSSCBCTTB
T ss_pred ccc-eeCHHHhccccCCCEEEeCCCCccccc
Confidence 999 67765 332 4566788999988753
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.18 E-value=3.1e-11 Score=124.46 Aligned_cols=121 Identities=22% Similarity=0.337 Sum_probs=94.6
Q ss_pred CCCCCCCCceEEEeCC--------CCCcEEEEEccCCCCcccCCccccCcccccccccccccCCCCCCC-cccccccccc
Q 002336 395 DPCVPVPWEWVTCSTT--------TPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIV 465 (935)
Q Consensus 395 dpC~~~~w~~v~c~~~--------~~~~l~~L~Ls~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L 465 (935)
+.|. |.|.++.|+.. .+++|+.|+|++|++++..+..|.++++|++|+|++|+|++.++. +.++++|++|
T Consensus 3 ~~C~-C~~~~v~c~~~~l~~~p~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 81 (208)
T 2o6s_A 3 SRCS-CSGTTVECYSQGRTSVPTGIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYL 81 (208)
T ss_dssp TTCE-EETTEEECCSSCCSSCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred CCCE-ECCCEEEecCCCccCCCCCCCCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEE
Confidence 3453 47899998753 245799999999999966666788999999999999999988774 6889999999
Q ss_pred ccccccccCCCCCccCccccccccccccccCCCCCCccc-cC--CceeeeecCCC
Q 002336 466 HLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL-LT--GKVIFKYDNNP 517 (935)
Q Consensus 466 ~L~~N~l~g~iP~~l~~l~~L~~L~l~~N~l~g~iP~~l-~~--~~~~~~~~~n~ 517 (935)
+|++|++++..+..++++++|+.|+|++|+++ .+|... .. ....+.+.+|.
T Consensus 82 ~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~l~~N~ 135 (208)
T 2o6s_A 82 NLSTNQLQSLPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQ 135 (208)
T ss_dssp ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSC
T ss_pred ECCCCcCCccCHhHhcCccCCCEEEcCCCcCc-ccCHhHhccCCcCCEEECCCCc
Confidence 99999999655566889999999999999998 555543 32 34455666664
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.17 E-value=2.3e-11 Score=126.85 Aligned_cols=119 Identities=22% Similarity=0.209 Sum_probs=98.0
Q ss_pred CCCceEEEeCC--------CCCcEEEEEccCCCCcccCCccccCcccccccccccccCCCCCC-Cccccccccccccccc
Q 002336 400 VPWEWVTCSTT--------TPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENN 470 (935)
Q Consensus 400 ~~w~~v~c~~~--------~~~~l~~L~Ls~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p-~~~~l~~L~~L~L~~N 470 (935)
|.|..+.|... .+++++.|+|++|+|++..+..|.++++|+.|+|++|+|++..| .|.++++|++|+|++|
T Consensus 11 C~~~~v~c~~~~l~~iP~~l~~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N 90 (220)
T 2v9t_B 11 CSNNIVDCRGKGLTEIPTNLPETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGN 90 (220)
T ss_dssp EETTEEECTTSCCSSCCSSCCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSS
T ss_pred ECCCEEEcCCCCcCcCCCccCcCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCC
Confidence 46777887643 23479999999999997777799999999999999999999987 6999999999999999
Q ss_pred cccCCCCCccCccccccccccccccCCCCCCccccC--CceeeeecCCCC
Q 002336 471 ELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLT--GKVIFKYDNNPK 518 (935)
Q Consensus 471 ~l~g~iP~~l~~l~~L~~L~l~~N~l~g~iP~~l~~--~~~~~~~~~n~~ 518 (935)
+|+...+..+..+++|+.|+|++|+|++..|..+.. ....+.+.+|..
T Consensus 91 ~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l 140 (220)
T 2v9t_B 91 KITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKL 140 (220)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred cCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcC
Confidence 999444445789999999999999999666665543 445666777754
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.16 E-value=1.3e-11 Score=125.91 Aligned_cols=91 Identities=22% Similarity=0.341 Sum_probs=86.3
Q ss_pred CCcEEEEEccCCCCcccCCccccCcccccccccccccCCCCCCC-ccccccccccccccccccCCCCCccCccccccccc
Q 002336 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 490 (935)
Q Consensus 412 ~~~l~~L~Ls~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~ 490 (935)
.++|+.|+|++|+|++..|..|.++++|+.|+|++|+|++.+|. |.++++|+.|+|++|+|++.+|..++.+++|+.|+
T Consensus 53 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 132 (192)
T 1w8a_A 53 LPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLN 132 (192)
T ss_dssp CTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEE
T ss_pred CCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEE
Confidence 46899999999999998899999999999999999999999985 89999999999999999999999999999999999
Q ss_pred cccccCCCCCCc
Q 002336 491 IENNSFVGEIPP 502 (935)
Q Consensus 491 l~~N~l~g~iP~ 502 (935)
|++|.+++..|.
T Consensus 133 L~~N~l~c~c~l 144 (192)
T 1w8a_A 133 LASNPFNCNCHL 144 (192)
T ss_dssp CTTCCBCCSGGG
T ss_pred eCCCCccCcCcc
Confidence 999999988774
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.15 E-value=4.5e-11 Score=130.22 Aligned_cols=110 Identities=27% Similarity=0.340 Sum_probs=96.1
Q ss_pred CCcEEEEEccCCCCcccCCccccCcccccccccccccCCCCCCC-ccccccccccccccccccCCCCCccCccccccccc
Q 002336 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 490 (935)
Q Consensus 412 ~~~l~~L~Ls~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~ 490 (935)
.++|+.|+|++|+|++..|..|.+|++|+.|+|++|+|++.++. |..+++|+.|+|++|+|++..+..+..+++|+.|+
T Consensus 99 l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~ 178 (290)
T 1p9a_G 99 LPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLL 178 (290)
T ss_dssp CTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEE
T ss_pred CCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEE
Confidence 46899999999999977778899999999999999999998884 78999999999999999944444578899999999
Q ss_pred cccccCCCCCCccccCC--ceeeeecCCCCCccc
Q 002336 491 IENNSFVGEIPPALLTG--KVIFKYDNNPKLHKE 522 (935)
Q Consensus 491 l~~N~l~g~iP~~l~~~--~~~~~~~~n~~~~~~ 522 (935)
|++|+|+ .||..++.. ...+.+.+||+.|.+
T Consensus 179 L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~C~c 211 (290)
T 1p9a_G 179 LQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCNC 211 (290)
T ss_dssp CCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCSG
T ss_pred CCCCcCC-ccChhhcccccCCeEEeCCCCccCcC
Confidence 9999999 999988763 456778999999863
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.15 E-value=1.7e-11 Score=136.86 Aligned_cols=102 Identities=21% Similarity=0.246 Sum_probs=87.5
Q ss_pred EEccCC-CCcccCCccccCccccccccccc-ccCCCCCC-CccccccccccccccccccCCCCCccCccccccccccccc
Q 002336 418 IALSGK-NLKGEIPPELKNMEALTELWLDG-NFLTGPLP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENN 494 (935)
Q Consensus 418 L~Ls~n-~l~g~ip~~i~~L~~L~~L~Ls~-N~l~g~~p-~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~l~~N 494 (935)
++++++ +|+ .||. |..+++|+.|+|++ |+|++.+| .|.+|++|+.|+|++|+|+|..|..|++|++|+.|+|++|
T Consensus 13 v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N 90 (347)
T 2ifg_A 13 LRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFN 90 (347)
T ss_dssp EECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSS
T ss_pred EEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCCC
Confidence 467777 788 6888 99999999999996 99999887 6899999999999999999888889999999999999999
Q ss_pred cCCCCCCccccCC--ceeeeecCCCCCccc
Q 002336 495 SFVGEIPPALLTG--KVIFKYDNNPKLHKE 522 (935)
Q Consensus 495 ~l~g~iP~~l~~~--~~~~~~~~n~~~~~~ 522 (935)
+|+ .+|..++.. ...+.+.+|+..|.+
T Consensus 91 ~l~-~~~~~~~~~~~L~~l~l~~N~~~c~c 119 (347)
T 2ifg_A 91 ALE-SLSWKTVQGLSLQELVLSGNPLHCSC 119 (347)
T ss_dssp CCS-CCCSTTTCSCCCCEEECCSSCCCCCG
T ss_pred ccc-eeCHHHcccCCceEEEeeCCCccCCC
Confidence 999 677766543 556778899988863
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.14 E-value=6.6e-11 Score=125.83 Aligned_cols=110 Identities=20% Similarity=0.214 Sum_probs=94.0
Q ss_pred CCcEEEEEccCCCCcccCCccccCcccccccccccccCCCCCCC-ccccccccccccccccccCCCCCccCccccccccc
Q 002336 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 490 (935)
Q Consensus 412 ~~~l~~L~Ls~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~ 490 (935)
.++|+.|+|++|++++..+..|.++++|++|+|++|+|++.++. +.++++|+.|+|++|+|++..|..++.+++|+.|+
T Consensus 82 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 161 (251)
T 3m19_A 82 LTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLS 161 (251)
T ss_dssp CTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCcCCEEECCCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEE
Confidence 45899999999999977777889999999999999999988885 78999999999999999966666899999999999
Q ss_pred cccccCCCCCCccccC--CceeeeecCCCCCcc
Q 002336 491 IENNSFVGEIPPALLT--GKVIFKYDNNPKLHK 521 (935)
Q Consensus 491 l~~N~l~g~iP~~l~~--~~~~~~~~~n~~~~~ 521 (935)
|++|+|++..|..+.. ....+.+.+|+..|.
T Consensus 162 L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 194 (251)
T 3m19_A 162 LSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCS 194 (251)
T ss_dssp CCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTT
T ss_pred CCCCcCCccCHHHHhCCCCCCEEEeeCCceeCC
Confidence 9999999444444433 456778899998874
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.13 E-value=3.6e-11 Score=125.42 Aligned_cols=123 Identities=15% Similarity=0.193 Sum_probs=100.7
Q ss_pred CCCCCCCCceEEEeCCC--------CCcEEEEEccCCCCcccCCc-cccCcccccccccccccCCCCCC-Cccccccccc
Q 002336 395 DPCVPVPWEWVTCSTTT--------PPRITKIALSGKNLKGEIPP-ELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRI 464 (935)
Q Consensus 395 dpC~~~~w~~v~c~~~~--------~~~l~~L~Ls~n~l~g~ip~-~i~~L~~L~~L~Ls~N~l~g~~p-~~~~l~~L~~ 464 (935)
..|. |.|..+.|+... +..++.|+|++|+|++..|. .|.++++|+.|+|++|+|++..+ .|.++++|+.
T Consensus 7 ~~C~-C~~~~l~~s~n~l~~iP~~~~~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~ 85 (220)
T 2v70_A 7 EKCR-CEGTTVDCSNQKLNKIPEHIPQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNE 85 (220)
T ss_dssp TTCE-EETTEEECCSSCCSSCCSCCCTTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCE
T ss_pred CCCE-ECCCEeEeCCCCcccCccCCCCCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCE
Confidence 3443 467777776432 34678999999999977664 58999999999999999999988 7999999999
Q ss_pred cccccccccCCCCCccCccccccccccccccCCCCCCccccC--CceeeeecCCCC
Q 002336 465 VHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLT--GKVIFKYDNNPK 518 (935)
Q Consensus 465 L~L~~N~l~g~iP~~l~~l~~L~~L~l~~N~l~g~iP~~l~~--~~~~~~~~~n~~ 518 (935)
|+|++|++++..|..+..+++|+.|+|++|+|++..|..+.. ....+.+.+|..
T Consensus 86 L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l 141 (220)
T 2v70_A 86 ILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQI 141 (220)
T ss_dssp EECCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCC
T ss_pred EECCCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcC
Confidence 999999999877778999999999999999999766776654 445566677753
|
| >2jwp_A Malectin, MGC80075; sugar binding, sugar binding protein; NMR {Xenopus laevis} PDB: 2k46_A* 2kr2_A* | Back alignment and structure |
|---|
Probab=99.12 E-value=3.4e-10 Score=113.48 Aligned_cols=141 Identities=14% Similarity=0.187 Sum_probs=95.1
Q ss_pred eEEEecCCCCCccCCCCCeEEecCCccccCCceeeecCC------C-CCcccccccccccCCCCcceEEeeecCCceeEE
Q 002336 25 FISIDCGSTSNYTDPSTGLAWISDIGIMNNGKSVKVENP------S-GNWMQYRTRRDLPIDNKKYCYNLITKERRRYLV 97 (935)
Q Consensus 25 ~~~idcg~~~~~~~~~~~~~~~~d~~~~~~g~~~~~~~~------~-~~~~~~~tlr~fp~~~~~~cy~l~~~~~~~ylv 97 (935)
-+.||||+.. .+| ..+.+|.+|..|...|........ . ...+.|.|-|.|| .+.+|.+|+.++++|+|
T Consensus 7 ~~~INcGg~~-~~d-~~gr~w~~D~~~~~~g~~~~~~~~~~~~~~~~~~~~lY~TaR~~~---~~~tY~f~v~~~G~Y~V 81 (174)
T 2jwp_A 7 IWAVNAGGES-HVD-VHGIHYRKDPLEGRVGRASDYGMKLPILRSNPEDQVLYQTERYNE---DSFGYDIPIKEEGEYVL 81 (174)
T ss_dssp EEEEEETSSS-EEE-TTTEEECSSCSSTTCCCCCCCCTTSCCSSSCHHHHHTTTCCCCCC---SCEEEEEECCSCEEEEE
T ss_pred EEEEECCCCC-ccC-CCCCEEcCCcCcccCCcccccccceEecccCCCCchhhhhhccCC---CCeEEEEEeCCCeEEEE
Confidence 4679999765 455 579999999988644532211110 0 1134678999998 37899999999999999
Q ss_pred EEEeeecCCCCCCCCCeEEEEEcCcee-EEEEec---CCccceEEEEEEe-------------cCCCCcccceeccCCCC
Q 002336 98 RATFQYGSLGSEASYPKFQLYLDATLW-STVTVL---DASRVYAKEMIIR-------------APSDSIDVCICCAVTGS 160 (935)
Q Consensus 98 r~~~~yg~yd~~~~~p~fd~~~~~~~w-~~v~~~---~~~~~~~~e~~~~-------------~~~~~~~vcl~~~~~~~ 160 (935)
|.-|.--.|.+ .....||++++|..- .-.++. .....+..+..+. .....+.|.|.....+.
T Consensus 82 rLhF~ei~~~~-~~~rvFdV~ing~~~l~~fdi~~~ag~~~~~~~~~~~~v~~~~l~i~~~~~~~~g~L~I~f~p~~~~~ 160 (174)
T 2jwp_A 82 VLKFAEVYFAQ-SQQKVFDVRVNGHTVVKDLDIFDRVGHSTAHDEIIPISIKKGKLSVQGEVSTFTGKLSVEFVKGYYDN 160 (174)
T ss_dssp EEEEECCSCCC-SSSSCEEEEETTEEEEEEECHHHHHSSSSCEEEEEEEEEETTEEEETTEEEECCSEEEEEEECSSSCS
T ss_pred EEEEeccccCC-CCCeEeEEEECCEEeecCcCHHHhhCCCeeEEEEEEEEEecCceeeeeeecccCCeEEEEEeccCCCC
Confidence 99997766653 566799999999542 222221 1223444554443 24456777777544568
Q ss_pred ceeeeeeeeec
Q 002336 161 PFISTLELRPL 171 (935)
Q Consensus 161 pfis~le~~~l 171 (935)
|||++||+.+-
T Consensus 161 a~inaIEI~~~ 171 (174)
T 2jwp_A 161 PKVCALFIMKG 171 (174)
T ss_dssp SSEEEEEEESS
T ss_pred cEEEEEEEEeC
Confidence 99999999874
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.11 E-value=5.4e-11 Score=119.39 Aligned_cols=90 Identities=19% Similarity=0.272 Sum_probs=81.0
Q ss_pred CCcEEEEEccCCCCcccCCccccCcccccccccccccCCCCCCC-ccccccccccccccccccCCCCCccCccccccccc
Q 002336 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 490 (935)
Q Consensus 412 ~~~l~~L~Ls~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~ 490 (935)
+.+|+.|+|++|+|++..|..|.+|++|+.|+|++|+|++.++. |.++++|+.|+|++|+|++..+..+..+++|+.|+
T Consensus 32 ~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~ 111 (174)
T 2r9u_A 32 PTDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDNHLKSIPRGAFDNLKSLTHIY 111 (174)
T ss_dssp CTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEE
T ss_pred CCCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCCccceeCHHHhccccCCCEEE
Confidence 45799999999999988899999999999999999999998885 68999999999999999955555699999999999
Q ss_pred cccccCCCCCCc
Q 002336 491 IENNSFVGEIPP 502 (935)
Q Consensus 491 l~~N~l~g~iP~ 502 (935)
|++|.+. ..|.
T Consensus 112 L~~N~~~-c~~~ 122 (174)
T 2r9u_A 112 LYNNPWD-CECR 122 (174)
T ss_dssp CCSSCBC-TTBG
T ss_pred eCCCCcc-cccc
Confidence 9999998 4444
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.11 E-value=1.1e-10 Score=120.23 Aligned_cols=109 Identities=20% Similarity=0.259 Sum_probs=92.6
Q ss_pred CCcEEEEEccCCCCcccCCccccCcccccccccccccCCCCCCC-ccccccccccccccccccCCCCCccCccccccccc
Q 002336 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 490 (935)
Q Consensus 412 ~~~l~~L~Ls~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~ 490 (935)
.++|+.|+|++|++++..+..|.++++|++|+|++|+|++.++. +.++++|+.|+|++|++++..+..+..+++|+.|+
T Consensus 51 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 130 (208)
T 2o6s_A 51 LTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLR 130 (208)
T ss_dssp CTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred cccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEE
Confidence 35899999999999965556689999999999999999988875 78999999999999999976666789999999999
Q ss_pred cccccCCCCCCccc-cC--CceeeeecCCCCCcc
Q 002336 491 IENNSFVGEIPPAL-LT--GKVIFKYDNNPKLHK 521 (935)
Q Consensus 491 l~~N~l~g~iP~~l-~~--~~~~~~~~~n~~~~~ 521 (935)
|++|+++ .+|... .. ....+.+.+|+..|.
T Consensus 131 l~~N~l~-~~~~~~~~~l~~L~~L~l~~N~~~~~ 163 (208)
T 2o6s_A 131 LYQNQLK-SVPDGVFDRLTSLQYIWLHDNPWDCT 163 (208)
T ss_dssp CCSSCCS-CCCTTTTTTCTTCCEEECCSCCBCCC
T ss_pred CCCCccc-eeCHHHhccCCCccEEEecCCCeecC
Confidence 9999999 566543 32 456678899988764
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.11 E-value=1e-10 Score=125.89 Aligned_cols=111 Identities=17% Similarity=0.154 Sum_probs=95.5
Q ss_pred CCcEEEEEccCCCCcccCCccccCcccccccccccccCCCCCCC-ccccccccccccccccccCCCCCccCccccccccc
Q 002336 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 490 (935)
Q Consensus 412 ~~~l~~L~Ls~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~ 490 (935)
.++|+.|+|++|++++..+..|.++++|+.|+|++|++++.++. +.++++|+.|+|++|++++..|..++.+++|+.|+
T Consensus 108 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 187 (272)
T 3rfs_A 108 LTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLR 187 (272)
T ss_dssp CTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEE
Confidence 46899999999999977777799999999999999999998885 68999999999999999977777789999999999
Q ss_pred cccccCCCCCCccccC--CceeeeecCCCCCccc
Q 002336 491 IENNSFVGEIPPALLT--GKVIFKYDNNPKLHKE 522 (935)
Q Consensus 491 l~~N~l~g~iP~~l~~--~~~~~~~~~n~~~~~~ 522 (935)
|++|++++..|..+.. ....+.+.+|+..|..
T Consensus 188 L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~ 221 (272)
T 3rfs_A 188 LYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTC 221 (272)
T ss_dssp CCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCT
T ss_pred CCCCcCCccCHHHHhCCcCCCEEEccCCCccccC
Confidence 9999999655544433 5567788999988753
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.10 E-value=4e-11 Score=119.17 Aligned_cols=104 Identities=22% Similarity=0.275 Sum_probs=86.8
Q ss_pred CCcEEEEEccCCCCc-ccCCccccCcccccccccccccCCCCCCCccccccccccccccccccCCCCCccCccccccccc
Q 002336 412 PPRITKIALSGKNLK-GEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 490 (935)
Q Consensus 412 ~~~l~~L~Ls~n~l~-g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~ 490 (935)
+++|+.|+|++|+++ |.+|..+..+++|+.|+|++|.+++. +.+..+++|+.|+|++|++++.+|..+.++++|+.|+
T Consensus 23 ~~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 101 (168)
T 2ell_A 23 PAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV-SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLN 101 (168)
T ss_dssp TTSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC-SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEE
T ss_pred cccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh-hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEe
Confidence 457999999999998 88999899999999999999999988 8889999999999999999987888888899999999
Q ss_pred cccccCCCCCC--ccccC--CceeeeecCCC
Q 002336 491 IENNSFVGEIP--PALLT--GKVIFKYDNNP 517 (935)
Q Consensus 491 l~~N~l~g~iP--~~l~~--~~~~~~~~~n~ 517 (935)
|++|+++ .+| ..+.. ....+.+.+|+
T Consensus 102 Ls~N~l~-~~~~~~~l~~l~~L~~L~l~~N~ 131 (168)
T 2ell_A 102 LSGNKLK-DISTLEPLKKLECLKSLDLFNCE 131 (168)
T ss_dssp CBSSSCC-SSGGGGGGSSCSCCCEEECCSSG
T ss_pred ccCCccC-cchhHHHHhcCCCCCEEEeeCCc
Confidence 9999998 555 44433 33445556664
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.10 E-value=4.8e-11 Score=132.35 Aligned_cols=107 Identities=16% Similarity=0.239 Sum_probs=84.4
Q ss_pred CCcEEEEEccCCCCcccCCccccCcccccccccccccCCCCCCCccccccccccccccccccCCCCCccCcccccccccc
Q 002336 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 491 (935)
Q Consensus 412 ~~~l~~L~Ls~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~l 491 (935)
.++|+.|+|++|+++ .+|..++++++|+.|+|++|.+++.++.+.++++|+.|+|++|++.+.+|..++++++|+.|+|
T Consensus 182 l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L 260 (328)
T 4fcg_A 182 LVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLIL 260 (328)
T ss_dssp STTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCCCCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEEC
T ss_pred CCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCcCchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEEC
Confidence 357888888888888 7888888888888888888888877667888888888888888888888888888888888888
Q ss_pred ccccCCCCCCccccC--CceeeeecCCCCC
Q 002336 492 ENNSFVGEIPPALLT--GKVIFKYDNNPKL 519 (935)
Q Consensus 492 ~~N~l~g~iP~~l~~--~~~~~~~~~n~~~ 519 (935)
++|++.+.+|..+.. ....+.+.+|+..
T Consensus 261 ~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~ 290 (328)
T 4fcg_A 261 KDCSNLLTLPLDIHRLTQLEKLDLRGCVNL 290 (328)
T ss_dssp TTCTTCCBCCTTGGGCTTCCEEECTTCTTC
T ss_pred CCCCchhhcchhhhcCCCCCEEeCCCCCch
Confidence 888888888877654 3445666666544
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.08 E-value=3.2e-11 Score=117.27 Aligned_cols=104 Identities=19% Similarity=0.228 Sum_probs=82.1
Q ss_pred CcEEEEEccCCCCc-ccCCccccCcccccccccccccCCCCCCCccccccccccccccccccCCCCCccCcccccccccc
Q 002336 413 PRITKIALSGKNLK-GEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 491 (935)
Q Consensus 413 ~~l~~L~Ls~n~l~-g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~l 491 (935)
++++.|+|++|+++ |.+|..+..+++|+.|+|++|.+++. +.++++++|+.|+|++|++++.+|..++.+++|+.|++
T Consensus 17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l 95 (149)
T 2je0_A 17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI-ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNL 95 (149)
T ss_dssp GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC-TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEEC
T ss_pred ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc-hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEEC
Confidence 57888899999888 88888888889999999999988887 77888888999999999988778888888888999999
Q ss_pred ccccCCCC-CCccccC--CceeeeecCCC
Q 002336 492 ENNSFVGE-IPPALLT--GKVIFKYDNNP 517 (935)
Q Consensus 492 ~~N~l~g~-iP~~l~~--~~~~~~~~~n~ 517 (935)
++|++++. .|..+.. ....+.+.+|+
T Consensus 96 s~N~i~~~~~~~~~~~l~~L~~L~l~~N~ 124 (149)
T 2je0_A 96 SGNKIKDLSTIEPLKKLENLKSLDLFNCE 124 (149)
T ss_dssp TTSCCCSHHHHGGGGGCTTCCEEECTTCG
T ss_pred CCCcCCChHHHHHHhhCCCCCEEeCcCCc
Confidence 99988841 2244443 34455566664
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.08 E-value=7.2e-11 Score=141.98 Aligned_cols=113 Identities=16% Similarity=0.167 Sum_probs=99.4
Q ss_pred CCCcEEEEEccCCCCc-ccCCccccCcccccccccccccCCCCCC-CccccccccccccccccccCCCCCccCccccccc
Q 002336 411 TPPRITKIALSGKNLK-GEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQE 488 (935)
Q Consensus 411 ~~~~l~~L~Ls~n~l~-g~ip~~i~~L~~L~~L~Ls~N~l~g~~p-~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~ 488 (935)
..+.++.|+|++|++. +.+|..|..|++|+.|+|++|+|++.+| .|.+|++|+.|+|++|+|++..|..++++++|+.
T Consensus 467 ~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~ 546 (635)
T 4g8a_A 467 GLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQV 546 (635)
T ss_dssp TCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCE
T ss_pred cchhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCE
Confidence 3568999999999854 4578889999999999999999999988 6899999999999999999888888999999999
Q ss_pred cccccccCCCCCCccccC---CceeeeecCCCCCcccc
Q 002336 489 LHIENNSFVGEIPPALLT---GKVIFKYDNNPKLHKES 523 (935)
Q Consensus 489 L~l~~N~l~g~iP~~l~~---~~~~~~~~~n~~~~~~~ 523 (935)
|+|++|+|++..|..+.. ....+.+++||+.|.+.
T Consensus 547 L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~C~ 584 (635)
T 4g8a_A 547 LDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCE 584 (635)
T ss_dssp EECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCSGG
T ss_pred EECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcccCC
Confidence 999999999887877653 45668899999999754
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.06 E-value=2.8e-10 Score=121.60 Aligned_cols=140 Identities=14% Similarity=0.072 Sum_probs=109.8
Q ss_pred HhhcccccccccEEEEEEEECCCcEEEEEEccCcchhhhHHHHHHHHHHHhcC-CCcccccceeeeccceEEEEEEecCC
Q 002336 615 NNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQRILVYEYMHN 693 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~-HpnIv~l~g~~~~~~~~~lV~E~~~~ 693 (935)
+.+...++.|+.+.||++... ++.+++|+...........+.+|+++++.+. +..+.++++++...+..++||||++|
T Consensus 16 ~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G 94 (263)
T 3tm0_A 16 YRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADG 94 (263)
T ss_dssp SEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSS
T ss_pred ceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCC
Confidence 344567888888999999865 7899999986532233456899999999995 67788899999888889999999999
Q ss_pred CCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhc------------------------------------------
Q 002336 694 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG------------------------------------------ 731 (935)
Q Consensus 694 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~------------------------------------------ 731 (935)
.+|.+.+.. ......++.+++++|+.||+.
T Consensus 95 ~~l~~~~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (263)
T 3tm0_A 95 VLCSEEYED--------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKD 166 (263)
T ss_dssp EEHHHHCCT--------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSS
T ss_pred eehhhccCC--------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCC
Confidence 999876421 112347889999999999971
Q ss_pred --------------CCCceEecCCCCCCccccCCCcEEEeeccccc
Q 002336 732 --------------CNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 763 (935)
Q Consensus 732 --------------~~~~ivH~DLkp~NILld~~~~vkL~DFGla~ 763 (935)
....++|||+++.||+++++..+.|+||+.+.
T Consensus 167 ~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 167 PRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp HHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 01459999999999999876666799998764
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.05 E-value=2.4e-10 Score=122.81 Aligned_cols=110 Identities=22% Similarity=0.282 Sum_probs=96.1
Q ss_pred CCcEEEEEccCCCCcccCCccccCcccccccccccccCCCCCCC-ccccccccccccccccccCCCCCccCccccccccc
Q 002336 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 490 (935)
Q Consensus 412 ~~~l~~L~Ls~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~ 490 (935)
.++|+.|+|++|++++..+..|.++++|+.|+|++|.|++.++. +..+++|+.|+|++|++++..|..+.++++|+.|+
T Consensus 108 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 187 (270)
T 2o6q_A 108 LVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLK 187 (270)
T ss_dssp CSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEE
T ss_pred ccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEE
Confidence 35899999999999987778899999999999999999998875 89999999999999999976666799999999999
Q ss_pred cccccCCCCCCccccC---CceeeeecCCCCCccc
Q 002336 491 IENNSFVGEIPPALLT---GKVIFKYDNNPKLHKE 522 (935)
Q Consensus 491 l~~N~l~g~iP~~l~~---~~~~~~~~~n~~~~~~ 522 (935)
|++|+++ .+|...+. ....+.+.+||+.|.+
T Consensus 188 L~~N~l~-~~~~~~~~~l~~L~~L~l~~N~~~c~c 221 (270)
T 2o6q_A 188 LDNNQLK-RVPEGAFDSLEKLKMLQLQENPWDCTC 221 (270)
T ss_dssp CCSSCCS-CCCTTTTTTCTTCCEEECCSSCBCCSS
T ss_pred CCCCcCC-cCCHHHhccccCCCEEEecCCCeeCCC
Confidence 9999999 67765433 4567788999998864
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.05 E-value=2e-10 Score=122.03 Aligned_cols=105 Identities=22% Similarity=0.281 Sum_probs=83.4
Q ss_pred CCcEEEEEccCCCCcccCCccccCcccccccccccccCCCCCC-CccccccccccccccccccCCCCCccCccccccccc
Q 002336 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 490 (935)
Q Consensus 412 ~~~l~~L~Ls~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p-~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~ 490 (935)
++.++.|+|++|++++..+..|.++++|++|+|++|.|++.+| .+.++++|+.|+|++|++++..|..+..+++|+.|+
T Consensus 34 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 113 (251)
T 3m19_A 34 PADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLY 113 (251)
T ss_dssp CTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEE
Confidence 4568889999999988777788999999999999999998887 478889999999999999866667788889999999
Q ss_pred cccccCCCCCCccccC---CceeeeecCCC
Q 002336 491 IENNSFVGEIPPALLT---GKVIFKYDNNP 517 (935)
Q Consensus 491 l~~N~l~g~iP~~l~~---~~~~~~~~~n~ 517 (935)
|++|+|+ .+|...+. ....+.+++|.
T Consensus 114 L~~N~l~-~~~~~~~~~l~~L~~L~Ls~N~ 142 (251)
T 3m19_A 114 LGGNQLK-SLPSGVFDRLTKLKELRLNTNQ 142 (251)
T ss_dssp CCSSCCC-CCCTTTTTTCTTCCEEECCSSC
T ss_pred cCCCcCC-CcChhHhccCCcccEEECcCCc
Confidence 9999988 56654432 34455556664
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.05 E-value=1.5e-10 Score=124.38 Aligned_cols=106 Identities=20% Similarity=0.272 Sum_probs=80.4
Q ss_pred CCcEEEEEccCCCCcccCCccccCcccccccccccccCCCCCCC-ccccccccccccccccccCCCCCccCccccccccc
Q 002336 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 490 (935)
Q Consensus 412 ~~~l~~L~Ls~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~ 490 (935)
++.++.|+|++|++++..+..|.++++|++|+|++|.++..++. +.++++|++|+|++|++++..+..+.++++|+.|+
T Consensus 36 ~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 115 (270)
T 2o6q_A 36 PADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELR 115 (270)
T ss_dssp CTTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEE
T ss_pred CCCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEE
Confidence 34688899999998866666888999999999999999877774 57889999999999998865556678889999999
Q ss_pred cccccCCCCCCccccC--CceeeeecCCC
Q 002336 491 IENNSFVGEIPPALLT--GKVIFKYDNNP 517 (935)
Q Consensus 491 l~~N~l~g~iP~~l~~--~~~~~~~~~n~ 517 (935)
|++|++++..|..+.. ....+.+++|.
T Consensus 116 l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~ 144 (270)
T 2o6q_A 116 LDRNQLKSLPPRVFDSLTKLTYLSLGYNE 144 (270)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred CCCCccCeeCHHHhCcCcCCCEEECCCCc
Confidence 9999988433333322 34455556664
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.05 E-value=9.5e-11 Score=138.96 Aligned_cols=117 Identities=17% Similarity=0.200 Sum_probs=98.2
Q ss_pred CCCceEEEeCCC----------CCcEEEEEccCCCCcccCCccccCcccccccccccccCCCCCC-Cccccccccccccc
Q 002336 400 VPWEWVTCSTTT----------PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLE 468 (935)
Q Consensus 400 ~~w~~v~c~~~~----------~~~l~~L~Ls~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p-~~~~l~~L~~L~L~ 468 (935)
|+|.++ |+|.. +++|+.|+|++|++++..|..|.++++|++|+|++|++++.+| .|+++++|++|+|+
T Consensus 4 C~~~~~-c~~~~~~l~~ip~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls 82 (549)
T 2z81_A 4 CDASGV-CDGRSRSFTSIPSGLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLS 82 (549)
T ss_dssp ECTTSE-EECTTSCCSSCCSCCCTTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECT
T ss_pred CCCCce-EECCCCccccccccCCCCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECC
Confidence 479998 98752 3579999999999998888999999999999999999999887 68999999999999
Q ss_pred cccccCCCCCccCccccccccccccccCCC-CCCccccC--CceeeeecCCC
Q 002336 469 NNELTGSLPSYMGSLPNLQELHIENNSFVG-EIPPALLT--GKVIFKYDNNP 517 (935)
Q Consensus 469 ~N~l~g~iP~~l~~l~~L~~L~l~~N~l~g-~iP~~l~~--~~~~~~~~~n~ 517 (935)
+|++++..|..++++++|++|+|++|++++ .+|..+.. ....+.+.+|.
T Consensus 83 ~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~ 134 (549)
T 2z81_A 83 DNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVE 134 (549)
T ss_dssp TSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESS
T ss_pred CCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCc
Confidence 999997777779999999999999999985 45655543 34455556664
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.02 E-value=1.3e-10 Score=139.63 Aligned_cols=105 Identities=15% Similarity=0.064 Sum_probs=88.2
Q ss_pred CCcEEEEEccCCCCcccCCccccCcccccccccccccCCCCCC-CccccccccccccccccccCCCCCccCccccccccc
Q 002336 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 490 (935)
Q Consensus 412 ~~~l~~L~Ls~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p-~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~ 490 (935)
|..++.|||++|+|++..|..|.+|++|++|+|++|+|++.+| .|.+|++|++|+|++|+|++..|..|.+|++|+.|+
T Consensus 51 p~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~ 130 (635)
T 4g8a_A 51 PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLV 130 (635)
T ss_dssp CTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEE
T ss_pred CcCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEE
Confidence 4579999999999997667789999999999999999999888 589999999999999999965556789999999999
Q ss_pred cccccCCCCCCcc-ccC--CceeeeecCCC
Q 002336 491 IENNSFVGEIPPA-LLT--GKVIFKYDNNP 517 (935)
Q Consensus 491 l~~N~l~g~iP~~-l~~--~~~~~~~~~n~ 517 (935)
|++|+|+ .+|.. +.. ....+.+++|.
T Consensus 131 Ls~N~l~-~l~~~~~~~L~~L~~L~Ls~N~ 159 (635)
T 4g8a_A 131 AVETNLA-SLENFPIGHLKTLKELNVAHNL 159 (635)
T ss_dssp CTTSCCC-CSTTCCCTTCTTCCEEECCSSC
T ss_pred CCCCcCC-CCChhhhhcCcccCeeccccCc
Confidence 9999999 56654 332 34455566664
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.01 E-value=2.1e-10 Score=132.63 Aligned_cols=111 Identities=19% Similarity=0.228 Sum_probs=96.4
Q ss_pred CCcEEEEEccCCCCcccCCccccCcccccccccccccCCCCCC-CccccccccccccccccccCCCCCccCccccccccc
Q 002336 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 490 (935)
Q Consensus 412 ~~~l~~L~Ls~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p-~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~ 490 (935)
.++|+.|+|++|++++..|..|.++++|+.|+|++|.+++.+| .+.++++|+.|+|++|++++..|..++++++|+.|+
T Consensus 298 l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 377 (455)
T 3v47_A 298 FTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELA 377 (455)
T ss_dssp CTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEE
T ss_pred CCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhccccccccEEE
Confidence 4689999999999998888899999999999999999988877 578999999999999999988899999999999999
Q ss_pred cccccCCCCCCccccC---CceeeeecCCCCCcccc
Q 002336 491 IENNSFVGEIPPALLT---GKVIFKYDNNPKLHKES 523 (935)
Q Consensus 491 l~~N~l~g~iP~~l~~---~~~~~~~~~n~~~~~~~ 523 (935)
|++|+++ .+|...+. ....+.+.+|+..|..+
T Consensus 378 L~~N~l~-~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 412 (455)
T 3v47_A 378 LDTNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCSCP 412 (455)
T ss_dssp CCSSCCS-CCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred CCCCccc-cCCHhHhccCCcccEEEccCCCcccCCC
Confidence 9999999 56665432 45677889999888644
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.00 E-value=2.4e-10 Score=127.37 Aligned_cols=103 Identities=19% Similarity=0.213 Sum_probs=85.1
Q ss_pred CCCCCCCceEEEeCC----------CCCcEEEEEccC-CCCcccCCccccCcccccccccccccCCCCCC-Ccccccccc
Q 002336 396 PCVPVPWEWVTCSTT----------TPPRITKIALSG-KNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLR 463 (935)
Q Consensus 396 pC~~~~w~~v~c~~~----------~~~~l~~L~Ls~-n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p-~~~~l~~L~ 463 (935)
.|..|.|..+.|+.. ...+|+.|+|++ |.|++..|..|++|++|+.|+|++|+|++.+| .|.+|++|+
T Consensus 4 ~c~~C~~~~v~~~~~n~l~~ip~l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~ 83 (347)
T 2ifg_A 4 ACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLS 83 (347)
T ss_dssp SSCCSSSSCEECCSSCCCTTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCC
T ss_pred cCccccCCEEEcCCCCCCCccCCCCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCC
Confidence 352346778888654 124699999996 99998777899999999999999999999999 589999999
Q ss_pred ccccccccccCCCCCccCccccccccccccccCCCC
Q 002336 464 IVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGE 499 (935)
Q Consensus 464 ~L~L~~N~l~g~iP~~l~~l~~L~~L~l~~N~l~g~ 499 (935)
.|+|++|+|++..|..+..++ |+.|+|.+|.|...
T Consensus 84 ~L~l~~N~l~~~~~~~~~~~~-L~~l~l~~N~~~c~ 118 (347)
T 2ifg_A 84 RLNLSFNALESLSWKTVQGLS-LQELVLSGNPLHCS 118 (347)
T ss_dssp EEECCSSCCSCCCSTTTCSCC-CCEEECCSSCCCCC
T ss_pred EEeCCCCccceeCHHHcccCC-ceEEEeeCCCccCC
Confidence 999999999954444555555 99999999999844
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.00 E-value=2.4e-10 Score=125.07 Aligned_cols=111 Identities=16% Similarity=0.169 Sum_probs=98.1
Q ss_pred CCcEEEEEccCCCCcc-cCCccccCcccccccccccccCCCCCC-CccccccccccccccccccCCCCCccCcccccccc
Q 002336 412 PPRITKIALSGKNLKG-EIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQEL 489 (935)
Q Consensus 412 ~~~l~~L~Ls~n~l~g-~ip~~i~~L~~L~~L~Ls~N~l~g~~p-~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L 489 (935)
.++|+.|+|++|.+++ .+|..+.++++|+.|+|++|++++.+| .+.++++|+.|+|++|++++..+..+..+++|+.|
T Consensus 149 l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 228 (306)
T 2z66_A 149 LSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVL 228 (306)
T ss_dssp CTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEE
T ss_pred CcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEe
Confidence 4689999999999997 688999999999999999999999877 68999999999999999997666689999999999
Q ss_pred ccccccCCCCCCccccC---CceeeeecCCCCCccc
Q 002336 490 HIENNSFVGEIPPALLT---GKVIFKYDNNPKLHKE 522 (935)
Q Consensus 490 ~l~~N~l~g~iP~~l~~---~~~~~~~~~n~~~~~~ 522 (935)
+|++|++++.+|..+.. ....+.+.+|+..|.+
T Consensus 229 ~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~~c 264 (306)
T 2z66_A 229 DYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTC 264 (306)
T ss_dssp ECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEECSG
T ss_pred ECCCCCCcccCHHHHHhhhccCCEEEccCCCeeccc
Confidence 99999999888877664 3456788999988753
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=98.99 E-value=2.3e-10 Score=123.91 Aligned_cols=110 Identities=19% Similarity=0.279 Sum_probs=94.8
Q ss_pred CCcEEEEEccCCCCcccCCccccCcccccccccccccCCCCCC-CccccccccccccccccccCCCCCccCccccccccc
Q 002336 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 490 (935)
Q Consensus 412 ~~~l~~L~Ls~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p-~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~ 490 (935)
.++|+.|+|++|++++..+..|+++++|+.|+|++|++++.++ .+.++++|+.|+|++|++++..|..++++++|+.|+
T Consensus 128 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 207 (285)
T 1ozn_A 128 LAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLY 207 (285)
T ss_dssp CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEE
T ss_pred CcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCcccccCHhHccCcccccEee
Confidence 4589999999999996666679999999999999999998887 489999999999999999988899999999999999
Q ss_pred cccccCCCCCCcc-ccC--CceeeeecCCCCCccc
Q 002336 491 IENNSFVGEIPPA-LLT--GKVIFKYDNNPKLHKE 522 (935)
Q Consensus 491 l~~N~l~g~iP~~-l~~--~~~~~~~~~n~~~~~~ 522 (935)
|++|++++ +|.. +.. ....+.+.+|+..|.+
T Consensus 208 l~~n~l~~-~~~~~~~~l~~L~~L~l~~N~~~c~~ 241 (285)
T 1ozn_A 208 LFANNLSA-LPTEALAPLRALQYLRLNDNPWVCDC 241 (285)
T ss_dssp CCSSCCSC-CCHHHHTTCTTCCEEECCSSCEECSG
T ss_pred CCCCcCCc-CCHHHcccCcccCEEeccCCCccCCC
Confidence 99999995 5543 433 4566788999988753
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=98.98 E-value=1.7e-10 Score=133.44 Aligned_cols=106 Identities=15% Similarity=0.192 Sum_probs=91.6
Q ss_pred CCcEEEEEccCCCCcccCCccccCcccccccccccccCCCCCC--CccccccccccccccccccCCCCCccCcccccccc
Q 002336 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP--DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQEL 489 (935)
Q Consensus 412 ~~~l~~L~Ls~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p--~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L 489 (935)
+++|+.|+|++|++++..|..|++|++|++|+|++|.+.+.++ .|.++++|++|+|++|++++..|..++++++|+.|
T Consensus 29 ~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L 108 (455)
T 3v47_A 29 PAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVL 108 (455)
T ss_dssp CTTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTTCTTCEECTTTTTTCTTCCEE
T ss_pred CCccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCCCccCccChhhccCcccCCEE
Confidence 3579999999999998889999999999999999999998765 58999999999999999998889999999999999
Q ss_pred ccccccCCCCCCcc--ccC--CceeeeecCCC
Q 002336 490 HIENNSFVGEIPPA--LLT--GKVIFKYDNNP 517 (935)
Q Consensus 490 ~l~~N~l~g~iP~~--l~~--~~~~~~~~~n~ 517 (935)
+|++|++++.+|.. +.. ....+.+.+|.
T Consensus 109 ~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~ 140 (455)
T 3v47_A 109 TLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNN 140 (455)
T ss_dssp ECTTSCCBTHHHHSSTTTTCTTCCEEECCSSB
T ss_pred eCCCCCCCccccCcccccCcccCCEEECCCCc
Confidence 99999999766654 332 34455666664
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=98.97 E-value=3.5e-10 Score=127.10 Aligned_cols=117 Identities=21% Similarity=0.165 Sum_probs=88.3
Q ss_pred CCceEEEeCC--------CCCcEEEEEccCCCCcccCCcccc-CcccccccccccccCCCCCC-Cccccccccccccccc
Q 002336 401 PWEWVTCSTT--------TPPRITKIALSGKNLKGEIPPELK-NMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENN 470 (935)
Q Consensus 401 ~w~~v~c~~~--------~~~~l~~L~Ls~n~l~g~ip~~i~-~L~~L~~L~Ls~N~l~g~~p-~~~~l~~L~~L~L~~N 470 (935)
.+..+.|+.. .+..++.|+|++|+|++..+..+. +|++|+.|+|++|+|++..| .|.++++|+.|+|++|
T Consensus 19 ~~~~l~c~~~~l~~iP~~~~~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N 98 (361)
T 2xot_A 19 ASNILSCSKQQLPNVPQSLPSYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSN 98 (361)
T ss_dssp ETTEEECCSSCCSSCCSSCCTTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred CCCEEEeCCCCcCccCccCCCCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCCC
Confidence 4566666542 134578899999999876666676 88999999999999998887 5888999999999999
Q ss_pred cccCCCCCccCccccccccccccccCCCCCCccccC--CceeeeecCCC
Q 002336 471 ELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLT--GKVIFKYDNNP 517 (935)
Q Consensus 471 ~l~g~iP~~l~~l~~L~~L~l~~N~l~g~iP~~l~~--~~~~~~~~~n~ 517 (935)
+|++..+..|.++++|+.|+|++|+|++..|..+.. ....+.+++|.
T Consensus 99 ~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~ 147 (361)
T 2xot_A 99 HLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQ 147 (361)
T ss_dssp CCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred cCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCc
Confidence 988666667888889999999999888544554443 34455556664
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=98.97 E-value=3.7e-10 Score=113.16 Aligned_cols=90 Identities=22% Similarity=0.338 Sum_probs=80.2
Q ss_pred CCcEEEEEccCCCCcccCCccccCcccccccccccccCCCCCCC-ccccccccccccccccccCCCCCccCccccccccc
Q 002336 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 490 (935)
Q Consensus 412 ~~~l~~L~Ls~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~ 490 (935)
.++|+.|+|++|+|++..+..|.++++|+.|+|++|+|++.++. +.++++|+.|+|++|++++..+..+..+++|+.|+
T Consensus 51 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ 130 (177)
T 2o6r_A 51 LTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIW 130 (177)
T ss_dssp CTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEE
T ss_pred cccccEEECCCCcceEeChhHccCCCccCEEECCCCCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEE
Confidence 35899999999999966666789999999999999999998885 78999999999999999955555578899999999
Q ss_pred cccccCCCCCC
Q 002336 491 IENNSFVGEIP 501 (935)
Q Consensus 491 l~~N~l~g~iP 501 (935)
|++|.+++..|
T Consensus 131 l~~N~~~~~~~ 141 (177)
T 2o6r_A 131 LHTNPWDCSCP 141 (177)
T ss_dssp CCSSCBCCCHH
T ss_pred ecCCCeeccCc
Confidence 99999998776
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=98.96 E-value=4.6e-10 Score=137.77 Aligned_cols=105 Identities=27% Similarity=0.360 Sum_probs=83.0
Q ss_pred CCcEEEEEccCCCCcccCCccccCcccccccccccccCCCCCCCccccccccccccccccccCCCCCccCcccccccccc
Q 002336 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 491 (935)
Q Consensus 412 ~~~l~~L~Ls~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~l 491 (935)
...|+.|+|++|++. .+|..+++|++|+.|+|++|.|+..++.|++|++|++|+|++|+|+ .||.+|++|++|+.|+|
T Consensus 223 l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L 300 (727)
T 4b8c_D 223 DQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLTELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYF 300 (727)
T ss_dssp CCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCSCCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEEC
T ss_pred CCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCcccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEEC
Confidence 457888888888887 7888888888888888888888843336888888888888888888 88888888888888888
Q ss_pred ccccCCCCCCccccC--CceeeeecCCCCC
Q 002336 492 ENNSFVGEIPPALLT--GKVIFKYDNNPKL 519 (935)
Q Consensus 492 ~~N~l~g~iP~~l~~--~~~~~~~~~n~~~ 519 (935)
++|.|+ .||.++.. ....+.+++|+..
T Consensus 301 ~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~ 329 (727)
T 4b8c_D 301 FDNMVT-TLPWEFGNLCNLQFLGVEGNPLE 329 (727)
T ss_dssp CSSCCC-CCCSSTTSCTTCCCEECTTSCCC
T ss_pred CCCCCC-ccChhhhcCCCccEEeCCCCccC
Confidence 888887 88887654 3455666777653
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=98.96 E-value=5.2e-10 Score=135.43 Aligned_cols=106 Identities=16% Similarity=0.223 Sum_probs=98.0
Q ss_pred CcEEEEEccCCCCcccCCcccc--CcccccccccccccCCCCCCCcccccccccccc------ccccccCCCCCccCccc
Q 002336 413 PRITKIALSGKNLKGEIPPELK--NMEALTELWLDGNFLTGPLPDMSRLIDLRIVHL------ENNELTGSLPSYMGSLP 484 (935)
Q Consensus 413 ~~l~~L~Ls~n~l~g~ip~~i~--~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~L------~~N~l~g~iP~~l~~l~ 484 (935)
++|+.|+|++|+|+ .+|..+. .+++|+.|+|++|+|++.+..+.++++|+.|+| ++|++.+.+|..+++++
T Consensus 488 ~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~ip~~~~~l~~L~~L~Ls~N~~ls~N~l~~~~p~~l~~l~ 566 (636)
T 4eco_A 488 YLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSKFPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCP 566 (636)
T ss_dssp GGCCEEECCSSCCC-BCCGGGSTTTCTTCCEEECCSSCCSSCCCGGGGCSSCCEEECCSCBCTTCCBCCCCCCTTGGGCS
T ss_pred CCccEEECcCCcCC-ccChhhhhccCCCcCEEECCCCCCCCcChhhhcCCCCCEEECCCCcccccCcccccChHHHhcCC
Confidence 48999999999999 8999998 999999999999999994447999999999999 56889999999999999
Q ss_pred cccccccccccCCCCCCccccCCceeeeecCCCCCc
Q 002336 485 NLQELHIENNSFVGEIPPALLTGKVIFKYDNNPKLH 520 (935)
Q Consensus 485 ~L~~L~l~~N~l~g~iP~~l~~~~~~~~~~~n~~~~ 520 (935)
+|+.|+|++|+| +.||..+......+.+++|+..|
T Consensus 567 ~L~~L~Ls~N~l-~~ip~~~~~~L~~L~Ls~N~l~~ 601 (636)
T 4eco_A 567 SLTQLQIGSNDI-RKVNEKITPNISVLDIKDNPNIS 601 (636)
T ss_dssp SCCEEECCSSCC-CBCCSCCCTTCCEEECCSCTTCE
T ss_pred CCCEEECCCCcC-CccCHhHhCcCCEEECcCCCCcc
Confidence 999999999999 69999988888888999999876
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.96 E-value=3.6e-10 Score=126.41 Aligned_cols=116 Identities=19% Similarity=0.235 Sum_probs=95.4
Q ss_pred CCCceEEEeCCC----------CCcEEEEEccCCCCcccCCccccCcccccccccccccCCCCCC-Cccccccccccccc
Q 002336 400 VPWEWVTCSTTT----------PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLE 468 (935)
Q Consensus 400 ~~w~~v~c~~~~----------~~~l~~L~Ls~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p-~~~~l~~L~~L~L~ 468 (935)
|+|.++ |+|+. +++|+.|+|++|++++..+..|.++++|+.|+|++|++++..| .+.++++|++|+|+
T Consensus 30 C~~~~~-c~~~~~~l~~iP~~~~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls 108 (353)
T 2z80_A 30 CDRNGI-CKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLS 108 (353)
T ss_dssp ECTTSE-EECCSTTCSSCCTTCCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECC
T ss_pred CCCCeE-eeCCCCCcccccccccccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEECC
Confidence 478887 88752 3479999999999997666689999999999999999999888 59999999999999
Q ss_pred cccccCCCCCccCccccccccccccccCCCCCCc-cccC---CceeeeecCCC
Q 002336 469 NNELTGSLPSYMGSLPNLQELHIENNSFVGEIPP-ALLT---GKVIFKYDNNP 517 (935)
Q Consensus 469 ~N~l~g~iP~~l~~l~~L~~L~l~~N~l~g~iP~-~l~~---~~~~~~~~~n~ 517 (935)
+|++++..+..++++++|+.|+|++|+++ .+|. ..+. ....+.+.+|.
T Consensus 109 ~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~~l~~L~~L~l~~n~ 160 (353)
T 2z80_A 109 YNYLSNLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMD 160 (353)
T ss_dssp SSCCSSCCHHHHTTCTTCSEEECTTCCCS-SSCSSCSCTTCTTCCEEEEEESS
T ss_pred CCcCCcCCHhHhCCCccCCEEECCCCCCc-ccCchhhhccCCCCcEEECCCCc
Confidence 99999543444899999999999999999 7877 3322 34455666663
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.96 E-value=4.4e-10 Score=129.73 Aligned_cols=109 Identities=24% Similarity=0.333 Sum_probs=96.6
Q ss_pred CCcEEEEEccCCCCcccCCccccCcccccccccccccCCCCCC-CccccccccccccccccccCCCCCccCccccccccc
Q 002336 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 490 (935)
Q Consensus 412 ~~~l~~L~Ls~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p-~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~ 490 (935)
.++|+.|+|++|+|+ .+| .+..+++|+.|+|++|+|++..| .|.++++|+.|+|++|++++..|..+.++++|+.|+
T Consensus 184 l~~L~~L~L~~n~l~-~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 261 (440)
T 3zyj_A 184 LSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEIN 261 (440)
T ss_dssp CSSCCEEECTTSCCS-SCC-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEE
T ss_pred ccccCeecCCCCcCc-ccc-ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEE
Confidence 468999999999998 676 58999999999999999999988 699999999999999999988889999999999999
Q ss_pred cccccCCCCCCccccC---CceeeeecCCCCCcccc
Q 002336 491 IENNSFVGEIPPALLT---GKVIFKYDNNPKLHKES 523 (935)
Q Consensus 491 l~~N~l~g~iP~~l~~---~~~~~~~~~n~~~~~~~ 523 (935)
|++|+|+ .+|...+. ....+.+.+||+.|.+.
T Consensus 262 L~~N~l~-~~~~~~~~~l~~L~~L~L~~Np~~CdC~ 296 (440)
T 3zyj_A 262 LAHNNLT-LLPHDLFTPLHHLERIHLHHNPWNCNCD 296 (440)
T ss_dssp CTTSCCC-CCCTTTTSSCTTCCEEECCSSCEECSST
T ss_pred CCCCCCC-ccChhHhccccCCCEEEcCCCCccCCCC
Confidence 9999999 66665543 45677889999998754
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=98.96 E-value=2.7e-10 Score=136.85 Aligned_cols=111 Identities=19% Similarity=0.138 Sum_probs=98.1
Q ss_pred CCcEEEEEccCCCCccc-CCccccCcccccccccccccCCCCCC-CccccccccccccccccccCCCCCccCcccccccc
Q 002336 412 PPRITKIALSGKNLKGE-IPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQEL 489 (935)
Q Consensus 412 ~~~l~~L~Ls~n~l~g~-ip~~i~~L~~L~~L~Ls~N~l~g~~p-~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L 489 (935)
.++|+.|+|++|++++. +|..|+++++|+.|+|++|++++.+| .+.++++|+.|+|++|++++.+|..++++++|+.|
T Consensus 447 l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 526 (606)
T 3vq2_A 447 LTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTL 526 (606)
T ss_dssp CTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEE
T ss_pred CCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEE
Confidence 46899999999999984 78889999999999999999999888 58999999999999999998889999999999999
Q ss_pred ccccccCCCCCCccccC---CceeeeecCCCCCcccc
Q 002336 490 HIENNSFVGEIPPALLT---GKVIFKYDNNPKLHKES 523 (935)
Q Consensus 490 ~l~~N~l~g~iP~~l~~---~~~~~~~~~n~~~~~~~ 523 (935)
+|++|+|+ .+|..+.. ....+.+.+||..|.+.
T Consensus 527 ~l~~N~l~-~~p~~~~~l~~~L~~l~l~~N~~~c~c~ 562 (606)
T 3vq2_A 527 DCSFNRIE-TSKGILQHFPKSLAFFNLTNNSVACICE 562 (606)
T ss_dssp ECTTSCCC-CEESCGGGSCTTCCEEECCSCCCCCSST
T ss_pred ECCCCcCc-ccCHhHhhhcccCcEEEccCCCcccCCc
Confidence 99999999 89987654 35677889999988643
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=98.96 E-value=7.9e-10 Score=120.33 Aligned_cols=106 Identities=28% Similarity=0.352 Sum_probs=92.8
Q ss_pred CCCcEEEEEccCCCCcccCCccccCcccccccccccccCCCCCC-CccccccccccccccccccCCCCCccCcccccccc
Q 002336 411 TPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQEL 489 (935)
Q Consensus 411 ~~~~l~~L~Ls~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p-~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L 489 (935)
..++|+.|+|++|+|+ .+|..+.++++|+.|+|++|+|++.+| .|.++++|+.|+|++|+|++..|..+..+++|+.|
T Consensus 75 ~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 153 (290)
T 1p9a_G 75 TLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKL 153 (290)
T ss_dssp CCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEE
T ss_pred CCCcCCEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEE
Confidence 3468999999999998 899999999999999999999999988 58999999999999999996666678999999999
Q ss_pred ccccccCCCCCCccccC---CceeeeecCCCC
Q 002336 490 HIENNSFVGEIPPALLT---GKVIFKYDNNPK 518 (935)
Q Consensus 490 ~l~~N~l~g~iP~~l~~---~~~~~~~~~n~~ 518 (935)
+|++|+|+ .+|...+. ....+.+.+|..
T Consensus 154 ~L~~N~l~-~l~~~~~~~l~~L~~L~L~~N~l 184 (290)
T 1p9a_G 154 SLANNNLT-ELPAGLLNGLENLDTLLLQENSL 184 (290)
T ss_dssp ECTTSCCS-CCCTTTTTTCTTCCEEECCSSCC
T ss_pred ECCCCcCC-ccCHHHhcCcCCCCEEECCCCcC
Confidence 99999999 78876643 445666777764
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=98.95 E-value=4.8e-10 Score=125.93 Aligned_cols=107 Identities=22% Similarity=0.287 Sum_probs=49.2
Q ss_pred CcEEEEEccCCCCcccCCccccCcccccccccccccCCCCCC-CccccccccccccccccccCCCCCcc----Ccccccc
Q 002336 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPSYM----GSLPNLQ 487 (935)
Q Consensus 413 ~~l~~L~Ls~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p-~~~~l~~L~~L~L~~N~l~g~iP~~l----~~l~~L~ 487 (935)
++|+.|+|++|+|++..+..|.+|++|+.|+|++|+|++..| .|.++++|+.|+|++|+|+ .+|..+ ..+++|+
T Consensus 88 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~~~~l~~L~ 166 (361)
T 2xot_A 88 PNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLM 166 (361)
T ss_dssp TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCC-SCCGGGTC----CTTCC
T ss_pred CCCCEEECCCCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCC-eeCHHHhcCcccCCcCC
Confidence 345555555555543333344555555555555555554444 3445555555555555555 233322 3445555
Q ss_pred ccccccccCCCCCCccccC-C----ceeeeecCCCCCcc
Q 002336 488 ELHIENNSFVGEIPPALLT-G----KVIFKYDNNPKLHK 521 (935)
Q Consensus 488 ~L~l~~N~l~g~iP~~l~~-~----~~~~~~~~n~~~~~ 521 (935)
.|+|++|+|+ .+|...+. . ...+.+.+||+.|.
T Consensus 167 ~L~L~~N~l~-~l~~~~~~~l~~~~l~~l~l~~N~~~C~ 204 (361)
T 2xot_A 167 LLDLSSNKLK-KLPLTDLQKLPAWVKNGLYLHNNPLECD 204 (361)
T ss_dssp EEECCSSCCC-CCCHHHHHHSCHHHHTTEECCSSCEECC
T ss_pred EEECCCCCCC-ccCHHHhhhccHhhcceEEecCCCccCC
Confidence 5555555554 33322111 1 02245566666654
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=98.95 E-value=1e-09 Score=118.08 Aligned_cols=107 Identities=21% Similarity=0.216 Sum_probs=88.9
Q ss_pred CCcEEEEEccCCCCcccCCccccCcccccccccccccCCCCCCC-ccccccccccccccccccCCCCCccCccccccccc
Q 002336 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 490 (935)
Q Consensus 412 ~~~l~~L~Ls~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~ 490 (935)
.++|+.|+|++|++++..+..|.++++|++|+|++|++++.++. +.++++|+.|+|++|++++..|..++.+++|+.|+
T Consensus 84 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 163 (272)
T 3rfs_A 84 LTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELD 163 (272)
T ss_dssp CTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEE
Confidence 46899999999999977777789999999999999999998885 79999999999999999977777789999999999
Q ss_pred cccccCCCCCCccccC--CceeeeecCCCC
Q 002336 491 IENNSFVGEIPPALLT--GKVIFKYDNNPK 518 (935)
Q Consensus 491 l~~N~l~g~iP~~l~~--~~~~~~~~~n~~ 518 (935)
|++|++++..|..+.. ....+.+.+|..
T Consensus 164 l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l 193 (272)
T 3rfs_A 164 LSYNQLQSLPEGVFDKLTQLKDLRLYQNQL 193 (272)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred CCCCCcCccCHHHhcCCccCCEEECCCCcC
Confidence 9999999444433332 455666677754
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=98.94 E-value=3.3e-10 Score=119.29 Aligned_cols=124 Identities=20% Similarity=0.279 Sum_probs=97.1
Q ss_pred CCCCCCCCCCceEEEeCC-------CCCcEEEEEccCCCCcccCCccccCccccccccccccc-CCCCCC-Ccccccccc
Q 002336 393 RGDPCVPVPWEWVTCSTT-------TPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNF-LTGPLP-DMSRLIDLR 463 (935)
Q Consensus 393 ~~dpC~~~~w~~v~c~~~-------~~~~l~~L~Ls~n~l~g~ip~~i~~L~~L~~L~Ls~N~-l~g~~p-~~~~l~~L~ 463 (935)
..++|.+..|..+.++|. .+..++.|+|++|++++..+..|.++++|+.|+|++|+ +++..+ .|.++++|+
T Consensus 4 cp~~C~C~~~~~~~v~c~~l~~ip~~~~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~ 83 (239)
T 2xwt_C 4 SSPPCECHQEEDFRVTCKDIQRIPSLPPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVT 83 (239)
T ss_dssp CSSSCSEEECSTTEEEECSCSSCCCCCTTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCC
T ss_pred CCCCCeeCCCCcceeEccCccccCCCCCcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCc
Confidence 345665444455553342 24579999999999997767789999999999999997 888777 689999999
Q ss_pred cccccc-ccccCCCCCccCccccccccccccccCCCCCCccccC--Cce---eeeecCCCC
Q 002336 464 IVHLEN-NELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLT--GKV---IFKYDNNPK 518 (935)
Q Consensus 464 ~L~L~~-N~l~g~iP~~l~~l~~L~~L~l~~N~l~g~iP~~l~~--~~~---~~~~~~n~~ 518 (935)
.|+|++ |++++..|..+.++++|+.|++++|+++ .+|. +.. ... .+.+.+|+.
T Consensus 84 ~L~l~~~n~l~~i~~~~f~~l~~L~~L~l~~n~l~-~lp~-~~~l~~L~~L~~L~l~~N~~ 142 (239)
T 2xwt_C 84 HIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPD-LTKVYSTDIFFILEITDNPY 142 (239)
T ss_dssp EEEEEEETTCCEECTTSEECCTTCCEEEEEEECCC-SCCC-CTTCCBCCSEEEEEEESCTT
T ss_pred EEECCCCCCeeEcCHHHhCCCCCCCEEeCCCCCCc-cccc-cccccccccccEEECCCCcc
Confidence 999999 9999655678999999999999999999 4887 332 222 566677743
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.94 E-value=1.5e-09 Score=115.18 Aligned_cols=131 Identities=17% Similarity=0.086 Sum_probs=99.1
Q ss_pred ccc-ccccEEEEEEEECCCcEEEEEEccCcchhhhHHHHHHHHHHHhcCCCc--ccccceeeeccceEEEEEEecCCCCH
Q 002336 620 KIG-KGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRN--LVPLIGYCEEEHQRILVYEYMHNGTL 696 (935)
Q Consensus 620 ~LG-~G~fG~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~Hpn--Iv~l~g~~~~~~~~~lV~E~~~~gsL 696 (935)
.++ .|..+.||++...+|+.+++|+.... ....+.+|+.+++.+.+.+ +.+++++...++..++||||++|.+|
T Consensus 26 ~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l 102 (264)
T 1nd4_A 26 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 102 (264)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred ecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCccc
Confidence 344 56669999998877888999987543 2356889999999996544 45688888877788999999999888
Q ss_pred HHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcC--------------------------------------------
Q 002336 697 RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC-------------------------------------------- 732 (935)
Q Consensus 697 ~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~-------------------------------------------- 732 (935)
. ... .+ ...++.++++.|+.||+..
T Consensus 103 ~--~~~------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (264)
T 1nd4_A 103 L--SSH------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF 171 (264)
T ss_dssp T--TSC------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred C--cCc------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHH
Confidence 4 221 11 2367788888888888621
Q ss_pred -----------CCceEecCCCCCCccccCCCcEEEeecccccc
Q 002336 733 -----------NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 764 (935)
Q Consensus 733 -----------~~~ivH~DLkp~NILld~~~~vkL~DFGla~~ 764 (935)
...++|||++|.||++++++.+.|+||+.+..
T Consensus 172 ~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 172 ARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp HHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 11399999999999998776677999998753
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.94 E-value=5.3e-10 Score=114.07 Aligned_cols=89 Identities=25% Similarity=0.277 Sum_probs=80.7
Q ss_pred CCcEEEEEccCCCCcccCCccccCcccccccccccccCCCCCC-CccccccccccccccccccCCCCCccCccccccccc
Q 002336 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 490 (935)
Q Consensus 412 ~~~l~~L~Ls~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p-~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~ 490 (935)
.++|+.|+|++|+|++..+..|.+|++|+.|+|++|+|++.+| .|.++++|+.|+|++|+|++..+..+..+++|+.|+
T Consensus 53 l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 132 (193)
T 2wfh_A 53 YKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLA 132 (193)
T ss_dssp CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEE
T ss_pred ccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEE
Confidence 4589999999999998777889999999999999999999998 699999999999999999955555789999999999
Q ss_pred cccccCCCCC
Q 002336 491 IENNSFVGEI 500 (935)
Q Consensus 491 l~~N~l~g~i 500 (935)
|++|.+....
T Consensus 133 L~~N~~~C~c 142 (193)
T 2wfh_A 133 IGANPLYCDC 142 (193)
T ss_dssp CCSSCEECSG
T ss_pred eCCCCeecCC
Confidence 9999998543
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=98.94 E-value=4.6e-10 Score=133.64 Aligned_cols=82 Identities=29% Similarity=0.383 Sum_probs=42.7
Q ss_pred cEEEEEccCCCCcccCCccccCcccccccccccccCCCCCCCccccccccccccccccccCCC-CCccCccccccccccc
Q 002336 414 RITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSL-PSYMGSLPNLQELHIE 492 (935)
Q Consensus 414 ~l~~L~Ls~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~i-P~~l~~l~~L~~L~l~ 492 (935)
+|+.|+|++|+|+ .+|..|++|++|+.|+|++|+|++ +|.+++|++|+.|+|++|+|++.+ |..+++|++|+.|+|+
T Consensus 464 ~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~ 541 (567)
T 1dce_A 464 LVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQ 541 (567)
T ss_dssp TCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CGGGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECT
T ss_pred cCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-CcccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEec
Confidence 4555555555555 455555555555555555555554 335555555555555555555443 5555555555555555
Q ss_pred cccCC
Q 002336 493 NNSFV 497 (935)
Q Consensus 493 ~N~l~ 497 (935)
+|+|+
T Consensus 542 ~N~l~ 546 (567)
T 1dce_A 542 GNSLC 546 (567)
T ss_dssp TSGGG
T ss_pred CCcCC
Confidence 55555
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=98.93 E-value=6.8e-10 Score=119.54 Aligned_cols=106 Identities=15% Similarity=0.035 Sum_probs=87.5
Q ss_pred CCcEEEEEccCCCCcccCCccccCcccccccccccccCCCCCC-CccccccccccccccccccCCCCCccCccccccccc
Q 002336 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 490 (935)
Q Consensus 412 ~~~l~~L~Ls~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p-~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~ 490 (935)
+++|+.|+|++|++++..+..|.++++|++|+|++|++++..+ .+.++++|+.|+|++|++++..|..+.++++|+.|+
T Consensus 27 ~~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 106 (276)
T 2z62_A 27 PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLV 106 (276)
T ss_dssp CTTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEE
T ss_pred CCCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEE
Confidence 3469999999999997777789999999999999999998887 689999999999999999977778899999999999
Q ss_pred cccccCCCCCCccccC--CceeeeecCCC
Q 002336 491 IENNSFVGEIPPALLT--GKVIFKYDNNP 517 (935)
Q Consensus 491 l~~N~l~g~iP~~l~~--~~~~~~~~~n~ 517 (935)
+++|++++..+..+.. ....+.+.+|.
T Consensus 107 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~ 135 (276)
T 2z62_A 107 AVETNLASLENFPIGHLKTLKELNVAHNL 135 (276)
T ss_dssp CTTSCCCCSTTCCCTTCTTCCEEECCSSC
T ss_pred CCCCCccccCchhcccCCCCCEEECcCCc
Confidence 9999998544434433 34455556664
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=98.93 E-value=4.2e-10 Score=134.01 Aligned_cols=102 Identities=25% Similarity=0.312 Sum_probs=89.2
Q ss_pred cEEEEEccCCCCcccCCccccCcccccccccccccCCCCCCCccccccccccccccccccCCCCCccCcccccccccccc
Q 002336 414 RITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIEN 493 (935)
Q Consensus 414 ~l~~L~Ls~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~l~~ 493 (935)
.|+.|+|++|+|++ +|. |++|++|+.|+|++|+|+..++.+++|++|+.|+|++|+|++ +| .+++|++|+.|+|++
T Consensus 442 ~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~ 517 (567)
T 1dce_A 442 DVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCN 517 (567)
T ss_dssp TCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCCCCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCS
T ss_pred CceEEEecCCCCCC-CcC-ccccccCcEeecCcccccccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCC
Confidence 57889999999995 786 999999999999999999544489999999999999999996 88 899999999999999
Q ss_pred ccCCCCC-CccccC--CceeeeecCCCCC
Q 002336 494 NSFVGEI-PPALLT--GKVIFKYDNNPKL 519 (935)
Q Consensus 494 N~l~g~i-P~~l~~--~~~~~~~~~n~~~ 519 (935)
|+|++.+ |..+.. ....+.+++|+..
T Consensus 518 N~l~~~~~p~~l~~l~~L~~L~L~~N~l~ 546 (567)
T 1dce_A 518 NRLQQSAAIQPLVSCPRLVLLNLQGNSLC 546 (567)
T ss_dssp SCCCSSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred CCCCCCCCcHHHhcCCCCCEEEecCCcCC
Confidence 9999766 888765 4566777888643
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=98.92 E-value=9.3e-10 Score=136.74 Aligned_cols=104 Identities=17% Similarity=0.285 Sum_probs=93.1
Q ss_pred cEEEEEccCCCCcccCCcccc--CcccccccccccccCCCCCCCcccccccccccccc------ccccCCCCCccCcccc
Q 002336 414 RITKIALSGKNLKGEIPPELK--NMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLEN------NELTGSLPSYMGSLPN 485 (935)
Q Consensus 414 ~l~~L~Ls~n~l~g~ip~~i~--~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~L~~------N~l~g~iP~~l~~l~~ 485 (935)
+|+.|+|++|+|+ .+|..+. +|++|+.|+|++|+|++.++.+.++++|+.|+|++ |++.+.+|..+++|++
T Consensus 729 ~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~lp~~l~~L~~L~~L~Ls~N~~ls~N~l~~~ip~~l~~L~~ 807 (876)
T 4ecn_A 729 LLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSSFPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPS 807 (876)
T ss_dssp GCCEEECCSSCCC-CCCGGGSTTTCTTCCEEECCSSCCSSCCCGGGGCTTCCEEECCCCBCTTCCBCCCCCCTTGGGCSS
T ss_pred CccEEECCCCCCc-cchHHhhhccCCCcCEEEeCCCCCCccchhhhcCCCCCEEECCCCCCcccccccccChHHHhcCCC
Confidence 8999999999999 8999887 99999999999999999545789999999999976 8889999999999999
Q ss_pred ccccccccccCCCCCCccccCCceeeeecCCCCC
Q 002336 486 LQELHIENNSFVGEIPPALLTGKVIFKYDNNPKL 519 (935)
Q Consensus 486 L~~L~l~~N~l~g~iP~~l~~~~~~~~~~~n~~~ 519 (935)
|+.|+|++|+| +.||..+......+.+++|+..
T Consensus 808 L~~L~Ls~N~L-~~Ip~~l~~~L~~LdLs~N~l~ 840 (876)
T 4ecn_A 808 LIQLQIGSNDI-RKVDEKLTPQLYILDIADNPNI 840 (876)
T ss_dssp CCEEECCSSCC-CBCCSCCCSSSCEEECCSCTTC
T ss_pred CCEEECCCCCC-CccCHhhcCCCCEEECCCCCCC
Confidence 99999999999 6999998877777888888865
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=98.91 E-value=6.7e-10 Score=128.66 Aligned_cols=109 Identities=23% Similarity=0.307 Sum_probs=96.1
Q ss_pred CCcEEEEEccCCCCcccCCccccCcccccccccccccCCCCCC-CccccccccccccccccccCCCCCccCccccccccc
Q 002336 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 490 (935)
Q Consensus 412 ~~~l~~L~Ls~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p-~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~ 490 (935)
.++|+.|+|++|++++ +| .+..+++|+.|+|++|.|++.+| .|.++++|+.|+|++|++++..|..+.++++|+.|+
T Consensus 195 l~~L~~L~L~~n~l~~-~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 272 (452)
T 3zyi_A 195 LFNLKYLNLGMCNIKD-MP-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELN 272 (452)
T ss_dssp CTTCCEEECTTSCCSS-CC-CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEE
T ss_pred CCCCCEEECCCCcccc-cc-cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEE
Confidence 4689999999999994 55 69999999999999999999988 699999999999999999988899999999999999
Q ss_pred cccccCCCCCCccccC---CceeeeecCCCCCcccc
Q 002336 491 IENNSFVGEIPPALLT---GKVIFKYDNNPKLHKES 523 (935)
Q Consensus 491 l~~N~l~g~iP~~l~~---~~~~~~~~~n~~~~~~~ 523 (935)
|++|+|+ .+|...+. ....+.+.+||+.|.+.
T Consensus 273 L~~N~l~-~~~~~~~~~l~~L~~L~L~~Np~~CdC~ 307 (452)
T 3zyi_A 273 LAHNNLS-SLPHDLFTPLRYLVELHLHHNPWNCDCD 307 (452)
T ss_dssp CCSSCCS-CCCTTSSTTCTTCCEEECCSSCEECSTT
T ss_pred CCCCcCC-ccChHHhccccCCCEEEccCCCcCCCCC
Confidence 9999999 66665543 45677889999998754
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=98.90 E-value=1.2e-09 Score=126.50 Aligned_cols=115 Identities=20% Similarity=0.238 Sum_probs=95.0
Q ss_pred CceEEEeCC--------CCCcEEEEEccCCCCcccCCccccCcccccccccccccCCCCCC-Cccccccccccccccccc
Q 002336 402 WEWVTCSTT--------TPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNEL 472 (935)
Q Consensus 402 w~~v~c~~~--------~~~~l~~L~Ls~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p-~~~~l~~L~~L~L~~N~l 472 (935)
|..+.|... .+++++.|+|++|+|++..|..|.+|++|+.|+|++|+|++..| .|.++++|+.|+|++|+|
T Consensus 56 ~~~v~c~~~~l~~iP~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l 135 (452)
T 3zyi_A 56 FSKVVCTRRGLSEVPQGIPSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWL 135 (452)
T ss_dssp SCEEECCSSCCSSCCSCCCTTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCC
T ss_pred CcEEEECCCCcCccCCCCCCCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCcC
Confidence 455666543 24579999999999999889999999999999999999999887 689999999999999999
Q ss_pred cCCCCCccCccccccccccccccCCCCCCccccC---CceeeeecCCC
Q 002336 473 TGSLPSYMGSLPNLQELHIENNSFVGEIPPALLT---GKVIFKYDNNP 517 (935)
Q Consensus 473 ~g~iP~~l~~l~~L~~L~l~~N~l~g~iP~~l~~---~~~~~~~~~n~ 517 (935)
++..+..++.+++|+.|+|++|+++ .+|...+. ....+.+.+|.
T Consensus 136 ~~~~~~~~~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~l~~~~ 182 (452)
T 3zyi_A 136 TVIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELK 182 (452)
T ss_dssp SBCCTTTSSSCTTCCEEECCSCCCC-EECTTTTTTCTTCCEEECCCCT
T ss_pred CccChhhhcccCCCCEEECCCCCcc-eeCHhHHhcCCcccEEeCCCCC
Confidence 9666667999999999999999999 67764433 33444555543
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=98.89 E-value=3.2e-10 Score=139.14 Aligned_cols=93 Identities=31% Similarity=0.399 Sum_probs=85.6
Q ss_pred CCcEEEEEccCCCCcccCCccccCcccccccccccccCCCCCCCccccccccccccccccccCCCCCccCcccccccccc
Q 002336 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 491 (935)
Q Consensus 412 ~~~l~~L~Ls~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~l 491 (935)
.++|+.|+|++|.|+ .+|..|++|++|+.|+|++|.|+..+..|++|++|+.|+|++|+|+ .||.+|++|++|+.|+|
T Consensus 246 l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L 323 (727)
T 4b8c_D 246 YDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLTSLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGV 323 (727)
T ss_dssp CCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCSSCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEEC
T ss_pred CCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCCccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeC
Confidence 468999999999999 9999999999999999999999955447999999999999999998 99999999999999999
Q ss_pred ccccCCCCCCccccC
Q 002336 492 ENNSFVGEIPPALLT 506 (935)
Q Consensus 492 ~~N~l~g~iP~~l~~ 506 (935)
++|.|+|.+|..+..
T Consensus 324 ~~N~l~~~~p~~~~~ 338 (727)
T 4b8c_D 324 EGNPLEKQFLKILTE 338 (727)
T ss_dssp TTSCCCSHHHHHHHH
T ss_pred CCCccCCCChHHHhh
Confidence 999999988887654
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=98.89 E-value=9e-10 Score=112.52 Aligned_cols=103 Identities=15% Similarity=0.222 Sum_probs=82.5
Q ss_pred CCcEEEEEccCCCCcccCCccccCcccccccccccccCCCCCC-CccccccccccccccccccCCCCCccCccccccccc
Q 002336 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 490 (935)
Q Consensus 412 ~~~l~~L~Ls~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p-~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~ 490 (935)
.++|+.|+|++|++++..|..|++|++|+.|+|++|++++..| .++++++|+.|+|++|++.+.+| .+..+++|+.|+
T Consensus 87 l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~~~~-~l~~l~~L~~L~ 165 (197)
T 4ezg_A 87 LSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIM-PLKTLPELKSLN 165 (197)
T ss_dssp CTTCCEEEEECTTCBGGGSCCCTTCTTCCEEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCCCCG-GGGGCSSCCEEE
T ss_pred CCCCCEEEeECCccCcccChhhcCCCCCCEEEecCCccCcHhHHHHhhCCCCCEEEccCCCCccccH-hhcCCCCCCEEE
Confidence 3578999999999998888899999999999999999998666 68889999999999998444777 688899999999
Q ss_pred cccccCCCCCCcccc--CCceeeeecCCC
Q 002336 491 IENNSFVGEIPPALL--TGKVIFKYDNNP 517 (935)
Q Consensus 491 l~~N~l~g~iP~~l~--~~~~~~~~~~n~ 517 (935)
+++|+++ .+| .+. .....+.+.+|+
T Consensus 166 l~~n~i~-~~~-~l~~l~~L~~L~l~~N~ 192 (197)
T 4ezg_A 166 IQFDGVH-DYR-GIEDFPKLNQLYAFSQT 192 (197)
T ss_dssp CTTBCCC-CCT-TGGGCSSCCEEEECBC-
T ss_pred CCCCCCc-ChH-HhccCCCCCEEEeeCcc
Confidence 9999998 455 232 244556666665
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=98.89 E-value=1.4e-09 Score=130.60 Aligned_cols=106 Identities=18% Similarity=0.073 Sum_probs=76.8
Q ss_pred CCcEEEEEccCCCCcccCCccccCcccccccccccccCCCCCC-CccccccccccccccccccCCCCCccCccccccccc
Q 002336 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 490 (935)
Q Consensus 412 ~~~l~~L~Ls~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p-~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~ 490 (935)
+.+++.|+|++|++++..+..|.++++|++|+|++|++++.+| .|.++++|++|+|++|++++..|..|++|++|++|+
T Consensus 31 ~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ 110 (606)
T 3vq2_A 31 PSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLV 110 (606)
T ss_dssp CTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEE
T ss_pred CCCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEE
Confidence 4568888888888887777788888888888888888888777 577888888888888888877777888888888888
Q ss_pred cccccCCCCCCccccC--CceeeeecCCC
Q 002336 491 IENNSFVGEIPPALLT--GKVIFKYDNNP 517 (935)
Q Consensus 491 l~~N~l~g~iP~~l~~--~~~~~~~~~n~ 517 (935)
|++|++++..|..+.. ....+.+.+|.
T Consensus 111 L~~n~l~~~~~~~~~~l~~L~~L~L~~n~ 139 (606)
T 3vq2_A 111 AVETKLASLESFPIGQLITLKKLNVAHNF 139 (606)
T ss_dssp CTTSCCCCSSSSCCTTCTTCCEEECCSSC
T ss_pred ccCCccccccccccCCCCCCCEEeCCCCc
Confidence 8888877433344433 23334444443
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.87 E-value=1.5e-09 Score=126.44 Aligned_cols=118 Identities=22% Similarity=0.254 Sum_probs=96.6
Q ss_pred CCceEEEeCC--------CCCcEEEEEccCCCCcccCCccccCcccccccccccccCCCCCC-Ccccccccccccccccc
Q 002336 401 PWEWVTCSTT--------TPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNE 471 (935)
Q Consensus 401 ~w~~v~c~~~--------~~~~l~~L~Ls~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p-~~~~l~~L~~L~L~~N~ 471 (935)
.|..+.|... -+.+++.|+|++|+|++..|..|.++++|++|+|++|.+++..| .|.++++|+.|+|++|+
T Consensus 12 ~~~~v~c~~~~l~~ip~~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~ 91 (477)
T 2id5_A 12 QDRAVLCHRKRFVAVPEGIPTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNR 91 (477)
T ss_dssp TTTEEECCSCCCSSCCSCCCTTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred CCCEEEeCCCCcCcCCCCCCCCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCc
Confidence 3566777643 24578999999999998888899999999999999999999887 69999999999999999
Q ss_pred ccCCCCCccCccccccccccccccCCCCCCccccC--CceeeeecCCCC
Q 002336 472 LTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLT--GKVIFKYDNNPK 518 (935)
Q Consensus 472 l~g~iP~~l~~l~~L~~L~l~~N~l~g~iP~~l~~--~~~~~~~~~n~~ 518 (935)
+++..+..++++++|+.|+|++|++++..|..+.. ....+.+.+|..
T Consensus 92 l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l 140 (477)
T 2id5_A 92 LKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDL 140 (477)
T ss_dssp CCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTC
T ss_pred CCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCcc
Confidence 99554556899999999999999999666665543 345556666643
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=98.87 E-value=8.1e-10 Score=129.30 Aligned_cols=107 Identities=21% Similarity=0.188 Sum_probs=90.1
Q ss_pred CCcEEEEEccCCCCcccCCcccc-CcccccccccccccCCCCCCCccccccccccccccccccCCCCCccCccccccccc
Q 002336 412 PPRITKIALSGKNLKGEIPPELK-NMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 490 (935)
Q Consensus 412 ~~~l~~L~Ls~n~l~g~ip~~i~-~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~ 490 (935)
.++|+.|+|++|.+++.+|..+. +|++|+.|+|++|.|++. |.+..+++|+.|+|++|+|++ +|..++.+++|+.|+
T Consensus 143 l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~-~~~~~l~~L~~L~Ls~N~l~~-~~~~~~~l~~L~~L~ 220 (487)
T 3oja_A 143 RSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-KGQVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWIS 220 (487)
T ss_dssp GSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-ECCCCCTTCCEEECCSSCCCE-ECGGGGGGTTCSEEE
T ss_pred CCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccccc-cccccCCCCCEEECCCCCCCC-CCHhHcCCCCccEEE
Confidence 35899999999999988888886 789999999999999987 445569999999999999995 666699999999999
Q ss_pred cccccCCCCCCccccC--CceeeeecCCCCCcc
Q 002336 491 IENNSFVGEIPPALLT--GKVIFKYDNNPKLHK 521 (935)
Q Consensus 491 l~~N~l~g~iP~~l~~--~~~~~~~~~n~~~~~ 521 (935)
|++|.|+ .+|..+.. ....+.+.+|+..|+
T Consensus 221 Ls~N~l~-~lp~~l~~l~~L~~L~l~~N~l~c~ 252 (487)
T 3oja_A 221 LRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCG 252 (487)
T ss_dssp CTTSCCC-EECTTCCCCTTCCEEECTTCCBCHH
T ss_pred ecCCcCc-ccchhhccCCCCCEEEcCCCCCcCc
Confidence 9999999 58887654 456678899998874
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=98.86 E-value=2.1e-09 Score=116.30 Aligned_cols=107 Identities=21% Similarity=0.213 Sum_probs=91.7
Q ss_pred CCcEEEEEccCCCCcccCCccccCcccccccccccccCCCCCCC-ccccccccccccccccccCCCCCccCccccccccc
Q 002336 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 490 (935)
Q Consensus 412 ~~~l~~L~Ls~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~ 490 (935)
.++|+.|+|++|++++..|..|.++++|++|+|++|.+++.++. +.++++|+.|+|++|++++..+..+..+++|+.|+
T Consensus 104 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 183 (285)
T 1ozn_A 104 LGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLL 183 (285)
T ss_dssp CTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEE
T ss_pred CcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEE
Confidence 35899999999999988888899999999999999999998874 89999999999999999965556799999999999
Q ss_pred cccccCCCCCCccccC--CceeeeecCCCC
Q 002336 491 IENNSFVGEIPPALLT--GKVIFKYDNNPK 518 (935)
Q Consensus 491 l~~N~l~g~iP~~l~~--~~~~~~~~~n~~ 518 (935)
|++|++++..|..+.. ....+.+.+|..
T Consensus 184 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l 213 (285)
T 1ozn_A 184 LHQNRVAHVHPHAFRDLGRLMTLYLFANNL 213 (285)
T ss_dssp CCSSCCCEECTTTTTTCTTCCEEECCSSCC
T ss_pred CCCCcccccCHhHccCcccccEeeCCCCcC
Confidence 9999999777877654 445566677754
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=98.86 E-value=1.8e-09 Score=119.43 Aligned_cols=106 Identities=23% Similarity=0.283 Sum_probs=93.1
Q ss_pred CcEEEEEccCCCCcccCCccccCcccccccccccccCCCCCC-CccccccccccccccccccCCCCCccCcccccccccc
Q 002336 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 491 (935)
Q Consensus 413 ~~l~~L~Ls~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p-~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~l 491 (935)
++|+.|+|++|++++..|..|.++++|+.|+|++|.+++.++ .+..+++|+.|+|++|+++ .+|..+..+++|+.|+|
T Consensus 192 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l 270 (330)
T 1xku_A 192 PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYL 270 (330)
T ss_dssp TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEEC
T ss_pred ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCChhhccCCCcCEEEC
Confidence 589999999999998889999999999999999999999888 6899999999999999999 99999999999999999
Q ss_pred ccccCCCCCCccccC---------CceeeeecCCCCCc
Q 002336 492 ENNSFVGEIPPALLT---------GKVIFKYDNNPKLH 520 (935)
Q Consensus 492 ~~N~l~g~iP~~l~~---------~~~~~~~~~n~~~~ 520 (935)
++|+++ .+|...+. ....+.+.+||..+
T Consensus 271 ~~N~i~-~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~~ 307 (330)
T 1xku_A 271 HNNNIS-AIGSNDFCPPGYNTKKASYSGVSLFSNPVQY 307 (330)
T ss_dssp CSSCCC-CCCTTSSSCSSCCTTSCCCSEEECCSSSSCG
T ss_pred CCCcCC-ccChhhcCCcccccccccccceEeecCcccc
Confidence 999999 66654442 22346678888654
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=98.86 E-value=1.2e-09 Score=109.46 Aligned_cols=101 Identities=23% Similarity=0.268 Sum_probs=81.6
Q ss_pred CcEEEEEccCCCCcccCCccccCcc-cccccccccccCCCCCCCccccccccccccccccccCCCCCc-cCccccccccc
Q 002336 413 PRITKIALSGKNLKGEIPPELKNME-ALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSY-MGSLPNLQELH 490 (935)
Q Consensus 413 ~~l~~L~Ls~n~l~g~ip~~i~~L~-~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~iP~~-l~~l~~L~~L~ 490 (935)
.+++.|+|++|+++ .+|. +..+. +|+.|+|++|.|++. +.+.++++|+.|+|++|+++ .+|.. ++.+++|+.|+
T Consensus 19 ~~L~~L~l~~n~l~-~i~~-~~~~~~~L~~L~Ls~N~l~~~-~~l~~l~~L~~L~Ls~N~l~-~~~~~~~~~l~~L~~L~ 94 (176)
T 1a9n_A 19 VRDRELDLRGYKIP-VIEN-LGATLDQFDAIDFSDNEIRKL-DGFPLLRRLKTLLVNNNRIC-RIGEGLDQALPDLTELI 94 (176)
T ss_dssp TSCEEEECTTSCCC-SCCC-GGGGTTCCSEEECCSSCCCEE-CCCCCCSSCCEEECCSSCCC-EECSCHHHHCTTCCEEE
T ss_pred CCceEEEeeCCCCc-hhHH-hhhcCCCCCEEECCCCCCCcc-cccccCCCCCEEECCCCccc-ccCcchhhcCCCCCEEE
Confidence 57899999999998 5654 66655 999999999999986 88999999999999999999 45554 48999999999
Q ss_pred cccccCCCCCCc--cccC--CceeeeecCCCC
Q 002336 491 IENNSFVGEIPP--ALLT--GKVIFKYDNNPK 518 (935)
Q Consensus 491 l~~N~l~g~iP~--~l~~--~~~~~~~~~n~~ 518 (935)
|++|+++ .+|. .+.. ....+.+.+|+.
T Consensus 95 L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i 125 (176)
T 1a9n_A 95 LTNNSLV-ELGDLDPLASLKSLTYLCILRNPV 125 (176)
T ss_dssp CCSCCCC-CGGGGGGGGGCTTCCEEECCSSGG
T ss_pred CCCCcCC-cchhhHhhhcCCCCCEEEecCCCC
Confidence 9999996 7886 4443 345566677764
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=98.85 E-value=7.7e-10 Score=125.41 Aligned_cols=108 Identities=18% Similarity=0.199 Sum_probs=94.0
Q ss_pred CCcEEEEEccCCCCcccCCccccCcccccccccccccCCCCCCCccccccccccccccccccCCCCCccCcccccccccc
Q 002336 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 491 (935)
Q Consensus 412 ~~~l~~L~Ls~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~l 491 (935)
.++|+.|+|++|.+++..|..|.++++|+.|+|++|++++..+.+..+++|+.|+|++|+++ .+|..++.+++|+.|+|
T Consensus 247 l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~L 325 (390)
T 3o6n_A 247 YPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYL 325 (390)
T ss_dssp CTTCSEEECCSSCCCEEESGGGTTCSSCCEEECCSSCCCEEECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEEC
T ss_pred CCCccEEECCCCcCCCcChhHccccccCCEEECCCCcCcccCcccCCCCCCCEEECCCCcce-ecCccccccCcCCEEEC
Confidence 45899999999999988899999999999999999999987667888999999999999999 78888999999999999
Q ss_pred ccccCCCCCCccccCCceeeeecCCCCCcc
Q 002336 492 ENNSFVGEIPPALLTGKVIFKYDNNPKLHK 521 (935)
Q Consensus 492 ~~N~l~g~iP~~l~~~~~~~~~~~n~~~~~ 521 (935)
++|+++ .+|.........+.+.+|+..|.
T Consensus 326 ~~N~i~-~~~~~~~~~L~~L~l~~N~~~~~ 354 (390)
T 3o6n_A 326 DHNSIV-TLKLSTHHTLKNLTLSHNDWDCN 354 (390)
T ss_dssp CSSCCC-CCCCCTTCCCSEEECCSSCEEHH
T ss_pred CCCccc-eeCchhhccCCEEEcCCCCccch
Confidence 999998 67765555667788899988763
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=98.85 E-value=5.9e-10 Score=122.51 Aligned_cols=106 Identities=19% Similarity=0.224 Sum_probs=82.3
Q ss_pred CCcEEEEEccCCCCcccCCccc--cCcccccccccccccCCCCCCCcccc-----ccccccccccccccCCCCCccCccc
Q 002336 412 PPRITKIALSGKNLKGEIPPEL--KNMEALTELWLDGNFLTGPLPDMSRL-----IDLRIVHLENNELTGSLPSYMGSLP 484 (935)
Q Consensus 412 ~~~l~~L~Ls~n~l~g~ip~~i--~~L~~L~~L~Ls~N~l~g~~p~~~~l-----~~L~~L~L~~N~l~g~iP~~l~~l~ 484 (935)
.++|+.|+|++|+++|.+|..+ ..+++|++|+|++|++++.++.+..+ ++|++|+|++|++++..|..+++++
T Consensus 94 l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~ 173 (312)
T 1wwl_A 94 ISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFP 173 (312)
T ss_dssp TSCCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSSSSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCS
T ss_pred cCCccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcchhHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCC
Confidence 3578899999999998888876 88899999999999999884456666 8899999999999877778899999
Q ss_pred cccccccccccCCCCC--Cccc--c--CCceeeeecCCC
Q 002336 485 NLQELHIENNSFVGEI--PPAL--L--TGKVIFKYDNNP 517 (935)
Q Consensus 485 ~L~~L~l~~N~l~g~i--P~~l--~--~~~~~~~~~~n~ 517 (935)
+|+.|+|++|++.|.+ |..+ . .....+.+++|.
T Consensus 174 ~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~ 212 (312)
T 1wwl_A 174 ALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAG 212 (312)
T ss_dssp SCCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSC
T ss_pred CCCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCc
Confidence 9999999999987663 3333 1 234445555553
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.85 E-value=1.5e-09 Score=129.15 Aligned_cols=112 Identities=18% Similarity=0.182 Sum_probs=95.1
Q ss_pred CCcEEEEEccCCCCcccCCccccCcccccccccccccCC-CCCC-CccccccccccccccccccCCCCCccCcccccccc
Q 002336 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLT-GPLP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQEL 489 (935)
Q Consensus 412 ~~~l~~L~Ls~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~-g~~p-~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L 489 (935)
.++|+.|+|++|.+.+.+|..+.++++|+.|+|++|.++ +.+| .+..+++|+.|+|++|++++..|..++++++|+.|
T Consensus 420 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 499 (570)
T 2z63_A 420 LRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVL 499 (570)
T ss_dssp CTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEE
T ss_pred CCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEE
Confidence 468999999999999889999999999999999999998 5666 68999999999999999998889999999999999
Q ss_pred ccccccCCCCCCccccC--CceeeeecCCCCCcccc
Q 002336 490 HIENNSFVGEIPPALLT--GKVIFKYDNNPKLHKES 523 (935)
Q Consensus 490 ~l~~N~l~g~iP~~l~~--~~~~~~~~~n~~~~~~~ 523 (935)
+|++|++++..|..+.. ....+.+.+|+..|..+
T Consensus 500 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 535 (570)
T 2z63_A 500 NMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 535 (570)
T ss_dssp ECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred eCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCc
Confidence 99999999655554443 45667889999887643
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=98.85 E-value=9.1e-10 Score=109.22 Aligned_cols=89 Identities=28% Similarity=0.301 Sum_probs=51.5
Q ss_pred CcEEEEEccCCCCcccCCccccCcccccccccccccCCCCC--CCccccccccccccccccccCCCC---CccCcccccc
Q 002336 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPL--PDMSRLIDLRIVHLENNELTGSLP---SYMGSLPNLQ 487 (935)
Q Consensus 413 ~~l~~L~Ls~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~--p~~~~l~~L~~L~L~~N~l~g~iP---~~l~~l~~L~ 487 (935)
++|+.|+|++|++++.+|..+.++++|+.|+|++|.+++.. +.+..+++|+.|+|++|++++..+ ..+..+++|+
T Consensus 71 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~ 150 (168)
T 2ell_A 71 PKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLT 150 (168)
T ss_dssp SSCCEEEEESCCCCSCCCHHHHHCTTCCEEECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCC
T ss_pred CCCCEEECcCCcCchHHHHHHhhCCCCCEEeccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCc
Confidence 35666666666666555555555666666666666666543 345566666666666666663222 2555666666
Q ss_pred ccccccccCCCCCCc
Q 002336 488 ELHIENNSFVGEIPP 502 (935)
Q Consensus 488 ~L~l~~N~l~g~iP~ 502 (935)
.|++++|.+. ++|+
T Consensus 151 ~L~l~~n~~~-~~~~ 164 (168)
T 2ell_A 151 YLDGYDREDQ-EAPD 164 (168)
T ss_dssp EETTEETTSC-BCCS
T ss_pred EecCCCCChh-hccc
Confidence 6666666665 5554
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=98.85 E-value=1.7e-09 Score=129.80 Aligned_cols=127 Identities=13% Similarity=0.024 Sum_probs=97.0
Q ss_pred CCCCCCCCCC-CCceEEEeCC--------CCCcEEEEEccCCCCcccCCccccCcccccccccccccCCCCCC-Cccccc
Q 002336 391 NDRGDPCVPV-PWEWVTCSTT--------TPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLI 460 (935)
Q Consensus 391 ~w~~dpC~~~-~w~~v~c~~~--------~~~~l~~L~Ls~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p-~~~~l~ 460 (935)
.|...+|... .+.-+.|... -+..++.|+|++|++++..|..|+++++|++|+|++|++++..| .|.+++
T Consensus 2 ~~~~~~C~~~~~~~~~~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~ 81 (606)
T 3t6q_A 2 TSSDQKCIEKEVNKTYNCENLGLNEIPGTLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQH 81 (606)
T ss_dssp ----CCCEEEETTTEEECTTSCCSSCCTTSCTTCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCT
T ss_pred ccccCceecccCCceEECCCCCcccCcCCCCCcCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCcc
Confidence 3556667532 2333555432 24579999999999998888999999999999999999999888 689999
Q ss_pred cccccccccccccCCCCCccCccccccccccccccCCCCCCccccC--CceeeeecCCC
Q 002336 461 DLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLT--GKVIFKYDNNP 517 (935)
Q Consensus 461 ~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~l~~N~l~g~iP~~l~~--~~~~~~~~~n~ 517 (935)
+|++|+|++|++++..|..++++++|+.|+|++|++++..|..+.. ....+.+++|.
T Consensus 82 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~l~~~~~~~l~~L~~L~L~~n~ 140 (606)
T 3t6q_A 82 RLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNH 140 (606)
T ss_dssp TCCEEECTTCCCSEECTTTTSSCTTCCEEECTTSCCSCGGGSCCTTCTTCCEEECCSSC
T ss_pred ccCeeeCCCCcccccChhhhcccccccEeeccccCcccCCcchhccCCcccEEECCCCc
Confidence 9999999999999888999999999999999999999533444433 34455555554
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=98.84 E-value=2.6e-09 Score=114.89 Aligned_cols=93 Identities=20% Similarity=0.264 Sum_probs=51.3
Q ss_pred CcEEEEEccCCCCcccCCccccCcccccccccccccCCCCCC-CccccccccccccccccccCCCCCccCcccccccccc
Q 002336 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 491 (935)
Q Consensus 413 ~~l~~L~Ls~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p-~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~l 491 (935)
++|+.|+|++|++++..+..|.++++|++|+|++|.+++..| .+.++++|+.|+|++|++++..+..++++++|+.|+|
T Consensus 52 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l 131 (276)
T 2z62_A 52 PELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNV 131 (276)
T ss_dssp TTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEEC
T ss_pred cCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEEC
Confidence 355555666665554444455555566666666665555554 3555555666666666555444445555555666666
Q ss_pred ccccCCC-CCCcccc
Q 002336 492 ENNSFVG-EIPPALL 505 (935)
Q Consensus 492 ~~N~l~g-~iP~~l~ 505 (935)
++|++++ .+|..+.
T Consensus 132 ~~n~l~~~~l~~~~~ 146 (276)
T 2z62_A 132 AHNLIQSFKLPEYFS 146 (276)
T ss_dssp CSSCCCCCCCCGGGG
T ss_pred cCCccceecCchhhc
Confidence 6655553 2444443
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.84 E-value=1.7e-09 Score=135.38 Aligned_cols=106 Identities=16% Similarity=0.165 Sum_probs=76.5
Q ss_pred CCcEEEEEccCCCCcccCCccccCcccccccccccccCCCCC-C-CccccccccccccccccccCCCCCccCcccccccc
Q 002336 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPL-P-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQEL 489 (935)
Q Consensus 412 ~~~l~~L~Ls~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~-p-~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L 489 (935)
+++|+.|+|++|.+++..|..|.+|++|++|+|++|.+.+.+ | .|.+|++|++|+|++|++++..|..|++|++|+.|
T Consensus 23 p~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 102 (844)
T 3j0a_A 23 LNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFEL 102 (844)
T ss_dssp CTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTSSCSCSSCCCE
T ss_pred CCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhHccCCcccCEe
Confidence 467888888888888777778888888888888888666665 3 57778888888888888877777777788888888
Q ss_pred ccccccCCCCCCcc--ccC--CceeeeecCCC
Q 002336 490 HIENNSFVGEIPPA--LLT--GKVIFKYDNNP 517 (935)
Q Consensus 490 ~l~~N~l~g~iP~~--l~~--~~~~~~~~~n~ 517 (935)
+|++|.+++.+|.. +.. ....+.+++|.
T Consensus 103 ~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~ 134 (844)
T 3j0a_A 103 RLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQ 134 (844)
T ss_dssp ECTTCCCSSCCSTTCCCSSCSSCCEEEEESCC
T ss_pred eCcCCCCCcccccCccccccCCCCEEECCCCc
Confidence 88888877766654 322 33344555554
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=98.84 E-value=6.6e-10 Score=107.92 Aligned_cols=89 Identities=18% Similarity=0.210 Sum_probs=78.5
Q ss_pred CCCcEEEEEccCCCCcccCCccccCcccccccccccccCCCCCCC-ccccccccccccccccccCC-CCCccCccccccc
Q 002336 411 TPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGS-LPSYMGSLPNLQE 488 (935)
Q Consensus 411 ~~~~l~~L~Ls~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~L~~N~l~g~-iP~~l~~l~~L~~ 488 (935)
..++|+.|+|++|++++. ..++++++|+.|+|++|.+++.+|. +.++++|+.|+|++|++++. .|..++.+++|+.
T Consensus 40 ~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ls~N~i~~~~~~~~~~~l~~L~~ 117 (149)
T 2je0_A 40 EFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKS 117 (149)
T ss_dssp TCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEECTTSCCCSHHHHGGGGGCTTCCE
T ss_pred hcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEECCCCcCCChHHHHHHhhCCCCCE
Confidence 346899999999999966 8899999999999999999998885 56799999999999999963 4588999999999
Q ss_pred cccccccCCCCCCc
Q 002336 489 LHIENNSFVGEIPP 502 (935)
Q Consensus 489 L~l~~N~l~g~iP~ 502 (935)
|++++|++++ +|.
T Consensus 118 L~l~~N~l~~-~~~ 130 (149)
T 2je0_A 118 LDLFNCEVTN-LND 130 (149)
T ss_dssp EECTTCGGGG-STT
T ss_pred EeCcCCcccc-hHH
Confidence 9999999994 443
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=98.83 E-value=9.2e-10 Score=132.25 Aligned_cols=108 Identities=18% Similarity=0.199 Sum_probs=94.7
Q ss_pred CCcEEEEEccCCCCcccCCccccCcccccccccccccCCCCCCCccccccccccccccccccCCCCCccCcccccccccc
Q 002336 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 491 (935)
Q Consensus 412 ~~~l~~L~Ls~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~l 491 (935)
.++|+.|+|++|.+++.+|..|+++++|+.|+|++|.|++.++.+..+++|+.|+|++|+++ .+|..++.+++|+.|+|
T Consensus 253 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~l~~L~~L~L 331 (597)
T 3oja_B 253 YPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYL 331 (597)
T ss_dssp CTTCSEEECCSSCCCEEESGGGTTCSSCCEEECTTSCCCEEECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEEC
T ss_pred CCCCCEEECCCCccCCCCHHHhcCccCCCEEECCCCCCCCCCcccccCCCCcEEECCCCCCC-ccCcccccCCCCCEEEC
Confidence 46899999999999999999999999999999999999997667888999999999999999 78988999999999999
Q ss_pred ccccCCCCCCccccCCceeeeecCCCCCcc
Q 002336 492 ENNSFVGEIPPALLTGKVIFKYDNNPKLHK 521 (935)
Q Consensus 492 ~~N~l~g~iP~~l~~~~~~~~~~~n~~~~~ 521 (935)
++|+|+ .+|.........+.+++|++.|.
T Consensus 332 ~~N~l~-~~~~~~~~~L~~L~l~~N~~~~~ 360 (597)
T 3oja_B 332 DHNSIV-TLKLSTHHTLKNLTLSHNDWDCN 360 (597)
T ss_dssp CSSCCC-CCCCCTTCCCSEEECCSSCEEHH
T ss_pred CCCCCC-CcChhhcCCCCEEEeeCCCCCCh
Confidence 999998 56665556677788899988764
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=98.82 E-value=2.3e-09 Score=118.70 Aligned_cols=106 Identities=22% Similarity=0.198 Sum_probs=92.5
Q ss_pred CcEEEEEccCCCCcccCCccccCcccccccccccccCCCCCC-CccccccccccccccccccCCCCCccCcccccccccc
Q 002336 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 491 (935)
Q Consensus 413 ~~l~~L~Ls~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p-~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~l 491 (935)
++|+.|+|++|.+++..|..|.++++|+.|+|++|++++.+| .+..+++|+.|+|++|+++ .+|..++.+++|+.|+|
T Consensus 193 ~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l 271 (332)
T 2ft3_A 193 ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYL 271 (332)
T ss_dssp SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTTGGGCTTCCEEEC
T ss_pred CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecChhhhcCccCCEEEC
Confidence 479999999999998888899999999999999999999988 6899999999999999999 99999999999999999
Q ss_pred ccccCCCCCCccccC---------CceeeeecCCCCCc
Q 002336 492 ENNSFVGEIPPALLT---------GKVIFKYDNNPKLH 520 (935)
Q Consensus 492 ~~N~l~g~iP~~l~~---------~~~~~~~~~n~~~~ 520 (935)
++|+++ .+|...+. ....+.+.+||..+
T Consensus 272 ~~N~l~-~~~~~~~~~~~~~~~~~~l~~L~l~~N~~~~ 308 (332)
T 2ft3_A 272 HTNNIT-KVGVNDFCPVGFGVKRAYYNGISLFNNPVPY 308 (332)
T ss_dssp CSSCCC-BCCTTSSSCSSCCSSSCCBSEEECCSSSSCG
T ss_pred CCCCCC-ccChhHccccccccccccccceEeecCcccc
Confidence 999999 56654332 12356778888763
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=98.81 E-value=1.9e-09 Score=129.38 Aligned_cols=108 Identities=20% Similarity=0.218 Sum_probs=68.0
Q ss_pred CcEEEEEccCCCCccc---CCccccCcccccccccccccCCCCCC-CccccccccccccccccccCCCCCccCccccccc
Q 002336 413 PRITKIALSGKNLKGE---IPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQE 488 (935)
Q Consensus 413 ~~l~~L~Ls~n~l~g~---ip~~i~~L~~L~~L~Ls~N~l~g~~p-~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~ 488 (935)
++|+.|+|++|.+.+. .+..+..+++|+.|+|++|++++.+| .+.++++|+.|+|++|++++.+|..+.++++| .
T Consensus 449 ~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~ 527 (606)
T 3t6q_A 449 PALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-Y 527 (606)
T ss_dssp TTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC-E
T ss_pred CCCCEEECCCCCCCccccccchhhccCCCccEEECCCCccCccChhhhccccCCCEEECCCCccCcCChhHhCccccc-E
Confidence 4566666666666652 22456666666666666666666655 46666667777777777666666666666666 6
Q ss_pred cccccccCCCCCCccccC--CceeeeecCCCCCcc
Q 002336 489 LHIENNSFVGEIPPALLT--GKVIFKYDNNPKLHK 521 (935)
Q Consensus 489 L~l~~N~l~g~iP~~l~~--~~~~~~~~~n~~~~~ 521 (935)
|+|++|++++.+|..+.. ....+.+.+||..|.
T Consensus 528 L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 562 (606)
T 3t6q_A 528 LNLASNHISIILPSLLPILSQQRTINLRQNPLDCT 562 (606)
T ss_dssp EECCSSCCCCCCGGGHHHHHTSSEEECTTCCEECS
T ss_pred EECcCCcccccCHhhcccCCCCCEEeCCCCCcccc
Confidence 677777766444443322 345566777777664
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=98.81 E-value=1.1e-09 Score=109.80 Aligned_cols=87 Identities=22% Similarity=0.223 Sum_probs=78.7
Q ss_pred CcEEEEEccCCCCcccCCccccCcccccccccccccCCCCCCCc-cccccccccccccccccCCCCC--ccCcccccccc
Q 002336 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNELTGSLPS--YMGSLPNLQEL 489 (935)
Q Consensus 413 ~~l~~L~Ls~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~~-~~l~~L~~L~L~~N~l~g~iP~--~l~~l~~L~~L 489 (935)
++|+.|+|++|+|++. +.|.++++|+.|+|++|.|++.+|.+ ..+++|+.|+|++|+++ .+|. .++.+++|+.|
T Consensus 42 ~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L 118 (176)
T 1a9n_A 42 DQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV-ELGDLDPLASLKSLTYL 118 (176)
T ss_dssp TCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCSCCCC-CGGGGGGGGGCTTCCEE
T ss_pred CCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCCEEECCCCcCC-cchhhHhhhcCCCCCEE
Confidence 4899999999999965 78999999999999999999887765 89999999999999996 7887 89999999999
Q ss_pred ccccccCCCCCCcc
Q 002336 490 HIENNSFVGEIPPA 503 (935)
Q Consensus 490 ~l~~N~l~g~iP~~ 503 (935)
++++|.++ .+|..
T Consensus 119 ~l~~N~i~-~~~~~ 131 (176)
T 1a9n_A 119 CILRNPVT-NKKHY 131 (176)
T ss_dssp ECCSSGGG-GSTTH
T ss_pred EecCCCCC-CcHhH
Confidence 99999998 77764
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=98.79 E-value=2.3e-09 Score=118.08 Aligned_cols=107 Identities=21% Similarity=0.196 Sum_probs=90.9
Q ss_pred CCcEEEEEccCCCCcccCCcccc-CcccccccccccccCCCCCCCccccccccccccccccccCCCCCccCccccccccc
Q 002336 412 PPRITKIALSGKNLKGEIPPELK-NMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 490 (935)
Q Consensus 412 ~~~l~~L~Ls~n~l~g~ip~~i~-~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~ 490 (935)
.++|+.|+|++|++++..|..+. .+++|++|+|++|.+++. |....+++|+.|+|++|+++ .+|..+..+++|+.|+
T Consensus 143 l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~ 220 (317)
T 3o53_A 143 RSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-KGQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWIS 220 (317)
T ss_dssp GSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-ECCCCCTTCCEEECCSSCCC-EECGGGGGGTTCSEEE
T ss_pred cCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCccc-ccccccccCCEEECCCCcCC-cchhhhcccCcccEEE
Confidence 35899999999999988777774 789999999999999887 54556999999999999999 5677799999999999
Q ss_pred cccccCCCCCCccccC--CceeeeecCCCCCcc
Q 002336 491 IENNSFVGEIPPALLT--GKVIFKYDNNPKLHK 521 (935)
Q Consensus 491 l~~N~l~g~iP~~l~~--~~~~~~~~~n~~~~~ 521 (935)
|++|+++ .+|..+.. ....+.+++|+..|.
T Consensus 221 L~~N~l~-~l~~~~~~l~~L~~L~l~~N~~~~~ 252 (317)
T 3o53_A 221 LRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCG 252 (317)
T ss_dssp CTTSCCC-EECTTCCCCTTCCEEECTTCCCBHH
T ss_pred CcCCccc-chhhHhhcCCCCCEEEccCCCccCc
Confidence 9999999 78887654 456778899998864
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.79 E-value=2.1e-09 Score=134.47 Aligned_cols=107 Identities=22% Similarity=0.312 Sum_probs=89.7
Q ss_pred CCcEEEEEccCCCCc-----ccCCccccCcccccccccccccCCCCCC-CccccccccccccccccccCCCCCccCcccc
Q 002336 412 PPRITKIALSGKNLK-----GEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPN 485 (935)
Q Consensus 412 ~~~l~~L~Ls~n~l~-----g~ip~~i~~L~~L~~L~Ls~N~l~g~~p-~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~ 485 (935)
.++|+.|+|++|.++ +..|..|.+|++|+.|+|++|+|++.+| .+.++++|+.|+|++|+|++..|..+. ++
T Consensus 450 ~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~--~~ 527 (844)
T 3j0a_A 450 NPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP--AN 527 (844)
T ss_dssp CTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC--SC
T ss_pred CCccccccCCCCccccccccccchhhhcCcccccEEECCCCcccccChhHccchhhhheeECCCCCCCccChhhhh--cc
Confidence 357888999999987 4455678899999999999999999988 478999999999999999965555555 89
Q ss_pred ccccccccccCCCCCCccccCCceeeeecCCCCCcc
Q 002336 486 LQELHIENNSFVGEIPPALLTGKVIFKYDNNPKLHK 521 (935)
Q Consensus 486 L~~L~l~~N~l~g~iP~~l~~~~~~~~~~~n~~~~~ 521 (935)
|+.|+|++|+|+|.+|..+. ....+.+.+||+.|.
T Consensus 528 L~~L~Ls~N~l~~~~~~~~~-~L~~l~l~~Np~~C~ 562 (844)
T 3j0a_A 528 LEILDISRNQLLAPNPDVFV-SLSVLDITHNKFICE 562 (844)
T ss_dssp CCEEEEEEECCCCCCSCCCS-SCCEEEEEEECCCCS
T ss_pred ccEEECCCCcCCCCChhHhC-CcCEEEecCCCcccc
Confidence 99999999999988877654 566788899999884
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=98.78 E-value=5.4e-09 Score=125.49 Aligned_cols=106 Identities=19% Similarity=0.191 Sum_probs=82.5
Q ss_pred CCCcEEEEEccCCCCcccCCccccCcccccccccccccCCCCCCC-ccccccccccccccccccCCCCCccCcccccccc
Q 002336 411 TPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQEL 489 (935)
Q Consensus 411 ~~~~l~~L~Ls~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L 489 (935)
..++|+.|+|++|.+++..|..|++|++|+.|+|++|.|++.++. |+++++|++|+|++|++++..|..++.+++|+.|
T Consensus 97 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 176 (597)
T 3oja_B 97 YAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNL 176 (597)
T ss_dssp TCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEE
T ss_pred CCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEE
Confidence 346788888888888877777788888888888888888877775 5888888888888888888777788888888888
Q ss_pred ccccccCCCCCCccccCCceeeeecCCC
Q 002336 490 HIENNSFVGEIPPALLTGKVIFKYDNNP 517 (935)
Q Consensus 490 ~l~~N~l~g~iP~~l~~~~~~~~~~~n~ 517 (935)
+|++|.++ .+|.........+.+.+|.
T Consensus 177 ~L~~N~l~-~~~~~~l~~L~~L~l~~n~ 203 (597)
T 3oja_B 177 QLSSNRLT-HVDLSLIPSLFHANVSYNL 203 (597)
T ss_dssp ECTTSCCS-BCCGGGCTTCSEEECCSSC
T ss_pred ECcCCCCC-CcChhhhhhhhhhhcccCc
Confidence 88888888 4555444445555555553
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.78 E-value=4.8e-09 Score=120.99 Aligned_cols=115 Identities=19% Similarity=0.202 Sum_probs=93.8
Q ss_pred CceEEEeCC--------CCCcEEEEEccCCCCcccCCccccCcccccccccccccCCCCCC-Cccccccccccccccccc
Q 002336 402 WEWVTCSTT--------TPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNEL 472 (935)
Q Consensus 402 w~~v~c~~~--------~~~~l~~L~Ls~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p-~~~~l~~L~~L~L~~N~l 472 (935)
|..+.|... .++.++.|+|++|++++..+..|.+|++|+.|+|++|.|++..+ .|.++++|+.|+|++|+|
T Consensus 45 ~~~v~c~~~~l~~iP~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l 124 (440)
T 3zyj_A 45 FSKVICVRKNLREVPDGISTNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRL 124 (440)
T ss_dssp SCEEECCSCCCSSCCSCCCTTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSCC
T ss_pred CCEEEeCCCCcCcCCCCCCCCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCCcC
Confidence 455666543 24578999999999998888999999999999999999999887 689999999999999999
Q ss_pred cCCCCCccCccccccccccccccCCCCCCccccC---CceeeeecCCC
Q 002336 473 TGSLPSYMGSLPNLQELHIENNSFVGEIPPALLT---GKVIFKYDNNP 517 (935)
Q Consensus 473 ~g~iP~~l~~l~~L~~L~l~~N~l~g~iP~~l~~---~~~~~~~~~n~ 517 (935)
++..+..+..+++|+.|+|++|+++ .+|...+. ....+.+.+|.
T Consensus 125 ~~~~~~~~~~l~~L~~L~L~~N~i~-~~~~~~~~~l~~L~~L~l~~~~ 171 (440)
T 3zyj_A 125 TTIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELK 171 (440)
T ss_dssp SSCCTTTSCSCSSCCEEECCSCCCC-EECTTTTTTCTTCCEEECCCCT
T ss_pred CeeCHhHhhccccCceeeCCCCccc-ccCHHHhhhCcccCEeCCCCCC
Confidence 9655567999999999999999998 66664433 33445555543
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=98.77 E-value=3.8e-09 Score=115.43 Aligned_cols=108 Identities=19% Similarity=0.256 Sum_probs=92.1
Q ss_pred CCcEEEEEccCCCCcccCCccccCcccccccccccccCCC-CCC-CccccccccccccccccccCCCCCccCcccccccc
Q 002336 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTG-PLP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQEL 489 (935)
Q Consensus 412 ~~~l~~L~Ls~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g-~~p-~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L 489 (935)
.++|+.|+|++|.+.+..|..+.++++|+.|+|++|.+++ .+| .+..+++|+.|+|++|++++..|..+..+++|+.|
T Consensus 125 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L 204 (306)
T 2z66_A 125 LRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVL 204 (306)
T ss_dssp CTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEE
T ss_pred ccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEE
Confidence 3589999999999999999999999999999999999998 455 68999999999999999998889999999999999
Q ss_pred ccccccCCCCCCccccC--CceeeeecCCCCC
Q 002336 490 HIENNSFVGEIPPALLT--GKVIFKYDNNPKL 519 (935)
Q Consensus 490 ~l~~N~l~g~iP~~l~~--~~~~~~~~~n~~~ 519 (935)
+|++|++++..+..+.. ....+.+++|...
T Consensus 205 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 236 (306)
T 2z66_A 205 NMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM 236 (306)
T ss_dssp ECTTSCCSBCCSGGGTTCTTCCEEECTTSCCC
T ss_pred ECCCCccCccChhhccCcccCCEeECCCCCCc
Confidence 99999999544434432 4556677777643
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.76 E-value=1.3e-08 Score=113.95 Aligned_cols=141 Identities=16% Similarity=0.231 Sum_probs=106.4
Q ss_pred cccccccccEEEEEEEECCCcEEEEEEcc--Ccc-hhhhHHHHHHHHHHHhcC--CCcccccceeeecc---ceEEEEEE
Q 002336 618 CKKIGKGSFGSVYYGKMKDGKEVAVKIMA--DSC-SHRTQQFVTEVALLSRIH--HRNLVPLIGYCEEE---HQRILVYE 689 (935)
Q Consensus 618 ~~~LG~G~fG~Vy~~~~~~g~~vAvK~~~--~~~-~~~~~~~~~E~~iL~~L~--HpnIv~l~g~~~~~---~~~~lV~E 689 (935)
.+.|+.|.++.||+.... +..+++|+.. ... ......+.+|+.+++.+. +..+.++++++.+. +..++|||
T Consensus 43 ~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme 121 (359)
T 3dxp_A 43 VEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIME 121 (359)
T ss_dssp EEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEE
T ss_pred EEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEE
Confidence 356899999999999876 4678888765 321 123457889999999997 45578888888766 45799999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcC-------------------------------------
Q 002336 690 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC------------------------------------- 732 (935)
Q Consensus 690 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~------------------------------------- 732 (935)
|++|..+.+.. ...++..++..++.++++.|+.||+..
T Consensus 122 ~v~G~~l~~~~-----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (359)
T 3dxp_A 122 FVSGRVLWDQS-----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPA 196 (359)
T ss_dssp CCCCBCCCCTT-----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHH
T ss_pred ecCCeecCCCc-----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChH
Confidence 99987775421 223678888999999999999999720
Q ss_pred ------------------CCceEecCCCCCCccccCCCc--EEEeecccccc
Q 002336 733 ------------------NPGIIHRDVKSSNILLDINMR--AKVSDFGLSRQ 764 (935)
Q Consensus 733 ------------------~~~ivH~DLkp~NILld~~~~--vkL~DFGla~~ 764 (935)
...++|||+++.|||++.++. +.|+||+.+..
T Consensus 197 ~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 197 MDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 257999999999999997753 68999998865
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=98.76 E-value=5.9e-09 Score=115.39 Aligned_cols=115 Identities=22% Similarity=0.339 Sum_probs=92.6
Q ss_pred CCCceEEEeCC--------CCCcEEEEEccCCCCcccCCccccCcccccccccccccCCCCCC-Cccccccccccccccc
Q 002336 400 VPWEWVTCSTT--------TPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENN 470 (935)
Q Consensus 400 ~~w~~v~c~~~--------~~~~l~~L~Ls~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p-~~~~l~~L~~L~L~~N 470 (935)
|.|..+.|... .+++++.|+|++|++++..|..|.++++|++|+|++|++++..| .+.++++|++|+|++|
T Consensus 33 c~l~~l~~~~~~l~~ip~~~~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n 112 (332)
T 2ft3_A 33 CHLRVVQCSDLGLKAVPKEISPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKN 112 (332)
T ss_dssp EETTEEECCSSCCSSCCSCCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCSS
T ss_pred ccCCEEECCCCCccccCCCCCCCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCCC
Confidence 46777877642 23578999999999997777889999999999999999999877 6899999999999999
Q ss_pred cccCCCCCccCccccccccccccccCCCCCCccccC---CceeeeecCCCC
Q 002336 471 ELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLT---GKVIFKYDNNPK 518 (935)
Q Consensus 471 ~l~g~iP~~l~~l~~L~~L~l~~N~l~g~iP~~l~~---~~~~~~~~~n~~ 518 (935)
+++ .+|..+. ++|+.|++++|+++ .+|...+. ....+.+.+|..
T Consensus 113 ~l~-~l~~~~~--~~L~~L~l~~n~i~-~~~~~~~~~l~~L~~L~l~~n~l 159 (332)
T 2ft3_A 113 HLV-EIPPNLP--SSLVELRIHDNRIR-KVPKGVFSGLRNMNCIEMGGNPL 159 (332)
T ss_dssp CCC-SCCSSCC--TTCCEEECCSSCCC-CCCSGGGSSCSSCCEEECCSCCC
T ss_pred cCC-ccCcccc--ccCCEEECCCCccC-ccCHhHhCCCccCCEEECCCCcc
Confidence 999 8888776 89999999999998 66654332 344555666654
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.75 E-value=6.5e-09 Score=121.01 Aligned_cols=105 Identities=19% Similarity=0.198 Sum_probs=76.8
Q ss_pred CcEEEEEccCCCCcccCCccccCcccccccccccccCCCCCCC-ccccccccccccccccccCCCCCccCcccccccccc
Q 002336 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 491 (935)
Q Consensus 413 ~~l~~L~Ls~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~l 491 (935)
++|+.|+|++|++++..|..|.+|++|++|+|++|++++.++. |.++++|+.|+|++|++++..|..+.++++|+.|+|
T Consensus 56 ~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l 135 (477)
T 2id5_A 56 PHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEV 135 (477)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEE
T ss_pred CCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcCCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEEC
Confidence 5778888888888877777888888888888888888877663 677888888888888888777777888888888888
Q ss_pred ccccCCCCCCccccC--CceeeeecCCC
Q 002336 492 ENNSFVGEIPPALLT--GKVIFKYDNNP 517 (935)
Q Consensus 492 ~~N~l~g~iP~~l~~--~~~~~~~~~n~ 517 (935)
++|++++..|..+.. ....+.+.+|.
T Consensus 136 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~ 163 (477)
T 2id5_A 136 GDNDLVYISHRAFSGLNSLEQLTLEKCN 163 (477)
T ss_dssp CCTTCCEECTTSSTTCTTCCEEEEESCC
T ss_pred CCCccceeChhhccCCCCCCEEECCCCc
Confidence 888887554544433 33444555553
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.75 E-value=2.8e-09 Score=125.44 Aligned_cols=106 Identities=14% Similarity=0.146 Sum_probs=80.5
Q ss_pred CCcEEEEEccCCCCcccCCccccCcccccccccccccCCC--CCC-CccccccccccccccccccCCCCCc-cCcccccc
Q 002336 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTG--PLP-DMSRLIDLRIVHLENNELTGSLPSY-MGSLPNLQ 487 (935)
Q Consensus 412 ~~~l~~L~Ls~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g--~~p-~~~~l~~L~~L~L~~N~l~g~iP~~-l~~l~~L~ 487 (935)
.++|+.|+|++|++++.+|..++++++|+.|+|++|++++ .+| .+.++++|+.|+|++|++++.+|.. +..+++|+
T Consensus 323 l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~ 402 (520)
T 2z7x_B 323 ISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLL 402 (520)
T ss_dssp CCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCC
T ss_pred CCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCC
Confidence 4578888888888888788888888888888888888886 344 4778888888888888888767764 67778888
Q ss_pred ccccccccCCCCCCccccCCceeeeecCCC
Q 002336 488 ELHIENNSFVGEIPPALLTGKVIFKYDNNP 517 (935)
Q Consensus 488 ~L~l~~N~l~g~iP~~l~~~~~~~~~~~n~ 517 (935)
.|+|++|++++.+|..+......+.+++|.
T Consensus 403 ~L~Ls~N~l~~~~~~~l~~~L~~L~Ls~N~ 432 (520)
T 2z7x_B 403 SLNMSSNILTDTIFRCLPPRIKVLDLHSNK 432 (520)
T ss_dssp EEECCSSCCCGGGGGSCCTTCCEEECCSSC
T ss_pred EEECcCCCCCcchhhhhcccCCEEECCCCc
Confidence 888888888777777765555556666664
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.75 E-value=2.7e-09 Score=117.11 Aligned_cols=106 Identities=17% Similarity=0.204 Sum_probs=78.0
Q ss_pred CCcEEEEEccCCCCccc--CC--ccccCcccccccccccccCCCCCC---C-ccccccccccccccccccCCCCCccCcc
Q 002336 412 PPRITKIALSGKNLKGE--IP--PELKNMEALTELWLDGNFLTGPLP---D-MSRLIDLRIVHLENNELTGSLPSYMGSL 483 (935)
Q Consensus 412 ~~~l~~L~Ls~n~l~g~--ip--~~i~~L~~L~~L~Ls~N~l~g~~p---~-~~~l~~L~~L~L~~N~l~g~iP~~l~~l 483 (935)
.++|+.|+|++|++.|. ++ ..++++++|++|+|++|+++...+ . +.++++|+.|+|++|++++.+|..++.+
T Consensus 168 l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~ 247 (310)
T 4glp_A 168 FPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMETPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRC 247 (310)
T ss_dssp CTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCCHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSC
T ss_pred CCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCchHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhc
Confidence 45788888888887753 32 234678888888888888864333 1 4677888888888888887778777776
Q ss_pred ---ccccccccccccCCCCCCccccCCceeeeecCCCC
Q 002336 484 ---PNLQELHIENNSFVGEIPPALLTGKVIFKYDNNPK 518 (935)
Q Consensus 484 ---~~L~~L~l~~N~l~g~iP~~l~~~~~~~~~~~n~~ 518 (935)
++|+.|+|++|+|+ .+|..+......+.+++|..
T Consensus 248 ~~~~~L~~L~Ls~N~l~-~lp~~~~~~L~~L~Ls~N~l 284 (310)
T 4glp_A 248 MWSSALNSLNLSFAGLE-QVPKGLPAKLRVLDLSSNRL 284 (310)
T ss_dssp CCCTTCCCEECCSSCCC-SCCSCCCSCCSCEECCSCCC
T ss_pred cCcCcCCEEECCCCCCC-chhhhhcCCCCEEECCCCcC
Confidence 58888888888888 78887776666666666653
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.75 E-value=5.3e-09 Score=123.10 Aligned_cols=105 Identities=18% Similarity=0.267 Sum_probs=69.5
Q ss_pred CcEEEEEccCCCCcccCCcc-ccCcccccccccccccCCCCCC-CccccccccccccccccccCCCCCccCccccccccc
Q 002336 413 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 490 (935)
Q Consensus 413 ~~l~~L~Ls~n~l~g~ip~~-i~~L~~L~~L~Ls~N~l~g~~p-~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~ 490 (935)
++|+.|+|++|.+++.+|.. +..+++|+.|+|++|++++.+| .+. ++|+.|+|++|+++ .+|..+..+++|+.|+
T Consensus 374 ~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~ 450 (520)
T 2z7x_B 374 KSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELN 450 (520)
T ss_dssp TTCCEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCGGGGGSCC--TTCCEEECCSSCCC-CCCGGGGGCTTCCEEE
T ss_pred CCCCEEECCCCcCCcccccchhccCccCCEEECcCCCCCcchhhhhc--ccCCEEECCCCccc-ccchhhhcCCCCCEEE
Confidence 45666666666666545543 5556666666666666665554 232 57777777777777 7777777888888888
Q ss_pred cccccCCCCCCcc-ccC--CceeeeecCCCCCcc
Q 002336 491 IENNSFVGEIPPA-LLT--GKVIFKYDNNPKLHK 521 (935)
Q Consensus 491 l~~N~l~g~iP~~-l~~--~~~~~~~~~n~~~~~ 521 (935)
|++|+|+ .+|.. +.. ....+.+.+|+..|.
T Consensus 451 L~~N~l~-~l~~~~~~~l~~L~~L~l~~N~~~c~ 483 (520)
T 2z7x_B 451 VASNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCS 483 (520)
T ss_dssp CCSSCCC-CCCTTTTTTCTTCCEEECCSSCBCCC
T ss_pred CCCCcCC-ccCHHHhccCCcccEEECcCCCCccc
Confidence 8888887 67776 322 345567788887764
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=98.75 E-value=4e-09 Score=107.65 Aligned_cols=88 Identities=17% Similarity=0.274 Sum_probs=46.9
Q ss_pred cEEEEEccCCCCcccCCccccCcccccccccccccCCCCCCCccccccccccccccccccCCCCCccCcccccccccccc
Q 002336 414 RITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIEN 493 (935)
Q Consensus 414 ~l~~L~Ls~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~l~~ 493 (935)
+|+.|+|++|+++ .+| .+..+++|+.|+|++|.++. ++.+..+++|+.|+|++|++++..|..++.|++|+.|+|++
T Consensus 45 ~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~~-~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~ 121 (197)
T 4ezg_A 45 SLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHATN-YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISH 121 (197)
T ss_dssp TCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCSC-CGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEECCS
T ss_pred CccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCCc-chhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEecC
Confidence 4555555555555 444 45555555555555554332 23455555555555555555555555555555555555555
Q ss_pred ccCCCCCCccc
Q 002336 494 NSFVGEIPPAL 504 (935)
Q Consensus 494 N~l~g~iP~~l 504 (935)
|++++.+|..+
T Consensus 122 n~i~~~~~~~l 132 (197)
T 4ezg_A 122 SAHDDSILTKI 132 (197)
T ss_dssp SBCBGGGHHHH
T ss_pred CccCcHhHHHH
Confidence 55554444433
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=98.73 E-value=1e-08 Score=113.23 Aligned_cols=116 Identities=24% Similarity=0.360 Sum_probs=87.0
Q ss_pred CCCceEEEeCC--------CCCcEEEEEccCCCCcccCCccccCcccccccccccccCCCCCC-Cccccccccccccccc
Q 002336 400 VPWEWVTCSTT--------TPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENN 470 (935)
Q Consensus 400 ~~w~~v~c~~~--------~~~~l~~L~Ls~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p-~~~~l~~L~~L~L~~N 470 (935)
+.|..+.|... .++.++.|+|++|++++..+..|+++++|++|+|++|++++..| .+.++++|++|+|++|
T Consensus 31 c~l~~l~~~~~~l~~lp~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n 110 (330)
T 1xku_A 31 CHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKN 110 (330)
T ss_dssp EETTEEECTTSCCCSCCCSCCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSS
T ss_pred CCCeEEEecCCCccccCccCCCCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCCC
Confidence 35677777532 24578889999999987666788999999999999999998877 6888999999999999
Q ss_pred cccCCCCCccCccccccccccccccCCCCCCccccC--CceeeeecCCCC
Q 002336 471 ELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLT--GKVIFKYDNNPK 518 (935)
Q Consensus 471 ~l~g~iP~~l~~l~~L~~L~l~~N~l~g~iP~~l~~--~~~~~~~~~n~~ 518 (935)
+++ .+|..+. ++|+.|++++|++++..|..+.. ....+.+.+|..
T Consensus 111 ~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l 157 (330)
T 1xku_A 111 QLK-ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPL 157 (330)
T ss_dssp CCS-BCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCC
T ss_pred cCC-ccChhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcC
Confidence 988 7887765 78999999999998433333332 334455555543
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=98.73 E-value=8.1e-09 Score=125.73 Aligned_cols=85 Identities=26% Similarity=0.294 Sum_probs=56.7
Q ss_pred CcEEEEEccCCCCcccCCccccCcccccccccccccCCCCCC-CccccccccccccccccccCCCCCccCcccccccccc
Q 002336 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 491 (935)
Q Consensus 413 ~~l~~L~Ls~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p-~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~l 491 (935)
++|+.|+|++|++++..+..|+++++|++|+|++|.+++.+| .++++++|++|+|++|++++..+..|+++++|++|+|
T Consensus 25 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L 104 (680)
T 1ziw_A 25 TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHL 104 (680)
T ss_dssp TTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEEC
T ss_pred CCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCccChhhhccCCCCCEEEC
Confidence 467777777777776555567777777777777777777666 3566667777777777666333335666666666666
Q ss_pred ccccCC
Q 002336 492 ENNSFV 497 (935)
Q Consensus 492 ~~N~l~ 497 (935)
++|+++
T Consensus 105 ~~n~l~ 110 (680)
T 1ziw_A 105 MSNSIQ 110 (680)
T ss_dssp CSSCCC
T ss_pred CCCccC
Confidence 666666
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=98.73 E-value=6.5e-09 Score=123.77 Aligned_cols=103 Identities=17% Similarity=0.219 Sum_probs=85.0
Q ss_pred CCcEEEEEccCCCCcccCCccccCcccccccccccccCCCCCC-CccccccccccccccccccCCCCCccCccccccccc
Q 002336 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 490 (935)
Q Consensus 412 ~~~l~~L~Ls~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p-~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~ 490 (935)
+++++.|+|++|++++..|..|.++++|++|+|++|++++..| .|.++++|++|+|++|+++ .+|.. .+++|+.|+
T Consensus 51 ~~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~ 127 (562)
T 3a79_B 51 PPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQ-NISCC--PMASLRHLD 127 (562)
T ss_dssp CTTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCC-EECSC--CCTTCSEEE
T ss_pred CCCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCC-ccCcc--ccccCCEEE
Confidence 3578999999999997777899999999999999999999877 5899999999999999998 78887 799999999
Q ss_pred cccccCCC-CCCccccC--CceeeeecCCC
Q 002336 491 IENNSFVG-EIPPALLT--GKVIFKYDNNP 517 (935)
Q Consensus 491 l~~N~l~g-~iP~~l~~--~~~~~~~~~n~ 517 (935)
|++|++++ .+|..+.. ....+.+++|.
T Consensus 128 Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~ 157 (562)
T 3a79_B 128 LSFNDFDVLPVCKEFGNLTKLTFLGLSAAK 157 (562)
T ss_dssp CCSSCCSBCCCCGGGGGCTTCCEEEEECSB
T ss_pred CCCCCccccCchHhhcccCcccEEecCCCc
Confidence 99999985 44566654 34455566654
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=98.73 E-value=1.4e-08 Score=115.02 Aligned_cols=105 Identities=19% Similarity=0.198 Sum_probs=88.6
Q ss_pred CCcEEEEEccCCCCcccCCccccCcccccccccccccCCCCCCC-ccccccccccccccccccCCCCCccCccccccccc
Q 002336 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 490 (935)
Q Consensus 412 ~~~l~~L~Ls~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~ 490 (935)
.++|+.|+|++|++++..|..|+++++|++|+|++|.++..++. +.++++|+.|+|++|++++..|..++.+++|+.|+
T Consensus 92 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 171 (390)
T 3o6n_A 92 AHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQ 171 (390)
T ss_dssp CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEE
T ss_pred CCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEE
Confidence 45899999999999987788899999999999999999977775 68999999999999999987788899999999999
Q ss_pred cccccCCCCCCccccCCceeeeecCCC
Q 002336 491 IENNSFVGEIPPALLTGKVIFKYDNNP 517 (935)
Q Consensus 491 l~~N~l~g~iP~~l~~~~~~~~~~~n~ 517 (935)
+++|+++ .++.........+.+.+|.
T Consensus 172 l~~n~l~-~~~~~~l~~L~~L~l~~n~ 197 (390)
T 3o6n_A 172 LSSNRLT-HVDLSLIPSLFHANVSYNL 197 (390)
T ss_dssp CCSSCCS-BCCGGGCTTCSEEECCSSC
T ss_pred CCCCcCC-ccccccccccceeeccccc
Confidence 9999998 4565555555555565553
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=98.70 E-value=1.1e-08 Score=121.82 Aligned_cols=106 Identities=15% Similarity=0.180 Sum_probs=81.5
Q ss_pred CCcEEEEEccCCCCcccCCccccCcccccccccccccCCCCC--C-CccccccccccccccccccCCCCCc-cCcccccc
Q 002336 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPL--P-DMSRLIDLRIVHLENNELTGSLPSY-MGSLPNLQ 487 (935)
Q Consensus 412 ~~~l~~L~Ls~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~--p-~~~~l~~L~~L~L~~N~l~g~iP~~-l~~l~~L~ 487 (935)
.++++.|+|++|++++.+|..++++++|+.|+|++|++++.. | .+.++++|+.|+|++|++++.+|.. +..+++|+
T Consensus 352 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~ 431 (562)
T 3a79_B 352 PSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESIL 431 (562)
T ss_dssp CCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCC
T ss_pred CCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCC
Confidence 457888888888888888888888888888888888888754 3 5788888888888888888767764 67788888
Q ss_pred ccccccccCCCCCCccccCCceeeeecCCC
Q 002336 488 ELHIENNSFVGEIPPALLTGKVIFKYDNNP 517 (935)
Q Consensus 488 ~L~l~~N~l~g~iP~~l~~~~~~~~~~~n~ 517 (935)
.|+|++|+++|.+|..+......+.+++|.
T Consensus 432 ~L~l~~n~l~~~~~~~l~~~L~~L~L~~N~ 461 (562)
T 3a79_B 432 VLNLSSNMLTGSVFRCLPPKVKVLDLHNNR 461 (562)
T ss_dssp EEECCSSCCCGGGGSSCCTTCSEEECCSSC
T ss_pred EEECCCCCCCcchhhhhcCcCCEEECCCCc
Confidence 888888888877777665445555666663
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=98.69 E-value=4.4e-09 Score=123.10 Aligned_cols=106 Identities=20% Similarity=0.132 Sum_probs=80.8
Q ss_pred CCCcEEEEEccCCCCcccCCccccCcccccccccccccCCCCCCC-----------------cccccccccccccccccc
Q 002336 411 TPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-----------------MSRLIDLRIVHLENNELT 473 (935)
Q Consensus 411 ~~~~l~~L~Ls~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~-----------------~~~l~~L~~L~L~~N~l~ 473 (935)
..++|+.|+|++|.+++.+| |+.|++|+.|+|++|.|++.++. ...+++|+.|+|++|+++
T Consensus 56 ~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~~~~L~~L~L~~N~l~~~~~~~l~~L~~L~L~~N~l~ 133 (487)
T 3oja_A 56 PFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLVGPSIETLHAANNNISRVSCSRGQGKKNIYLANNKIT 133 (487)
T ss_dssp TCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEECTTCCEEECCSSCCCCEEECCCSSCEEEECCSSCCC
T ss_pred CCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCCCCCcCEEECcCCcCCCCCccccCCCCEEECCCCCCC
Confidence 34688999999999987665 88888888888888887764421 123567888888888888
Q ss_pred CCCCCccCccccccccccccccCCCCCCcccc---CCceeeeecCCCC
Q 002336 474 GSLPSYMGSLPNLQELHIENNSFVGEIPPALL---TGKVIFKYDNNPK 518 (935)
Q Consensus 474 g~iP~~l~~l~~L~~L~l~~N~l~g~iP~~l~---~~~~~~~~~~n~~ 518 (935)
+..|..++++++|+.|+|++|.|++.+|..+. .....+.+++|..
T Consensus 134 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l 181 (487)
T 3oja_A 134 MLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFI 181 (487)
T ss_dssp SGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCC
T ss_pred CCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCcc
Confidence 88888888899999999999999987887765 3455566666653
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=98.68 E-value=1.3e-08 Score=124.01 Aligned_cols=106 Identities=22% Similarity=0.183 Sum_probs=83.6
Q ss_pred CCcEEEEEccCCCCcccCCccccCcccccccccccccCCCCCC-CccccccccccccccccccCCCCCccCccccccccc
Q 002336 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 490 (935)
Q Consensus 412 ~~~l~~L~Ls~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p-~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~ 490 (935)
.++|+.|+|++|++++..+..|++|++|++|+|++|++++.+| .|+++++|++|+|++|++++..|..++++++|+.|+
T Consensus 72 l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~ 151 (680)
T 1ziw_A 72 LPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELL 151 (680)
T ss_dssp CTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEE
T ss_pred ccCcCEEECCCCccCccChhhhccCCCCCEEECCCCccCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEE
Confidence 3578899999999984444468899999999999999988877 588899999999999999988888888999999999
Q ss_pred cccccCCCCCCcccc----CCceeeeecCCC
Q 002336 491 IENNSFVGEIPPALL----TGKVIFKYDNNP 517 (935)
Q Consensus 491 l~~N~l~g~iP~~l~----~~~~~~~~~~n~ 517 (935)
|++|++++..|..+. .....+.+.+|.
T Consensus 152 L~~n~l~~~~~~~~~~~~~~~L~~L~L~~n~ 182 (680)
T 1ziw_A 152 LSNNKIQALKSEELDIFANSSLKKLELSSNQ 182 (680)
T ss_dssp CCSSCCCCBCHHHHGGGTTCEESEEECTTCC
T ss_pred ccCCcccccCHHHhhccccccccEEECCCCc
Confidence 999999865555432 233455566664
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=98.68 E-value=8.9e-09 Score=121.89 Aligned_cols=90 Identities=22% Similarity=0.269 Sum_probs=58.3
Q ss_pred CcEEEEEccCCCCcccCCccccCcccccccccccccCCCCCCC-ccccccccccccccccccC-CCCCccCccccccccc
Q 002336 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTG-SLPSYMGSLPNLQELH 490 (935)
Q Consensus 413 ~~l~~L~Ls~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~L~~N~l~g-~iP~~l~~l~~L~~L~ 490 (935)
++|+.|+|++|++++..|..|++|++|++|+|++|.+++.+|. ++++++|++|+|++|++++ .+|..++++++|+.|+
T Consensus 50 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~ 129 (549)
T 2z81_A 50 ANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLR 129 (549)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEE
T ss_pred CcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEE
Confidence 4566666666666666666666666666666666666666663 6666666666666666664 3455666666666666
Q ss_pred cccccCCCCCCc
Q 002336 491 IENNSFVGEIPP 502 (935)
Q Consensus 491 l~~N~l~g~iP~ 502 (935)
+++|++.+.+|.
T Consensus 130 L~~n~~~~~~~~ 141 (549)
T 2z81_A 130 IGNVETFSEIRR 141 (549)
T ss_dssp EEESSSCCEECT
T ss_pred CCCCccccccCH
Confidence 666665555654
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=98.68 E-value=2.1e-09 Score=118.08 Aligned_cols=105 Identities=18% Similarity=0.163 Sum_probs=72.0
Q ss_pred CCcEEEEEccCCCCcccCCccccCc-----ccccccccccccCCCCCC-CccccccccccccccccccCC--CCCcc--C
Q 002336 412 PPRITKIALSGKNLKGEIPPELKNM-----EALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGS--LPSYM--G 481 (935)
Q Consensus 412 ~~~l~~L~Ls~n~l~g~ip~~i~~L-----~~L~~L~Ls~N~l~g~~p-~~~~l~~L~~L~L~~N~l~g~--iP~~l--~ 481 (935)
.++|+.|+|++|++++. |..++.+ ++|++|+|++|++++.+| .++++++|+.|+|++|++.|. +|..+ +
T Consensus 120 l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~ 198 (312)
T 1wwl_A 120 GPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPL 198 (312)
T ss_dssp SCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHHHSCTT
T ss_pred CCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHHHHHhc
Confidence 35778888888888766 7777776 788888888888877775 577788888888888887765 33444 7
Q ss_pred ccccccccccccccCCC--CCCcccc---CCceeeeecCCC
Q 002336 482 SLPNLQELHIENNSFVG--EIPPALL---TGKVIFKYDNNP 517 (935)
Q Consensus 482 ~l~~L~~L~l~~N~l~g--~iP~~l~---~~~~~~~~~~n~ 517 (935)
.+++|+.|+|++|+|++ .+|..++ .....+.+++|.
T Consensus 199 ~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~ 239 (312)
T 1wwl_A 199 KFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNS 239 (312)
T ss_dssp SCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSC
T ss_pred cCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCc
Confidence 77788888888888772 2333332 234455556664
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.68 E-value=7.7e-09 Score=113.38 Aligned_cols=85 Identities=18% Similarity=0.221 Sum_probs=60.4
Q ss_pred cEEEEEccCCCCcccCCccc--cCcccccccccccccCCCCCCC-----ccccccccccccccccccCCCCCccCccccc
Q 002336 414 RITKIALSGKNLKGEIPPEL--KNMEALTELWLDGNFLTGPLPD-----MSRLIDLRIVHLENNELTGSLPSYMGSLPNL 486 (935)
Q Consensus 414 ~l~~L~Ls~n~l~g~ip~~i--~~L~~L~~L~Ls~N~l~g~~p~-----~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L 486 (935)
+|++|+|++|++.|.+|..+ .++++|+.|+|++|.+++..|. +..+++|++|+|++|++++..|..++.+++|
T Consensus 92 ~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L 171 (310)
T 4glp_A 92 RLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPAL 171 (310)
T ss_dssp CCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTTC
T ss_pred ceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCCC
Confidence 46777777777777777776 7777777777777777776552 3457777777777777776666677777777
Q ss_pred cccccccccCCC
Q 002336 487 QELHIENNSFVG 498 (935)
Q Consensus 487 ~~L~l~~N~l~g 498 (935)
+.|+|++|++.|
T Consensus 172 ~~L~Ls~N~l~~ 183 (310)
T 4glp_A 172 TSLDLSDNPGLG 183 (310)
T ss_dssp CEEECCSCTTCH
T ss_pred CEEECCCCCCcc
Confidence 777777777654
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.67 E-value=1.7e-08 Score=119.84 Aligned_cols=93 Identities=18% Similarity=0.302 Sum_probs=71.2
Q ss_pred CCcEEEEEccCCCCcccCCccccCcccccccccccccCCCCCC-CccccccccccccccccccC-CCCCccCcccccccc
Q 002336 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTG-SLPSYMGSLPNLQEL 489 (935)
Q Consensus 412 ~~~l~~L~Ls~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p-~~~~l~~L~~L~L~~N~l~g-~iP~~l~~l~~L~~L 489 (935)
.++|+.|+|++|.+++..|..|++|++|++|+|++|++++..+ .++++++|++|+|++|++++ .+|..++++++|+.|
T Consensus 75 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L 154 (570)
T 2z63_A 75 LSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHL 154 (570)
T ss_dssp CTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEE
T ss_pred chhCCEEeCcCCcCCccCHhhhcCccccccccccccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEE
Confidence 4578888888888876666778888888888888888887766 57888888888888888876 477888888888888
Q ss_pred ccccccCCCCCCccc
Q 002336 490 HIENNSFVGEIPPAL 504 (935)
Q Consensus 490 ~l~~N~l~g~iP~~l 504 (935)
++++|++++..|..+
T Consensus 155 ~l~~n~l~~~~~~~~ 169 (570)
T 2z63_A 155 DLSSNKIQSIYCTDL 169 (570)
T ss_dssp ECTTSCCCEECGGGG
T ss_pred eCcCCccceecHHHc
Confidence 888888875444444
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=98.66 E-value=9.7e-09 Score=108.00 Aligned_cols=103 Identities=22% Similarity=0.284 Sum_probs=75.1
Q ss_pred CcEEEEEccC-CCCcccCCccccCcccccccccccccCCCCCCCcccccccc---ccccccc-cccCCCCCccCcccccc
Q 002336 413 PRITKIALSG-KNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLR---IVHLENN-ELTGSLPSYMGSLPNLQ 487 (935)
Q Consensus 413 ~~l~~L~Ls~-n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~---~L~L~~N-~l~g~iP~~l~~l~~L~ 487 (935)
++|+.|+|++ |++++..+..|.++++|+.|+|++|.+++ +|.+.++++|+ .|+|++| ++++..+..+.++++|+
T Consensus 80 ~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~l~~n~l~~-lp~~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~ 158 (239)
T 2xwt_C 80 SKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKM-FPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNET 158 (239)
T ss_dssp TTCCEEEEEEETTCCEECTTSEECCTTCCEEEEEEECCCS-CCCCTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSE
T ss_pred cCCcEEECCCCCCeeEcCHHHhCCCCCCCEEeCCCCCCcc-ccccccccccccccEEECCCCcchhhcCcccccchhcce
Confidence 4788888887 88885555678888888888888888887 45577777777 8888888 78754455678888888
Q ss_pred -ccccccccCCCCCCccccCC--ceeeeecCCC
Q 002336 488 -ELHIENNSFVGEIPPALLTG--KVIFKYDNNP 517 (935)
Q Consensus 488 -~L~l~~N~l~g~iP~~l~~~--~~~~~~~~n~ 517 (935)
.|++++|+++ .||...+.. ...+.+.+|+
T Consensus 159 ~~L~l~~n~l~-~i~~~~~~~~~L~~L~L~~n~ 190 (239)
T 2xwt_C 159 LTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNK 190 (239)
T ss_dssp EEEECCSCCCC-EECTTTTTTCEEEEEECTTCT
T ss_pred eEEEcCCCCCc-ccCHhhcCCCCCCEEEcCCCC
Confidence 8888888887 777765543 2334455564
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=98.65 E-value=7.5e-09 Score=122.89 Aligned_cols=87 Identities=25% Similarity=0.446 Sum_probs=45.1
Q ss_pred CceE-EEeCCCCCcEEEEEccCCCCcccCCccccCcccccccccccccCCCCCCCccccccccccccccccccCCCCCcc
Q 002336 402 WEWV-TCSTTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYM 480 (935)
Q Consensus 402 w~~v-~c~~~~~~~l~~L~Ls~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~iP~~l 480 (935)
|.++ .|.|. +|+.|+|++|+|++ +|..+. ++|+.|+|++|+|+ .+| ..+++|+.|+|++|+|++ +|. +
T Consensus 50 ~~~l~~C~~~---~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~-~ip--~~l~~L~~L~Ls~N~l~~-ip~-l 118 (571)
T 3cvr_A 50 VSLLKECLIN---QFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALI-SLP--ELPASLEYLDACDNRLST-LPE-L 118 (571)
T ss_dssp HHHHHHHHHT---TCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCS-CCC--CCCTTCCEEECCSSCCSC-CCC-C
T ss_pred hhhccccccC---CccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCc-ccc--cccCCCCEEEccCCCCCC-cch-h
Confidence 5555 45442 45556666666654 555442 45555555555555 233 334555555555555553 554 4
Q ss_pred CccccccccccccccCCCCCCc
Q 002336 481 GSLPNLQELHIENNSFVGEIPP 502 (935)
Q Consensus 481 ~~l~~L~~L~l~~N~l~g~iP~ 502 (935)
++ +|+.|+|++|+|++ ||.
T Consensus 119 ~~--~L~~L~Ls~N~l~~-lp~ 137 (571)
T 3cvr_A 119 PA--SLKHLDVDNNQLTM-LPE 137 (571)
T ss_dssp CT--TCCEEECCSSCCSC-CCC
T ss_pred hc--CCCEEECCCCcCCC-CCC
Confidence 33 55555555555553 444
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=98.64 E-value=1.9e-08 Score=112.30 Aligned_cols=103 Identities=20% Similarity=0.230 Sum_probs=85.7
Q ss_pred CCCCceEEEeCC--------CCCcEEEEEccCCCCcccCC-ccccCcccccccccccccCCCCCC--Cccccccccc-cc
Q 002336 399 PVPWEWVTCSTT--------TPPRITKIALSGKNLKGEIP-PELKNMEALTELWLDGNFLTGPLP--DMSRLIDLRI-VH 466 (935)
Q Consensus 399 ~~~w~~v~c~~~--------~~~~l~~L~Ls~n~l~g~ip-~~i~~L~~L~~L~Ls~N~l~g~~p--~~~~l~~L~~-L~ 466 (935)
.|.|..|.|+.. -+.++++|+|++|+|+ .|| ..|.+|++|++|+|++|++.+.+| .|.+|++|+. +.
T Consensus 8 ~C~~~~v~C~~~~Lt~iP~~l~~~l~~L~Ls~N~i~-~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~ 86 (350)
T 4ay9_X 8 HCSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRI 86 (350)
T ss_dssp EEETTEEEEESTTCCSCCTTCCTTCSEEEEESCCCS-EECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEE
T ss_pred EeeCCEEEecCCCCCccCcCcCCCCCEEEccCCcCC-CcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhc
Confidence 346777888753 2357999999999999 565 579999999999999999998877 4789998765 67
Q ss_pred cccccccCCCCCccCccccccccccccccCCCCCCcc
Q 002336 467 LENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPA 503 (935)
Q Consensus 467 L~~N~l~g~iP~~l~~l~~L~~L~l~~N~l~g~iP~~ 503 (935)
++.|+++...|..+..+++|+.|++++|+++ .+|+.
T Consensus 87 ~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~-~~~~~ 122 (350)
T 4ay9_X 87 EKANNLLYINPEAFQNLPNLQYLLISNTGIK-HLPDV 122 (350)
T ss_dssp EEETTCCEECTTSBCCCTTCCEEEEEEECCS-SCCCC
T ss_pred ccCCcccccCchhhhhccccccccccccccc-cCCch
Confidence 7889999666788999999999999999999 55553
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.61 E-value=1.8e-08 Score=112.50 Aligned_cols=93 Identities=25% Similarity=0.218 Sum_probs=50.3
Q ss_pred CcEEEEEccCCCCcccCCccccCcccccccccccccCCCCCC--Ccccccccccccccccc-ccCCCCCccCcccccccc
Q 002336 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP--DMSRLIDLRIVHLENNE-LTGSLPSYMGSLPNLQEL 489 (935)
Q Consensus 413 ~~l~~L~Ls~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p--~~~~l~~L~~L~L~~N~-l~g~iP~~l~~l~~L~~L 489 (935)
++|+.|+|++|++++..+..|.++++|++|+|++|++++.++ .+.++++|+.|+|++|+ +.+..|..++++++|+.|
T Consensus 100 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L 179 (353)
T 2z80_A 100 GSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEEL 179 (353)
T ss_dssp TTCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEE
T ss_pred CCCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEE
Confidence 355666666666653222235556666666666666655444 35556666666666653 443334455556666666
Q ss_pred ccccccCCCCCCcccc
Q 002336 490 HIENNSFVGEIPPALL 505 (935)
Q Consensus 490 ~l~~N~l~g~iP~~l~ 505 (935)
++++|++++..|..+.
T Consensus 180 ~l~~n~l~~~~~~~l~ 195 (353)
T 2z80_A 180 EIDASDLQSYEPKSLK 195 (353)
T ss_dssp EEEETTCCEECTTTTT
T ss_pred ECCCCCcCccCHHHHh
Confidence 6666666544454443
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=98.58 E-value=2.8e-08 Score=108.02 Aligned_cols=100 Identities=22% Similarity=0.374 Sum_probs=74.2
Q ss_pred CCcEEEEEccCCCCcccCCccccCcccccccccccccCCCCCCCccccccccccccccccccCCCCCccCcccccccccc
Q 002336 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 491 (935)
Q Consensus 412 ~~~l~~L~Ls~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~l 491 (935)
.++|+.|+|++|++++ + +.+.++++|+.|+|++|++++. +.+..+++|+.|+|++|++++..| +..+++|+.|+|
T Consensus 111 l~~L~~L~L~~n~i~~-~-~~l~~l~~L~~L~l~~n~l~~~-~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~L 185 (291)
T 1h6t_A 111 LKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITDI-TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYL 185 (291)
T ss_dssp CTTCCEEECTTSCCCC-C-GGGGGCTTCCEEECCSSCCCCC-GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEEC
T ss_pred CCCCCEEECCCCcCCC-C-hhhcCCCCCCEEEccCCcCCcc-hhhccCCCCCEEEccCCccccchh--hcCCCccCEEEC
Confidence 3578888888888875 3 5688888888888888888876 778888888888888888885444 888888888888
Q ss_pred ccccCCCCCCccccC--CceeeeecCCCC
Q 002336 492 ENNSFVGEIPPALLT--GKVIFKYDNNPK 518 (935)
Q Consensus 492 ~~N~l~g~iP~~l~~--~~~~~~~~~n~~ 518 (935)
++|+++ .+|. +.. ....+.+.+|+.
T Consensus 186 ~~N~i~-~l~~-l~~l~~L~~L~l~~n~i 212 (291)
T 1h6t_A 186 SKNHIS-DLRA-LAGLKNLDVLELFSQEC 212 (291)
T ss_dssp CSSCCC-BCGG-GTTCTTCSEEEEEEEEE
T ss_pred CCCcCC-CChh-hccCCCCCEEECcCCcc
Confidence 888887 4554 322 334455555543
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=98.57 E-value=4.9e-08 Score=115.90 Aligned_cols=92 Identities=24% Similarity=0.392 Sum_probs=65.9
Q ss_pred cEEEEEccCCCCcccCCccccCcccccccccccccCCCCCCCccccccccccccccccccCCCCCccCcccccccccccc
Q 002336 414 RITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIEN 493 (935)
Q Consensus 414 ~l~~L~Ls~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~l~~ 493 (935)
+|+.|+|++|+|++ +|. .+++|+.|+|++|+|++ +|. .+++|+.|+|++|+|++ +|. ++ ++|+.|+|++
T Consensus 121 ~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~--~l~~L~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~ 189 (571)
T 3cvr_A 121 SLKHLDVDNNQLTM-LPE---LPALLEYINADNNQLTM-LPE--LPTSLEVLSVRNNQLTF-LPE-LP--ESLEALDVST 189 (571)
T ss_dssp TCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC--CCTTCCEEECCSSCCSC-CCC-CC--TTCCEEECCS
T ss_pred CCCEEECCCCcCCC-CCC---cCccccEEeCCCCccCc-CCC--cCCCcCEEECCCCCCCC-cch-hh--CCCCEEECcC
Confidence 67788888888875 666 67788888888888877 444 56778888888888885 777 65 7888888888
Q ss_pred ccCCCCCCccccCCc-------eeeeecCCCC
Q 002336 494 NSFVGEIPPALLTGK-------VIFKYDNNPK 518 (935)
Q Consensus 494 N~l~g~iP~~l~~~~-------~~~~~~~n~~ 518 (935)
|+|+ .||. +.... ..+.+++|..
T Consensus 190 N~L~-~lp~-~~~~L~~~~~~L~~L~Ls~N~l 219 (571)
T 3cvr_A 190 NLLE-SLPA-VPVRNHHSEETEIFFRCRENRI 219 (571)
T ss_dssp SCCS-SCCC-CC--------CCEEEECCSSCC
T ss_pred CCCC-chhh-HHHhhhcccccceEEecCCCcc
Confidence 8887 7777 55444 4556666654
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=98.57 E-value=2.4e-08 Score=110.96 Aligned_cols=103 Identities=21% Similarity=0.288 Sum_probs=77.6
Q ss_pred CCcEEEEEccCCCCcccCCccccCcccccccccccccCCCCCCCccccccccccccccccccCCCCCccCcccccccccc
Q 002336 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 491 (935)
Q Consensus 412 ~~~l~~L~Ls~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~l 491 (935)
.++|+.|+|++|.+++ + +.+..+++|+.|+|++|.+++. |.+..+++|+.|+|++|++++..|..++++++|+.|+|
T Consensus 242 l~~L~~L~l~~n~l~~-~-~~~~~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L 318 (347)
T 4fmz_A 242 LSQLTWLEIGTNQISD-I-NAVKDLTKLKMLNVGSNQISDI-SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFL 318 (347)
T ss_dssp CTTCCEEECCSSCCCC-C-GGGTTCTTCCEEECCSSCCCCC-GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEEC
T ss_pred CCCCCEEECCCCccCC-C-hhHhcCCCcCEEEccCCccCCC-hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEc
Confidence 4578888888888875 3 4688888888888888888875 66788888888888888888777778888888888888
Q ss_pred ccccCCCCCCccccCCceeeeecCCC
Q 002336 492 ENNSFVGEIPPALLTGKVIFKYDNNP 517 (935)
Q Consensus 492 ~~N~l~g~iP~~l~~~~~~~~~~~n~ 517 (935)
++|++++..|-.-......+.+.+|+
T Consensus 319 ~~n~l~~~~~~~~l~~L~~L~l~~N~ 344 (347)
T 4fmz_A 319 SQNHITDIRPLASLSKMDSADFANQV 344 (347)
T ss_dssp CSSSCCCCGGGGGCTTCSEESSSCC-
T ss_pred cCCccccccChhhhhccceeehhhhc
Confidence 88888865553333344556666664
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.57 E-value=1.2e-08 Score=111.70 Aligned_cols=186 Identities=22% Similarity=0.244 Sum_probs=120.4
Q ss_pred ccccccccEEEEEEEECCCcEEEEEEccCcchhhhHHHHHHHHHHHhcC-CCc--ccccceeeeccc---eEEEEEEecC
Q 002336 619 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIH-HRN--LVPLIGYCEEEH---QRILVYEYMH 692 (935)
Q Consensus 619 ~~LG~G~fG~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~-Hpn--Iv~l~g~~~~~~---~~~lV~E~~~ 692 (935)
+.++.|....||+.. +.+++|+.... .....+.+|+++|+.+. +.. +.+++....... ..++|||+++
T Consensus 26 ~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~ 99 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIK 99 (304)
T ss_dssp CEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCC
T ss_pred EecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccC
Confidence 568999999999864 56889985432 34567889999999884 333 334444433332 3478999999
Q ss_pred CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhc-----------------------------------------
Q 002336 693 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG----------------------------------------- 731 (935)
Q Consensus 693 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~----------------------------------------- 731 (935)
|.+|.+... ..++..++..++.++++.|+.||+.
T Consensus 100 G~~l~~~~~-----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 174 (304)
T 3sg8_A 100 GVPLTPLLL-----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVD 174 (304)
T ss_dssp CEECCHHHH-----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHH
T ss_pred CeECCcccc-----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHH
Confidence 988865332 2356777888888888888888851
Q ss_pred --------------CCCceEecCCCCCCccccC--CCcEEEeeccccccccccccceeecccCCccccCCCCC-------
Q 002336 732 --------------CNPGIIHRDVKSSNILLDI--NMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY------- 788 (935)
Q Consensus 732 --------------~~~~ivH~DLkp~NILld~--~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l------- 788 (935)
....++|||+++.||++++ ...+.|+||+.+.......+... ..... .-..|+..
T Consensus 175 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~-~~~~~-~~~~~~~~~~~l~~Y 252 (304)
T 3sg8_A 175 DFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFIS-LMEDD-EEYGMEFVSKILNHY 252 (304)
T ss_dssp HHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHT-TCCTT-TSCCHHHHHHHHHHH
T ss_pred HHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHH-HHhhc-cccCHHHHHHHHHHc
Confidence 1145899999999999998 45678999998765322111000 00000 00111110
Q ss_pred CCC-------CCCchhHHHHHHHHHHHHHhCCCCCC
Q 002336 789 GNQ-------QLTEKSDVYSFGVVLLELISGKKPVS 817 (935)
Q Consensus 789 ~~~-------~~s~ksDVwS~Gvil~eLltG~~Pf~ 817 (935)
... ......+.|+++.+++++.+|..+|-
T Consensus 253 ~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 253 KHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp TCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred CCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence 000 01123689999999999999987653
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=98.57 E-value=5.6e-08 Score=104.00 Aligned_cols=99 Identities=26% Similarity=0.322 Sum_probs=69.9
Q ss_pred CCcEEEEEccCCCCcccCCccccCcccccccccccccCCCCCCCccccccccccccccccccCCCCCccCcccccccccc
Q 002336 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 491 (935)
Q Consensus 412 ~~~l~~L~Ls~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~l 491 (935)
.++|+.|+|++|+|++ +|+ +.+|++|+.|+|++|++++.. .+.. ++|+.|+|++|++++ +| .++.+++|+.|+|
T Consensus 62 l~~L~~L~L~~N~i~~-~~~-l~~l~~L~~L~L~~N~l~~l~-~~~~-~~L~~L~L~~N~l~~-~~-~l~~l~~L~~L~L 135 (263)
T 1xeu_A 62 FTNLKELHLSHNQISD-LSP-LKDLTKLEELSVNRNRLKNLN-GIPS-ACLSRLFLDNNELRD-TD-SLIHLKNLEILSI 135 (263)
T ss_dssp CTTCCEEECCSSCCCC-CGG-GTTCSSCCEEECCSSCCSCCT-TCCC-SSCCEEECCSSCCSB-SG-GGTTCTTCCEEEC
T ss_pred CCCCCEEECCCCccCC-Chh-hccCCCCCEEECCCCccCCcC-cccc-CcccEEEccCCccCC-Ch-hhcCcccccEEEC
Confidence 3578888888888884 444 888888888888888888743 3333 788888888888884 44 5778888888888
Q ss_pred ccccCCCCCCcccc--CCceeeeecCCCC
Q 002336 492 ENNSFVGEIPPALL--TGKVIFKYDNNPK 518 (935)
Q Consensus 492 ~~N~l~g~iP~~l~--~~~~~~~~~~n~~ 518 (935)
++|+++ .+| .+. .....+.+.+|..
T Consensus 136 s~N~i~-~~~-~l~~l~~L~~L~L~~N~i 162 (263)
T 1xeu_A 136 RNNKLK-SIV-MLGFLSKLEVLDLHGNEI 162 (263)
T ss_dssp TTSCCC-BCG-GGGGCTTCCEEECTTSCC
T ss_pred CCCcCC-CCh-HHccCCCCCEEECCCCcC
Confidence 888887 454 232 2344555566653
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=98.56 E-value=5.2e-08 Score=105.90 Aligned_cols=101 Identities=24% Similarity=0.303 Sum_probs=72.3
Q ss_pred CCcEEEEEccCCCCcccCCccccCcccccccccccccCCCCCCCccccccccccccccccccCCCCCccCcccccccccc
Q 002336 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 491 (935)
Q Consensus 412 ~~~l~~L~Ls~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~l 491 (935)
.++|+.|+|++|.+++ +| .+.++++|+.|+|++|++++. +.+..+++|+.|+|++|++++. ..++.+++|+.|+|
T Consensus 89 l~~L~~L~l~~n~l~~-~~-~l~~l~~L~~L~L~~n~i~~~-~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L 163 (291)
T 1h6t_A 89 LKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSLEHNGISDI-NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSL 163 (291)
T ss_dssp CTTCCEEECCSSCCCC-GG-GGTTCTTCCEEECTTSCCCCC-GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEEC
T ss_pred CCCCCEEECCCCcCCC-Ch-hhccCCCCCEEECCCCcCCCC-hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEc
Confidence 3578888888888874 43 488888888888888888874 6778888888888888888853 56788888888888
Q ss_pred ccccCCCCCCccccCCceeeeecCCC
Q 002336 492 ENNSFVGEIPPALLTGKVIFKYDNNP 517 (935)
Q Consensus 492 ~~N~l~g~iP~~l~~~~~~~~~~~n~ 517 (935)
++|++++..|-.-......+.+++|.
T Consensus 164 ~~N~l~~~~~l~~l~~L~~L~L~~N~ 189 (291)
T 1h6t_A 164 EDNQISDIVPLAGLTKLQNLYLSKNH 189 (291)
T ss_dssp CSSCCCCCGGGTTCTTCCEEECCSSC
T ss_pred cCCccccchhhcCCCccCEEECCCCc
Confidence 88888844331111234445556664
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=98.56 E-value=3.1e-08 Score=108.63 Aligned_cols=102 Identities=22% Similarity=0.355 Sum_probs=61.7
Q ss_pred CCcEEEEEccCCCCcccCCccccCcccccccccccccCCCCCCCccccccccccccccccccCCCCCccCcccccccccc
Q 002336 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 491 (935)
Q Consensus 412 ~~~l~~L~Ls~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~l 491 (935)
.++|+.|+|++|++++. ++ +.++++|+.|+|++|++++..+ +.++++|+.|+|++|++++ +|. +..+++|+.|+|
T Consensus 128 l~~L~~L~l~~n~l~~~-~~-l~~l~~L~~L~l~~n~l~~~~~-l~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~L 202 (308)
T 1h6u_A 128 LSNLQVLYLDLNQITNI-SP-LAGLTNLQYLSIGNAQVSDLTP-LANLSKLTTLKADDNKISD-ISP-LASLPNLIEVHL 202 (308)
T ss_dssp CTTCCEEECCSSCCCCC-GG-GGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCC-CGG-GGGCTTCCEEEC
T ss_pred CCCCCEEECCCCccCcC-cc-ccCCCCccEEEccCCcCCCChh-hcCCCCCCEEECCCCccCc-Chh-hcCCCCCCEEEc
Confidence 35677777777777643 32 6677777777777777766544 6677777777777777763 333 666777777777
Q ss_pred ccccCCCCCCccccCCceeeeecCCCC
Q 002336 492 ENNSFVGEIPPALLTGKVIFKYDNNPK 518 (935)
Q Consensus 492 ~~N~l~g~iP~~l~~~~~~~~~~~n~~ 518 (935)
++|++++..|-.-......+.+.+|+.
T Consensus 203 ~~N~l~~~~~l~~l~~L~~L~l~~N~i 229 (308)
T 1h6u_A 203 KNNQISDVSPLANTSNLFIVTLTNQTI 229 (308)
T ss_dssp TTSCCCBCGGGTTCTTCCEEEEEEEEE
T ss_pred cCCccCccccccCCCCCCEEEccCCee
Confidence 777776333211112333444555543
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=98.54 E-value=6.1e-08 Score=106.21 Aligned_cols=101 Identities=25% Similarity=0.449 Sum_probs=81.6
Q ss_pred CCcEEEEEccCCCCcccCCccccCcccccccccccccCCCCCCCccccccccccccccccccCCCCCccCcccccccccc
Q 002336 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 491 (935)
Q Consensus 412 ~~~l~~L~Ls~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~l 491 (935)
.++|+.|+|++|++++ +|+ +.++++|+.|+|++|.+++..+ +.++++|+.|+|++|++++ +|. +..+++|+.|+|
T Consensus 106 l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~~~~-l~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~l 180 (308)
T 1h6u_A 106 LQSIKTLDLTSTQITD-VTP-LAGLSNLQVLYLDLNQITNISP-LAGLTNLQYLSIGNAQVSD-LTP-LANLSKLTTLKA 180 (308)
T ss_dssp CTTCCEEECTTSCCCC-CGG-GTTCTTCCEEECCSSCCCCCGG-GGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEEC
T ss_pred CCCCCEEECCCCCCCC-chh-hcCCCCCCEEECCCCccCcCcc-ccCCCCccEEEccCCcCCC-Chh-hcCCCCCCEEEC
Confidence 4689999999999985 554 9999999999999999998766 8899999999999999995 555 899999999999
Q ss_pred ccccCCCCCCc-cccCCceeeeecCCCC
Q 002336 492 ENNSFVGEIPP-ALLTGKVIFKYDNNPK 518 (935)
Q Consensus 492 ~~N~l~g~iP~-~l~~~~~~~~~~~n~~ 518 (935)
++|+++ .+|. .-......+.+++|..
T Consensus 181 ~~n~l~-~~~~l~~l~~L~~L~L~~N~l 207 (308)
T 1h6u_A 181 DDNKIS-DISPLASLPNLIEVHLKNNQI 207 (308)
T ss_dssp CSSCCC-CCGGGGGCTTCCEEECTTSCC
T ss_pred CCCccC-cChhhcCCCCCCEEEccCCcc
Confidence 999998 4554 2222445566677754
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=98.54 E-value=1.7e-09 Score=110.48 Aligned_cols=102 Identities=24% Similarity=0.207 Sum_probs=75.5
Q ss_pred CCcEEEEEccCCCCcccCCccccCcccccccccccccCCCCCCCccccccccccccccccccCCCCCccCcccccccccc
Q 002336 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 491 (935)
Q Consensus 412 ~~~l~~L~Ls~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~l 491 (935)
.++|+.|+|++|++++ +| .+.++++|+.|+|++|.++..++.+..+++|+.|+|++|++++ +| .++.+++|+.|+|
T Consensus 47 l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~~l~~~~~~~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l 122 (198)
T 1ds9_A 47 LKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIKKIENLDAVADTLEELWISYNQIAS-LS-GIEKLVNLRVLYM 122 (198)
T ss_dssp TTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEECSCSSHHHHHHHCSEEEEEEEECCC-HH-HHHHHHHSSEEEE
T ss_pred CCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcccccchhhcCCcCCEEECcCCcCCc-CC-ccccCCCCCEEEC
Confidence 3578888888888885 77 8888888888888888888543346677888888888888885 66 6888888888888
Q ss_pred ccccCCCCCCc--cccC--CceeeeecCCCC
Q 002336 492 ENNSFVGEIPP--ALLT--GKVIFKYDNNPK 518 (935)
Q Consensus 492 ~~N~l~g~iP~--~l~~--~~~~~~~~~n~~ 518 (935)
++|+++ .+|. .+.. ....+.+.+|+.
T Consensus 123 ~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~l 152 (198)
T 1ds9_A 123 SNNKIT-NWGEIDKLAALDKLEDLLLAGNPL 152 (198)
T ss_dssp SEEECC-CHHHHHHHTTTTTCSEEEECSCHH
T ss_pred CCCcCC-chhHHHHHhcCCCCCEEEecCCcc
Confidence 888887 4443 3322 344555666654
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=98.53 E-value=5.7e-08 Score=116.38 Aligned_cols=99 Identities=22% Similarity=0.387 Sum_probs=68.4
Q ss_pred CCcEEEEEccCCCCcccCCccccCcccccccccccccCCCCCCCccccccccccccccccccCCCCCccCcccccccccc
Q 002336 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 491 (935)
Q Consensus 412 ~~~l~~L~Ls~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~l 491 (935)
.++|+.|+|++|.|++ + +.+.+|++|+.|+|++|.|++. +.+..|++|+.|+|++|+|++..| +..|++|+.|+|
T Consensus 108 l~~L~~L~Ls~N~l~~-l-~~l~~l~~L~~L~Ls~N~l~~l-~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~L 182 (605)
T 1m9s_A 108 LKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITDI-TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYL 182 (605)
T ss_dssp CTTCCEEECTTSCCCC-C-GGGGGCTTCSEEECCSSCCCCC-GGGGSCTTCSEEECCSSCCCCCGG--GTTCTTCCEEEC
T ss_pred CCCCCEEEecCCCCCC-C-ccccCCCccCEEECCCCccCCc-hhhcccCCCCEEECcCCcCCCchh--hccCCCCCEEEC
Confidence 4577778888887774 3 4577778888888888877776 667777788888888888876555 777788888888
Q ss_pred ccccCCCCCCccccC--CceeeeecCCC
Q 002336 492 ENNSFVGEIPPALLT--GKVIFKYDNNP 517 (935)
Q Consensus 492 ~~N~l~g~iP~~l~~--~~~~~~~~~n~ 517 (935)
++|+|+ .+|. +.. ....+.+.+|+
T Consensus 183 s~N~i~-~l~~-l~~l~~L~~L~L~~N~ 208 (605)
T 1m9s_A 183 SKNHIS-DLRA-LAGLKNLDVLELFSQE 208 (605)
T ss_dssp CSSCCC-BCGG-GTTCTTCSEEECCSEE
T ss_pred cCCCCC-CChH-HccCCCCCEEEccCCc
Confidence 888777 3443 322 33344455554
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=98.51 E-value=3.6e-09 Score=108.09 Aligned_cols=100 Identities=23% Similarity=0.350 Sum_probs=83.5
Q ss_pred cEEEEEccCCCCcccCCc------cccCcccccccccccccCCCCCCCccccccccccccccccccCCCCCccCcccccc
Q 002336 414 RITKIALSGKNLKGEIPP------ELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQ 487 (935)
Q Consensus 414 ~l~~L~Ls~n~l~g~ip~------~i~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~ 487 (935)
+++.++|+++.+.|.+|. .|.++++|+.|+|++|.+++ +|.+.++++|+.|+|++|+++ .+|..+..+++|+
T Consensus 19 ~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L~ 96 (198)
T 1ds9_A 19 SVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-ISSLSGMENLRILSLGRNLIK-KIENLDAVADTLE 96 (198)
T ss_dssp CCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CCCHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHCS
T ss_pred cccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-ccccccCCCCCEEECCCCCcc-cccchhhcCCcCC
Confidence 566777888888888877 99999999999999999999 569999999999999999999 8999888999999
Q ss_pred ccccccccCCCCCCccccC--CceeeeecCCC
Q 002336 488 ELHIENNSFVGEIPPALLT--GKVIFKYDNNP 517 (935)
Q Consensus 488 ~L~l~~N~l~g~iP~~l~~--~~~~~~~~~n~ 517 (935)
.|+|++|+++ .+| .+.. ....+.+.+|.
T Consensus 97 ~L~L~~N~l~-~l~-~~~~l~~L~~L~l~~N~ 126 (198)
T 1ds9_A 97 ELWISYNQIA-SLS-GIEKLVNLRVLYMSNNK 126 (198)
T ss_dssp EEEEEEEECC-CHH-HHHHHHHSSEEEESEEE
T ss_pred EEECcCCcCC-cCC-ccccCCCCCEEECCCCc
Confidence 9999999999 466 3332 33444555554
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=98.50 E-value=8.8e-08 Score=102.49 Aligned_cols=99 Identities=20% Similarity=0.309 Sum_probs=82.4
Q ss_pred CCcEEEEEccCCCCcccCCccccCcccccccccccccCCCCCCCccccccccccccccccccCCCCCccCcccccccccc
Q 002336 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 491 (935)
Q Consensus 412 ~~~l~~L~Ls~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~l 491 (935)
.++|+.|+|++|+++ .+| .+..+++|+.|+|++|+|++..| +.++++|+.|+|++|++++ +|.... ++|+.|+|
T Consensus 40 l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~L~~N~i~~~~~-l~~l~~L~~L~L~~N~l~~-l~~~~~--~~L~~L~L 113 (263)
T 1xeu_A 40 LSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQISDLSP-LKDLTKLEELSVNRNRLKN-LNGIPS--ACLSRLFL 113 (263)
T ss_dssp HTTCSEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG-GTTCSSCCEEECCSSCCSC-CTTCCC--SSCCEEEC
T ss_pred cCcCcEEECcCCCcc-cch-HHhhCCCCCEEECCCCccCCChh-hccCCCCCEEECCCCccCC-cCcccc--CcccEEEc
Confidence 458999999999998 677 79999999999999999999887 9999999999999999994 665444 99999999
Q ss_pred ccccCCCCCCccccC--CceeeeecCCCC
Q 002336 492 ENNSFVGEIPPALLT--GKVIFKYDNNPK 518 (935)
Q Consensus 492 ~~N~l~g~iP~~l~~--~~~~~~~~~n~~ 518 (935)
++|+++ .+|. +.. ....+.+++|..
T Consensus 114 ~~N~l~-~~~~-l~~l~~L~~L~Ls~N~i 140 (263)
T 1xeu_A 114 DNNELR-DTDS-LIHLKNLEILSIRNNKL 140 (263)
T ss_dssp CSSCCS-BSGG-GTTCTTCCEEECTTSCC
T ss_pred cCCccC-CChh-hcCcccccEEECCCCcC
Confidence 999999 4553 333 445566666653
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=98.50 E-value=5.8e-08 Score=116.34 Aligned_cols=85 Identities=21% Similarity=0.366 Sum_probs=64.6
Q ss_pred CCcEEEEEccCCCCcccCCccccCcccccccccccccCCCCCCCccccccccccccccccccCCCCCccCcccccccccc
Q 002336 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 491 (935)
Q Consensus 412 ~~~l~~L~Ls~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~l 491 (935)
.++|+.|+|++|.|++. +.|..|++|+.|+|++|.|++.+| +..|++|+.|+|++|+|++ +| .+..|++|+.|+|
T Consensus 130 l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~-l~~l~~L~~L~Ls~N~i~~-l~-~l~~l~~L~~L~L 204 (605)
T 1m9s_A 130 LPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP-LAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLEL 204 (605)
T ss_dssp CTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEEC
T ss_pred CCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCchh-hccCCCCCEEECcCCCCCC-Ch-HHccCCCCCEEEc
Confidence 45788888888888754 577788888888888888887777 7778888888888888874 44 5777888888888
Q ss_pred ccccCCCCCCc
Q 002336 492 ENNSFVGEIPP 502 (935)
Q Consensus 492 ~~N~l~g~iP~ 502 (935)
++|+++ ..|.
T Consensus 205 ~~N~l~-~~p~ 214 (605)
T 1m9s_A 205 FSQECL-NKPI 214 (605)
T ss_dssp CSEEEE-CCCC
T ss_pred cCCcCc-CCcc
Confidence 888887 3443
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=98.49 E-value=2.1e-08 Score=110.38 Aligned_cols=91 Identities=18% Similarity=0.193 Sum_probs=78.7
Q ss_pred CCcEEEEEccCCCCcccCCccccCcccccccccccccCCCCCCCccccccccccccccccccCCCCCccCcccccccccc
Q 002336 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 491 (935)
Q Consensus 412 ~~~l~~L~Ls~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~l 491 (935)
.++|+.|+|++|++++. | ....+++|+.|+|++|++++.++.+..+++|+.|+|++|+++ .+|..+..+++|+.|+|
T Consensus 168 l~~L~~L~L~~N~l~~~-~-~~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~l~~L~~L~l 244 (317)
T 3o53_A 168 SDTLEHLNLQYNFIYDV-K-GQVVFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDL 244 (317)
T ss_dssp TTTCCEEECTTSCCCEE-E-CCCCCTTCCEEECCSSCCCEECGGGGGGTTCSEEECTTSCCC-EECTTCCCCTTCCEEEC
T ss_pred cCcCCEEECCCCcCccc-c-cccccccCCEEECCCCcCCcchhhhcccCcccEEECcCCccc-chhhHhhcCCCCCEEEc
Confidence 35899999999999855 3 344599999999999999998889999999999999999999 78999999999999999
Q ss_pred ccccCC-CCCCcccc
Q 002336 492 ENNSFV-GEIPPALL 505 (935)
Q Consensus 492 ~~N~l~-g~iP~~l~ 505 (935)
++|.++ +.+|..+.
T Consensus 245 ~~N~~~~~~~~~~~~ 259 (317)
T 3o53_A 245 RGNGFHCGTLRDFFS 259 (317)
T ss_dssp TTCCCBHHHHHHHHH
T ss_pred cCCCccCcCHHHHHh
Confidence 999998 66665544
|
| >2jwp_A Malectin, MGC80075; sugar binding, sugar binding protein; NMR {Xenopus laevis} PDB: 2k46_A* 2kr2_A* | Back alignment and structure |
|---|
Probab=98.48 E-value=1.7e-07 Score=93.70 Aligned_cols=152 Identities=20% Similarity=0.104 Sum_probs=89.3
Q ss_pred EEeeecCCCCCCCccCCCCCCCCccccCCCCCCCceeccCCceeeecccccccCCCCCCChHhHhhhceeccCceEEEee
Q 002336 189 AARVNFGALTKDALRYPDDPYDRIWDSDLDRRPNFVVGAASGTVRINTTKNIETRTREYPPVKVMQTAVVGTEGVLSYRL 268 (935)
Q Consensus 189 ~~R~~~g~~~~~~~~y~~d~~~R~W~~~~~~~~~~~~~~~~~~~~i~~~~~i~~~~~~~pP~~v~qtA~~~~~~~~~~~~ 268 (935)
.-|+|+|+.. +. |..+|.|+++...... +..+.. ...+.....+.+|..|+|||-.. ..+++|..
T Consensus 7 ~~~INcGg~~---~~---d~~gr~w~~D~~~~~~---g~~~~~-----~~~~~~~~~~~~~~~lY~TaR~~-~~~~tY~f 71 (174)
T 2jwp_A 7 IWAVNAGGES---HV---DVHGIHYRKDPLEGRV---GRASDY-----GMKLPILRSNPEDQVLYQTERYN-EDSFGYDI 71 (174)
T ss_dssp EEEEEETSSS---EE---ETTTEEECSSCSSTTC---CCCCCC-----CTTSCCSSSCHHHHHTTTCCCCC-CSCEEEEE
T ss_pred EEEEECCCCC---cc---CCCCCEEcCCcCcccC---Cccccc-----ccceEecccCCCCchhhhhhccC-CCCeEEEE
Confidence 4599999743 21 6789999998542111 111100 00111112244688999999875 35778887
Q ss_pred cCCCCccccceeeeeccccCcCCCcceEEEeecCcccccccceeeeeccCCCceeeecccccee------------eeee
Q 002336 269 NLEDFPANARAFAYFAEIQDLGPSETRKFKLEQPYFADYSNAVVNIAENANGSYTLYEPSYMNV------------TLNF 336 (935)
Q Consensus 269 ~~~~~~~~~~~~lyFae~~~~~~~~~R~F~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~ 336 (935)
+.. .+-.|.+-|||+|+.. +..+.|.|||.++.... ...+++...+++...++.--..++ +..+
T Consensus 72 ~v~-~~G~Y~VrLhF~ei~~-~~~~~rvFdV~ing~~~--l~~fdi~~~ag~~~~~~~~~~~~v~~~~l~i~~~~~~~~g 147 (174)
T 2jwp_A 72 PIK-EEGEYVLVLKFAEVYF-AQSQQKVFDVRVNGHTV--VKDLDIFDRVGHSTAHDEIIPISIKKGKLSVQGEVSTFTG 147 (174)
T ss_dssp ECC-SCEEEEEEEEEECCSC-CCSSSSCEEEEETTEEE--EEEECHHHHHSSSSCEEEEEEEEEETTEEEETTEEEECCS
T ss_pred EeC-CCeEEEEEEEEecccc-CCCCCeEeEEEECCEEe--ecCcCHHHhhCCCeeEEEEEEEEEecCceeeeeeecccCC
Confidence 763 2356777799999974 55799999996554333 233555444332111111000111 2456
Q ss_pred EEEEEeeecCCCcchhhhhhhhhce
Q 002336 337 VLSFSFVKTRDSTLGPLLNAIEISK 361 (935)
Q Consensus 337 ~~~~~~~~~~~s~l~p~ina~e~~~ 361 (935)
.+.+++.|. ..-.|+|||+|+++
T Consensus 148 ~L~I~f~p~--~~~~a~inaIEI~~ 170 (174)
T 2jwp_A 148 KLSVEFVKG--YYDNPKVCALFIMK 170 (174)
T ss_dssp EEEEEEECS--SSCSSSEEEEEEES
T ss_pred eEEEEEecc--CCCCcEEEEEEEEe
Confidence 788888874 34579999999975
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=98.42 E-value=9.6e-08 Score=110.91 Aligned_cols=100 Identities=25% Similarity=0.309 Sum_probs=55.9
Q ss_pred CcEEEEEccCCCCcccCCccccCcccccccccccccCCCCCCCccccccccccccccccccCCCCCccCccccccccccc
Q 002336 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIE 492 (935)
Q Consensus 413 ~~l~~L~Ls~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~l~ 492 (935)
++|+.|+|++|++.+..| +..+++|+.|+|++|++++.+| +..+++|+.|+|++|++++. ..++++++|+.|+++
T Consensus 287 ~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~-~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~ 361 (466)
T 1o6v_A 287 TALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP-VSSLTKLQRLFFYNNKVSDV--SSLANLTNINWLSAG 361 (466)
T ss_dssp TTCSEEECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG-GGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECC
T ss_pred CccCeEEcCCCcccCchh--hcCCCCCCEEECcCCcCCCchh-hccCccCCEeECCCCccCCc--hhhccCCCCCEEeCC
Confidence 456666666666654322 5566666666666666666555 55666666666666666643 345666666666666
Q ss_pred cccCCCCCCccccCCceeeeecCCC
Q 002336 493 NNSFVGEIPPALLTGKVIFKYDNNP 517 (935)
Q Consensus 493 ~N~l~g~iP~~l~~~~~~~~~~~n~ 517 (935)
+|+++|.+|-.-......+.+.+|+
T Consensus 362 ~n~l~~~~~~~~l~~L~~L~l~~n~ 386 (466)
T 1o6v_A 362 HNQISDLTPLANLTRITQLGLNDQA 386 (466)
T ss_dssp SSCCCBCGGGTTCTTCCEEECCCEE
T ss_pred CCccCccchhhcCCCCCEEeccCCc
Confidence 6666655552222233334444443
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=98.42 E-value=1.4e-07 Score=109.37 Aligned_cols=80 Identities=31% Similarity=0.444 Sum_probs=42.2
Q ss_pred CcEEEEEccCCCCcccCCccccCcccccccccccccCCCCCCCccccccccccccccccccCCCCCccCccccccccccc
Q 002336 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIE 492 (935)
Q Consensus 413 ~~l~~L~Ls~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~l~ 492 (935)
++|+.|+|++|++++. |+ +..+++|+.|+|++|++++.+| +..+++|+.|+|++|++++..| ++.+++|+.|+++
T Consensus 265 ~~L~~L~l~~n~l~~~-~~-~~~l~~L~~L~L~~n~l~~~~~-~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~ 339 (466)
T 1o6v_A 265 TKLTELKLGANQISNI-SP-LAGLTALTNLELNENQLEDISP-ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFY 339 (466)
T ss_dssp TTCSEEECCSSCCCCC-GG-GTTCTTCSEEECCSSCCSCCGG-GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECC
T ss_pred CCCCEEECCCCccCcc-cc-ccCCCccCeEEcCCCcccCchh-hcCCCCCCEEECcCCcCCCchh--hccCccCCEeECC
Confidence 3455555555555532 22 5555555555555555555433 5555555555555555554433 4555555555555
Q ss_pred cccCC
Q 002336 493 NNSFV 497 (935)
Q Consensus 493 ~N~l~ 497 (935)
+|+++
T Consensus 340 ~n~l~ 344 (466)
T 1o6v_A 340 NNKVS 344 (466)
T ss_dssp SSCCC
T ss_pred CCccC
Confidence 55555
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=98.42 E-value=1.1e-07 Score=110.24 Aligned_cols=87 Identities=28% Similarity=0.476 Sum_probs=50.4
Q ss_pred CcEEEEEccCCCCcccCCccccCcccccccccccccCCCCCCCccccccccccccccccccC--CCCCccCcc-------
Q 002336 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTG--SLPSYMGSL------- 483 (935)
Q Consensus 413 ~~l~~L~Ls~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~L~~N~l~g--~iP~~l~~l------- 483 (935)
.+|+.|+|++|++++ +|.. +++|+.|+|++|++++ +|. .+++|+.|+|++|+++| .+|.+++.|
T Consensus 317 ~~L~~L~Ls~N~l~~-lp~~---~~~L~~L~L~~N~l~~-lp~--~l~~L~~L~L~~N~l~~l~~ip~~l~~L~~n~~~~ 389 (454)
T 1jl5_A 317 PSLEELNVSNNKLIE-LPAL---PPRLERLIASFNHLAE-VPE--LPQNLKQLHVEYNPLREFPDIPESVEDLRMNSHLA 389 (454)
T ss_dssp TTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSC-CCC--CCTTCCEEECCSSCCSSCCCCCTTCCEEECCC---
T ss_pred CcCCEEECCCCcccc-cccc---CCcCCEEECCCCcccc-ccc--hhhhccEEECCCCCCCcCCCChHHHHhhhhccccc
Confidence 478888888888885 6654 5788888888888885 444 57888888888888888 788888887
Q ss_pred ------ccccccccccccCCC--CCCccccC
Q 002336 484 ------PNLQELHIENNSFVG--EIPPALLT 506 (935)
Q Consensus 484 ------~~L~~L~l~~N~l~g--~iP~~l~~ 506 (935)
++|+.|++++|+++| .||.++..
T Consensus 390 ~i~~~~~~L~~L~ls~N~l~~~~~iP~sl~~ 420 (454)
T 1jl5_A 390 EVPELPQNLKQLHVETNPLREFPDIPESVED 420 (454)
T ss_dssp -------------------------------
T ss_pred ccccccCcCCEEECCCCcCCccccchhhHhh
Confidence 778888888888886 77776543
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=98.41 E-value=2.2e-07 Score=107.70 Aligned_cols=18 Identities=28% Similarity=0.204 Sum_probs=6.8
Q ss_pred cCcccccccccccccCCC
Q 002336 434 KNMEALTELWLDGNFLTG 451 (935)
Q Consensus 434 ~~L~~L~~L~Ls~N~l~g 451 (935)
+.+++|+.|+|++|++++
T Consensus 188 ~~l~~L~~L~l~~N~l~~ 205 (457)
T 3bz5_A 188 SQNKLLNRLNCDTNNITK 205 (457)
T ss_dssp TTCTTCCEEECCSSCCSC
T ss_pred ccCCCCCEEECcCCcCCe
Confidence 333333333333333333
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=98.40 E-value=2.7e-07 Score=106.91 Aligned_cols=96 Identities=25% Similarity=0.251 Sum_probs=61.6
Q ss_pred CCcEEEEEccCCCCcccCCccccCcccccccccccccCCCCCCCccccccccccccccccccCCCCCccCcccccccccc
Q 002336 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 491 (935)
Q Consensus 412 ~~~l~~L~Ls~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~l 491 (935)
.++|+.|+|++|++++ +| ++++++|++|+|++|.|++. | ++++++|++|+|++|++++ +| ++.+++|+.|++
T Consensus 63 l~~L~~L~Ls~n~l~~-~~--~~~l~~L~~L~Ls~N~l~~~-~-~~~l~~L~~L~L~~N~l~~-l~--~~~l~~L~~L~l 134 (457)
T 3bz5_A 63 LTGLTKLICTSNNITT-LD--LSQNTNLTYLACDSNKLTNL-D-VTPLTKLTYLNCDTNKLTK-LD--VSQNPLLTYLNC 134 (457)
T ss_dssp CTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCC-C-CTTCTTCCEEECCSSCCSC-CC--CTTCTTCCEEEC
T ss_pred cCCCCEEEccCCcCCe-Ec--cccCCCCCEEECcCCCCcee-e-cCCCCcCCEEECCCCcCCe-ec--CCCCCcCCEEEC
Confidence 3467777777777775 33 67777777777777777764 2 6677777777777777774 44 677777777777
Q ss_pred ccccCCCCCCccccCCceeeeecCC
Q 002336 492 ENNSFVGEIPPALLTGKVIFKYDNN 516 (935)
Q Consensus 492 ~~N~l~g~iP~~l~~~~~~~~~~~n 516 (935)
++|++++ +|-.-......+.+.+|
T Consensus 135 ~~N~l~~-l~l~~l~~L~~L~l~~n 158 (457)
T 3bz5_A 135 ARNTLTE-IDVSHNTQLTELDCHLN 158 (457)
T ss_dssp TTSCCSC-CCCTTCTTCCEEECTTC
T ss_pred CCCccce-eccccCCcCCEEECCCC
Confidence 7777774 44322233444455555
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=98.36 E-value=4.4e-07 Score=105.09 Aligned_cols=96 Identities=30% Similarity=0.415 Sum_probs=76.2
Q ss_pred CcEEEEEccCCCCcccCCccccCcccccccccccccCCCCCCCccccccccccccccccccCCCCCccCccccccccccc
Q 002336 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIE 492 (935)
Q Consensus 413 ~~l~~L~Ls~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~l~ 492 (935)
++|+.|+|++|++++ +| +|+++++|++|+|++|++++ +|.. +.+|+.|+|++|++++ +| .++++++|+.|+++
T Consensus 131 ~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~N~l~~-lp~~--~~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~ 203 (454)
T 1jl5_A 131 PLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSLKK-LPDL--PPSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYAD 203 (454)
T ss_dssp TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSC-CCCC--CTTCCEEECCSSCCSS-CC-CCTTCTTCCEEECC
T ss_pred CCCCEEECcCCCCCC-Cc-ccCCCCCCCEEECCCCcCcc-cCCC--cccccEEECcCCcCCc-Cc-cccCCCCCCEEECC
Confidence 579999999999996 88 69999999999999999998 4432 2489999999999996 77 68999999999999
Q ss_pred cccCCCCCCccccCCceeeeecCCC
Q 002336 493 NNSFVGEIPPALLTGKVIFKYDNNP 517 (935)
Q Consensus 493 ~N~l~g~iP~~l~~~~~~~~~~~n~ 517 (935)
+|++++ +|... .....+.+.+|.
T Consensus 204 ~N~l~~-l~~~~-~~L~~L~l~~n~ 226 (454)
T 1jl5_A 204 NNSLKK-LPDLP-LSLESIVAGNNI 226 (454)
T ss_dssp SSCCSS-CCCCC-TTCCEEECCSSC
T ss_pred CCcCCc-CCCCc-CcccEEECcCCc
Confidence 999984 66543 234455555553
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=98.34 E-value=1.3e-07 Score=113.42 Aligned_cols=85 Identities=26% Similarity=0.307 Sum_probs=59.5
Q ss_pred CcEEEEEccCCCCcccCCccccCcccccccccccccCCCCCCCccccccccccccccccccCCCCCccCccccccccccc
Q 002336 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIE 492 (935)
Q Consensus 413 ~~l~~L~Ls~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~l~ 492 (935)
++|+.|+|++|+|++ +| ..+++|+.|+|++|+|+..++ .+++|+.|+|++|+|+ .+|..++++++|+.|+|+
T Consensus 221 ~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~~lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~ 292 (622)
T 3g06_A 221 SGLKELIVSGNRLTS-LP---VLPSELKELMVSGNRLTSLPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLE 292 (622)
T ss_dssp TTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSCCCC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEECC
T ss_pred CCCCEEEccCCccCc-CC---CCCCcCcEEECCCCCCCcCCc---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEec
Confidence 467777777777774 55 455677777777777775433 5667777777777777 777777777777777777
Q ss_pred cccCCCCCCcccc
Q 002336 493 NNSFVGEIPPALL 505 (935)
Q Consensus 493 ~N~l~g~iP~~l~ 505 (935)
+|+|+|.+|..+.
T Consensus 293 ~N~l~~~~~~~l~ 305 (622)
T 3g06_A 293 GNPLSERTLQALR 305 (622)
T ss_dssp SCCCCHHHHHHHH
T ss_pred CCCCCCcCHHHHH
Confidence 7777766666543
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=98.33 E-value=2.3e-07 Score=102.87 Aligned_cols=103 Identities=17% Similarity=0.306 Sum_probs=83.4
Q ss_pred CCcEEEEEccCCCCcccCCccccCcccccccccccccCCCCCCCccccccccccccccccccCCCCCccCcccccccccc
Q 002336 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 491 (935)
Q Consensus 412 ~~~l~~L~Ls~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~l 491 (935)
.++|+.|+|++|++++ +++ +..+++|+.|+|++|.+++. +.+..+++|+.|+|++|++++ +| .+..+++|+.|++
T Consensus 220 ~~~L~~L~l~~n~l~~-~~~-~~~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~l~~n~l~~-~~-~~~~l~~L~~L~L 294 (347)
T 4fmz_A 220 MTRLNSLKIGNNKITD-LSP-LANLSQLTWLEIGTNQISDI-NAVKDLTKLKMLNVGSNQISD-IS-VLNNLSQLNSLFL 294 (347)
T ss_dssp CTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCCC-GGGTTCTTCCEEECCSSCCCC-CG-GGGGCTTCSEEEC
T ss_pred CCcCCEEEccCCccCC-Ccc-hhcCCCCCEEECCCCccCCC-hhHhcCCCcCEEEccCCccCC-Ch-hhcCCCCCCEEEC
Confidence 4589999999999984 444 88999999999999999874 678899999999999999985 43 5888999999999
Q ss_pred ccccCCCCCCccccC--CceeeeecCCCCC
Q 002336 492 ENNSFVGEIPPALLT--GKVIFKYDNNPKL 519 (935)
Q Consensus 492 ~~N~l~g~iP~~l~~--~~~~~~~~~n~~~ 519 (935)
++|++++..|..+.. ....+.+.+|+..
T Consensus 295 ~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~ 324 (347)
T 4fmz_A 295 NNNQLGNEDMEVIGGLTNLTTLFLSQNHIT 324 (347)
T ss_dssp CSSCCCGGGHHHHHTCTTCSEEECCSSSCC
T ss_pred cCCcCCCcChhHhhccccCCEEEccCCccc
Confidence 999998777665543 4456677777654
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=98.25 E-value=4.4e-08 Score=110.76 Aligned_cols=84 Identities=21% Similarity=0.351 Sum_probs=37.2
Q ss_pred cEEEEEccCCCCc-ccCC---ccccCcccccccccccccCC--C---CCC-Ccccccccccccccccccc----CCCCCc
Q 002336 414 RITKIALSGKNLK-GEIP---PELKNMEALTELWLDGNFLT--G---PLP-DMSRLIDLRIVHLENNELT----GSLPSY 479 (935)
Q Consensus 414 ~l~~L~Ls~n~l~-g~ip---~~i~~L~~L~~L~Ls~N~l~--g---~~p-~~~~l~~L~~L~L~~N~l~----g~iP~~ 479 (935)
+|+.|+|++|+++ +.+| ..+..+++|+.|+|++|.++ | .+| .+.++++|+.|+|++|+++ +.+|..
T Consensus 160 ~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~ 239 (386)
T 2ca6_A 160 PLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIA 239 (386)
T ss_dssp CCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHH
T ss_pred CCcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHH
Confidence 3444444444444 2233 23344444444444444444 2 223 3444444444444444443 344444
Q ss_pred cCccccccccccccccCC
Q 002336 480 MGSLPNLQELHIENNSFV 497 (935)
Q Consensus 480 l~~l~~L~~L~l~~N~l~ 497 (935)
+..+++|+.|+|++|.++
T Consensus 240 l~~~~~L~~L~L~~n~i~ 257 (386)
T 2ca6_A 240 LKSWPNLRELGLNDCLLS 257 (386)
T ss_dssp GGGCTTCCEEECTTCCCC
T ss_pred HccCCCcCEEECCCCCCc
Confidence 444444444444444444
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=98.25 E-value=8.2e-07 Score=106.57 Aligned_cols=94 Identities=26% Similarity=0.353 Sum_probs=59.6
Q ss_pred cEEEEEccCCCCcccCCccccCcccccccccccccCCCCCCCccccccccccccccccccCCCCCccCcccccccccccc
Q 002336 414 RITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIEN 493 (935)
Q Consensus 414 ~l~~L~Ls~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~l~~ 493 (935)
+|+.|+|++|.++ .+|.. +++|+.|+|++|+|++.+ ..+++|+.|+|++|+|+ .+|. .+++|+.|+|++
T Consensus 202 ~L~~L~L~~N~l~-~l~~~---~~~L~~L~Ls~N~L~~lp---~~l~~L~~L~Ls~N~L~-~lp~---~~~~L~~L~Ls~ 270 (622)
T 3g06_A 202 ELYKLWAYNNRLT-SLPAL---PSGLKELIVSGNRLTSLP---VLPSELKELMVSGNRLT-SLPM---LPSGLLSLSVYR 270 (622)
T ss_dssp TCCEEECCSSCCS-SCCCC---CTTCCEEECCSSCCSCCC---CCCTTCCEEECCSSCCS-CCCC---CCTTCCEEECCS
T ss_pred hhhEEECcCCccc-ccCCC---CCCCCEEEccCCccCcCC---CCCCcCcEEECCCCCCC-cCCc---ccccCcEEeCCC
Confidence 4455555555554 34422 356777777777777633 44567777777777777 5666 466777778888
Q ss_pred ccCCCCCCccccC--CceeeeecCCCCC
Q 002336 494 NSFVGEIPPALLT--GKVIFKYDNNPKL 519 (935)
Q Consensus 494 N~l~g~iP~~l~~--~~~~~~~~~n~~~ 519 (935)
|+|+ .||..+.. ....+.+.+|+..
T Consensus 271 N~L~-~lp~~l~~l~~L~~L~L~~N~l~ 297 (622)
T 3g06_A 271 NQLT-RLPESLIHLSSETTVNLEGNPLS 297 (622)
T ss_dssp SCCC-SCCGGGGGSCTTCEEECCSCCCC
T ss_pred CCCC-cCCHHHhhccccCEEEecCCCCC
Confidence 8777 77776554 3345566666643
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=98.21 E-value=5.2e-08 Score=110.16 Aligned_cols=107 Identities=16% Similarity=0.203 Sum_probs=86.5
Q ss_pred CcEEEEEccCCCCc--c---cCCccccCcccccccccccccCC----CCCC-CccccccccccccccccccCC----CCC
Q 002336 413 PRITKIALSGKNLK--G---EIPPELKNMEALTELWLDGNFLT----GPLP-DMSRLIDLRIVHLENNELTGS----LPS 478 (935)
Q Consensus 413 ~~l~~L~Ls~n~l~--g---~ip~~i~~L~~L~~L~Ls~N~l~----g~~p-~~~~l~~L~~L~L~~N~l~g~----iP~ 478 (935)
++|+.|+|++|+++ | .+|..+.++++|+.|+|++|.|+ +.+| .+..+++|+.|+|++|++++. +|.
T Consensus 187 ~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~ 266 (386)
T 2ca6_A 187 RLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVD 266 (386)
T ss_dssp TTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHH
T ss_pred CCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhHHHHHH
Confidence 47999999999998 3 34558899999999999999996 5566 588899999999999999866 677
Q ss_pred cc--CccccccccccccccCCC----CCCccc---cCCceeeeecCCCCC
Q 002336 479 YM--GSLPNLQELHIENNSFVG----EIPPAL---LTGKVIFKYDNNPKL 519 (935)
Q Consensus 479 ~l--~~l~~L~~L~l~~N~l~g----~iP~~l---~~~~~~~~~~~n~~~ 519 (935)
.+ +.+++|+.|+|++|.+++ .+|..+ ......+.+.+|+..
T Consensus 267 ~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~ 316 (386)
T 2ca6_A 267 AFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 316 (386)
T ss_dssp HHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSC
T ss_pred HHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCC
Confidence 76 448999999999999996 488876 245566677777654
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.19 E-value=3.4e-07 Score=97.70 Aligned_cols=65 Identities=26% Similarity=0.411 Sum_probs=28.6
Q ss_pred CcccccccccccccCCCC--CCC-ccccccccccccccccccCCCCCccCccc--cccccccccccCCCCCC
Q 002336 435 NMEALTELWLDGNFLTGP--LPD-MSRLIDLRIVHLENNELTGSLPSYMGSLP--NLQELHIENNSFVGEIP 501 (935)
Q Consensus 435 ~L~~L~~L~Ls~N~l~g~--~p~-~~~l~~L~~L~L~~N~l~g~iP~~l~~l~--~L~~L~l~~N~l~g~iP 501 (935)
+|++|+.|+|++|+|++. +|. +..+++|+.|+|++|+|++. ..+..+. +|+.|+|++|.+++.+|
T Consensus 168 ~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~ 237 (267)
T 3rw6_A 168 NIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFR 237 (267)
T ss_dssp HCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCS
T ss_pred hCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccC
Confidence 344444455555544442 222 23444455555555554432 2223333 44555555555544444
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=98.18 E-value=1.7e-07 Score=105.13 Aligned_cols=89 Identities=20% Similarity=0.195 Sum_probs=59.9
Q ss_pred CcEEEEEccCCCCcccCC----ccccCcc-cccccccccccCCCCCC-Ccccc-----ccccccccccccccCCCCCccC
Q 002336 413 PRITKIALSGKNLKGEIP----PELKNME-ALTELWLDGNFLTGPLP-DMSRL-----IDLRIVHLENNELTGSLPSYMG 481 (935)
Q Consensus 413 ~~l~~L~Ls~n~l~g~ip----~~i~~L~-~L~~L~Ls~N~l~g~~p-~~~~l-----~~L~~L~L~~N~l~g~iP~~l~ 481 (935)
.+|+.|+|++|++++..+ ..+.+++ +|++|+|++|.|++..+ .+..+ ++|+.|+|++|++++..+..++
T Consensus 22 ~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~ 101 (362)
T 3goz_A 22 HGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELV 101 (362)
T ss_dssp TTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHH
T ss_pred CCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCccEEECcCCcCChHHHHHHH
Confidence 347777777777775555 5566676 77777777777777655 44444 7777777777777766665444
Q ss_pred cc-----ccccccccccccCCCCCC
Q 002336 482 SL-----PNLQELHIENNSFVGEIP 501 (935)
Q Consensus 482 ~l-----~~L~~L~l~~N~l~g~iP 501 (935)
.+ ++|+.|+|++|++++..+
T Consensus 102 ~~l~~~~~~L~~L~Ls~N~l~~~~~ 126 (362)
T 3goz_A 102 KTLAAIPFTITVLDLGWNDFSSKSS 126 (362)
T ss_dssp HHHHTSCTTCCEEECCSSCGGGSCH
T ss_pred HHHHhCCCCccEEECcCCcCCcHHH
Confidence 43 677777777777764443
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.15 E-value=6.4e-06 Score=87.88 Aligned_cols=135 Identities=17% Similarity=0.115 Sum_probs=98.2
Q ss_pred ccccccccE-EEEEEEEC-CCcEEEEEEccCcchhhhHHHHHHHHHHHhcC-CCcccccceeeeccceEEEEEEecCCCC
Q 002336 619 KKIGKGSFG-SVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQRILVYEYMHNGT 695 (935)
Q Consensus 619 ~~LG~G~fG-~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~-HpnIv~l~g~~~~~~~~~lV~E~~~~gs 695 (935)
+.+..|..| .||+.... ++..+++|+-.. .....+.+|...|+.+. +--+.++++++.+.+..++|||+++|.+
T Consensus 30 ~~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~---~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~ 106 (272)
T 4gkh_A 30 ARDNVGQSGATIYRLYGKPNAPELFLKHGKG---SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKT 106 (272)
T ss_dssp EEEECSSSSCEEEEEECCTTCCCEEEEEEET---HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEE
T ss_pred EEccCCCcCCeEEEEEecCCCeEEEEEECCC---CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcc
Confidence 345556555 68988765 467799997543 23456888999999884 3336677888888889999999999988
Q ss_pred HHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhc--------------------------------------------
Q 002336 696 LRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG-------------------------------------------- 731 (935)
Q Consensus 696 L~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~-------------------------------------------- 731 (935)
+.+..... ......++.++++.|+.||+.
T Consensus 107 ~~~~~~~~-------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (272)
T 4gkh_A 107 AFQVLEEY-------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQV 179 (272)
T ss_dssp HHHHHHHC-------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHH
T ss_pred ccccccCC-------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHH
Confidence 87765421 123345667777777777751
Q ss_pred -----------CCCceEecCCCCCCccccCCCcEEEeeccccc
Q 002336 732 -----------CNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 763 (935)
Q Consensus 732 -----------~~~~ivH~DLkp~NILld~~~~vkL~DFGla~ 763 (935)
....++|||+.+.|||+++++.+-|+||+.+.
T Consensus 180 ~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 180 WKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp HHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 01238999999999999987777899999775
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.12 E-value=9.2e-06 Score=88.75 Aligned_cols=135 Identities=15% Similarity=0.187 Sum_probs=95.0
Q ss_pred ccccccccEEEEEEEECCCcEEEEEEccCcchhhhHHHHHHHHHHHhcCCC---cccccceeee-ccceEEEEEEecCCC
Q 002336 619 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHR---NLVPLIGYCE-EEHQRILVYEYMHNG 694 (935)
Q Consensus 619 ~~LG~G~fG~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~Hp---nIv~l~g~~~-~~~~~~lV~E~~~~g 694 (935)
+.++.|....||+. |+.+++|+-.. ......+.+|+++|+.+.+. .+.+++.++. ..+..++|||+++|.
T Consensus 25 ~~l~~G~~n~v~~v----g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~ 98 (306)
T 3tdw_A 25 ESLGEGFRNYAILV----NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQ 98 (306)
T ss_dssp EEEEECSSEEEEEE----TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSE
T ss_pred eecCCCcceeEEEE----CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCe
Confidence 46888999999987 56788887432 23456789999999999642 2455566653 445578999999998
Q ss_pred CHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhc-------------------------------------------
Q 002336 695 TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG------------------------------------------- 731 (935)
Q Consensus 695 sL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~------------------------------------------- 731 (935)
+|.+..- ..++..++..++.++++.|+.||+.
T Consensus 99 ~l~~~~~-----~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~ 173 (306)
T 3tdw_A 99 ILGEDGM-----AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLT 173 (306)
T ss_dssp ECHHHHH-----TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHH
T ss_pred ECchhhh-----hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHH
Confidence 8876322 1234555556666666666666641
Q ss_pred --------------CCCceEecCCCCCCccccC---CCc-EEEeecccccc
Q 002336 732 --------------CNPGIIHRDVKSSNILLDI---NMR-AKVSDFGLSRQ 764 (935)
Q Consensus 732 --------------~~~~ivH~DLkp~NILld~---~~~-vkL~DFGla~~ 764 (935)
....++|||+++.||+++. ++. +.|+||+.+..
T Consensus 174 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 174 LRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 1235799999999999987 455 48999997754
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=98.12 E-value=1.6e-07 Score=103.72 Aligned_cols=103 Identities=12% Similarity=0.078 Sum_probs=72.1
Q ss_pred CcEEEEEccCCCCcccCCccccCcccccccccccccCCCC-CC-CccccccccccccccccccCCCCCccCccccccccc
Q 002336 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGP-LP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 490 (935)
Q Consensus 413 ~~l~~L~Ls~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~-~p-~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~ 490 (935)
.+++.|+|++|.+.+.++. +.++++|++|+|++|.+++. +| .+.++++|+.|+|++|++++.+|..++++++|+.|+
T Consensus 70 ~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~ 148 (336)
T 2ast_B 70 QGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLN 148 (336)
T ss_dssp TTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEE
T ss_pred ccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEE
Confidence 5677888888888765554 56778888888888887765 55 467788888888888888777777777888888888
Q ss_pred cccc-cCCCC-CCcccc--CCceeeeecCC
Q 002336 491 IENN-SFVGE-IPPALL--TGKVIFKYDNN 516 (935)
Q Consensus 491 l~~N-~l~g~-iP~~l~--~~~~~~~~~~n 516 (935)
|++| .+++. +|..+. .....+.+.+|
T Consensus 149 L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~ 178 (336)
T 2ast_B 149 LSGCSGFSEFALQTLLSSCSRLDELNLSWC 178 (336)
T ss_dssp CTTCBSCCHHHHHHHHHHCTTCCEEECCCC
T ss_pred CCCCCCCCHHHHHHHHhcCCCCCEEcCCCC
Confidence 8888 56642 444332 23344455555
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=97.98 E-value=5.5e-07 Score=99.30 Aligned_cols=102 Identities=20% Similarity=0.285 Sum_probs=87.5
Q ss_pred CcEEEEEccCCCCcccCCccccCc--ccccccccccccCCCCCCCccccccccccccccccccCC-CCCccCcccccccc
Q 002336 413 PRITKIALSGKNLKGEIPPELKNM--EALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGS-LPSYMGSLPNLQEL 489 (935)
Q Consensus 413 ~~l~~L~Ls~n~l~g~ip~~i~~L--~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~-iP~~l~~l~~L~~L 489 (935)
..++.|+|++|++. |..+..+ ++|+.|+|++|.+++.++.+.++++|+.|+|++|++++. +|..+..+++|+.|
T Consensus 47 ~~~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L 123 (336)
T 2ast_B 47 SLWQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNL 123 (336)
T ss_dssp TTSSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCSCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEE
T ss_pred hhheeeccccccCC---HHHHHhhhhccceEEEcCCccccccchhhccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEE
Confidence 35778999999987 5677887 999999999999999999999999999999999999876 88899999999999
Q ss_pred ccccccCCCCCCccccC--CceeeeecCCC
Q 002336 490 HIENNSFVGEIPPALLT--GKVIFKYDNNP 517 (935)
Q Consensus 490 ~l~~N~l~g~iP~~l~~--~~~~~~~~~n~ 517 (935)
+|++|++++.+|..+.. ....+.+.+|.
T Consensus 124 ~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~ 153 (336)
T 2ast_B 124 SLEGLRLSDPIVNTLAKNSNLVRLNLSGCS 153 (336)
T ss_dssp ECTTCBCCHHHHHHHTTCTTCSEEECTTCB
T ss_pred eCcCcccCHHHHHHHhcCCCCCEEECCCCC
Confidence 99999999888876654 34455666663
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.95 E-value=1e-05 Score=90.13 Aligned_cols=80 Identities=5% Similarity=0.037 Sum_probs=56.3
Q ss_pred ccc-cccccEEEEEEEEC-------CCcEEEEEEccCcc---hhhhHHHHHHHHHHHhcC-C--Ccccccceeeecc---
Q 002336 619 KKI-GKGSFGSVYYGKMK-------DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIH-H--RNLVPLIGYCEEE--- 681 (935)
Q Consensus 619 ~~L-G~G~fG~Vy~~~~~-------~g~~vAvK~~~~~~---~~~~~~~~~E~~iL~~L~-H--pnIv~l~g~~~~~--- 681 (935)
+.| +.|....+|+.... +++.+++|+..... ......+.+|+.+++.+. + -.+.++++++.+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 567 88999999998764 26788999865422 001256788999998884 3 3466777777654
Q ss_pred ceEEEEEEecCCCCHHH
Q 002336 682 HQRILVYEYMHNGTLRD 698 (935)
Q Consensus 682 ~~~~lV~E~~~~gsL~~ 698 (935)
+..++||||++|..+.+
T Consensus 106 g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp SSCEEEEECCCCBCCCB
T ss_pred CCceEEEEecCCCChhh
Confidence 35689999999876543
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=97.95 E-value=5.9e-07 Score=95.81 Aligned_cols=78 Identities=22% Similarity=0.362 Sum_probs=66.3
Q ss_pred CCcEEEEEccCCCCcc--cCCccccCcccccccccccccCCCCCCCccccc--cccccccccccccCCCCC-------cc
Q 002336 412 PPRITKIALSGKNLKG--EIPPELKNMEALTELWLDGNFLTGPLPDMSRLI--DLRIVHLENNELTGSLPS-------YM 480 (935)
Q Consensus 412 ~~~l~~L~Ls~n~l~g--~ip~~i~~L~~L~~L~Ls~N~l~g~~p~~~~l~--~L~~L~L~~N~l~g~iP~-------~l 480 (935)
.++|+.|+|++|+|++ .+|..+..|++|+.|+|++|+|++. .++..+. +|+.|+|++|.+++.+|+ .+
T Consensus 169 l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~-~~l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~~il 247 (267)
T 3rw6_A 169 IPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE-RELDKIKGLKLEELWLDGNSLCDTFRDQSTYISAIR 247 (267)
T ss_dssp CTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG-GGGGGGTTSCCSEEECTTSTTGGGCSSHHHHHHHHH
T ss_pred CCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc-hhhhhcccCCcceEEccCCcCccccCcchhHHHHHH
Confidence 5689999999999998 6778889999999999999999986 4344444 999999999999998884 26
Q ss_pred Cccccccccc
Q 002336 481 GSLPNLQELH 490 (935)
Q Consensus 481 ~~l~~L~~L~ 490 (935)
..+++|+.||
T Consensus 248 ~~~P~L~~LD 257 (267)
T 3rw6_A 248 ERFPKLLRLD 257 (267)
T ss_dssp HHCTTCCEES
T ss_pred HHCcccCeEC
Confidence 7788888876
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=97.92 E-value=9.5e-06 Score=90.30 Aligned_cols=102 Identities=14% Similarity=0.134 Sum_probs=58.7
Q ss_pred cEEEEEccC-CCCcccCCccccCcc-cccccccccccCCCCCCCccccccccccccccccccCCCCC-ccCccccccccc
Q 002336 414 RITKIALSG-KNLKGEIPPELKNME-ALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPS-YMGSLPNLQELH 490 (935)
Q Consensus 414 ~l~~L~Ls~-n~l~g~ip~~i~~L~-~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~iP~-~l~~l~~L~~L~ 490 (935)
++..|++.+ +++....+..|..+. .|+.|+|++|+|+...+......+|+.|+|++|+..+.||. .+..+++|+.|+
T Consensus 129 ~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~~i~~~~f~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~Ld 208 (350)
T 4ay9_X 129 QKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILD 208 (350)
T ss_dssp SCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCEECTTSSTTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEE
T ss_pred hhhhhhhccccccccccccchhhcchhhhhhccccccccCCChhhccccchhHHhhccCCcccCCCHHHhccCcccchhh
Confidence 455666644 344422233455553 46667777777766655555566677777765333335654 356677777777
Q ss_pred cccccCCCCCCccccCCceeeeecCC
Q 002336 491 IENNSFVGEIPPALLTGKVIFKYDNN 516 (935)
Q Consensus 491 l~~N~l~g~iP~~l~~~~~~~~~~~n 516 (935)
|++|+|+ .||...+.....+...++
T Consensus 209 Ls~N~l~-~lp~~~~~~L~~L~~l~~ 233 (350)
T 4ay9_X 209 ISRTRIH-SLPSYGLENLKKLRARST 233 (350)
T ss_dssp CTTSCCC-CCCSSSCTTCCEEECTTC
T ss_pred cCCCCcC-ccChhhhccchHhhhccC
Confidence 7777776 666655554444444333
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=97.89 E-value=1.1e-06 Score=98.37 Aligned_cols=101 Identities=14% Similarity=0.057 Sum_probs=84.2
Q ss_pred EEEccCCCCcccCCccccCcccccccccccccCCCCCC-----Cccccc-cccccccccccccCCCCCccCcc-----cc
Q 002336 417 KIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-----DMSRLI-DLRIVHLENNELTGSLPSYMGSL-----PN 485 (935)
Q Consensus 417 ~L~Ls~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p-----~~~~l~-~L~~L~L~~N~l~g~iP~~l~~l-----~~ 485 (935)
.++|++|+++|.+|..+...++|++|+|++|.|++..+ .+.+++ +|+.|+|++|++++..+..+..+ ++
T Consensus 2 ~~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~ 81 (362)
T 3goz_A 2 NYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN 81 (362)
T ss_dssp EEECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTT
T ss_pred ccccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCC
Confidence 46899999999999988888889999999999999876 367788 89999999999998888888876 99
Q ss_pred ccccccccccCCCCCCccccC-------CceeeeecCCC
Q 002336 486 LQELHIENNSFVGEIPPALLT-------GKVIFKYDNNP 517 (935)
Q Consensus 486 L~~L~l~~N~l~g~iP~~l~~-------~~~~~~~~~n~ 517 (935)
|+.|+|++|++++..+..+.. ....+.+++|.
T Consensus 82 L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~ 120 (362)
T 3goz_A 82 VTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWND 120 (362)
T ss_dssp CCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSC
T ss_pred ccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCc
Confidence 999999999999766654332 34455666665
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=97.66 E-value=1.5e-06 Score=100.17 Aligned_cols=105 Identities=18% Similarity=0.211 Sum_probs=57.6
Q ss_pred CcEEEEEccCCCCcccCCccccCc-----ccccccccccccCCCC----CC-CccccccccccccccccccCCCCCccCc
Q 002336 413 PRITKIALSGKNLKGEIPPELKNM-----EALTELWLDGNFLTGP----LP-DMSRLIDLRIVHLENNELTGSLPSYMGS 482 (935)
Q Consensus 413 ~~l~~L~Ls~n~l~g~ip~~i~~L-----~~L~~L~Ls~N~l~g~----~p-~~~~l~~L~~L~L~~N~l~g~iP~~l~~ 482 (935)
++|+.|+|++|.+.+..+..+... ++|+.|+|++|.+++. ++ .+..+++|+.|+|++|++++..+..+..
T Consensus 284 ~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~ 363 (461)
T 1z7x_W 284 ESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQ 363 (461)
T ss_dssp TTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHH
T ss_pred CCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHH
Confidence 456666666666654433333322 4666666666666654 22 3455566666666666666444443332
Q ss_pred -----cccccccccccccCCC----CCCccccC--CceeeeecCCC
Q 002336 483 -----LPNLQELHIENNSFVG----EIPPALLT--GKVIFKYDNNP 517 (935)
Q Consensus 483 -----l~~L~~L~l~~N~l~g----~iP~~l~~--~~~~~~~~~n~ 517 (935)
+++|+.|+|++|++++ .+|..+.. ....+.+.+|+
T Consensus 364 ~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~N~ 409 (461)
T 1z7x_W 364 GLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNC 409 (461)
T ss_dssp HHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSS
T ss_pred HHcCCCCceEEEECCCCCCChhhHHHHHHHHHhCCCccEEECCCCC
Confidence 4566666666666664 45554432 33344555554
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=97.64 E-value=8.7e-07 Score=102.18 Aligned_cols=90 Identities=21% Similarity=0.197 Sum_probs=62.1
Q ss_pred CcEEEEEccCCCCccc----CCccccCcccccccccccccCCCCCC-Ccc-----ccccccccccccccccCC----CCC
Q 002336 413 PRITKIALSGKNLKGE----IPPELKNMEALTELWLDGNFLTGPLP-DMS-----RLIDLRIVHLENNELTGS----LPS 478 (935)
Q Consensus 413 ~~l~~L~Ls~n~l~g~----ip~~i~~L~~L~~L~Ls~N~l~g~~p-~~~-----~l~~L~~L~L~~N~l~g~----iP~ 478 (935)
++|+.|+|++|++++. ++..+.++++|++|+|++|.+++..+ .+. ..++|+.|+|++|++++. +|.
T Consensus 256 ~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~ 335 (461)
T 1z7x_W 256 SRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSS 335 (461)
T ss_dssp CCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHH
T ss_pred CCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHH
Confidence 4677788888877754 66667777788888888887765433 222 235788888888887755 556
Q ss_pred ccCccccccccccccccCCCCCCc
Q 002336 479 YMGSLPNLQELHIENNSFVGEIPP 502 (935)
Q Consensus 479 ~l~~l~~L~~L~l~~N~l~g~iP~ 502 (935)
.+..+++|+.|+|++|++++..+.
T Consensus 336 ~l~~~~~L~~L~Ls~n~i~~~~~~ 359 (461)
T 1z7x_W 336 VLAQNRFLLELQISNNRLEDAGVR 359 (461)
T ss_dssp HHHHCSSCCEEECCSSBCHHHHHH
T ss_pred HHhhCCCccEEEccCCccccccHH
Confidence 666778888888888877744443
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.59 E-value=0.00014 Score=82.30 Aligned_cols=75 Identities=17% Similarity=0.220 Sum_probs=49.4
Q ss_pred cccccccccEEEEEEEEC-CCcEEEEEEccCcch-------hhhHHHHHHHHHHHhcCC--Cccc-ccceeeeccceEEE
Q 002336 618 CKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS-------HRTQQFVTEVALLSRIHH--RNLV-PLIGYCEEEHQRIL 686 (935)
Q Consensus 618 ~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~-------~~~~~~~~E~~iL~~L~H--pnIv-~l~g~~~~~~~~~l 686 (935)
.+.||.|..+.||++... +++.++||....... .....+..|.++++.+.. +..+ +++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 357999999999999764 478899998653221 123456789999988742 3333 44443 3345689
Q ss_pred EEEecCCC
Q 002336 687 VYEYMHNG 694 (935)
Q Consensus 687 V~E~~~~g 694 (935)
|||++++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999764
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.54 E-value=0.00017 Score=79.22 Aligned_cols=140 Identities=17% Similarity=0.253 Sum_probs=79.3
Q ss_pred ccccccccEEEEEEEECCCcEEEEEEccCcchhhhHHHHHHHHHHHhcC-----CCcccccc-e--eeeccceEEEEEEe
Q 002336 619 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIH-----HRNLVPLI-G--YCEEEHQRILVYEY 690 (935)
Q Consensus 619 ~~LG~G~fG~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~-----HpnIv~l~-g--~~~~~~~~~lV~E~ 690 (935)
+.|+.|..+.||+....+| .+++|+.... ...+..|+.+++.|. .|.++... | +....+..+++|||
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 3466677899999987655 5899988652 133445566665553 23333311 1 12345667899999
Q ss_pred cCCCCHH--------------HHhccC---CC-C-------CCCCHHHH-------------------------------
Q 002336 691 MHNGTLR--------------DRLHGS---VN-Q-------KPLDWLTR------------------------------- 714 (935)
Q Consensus 691 ~~~gsL~--------------~~L~~~---~~-~-------~~l~~~~~------------------------------- 714 (935)
++|..+. ..++.. .. . ....|...
T Consensus 113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 192 (346)
T 2q83_A 113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI 192 (346)
T ss_dssp CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence 9986431 011110 00 0 01122211
Q ss_pred HHHHHHHHHHhHHhhh----------cCCCceEecCCCCCCccccCCCcEEEeeccccc
Q 002336 715 LQIAHDAAKGLEYLHT----------GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 763 (935)
Q Consensus 715 ~~i~~qia~gL~yLHs----------~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~ 763 (935)
..+..++.+++.+|+. .....++|||+++.|||++.++.+.|+||+.+.
T Consensus 193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 0111223445666652 124789999999999999888889999999764
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=97.45 E-value=5.5e-05 Score=83.22 Aligned_cols=90 Identities=18% Similarity=0.154 Sum_probs=76.4
Q ss_pred CcEEEEEccCCCCcccCC-ccccCcccccccccccccCCCCCC-Ccccccccc-ccccccccccCCCCCccCcccccccc
Q 002336 413 PRITKIALSGKNLKGEIP-PELKNMEALTELWLDGNFLTGPLP-DMSRLIDLR-IVHLENNELTGSLPSYMGSLPNLQEL 489 (935)
Q Consensus 413 ~~l~~L~Ls~n~l~g~ip-~~i~~L~~L~~L~Ls~N~l~g~~p-~~~~l~~L~-~L~L~~N~l~g~iP~~l~~l~~L~~L 489 (935)
++|+.|+|++|+++ .|| ..|.++++|+.|+|++| +....+ .|.++.+|+ .|+|.+ +++-.-+..|.+|++|+.|
T Consensus 226 ~~L~~l~L~~n~i~-~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l 302 (329)
T 3sb4_A 226 PNLVSLDISKTNAT-TIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYV 302 (329)
T ss_dssp TTCCEEECTTBCCC-EECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEE
T ss_pred CCCeEEECCCCCcc-eecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEE
Confidence 47999999999999 555 57999999999999998 666555 699999999 999998 7773334679999999999
Q ss_pred ccccccCCCCCCccccC
Q 002336 490 HIENNSFVGEIPPALLT 506 (935)
Q Consensus 490 ~l~~N~l~g~iP~~l~~ 506 (935)
++++|+++ .|+...+.
T Consensus 303 ~l~~n~i~-~I~~~aF~ 318 (329)
T 3sb4_A 303 LATGDKIT-TLGDELFG 318 (329)
T ss_dssp EECSSCCC-EECTTTTC
T ss_pred EeCCCccC-ccchhhhc
Confidence 99999999 88886654
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.35 E-value=0.00057 Score=73.51 Aligned_cols=74 Identities=19% Similarity=0.275 Sum_probs=54.0
Q ss_pred cccccccccEEEEEEEECCCcEEEEEEccCcchhhhHHHHHHHHHHHhcCCC---cccccceeeeccceEEEEEEecCCC
Q 002336 618 CKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHR---NLVPLIGYCEEEHQRILVYEYMHNG 694 (935)
Q Consensus 618 ~~~LG~G~fG~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~Hp---nIv~l~g~~~~~~~~~lV~E~~~~g 694 (935)
.+.+|.|..+.||+.+..+|+.+++|+-..........|..|+..|+.|.-. -+.+++++. ..++||||++++
T Consensus 20 v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~l~~~ 95 (288)
T 3f7w_A 20 VAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEWVDER 95 (288)
T ss_dssp EEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEECCCCC
T ss_pred EEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEeeccc
Confidence 3568999999999999999999999986544333345688999999988421 233444432 237899999876
Q ss_pred C
Q 002336 695 T 695 (935)
Q Consensus 695 s 695 (935)
.
T Consensus 96 ~ 96 (288)
T 3f7w_A 96 P 96 (288)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.34 E-value=8e-06 Score=91.84 Aligned_cols=84 Identities=23% Similarity=0.214 Sum_probs=58.8
Q ss_pred cEEEEEccCCCCcc----cCCccccCcccccccccccccCCCCC----C-CccccccccccccccccccC----CCCCcc
Q 002336 414 RITKIALSGKNLKG----EIPPELKNMEALTELWLDGNFLTGPL----P-DMSRLIDLRIVHLENNELTG----SLPSYM 480 (935)
Q Consensus 414 ~l~~L~Ls~n~l~g----~ip~~i~~L~~L~~L~Ls~N~l~g~~----p-~~~~l~~L~~L~L~~N~l~g----~iP~~l 480 (935)
+|+.|+|++|+|+. .++..+..+++|++|+|++|.|+..- + .+...++|+.|+|++|+++. .++..+
T Consensus 156 ~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~L 235 (372)
T 3un9_A 156 QITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAA 235 (372)
T ss_dssp CCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHHHHHH
T ss_pred ccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHHHHHH
Confidence 67888888888764 24455567778888888888876532 2 35566778888888888764 234445
Q ss_pred CccccccccccccccCC
Q 002336 481 GSLPNLQELHIENNSFV 497 (935)
Q Consensus 481 ~~l~~L~~L~l~~N~l~ 497 (935)
..+++|+.|+|++|.|+
T Consensus 236 ~~~~~L~~L~Ls~N~i~ 252 (372)
T 3un9_A 236 REHPSLELLHLYFNELS 252 (372)
T ss_dssp HHCSSCCEEECTTSSCC
T ss_pred HhCCCCCEEeccCCCCC
Confidence 55677888888888876
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.32 E-value=0.00025 Score=80.93 Aligned_cols=80 Identities=11% Similarity=0.105 Sum_probs=49.0
Q ss_pred CCceEecCCCCCCccccCCCcEEEeeccccccccccccceeecccCCccccCCCCCCCC---CCCchhHHHHHHHHHHHH
Q 002336 733 NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ---QLTEKSDVYSFGVVLLEL 809 (935)
Q Consensus 733 ~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~---~~s~ksDVwS~Gvil~eL 809 (935)
...++|||+++.|||++.++ ++++||+.+.......+.......-...|++|+..... ......++......+|+.
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNL 309 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHH
Confidence 47899999999999998776 99999998865432211110000001345665544311 112345666788888887
Q ss_pred HhCC
Q 002336 810 ISGK 813 (935)
Q Consensus 810 ltG~ 813 (935)
+.++
T Consensus 310 y~~~ 313 (420)
T 2pyw_A 310 FNKR 313 (420)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 7653
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.29 E-value=0.00062 Score=74.29 Aligned_cols=137 Identities=18% Similarity=0.219 Sum_probs=90.5
Q ss_pred ccccccccEEEEEEEECCCcEEEEEEccCcchhhhHHHHHHHHHHHhcC---CCcccccceeeeccceEEEEEEecCCCC
Q 002336 619 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIH---HRNLVPLIGYCEEEHQRILVYEYMHNGT 695 (935)
Q Consensus 619 ~~LG~G~fG~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~---HpnIv~l~g~~~~~~~~~lV~E~~~~gs 695 (935)
+.|+.|....+|+.... ++.+++|+.... ....+..|+..|+.|. ...+.++++++...+..++||||+++..
T Consensus 42 ~~l~gG~~n~~y~v~~~-~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~ 117 (312)
T 3jr1_A 42 EKLYSGEMNEIWLINDE-VQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSK 117 (312)
T ss_dssp EEECCSSSSEEEEEESS-SCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCC
T ss_pred EEeCCccceeeeEEEEC-CCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCC
Confidence 46899999999998864 778899986532 3467889999999884 3567888888877788999999999875
Q ss_pred HH--------H---HhccCCC-C------------------CCCCHHHHH---HHH----------------HHHHHHh-
Q 002336 696 LR--------D---RLHGSVN-Q------------------KPLDWLTRL---QIA----------------HDAAKGL- 725 (935)
Q Consensus 696 L~--------~---~L~~~~~-~------------------~~l~~~~~~---~i~----------------~qia~gL- 725 (935)
+. . .|+.... . -.-+|.... ++. .++++.+
T Consensus 118 ~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l~ 197 (312)
T 3jr1_A 118 NKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIVA 197 (312)
T ss_dssp CCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHHH
T ss_pred CCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHHH
Confidence 41 1 1222111 0 012344321 111 1111111
Q ss_pred HHhhh-cCCCceEecCCCCCCccccCCCcEEEeecc
Q 002336 726 EYLHT-GCNPGIIHRDVKSSNILLDINMRAKVSDFG 760 (935)
Q Consensus 726 ~yLHs-~~~~~ivH~DLkp~NILld~~~~vkL~DFG 760 (935)
..|.. .....++|+|+.+.|++++.++ +.|.|+.
T Consensus 198 ~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 198 DTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 23321 1247899999999999999887 8899974
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.13 E-value=2.6e-05 Score=87.58 Aligned_cols=84 Identities=18% Similarity=0.141 Sum_probs=38.1
Q ss_pred cEEEEEccCCCCcccCCccc-cCcccccccccccccCCCCCC-Cc-----cccccccccccccccccC----CCCCccCc
Q 002336 414 RITKIALSGKNLKGEIPPEL-KNMEALTELWLDGNFLTGPLP-DM-----SRLIDLRIVHLENNELTG----SLPSYMGS 482 (935)
Q Consensus 414 ~l~~L~Ls~n~l~g~ip~~i-~~L~~L~~L~Ls~N~l~g~~p-~~-----~~l~~L~~L~L~~N~l~g----~iP~~l~~ 482 (935)
+|+.|+|++|+|+..-...+ ..|++|+.|+|++|.|+.... .+ ...++|+.|+|++|+|+. .++..+..
T Consensus 102 ~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~ 181 (372)
T 3un9_A 102 ALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAG 181 (372)
T ss_dssp CEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHHT
T ss_pred CceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHhc
Confidence 45555555555543322222 224455555555555543222 11 123445555555555542 12333344
Q ss_pred cccccccccccccCC
Q 002336 483 LPNLQELHIENNSFV 497 (935)
Q Consensus 483 l~~L~~L~l~~N~l~ 497 (935)
+++|+.|+|++|.|+
T Consensus 182 ~~~L~~L~Ls~N~l~ 196 (372)
T 3un9_A 182 NTSVTHLSLLHTGLG 196 (372)
T ss_dssp CSSCCEEECTTSSCH
T ss_pred CCCcCEEeCCCCCCC
Confidence 455555555555554
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=96.92 E-value=4.9e-05 Score=76.45 Aligned_cols=85 Identities=21% Similarity=0.289 Sum_probs=63.4
Q ss_pred CcEEEEEccCC-CCccc----CCccccCcccccccccccccCCCCC----C-CccccccccccccccccccCC----CCC
Q 002336 413 PRITKIALSGK-NLKGE----IPPELKNMEALTELWLDGNFLTGPL----P-DMSRLIDLRIVHLENNELTGS----LPS 478 (935)
Q Consensus 413 ~~l~~L~Ls~n-~l~g~----ip~~i~~L~~L~~L~Ls~N~l~g~~----p-~~~~l~~L~~L~L~~N~l~g~----iP~ 478 (935)
+.|++|+|++| ++... +...+...++|++|+|++|.|...- . .+...+.|+.|+|++|++... +..
T Consensus 36 ~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~~l~~ 115 (185)
T 1io0_A 36 PDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVE 115 (185)
T ss_dssp TTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHH
T ss_pred CCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHHHHHH
Confidence 47888999988 77642 4455677788999999999886421 1 245567889999999988743 456
Q ss_pred ccCcccccccccc--ccccCC
Q 002336 479 YMGSLPNLQELHI--ENNSFV 497 (935)
Q Consensus 479 ~l~~l~~L~~L~l--~~N~l~ 497 (935)
.+...++|+.|+| ++|.+.
T Consensus 116 ~L~~n~~L~~L~L~~~~N~i~ 136 (185)
T 1io0_A 116 ALQSNTSLIELRIDNQSQPLG 136 (185)
T ss_dssp GGGGCSSCCEEECCCCSSCCC
T ss_pred HHHhCCCceEEEecCCCCCCC
Confidence 6777788999999 778887
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=96.79 E-value=6.5e-05 Score=89.38 Aligned_cols=65 Identities=20% Similarity=0.131 Sum_probs=28.7
Q ss_pred ccCcccccccccccc--cCCCCCC-Ccc-ccccccccccccccccC-CCCCccCccccccccccccccCC
Q 002336 433 LKNMEALTELWLDGN--FLTGPLP-DMS-RLIDLRIVHLENNELTG-SLPSYMGSLPNLQELHIENNSFV 497 (935)
Q Consensus 433 i~~L~~L~~L~Ls~N--~l~g~~p-~~~-~l~~L~~L~L~~N~l~g-~iP~~l~~l~~L~~L~l~~N~l~ 497 (935)
+.++++|+.|+|+++ .+++..+ .+. .+++|+.|+|++|++++ .++..+..+++|+.|+|++|.|+
T Consensus 432 ~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~ 501 (592)
T 3ogk_B 432 LIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFS 501 (592)
T ss_dssp HHHCTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCB
T ss_pred HHhCCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCc
Confidence 444555555555421 2333222 222 24445555555555543 23333344455555555555544
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=96.71 E-value=5.8e-05 Score=75.89 Aligned_cols=85 Identities=15% Similarity=0.246 Sum_probs=67.7
Q ss_pred CcEEEEEccCCCCccc----CCccccCcccccccccccccCCCC----CC-Ccccccccccccc--ccccccCC----CC
Q 002336 413 PRITKIALSGKNLKGE----IPPELKNMEALTELWLDGNFLTGP----LP-DMSRLIDLRIVHL--ENNELTGS----LP 477 (935)
Q Consensus 413 ~~l~~L~Ls~n~l~g~----ip~~i~~L~~L~~L~Ls~N~l~g~----~p-~~~~l~~L~~L~L--~~N~l~g~----iP 477 (935)
+.|+.|+|++|+|... +...+...++|++|+|++|.|+.. +. .+...+.|+.|+| ++|.+... +.
T Consensus 65 ~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~ 144 (185)
T 1io0_A 65 TYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIA 144 (185)
T ss_dssp CSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHH
T ss_pred CCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHH
Confidence 4799999999999753 445566678999999999999864 22 5677889999999 88998744 34
Q ss_pred CccCccccccccccccccCC
Q 002336 478 SYMGSLPNLQELHIENNSFV 497 (935)
Q Consensus 478 ~~l~~l~~L~~L~l~~N~l~ 497 (935)
..+...++|+.|+|++|.+.
T Consensus 145 ~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 145 NMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HHHHHCSSCCEEECCCSSHH
T ss_pred HHHHhCCCcCEEeccCCCCC
Confidence 45566689999999999986
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.70 E-value=0.003 Score=68.29 Aligned_cols=138 Identities=14% Similarity=0.118 Sum_probs=75.5
Q ss_pred cccccccccEEEEEEEECCCcEEEEEEccCcchhhhHHHHHHHHHHHhcCCCcc-cccceeeeccceEEEEEEec-CCCC
Q 002336 618 CKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNL-VPLIGYCEEEHQRILVYEYM-HNGT 695 (935)
Q Consensus 618 ~~~LG~G~fG~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~HpnI-v~l~g~~~~~~~~~lV~E~~-~~gs 695 (935)
.+.|+.|....+|+. +.+++|+..... .......+|+.+++.+...++ .++++++. +.-++++||+ ++.+
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~-~~~~~r~~E~~~l~~l~~~g~~P~~~~~~~--~~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGT-EEYINRANEAVAAREAAKAGVSPEVLHVDP--ATGVMVTRYIAGAQT 94 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEECT--TTCCEEEECCTTCEE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCc-cceeCHHHHHHHHHHHHHcCCCCceEEEEC--CCCEEEEeecCCCcc
Confidence 467889999999998 568888875431 112234568888887753233 35555443 3347899999 5544
Q ss_pred HHH------------------HhccCCC--CCCCC-HHHHHHHHHH--------------HHHHhH----Hhh-hcCCCc
Q 002336 696 LRD------------------RLHGSVN--QKPLD-WLTRLQIAHD--------------AAKGLE----YLH-TGCNPG 735 (935)
Q Consensus 696 L~~------------------~L~~~~~--~~~l~-~~~~~~i~~q--------------ia~gL~----yLH-s~~~~~ 735 (935)
+.. .++.... ....+ +.....+... +.+.+. .|. ......
T Consensus 95 l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~~ 174 (301)
T 3dxq_A 95 MSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPLA 174 (301)
T ss_dssp CCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCCE
T ss_pred CCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCce
Confidence 321 1111100 00011 1111111110 111111 111 012356
Q ss_pred eEecCCCCCCccccCCCcEEEeecccccc
Q 002336 736 IIHRDVKSSNILLDINMRAKVSDFGLSRQ 764 (935)
Q Consensus 736 ivH~DLkp~NILld~~~~vkL~DFGla~~ 764 (935)
++|+|+.+.||+ ..++.+.|+||..+..
T Consensus 175 l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 175 ACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp EECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred eeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 999999999999 6667789999987754
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.67 E-value=0.0058 Score=66.93 Aligned_cols=142 Identities=12% Similarity=0.064 Sum_probs=73.9
Q ss_pred ccccccccEE-EEEEEECCCcEEEEEEccCcchhhhHHHHHHHHHHHhcCC--CcccccceeeeccceEEEEEEecCCCC
Q 002336 619 KKIGKGSFGS-VYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHH--RNLVPLIGYCEEEHQRILVYEYMHNGT 695 (935)
Q Consensus 619 ~~LG~G~fG~-Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~H--pnIv~l~g~~~~~~~~~lV~E~~~~gs 695 (935)
+.|+.|.... +|+....+|+.+++|...... ...+..|+.+++.+.. -.+.+++.+..+.+ +++||++.+..
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~---~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~~ 98 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEE---GGDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDAL 98 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTT---TCCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSCB
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCC---CccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCcc
Confidence 4566665554 567765447778887654321 1345567777777742 23455666543333 78999997766
Q ss_pred HHHHhccC---------------------CC--CCCCCHHHHH-------HH-------------HHHHHHHhHHhh---
Q 002336 696 LRDRLHGS---------------------VN--QKPLDWLTRL-------QI-------------AHDAAKGLEYLH--- 729 (935)
Q Consensus 696 L~~~L~~~---------------------~~--~~~l~~~~~~-------~i-------------~~qia~gL~yLH--- 729 (935)
+.+.+... .. ...++..... .+ ...+.+.+..|.
T Consensus 99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~ 178 (333)
T 3csv_A 99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ 178 (333)
T ss_dssp HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence 65433211 00 0111111100 00 001111222221
Q ss_pred hcCCCceEecCCCCCCccccCC----CcEEEeeccccccc
Q 002336 730 TGCNPGIIHRDVKSSNILLDIN----MRAKVSDFGLSRQA 765 (935)
Q Consensus 730 s~~~~~ivH~DLkp~NILld~~----~~vkL~DFGla~~~ 765 (935)
......++|||+.+.||+++.+ +.+.|+||+.+...
T Consensus 179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 1124689999999999999875 67999999987643
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.64 E-value=0.0029 Score=72.25 Aligned_cols=71 Identities=15% Similarity=0.309 Sum_probs=49.3
Q ss_pred ccccccccEEEEEEEECC--------CcEEEEEEccCcchhhhHHHHHHHHHHHhcCCCcc-cccceeeeccceEEEEEE
Q 002336 619 KKIGKGSFGSVYYGKMKD--------GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNL-VPLIGYCEEEHQRILVYE 689 (935)
Q Consensus 619 ~~LG~G~fG~Vy~~~~~~--------g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~HpnI-v~l~g~~~~~~~~~lV~E 689 (935)
+.|+.|....+|+....+ ++.+++|+...... ...+..|..+++.+...++ .++++.+.+ .+|+|
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~--~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e 152 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET--ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 152 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC--HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCc--HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEE
Confidence 467889999999998753 57899998743211 1455679999998853333 556666543 38999
Q ss_pred ecCCCC
Q 002336 690 YMHNGT 695 (935)
Q Consensus 690 ~~~~gs 695 (935)
|++|.+
T Consensus 153 ~l~G~~ 158 (429)
T 1nw1_A 153 YIPSRP 158 (429)
T ss_dssp CCCEEE
T ss_pred EeCCcc
Confidence 998643
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.55 E-value=0.01 Score=64.55 Aligned_cols=142 Identities=15% Similarity=0.213 Sum_probs=79.1
Q ss_pred ccccccccEEEEEEEECCCcEEEEEEccCcchhhhHHHHHHHHHHHhcCCCc--cccccee------eeccceEEEEEEe
Q 002336 619 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRN--LVPLIGY------CEEEHQRILVYEY 690 (935)
Q Consensus 619 ~~LG~G~fG~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~Hpn--Iv~l~g~------~~~~~~~~lV~E~ 690 (935)
+.|+.|....+|+....+| .+++|+.... .....+..|+.+++.+.... +.+++.. ....+..+++|+|
T Consensus 28 ~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~ 104 (322)
T 2ppq_A 28 KGIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISF 104 (322)
T ss_dssp EEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEEC
T ss_pred eccCCCcccceEEEEeCCc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEe
Confidence 4577788899999987755 6888987652 12345667888887774212 2333321 1223567899999
Q ss_pred cCCCCHHH--------------HhccC---CCCC---CC---CHHHHHHH------------HHHHHHHhHHhhhc----
Q 002336 691 MHNGTLRD--------------RLHGS---VNQK---PL---DWLTRLQI------------AHDAAKGLEYLHTG---- 731 (935)
Q Consensus 691 ~~~gsL~~--------------~L~~~---~~~~---~l---~~~~~~~i------------~~qia~gL~yLHs~---- 731 (935)
++|..+.. .++.. .... .. .|.....- ...+.+.++.+++.
T Consensus 105 l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~ 184 (322)
T 2ppq_A 105 LEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKD 184 (322)
T ss_dssp CCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCS
T ss_pred CCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCccc
Confidence 98864311 11110 0000 01 12221100 01133444455421
Q ss_pred CCCceEecCCCCCCccccCCCcEEEeeccccc
Q 002336 732 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 763 (935)
Q Consensus 732 ~~~~ivH~DLkp~NILld~~~~vkL~DFGla~ 763 (935)
...+++|+|+++.|||++++..+.|+||+.+.
T Consensus 185 ~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 185 LPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp SCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred CCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 23689999999999999987666899998764
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.51 E-value=0.012 Score=64.17 Aligned_cols=141 Identities=12% Similarity=0.167 Sum_probs=80.9
Q ss_pred cccccccEEEEEEEECCCcEEEEEEccCcchhhhHHHHHHHHHHHhcCCC--ccccccee-----eeccceEEEEEEecC
Q 002336 620 KIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHR--NLVPLIGY-----CEEEHQRILVYEYMH 692 (935)
Q Consensus 620 ~LG~G~fG~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~Hp--nIv~l~g~-----~~~~~~~~lV~E~~~ 692 (935)
.++ |....||+....+|+.+++|...... .....+..|..+++.+... .+.+++.. ....+..+++|++++
T Consensus 33 ~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i~ 110 (328)
T 1zyl_A 33 PLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVG 110 (328)
T ss_dssp EEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCC
T ss_pred eec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEecC
Confidence 466 77889999887778889999986331 1234667788888877422 23444443 122445678999998
Q ss_pred CCCHH-----H------H---hcc----CC--CCCCCCHHHH----------------------HHHHHHHHHHhHHhhh
Q 002336 693 NGTLR-----D------R---LHG----SV--NQKPLDWLTR----------------------LQIAHDAAKGLEYLHT 730 (935)
Q Consensus 693 ~gsL~-----~------~---L~~----~~--~~~~l~~~~~----------------------~~i~~qia~gL~yLHs 730 (935)
|..+. . . ++. .. .....++... ...+.++++.+.-+-.
T Consensus 111 G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 190 (328)
T 1zyl_A 111 GRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWR 190 (328)
T ss_dssp CEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCC
T ss_pred CCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHhh
Confidence 75431 0 0 111 00 0111222111 1111122222221110
Q ss_pred -cCCCceEecCCCCCCccccCCCcEEEeecccccc
Q 002336 731 -GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 764 (935)
Q Consensus 731 -~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~ 764 (935)
.....++|||+++.|||++ + .+.|+||+.+..
T Consensus 191 ~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 191 EDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp SCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 1246789999999999999 4 899999987653
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.45 E-value=0.0075 Score=69.31 Aligned_cols=73 Identities=11% Similarity=0.088 Sum_probs=48.0
Q ss_pred ccccccccEEEEEEEECC-CcEEEEEEccCcchhhhHHHHHHHHHHHhcCCCcc-cccceeeeccceEEEEEEecCCCCH
Q 002336 619 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNL-VPLIGYCEEEHQRILVYEYMHNGTL 696 (935)
Q Consensus 619 ~~LG~G~fG~Vy~~~~~~-g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~HpnI-v~l~g~~~~~~~~~lV~E~~~~gsL 696 (935)
+.|+.|....+|+....+ ++.+++|+...... ..-.-..|..+++.|...++ .++++.+.. .+||||++|.+|
T Consensus 114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~-~~idR~~E~~vl~~L~~~gl~P~ll~~~~~----G~v~e~I~G~~l 188 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTD-EIINREREKKISCILYNKNIAKKIYVFFTN----GRIEEFMDGYAL 188 (458)
T ss_dssp EEECC--CEEEEEEEETTTTEEEEEEEECC-CC-SCSCHHHHHHHHHHHTTSSSBCCEEEEETT----EEEEECCCSEEC
T ss_pred EEcCCCeEeEEEEEEECCCCceEEEEECCCChh-hhcCHHHHHHHHHHHHhcCCCCCEEEEeCC----eEEEEeeCCccC
Confidence 568889999999998875 57889998643221 11122589999999965444 456666632 359999987443
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=96.38 E-value=0.00015 Score=86.26 Aligned_cols=106 Identities=14% Similarity=0.112 Sum_probs=64.0
Q ss_pred CCcEEEEEcc--C----CCCcc-----cCCccccCcccccccccccccCCCCCC-Cccc-cccccccccccccccCCCCC
Q 002336 412 PPRITKIALS--G----KNLKG-----EIPPELKNMEALTELWLDGNFLTGPLP-DMSR-LIDLRIVHLENNELTGSLPS 478 (935)
Q Consensus 412 ~~~l~~L~Ls--~----n~l~g-----~ip~~i~~L~~L~~L~Ls~N~l~g~~p-~~~~-l~~L~~L~L~~N~l~g~iP~ 478 (935)
.++|+.|+|+ + +++++ .++..+.++++|+.|+|++ .++...+ .+.. +++|+.|+|++|.+++..+.
T Consensus 396 ~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~ 474 (594)
T 2p1m_B 396 RPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMH 474 (594)
T ss_dssp CTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHH
T ss_pred CCCcceeEeecccCCCcccccCCchhhHHHHHHhhCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHH
Confidence 3577888887 3 45541 1222356677888888866 4444322 4444 77788888888887655554
Q ss_pred cc-CccccccccccccccCCCCCCccccC---CceeeeecCCCC
Q 002336 479 YM-GSLPNLQELHIENNSFVGEIPPALLT---GKVIFKYDNNPK 518 (935)
Q Consensus 479 ~l-~~l~~L~~L~l~~N~l~g~iP~~l~~---~~~~~~~~~n~~ 518 (935)
.+ ..+++|+.|+|++|.+++..+..+.. ....+.+.+|+.
T Consensus 475 ~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~ 518 (594)
T 2p1m_B 475 HVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCSV 518 (594)
T ss_dssp HHHHHCTTCCEEEEESCSCCHHHHHHTGGGGGGSSEEEEESSCC
T ss_pred HHHhcCCCcCEEECcCCCCcHHHHHHHHHhCCCCCEEeeeCCCC
Confidence 44 56788888888888875433332222 334455555543
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.36 E-value=0.0075 Score=67.53 Aligned_cols=141 Identities=17% Similarity=0.196 Sum_probs=84.4
Q ss_pred ccccccccEEEEEEEEC--------CCcEEEEEEccCcchhhhHHHHHHHHHHHhcC-CCcccccceeeeccceEEEEEE
Q 002336 619 KKIGKGSFGSVYYGKMK--------DGKEVAVKIMADSCSHRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQRILVYE 689 (935)
Q Consensus 619 ~~LG~G~fG~Vy~~~~~--------~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~-HpnIv~l~g~~~~~~~~~lV~E 689 (935)
+.|..|....+|+.... +++.+++|+.... ........+|.++++.|. +.-..++++++.+ .+|||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e 130 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ 130 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence 45777888889998875 3578999986332 223455668999998884 3323556666654 29999
Q ss_pred ecCCCCHHH-----------------HhccCC--CCCCCC--HHHHHHHHHHHHH-------------------HhHHhh
Q 002336 690 YMHNGTLRD-----------------RLHGSV--NQKPLD--WLTRLQIAHDAAK-------------------GLEYLH 729 (935)
Q Consensus 690 ~~~~gsL~~-----------------~L~~~~--~~~~l~--~~~~~~i~~qia~-------------------gL~yLH 729 (935)
|++|..|.. .|+... ..+... +.++.++..++.. .+..|.
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 998755421 112111 112222 4555556554432 123332
Q ss_pred h-----cCCCceEecCCCCCCccccCC----CcEEEeecccccc
Q 002336 730 T-----GCNPGIIHRDVKSSNILLDIN----MRAKVSDFGLSRQ 764 (935)
Q Consensus 730 s-----~~~~~ivH~DLkp~NILld~~----~~vkL~DFGla~~ 764 (935)
+ .....++|+|+.+.||+++.+ +.+.++||..+..
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 1 124579999999999999876 7899999987753
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=96.31 E-value=0.00035 Score=69.32 Aligned_cols=85 Identities=12% Similarity=0.095 Sum_probs=64.8
Q ss_pred CcEEEEEccCCCCcccCCccccCccccccccccccc-CCCC-CCCcccc----cccccccccccc-ccCCCCCccCcccc
Q 002336 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNF-LTGP-LPDMSRL----IDLRIVHLENNE-LTGSLPSYMGSLPN 485 (935)
Q Consensus 413 ~~l~~L~Ls~n~l~g~ip~~i~~L~~L~~L~Ls~N~-l~g~-~p~~~~l----~~L~~L~L~~N~-l~g~iP~~l~~l~~ 485 (935)
.+|++|||+++.++..--..+.++++|+.|+|+++. ++.. +..++.+ ++|+.|+|++|. ++..-=..+.++++
T Consensus 61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~ 140 (176)
T 3e4g_A 61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRN 140 (176)
T ss_dssp CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTT
T ss_pred ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCC
Confidence 479999999999876544568899999999999995 5542 2345554 479999999985 65332235778999
Q ss_pred cccccccccc-CC
Q 002336 486 LQELHIENNS-FV 497 (935)
Q Consensus 486 L~~L~l~~N~-l~ 497 (935)
|+.|+|+++. ++
T Consensus 141 L~~L~L~~c~~It 153 (176)
T 3e4g_A 141 LKYLFLSDLPGVK 153 (176)
T ss_dssp CCEEEEESCTTCC
T ss_pred CCEEECCCCCCCC
Confidence 9999999886 44
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=96.26 E-value=0.00086 Score=79.56 Aligned_cols=34 Identities=21% Similarity=0.221 Sum_probs=13.8
Q ss_pred ccccccccccccccccCCCCCccCccccccccccc
Q 002336 458 RLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIE 492 (935)
Q Consensus 458 ~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~l~ 492 (935)
++++|+.|+|++|.+.+ +|..++++++|+.|+++
T Consensus 218 ~~~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~ 251 (592)
T 3ogk_B 218 NCRSLVSVKVGDFEILE-LVGFFKAAANLEEFCGG 251 (592)
T ss_dssp HCTTCCEEECSSCBGGG-GHHHHHHCTTCCEEEEC
T ss_pred hCCCCcEEeccCccHHH-HHHHHhhhhHHHhhccc
Confidence 34444444444444442 33333333344443333
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.19 E-value=0.0065 Score=67.68 Aligned_cols=72 Identities=13% Similarity=0.173 Sum_probs=44.5
Q ss_pred ccccccccEEEEEEEECC---------CcEEEEEEccCcchhhhHHHHHHHHHHHhcCCCc-ccccceeeeccceEEEEE
Q 002336 619 KKIGKGSFGSVYYGKMKD---------GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRN-LVPLIGYCEEEHQRILVY 688 (935)
Q Consensus 619 ~~LG~G~fG~Vy~~~~~~---------g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~Hpn-Iv~l~g~~~~~~~~~lV~ 688 (935)
+.|+.|....+|+....+ ++.+++|+..... ........|.++++.+...+ ..++++... -++||
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~~~~E~~~l~~L~~~g~~P~~~~~~~----~~~v~ 113 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV-DELYNTISEFEVYKTMSKYKIAPQLLNTFN----GGRIE 113 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG-GGTSCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc-cceecHHHHHHHHHHHHhcCCCCceEEecC----CcEEE
Confidence 467888889999998764 2689999865432 22223467888888885333 335555442 26899
Q ss_pred EecCCCC
Q 002336 689 EYMHNGT 695 (935)
Q Consensus 689 E~~~~gs 695 (935)
||++|..
T Consensus 114 e~i~G~~ 120 (369)
T 3c5i_A 114 EWLYGDP 120 (369)
T ss_dssp ECCCSEE
T ss_pred EEecCCc
Confidence 9998754
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.11 E-value=0.0035 Score=58.96 Aligned_cols=55 Identities=31% Similarity=0.383 Sum_probs=36.5
Q ss_pred EEEccCCCCc-ccCCccccCcccccccccccccCCCCCC-Ccccccccccccccccccc
Q 002336 417 KIALSGKNLK-GEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELT 473 (935)
Q Consensus 417 ~L~Ls~n~l~-g~ip~~i~~L~~L~~L~Ls~N~l~g~~p-~~~~l~~L~~L~L~~N~l~ 473 (935)
.++.++++|+ ..+|..|. .+|+.|+|++|+|+...+ .|..+++|+.|+|++|.+.
T Consensus 12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 6788888886 46665432 357777777777776665 3566666777666666554
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=96.04 E-value=0.00043 Score=82.14 Aligned_cols=83 Identities=12% Similarity=0.188 Sum_probs=60.2
Q ss_pred CcEEEEEccCCCCcccCCcccc-Ccccccccccccc-cCCCC-CCCc-cccccccccccccccccCCCCCccC----ccc
Q 002336 413 PRITKIALSGKNLKGEIPPELK-NMEALTELWLDGN-FLTGP-LPDM-SRLIDLRIVHLENNELTGSLPSYMG----SLP 484 (935)
Q Consensus 413 ~~l~~L~Ls~n~l~g~ip~~i~-~L~~L~~L~Ls~N-~l~g~-~p~~-~~l~~L~~L~L~~N~l~g~iP~~l~----~l~ 484 (935)
++|+.|+|++|.+++..+..+. .+++|+.|+|++| .++.. ++.+ .++++|+.|+|++|.+++..+..+. .++
T Consensus 105 ~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~ 184 (594)
T 2p1m_B 105 TWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYT 184 (594)
T ss_dssp TTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCC
T ss_pred CCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCC
Confidence 4788888888888877777775 6788888888888 44432 4443 4688888888888887765544333 566
Q ss_pred ccccccccccc
Q 002336 485 NLQELHIENNS 495 (935)
Q Consensus 485 ~L~~L~l~~N~ 495 (935)
+|+.|+|++|.
T Consensus 185 ~L~~L~l~~~~ 195 (594)
T 2p1m_B 185 SLVSLNISCLA 195 (594)
T ss_dssp CCCEEECTTCC
T ss_pred cCcEEEecccC
Confidence 88888888886
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=95.85 E-value=0.026 Score=62.10 Aligned_cols=68 Identities=13% Similarity=0.244 Sum_probs=44.5
Q ss_pred cccccEEEEEEEECCCcEEEEEEccCcchhhhHHHHHHHHHHHhcC---CCccccccee------eeccceEEEEEEecC
Q 002336 622 GKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIH---HRNLVPLIGY------CEEEHQRILVYEYMH 692 (935)
Q Consensus 622 G~G~fG~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~---HpnIv~l~g~------~~~~~~~~lV~E~~~ 692 (935)
|.|....||+....+| .+++|+...... ..|+.+++.|. -|.+.+++.. ....+..+++|+|++
T Consensus 32 G~g~~N~vy~v~~~~g-~~vLK~~~~~~~------~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~ 104 (339)
T 3i1a_A 32 GADTNAFAYQADSESK-SYFIKLKYGYHD------EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIH 104 (339)
T ss_dssp TSCSSCEEEEEECSSC-EEEEEEEECSSC------CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCC
T ss_pred cCccccceEEEEeCCC-CEEEEEecCccc------hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccC
Confidence 3444689999988777 899998765331 35666666663 2224455432 234567899999999
Q ss_pred CCCH
Q 002336 693 NGTL 696 (935)
Q Consensus 693 ~gsL 696 (935)
|..+
T Consensus 105 G~~~ 108 (339)
T 3i1a_A 105 APNG 108 (339)
T ss_dssp CCBT
T ss_pred CCcC
Confidence 8755
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=95.82 E-value=0.00099 Score=74.29 Aligned_cols=86 Identities=15% Similarity=0.272 Sum_probs=51.2
Q ss_pred CcEEEEEccCCCCcccCCcccc--Cccccccccccc--ccCCCC--C----CCc--cccccccccccccccccCCCCCcc
Q 002336 413 PRITKIALSGKNLKGEIPPELK--NMEALTELWLDG--NFLTGP--L----PDM--SRLIDLRIVHLENNELTGSLPSYM 480 (935)
Q Consensus 413 ~~l~~L~Ls~n~l~g~ip~~i~--~L~~L~~L~Ls~--N~l~g~--~----p~~--~~l~~L~~L~L~~N~l~g~iP~~l 480 (935)
++|+.|+|..+++....-..++ +|++|+.|+|+. |...|. + +.+ ..+++|++|+|.+|.+....+..+
T Consensus 193 ~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~l 272 (362)
T 2ra8_A 193 PNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMF 272 (362)
T ss_dssp TTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESCTTHHHHHHHH
T ss_pred CCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCCCCchHHHHHH
Confidence 4677777777776544434443 677777777753 222221 1 112 246777888887777764433333
Q ss_pred ---CccccccccccccccCCC
Q 002336 481 ---GSLPNLQELHIENNSFVG 498 (935)
Q Consensus 481 ---~~l~~L~~L~l~~N~l~g 498 (935)
..+++|+.|+|+.|.|.+
T Consensus 273 a~a~~~~~L~~LdLs~n~L~d 293 (362)
T 2ra8_A 273 LESDILPQLETMDISAGVLTD 293 (362)
T ss_dssp HHCSSGGGCSEEECCSSCCBH
T ss_pred HhCccCCCCCEEECCCCCCCh
Confidence 246777888887777764
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=95.79 E-value=0.057 Score=54.92 Aligned_cols=104 Identities=12% Similarity=0.047 Sum_probs=69.1
Q ss_pred CCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccccccccee
Q 002336 694 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 773 (935)
Q Consensus 694 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~~~ 773 (935)
-+|.++|... +.++++.+++.++.|.+.+|.-+-.. +.-..+=+.|..|++..+|.+...+ ..+.
T Consensus 33 vSL~eIL~~~--~~PlsEEqaWALc~Qc~~~L~~~~~~--~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~---------- 97 (229)
T 2yle_A 33 LSLEEILRLY--NQPINEEQAWAVCYQCCGSLRAAARR--RQPRHRVRSAAQIRVWRDGAVTLAP-AADD---------- 97 (229)
T ss_dssp EEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCCSGGGEEEETTSCEEECC-C-------------
T ss_pred ccHHHHHHHc--CCCcCHHHHHHHHHHHHHHHHhhhhc--ccCCceecCCcceEEecCCceeccc-cccc----------
Confidence 3799999863 67899999999999999998776210 1111334456888899999888764 1110
Q ss_pred ecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCC
Q 002336 774 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPV 816 (935)
Q Consensus 774 ~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf 816 (935)
.....+.+||... ...+.+.=|||+|+++|.-+--..|-
T Consensus 98 ---~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~e 136 (229)
T 2yle_A 98 ---AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLKE 136 (229)
T ss_dssp ------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred ---ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCCc
Confidence 1123467888764 45678999999999999998765553
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=95.43 E-value=0.0067 Score=66.34 Aligned_cols=77 Identities=19% Similarity=0.055 Sum_probs=64.4
Q ss_pred CcEEEEEccCCCCcccCCccccCccccc-ccccccccCCCCCC-CccccccccccccccccccCCCCCccCccccccccc
Q 002336 413 PRITKIALSGKNLKGEIPPELKNMEALT-ELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 490 (935)
Q Consensus 413 ~~l~~L~Ls~n~l~g~ip~~i~~L~~L~-~L~Ls~N~l~g~~p-~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~ 490 (935)
.+|++|+|++| +...-+..|.++++|+ .|+|.+ +++...+ .|.++++|+.|+|++|+++..-+..|.+|++|+.|+
T Consensus 250 ~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L~~ly 327 (329)
T 3sb4_A 250 KYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFGNGVPSKLIY 327 (329)
T ss_dssp TTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTCCCCEEE
T ss_pred CCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCccchhhhcCCcchhhhc
Confidence 47999999998 7744445799999999 999999 7776666 699999999999999999944445799999999886
Q ss_pred c
Q 002336 491 I 491 (935)
Q Consensus 491 l 491 (935)
.
T Consensus 328 ~ 328 (329)
T 3sb4_A 328 K 328 (329)
T ss_dssp C
T ss_pred c
Confidence 4
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=95.28 E-value=0.011 Score=55.62 Aligned_cols=53 Identities=30% Similarity=0.468 Sum_probs=31.9
Q ss_pred ccccccccCC-CCCC-CccccccccccccccccccCCCCC-ccCccccccccccccccC
Q 002336 441 ELWLDGNFLT-GPLP-DMSRLIDLRIVHLENNELTGSLPS-YMGSLPNLQELHIENNSF 496 (935)
Q Consensus 441 ~L~Ls~N~l~-g~~p-~~~~l~~L~~L~L~~N~l~g~iP~-~l~~l~~L~~L~l~~N~l 496 (935)
.++.+++.|+ ..+| .+. .+|+.|+|++|+|+ .||. .|..+++|+.|+|++|.+
T Consensus 12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~-~l~~~~f~~l~~L~~L~L~~NP~ 67 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLT-ALPPGLLDALPALRTAHLGANPW 67 (130)
T ss_dssp EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCS-SCCTTTGGGCTTCCEEECCSSCC
T ss_pred EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCC-ccChhhhhhccccCEEEecCCCe
Confidence 6777777776 2333 332 24777777777777 4444 456666666665554444
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=95.12 E-value=0.0022 Score=71.43 Aligned_cols=86 Identities=20% Similarity=0.195 Sum_probs=49.8
Q ss_pred CCcEEEEEccCCCCcccCCccccCcccccccccccccCCCCCC-Cc--ccccccccccccc--ccccCC-----CCCcc-
Q 002336 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DM--SRLIDLRIVHLEN--NELTGS-----LPSYM- 480 (935)
Q Consensus 412 ~~~l~~L~Ls~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p-~~--~~l~~L~~L~L~~--N~l~g~-----iP~~l- 480 (935)
.|+|++|+|++|.-. .+++ + .+++|+.|+|..|.++...- .+ ..+++|+.|+|+. |...|. +...+
T Consensus 171 ~P~L~~L~L~g~~~l-~l~~-~-~~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~ 247 (362)
T 2ra8_A 171 MPLLNNLKIKGTNNL-SIGK-K-PRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFS 247 (362)
T ss_dssp CTTCCEEEEECCBTC-BCCS-C-BCTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGSC
T ss_pred CCCCcEEEEeCCCCc-eecc-c-cCCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHHHHHHh
Confidence 457888888776311 3443 3 37788888887776543221 23 3677888887753 222221 11112
Q ss_pred -CccccccccccccccCCCCC
Q 002336 481 -GSLPNLQELHIENNSFVGEI 500 (935)
Q Consensus 481 -~~l~~L~~L~l~~N~l~g~i 500 (935)
+.+++|+.|+|.+|.+....
T Consensus 248 ~~~~p~Lr~L~L~~~~i~~~~ 268 (362)
T 2ra8_A 248 KDRFPNLKWLGIVDAEEQNVV 268 (362)
T ss_dssp TTTCTTCCEEEEESCTTHHHH
T ss_pred cCCCCCcCEEeCCCCCCchHH
Confidence 34678888888888776433
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=93.83 E-value=0.042 Score=62.00 Aligned_cols=75 Identities=15% Similarity=0.174 Sum_probs=34.0
Q ss_pred EEEEEccCCCCcccCCccccCcccccccccccccCCC----CCC--CccccccccccccccccccCCCCC-ccCcccccc
Q 002336 415 ITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTG----PLP--DMSRLIDLRIVHLENNELTGSLPS-YMGSLPNLQ 487 (935)
Q Consensus 415 l~~L~Ls~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g----~~p--~~~~l~~L~~L~L~~N~l~g~iP~-~l~~l~~L~ 487 (935)
|+.|.| .++++-.-+..|.++++|+.|+|.+|.+.. .++ .|.++++|+.|+|. |+++ .|+. .|.+|++|+
T Consensus 250 L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~-~I~~~aF~~c~~L~ 326 (401)
T 4fdw_A 250 ITTVKL-PNGVTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIR-ILGQGLLGGNRKVT 326 (401)
T ss_dssp CSEEEE-ETTCCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCC-EECTTTTTTCCSCC
T ss_pred ccEEEe-CCCccEEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeC-CceE-EEhhhhhcCCCCcc
Confidence 444444 233442223345555555555555554431 122 34555555555555 2344 3332 344555555
Q ss_pred ccccc
Q 002336 488 ELHIE 492 (935)
Q Consensus 488 ~L~l~ 492 (935)
.|.|.
T Consensus 327 ~l~lp 331 (401)
T 4fdw_A 327 QLTIP 331 (401)
T ss_dssp EEEEC
T ss_pred EEEEC
Confidence 55553
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=93.82 E-value=0.13 Score=58.37 Aligned_cols=141 Identities=13% Similarity=0.190 Sum_probs=85.2
Q ss_pred cccccccccEEEEEEEECC--------CcEEEEEEccCcchhhhHHHHHHHHHHHhcC-CCcccccceeeeccceEEEEE
Q 002336 618 CKKIGKGSFGSVYYGKMKD--------GKEVAVKIMADSCSHRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQRILVY 688 (935)
Q Consensus 618 ~~~LG~G~fG~Vy~~~~~~--------g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~-HpnIv~l~g~~~~~~~~~lV~ 688 (935)
.+.+..|-...+|+....+ ++.+++|+..... ...-...+|.++++.+. +.-..++++.+. -++||
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~ 149 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADFP----EGRIE 149 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEE
Confidence 3567788889999998763 5789999864322 22223467888888885 322344555332 27899
Q ss_pred EecCCCCHHH--------------H---hccC-------C---CCCCCCHHHHHHHHHHHH-------------------
Q 002336 689 EYMHNGTLRD--------------R---LHGS-------V---NQKPLDWLTRLQIAHDAA------------------- 722 (935)
Q Consensus 689 E~~~~gsL~~--------------~---L~~~-------~---~~~~l~~~~~~~i~~qia------------------- 722 (935)
||++|..|.. . |+.. . ...+.-+.++.++..++-
T Consensus 150 efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~ 229 (424)
T 3mes_A 150 EFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKIL 229 (424)
T ss_dssp ECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHH
T ss_pred EEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHH
Confidence 9999865311 0 1100 0 111122444444443322
Q ss_pred HHhHHhhh---------------------cCCCceEecCCCCCCccccCCCcEEEeecccccc
Q 002336 723 KGLEYLHT---------------------GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 764 (935)
Q Consensus 723 ~gL~yLHs---------------------~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~ 764 (935)
+.+.+|.+ .....++|+|+.+.||+ +.++.+.++||..+..
T Consensus 230 ~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 230 EEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp HHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred HHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 22233321 11357999999999999 8888999999988753
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=93.28 E-value=0.05 Score=61.37 Aligned_cols=88 Identities=11% Similarity=0.139 Sum_probs=66.9
Q ss_pred CcEEEEEccCCCCc-----ccCCccccCcccccccccccccCCCCCC-CccccccccccccccccccCCCC-CccCcccc
Q 002336 413 PRITKIALSGKNLK-----GEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLP-SYMGSLPN 485 (935)
Q Consensus 413 ~~l~~L~Ls~n~l~-----g~ip~~i~~L~~L~~L~Ls~N~l~g~~p-~~~~l~~L~~L~L~~N~l~g~iP-~~l~~l~~ 485 (935)
.+|+.|+|.+|.+. -.-+..|.++++|+.|+|.+ +++.... .|.++++|+.|+|.+| ++ .|+ ..|.+| +
T Consensus 271 ~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~~-~i~~I~~~aF~~c~~L~~l~lp~~-l~-~I~~~aF~~~-~ 346 (401)
T 4fdw_A 271 PELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIPE-SIRILGQGLLGGNRKVTQLTIPAN-VT-QINFSAFNNT-G 346 (401)
T ss_dssp TTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCCT-TCCEECTTTTTTCCSCCEEEECTT-CC-EECTTSSSSS-C
T ss_pred CCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeCC-ceEEEhhhhhcCCCCccEEEECcc-cc-EEcHHhCCCC-C
Confidence 47889999888765 23345788999999999994 4665544 6889999999999665 66 454 568888 9
Q ss_pred ccccccccccCCCCCCcccc
Q 002336 486 LQELHIENNSFVGEIPPALL 505 (935)
Q Consensus 486 L~~L~l~~N~l~g~iP~~l~ 505 (935)
|+.|++++|.+. .++...+
T Consensus 347 L~~l~l~~n~~~-~l~~~~F 365 (401)
T 4fdw_A 347 IKEVKVEGTTPP-QVFEKVW 365 (401)
T ss_dssp CCEEEECCSSCC-BCCCSSC
T ss_pred CCEEEEcCCCCc-ccccccc
Confidence 999999999887 5665443
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=90.75 E-value=0.025 Score=56.95 Aligned_cols=83 Identities=13% Similarity=0.169 Sum_probs=58.4
Q ss_pred CcEEEEEccCC-CCcc----cCCccccCcccccccccccccCCCCC--C---CccccccccccccccccccCC----CCC
Q 002336 413 PRITKIALSGK-NLKG----EIPPELKNMEALTELWLDGNFLTGPL--P---DMSRLIDLRIVHLENNELTGS----LPS 478 (935)
Q Consensus 413 ~~l~~L~Ls~n-~l~g----~ip~~i~~L~~L~~L~Ls~N~l~g~~--p---~~~~l~~L~~L~L~~N~l~g~----iP~ 478 (935)
+.|++|+|++| +|.. .|-..+..=+.|+.|+|++|.|...- . .+..-+.|+.|+|++|+|... |-+
T Consensus 41 ~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ala~ 120 (197)
T 1pgv_A 41 TDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLR 120 (197)
T ss_dssp SSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHH
T ss_pred CCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHHHHH
Confidence 36889999986 6643 24455666789999999999987421 1 244557799999999998733 223
Q ss_pred ccCcccccccccccccc
Q 002336 479 YMGSLPNLQELHIENNS 495 (935)
Q Consensus 479 ~l~~l~~L~~L~l~~N~ 495 (935)
.+..-+.|+.|+|++|.
T Consensus 121 aL~~N~tL~~L~L~n~~ 137 (197)
T 1pgv_A 121 STLVTQSIVEFKADNQR 137 (197)
T ss_dssp HTTTTCCCSEEECCCCS
T ss_pred HHhhCCceeEEECCCCc
Confidence 44445679999998763
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=88.02 E-value=0.058 Score=53.27 Aligned_cols=70 Identities=10% Similarity=0.125 Sum_probs=49.6
Q ss_pred cCCccccCcccccccccccccCCCC-CCCcccccccccccccccc-ccCCCCCccCcc----cccccccccccc-CC
Q 002336 428 EIPPELKNMEALTELWLDGNFLTGP-LPDMSRLIDLRIVHLENNE-LTGSLPSYMGSL----PNLQELHIENNS-FV 497 (935)
Q Consensus 428 ~ip~~i~~L~~L~~L~Ls~N~l~g~-~p~~~~l~~L~~L~L~~N~-l~g~iP~~l~~l----~~L~~L~l~~N~-l~ 497 (935)
.+|.....--.|+.|||+++.++.. +..+.++++|+.|+|++|. ++..-=..|+.+ ++|+.|+|+++. ++
T Consensus 52 ~LP~~~~~~~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~IT 128 (176)
T 3e4g_A 52 HLPTGPLDKYKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVT 128 (176)
T ss_dssp GSCCCSTTCCCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCC
T ss_pred cCCcccCCCceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCC
Confidence 3454332335799999999987653 4467899999999999996 553222234443 479999999975 66
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=87.11 E-value=1.1 Score=50.21 Aligned_cols=30 Identities=30% Similarity=0.383 Sum_probs=25.1
Q ss_pred ceEecCCCCCCccc------cCCCcEEEeecccccc
Q 002336 735 GIIHRDVKSSNILL------DINMRAKVSDFGLSRQ 764 (935)
Q Consensus 735 ~ivH~DLkp~NILl------d~~~~vkL~DFGla~~ 764 (935)
.++|+|+.+.|||+ +++..++++||..|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 46799999999999 4567799999988754
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=83.86 E-value=0.73 Score=50.86 Aligned_cols=87 Identities=13% Similarity=0.138 Sum_probs=58.0
Q ss_pred cEEEEEccCCCCcccCCccccCcccccccccccccCCCCCC-CccccccccccccccccccCCCCC-ccCcccccccccc
Q 002336 414 RITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPS-YMGSLPNLQELHI 491 (935)
Q Consensus 414 ~l~~L~Ls~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p-~~~~l~~L~~L~L~~N~l~g~iP~-~l~~l~~L~~L~l 491 (935)
.++.+.+.+ ++.-.-...|.++++|+.+.|.+|.++.... .|.++.+|+.+.|.++ ++ .|.. .|.+|++|+.+.+
T Consensus 264 ~l~~i~l~~-~i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~-~I~~~aF~~C~~L~~i~i 340 (379)
T 4h09_A 264 ALKTLNFYA-KVKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LK-TIQVYAFKNCKALSTISY 340 (379)
T ss_dssp TCCEEEECC-CCSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CC-EECTTTTTTCTTCCCCCC
T ss_pred hhccccccc-cceeccccccccccccccccccccccceehhhhhcCCCCCCEEEcCcc-cc-EEHHHHhhCCCCCCEEEE
Confidence 466666654 3542223467788888888888887776555 5788888888888754 55 5554 5778888888877
Q ss_pred ccccCCCCCCcccc
Q 002336 492 ENNSFVGEIPPALL 505 (935)
Q Consensus 492 ~~N~l~g~iP~~l~ 505 (935)
..| ++ .|.+..+
T Consensus 341 p~~-v~-~I~~~aF 352 (379)
T 4h09_A 341 PKS-IT-LIESGAF 352 (379)
T ss_dssp CTT-CC-EECTTTT
T ss_pred CCc-cC-EEchhHh
Confidence 654 54 4554443
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=83.83 E-value=0.62 Score=51.87 Aligned_cols=78 Identities=12% Similarity=0.086 Sum_probs=50.9
Q ss_pred CcEEEEEccCCCCcccCCccccCcccccccccccccCCCCCC-CccccccccccccccccccCCCCC-ccCccccccccc
Q 002336 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPS-YMGSLPNLQELH 490 (935)
Q Consensus 413 ~~l~~L~Ls~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p-~~~~l~~L~~L~L~~N~l~g~iP~-~l~~l~~L~~L~ 490 (935)
..|+.+.+.++ ++-.-...|.++++|+.++|.++ ++..-. .|.++.+|+.++|..| ++ .|++ .|.+|++|+.++
T Consensus 297 ~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~-~I~~~aF~~C~~L~~i~ 372 (394)
T 4fs7_A 297 SSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LR-KIGANAFQGCINLKKVE 372 (394)
T ss_dssp TTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CC-EECTTTBTTCTTCCEEE
T ss_pred ccccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-cc-EehHHHhhCCCCCCEEE
Confidence 35667777543 55222346777888888888644 443333 5777888888888766 55 4543 577788888887
Q ss_pred cccc
Q 002336 491 IENN 494 (935)
Q Consensus 491 l~~N 494 (935)
|..|
T Consensus 373 lp~~ 376 (394)
T 4fs7_A 373 LPKR 376 (394)
T ss_dssp EEGG
T ss_pred ECCC
Confidence 7654
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=82.71 E-value=0.051 Score=54.70 Aligned_cols=84 Identities=17% Similarity=0.172 Sum_probs=56.6
Q ss_pred CcEEEEEccCCCCccc----CCccccCcccccccccccccCCCCCC-----Cccccccccccccccccc---cC----CC
Q 002336 413 PRITKIALSGKNLKGE----IPPELKNMEALTELWLDGNFLTGPLP-----DMSRLIDLRIVHLENNEL---TG----SL 476 (935)
Q Consensus 413 ~~l~~L~Ls~n~l~g~----ip~~i~~L~~L~~L~Ls~N~l~g~~p-----~~~~l~~L~~L~L~~N~l---~g----~i 476 (935)
..|+.|+|++|+|... |...+..=+.|+.|+|++|.|...-- .+..-+.|+.|+|++|.. .. .|
T Consensus 70 ~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ala~aL~~N~tL~~L~L~n~~~~~ig~~g~~~i 149 (197)
T 1pgv_A 70 KHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDM 149 (197)
T ss_dssp SCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHH
T ss_pred CCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHHHHHHHhhCCceeEEECCCCcCcCcCHHHHHHH
Confidence 4799999999999743 23344455899999999999985321 355556799999987633 21 12
Q ss_pred CCccCccccccccccccccC
Q 002336 477 PSYMGSLPNLQELHIENNSF 496 (935)
Q Consensus 477 P~~l~~l~~L~~L~l~~N~l 496 (935)
.+.+..=+.|+.|+++.|.+
T Consensus 150 a~aL~~N~tL~~L~l~~~~~ 169 (197)
T 1pgv_A 150 MMAIEENESLLRVGISFASM 169 (197)
T ss_dssp HHHHHHCSSCCEEECCCCCH
T ss_pred HHHHHhCCCcCeEeccCCCc
Confidence 23344445677777765554
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 935 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-66 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 5e-64 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-63 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-63 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 6e-63 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 5e-62 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 3e-60 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 5e-59 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-58 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 5e-58 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 7e-58 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 7e-58 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-57 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 3e-57 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 9e-57 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-56 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-56 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 4e-56 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 3e-55 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-55 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 4e-55 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-54 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 4e-54 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-53 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-52 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-52 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 3e-52 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 6e-51 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 3e-50 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 5e-50 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 3e-49 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-48 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-48 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-47 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 6e-47 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 6e-46 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-45 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 3e-45 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 3e-45 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-44 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-44 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 4e-44 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 8e-44 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-42 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-42 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 3e-42 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 9e-42 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-41 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-41 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 4e-41 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 3e-40 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 4e-40 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 5e-40 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-39 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 6e-39 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 6e-38 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-36 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 4e-35 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 4e-35 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-31 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 3e-31 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 7e-31 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-21 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 3e-12 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 8e-09 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-05 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-04 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 0.001 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 0.002 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-10 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 5e-10 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 4e-09 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 6e-09 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 7e-08 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 6e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 6e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.004 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 4e-07 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 2e-06 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 0.003 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-05 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 4e-04 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 6e-04 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 0.001 | |
| d1j7la_ | 263 | d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phos | 0.003 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.004 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 221 bits (565), Expect = 2e-66
Identities = 78/276 (28%), Positives = 137/276 (49%), Gaps = 25/276 (9%)
Query: 617 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPL 674
++IG GSFG+VY GK +VAVK++ + + Q F EV +L + H N++
Sbjct: 12 VGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 69
Query: 675 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 734
+GY +V ++ +L LH + + + + IA A+G++YLH
Sbjct: 70 MGYSTAPQ-LAIVTQWCEGSSLYHHLHI--IETKFEMIKLIDIARQTAQGMDYLH---AK 123
Query: 735 GIIHRDVKSSNILLDINMRAKVSDFGLSRQ-AEEDLTHISSVARGTVGYLDPEYYGNQQ- 792
IIHRD+KS+NI L ++ K+ DFGL+ + +H G++ ++ PE Q
Sbjct: 124 SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDK 183
Query: 793 --LTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 850
+ +SDVY+FG+VL EL++G+ P S +N M+ +G + P L
Sbjct: 184 NPYSFQSDVYAFGIVLYELMTGQLPYS------NINNRDQIIFMVGRG----YLSPDL-S 232
Query: 851 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 886
V+ + + +C++++ RP +I+ +I+
Sbjct: 233 KVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIE 268
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (547), Expect = 5e-64
Identities = 67/271 (24%), Positives = 122/271 (45%), Gaps = 21/271 (7%)
Query: 617 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 676
+++G G FG V+ G +VAVK + S F+ E L+ ++ H+ LV L
Sbjct: 17 LVERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYA 75
Query: 677 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 736
+E ++ EYM NG+L D L + L L +A A+G+ ++
Sbjct: 76 VVTQEP-IYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIE---ERNY 130
Query: 737 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEK 796
IHRD++++NIL+ + K++DFGL+R E++ A+ + + PE T K
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIK 190
Query: 797 SDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIES 856
SDV+SFG++L E+++ + E+ +++G + D
Sbjct: 191 SDVWSFGILLTEIVTHGRIPYPGMTNPEV------IQNLERGYRMVRPDNCP-------- 236
Query: 857 IWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 887
+ ++ C ++R RP + ++D
Sbjct: 237 -EELYQLMRLCWKERPEDRPTFDYLRSVLED 266
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 213 bits (542), Expect = 2e-63
Identities = 72/272 (26%), Positives = 124/272 (45%), Gaps = 21/272 (7%)
Query: 616 NFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLI 675
F ++IG G FG V+ G + +VA+K + + + F+ E ++ ++ H LV L
Sbjct: 8 TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE-EDFIEEAEVMMKLSHPKLVQLY 66
Query: 676 GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 735
G C E+ LV+E+M +G L D + + T L + D +G+ YL
Sbjct: 67 GVCLEQAPICLVFEFMEHGCLSD--YLRTQRGLFAAETLLGMCLDVCEGMAYL---EEAC 121
Query: 736 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTE 795
+IHRD+ + N L+ N KVSDFG++R +D S+ + V + PE + + +
Sbjct: 122 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSS 181
Query: 796 KSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIE 855
KSDV+SFGV++ E+ S K +E+ I G + P L
Sbjct: 182 KSDVWSFGVLMWEVFSEGKIPYENRSNSEV------VEDISTG--FRLYKPRLAST---- 229
Query: 856 SIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 887
+ ++ C ++R RP ++ + +
Sbjct: 230 ---HVYQIMNHCWKERPEDRPAFSRLLRQLAE 258
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (545), Expect = 2e-63
Identities = 74/301 (24%), Positives = 132/301 (43%), Gaps = 34/301 (11%)
Query: 619 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYC 678
+ IGKG FG V+ GK + G+EVAVKI S R+ E+ + H N++ I
Sbjct: 9 ESIGKGRFGEVWRGKWR-GEEVAVKIF-SSREERSWFREAEIYQTVMLRHENILGFIAAD 66
Query: 679 EEEH----QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC-- 732
+++ Q LV +Y +G+L D L+ + + +++A A GL +LH
Sbjct: 67 NKDNGTWTQLWLVSDYHEHGSLFDYLN----RYTVTVEGMIKLALSTASGLAHLHMEIVG 122
Query: 733 ---NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR---GTVGYLDPE 786
P I HRD+KS NIL+ N ++D GL+ + + I GT Y+ PE
Sbjct: 123 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 182
Query: 787 YY------GNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFG----AELNIVHWARSMIK 836
+ + +++D+Y+ G+V E+ + + +L + ++
Sbjct: 183 VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMR 242
Query: 837 KGDVISIVDPVLIGNVK-IESIWRIAEVAIQCVEQRGFSRPKMQEIV-----LAIQDSIK 890
K + P + + E++ +A++ +C G +R I L+ Q+ IK
Sbjct: 243 KVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGIK 302
Query: 891 I 891
+
Sbjct: 303 M 303
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (538), Expect = 6e-63
Identities = 72/272 (26%), Positives = 125/272 (45%), Gaps = 21/272 (7%)
Query: 616 NFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLI 675
F K++G G FG V YGK + +VA+K++ + S +F+ E ++ + H LV L
Sbjct: 7 TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQLY 65
Query: 676 GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 735
G C ++ ++ EYM NG L + L + L++ D + +EYL +
Sbjct: 66 GVCTKQRPIFIITEYMANGCLLNYLR--EMRHRFQTQQLLEMCKDVCEAMEYLE---SKQ 120
Query: 736 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTE 795
+HRD+ + N L++ KVSDFGLSR +D S ++ V + PE + +
Sbjct: 121 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSS 180
Query: 796 KSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIE 855
KSD+++FGV++ E+ S K +E I +G + + P L
Sbjct: 181 KSDIWAFGVLMWEIYSLGKMPYERFTNSET------AEHIAQG--LRLYRPHLASE---- 228
Query: 856 SIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 887
++ + C ++ RP + ++ I D
Sbjct: 229 ---KVYTIMYSCWHEKADERPTFKILLSNILD 257
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (538), Expect = 5e-62
Identities = 55/215 (25%), Positives = 98/215 (45%), Gaps = 12/215 (5%)
Query: 610 LEEATNNF--CKKIGKGSFGSVYYGKMK-DGKEVAVKIM-ADSCSHRTQQFVTEVALLSR 665
+E ++F ++G G+ G V+ K G +A K++ + Q + E+ +L
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 666 IHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGL 725
+ +V G + + + E+M G+L L + +++ KGL
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK---KAGRIPEQILGKVSIAVIKGL 117
Query: 726 EYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDP 785
YL I+HRDVK SNIL++ K+ DFG+S Q + + + GT Y+ P
Sbjct: 118 TYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN---SFVGTRSYMSP 172
Query: 786 EYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 820
E + +SD++S G+ L+E+ G+ P+ D
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD 207
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (519), Expect = 3e-60
Identities = 73/272 (26%), Positives = 124/272 (45%), Gaps = 27/272 (9%)
Query: 617 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 676
+ IGKG FG V G + G +VAVK + + + Q F+ E ++++++ H NLV L+G
Sbjct: 11 LLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLG 67
Query: 677 YCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 735
EE + +V EYM G+L D L + L L+ + D + +EYL
Sbjct: 68 VIVEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLE---GNN 123
Query: 736 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTE 795
+HRD+ + N+L+ + AKVSDFGL+++A + V + PE ++ +
Sbjct: 124 FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT----GKLPVKWTAPEALREKKFST 179
Query: 796 KSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIE 855
KSDV+SFG++L E+ S + ++ ++KG + D
Sbjct: 180 KSDVWSFGILLWEIYSFGRVPYPRIPLKDV------VPRVEKGYKMDAPDGCP------- 226
Query: 856 SIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 887
+ EV C RP ++ ++
Sbjct: 227 --PAVYEVMKNCWHLDAAMRPSFLQLREQLEH 256
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (512), Expect = 5e-59
Identities = 69/274 (25%), Positives = 120/274 (43%), Gaps = 21/274 (7%)
Query: 617 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 676
K+G+G FG V+ G VA+K + + + F+ E ++ ++ H LV L
Sbjct: 21 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYA 79
Query: 677 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 736
EE +V EYM G+L D L G K L + +A A G+ Y+
Sbjct: 80 VVSEEP-IYIVTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVE---RMNY 134
Query: 737 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEK 796
+HRD++++NIL+ N+ KV+DFGL+R E++ A+ + + PE + T K
Sbjct: 135 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 194
Query: 797 SDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIES 856
SDV+SFG++L EL + + E+ +++G +
Sbjct: 195 SDVWSFGILLTELTTKGRVPYPGMVNREV------LDQVERGYRMPCPPECPE------- 241
Query: 857 IWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 890
+ ++ QC + RP + + ++D
Sbjct: 242 --SLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 273
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 200 bits (510), Expect = 1e-58
Identities = 77/311 (24%), Positives = 123/311 (39%), Gaps = 49/311 (15%)
Query: 607 LPELEEATNNF--CKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSCSHRTQ-QFV 657
L LE NN + IG+G+FG V+ + VAVK++ + S Q F
Sbjct: 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQ 64
Query: 658 TEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHG--------------- 702
E AL++ + N+V L+G C L++EYM G L + L
Sbjct: 65 REAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLS 124
Query: 703 ------SVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKV 756
S PL +L IA A G+ YL +HRD+ + N L+ NM K+
Sbjct: 125 TRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKI 181
Query: 757 SDFGLSRQ-AEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 815
+DFGLSR D + ++ PE + T +SDV+++GVVL E+ S
Sbjct: 182 ADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 241
Query: 816 VSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSR 875
E+ ++ G++++ + + + + C + R
Sbjct: 242 PYYGMAHEEV------IYYVRDGNILACPENCPL---------ELYNLMRLCWSKLPADR 286
Query: 876 PKMQEIVLAIQ 886
P I +Q
Sbjct: 287 PSFCSIHRILQ 297
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (504), Expect = 5e-58
Identities = 67/276 (24%), Positives = 124/276 (44%), Gaps = 29/276 (10%)
Query: 619 KKIGKGSFGSVYYGKMKD---GKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVP 673
K++G G+FG+V G + K VAVKI+ + + + + E ++ ++ + +V
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72
Query: 674 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 733
+IG CE E +LV E G L L + + +++ H + G++YL
Sbjct: 73 MIGICEAES-WMLVMEMAELGPLNKYLQ---QNRHVKDKNIIELVHQVSMGMKYLE---E 125
Query: 734 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISS--VARGTVGYLDPEYYGNQ 791
+HRD+ + N+LL AK+SDFGLS+ D + + + V + PE
Sbjct: 126 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 185
Query: 792 QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 851
+ + KSDV+SFGV++ E S + G+E+ +M++KG+ +
Sbjct: 186 KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV------TAMLEKGERMGCPAGCP--- 236
Query: 852 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 887
+ ++ C +RP + L +++
Sbjct: 237 ------REMYDLMNLCWTYDVENRPGFAAVELRLRN 266
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 198 bits (504), Expect = 7e-58
Identities = 73/276 (26%), Positives = 118/276 (42%), Gaps = 21/276 (7%)
Query: 616 NFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPL 674
K+G G +G VY G K VAVK + + + ++F+ E A++ I H NLV L
Sbjct: 20 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQL 78
Query: 675 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 734
+G C E ++ E+M G L D L N++ + + L +A + +EYL
Sbjct: 79 LGVCTREPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLE---KK 134
Query: 735 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLT 794
IHRD+ + N L+ N KV+DFGLSR D + A+ + + PE + +
Sbjct: 135 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 194
Query: 795 EKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKI 854
KSDV++FGV+L E+ + I V +++
Sbjct: 195 IKSDVWAFGVLLWEIATYGMSP---------------YPGIDLSQVYELLEKDYRMERPE 239
Query: 855 ESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 890
++ E+ C + RP EI A + +
Sbjct: 240 GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (503), Expect = 7e-58
Identities = 75/274 (27%), Positives = 116/274 (42%), Gaps = 30/274 (10%)
Query: 617 FCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVP 673
F +IG+GSF +VY G + EVA + D ++ Q+F E +L + H N+V
Sbjct: 13 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVR 72
Query: 674 LIGYCEE----EHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 729
E + +LV E M +GTL+ L K + KGL++LH
Sbjct: 73 FYDSWESTVKGKKCIVLVTELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQFLH 129
Query: 730 TGCNPGIIHRDVKSSNILL-DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY 788
T P IIHRD+K NI + K+ D GL+ GT ++ PE Y
Sbjct: 130 T-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK---AVIGTPEFMAPEMY 185
Query: 789 GNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 848
++ E DVY+FG+ +LE+ + + P S E + G + D V
Sbjct: 186 -EEKYDESVDVYAFGMCMLEMATSEYPYS------ECQNAAQIYRRVTSGVKPASFDKVA 238
Query: 849 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIV 882
I VK E+ C+ Q R +++++
Sbjct: 239 IPEVK--------EIIEGCIRQNKDERYSIKDLL 264
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (503), Expect = 1e-57
Identities = 63/288 (21%), Positives = 123/288 (42%), Gaps = 30/288 (10%)
Query: 609 ELEEATNNFC---KKIGKGSFGSVYYGKMK---DGKEVAVKIM-ADSCSHRTQQFVTEVA 661
+L +N ++G G+FGSV G + +VA+K++ + T++ + E
Sbjct: 2 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQ 61
Query: 662 LLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDA 721
++ ++ + +V LIG C+ +LV E G L L G ++ + ++ H
Sbjct: 62 IMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQV 118
Query: 722 AKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED--LTHISSVARGT 779
+ G++YL +HRD+ + N+LL AK+SDFGLS+ D S +
Sbjct: 119 SMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWP 175
Query: 780 VGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD 839
+ + PE ++ + +SDV+S+GV + E +S + + G E+ + I++G
Sbjct: 176 LKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV------MAFIEQGK 229
Query: 840 VISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 887
+ + + C + RP + ++
Sbjct: 230 RMECPPECP---------PELYALMSDCWIYKWEDRPDFLTVEQRMRA 268
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 196 bits (500), Expect = 3e-57
Identities = 72/303 (23%), Positives = 136/303 (44%), Gaps = 42/303 (13%)
Query: 609 ELEEATNNFC-----------KKIGKGSFGSVYYGKMKDGKE----VAVKIMADSCSHRT 653
+ EA F + IG G FG V G +K + VA+K + + +
Sbjct: 11 DPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQ 70
Query: 654 -QQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWL 712
+ F++E +++ + H N++ L G + +++ E+M NG+L L N +
Sbjct: 71 RRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQ--NDGQFTVI 128
Query: 713 TRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 772
+ + A G++YL + +HRD+ + NIL++ N+ KVSDFGLSR E+D +
Sbjct: 129 QLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDP 185
Query: 773 SSVA----RGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNI 827
+ + + + + PE ++ T SDV+S+G+V+ E++S G++P +N
Sbjct: 186 TYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINA 245
Query: 828 VHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 887
+ + D S + ++ + C ++ RPK +IV +
Sbjct: 246 IEQDYRLPPPMDCPS----------------ALHQLMLDCWQKDRNHRPKFGQIVNTLDK 289
Query: 888 SIK 890
I+
Sbjct: 290 MIR 292
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (494), Expect = 9e-57
Identities = 68/275 (24%), Positives = 110/275 (40%), Gaps = 25/275 (9%)
Query: 616 NFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLV 672
IG GS+G + K DGK + K + Q V+EV LL + H N+V
Sbjct: 7 EVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIV 66
Query: 673 PLIGYCEEEHQRIL--VYEYMHNGTLRDRLH-GSVNQKPLDWLTRLQIAHDAAKGLEYLH 729
+ L V EY G L + G+ ++ LD L++ L+ H
Sbjct: 67 RYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH 126
Query: 730 --TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 787
+ ++HRD+K +N+ LD K+ DFGL+R D + + GT Y+ PE
Sbjct: 127 RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAF-VGTPYYMSPEQ 185
Query: 788 YGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 847
EKSD++S G +L EL + P + I++G I
Sbjct: 186 MNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAG-------KIREGKFRRIPYRY 238
Query: 848 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIV 882
+ E+ + + + + RP ++EI+
Sbjct: 239 SD---------ELNEIITRMLNLKDYHRPSVEEIL 264
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 195 bits (497), Expect = 1e-56
Identities = 68/271 (25%), Positives = 113/271 (41%), Gaps = 33/271 (12%)
Query: 619 KKIGKGSFGSVYYGKMK-DGKEVAVKIM---ADSCSHRTQQFVTEVALLSRIHHRNLVPL 674
++IG GSFG+VY+ + + + VA+K M + + Q + EV L ++ H N +
Sbjct: 21 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80
Query: 675 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 734
G EH LV EY ++KPL + + H A +GL YLH +
Sbjct: 81 RGCYLREHTAWLVMEYCLGSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLH---SH 134
Query: 735 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY---GNQ 791
+IHRDVK+ NILL K+ DFG + + + GT ++ PE
Sbjct: 135 NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV-----GTPYWMAPEVILAMDEG 189
Query: 792 QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 851
Q K DV+S G+ +EL K P+ + + L I + + ++
Sbjct: 190 QYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY-------HIAQNESPALQSGHWSEY 242
Query: 852 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIV 882
+ C+++ RP + ++
Sbjct: 243 FR--------NFVDSCLQKIPQDRPTSEVLL 265
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (496), Expect = 2e-56
Identities = 75/286 (26%), Positives = 121/286 (42%), Gaps = 29/286 (10%)
Query: 611 EEATNNFCKKIGKGSFGSVYYGKMKDGK----EVAVKIM-ADSCSHRTQQFVTEVALLSR 665
+F + IG+G FG VY+G + D AVK + + QF+TE ++
Sbjct: 25 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKD 84
Query: 666 IHHRNLVPLIGYC-EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKG 724
H N++ L+G C E ++V YM +G LR+ + AKG
Sbjct: 85 FSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPTVKDLIGFGLQVAKG 142
Query: 725 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA---EEDLTHISSVARGTVG 781
+ + +HRD+ + N +LD KV+DFGL+R E D H + A+ V
Sbjct: 143 M---KFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVK 199
Query: 782 YLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVI 841
++ E Q+ T KSDV+SFGV+L EL++ P ++N + +G +
Sbjct: 200 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP-----PYPDVNTFDITV-YLLQGRRL 253
Query: 842 SIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 887
+ + EV ++C + RP E+V I
Sbjct: 254 LQPE---------YCPDPLYEVMLKCWHPKAEMRPSFSELVSRISA 290
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (492), Expect = 4e-56
Identities = 58/269 (21%), Positives = 114/269 (42%), Gaps = 26/269 (9%)
Query: 619 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 677
++G G+FG VY + K+ A K++ + ++ E+ +L+ H N+V L+
Sbjct: 18 GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 77
Query: 678 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGII 737
E+ ++ E+ G + + ++PL + L YLH + II
Sbjct: 78 FYYENNLWILIEFCAGGAVDAVMLE--LERPLTESQIQVVCKQTLDALNYLH---DNKII 132
Query: 738 HRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY-----YGNQQ 792
HRD+K+ NIL ++ K++DFG+S + + S GT ++ PE ++
Sbjct: 133 HRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSF-IGTPYWMAPEVVMCETSKDRP 191
Query: 793 LTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNV 852
K+DV+S G+ L+E+ + P + L I K + ++ P +
Sbjct: 192 YDYKADVWSLGITLIEMAEIEPPHHELNPMRVLL-------KIAKSEPPTLAQPSRWSS- 243
Query: 853 KIESIWRIAEVAIQCVEQRGFSRPKMQEI 881
+ +C+E+ +R ++
Sbjct: 244 ------NFKDFLKKCLEKNVDARWTTSQL 266
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (483), Expect = 3e-55
Identities = 67/268 (25%), Positives = 109/268 (40%), Gaps = 30/268 (11%)
Query: 619 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQ---QFVTEVALLSRIHHRNLVPL 674
+ +GKG FG+VY + K +A+K++ + + Q EV + S + H N++ L
Sbjct: 12 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 71
Query: 675 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 734
GY + + L+ EY GT+ L D + A L Y H +
Sbjct: 72 YGYFHDATRVYLILEYAPLGTVYRELQ---KLSKFDEQRTATYITELANALSYCH---SK 125
Query: 735 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLT 794
+IHRD+K N+LL K++DFG S A GT+ YL PE +
Sbjct: 126 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTL---CGTLDYLPPEMIEGRMHD 182
Query: 795 EKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKI 854
EK D++S GV+ E + GK P F A + R + V
Sbjct: 183 EKVDLWSLGVLCYEFLVGKPP-----FEANTYQETYKRISRVEFTFPDFVTEGAR----- 232
Query: 855 ESIWRIAEVAIQCVEQRGFSRPKMQEIV 882
++ + ++ RP ++E++
Sbjct: 233 -------DLISRLLKHNPSQRPMLREVL 253
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (484), Expect = 3e-55
Identities = 75/280 (26%), Positives = 129/280 (46%), Gaps = 28/280 (10%)
Query: 619 KKIGKGSFGSVYYGKMKDGKE-----VAVKIMADSCSHRTQ-QFVTEVALLSRIHHRNLV 672
K IG G FG VY G +K VA+K + + + + F+ E ++ + H N++
Sbjct: 13 KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNII 72
Query: 673 PLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 732
L G + +++ EYM NG L L L + + A G++YL
Sbjct: 73 RLEGVISKYKPMMIITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYLA--- 127
Query: 733 NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED--LTHISSVARGTVGYLDPEYYGN 790
N +HRD+ + NIL++ N+ KVSDFGLSR E+D T+ +S + + + PE
Sbjct: 128 NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISY 187
Query: 791 QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 850
++ T SDV+SFG+V+ E+++ + E +V+ ++
Sbjct: 188 RKFTSASDVWSFGIVMWEVMTYGERPYWEL---------------SNHEVMKAINDGFRL 232
Query: 851 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 890
++ I ++ +QC +Q RPK +IV + I+
Sbjct: 233 PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 272
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (486), Expect = 4e-55
Identities = 74/298 (24%), Positives = 124/298 (41%), Gaps = 41/298 (13%)
Query: 617 FCKKIGKGSFGSVYYGKMK------DGKEVAVKIM-ADSCSHRTQQFVTEVALLSRI-HH 668
F K +G G+FG V VAVK++ + + ++E+ +LS + +H
Sbjct: 27 FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 86
Query: 669 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHG---------------SVNQKPLDWLT 713
N+V L+G C +++ EY G L + L ++ LD
Sbjct: 87 MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 146
Query: 714 RLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH-I 772
L ++ AKG+ +L + IHRD+ + NILL K+ DFGL+R + D + +
Sbjct: 147 LLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVV 203
Query: 773 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWAR 832
AR V ++ PE N T +SDV+S+G+ L EL S + +
Sbjct: 204 KGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS-----PYPGMPVDSKFY 258
Query: 833 SMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 890
MIK+G + + + ++ C + RP ++IV I+ I
Sbjct: 259 KMIKEGFRMLSPEHAP---------AEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (480), Expect = 2e-54
Identities = 54/198 (27%), Positives = 102/198 (51%), Gaps = 9/198 (4%)
Query: 619 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 677
+KIG+G+ G+VY G+EVA++ M + + + E+ ++ + N+V +
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 678 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGII 737
+ +V EY+ G+L D + + +D + + + LE+LH + +I
Sbjct: 86 YLVGDELWVVMEYLAGGSLTDVVT----ETCMDEGQIAAVCRECLQALEFLH---SNQVI 138
Query: 738 HRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKS 797
HRD+KS NILL ++ K++DFG Q + + S++ GT ++ PE + K
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKV 197
Query: 798 DVYSFGVVLLELISGKKP 815
D++S G++ +E+I G+ P
Sbjct: 198 DIWSLGIMAIEMIEGEPP 215
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (479), Expect = 4e-54
Identities = 77/296 (26%), Positives = 128/296 (43%), Gaps = 38/296 (12%)
Query: 616 NFCKKIGKGSFGSVYYGKMKDG---KEVAVKIMADSCSHR-TQQFVTEVALLSRI-HHRN 670
F IG+G+FG V ++K + A+K M + S + F E+ +L ++ HH N
Sbjct: 13 KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPN 72
Query: 671 LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHG-------------SVNQKPLDWLTRLQI 717
++ L+G CE L EY +G L D L + L L
Sbjct: 73 IINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 132
Query: 718 AHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR 777
A D A+G++YL IHRD+ + NIL+ N AK++DFGLSR E + ++ R
Sbjct: 133 AADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK--TMGR 187
Query: 778 GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKK 837
V ++ E T SDV+S+GV+L E++S AEL + +
Sbjct: 188 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL------YEKLPQ 241
Query: 838 GDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 893
G + + ++ QC ++ + RP +I++++ ++ K
Sbjct: 242 GYRLEKPLNCD---------DEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 288
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (475), Expect = 2e-53
Identities = 64/295 (21%), Positives = 113/295 (38%), Gaps = 46/295 (15%)
Query: 617 FCKKIGKGSFGSVYYGKMKD------GKEVAVKIM-ADSCSHRTQQFVTEVALLSRI-HH 668
F K +G G+FG V +VAVK++ + S + ++E+ +++++ H
Sbjct: 41 FGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSH 100
Query: 669 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHG--------------------SVNQKP 708
N+V L+G C L++EY G L + L +
Sbjct: 101 ENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 160
Query: 709 LDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 768
L + L A+ AKG+E+L +HRD+ + N+L+ K+ DFGL+R D
Sbjct: 161 LTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSD 217
Query: 769 LTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNI 827
+ + AR V ++ PE T KSDV+S+G++L E+ S
Sbjct: 218 SNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVN------------ 265
Query: 828 VHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIV 882
+ + ++ + + I + C RP +
Sbjct: 266 --PYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLT 318
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (465), Expect = 1e-52
Identities = 68/281 (24%), Positives = 112/281 (39%), Gaps = 29/281 (10%)
Query: 617 FCKKIGKGSFGSVYYGKMK----DGKEVAVKIMADSCSHRTQ---QFVTEVALLSRIHHR 669
+K+G GSFG V G+ VAVK + + + F+ EV + + HR
Sbjct: 12 LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHR 71
Query: 670 NLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 729
NL+ L G ++ V E G+L DRL +Q T + A A+G+ YL
Sbjct: 72 NLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRK--HQGHFLLGTLSRYAVQVAEGMGYLE 128
Query: 730 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH--ISSVARGTVGYLDPEY 787
+ IHRD+ + N+LL K+ DFGL R ++ H + + + PE
Sbjct: 129 ---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPES 185
Query: 788 YGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 847
+ + SD + FGV L E+ + + LN + K+G+ + +
Sbjct: 186 LKTRTFSHASDTWMFGVTLWEMFTYGQE-----PWIGLNGSQILHKIDKEGERLPRPEDC 240
Query: 848 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 888
I V +QC + RP + + ++
Sbjct: 241 ---------PQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (464), Expect = 1e-52
Identities = 58/211 (27%), Positives = 99/211 (46%), Gaps = 12/211 (5%)
Query: 607 LPELEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIM-ADSCSHRTQQFVTEVALLS 664
+P +E+ + +G+G++G V + + VAVKI+ + E+ +
Sbjct: 1 VPFVEDWD--LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINK 58
Query: 665 RIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKG 724
++H N+V G+ E + + L EY G L DR+ + + H G
Sbjct: 59 MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAG 115
Query: 725 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED-LTHISSVARGTVGYL 783
+ YLH GI HRD+K N+LLD K+SDFGL+ + + + GT+ Y+
Sbjct: 116 VVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 172
Query: 784 DPEYYGNQQL-TEKSDVYSFGVVLLELISGK 813
PE ++ E DV+S G+VL +++G+
Sbjct: 173 APELLKRREFHAEPVDVWSCGIVLTAMLAGE 203
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (462), Expect = 3e-52
Identities = 63/282 (22%), Positives = 117/282 (41%), Gaps = 26/282 (9%)
Query: 617 FCKKIGKGSFGSVYYGKMKDGKE----VAVKIMADSCSHRT-QQFVTEVALLSRIHHRNL 671
+ IG+G FG V+ G + VA+K + S ++F+ E + + H ++
Sbjct: 11 LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 70
Query: 672 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 731
V LIG E ++ E G LR V + LD + + A+ + L YL
Sbjct: 71 VKLIGVITENP-VWIIMELCTLGELRS--FLQVRKYSLDLASLILYAYQLSTALAYLE-- 125
Query: 732 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ 791
+ +HRD+ + N+L+ N K+ DFGLSR E+ + +S + + ++ PE +
Sbjct: 126 -SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR 184
Query: 792 QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 851
+ T SDV+ FGV + E++ ++ I+ G+ + +
Sbjct: 185 RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV------IGRIENGERLPMPPNCPP-- 236
Query: 852 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 893
+ + +C RP+ E+ + ++ EK
Sbjct: 237 -------TLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEK 271
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (455), Expect = 6e-51
Identities = 65/289 (22%), Positives = 123/289 (42%), Gaps = 33/289 (11%)
Query: 617 FCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSCSHR-TQQFVTEVALLSRIHHR 669
+++G+GSFG VY G K VA+K + ++ S R +F+ E +++ +
Sbjct: 24 MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 83
Query: 670 NLVPLIGYCEEEHQRILVYEYMHNGTLRDRLH-------GSVNQKPLDWLTRLQIAHDAA 722
++V L+G + +++ E M G L+ L + P +Q+A + A
Sbjct: 84 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 143
Query: 723 KGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA-EEDLTHISSVARGTVG 781
G+ YL +HRD+ + N ++ + K+ DFG++R E D V
Sbjct: 144 DGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 200
Query: 782 YLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVI 841
++ PE + T SDV+SFGVVL E+ + + ++ + +G ++
Sbjct: 201 WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV------LRFVMEGGLL 254
Query: 842 SIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 890
D + E+ C + RP EI+ +I++ ++
Sbjct: 255 DKPDNCP---------DMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 179 bits (454), Expect = 3e-50
Identities = 45/200 (22%), Positives = 92/200 (46%), Gaps = 10/200 (5%)
Query: 619 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 677
+++G G+FG V+ G+ K + E+++++++HH L+ L
Sbjct: 35 EELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDA 94
Query: 678 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGII 737
E++++ +L+ E++ G L DR+ + + A +GL+++H I+
Sbjct: 95 FEDKYEMVLILEFLSGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMH---EHSIV 149
Query: 738 HRDVKSSNILLDI--NMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTE 795
H D+K NI+ + K+ DFGL+ + D + T + PE + +
Sbjct: 150 HLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT--ATAEFAAPEIVDREPVGF 207
Query: 796 KSDVYSFGVVLLELISGKKP 815
+D+++ GV+ L+SG P
Sbjct: 208 YTDMWAIGVLGYVLLSGLSP 227
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 178 bits (452), Expect = 5e-50
Identities = 46/200 (23%), Positives = 90/200 (45%), Gaps = 10/200 (5%)
Query: 619 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 677
+++G G+FG V+ + G A K + + E+ +S + H LV L
Sbjct: 32 EELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDA 91
Query: 678 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGII 737
E++++ +++YE+M G L +++ + ++ KGL ++H +
Sbjct: 92 FEDDNEMVMIYEFMSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHEN---NYV 146
Query: 738 HRDVKSSNILL--DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTE 795
H D+K NI+ + K+ DFGL+ + + + GT + PE + +
Sbjct: 147 HLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT--GTAEFAAPEVAEGKPVGY 204
Query: 796 KSDVYSFGVVLLELISGKKP 815
+D++S GV+ L+SG P
Sbjct: 205 YTDMWSVGVLSYILLSGLSP 224
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (444), Expect = 3e-49
Identities = 60/271 (22%), Positives = 127/271 (46%), Gaps = 28/271 (10%)
Query: 619 KKIGKGSFGSVYYGKMKDGKE-----VAVKIMADSCSHRT-QQFVTEVALLSRIHHRNLV 672
K +G G+FG+VY G E VA+K + ++ S + ++ + E +++ + + ++
Sbjct: 15 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 74
Query: 673 PLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 732
L+G C + L+ + M G L D + ++ + L AKG+ YL
Sbjct: 75 RLLGICLTSTVQ-LITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYL---E 128
Query: 733 NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ-AEEDLTHISSVARGTVGYLDPEYYGNQ 791
+ ++HRD+ + N+L+ K++DFGL++ E+ + + + + ++ E ++
Sbjct: 129 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 188
Query: 792 QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 851
T +SDV+S+GV + EL++ +E+ S+++KG+ + I
Sbjct: 189 IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI------SSILEKGERLPQPPICTI-- 240
Query: 852 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIV 882
+ + ++C SRPK +E++
Sbjct: 241 -------DVYMIMVKCWMIDADSRPKFRELI 264
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (438), Expect = 1e-48
Identities = 70/297 (23%), Positives = 125/297 (42%), Gaps = 40/297 (13%)
Query: 617 FCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSCSHRTQQ-FVTEVALLSRI-HH 668
K +G+G+FG V + VAVK++ + +H + ++E+ +L I HH
Sbjct: 17 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 76
Query: 669 RNLVPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHG-------------SVNQKPLDWLTR 714
N+V L+G C + + ++ E+ G L L + + L
Sbjct: 77 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 136
Query: 715 LQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI-S 773
+ + AKG+E+L + IHRD+ + NILL K+ DFGL+R +D ++
Sbjct: 137 ICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 193
Query: 774 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARS 833
AR + ++ PE ++ T +SDV+SFGV+L E+ S + I
Sbjct: 194 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS-----PYPGVKIDEEFCR 248
Query: 834 MIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 890
+K+G + D + + + C RP E+V + + ++
Sbjct: 249 RLKEGTRMRAPDYTTP---------EMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (437), Expect = 1e-48
Identities = 54/204 (26%), Positives = 95/204 (46%), Gaps = 11/204 (5%)
Query: 617 FCKKIGKGSFGSVYYGK-MKDGKEVAVKIM---ADSCSHRTQQFVTEVALLSRIHHRNLV 672
F K +G+GSF +V + + +E A+KI+ ++ E ++SR+ H V
Sbjct: 12 FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFV 71
Query: 673 PLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 732
L +++ + Y NG L + D + LEYLH
Sbjct: 72 KLYFTFQDDEKLYFGLSYAKNGELLKYIR---KIGSFDETCTRFYTAEIVSALEYLH--- 125
Query: 733 NPGIIHRDVKSSNILLDINMRAKVSDFGLSR-QAEEDLTHISSVARGTVGYLDPEYYGNQ 791
GIIHRD+K NILL+ +M +++DFG ++ + E ++ GT Y+ PE +
Sbjct: 126 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK 185
Query: 792 QLTEKSDVYSFGVVLLELISGKKP 815
+ SD+++ G ++ +L++G P
Sbjct: 186 SACKSSDLWALGCIIYQLVAGLPP 209
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (429), Expect = 1e-47
Identities = 64/294 (21%), Positives = 123/294 (41%), Gaps = 42/294 (14%)
Query: 617 FCKKIGKGSFGSVYYGKMK--------DGKEVAVKIM-ADSCSHRTQQFVTEVALLSRI- 666
K +G+G+FG V + +VAVK++ +D+ ++E+ ++ I
Sbjct: 17 LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 76
Query: 667 HHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLH-------------GSVNQKPLDWLT 713
H+N++ L+G C ++ ++ EY G LR+ L ++ L
Sbjct: 77 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 136
Query: 714 RLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 773
+ A+ A+G+EYL + IHRD+ + N+L+ + K++DFGL+R +
Sbjct: 137 LVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 193
Query: 774 S-VARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWAR 832
+ R V ++ PE ++ T +SDV+SFGV+L E+ + V
Sbjct: 194 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY------PGVPVEELF 247
Query: 833 SMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 886
++K+G + + + C RP +++V +
Sbjct: 248 KLLKEGHRMDKPSNCT---------NELYMMMRDCWHAVPSQRPTFKQLVEDLD 292
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (427), Expect = 6e-47
Identities = 61/322 (18%), Positives = 136/322 (42%), Gaps = 36/322 (11%)
Query: 619 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 677
+ +G+G FG V+ K K + + + E+++L+ HRN++ L
Sbjct: 11 EDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ-VLVKKEISILNIARHRNILHLHES 69
Query: 678 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGII 737
E + ++++E++ + +R++ + L+ + H + L++LH + I
Sbjct: 70 FESMEELVMIFEFISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLH---SHNIG 124
Query: 738 HRDVKSSNILLDI--NMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTE 795
H D++ NI+ + K+ +FG +RQ + Y PE + + ++
Sbjct: 125 HFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLL--FTAPEYYAPEVHQHDVVST 182
Query: 796 KSDVYSFGVVLLELISGKKPVSVEDFGAEL-NIVHWARSMIKKG------DVISIVDPVL 848
+D++S G ++ L+SG P E + NI++ + ++ + + VD +L
Sbjct: 183 ATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLL 242
Query: 849 IGNVK--------------IESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKG 894
+ K + I R++ I+ ++ R + +++ + + + +I G
Sbjct: 243 VKERKSRMTASEALQHPWLKQKIERVSTKVIRTLKHRRYYHTLIKKDLNMVVSAARISCG 302
Query: 895 GDQKFSSSSSKGQSSRKTLLTS 916
G + S KG S K + S
Sbjct: 303 G----AIRSQKGVSVAKVKVAS 320
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 164 bits (415), Expect = 6e-46
Identities = 59/207 (28%), Positives = 100/207 (48%), Gaps = 16/207 (7%)
Query: 619 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRT---QQFVTEVALLSRIHHRNLVPL 674
+ +G G V+ + ++ ++VAVK++ + +F E + ++H +V +
Sbjct: 13 EILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAV 72
Query: 675 IGYCEEEHQRI----LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 730
E E +V EY+ TLRD +H + P+ +++ DA + L +
Sbjct: 73 YDTGEAETPAGPLPYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQALNFS-- 127
Query: 731 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR--GTVGYLDPEYY 788
GIIHRDVK +NI++ KV DFG++R + ++ A GT YL PE
Sbjct: 128 -HQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 186
Query: 789 GNQQLTEKSDVYSFGVVLLELISGKKP 815
+ +SDVYS G VL E+++G+ P
Sbjct: 187 RGDSVDARSDVYSLGCVLYEVLTGEPP 213
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 162 bits (411), Expect = 2e-45
Identities = 59/214 (27%), Positives = 92/214 (42%), Gaps = 25/214 (11%)
Query: 619 KKIGKGSFGSVYYGKMK-DGKEVAVKIM---------ADSCSHRTQQFVTEVALLSRIH- 667
+ +G+G V K KE AVKI+ A+ + + EV +L ++
Sbjct: 9 EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSG 68
Query: 668 HRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEY 727
H N++ L E LV++ M G L D L + L +I + +
Sbjct: 69 HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT---EKVTLSEKETRKIMRALLEVICA 125
Query: 728 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 787
LH I+HRD+K NILLD +M K++DFG S Q + GT YL PE
Sbjct: 126 LH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG--EKLREVCGTPSYLAPEI 180
Query: 788 Y------GNQQLTEKSDVYSFGVVLLELISGKKP 815
+ ++ D++S GV++ L++G P
Sbjct: 181 IECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 214
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 165 bits (418), Expect = 3e-45
Identities = 56/230 (24%), Positives = 92/230 (40%), Gaps = 19/230 (8%)
Query: 615 NNF--CKKIGKGSFGSVYYGKMKD-GKEVAVKIM------ADSCSHRTQQFVTEVALLSR 665
N+F + IG+G FG VY + D GK A+K + ++L+S
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 666 IHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGL 725
+V + + + + M+ G L L A + GL
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS---QHGVFSEADMRFYAAEIILGL 120
Query: 726 EYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDP 785
E++H N +++RD+K +NILLD + ++SD GL+ + H S GT GY+ P
Sbjct: 121 EHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---VGTHGYMAP 174
Query: 786 EYY-GNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSM 834
E +D +S G +L +L+ G P + I +M
Sbjct: 175 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM 224
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 163 bits (413), Expect = 3e-45
Identities = 54/205 (26%), Positives = 93/205 (45%), Gaps = 13/205 (6%)
Query: 616 NFCKKIGKGSFGSVYYGK-MKDGKEVAVKIMA-DSCSHRTQQFVTEVALLSRIHHRNLVP 673
+F +G G+F V + + K VA+K +A + + E+A+L +I H N+V
Sbjct: 12 DFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVA 71
Query: 674 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 733
L E L+ + + G L DR+ + ++ ++YLH
Sbjct: 72 LDDIYESGGHLYLIMQLVSGGELFDRIV---EKGFYTERDASRLIFQVLDAVKYLHDLG- 127
Query: 734 PGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN 790
I+HRD+K N+L D + + +SDFGLS+ + ++ GT GY+ PE
Sbjct: 128 --IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTAC--GTPGYVAPEVLAQ 183
Query: 791 QQLTEKSDVYSFGVVLLELISGKKP 815
+ ++ D +S GV+ L+ G P
Sbjct: 184 KPYSKAVDCWSIGVIAYILLCGYPP 208
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (408), Expect = 2e-44
Identities = 56/227 (24%), Positives = 98/227 (43%), Gaps = 12/227 (5%)
Query: 617 FCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHR---TQQFVTEVALLSR-IHHRNL 671
K +GKGSFG V+ + K + A+K + + + E +LS H L
Sbjct: 6 LHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFL 65
Query: 672 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 731
+ + + V EY++ G L + + D A + GL++L
Sbjct: 66 THMFCTFQTKENLFFVMEYLNGGDLMYHIQ---SCHKFDLSRATFYAAEIILGLQFL--- 119
Query: 732 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ 791
+ GI++RD+K NILLD + K++DFG+ ++ ++ GT Y+ PE Q
Sbjct: 120 HSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC-GTPDYIAPEILLGQ 178
Query: 792 QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG 838
+ D +SFGV+L E++ G+ P +D + + +
Sbjct: 179 KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRW 225
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 161 bits (407), Expect = 2e-44
Identities = 54/201 (26%), Positives = 97/201 (48%), Gaps = 14/201 (6%)
Query: 619 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQ---FVTEVALLSRIHHRNLVPL 674
+ +G GSFG V+ + + +G+ A+K++ R +Q E +LS + H ++ +
Sbjct: 10 RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 69
Query: 675 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 734
G ++ Q ++ +Y+ G L L + A + LEYLH +
Sbjct: 70 WGTFQDAQQIFMIMDYIEGGELFSLLR---KSQRFPNPVAKFYAAEVCLALEYLH---SK 123
Query: 735 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLT 794
II+RD+K NILLD N K++DFG ++ + + GT Y+ PE +
Sbjct: 124 DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTL----CGTPDYIAPEVVSTKPYN 179
Query: 795 EKSDVYSFGVVLLELISGKKP 815
+ D +SFG+++ E+++G P
Sbjct: 180 KSIDWWSFGILIYEMLAGYTP 200
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 159 bits (403), Expect = 4e-44
Identities = 61/283 (21%), Positives = 97/283 (34%), Gaps = 28/283 (9%)
Query: 619 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 677
+KIG GSFG +Y G + G+EVA+K+ H Q E + + +P I +
Sbjct: 13 RKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRW 70
Query: 678 C-EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 736
C E ++V E + + T L +A +EY+H +
Sbjct: 71 CGAEGDYNVMVMELLGPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIH---SKNF 124
Query: 737 IHRDVKSSNIL---LDINMRAKVSDFGLSRQAEEDLTHI------SSVARGTVGYLDPEY 787
IHRDVK N L + DFGL+++ + TH + GT Y
Sbjct: 125 IHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINT 184
Query: 788 YGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 847
+ + + + D+ S G VL+ G P + +S V
Sbjct: 185 HLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK-----MSTPIEV 239
Query: 848 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 890
L E A C R +P + ++
Sbjct: 240 LCKGYPSE----FATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 278
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 158 bits (400), Expect = 8e-44
Identities = 42/199 (21%), Positives = 89/199 (44%), Gaps = 8/199 (4%)
Query: 619 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPLIG 676
+KIG+G++G VY + G+ A+K + + E+++L + H N+V L
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 677 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 736
+ + +LV+E++ + + L+ +T G+ Y H + +
Sbjct: 68 VIHTKKRLVLVFEHLDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCH---DRRV 121
Query: 737 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEK 796
+HRD+K N+L++ K++DFGL+R + + G+++ +
Sbjct: 122 LHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTT 181
Query: 797 SDVYSFGVVLLELISGKKP 815
D++S G + E+++G
Sbjct: 182 IDIWSVGCIFAEMVNGTPL 200
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (397), Expect = 1e-42
Identities = 60/214 (28%), Positives = 98/214 (45%), Gaps = 18/214 (8%)
Query: 611 EEATNNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHR 669
+E + K IG GSFG VY K+ D G+ VA+K + + E+ ++ ++ H
Sbjct: 18 QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHC 73
Query: 670 NLVPLIGYCEEEHQR------ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK 723
N+V L + ++ LV +Y+ R H S ++ L + + +
Sbjct: 74 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 133
Query: 724 GLEYLHTGCNPGIIHRDVKSSNILLDIN-MRAKVSDFGLSRQAEEDLTHISSVARGTVGY 782
L Y+H + GI HRD+K N+LLD + K+ DFG ++Q ++S + Y
Sbjct: 134 SLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR--YY 188
Query: 783 LDP-EYYGNQQLTEKSDVYSFGVVLLELISGKKP 815
P +G T DV+S G VL EL+ G+
Sbjct: 189 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQPI 222
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 155 bits (392), Expect = 1e-42
Identities = 42/284 (14%), Positives = 91/284 (32%), Gaps = 28/284 (9%)
Query: 619 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 677
++IG+GSFG ++ G + + ++VA+K Q E + +P + Y
Sbjct: 11 RRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTGIPNVYY 68
Query: 678 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGII 737
+E ++ + +L D L + + T A ++ +H ++
Sbjct: 69 FGQEGLHNVLVIDLLGPSLEDLLD--LCGRKFSVKTVAMAAKQMLARVQSIH---EKSLV 123
Query: 738 HRDVKSSNILLD-----INMRAKVSDFGLSRQAEEDLTHI------SSVARGTVGYLDPE 786
+RD+K N L+ V DFG+ + + +T GT Y+
Sbjct: 124 YRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSIN 183
Query: 787 YYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP 846
+ ++ + + D+ + G V + + G P + +
Sbjct: 184 THLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL-----R 238
Query: 847 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 890
L E + + P + ++
Sbjct: 239 ELCAGFPEE----FYKYMHYARNLAFDATPDYDYLQGLFSKVLE 278
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (389), Expect = 3e-42
Identities = 43/200 (21%), Positives = 88/200 (44%), Gaps = 8/200 (4%)
Query: 619 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPLI 675
+KIG+G++G VY + K G+ VA+K + + E++LL ++H N+V L+
Sbjct: 8 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 67
Query: 676 GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 735
E++ LV+E++H + + +GL + +
Sbjct: 68 DVIHTENKLYLVFEFLHQDLKKFMDAS--ALTGIPLPLIKSYLFQLLQGLAFC---HSHR 122
Query: 736 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTE 795
++HRD+K N+L++ K++DFGL+R + + G + +
Sbjct: 123 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYST 182
Query: 796 KSDVYSFGVVLLELISGKKP 815
D++S G + E+++ +
Sbjct: 183 AVDIWSLGCIFAEMVTRRAL 202
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (386), Expect = 9e-42
Identities = 49/231 (21%), Positives = 90/231 (38%), Gaps = 15/231 (6%)
Query: 619 KKIGKGSFGSVYYGKMK--DGKEVAVKIM-----ADSCSHRTQQFVTEVALLSRIHHRNL 671
+IG+G++G V+ + G+ VA+K + + T + V + L H N+
Sbjct: 13 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 72
Query: 672 VPLIGYCEEEHQRILVYEYMHNGTLR---DRLHGSVNQKPLDWLTRLQIAHDAAKGLEYL 728
V L C + + V + + T + +GL++L
Sbjct: 73 VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL 132
Query: 729 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY 788
H + ++HRD+K NIL+ + + K++DFGL+R + S V T+ Y PE
Sbjct: 133 H---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVV--VTLWYRAPEVL 187
Query: 789 GNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD 839
D++S G + E+ K +L + + + D
Sbjct: 188 LQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 238
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (384), Expect = 1e-41
Identities = 51/204 (25%), Positives = 88/204 (43%), Gaps = 14/204 (6%)
Query: 619 KKIGKGSFGSVYYGKMK-DGKEVAVKIM-----ADSCSHRTQQFVTEVALLSRIHHRNLV 672
+G+G F +VY + K + VA+K + +++ + + E+ LL + H N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 673 PLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 732
L+ + LV+++M N L +GLEYLH
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLH--- 117
Query: 733 NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY-GNQ 791
I+HRD+K +N+LLD N K++DFGL++ + T Y PE G +
Sbjct: 118 QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV-VTRWYRAPELLFGAR 176
Query: 792 QLTEKSDVYSFGVVLLELISGKKP 815
D+++ G +L EL+
Sbjct: 177 MYGVGVDMWAVGCILAELLLRVPF 200
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (387), Expect = 2e-41
Identities = 52/231 (22%), Positives = 94/231 (40%), Gaps = 23/231 (9%)
Query: 619 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIG 676
+ +G G G V K ++ A+K++ D + EV L R ++V ++
Sbjct: 18 QVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVD 72
Query: 677 YCE----EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 732
E ++V E + G L R+ + +I + ++YLH
Sbjct: 73 VYENLYAGRKCLLIVMECLDGGELFSRIQ-DRGDQAFTEREASEIMKSIGEAIQYLH--- 128
Query: 733 NPGIIHRDVKSSNILLD---INMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYG 789
+ I HRDVK N+L N K++DFG +++ + + T Y+ PE G
Sbjct: 129 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTP--CYTPYYVAPEVLG 186
Query: 790 NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV 840
++ + D++S GV++ L+ G P L I ++ I+ G
Sbjct: 187 PEKYDKSCDMWSLGVIMYILLCGYPPFYSNH---GLAISPGMKTRIRMGQY 234
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (385), Expect = 4e-41
Identities = 54/232 (23%), Positives = 103/232 (44%), Gaps = 8/232 (3%)
Query: 619 KKIGKGSFGSVYYGKMK-DGKEVAVKIM-ADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 676
IG+G++G V + VA+K + Q+ + E+ +L R H N++ +
Sbjct: 14 SYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 73
Query: 677 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 736
+ Y+ + L+ + + L + +GL+Y+H + +
Sbjct: 74 IIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANV 130
Query: 737 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR--GTVGYLDPEYYGNQQL- 793
+HRD+K SN+LL+ K+ DFGL+R A+ D H + T Y PE N +
Sbjct: 131 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGY 190
Query: 794 TEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 845
T+ D++S G +L E++S + + + +LN + + D+ I++
Sbjct: 191 TKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 242
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (373), Expect = 3e-40
Identities = 47/200 (23%), Positives = 89/200 (44%), Gaps = 9/200 (4%)
Query: 619 KKIGKGSFGSVYYGKMK-DGKEVAVKIM--ADSCSHRTQQFVTEVALLSRIHHRNLVPLI 675
+KIG+G++G+V+ K + + VA+K + D + E+ LL + H+N+V L
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 676 GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 735
+ + LV+E+ + LD KGL + H +
Sbjct: 68 DVLHSDKKLTLVFEFCDQDLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCH---SRN 121
Query: 736 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTE 795
++HRD+K N+L++ N K+++FGL+R + S+ +G + +
Sbjct: 122 VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYST 181
Query: 796 KSDVYSFGVVLLELISGKKP 815
D++S G + EL + +P
Sbjct: 182 SIDMWSAGCIFAELANAGRP 201
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (373), Expect = 4e-40
Identities = 54/208 (25%), Positives = 91/208 (43%), Gaps = 19/208 (9%)
Query: 619 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRT------QQFVTEVALLSRIHHRNL 671
+++G G F V + K G + A K + + + + EV++L I H N+
Sbjct: 16 EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 75
Query: 672 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 731
+ L E + IL+ E + G L D L ++ L + G+ YLH
Sbjct: 76 ITLHEVYENKTDVILILELVAGGELFDFLA---EKESLTEEEATEFLKQILNGVYYLH-- 130
Query: 732 CNPGIIHRDVKSSNILLD----INMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 787
+ I H D+K NI+L R K+ DFGL+ + + + GT ++ PE
Sbjct: 131 -SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF--GTPEFVAPEI 187
Query: 788 YGNQQLTEKSDVYSFGVVLLELISGKKP 815
+ L ++D++S GV+ L+SG P
Sbjct: 188 VNYEPLGLEADMWSIGVITYILLSGASP 215
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 5e-40
Identities = 54/216 (25%), Positives = 91/216 (42%), Gaps = 11/216 (5%)
Query: 617 FCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSH---RTQQFVTEVALLSRIHHRNLV 672
+ K +GKG+FG V + K G+ A+KI+ VTE +L H L
Sbjct: 9 YLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLT 68
Query: 673 PLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 732
L + + V EY + G L L T + A+ + L
Sbjct: 69 ALKYAFQTHDRLCFVMEYANGGELFFHLSRE------RVFTEERARFYGAEIVSALEYLH 122
Query: 733 NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQ 792
+ +++RD+K N++LD + K++DFGL ++ D + + GT YL PE +
Sbjct: 123 SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPEYLAPEVLEDND 181
Query: 793 LTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIV 828
D + GVV+ E++ G+ P +D ++
Sbjct: 182 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI 217
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 2e-39
Identities = 49/223 (21%), Positives = 87/223 (39%), Gaps = 24/223 (10%)
Query: 619 KKIGKGSFGSVYYGK-MKDGKEVAVKIM------ADSCSHRTQQFVTEVALLSRIH--HR 669
+G G FGSVY G + D VA+K + + EV LL ++
Sbjct: 10 PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 69
Query: 670 NLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 729
++ L+ + E +L+ E + L + + +
Sbjct: 70 GVIRLLDWFERPDSFVLILERPEPVQDLFDFI--TERGALQEELARSFFWQVLEAVRHC- 126
Query: 730 TGCNPGIIHRDVKSSNILLDIN-MRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY 788
N G++HRD+K NIL+D+N K+ DFG ++ + GT Y PE+
Sbjct: 127 --HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT---DFDGTRVYSPPEWI 181
Query: 789 -GNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHW 830
++ + V+S G++L +++ G P F + I+
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGDIP-----FEHDEEIIRG 219
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 146 bits (369), Expect = 6e-39
Identities = 51/218 (23%), Positives = 90/218 (41%), Gaps = 14/218 (6%)
Query: 619 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQ---FVTEVALLSRIHHRNLVPL 674
K +G GSFG V K K G A+KI+ + +Q + E +L ++ LV L
Sbjct: 47 KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 675 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 734
++ +V EY+ G + L A EYLH +
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLR---RIGRFSEPHARFYAAQIVLTFEYLH---SL 160
Query: 735 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLT 794
+I+RD+K N+L+D +V+DFG +++ + + GT L PE ++
Sbjct: 161 DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTL----CGTPEALAPEIILSKGYN 216
Query: 795 EKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWAR 832
+ D ++ GV++ E+ +G P + + +
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK 254
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 6e-38
Identities = 50/225 (22%), Positives = 97/225 (43%), Gaps = 21/225 (9%)
Query: 619 KKIGKGSFGSVYYGK-MKDGKEVAVKIM--ADSCSHRTQQFVTEVALLSRIHHRNLVPLI 675
KIG+G+FG V+ + K G++VA+K + + + E+ +L + H N+V LI
Sbjct: 16 AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 75
Query: 676 GYCEE--------EHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEY 727
C + LV+++ + + L T +I L
Sbjct: 76 EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSN------VLVKFTLSEIKRVMQMLLNG 129
Query: 728 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ---AEEDLTHISSVARGTVGYLD 784
L+ I+HRD+K++N+L+ + K++DFGL+R A+ + + T+ Y
Sbjct: 130 LYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRP 189
Query: 785 PEYY-GNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIV 828
PE G + D++ G ++ E+ + + +L ++
Sbjct: 190 PELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALI 234
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (350), Expect = 2e-36
Identities = 46/201 (22%), Positives = 88/201 (43%), Gaps = 10/201 (4%)
Query: 619 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPLI 675
+ +G G++G+V + G +VA+K + ++ E+ LL + H N++ L+
Sbjct: 24 QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLL 83
Query: 676 GYCEEEHQRILVYEYMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 734
+ ++ G + + L + + KGL Y+H
Sbjct: 84 DVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIH---AA 140
Query: 735 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLT 794
GIIHRD+K N+ ++ + K+ DFGL+RQA+ ++T + T
Sbjct: 141 GIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMT---GYVVTRWYRAPEVILNWMRYT 197
Query: 795 EKSDVYSFGVVLLELISGKKP 815
+ D++S G ++ E+I+GK
Sbjct: 198 QTVDIWSVGCIMAEMITGKTL 218
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 134 bits (338), Expect = 4e-35
Identities = 45/205 (21%), Positives = 92/205 (44%), Gaps = 20/205 (9%)
Query: 617 FCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPL 674
+K+G+G + V+ + ++V VKI+ + ++ E+ +L + N++ L
Sbjct: 39 LVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITL 95
Query: 675 IGYCEEEHQR--ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 732
++ R LV+E+++N + + L ++ K L+Y H
Sbjct: 96 ADIVKDPVSRTPALVFEHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCH--- 146
Query: 733 NPGIIHRDVKSSNILLDI-NMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY-GN 790
+ GI+HRDVK N+++D + + ++ D+GL+ + V + + PE
Sbjct: 147 SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRV--ASRYFKGPELLVDY 204
Query: 791 QQLTEKSDVYSFGVVLLELISGKKP 815
Q D++S G +L +I K+P
Sbjct: 205 QMYDYSLDMWSLGCMLASMIFRKEP 229
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (337), Expect = 4e-35
Identities = 57/208 (27%), Positives = 96/208 (46%), Gaps = 17/208 (8%)
Query: 619 KKIGKGSFGSVYYGK----MKDGKEVAVKIM----ADSCSHRTQQFVTEVALLSRI-HHR 669
K +G G++G V+ + GK A+K++ + T+ TE +L I
Sbjct: 30 KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 89
Query: 670 NLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 729
LV L + E + L+ +Y++ G L L + T ++ + + L
Sbjct: 90 FLVTLHYAFQTETKLHLILDYINGGELFTHLSQR------ERFTEHEVQIYVGEIVLALE 143
Query: 730 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE--Y 787
GII+RD+K NILLD N ++DFGLS++ D T + GT+ Y+ P+
Sbjct: 144 HLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVR 203
Query: 788 YGNQQLTEKSDVYSFGVVLLELISGKKP 815
G+ + D +S GV++ EL++G P
Sbjct: 204 GGDSGHDKAVDWWSLGVLMYELLTGASP 231
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (311), Expect = 2e-31
Identities = 44/205 (21%), Positives = 87/205 (42%), Gaps = 18/205 (8%)
Query: 619 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPLI 675
+G G++GSV K G VAVK ++ ++ E+ LL + H N++ L+
Sbjct: 24 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 83
Query: 676 GYCEE-----EHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 730
E + + ++ L + + + L + + +GL+Y+H
Sbjct: 84 DVFTPARSLEEFNDVYLVTHLMGADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIH- 138
Query: 731 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN 790
+ IIHRD+K SN+ ++ + K+ DFGL+R + ++
Sbjct: 139 --SADIIHRDLKPSNLAVNEDCELKILDFGLARHTD---DEMTGYVATRWYRAPEIMLNW 193
Query: 791 QQLTEKSDVYSFGVVLLELISGKKP 815
+ D++S G ++ EL++G+
Sbjct: 194 MHYNQTVDIWSVGCIMAELLTGRTL 218
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (310), Expect = 3e-31
Identities = 55/217 (25%), Positives = 93/217 (42%), Gaps = 20/217 (9%)
Query: 619 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPLI 675
K IG G+ G V + VA+K ++ ++T ++ E+ L+ ++H+N++ L+
Sbjct: 23 KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 82
Query: 676 GYC------EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 729
EE LV E M + Q LD + + G+++LH
Sbjct: 83 NVFTPQKTLEEFQDVYLVMELMDANLCQVI------QMELDHERMSYLLYQMLCGIKHLH 136
Query: 730 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYG 789
+ IHRD+K SNI++ + K+ DFGL+R A V T Y PE
Sbjct: 137 SAGI---IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV--VTRYYRAPEVIL 191
Query: 790 NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELN 826
E D++S G ++ E++ K D+ + N
Sbjct: 192 GMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWN 228
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 123 bits (308), Expect = 7e-31
Identities = 50/238 (21%), Positives = 94/238 (39%), Gaps = 27/238 (11%)
Query: 619 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 677
+K+G G F +V+ K M + VA+KI+ T+ E+ LL R++ +
Sbjct: 19 RKLGWGHFSTVWLAKDMVNNTHVAMKIV-RGDKVYTEAAEDEIKLLQRVNDADNTKEDSM 77
Query: 678 CEEEHQRILVY-------------EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKG 724
++L + + G L + + + QI+ G
Sbjct: 78 GANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLG 137
Query: 725 LEYLHTGCNPGIIHRDVKSSNILLDIN------MRAKVSDFGLSRQAEEDLTHISSVARG 778
L+Y+H GIIH D+K N+L++I ++ K++D G + +E T+
Sbjct: 138 LDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNS----IQ 191
Query: 779 TVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIK 836
T Y PE +D++S ++ ELI+G ++ + +I+
Sbjct: 192 TREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIE 249
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 91.0 bits (225), Expect = 1e-21
Identities = 24/163 (14%), Positives = 49/163 (30%), Gaps = 28/163 (17%)
Query: 619 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCS----------HRTQQFVTEVALLSRIHH 668
K +G+G +V+ + E VK + + F +R
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 669 RNLVPLIGYCEEEH----QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKG 724
R L L G + ++ E + + ++ +
Sbjct: 66 RALQKLQGLAVPKVYAWEGNAVLMELIDAK----------ELYRVRVENPDEVLDMILEE 115
Query: 725 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 767
+ + + GI+H D+ N+L+ + DF S + E
Sbjct: 116 VAKFY---HRGIVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGE 154
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 67.3 bits (163), Expect = 3e-12
Identities = 12/93 (12%), Positives = 37/93 (39%), Gaps = 5/93 (5%)
Query: 402 WEWVTCSTTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLID 461
+ +T + L N+ P + ++ L L+ N ++ ++ L +
Sbjct: 296 QLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSDV-SSLANLTN 352
Query: 462 LRIVHLENNELTGSLPSYMGSLPNLQELHIENN 494
+ + +N+++ P + +L + +L + +
Sbjct: 353 INWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 56.2 bits (134), Expect = 8e-09
Identities = 21/72 (29%), Positives = 35/72 (48%), Gaps = 3/72 (4%)
Query: 435 NMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENN 494
N++ LT L L N ++ P +S L L+ + NN+++ S + +L N+ L +N
Sbjct: 305 NLKNLTYLTLYFNNISDISP-VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHN 361
Query: 495 SFVGEIPPALLT 506
P A LT
Sbjct: 362 QISDLTPLANLT 373
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 45.8 bits (107), Expect = 2e-05
Identities = 17/78 (21%), Positives = 35/78 (44%), Gaps = 5/78 (6%)
Query: 417 KIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSL 476
K L N+ + +++ +T L D + + + L +L ++ NN+LT
Sbjct: 26 KTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS-IDGVEYLNNLTQINFSNNQLTDIT 82
Query: 477 PSYMGSLPNLQELHIENN 494
P + +L L ++ + NN
Sbjct: 83 P--LKNLTKLVDILMNNN 98
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 42.3 bits (98), Expect = 2e-04
Identities = 12/73 (16%), Positives = 26/73 (35%), Gaps = 3/73 (4%)
Query: 434 KNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIEN 493
+ + L +T + + L + + + + S+ + L NL +++ N
Sbjct: 19 TALAEKMKTVLGKTNVTDTVSQ-TDLDQVTTLQADRLGIK-SIDG-VEYLNNLTQINFSN 75
Query: 494 NSFVGEIPPALLT 506
N P LT
Sbjct: 76 NQLTDITPLKNLT 88
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 40.0 bits (92), Expect = 0.001
Identities = 28/125 (22%), Positives = 49/125 (39%), Gaps = 23/125 (18%)
Query: 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNE 471
+ +++L+G LK L ++ LT+L L N ++ L +S L L + L N+
Sbjct: 218 LTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISN-LAPLSGLTKLTELKLGANQ 274
Query: 472 LTGSLP--------------------SYMGSLPNLQELHIENNSFVGEIPPALLTGKVIF 511
++ P S + +L NL L + N+ P + LT
Sbjct: 275 ISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISPVSSLTKLQRL 334
Query: 512 KYDNN 516
+ NN
Sbjct: 335 FFANN 339
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 38.8 bits (89), Expect = 0.002
Identities = 16/67 (23%), Positives = 25/67 (37%), Gaps = 3/67 (4%)
Query: 435 NMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENN 494
+ L L N ++ P +L + L N+L + SL NL +L + NN
Sbjct: 195 KLTNLESLIATNNQISDITPLGIL-TNLDELSLNGNQLKD--IGTLASLTNLTDLDLANN 251
Query: 495 SFVGEIP 501
P
Sbjct: 252 QISNLAP 258
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 60.9 bits (146), Expect = 2e-10
Identities = 18/84 (21%), Positives = 29/84 (34%), Gaps = 2/84 (2%)
Query: 397 CVPVPWEWVTCSTTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM 456
+ + + L + G +P L ++ L L + N L G +P
Sbjct: 228 LAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG 287
Query: 457 SRLIDLRIVHLENN-ELTGS-LPS 478
L + NN L GS LP+
Sbjct: 288 GNLQRFDVSAYANNKCLCGSPLPA 311
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 59.4 bits (142), Expect = 5e-10
Identities = 34/141 (24%), Positives = 64/141 (45%), Gaps = 9/141 (6%)
Query: 372 QDVMVLEALR-SISDESERT--NDRGDPCVPVPWEWVTCS-TTTPPRITKIALSGKNLKG 427
QD L ++ + + + + D C W V C T R+ + LSG NL
Sbjct: 6 QDKQALLQIKKDLGNPTTLSSWLPTTDCC-NRTWLGVLCDTDTQTYRVNNLDLSGLNLPK 64
Query: 428 --EIPPELKNMEALTELWLDG--NFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSL 483
IP L N+ L L++ G N + P +++L L +++ + ++G++P ++ +
Sbjct: 65 PYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQI 124
Query: 484 PNLQELHIENNSFVGEIPPAL 504
L L N+ G +PP++
Sbjct: 125 KTLVTLDFSYNALSGTLPPSI 145
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 56.7 bits (135), Expect = 4e-09
Identities = 19/55 (34%), Positives = 26/55 (47%), Gaps = 1/55 (1%)
Query: 466 HLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPP-ALLTGKVIFKYDNNPKL 519
L NN + G+LP + L L L++ N+ GEIP L + Y NN L
Sbjct: 250 DLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCL 304
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 56.3 bits (134), Expect = 6e-09
Identities = 16/60 (26%), Positives = 26/60 (43%), Gaps = 2/60 (3%)
Query: 443 WLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIP 501
L N + G LP +++L L +++ N L G +P G+L NN + P
Sbjct: 250 DLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNKCLCGSP 308
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 52.7 bits (125), Expect = 7e-08
Identities = 23/112 (20%), Positives = 40/112 (35%), Gaps = 11/112 (9%)
Query: 406 TCSTTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRI 464
C + S L+ ++P +L L L N +T D L +L
Sbjct: 9 QCHLRV------VQCSDLGLE-KVPKDL--PPDTALLDLQNNKITEIKDGDFKNLKNLHT 59
Query: 465 VHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNN 516
+ L NN+++ P L L+ L++ N E+P + + N
Sbjct: 60 LILINNKISKISPGAFAPLVKLERLYLSKNQL-KELPEKMPKTLQELRVHEN 110
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 40.4 bits (93), Expect = 6e-04
Identities = 22/124 (17%), Positives = 41/124 (33%), Gaps = 31/124 (25%)
Query: 411 TPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNF---------------------- 448
PP +T++ L G + LK + L +L L N
Sbjct: 169 LPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNN 228
Query: 449 --LTGPLPDMSRLIDLRIVHLENNELTG------SLPSYMGSLPNLQELHIENNSF-VGE 499
L ++ +++V+L NN ++ P Y + + + +N E
Sbjct: 229 NKLVKVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWE 288
Query: 500 IPPA 503
I P+
Sbjct: 289 IQPS 292
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 51.7 bits (122), Expect = 2e-07
Identities = 19/84 (22%), Positives = 36/84 (42%), Gaps = 8/84 (9%)
Query: 404 WVTCSTTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLR 463
+ PP + ++ +S L E+P L L N L +P++ + +L+
Sbjct: 275 EIRSLCDLPPSLEELNVSNNKLI-ELPALPPR---LERLIASFNHLAE-VPELPQ--NLK 327
Query: 464 IVHLENNELTGSLPSYMGSLPNLQ 487
+H+E N L P S+ +L+
Sbjct: 328 QLHVEYNPLR-EFPDIPESVEDLR 350
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 47.1 bits (110), Expect = 6e-06
Identities = 22/116 (18%), Positives = 37/116 (31%), Gaps = 9/116 (7%)
Query: 391 NDRGDPCVPVPWEWVTCSTTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLT 450
+ P + + + EI +L EL + N L
Sbjct: 238 DLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI 297
Query: 451 GPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSF--VGEIPPAL 504
LP + L + N L +P NL++LH+E N +IP ++
Sbjct: 298 E-LPAL--PPRLERLIASFNHLA-EVPE---LPQNLKQLHVEYNPLREFPDIPESV 346
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 38.3 bits (87), Expect = 0.004
Identities = 15/53 (28%), Positives = 26/53 (49%), Gaps = 4/53 (7%)
Query: 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRI 464
PPR+ ++ S +L E+P +N L +L ++ N L + DLR+
Sbjct: 303 PPRLERLIASFNHLA-EVPELPQN---LKQLHVEYNPLREFPDIPESVEDLRM 351
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 47.4 bits (112), Expect = 4e-07
Identities = 23/103 (22%), Positives = 38/103 (36%), Gaps = 25/103 (24%)
Query: 420 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDL----------------- 462
L+ K+L + L+ + +T L L N L P ++ L L
Sbjct: 5 LAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVDGVA 62
Query: 463 -----RIVHLENNELTG-SLPSYMGSLPNLQELHIENNSFVGE 499
+ + L NN L + + S P L L+++ NS E
Sbjct: 63 NLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 47.3 bits (111), Expect = 2e-06
Identities = 18/64 (28%), Positives = 33/64 (51%), Gaps = 3/64 (4%)
Query: 430 PPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQEL 489
L N+ LT L D N ++ + ++ L +L VHL+NN+++ P + + NL +
Sbjct: 166 LTPLANLSKLTTLKADDNKISD-ISPLASLPNLIEVHLKNNQISDVSP--LANTSNLFIV 222
Query: 490 HIEN 493
+ N
Sbjct: 223 TLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 37.7 bits (86), Expect = 0.003
Identities = 15/53 (28%), Positives = 28/53 (52%), Gaps = 2/53 (3%)
Query: 454 PDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLT 506
++ L L + ++N+++ P + SLPNL E+H++NN P A +
Sbjct: 167 TPLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSPLANTS 217
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.4 bits (105), Expect = 3e-05
Identities = 15/75 (20%), Positives = 30/75 (40%), Gaps = 6/75 (8%)
Query: 439 LTELWLDGNFLT-GPLPDM-SRLIDLRIVHLENNELTG----SLPSYMGSLPNLQELHIE 492
+ L + L+ ++ L ++V L++ LT + S + P L EL++
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 493 NNSFVGEIPPALLTG 507
+N +L G
Sbjct: 64 SNELGDVGVHCVLQG 78
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 40.4 bits (93), Expect = 4e-04
Identities = 15/94 (15%), Positives = 29/94 (30%), Gaps = 4/94 (4%)
Query: 427 GEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNL 486
+I + L +T + + L + + N+++ + LPN+
Sbjct: 15 KQIFS-DDAFAETIKDNLKKKSVTDAVT-QNELNSIDQIIANNSDIKSVQG--IQYLPNV 70
Query: 487 QELHIENNSFVGEIPPALLTGKVIFKYDNNPKLH 520
+L + N P A L D N
Sbjct: 71 TKLFLNGNKLTDIKPLANLKNLGWLFLDENKVKD 104
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.4 bits (90), Expect = 6e-04
Identities = 23/127 (18%), Positives = 39/127 (30%), Gaps = 19/127 (14%)
Query: 395 DPCVPVPWEWVTCSTTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP 454
D C P + C+ + L E LTEL+++ L
Sbjct: 3 DACCPHGSSGLRCT-------------RDGAL-DSLHHLPGAENLTELYIENQQHLQHLE 48
Query: 455 D--MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG--KVI 510
+ L +LR + + + L P P L L++ N+ + + G
Sbjct: 49 LRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQE 107
Query: 511 FKYDNNP 517
NP
Sbjct: 108 LVLSGNP 114
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.7 bits (91), Expect = 0.001
Identities = 16/75 (21%), Positives = 29/75 (38%), Gaps = 2/75 (2%)
Query: 432 ELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 491
E+ + + E+ D LT PD+ + D I+HL N L + + L +L++
Sbjct: 5 EVSKVASHLEVNCDKRNLTALPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLTQLNL 62
Query: 492 ENNSFVGEIPPALLT 506
+ L
Sbjct: 63 DRAELTKLQVDGTLP 77
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Score = 38.4 bits (88), Expect = 0.003
Identities = 17/135 (12%), Positives = 45/135 (33%), Gaps = 10/135 (7%)
Query: 608 PELEEATNNF-CKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRI 666
PEL++ + C K +G + Y + + + + +K+ T E ++ +
Sbjct: 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGTTYDVEREKDMMLWL 66
Query: 667 HHRNLVP-LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGL 725
+ VP ++ + + L+ + D + +I A+ +
Sbjct: 67 EGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEE--------YEDEQSPEKIIELYAECI 118
Query: 726 EYLHTGCNPGIIHRD 740
H+ + +
Sbjct: 119 RLFHSIDISDCPYTN 133
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 38.3 bits (87), Expect = 0.004
Identities = 17/112 (15%), Positives = 33/112 (29%), Gaps = 29/112 (25%)
Query: 420 LSGKNLK---------GEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENN 470
+ GK+LK + L +++ E+ L GN +
Sbjct: 5 IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIG-------------------T 45
Query: 471 ELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFK-YDNNPKLHK 521
E L + S +L+ + +++ + PKLH
Sbjct: 46 EAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHT 97
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 935 | |||
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.79 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.7 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.32 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.15 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.06 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.06 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 98.99 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 98.99 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 98.94 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 98.94 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 98.92 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 98.79 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 98.73 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 98.72 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 98.58 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 98.5 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 98.49 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 98.39 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 98.36 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 98.35 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 98.26 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 98.24 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 98.22 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 98.19 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 98.18 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 98.11 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.11 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 98.1 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 98.0 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 97.72 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.69 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 97.62 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 97.6 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 97.4 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 97.24 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.02 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 96.59 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.54 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 95.94 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 95.81 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 95.64 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 95.58 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 95.4 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 95.39 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 95.37 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 93.9 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 93.14 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 89.67 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 86.77 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-47 Score=406.81 Aligned_cols=254 Identities=29% Similarity=0.475 Sum_probs=199.1
Q ss_pred HhhcccccccccEEEEEEEECCCcEEEEEEccCcchhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEecCCC
Q 002336 615 NNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNG 694 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~~~g 694 (935)
+++.+.||+|+||.||+|.+.+++.||||+++... ...++|.+|++++++++|||||+++|+|..++..++||||+++|
T Consensus 7 ~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g 85 (263)
T d1sm2a_ 7 LTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHG 85 (263)
T ss_dssp EEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTC
T ss_pred cEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCCC
Confidence 45678999999999999999989999999997543 34568999999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccccceee
Q 002336 695 TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISS 774 (935)
Q Consensus 695 sL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~ 774 (935)
+|.+++... ...+++..++.++.|+|+||+|||+ ++|+||||||+|||+++++.+||+|||+++...........
T Consensus 86 ~L~~~l~~~--~~~~~~~~~~~i~~qia~gl~~lH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~ 160 (263)
T d1sm2a_ 86 CLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST 160 (263)
T ss_dssp BHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCTTCSGGGEEECGGGCEEECSCC--------------
T ss_pred cHHHHhhcc--ccCCCHHHHHHHHHHHHHHHHhhhc---cceeecccchhheeecCCCCeEecccchheeccCCCceeec
Confidence 999998743 4668999999999999999999998 89999999999999999999999999999876554444444
Q ss_pred cccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhC-CCCCCccCcccchhHHHHHHHhhhcCCeeecccccccCCCC
Q 002336 775 VARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISG-KKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVK 853 (935)
Q Consensus 775 ~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG-~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~~~~ 853 (935)
...||+.|+|||++.+..++.++|||||||++|||+|+ ++|+.... ...+.+. +..+.. ...|
T Consensus 161 ~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~---~~~~~~~----i~~~~~--~~~p------- 224 (263)
T d1sm2a_ 161 GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS---NSEVVED----ISTGFR--LYKP------- 224 (263)
T ss_dssp ----CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCC---HHHHHHH----HHHTCC--CCCC-------
T ss_pred ceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCC---HHHHHHH----HHhcCC--CCCc-------
Confidence 45689999999999999999999999999999999995 55554221 1122222 222211 1111
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhhhh
Q 002336 854 IESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 890 (935)
Q Consensus 854 ~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~~~ 890 (935)
......+.+++.+||+.||++||||+||++.|+++..
T Consensus 225 ~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 225 RLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 1122468899999999999999999999999998754
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-47 Score=410.04 Aligned_cols=258 Identities=25% Similarity=0.425 Sum_probs=209.0
Q ss_pred HHHHhhcccccccccEEEEEEEECCCcEEEEEEccCcchhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEec
Q 002336 612 EATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 691 (935)
Q Consensus 612 ~~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~ 691 (935)
...+++.+.||+|+||.||+|.+++++.||||+++... ...+.|.+|+++|++++|||||+++|++.+ +..++||||+
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~ 89 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM 89 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeC
Confidence 34567789999999999999999988999999997543 345679999999999999999999998865 4679999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccccc
Q 002336 692 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 771 (935)
Q Consensus 692 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~ 771 (935)
++|+|.+++... ....+++..+++++.||++||+|||+ ++|+||||||+||||++++.+||+|||+++...+....
T Consensus 90 ~~g~L~~~~~~~-~~~~l~~~~~~~i~~qi~~gl~~lH~---~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~ 165 (272)
T d1qpca_ 90 ENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT 165 (272)
T ss_dssp TTCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE
T ss_pred CCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccchhheeeecccceeeccccceEEccCCccc
Confidence 999999987643 23458999999999999999999998 89999999999999999999999999999987655444
Q ss_pred eeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccCC
Q 002336 772 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 851 (935)
Q Consensus 772 ~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~~ 851 (935)
......||+.|+|||++.+..++.++|||||||++|||+||..|+.... ......+ .+..+... ..
T Consensus 166 ~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~--~~~~~~~----~i~~~~~~-----~~--- 231 (272)
T d1qpca_ 166 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM--TNPEVIQ----NLERGYRM-----VR--- 231 (272)
T ss_dssp CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTC--CHHHHHH----HHHTTCCC-----CC---
T ss_pred cccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCC--CHHHHHH----HHHhcCCC-----CC---
Confidence 4445568999999999988899999999999999999999665543121 1112222 22222111 11
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhhhh
Q 002336 852 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 890 (935)
Q Consensus 852 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~~~ 890 (935)
+......+.+++.+||+.+|++||||+||++.|++.-.
T Consensus 232 -p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 232 -PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp -CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -cccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 11223468899999999999999999999999987643
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-46 Score=403.34 Aligned_cols=258 Identities=29% Similarity=0.501 Sum_probs=201.7
Q ss_pred HHhhcccccccccEEEEEEEECCCcEEEEEEccCc--chhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEec
Q 002336 614 TNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 691 (935)
Q Consensus 614 ~~~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~~~~~--~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~ 691 (935)
.+.+.+.||+|+||.||+|+++ ..||||+++.. .....+.|.+|+++|++++|||||+++|++.+ +..++||||+
T Consensus 9 ~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~Ey~ 85 (276)
T d1uwha_ 9 QITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQWC 85 (276)
T ss_dssp CCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred cEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEecC
Confidence 3556789999999999999876 36999998643 33456789999999999999999999999865 4689999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccccccc-
Q 002336 692 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT- 770 (935)
Q Consensus 692 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~- 770 (935)
++|+|.+++... +..+++..++.++.|+++||+|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 86 ~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~gl~yLH~---~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~ 160 (276)
T d1uwha_ 86 EGSSLYHHLHII--ETKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS 160 (276)
T ss_dssp CEEEHHHHHHTS--CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTSSEEECCCCCSCC-------
T ss_pred CCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHhc---CCEeccccCHHHEEEcCCCCEEEccccceeeccccCCc
Confidence 999999999743 4569999999999999999999998 8999999999999999999999999999987644322
Q ss_pred ceeecccCCccccCCCCCCC---CCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeeccccc
Q 002336 771 HISSVARGTVGYLDPEYYGN---QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 847 (935)
Q Consensus 771 ~~~~~~~gt~~y~APE~l~~---~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~ 847 (935)
.......||+.|+|||++.+ ..++.++|||||||++|||+||+.||....... . +...+..+.....+.
T Consensus 161 ~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~--~----~~~~~~~~~~~p~~~-- 232 (276)
T d1uwha_ 161 HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD--Q----IIFMVGRGYLSPDLS-- 232 (276)
T ss_dssp -----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH--H----HHHHHHHTSCCCCGG--
T ss_pred ccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHH--H----HHHHHhcCCCCCcch--
Confidence 22334569999999998854 358999999999999999999999997432211 1 122222222111110
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhhhh
Q 002336 848 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 890 (935)
Q Consensus 848 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~~~ 890 (935)
..+...+..+.+++.+||+.+|++|||++||++.|+.+..
T Consensus 233 ---~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~ 272 (276)
T d1uwha_ 233 ---KVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR 272 (276)
T ss_dssp ---GSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---hccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 1122223478899999999999999999999999998765
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=7e-47 Score=411.34 Aligned_cols=259 Identities=28% Similarity=0.408 Sum_probs=213.0
Q ss_pred HHHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcchhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEe
Q 002336 612 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 690 (935)
Q Consensus 612 ~~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~ 690 (935)
...+++.+.||+|+||+||+|.++ +|+.||||+++... ...++|.+|+++|++++|||||+++|+|.+++..++||||
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~ 94 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 94 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeec
Confidence 345677899999999999999986 58899999987543 3456799999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccccccc
Q 002336 691 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 770 (935)
Q Consensus 691 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~ 770 (935)
+++|+|.+++... ....+++..++.++.|+++||+|||+ ++|+||||||+|||+++++.+||+|||+++.......
T Consensus 95 ~~~g~l~~~l~~~-~~~~~~~~~~~~i~~qi~~gL~yLH~---~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~ 170 (287)
T d1opja_ 95 MTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 170 (287)
T ss_dssp CTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSS
T ss_pred ccCcchHHHhhhc-cccchHHHHHHHHHHHHHHHHHHHHH---CCcccCccccCeEEECCCCcEEEccccceeecCCCCc
Confidence 9999999998754 35679999999999999999999998 8999999999999999999999999999998765544
Q ss_pred ceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccC
Q 002336 771 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 850 (935)
Q Consensus 771 ~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~ 850 (935)
.......|++.|+|||++.+..++.++|||||||++|||++|..|+..... ...+. +.+..+...
T Consensus 171 ~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~--~~~~~----~~i~~~~~~--------- 235 (287)
T d1opja_ 171 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID--LSQVY----ELLEKDYRM--------- 235 (287)
T ss_dssp EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCC--HHHHH----HHHHTTCCC---------
T ss_pred eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcch--HHHHH----HHHhcCCCC---------
Confidence 444445689999999999989999999999999999999997777642211 11122 222222111
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhhhh
Q 002336 851 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 890 (935)
Q Consensus 851 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~~~ 890 (935)
..+......+.+++.+||+.||++|||++||++.|+.+..
T Consensus 236 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~ 275 (287)
T d1opja_ 236 ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275 (287)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 1122223468899999999999999999999999987643
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=9e-46 Score=404.93 Aligned_cols=254 Identities=27% Similarity=0.479 Sum_probs=197.3
Q ss_pred hcccccccccEEEEEEEECC-C---cEEEEEEccCcc-hhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEec
Q 002336 617 FCKKIGKGSFGSVYYGKMKD-G---KEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 691 (935)
Q Consensus 617 ~~~~LG~G~fG~Vy~~~~~~-g---~~vAvK~~~~~~-~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~ 691 (935)
+.+.||+|+||+||+|.++. + ..||||++.... ....+.|.+|+++|++++|||||+++|++.+++..++||||+
T Consensus 30 ~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~Ey~ 109 (299)
T d1jpaa_ 30 IEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFM 109 (299)
T ss_dssp EEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred EeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEec
Confidence 35689999999999998752 3 258999886543 344578999999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccccc
Q 002336 692 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 771 (935)
Q Consensus 692 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~ 771 (935)
++|+|.+++.. ....+++.++++++.|||+||+|||+ ++|+||||||+||||+.++.+||+|||+++........
T Consensus 110 ~~g~L~~~~~~--~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~ 184 (299)
T d1jpaa_ 110 ENGSLDSFLRQ--NDGQFTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSD 184 (299)
T ss_dssp TTEEHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC------------
T ss_pred CCCcceeeecc--ccCCCCHHHHHHHHHHHHHHHHHHhh---CCCccCccccceEEECCCCcEEECCcccceEccCCCCc
Confidence 99999998874 24569999999999999999999998 89999999999999999999999999999876543221
Q ss_pred e----eecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCcccchhHHHHHHHhhhcCCeeecccc
Q 002336 772 I----SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP 846 (935)
Q Consensus 772 ~----~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~ 846 (935)
. .....||+.|+|||.+.+..++.++|||||||++|||+| |+.||..... ..+.. .+..+...
T Consensus 185 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~---~~~~~----~i~~~~~~----- 252 (299)
T d1jpaa_ 185 PTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN---QDVIN----AIEQDYRL----- 252 (299)
T ss_dssp -----------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHH----HHHTTCCC-----
T ss_pred ceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCH---HHHHH----HHHcCCCC-----
Confidence 1 112347899999999999999999999999999999998 8999974322 12222 22222111
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhhhhh
Q 002336 847 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 891 (935)
Q Consensus 847 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~~~~ 891 (935)
..+.+....+.+++.+||+.+|++|||++||++.|++++.-
T Consensus 253 ----~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~ 293 (299)
T d1jpaa_ 253 ----PPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293 (299)
T ss_dssp ----CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred ----CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence 11222344688999999999999999999999999988763
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-45 Score=400.05 Aligned_cols=248 Identities=24% Similarity=0.370 Sum_probs=205.6
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcchhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEecC
Q 002336 614 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 692 (935)
Q Consensus 614 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~~ 692 (935)
.|++.+.||+|+||+||+|.+. +|+.||||++........+.+.+|+++|++++|||||++++++.+++..++||||++
T Consensus 21 ~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~ 100 (293)
T d1yhwa1 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLA 100 (293)
T ss_dssp TBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred ccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecC
Confidence 3667789999999999999875 699999999876544556789999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccccce
Q 002336 693 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 772 (935)
Q Consensus 693 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~~ 772 (935)
+|+|.+++.. ..+++.++..++.||+.||+|||+ ++|+||||||+|||++.++++||+|||+++........
T Consensus 101 gg~L~~~~~~----~~l~~~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~- 172 (293)
T d1yhwa1 101 GGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK- 172 (293)
T ss_dssp TCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC-
T ss_pred CCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCcHHHeEECCCCcEeeccchhheeecccccc-
Confidence 9999998863 469999999999999999999998 89999999999999999999999999999876543322
Q ss_pred eecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccCCC
Q 002336 773 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNV 852 (935)
Q Consensus 773 ~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~~~ 852 (935)
.....||+.|+|||++.+..++.++||||+||++|||++|+.||...... +........+.. .. ..
T Consensus 173 ~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~------~~~~~~~~~~~~-~~-------~~ 238 (293)
T d1yhwa1 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL------RALYLIATNGTP-EL-------QN 238 (293)
T ss_dssp BCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHHCSC-CC-------SS
T ss_pred ccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHH------HHHHHHHhCCCC-CC-------CC
Confidence 33456999999999999999999999999999999999999999743221 112222222211 11 11
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 853 KIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 853 ~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
+......+.+++.+||+.||++|||++|+++
T Consensus 239 ~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 239 PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp GGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred cccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1222346889999999999999999999865
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-45 Score=397.11 Aligned_cols=249 Identities=24% Similarity=0.370 Sum_probs=200.0
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc-hhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEecC
Q 002336 615 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 692 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~-~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~~ 692 (935)
|++.+.||+|+||+||+|+++ +|+.||||++.... .+..+.+.+|+++|++++|||||++++++.+++..++||||++
T Consensus 7 y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~ 86 (271)
T d1nvra_ 7 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCS 86 (271)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred eEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEeccC
Confidence 567899999999999999986 68999999986543 2334679999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccc-cc
Q 002336 693 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL-TH 771 (935)
Q Consensus 693 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~-~~ 771 (935)
+|+|.+++. ....+++.++..++.|+++||+|||+ ++|+||||||+|||+++++.+||+|||+|+...... ..
T Consensus 87 gg~L~~~l~---~~~~l~e~~~~~i~~qi~~al~ylH~---~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~ 160 (271)
T d1nvra_ 87 GGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 160 (271)
T ss_dssp TEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred CCcHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH---cCCccCcccHHHEEECCCCCEEEccchhheeeccCCccc
Confidence 999999997 35679999999999999999999998 899999999999999999999999999998764332 22
Q ss_pred eeecccCCccccCCCCCCCCCC-CchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccC
Q 002336 772 ISSVARGTVGYLDPEYYGNQQL-TEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 850 (935)
Q Consensus 772 ~~~~~~gt~~y~APE~l~~~~~-s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~ 850 (935)
......||+.|+|||++.+..+ +.++||||+||++|||++|+.||....... .....+ ....... .
T Consensus 161 ~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~-~~~~~~----~~~~~~~---~----- 227 (271)
T d1nvra_ 161 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDW----KEKKTYL---N----- 227 (271)
T ss_dssp CBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTS-HHHHHH----HTTCTTS---T-----
T ss_pred cccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHH-HHHHHH----hcCCCCC---C-----
Confidence 2344679999999999987765 578999999999999999999997433221 111111 1111100 0
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 851 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 851 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
........+.+++.+||+.||++|||++|+++
T Consensus 228 -~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 228 -PWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp -TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 00112236779999999999999999999864
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-45 Score=394.50 Aligned_cols=252 Identities=28% Similarity=0.479 Sum_probs=210.5
Q ss_pred HhhcccccccccEEEEEEEECCCcEEEEEEccCcchhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEecCCC
Q 002336 615 NNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNG 694 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~~~g 694 (935)
+++.++||+|+||+||+|++++++.||||+++.... ..++|.+|+.++++++||||++++|+|.+++..++||||+++|
T Consensus 6 ~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g 84 (258)
T d1k2pa_ 6 LTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANG 84 (258)
T ss_dssp CCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTTE
T ss_pred CEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCCC
Confidence 356889999999999999999889999999876433 3568999999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccccceee
Q 002336 695 TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISS 774 (935)
Q Consensus 695 sL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~~~~ 774 (935)
+|.+++... ...+++..+++++.|+++||+|||+ ++|+||||||+|||+++++.+||+|||+++...........
T Consensus 85 ~l~~~~~~~--~~~~~~~~~~~i~~qi~~gl~~LH~---~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~ 159 (258)
T d1k2pa_ 85 CLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV 159 (258)
T ss_dssp EHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHH---TTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCC
T ss_pred cHHHhhhcc--ccCCcHHHHHHHHHHHHHHHHHHhh---cCcccccccceeEEEcCCCcEEECcchhheeccCCCceeec
Confidence 999987643 4568899999999999999999998 89999999999999999999999999999876554443344
Q ss_pred cccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccCCCC
Q 002336 775 VARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVK 853 (935)
Q Consensus 775 ~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~~~~ 853 (935)
...||+.|+|||.+.+..++.++||||||+++|||+| |+.||...... . +...+.++... ..|
T Consensus 160 ~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~---~----~~~~i~~~~~~--~~p------- 223 (258)
T d1k2pa_ 160 GSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS---E----TAEHIAQGLRL--YRP------- 223 (258)
T ss_dssp CSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHH---H----HHHHHHTTCCC--CCC-------
T ss_pred ccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHH---H----HHHHHHhCCCC--CCc-------
Confidence 4568999999999998899999999999999999998 89999743321 1 12233333211 111
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhh
Q 002336 854 IESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 888 (935)
Q Consensus 854 ~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~ 888 (935)
......+.+++.+||+.+|++|||++||++.|.++
T Consensus 224 ~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 224 HLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred ccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 12224688999999999999999999999998753
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-45 Score=394.37 Aligned_cols=243 Identities=26% Similarity=0.425 Sum_probs=203.4
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc---hhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEe
Q 002336 615 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 690 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~ 690 (935)
|++.+.||+|+||.||+|+++ +|+.||+|++.... ....+.+.+|++++++++|||||++++++.+++..++||||
T Consensus 8 y~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmEy 87 (263)
T d2j4za1 8 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEY 87 (263)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred eEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEee
Confidence 667899999999999999986 68999999986432 22346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccccccc
Q 002336 691 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 770 (935)
Q Consensus 691 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~ 770 (935)
+++|+|.+++.. ...+++..+..++.||++||+|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 88 ~~~g~L~~~l~~---~~~l~e~~~~~i~~qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~- 160 (263)
T d2j4za1 88 APLGTVYRELQK---LSKFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR- 160 (263)
T ss_dssp CTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC-
T ss_pred cCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeeeeccccceecCCCCEeecccceeeecCCCc-
Confidence 999999999973 4579999999999999999999998 899999999999999999999999999998764432
Q ss_pred ceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccC
Q 002336 771 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 850 (935)
Q Consensus 771 ~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~ 850 (935)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||......+ . ...+..+.. .+
T Consensus 161 --~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~---~----~~~i~~~~~------~~-- 223 (263)
T d2j4za1 161 --RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE---T----YKRISRVEF------TF-- 223 (263)
T ss_dssp --CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH---H----HHHHHTTCC------CC--
T ss_pred --ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHH---H----HHHHHcCCC------CC--
Confidence 234569999999999999999999999999999999999999997433211 1 122222221 11
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 851 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 851 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
+......+.+++.+||+.||++|||++|+++
T Consensus 224 --p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 224 --PDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp --CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --CccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 1112346789999999999999999999975
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-45 Score=397.24 Aligned_cols=249 Identities=22% Similarity=0.358 Sum_probs=204.3
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCcchhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEecCC
Q 002336 615 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 693 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~~~ 693 (935)
|++.+.||+|+||.||+|++. +|+.||||++........+.+.+|+++|++++|||||++++++.+++..++||||+++
T Consensus 14 Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~ 93 (288)
T d2jfla1 14 WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred eEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCCC
Confidence 567889999999999999976 6899999999776666678899999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccccccccee
Q 002336 694 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 773 (935)
Q Consensus 694 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~~~ 773 (935)
|+|.+++... ...+++.++..++.||++||.|||+ ++|+||||||+|||++.++.+||+|||+++....... ..
T Consensus 94 g~L~~~~~~~--~~~l~e~~~~~i~~qi~~gL~ylH~---~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~-~~ 167 (288)
T d2jfla1 94 GAVDAVMLEL--ERPLTESQIQVVCKQTLDALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ-RR 167 (288)
T ss_dssp EEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHH-HH
T ss_pred CcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCEEEeecChhheeECCCCCEEEEechhhhccCCCcc-cc
Confidence 9999987642 4569999999999999999999998 8999999999999999999999999999976543222 12
Q ss_pred ecccCCccccCCCCCC-----CCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccccc
Q 002336 774 SVARGTVGYLDPEYYG-----NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 848 (935)
Q Consensus 774 ~~~~gt~~y~APE~l~-----~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l 848 (935)
....||+.|+|||++. +..++.++|||||||++|||++|+.||......+ .. .... .+......
T Consensus 168 ~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~---~~---~~i~-~~~~~~~~---- 236 (288)
T d2jfla1 168 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR---VL---LKIA-KSEPPTLA---- 236 (288)
T ss_dssp TCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG---HH---HHHH-HSCCCCCS----
T ss_pred cccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH---HH---HHHH-cCCCCCCC----
Confidence 2356999999999873 4568899999999999999999999997433221 11 1111 12211111
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 849 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 849 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
.+......+.+++.+||+.||++|||++|+++
T Consensus 237 ---~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 237 ---QPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp ---SGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ---ccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11222346889999999999999999999865
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-44 Score=388.30 Aligned_cols=244 Identities=29% Similarity=0.432 Sum_probs=195.9
Q ss_pred hhcccccccccEEEEEEEEC-CCcEEEEEEccCc--chhhhHHHHHHHHHHHhcCCCcccccceeeec----cceEEEEE
Q 002336 616 NFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEE----EHQRILVY 688 (935)
Q Consensus 616 ~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~--~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~----~~~~~lV~ 688 (935)
++.++||+|+||+||+|.+. +++.||+|++... .....+.+.+|+++|++++|||||++++++.+ +...++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 45678999999999999886 6889999998653 23345679999999999999999999999864 45679999
Q ss_pred EecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCc--eEecCCCCCCcccc-CCCcEEEeeccccccc
Q 002336 689 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG--IIHRDVKSSNILLD-INMRAKVSDFGLSRQA 765 (935)
Q Consensus 689 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~--ivH~DLkp~NILld-~~~~vkL~DFGla~~~ 765 (935)
||+++|+|.+++.. ...+++..+..++.||++||+|||+ ++ |+||||||+|||++ +++.+||+|||+++..
T Consensus 92 E~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~gl~yLH~---~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~ 165 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 165 (270)
T ss_dssp ECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred eCCCCCcHHHHHhc---cccccHHHHHHHHHHHHHHHHHHHH---CCCCEEeCCcChhhceeeCCCCCEEEeecCcceec
Confidence 99999999999974 4579999999999999999999997 66 99999999999996 5789999999999864
Q ss_pred cccccceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeeccc
Q 002336 766 EEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 845 (935)
Q Consensus 766 ~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d 845 (935)
.... .....||+.|+|||++.+ .++.++|||||||++|||++|+.||...... .. +.+.+..+.....++
T Consensus 166 ~~~~---~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~--~~----~~~~i~~~~~~~~~~ 235 (270)
T d1t4ha_ 166 RASF---AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA--AQ----IYRRVTSGVKPASFD 235 (270)
T ss_dssp CTTS---BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH--HH----HHHHHTTTCCCGGGG
T ss_pred cCCc---cCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccH--HH----HHHHHHcCCCCcccC
Confidence 3322 234579999999999876 5899999999999999999999999632211 11 122233332211111
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 846 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 846 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
+ .. ...+.+++.+||+.||++|||++|+++
T Consensus 236 ~----~~----~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 236 K----VA----IPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp G----CC----CHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred c----cC----CHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 1 11 225789999999999999999999975
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-45 Score=393.92 Aligned_cols=252 Identities=26% Similarity=0.379 Sum_probs=192.4
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc--hhhhHHHHHHHHHHHhcCCCcccccceeeec--cceEEEEEE
Q 002336 615 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEE--EHQRILVYE 689 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~--~~~~~lV~E 689 (935)
|++.+.||+|+||.||+|+.+ +|+.||||++.... ....+.+.+|+++|++++|||||++++++.+ .+..++|||
T Consensus 6 y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivmE 85 (269)
T d2java1 6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVME 85 (269)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEEE
T ss_pred CEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEEe
Confidence 667899999999999999875 68999999986542 3345678999999999999999999998854 456899999
Q ss_pred ecCCCCHHHHhccCC-CCCCCCHHHHHHHHHHHHHHhHHhhhcC--CCceEecCCCCCCccccCCCcEEEeecccccccc
Q 002336 690 YMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGC--NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 766 (935)
Q Consensus 690 ~~~~gsL~~~L~~~~-~~~~l~~~~~~~i~~qia~gL~yLHs~~--~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~ 766 (935)
|+++|+|.+++.... .+..+++..++.++.|++.||+|||+.. ..+|+||||||+|||++.++.+||+|||+++...
T Consensus 86 y~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~ 165 (269)
T d2java1 86 YCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILN 165 (269)
T ss_dssp CCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC-
T ss_pred cCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeecc
Confidence 999999999886432 3567999999999999999999999721 1249999999999999999999999999998765
Q ss_pred ccccceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccc
Q 002336 767 EDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP 846 (935)
Q Consensus 767 ~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~ 846 (935)
..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+.. . +...+.++....+
T Consensus 166 ~~~~~-~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~---~----~~~~i~~~~~~~~--- 234 (269)
T d2java1 166 HDTSF-AKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK---E----LAGKIREGKFRRI--- 234 (269)
T ss_dssp -----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH---H----HHHHHHHTCCCCC---
T ss_pred cCCCc-cccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHH---H----HHHHHHcCCCCCC---
Confidence 43322 23456999999999999999999999999999999999999999743221 1 1222333333221
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 847 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 847 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
...+ ...+.+++.+||+.||++|||++|+++
T Consensus 235 --~~~~----s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 235 --PYRY----SDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp --CTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --Cccc----CHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 1122 236889999999999999999999874
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-45 Score=399.04 Aligned_cols=257 Identities=29% Similarity=0.466 Sum_probs=200.8
Q ss_pred HhhcccccccccEEEEEEEECCC-----cEEEEEEccCcch-hhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEE
Q 002336 615 NNFCKKIGKGSFGSVYYGKMKDG-----KEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 688 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~~g-----~~vAvK~~~~~~~-~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~ 688 (935)
+++.+.||+|+||.||+|.++.. ..||||++..... ....+|.+|+++|++++|||||+++|++.+.+..++||
T Consensus 9 ~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~ 88 (283)
T d1mqba_ 9 VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIIT 88 (283)
T ss_dssp EEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred eEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEEE
Confidence 45578999999999999987642 3799999865433 34567999999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccccc
Q 002336 689 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 768 (935)
Q Consensus 689 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~ 768 (935)
||+.++++.+.+... ...+++.++++++.|++.||+|||+ ++|+||||||+||||+.++.+||+|||+++.....
T Consensus 89 e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~~i~~gl~~lH~---~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~ 163 (283)
T d1mqba_ 89 EYMENGALDKFLREK--DGEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 163 (283)
T ss_dssp ECCTTEEHHHHHHHT--TTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred EecccCcchhhhhcc--cccccHHHHHHHHHHHHHhhhhccc---cccccCccccceEEECCCCeEEEcccchhhcccCC
Confidence 999999999987643 4679999999999999999999998 89999999999999999999999999999876443
Q ss_pred ccc--eeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccc
Q 002336 769 LTH--ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP 846 (935)
Q Consensus 769 ~~~--~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~ 846 (935)
... ......||+.|+|||++.+..++.++|||||||++|||++|..|+..... ...+.+ .+..+...
T Consensus 164 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~--~~~~~~----~i~~~~~~----- 232 (283)
T d1mqba_ 164 PEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS--NHEVMK----AINDGFRL----- 232 (283)
T ss_dssp ----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--HHHHHH----HHHTTCCC-----
T ss_pred CccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCC--HHHHHH----HHhccCCC-----
Confidence 221 22334589999999999999999999999999999999997666542221 112222 22222111
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhhhhh
Q 002336 847 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 891 (935)
Q Consensus 847 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~~~~ 891 (935)
..+...+..+.+++.+||+.+|++||||+||++.|++++..
T Consensus 233 ----~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 233 ----PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp ----CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred ----CCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence 11222334688999999999999999999999999987764
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-44 Score=391.13 Aligned_cols=253 Identities=25% Similarity=0.435 Sum_probs=206.0
Q ss_pred hcc-cccccccEEEEEEEEC---CCcEEEEEEccCcc-hhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEec
Q 002336 617 FCK-KIGKGSFGSVYYGKMK---DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 691 (935)
Q Consensus 617 ~~~-~LG~G~fG~Vy~~~~~---~g~~vAvK~~~~~~-~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~ 691 (935)
+.+ +||+|+||.||+|.++ ++..||||+++... ....++|.+|+++|++++|||||+++|++.. +..++||||+
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvmE~~ 90 (285)
T d1u59a_ 12 IADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMA 90 (285)
T ss_dssp EEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECC
T ss_pred ECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEEEeC
Confidence 345 4999999999999875 35579999987543 3456789999999999999999999999965 4689999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccccc
Q 002336 692 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 771 (935)
Q Consensus 692 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~ 771 (935)
++|+|.+++.. .+..+++..+++++.|+++||+|||+ ++|+||||||+|||++.++.+||+|||+++........
T Consensus 91 ~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~gL~ylH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~ 165 (285)
T d1u59a_ 91 GGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSY 165 (285)
T ss_dssp TTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCE
T ss_pred CCCcHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCcCchhheeeccCCceeeccchhhhcccccccc
Confidence 99999998764 34579999999999999999999998 89999999999999999999999999999876543322
Q ss_pred --eeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCcccchhHHHHHHHhhhcCCeeecccccc
Q 002336 772 --ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 848 (935)
Q Consensus 772 --~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l 848 (935)
......||+.|+|||++.+..++.++|||||||++|||+| |+.||...... .+. ..+..+...+.
T Consensus 166 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~---~~~----~~i~~~~~~~~----- 233 (285)
T d1u59a_ 166 YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP---EVM----AFIEQGKRMEC----- 233 (285)
T ss_dssp ECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH---HHH----HHHHTTCCCCC-----
T ss_pred cccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH---HHH----HHHHcCCCCCC-----
Confidence 2233458999999999988899999999999999999998 99999743321 222 23333332211
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhhhhh
Q 002336 849 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 891 (935)
Q Consensus 849 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~~~~ 891 (935)
+...+..+.+++.+||+.+|++|||+.+|++.|+.....
T Consensus 234 ----p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 234 ----PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp ----CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----CCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 122234688999999999999999999999999876543
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-44 Score=391.18 Aligned_cols=247 Identities=28% Similarity=0.470 Sum_probs=199.4
Q ss_pred ccccccccEEEEEEEECC---CcEEEEEEccCcc--hhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEecCC
Q 002336 619 KKIGKGSFGSVYYGKMKD---GKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 693 (935)
Q Consensus 619 ~~LG~G~fG~Vy~~~~~~---g~~vAvK~~~~~~--~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~~~ 693 (935)
++||+|+||.||+|.+++ ++.||||+++... ....++|.+|+++|++++|||||+++|+|..+ ..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCCC
Confidence 579999999999998753 4689999986532 23456899999999999999999999999654 57899999999
Q ss_pred CCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccccce-
Q 002336 694 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI- 772 (935)
Q Consensus 694 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~~- 772 (935)
|+|.+++.. ...+++..+++++.||++||+|||+ ++|+||||||+|||++.++.+||+|||+++.........
T Consensus 92 g~L~~~l~~---~~~l~~~~~~~i~~qi~~gl~ylH~---~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~ 165 (277)
T d1xbba_ 92 GPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 165 (277)
T ss_dssp EEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE
T ss_pred CcHHHHHhh---ccCCCHHHHHHHHHHHHHHHhhHHh---CCcccCCCcchhhcccccCcccccchhhhhhccccccccc
Confidence 999999874 4679999999999999999999998 899999999999999999999999999998765433222
Q ss_pred -eecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccC
Q 002336 773 -SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 850 (935)
Q Consensus 773 -~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~ 850 (935)
.....||+.|+|||.+.+..++.++|||||||++|||+| |+.||...... . +...+..+....
T Consensus 166 ~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~---~----~~~~i~~~~~~~-------- 230 (277)
T d1xbba_ 166 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS---E----VTAMLEKGERMG-------- 230 (277)
T ss_dssp C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---H----HHHHHHTTCCCC--------
T ss_pred cccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHH---H----HHHHHHcCCCCC--------
Confidence 233468999999999988899999999999999999998 89999743221 1 222333332211
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhh
Q 002336 851 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 888 (935)
Q Consensus 851 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~ 888 (935)
.+...+..+.+++.+||+.||++|||+++|++.|+..
T Consensus 231 -~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~ 267 (277)
T d1xbba_ 231 -CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 267 (277)
T ss_dssp -CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred -CCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence 1122234688999999999999999999999988764
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-45 Score=395.38 Aligned_cols=258 Identities=26% Similarity=0.416 Sum_probs=203.1
Q ss_pred HHHhhcccccccccEEEEEEEECCCcEEEEEEccCcchhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEecC
Q 002336 613 ATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 692 (935)
Q Consensus 613 ~~~~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~~ 692 (935)
..+++.+.||+|+||.||+|.+++++.||||+++.. ....+.|.+|+.+|++++|||||+++|++.+ +..++||||++
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~ 94 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS 94 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecC
Confidence 357788999999999999999998889999999754 3345789999999999999999999999965 56789999999
Q ss_pred CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccccce
Q 002336 693 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 772 (935)
Q Consensus 693 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~~ 772 (935)
+|+|.+.+... ....+++.+++.++.||++||+|||+ ++|+||||||+||||+.++.+||+|||+++.........
T Consensus 95 ~g~l~~~~~~~-~~~~l~~~~~~~i~~~i~~gl~~LH~---~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 170 (285)
T d1fmka3 95 KGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 170 (285)
T ss_dssp TCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred CCchhhhhhhc-ccccchHHHHHHHHHHHHHHHHHHhh---hheecccccceEEEECCCCcEEEcccchhhhccCCCcee
Confidence 99999988743 23469999999999999999999998 899999999999999999999999999998765544433
Q ss_pred eecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccCCC
Q 002336 773 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNV 852 (935)
Q Consensus 773 ~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~~~ 852 (935)
.....||+.|+|||++....++.++|||||||++|||++|..|+..... ......++ ..+... . .
T Consensus 171 ~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~--~~~~~~~i----~~~~~~-----~----~ 235 (285)
T d1fmka3 171 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV--NREVLDQV----ERGYRM-----P----C 235 (285)
T ss_dssp -----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC--HHHHHHHH----HTTCCC-----C----C
T ss_pred eccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCC--HHHHHHHH----HhcCCC-----C----C
Confidence 4445689999999999999999999999999999999997666542211 11222222 222111 1 1
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhhhhh
Q 002336 853 KIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 891 (935)
Q Consensus 853 ~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~~~~ 891 (935)
+......+.+++.+||+.||++||++++|+++|++....
T Consensus 236 ~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~ 274 (285)
T d1fmka3 236 PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 274 (285)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred CcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcC
Confidence 122234688999999999999999999999999886643
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-45 Score=402.13 Aligned_cols=257 Identities=27% Similarity=0.433 Sum_probs=205.0
Q ss_pred HHHHhhcccccccccEEEEEEEECC-C-----cEEEEEEccCcc-hhhhHHHHHHHHHHHhc-CCCcccccceeeeccce
Q 002336 612 EATNNFCKKIGKGSFGSVYYGKMKD-G-----KEVAVKIMADSC-SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQ 683 (935)
Q Consensus 612 ~~~~~~~~~LG~G~fG~Vy~~~~~~-g-----~~vAvK~~~~~~-~~~~~~~~~E~~iL~~L-~HpnIv~l~g~~~~~~~ 683 (935)
...+++.+.||+|+||+||+|++.. + ..||+|++.... ......+.+|+.+|.++ +|||||++++++.+.+.
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~ 115 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 115 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence 3456788999999999999998753 2 369999986543 33456799999999998 89999999999999999
Q ss_pred EEEEEEecCCCCHHHHhccCCC--------------------CCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCC
Q 002336 684 RILVYEYMHNGTLRDRLHGSVN--------------------QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKS 743 (935)
Q Consensus 684 ~~lV~E~~~~gsL~~~L~~~~~--------------------~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp 743 (935)
.++||||+++|+|.++++.... ...+++..++.++.|+++||+|||+ ++|+||||||
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~---~~IiHRDlKp 192 (325)
T d1rjba_ 116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAA 192 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEETTCSG
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCch
Confidence 9999999999999999975421 2358999999999999999999998 8999999999
Q ss_pred CCccccCCCcEEEeeccccccccccccc-eeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCc
Q 002336 744 SNILLDINMRAKVSDFGLSRQAEEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDF 821 (935)
Q Consensus 744 ~NILld~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLlt-G~~Pf~~~~~ 821 (935)
+|||++.++.+||+|||+|+........ ......||+.|+|||.+.+..++.++|||||||++|||+| |+.||.+...
T Consensus 193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~ 272 (325)
T d1rjba_ 193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 272 (325)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred hccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCH
Confidence 9999999999999999999876544332 2234458999999999999999999999999999999998 8999974333
Q ss_pred ccchhHHHHHHHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 002336 822 GAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 886 (935)
Q Consensus 822 ~~~~~l~~~~~~~i~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~ 886 (935)
. ..+. +.++.+... ..+......+.+++.+||+.+|++|||++||+++|.
T Consensus 273 ~--~~~~----~~~~~~~~~---------~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 273 D--ANFY----KLIQNGFKM---------DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp S--HHHH----HHHHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred H--HHHH----HHHhcCCCC---------CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 2 1222 222222111 112222346889999999999999999999999985
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-45 Score=401.41 Aligned_cols=200 Identities=27% Similarity=0.394 Sum_probs=175.8
Q ss_pred HHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc-hhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEe
Q 002336 613 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 690 (935)
Q Consensus 613 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~-~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~ 690 (935)
..|++.+.||+|+||+||+|++. +|+.||+|+++... ....+.+.+|+.+|++++|||||+++++|.++++.++||||
T Consensus 6 d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy 85 (322)
T d1s9ja_ 6 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 85 (322)
T ss_dssp GGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred cCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 34667889999999999999975 68999999987543 33456789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccccccc
Q 002336 691 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 770 (935)
Q Consensus 691 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~ 770 (935)
+++|+|.+++.. ...+++..+..++.|+++||.|||+ ..+|+||||||+|||+++++++||+|||+|+...+..
T Consensus 86 ~~gg~L~~~l~~---~~~l~~~~~~~~~~qil~aL~yLH~--~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~- 159 (322)
T d1s9ja_ 86 MDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM- 159 (322)
T ss_dssp CTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH--HHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHT-
T ss_pred CCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHH--hCCEEccccCHHHeeECCCCCEEEeeCCCccccCCCc-
Confidence 999999999974 4569999999999999999999997 1489999999999999999999999999998754322
Q ss_pred ceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccC
Q 002336 771 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 820 (935)
Q Consensus 771 ~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~ 820 (935)
.....||+.|+|||++.+..++.++||||+||++|||++|+.||...+
T Consensus 160 --~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~ 207 (322)
T d1s9ja_ 160 --ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD 207 (322)
T ss_dssp --C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCC
T ss_pred --cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 234579999999999999999999999999999999999999997543
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-44 Score=393.76 Aligned_cols=246 Identities=24% Similarity=0.350 Sum_probs=201.3
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc---hhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEe
Q 002336 615 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 690 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~ 690 (935)
|++.+.||+|+||+||+|++. +|+.||||++.... ....+.+.+|+++|++++|||||++++++.+++..++||||
T Consensus 10 y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy 89 (288)
T d1uu3a_ 10 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSY 89 (288)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEECC
T ss_pred CEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEEc
Confidence 678899999999999999985 68999999986432 22346789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccccccc
Q 002336 691 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 770 (935)
Q Consensus 691 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~ 770 (935)
+++|+|.+++.. .+.+++..+..++.|++.||+|||+ ++|+||||||+|||+++++.+||+|||+++.......
T Consensus 90 ~~gg~L~~~~~~---~~~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~ 163 (288)
T d1uu3a_ 90 AKNGELLKYIRK---IGSFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 163 (288)
T ss_dssp CTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred cCCCCHHHhhhc---cCCCCHHHHHHHHHHHHHHHHhhcc---ccEEcCcCCccccccCCCceEEecccccceecccCCc
Confidence 999999998873 4679999999999999999999998 8999999999999999999999999999987654322
Q ss_pred -ceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeeccccccc
Q 002336 771 -HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 849 (935)
Q Consensus 771 -~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~ 849 (935)
.......||+.|+|||++.+..++.++||||+||++|||++|+.||...+.. .+ ...+..+.. .+.
T Consensus 164 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~---~~----~~~i~~~~~------~~p 230 (288)
T d1uu3a_ 164 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEY---LI----FQKIIKLEY------DFP 230 (288)
T ss_dssp ------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HH----HHHHHTTCC------CCC
T ss_pred ccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHH---HH----HHHHHcCCC------CCC
Confidence 2233456999999999999999999999999999999999999999743221 11 122222221 111
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 850 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 850 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
.. ....+.+++.+||+.||++|||++|+.+
T Consensus 231 ~~----~s~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 231 EK----FFPKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp TT----CCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred cc----CCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 11 2236789999999999999999998743
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-44 Score=387.76 Aligned_cols=259 Identities=25% Similarity=0.407 Sum_probs=199.6
Q ss_pred HHHhhcccccccccEEEEEEEECC----CcEEEEEEccCcch-hhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEE
Q 002336 613 ATNNFCKKIGKGSFGSVYYGKMKD----GKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILV 687 (935)
Q Consensus 613 ~~~~~~~~LG~G~fG~Vy~~~~~~----g~~vAvK~~~~~~~-~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV 687 (935)
..+++.+.||+|+||.||+|.+.. +..||||.++.... ...+.|.+|+++|++++|||||+++|++.+ +..++|
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~iv 85 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWII 85 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSCEEE
T ss_pred HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CeEEEE
Confidence 456778999999999999998753 35689999865433 345679999999999999999999999964 578999
Q ss_pred EEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccc
Q 002336 688 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 767 (935)
Q Consensus 688 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~ 767 (935)
|||+++|+|.+++.. ....+++..++.++.||++||+|||+ ++|+||||||+||++++++.+||+|||+++....
T Consensus 86 ~E~~~~g~l~~~~~~--~~~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~ 160 (273)
T d1mp8a_ 86 MELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 160 (273)
T ss_dssp EECCTTEEHHHHHHH--TTTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred EEeccCCcHHhhhhc--cCCCCCHHHHHHHHHHHHHHhhhhcc---cCeeccccchhheeecCCCcEEEccchhheeccC
Confidence 999999999998764 34678999999999999999999998 9999999999999999999999999999987655
Q ss_pred cccceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCcccchhHHHHHHHhhhcCCeeecccc
Q 002336 768 DLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP 846 (935)
Q Consensus 768 ~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~ 846 (935)
..........||+.|+|||.+.+..++.++|||||||++|||++ |..||...... .+.. .+.++....
T Consensus 161 ~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~---~~~~----~i~~~~~~~---- 229 (273)
T d1mp8a_ 161 STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN---DVIG----RIENGERLP---- 229 (273)
T ss_dssp ----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---GHHH----HHHTTCCCC----
T ss_pred CcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHH---HHHH----HHHcCCCCC----
Confidence 44444445568999999999998999999999999999999998 89999744332 2222 222332211
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhhhhhcc
Q 002336 847 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 893 (935)
Q Consensus 847 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~~~~~~ 893 (935)
. +......+.+++.+||+.||++|||++||++.|+.++..++
T Consensus 230 -~----~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~k 271 (273)
T d1mp8a_ 230 -M----PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEK 271 (273)
T ss_dssp -C----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred -C----CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhh
Confidence 1 12223468899999999999999999999999998876543
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.1e-43 Score=389.78 Aligned_cols=245 Identities=28% Similarity=0.393 Sum_probs=200.4
Q ss_pred HHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc---hhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEE
Q 002336 613 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 688 (935)
Q Consensus 613 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~ 688 (935)
..|+..+.||+|+||.||+|++. +|+.||||++.... ....+.+.+|+++|++++|||||++++++.+++..++||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 45677899999999999999875 68899999986543 233467999999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccccc
Q 002336 689 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 768 (935)
Q Consensus 689 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~ 768 (935)
|||++|+|..++. ...++++.++..++.||+.||.|||+ ++|+||||||+|||+++++.+||+|||+++.....
T Consensus 95 E~~~~g~l~~~~~---~~~~l~e~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~ 168 (309)
T d1u5ra_ 95 EYCLGSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168 (309)
T ss_dssp ECCSEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB
T ss_pred EecCCCchHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEECCCCCEEEeecccccccCCC
Confidence 9999999987665 34679999999999999999999998 89999999999999999999999999999865432
Q ss_pred ccceeecccCCccccCCCCCCC---CCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeeccc
Q 002336 769 LTHISSVARGTVGYLDPEYYGN---QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 845 (935)
Q Consensus 769 ~~~~~~~~~gt~~y~APE~l~~---~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d 845 (935)
....||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... .+....... +.......
T Consensus 169 -----~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~------~~~~~~i~~-~~~~~~~~ 236 (309)
T d1u5ra_ 169 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MSALYHIAQ-NESPALQS 236 (309)
T ss_dssp -----CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHHH-SCCCCCSC
T ss_pred -----CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCH------HHHHHHHHh-CCCCCCCC
Confidence 23469999999998753 4689999999999999999999999973322 111122222 21111111
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 846 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 846 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
..+ ...+.+++.+||+.||++|||++|+++
T Consensus 237 ----~~~----s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 237 ----GHW----SEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp ----TTS----CHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ----CCC----CHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 112 236889999999999999999999975
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.7e-44 Score=391.19 Aligned_cols=250 Identities=25% Similarity=0.358 Sum_probs=189.2
Q ss_pred HHHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcch-hhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEe
Q 002336 613 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 690 (935)
Q Consensus 613 ~~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~-~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~ 690 (935)
..|++.+.||+|+||+||+|+++ +|+.||||++..... ...+.+.+|+.+|++++|||||++++++.+++..++||||
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~ 88 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQL 88 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 34778899999999999999986 689999999875432 3345688999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCcccc---CCCcEEEeeccccccccc
Q 002336 691 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD---INMRAKVSDFGLSRQAEE 767 (935)
Q Consensus 691 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld---~~~~vkL~DFGla~~~~~ 767 (935)
+++|+|.+++.. ...+++.++..++.||+.||+|||+ ++|+||||||+|||+. +++.+||+|||+++....
T Consensus 89 ~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~ 162 (307)
T d1a06a_ 89 VSGGELFDRIVE---KGFYTERDASRLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP 162 (307)
T ss_dssp CCSCBHHHHHHT---CSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCC--------
T ss_pred cCCCcHHHhhhc---ccCCCHHHHHHHHHHHHHHHHhhhh---ceeeeEEecccceeecccCCCceEEEeccceeEEccC
Confidence 999999999973 5679999999999999999999998 8999999999999994 578999999999987644
Q ss_pred cccceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeeccccc
Q 002336 768 DLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 847 (935)
Q Consensus 768 ~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~ 847 (935)
... .....||+.|+|||++.+..++.++||||+||++|||++|+.||...... ... ..+..+... ....
T Consensus 163 ~~~--~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~---~~~----~~i~~~~~~--~~~~ 231 (307)
T d1a06a_ 163 GSV--LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDA---KLF----EQILKAEYE--FDSP 231 (307)
T ss_dssp ------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHH----HHHHTTCCC--CCTT
T ss_pred CCe--eeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHH---HHH----HHHhccCCC--CCCc
Confidence 322 23356999999999999999999999999999999999999999743221 111 112222111 1111
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 848 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 848 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
. .......+.+++.+||+.||++|||++|+++
T Consensus 232 ~----~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 232 Y----WDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp T----TTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred c----ccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 1 1122346889999999999999999999987
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.7e-43 Score=394.70 Aligned_cols=251 Identities=21% Similarity=0.327 Sum_probs=206.9
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcchhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEecC
Q 002336 614 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 692 (935)
Q Consensus 614 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~~ 692 (935)
.|++.+.||+|+||.||+|++. +|+.||||++........+.+.+|+++|++++|||||++++++.+++..++|||||+
T Consensus 27 ~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~ 106 (350)
T d1koaa2 27 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMS 106 (350)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCC
Confidence 4678899999999999999875 689999999987666667789999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCcccc--CCCcEEEeecccccccccccc
Q 002336 693 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD--INMRAKVSDFGLSRQAEEDLT 770 (935)
Q Consensus 693 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld--~~~~vkL~DFGla~~~~~~~~ 770 (935)
+|+|.+++.. ....+++..+..++.||+.||+|||+ ++|+||||||+|||++ .++.+||+|||+++.......
T Consensus 107 gg~L~~~l~~--~~~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~ 181 (350)
T d1koaa2 107 GGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS 181 (350)
T ss_dssp SCBHHHHHTC--TTSCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSC
T ss_pred CCCHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHh---cCCeeeeechhHeeeccCCCCeEEEeecchheecccccc
Confidence 9999999864 24569999999999999999999998 9999999999999995 467899999999987654332
Q ss_pred ceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccC
Q 002336 771 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 850 (935)
Q Consensus 771 ~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~ 850 (935)
.....||+.|+|||++.+..++.++||||+||++|||++|+.||.+.... .. ... +..+... .+...
T Consensus 182 --~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~---~~---~~~-i~~~~~~--~~~~~-- 248 (350)
T d1koaa2 182 --VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD---ET---LRN-VKSCDWN--MDDSA-- 248 (350)
T ss_dssp --EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HH---HHH-HHHTCCC--SCCGG--
T ss_pred --cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHH---HH---HHH-HHhCCCC--CCccc--
Confidence 23456899999999999999999999999999999999999999744321 11 111 2111110 01111
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002336 851 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 884 (935)
Q Consensus 851 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~ 884 (935)
.......+.+++.+||+.||++|||++|+++.
T Consensus 249 --~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 249 --FSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp --GGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred --ccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11122367899999999999999999999874
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=2.7e-43 Score=393.36 Aligned_cols=251 Identities=21% Similarity=0.341 Sum_probs=207.4
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcchhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEecC
Q 002336 614 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 692 (935)
Q Consensus 614 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~~ 692 (935)
.|++.+.||+|+||.||+|... +|+.||||++........+.+.+|+++|++++|||||++++++.+++..++||||++
T Consensus 30 ~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~ 109 (352)
T d1koba_ 30 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLS 109 (352)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCC
T ss_pred ceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCC
Confidence 3677899999999999999875 799999999977655666788999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCcccc--CCCcEEEeecccccccccccc
Q 002336 693 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD--INMRAKVSDFGLSRQAEEDLT 770 (935)
Q Consensus 693 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld--~~~~vkL~DFGla~~~~~~~~ 770 (935)
+|+|.+.+.. ....+++.+++.++.||++||+|||+ ++|+||||||+|||++ .++.+||+|||+++.......
T Consensus 110 gg~L~~~~~~--~~~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~ 184 (352)
T d1koba_ 110 GGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI 184 (352)
T ss_dssp CCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC
T ss_pred CChHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccccccccccccCCCeEEEeecccceecCCCCc
Confidence 9999988763 34569999999999999999999998 9999999999999997 678999999999987754322
Q ss_pred ceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccC
Q 002336 771 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 850 (935)
Q Consensus 771 ~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~ 850 (935)
.....||+.|+|||++.+..++.++||||+||++|||++|+.||.+.+... .. ..+..+... ..+
T Consensus 185 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~---~~----~~i~~~~~~--~~~---- 249 (352)
T d1koba_ 185 --VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE---TL----QNVKRCDWE--FDE---- 249 (352)
T ss_dssp --EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH---HH----HHHHHCCCC--CCS----
T ss_pred --eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH---HH----HHHHhCCCC--CCc----
Confidence 334568999999999999999999999999999999999999997433211 11 112222211 011
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002336 851 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 884 (935)
Q Consensus 851 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~ 884 (935)
.........+.+++.+||+.||++|||++|+++.
T Consensus 250 ~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 250 DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1111223367899999999999999999999763
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-44 Score=387.18 Aligned_cols=250 Identities=30% Similarity=0.481 Sum_probs=198.0
Q ss_pred HhhcccccccccEEEEEEEECCCcEEEEEEccCcchhhhHHHHHHHHHHHhcCCCcccccceeeec-cceEEEEEEecCC
Q 002336 615 NNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEE-EHQRILVYEYMHN 693 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~-~~~~~lV~E~~~~ 693 (935)
+++.+.||+|+||.||+|.++ |+.||||+++.. ...+.|.+|++++++++||||++++|+|.+ .+..++||||+++
T Consensus 9 ~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~ 85 (262)
T d1byga_ 9 LKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAK 85 (262)
T ss_dssp EEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTT
T ss_pred eEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCC
Confidence 467889999999999999996 889999999754 344679999999999999999999999854 5668999999999
Q ss_pred CCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccccccccee
Q 002336 694 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 773 (935)
Q Consensus 694 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~~~ 773 (935)
|+|.+++... ....+++..+++++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 86 g~L~~~l~~~-~~~~l~~~~~~~i~~~i~~al~ylH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~---- 157 (262)
T d1byga_ 86 GSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ---- 157 (262)
T ss_dssp EEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC------------
T ss_pred CCHHHHHHhc-CCCCCCHHHHHHHHHHHHhhcccccc---CceeccccchHhheecCCCCEeecccccceecCCCC----
Confidence 9999998743 23358999999999999999999998 899999999999999999999999999998754432
Q ss_pred ecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccCCC
Q 002336 774 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNV 852 (935)
Q Consensus 774 ~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~~~ 852 (935)
....++..|+|||++.+..++.++||||||+++|||+| |+.||..... .++..+ +.++...++
T Consensus 158 ~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~---~~~~~~----i~~~~~~~~--------- 221 (262)
T d1byga_ 158 DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---KDVVPR----VEKGYKMDA--------- 221 (262)
T ss_dssp ----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG---GGHHHH----HTTTCCCCC---------
T ss_pred ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCH---HHHHHH----HHcCCCCCC---------
Confidence 22357899999999988899999999999999999998 6887763322 233333 222222111
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhhhhh
Q 002336 853 KIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 891 (935)
Q Consensus 853 ~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~~~~ 891 (935)
+......+.+++.+||+.||++|||++||+++|++++.-
T Consensus 222 ~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~~ 260 (262)
T d1byga_ 222 PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 260 (262)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHhC
Confidence 112224678999999999999999999999999988653
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-43 Score=383.48 Aligned_cols=249 Identities=22% Similarity=0.297 Sum_probs=202.5
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcch------hhhHHHHHHHHHHHhcCCCcccccceeeeccceEEE
Q 002336 614 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS------HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRIL 686 (935)
Q Consensus 614 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~------~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~l 686 (935)
.|++.+.||+|+||+||+|.++ +|+.||||++..... ...+.+.+|+++|++++|||||++++++.+.+..++
T Consensus 11 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 90 (293)
T d1jksa_ 11 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVIL 90 (293)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 4677899999999999999985 799999999864321 134679999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCC----cEEEeecccc
Q 002336 687 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM----RAKVSDFGLS 762 (935)
Q Consensus 687 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~----~vkL~DFGla 762 (935)
|||||++|+|.+++.. ...+++..+..++.|++.||+|||+ ++|+||||||+|||++.++ .+||+|||++
T Consensus 91 v~E~~~gg~L~~~i~~---~~~l~~~~~~~~~~qi~~al~yLH~---~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a 164 (293)
T d1jksa_ 91 ILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 164 (293)
T ss_dssp EEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred EEEcCCCccccchhcc---ccccchhHHHHHHHHHHHHHHhhhh---cceeecccccceEEEecCCCcccceEecchhhh
Confidence 9999999999999974 4579999999999999999999998 8999999999999998776 4999999999
Q ss_pred ccccccccceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeee
Q 002336 763 RQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVIS 842 (935)
Q Consensus 763 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~ 842 (935)
+....... .....||+.|+|||++.+..++.++||||+||++|||++|+.||.+....+ . . ..+..+...
T Consensus 165 ~~~~~~~~--~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~---~---~-~~i~~~~~~- 234 (293)
T d1jksa_ 165 HKIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE---T---L-ANVSAVNYE- 234 (293)
T ss_dssp EECTTSCB--CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---H---H-HHHHTTCCC-
T ss_pred hhcCCCcc--ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHH---H---H-HHHHhcCCC-
Confidence 87644322 233568999999999999999999999999999999999999997432211 1 1 112222110
Q ss_pred cccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 843 IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 843 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
..+.... .....+.+++.+||+.||++|||++|+++
T Consensus 235 -~~~~~~~----~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 235 -FEDEYFS----NTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp -CCHHHHT----TSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -CCchhcC----CCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000001 12236789999999999999999999875
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.4e-43 Score=388.20 Aligned_cols=257 Identities=27% Similarity=0.440 Sum_probs=207.5
Q ss_pred HHhhcccccccccEEEEEEEEC------CCcEEEEEEccCcchh-hhHHHHHHHHHHHhcCCCcccccceeeeccceEEE
Q 002336 614 TNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSCSH-RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRIL 686 (935)
Q Consensus 614 ~~~~~~~LG~G~fG~Vy~~~~~------~g~~vAvK~~~~~~~~-~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~l 686 (935)
.+++.+.||+|+||+||+|+++ +++.||||++...... ..++|.+|+++|++++||||++++++|...+..++
T Consensus 14 ~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~~ 93 (301)
T d1lufa_ 14 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCL 93 (301)
T ss_dssp GCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEE
T ss_pred HcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceEE
Confidence 4567899999999999999874 3578999998764333 45679999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhccCC---------------------CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCC
Q 002336 687 VYEYMHNGTLRDRLHGSV---------------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSN 745 (935)
Q Consensus 687 V~E~~~~gsL~~~L~~~~---------------------~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~N 745 (935)
||||+++|+|.+++.... ....+++..++.++.|++.||+|||+ ++|+||||||+|
T Consensus 94 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~---~~ivHrDlKp~N 170 (301)
T d1lufa_ 94 LFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRN 170 (301)
T ss_dssp EEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGG
T ss_pred EEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhccc---CCeEeeEEcccc
Confidence 999999999999986421 12358999999999999999999998 899999999999
Q ss_pred ccccCCCcEEEeeccccccccccc-cceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCC-CCCCccCccc
Q 002336 746 ILLDINMRAKVSDFGLSRQAEEDL-THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGK-KPVSVEDFGA 823 (935)
Q Consensus 746 ILld~~~~vkL~DFGla~~~~~~~-~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~-~Pf~~~~~~~ 823 (935)
||++.++.+||+|||+++...... ........|++.|+|||.+.+..++.++|||||||++|||++|. .||.....
T Consensus 171 ILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~-- 248 (301)
T d1lufa_ 171 CLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH-- 248 (301)
T ss_dssp EEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH--
T ss_pred eEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCH--
Confidence 999999999999999998654332 22233456889999999999999999999999999999999986 56653222
Q ss_pred chhHHHHHHHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhhh
Q 002336 824 ELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI 889 (935)
Q Consensus 824 ~~~l~~~~~~~i~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~~ 889 (935)
.... ..+.++..... +...+..+.+++.+||+.+|++||||.||+++|++++
T Consensus 249 -~e~~----~~v~~~~~~~~---------p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 249 -EEVI----YYVRDGNILAC---------PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp -HHHH----HHHHTTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred -HHHH----HHHHcCCCCCC---------CccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 1122 22333433221 1122336889999999999999999999999999875
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.6e-43 Score=382.82 Aligned_cols=256 Identities=29% Similarity=0.461 Sum_probs=204.2
Q ss_pred hhcccccccccEEEEEEEECCC----cEEEEEEccCc-chhhhHHHHHHHHHHHhcCCCcccccceeeec-cceEEEEEE
Q 002336 616 NFCKKIGKGSFGSVYYGKMKDG----KEVAVKIMADS-CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEE-EHQRILVYE 689 (935)
Q Consensus 616 ~~~~~LG~G~fG~Vy~~~~~~g----~~vAvK~~~~~-~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~-~~~~~lV~E 689 (935)
+|.++||+|+||+||+|.+.++ ..||||+++.. .....++|.+|+++|++++|||||+++|++.+ +...++|||
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E 109 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP 109 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEE
T ss_pred ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEE
Confidence 4467899999999999987532 36899998753 34456789999999999999999999999865 567899999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccc
Q 002336 690 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 769 (935)
Q Consensus 690 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~ 769 (935)
|+++|+|.+++... ...+++..+++++.|+++||.|||+ ++|+||||||+|||+++++.+||+|||+++......
T Consensus 110 ~~~~g~l~~~~~~~--~~~~~~~~~~~i~~qia~gL~~lH~---~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~ 184 (311)
T d1r0pa_ 110 YMKHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 184 (311)
T ss_dssp CCTTCBHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTT
T ss_pred EeecCchhhhhccc--cccchHHHHHHHHHHHHHhhhhhcc---cCcccCCccHHhEeECCCCCEEEecccchhhccccc
Confidence 99999999998753 4567888999999999999999998 899999999999999999999999999998764432
Q ss_pred cc---eeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccc
Q 002336 770 TH---ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP 846 (935)
Q Consensus 770 ~~---~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~ 846 (935)
.. ......||+.|+|||.+.+..++.++||||||+++|||++|+.||..... ...+..+ +..+... ..
T Consensus 185 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~--~~~~~~~----i~~g~~~--~~- 255 (311)
T d1r0pa_ 185 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN--TFDITVY----LLQGRRL--LQ- 255 (311)
T ss_dssp CCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHH----HHTTCCC--CC-
T ss_pred cccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCC--HHHHHHH----HHcCCCC--CC-
Confidence 22 22234689999999999989999999999999999999998888763221 1122222 2222211 11
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhhhhh
Q 002336 847 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 891 (935)
Q Consensus 847 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~~~~ 891 (935)
+......+.+++.+||+.||++||+|+||++.|++++..
T Consensus 256 ------p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~ 294 (311)
T d1r0pa_ 256 ------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294 (311)
T ss_dssp ------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred ------cccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 111234688999999999999999999999999988764
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-42 Score=384.46 Aligned_cols=245 Identities=24% Similarity=0.358 Sum_probs=203.6
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc---hhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEe
Q 002336 615 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 690 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~ 690 (935)
|++.+.||+|+||.||+|+.+ +|+.||||++.... ....+.+.+|+.+|++++||||+++++++.+.+..++||||
T Consensus 7 y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ey 86 (337)
T d1o6la_ 7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEY 86 (337)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred cEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccceec
Confidence 667899999999999999875 79999999986532 22346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccccccc
Q 002336 691 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 770 (935)
Q Consensus 691 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~ 770 (935)
+++|+|.+++.. ...+++..+..++.|++.||+|||+ ++|+||||||+|||++.+|.+||+|||+++.......
T Consensus 87 ~~gg~L~~~~~~---~~~~~e~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~ 160 (337)
T d1o6la_ 87 ANGGELFFHLSR---ERVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA 160 (337)
T ss_dssp CTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC
T ss_pred cCCCchhhhhhc---ccCCcHHHHHHHHHHHhhhhhhhhh---cCccccccCHHHeEecCCCCEEEeecccccccccCCc
Confidence 999999999884 4678999999999999999999998 9999999999999999999999999999987543322
Q ss_pred ceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccC
Q 002336 771 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 850 (935)
Q Consensus 771 ~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~ 850 (935)
......||+.|+|||++.+..++.++||||+||++|||++|+.||...+... + .+.+..+.+ .+..
T Consensus 161 -~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~---~----~~~i~~~~~------~~p~ 226 (337)
T d1o6la_ 161 -TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER---L----FELILMEEI------RFPR 226 (337)
T ss_dssp -CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---H----HHHHHHCCC------CCCT
T ss_pred -ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHH---H----HHHHhcCCC------CCCc
Confidence 2334569999999999999999999999999999999999999998543321 1 122222221 1111
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 002336 851 NVKIESIWRIAEVAIQCVEQRGFSRPK-----MQEIVL 883 (935)
Q Consensus 851 ~~~~~~~~~l~~li~~Cl~~dP~~RPs-----~~ev~~ 883 (935)
.. ...+.+++.+||+.||++||+ ++|+++
T Consensus 227 ~~----s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 227 TL----SPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp TS----CHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred cC----CHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 22 235789999999999999995 788876
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-43 Score=383.88 Aligned_cols=262 Identities=26% Similarity=0.394 Sum_probs=199.0
Q ss_pred HHHHhhcccccccccEEEEEEEEC------CCcEEEEEEccCcc-hhhhHHHHHHHHHHHhc-CCCcccccceeeec-cc
Q 002336 612 EATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSC-SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEE-EH 682 (935)
Q Consensus 612 ~~~~~~~~~LG~G~fG~Vy~~~~~------~g~~vAvK~~~~~~-~~~~~~~~~E~~iL~~L-~HpnIv~l~g~~~~-~~ 682 (935)
...+++.+.||+|+||.||+|.+. +++.||||+++... ....+.+.+|..++.++ +|+||+.+++++.+ +.
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~ 91 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 91 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCC
Confidence 345778899999999999999864 34689999987543 33456788888888887 68999999998765 45
Q ss_pred eEEEEEEecCCCCHHHHhccCC-------------CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCcccc
Q 002336 683 QRILVYEYMHNGTLRDRLHGSV-------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD 749 (935)
Q Consensus 683 ~~~lV~E~~~~gsL~~~L~~~~-------------~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld 749 (935)
..++||||+++|+|.++++... ....+++.+++.++.||++||+|||+ ++|+||||||+|||++
T Consensus 92 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~---~~ivHrDlKp~NILl~ 168 (299)
T d1ywna1 92 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLS 168 (299)
T ss_dssp CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEC
T ss_pred eEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHh---CCCcCCcCCccceeEC
Confidence 6899999999999999987432 13458999999999999999999998 8999999999999999
Q ss_pred CCCcEEEeeccccccccccccc-eeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCC-CCCCccCcccchhH
Q 002336 750 INMRAKVSDFGLSRQAEEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGK-KPVSVEDFGAELNI 827 (935)
Q Consensus 750 ~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~-~Pf~~~~~~~~~~l 827 (935)
+++.+||+|||+++........ ......||+.|+|||.+.+..++.++|||||||++|||++|. .||...... ..
T Consensus 169 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~--~~- 245 (299)
T d1ywna1 169 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--EE- 245 (299)
T ss_dssp GGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS--HH-
T ss_pred CCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHH--HH-
Confidence 9999999999999875443322 233456899999999999999999999999999999999975 577633222 11
Q ss_pred HHHHHHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhhhhh
Q 002336 828 VHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 891 (935)
Q Consensus 828 ~~~~~~~i~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~~~~ 891 (935)
+...+..+..... +......+.+++.+||+.||++|||++||+++|+++++.
T Consensus 246 ---~~~~~~~~~~~~~---------~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~ 297 (299)
T d1ywna1 246 ---FCRRLKEGTRMRA---------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 297 (299)
T ss_dssp ---HHHHHHHTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---HHHHHhcCCCCCC---------CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 2223333322221 112233688999999999999999999999999988653
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-43 Score=384.73 Aligned_cols=254 Identities=23% Similarity=0.420 Sum_probs=201.3
Q ss_pred HhhcccccccccEEEEEEEEC-CCc----EEEEEEccCcc-hhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEE
Q 002336 615 NNFCKKIGKGSFGSVYYGKMK-DGK----EVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 688 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~-~g~----~vAvK~~~~~~-~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~ 688 (935)
|++.+.||+|+||+||+|.+. +|+ .||+|+++... ....++|.+|+++|++++|||||+++|+|.++ ..++++
T Consensus 11 y~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~v~ 89 (317)
T d1xkka_ 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLIT 89 (317)
T ss_dssp EEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEE
T ss_pred CEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeEEE
Confidence 667899999999999999875 344 58999886533 33457899999999999999999999999875 567889
Q ss_pred EecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccccc
Q 002336 689 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 768 (935)
Q Consensus 689 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~ 768 (935)
|++.+|+|.+.+.. ....+++..+++++.|||+||+|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 90 e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~gl~yLH~---~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~ 164 (317)
T d1xkka_ 90 QLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 164 (317)
T ss_dssp ECCTTCBHHHHHHH--TSSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTT
T ss_pred EeccCCcccccccc--cccCCCHHHHHHHHHHHHHHHHHHHH---cCcccCcchhhcceeCCCCCeEeeccccceecccc
Confidence 99999999998775 35679999999999999999999998 89999999999999999999999999999876543
Q ss_pred ccc-eeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCcccchhHHHHHHHhhhcCCeeecccc
Q 002336 769 LTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP 846 (935)
Q Consensus 769 ~~~-~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~ 846 (935)
... ......||+.|+|||.+.+..++.++|||||||++|||+| |+.||....... +.. .+..+...
T Consensus 165 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~---~~~----~i~~~~~~----- 232 (317)
T d1xkka_ 165 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISS----ILEKGERL----- 232 (317)
T ss_dssp CC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG---HHH----HHHHTCCC-----
T ss_pred cccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH---HHH----HHHcCCCC-----
Confidence 322 2233458999999999998899999999999999999998 889987443322 222 22222211
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhhhh
Q 002336 847 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 890 (935)
Q Consensus 847 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~~~ 890 (935)
..+......+.+++.+||+.+|++|||++||++.|+.+..
T Consensus 233 ----~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~ 272 (317)
T d1xkka_ 233 ----PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272 (317)
T ss_dssp ----CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----CCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence 1112223468899999999999999999999999887654
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-43 Score=375.95 Aligned_cols=254 Identities=28% Similarity=0.415 Sum_probs=195.5
Q ss_pred HHhhcccccccccEEEEEEEEC--CC--cEEEEEEccCcc---hhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEE
Q 002336 614 TNNFCKKIGKGSFGSVYYGKMK--DG--KEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRIL 686 (935)
Q Consensus 614 ~~~~~~~LG~G~fG~Vy~~~~~--~g--~~vAvK~~~~~~---~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~l 686 (935)
.+++.+.||+|+||.||+|++. ++ ..||||++.... .+..++|.+|+++|++++|||||+++|+|.++ ..++
T Consensus 9 d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~-~~~l 87 (273)
T d1u46a_ 9 DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-PMKM 87 (273)
T ss_dssp GEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SCEE
T ss_pred HeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec-chhe
Confidence 3567889999999999999864 22 378999986532 23456899999999999999999999999764 6789
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccc
Q 002336 687 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 766 (935)
Q Consensus 687 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~ 766 (935)
||||+++|++.+.+... ...+++..++.++.|+|+||.|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 88 v~e~~~~~~l~~~~~~~--~~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~ 162 (273)
T d1u46a_ 88 VTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALP 162 (273)
T ss_dssp EEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred eeeeecCcchhhhhhcc--cCCCCHHHHHHHHHHHHHHHHHhhh---CCEeeeeecHHHhccccccceeeccchhhhhcc
Confidence 99999999999887642 4569999999999999999999998 899999999999999999999999999999765
Q ss_pred ccccce--eecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCcccchhHHHHHHHhhhcCCeeec
Q 002336 767 EDLTHI--SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISI 843 (935)
Q Consensus 767 ~~~~~~--~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~ 843 (935)
...... .....|+..|+|||.+.+..++.++||||||+++|||+| |+.||...+.. ... ....+.+....
T Consensus 163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~---~~~---~~i~~~~~~~~- 235 (273)
T d1u46a_ 163 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS---QIL---HKIDKEGERLP- 235 (273)
T ss_dssp C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHH---HHHHTSCCCCC-
T ss_pred cCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHH---HHH---HHHHhCCCCCC-
Confidence 443322 233457889999999999999999999999999999998 89999743222 121 22222221111
Q ss_pred ccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhh
Q 002336 844 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 888 (935)
Q Consensus 844 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~ 888 (935)
. +...+..+.+++.+||+.||++|||++||.+.|++.
T Consensus 236 ----~----~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 236 ----R----PEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp ----C----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----C----cccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 1 112224688999999999999999999999999875
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-42 Score=378.61 Aligned_cols=269 Identities=26% Similarity=0.362 Sum_probs=201.9
Q ss_pred HhhcccccccccEEEEEEEECCCcEEEEEEccCcchhhhHHHHHHHHHHHhcCCCcccccceeeeccc----eEEEEEEe
Q 002336 615 NNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH----QRILVYEY 690 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~----~~~lV~E~ 690 (935)
+.+.+.||+|+||.||+|+++ |+.||||+++.... ....++.|+..+..++|||||+++|+|.+++ ..++||||
T Consensus 5 ~~l~~~iG~G~fg~Vy~~~~~-g~~vAvK~~~~~~~-~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey 82 (303)
T d1vjya_ 5 IVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDY 82 (303)
T ss_dssp EEEEEEEECCSSSEEEEEEET-TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEEC
T ss_pred EEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccch-hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEec
Confidence 345688999999999999975 89999999864322 1222334555556789999999999997643 57999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcC-----CCceEecCCCCCCccccCCCcEEEeeccccccc
Q 002336 691 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC-----NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 765 (935)
Q Consensus 691 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~-----~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~ 765 (935)
+++|+|.++++. ..++|..+++++.|+|.||+|||+.. +++|+||||||+||||++++.+||+|||+++..
T Consensus 83 ~~~g~L~~~l~~----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~ 158 (303)
T d1vjya_ 83 HEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH 158 (303)
T ss_dssp CTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred ccCCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccc
Confidence 999999999974 36899999999999999999999621 369999999999999999999999999999876
Q ss_pred cccccc---eeecccCCccccCCCCCCCC------CCCchhHHHHHHHHHHHHHhCCCCCCccCcccc--------hhHH
Q 002336 766 EEDLTH---ISSVARGTVGYLDPEYYGNQ------QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAE--------LNIV 828 (935)
Q Consensus 766 ~~~~~~---~~~~~~gt~~y~APE~l~~~------~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~--------~~l~ 828 (935)
...... ......||+.|+|||++.+. .++.++|||||||++|||+||..|+........ ....
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~ 238 (303)
T d1vjya_ 159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV 238 (303)
T ss_dssp ETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred cCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchH
Confidence 543322 23345699999999987654 257799999999999999999988753322110 0111
Q ss_pred HHHHHhhhcCCeeecccccccCCC-CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhhhhhcc
Q 002336 829 HWARSMIKKGDVISIVDPVLIGNV-KIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 893 (935)
Q Consensus 829 ~~~~~~i~~~~~~~~~d~~l~~~~-~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~~~~~~ 893 (935)
.........+. ++|.+.... +.+....+.+++.+||+.||++|||+.||++.|+++...+.
T Consensus 239 ~~~~~~~~~~~----~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~~ 300 (303)
T d1vjya_ 239 EEMRKVVCEQK----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG 300 (303)
T ss_dssp HHHHHHHTTSC----CCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred HHHHHHHhccc----cCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhcC
Confidence 22222222221 122222222 23456679999999999999999999999999998876543
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.1e-42 Score=380.80 Aligned_cols=243 Identities=22% Similarity=0.344 Sum_probs=202.8
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc---hhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEe
Q 002336 615 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 690 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~ 690 (935)
|++.+.||+|+||+||+|+++ +|+.||||+++... ....+.+.+|+.+|++++|||||++++++.+.+..++||||
T Consensus 6 y~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 85 (316)
T d1fota_ 6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDY 85 (316)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECC
T ss_pred eEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEeee
Confidence 567899999999999999985 69999999986432 22346789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccccccc
Q 002336 691 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 770 (935)
Q Consensus 691 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~ 770 (935)
++||+|.+++.. ...+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 86 ~~gg~l~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~~- 158 (316)
T d1fota_ 86 IEGGELFSLLRK---SQRFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT- 158 (316)
T ss_dssp CCSCBHHHHHHH---TSSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEECSSCB-
T ss_pred cCCccccccccc---cccccccHHHHHHHHHHHhhhhhcc---CcEEccccCchheeEcCCCCEEEecCccceEecccc-
Confidence 999999998873 5668889999999999999999998 899999999999999999999999999998765432
Q ss_pred ceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccC
Q 002336 771 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 850 (935)
Q Consensus 771 ~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~ 850 (935)
....||+.|+|||++.+..++.++||||+||++|||++|+.||...+.. +... .+..+.. .
T Consensus 159 ---~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~------~~~~-~i~~~~~------~--- 219 (316)
T d1fota_ 159 ---YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM------KTYE-KILNAEL------R--- 219 (316)
T ss_dssp ---CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHH-HHHHCCC------C---
T ss_pred ---ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHH------HHHH-HHHcCCC------C---
Confidence 2356999999999999999999999999999999999999999743221 1111 2222211 1
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 002336 851 NVKIESIWRIAEVAIQCVEQRGFSRP-----KMQEIVLA 884 (935)
Q Consensus 851 ~~~~~~~~~l~~li~~Cl~~dP~~RP-----s~~ev~~~ 884 (935)
.+......+.+++.+||+.||++|| |++|+++.
T Consensus 220 -~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 220 -FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp -CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred -CCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 1112223688999999999999996 89998764
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=4.2e-42 Score=371.80 Aligned_cols=257 Identities=25% Similarity=0.369 Sum_probs=200.5
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc---hhhhHHHHHHHHHHHhcCCCcccccceeeeccc----eEE
Q 002336 614 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH----QRI 685 (935)
Q Consensus 614 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~----~~~ 685 (935)
.|++.+.||+|+||.||+|++. +|+.||||+++... ....+.+.+|+++|+.++|||||++++++...+ ..+
T Consensus 8 rY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~ 87 (277)
T d1o6ya_ 8 RYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPY 87 (277)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred eeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEE
Confidence 3667899999999999999875 79999999987543 233467999999999999999999999987643 478
Q ss_pred EEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccc
Q 002336 686 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 765 (935)
Q Consensus 686 lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~ 765 (935)
+||||+++++|.+++.. .+.+++.+++.++.||++||+|||+ ++|+||||||+|||++.++..+|+|||.+...
T Consensus 88 lvmE~~~g~~L~~~~~~---~~~l~~~~~~~i~~qi~~al~~lH~---~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~ 161 (277)
T d1o6ya_ 88 IVMEYVDGVTLRDIVHT---EGPMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAI 161 (277)
T ss_dssp EEEECCCEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTSCEEECCCTTCEEC
T ss_pred EEEECCCCCEehhhhcc---cCCCCHHHHHHHHHHHHHHHHHHHh---CCccCccccCcccccCccccceeehhhhhhhh
Confidence 99999999999998873 4679999999999999999999998 89999999999999999999999999998764
Q ss_pred ccccc--ceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeec
Q 002336 766 EEDLT--HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISI 843 (935)
Q Consensus 766 ~~~~~--~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~ 843 (935)
..... .......||+.|+|||++.+..++.++||||+||++|||+||+.||..... .+...+.+..+.....
T Consensus 162 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~------~~~~~~~~~~~~~~~~ 235 (277)
T d1o6ya_ 162 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP------VSVAYQHVREDPIPPS 235 (277)
T ss_dssp C----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHHCCCCCGG
T ss_pred ccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCH------HHHHHHHHhcCCCCCc
Confidence 33221 223345699999999999999999999999999999999999999974322 1222233333222110
Q ss_pred ccccccCCCCHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHHhhhh
Q 002336 844 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRP-KMQEIVLAIQDSI 889 (935)
Q Consensus 844 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-s~~ev~~~L~~~~ 889 (935)
... ......+.+++.+||+.||++|| |++++.+.|.++.
T Consensus 236 ---~~~----~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 236 ---ARH----EGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp ---GTS----SSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred ---hhc----cCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 111 11223688999999999999999 8999998887654
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-42 Score=377.30 Aligned_cols=260 Identities=25% Similarity=0.429 Sum_probs=206.9
Q ss_pred HHHhhcccccccccEEEEEEEECC--------CcEEEEEEccCcch-hhhHHHHHHHHHHHhc-CCCcccccceeeeccc
Q 002336 613 ATNNFCKKIGKGSFGSVYYGKMKD--------GKEVAVKIMADSCS-HRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEH 682 (935)
Q Consensus 613 ~~~~~~~~LG~G~fG~Vy~~~~~~--------g~~vAvK~~~~~~~-~~~~~~~~E~~iL~~L-~HpnIv~l~g~~~~~~ 682 (935)
..+++.+.||+|+||.||+|+... +..||||+++.... ....++.+|+..+.++ +|||||+++++|.+++
T Consensus 13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~ 92 (299)
T d1fgka_ 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 92 (299)
T ss_dssp GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCC
Confidence 456778999999999999998642 34799999976544 3457889999999888 7999999999999999
Q ss_pred eEEEEEEecCCCCHHHHhccCC-------------CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCcccc
Q 002336 683 QRILVYEYMHNGTLRDRLHGSV-------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD 749 (935)
Q Consensus 683 ~~~lV~E~~~~gsL~~~L~~~~-------------~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld 749 (935)
..++||||+++|+|.+++.... ....+++.++++++.|++.||+|||+ ++|+||||||+|||++
T Consensus 93 ~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~---~~ivHrDiKp~NiLl~ 169 (299)
T d1fgka_ 93 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVT 169 (299)
T ss_dssp SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEC
T ss_pred eEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhh---CCEEeeeecccceeec
Confidence 9999999999999999997542 13468999999999999999999998 9999999999999999
Q ss_pred CCCcEEEeeccccccccccccc-eeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCcccchhH
Q 002336 750 INMRAKVSDFGLSRQAEEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNI 827 (935)
Q Consensus 750 ~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~~~l 827 (935)
.++.+||+|||+++........ ......|++.|+|||.+.+..++.++||||||+++|||++ |..||...... .
T Consensus 170 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~---~- 245 (299)
T d1fgka_ 170 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE---E- 245 (299)
T ss_dssp TTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---H-
T ss_pred CCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH---H-
Confidence 9999999999999876543322 2334568999999999999999999999999999999998 78888633221 1
Q ss_pred HHHHHHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhhhhh
Q 002336 828 VHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 891 (935)
Q Consensus 828 ~~~~~~~i~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~~~~ 891 (935)
+.+.+..+..... +......+.+++.+||+.+|++|||+.||++.|+++++.
T Consensus 246 ---~~~~i~~~~~~~~---------p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a~ 297 (299)
T d1fgka_ 246 ---LFKLLKEGHRMDK---------PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 297 (299)
T ss_dssp ---HHHHHHTTCCCCC---------CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---HHHHHHcCCCCCC---------CccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhhc
Confidence 2233333322211 111223688999999999999999999999999998764
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-42 Score=380.44 Aligned_cols=264 Identities=29% Similarity=0.439 Sum_probs=211.8
Q ss_pred HHHHHHhhcccccccccEEEEEEEEC------CCcEEEEEEccCcc-hhhhHHHHHHHHHHHhc-CCCcccccceeeecc
Q 002336 610 LEEATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSC-SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEE 681 (935)
Q Consensus 610 l~~~~~~~~~~LG~G~fG~Vy~~~~~------~g~~vAvK~~~~~~-~~~~~~~~~E~~iL~~L-~HpnIv~l~g~~~~~ 681 (935)
+....+++.+.||+|+||.||+|++. +++.||||+++... ......|.+|+.+++++ +|||||+++|+|.+.
T Consensus 20 ~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~ 99 (311)
T d1t46a_ 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG 99 (311)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeC
Confidence 44456778899999999999999863 46789999997643 33456799999999999 699999999999999
Q ss_pred ceEEEEEEecCCCCHHHHhccCC---------------CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCc
Q 002336 682 HQRILVYEYMHNGTLRDRLHGSV---------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNI 746 (935)
Q Consensus 682 ~~~~lV~E~~~~gsL~~~L~~~~---------------~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NI 746 (935)
+..++||||+++|+|.++++... ....+++..+.+++.||++||+|||+ ++++||||||+||
T Consensus 100 ~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~---~~ivHrDLKp~NI 176 (311)
T d1t46a_ 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNI 176 (311)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGE
T ss_pred CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccccccc
Confidence 99999999999999999987542 23368999999999999999999998 8999999999999
Q ss_pred cccCCCcEEEeeccccccccccccc-eeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHh-CCCCCCccCcccc
Q 002336 747 LLDINMRAKVSDFGLSRQAEEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAE 824 (935)
Q Consensus 747 Lld~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLlt-G~~Pf~~~~~~~~ 824 (935)
|++.++.+||+|||+++........ ......||+.|+|||.+.+..++.++||||||+++|||+| |++|+......
T Consensus 177 l~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~-- 254 (311)
T d1t46a_ 177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD-- 254 (311)
T ss_dssp EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS--
T ss_pred cccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHH--
Confidence 9999999999999999876544332 2334568999999999999999999999999999999999 55555432221
Q ss_pred hhHHHHHHHhhhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhhhhh
Q 002336 825 LNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 891 (935)
Q Consensus 825 ~~l~~~~~~~i~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~~~~ 891 (935)
..+.+ .+..+... ..+......+.+++.+||+.||++|||++||+++|++.+..
T Consensus 255 ~~~~~----~i~~~~~~---------~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~ 308 (311)
T d1t46a_ 255 SKFYK----MIKEGFRM---------LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (311)
T ss_dssp HHHHH----HHHHTCCC---------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHH----HHhcCCCC---------CCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence 12222 22222111 11122234688999999999999999999999999987653
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-43 Score=384.56 Aligned_cols=257 Identities=30% Similarity=0.496 Sum_probs=204.0
Q ss_pred HHhhcccccccccEEEEEEEEC-CCc--EEEEEEccCc-chhhhHHHHHHHHHHHhc-CCCcccccceeeeccceEEEEE
Q 002336 614 TNNFCKKIGKGSFGSVYYGKMK-DGK--EVAVKIMADS-CSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVY 688 (935)
Q Consensus 614 ~~~~~~~LG~G~fG~Vy~~~~~-~g~--~vAvK~~~~~-~~~~~~~~~~E~~iL~~L-~HpnIv~l~g~~~~~~~~~lV~ 688 (935)
.+++.+.||+|+||.||+|.++ +|. .||||++... .....+.|.+|+++|+++ +|||||+++|+|.+++..++||
T Consensus 11 ~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~ 90 (309)
T d1fvra_ 11 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAI 90 (309)
T ss_dssp GCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEE
Confidence 3567889999999999999886 344 5788887543 333556899999999999 7999999999999999999999
Q ss_pred EecCCCCHHHHhccC-------------CCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEE
Q 002336 689 EYMHNGTLRDRLHGS-------------VNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAK 755 (935)
Q Consensus 689 E~~~~gsL~~~L~~~-------------~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vk 755 (935)
||+++|+|.++++.. .....+++.++++++.|||+||.|||+ ++|+||||||+|||++.++.+|
T Consensus 91 ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~---~~iiHrDlkp~NIL~~~~~~~k 167 (309)
T d1fvra_ 91 EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAK 167 (309)
T ss_dssp CCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCEE
T ss_pred EecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhc---CCccccccccceEEEcCCCceE
Confidence 999999999999743 134679999999999999999999998 8999999999999999999999
Q ss_pred EeeccccccccccccceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCC-CCCccCcccchhHHHHHHHh
Q 002336 756 VSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKK-PVSVEDFGAELNIVHWARSM 834 (935)
Q Consensus 756 L~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~-Pf~~~~~~~~~~l~~~~~~~ 834 (935)
|+|||+++........ ....||..|+|||.+.+..++.++|||||||++|||++|.. ||..... ..+ ...
T Consensus 168 l~DfG~a~~~~~~~~~--~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~---~~~----~~~ 238 (309)
T d1fvra_ 168 IADFGLSRGQEVYVKK--TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC---AEL----YEK 238 (309)
T ss_dssp ECCTTCEESSCEECCC------CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHH----HHH
T ss_pred Eccccccccccccccc--cceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCH---HHH----HHH
Confidence 9999999865433222 23458999999999999999999999999999999999764 6653221 111 122
Q ss_pred hhcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhhhhh
Q 002336 835 IKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 891 (935)
Q Consensus 835 i~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~~~~ 891 (935)
+.++.... .+......+.+++.+||+.||++||||+||++.|++++..
T Consensus 239 i~~~~~~~---------~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~ 286 (309)
T d1fvra_ 239 LPQGYRLE---------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 286 (309)
T ss_dssp GGGTCCCC---------CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred HHhcCCCC---------CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 32222111 1122234788999999999999999999999999998753
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.2e-41 Score=367.74 Aligned_cols=248 Identities=25% Similarity=0.301 Sum_probs=201.1
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCcch---------hhhHHHHHHHHHHHhcC-CCcccccceeeeccce
Q 002336 615 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---------HRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQ 683 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~---------~~~~~~~~E~~iL~~L~-HpnIv~l~g~~~~~~~ 683 (935)
|++.+.||+|+||+||+|++. +|+.||||++..... ...+.+.+|+.+|++++ ||||+++++++.+++.
T Consensus 5 y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~ 84 (277)
T d1phka_ 5 YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTF 84 (277)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCcc
Confidence 566889999999999999875 789999999865321 12346889999999997 9999999999999999
Q ss_pred EEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccc
Q 002336 684 RILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 763 (935)
Q Consensus 684 ~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~ 763 (935)
.++||||+++|+|.+++.. ...+++.++..++.||++||+|||+ ++|+||||||+|||++.++.+||+|||+++
T Consensus 85 ~~ivmE~~~~g~L~~~l~~---~~~l~e~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~~kl~DFG~a~ 158 (277)
T d1phka_ 85 FFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSC 158 (277)
T ss_dssp EEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred eEEEEEcCCCchHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---cCCcccccccceEEEcCCCCeEEccchhee
Confidence 9999999999999999973 4679999999999999999999998 899999999999999999999999999998
Q ss_pred cccccccceeecccCCccccCCCCCC------CCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhc
Q 002336 764 QAEEDLTHISSVARGTVGYLDPEYYG------NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKK 837 (935)
Q Consensus 764 ~~~~~~~~~~~~~~gt~~y~APE~l~------~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~ 837 (935)
....... .....||+.|+|||.+. ...++.++||||+||++|||++|+.||....... ..+.+..
T Consensus 159 ~~~~~~~--~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~-------~~~~i~~ 229 (277)
T d1phka_ 159 QLDPGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML-------MLRMIMS 229 (277)
T ss_dssp ECCTTCC--BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHH
T ss_pred EccCCCc--eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHH-------HHHHHHh
Confidence 7654322 23456999999999874 3457899999999999999999999997433211 1122222
Q ss_pred CCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 838 GDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 838 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
+... . ...........+.+++.+||+.+|++|||++||++
T Consensus 230 ~~~~-~-----~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 230 GNYQ-F-----GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp TCCC-C-----CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred CCCC-C-----CCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 2221 0 00011122346889999999999999999999865
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-42 Score=373.51 Aligned_cols=256 Identities=21% Similarity=0.211 Sum_probs=195.2
Q ss_pred cccccccccEEEEEEEEC-CCcEEEEEEccCcchh-----hhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEec
Q 002336 618 CKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSH-----RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 691 (935)
Q Consensus 618 ~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~~-----~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~ 691 (935)
.++||+|+||+||+|+++ +|+.||||+++..... ..+.+.+|+++|++++|||||++++++.+++..++||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 468999999999999975 6899999998643222 1356889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccccc
Q 002336 692 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 771 (935)
Q Consensus 692 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~ 771 (935)
.++++..+.. ....+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++........
T Consensus 83 ~~~~~~~~~~---~~~~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~ 156 (299)
T d1ua2a_ 83 ETDLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA 156 (299)
T ss_dssp SEEHHHHHTT---CCSSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC
T ss_pred cchHHhhhhh---cccCCCHHHHHHHHHHHHHHHHHhhc---cceecccCCcceEEecCCCccccccCccccccCCCccc
Confidence 9988777765 35678899999999999999999998 99999999999999999999999999999876544322
Q ss_pred eeecccCCccccCCCCCCC-CCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCC---eeecc---
Q 002336 772 ISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD---VISIV--- 844 (935)
Q Consensus 772 ~~~~~~gt~~y~APE~l~~-~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~---~~~~~--- 844 (935)
.....||+.|+|||++.. ..++.++||||+||++|||++|+.||......+ ....+.+...... .....
T Consensus 157 -~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~---~l~~i~~~~~~~~~~~~~~~~~~~ 232 (299)
T d1ua2a_ 157 -YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD---QLTRIFETLGTPTEEQWPDMCSLP 232 (299)
T ss_dssp -CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHHHCCCCTTTSSSTTSST
T ss_pred -ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHH---HHHHHHHhcCCCChhhccchhccc
Confidence 233468999999998764 567999999999999999999999997443221 1111111111100 00000
Q ss_pred ccccc---CCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 845 DPVLI---GNVK-----IESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 845 d~~l~---~~~~-----~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
..... ...+ ......+.+++.+||+.||++|||++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 233 DYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp TCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred hhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 00000 0001 112246889999999999999999999875
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-42 Score=376.60 Aligned_cols=260 Identities=24% Similarity=0.409 Sum_probs=209.0
Q ss_pred HHHHhhcccccccccEEEEEEEEC------CCcEEEEEEccCcc-hhhhHHHHHHHHHHHhcCCCcccccceeeeccceE
Q 002336 612 EATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQR 684 (935)
Q Consensus 612 ~~~~~~~~~LG~G~fG~Vy~~~~~------~g~~vAvK~~~~~~-~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~ 684 (935)
...+++.+.||+|+||.||+|.++ +++.||||+++... ......|.+|++++++++|||||+++|+|..++..
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~ 98 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 98 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce
Confidence 345567899999999999999874 35789999997543 33446799999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhccCC-------CCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEe
Q 002336 685 ILVYEYMHNGTLRDRLHGSV-------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVS 757 (935)
Q Consensus 685 ~lV~E~~~~gsL~~~L~~~~-------~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~ 757 (935)
++||||+++|+|.+++.... ....+++..+.+++.|+|+||.|||+ ++|+||||||+|||++.++++||+
T Consensus 99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~---~~ivHrDlk~~NiLld~~~~~Kl~ 175 (308)
T d1p4oa_ 99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIG 175 (308)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEECTTCCEEEC
T ss_pred eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeeceEcCCceeecCCceEEEe
Confidence 99999999999999876321 23457899999999999999999998 899999999999999999999999
Q ss_pred eccccccccccccce-eecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCC-CCCCccCcccchhHHHHHHHhh
Q 002336 758 DFGLSRQAEEDLTHI-SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGK-KPVSVEDFGAELNIVHWARSMI 835 (935)
Q Consensus 758 DFGla~~~~~~~~~~-~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~-~Pf~~~~~~~~~~l~~~~~~~i 835 (935)
|||+++......... .....||+.|+|||.+.+..++.++||||||+++|||+||. .||.... ..+... .+
T Consensus 176 DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~------~~~~~~-~i 248 (308)
T d1p4oa_ 176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS------NEQVLR-FV 248 (308)
T ss_dssp CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC------HHHHHH-HH
T ss_pred ecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCC------HHHHHH-HH
Confidence 999998765443322 22335899999999999999999999999999999999985 6665322 122222 22
Q ss_pred hcCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhhhh
Q 002336 836 KKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 890 (935)
Q Consensus 836 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~~~ 890 (935)
.++..... +......+.+++.+||+.+|++|||++||++.|++.+.
T Consensus 249 ~~~~~~~~---------p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 249 MEGGLLDK---------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp HTTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred HhCCCCCC---------cccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 23322111 11122468899999999999999999999999987654
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=2.1e-41 Score=379.85 Aligned_cols=246 Identities=22% Similarity=0.269 Sum_probs=195.6
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCcch---hhhHHHHH---HHHHHHhcCCCcccccceeeeccceEEEE
Q 002336 615 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVT---EVALLSRIHHRNLVPLIGYCEEEHQRILV 687 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~---~~~~~~~~---E~~iL~~L~HpnIv~l~g~~~~~~~~~lV 687 (935)
|++.+.||+|+||.||+|++. +|+.||||++..... .....+.+ |+.+++.++|||||++++++.+.+..++|
T Consensus 6 y~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~iv 85 (364)
T d1omwa3 6 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFI 85 (364)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEE
T ss_pred CeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEEE
Confidence 567889999999999999976 699999999864221 11223444 46667777899999999999999999999
Q ss_pred EEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccc
Q 002336 688 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 767 (935)
Q Consensus 688 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~ 767 (935)
|||+++|+|.+++.. ...+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 86 mE~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~aL~ylH~---~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~ 159 (364)
T d1omwa3 86 LDLMNGGDLHYHLSQ---HGVFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSK 159 (364)
T ss_dssp ECCCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSSSCEEECCCTTCEECSS
T ss_pred EEecCCCcHHHHHHh---cccccHHHHHHHHHHHHHHHHHHHH---CCccceeeccceeEEcCCCcEEEeeeceeeecCC
Confidence 999999999999974 4678899999999999999999998 9999999999999999999999999999987654
Q ss_pred cccceeecccCCccccCCCCCCC-CCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccc
Q 002336 768 DLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP 846 (935)
Q Consensus 768 ~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~ 846 (935)
.. .....||+.|+|||++.. ..++.++|||||||++|||++|+.||.......... +.+...... .
T Consensus 160 ~~---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~----~~~~~~~~~------~ 226 (364)
T d1omwa3 160 KK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE----IDRMTLTMA------V 226 (364)
T ss_dssp SC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHH----HHHHSSSCC------C
T ss_pred Cc---ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHH----HHHhcccCC------C
Confidence 32 233569999999999864 568999999999999999999999997543322211 111111111 1
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 002336 847 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPK-----MQEIVL 883 (935)
Q Consensus 847 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs-----~~ev~~ 883 (935)
...... ...+.+++.+||+.||++||| ++|+++
T Consensus 227 ~~~~~~----s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 227 ELPDSF----SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp CCCSSS----CHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred CCCCCC----CHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 111122 236789999999999999999 688765
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-41 Score=370.70 Aligned_cols=248 Identities=20% Similarity=0.297 Sum_probs=201.8
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCcchhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEecCC
Q 002336 615 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 693 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~~~ 693 (935)
|.+.+.||+|+||+||+|.++ +|+.||||+++... .....+.+|+++|+.++|||||++++++.+++..|+|||||++
T Consensus 7 Y~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~g 85 (321)
T d1tkia_ 7 YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISG 85 (321)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCC
T ss_pred eEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCCC
Confidence 567889999999999999886 68899999997643 3345688999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCC--CcEEEeeccccccccccccc
Q 002336 694 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN--MRAKVSDFGLSRQAEEDLTH 771 (935)
Q Consensus 694 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~--~~vkL~DFGla~~~~~~~~~ 771 (935)
|+|.+++... +..+++.++..++.||++||+|||+ ++|+||||||+|||++.+ ..+||+|||+++.......
T Consensus 86 g~L~~~i~~~--~~~l~e~~~~~i~~qi~~al~yLH~---~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~- 159 (321)
T d1tkia_ 86 LDIFERINTS--AFELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN- 159 (321)
T ss_dssp CBHHHHHTSS--SCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE-
T ss_pred CcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---cCCCcccccccceeecCCCceEEEEcccchhhccccCCc-
Confidence 9999999742 3469999999999999999999998 899999999999999854 5799999999987644322
Q ss_pred eeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccccccCC
Q 002336 772 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 851 (935)
Q Consensus 772 ~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~~~ 851 (935)
.....+++.|+|||.+.+..++.++||||+||++|+|++|+.||...... .. .. .+..+... ++......
T Consensus 160 -~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~---~~---~~-~i~~~~~~--~~~~~~~~ 229 (321)
T d1tkia_ 160 -FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ---QI---IE-NIMNAEYT--FDEEAFKE 229 (321)
T ss_dssp -EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH---HH---HH-HHHHTCCC--CCHHHHTT
T ss_pred -ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHH---HH---HH-HHHhCCCC--CChhhccC
Confidence 23346899999999999999999999999999999999999999743321 11 11 12222110 01001111
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 852 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 852 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
. ...+.+++.+||+.||++|||++|+++
T Consensus 230 ~----s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 230 I----SIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp S----CHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred C----CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1 235789999999999999999999987
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.4e-41 Score=379.32 Aligned_cols=243 Identities=23% Similarity=0.288 Sum_probs=202.3
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc---hhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEE
Q 002336 614 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 689 (935)
Q Consensus 614 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E 689 (935)
.|++.+.||+|+||.||+|+++ +|+.||||++.... ....+.+.+|+++|+.++|||||++++++.+....++|||
T Consensus 42 ~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e 121 (350)
T d1rdqe_ 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVME 121 (350)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccccc
Confidence 4667889999999999999885 79999999986432 1234578899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccc
Q 002336 690 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 769 (935)
Q Consensus 690 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~ 769 (935)
|+.+|+|.+.+.. .+.+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 122 ~~~~g~l~~~l~~---~~~l~e~~~~~i~~qi~~aL~yLH~---~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~~ 195 (350)
T d1rdqe_ 122 YVAGGEMFSHLRR---IGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT 195 (350)
T ss_dssp CCTTCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCB
T ss_pred cccccchhhhHhh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCcCCHHHcccCCCCCEEeeeceeeeeccccc
Confidence 9999999999873 4579999999999999999999998 899999999999999999999999999998765432
Q ss_pred cceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeeccccccc
Q 002336 770 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 849 (935)
Q Consensus 770 ~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~ 849 (935)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...... . ....+..+.. ..
T Consensus 196 ----~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~------~-~~~~i~~~~~------~~- 257 (350)
T d1rdqe_ 196 ----WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI------Q-IYEKIVSGKV------RF- 257 (350)
T ss_dssp ----CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------H-HHHHHHHCCC------CC-
T ss_pred ----ccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHH------H-HHHHHhcCCC------CC-
Confidence 2356999999999999999999999999999999999999999743221 1 1112222221 11
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 002336 850 GNVKIESIWRIAEVAIQCVEQRGFSRP-----KMQEIVL 883 (935)
Q Consensus 850 ~~~~~~~~~~l~~li~~Cl~~dP~~RP-----s~~ev~~ 883 (935)
+......+.+++.+||+.||++|+ |++|+++
T Consensus 258 ---p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 258 ---PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp ---CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred ---CccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 111223688999999999999994 8999876
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-42 Score=376.58 Aligned_cols=245 Identities=24% Similarity=0.362 Sum_probs=200.0
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc---hhhhHHHHHHHHHHH-hcCCCcccccceeeeccceEEEEEE
Q 002336 615 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLS-RIHHRNLVPLIGYCEEEHQRILVYE 689 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~---~~~~~~~~~E~~iL~-~L~HpnIv~l~g~~~~~~~~~lV~E 689 (935)
|++.+.||+|+||+||+|+++ +|+.||||+++... ....+.+..|..++. .++|||||++++++.+++..++|||
T Consensus 4 y~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivmE 83 (320)
T d1xjda_ 4 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVME 83 (320)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEE
T ss_pred eEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEEe
Confidence 567899999999999999886 68999999986432 223345677777765 6899999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccc
Q 002336 690 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 769 (935)
Q Consensus 690 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~ 769 (935)
|+++|+|.+++.. ...+++.++..++.||+.||+|||+ ++|+||||||+|||+++++++||+|||+++......
T Consensus 84 y~~~g~L~~~i~~---~~~~~e~~~~~~~~qi~~al~ylH~---~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~ 157 (320)
T d1xjda_ 84 YLNGGDLMYHIQS---CHKFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD 157 (320)
T ss_dssp CCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred ecCCCcHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCcccceeecCCCceeccccchhhhccccc
Confidence 9999999999973 4568999999999999999999998 899999999999999999999999999998654433
Q ss_pred cceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeeccccccc
Q 002336 770 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 849 (935)
Q Consensus 770 ~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~~l~ 849 (935)
.. .....||+.|+|||++.+..++.++||||+||++|||++|+.||.+.+.. . +...+..+.. .+.
T Consensus 158 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~---~----~~~~i~~~~~------~~p 223 (320)
T d1xjda_ 158 AK-TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE---E----LFHSIRMDNP------FYP 223 (320)
T ss_dssp CC-BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---H----HHHHHHHCCC------CCC
T ss_pred cc-ccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHH---H----HHHHHHcCCC------CCC
Confidence 22 33456999999999999999999999999999999999999999743321 1 1222222221 111
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHH-HHHH
Q 002336 850 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQ-EIVL 883 (935)
Q Consensus 850 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~-ev~~ 883 (935)
.. ....+.+++.+||+.||++||+++ |+.+
T Consensus 224 ~~----~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 224 RW----LEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp TT----SCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred cc----CCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 11 223688999999999999999996 6754
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-41 Score=372.97 Aligned_cols=249 Identities=22% Similarity=0.300 Sum_probs=194.8
Q ss_pred Hhhc-ccccccccEEEEEEEEC-CCcEEEEEEccCcchhhhHHHHHHHHHHHhc-CCCcccccceeeec----cceEEEE
Q 002336 615 NNFC-KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEE----EHQRILV 687 (935)
Q Consensus 615 ~~~~-~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L-~HpnIv~l~g~~~~----~~~~~lV 687 (935)
|++. +.||+|+||.||+|.+. +++.||||+++. .+.+.+|++++.++ +|||||++++++.+ +...++|
T Consensus 13 y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~iv 87 (335)
T d2ozaa1 13 YKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIV 87 (335)
T ss_dssp EEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEE
T ss_pred EEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEE
Confidence 5554 56999999999999874 789999999864 24577899987655 89999999998865 4678999
Q ss_pred EEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccC---CCcEEEeecccccc
Q 002336 688 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI---NMRAKVSDFGLSRQ 764 (935)
Q Consensus 688 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~---~~~vkL~DFGla~~ 764 (935)
||||+||+|.+++... ....+++.++..++.||+.||+|||+ ++|+||||||+|||++. ++.+||+|||+++.
T Consensus 88 mEy~~gg~L~~~i~~~-~~~~l~e~~~~~i~~qi~~al~ylH~---~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~ 163 (335)
T d2ozaa1 88 MECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE 163 (335)
T ss_dssp EECCCSEEHHHHHHSC-SCCCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred EECCCCCcHHHHHHhc-CCCCcCHHHHHHHHHHHHHHHHHHHH---cCCccccccccccccccccccccccccccceeee
Confidence 9999999999999743 34579999999999999999999998 99999999999999985 56799999999987
Q ss_pred ccccccceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecc
Q 002336 765 AEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 844 (935)
Q Consensus 765 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~ 844 (935)
...... .....||+.|+|||++.+..++.++||||+||++|+|+||+.||........ ...+...+..+..
T Consensus 164 ~~~~~~--~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~---~~~~~~~i~~~~~---- 234 (335)
T d2ozaa1 164 TTSHNS--LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI---SPGMKTRIRMGQY---- 234 (335)
T ss_dssp CCCCCC--CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------CCCSCSS----
T ss_pred ccCCCc--cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHH---HHHHHHHHhcCCC----
Confidence 654332 2345699999999999999999999999999999999999999974332211 1111111111111
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 845 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 845 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
.+...........+.+++.+||+.||++|||+.|+++
T Consensus 235 --~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 235 --EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp --SCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred --CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 0000001122346889999999999999999999987
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=7.9e-41 Score=363.45 Aligned_cols=259 Identities=18% Similarity=0.265 Sum_probs=197.6
Q ss_pred HhhcccccccccEEEEEEEECCCcEEEEEEccCcch--hhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEecC
Q 002336 615 NNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 692 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~~g~~vAvK~~~~~~~--~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~~ 692 (935)
|++.++||+|+||+||+|++++|+.||||+++.... ...+.+.+|+.+|++++|||||++++++..++..+++||++.
T Consensus 4 Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~~ 83 (286)
T d1ob3a_ 4 YHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLD 83 (286)
T ss_dssp EEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCS
T ss_pred ceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEeeh
Confidence 456789999999999999999999999999865432 234689999999999999999999999999999999999998
Q ss_pred CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccccce
Q 002336 693 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 772 (935)
Q Consensus 693 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~~ 772 (935)
++.+..+.. ..+.+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||.+.........
T Consensus 84 ~~~~~~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~---~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~- 156 (286)
T d1ob3a_ 84 QDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK- 156 (286)
T ss_dssp EEHHHHHHT---STTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred hhhHHHHHh---hcCCcchhhhHHHHHHHHHHHHHhcc---CcEEecCCCCceeeEcCCCCEEecccccceecccCccc-
Confidence 877777765 35779999999999999999999998 89999999999999999999999999999876443222
Q ss_pred eecccCCccccCCCCCCC-CCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcC---Ce---eec--
Q 002336 773 SSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG---DV---ISI-- 843 (935)
Q Consensus 773 ~~~~~gt~~y~APE~l~~-~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~---~~---~~~-- 843 (935)
.....+++.|+|||.+.+ ..++.++||||+||++|||++|+.||......+. +.+ +....... .. ...
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~--~~~-i~~~~~~~~~~~~~~~~~~~~ 233 (286)
T d1ob3a_ 157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ--LMR-IFRILGTPNSKNWPNVTELPK 233 (286)
T ss_dssp -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHH-HHHHHCCCCTTTSTTGGGSTT
T ss_pred cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHH--HHH-HHHhhCCCChhhccchhhhhh
Confidence 233458999999998765 5679999999999999999999999974332111 111 11111000 00 000
Q ss_pred -------ccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 844 -------VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 844 -------~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
..+.............+.+++.+||+.||++|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000000111122346789999999999999999999974
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-40 Score=363.71 Aligned_cols=259 Identities=21% Similarity=0.288 Sum_probs=195.4
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCcch--hhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEec
Q 002336 615 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 691 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~--~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~ 691 (935)
|++.+.||+|+||+||+|++. +|+.||||+++.... ...+.+.+|+++|++++|||||++++++.+++..++||||+
T Consensus 4 Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~ 83 (298)
T d1gz8a_ 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL 83 (298)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred CEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEeec
Confidence 456789999999999999875 799999999865432 23467999999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccccc
Q 002336 692 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 771 (935)
Q Consensus 692 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~ 771 (935)
.++.+ +.+... ....+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++........
T Consensus 84 ~~~~~-~~~~~~-~~~~l~e~~~~~~~~qil~~L~yLH~---~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~ 158 (298)
T d1gz8a_ 84 HQDLK-KFMDAS-ALTGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT 158 (298)
T ss_dssp SEEHH-HHHHHT-TTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBC
T ss_pred CCchh-hhhhhh-cccCCCHHHHHHHHHHHHHHHHHhhc---CCEEccccCchheeecccCcceeccCCcceeccCCccc
Confidence 76544 444322 35679999999999999999999998 89999999999999999999999999999876443222
Q ss_pred eeecccCCccccCCCCCCCC-CCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeecccc----
Q 002336 772 ISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP---- 846 (935)
Q Consensus 772 ~~~~~~gt~~y~APE~l~~~-~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~~d~---- 846 (935)
.....||+.|+|||.+... .++.++||||+||++|+|++|+.||...+..+ .+....+. . +...+...+
T Consensus 159 -~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~--~~~~i~~~-~--~~~~~~~~~~~~~ 232 (298)
T d1gz8a_ 159 -YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID--QLFRIFRT-L--GTPDEVVWPGVTS 232 (298)
T ss_dssp -TTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHH-H--CCCCTTTSTTGGG
T ss_pred -ceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHH--HHHHHHHh-c--CCCchhhcccccc
Confidence 2334689999999986654 45899999999999999999999997433211 11111110 0 110000000
Q ss_pred --cccCC------CC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002336 847 --VLIGN------VK-----IESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 884 (935)
Q Consensus 847 --~l~~~------~~-----~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~ 884 (935)
..... .+ ......+.+++.+||+.||++|||++|+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 233 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp STTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 00000 00 1112467899999999999999999999864
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-41 Score=361.45 Aligned_cols=238 Identities=24% Similarity=0.390 Sum_probs=193.6
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcch------hhhHHHHHHHHHHHhcC--CCcccccceeeeccceE
Q 002336 614 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS------HRTQQFVTEVALLSRIH--HRNLVPLIGYCEEEHQR 684 (935)
Q Consensus 614 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~------~~~~~~~~E~~iL~~L~--HpnIv~l~g~~~~~~~~ 684 (935)
.|++.+.||+|+||+||+|++. +|+.||||++..... ....++.+|+.+|++++ |||||++++++.+.+..
T Consensus 5 ~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~ 84 (273)
T d1xwsa_ 5 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSF 84 (273)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEE
T ss_pred eEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCeE
Confidence 3667899999999999999875 789999999864321 12245778999999996 89999999999999999
Q ss_pred EEEEEecCC-CCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccC-CCcEEEeecccc
Q 002336 685 ILVYEYMHN-GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI-NMRAKVSDFGLS 762 (935)
Q Consensus 685 ~lV~E~~~~-gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~-~~~vkL~DFGla 762 (935)
++||||+.+ +++.+++.. ...+++.++..++.|+++||+|||+ ++|+||||||+|||++. ++.+||+|||++
T Consensus 85 ~lv~e~~~~~~~l~~~~~~---~~~l~e~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NIll~~~~~~vkl~DFG~a 158 (273)
T d1xwsa_ 85 VLILERPEPVQDLFDFITE---RGALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSG 158 (273)
T ss_dssp EEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred EEEEEeccCcchHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHH---CCCccccCcccceEEecCCCeEEECccccc
Confidence 999999976 678888763 4679999999999999999999998 99999999999999985 579999999999
Q ss_pred ccccccccceeecccCCccccCCCCCCCCCC-CchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCee
Q 002336 763 RQAEEDLTHISSVARGTVGYLDPEYYGNQQL-TEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVI 841 (935)
Q Consensus 763 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~-s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~ 841 (935)
+...... .....||+.|+|||++.+..+ +.++||||+||++|||++|+.||.... . +..+..
T Consensus 159 ~~~~~~~---~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-----~--------i~~~~~- 221 (273)
T d1xwsa_ 159 ALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-----E--------IIRGQV- 221 (273)
T ss_dssp EECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----H--------HHHCCC-
T ss_pred eeccccc---ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch-----H--------Hhhccc-
Confidence 8654332 234569999999999876554 677999999999999999999997321 0 111111
Q ss_pred ecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 842 SIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 842 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
.+....+ ..+.+++.+||+.||++|||++|+++
T Consensus 222 -----~~~~~~s----~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 222 -----FFRQRVS----SECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp -----CCSSCCC----HHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -----CCCCCCC----HHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 1111222 36789999999999999999999976
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-40 Score=359.71 Aligned_cols=261 Identities=21% Similarity=0.255 Sum_probs=195.2
Q ss_pred HHhhcccccccccEEEEEEEEC-C-CcEEEEEEccCcch--hhhHHHHHHHHHHHhc---CCCcccccceeeec-----c
Q 002336 614 TNNFCKKIGKGSFGSVYYGKMK-D-GKEVAVKIMADSCS--HRTQQFVTEVALLSRI---HHRNLVPLIGYCEE-----E 681 (935)
Q Consensus 614 ~~~~~~~LG~G~fG~Vy~~~~~-~-g~~vAvK~~~~~~~--~~~~~~~~E~~iL~~L---~HpnIv~l~g~~~~-----~ 681 (935)
.|++.+.||+|+||+||+|++. + ++.||||+++.... .....+.+|+.+|+.| +||||++++++|.. .
T Consensus 8 ~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~ 87 (305)
T d1blxa_ 8 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 87 (305)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSE
T ss_pred CEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccccC
Confidence 4667889999999999999874 4 66799999865322 2234577888887776 79999999998843 3
Q ss_pred ceEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccc
Q 002336 682 HQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGL 761 (935)
Q Consensus 682 ~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGl 761 (935)
...+++||+++++.+...... ....+++..+..++.|++.||+|||+ ++|+||||||+|||+++++.+||+|||+
T Consensus 88 ~~~~~~~e~~~~~~~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~yLH~---~~ivHrDiKp~NILi~~~~~~kl~dfg~ 162 (305)
T d1blxa_ 88 TKLTLVFEHVDQDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGL 162 (305)
T ss_dssp EEEEEEEECCSCBHHHHHHHS--CTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred ceEEEEEEeccCCchhhhhhc--cCCCCCHHHHHHHHHHHHHHHHHHHh---CCEEecCCCccEEEEcCCCCeeecchhh
Confidence 568999999998877655442 35678999999999999999999998 8999999999999999999999999999
Q ss_pred cccccccccceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcC---
Q 002336 762 SRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG--- 838 (935)
Q Consensus 762 a~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~--- 838 (935)
++...... ......||+.|+|||++.+..++.++||||+||++|||++|+.||......+. +.. +.+.....
T Consensus 163 ~~~~~~~~--~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~--~~~-i~~~~~~~~~~ 237 (305)
T d1blxa_ 163 ARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ--LGK-ILDVIGLPGEE 237 (305)
T ss_dssp CCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHH-HHHHHCCCCGG
T ss_pred hhhhcccc--cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHH--HHH-HHHhhCCCchh
Confidence 88654332 23345699999999999999999999999999999999999999975432211 111 11111000
Q ss_pred Cee------eccc----ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002336 839 DVI------SIVD----PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 884 (935)
Q Consensus 839 ~~~------~~~d----~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~ 884 (935)
... .... ..............+.+++.+||+.||++|||++|+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 238 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp GSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 000 0000 000001111223467899999999999999999998763
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=9.4e-39 Score=348.18 Aligned_cols=261 Identities=16% Similarity=0.202 Sum_probs=208.4
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcchhhhHHHHHHHHHHHhcCC-CcccccceeeeccceEEEEEEec
Q 002336 614 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHH-RNLVPLIGYCEEEHQRILVYEYM 691 (935)
Q Consensus 614 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~H-pnIv~l~g~~~~~~~~~lV~E~~ 691 (935)
.|++.+.||+|+||+||+|++. +|+.||||++... ...+.+.+|++.++.++| +|++.+++++.++...++||||+
T Consensus 6 ~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~--~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~ 83 (293)
T d1csna_ 6 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL 83 (293)
T ss_dssp TEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECC--TTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC
T ss_pred ceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccc--cCcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec
Confidence 3567899999999999999976 6899999987543 234568889999999965 89999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccC-----CCcEEEeecccccccc
Q 002336 692 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI-----NMRAKVSDFGLSRQAE 766 (935)
Q Consensus 692 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~-----~~~vkL~DFGla~~~~ 766 (935)
+++|.+++... +..+++.++..++.|++.||+|||+ ++|+||||||+|||++. ++.+||+|||+++...
T Consensus 84 -~~~l~~~~~~~--~~~~~~~~~~~i~~q~~~~l~~lH~---~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~ 157 (293)
T d1csna_ 84 -GPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 157 (293)
T ss_dssp -CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred -CCCHHHHHHhh--ccchhhHHHHHHHHHHHHHHHHHHH---CCceeccCCccceeecCcccccCCceEEcccceeEEcc
Confidence 78999988643 4568999999999999999999998 99999999999999974 5789999999998765
Q ss_pred ccccc------eeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCe
Q 002336 767 EDLTH------ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV 840 (935)
Q Consensus 767 ~~~~~------~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~ 840 (935)
+.... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||..............+.........
T Consensus 158 ~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (293)
T d1csna_ 158 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL 237 (293)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCH
T ss_pred cCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCCh
Confidence 43221 123456999999999999999999999999999999999999999855544333322222222211111
Q ss_pred eecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhhhhh
Q 002336 841 ISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 891 (935)
Q Consensus 841 ~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~~~~ 891 (935)
.+ +....+ ..+.+++..|+..+|++||+++.+.+.|+++...
T Consensus 238 ~~-----l~~~~p----~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~ 279 (293)
T d1csna_ 238 RE-----LCAGFP----EEFYKYMHYARNLAFDATPDYDYLQGLFSKVLER 279 (293)
T ss_dssp HH-----HTTTSC----HHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred HH-----hcCCCC----HHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHH
Confidence 11 111222 3688999999999999999999999999887653
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-39 Score=354.04 Aligned_cols=261 Identities=19% Similarity=0.241 Sum_probs=192.6
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc--hhhhHHHHHHHHHHHhcCCCcccccceeeec--------cc
Q 002336 614 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEE--------EH 682 (935)
Q Consensus 614 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~--------~~ 682 (935)
.|++.+.||+|+||+||+|++. +|+.||||++.... ....+++.+|+++|++++||||+++++++.. ..
T Consensus 11 rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~ 90 (318)
T d3blha1 11 KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKG 90 (318)
T ss_dssp GEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----------
T ss_pred CEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccCc
Confidence 4567889999999999999975 79999999985432 2234678999999999999999999998754 34
Q ss_pred eEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccc
Q 002336 683 QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS 762 (935)
Q Consensus 683 ~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla 762 (935)
..++||||++++.+..... ....+++..+..++.|+++||.|||+ ++|+||||||+|||++.++.+||+|||++
T Consensus 91 ~~~iv~e~~~~~~~~~~~~---~~~~~~~~~~~~i~~qil~~l~~lH~---~~ivHrDlKp~NILl~~~~~~kl~dfg~~ 164 (318)
T d3blha1 91 SIYLVFDFCEHDLAGLLSN---VLVKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLA 164 (318)
T ss_dssp CEEEEEECCCEEHHHHHTC---TTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred eEEEEEeccCCCccchhhh---cccccccHHHHHHHHHHHHHHHHhcc---CCEEecCcCchheeecCCCcEEeeeccee
Confidence 6799999998887766554 45678899999999999999999998 89999999999999999999999999999
Q ss_pred cccccccc---ceeecccCCccccCCCCCCCC-CCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhc-
Q 002336 763 RQAEEDLT---HISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKK- 837 (935)
Q Consensus 763 ~~~~~~~~---~~~~~~~gt~~y~APE~l~~~-~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~- 837 (935)
+....... .......||+.|+|||.+.+. .++.++||||+||++|||++|+.||........... +.+....
T Consensus 165 ~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~---i~~~~~~~ 241 (318)
T d3blha1 165 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLAL---ISQLCGSI 241 (318)
T ss_dssp EECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH---HHHHHCCC
T ss_pred eecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHH---HHHhcCCC
Confidence 76543221 122234689999999988654 689999999999999999999999974432221111 1111110
Q ss_pred --CCeeec--------ccccccCCCCHH-------HHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 838 --GDVISI--------VDPVLIGNVKIE-------SIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 838 --~~~~~~--------~d~~l~~~~~~~-------~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
...... ............ ....+.+++.+||+.||++|||++|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~ 304 (318)
T d3blha1 242 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304 (318)
T ss_dssp CTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence 000000 000000000111 1125678999999999999999999975
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.4e-38 Score=347.85 Aligned_cols=259 Identities=23% Similarity=0.304 Sum_probs=197.7
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCcchhhhHHHHHHHHHHHhcCCCcccccce-eeeccceEEEEEEecC
Q 002336 615 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG-YCEEEHQRILVYEYMH 692 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~HpnIv~l~g-~~~~~~~~~lV~E~~~ 692 (935)
|++.+.||+|+||.||+|++. +|+.||||++.... ..+++..|+++++.++|+|++..++ +..+.+..++||||+
T Consensus 9 Y~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~- 85 (299)
T d1ckia_ 9 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL- 85 (299)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC-
T ss_pred EEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc--cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc-
Confidence 667899999999999999875 68999999876532 3356889999999998777665554 556777889999999
Q ss_pred CCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCcccc---CCCcEEEeeccccccccccc
Q 002336 693 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD---INMRAKVSDFGLSRQAEEDL 769 (935)
Q Consensus 693 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld---~~~~vkL~DFGla~~~~~~~ 769 (935)
+++|.+.+.. ....+++..+..++.|++.||+|||+ ++|+||||||+|||++ .+..+||+|||+++...+..
T Consensus 86 ~~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~ 160 (299)
T d1ckia_ 86 GPSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 160 (299)
T ss_dssp CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTT
T ss_pred CCchhhhhhh--ccCCCcHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHhhccccccCCCceeeeeccCcceeccccc
Confidence 5666666543 35679999999999999999999998 9999999999999875 45679999999998765432
Q ss_pred cc------eeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHH-HHHHHhhhcCCeee
Q 002336 770 TH------ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIV-HWARSMIKKGDVIS 842 (935)
Q Consensus 770 ~~------~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~-~~~~~~i~~~~~~~ 842 (935)
.. ......||+.|+|||.+.+..++.++|||||||++|||++|+.||............ .+...... ...
T Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~-~~~-- 237 (299)
T d1ckia_ 161 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS-TPI-- 237 (299)
T ss_dssp TCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHH-SCH--
T ss_pred cccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCC-CCh--
Confidence 21 223456999999999999999999999999999999999999999754433222211 11111111 111
Q ss_pred cccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhhhhhh
Q 002336 843 IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 891 (935)
Q Consensus 843 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~L~~~~~~ 891 (935)
+.+.... +..+.+++.+||+.+|++||+++++.+.|++....
T Consensus 238 ---~~~~~~~----p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~ 279 (299)
T d1ckia_ 238 ---EVLCKGY----PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 279 (299)
T ss_dssp ---HHHTTTS----CHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred ---hHhccCC----CHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHH
Confidence 1111122 23688999999999999999999999999887543
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-39 Score=358.83 Aligned_cols=266 Identities=24% Similarity=0.251 Sum_probs=194.2
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcchhhhHHHHHHHHHHHhcCCCcccccceeeec------cceEEE
Q 002336 614 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEE------EHQRIL 686 (935)
Q Consensus 614 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~------~~~~~l 686 (935)
+|+..++||+|+||+||+|++. +|+.||||++.... ..+.+|+++|++++||||+++++++.. ....++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS----SSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccc----hHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 3556789999999999999986 69999999986542 233479999999999999999998843 335789
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCC-cEEEeeccccccc
Q 002336 687 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM-RAKVSDFGLSRQA 765 (935)
Q Consensus 687 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~-~vkL~DFGla~~~ 765 (935)
||||++++.+..+.........+++.++..++.||+.||+|||+ ++|+||||||+|||++.++ .+||+|||+++..
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~---~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHh---cCCcccCCCcceEEEecCCCceeEecccchhhc
Confidence 99999876544443322246679999999999999999999998 9999999999999999775 8999999999876
Q ss_pred cccccceeecccCCccccCCCCCC-CCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHH---------HHHHHhh
Q 002336 766 EEDLTHISSVARGTVGYLDPEYYG-NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIV---------HWARSMI 835 (935)
Q Consensus 766 ~~~~~~~~~~~~gt~~y~APE~l~-~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~---------~~~~~~i 835 (935)
..... .....|+..|+|||.+. ...++.++||||+||++|||++|+.||......+..... ++.....
T Consensus 174 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~ 251 (350)
T d1q5ka_ 174 VRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 251 (350)
T ss_dssp CTTSC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHC
T ss_pred cCCcc--cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhc
Confidence 44332 23356899999999765 457899999999999999999999999744322111100 0011100
Q ss_pred h---cCCeeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--Hhhh
Q 002336 836 K---KGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA--IQDS 888 (935)
Q Consensus 836 ~---~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~--L~~~ 888 (935)
. .......................+.+++.+||+.||++|||++|+++. ++++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 309 (350)
T d1q5ka_ 252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309 (350)
T ss_dssp C---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred cchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccc
Confidence 0 000000000000011111223468899999999999999999999863 5444
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-38 Score=352.42 Aligned_cols=260 Identities=21% Similarity=0.293 Sum_probs=192.8
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc-hhhhHHHHHHHHHHHhcCCCcccccceeeeccc----eEEEEE
Q 002336 615 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH----QRILVY 688 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~-~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~----~~~lV~ 688 (935)
|++.+.||+|+||+||+|... +|+.||||++.... ....+.+.+|+++|+.++||||+++++++.... ..++++
T Consensus 10 Y~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~ 89 (345)
T d1pmea_ 10 YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLV 89 (345)
T ss_dssp EEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEE
T ss_pred eEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEEE
Confidence 566789999999999999874 79999999987543 334568999999999999999999999986543 235556
Q ss_pred EecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccccc
Q 002336 689 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 768 (935)
Q Consensus 689 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~ 768 (935)
+++.+|+|.+++.. ..+++..+..++.|+++||+|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 90 ~~~~~g~L~~~l~~----~~l~~~~i~~i~~qil~al~yLH~---~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~ 162 (345)
T d1pmea_ 90 THLMGADLYKLLKT----QHLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 162 (345)
T ss_dssp EECCCEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECCGG
T ss_pred EeecCCchhhhhhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCcceEEECCCCCEEEcccCceeeccCC
Confidence 67779999999973 369999999999999999999998 89999999999999999999999999999865443
Q ss_pred ccc--eeecccCCccccCCCCCCC-CCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeee---
Q 002336 769 LTH--ISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVIS--- 842 (935)
Q Consensus 769 ~~~--~~~~~~gt~~y~APE~l~~-~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~--- 842 (935)
... ......||+.|+|||.+.. ..++.++||||+||+++||++|+.||......+...... ..........
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~---~~~~~~~~~~~~~ 239 (345)
T d1pmea_ 163 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL---GILGSPSQEDLNC 239 (345)
T ss_dssp GCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH---HHHCSCCHHHHHT
T ss_pred CccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHh---hhccCCChhhhhh
Confidence 221 2234568999999998854 567899999999999999999999997543321111110 0000000000
Q ss_pred --------c-ccccccCCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002336 843 --------I-VDPVLIGNVK-----IESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 884 (935)
Q Consensus 843 --------~-~d~~l~~~~~-----~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~ 884 (935)
. .........+ ......+.+++.+||+.||++|||++|+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 240 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp CCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 0000000000 0111257899999999999999999999874
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-38 Score=351.72 Aligned_cols=263 Identities=22% Similarity=0.308 Sum_probs=193.1
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc--hhhhHHHHHHHHHHHhcCCCcccccceeeeccc------eE
Q 002336 614 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH------QR 684 (935)
Q Consensus 614 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~------~~ 684 (935)
.|++.+.||+|+||+||+|.+. +|+.||||+++... ....+.+.+|+++|+.++|||||+++++|...+ +.
T Consensus 19 ~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~ 98 (346)
T d1cm8a_ 19 VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDF 98 (346)
T ss_dssp SEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCC
T ss_pred cEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceE
Confidence 3667789999999999999875 69999999997532 234567899999999999999999999987654 57
Q ss_pred EEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccc
Q 002336 685 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 764 (935)
Q Consensus 685 ~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~ 764 (935)
++||||+ +.+|..+.+ ...+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++.
T Consensus 99 ~lv~e~~-~~~l~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~---~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~ 170 (346)
T d1cm8a_ 99 YLVMPFM-GTDLGKLMK----HEKLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQ 170 (346)
T ss_dssp EEEEECC-SEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEecc-cccHHHHHH----hccccHHHHHHHHHHHHHHHHHHHh---CCCcccccCcchhhcccccccccccccceec
Confidence 9999999 667888775 3469999999999999999999998 9999999999999999999999999999987
Q ss_pred ccccccceeecccCCccccCCCCCCC-CCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHH-----hhhcC
Q 002336 765 AEEDLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARS-----MIKKG 838 (935)
Q Consensus 765 ~~~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~-----~i~~~ 838 (935)
..... ....||+.|+|||.+.+ ..++.++||||+||++|||++|+.||...+............. .....
T Consensus 171 ~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (346)
T d1cm8a_ 171 ADSEM----TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRL 246 (346)
T ss_dssp CCSSC----CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTC
T ss_pred cCCcc----ccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhh
Confidence 65432 23568999999998765 5678999999999999999999999975432211111000000 00000
Q ss_pred C----------eeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--Hhhhh
Q 002336 839 D----------VISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA--IQDSI 889 (935)
Q Consensus 839 ~----------~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~--L~~~~ 889 (935)
. ..+.....+. .........+.+++.+||+.||++|||++|+++. ++++.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~ 308 (346)
T d1cm8a_ 247 QSDEAKNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308 (346)
T ss_dssp SCHHHHHHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred cchhhhhhhccCCcccccchH-HhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence 0 0000000000 0011112357899999999999999999999875 55543
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-38 Score=350.92 Aligned_cols=250 Identities=26% Similarity=0.357 Sum_probs=200.1
Q ss_pred HhhcccccccccEEEEEEEEC----CCcEEEEEEccCcc----hhhhHHHHHHHHHHHhcCC-CcccccceeeeccceEE
Q 002336 615 NNFCKKIGKGSFGSVYYGKMK----DGKEVAVKIMADSC----SHRTQQFVTEVALLSRIHH-RNLVPLIGYCEEEHQRI 685 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~----~g~~vAvK~~~~~~----~~~~~~~~~E~~iL~~L~H-pnIv~l~g~~~~~~~~~ 685 (935)
|++.+.||+|+||+||+|... +|+.||||+++... ....+.+.+|+++|++++| |||+++++++.+....+
T Consensus 26 y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~~ 105 (322)
T d1vzoa_ 26 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLH 105 (322)
T ss_dssp EEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEE
T ss_pred eEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCcee
Confidence 778899999999999999862 48899999986432 2234678899999999966 89999999999999999
Q ss_pred EEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccc
Q 002336 686 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 765 (935)
Q Consensus 686 lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~ 765 (935)
++|||+.+|+|.+++.. ...+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++..
T Consensus 106 ~v~e~~~~~~L~~~i~~---~~~~~e~~~~~~~~Qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~ 179 (322)
T d1vzoa_ 106 LILDYINGGELFTHLSQ---RERFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 179 (322)
T ss_dssp EEECCCCSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred eeeecccccHHHHHHHh---cccccHHHHHHHHHHHHHHHHHhhc---CCEEeccCCccceeecCCCCEEEeeccchhhh
Confidence 99999999999999874 4567889999999999999999998 89999999999999999999999999999876
Q ss_pred cccccceeecccCCccccCCCCCCCC--CCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCCeeec
Q 002336 766 EEDLTHISSVARGTVGYLDPEYYGNQ--QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISI 843 (935)
Q Consensus 766 ~~~~~~~~~~~~gt~~y~APE~l~~~--~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~~~~~ 843 (935)
............|++.|+|||.+.+. .++.++||||+||+||||++|+.||.......... ...+.... ..
T Consensus 180 ~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~--~i~~~~~~-~~---- 252 (322)
T d1vzoa_ 180 VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQA--EISRRILK-SE---- 252 (322)
T ss_dssp CGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHH--HHHHHHHH-CC----
T ss_pred cccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHH--HHHHhccc-CC----
Confidence 55544444556799999999988653 57889999999999999999999997554332211 11111111 11
Q ss_pred ccccccCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 002336 844 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPK-----MQEIVL 883 (935)
Q Consensus 844 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs-----~~ev~~ 883 (935)
+.. +......+.+++.+||+.||++||| ++|+++
T Consensus 253 --~~~----~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 253 --PPY----PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp --CCC----CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred --CCC----cccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 111 1222347889999999999999994 788865
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-38 Score=340.96 Aligned_cols=260 Identities=20% Similarity=0.249 Sum_probs=199.9
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc--hhhhHHHHHHHHHHHhcCCCcccccceeeeccceEEEEEEec
Q 002336 615 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 691 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~~~~~~lV~E~~ 691 (935)
|++.+.||+|+||+||+|++. +|+.||||+++... .....++.+|+.+|+.++||||+++++++.+....++|+|++
T Consensus 4 y~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~~ 83 (292)
T d1unla_ 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC 83 (292)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred CEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeeec
Confidence 566789999999999999975 78999999986432 234578999999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccccccccc
Q 002336 692 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 771 (935)
Q Consensus 692 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~~~~~~ 771 (935)
.+++|..++. ..+.+++..+..++.|+++||+|||+ ++|+||||||+|||++.++.+||+|||.++........
T Consensus 84 ~~~~l~~~~~---~~~~~~~~~~~~~~~q~~~aL~~lH~---~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~ 157 (292)
T d1unla_ 84 DQDLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC 157 (292)
T ss_dssp SEEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSC
T ss_pred cccccccccc---cccccchhHHHHHHHHHHHHHHHhhc---CCEeeecccCcccccccCCceeeeecchhhcccCCCcc
Confidence 9999988877 45678999999999999999999998 89999999999999999999999999999876543322
Q ss_pred eeecccCCccccCCCCCCCC-CCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhc---CCee---ecc
Q 002336 772 ISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKK---GDVI---SIV 844 (935)
Q Consensus 772 ~~~~~~gt~~y~APE~l~~~-~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~---~~~~---~~~ 844 (935)
.....++..|+|||.+... .++.++||||+||++|||++|+.||...... .+...-+...... .... ...
T Consensus 158 -~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (292)
T d1unla_ 158 -YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV--DDQLKRIFRLLGTPTEEQWPSMTKLP 234 (292)
T ss_dssp -CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSH--HHHHHHHHHHHCCCCTTTCTTGGGST
T ss_pred -ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCH--HHHHHHHHhhcCCCChhhhhhhhhcc
Confidence 2234578889999987655 4689999999999999999999997522211 1111111111110 0000 000
Q ss_pred c---------ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 845 D---------PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 845 d---------~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
+ ..-...........+.+++.+||+.||++|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred cccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 00000111222346789999999999999999999875
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.9e-37 Score=343.44 Aligned_cols=256 Identities=19% Similarity=0.279 Sum_probs=193.4
Q ss_pred HHhhcccccccccEEEEEEEEC-CCcEEEEEEccCcchhhhHHHHHHHHHHHhcC-CCcccccceeeec--cceEEEEEE
Q 002336 614 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIH-HRNLVPLIGYCEE--EHQRILVYE 689 (935)
Q Consensus 614 ~~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~-HpnIv~l~g~~~~--~~~~~lV~E 689 (935)
.|++.++||+|+||+||+|++. +|+.||||+++.. ..+++.+|+++|+.++ ||||+++++++.. ....++|||
T Consensus 36 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e 112 (328)
T d3bqca1 36 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFE 112 (328)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEE
T ss_pred CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEe
Confidence 4777899999999999999985 7899999998753 2457889999999995 9999999999864 456899999
Q ss_pred ecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCC-cEEEeecccccccccc
Q 002336 690 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM-RAKVSDFGLSRQAEED 768 (935)
Q Consensus 690 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~-~vkL~DFGla~~~~~~ 768 (935)
|+.+++|.... +.+++..+..++.||+.||+|||+ ++|+||||||+|||++.++ .+||+|||+++.....
T Consensus 113 ~~~~~~L~~~~------~~l~e~~i~~i~~qil~aL~~LH~---~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~ 183 (328)
T d3bqca1 113 HVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 183 (328)
T ss_dssp CCCSCBGGGTT------TSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT
T ss_pred ecCCCcHHHHh------cCCCHHHHHHHHHHHHHHHHHHhh---cccccccccccceEEcCCCCeeeecccccceeccCC
Confidence 99999997754 358999999999999999999998 9999999999999998655 6999999999876543
Q ss_pred ccceeecccCCccccCCCCCCCC-CCCchhHHHHHHHHHHHHHhCCCCCCccCcccch--h---------HHHHHHHhhh
Q 002336 769 LTHISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAEL--N---------IVHWARSMIK 836 (935)
Q Consensus 769 ~~~~~~~~~gt~~y~APE~l~~~-~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~--~---------l~~~~~~~i~ 836 (935)
.. .....+|+.|+|||.+.+. .++.++||||+||+++||++|+.||......... . ...|......
T Consensus 184 ~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 261 (328)
T d3bqca1 184 QE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 261 (328)
T ss_dssp CC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTC
T ss_pred Cc--ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhccc
Confidence 22 2345689999999987654 5799999999999999999999999744322110 0 0111110000
Q ss_pred cCC--eeeccc--------ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 837 KGD--VISIVD--------PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 837 ~~~--~~~~~d--------~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
... ...... ..............+.+++.+||+.||++|||++|+++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 262 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp CCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000 000000 00000011122346789999999999999999999976
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-36 Score=340.85 Aligned_cols=259 Identities=22% Similarity=0.267 Sum_probs=187.6
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc--hhhhHHHHHHHHHHHhcCCCcccccceeeec------cceEE
Q 002336 615 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEE------EHQRI 685 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~------~~~~~ 685 (935)
|++.++||+|+||+||+|.+. +|+.||||++.... ....+.+.+|+.+|++++|||||++++++.. ....|
T Consensus 19 Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~ 98 (355)
T d2b1pa1 19 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVY 98 (355)
T ss_dssp EEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEE
T ss_pred eEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCceeE
Confidence 567789999999999999986 69999999997542 3345678999999999999999999999853 46789
Q ss_pred EEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeeccccccc
Q 002336 686 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 765 (935)
Q Consensus 686 lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~ 765 (935)
+||||+.++.+. .+. ..+++..+..++.||+.||+|||+ +||+||||||+|||++.++.+|++|||+++..
T Consensus 99 iv~Ey~~~~l~~-~~~-----~~~~~~~i~~~~~qil~gl~~LH~---~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~ 169 (355)
T d2b1pa1 99 LVMELMDANLCQ-VIQ-----MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 169 (355)
T ss_dssp EEEECCSEEHHH-HHT-----SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EEEeccchHHHH-hhh-----cCCCHHHHHHHHHHHHHHHHHhhh---cccccccCCccccccccccceeeechhhhhcc
Confidence 999999765554 443 347899999999999999999998 89999999999999999999999999998765
Q ss_pred cccccceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHH----------------H
Q 002336 766 EEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIV----------------H 829 (935)
Q Consensus 766 ~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~----------------~ 829 (935)
..... .....+|+.|+|||.+.+..++.++||||+||+++||++|+.||.+.+........ .
T Consensus 170 ~~~~~--~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 247 (355)
T d2b1pa1 170 GTSFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 247 (355)
T ss_dssp -------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCH
T ss_pred ccccc--cccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhh
Confidence 44322 23446899999999999999999999999999999999999999754322111000 0
Q ss_pred HHHHhhhcCC-e-----eecccccccCCC---CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002336 830 WARSMIKKGD-V-----ISIVDPVLIGNV---KIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 884 (935)
Q Consensus 830 ~~~~~i~~~~-~-----~~~~d~~l~~~~---~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~~ 884 (935)
..+....... . ............ .......+.+++.+||+.||++|||++|+++.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp HHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0001111100 0 000111111111 12334578899999999999999999999764
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-37 Score=341.25 Aligned_cols=254 Identities=21% Similarity=0.306 Sum_probs=190.5
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCcc--hhhhHHHHHHHHHHHhcCCCcccccceeeec-----cceEEE
Q 002336 615 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEE-----EHQRIL 686 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~--~~~~~~~~~E~~iL~~L~HpnIv~l~g~~~~-----~~~~~l 686 (935)
|++.+.||+|+||+||+|++. +|+.||||+++... ....+.+.+|+++|+.++|||||++++++.. ....++
T Consensus 20 Y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 99 (348)
T d2gfsa1 20 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY 99 (348)
T ss_dssp EEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCCE
T ss_pred eEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceEE
Confidence 667889999999999999875 79999999987542 2345678999999999999999999999853 334567
Q ss_pred EEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEeecccccccc
Q 002336 687 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 766 (935)
Q Consensus 687 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~DFGla~~~~ 766 (935)
+++++.+|+|.+++. ...+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+|++|||++....
T Consensus 100 i~~~~~gg~L~~~~~----~~~l~e~~~~~i~~qil~aL~~LH~---~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~ 172 (348)
T d2gfsa1 100 LVTHLMGADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD 172 (348)
T ss_dssp EEEECCSEEHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCC----CCT
T ss_pred EEEeecCCchhhhcc----cccccHHHHHHHHHHHHHHHHHHHh---CCCcccccCCccccccccccccccccchhcccC
Confidence 788888999999986 3469999999999999999999998 899999999999999999999999999987654
Q ss_pred ccccceeecccCCccccCCCCCCC-CCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchhHHHHHHHhhhcCC------
Q 002336 767 EDLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD------ 839 (935)
Q Consensus 767 ~~~~~~~~~~~gt~~y~APE~l~~-~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~l~~~~~~~i~~~~------ 839 (935)
... ....|++.|+|||.+.+ ..++.++||||+||++|+|++|+.||.+.+...... .+.+......
T Consensus 173 ~~~----~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~---~i~~~~~~~~~~~~~~ 245 (348)
T d2gfsa1 173 DEM----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLK---LILRLVGTPGAELLKK 245 (348)
T ss_dssp GGG----SSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH---HHHHHHCCCCHHHHTT
T ss_pred ccc----ccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHH---HHHHhcCCCChHHhhh
Confidence 332 23458899999997655 456899999999999999999999997543221111 1111100000
Q ss_pred ------------eeecccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 840 ------------VISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 840 ------------~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
........+.. ........+.+++.+||+.||++|||++|+++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~ 300 (348)
T d2gfsa1 246 ISSESARNYIQSLTQMPKMNFAN-VFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300 (348)
T ss_dssp CCCHHHHHHHTTSCCCCCCCHHH-HSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccchhhhhhhhhcccCCCcchhh-hcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence 00000000000 00011235789999999999999999999986
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=9e-34 Score=317.70 Aligned_cols=274 Identities=20% Similarity=0.281 Sum_probs=195.4
Q ss_pred HhhcccccccccEEEEEEEEC-CCcEEEEEEccCcchhhhHHHHHHHHHHHhcC-----------CCcccccceeeec--
Q 002336 615 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIH-----------HRNLVPLIGYCEE-- 680 (935)
Q Consensus 615 ~~~~~~LG~G~fG~Vy~~~~~-~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~-----------HpnIv~l~g~~~~-- 680 (935)
|++.++||+|+||+||+|+.. +|+.||||+++... ...+.+.+|+++++.++ |+||+++++++..
T Consensus 15 Y~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~ 93 (362)
T d1q8ya_ 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKG 93 (362)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEE
T ss_pred EEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeecc
Confidence 678899999999999999975 79999999997543 23467788999988875 5789999988754
Q ss_pred cceEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCc------E
Q 002336 681 EHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMR------A 754 (935)
Q Consensus 681 ~~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~------v 754 (935)
....+++|+++..+..............+++..+..++.|++.||+|||+ ..+|+||||||+|||++.++. +
T Consensus 94 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~--~~~IvHrDlKp~NIll~~~~~~~~~~~~ 171 (362)
T d1q8ya_ 94 PNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQI 171 (362)
T ss_dssp TTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGGGEEEEEEETTTTEEEE
T ss_pred ccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhh--hcCcccccCChhHeeeeccCccccccee
Confidence 34566777776655433333223356678999999999999999999997 478999999999999986553 9
Q ss_pred EEeeccccccccccccceeecccCCccccCCCCCCCCCCCchhHHHHHHHHHHHHHhCCCCCCccCcccchh----HHHH
Q 002336 755 KVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELN----IVHW 830 (935)
Q Consensus 755 kL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~s~ksDVwS~Gvil~eLltG~~Pf~~~~~~~~~~----l~~~ 830 (935)
+++|||.+...... .....||+.|+|||++....++.++||||+||++++|++|+.||...+...... +...
T Consensus 172 kl~dfg~s~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~ 247 (362)
T d1q8ya_ 172 KIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQI 247 (362)
T ss_dssp EECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHH
T ss_pred eEeecccccccccc----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHH
Confidence 99999998765432 234569999999999988899999999999999999999999997443321111 1111
Q ss_pred HHHh-------hhcCC----------eeecccc----------cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002336 831 ARSM-------IKKGD----------VISIVDP----------VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 883 (935)
Q Consensus 831 ~~~~-------i~~~~----------~~~~~d~----------~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev~~ 883 (935)
+... ...+. ....+.. .............+.+++.+||+.||++|||++|+++
T Consensus 248 ~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~ 327 (362)
T d1q8ya_ 248 IELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVN 327 (362)
T ss_dssp HHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHT
T ss_pred HHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 1100 00000 0000000 0011223456678999999999999999999999987
Q ss_pred H--HhhhhhhccCC
Q 002336 884 A--IQDSIKIEKGG 895 (935)
Q Consensus 884 ~--L~~~~~~~~~~ 895 (935)
. +++....++-.
T Consensus 328 Hp~f~~~~~~~~~~ 341 (362)
T d1q8ya_ 328 HPWLKDTLGMEEIR 341 (362)
T ss_dssp CGGGTTCTTCTTCC
T ss_pred CcccCCCCCcccCC
Confidence 4 66555444433
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.79 E-value=9.8e-20 Score=183.98 Aligned_cols=132 Identities=15% Similarity=0.163 Sum_probs=105.1
Q ss_pred hcccccccccEEEEEEEECCCcEEEEEEccCcch------------------hhhHHHHHHHHHHHhcCCCcccccceee
Q 002336 617 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCS------------------HRTQQFVTEVALLSRIHHRNLVPLIGYC 678 (935)
Q Consensus 617 ~~~~LG~G~fG~Vy~~~~~~g~~vAvK~~~~~~~------------------~~~~~~~~E~~iL~~L~HpnIv~l~g~~ 678 (935)
+.++||+|+||.||+|...+|+.||||+++.... ........|+..+.++.|.+++..+++.
T Consensus 4 vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~ 83 (191)
T d1zara2 4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE 83 (191)
T ss_dssp EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE
T ss_pred hCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEec
Confidence 4689999999999999998999999998753211 0123456788999999999998887653
Q ss_pred eccceEEEEEEecCCCCHHHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhcCCCceEecCCCCCCccccCCCcEEEee
Q 002336 679 EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSD 758 (935)
Q Consensus 679 ~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~~~~~ivH~DLkp~NILld~~~~vkL~D 758 (935)
. .+++|||+++..+.+ ++.....+++.|++++|+|||+ .+|+||||||+|||++++ .++|+|
T Consensus 84 ~----~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~---~giiHrDiKP~NILv~~~-~~~liD 145 (191)
T d1zara2 84 G----NAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYH---RGIVHGDLSQYNVLVSEE-GIWIID 145 (191)
T ss_dssp T----TEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEETT-EEEECC
T ss_pred C----CEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHhh---CCEEEccCChhheeeeCC-CEEEEE
Confidence 2 379999998765543 2333456899999999999998 899999999999999965 489999
Q ss_pred cccccccc
Q 002336 759 FGLSRQAE 766 (935)
Q Consensus 759 FGla~~~~ 766 (935)
||++....
T Consensus 146 FG~a~~~~ 153 (191)
T d1zara2 146 FPQSVEVG 153 (191)
T ss_dssp CTTCEETT
T ss_pred CCCcccCC
Confidence 99987654
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.70 E-value=8.3e-18 Score=182.89 Aligned_cols=150 Identities=26% Similarity=0.489 Sum_probs=127.6
Q ss_pred CchhhHHHHHHHHhhcCCC-CCCCCC-CCCCCCCCCceEEEeCC-CCCcEEEEEccCCCCcc--cCCccccCcccccccc
Q 002336 369 TEWQDVMVLEALRSISDES-ERTNDR-GDPCVPVPWEWVTCSTT-TPPRITKIALSGKNLKG--EIPPELKNMEALTELW 443 (935)
Q Consensus 369 t~~~d~~~l~~l~~~~~~~-~~~~w~-~dpC~~~~w~~v~c~~~-~~~~l~~L~Ls~n~l~g--~ip~~i~~L~~L~~L~ 443 (935)
+.++|.+||.++|+.+.++ ...+|. +..||.+.|.||+|+.. ...||++|+|++|+++| .+|++|++|++|++|+
T Consensus 3 c~~~e~~aLl~~k~~~~~~~~l~sW~~~~d~C~~~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~ 82 (313)
T d1ogqa_ 3 CNPQDKQALLQIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLY 82 (313)
T ss_dssp SCHHHHHHHHHHHHHTTCCGGGTTCCTTSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCSEEE
T ss_pred CCHHHHHHHHHHHHHCCCCCcCCCCCCCCCCCCCcCCCeEEeCCCCcEEEEEEECCCCCCCCCCCCChHHhcCccccccc
Confidence 5789999999999988653 445674 44455567999999865 34589999999999998 5899999999999999
Q ss_pred ccc-ccCCCCCC-CccccccccccccccccccCCCCCccCccccccccccccccCCCCCCccccC--CceeeeecCCCC
Q 002336 444 LDG-NFLTGPLP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLT--GKVIFKYDNNPK 518 (935)
Q Consensus 444 Ls~-N~l~g~~p-~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~l~~N~l~g~iP~~l~~--~~~~~~~~~n~~ 518 (935)
|++ |+++|.+| +|++|++|++|+|++|++.|..|..+.++.+|+.+++++|++.+.+|..+.. ....+.+.+|..
T Consensus 83 Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l 161 (313)
T d1ogqa_ 83 IGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRI 161 (313)
T ss_dssp EEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCC
T ss_pred cccccccccccccccccccccchhhhccccccccccccccchhhhcccccccccccccCchhhccCcccceeecccccc
Confidence 996 89999988 7999999999999999999999999999999999999999999999998876 334455566653
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.32 E-value=5.2e-13 Score=133.89 Aligned_cols=121 Identities=19% Similarity=0.219 Sum_probs=101.7
Q ss_pred CCceEEEeCC--------CCCcEEEEEccCCCCcccCC-ccccCcccccccccccccCCCCCC-Cccccccccccccccc
Q 002336 401 PWEWVTCSTT--------TPPRITKIALSGKNLKGEIP-PELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENN 470 (935)
Q Consensus 401 ~w~~v~c~~~--------~~~~l~~L~Ls~n~l~g~ip-~~i~~L~~L~~L~Ls~N~l~g~~p-~~~~l~~L~~L~L~~N 470 (935)
.|..|.|+.. -+.+++.|+|++|+|++.++ ..|.++++|+.|+|++|.+.+.++ .+..+++|+.|+|++|
T Consensus 9 ~~~~v~Cs~~~L~~iP~~lp~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N 88 (192)
T d1w8aa_ 9 EGTTVDCTGRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGEN 88 (192)
T ss_dssp ETTEEECTTSCCSSCCSCCCTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSC
T ss_pred cCCEEEEeCCCcCccCCCCCCCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeeccc
Confidence 5677777642 24579999999999987664 567999999999999999999988 6889999999999999
Q ss_pred cccCCCCCccCccccccccccccccCCCCCCccccC---CceeeeecCCCCCccc
Q 002336 471 ELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLT---GKVIFKYDNNPKLHKE 522 (935)
Q Consensus 471 ~l~g~iP~~l~~l~~L~~L~l~~N~l~g~iP~~l~~---~~~~~~~~~n~~~~~~ 522 (935)
+|++..|..|.++++|+.|+|++|+|+ .||+..+. ....+.+.+|+..|..
T Consensus 89 ~l~~l~~~~F~~l~~L~~L~L~~N~l~-~i~~~~f~~l~~L~~l~L~~N~~~~~~ 142 (192)
T d1w8aa_ 89 KIKEISNKMFLGLHQLKTLNLYDNQIS-CVMPGSFEHLNSLTSLNLASNPFNCNC 142 (192)
T ss_dssp CCCEECSSSSTTCTTCCEEECCSSCCC-EECTTSSTTCTTCCEEECTTCCBCCSG
T ss_pred cccccCHHHHhCCCcccccccCCcccc-ccCHHHhcCCccccccccccccccccc
Confidence 999666778999999999999999999 67766543 4556788999998753
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.15 E-value=2.3e-12 Score=139.07 Aligned_cols=109 Identities=26% Similarity=0.307 Sum_probs=97.5
Q ss_pred cEEEEEccCCCCcccCCccccCcccccccccccccCCCCCCCccccccccccccccccccCCCCCccCcccccccccccc
Q 002336 414 RITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIEN 493 (935)
Q Consensus 414 ~l~~L~Ls~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~l~~ 493 (935)
....++++++.+.|.+|..++.+++|+.|++++|.+++.+|.++.+++|+.|+|++|+|+|.+|++|++|++|+.|+|++
T Consensus 198 ~~~~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~ 277 (313)
T d1ogqa_ 198 NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSF 277 (313)
T ss_dssp CCSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGGCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccCccCeecccCChHHhCCCCCCEEECcC
Confidence 34569999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccCCCCCCccc-cCCceeeeecCCCCCccc
Q 002336 494 NSFVGEIPPAL-LTGKVIFKYDNNPKLHKE 522 (935)
Q Consensus 494 N~l~g~iP~~l-~~~~~~~~~~~n~~~~~~ 522 (935)
|+|+|.||+.. ......+.+.+|+.+|+.
T Consensus 278 N~l~g~iP~~~~L~~L~~l~l~~N~~l~g~ 307 (313)
T d1ogqa_ 278 NNLCGEIPQGGNLQRFDVSAYANNKCLCGS 307 (313)
T ss_dssp SEEEEECCCSTTGGGSCGGGTCSSSEEEST
T ss_pred CcccccCCCcccCCCCCHHHhCCCccccCC
Confidence 99999999631 124455678999988864
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.06 E-value=6.3e-11 Score=109.65 Aligned_cols=97 Identities=26% Similarity=0.352 Sum_probs=66.7
Q ss_pred EEEccCCCCcccCCccccCcccccccccccccCCCCCCCccccccccccccccccccCCCCCccCccccccccccccccC
Q 002336 417 KIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSF 496 (935)
Q Consensus 417 ~L~Ls~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~l~~N~l 496 (935)
.|+|++|+|+ .++ .+.+|++|++|+|++|+|+..++.++.+++|+.|+|++|+++ .+| .++++++|+.|++++|++
T Consensus 2 ~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~~lp~~~~~l~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~l~~N~i 77 (124)
T d1dcea3 2 VLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNRL 77 (124)
T ss_dssp EEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCCCCCGGGGGCTTCCEEECCSSCCC-CCG-GGTTCSSCCEEECCSSCC
T ss_pred EEEcCCCCCC-CCc-ccccCCCCCEEECCCCccCcchhhhhhhhccccccccccccc-ccC-ccccccccCeEECCCCcc
Confidence 4777888877 555 477777888888888888765556777788888888888877 455 377777888888888877
Q ss_pred CCCCCc--cccC--CceeeeecCCCC
Q 002336 497 VGEIPP--ALLT--GKVIFKYDNNPK 518 (935)
Q Consensus 497 ~g~iP~--~l~~--~~~~~~~~~n~~ 518 (935)
+ .+|. .+.. ....+.+.+|+.
T Consensus 78 ~-~~~~~~~l~~~~~L~~L~l~~N~i 102 (124)
T d1dcea3 78 Q-QSAAIQPLVSCPRLVLLNLQGNSL 102 (124)
T ss_dssp C-SSSTTGGGGGCTTCCEEECTTSGG
T ss_pred C-CCCCchhhcCCCCCCEEECCCCcC
Confidence 7 4543 2322 334455666654
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.06 E-value=7.8e-11 Score=113.66 Aligned_cols=103 Identities=18% Similarity=0.184 Sum_probs=84.4
Q ss_pred EEccCCCCcccCCccccCccccccccccccc-CCCCCC-CccccccccccccccccccCCCCCccCcccccccccccccc
Q 002336 418 IALSGKNLKGEIPPELKNMEALTELWLDGNF-LTGPLP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNS 495 (935)
Q Consensus 418 L~Ls~n~l~g~ip~~i~~L~~L~~L~Ls~N~-l~g~~p-~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~l~~N~ 495 (935)
++++++++. .+|..+..+++|++|+|++|+ |+...+ .|.+|++|+.|+|++|+|+..-|..|..+++|+.|+|++|+
T Consensus 13 l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~ 91 (156)
T d2ifga3 13 LRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNA 91 (156)
T ss_dssp EECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSC
T ss_pred EEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccCCC
Confidence 555666776 678888899999999997664 777665 68999999999999999996556778999999999999999
Q ss_pred CCCCCCccccC--CceeeeecCCCCCccc
Q 002336 496 FVGEIPPALLT--GKVIFKYDNNPKLHKE 522 (935)
Q Consensus 496 l~g~iP~~l~~--~~~~~~~~~n~~~~~~ 522 (935)
|+ .+|...+. ....+.+++||+.|.+
T Consensus 92 l~-~l~~~~~~~~~l~~L~L~~Np~~C~C 119 (156)
T d2ifga3 92 LE-SLSWKTVQGLSLQELVLSGNPLHCSC 119 (156)
T ss_dssp CS-CCCSTTTCSCCCCEEECCSSCCCCCG
T ss_pred Cc-ccChhhhccccccccccCCCcccCCc
Confidence 98 88887765 3456778999998754
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.99 E-value=2.7e-10 Score=119.74 Aligned_cols=110 Identities=27% Similarity=0.325 Sum_probs=98.8
Q ss_pred CCcEEEEEccCCCCcccCCccccCcccccccccccccCCCCCCC-ccccccccccccccccccCCCCCccCccccccccc
Q 002336 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 490 (935)
Q Consensus 412 ~~~l~~L~Ls~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~ 490 (935)
.++|+.|+|++|.+.+..+..+..+.+|+.|++++|.++..++. +..+++|+.|++++|+|++..|..+..+++|+.|+
T Consensus 99 l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~ 178 (266)
T d1p9ag_ 99 LPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLL 178 (266)
T ss_dssp CTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEE
T ss_pred ccccccccccccccceeeccccccccccccccccccccceeccccccccccchhcccccccccccCccccccccccceee
Confidence 46899999999999977778889999999999999999998884 68899999999999999977778899999999999
Q ss_pred cccccCCCCCCccccC--CceeeeecCCCCCccc
Q 002336 491 IENNSFVGEIPPALLT--GKVIFKYDNNPKLHKE 522 (935)
Q Consensus 491 l~~N~l~g~iP~~l~~--~~~~~~~~~n~~~~~~ 522 (935)
|++|+|+ .||++++. ....+.+.+||+.|.+
T Consensus 179 Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~CdC 211 (266)
T d1p9ag_ 179 LQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCNC 211 (266)
T ss_dssp CCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCSG
T ss_pred cccCCCc-ccChhHCCCCCCCEEEecCCCCCCCc
Confidence 9999999 99998876 4456788999999974
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=98.99 E-value=1.1e-10 Score=108.00 Aligned_cols=83 Identities=28% Similarity=0.350 Sum_probs=76.1
Q ss_pred CCcEEEEEccCCCCcccCCccccCcccccccccccccCCCCCCCccccccccccccccccccCCCC--CccCcccccccc
Q 002336 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLP--SYMGSLPNLQEL 489 (935)
Q Consensus 412 ~~~l~~L~Ls~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~iP--~~l~~l~~L~~L 489 (935)
..+|+.|+|++|+|+ .+|+.++.+++|+.|+|++|.|+.. |++.++++|+.|++++|+++ .+| ..++.+++|+.|
T Consensus 19 l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~l-~~~~~l~~L~~L~l~~N~i~-~~~~~~~l~~~~~L~~L 95 (124)
T d1dcea3 19 LLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALENV-DGVANLPRLQELLLCNNRLQ-QSAAIQPLVSCPRLVLL 95 (124)
T ss_dssp GTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCC-GGGTTCSSCCEEECCSSCCC-SSSTTGGGGGCTTCCEE
T ss_pred CCCCCEEECCCCccC-cchhhhhhhhccccccccccccccc-CccccccccCeEECCCCccC-CCCCchhhcCCCCCCEE
Confidence 458999999999998 7899999999999999999999975 67999999999999999999 455 468999999999
Q ss_pred ccccccCC
Q 002336 490 HIENNSFV 497 (935)
Q Consensus 490 ~l~~N~l~ 497 (935)
++++|+++
T Consensus 96 ~l~~N~i~ 103 (124)
T d1dcea3 96 NLQGNSLC 103 (124)
T ss_dssp ECTTSGGG
T ss_pred ECCCCcCC
Confidence 99999998
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=98.94 E-value=2e-10 Score=114.68 Aligned_cols=90 Identities=22% Similarity=0.340 Sum_probs=82.7
Q ss_pred CCcEEEEEccCCCCcccCCccccCcccccccccccccCCCCCC-CccccccccccccccccccCCCCCccCccccccccc
Q 002336 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 490 (935)
Q Consensus 412 ~~~l~~L~Ls~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p-~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~ 490 (935)
.++|+.|+|++|++.+..+..+..+++|++|+|++|+|++.+| .|.+|++|+.|+|++|+|++..|+.|..+++|+.|+
T Consensus 53 l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~ 132 (192)
T d1w8aa_ 53 LPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLN 132 (192)
T ss_dssp CTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEE
T ss_pred CceEeeeeccccccccccccccccccccceeeeccccccccCHHHHhCCCcccccccCCccccccCHHHhcCCccccccc
Confidence 4689999999999998889999999999999999999999888 589999999999999999976777899999999999
Q ss_pred cccccCCCCCC
Q 002336 491 IENNSFVGEIP 501 (935)
Q Consensus 491 l~~N~l~g~iP 501 (935)
|++|.+.+..+
T Consensus 133 L~~N~~~~~~~ 143 (192)
T d1w8aa_ 133 LASNPFNCNCH 143 (192)
T ss_dssp CTTCCBCCSGG
T ss_pred ccccccccccc
Confidence 99999985543
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.94 E-value=2.1e-10 Score=121.65 Aligned_cols=111 Identities=19% Similarity=0.235 Sum_probs=96.9
Q ss_pred CCcEEEEEccCCCCcccCCccccCcccccccccccccCCCCCC-CccccccccccccccccccCCCCCccCccccccccc
Q 002336 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 490 (935)
Q Consensus 412 ~~~l~~L~Ls~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p-~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~ 490 (935)
...|..|++++|+|++..+..|.++++|+.|+|++|+|++.++ .|.++++|+.|+|++|++++..|..|..+++|+.|+
T Consensus 128 ~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~ 207 (284)
T d1ozna_ 128 LAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLY 207 (284)
T ss_dssp CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEE
T ss_pred hcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhhhhhccccccChhHhhhhhhccccc
Confidence 3578999999999996666789999999999999999999888 689999999999999999998899999999999999
Q ss_pred cccccCCCCCCccccC--CceeeeecCCCCCccc
Q 002336 491 IENNSFVGEIPPALLT--GKVIFKYDNNPKLHKE 522 (935)
Q Consensus 491 l~~N~l~g~iP~~l~~--~~~~~~~~~n~~~~~~ 522 (935)
+++|++.+..|..+.. ....+.+++||..|.+
T Consensus 208 l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C 241 (284)
T d1ozna_ 208 LFANNLSALPTEALAPLRALQYLRLNDNPWVCDC 241 (284)
T ss_dssp CCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSG
T ss_pred ccccccccccccccccccccCEEEecCCCCCCCc
Confidence 9999999555555544 4567788999998853
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.92 E-value=2.6e-10 Score=110.62 Aligned_cols=103 Identities=21% Similarity=0.256 Sum_probs=85.1
Q ss_pred CCcEEEEEccCCCCcccCCccccCcccccccccccccCCCCCCCccccccccccccccccccCCCCCc-cCccccccccc
Q 002336 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSY-MGSLPNLQELH 490 (935)
Q Consensus 412 ~~~l~~L~Ls~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~iP~~-l~~l~~L~~L~ 490 (935)
+.++.+|+|++|+|+ .||..+..+++|+.|+|++|+|+.. +.+..+++|+.|+|++|+++ .+|.. +..+++|+.|+
T Consensus 17 ~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~~l-~~~~~l~~L~~L~ls~N~i~-~l~~~~~~~l~~L~~L~ 93 (162)
T d1a9na_ 17 AVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKL-DGFPLLRRLKTLLVNNNRIC-RIGEGLDQALPDLTELI 93 (162)
T ss_dssp TTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCCEE-CCCCCCSSCCEEECCSSCCC-EECSCHHHHCTTCCEEE
T ss_pred cCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCCcc-CCcccCcchhhhhccccccc-CCCccccccccccccce
Confidence 347899999999998 7787778899999999999999854 78999999999999999999 56554 56799999999
Q ss_pred cccccCCCCCCc--ccc--CCceeeeecCCCC
Q 002336 491 IENNSFVGEIPP--ALL--TGKVIFKYDNNPK 518 (935)
Q Consensus 491 l~~N~l~g~iP~--~l~--~~~~~~~~~~n~~ 518 (935)
|++|+++ .+++ .+. .....+.+.+|+.
T Consensus 94 L~~N~i~-~~~~l~~l~~l~~L~~L~l~~N~i 124 (162)
T d1a9na_ 94 LTNNSLV-ELGDLDPLASLKSLTYLCILRNPV 124 (162)
T ss_dssp CCSCCCC-CGGGGGGGGGCTTCCEEECCSSGG
T ss_pred ecccccc-ccccccccccccccchhhcCCCcc
Confidence 9999998 6664 232 2455667777764
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=98.79 E-value=2.3e-09 Score=114.57 Aligned_cols=107 Identities=23% Similarity=0.304 Sum_probs=94.3
Q ss_pred CCcEEEEEccCCCCcccCCccccCcccccccccccccCCCCCC-CccccccccccccccccccCCCCCccCccccccccc
Q 002336 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 490 (935)
Q Consensus 412 ~~~l~~L~Ls~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p-~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~ 490 (935)
.++++.|+|++|.+.+..+..+.+++.++.|++++|.+++..+ .+.++++|+.|+|++|+|+ .+|.++.++++|+.|+
T Consensus 170 ~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~ 248 (305)
T d1xkua_ 170 PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVY 248 (305)
T ss_dssp CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEE
T ss_pred CCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeeccccccc-ccccccccccCCCEEE
Confidence 3589999999999999999999999999999999999999888 5899999999999999999 8999999999999999
Q ss_pred cccccCCCCCCccccC---------CceeeeecCCCCCc
Q 002336 491 IENNSFVGEIPPALLT---------GKVIFKYDNNPKLH 520 (935)
Q Consensus 491 l~~N~l~g~iP~~l~~---------~~~~~~~~~n~~~~ 520 (935)
|++|+|+ .|+...+. ....+.+.+||..+
T Consensus 249 Ls~N~i~-~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~~ 286 (305)
T d1xkua_ 249 LHNNNIS-AIGSNDFCPPGYNTKKASYSGVSLFSNPVQY 286 (305)
T ss_dssp CCSSCCC-CCCTTSSSCSSCCTTSCCCSEEECCSSSSCG
T ss_pred CCCCccC-ccChhhccCcchhcccCCCCEEECCCCcCcc
Confidence 9999999 88765432 23456778998754
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.73 E-value=2.6e-09 Score=102.75 Aligned_cols=102 Identities=22% Similarity=0.224 Sum_probs=86.4
Q ss_pred CCCCCCCCceEEEeCC----------CCCcEEEEEccCCC-CcccCCccccCcccccccccccccCCCCCC-Cccccccc
Q 002336 395 DPCVPVPWEWVTCSTT----------TPPRITKIALSGKN-LKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDL 462 (935)
Q Consensus 395 dpC~~~~w~~v~c~~~----------~~~~l~~L~Ls~n~-l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p-~~~~l~~L 462 (935)
+.|++..++++.|... ..+++++|+|++|+ |+..-+..|.+|++|+.|+|++|+|+...| .|..+++|
T Consensus 3 ~~C~c~~~~~l~c~~~~~~~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L 82 (156)
T d2ifga3 3 DACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRL 82 (156)
T ss_dssp SSSCCSSSSCEECCSSCCCTTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCC
T ss_pred CCCCcCCCCeEEecCCCCccCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccc
Confidence 5677777888888752 23578999998775 874445679999999999999999999888 58999999
Q ss_pred cccccccccccCCCCCccCccccccccccccccCC
Q 002336 463 RIVHLENNELTGSLPSYMGSLPNLQELHIENNSFV 497 (935)
Q Consensus 463 ~~L~L~~N~l~g~iP~~l~~l~~L~~L~l~~N~l~ 497 (935)
+.|+|++|+|+ .+|..+....+|+.|+|++|.|.
T Consensus 83 ~~L~Ls~N~l~-~l~~~~~~~~~l~~L~L~~Np~~ 116 (156)
T d2ifga3 83 SRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116 (156)
T ss_dssp CEEECCSSCCS-CCCSTTTCSCCCCEEECCSSCCC
T ss_pred cceeccCCCCc-ccChhhhccccccccccCCCccc
Confidence 99999999999 88887666668999999999995
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.72 E-value=3.8e-09 Score=110.74 Aligned_cols=91 Identities=32% Similarity=0.305 Sum_probs=76.0
Q ss_pred CCcEEEEEccCCCCcccCCccccCcccccccccccccCCCCCCCccccccccccccccccccCCCCCccCcccccccccc
Q 002336 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 491 (935)
Q Consensus 412 ~~~l~~L~Ls~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~l 491 (935)
+++++.|+|++|+|++..+..|.+|++|++|+|++|+|+. +|.++.+++|+.|+|++|+++ .+|..+.++++|+.|++
T Consensus 30 p~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~-l~~~~~l~~L~~L~Ls~N~l~-~~~~~~~~l~~L~~L~l 107 (266)
T d1p9ag_ 30 PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK-LQVDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDV 107 (266)
T ss_dssp CTTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCE-EECCSCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEEC
T ss_pred CcCCCEEECcCCcCCCcCHHHhhccccccccccccccccc-ccccccccccccccccccccc-ccccccccccccccccc
Confidence 3478999999999986555789999999999999999985 566788999999999999998 56778899999999999
Q ss_pred ccccCCCCCCcccc
Q 002336 492 ENNSFVGEIPPALL 505 (935)
Q Consensus 492 ~~N~l~g~iP~~l~ 505 (935)
++|.+. .++....
T Consensus 108 ~~~~~~-~~~~~~~ 120 (266)
T d1p9ag_ 108 SFNRLT-SLPLGAL 120 (266)
T ss_dssp CSSCCC-CCCSSTT
T ss_pred cccccc-eeecccc
Confidence 999988 5555443
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.58 E-value=5.4e-09 Score=101.06 Aligned_cols=87 Identities=22% Similarity=0.231 Sum_probs=76.2
Q ss_pred CCcEEEEEccCCCCcccCCccccCcccccccccccccCCCCCCC-ccccccccccccccccccCCCCC--ccCccccccc
Q 002336 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPS--YMGSLPNLQE 488 (935)
Q Consensus 412 ~~~l~~L~Ls~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~-~~~l~~L~~L~L~~N~l~g~iP~--~l~~l~~L~~ 488 (935)
..+|+.|+|++|+|+ .++ .|..|++|+.|+|++|+++...+. +..+++|+.|+|++|+++ .+++ .+..+++|+.
T Consensus 40 l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L~L~~N~i~-~~~~l~~l~~l~~L~~ 116 (162)
T d1a9na_ 40 LDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV-ELGDLDPLASLKSLTY 116 (162)
T ss_dssp TTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCSCCCC-CGGGGGGGGGCTTCCE
T ss_pred cccCCEEECCCCCCC-ccC-CcccCcchhhhhcccccccCCCccccccccccccceecccccc-ccccccccccccccch
Confidence 357999999999999 664 589999999999999999998886 467999999999999998 5664 6889999999
Q ss_pred cccccccCCCCCCc
Q 002336 489 LHIENNSFVGEIPP 502 (935)
Q Consensus 489 L~l~~N~l~g~iP~ 502 (935)
|++++|.++ .+|.
T Consensus 117 L~l~~N~i~-~~~~ 129 (162)
T d1a9na_ 117 LCILRNPVT-NKKH 129 (162)
T ss_dssp EECCSSGGG-GSTT
T ss_pred hhcCCCccc-cccc
Confidence 999999998 5553
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=98.50 E-value=4.2e-08 Score=104.41 Aligned_cols=95 Identities=23% Similarity=0.318 Sum_probs=53.2
Q ss_pred EEccCCCCcccCCccccCcccccccccccccCCCCCC-CccccccccccccccccccCCCCCccCccccccccccccccC
Q 002336 418 IALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSF 496 (935)
Q Consensus 418 L~Ls~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p-~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~l~~N~l 496 (935)
++-++++|+ ++|..|. +.|++|+|++|+|+..++ .|.++++|+.|++++|.++...|..|.++++|+.|++++|++
T Consensus 15 ~~C~~~~L~-~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~n~l 91 (305)
T d1xkua_ 15 VQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQL 91 (305)
T ss_dssp EECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCC
T ss_pred EEecCCCCC-ccCCCCC--CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEecccCCcc
Confidence 444555555 5555443 456666666666665555 456666666666666666644455566666666666666666
Q ss_pred CCCCCccccCCceeeeecCC
Q 002336 497 VGEIPPALLTGKVIFKYDNN 516 (935)
Q Consensus 497 ~g~iP~~l~~~~~~~~~~~n 516 (935)
+ .+|.........+....|
T Consensus 92 ~-~l~~~~~~~l~~L~~~~n 110 (305)
T d1xkua_ 92 K-ELPEKMPKTLQELRVHEN 110 (305)
T ss_dssp S-BCCSSCCTTCCEEECCSS
T ss_pred C-cCccchhhhhhhhhcccc
Confidence 5 555554443333333333
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.49 E-value=5.6e-08 Score=102.46 Aligned_cols=107 Identities=20% Similarity=0.198 Sum_probs=92.3
Q ss_pred CCcEEEEEccCCCCcccCCccccCcccccccccccccCCCCCC-CccccccccccccccccccCCCCCccCccccccccc
Q 002336 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 490 (935)
Q Consensus 412 ~~~l~~L~Ls~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p-~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~ 490 (935)
.++|+.|+|++|++.+..+..+..+++|+.|++++|+|++.++ .|..+++|+.|+|++|+|++..|..+.++++|+.|+
T Consensus 104 l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~ 183 (284)
T d1ozna_ 104 LGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLL 183 (284)
T ss_dssp CTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEE
T ss_pred cccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhh
Confidence 3589999999999987777788999999999999999999887 588999999999999999977778899999999999
Q ss_pred cccccCCCCCCccccC--CceeeeecCCCC
Q 002336 491 IENNSFVGEIPPALLT--GKVIFKYDNNPK 518 (935)
Q Consensus 491 l~~N~l~g~iP~~l~~--~~~~~~~~~n~~ 518 (935)
+++|++++..|..+.. ....+.+.+|..
T Consensus 184 l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i 213 (284)
T d1ozna_ 184 LHQNRVAHVHPHAFRDLGRLMTLYLFANNL 213 (284)
T ss_dssp CCSSCCCEECTTTTTTCTTCCEEECCSSCC
T ss_pred hhhccccccChhHhhhhhhccccccccccc
Confidence 9999999777776654 345566677654
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=98.39 E-value=3.6e-09 Score=105.89 Aligned_cols=102 Identities=25% Similarity=0.221 Sum_probs=81.3
Q ss_pred CCcEEEEEccCCCCcccCCccccCcccccccccccccCCCCCCCccccccccccccccccccCCCCCccCcccccccccc
Q 002336 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 491 (935)
Q Consensus 412 ~~~l~~L~Ls~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~l 491 (935)
..+|+.|+|++|+|+ .++ .|.+|++|+.|+|++|.|+...+-+..+++|+.|+|++|+++ .++ .+..+++|+.|+|
T Consensus 47 L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~~i~~~~~~~~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~L 122 (198)
T d1m9la_ 47 LKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIKKIENLDAVADTLEELWISYNQIA-SLS-GIEKLVNLRVLYM 122 (198)
T ss_dssp TTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEECSCSSHHHHHHHCCEEECSEEECC-CHH-HHHHHHHSSEEEE
T ss_pred ccccceeECcccCCC-Ccc-cccCCccccChhhccccccccccccccccccccccccccccc-ccc-ccccccccccccc
Confidence 568999999999998 675 599999999999999999864433455678999999999999 554 4888999999999
Q ss_pred ccccCCCCCCc--cccC--CceeeeecCCCC
Q 002336 492 ENNSFVGEIPP--ALLT--GKVIFKYDNNPK 518 (935)
Q Consensus 492 ~~N~l~g~iP~--~l~~--~~~~~~~~~n~~ 518 (935)
++|+++ .++. .+.. ....+.+.+||.
T Consensus 123 ~~N~i~-~~~~~~~l~~l~~L~~L~L~~N~l 152 (198)
T d1m9la_ 123 SNNKIT-NWGEIDKLAALDKLEDLLLAGNPL 152 (198)
T ss_dssp SEEECC-CHHHHHHHTTTTTCSEEEECSSHH
T ss_pred ccchhc-cccccccccCCCccceeecCCCcc
Confidence 999998 6653 2332 455667788864
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=98.36 E-value=6.9e-08 Score=105.57 Aligned_cols=76 Identities=14% Similarity=0.364 Sum_probs=42.9
Q ss_pred cEEEEEccCCCCcccCCccccCcccccccccccccCCCCCCCccccccccccccccccccCCCCCccCcccccccccccc
Q 002336 414 RITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIEN 493 (935)
Q Consensus 414 ~l~~L~Ls~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~l~~ 493 (935)
.++.|+|++|++++. + .+..+++|+.|+|++|+|++ ++.+.++++|++|+|++|++++..| +.+|++|+.|+|++
T Consensus 308 ~l~~L~ls~n~l~~l-~-~l~~l~~L~~L~L~~n~l~~-l~~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~ 382 (384)
T d2omza2 308 NLTYLTLYFNNISDI-S-PVSSLTKLQRLFFANNKVSD-VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLND 382 (384)
T ss_dssp TCSEEECCSSCCSCC-G-GGGGCTTCCEEECCSSCCCC-CGGGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCC
T ss_pred ccCeEECCCCCCCCC-c-ccccCCCCCEEECCCCCCCC-ChhHcCCCCCCEEECCCCcCCCChh--hccCCCCCEeeCCC
Confidence 455566666666532 2 25556666666666666554 3355556666666666666664332 55566666666665
Q ss_pred c
Q 002336 494 N 494 (935)
Q Consensus 494 N 494 (935)
|
T Consensus 383 N 383 (384)
T d2omza2 383 Q 383 (384)
T ss_dssp E
T ss_pred C
Confidence 5
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=98.35 E-value=1.7e-07 Score=93.32 Aligned_cols=79 Identities=24% Similarity=0.403 Sum_probs=42.8
Q ss_pred cEEEEEccCCCCcccCCccccCcccccccccccccCCCCCCCccccccccccccccccccCCCCCccCcccccccccccc
Q 002336 414 RITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIEN 493 (935)
Q Consensus 414 ~l~~L~Ls~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~l~~ 493 (935)
+++.|+|++|+++ .++ .+..|++|++|+|++|++++..| ++++++|+.|++++|.+. .+|. ++++++|+.|++++
T Consensus 41 ~l~~L~l~~~~i~-~l~-~l~~l~nL~~L~Ls~N~l~~~~~-l~~l~~L~~L~l~~n~~~-~~~~-l~~l~~L~~L~l~~ 115 (199)
T d2omxa2 41 QVTTLQADRLGIK-SID-GVEYLNNLTQINFSNNQLTDITP-LKNLTKLVDILMNNNQIA-DITP-LANLTNLTGLTLFN 115 (199)
T ss_dssp TCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCC-CCGG-GTTCTTCSEEECCS
T ss_pred CCCEEECCCCCCC-Ccc-ccccCCCcCcCccccccccCccc-ccCCcccccccccccccc-cccc-cccccccccccccc
Confidence 4555555555555 332 35555555556666555555433 555555555555555555 3332 55555555555555
Q ss_pred ccCC
Q 002336 494 NSFV 497 (935)
Q Consensus 494 N~l~ 497 (935)
|.+.
T Consensus 116 ~~~~ 119 (199)
T d2omxa2 116 NQIT 119 (199)
T ss_dssp SCCC
T ss_pred cccc
Confidence 5554
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=98.26 E-value=3.7e-07 Score=91.65 Aligned_cols=79 Identities=25% Similarity=0.463 Sum_probs=47.7
Q ss_pred cEEEEEccCCCCcccCCccccCcccccccccccccCCCCCCCccccccccccccccccccCCCCCccCcccccccccccc
Q 002336 414 RITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIEN 493 (935)
Q Consensus 414 ~l~~L~Ls~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~l~~ 493 (935)
.|+.|++++|+++ .++ .|..|++|++|+|++|+|++. +.+++|++|+.|+|++|+++ .+| .+.++++|+.|++++
T Consensus 47 ~L~~L~l~~~~i~-~l~-~l~~l~~L~~L~L~~n~i~~l-~~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~ 121 (210)
T d1h6ta2 47 SIDQIIANNSDIK-SVQ-GIQYLPNVTKLFLNGNKLTDI-KPLANLKNLGWLFLDENKVK-DLS-SLKDLKKLKSLSLEH 121 (210)
T ss_dssp TCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCC-GGGTTCTTCCEEECCSSCCC-CGG-GGTTCTTCCEEECTT
T ss_pred CccEEECcCCCCC-Cch-hHhhCCCCCEEeCCCccccCc-cccccCcccccccccccccc-ccc-ccccccccccccccc
Confidence 4566666666665 233 255666666666666666653 34556666666666666666 344 356666666666666
Q ss_pred ccCC
Q 002336 494 NSFV 497 (935)
Q Consensus 494 N~l~ 497 (935)
|.+.
T Consensus 122 ~~~~ 125 (210)
T d1h6ta2 122 NGIS 125 (210)
T ss_dssp SCCC
T ss_pred cccc
Confidence 6665
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=98.24 E-value=2.1e-07 Score=94.53 Aligned_cols=75 Identities=21% Similarity=0.368 Sum_probs=43.6
Q ss_pred CcEEEEEccCCCCcccCCccccCcccccccccccccCCCCCCCccccccccccccccccccCCCCCccCccccccccccc
Q 002336 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIE 492 (935)
Q Consensus 413 ~~l~~L~Ls~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~l~ 492 (935)
++++.|++++|.+.+.. .++++++|+.|+|++|++++ ++.++++++|+.|+|++|+++ .+|. ++++++|+.|+|+
T Consensus 151 ~~L~~L~l~~n~~~~~~--~l~~l~~L~~L~Ls~n~l~~-l~~l~~l~~L~~L~Ls~N~lt-~i~~-l~~l~~L~~L~ls 225 (227)
T d1h6ua2 151 TNLQYLSIGNAQVSDLT--PLANLSKLTTLKADDNKISD-ISPLASLPNLIEVHLKNNQIS-DVSP-LANTSNLFIVTLT 225 (227)
T ss_dssp TTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCC-CGGGGGCTTCCEEECTTSCCC-BCGG-GTTCTTCCEEEEE
T ss_pred cccccccccccccccch--hhcccccceecccCCCccCC-ChhhcCCCCCCEEECcCCcCC-CCcc-cccCCCCCEEEee
Confidence 35666666666655322 25666666666666666654 344566666666666666666 3442 5566666666665
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=98.22 E-value=3.5e-07 Score=99.73 Aligned_cols=99 Identities=22% Similarity=0.277 Sum_probs=77.7
Q ss_pred CcEEEEEccCCCCcccCCccccCcccccccccccccCCCCCCCccccccccccccccccccCCCCCccCccccccccccc
Q 002336 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIE 492 (935)
Q Consensus 413 ~~l~~L~Ls~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~l~ 492 (935)
..+..+++++|.+.+ ...+..+++|+.|+|++|++++.. .+..+++|+.|+|++|+++ .+| .+++|++|+.|+|+
T Consensus 285 ~~l~~l~~~~n~l~~--~~~~~~~~~l~~L~ls~n~l~~l~-~l~~l~~L~~L~L~~n~l~-~l~-~l~~l~~L~~L~l~ 359 (384)
T d2omza2 285 TALTNLELNENQLED--ISPISNLKNLTYLTLYFNNISDIS-PVSSLTKLQRLFFANNKVS-DVS-SLANLTNINWLSAG 359 (384)
T ss_dssp TTCSEEECCSSCCSC--CGGGGGCTTCSEEECCSSCCSCCG-GGGGCTTCCEEECCSSCCC-CCG-GGGGCTTCCEEECC
T ss_pred ccccccccccccccc--ccccchhcccCeEECCCCCCCCCc-ccccCCCCCEEECCCCCCC-CCh-hHcCCCCCCEEECC
Confidence 467788888888885 345888999999999999999864 5889999999999999998 566 69999999999999
Q ss_pred cccCCCCCCccccCCceeeeecCC
Q 002336 493 NNSFVGEIPPALLTGKVIFKYDNN 516 (935)
Q Consensus 493 ~N~l~g~iP~~l~~~~~~~~~~~n 516 (935)
+|+|++-.|-.-......+.+++|
T Consensus 360 ~N~l~~l~~l~~l~~L~~L~L~~N 383 (384)
T d2omza2 360 HNQISDLTPLANLTRITQLGLNDQ 383 (384)
T ss_dssp SSCCCBCGGGTTCTTCSEEECCCE
T ss_pred CCcCCCChhhccCCCCCEeeCCCC
Confidence 999995444222223444455544
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=98.19 E-value=6e-07 Score=90.06 Aligned_cols=81 Identities=32% Similarity=0.510 Sum_probs=59.3
Q ss_pred CCcEEEEEccCCCCcccCCccccCcccccccccccccCCCCCCCccccccccccccccccccCCCCCccCcccccccccc
Q 002336 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 491 (935)
Q Consensus 412 ~~~l~~L~Ls~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~l 491 (935)
.++|++|+|++|++++ ++ .+++|++|+.|+|++|++++ +|.+.++++|+.|++++|.+. .++ .+..+++|+.+++
T Consensus 67 l~~L~~L~L~~n~i~~-l~-~~~~l~~L~~L~l~~n~i~~-l~~l~~l~~L~~L~l~~~~~~-~~~-~l~~l~~l~~l~~ 141 (210)
T d1h6ta2 67 LPNVTKLFLNGNKLTD-IK-PLANLKNLGWLFLDENKVKD-LSSLKDLKKLKSLSLEHNGIS-DIN-GLVHLPQLESLYL 141 (210)
T ss_dssp CTTCCEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCCC-GGGGTTCTTCCEEECTTSCCC-CCG-GGGGCTTCCEEEC
T ss_pred CCCCCEEeCCCccccC-cc-ccccCccccccccccccccc-ccccccccccccccccccccc-ccc-ccccccccccccc
Confidence 3578888888888874 44 36778888888888888876 456777888888888888776 343 4666777777777
Q ss_pred ccccCC
Q 002336 492 ENNSFV 497 (935)
Q Consensus 492 ~~N~l~ 497 (935)
++|.++
T Consensus 142 ~~n~l~ 147 (210)
T d1h6ta2 142 GNNKIT 147 (210)
T ss_dssp CSSCCC
T ss_pred cccccc
Confidence 777776
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.18 E-value=4.8e-07 Score=92.45 Aligned_cols=101 Identities=21% Similarity=0.264 Sum_probs=82.2
Q ss_pred CCceEEEeCCC--------CCcEEEEEccCCCCcccCCccccCcccccccccccccCCCCCC--Ccccccccccccccc-
Q 002336 401 PWEWVTCSTTT--------PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP--DMSRLIDLRIVHLEN- 469 (935)
Q Consensus 401 ~w~~v~c~~~~--------~~~l~~L~Ls~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p--~~~~l~~L~~L~L~~- 469 (935)
....+.|.... +.++++|+|++|+|+...+..|.+|++|++|+|++|.+...+| .|.++++|+.|.+..
T Consensus 9 ~~~~i~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~ 88 (242)
T d1xwdc1 9 SNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKA 88 (242)
T ss_dssp CSSEEEEESCSCSSCCSCSCSCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECC
T ss_pred cCCEEEEeCCCCCCcCCCCCCCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeecccccccccccccccccc
Confidence 45667887532 3479999999999984444578999999999999999988766 578899999999864
Q ss_pred ccccCCCCCccCccccccccccccccCCCCCCc
Q 002336 470 NELTGSLPSYMGSLPNLQELHIENNSFVGEIPP 502 (935)
Q Consensus 470 N~l~g~iP~~l~~l~~L~~L~l~~N~l~g~iP~ 502 (935)
|++....+..+.++++|+.|++++|++. .+|.
T Consensus 89 n~l~~~~~~~~~~l~~L~~l~l~~~~l~-~~~~ 120 (242)
T d1xwdc1 89 NNLLYINPEAFQNLPNLQYLLISNTGIK-HLPD 120 (242)
T ss_dssp TTCCEECTTSEECCTTCCEEEEESCCCC-SCCC
T ss_pred ccccccccccccccccccccccchhhhc-cccc
Confidence 6788677778999999999999999998 4544
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=98.11 E-value=2.7e-08 Score=99.32 Aligned_cols=83 Identities=23% Similarity=0.446 Sum_probs=73.6
Q ss_pred CcEEEEEccCCCCcccCCccccCcccccccccccccCCCCCCCccccccccccccccccccCCCC--CccCccccccccc
Q 002336 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLP--SYMGSLPNLQELH 490 (935)
Q Consensus 413 ~~l~~L~Ls~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~iP--~~l~~l~~L~~L~ 490 (935)
++|+.|+|++|.|+ .+|..+..+++|+.|+|++|+++. ++.+.++++|+.|+|++|+++ .++ ..+.+|++|+.|+
T Consensus 70 ~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~-l~~~~~l~~L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~ 146 (198)
T d1m9la_ 70 ENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LSGIEKLVNLRVLYMSNNKIT-NWGEIDKLAALDKLEDLL 146 (198)
T ss_dssp TTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCC-HHHHHHHHHSSEEEESEEECC-CHHHHHHHTTTTTCSEEE
T ss_pred ccccChhhcccccc-cccccccccccccccccccccccc-cccccccccccccccccchhc-cccccccccCCCccceee
Confidence 58999999999998 788777778899999999999986 466889999999999999998 555 4689999999999
Q ss_pred cccccCCC
Q 002336 491 IENNSFVG 498 (935)
Q Consensus 491 l~~N~l~g 498 (935)
|++|++..
T Consensus 147 L~~N~l~~ 154 (198)
T d1m9la_ 147 LAGNPLYN 154 (198)
T ss_dssp ECSSHHHH
T ss_pred cCCCcccc
Confidence 99999873
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.11 E-value=4.6e-06 Score=85.93 Aligned_cols=132 Identities=14% Similarity=0.092 Sum_probs=93.7
Q ss_pred cccEEEEEEEECCCcEEEEEEccCcchhhhHHHHHHHHHHHhcC-CCcccccceeeeccceEEEEEEecCCCCHHHHhcc
Q 002336 624 GSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHG 702 (935)
Q Consensus 624 G~fG~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~-HpnIv~l~g~~~~~~~~~lV~E~~~~gsL~~~L~~ 702 (935)
+..+.||+...+ ++.+++|+...........+.+|...++.+. +--+.+++.+...++..++||++++|.++.+....
T Consensus 25 ~s~~~v~rv~~~-~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~~ 103 (263)
T d1j7la_ 25 MSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYED 103 (263)
T ss_dssp CSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHTTT
T ss_pred CCCCcEEEEEeC-CCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEecccccccccccc
Confidence 344689988654 6677888876554444556888999988874 33356677888888889999999999888765431
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHhHHhhhcC--------------------------------------------------
Q 002336 703 SVNQKPLDWLTRLQIAHDAAKGLEYLHTGC-------------------------------------------------- 732 (935)
Q Consensus 703 ~~~~~~l~~~~~~~i~~qia~gL~yLHs~~-------------------------------------------------- 732 (935)
. .....++.++++.++.||+..
T Consensus 104 ~--------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 175 (263)
T d1j7la_ 104 E--------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLK 175 (263)
T ss_dssp C--------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHHH
T ss_pred c--------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHHH
Confidence 1 112345666666677777410
Q ss_pred ------CCceEecCCCCCCccccCCCcEEEeecccccc
Q 002336 733 ------NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 764 (935)
Q Consensus 733 ------~~~ivH~DLkp~NILld~~~~vkL~DFGla~~ 764 (935)
...++|+|+.|.|||+++++.+-|.||+.+..
T Consensus 176 ~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 176 TEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp HSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred hcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 12389999999999999876677999987753
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=98.10 E-value=1.3e-06 Score=86.61 Aligned_cols=84 Identities=27% Similarity=0.479 Sum_probs=62.5
Q ss_pred CCcEEEEEccCCCCcccCCccccCcccccccccccccCCCCCCCccccccccccccccccccCCCCCccCcccccccccc
Q 002336 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 491 (935)
Q Consensus 412 ~~~l~~L~Ls~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~l 491 (935)
.++|+.|+|++|++++ +++ |++|++|+.|++++|.+... +.+.+++.|+.|++++|.+.. + ..+..+++|+.|++
T Consensus 61 l~nL~~L~Ls~N~l~~-~~~-l~~l~~L~~L~l~~n~~~~~-~~l~~l~~L~~L~l~~~~~~~-~-~~~~~l~~L~~L~l 135 (199)
T d2omxa2 61 LNNLTQINFSNNQLTD-ITP-LKNLTKLVDILMNNNQIADI-TPLANLTNLTGLTLFNNQITD-I-DPLKNLTNLNRLEL 135 (199)
T ss_dssp CTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCCC-GGGTTCTTCSEEECCSSCCCC-C-GGGTTCTTCSEEEC
T ss_pred CCCcCcCccccccccC-ccc-ccCCcccccccccccccccc-ccccccccccccccccccccc-c-cccchhhhhHHhhh
Confidence 3578888888888874 333 88888888888888887653 457788888888888887773 3 23677888888888
Q ss_pred ccccCCCCCC
Q 002336 492 ENNSFVGEIP 501 (935)
Q Consensus 492 ~~N~l~g~iP 501 (935)
++|++. .+|
T Consensus 136 ~~n~l~-~~~ 144 (199)
T d2omxa2 136 SSNTIS-DIS 144 (199)
T ss_dssp CSSCCC-CCG
T ss_pred hhhhhc-ccc
Confidence 888876 454
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=98.00 E-value=1.9e-06 Score=87.24 Aligned_cols=84 Identities=20% Similarity=0.397 Sum_probs=71.3
Q ss_pred CcEEEEEccCCCCcccCCccccCcccccccccccccCCCCCCCccccccccccccccccccCCCCCccCccccccccccc
Q 002336 413 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIE 492 (935)
Q Consensus 413 ~~l~~L~Ls~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~l~ 492 (935)
+.+..+.++++.+.... .+.++++|+.|++++|.++... .+.++++|+.|+|++|+++ .+|. ++++++|++|+|+
T Consensus 129 ~~~~~l~~~~~~~~~~~--~~~~~~~L~~L~l~~n~~~~~~-~l~~l~~L~~L~Ls~n~l~-~l~~-l~~l~~L~~L~Ls 203 (227)
T d1h6ua2 129 SNLQVLYLDLNQITNIS--PLAGLTNLQYLSIGNAQVSDLT-PLANLSKLTTLKADDNKIS-DISP-LASLPNLIEVHLK 203 (227)
T ss_dssp TTCCEEECCSSCCCCCG--GGGGCTTCCEEECCSSCCCCCG-GGTTCTTCCEEECCSSCCC-CCGG-GGGCTTCCEEECT
T ss_pred cchhhhhchhhhhchhh--hhccccccccccccccccccch-hhcccccceecccCCCccC-CChh-hcCCCCCCEEECc
Confidence 46788899999887443 4788899999999999997654 4889999999999999999 4654 8999999999999
Q ss_pred cccCCCCCCc
Q 002336 493 NNSFVGEIPP 502 (935)
Q Consensus 493 ~N~l~g~iP~ 502 (935)
+|+++ .+|+
T Consensus 204 ~N~lt-~i~~ 212 (227)
T d1h6ua2 204 NNQIS-DVSP 212 (227)
T ss_dssp TSCCC-BCGG
T ss_pred CCcCC-CCcc
Confidence 99999 6664
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=97.72 E-value=1.6e-05 Score=84.64 Aligned_cols=75 Identities=28% Similarity=0.426 Sum_probs=33.9
Q ss_pred EEEEEccCCCCcccCCccccCcccccccccccccCCCCCCCccccccccccccccccccCCCCCccCccccccccccccc
Q 002336 415 ITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENN 494 (935)
Q Consensus 415 l~~L~Ls~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~l~~N 494 (935)
++.|||++|+|+ .+|+. +++|++|+|++|+|+. +|+. +.+|+.|++++|+++ .+++- .+.|++|++++|
T Consensus 40 l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~~-lp~~--~~~L~~L~l~~n~l~-~l~~l---p~~L~~L~L~~n 108 (353)
T d1jl5a_ 40 AHELELNNLGLS-SLPEL---PPHLESLVASCNSLTE-LPEL--PQSLKSLLVDNNNLK-ALSDL---PPLLEYLGVSNN 108 (353)
T ss_dssp CSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCSS-CCCC--CTTCCEEECCSSCCS-CCCSC---CTTCCEEECCSS
T ss_pred CCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCcc-cccc--hhhhhhhhhhhcccc-hhhhh---cccccccccccc
Confidence 445555555554 45532 2345555555555552 2321 224444455555544 33321 123455555555
Q ss_pred cCCCCCC
Q 002336 495 SFVGEIP 501 (935)
Q Consensus 495 ~l~g~iP 501 (935)
.++ .+|
T Consensus 109 ~l~-~lp 114 (353)
T d1jl5a_ 109 QLE-KLP 114 (353)
T ss_dssp CCS-SCC
T ss_pred ccc-ccc
Confidence 554 444
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.69 E-value=4.2e-05 Score=78.04 Aligned_cols=130 Identities=17% Similarity=0.096 Sum_probs=87.6
Q ss_pred ccccccc-EEEEEEEECCCcEEEEEEccCcchhhhHHHHHHHHHHHhcCC--CcccccceeeeccceEEEEEEecCCCCH
Q 002336 620 KIGKGSF-GSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHH--RNLVPLIGYCEEEHQRILVYEYMHNGTL 696 (935)
Q Consensus 620 ~LG~G~f-G~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~H--pnIv~l~g~~~~~~~~~lV~E~~~~gsL 696 (935)
.+..|.. +.||+...+++..+++|..... ....+..|+..++.+.. -.+.+++++..+++..++||++++|.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~---~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCcc---CHhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 4455553 6799999888888999986543 23457788888887743 3356677887888889999999988655
Q ss_pred HHHhccCCCCCCCCHHHHHHHHHHHHHHhHHhhhc---------------------------------------------
Q 002336 697 RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG--------------------------------------------- 731 (935)
Q Consensus 697 ~~~L~~~~~~~~l~~~~~~~i~~qia~gL~yLHs~--------------------------------------------- 731 (935)
.+.. ... ...+.++++.|+-||+.
T Consensus 94 ~~~~--------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (255)
T d1nd4a_ 94 LSSH--------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF 162 (255)
T ss_dssp TTSC--------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred cccc--------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHH
Confidence 3211 111 12223344444444420
Q ss_pred ----------CCCceEecCCCCCCccccCCCcEEEeeccccc
Q 002336 732 ----------CNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 763 (935)
Q Consensus 732 ----------~~~~ivH~DLkp~NILld~~~~vkL~DFGla~ 763 (935)
....++|+|+.|.|||++++..+-|+||+.+.
T Consensus 163 ~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 163 ARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp HHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 02348999999999999987767899998764
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=97.62 E-value=2.3e-05 Score=83.48 Aligned_cols=82 Identities=28% Similarity=0.478 Sum_probs=67.1
Q ss_pred CCcEEEEEccCCCCcccCCccccCcccccccccccccCCCCCCCccccccccccccccccccCCCCCccCcccccccccc
Q 002336 412 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 491 (935)
Q Consensus 412 ~~~l~~L~Ls~n~l~g~ip~~i~~L~~L~~L~Ls~N~l~g~~p~~~~l~~L~~L~L~~N~l~g~iP~~l~~l~~L~~L~l 491 (935)
+++|+.|+|++|+|+ .+|..+ .+|+.|++++|+++.. +.+. +.|++|+|++|+++ .+|. ++.+++|+.|++
T Consensus 57 ~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~~l-~~lp--~~L~~L~L~~n~l~-~lp~-~~~l~~L~~L~l 127 (353)
T d1jl5a_ 57 PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLKAL-SDLP--PLLEYLGVSNNQLE-KLPE-LQNSSFLKIIDV 127 (353)
T ss_dssp CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCSCC-CSCC--TTCCEEECCSSCCS-SCCC-CTTCTTCCEEEC
T ss_pred CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccchh-hhhc--cccccccccccccc-cccc-hhhhccceeecc
Confidence 468999999999999 889765 4678888999988753 3332 46999999999999 7885 688999999999
Q ss_pred ccccCCCCCCcc
Q 002336 492 ENNSFVGEIPPA 503 (935)
Q Consensus 492 ~~N~l~g~iP~~ 503 (935)
++|.++ ..|..
T Consensus 128 ~~~~~~-~~~~~ 138 (353)
T d1jl5a_ 128 DNNSLK-KLPDL 138 (353)
T ss_dssp CSSCCS-CCCCC
T ss_pred cccccc-ccccc
Confidence 999998 55543
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.60 E-value=4.2e-06 Score=80.12 Aligned_cols=73 Identities=25% Similarity=0.195 Sum_probs=48.0
Q ss_pred cCCccccCcccccccccccccCCCCCC---CccccccccccccccccccCCCCC-ccCccccccccccccccCCCCCC
Q 002336 428 EIPPELKNMEALTELWLDGNFLTGPLP---DMSRLIDLRIVHLENNELTGSLPS-YMGSLPNLQELHIENNSFVGEIP 501 (935)
Q Consensus 428 ~ip~~i~~L~~L~~L~Ls~N~l~g~~p---~~~~l~~L~~L~L~~N~l~g~iP~-~l~~l~~L~~L~l~~N~l~g~iP 501 (935)
.++..+.++++|++|+|++|+|+..-+ .+..+++|+.|+|++|+++ .+++ ......+|+.|++++|.++....
T Consensus 56 ~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~-~l~~l~~l~~~~L~~L~L~~Npl~~~~~ 132 (162)
T d1koha1 56 TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELK-SERELDKIKGLKLEELWLDGNSLSDTFR 132 (162)
T ss_dssp HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCC-CGGGHHHHTTCCCSSCCCTTSTTSSSSS
T ss_pred hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccc-cchhhhhhhccccceeecCCCCcCcCcc
Confidence 344444567778888888888876533 2566778888888888877 5554 22233467788888888775443
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.40 E-value=9.3e-05 Score=74.75 Aligned_cols=89 Identities=16% Similarity=0.131 Sum_probs=39.7
Q ss_pred cEEEEEccCCCCcccCCccccCcc-cccccccccccCCCCCCCcccccccc-ccccccccccCCCCC-ccCccccccccc
Q 002336 414 RITKIALSGKNLKGEIPPELKNME-ALTELWLDGNFLTGPLPDMSRLIDLR-IVHLENNELTGSLPS-YMGSLPNLQELH 490 (935)
Q Consensus 414 ~l~~L~Ls~n~l~g~ip~~i~~L~-~L~~L~Ls~N~l~g~~p~~~~l~~L~-~L~L~~N~l~g~iP~-~l~~l~~L~~L~ 490 (935)
.+..+..+++++...-+..+..++ .++.|++++|+++...+...+..+++ .+++++|+++ .+|. .+.++++|+.|+
T Consensus 129 ~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~~i~~~~~~~~~l~~~~~l~~n~l~-~l~~~~f~~l~~L~~L~ 207 (242)
T d1xwdc1 129 KVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLE-ELPNDVFHGASGPVILD 207 (242)
T ss_dssp CEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCEECTTTTTTCCEEEEECTTCTTCC-CCCTTTTTTSCCCSEEE
T ss_pred ccccccccccccccccccccccccccceeeecccccccccccccccchhhhccccccccccc-cccHHHhcCCCCCCEEE
Confidence 344444444444432233344432 45555555555554444333333322 2234444454 3433 244555555555
Q ss_pred cccccCCCCCCccc
Q 002336 491 IENNSFVGEIPPAL 504 (935)
Q Consensus 491 l~~N~l~g~iP~~l 504 (935)
|++|+|+ .+|...
T Consensus 208 Ls~N~l~-~l~~~~ 220 (242)
T d1xwdc1 208 ISRTRIH-SLPSYG 220 (242)
T ss_dssp CTTSCCC-CCCSSS
T ss_pred CCCCcCC-ccCHHH
Confidence 5555555 454443
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.24 E-value=3.7e-05 Score=73.29 Aligned_cols=78 Identities=23% Similarity=0.318 Sum_probs=41.6
Q ss_pred CcEEEEEccCCCCccc--CCccccCcccccccccccccCCCCCC-CccccccccccccccccccCCCCCc-------cCc
Q 002336 413 PRITKIALSGKNLKGE--IPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPSY-------MGS 482 (935)
Q Consensus 413 ~~l~~L~Ls~n~l~g~--ip~~i~~L~~L~~L~Ls~N~l~g~~p-~~~~l~~L~~L~L~~N~l~g~iP~~-------l~~ 482 (935)
+.|+.|+|++|+|+.. ++..+..|++|+.|+|++|.++...+ ......+|+.|+|++|.++...... +..
T Consensus 65 ~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~~~i~~~ 144 (162)
T d1koha1 65 PELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRER 144 (162)
T ss_dssp TTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHHHHHHTT
T ss_pred CCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccceeecCCCCcCcCcccchhHHHHHHHH
Confidence 3566666666666532 22345556666666666666665433 2223345666666666665443322 344
Q ss_pred cccccccc
Q 002336 483 LPNLQELH 490 (935)
Q Consensus 483 l~~L~~L~ 490 (935)
+|+|+.||
T Consensus 145 ~P~L~~LD 152 (162)
T d1koha1 145 FPKLLRLD 152 (162)
T ss_dssp STTCCEET
T ss_pred CCCCCEEC
Confidence 55665554
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.02 E-value=0.00078 Score=73.37 Aligned_cols=76 Identities=16% Similarity=0.203 Sum_probs=48.3
Q ss_pred cccccccccEEEEEEEECC-CcEEEEEEccCcc-------hhhhHHHHHHHHHHHhcC-C-C-cccccceeeeccceEEE
Q 002336 618 CKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSC-------SHRTQQFVTEVALLSRIH-H-R-NLVPLIGYCEEEHQRIL 686 (935)
Q Consensus 618 ~~~LG~G~fG~Vy~~~~~~-g~~vAvK~~~~~~-------~~~~~~~~~E~~iL~~L~-H-p-nIv~l~g~~~~~~~~~l 686 (935)
.+.||.|....||+....+ ++.++||.-.+.. .....+...|.+.|+.+. + | .+.+++.+ +....++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 3579999999999998754 6789999643211 112234567888888773 3 2 34444444 3445689
Q ss_pred EEEecCCCC
Q 002336 687 VYEYMHNGT 695 (935)
Q Consensus 687 V~E~~~~gs 695 (935)
|||++.+..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999997654
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.59 E-value=4.6e-05 Score=83.97 Aligned_cols=84 Identities=31% Similarity=0.398 Sum_probs=44.3
Q ss_pred cEEEEEccCCCCcc----cCCccccCcccccccccccccCCCC----CC-Ccc-ccccccccccccccccCC----CCCc
Q 002336 414 RITKIALSGKNLKG----EIPPELKNMEALTELWLDGNFLTGP----LP-DMS-RLIDLRIVHLENNELTGS----LPSY 479 (935)
Q Consensus 414 ~l~~L~Ls~n~l~g----~ip~~i~~L~~L~~L~Ls~N~l~g~----~p-~~~-~l~~L~~L~L~~N~l~g~----iP~~ 479 (935)
+++.|+|++|+|+- .|...+..+++|++|||++|.|+.. +. .+. ...+|+.|+|++|+++.. ++..
T Consensus 28 ~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~it~~~~~~l~~~ 107 (460)
T d1z7xw1 28 QCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSST 107 (460)
T ss_dssp TCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGHHHHHHH
T ss_pred CCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcCCCCCCEEECCCCCccccccccccch
Confidence 34456666666541 2334455566666666666665421 11 111 223566666666666532 3444
Q ss_pred cCccccccccccccccCC
Q 002336 480 MGSLPNLQELHIENNSFV 497 (935)
Q Consensus 480 l~~l~~L~~L~l~~N~l~ 497 (935)
+..+++|++|+|++|.++
T Consensus 108 l~~~~~L~~L~L~~N~i~ 125 (460)
T d1z7xw1 108 LRTLPTLQELHLSDNLLG 125 (460)
T ss_dssp TTSCTTCCEEECCSSBCH
T ss_pred hhccccccccccccccch
Confidence 555666666666666654
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.54 E-value=0.0045 Score=65.18 Aligned_cols=135 Identities=12% Similarity=0.141 Sum_probs=78.8
Q ss_pred EEEEEEEECCCcEEEEEEccCcchhhhHHHHHHHHHHHhcCCCcc--cccce-----eeeccceEEEEEEecCCCCHH--
Q 002336 627 GSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNL--VPLIG-----YCEEEHQRILVYEYMHNGTLR-- 697 (935)
Q Consensus 627 G~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~HpnI--v~l~g-----~~~~~~~~~lV~E~~~~gsL~-- 697 (935)
-.||+++.++|+.+++|+.++. ....+++..|...+..|....+ +..+. .....+..+.++++++|..+.
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~ 114 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD 114 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred ceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCC
Confidence 4799999999999999997653 2345678889999888852222 22221 234456678899998764321
Q ss_pred ----------------HHhccCC--CCCCCCHH----------------------HHHHHHHHHHHHhHHh-hhcCCCce
Q 002336 698 ----------------DRLHGSV--NQKPLDWL----------------------TRLQIAHDAAKGLEYL-HTGCNPGI 736 (935)
Q Consensus 698 ----------------~~L~~~~--~~~~l~~~----------------------~~~~i~~qia~gL~yL-Hs~~~~~i 736 (935)
....... .....+.. .....+.++...+.-+ .+....++
T Consensus 115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l 194 (325)
T d1zyla1 115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR 194 (325)
T ss_dssp CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred CHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCcee
Confidence 0011100 11111111 1122233333333222 12234689
Q ss_pred EecCCCCCCccccCCCcEEEeecccccc
Q 002336 737 IHRDVKSSNILLDINMRAKVSDFGLSRQ 764 (935)
Q Consensus 737 vH~DLkp~NILld~~~~vkL~DFGla~~ 764 (935)
+|+|+.+.|||++++ ..++||+-+..
T Consensus 195 iHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 195 LHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred ecCCCCcccEEEeCC--ceEEechhccc
Confidence 999999999999743 45899997764
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=95.94 E-value=0.00092 Score=69.29 Aligned_cols=81 Identities=22% Similarity=0.320 Sum_probs=42.9
Q ss_pred cEEEEEccCC--CCccc-CCccccCcccccccccccc-cCCCCC-CCccccccccccccccc-cccCCCCCccCcccccc
Q 002336 414 RITKIALSGK--NLKGE-IPPELKNMEALTELWLDGN-FLTGPL-PDMSRLIDLRIVHLENN-ELTGSLPSYMGSLPNLQ 487 (935)
Q Consensus 414 ~l~~L~Ls~n--~l~g~-ip~~i~~L~~L~~L~Ls~N-~l~g~~-p~~~~l~~L~~L~L~~N-~l~g~iP~~l~~l~~L~ 487 (935)
+++.|+|++. +++.. +..-+.++++|++|+|++| .+++.. ..+.++++|++|+|++| +++......++++++|+
T Consensus 149 ~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~ 228 (284)
T d2astb2 149 TITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLK 228 (284)
T ss_dssp TCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCC
T ss_pred ccchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCC
Confidence 5566666543 23221 2222344566666666654 344332 24566666666666663 45544455566666666
Q ss_pred ccccccc
Q 002336 488 ELHIENN 494 (935)
Q Consensus 488 ~L~l~~N 494 (935)
.|+++++
T Consensus 229 ~L~l~~~ 235 (284)
T d2astb2 229 TLQVFGI 235 (284)
T ss_dssp EEECTTS
T ss_pred EEeeeCC
Confidence 6666554
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=95.81 E-value=0.00018 Score=78.96 Aligned_cols=84 Identities=19% Similarity=0.239 Sum_probs=56.2
Q ss_pred cEEEEEccCCCCcccCCccc----cCcccccccccccccCCCC----CC-Ccc-ccccccccccccccccC----CCCCc
Q 002336 414 RITKIALSGKNLKGEIPPEL----KNMEALTELWLDGNFLTGP----LP-DMS-RLIDLRIVHLENNELTG----SLPSY 479 (935)
Q Consensus 414 ~l~~L~Ls~n~l~g~ip~~i----~~L~~L~~L~Ls~N~l~g~----~p-~~~-~l~~L~~L~L~~N~l~g----~iP~~ 479 (935)
.++.+++++|.++..-...| ...++|++|+|++|.|+.. ++ .+. ..+.|++|+|++|+|+. .+++.
T Consensus 313 ~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~ 392 (460)
T d1z7xw1 313 QLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAAT 392 (460)
T ss_dssp CCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHH
T ss_pred ccccccccccchhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHHHHHHHHH
Confidence 57788888887775433333 3445788888888887642 22 232 35568888888888863 24555
Q ss_pred cCccccccccccccccCC
Q 002336 480 MGSLPNLQELHIENNSFV 497 (935)
Q Consensus 480 l~~l~~L~~L~l~~N~l~ 497 (935)
+..+++|++|+|++|+|+
T Consensus 393 l~~~~~L~~L~Ls~N~i~ 410 (460)
T d1z7xw1 393 LLANHSLRELDLSNNCLG 410 (460)
T ss_dssp HHHCCCCCEEECCSSSCC
T ss_pred HhcCCCCCEEECCCCcCC
Confidence 666788888888888876
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=95.64 E-value=0.00092 Score=69.27 Aligned_cols=84 Identities=21% Similarity=0.286 Sum_probs=40.6
Q ss_pred cEEEEEccCC-CCccc-CCccccCc-ccccccccccc--cCCCC-CCCc-cccccccccccccc-cccCCCCCccCcccc
Q 002336 414 RITKIALSGK-NLKGE-IPPELKNM-EALTELWLDGN--FLTGP-LPDM-SRLIDLRIVHLENN-ELTGSLPSYMGSLPN 485 (935)
Q Consensus 414 ~l~~L~Ls~n-~l~g~-ip~~i~~L-~~L~~L~Ls~N--~l~g~-~p~~-~~l~~L~~L~L~~N-~l~g~iP~~l~~l~~ 485 (935)
+|++|+|+++ +++.. +...+..+ +.|+.|+|++. .++.. +..+ .++++|+.|+|++| .+++..+..++++++
T Consensus 122 ~L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~ 201 (284)
T d2astb2 122 RLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNY 201 (284)
T ss_dssp TCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTT
T ss_pred hccccccccccccccccchhhhcccccccchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccCc
Confidence 5666666653 23211 22223222 45666666543 22221 1222 34556666666654 355555555666666
Q ss_pred ccccccccc-cCC
Q 002336 486 LQELHIENN-SFV 497 (935)
Q Consensus 486 L~~L~l~~N-~l~ 497 (935)
|++|+|+++ .++
T Consensus 202 L~~L~L~~C~~i~ 214 (284)
T d2astb2 202 LQHLSLSRCYDII 214 (284)
T ss_dssp CCEEECTTCTTCC
T ss_pred CCEEECCCCCCCC
Confidence 666666663 444
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=95.58 E-value=0.0004 Score=74.01 Aligned_cols=41 Identities=27% Similarity=0.234 Sum_probs=17.5
Q ss_pred ccCcccccccccccccCCCC----C-CCcccccccccccccccccc
Q 002336 433 LKNMEALTELWLDGNFLTGP----L-PDMSRLIDLRIVHLENNELT 473 (935)
Q Consensus 433 i~~L~~L~~L~Ls~N~l~g~----~-p~~~~l~~L~~L~L~~N~l~ 473 (935)
+..+++|+.|+|++|.++.. + ..+..+++|+.|+|++|+++
T Consensus 211 l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~ 256 (344)
T d2ca6a1 211 LAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLS 256 (344)
T ss_dssp GGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCC
T ss_pred hcchhhhcccccccccccccccccccccccccccchhhhhhcCccC
Confidence 34444444444444444321 1 12334444444444444443
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=95.40 E-value=0.0006 Score=64.87 Aligned_cols=85 Identities=14% Similarity=0.167 Sum_probs=63.5
Q ss_pred CcEEEEEccCC-CCccc----CCccccCcccccccccccccCCCCC-C----CccccccccccccccccccCC----CCC
Q 002336 413 PRITKIALSGK-NLKGE----IPPELKNMEALTELWLDGNFLTGPL-P----DMSRLIDLRIVHLENNELTGS----LPS 478 (935)
Q Consensus 413 ~~l~~L~Ls~n-~l~g~----ip~~i~~L~~L~~L~Ls~N~l~g~~-p----~~~~l~~L~~L~L~~N~l~g~----iP~ 478 (935)
+.|++|+|+++ .++.. +-..+...+.|+.|+|++|.+...- . .+...+.|+.|+|++|+++.. +-.
T Consensus 15 ~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~~ 94 (167)
T d1pgva_ 15 TDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLR 94 (167)
T ss_dssp SSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHH
T ss_pred CCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHHH
Confidence 57999999975 45432 3345777889999999999986421 1 245678899999999998743 233
Q ss_pred ccCccccccccccccccCC
Q 002336 479 YMGSLPNLQELHIENNSFV 497 (935)
Q Consensus 479 ~l~~l~~L~~L~l~~N~l~ 497 (935)
.+...++|+.|+|++|.+.
T Consensus 95 aL~~n~sL~~L~l~~n~~~ 113 (167)
T d1pgva_ 95 STLVTQSIVEFKADNQRQS 113 (167)
T ss_dssp HTTTTCCCSEEECCCCSSC
T ss_pred HHHhCCcCCEEECCCCcCC
Confidence 5667788999999999876
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=95.39 E-value=0.013 Score=63.27 Aligned_cols=73 Identities=14% Similarity=0.231 Sum_probs=49.7
Q ss_pred cccccccccEEEEEEEECC--------CcEEEEEEccCcchhhhHHHHHHHHHHHhcC-CCcccccceeeeccceEEEEE
Q 002336 618 CKKIGKGSFGSVYYGKMKD--------GKEVAVKIMADSCSHRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQRILVY 688 (935)
Q Consensus 618 ~~~LG~G~fG~Vy~~~~~~--------g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~-HpnIv~l~g~~~~~~~~~lV~ 688 (935)
.+.|+.|-.-.+|+....+ .+.|++++..... ......+|..+++.+. +.-..++++++.+ .+|+
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~--~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ 120 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 120 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcc--hhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEE
Confidence 3568889999999998764 3567777764322 2234567999998885 4334467777753 6899
Q ss_pred EecCCCCH
Q 002336 689 EYMHNGTL 696 (935)
Q Consensus 689 E~~~~gsL 696 (935)
||++|..|
T Consensus 121 efi~g~~l 128 (395)
T d1nw1a_ 121 EYIPSRPL 128 (395)
T ss_dssp CCCCEEEC
T ss_pred EEeccccC
Confidence 99987543
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=95.37 E-value=0.00064 Score=72.38 Aligned_cols=86 Identities=21% Similarity=0.313 Sum_probs=67.6
Q ss_pred CcEEEEEccCCCCcc----cCCccccCcccccccccccccCCCC-----C-CCccccccccccccccccccCC----CCC
Q 002336 413 PRITKIALSGKNLKG----EIPPELKNMEALTELWLDGNFLTGP-----L-PDMSRLIDLRIVHLENNELTGS----LPS 478 (935)
Q Consensus 413 ~~l~~L~Ls~n~l~g----~ip~~i~~L~~L~~L~Ls~N~l~g~-----~-p~~~~l~~L~~L~L~~N~l~g~----iP~ 478 (935)
+.++.|++++|.+.. .+...+..++.|+.|+|++|+++.. + ..+..+++|+.|+|++|.++.. +..
T Consensus 158 ~~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~ 237 (344)
T d2ca6a1 158 PPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAI 237 (344)
T ss_dssp CCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHH
T ss_pred cccceeecccccccccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccc
Confidence 478889999998863 2444566788999999999998742 2 2467889999999999998632 455
Q ss_pred ccCccccccccccccccCCC
Q 002336 479 YMGSLPNLQELHIENNSFVG 498 (935)
Q Consensus 479 ~l~~l~~L~~L~l~~N~l~g 498 (935)
.+..+++|+.|+|++|.+++
T Consensus 238 ~l~~~~~L~~L~Ls~n~i~~ 257 (344)
T d2ca6a1 238 ALKSWPNLRELGLNDCLLSA 257 (344)
T ss_dssp HGGGCTTCCEEECTTCCCCH
T ss_pred cccccccchhhhhhcCccCc
Confidence 67788999999999999873
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=93.90 E-value=0.11 Score=53.34 Aligned_cols=141 Identities=13% Similarity=0.135 Sum_probs=73.7
Q ss_pred cccccccEEEEEEEECCCcEEEEEEccCcchhhhHHHHHHHHHHHhcCCCcc--cccce------eeeccceEEEEEEec
Q 002336 620 KIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNL--VPLIG------YCEEEHQRILVYEYM 691 (935)
Q Consensus 620 ~LG~G~fG~Vy~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~iL~~L~HpnI--v~l~g------~~~~~~~~~lV~E~~ 691 (935)
.|..|.--+.|+.+.++|+ +++|+.... ...+.+..|++++..|...++ ...+. +.........++.+.
T Consensus 25 ~i~~G~~N~ny~v~t~~g~-yVLri~~~~--~~~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~~~~~~~~~~~~ 101 (316)
T d2ppqa1 25 GIAEGVENSNFLLHTTKDP-LILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISFL 101 (316)
T ss_dssp EECC---EEEEEEEESSCC-EEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEECC
T ss_pred cCCCCcccCeEEEEECCCc-EEEEEcCCC--CCHHHHHHHHHHHHhhhhccccccccceecCCCcceeeecccceeeeec
Confidence 3566777888999887665 899987543 233456667777777743222 11111 122244556677776
Q ss_pred CCCCHHH--------------Hhc----cCCCCC--CCC------------------HHHHHHHHHHHHHHhHHhhh-cC
Q 002336 692 HNGTLRD--------------RLH----GSVNQK--PLD------------------WLTRLQIAHDAAKGLEYLHT-GC 732 (935)
Q Consensus 692 ~~gsL~~--------------~L~----~~~~~~--~l~------------------~~~~~~i~~qia~gL~yLHs-~~ 732 (935)
.+..... .++ ...... ... .......+......+.-.+. ..
T Consensus 102 ~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~L 181 (316)
T d2ppqa1 102 EGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKDL 181 (316)
T ss_dssp CCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCSS
T ss_pred ccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHHHHHHhhhccCcccc
Confidence 6542210 000 000000 000 00111222222222222221 23
Q ss_pred CCceEecCCCCCCccccCCCcEEEeeccccc
Q 002336 733 NPGIIHRDVKSSNILLDINMRAKVSDFGLSR 763 (935)
Q Consensus 733 ~~~ivH~DLkp~NILld~~~~vkL~DFGla~ 763 (935)
..++||+|+.+.||+++.+...-|.||+.+.
T Consensus 182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 182 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccccccCCcchhhhhcccccceeEecccccc
Confidence 5789999999999999988777899999775
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=93.14 E-value=0.0029 Score=59.85 Aligned_cols=84 Identities=17% Similarity=0.157 Sum_probs=60.1
Q ss_pred CcEEEEEccCCCCccc----CCccccCcccccccccccccCCCCCC-----CccccccccccccccccccCC-------C
Q 002336 413 PRITKIALSGKNLKGE----IPPELKNMEALTELWLDGNFLTGPLP-----DMSRLIDLRIVHLENNELTGS-------L 476 (935)
Q Consensus 413 ~~l~~L~Ls~n~l~g~----ip~~i~~L~~L~~L~Ls~N~l~g~~p-----~~~~l~~L~~L~L~~N~l~g~-------i 476 (935)
..|++|+|++|++... +...+...+.|++|+|++|.|+..-- .+..-+.|+.|+|++|++... +
T Consensus 44 ~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l 123 (167)
T d1pgva_ 44 KHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDM 123 (167)
T ss_dssp SCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHH
T ss_pred CccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHHHHHHhCCcCCEEECCCCcCCCccHHHHHHH
Confidence 4689999999999743 22345566899999999999886421 366778899999999976521 3
Q ss_pred CCccCccccccccccccccC
Q 002336 477 PSYMGSLPNLQELHIENNSF 496 (935)
Q Consensus 477 P~~l~~l~~L~~L~l~~N~l 496 (935)
...+...++|+.|+++.+..
T Consensus 124 ~~~L~~n~sL~~l~l~~~~~ 143 (167)
T d1pgva_ 124 MMAIEENESLLRVGISFASM 143 (167)
T ss_dssp HHHHHHCSSCCEEECCCCCH
T ss_pred HHHHHhCCCccEeeCcCCCc
Confidence 33444567778887766543
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=89.67 E-value=0.012 Score=55.09 Aligned_cols=85 Identities=20% Similarity=0.264 Sum_probs=56.7
Q ss_pred CcEEEEEccC-CCCccc----CCccccCcccccccccccccCCCCCC-----CccccccccccccccccccCC----CCC
Q 002336 413 PRITKIALSG-KNLKGE----IPPELKNMEALTELWLDGNFLTGPLP-----DMSRLIDLRIVHLENNELTGS----LPS 478 (935)
Q Consensus 413 ~~l~~L~Ls~-n~l~g~----ip~~i~~L~~L~~L~Ls~N~l~g~~p-----~~~~l~~L~~L~L~~N~l~g~----iP~ 478 (935)
+.|++|+|++ +.++.. +-..+...++|++|+|++|.++..-- .+...++|+.|++++|.+... +-.
T Consensus 17 ~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l~~ 96 (166)
T d1io0a_ 17 PDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVE 96 (166)
T ss_dssp TTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHH
T ss_pred CCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHHHH
Confidence 4788899987 456432 33445678889999999998765321 245667888899988887533 234
Q ss_pred ccCcccccccc--ccccccCC
Q 002336 479 YMGSLPNLQEL--HIENNSFV 497 (935)
Q Consensus 479 ~l~~l~~L~~L--~l~~N~l~ 497 (935)
.+...++|+.+ ++++|.+.
T Consensus 97 ~l~~~~~L~~l~L~l~~n~i~ 117 (166)
T d1io0a_ 97 ALQSNTSLIELRIDNQSQPLG 117 (166)
T ss_dssp GGGGCSSCCEEECCCCSSCCC
T ss_pred HHHhCccccEEeeccCCCcCc
Confidence 56667778764 44556664
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=86.77 E-value=0.016 Score=54.35 Aligned_cols=85 Identities=14% Similarity=0.197 Sum_probs=62.2
Q ss_pred CcEEEEEccCCCCccc----CCccccCcccccccccccccCCCCC-----CCccccccccc--cccccccccC----CCC
Q 002336 413 PRITKIALSGKNLKGE----IPPELKNMEALTELWLDGNFLTGPL-----PDMSRLIDLRI--VHLENNELTG----SLP 477 (935)
Q Consensus 413 ~~l~~L~Ls~n~l~g~----ip~~i~~L~~L~~L~Ls~N~l~g~~-----p~~~~l~~L~~--L~L~~N~l~g----~iP 477 (935)
++|++|+|++|+++.. +-..+...+.|+.|++++|.++..- ..+...++|+. |++++|.+.. .|.
T Consensus 46 ~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La 125 (166)
T d1io0a_ 46 TYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIA 125 (166)
T ss_dssp CSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHH
T ss_pred CccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHHHHHHHhCccccEEeeccCCCcCcHHHHHHHH
Confidence 4799999999998754 3334566799999999999987542 24677788886 4556777742 355
Q ss_pred CccCccccccccccccccCC
Q 002336 478 SYMGSLPNLQELHIENNSFV 497 (935)
Q Consensus 478 ~~l~~l~~L~~L~l~~N~l~ 497 (935)
..+...++|+.|+++.|...
T Consensus 126 ~~L~~n~~L~~L~l~~~~~~ 145 (166)
T d1io0a_ 126 NMLEKNTTLLKFGYHFTQQG 145 (166)
T ss_dssp HHHHHCSSCCEEECCCSSHH
T ss_pred HHHHhCCCcCEEeCcCCCCc
Confidence 56667889999998776543
|